PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hadebe, SI; Ngubane, PS; Serumula, MR; Musabayane, CT				Hadebe, Silindile I.; Ngubane, Phikelelani S.; Serumula, Metse R.; Musabayane, Cephas T.			Transdermal Delivery of Insulin by Amidated Pectin Hydrogel Matrix Patch in Streptozotocin-Induced Diabetic Rats: Effects on Some Selected Metabolic Parameters	PLOS ONE			English	Article							ETHANOLIC EXTRACT; OLEANOLIC ACID; GLUCOSE; RESISTANCE; TRANSPORT; SKIN; HYPERINSULINEMIA; PHOSPHORYLATION; COMBINATION; MECHANISMS	Purpose: Studies in our laboratory are concerned with developing optional insulin delivery routes based on amidated pectin hydrogel matrix gel. We therefore investigated whether the application of pectin insulin (PI)-containing dermal patches of different insulin concentrations sustain controlled release of insulin into the bloodstream of streptozotocin (STZ)-induced diabetic rats with concomitant alleviation of diabetic symptoms in target tissues, most importantly, muscle and liver. Methods: Oral glucose test (OGT) responses to PI dermal matrix patches (2.47, 3.99, 9.57, 16.80 mu g/kg) prepared by dissolving pectin/insulin in deionised water and solidified with CaCl2 were monitored in diabetic rats given a glucose load after an 18-h fast. Short-term (5 weeks) metabolic effects were assessed in animals treated thrice daily with PI patches 8 hours apart. Animals treated with drug-free pectin and insulin (175 mu g/kg, sc) acted as untreated and treated positive controls, respectively. Blood, muscle and liver samples were collected for measurements of selected biochemical parameters. Results: After 5 weeks, untreated diabetic rats exhibited hyperglycaemia and depleted hepatic and muscle glycogen concentrations. Compared to untreated STZ-induced diabetic animals, OGT responses of diabetic rats transdermally applied PI patches exhibited lower blood glucose levels whilst short-term treatments restored hepatic and muscle glycogen concentrations. Plasma insulin concentrations of untreated diabetic rats were low compared with control non-diabetic rats. All PI treatments elevated plasma insulin concentrations of diabetic rats although the levels induced by high doses (9.57 and 16.80 mu g/kg) were greater than those caused by low doses (2.47 and 3.99 mu g/kg) but comparable to those in sc insulin treated animals. Conclusions: The data suggest that the PI hydrogel matrix patch can deliver physiologically relevant amounts of pharmacologically active insulin. Novelty of the Work: A new method to administer insulin into the bloodstream via a skin patch which could have potential future applications in diabetes management is reported.	[Musabayane, Cephas T.] Univ KwaZulu Natal, Sch Lab Med Sci, Durban, South Africa; Univ KwaZulu Natal, Sch Med Sci, Durban, South Africa	University of Kwazulu Natal; University of Kwazulu Natal	Musabayane, CT (corresponding author), Univ KwaZulu Natal, Sch Lab Med Sci, Durban, South Africa.	musabayanec@ukzn.ac.za			NRF South Africa; University of KwaZulu-Natal, Research Division	NRF South Africa(National Research Foundation - South Africa); University of KwaZulu-Natal, Research Division	The authors are grateful to the NRF South Africa and the University of KwaZulu-Natal, Research Division for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Asche CV, 2010, DIABETES TECHNOL THE, V12, pS101, DOI 10.1089/dia.2009.0180; Bastaki S., 2005, INT J DIABETES METAB, V13, P111; Benson HAE, 2002, CURRENT DRUG DELIVER, V2, P23; Boucaud A, 2002, J CONTROL RELEASE, V81, P113, DOI 10.1016/S0168-3659(02)00054-8; Brand RM, 2000, AAPS PHARMSCI, V2; Brange I., 1987, GALENICS INSULIN PHY; BUYSSCHAERT M, 1989, LANCET, V1, P965; Despres JP, 1996, NEW ENGL J MED, V334, P952, DOI 10.1056/NEJM199604113341504; Duan X, 2010, DRUG DISCOV TODAY, V15, P11; GARVEY WT, 1991, J CLIN INVEST, V87, P1072, DOI 10.1172/JCI115068; GRANT GT, 1973, FEBS LETT, V32, P195, DOI 10.1016/0014-5793(73)80770-7; Holden SE, 2012, ATHEROSCLEROSIS, V222, P26, DOI 10.1016/j.atherosclerosis.2012.01.052; Hsieh TJ, 2011, CELL BIOL TOXICOL, V27, P397, DOI 10.1007/s10565-011-9195-5; Karande P, 2002, J CONTROL RELEASE, V110, P307; KASUGA M, 1982, SCIENCE, V215, P185, DOI 10.1126/science.7031900; Khafagy ES, 2007, ADV DRUG DELIVER REV, V59, P1521, DOI 10.1016/j.addr.2007.08.019; Khathi A, 2013, J DIABETES, V5, P80, DOI 10.1111/j.1753-0407.2012.00230.x; Krishnankutty RK, 2009, J CENT S U, V34, P0933; KRUSTEVA S, 1990, PHARMAZIE, V45, P195; Lamounier-Zepter V, 2006, BEST PRACT RES CL EN, V20, P355, DOI 10.1016/j.beem.2006.07.002; Lenhard MJ, 2001, ARCH INTERN MED, V161, P2293, DOI 10.1001/archinte.161.19.2293; Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7; Li YH, 2005, J ETHNOPHARMACOL, V99, P239, DOI 10.1016/j.jep.2005.02.030; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mason TM, 2002, ATHEROSCLEROSIS, V161, P345, DOI 10.1016/S0021-9150(01)00659-1; Matthaei S, 2000, ENDOCR REV, V21, P585, DOI 10.1210/er.21.6.585; Mitragotri S, 2000, BIOTECHNOL PROGR, V16, P488, DOI 10.1021/bp000024+; Munjeri O, 1998, J PHARM SCI-US, V87, P905, DOI 10.1021/js9801283; Musabayane CT, 2007, RENAL FAILURE, V29, P389, DOI 10.1080/08860220701260735; Musabayane CT, 2005, J ETHNOPHARMACOL, V97, P485, DOI 10.1016/j.jep.2004.12.005; Musabayane CT, 2003, RENAL FAILURE, V25, P525, DOI 10.1081/JDI-120022543; Musabayane CT, 2000, J ENDOCRINOL, V164, P1, DOI 10.1677/joe.0.1640001; Ngubane PS, 2011, RENAL FAILURE, V33, P434, DOI 10.3109/0886022X.2011.568147; Pelegrinelli FFF, 2001, J INVEST DERMATOL, V117, P971, DOI 10.1046/j.0022-202x.2001.01473.x; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Pinent M, 2004, ENDOCRINOLOGY, V145, P4985, DOI 10.1210/en.2004-0764; Prausnitz MR, 2008, NAT BIOTECHNOL, V26, P1261, DOI 10.1038/nbt.1504; Prausnitz MR, 1996, J PHARM SCI, V85, P1363, DOI 10.1021/js960020s; PRONK GJ, 1993, J BIOL CHEM, V268, P5748; Sen A, 2002, BIOPHYS J, V83, P2064, DOI 10.1016/S0006-3495(02)73967-2; Shivanand P, 2010, INT J PHARM SCI REV, V2, P14; SINHA MK, 1991, DIABETES, V40, P472, DOI 10.2337/diabetes.40.4.472; Sonaje K, 2010, BIOMATERIALS, V31, P6849, DOI 10.1016/j.biomaterials.2010.05.042; Subramanian Rammohan, 2008, Diabetologia Croatica, V37, P13; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Szkudelski T, 2001, PHYSIOL RES, V50, P537; Weng JP, 2008, LANCET, V371, P1753, DOI 10.1016/S0140-6736(08)60762-X; Wertheimer E, 2000, J INVEST DERMATOL, V115, P24, DOI 10.1046/j.1523-1747.2000.00008.x; WHITE MF, 1994, J BIOL CHEM, V269, P1; Wiernsperger NF, 2005, DIABETES METAB, V31, P415, DOI 10.1016/S1262-3636(07)70212-4; Zakzewski CA, 1998, J CONTROL RELEASE, V50, P267, DOI 10.1016/S0168-3659(97)00143-0	52	38	40	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101461	10.1371/journal.pone.0101461	http://dx.doi.org/10.1371/journal.pone.0101461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987850	Green Submitted, Green Published, gold			2022-12-27	WOS:000341354100092
J	Jiang, WW; Kong, LL; Ni, QF; Lu, YT; Ding, WZ; Liu, GQ; Pu, LY; Tang, WB; Kong, LB				Jiang, Weiwei; Kong, Liangliang; Ni, Qingfeng; Lu, Yeting; Ding, Wenzhou; Liu, Guoqing; Pu, Liyong; Tang, Weibing; Kong, Lianbao			miR-146a Ameliorates Liver Ischemia/Reperfusion Injury by Suppressing IRAK1 and TRAF6	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; RECEPTOR 4; GENE-EXPRESSION; DOWN-REGULATION; IN-VITRO; T-CELLS; INFLAMMATION; MICRORNAS; SIZE; IMMUNITY	A critical role of the Toll-like receptor(TLR) and its downstream molecules, including IL-1 receptor-associated kinase 1(IRAK1) and tumor necrosis factor receptor-associated factor 6(TRAF6), in the pathogenesis of liver ischemia/reperfusion (I/R) injury has been documented. Recently a microRNA, miR-146a, was identified as a potent negative regulator of the TLR signaling pathway. In this study, we investigated the role of miR-146a to attenuate TLR signaling and liver I/R injury in vivo and in vitro. miR-146a was decreased in mice Kupffer cells following hepatic I/R, whereas IRAK1 and TRAF6 increased. Overexpression of miR-146a directly decreased IRAK1 and TRAF6 expression and attenuated the release of proinflammatory cytokines through the inactivation of NF-kappa B P65 in hypoxia/reoxygenation (H/R)-induced macrophages, RAW264.7 cells. Knockdown experiments demonstrated that IRAK1 and TRAF6 are two potential targets for reducing the release of proinflammatory cytokines. Moreover, co-culture assays indicated that miR-146a decreases the apoptosis of hepatocytes after H/R. In vivo administration of Ago-miR-146a, a stable version of miR-146a in vivo, protected against liver injury in mice after I/R via inactivation of the TLR signaling pathway. We conclude that miR-146a ameliorates liver ischemia/reperfusion injury in vivo and hypoxia/reoxygenation injury in vitro by directly suppressing IRAK1 and TRAF6.	[Jiang, Weiwei; Liu, Guoqing; Tang, Weibing] Nanjing Med Univ, Nanjing Childrens Hosp, Dept Neonatal Surg, Nanjing, Jiangsu, Peoples R China; [Kong, Liangliang; Ni, Qingfeng; Lu, Yeting; Ding, Wenzhou; Pu, Liyong; Kong, Lianbao] Nanjing Med Univ, Affiliated Hosp 1, Dept Liver Transplantat Ctr, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Kong, LB (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Liver Transplantat Ctr, Nanjing, Jiangsu, Peoples R China.	lbkong@njmu.edu.cn			National Natural Science Foundation of China [81100318, 81270483]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (81100318, 81270483). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MM, 2011, EUR J IMMUNOL, V41, P2482, DOI 10.1002/eji.201141740; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arias-Diaz J, 2009, LAB INVEST, V89, P433, DOI 10.1038/labinvest.2009.3; Bhogal RH, 2010, LIVER TRANSPLANT, V16, P1303, DOI 10.1002/lt.22157; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Chassin C, 2012, EMBO MOL MED, V4, P1308, DOI 10.1002/emmm.201201298; Chen Q, 2013, TRANSPL P, V45, P492, DOI 10.1016/j.transproceed.2012.10.045; de Creus A, 2005, J IMMUNOL, V174, P2037, DOI 10.4049/jimmunol.174.4.2037; Ellett JD, 2009, LIVER TRANSPLANT, V15, P1101, DOI 10.1002/lt.21782; Jiang W, 2011, TRANSPL P, V43, P1462, DOI 10.1016/j.transproceed.2011.01.191; Ke BB, 2012, J HEPATOL, V56, P359, DOI 10.1016/j.jhep.2011.05.023; Kinsey GR, 2009, J AM SOC NEPHROL, V20, P1744, DOI 10.1681/ASN.2008111160; Klune JR, 2010, SURG CLIN N AM, V90, P665, DOI 10.1016/j.suc.2010.04.003; Liang TB, 2003, TRANSPLANTATION, V75, P673, DOI 10.1097/01.TP.0000048490.24429.89; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Lu L, 2009, INT IMMUNOPHARMACOL, V9, P549, DOI 10.1016/j.intimp.2009.01.020; Luan X, 2012, TRANSPL P, V44, P937, DOI 10.1016/j.transproceed.2011.11.001; Ma Y, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-85; Matsumura T, 2000, J INTERF CYTOK RES, V20, P915, DOI 10.1089/10799900050163299; McGhan LJ, 2012, INJURY, V43, P129, DOI 10.1016/j.injury.2011.05.032; Montalvo-Jave EE, 2008, J SURG RES, V147, P153, DOI 10.1016/j.jss.2007.06.015; Nace GW, 2013, HEPATOLOGY, V58, P374, DOI 10.1002/hep.26346; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Onoe T, 2013, TRANSPLANTATION, V95, P1521, DOI 10.1097/TP.0b013e31829150a4; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tan S, 1998, CRIT CARE MED, V26, P1089, DOI 10.1097/00003246-199806000-00034; Theodoraki K, 2012, WORLD J SURG, V36, P2895, DOI 10.1007/s00268-012-1779-6; Tsung A, 2005, J IMMUNOL, V175, P7661, DOI 10.4049/jimmunol.175.11.7661; Tukov FF, 2006, TOXICOL IN VITRO, V20, P1488, DOI 10.1016/j.tiv.2006.04.005; Uhrig A, 2005, J LEUKOCYTE BIOL, V77, P626, DOI 10.1189/jlb.0604332; van Golen RF, 2012, CYTOKINE GROWTH F R, V23, P69, DOI 10.1016/j.cytogfr.2012.04.006; Wang XG, 2013, NAT MED, V19, P93, DOI 10.1038/nm.3026; Wu JD, 2010, J HEPATOL, V53, P73, DOI 10.1016/j.jhep.2010.01.032; Yang ZF, 2004, AM J TRANSPLANT, V4, P196, DOI 10.1046/j.1600-6143.2003.00313.x; Ye YM, 2011, PHYSIOL GENOMICS, V43, P534, DOI 10.1152/physiolgenomics.00130.2010; Yuan P, 2013, NEUROL SCI, V34, P1133, DOI 10.1007/s10072-012-1199-2; Zhang L, 2012, ARTERIOSCL THROM VAS, V32, P1856, DOI 10.1161/ATVBAHA.112.252619; Zhao JL, 2011, P NATL ACAD SCI USA, V108, P9184, DOI 10.1073/pnas.1105398108	43	64	77	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101530	10.1371/journal.pone.0101530	http://dx.doi.org/10.1371/journal.pone.0101530			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987958	Green Published, gold, Green Submitted			2022-12-27	WOS:000341354100109
J	Monahan, WB; Fisichelli, NA				Monahan, William B.; Fisichelli, Nicholas A.			Climate Exposure of US National Parks in a New Era of Change	PLOS ONE			English	Article							VULNERABILITY; CONSERVATION; ECOSYSTEMS; IMPACTS; MANAGEMENT	US national parks are challenged by climate and other forms of broad-scale environmental change that operate beyond administrative boundaries and in some instances are occurring at especially rapid rates. Here, we evaluate the climate change exposure of 289 natural resource parks administered by the US National Park Service (NPS), and ask which are presently (past 10 to 30 years) experiencing extreme (<5th percentile or >95th percentile) climates relative to their 19012012 historical range of variability (HRV). We consider parks in a landscape context (including surrounding 30 km) and evaluate both mean and inter-annual variation in 25 biologically relevant climate variables related to temperature, precipitation, frost and wet day frequencies, vapor pressure, cloud cover, and seasonality. We also consider sensitivity of findings to the moving time window of analysis (10, 20, and 30 year windows). Results show that parks are overwhelmingly at the extreme warm end of historical temperature distributions and this is true for several variables (e. g., annual mean temperature, minimum temperature of the coldest month, mean temperature of the warmest quarter). Precipitation and other moisture patterns are geographically more heterogeneous across parks and show greater variation among variables. Across climate variables, recent inter-annual variation is generally well within the range of variability observed since 1901. Moving window size has a measureable effect on these estimates, but parks with extreme climates also tend to exhibit low sensitivity to the time window of analysis. We highlight particular parks that illustrate different extremes and may facilitate understanding responses of park resources to ongoing climate change. We conclude with discussion of how results relate to anticipated future changes in climate, as well as how they can inform NPS and neighboring land management and planning in a new era of change.	[Monahan, William B.; Fisichelli, Nicholas A.] Natl Pk Serv, Ft Collins, CO 80525 USA	United States Department of the Interior	Monahan, WB (corresponding author), Natl Pk Serv, Ft Collins, CO 80525 USA.	Bill_Monahan@nps.gov			National Park Service; NASA [10-BIOCLIM10-0034]	National Park Service; NASA(National Aeronautics & Space Administration (NASA))	Support for this study was provided by the National Park Service, and by the NASA Applied Sciences program through award number 10-BIOCLIM10-0034. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; [Anonymous], 2014, R LANG ENV STAT COMP; Carter LM, 2014, SE CARIBBEAN CLIMATE, P396, DOI DOI 10.7930/J0NP22CB; Cole DN, 1996, ECOL APPL, V6, P168, DOI 10.2307/2269562; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Dolanc CR, 2013, GLOBAL ECOL BIOGEOGR, V22, P264, DOI 10.1111/j.1466-8238.2011.00748.x; Fisichelli N, 2012, GLOBAL CHANGE BIOL, V18, P3455, DOI 10.1111/j.1365-2486.2012.02785.x; Fisichelli NA, 2014, FOREST ECOL MANAG, V327, P31, DOI 10.1016/j.foreco.2014.04.033; Fritts H. C., 1976, TREE RINGS CLIMATE; Garfin G, 2014, SW CLIMATE CHANGE IM, P462, DOI DOI 10.7930/J08G8HMN; Hameed SO, 2013, J ENVIRON MANAGE, V121, P37, DOI 10.1016/j.jenvman.2013.02.034; Hansen AJ, 2014, ECOL APPL, V24, P484, DOI 10.1890/13-0905.1; Hansen AJ, 2011, BIOSCIENCE, V61, P363, DOI 10.1525/bio.2011.61.5.5; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Harris JA, 2006, RESTOR ECOL, V14, P170, DOI 10.1111/j.1526-100X.2006.00136.x; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hijmans R, 2006, BIOCLIM AML VERSION; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; Horton R, 2014, CLIMATE CHANGE IMPAC; Intergovernmental Panel on Climate Change, 2013, CLIM CHANG 2013 PHYS; Kareiva PC, 2008, PRELIMINARY REV ADAP, P622; Keane RE, 2009, FOREST ECOL MANAG, V258, P1025, DOI 10.1016/j.foreco.2009.05.035; Klausmeyer KR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00044.1; Knapp AK, 2008, BIOSCIENCE, V58, P811, DOI 10.1641/B580908; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3_9; Leong J-A, 2014, CLIMATE CHANGE IMPAC, P537, DOI DOI 10.7930/J0W66HPM; LEVINS R, 1966, AM SCI, V54, P421; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Magness DR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00200.1; Menne MJ, 2013, US HIST CLIMATOLOGY; MetOffice, 2014, CLIM AV; Mora C, 2013, NATURE, V502, P183, DOI 10.1038/nature12540; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; National Academy of Public Administration, 2010, STRENGTH AM BEST ID; National Park Service, 2013, NPSCAPE STAND OP PRO; National Park Service, 2004, PROGR STAND PARK PLA; National Park Service, 2011, NPSCAPE NPS BOUND DE; National Park Service (US), 2010, CLIM CHANG RESP STRA; National Park System Advisory Board, 2012, REV LEOP RES STEW NA; National Parks Second Century Commission, 2009, ADV NAT PARK ID SCI; Nordstrom R, 2014, NATL CLIMATE ASSESSM, P418; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Rosenfeld D, 2014, SCIENCE, V343, P379, DOI 10.1126/science.1247490; Rubidge EM, 2011, GLOBAL CHANGE BIOL, V17, P696, DOI 10.1111/j.1365-2486.2010.02297.x; Sherwood SC, 2014, NATURE, V505, P37, DOI 10.1038/nature12829; Stenseth NC, 2003, P ROY SOC B-BIOL SCI, V270, P2087, DOI 10.1098/rspb.2003.2415; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Walsh J., 2014, CLIMATE CHANGE IMPAC, P19, DOI [DOI 10.7930/J0KW5CXT, 10.7930/J0KW5CXT]	50	50	50	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101302	10.1371/journal.pone.0101302	http://dx.doi.org/10.1371/journal.pone.0101302			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988483	Green Submitted, Green Published, gold			2022-12-27	WOS:000341354100075
J	Meier, F; Giesert, F; Delic, S; Faus-Kessler, T; Matheus, F; Simeone, A; Holter, SM; Kuhn, R; Weisenhorn, DMV; Wurst, W; Prakash, N				Meier, Florian; Giesert, Florian; Delic, Sabit; Faus-Kessler, Theresa; Matheus, Friederike; Simeone, Antonio; Hoelter, Sabine M.; Kuehn, Ralf; Weisenhorn, Daniela M. Vogt; Wurst, Wolfgang; Prakash, Nilima			FGF/FGFR2 Signaling Regulates the Generation and Correct Positioning of Bergmann Glia Cells in the Developing Mouse Cerebellum	PLOS ONE			English	Article							FIBROBLAST GROWTH-FACTORS; SONIC-HEDGEHOG; BINDING-PROTEIN; PURKINJE-CELLS; NEURONAL PROGENITORS; GRANULE NEURONS; MULTIPLE ROLES; RAT CEREBELLUM; NERVOUS-SYSTEM; FGF RECEPTOR-1	The normal cellular organization and layering of the vertebrate cerebellum is established during embryonic and early postnatal development by the interplay of a complex array of genetic and signaling pathways. Disruption of these processes and of the proper layering of the cerebellum usually leads to ataxic behaviors. Here, we analyzed the relative contribution of Fibroblast growth factor receptor 2 (FGFR2)-mediated signaling to cerebellar development in conditional Fgfr2 single mutant mice. We show that during embryonic mouse development, Fgfr2 expression is higher in the anterior cerebellar primordium and excluded from the proliferative ventricular neuroepithelium. Consistent with this finding, conditional Fgfr2 single mutant mice display the most prominent defects in the anterior lobules of the adult cerebellum. In this context, FGFR2-mediated signaling is required for the proper generation of Bergmann glia cells and the correct positioning of these cells within the Purkinje cell layer, and for cell survival in the developing cerebellar primordium. Using cerebellar microexplant cultures treated with an FGFR agonist (FGF9) or antagonist (SU5402), we also show that FGF9/FGFR-mediated signaling inhibits the outward migration of radial glia and Bergmann glia precursors and cells, and might thus act as a positioning cue for these cells. Altogether, our findings reveal the specific functions of the FGFR2-mediated signaling pathway in the generation and positioning of Bergmann glia cells during cerebellar development in the mouse.	[Meier, Florian; Giesert, Florian; Delic, Sabit; Faus-Kessler, Theresa; Matheus, Friederike; Hoelter, Sabine M.; Kuehn, Ralf; Weisenhorn, Daniela M. Vogt; Wurst, Wolfgang; Prakash, Nilima] Deutsch Forschungszentrum Gesundheit & Umwelt Gmb, Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany; [Delic, Sabit] Regensburg Univ Hosp, Dept Neuropathol, Regensburg, Germany; [Simeone, Antonio] European Sch Mol Med, Ctr Genet Engn CEINGE Biotecnol Avanzate, Naples, Italy; [Simeone, Antonio] Inst Genet & Biophys A Buzzati Traverso, Naples, Italy; [Kuehn, Ralf; Weisenhorn, Daniela M. Vogt; Wurst, Wolfgang; Prakash, Nilima] Tech Univ Munchen Weihenstephan, Lehrstuhl Entwicklungsgenet, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Weisenhorn, Daniela M. Vogt] Deutsch Zentrum Neurodegenerat Erkrankungen DZNE, Munich, Germany; [Weisenhorn, Daniela M. Vogt; Wurst, Wolfgang] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Wurst, Wolfgang] Univ Munich, Adolf Butenandt Inst, Munich Cluster Syst Neurol SyNergy, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Regensburg; CEINGE Biotecnologie Avanzate; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Max Planck Society; University of Munich	Wurst, W (corresponding author), Deutsch Forschungszentrum Gesundheit & Umwelt Gmb, Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany.	wurst@helmholtz-muenchen.de; nilima.prakash@helmholtz-muenchen.de	Prakash, Nilima/AAC-9402-2019; Kühn, Ralf/U-1278-2017; Giesert, Florian/AAF-6499-2020; Simeone, Antonio/ABG-5269-2020; Hölter, Sabine M./N-5868-2014	Prakash, Nilima/0000-0002-0568-6262; Kühn, Ralf/0000-0003-1694-9803; Simeone, Antonio/0000-0003-2693-9836; Hölter, Sabine M./0000-0003-4878-5241; Giesert, Florian/0000-0001-6825-8858; Wurst, Wolfgang/0000-0003-4422-7410; Vogt Weisenhorn, Daniela/0000-0002-4566-6506	EU grant 'Systems Biology of Stem Cells and Reprogramming' (SyBoSS) [FP7-Health-F4-2010-2421291]; Helmholtz Alliance HeIMA-Helmholtz Alliance for Mental Health in an Ageing Society, through the Initiative and Network Fund of the Helmholtz Association; Bundesministerium fur Bildung und Forschung in the DiGtoP consortium [FKZ01GS0858]; BMBF in the network 'Neurogenesis from brain and skin cells' [01GN1009C]	EU grant 'Systems Biology of Stem Cells and Reprogramming' (SyBoSS); Helmholtz Alliance HeIMA-Helmholtz Alliance for Mental Health in an Ageing Society, through the Initiative and Network Fund of the Helmholtz Association; Bundesministerium fur Bildung und Forschung in the DiGtoP consortium; BMBF in the network 'Neurogenesis from brain and skin cells'	This work was supported by the EU grant 'Systems Biology of Stem Cells and Reprogramming' (SyBoSS (FP7-Health-F4-2010-2421291) and by the Helmholtz Alliance HeIMA-Helmholtz Alliance for Mental Health in an Ageing Society, through the Initiative and Network Fund of the Helmholtz Association. Part of this work was performed within the project framework of the German national genome research funded by the Bundesministerium fur Bildung und Forschung with grant number FKZ01GS0858 in the DiGtoP consortium and the BMBF funded grant 01GN1009C in the network 'Neurogenesis from brain and skin cells'. All responsibilities of this publication are due to the author(s). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1985, J COMP NEUROL, V231, P42, DOI 10.1002/cne.902310105; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Basson MA, 2008, DEVELOPMENT, V135, P889, DOI 10.1242/dev.011569; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Bilovocky NA, 2003, J NEUROSCI, V23, P5105; Blak AA, 2005, DEV DYNAM, V233, P1023, DOI 10.1002/dvdy.20386; Blak AA, 2007, DEV BIOL, V303, P231, DOI 10.1016/j.ydbio.2006.11.008; Brodski C, 2003, J NEUROSCI, V23, P4199; Chou DKH, 2000, J NEUROSCI RES, V59, P188, DOI 10.1002/(SICI)1097-4547(20000115)59:2<188::AID-JNR5>3.0.CO;2-M; Colvin JS, 1999, DEV DYNAM, V216, P72; Corrales JD, 2006, DEVELOPMENT, V133, P1811, DOI 10.1242/dev.02351; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Doherty D, 2013, LANCET NEUROL, V12, P381, DOI 10.1016/S1474-4422(13)70024-3; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; EDWARDS MA, 1990, NEUROSCIENCE, V36, P121, DOI 10.1016/0306-4522(90)90356-9; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Engelkamp D, 1999, DEVELOPMENT, V126, P3585; Farago AF, 2006, NEURON, V50, P205, DOI 10.1016/j.neuron.2006.03.014; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Fischer T, 2007, NEUROSCIENCE, V147, P693, DOI 10.1016/j.neuroscience.2007.04.060; Guimera J, 2006, DEVELOPMENT, V133, P3847, DOI 10.1242/dev.02557; Hagihara K, 2009, DEV BIOL, V334, P276, DOI 10.1016/j.ydbio.2009.07.029; HECHT D, 1995, GROWTH FACTORS, V12, P223, DOI 10.3109/08977199509036882; Helms AW, 1998, DEVELOPMENT, V125, P919; Kallnik M, 2007, MAMM GENOME, V18, P173, DOI 10.1007/s00335-007-9002-z; Klein RS, 2001, DEVELOPMENT, V128, P1971; KUNEMUND V, 1988, J CELL BIOL, V106, P213, DOI 10.1083/jcb.106.1.213; KURTZ A, 1994, DEVELOPMENT, V120, P2637; Lewis PM, 2004, DEV BIOL, V270, P393, DOI 10.1016/j.ydbio.2004.03.007; Li KR, 2014, J NEUROSCI, V34, P922, DOI 10.1523/JNEUROSCI.3476-13.2014; Lin YS, 2009, DEV BIOL, V329, P44, DOI 10.1016/j.ydbio.2009.02.011; Lin YS, 2006, GENESIS, V44, P150, DOI 10.1002/gene.20194; Martinez S, 1999, DEVELOPMENT, V126, P1189; Martinez S, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00018; Mason I, 2007, NAT REV NEUROSCI, V8, P583, DOI 10.1038/nrn2189; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Morales D, 2006, J NEUROSCI, V26, P12226, DOI 10.1523/JNEUROSCI.3493-06.2006; Peng CG, 2011, J NEUROSCI, V31, P12802, DOI 10.1523/JNEUROSCI.0898-11.2011; PIERCE E T, 1975, Brain Research, V95, P503, DOI 10.1016/0006-8993(75)90124-9; Pogoriler J, 2006, DEVELOPMENT, V133, P3929, DOI 10.1242/dev.02556; Puelles E, 2004, DEVELOPMENT, V131, P2037, DOI 10.1242/dev.01107; Puelles E, 2003, NAT NEUROSCI, V6, P453, DOI 10.1038/nn1037; Reeber SL, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00083; SantosOcampo S, 1996, J BIOL CHEM, V271, P1726, DOI 10.1074/jbc.271.3.1726; Sillitoe RV, 2007, ANNU REV CELL DEV BI, V23, P549, DOI 10.1146/annurev.cellbio.23.090506.123237; Smith KM, 2012, BRAIN RES, V1460, P12, DOI 10.1016/j.brainres.2012.04.002; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sotelo C, 2004, PROG NEUROBIOL, V72, P295, DOI 10.1016/j.pneurobio.2004.03.004; Sottile V, 2006, BRAIN RES, V1099, P8, DOI 10.1016/j.brainres.2006.04.127; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; WASSEF M, 1985, DEV BIOL, V111, P129, DOI 10.1016/0012-1606(85)90441-5; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Yaguchi Y, 2009, DEV DYNAM, V238, P2058, DOI 10.1002/dvdy.22013; Yamada Keiko, 2002, Anatomical Science International, V77, P94, DOI 10.1046/j.0022-7722.2002.00021.x; Yaylaoglu MB, 2005, DEV DYNAM, V234, P371, DOI 10.1002/dvdy.20441; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Yu TA, 2011, DEVELOPMENT, V138, P2957, DOI 10.1242/dev.063784; YUASA S, 1991, ANAT EMBRYOL, V184, P195, DOI 10.1007/BF01673256; Yuasa S, 1996, ANAT EMBRYOL, V194, P223	61	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101124	10.1371/journal.pone.0101124	http://dx.doi.org/10.1371/journal.pone.0101124			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983448	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000339635000055
J	Nevoral, J; Petr, J; Gelaude, A; Bodart, JF; Kucerova-Chrpova, V; Sedmikova, M; Krejcova, T; Kolbabova, T; Dvorakova, M; Vyskocilova, A; Weingartova, I; Krivohlavkova, L; Zalmanova, T; Jilek, F				Nevoral, Jan; Petr, Jaroslav; Gelaude, Armance; Bodart, Jean-Francois; Kucerova-Chrpova, Veronika; Sedmikova, Marketa; Krejcova, Tereza; Kolbabova, Tereza; Dvorakova, Marketa; Vyskocilova, Alena; Weingartova, Ivona; Krivohlavkova, Lenka; Zalmanova, Tereza; Jilek, Frantisek			Dual Effects of Hydrogen Sulfide Donor on Meiosis and Cumulus Expansion of Porcine Cumulus-Oocyte Complexes	PLOS ONE			English	Article							CYSTATHIONINE BETA-SYNTHASE; AKT PROTEIN-KINASE; MEIOTIC MATURATION; PIG OOCYTES; MOUSE OOCYTES; MAP KINASE; FOLLICULAR DEVELOPMENT; GASEOUS TRANSMITTER; CELLS; ACTIVATION	Hydrogen sulfide (H2S) has been revealed to be a signal molecule with second messenger action in the somatic cells of many tissues, including the reproductive tract. The aim of this study was to address how exogenous H2S acts on the meiotic maturation of porcine oocytes, including key maturation factors such as MPF and MAPK, and cumulus expansion intensity of cumulus-oocyte complexes. We observed that the H2S donor, Na2S, accelerated oocyte in vitro maturation in a dose-dependent manner, following an increase of MPF activity around germinal vesicle breakdown. Concurrently, the H2S donor affected cumulus expansion, monitored by hyaluronic acid production. Our results suggest that the H2S donor influences oocyte maturation and thus also participates in the regulation of cumulus expansion. The exogenous H2S donor apparently affects key signal pathways of oocyte maturation and cumulus expansion, resulting in faster oocyte maturation with little need of cumulus expansion.	[Nevoral, Jan; Kucerova-Chrpova, Veronika; Sedmikova, Marketa; Krejcova, Tereza; Kolbabova, Tereza; Dvorakova, Marketa; Vyskocilova, Alena; Weingartova, Ivona; Krivohlavkova, Lenka; Zalmanova, Tereza; Jilek, Frantisek] Czech Univ Life Sci Prague, Dept Vet Sci, Prague, Czech Republic; [Petr, Jaroslav] Res Inst Anim Prod, Prague, Czech Republic; [Gelaude, Armance; Bodart, Jean-Francois] Univ Lille 1, Lab Regulat Signaux Div, IFR 147, EA 4479, F-59655 Villeneuve Dascq, France	Czech University of Life Sciences Prague; Czech Research Institute of Animal Science; Universite de Lille - ISITE; Universite de Lille	Nevoral, J (corresponding author), Czech Univ Life Sci Prague, Dept Vet Sci, Prague, Czech Republic.	nevoral@af.czu.cz	Bodart, Jean-François Laurent/AAZ-2075-2021; Sedmíková, Markéta/B-5768-2018; Krejcova, Tereza/AAX-1542-2021	Bodart, Jean-François Laurent/0000-0002-6113-7700; Sedmíková, Markéta/0000-0003-0947-4256; Krejcova, Tereza/0000-0001-5840-9499	National Agency of Agriculture Sciences [NAZV QI 101A166]; Czech ministry of Agriculture [MZeRO 0714]; Czech University of Life Sciences in Prague [CIGA 20122038, CIGA 20122034, CIGA 20132035]	National Agency of Agriculture Sciences; Czech ministry of Agriculture(Ministry of Agriculture, Czech Republic); Czech University of Life Sciences in Prague	This work was supported by the National Agency of Agriculture Sciences (NAZV QI 101A166), the Czech ministry of Agriculture (MZeRO 0714) and the Czech University of Life Sciences in Prague (CIGA 20122038, CIGA 20122034, CIGA 20132035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anger M, 2004, MOL REPROD DEV, V69, P11, DOI 10.1002/mrd.20151; Bagg MA, 2009, REPROD FERT DEVELOP, V21, P796, DOI 10.1071/RD08165; Bucci M, 2010, ARTERIOSCL THROM VAS, V30, P1998, DOI 10.1161/ATVBAHA.110.209783; DOWNS SM, 1995, DEV BIOL, V172, P72, DOI 10.1006/dbio.1995.0006; Dragovic RA, 2005, ENDOCRINOLOGY, V146, P2798, DOI 10.1210/en.2005-0098; Eppig JJ, 2001, REPRODUCTION, V122, P829, DOI 10.1530/rep.0.1220829; Fan HY, 2002, MOL REPROD DEV, V63, P480, DOI 10.1002/mrd.10194; Geng B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073892; Ghasemi M, 2012, BIOCHEM PHARMACOL, V83, P1261, DOI 10.1016/j.bcp.2012.01.026; Guzman MA, 2006, HUM MOL GENET, V15, P3168, DOI 10.1093/hmg/ddl393; HAMPL A, 1995, DEVELOPMENT, V121, P925; Han ZB, 2006, REPRODUCTION, V132, P749, DOI 10.1530/REP-06-0055; Hu Y, 2008, PFLUG ARCH EUR J PHY, V455, P607, DOI 10.1007/s00424-007-0321-4; Huang Y, 2010, TOHOKU J EXP MED, V221, P125, DOI 10.1620/tjem.221.125; Jezova M, 2001, ANIM REPROD SCI, V65, P115, DOI 10.1016/S0378-4320(00)00219-0; Jilek F, 2001, REPROD DOMEST ANIM, V36, P139, DOI 10.1046/j.1439-0531.2001.d01-27.x; Kalous J, 2009, REPRODUCTION, V138, P645, DOI 10.1530/REP-08-0461; Kimura N, 2002, BIOL REPROD, V66, P707, DOI 10.1095/biolreprod66.3.707; Kubelka M, 2000, BIOL REPROD, V62, P292, DOI 10.1095/biolreprod62.2.292; Liang R, 2007, REPROD TOXICOL, V24, P89, DOI 10.1016/j.reprotox.2007.04.002; Liang R, 2006, CHINESE MED J-PEKING, V119, P1877, DOI 10.1097/00029330-200611020-00006; Mard SA, 2012, DIGEST DIS SCI, V57, P1496, DOI 10.1007/s10620-012-2051-5; MOTLIK J, 1976, J EXP ZOOL, V198, P155, DOI 10.1002/jez.1401980205; MOTLIK J, 1990, MOL REPROD DEV, V27, P366, DOI 10.1002/mrd.1080270411; MOTLIK J, 1986, THERIOGENOLOGY, V25, P87, DOI 10.1016/0093-691X(86)90185-8; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Nagyova E, 2000, BIOL REPROD, V63, P1149, DOI 10.1095/biolreprod63.4.1149; Njie-Mbye YF, 2012, EXP EYE RES, V98, P16, DOI 10.1016/j.exer.2012.03.001; Peter M, 2001, NAT CELL BIOL, V3, P83, DOI 10.1038/35050607; PETTERS RM, 1993, J REPROD FERTIL, P61; PROCHAZKA R, 1991, J REPROD FERTIL, V93, P569, DOI 10.1530/jrf.0.0930569; REIFFENSTEIN RJ, 1992, ANNU REV PHARMACOL, V32, P109, DOI 10.1146/annurev.pa.32.040192.000545; Rolfe M, 1997, J MOL MED-JMM, V75, P5, DOI 10.1007/s001090050081; SALUSTRI A, 1989, J BIOL CHEM, V264, P13840; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Srilatha B, 2009, J SEX MED, V6, P1875, DOI 10.1111/j.1743-6109.2009.01291.x; Tang GH, 2010, CLIN EXP PHARMACOL P, V37, P753, DOI 10.1111/j.1440-1681.2010.05351.x; Tanghe S, 2002, MOL REPROD DEV, V61, P414, DOI 10.1002/mrd.10102; VERLHAC MH, 1993, DEV BIOL, V158, P330, DOI 10.1006/dbio.1993.1192; VERLHAC MH, 1994, DEVELOPMENT, V120, P1017; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wassarman P.M., 1988, P69; Yamashita Y, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-20; Yokoo M, 2010, J REPROD DEVELOP, V56, P15, DOI 10.1262/jrd.09-173E; Zhao H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067322	45	11	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e99613	10.1371/journal.pone.0099613	http://dx.doi.org/10.1371/journal.pone.0099613			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984032	Green Published, gold, Green Submitted			2022-12-27	WOS:000339635000012
J	Stuck, AK; Mean, M; Limacher, A; Righini, M; Jaeger, K; Beer, HJ; Osterwalder, J; Frauchiger, B; Matter, CM; Kucher, N; Egloff, M; Aschwanden, M; Husmann, M; Angelillo-Scherrer, A; Rodondi, N; Aujesky, D				Stuck, Anna K.; Mean, Marie; Limacher, Andreas; Righini, Marc; Jaeger, Kurt; Beer, Hans-Juerg; Osterwalder, Joseph; Frauchiger, Beat; Matter, Christian M.; Kucher, Nils; Egloff, Michael; Aschwanden, Markus; Husmann, Marc; Angelillo-Scherrer, Anne; Rodondi, Nicolas; Aujesky, Drahomir			The Adherence to Initial Processes of Care in Elderly Patients with Acute Venous Thromboembolism	PLOS ONE			English	Article							MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; ANTITHROMBOTIC THERAPY; ORAL ANTICOAGULATION; GUIDELINES; DIAGNOSIS; ULTRASONOGRAPHY; PROPHYLAXIS; EFFICACY; WARFARIN	Background: We aimed to assess whether elderly patients with acute venous thromboembolism (VTE) receive recommended initial processes of care and to identify predictors of process adherence. Methods: We prospectively studied in-and outpatients aged >= 65 years with acute symptomatic VTE in a multicenter cohort study from nine Swiss university-and non-university hospitals between September 2009 and March 2011. We systematically assessed whether initial processes of care, which are recommended by the 2008 American College of Chest Physicians guidelines, were performed in each patient. We used multivariable logistic models to identify patient factors independently associated with process adherence. Results: Our cohort comprised 950 patients (mean age 76 years). Of these, 86% (645/750) received parenteral anticoagulation for >= 5 days, 54% (405/750) had oral anticoagulation started on the first treatment day, and 37% (274/750) had an international normalized ratio (INR) >= 2 for >= 24 hours before parenteral anticoagulation was discontinued. Overall, 35% (53/153) of patients with cancer received low-molecular-weight heparin monotherapy and 72% (304/423) of patients with symptomatic deep vein thrombosis were prescribed compression stockings. In multivariate analyses, symptomatic pulmonary embolism, hospital-acquired VTE, and concomitant antiplatelet therapy were associated with a significantly lower anticoagulation-related process adherence. Conclusions: Adherence to several recommended processes of care was suboptimal in elderly patients with VTE. Quality of care interventions should particularly focus on processes with low adherence, such as the prescription of continued low-molecular-weight heparin therapy in patients with cancer and the achievement of an INR >= 2 for >= 24 hours before parenteral anticoagulants are stopped.	[Stuck, Anna K.; Mean, Marie; Rodondi, Nicolas; Aujesky, Drahomir] Univ Hosp Bern, Div Gen Internal Med, CH-3010 Bern, Switzerland; [Limacher, Andreas] Univ Bern, Dept Clin Res, CTU Bern, Bern, Switzerland; [Limacher, Andreas] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Righini, Marc] Univ Hosp Geneva, Div Angiol & Hemostasis, Geneva, Switzerland; [Jaeger, Kurt; Aschwanden, Markus] Univ Basel Hosp, Div Angiol, CH-4031 Basel, Switzerland; [Beer, Hans-Juerg] Cantonal Hosp Baden, Baden, Switzerland; [Osterwalder, Joseph] Cantonal Hosp St Gallen, Emergency Dept, St Gallen, Switzerland; [Frauchiger, Beat] Cantonal Hosp Frauenfeld, Dept Internal Med, Frauenfeld, Switzerland; [Matter, Christian M.] Univ Zurich, Inst Physiol, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Kucher, Nils] Univ Hosp Bern, Div Angiol, CH-3010 Bern, Switzerland; [Egloff, Michael] Univ Hosp Geneva, Div Diabetol, Geneva, Switzerland; [Husmann, Marc] Univ Zurich Hosp, Clin Angiol, CH-8091 Zurich, Switzerland; [Angelillo-Scherrer, Anne] Univ Hosp Bern, Univ Clin Hematol, CH-3010 Bern, Switzerland; [Angelillo-Scherrer, Anne] Univ Hosp Bern, Cent Hematol Lab, CH-3010 Bern, Switzerland; [Matter, Christian M.] Univ Zurich Hosp, Div Cardiol, CH-8091 Zurich, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University of Geneva; University of Basel; Kantonsspital St. Gallen; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Bern; University Hospital of Bern; University of Geneva; University of Zurich; University Zurich Hospital; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Zurich; University Zurich Hospital	Stuck, AK (corresponding author), Univ Hosp Bern, Div Gen Internal Med, CH-3010 Bern, Switzerland.	anna.stuck@insel.ch	Righini, Marc/AAX-8731-2020	Mean, Marie/0000-0003-0477-7899; Limacher, Andreas/0000-0002-9094-9476; Rodondi, Nicolas/0000-0001-9083-6896; Stuck, Anna K./0000-0001-8322-5501; Beer, Jurg Hans/0000-0002-7199-0406; Angelillo-Scherrer, Anne/0000-0003-2872-4863	Swiss National Science Foundation [33CSCO-122659/139470]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was funded by a grant from the Swiss National Science Foundation (33CSCO-122659/139470). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akl EA, 2011, COCHRANE DATABASE SY; Arpaia G, 2009, J THROMB THROMBOLYS, V28, P389, DOI 10.1007/s11239-009-0316-4; Aujesky D, 2007, J CLIN EPIDEMIOL, V60, P410, DOI 10.1016/j.jclinepi.2006.06.023; Buller HR, 2003, NEW ENGL J MED, V349, P1695; Caprini JA, 2005, J VASC SURG, V42, P726, DOI 10.1016/j.jvs.2005.05.053; Caprini JA, 2006, MANAG CARE, V15, P66; Caprini JA, 2006, MANAG CARE, V15, P53; Caprini Joseph A, 2006, Manag Care, V15, P49; Dauzat M, 1997, J CLIN ULTRASOUND, V25, P343, DOI 10.1002/(SICI)1097-0096(199709)25:7<343::AID-JCU1>3.0.CO;2-A; Deitelzweig SB, 2011, AM J HEMATOL, V86, P217, DOI 10.1002/ajh.21917; Fraser DGW, 2002, ANN INTERN MED, V136, P89, DOI 10.7326/0003-4819-136-2-200201150-00006; GALLUS A, 1986, LANCET, V2, P1293; Ganz DA, 2000, J GEN INTERN MED, V15, P776, DOI 10.1046/j.1525-1497.2000.91022.x; Kahn SR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008201.pub2; Kahn SR, 2012, THROMB HAEMOSTASIS, V108, P493, DOI 10.1160/TH12-03-0169; Kakkos SK, 2006, THROMB HAEMOSTASIS, V96, P441, DOI 10.1160/TH06-05-0258; Kearon C, 1998, ANN INTERN MED, V129, P1044, DOI 10.7326/0003-4819-129-12-199812150-00009; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Le Gal G, 2006, THROMB HAEMOSTASIS, V95, P963, DOI 10.1160/TH06-03-0158; Leroyer C, 1998, HAEMOSTASIS, V28, P70; Mahan Charles E, 2010, Hosp Pract (1995), V38, P97; Marcucci M, 2010, EUR J INTERN MED, V21, P516, DOI 10.1016/j.ejim.2010.07.014; Marcucci M, 2013, INTERN EMERG MED, V8, P509, DOI 10.1007/s11739-013-0944-8; Mean M, 2013, J THROMB THROMBOLYS, V36, P475, DOI 10.1007/s11239-013-0875-2; Merli Geno, 2010, Hosp Pract (1995), V38, P7; MOHIUDDIN SM, 1992, AM HEART J, V123, P729, DOI 10.1016/0002-8703(92)90513-U; Noble SIR, 2006, BMJ-BRIT MED J, V332, P577, DOI 10.1136/bmj.38733.616065.802; Rose AJ, 2013, CHEST, V143, P751, DOI 10.1378/chest.12-1119; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Rubin DB, 2004, MULTIPLE IMPUTATION; Smith SB, 2010, CHEST, V137, P1382, DOI 10.1378/chest.09-0959; Spencer FA, 2008, THROMB HAEMOSTASIS, V100, P780, DOI 10.1160/TH08-04-0255; Spirk D, 2011, THROMB HAEMOSTASIS, V105, P239, DOI 10.1160/TH10-08-0506; Tapson VF, 2005, ARCH INTERN MED, V165, P1458, DOI 10.1001/archinte.165.13.1458; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66; Whittle J, 1998, J GEN INTERN MED, V13, P373, DOI 10.1046/j.1525-1497.1998.00117.x	37	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100164	10.1371/journal.pone.0100164	http://dx.doi.org/10.1371/journal.pone.0100164			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983634	Green Accepted, Green Published, gold			2022-12-27	WOS:000339635000016
J	Zeng, W; Rong, MY; Hu, XY; Xiao, W; Qi, FY; Huang, JH; Luo, ZJ				Zeng, Wen; Rong, Mengyao; Hu, Xueyu; Xiao, Wei; Qi, Fengyu; Huang, Jinghui; Luo, Zhuojing			Incorporation of Chitosan Microspheres into Collagen-Chitosan Scaffolds for the Controlled Release of Nerve Growth Factor	PLOS ONE			English	Article							AXONAL REGENERATION; CONTROLLED DELIVERY; CONDUITS; INJURY; EXPRESSION	Background: Artifical nerve scaffold can be used as a promising alternative to autologous nerve grafts to enhance the repair of peripheral nerve defects. However, current nerve scaffolds lack efficient microstructure and neurotrophic support. Methods: Microsphere-Scaffold composite was developed by incorporating chitosan microspheres loaded with nerve growth factor (NGF-CMSs) into collagen-chitosan scaffolds (CCH) with longitudinally oriented microchannels (NGF-CMSs/CCH). The morphological characterizations, in vitro release kinetics study, neurite outgrowth assay, and bioactivity assay were evaluated. After that, a 15-mm-long sciatic nerve gap in rats was bridged by the NGF-CMSs/CCH, CCH physically absorbed NGF (NGF/CCH), CCH or nerve autograft. 16 weeks after implantation, electrophysiology, fluoro-gold retrograde tracing, and nerve morphometry were performed. Results: The NGF-CMSs were evenly distributed throughout the longitudinally oriented microchannels of the scaffold. The NGF-CMSs/CCH was capable of sustained release of bioactive NGF within 28 days as compared with others in vitro. In vivo animal study demonstrated that the outcomes of NGF-CMSs/CCH were better than those of NGF/CCH or CCH. Conclusion: Our findings suggest that incorporation of NGF-CMSs into the CCH may be a promising tool in the repair of peripheral nerve defects.	[Zeng, Wen; Hu, Xueyu; Xiao, Wei; Qi, Fengyu; Huang, Jinghui; Luo, Zhuojing] Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Xian 710032, Peoples R China; [Zeng, Wen] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian 710032, Peoples R China; [Rong, Mengyao] Fourth Mil Med Univ, Xijing Hosp, Dept Clin Immunol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Huang, JH (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Xian 710032, Peoples R China.	huangjh@fmmu.edu.cn; zhuojingl@163.com		zeng, wen/0000-0002-5614-5925; Huang, Jinghui/0000-0002-0991-0591	National Natural Science Foundation of China [30770571, 30973052]; National Hi-Tech Research and Development Program of China (863 Program) [2002AA216101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Hi-Tech Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by grants from the National Natural Science Foundation of China (No. 30770571 and No. 30973052) and the National Hi-Tech Research and Development Program of China (863 Program) (No. 2002AA216101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao QA, 2011, BIOMATERIALS, V32, P787, DOI 10.1016/j.biomaterials.2010.09.046; Belkas JS, 2004, NEUROL RES, V26, P151, DOI 10.1179/016164104225013798; DERBY A, 1993, EXP NEUROL, V119, P176, DOI 10.1006/exnr.1993.1019; ERNFORS P, 1989, NEURON, V2, P1605, DOI 10.1016/0896-6273(89)90049-4; Fu K, 2000, NAT BIOTECHNOL, V18, P24, DOI 10.1038/71875; Gold BG, 1997, NEUROSCIENCE, V76, P1153, DOI 10.1016/S0306-4522(96)00416-2; He C, 1992, MICROSURG, V13, P141; Hu XY, 2009, TISSUE ENG PT A, V15, P3297, DOI [10.1089/ten.tea.2009.0017, 10.1089/ten.TEA.2009.0017]; Jiao HS, 2009, BIOMATERIALS, V30, P5004, DOI 10.1016/j.biomaterials.2009.05.059; Kehoe S, 2012, INJURY, V43, P553, DOI 10.1016/j.injury.2010.12.030; Kemp SWP, 2009, TISSUE ENG PT A, V15, P1975, DOI 10.1089/ten.tea.2008.0338; Lee AC, 2003, EXP NEUROL, V184, P295, DOI 10.1016/S0014-4886(03)00258-9; Lee JE, 2004, BIOMATERIALS, V25, P4163, DOI 10.1016/j.biomaterials.2003.10.057; MACKINNON SE, 1985, ANN PLAS SURG, V14, P428, DOI 10.1097/00000637-198505000-00005; Meek MF, 2008, ANN PLAS SURG, V60, P110, DOI 10.1097/SAP.0b013e31804d441c; Meek MF, 2009, MICROSURG, V29, P473, DOI 10.1002/micr.20642; Niu XF, 2011, ARTIF ORGANS, V35, pE119, DOI 10.1111/j.1525-1594.2011.01274.x; Niu XF, 2009, J CONTROL RELEASE, V134, P111, DOI 10.1016/j.jconrel.2008.11.020; RICH KM, 1989, EXP NEUROL, V105, P162, DOI 10.1016/0014-4886(89)90115-5; Romero MI, 2000, J NEUROSCI, V20, P4435, DOI 10.1523/JNEUROSCI.20-12-04435.2000; Suzuki Y, 1999, NEUROSCI LETT, V259, P75, DOI 10.1016/S0304-3940(98)00924-0; Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034; van Bergeijk J, 2006, CHEM BIOL DRUG DES, V67, P244, DOI 10.1111/j.1747-0285.2006.00369.x; Wang HK, 2012, BIOTECHNOL APPL BIOC, V59, P388, DOI 10.1002/bab.1031; Weber RA, 2000, PLAST RECONSTR SURG, V106, P1036, DOI 10.1097/00006534-200010000-00013; Wei GB, 2006, J CONTROL RELEASE, V112, P103, DOI 10.1016/j.jconrel.2006.01.011; Xu XY, 2003, BIOMATERIALS, V24, P2405, DOI 10.1016/S0142-9612(03)00109-1; Yang YM, 2009, CELL BIOL INT, V33, P352, DOI 10.1016/j.cellbi.2009.01.005; Yucel D, 2010, BIOMATERIALS, V31, P1596, DOI 10.1016/j.biomaterials.2009.11.013; Zeng W, 2011, INT J PHARMACEUT, V421, P283, DOI 10.1016/j.ijpharm.2011.10.005	30	48	51	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101300	10.1371/journal.pone.0101300	http://dx.doi.org/10.1371/journal.pone.0101300			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983464	gold, Green Published, Green Submitted			2022-12-27	WOS:000339635000085
J	Zhou, XY; Li, L; Su, J; Zhang, GX				Zhou, Xiaoying; Li, Lin; Su, Jing; Zhang, Guoxin			Decreased miR-204 in H. pylori-Associated Gastric Cancer Promotes Cancer Cell Proliferation and Invasion by Targeting SOX4	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; EXPRESSION; FAMILY	Background: The molecular mechanism between Helicobacter pylori (H. pylori) infection and gastric cancer remained largely unknown. In this study, we determined the role of miRNA in H. pylori induced gastric cancer. Methods and Results: We found that miR-204 was decreased in H. pylori positive tissues by qRT-PCR. Knockdown of miR-204 enhanced the invasion and proliferation ability of gastric cancer cells in vitro. Luciferase assay revealed that SOX4 was target gene of miR-204, which was found up-regulated in H. pylori positive tissues. Down-regulation of miR-204 and overexpression of SOX4 promoted epithelial-mesenchymal transition process. Conclusion: Taken together, our findings demonstrated that miR-204 may act as a tumor suppressor in H. pylori induced gastric cancer by targeting SOX4.	[Zhou, Xiaoying; Li, Lin; Su, Jing; Zhang, Guoxin] Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China; [Zhou, Xiaoying; Li, Lin; Su, Jing; Zhang, Guoxin] Nanjing Med Univ, Clin Med Coll 1, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Zhang, GX (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China.	guoxinz@njmu.edu.cn	Zhou, Xiaoying/I-5400-2016		National Natural Science Foundation of China [81270476]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Guoxin Zhang was funded by National Natural Science Foundation of China (No. 81270476) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carrasco G, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/393015; Castillo SD, 2012, CANCER RES, V72, P176, DOI 10.1158/0008-5472.CAN-11-3506; Chen ZY, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-105; Chu DK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090526; de Maat MFG, 2007, J CLIN ONCOL, V25, P4887, DOI 10.1200/JCO.2006.09.8921; Gunes S, 2011, PATHOL RES PRACT, V207, P423, DOI 10.1016/j.prp.2011.05.005; He WL, 2014, J GASTROEN HEPATOL, V29, P1427, DOI 10.1111/jgh.12558; Isomoto H, 2009, GUT, V58, P331, DOI 10.1136/gut.2008.165381; Kim YI, 2014, HELICOBACTER, V19, P194, DOI 10.1111/hel.12116; Lian GD, 2014, AM J PATHOL, V184, P1343, DOI 10.1016/j.ajpath.2014.01.027; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; Matsushima K, 2011, INT J CANCER, V128, P361, DOI 10.1002/ijc.25348; Ning JF, 2013, ONCOL RES, V21, P67, DOI 10.3727/096504013X13747716581417; Parvani JG, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3466; Qiu T, 2014, FEBS LETT, DOI [10.1016/j.febslet, DOI 10.1016/J.FEBSLET]; Qiu YH, 2013, CELL PHYSIOL BIOCHEM, V32, P1331, DOI 10.1159/000354531; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tiwari N, 2013, CANCER CELL, V23, P768, DOI 10.1016/j.ccr.2013.04.020; Vervoort SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053238; Wang L, 2013, PROSTATE CANCER P D, V16, P301, DOI 10.1038/pcan.2013.25; Wang L, 2014, PROSTATE, V74, P647, DOI 10.1002/pros.22783; Wang YW, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0094548, 10.1371/journal.pone.0091307, 10.1371/journal.pone.0095143]; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4; Xie MY, 2013, CELL, V155, P1568, DOI 10.1016/j.cell.2013.11.027; Yu XC, 2013, GENE, V532, P87, DOI 10.1016/j.gene.2013.09.048; Zhang JC, 2012, CANCER RES, V72, P4597, DOI 10.1158/0008-5472.CAN-12-1045; Zhao LY, 2014, DIG DIS SCI; Zhao XN, 2013, FRONT BIOSCI-LANDMRK, V18, P803, DOI 10.2741/4144	29	58	61	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101457	10.1371/journal.pone.0101457	http://dx.doi.org/10.1371/journal.pone.0101457			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984017	Green Published, Green Submitted, gold			2022-12-27	WOS:000339635000111
J	Belchamber, K; Hall, DA; Hourani, SMO				Belchamber, Kylie; Hall, David A.; Hourani, Susanna M. O.			Smoking Enhances the Proinflammatory Effects of Nucleotides on Cytokine Release from Human Lung	PLOS ONE			English	Article							EXTRACELLULAR ATP TRIGGERS; INTERFERON-GAMMA; IFN-GAMMA; AIRWAY INFLAMMATION; P2X(7) RECEPTOR; P2 RECEPTORS; VAS-DEFERENS; IMMUNE; CELLS; PATHOGENESIS	Nucleotides have effects on immune cells which are complex but generally proinflammatory, and have been suggested to play a role in smoking-related lung diseases. However, there have been no studies directly measuring functional responses to nucleotides in human lungs taken from smokers. We used fragments of post mortem human lung from smokers and nonsmokers, incubated them with a range of nucleotides (4-1000 mu M) in the presence of lipopolysaccharide (LPS; 10 mu g/ml) for 24 hours and measured cytokines (IL-1 beta, IFN gamma, IL-17, TNF alpha, IL-6, IL-8, IL-2 and IL-10) in the supernatants using multiplex immunoassays. Although the basal cytokine levels in the smokers were generally higher in the smokers than the nonsmokers, there were no significant differences in either the basal release or the LPS-stimulated release of any of the cytokines when lungs from smokers and non-smokers were compared. There were no significant effects of ATP, ADP, AMP, UTP, alpha,beta-methylene-ATP, P-1, P-4-diATP, 2-methylthio-ATP or Bz-ATP on the release of cytokines from the lungs. However, the stable ATP analogue ATP gamma S increased the release of IL-1 beta and IFN gamma, and the effect was greatly increased in lungs from smokers. In non-smokers but not in smokers ATP gamma S increased the release of IL-17. Overall these results clearly demonstrate for the first time that in normal human lung a stable ATP analogue can enhance LPS-induced pro-inflammatory cytokine release, and that these effects are greatly altered by a prior history of smoking. This provides strong support for the suggestion that nucleotides are involved in the pathogenesis of smoking-related diseases.	[Belchamber, Kylie; Hourani, Susanna M. O.] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England; [Hall, David A.] GlaxoSmithKline, Fibrosis Discovery Performance Unit, Stevenage, Herts, England	University of Surrey; GlaxoSmithKline	Hall, DA (corresponding author), GlaxoSmithKline, Fibrosis Discovery Performance Unit, Stevenage, Herts, England.	david.a.hall@gsk.com		Hall, David/0000-0002-3350-5705; Belchamber, Kylie/0000-0003-3241-258X	BBSRC; GlaxoSmithKline (BBSRC) [BB/G529716/1]; CASE Studentship, GSK	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GlaxoSmithKline (BBSRC); CASE Studentship, GSK	This project was funded by a BBSRC Industrial CASE studentship in collaboration with GlaxoSmithKline (BBSRC Research Industrial Partnership Grant BB/G529716/1). In addition to funding supplied under the terms of the CASE Studentship, GSK provided support in the form of salaries for author DAH, but did not play any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; BAILEY SJ, 1995, BRIT J PHARMACOL, V114, P1125, DOI 10.1111/j.1476-5381.1995.tb13324.x; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Burnstock G, 2012, PHARMACOL REV, V64, P834, DOI 10.1124/pr.111.005389; Chen JZ, 2009, CELL IMMUNOL, V254, P85, DOI 10.1016/j.cellimm.2008.09.001; Chen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020333; Cicko S, 2010, J IMMUNOL, V185, P688, DOI 10.4049/jimmunol.0904042; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Dubyak GR, 2012, CELL MICROBIOL, V14, P1697, DOI 10.1111/cmi.12001; EDEN E, 1986, AM REV RESPIR DIS, V133, P455; Eltom S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024097; Esther CR, 2011, CHEST, V140, P954, DOI 10.1378/chest.10-2471; Ferrari D, 1997, J IMMUNOL, V159, P1451; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Frucht DM, 2001, TRENDS IMMUNOL, V22, P556, DOI 10.1016/S1471-4906(01)02005-1; Gabel CA, 2007, PURINERG SIGNAL, V3, P27, DOI 10.1007/s11302-006-9034-y; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; HOLT PG, 1986, CLIN EXP IMMUNOL, V66, P188; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Jacobson KA, 2002, J MED CHEM, V45, P4057, DOI 10.1021/jm020046y; Jacobson KA, 2010, DRUG DISCOV TODAY, V15, P570, DOI 10.1016/j.drudis.2010.05.011; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; King BF, 2008, J PHARMACOL EXP THER, V324, P1055, DOI 10.1124/jpet.107.131169; Kumar V, 2009, EUR J PHARMACOL, V616, P7, DOI 10.1016/j.ejphar.2009.05.005; Lommatzsch M, 2010, AM J RESP CRIT CARE, V181, P928, DOI 10.1164/rccm.200910-1506OC; Lucattelli M, 2011, AM J RESP CELL MOL, V44, P423, DOI 10.1165/rcmb.2010-0038OC; Manthei DM, 2012, J ALLERGY CLIN IMMUN, V130, P496, DOI 10.1016/j.jaci.2012.05.040; Mehta H, 2008, INFLAMM RES, V57, P497, DOI 10.1007/s00011-008-8078-6; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Mortaz E, 2010, EUR J PHARMACOL, V638, P1, DOI 10.1016/j.ejphar.2010.04.019; Mortaz E, 2009, EUR J PHARMACOL, V619, P92, DOI 10.1016/j.ejphar.2009.07.022; Muller T, 2011, AM J RESP CELL MOL, V44, P456, DOI 10.1165/rcmb.2010-0129OC; Pearl-Yafe M, 2007, SHOCK, V27, P226, DOI 10.1097/01.shk.0000239765.80033.37; Rayah A, 2012, MICROBES INFECT, V14, P1254, DOI 10.1016/j.micinf.2012.07.006; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shan M, 2012, SCI TRANSL MED, V4; SONE S, 1994, EUR RESPIR J, V7, P657, DOI 10.1183/09031936.94.07040657; Thorne GR, 2012, BIOMED PHARMACOTHER, V66, P206; Thorne GR, 2009, INHAL TOXICOL, V21, P906; Vitiello L, 2012, BLOOD, V120, P511, DOI 10.1182/blood-2012-01-406496; WELFORD LA, 1987, EUR J PHARMACOL, V141, P123, DOI 10.1016/0014-2999(87)90418-3; WELFORD LA, 1986, EUR J PHARMACOL, V129, P217, DOI 10.1016/0014-2999(86)90431-0; Westfall TD, 1996, BRIT J PHARMACOL, V117, P867, DOI 10.1111/j.1476-5381.1996.tb15273.x; YOUNG HA, 1995, J LEUKOCYTE BIOL, V58, P373, DOI 10.1002/jlb.58.4.373; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4	46	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e99711	10.1371/journal.pone.0099711	http://dx.doi.org/10.1371/journal.pone.0099711			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978193	Green Published, gold, Green Submitted			2022-12-27	WOS:000338506400008
J	Zhang, P; Xi, M; Zhao, L; Li, QQ; He, LR; Liu, SL; Shen, JX; Liu, MZ				Zhang, Peng; Xi, Mian; Zhao, Lei; Li, Qiao-Qiao; He, Liru; Liu, Shiliang; Shen, Jingxian; Liu, Meng-Zhong			Unilateral Cervical Nodal Metastasis Is an Independent Prognostic Factor for Esophageal Squamous Cell Carcinoma Patients Undergoing Chemoradiotherapy: A Retrospective Study	PLOS ONE			English	Article							TUMOR LENGTH; CANCER; SURVIVAL; PATTERN	Purpose: To determine the prognostic significance of unilateral cervical lymph nodal metastasis (CLNM) in patients with inoperable thoracic esophageal squamous cell carcinoma (SCC) and to identify significant prognostic factors in these patients. Patients and methods: This retrospective study involved 395 patients with inoperable esophageal SCC treated with concurrent chemoradiotherapy. The patients were classified into three groups according to their cervical lymph node status: group A, no evidence of CLNM; group B, unilateral CLNM; group C, other distant metastases. Overall survival (OS) and progression-free survival (PFS) were calculated. Significant prognostic factors were identified using univariate and multivariate analyses. Results: The 3-year OS rates in groups A, B and C were 46.7%, 33.5% and 8.3%, respectively (p<0.001, log-rank test). The corresponding PFS rates were 40.7%, 26.4% and 4.7% (p<0.001, log-rank test). Group B had a similar prognosis to that of group A and better 3-year OS (p = 0.009) and PFS (p = 0.006) rates than those of group C. Multivariate analysis demonstrated that T stage, chemotherapy regimen and cervical lymph node involvement were independent prognostic factors affecting OS and PFS. Conclusions: Compared to other distant metastases, unilateral CLNM is associated with longer OS in esophageal SCC and should be regarded as a regional disease. Sex, T stage, concurrent chemotherapy modality and cervical lymph node involvement are independent predictors of survival in esophageal SCC.	[Zhang, Peng; Xi, Mian; Zhao, Lei; Li, Qiao-Qiao; He, Liru; Liu, Shiliang; Shen, Jingxian; Liu, Meng-Zhong] Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Peng; Xi, Mian; Zhao, Lei; Li, Qiao-Qiao; He, Liru; Liu, Shiliang; Shen, Jingxian; Liu, Meng-Zhong] Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Zhang, Peng; Xi, Mian; Zhao, Lei; Li, Qiao-Qiao; He, Liru; Liu, Shiliang; Liu, Meng-Zhong] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Shen, Jingxian] Sun Yat Sen Univ, Ctr Canc, Imaging Diag & Intervent Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Liu, MZ (corresponding author), Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	liumengzhong@126.com			Natural Science Foundation of China [81272487]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Natural Science Foundation of China (No. 81272487). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, CHIN J RAD ONCOL, V19, P179, DOI DOI 10.3760/CMA.J.ISSN.1004-4221.2010.03.001; Chen JQ, 2009, EUR J CARDIO-THORAC, V36, P480, DOI 10.1016/j.ejcts.2009.03.056; Chen LQ, 2008, CHIN J CLIN THORAC C, V15, P52; Christie NA, 1999, J THORAC CARDIOV SUR, V118, P900, DOI 10.1016/S0022-5223(99)70060-7; Eloubeidi MA, 2002, CANCER-AM CANCER SOC, V95, P1434, DOI 10.1002/cncr.10868; Heo M, 2013, INT J STAT MED RES, V2, P104; Huang W, 2010, RADIOTHER ONCOL, V95, P229, DOI 10.1016/j.radonc.2010.01.006; Isono K, 2004, ESOPHAGUS, V1, P61; Kato H, 2000, J SURG ONCOL, V74, P282, DOI 10.1002/1096-9098(200008)74:4<282::AID-JSO8>3.0.CO;2-R; Kim K, 2001, ANN THORAC SURG, V71, P290, DOI 10.1016/S0003-4975(00)02221-9; Li HC, 2007, EUR SURG RES, V39, P1, DOI 10.1159/000096925; Li QQ, 2010, DIS ESOPHAGUS, V23, P253, DOI 10.1111/j.1442-2050.2009.01003.x; Li WF, 2013, INT J RADIAT ONCOL, V86, P249, DOI 10.1016/j.ijrobp.2012.09.003; Liu H, 2011, RADIOTHER ONCOL, V99, P181, DOI 10.1016/j.radonc.2011.05.011; Micheli A, 1998, EUR J CANCER, V34, P2271, DOI 10.1016/S0959-8049(98)00324-4; Minsky BD, 2002, J CLIN ONCOL, V20, P1167, DOI 10.1200/JCO.20.5.1167; Nomura M, 2012, INT J RADIAT ONCOL, V82, P946, DOI 10.1016/j.ijrobp.2010.12.045; Prenzel KL, 2010, ANN THORAC SURG, V90, P1662, DOI 10.1016/j.athoracsur.2010.07.008; Rice TW, 2010, ANN SURG ONCOL, V17, P1721, DOI 10.1245/s10434-010-1024-1; Rice TW, 1998, ANN THORAC SURG, V65, P787, DOI 10.1016/S0003-4975(97)01387-8; Shimada H, 2007, HEPATO-GASTROENTEROL, V54, P100; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Tong DKH, 2008, J GASTROINTEST SURG, V12, P1638, DOI 10.1007/s11605-008-0654-0; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Yendamuri S, 2009, CANCER-AM CANCER SOC, V115, P508, DOI 10.1002/cncr.24062	25	3	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101332	10.1371/journal.pone.0101332	http://dx.doi.org/10.1371/journal.pone.0101332			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979040	Green Published, gold, Green Submitted			2022-12-27	WOS:000338506400119
J	Sakurai, MA; Ozaki, Y; Okuzaki, D; Naito, Y; Sasakura, T; Okamoto, A; Tabara, H; Inoue, T; Hagiyama, M; Ito, A; Yabuta, N; Nojima, H				Sakurai, Minami A.; Ozaki, Yuki; Okuzaki, Daisuke; Naito, Yoko; Sasakura, Towa; Okamoto, Ayumi; Tabara, Hiroe; Inoue, Takao; Hagiyama, Man; Ito, Akihiko; Yabuta, Norikazu; Nojima, Hiroshi			Gefitinib and Luteolin Cause Growth Arrest of Human Prostate Cancer PC-3 Cells via Inhibition of Cyclin G-Associated Kinase and Induction of miR-630	PLOS ONE			English	Article							ANDROGEN RECEPTOR; MUTATION ANALYSIS; CELLULAR TARGETS; TYROSINE KINASE; LUNG-CANCER; THERAPY; OSTEOSARCOMA; TRAFFICKING; EXPRESSION; REGULATOR	Cyclin G-associated kinase (GAK), a key player in clathrin-mediated membrane trafficking, is overexpressed in various cancer cells. Here, we report that GAK expression is positively correlated with the Gleason score in surgical specimens from prostate cancer patients. Embryonic fibroblasts from knockout mice expressing a kinase-dead (KD) form of GAK showed constitutive hyper-phosphorylation of the epidermal growth factor receptor (EGFR). In addition to the well-known EGFR inhibitors gefitinib and erlotinib, the dietary flavonoid luteolin was a potent inhibitor of the Ser/Thr kinase activity of GAK in vitro. Co-administration of luteolin and gefitinib to PC-3 cells had a greater effect on cell viability than administration of either compound alone; this decrease in viability was associated with drastic down-regulation of GAK protein expression. A comprehensive microRNA array analysis revealed increased expression of miR-630 and miR-5703 following treatment of PC-3 cells with luteolin and/or gefitinib, and exogenous overexpression of miR-630 caused growth arrest of these cells. GAK appears to be essential for cell death because co-administration of gefitinib and luteolin to EGFR-deficient U2OS osteosarcoma cells also had a greater effect on cell viability than administration of either compound alone. Taken together, these findings suggest that GAK may be a new therapeutic target for prostate cancer and osteosarcoma.	[Sakurai, Minami A.; Ozaki, Yuki; Okuzaki, Daisuke; Naito, Yoko; Sasakura, Towa; Okamoto, Ayumi; Tabara, Hiroe; Yabuta, Norikazu; Nojima, Hiroshi] Osaka Univ, Dept Mol Genet, Suita, Osaka, Japan; [Okuzaki, Daisuke; Nojima, Hiroshi] Osaka Univ, Microbial Dis Res Inst, DNA Chip Dev Ctr Infect Dis, Suita, Osaka, Japan; [Inoue, Takao; Hagiyama, Man; Ito, Akihiko] Kinki Univ, Fac Med, Dept Pathol, Osaka, Japan	Osaka University; Osaka University; Kindai University (Kinki University)	Nojima, H (corresponding author), Osaka Univ, Dept Mol Genet, Suita, Osaka, Japan.	snj-0212@biken.osaka-u.ac.jp	Okuzaki, Daisuke/AAN-5641-2020	Okuzaki, Daisuke/0000-0002-4552-783X	Ministry of Education, Culture, Sports, Science and Technology of Japan [15101006, 20370081, 23370086, 21651085, 22570185]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research S (No. 15101006), Scientific Research B (No. 20370081 and 23370086), and Exploratory Research (No. 21651085) to HN; and Scientific Research C (No. 22570185) to NY from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brehmer D, 2005, CANCER RES, V65, P379; Chowdhury AR, 2002, BIOCHEM J, V366, P653, DOI 10.1042/BJ20020098; Cimino S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/632959; D'Arcangelo M, 2013, EXPERT REV ANTICANC, V13, P523, DOI [10.1586/era.13.23, 10.1586/ERA.13.23]; Eisenberg E, 2007, TRAFFIC, V8, P640, DOI 10.1111/j.1600-0854.2007.00568.x; Farhana L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061015; Galluzzi L, 2010, CANCER RES, V70, P1793, DOI 10.1158/0008-5472.CAN-09-3112; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Ito A, 2003, LAB INVEST, V83, P1175, DOI 10.1097/01.LAB.0000081391.28136.80; Joensuu G, 2010, INT J RADIAT ONCOL, V78, P42, DOI 10.1016/j.ijrobp.2009.07.1731; Kai L, 2011, ANTICANCER RES, V31, P3323; Kosaki K, 1999, AM J HUM GENET, V64, P712, DOI 10.1086/302289; Lawrence MG, 2011, PROSTATE, V71, P1198, DOI 10.1002/pros.21335; Lee D, 2008, MOL BIOL CELL, V19, P2766, DOI 10.1091/mbc.E07-11-1115; Lee JA, 2012, CANCER RES TREAT, V44, P202, DOI 10.4143/crt.2012.44.3.202; Markaverich BM, 2010, J STEROID BIOCHEM, V122, P219, DOI 10.1016/j.jsbmb.2010.06.006; Massard C, 2011, CLIN CANCER RES, V17, P3876, DOI 10.1158/1078-0432.CCR-10-2815; Naito Y, 2012, CELL CYCLE, V11, P604, DOI 10.4161/cc.11.3.19114; Olszewski MB, 2014, TRAFFIC, V15, P60, DOI 10.1111/tra.12132; Peraldo-Neia C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-31; Ray MR, 2006, INT J CANCER, V118, P1108, DOI 10.1002/ijc.21469; Roengvoraphoj M, 2013, CANCER TREAT REV, V39, P839, DOI 10.1016/j.ctrv.2013.05.001; Russo P, 2012, CURR MED CHEM, V19, P5287, DOI 10.2174/092986712803833272; Sato J, 2009, GENES CELLS, V14, P627, DOI 10.1111/j.1365-2443.2009.01296.x; Shimizu H, 2009, J CELL SCI, V122, P3145, DOI 10.1242/jcs.052795; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sirotnak FM, 2000, CLIN CANCER RES, V6, P4885; Small EJ, 2007, BJU INT, V100, P765, DOI 10.1111/j.1464-410X.2007.07121.x; Susa M, 2010, MOL CANCER THER, V9, P3342, DOI 10.1158/1535-7163.MCT-10-0637; Tabara H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026034; Thadani-Mulero M, 2012, CANCER RES, V72, P4611, DOI 10.1158/0008-5472.CAN-12-0783; Trojan L, 2005, ANTICANCER RES, V25, P551; Vulky J, 2009, CANCER, V115, P784, DOI 10.1002/cncr.24092; Wang G, 2012, PROG NEUROBIOL, V98, P207, DOI 10.1016/j.pneurobio.2012.06.003; Zhang L, 2004, P NATL ACAD SCI USA, V101, P10296, DOI 10.1073/pnas.0403175101	35	56	58	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100124	10.1371/journal.pone.0100124	http://dx.doi.org/10.1371/journal.pone.0100124			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971999	Green Published, gold, Green Submitted			2022-12-27	WOS:000338512200020
J	Xia, Y; Zhao, Y; Yang, MP; Zeng, SQ; Shu, YS				Xia, Yang; Zhao, Yuan; Yang, Mingpo; Zeng, Shaoqun; Shu, Yousheng			Regulation of Action Potential Waveforms by Axonal GABA(A) Receptors in Cortical Pyramidal Neurons	PLOS ONE			English	Article							PRESYNAPTIC INHIBITION; TRANSMITTER RELEASE; EXCITATORY ACTIONS; INITIAL SEGMENT; CELLS; CHANNELS; MODULATION; ACTIVATION; RESPONSES; DEPOLARIZATION	GABA(A) receptors distributed in somatodendritic compartments play critical roles in regulating neuronal activities, including spike timing and firing pattern; however, the properties and functions of GABA(A) receptors at the axon are still poorly understood. By recording from the cut end (bleb) of the main axon trunk of layer -5 pyramidal neurons in prefrontal cortical slices, we found that currents evoked by GABA iontophoresis could be blocked by picrotoxin, indicating the expression of GABA(A) receptors in axons. Stationary noise analysis revealed that single-channel properties of axonal GABA(A) receptors were similar to those of somatic receptors. Perforated patch recording with gramicidin revealed that the reversal potential of the GABA response was more negative than the resting membrane potential at the axon trunk, suggesting that GABA may hyperpolarize the axonal membrane potential. Further experiments demonstrated that the activation of axonal GABA(A) receptors regulated the amplitude and duration of action potentials (APs) and decreased the AP-induced Ca2+ transients at the axon. Together, our results indicate that the waveform of axonal APs and the downstream Ca2+ signals are modulated by axonal GABA(A) receptors.	[Xia, Yang; Yang, Mingpo] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Inst Neurosci, Shanghai, Peoples R China; [Zhao, Yuan; Zeng, Shaoqun] Huazhong Univ Sci & Technol, Wuhan Natl Lab Optoelect, Britton Chance Ctr Biomed Photon, Wuhan 430074, Peoples R China; [Shu, Yousheng] Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Shu, Yousheng] Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Huazhong University of Science & Technology; Beijing Normal University; Beijing Normal University	Zeng, SQ (corresponding author), Huazhong Univ Sci & Technol, Wuhan Natl Lab Optoelect, Britton Chance Ctr Biomed Photon, Wuhan 430074, Peoples R China.	sqzeng@hust.edu.cn; yousheng@bnu.edu.cn	Shu, Yousheng/AAC-3881-2020	Shu, Yousheng/0000-0002-2834-2876	973 Program [2011CBA00400]; National Natural Science Foundation of China Project [31025012, 81327802]; Chinese Academy of Sciences	973 Program(National Basic Research Program of China); National Natural Science Foundation of China Project(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was funded by the 973 Program (No. 2011CBA00400 YS), the National Natural Science Foundation of China Project (No. 31025012 YS, 81327802 SZ), and the Hundreds of Talents Program (YS) from Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; Alle H, 2008, CURR OPIN NEUROBIOL, V18, P314, DOI 10.1016/j.conb.2008.08.006; AUGUSTINE GJ, 1990, J PHYSIOL-LONDON, V431, P343, DOI 10.1113/jphysiol.1990.sp018333; BARKER JL, 1982, J PHYSIOL-LONDON, V322, P365, DOI 10.1113/jphysiol.1982.sp014042; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Bischofberger J, 2002, J NEUROSCI, V22, P10593; Cattaert D, 1999, J NEUROSCI, V19, P6079, DOI 10.1523/JNEUROSCI.19-14-06079.1999; Cavelier P, 2005, PROG BIOPHYS MOL BIO, V87, P3, DOI 10.1016/j.pbiomolbio.2004.06.001; Chavas J, 2003, J NEUROSCI, V23, P2019; Chiang PH, 2012, J NEUROSCI, V32, P62, DOI 10.1523/JNEUROSCI.3393-11.2012; Christie JM, 2008, NEURON, V60, P298, DOI 10.1016/j.neuron.2008.08.028; Christie JM, 2009, J NEUROSCI, V29, P11441, DOI 10.1523/JNEUROSCI.2387-09.2009; Debanne D, 2004, NAT REV NEUROSCI, V5, P304, DOI 10.1038/nrn1397; ECCLES JC, 1961, J PHYSIOL-LONDON, V159, P147, DOI 10.1113/jphysiol.1961.sp006798; Engelman HS, 2004, NAT REV NEUROSCI, V5, P135, DOI 10.1038/nrn1297; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Farrant M, 2007, PROG BRAIN RES, V160, P59, DOI 10.1016/S0079-6123(06)60005-8; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Glickfeld LL, 2009, NAT NEUROSCI, V12, P21, DOI 10.1038/nn.2230; Golding NL, 1996, J NEUROSCI, V16, P2208; Gulledge AT, 2003, NEURON, V37, P299, DOI 10.1016/S0896-6273(02)01146-7; HOWE JR, 1987, J PHYSIOL-LONDON, V384, P539, DOI 10.1113/jphysiol.1987.sp016469; Hu WQ, 2012, NEUROSCI BULL, V28, P342, DOI 10.1007/s12264-012-1247-1; Khirug S, 2008, J NEUROSCI, V28, P4635, DOI 10.1523/JNEUROSCI.0908-08.2008; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Kullmann DM, 2005, PROG BIOPHYS MOL BIO, V87, P33, DOI 10.1016/j.pbiomolbio.2004.06.003; Lv XH, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2190047; Martina M, 2001, J NEUROPHYSIOL, V86, P2887, DOI 10.1152/jn.2001.86.6.2887; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MODY I, 1994, TRENDS NEUROSCI, V17, P517, DOI 10.1016/0166-2236(94)90155-4; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Mozrzymas JW, 2004, NEUROPHARMACOLOGY, V47, P945, DOI 10.1016/j.neuropharm.2004.07.003; NEHER E, 1977, ANNU REV BIOPHYS BIO, V6, P345, DOI 10.1146/annurev.bb.06.060177.002021; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pouzat C, 1999, J NEUROSCI, V19, P1675; Pugh JR, 2011, J NEUROSCI, V31, P565, DOI 10.1523/JNEUROSCI.4506-10.2011; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; Ruiz A, 2003, NEURON, V39, P961, DOI 10.1016/S0896-6273(03)00559-2; Ruiz A, 2010, NAT NEUROSCI, V13, P431, DOI 10.1038/nn.2512; Santhakumar V, 2006, J NEUROSCI, V26, P3357, DOI 10.1523/JNEUROSCI.4799-05.2006; Sasaki T, 2011, SCIENCE, V331, P599, DOI 10.1126/science.1197598; SEGEV I, 1990, J NEUROPHYSIOL, V63, P987, DOI 10.1152/jn.1990.63.5.987; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Shu YS, 2007, P NATL ACAD SCI USA, V104, P11453, DOI 10.1073/pnas.0702041104; Shu YS, 2007, J NEUROPHYSIOL, V97, P746, DOI 10.1152/jn.00922.2006; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; TACHIBANA M, 1987, P NATL ACAD SCI USA, V84, P3501, DOI 10.1073/pnas.84.10.3501; Trigo FF, 2008, EUR J NEUROSCI, V28, P841, DOI 10.1111/j.1460-9568.2008.06404.x; Turecek R, 2002, P NATL ACAD SCI USA, V99, P13884, DOI 10.1073/pnas.212419699; Turecek R, 2001, NATURE, V411, P587, DOI 10.1038/35079084; Vardi N, 2000, J NEUROSCI, V20, P7657; Wagner S, 1997, NATURE, V387, P598, DOI 10.1038/42468; Yang J, 2013, J PHYSIOL-LONDON, V591, P3233, DOI 10.1113/jphysiol.2013.251058; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	60	15	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100968	10.1371/journal.pone.0100968	http://dx.doi.org/10.1371/journal.pone.0100968			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971996	gold, Green Published, Green Submitted			2022-12-27	WOS:000338512200076
J	Walia, GK; Gupta, V; Aggarwal, A; Asghar, M; Dudbridge, F; Timpson, N; Singh, NS; Kumar, MR; Kinra, S; Prabhakaran, D; Reddy, KS; Chandak, GR; Smith, GD; Ebrahim, S				Walia, Gagandeep Kaur; Gupta, Vipin; Aggarwal, Aastha; Asghar, Mohammad; Dudbridge, Frank; Timpson, Nicholas; Singh, Nongmaithem Suraj; Kumar, M. Ravi; Kinra, Sanjay; Prabhakaran, Dorairaj; Reddy, K. Srinath; Chandak, Giriraj Ratan; Smith, George Davey; Ebrahim, Shah			Association of Common Genetic Variants with Lipid Traits in the Indian Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DISEASE RISK; LOCI; CHOLESTEROL; LINKAGE; OBESITY	Genome-wide association studies (GWAS) have been instrumental in identifying novel genetic variants associated with altered plasma lipid levels. However, these quantitative trait loci have not been tested in the Indian population, where there is a poorly understood and growing burden of cardiometabolic disorders. We present the association of six single nucleotide polymorphisms in 1671 sib pairs (3342 subjects) with four lipid traits: total cholesterol, triglycerides, high density lipoprotein cholesterol (HDL-C) and low density lipoprotein cholesterol (LDL-C). We also investigated the interaction effects of gender, location, fat intake and physical activity. Each copy of the risk allele of rs964184 at APOA1 was associated with 1.06 mmol/l increase in triglycerides (SE = 0.049; p = 0.006), rs3764261 at CETP with 1.02 mmol/l increase in both total cholesterol (SE = 0.042; p = 0.017) and HDL-C (SE = 0.041; p = 0.008), rs646776 at CELSR2-PSRC1-SORT1 with 0.96 mmol/l decrease in cholesterol (SE = 0.043; p = 0.0003) and 0.15 mmol/l decrease in LDL-C levels (SE = 0.043; p = 0.0003) and rs2954029 at TRIB1 with 1.02 mmol/l increase in HDL-C (SE = 0.039; p = 0.047). A combined risk score of APOA1 and CETP loci predicted an increase of 1.25 mmol/l in HDL-C level (SE = 0.312; p = 0.0007). Urban location and sex had strong interaction effects on the genetic association of most of the studied loci with lipid traits. To conclude, we validated four genetic variants (identified by GWAS in western populations) associated with lipid traits in the Indian population. The interaction effects found here may explain the sex-specific differences in lipid levels and their heritability. Urbanization appears to influence the nature of the association with GWAS lipid loci in this population. However, these findings will require replication in other Indian populations.	[Walia, Gagandeep Kaur; Aggarwal, Aastha; Ebrahim, Shah] PHFI, SANCD, New Delhi, India; [Gupta, Vipin] Univ Delhi, Dept Anthropol, Delhi 110007, India; [Asghar, Mohammad] Rajiv Gandhi Univ, Dept Anthropol, Itanagar, Arunachal Prade, India; [Dudbridge, Frank; Kinra, Sanjay; Ebrahim, Shah] London Sch Hyg & Trop Med, Dept Non Communicable Dis Epidemiol, London WC1, England; [Timpson, Nicholas; Smith, George Davey] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Singh, Nongmaithem Suraj; Kumar, M. Ravi; Chandak, Giriraj Ratan] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India; [Prabhakaran, Dorairaj; Reddy, K. Srinath] Publ Hlth Fdn India, New Delhi, India	Public Health Foundation of India; University of Delhi; Rajiv Gandhi University, Itanagar; University of London; London School of Hygiene & Tropical Medicine; University of Bristol; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Public Health Foundation of India	Walia, GK (corresponding author), PHFI, SANCD, New Delhi, India.	gkaurw@gmail.com; udaiig@gmail.com	Timpson, Nicholas John/O-7548-2015; Fox, Laura J/C-6249-2016; Gupta, Vipin/D-1704-2014; Prabhakaran, Dorairaj/B-4147-2011; Attrill, Lauren/V-1688-2018; Aggarwal, Aastha/AAT-1347-2020; Davey Smith, George/A-7407-2013	Timpson, Nicholas John/0000-0002-7141-9189; Gupta, Vipin/0000-0002-0607-5543; Prabhakaran, Dorairaj/0000-0002-3172-834X; Aggarwal, Aastha/0000-0002-8180-8743; Davey Smith, George/0000-0002-1407-8314; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Chandak, Giriraj Ratan/0000-0002-3095-9453; nongmaithem, suraj/0000-0001-5390-0449; Reddy, K Srinath/0000-0003-3416-3548; s, hema/0000-0002-3440-9475	Wellcome Trust [GR070797MF, 083541/Z/07/Z, 089645/Z/09/Z]; Medical Research Council [G0600705, G1000718] Funding Source: researchfish; MRC [G1000718, G0600705] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Indian Migration Study was funded by the Wellcome Trust (grant number GR070797MF). The genetic work was funded by a project grant from the Wellcome Trust (083541/Z/07/Z). GDS was supported by a Wellcome Trust Sabbatical Award (089645/Z/09/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Braun TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037056; Castelli W P, 1992, Ann Epidemiol, V2, P23, DOI 10.1016/1047-2797(92)90033-M; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Chitra Uma, 2012, Indian Heart J, V64, P28, DOI 10.1016/S0019-4832(12)60007-8; Cooper RS, 2008, HUM MOL GENET, V17, pR151, DOI 10.1093/hmg/ddn263; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; El-Hazmi MAF, 2001, ANN SAUDI MED, V21, P21, DOI 10.5144/0256-4947.2001.21; Frank D., 2013, PLOS GENET, V9; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; Gottesman O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046419; Gu QP, 2010, AM J HYPERTENS, V23, P38, DOI 10.1038/ajh.2009.191; HASKELL WL, 1984, PREV MED, V13, P23, DOI 10.1016/0091-7435(84)90038-0; Isaacs A, 2013, ARTERIOSCL THROM VAS, V33, P2233, DOI 10.1161/ATVBAHA.113.301236; Kannel W B, 1979, Diabetes Care, V2, P120, DOI 10.2337/diacare.2.2.120; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S17; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kruglyak L, 1999, P NATL ACAD SCI USA, V96, P1170, DOI 10.1073/pnas.96.4.1170; Lu YC, 2010, ATHEROSCLEROSIS, V213, P200, DOI 10.1016/j.atherosclerosis.2010.08.053; Lyngdoh T, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-2; Muendlein A, 2009, ATHEROSCLEROSIS, V206, P494, DOI 10.1016/j.atherosclerosis.2009.02.040; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Patel V, 2011, LANCET, V377, P413, DOI 10.1016/S0140-6736(10)61188-9; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Rafiq S, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-155; Reaven GM, 1996, NEW ENGL J MED, V334, P374, DOI 10.1056/NEJM199602083340607; Reddy KS, 2005, LANCET, V366, P1744, DOI [10.1016/s0140-6736(05)67343-6, 10.1016/S0140-6736(05)67343-6]; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Rexrode KM, 1996, CURR OPIN CARDIOL, V11, P490, DOI 10.1097/00001573-199609000-00007; Saleheen D, 2010, CIRC-CARDIOVASC GENE, V3, P348, DOI 10.1161/CIRCGENETICS.109.906180; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Schierer A, 2012, PHARMACOGENET GENOM, V22, P95, DOI 10.1097/FPC.0b013e32834dc9ef; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Varbo A, 2011, ARTERIOSCL THROM VAS, V31, P451, DOI 10.1161/ATVBAHA.110.216333; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yajnik CS, 2001, NUTR REV, V59, P1; Zhang L, 2010, J CLIN ENDOCR METAB, V95, P1793, DOI 10.1210/jc.2009-2348; Zhang LX, 2012, BIOMED ENVIRON SCI, V25, P305, DOI 10.3967/0895-3988.2012.03.008	43	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101688	10.1371/journal.pone.0101688	http://dx.doi.org/10.1371/journal.pone.0101688			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991929	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000341253400106
J	Rougerie, R; Kitching, IJ; Haxaire, J; Miller, SE; Hausmann, A; Hebert, PDN				Rougerie, Rodolphe; Kitching, Ian J.; Haxaire, Jean; Miller, Scott E.; Hausmann, Axel; Hebert, Paul D. N.			Australian Sphingidae - DNA Barcodes Challenge Current Species Boundaries and Distributions	PLOS ONE			English	Article							LEPIDOPTERA; BIODIVERSITY; DIVERSITY; ENDEMISM; MOTHS; FAUNA	Main Objective: We examine the extent of taxonomic and biogeographical uncertainty in a well-studied group of Australian Lepidoptera, the hawkmoths (Sphingidae). Methods: We analysed the diversity of Australian sphingids through the comparative analysis of their DNA barcodes, supplemented by morphological re-examinations and sequence information from a nuclear marker in selected cases. The results from the analysis of Australian sphingids were placed in a broader context by including conspecifics and closely related taxa from outside Australia to test taxonomic boundaries. Results: Our results led to the discovery of six new species in Australia, one case of erroneously synonymized species, and three cases of synonymy. As a result, we establish the occurrence of 75 species of hawkmoths on the continent. The analysis of records from outside Australia also challenges the validity of current taxonomic boundaries in as many as 18 species, including Agrius convolvuli (Linnaeus, 1758), a common species that has gained adoption as a model system. Our work has revealed a higher level of endemism than previously recognized. Most (90%) Australian sphingids are endemic to the continent (45%) or to Australia, the Pacific Islands and the Papuan and Wallacean regions (45%). Only seven species (10%) have ranges that extend beyond this major biogeographical boundary toward SE Asia and other regions of the Old World. Main Conclusions: This study has established that overlooked cryptic diversity and inaccurate species delineation produced significant misconceptions concerning diversity and distribution patterns in a group of insects that is considered well known taxonomically. Because DNA barcoding represents a straightforward way to test taxonomic boundaries, its implementation can improve the accuracy of primary diversity data in biogeography and conservation studies.	[Rougerie, Rodolphe; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Kitching, Ian J.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Haxaire, Jean] Museum Natl Hist Nat Paris, Le Roc, Laplume, France; [Miller, Scott E.] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA; [Hausmann, Axel] Bavarian State Collect Zool, Sect Lepidoptera, Munich, Germany	University of Guelph; Natural History Museum London; Museum National d'Histoire Naturelle (MNHN); Smithsonian Institution; Smithsonian National Museum of Natural History	Rougerie, R (corresponding author), INRA, Zool Forestiere UR633, Orleans, France.	rrougeri@gmail.com	Rougerie, Rodolphe/D-2930-2009; Hebert, Paul DN/C-4161-2013	Rougerie, Rodolphe/0000-0003-0937-2815; Hebert, Paul DN/0000-0002-3081-6700; Miller, Scott/0000-0002-4138-1378	government of Canada through Genome Canada; Ontario Genomics Institute; Natural Sciences and Engineering Research Council of Canada (NSERC)	government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by funding from the government of Canada through Genome Canada (www.genomecanada.ca) and the Ontario Genomics Institute (www.ontariogenomics.ca) in support of the International Barcode of Life project (www.iBOL.org), and by the Natural Sciences and Engineering Research Council of Canada (NSERC, www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin AD, 2004, AUST J ENTOMOL, V43, P216, DOI 10.1111/j.1326-6756.2004.00448.x; Beck J, 2006, BIOL J LINN SOC, V89, P455, DOI 10.1111/j.1095-8312.2006.00686.x; Brechlin Ronald, 2010, Entomo-Satsphingia, V3, P66; Brechlin Ronald, 2001, Arthropoda, V9, P6; Chapman A, 2009, NUMBERS LIVING SPECI, P1; Cranston PS, 2010, ANNU REV ENTOMOL, V55, P55, DOI 10.1146/annurev-ento-112408-085348; Darge P., 1975, Bulletin Soc Ent France, V80, P179; Eitschberger Ulf, 2001, Neue Entomologische Nachrichten, V52, P3; Gehring PS, 2012, ECOL EVOL, V2, P1468, DOI 10.1002/ece3.269; Godfray HCJ, 2006, TRENDS ECOL EVOL, V21, P603, DOI DOI 10.1016/J.TREE.2006.06.010; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Hausmann A, 2009, ZOOTAXA, P1; Hausmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017134; Haxaire J., 2007, EUROPEAN ENTOMOLOGIS, V1, P7; Hebert PDN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068535; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Holloway J. D., 2011, Malayan Nature Journal, V63, P1; James SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015629; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kitching I. J., 2000, HAWKMOTHS WORLD ANNO; Kristensen NP, 2007, ZOOTAXA, P699, DOI 10.11646/zootaxa.1668.1.30; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Landry JF, 2013, ZOOKEYS, P43, DOI 10.3897/zookeys.327.5831; Lane David, 2011, Nachrichten des Entomologischen Vereins Apollo, V31, P227; Lees DC, 2014, MOL ECOL RESOUR, V14, P286, DOI 10.1111/1755-0998.12178; Lees DC, 2010, ZOOL SCR, V39, P642, DOI 10.1111/j.1463-6409.2010.00447.x; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lomolino MV, 2004, CONSERVATION BIOGEOG, P293; Marin J, 2013, BIOL J LINN SOC, V110, P427, DOI 10.1111/bij.12132; May RM, 2009, SCIENCE, V323, P687, DOI 10.1126/science.1170937; Moulds MS, 2014, EUROPEAN ENTOMOLOGIS, V5, P11; Moulds MS, 1996, CHECKLIST LEPIDOPTER, P529; Mutanen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047214; Oliver PM, 2009, P ROY SOC B-BIOL SCI, V276, P2001, DOI 10.1098/rspb.2008.1881; Padial JM, 2007, ZOOTAXA, P67, DOI 10.11646/zootaxa.1586.1.7; Parks DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069885; Peters J, 2001, LOCAL HUMAN SWEET PO; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Riddle Brett R., 2011, P47; Riedel A, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-15; Riotte J.C.E., 1979, Entomologische Zeitschrift, V89, P225; Roe Amanda D., 2010, P1; Romero D, 2014, J BIOGEOGR, V41, P111, DOI 10.1111/jbi.12189; Rougerie R, 2012, INVERTEBR SYST, V26, P445, DOI 10.1071/IS12029; Rougerie R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043920; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Sharma P, 2013, ZOOTAXA, V3702, P79, DOI 10.11646/zootaxa.3702.1.5; Smith MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036514; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tuttle JP, 2012, EUROPEAN ENTOMOLOGIS, V1, P65; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Wakamura S, 1996, APPL ENTOMOL ZOOL, V31, P171, DOI 10.1303/aez.31.171; Williams J., 2001, BIODIVERSITY AUSTR S; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	56	31	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101108	10.1371/journal.pone.0101108	http://dx.doi.org/10.1371/journal.pone.0101108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987846	Green Published, Green Submitted, gold			2022-12-27	WOS:000341354100060
J	Wun, T; Styles, L; DeCastro, L; Telen, MJ; Kuypers, F; Cheung, A; Kramer, W; Flanner, H; Rhee, S; Magnani, JL; Thackray, H				Wun, Ted; Styles, Lori; DeCastro, Laura; Telen, Marilyn J.; Kuypers, Frans; Cheung, Anthony; Kramer, William; Flanner, Henry; Rhee, Seungshin; Magnani, John L.; Thackray, Helen			Phase 1 Study of the E-Selectin Inhibitor GMI 1070 in Patients with Sickle Cell Anemia	PLOS ONE			English	Article							P-SELECTIN; MICROVASCULAR ABNORMALITIES; ERYTHROCYTE ADHERENCE; INTRAVENOUS INFUSIONS; DOSE PHARMACOKINETICS; ANTAGONIST GMI-1070; ADHESION; DISEASE; HYDROXYUREA; ENDOTHELIUM	Background: Sickle cell anemia is an inherited disorder of hemoglobin that leads to a variety of acute and chronic complications. Abnormal cellular adhesion, mediated in part by selectins, has been implicated in the pathophysiology of the vaso-occlusion seen in sickle cell anemia, and selectin inhibition was able to restore blood flow in a mouse model of sickle cell disease. Methods: We performed a Phase 1 study of the selectin inhibitor GMI 1070 in patients with sickle cell anemia. Fifteen patients who were clinically stable received GMI 1070 in two infusions. Results: The drug was well tolerated without significant adverse events. There was a modest increase in total peripheral white blood cell count without clinical symptoms. Plasma concentrations were well-described by a two-compartment model with an elimination T-1/2 of 7.7 hours and CLr of 19.6 mL/hour/kg. Computer-assisted intravital microscopy showed transient increases in red blood cell velocity in 3 of the 4 patients studied. Conclusions: GMI 1070 was safe in stable patients with sickle cell anemia, and there was suggestion of increased blood flow in a subset of patients. At some time points between 4 and 48 hours after treatment with GMI 1070, there were significant decreases in biomarkers of endothelial activation (sE-selectin, sP-selectin, sICAM), leukocyte activation (MAC-1, LFA-1, PM aggregates) and the coagulation cascade (tissue factor, thrombin-antithrombin complexes). Development of GMI 1070 for the treatment of acute vaso-occlusive crisis is ongoing.	[Wun, Ted] Univ Calif Davis, Sch Med, Div Hematol Oncol, Sacramento, CA 95817 USA; [Wun, Ted] UC Davis Sch Med, Clin & Translat Sci Ctr, Sacramento, CA USA; [Wun, Ted; Cheung, Anthony] UC Davis Sch Med, Dept Pathol & Lab Med, Sacramento, CA USA; [Wun, Ted] VA Northern Calif Hlth Care Syst, Sacramento, CA USA; [Styles, Lori; Kuypers, Frans] Childrens Hosp, Oakland, CA 94609 USA; [Styles, Lori; Kuypers, Frans] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; [DeCastro, Laura; Telen, Marilyn J.] Univ Pittsburgh, Div Hematol & Oncol, Pittsburgh, PA USA; [Kramer, William] Kramer Consulting LLC, North Potomac, MD USA; [Flanner, Henry; Magnani, John L.; Thackray, Helen] GlycoMimetics Inc, Gaithersburg, MD USA; [Rhee, Seungshin] Rho Inc, Chapel Hill, NC USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Rho	Wun, T (corresponding author), Univ Calif Davis, Sch Med, Div Hematol Oncol, Sacramento, CA 95817 USA.	ted.wun@ucdmc.ucdavis.edu	Wun, Ted/AAV-8140-2020	Wun, Ted/0000-0001-6383-7172; Telen, Marilyn/0000-0003-3809-1780	Glycomimetics, Inc.; NCATS, NIHGlycomimetics, Inc. [UL1 TR 000002]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000002] Funding Source: NIH RePORTER	Glycomimetics, Inc.; NCATS, NIHGlycomimetics, Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Glycomimetics, Inc. funded this clinical trial. Part of this research was carried out at the UC Davis CTSC Clinical Research Center, supported by the grant UL1 TR 000002, NCATS, NIHGlycomimetics, Inc. (H.T.) participated in the study design, data collection and analysis, decision to publish, and preparation of the manuscript in collaboration with the academic authors.	BERG EL, 1991, J BIOL CHEM, V266, P14869; BRITTAIN HA, 1993, BLOOD, V81, P2137; Bullard DC, 1996, J EXP MED, V183, P2329, DOI 10.1084/jem.183.5.2329; Canalli AA, 2008, HAEMATOLOGICA, V93, P605, DOI 10.3324/haematol.12119; Canalli AA, 2007, EUR J HAEMATOL, V79, P330, DOI 10.1111/j.1600-0609.2007.00926.x; Chang JS, 2010, BLOOD, V116, P1779, DOI 10.1182/blood-2009-12-260513; CHARACHE S, 1992, BLOOD, V79, P2555; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Charache S, 1997, SEMIN HEMATOL, V34, P15; Cheung ATW, 2012, J PEDIAT HEMATOL ONC, V34, P169, DOI 10.1097/MPH.0b013e31823c27ef; Cheung ATW, 2010, AM J HEMATOL, V85, P899, DOI 10.1002/ajh.21853; Cheung ATW, 2004, J INVEST MED, V52, P402, DOI 10.1136/jim-52-06-35; Cheung ATW, 2002, BLOOD, V99, P3999, DOI 10.1182/blood.V99.11.3999; Cheung ATW, 2001, BLOOD, V97, P3401, DOI 10.1182/blood.V97.11.3401; Embury SH, 2004, BLOOD, V104, P3378, DOI 10.1182/blood-2004-02-0713; Flanner H, 2009, J CLIN PHARMACOL, V49, P1105; Flanner HH, 2010, J CLIN PHARMACOL, V50, P1081; Frenette PS, 2007, J CLIN INVEST, V117, P850, DOI 10.1172/JCI30920; Frenette PS, 1997, THROMB HAEMOSTASIS, V78, P60; Frenette PS, 2004, MICROCIRCULATION, V11, P167, DOI 10.1080/10739680490278556; Frenette PS, 2002, CURR OPIN HEMATOL, V9, P101, DOI 10.1097/00062752-200203000-00003; Haynes J, 2008, AM J PHYSIOL-HEART C, V294, pH379, DOI 10.1152/ajpheart.01068.2007; Hebbel R P, 1980, Trans Assoc Am Physicians, V93, P94; HEBBEL RP, 1991, BLOOD, V77, P214; HEBBEL RP, 1980, NEW ENGL J MED, V302, P992, DOI 10.1056/NEJM198005013021803; Hidalgo A, 2009, NAT MED, V15, P384, DOI 10.1038/nm.1939; Johnson C, 2008, HAEMATOLOGICA, V93, P481, DOI 10.3324/haematol.12734; Kaul DK, 2009, MICROCIRCULATION, V16, P97, DOI 10.1080/10739680802279394; Leppanen A, 2000, J BIOL CHEM, V275, P39569, DOI 10.1074/jbc.M005005200; Lum AFH, 2004, AM J HEMATOL, V76, P126, DOI 10.1002/ajh.20059; Okpala H, 2004, BLOOD REV, V18, P65, DOI 10.1016/S0268-960X(03)00037-7; Parise Leslie V, 2003, Curr Hematol Rep, V2, P102; PLATT OS, 1994, NEW ENGL J MED, V330, P783, DOI 10.1056/NEJM199403173301110; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Saleh AW, 1999, ACTA HAEMATOL-BASEL, V102, P31, DOI 10.1159/000040964; Simon SI, 2005, ANNU REV BIOMED ENG, V7, P151, DOI 10.1146/annurev.bioeng.7.060804.100423; Steinberg MH, 1997, BLOOD, V89, P1078, DOI 10.1182/blood.V89.3.1078; Styles L, 2010, BLOOD, V116, P685; SWERLICK RA, 1993, BLOOD, V82, P1891; Turhan A, 2002, P NATL ACAD SCI USA, V99, P3047, DOI 10.1073/pnas.052522799; Vichinsky EP, 1997, BLOOD, V89, P1787, DOI 10.1182/blood.V89.5.1787.1787_1787_1792; Walmet PS, 2003, AM J HEMATOL, V73, P215, DOI 10.1002/ajh.10360; Wun T, 2002, CLIN LAB HAEMATOL, V24, P81; Wun T, 1999, BLOOD, V94, p198A; Zennadi R, 2008, TRANSFUS CLIN BIOL, V15, P23, DOI 10.1016/j.tracli.2008.04.009; Zennadi R, 2007, BLOOD, V110, P2708, DOI 10.1182/blood-2006-11-056101	47	50	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101301	10.1371/journal.pone.0101301	http://dx.doi.org/10.1371/journal.pone.0101301			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988449	Green Published, gold, Green Accepted			2022-12-27	WOS:000341354100074
J	Zaharieva, MM; Kirilov, M; Chai, MQ; Berger, SM; Konstantinov, S; Berger, MR				Zaharieva, Maya M.; Kirilov, Milen; Chai, Minquang; Berger, Stefan M.; Konstantinov, Spiro; Berger, Martin R.			Reduced Expression of the Retinoblastoma Protein Shows That the Related Signaling Pathway Is Essential for Mediating the Antineoplastic Activity of Erufosine	PLOS ONE			English	Article							ABL TYROSINE KINASE; CELL-CYCLE; C-ABL; TUMOR-SUPPRESSOR; INDUCED APOPTOSIS; RB; CANCER; ALKYLPHOSPHOCHOLINE; GENE; LEUKEMIA	Erufosine is a new antineoplastic agent of the group of alkylphosphocholines, which interferes with signal transduction and induces apoptosis in various leukemic and tumor cell lines. The present study was designed to examine for the first time the mechanism of resistance to erufosine in malignant cells with permanently reduced expression of the retinoblastoma (Rb) protein. Bearing in mind the high number of malignancies with reduced level of this tumor-suppressor, this investigation was deemed important for using erufosine, alone or in combination, in patients with compromised RB1 gene expression. For this purpose, clones of the leukemic T-cell line SKW-3 were used, which had been engineered to constantly express differently low Rb levels. The alkylphosphocholine induced apoptosis, stimulated the expression of the cyclin dependent kinase inhibitor p27(Kip1) and inhibited the synthesis of cyclin D3, thereby causing a G(2) phase cell cycle arrest and death of cells with wild type Rb expression. In contrast, Rb-deficiency impeded the changes induced by eru-fosine in the expression of these proteins and abrogated the induction of G(2) arrest, which was correlated with reduced antiproliferative and anticlonogenic activities of the compound. In conclusion, analysis of our results showed for the first time that the Rb signaling pathway is essential for mediating the antineoplastic activity of erufosine and its efficacy in patients with malignant diseases may be predicted by determining the Rb status.	[Zaharieva, Maya M.; Berger, Martin R.] German Canc Res Ctr, Toxicol & Chemotherapy Unit, Heidelberg, Germany; [Kirilov, Milen; Chai, Minquang] German Canc Res Ctr, Dept Mol Biol Cell 1, Heidelberg, Germany; [Berger, Stefan M.] Cent Inst Mental Hlth, Dept Mol Biol, Mannheim, Germany; [Konstantinov, Spiro] Med Univ Sofia, Fac Pharm, Dept Pharmacol Pharmacotherapy & Toxicol, Lab Mol Pharmacol & Expt Chemotherapy, Sofia, Bulgaria	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Central Institute of Mental Health; Medical University Sofia	Berger, MR (corresponding author), German Canc Res Ctr, Toxicol & Chemotherapy Unit, Heidelberg, Germany.	M.Berger@dkfz-heidelberg.de	Zaharieva, Maya Margaritova/ABH-8344-2020	Zaharieva, Maya Margaritova/0000-0001-8548-5649	Alexander von Humboldt Foundation	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	One of the authors (MMZ) was funded by the Alexander von Humboldt Foundation. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azkargorta M, 2006, PROTEOMICS, V6, pS42, DOI 10.1002/pmic.200500438; BENEDICT WF, 1990, J CLIN INVEST, V85, P988, DOI 10.1172/JCI114575; Berger MR, 2003, ANN NY ACAD SCI, V1010, P307, DOI 10.1196/annals.1299.054; Blanco R, 2009, HUM MUTAT, V30, P1199, DOI 10.1002/humu.21028; Borges HL, 2007, ONCOGENE, V26, P3868, DOI 10.1038/sj.onc.1210157; Borriello A, 2011, EXPERT OPIN THER TAR, V15, P677, DOI 10.1517/14728222.2011.561318; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Celeghini C, 2011, INVEST NEW DRUG, V29, P392, DOI 10.1007/s10637-009-9370-1; Chabner B, 2011, GOODMAN GILMANS PHAR; Chau BN, 2004, MOL CELL BIOL, V24, P4438, DOI 10.1128/MCB.24.10.4438-4447.2004; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Dean JL, 2010, ONCOGENE, V29, P68, DOI 10.1038/onc.2009.313; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dineva IK, 2012, J CANCER RES CLIN, V138, P1909, DOI 10.1007/s00432-012-1271-6; EIBL H, 1992, PROG EXP TUMOR RES, V34, P1; Erdlenbruch B, 1999, CANCER CHEMOTH PHARM, V44, P484, DOI 10.1007/s002800051122; Fiegl M, 2008, CANCER CHEMOTH PHARM, V62, P321, DOI 10.1007/s00280-007-0612-7; Goldberg Z, 2002, EMBO J, V21, P3715, DOI 10.1093/emboj/cdf384; Gudas JM, 1999, MOL CELL BIOL, V19, P612; He F, 2009, CANCER RES, V69, P9413, DOI 10.1158/0008-5472.CAN-09-2158; Infante A, 2008, CELL CYCLE, V7, P3915, DOI 10.4161/cc.7.24.7379; Jackson JG, 2006, MOL CELL BIOL, V26, P2501, DOI 10.1128/MCB.26.7.2501-2510.2006; Jakel H, 2011, ONCOGENE, V30, P3502, DOI 10.1038/onc.2011.68; Jendrossek V, 2003, ONCOGENE, V22, P2621, DOI 10.1038/sj.onc.1206355; Jendrossek V, 2002, CANCER CHEMOTH PHARM, V50, P71, DOI 10.1007/s00280-002-0440-8; Kapoor V, 2012, CANCER LETT, V319, P39, DOI 10.1016/j.canlet.2011.12.032; Knudsen ES, 2010, CLIN CANCER RES, V16, P1094, DOI 10.1158/1078-0432.CCR-09-0787; Konigs SK, 2010, LEUKEMIA RES, V34, P1064, DOI 10.1016/j.leukres.2009.12.003; Konstantinov SM, 1998, INT J CANCER, V77, P778, DOI 10.1002/(SICI)1097-0215(19980831)77:5<778::AID-IJC18>3.0.CO;2-Y; Konstantinov SM, 1998, CANCER CHEMOTH PHARM, V41, P210; Konstantinov SM, 1999, BRIT J HAEMATOL, V107, P365, DOI 10.1046/j.1365-2141.1999.01700.x; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Martelli AM, 2010, LEUKEMIA, V24, P687, DOI 10.1038/leu.2010.32; Mayhew CN, 2004, ONCOGENE, V23, P4107, DOI 10.1038/sj.onc.1207503; Metcalf RA, 2010, MODERN PATHOL, V23, P420, DOI 10.1038/modpathol.2009.173; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nagano K, 2006, ONCOGENE, V25, P493, DOI 10.1038/sj.onc.1208996; Ng KP, 2011, LEUKEMIA, V25, P1739, DOI 10.1038/leu.2011.159; Oberle C, 2005, BIOL CHEM, V386, P237, DOI 10.1515/BC.2005.029; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Opavsky R, 2007, P NATL ACAD SCI USA, V104, P15400, DOI 10.1073/pnas.0706307104; Ouillette P, 2010, CLIN CANCER RES, V16, P835, DOI 10.1158/1078-0432.CCR-09-2534; Pusapati RV, 2014, MOL CARCINOG, V49, P152; Raina D, 2005, J BIOL CHEM, V280, P11147, DOI 10.1074/jbc.M413787200; Reed CA, 2010, J BIOL CHEM, V285, P1089, DOI 10.1074/jbc.M109.043380; Reed MF, 2007, J SURG RES, V142, P364, DOI 10.1016/j.jss.2007.03.038; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; Seeley SL, 2007, CANCER LETT, V245, P205, DOI 10.1016/j.canlet.2006.01.028; Shaul Y, 2005, CELL RES, V15, P33, DOI 10.1038/sj.cr.7290261; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Troncone G, 2009, CANCER CYTOPATHOL, V117, P522, DOI 10.1002/cncy.20050; Wang JYJ, 2001, ACTA ONCOL, V40, P689; Wang JYJ, 2000, ONCOGENE, V19, P5643, DOI 10.1038/sj.onc.1203878; WELCH PJ, 1995, GENE DEV, V9, P31, DOI 10.1101/gad.9.1.31; WELCH PJ, 1993, CELL, V75, P779, DOI 10.1016/0092-8674(93)90497-E; Yosifov DY, 2007, CANCER BIOL THER, V6, P930, DOI 10.4161/cbt.6.6.4188; Yosifov DY, 2011, CANCER CHEMOTH PHARM, V67, P13, DOI 10.1007/s00280-010-1273-5; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366; Yuan ZM, 1997, P NATL ACAD SCI USA, V94, P1437, DOI 10.1073/pnas.94.4.1437; Zaharieva MM, 2007, ANN NY ACAD SCI, V1095, P182, DOI 10.1196/annals.1397.022	65	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100950	10.1371/journal.pone.0100950	http://dx.doi.org/10.1371/journal.pone.0100950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987858	Green Submitted, Green Published, gold			2022-12-27	WOS:000341354100052
J	Barnette, DN; VandeKopple, M; Wu, YG; Willoughby, DA; Lincoln, J				Barnette, Damien N.; VandeKopple, Matthew; Wu, Yonggan; Willoughby, David A.; Lincoln, Joy			RNA-Seq Analysis to Identify Novel Roles of Scleraxis during Embryonic Mouse Heart Valve Remodeling	PLOS ONE			English	Article							GENE-EXPRESSION; DISEASE; DIFFERENTIATION; TENDONS; CHICKEN; DOMAIN	Heart valve disease affects up to 30% of the population and has been shown to have origins during embryonic development. Valvulogenesis begins with formation of endocardial cushions in the atrioventricular canal and outflow tract regions. Subsequently, endocardial cushions remodel, elongate and progressively form mature valve structures composed of a highly organized connective tissue that provides the necessary biomechanical function throughout life. While endocardial cushion formation has been well studied, the processes required for valve remodeling are less well understood. The transcription factor Scleraxis (Scx) is detected in mouse valves from E15.5 during initial stages of remodeling, and expression remains high until birth when formation of the highly organized mature structure is complete. Heart valves from Scx(-/-) mice are abnormally thick and develop fibrotic phenotypes similar to human disease by juvenile stages. These phenotypes begin around E15.5 and are associated with defects in connective tissue organization and valve interstitial cell differentiation. In order to understand the etiology of this phenotype, we analyzed the transcriptome of remodeling valves isolated from E15.5 Scx(-/-) embryos using RNA-seq. From this, we have identified a profile of protein and non-protein mRNAs that are dependent on Scx function and using bioinformatics we can predict the molecular functions and biological processes affected by these genes. These include processes and functions associated with gene regulation (methyltransferase activity, DNA binding, Notch signaling), vitamin A metabolism (retinoic acid biosynthesis) and cellular development (cell morphology, cell assembly and organization). In addition, several mRNAs are affected by alternative splicing events in the absence of Scx, suggesting additional roles in post-transcriptional modification. In summary, our findings have identified transcriptome profiles from abnormal heart valves isolated from E15.5 Scx(-/-) embryos that could be used in the future to understand mechanisms of heart valve disease in the human population.	[Barnette, Damien N.] Leonard M Miller Sch Med, Mol & Cellular Pharmacol Grad Program, Miami, FL USA; [Barnette, Damien N.; VandeKopple, Matthew; Lincoln, Joy] Nationwide Childrens Hosp, Res Inst, Ctr Cardiovasc & Pulm Res, Columbus, OH 43210 USA; [Barnette, Damien N.; VandeKopple, Matthew; Lincoln, Joy] Nationwide Childrens Hosp, Res Inst, Ctr Heart, Columbus, OH USA; [VandeKopple, Matthew] Ohio State Univ, Mol Cellular & Dev Biol Grad Program, Columbus, OH 43210 USA; [Wu, Yonggan; Willoughby, David A.] Ocean Ridge Biosci LLC, Palm Beach Gardens, FL USA; [Lincoln, Joy] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Lincoln, J (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Cardiovasc & Pulm Res, Columbus, OH 43210 USA.	joy.lincoln@nationwidechildrens.org		Lincoln, Joy/0000-0003-1517-6888	NIH [NHLBI R01HL091878]; American Heart Association [PRE16270014]; Ocean Ridge Biosciences LLC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091878] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Ocean Ridge Biosciences LLC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH (NHLBI R01HL091878 (JL)) and The American Heart Association (PRE16270014 (DNB)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ocean Ridge Biosciences LLC provided support in the form of salaries for authors Yonggan Wu and David A. Willoughby, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors is articulated in the 'author contributions' section.	Bach DS, 2007, J HEART VALVE DIS, V16, P362; Bagchi RA, 2012, BBA-MOL CELL RES, V1823, P1936, DOI 10.1016/j.bbamcr.2012.07.002; Barnette DN, 2013, J MOL CELL CARDIOL; Bosse K, 2013, J MOL CELL CARDIOL, V60, P27, DOI 10.1016/j.yjmcc.2013.04.001; Breuer CK, 2004, TISSUE ENG, V10, P1725, DOI 10.1089/ten.2004.10.1725; Combs MD, 2009, CIRC RES, V105, P408, DOI 10.1161/CIRCRESAHA.109.201566; Espira L, 2009, J MOL CELL CARDIOL, V47, P188, DOI 10.1016/j.yjmcc.2009.03.024; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Gould R. A., 2010, J VIS EXP; Hinton RB, 2006, J HEART VALVE DIS, V15, P352; Janzen CJ, 2006, MOL CELL, V23, P497, DOI 10.1016/j.molcel.2006.06.027; Levay AK, 2008, CIRC RES, V103, P948, DOI 10.1161/CIRCRESAHA.108.177238; Li N, 2013, MICROSC MICROANAL, V19, P842, DOI 10.1017/S1431927613001633; Lincoln J, 2004, DEV DYNAM, V230, P239, DOI 10.1002/dvdy.20051; Lincoln J, 2011, BIRTH DEFECTS RES A, V91, P526, DOI 10.1002/bdra.20799; MacGrogan D, 2011, BIRTH DEFECTS RES A, V91, P449, DOI 10.1002/bdra.20815; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Person AD, 2005, INT REV CYTOL, V243, P287, DOI 10.1016/S0074-7696(05)43005-3; Rabkin E, 2001, CIRCULATION, V104, P2525, DOI 10.1161/hc4601.099489; Schoen FJ, 2008, CIRCULATION, V118, P1864, DOI 10.1161/CIRCULATIONAHA.108.805911; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Singer MS, 1998, GENETICS, V150, P613; Tao G, 2013, DEV DYNAM, V242, P699, DOI 10.1002/dvdy.23967; Tao G, 2012, CURR TOP DEV BIOL, V100, P203, DOI 10.1016/B978-0-12-387786-4.00006-3; Yamamoto K, 2013, J BIOL CHEM, V288, P21648, DOI 10.1074/jbc.M113.481424	26	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101425	10.1371/journal.pone.0101425	http://dx.doi.org/10.1371/journal.pone.0101425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983472	Green Published, gold, Green Submitted			2022-12-27	WOS:000339635000105
J	Jiao, TF; Wang, YJ; Zhang, QR; Yan, XH; Zhao, XQ; Zhou, JX; Gao, FM				Jiao, Tifeng; Wang, Yujin; Zhang, Qingrui; Yan, Xuehai; Zhao, Xiaoqing; Zhou, Jingxin; Gao, Faming			Self-Assembly and Headgroup Effect in Nanostructured Organogels via Cationic Amphiphile-Graphene Oxide Composites	PLOS ONE			English	Article							SENSITIZED SOLAR-CELLS; GRAPHITE OXIDE; POLYMER NANOCOMPOSITES; CHEMICAL-REDUCTION; IMIDE DERIVATIVES; IONIC LIQUIDS; HYDROGELS; NANOSHEETS; FABRICATION; SUPERCAPACITORS	Self-assembly of hierarchical graphene oxide (GO)-based nanomaterials with novel functions has received a great deal of attentions. In this study, nanostructured organogels based on cationic amphiphile-GO composites were prepared. The gelation behaviors of amphiphile-GO composites in organic solvents can be regulated by changing the headgroups of amphiphiles. Ammonium substituted headgroup in molecular structures in present self-assembled composites is more favorable for the gelation in comparison to pyridinium headgroup. A possible mechanism for headgroup effects on self-assembly and as-prepared nanostructures is proposed. It is believed that the present amphiphile-GO self-assembled system will provide an alternative platform for the design of new GO nanomaterials and soft matters.	[Jiao, Tifeng; Wang, Yujin; Zhang, Qingrui; Zhao, Xiaoqing; Zhou, Jingxin; Gao, Faming] Yanshan Univ, Sch Environm & Chem Engn, Hebei Key Lab Appl Chem, Qinhuangdao, Peoples R China; [Jiao, Tifeng; Yan, Xuehai] Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing, Peoples R China	Yanshan University; Chinese Academy of Sciences; Institute of Process Engineering, CAS	Jiao, TF (corresponding author), Yanshan Univ, Sch Environm & Chem Engn, Hebei Key Lab Appl Chem, Qinhuangdao, Peoples R China.	tfjiao@ysu.edu.cn; zhangqr@ysu.edu.cn; yanxh@home.ipe.ac.cn	Yan, Xuehai/E-8722-2012	Yan, Xuehai/0000-0002-0890-0340; Zhou, Jingxin/0000-0003-0471-1961; Jiao, Tifeng/0000-0003-1238-0277	National Natural Science Foundation of China [21207112]; Natural Science Foundation of Hebei Province [B2012203060, B2013203108]; Science Foundation for the Excellent Youth Scholars from Universities and Colleges of Hebei Province [Y2011113, YQ2013026]; Support Program for the Top Young Talents of Hebei Province; Open Foundation of National Key Laboratory of Biochemical Engineering, Institute of Process Engineering of CAS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); Science Foundation for the Excellent Youth Scholars from Universities and Colleges of Hebei Province; Support Program for the Top Young Talents of Hebei Province; Open Foundation of National Key Laboratory of Biochemical Engineering, Institute of Process Engineering of CAS	National Natural Science Foundation of China (No. 21207112), http://www.nsfc.gov.cn/, QZ; Natural Science Foundation of Hebei Province (Nos. B2012203060 and B2013203108) http://www.hensf.gov.cn/, QZ, TJ; Science Foundation for the Excellent Youth Scholars from Universities and Colleges of Hebei Province (Nos. Y2011113 and YQ2013026), http://www.hee.cn/, QZ, TJ; Support Program for the Top Young Talents of Hebei Province, http://www.hebei.gov.cn/, TJ; Open Foundation of National Key Laboratory of Biochemical Engineering, Institute of Process Engineering of CAS, http://www.ipe.cas.cn/, TJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari B, 2011, CHEM-EUR J, V17, P11488, DOI 10.1002/chem.201101360; Ahmad I, 2011, J MATER CHEM, V21, P16990, DOI 10.1039/c1jm11537e; Atsbeha T, 2011, J MOL STRUCT, V993, P459, DOI 10.1016/j.molstruc.2010.12.046; Bai H, 2011, J PHYS CHEM C, V115, P5545, DOI 10.1021/jp1120299; Bai H, 2010, CHEM COMMUN, V46, P2376, DOI 10.1039/c000051e; Bissessur R, 2006, SYNTHETIC MET, V156, P1023, DOI 10.1016/j.synthmet.2006.06.024; Bora C, 2012, POLYMER, V53, P923, DOI 10.1016/j.polymer.2011.12.054; Bose S, 2010, POLYMER, V51, P5921, DOI 10.1016/j.polymer.2010.10.014; Cheng QY, 2012, LANGMUIR, V28, P3005, DOI 10.1021/la204558f; Compton OC, 2010, SMALL, V6, P711, DOI 10.1002/smll.200901934; Fong C, 2012, CHEM SOC REV, V41, P1297, DOI 10.1039/c1cs15148g; Gao HC, 2013, ACS APPL MATER INTER, V5, P425, DOI 10.1021/am302500v; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; Greaves TL, 2008, CHEM REV, V108, P206, DOI 10.1021/cr068040u; Greaves TL, 2013, CHEM SOC REV, V42, P1096, DOI 10.1039/c2cs35339c; Gun J, 2012, ELECTROCHEM COMMUN, V19, P108, DOI 10.1016/j.elecom.2012.03.025; Guo CX, 2010, ANGEW CHEM INT EDIT, V49, P3014, DOI 10.1002/anie.200906291; Hang F, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0993; He QY, 2012, CHEM SCI, V3, P1764, DOI 10.1039/c2sc20205k; Huang CC, 2011, CHEM COMMUN, V47, P4962, DOI 10.1039/c1cc10412h; Huang H, 2013, SMALL, V9, P1397, DOI 10.1002/smll.201202965; Huang H, 2012, SOFT MATTER, V8, P4609, DOI 10.1039/c2sm25090j; Huang X, 2012, CHEM SOC REV, V41, P666, DOI 10.1039/c1cs15078b; Huang X, 2012, ADV MATER, V24, P5979, DOI 10.1002/adma.201201587; Huang X, 2011, SMALL, V7, P1876, DOI 10.1002/smll.201002009; HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017; Jiao TF, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-278; Jiao TF, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-160; Kaczmarek H, 2007, POLYM DEGRAD STABIL, V92, P939, DOI 10.1016/j.polymdegradstab.2007.03.013; Konwer S, 2011, J ELECTRON MATER, V40, P2248, DOI 10.1007/s11664-011-1749-z; Kumar NA, 2013, J MATER CHEM A, V1, P4431, DOI 10.1039/c3ta10337d; Kumar NA, 2012, J MATER CHEM, V22, P12268, DOI 10.1039/c2jm30701d; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Li D, 2008, SCIENCE, V320, P1170, DOI 10.1126/science.1158180; Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451; Mulet X, 2013, ACCOUNTS CHEM RES, V46, P1497, DOI 10.1021/ar300285u; Park KM, 2012, ACS NANO, V6, P2960, DOI 10.1021/nn204123p; Peigney A, 2001, CARBON, V39, P507, DOI 10.1016/S0008-6223(00)00155-X; Qi XY, 2013, NANOSCALE, V5, P1440, DOI 10.1039/c2nr33145d; Qi XY, 2010, ANGEW CHEM INT EDIT, V49, P9426, DOI 10.1002/anie.201004497; Qi XY, 2010, SMALL, V6, P663, DOI 10.1002/smll.200902221; Rao CNR, 2009, ANGEW CHEM INT EDIT, V48, P7752, DOI 10.1002/anie.200901678; Sharma A, 2009, INT J HYDROGEN ENERG, V34, P3977, DOI 10.1016/j.ijhydene.2009.02.068; Sheng KX, 2011, NEW CARBON MATER, V26, P9, DOI 10.1016/S1872-5805(11)60062-0; Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034; Sui ZY, 2011, CARBON, V49, P4314, DOI 10.1016/j.carbon.2011.06.006; Sun YQ, 2011, PHYS CHEM CHEM PHYS, V13, P17249, DOI 10.1039/c1cp22409c; Tai ZX, 2013, RSC ADV, V3, P12751, DOI 10.1039/c3ra22335c; Tao CA, 2012, J MATER CHEM, V22, P24856, DOI 10.1039/c2jm34461k; Titelman GI, 2005, CARBON, V43, P641, DOI 10.1016/j.carbon.2004.10.035; Vickery JL, 2009, ADV MATER, V21, P2180, DOI 10.1002/adma.200803606; Wang Z, 2013, J MATER SCI, V48, P2284, DOI 10.1007/s10853-012-7006-x; Wu SX, 2013, SMALL, V9, P1160, DOI 10.1002/smll.201202896; Xin H, 2011, J MOL LIQ, V160, P17, DOI 10.1016/j.molliq.2011.02.002; Xu YX, 2010, ACS NANO, V4, P7358, DOI 10.1021/nn1027104; Xu YX, 2010, ACS NANO, V4, P4324, DOI 10.1021/nn101187z; Xu YX, 2009, J AM CHEM SOC, V131, P13490, DOI 10.1021/ja905032g; Xue P, 2007, CHEM-EUR J, V13, P8231, DOI 10.1002/chem.200700321; Yan L, 2012, CHEM SOC REV, V41, P97, DOI 10.1039/c1cs15193b; Yan XH, 2008, CHEM MATER, V20, P1522, DOI 10.1021/cm702931b; Yang SB, 2010, ANGEW CHEM INT EDIT, V49, P4795, DOI 10.1002/anie.201001634; Zhang L, 2006, COLLOID SURFACE A, V284, P130, DOI 10.1016/j.colsurfa.2005.11.013; Zhang L, 2011, J PHYS CHEM C, V115, P17206, DOI 10.1021/jp204036a; Zhang XT, 2011, J MATER CHEM, V21, P6494, DOI 10.1039/c1jm10239g; Zhu PL, 2010, CHEM-EUR J, V16, P3176, DOI 10.1002/chem.200902139; Zu SZ, 2009, J PHYS CHEM C, V113, P13651, DOI 10.1021/jp9035887	67	25	25	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101620	10.1371/journal.pone.0101620	http://dx.doi.org/10.1371/journal.pone.0101620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983466	Green Submitted, Green Published, gold			2022-12-27	WOS:000339635000125
J	Kim, H; Meyer, K; Di Bisceglie, AM; Ray, R				Kim, Hangeun; Meyer, Keith; Di Bisceglie, Adrian M.; Ray, Ranjit			Inhibition of C3 Convertase Activity by Hepatitis C Virus as an Additional Lesion in the Regulation of Complement Components	PLOS ONE			English	Article							FACTOR-I DEFICIENCY; DISEASE ASSOCIATIONS; FACTOR-H; SYSTEM; INFECTIONS; PROTEINS	We have previously reported that in vitro HCV infection of cells of hepatocyte origin attenuates complement system at multiple steps, and attenuation also occurs in chronically HCV infected liver, irrespective of the disease stage. However, none of these regulations alone completely impaired complement pathways. Modulation of the upstream proteins involved in proteolytic processing of the complement cascade prior to convertase formation is critical in promoting the function of the complement system in response to infection. Here, we examined the regulation of C2 complement expression in hepatoma cells infected in vitro with cell culture grown virus, and validated our observations using randomly selected chronically HCV infected patient liver biopsy specimens. C2 mRNA expression was significantly inhibited, and classical C3 convertase (C4b2a) decreased. In separate experiments for C3 convertase function, C3b deposition onto bacterial membrane was reduced using HCV infected patient sera as compared to uninfected control, suggesting impaired C3 convertase. Further, iC3b level, a proteolytically inactive form of C3b, was lower in HCV infected patient sera, reflecting impairment of both C3 convertase and Factor I activity. The expression level of Factor I was significantly reduced in HCV infected liver biopsy specimens, while Factor H level remained unchanged or enhanced. Together, these results suggested that inhibition of C3 convertase activity is an additional cumulative effect for attenuation of complement system adopted by HCV for weakening innate immune response.	[Kim, Hangeun; Meyer, Keith; Di Bisceglie, Adrian M.; Ray, Ranjit] St Louis Univ, Dept Internal Med, St Louis, MO 63103 USA; [Di Bisceglie, Adrian M.; Ray, Ranjit] St Louis Univ, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA	Saint Louis University; Saint Louis University	Ray, R (corresponding author), St Louis Univ, Dept Internal Med, St Louis, MO 63103 USA.	rayr@slu.edu			NIDDK [DK080812]; NAID [U54-AI057160]; Internal Blue Ribbon Fund of Saint Louis University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080812] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NAID; Internal Blue Ribbon Fund of Saint Louis University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by research grants DK080812 from NIDDK, U54-AI057160 from the NAID to the Midwest Regional Center of Excellence (MRCE) for Biodefense and Emerging Infectious Diseases Research, and the Internal Blue Ribbon Fund of Saint Louis University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadei N, 2001, SCAND J IMMUNOL, V53, P615, DOI 10.1046/j.1365-3083.2001.00931.x; Banerjee A, 2011, J VIROL, V85, P4157, DOI 10.1128/JVI.02449-10; DAY NK, 1975, J EXP MED, V141, P1464, DOI 10.1084/jem.141.6.1464; de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; Egan AM, 1996, INFECT IMMUN, V64, P4952, DOI 10.1128/IAI.64.12.4952-4959.1996; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; FIGUEROA JE, 1991, CLIN MICROBIOL REV, V4, P359, DOI 10.1128/CMR.4.3.359-395.1991; Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231; Jonsson G, 2005, MEDICINE, V84, P23, DOI 10.1097/01.md.0000152371.22747.1e; Kanda T, 2006, J VIROL, V80, P4633, DOI 10.1128/JVI.80.9.4633-4639.2006; Klenerman P, 2012, QJM-INT J MED, V105, P29, DOI 10.1093/qjmed/hcr231; Kwan WH, 2012, IMMUNOL RES, V54, P247, DOI 10.1007/s12026-012-8327-1; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Mawatari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082094; Mayilyan KR, 2012, PROTEIN CELL, V3, P487, DOI 10.1007/s13238-012-2924-6; Mazumdar B, 2013, J VIROL, V87, P7902, DOI [10.1128/JVI.00917-13, 10.1128/JVI.00174-13]; Mazumdar B, 2012, J VIROL, V86, P2221, DOI 10.1128/JVI.06577-11; Nilsson SC, 2010, J BIOL CHEM, V285, P6235, DOI 10.1074/jbc.M109.097212; Nilsson SC, 2009, EUR J IMMUNOL, V39, P310, DOI 10.1002/eji.200838702; Okroj M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047245; Petrovic D, 2012, EUR J IMMUNOL, V42, P17, DOI 10.1002/eji.201141593; Pickering M C, 2000, Adv Immunol, V76, P227; Qin XB, 2006, CELL MOL IMMUNOL, V3, P333; Ray RB, 2000, VIROLOGY, V271, P197, DOI 10.1006/viro.2000.0295; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; Skattum L, 2011, MOL IMMUNOL, V48, P1643, DOI 10.1016/j.molimm.2011.05.001; Tedesco F, 2008, VACCINE, V26, pI3, DOI 10.1016/j.vaccine.2008.11.010; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	29	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101422	10.1371/journal.pone.0101422	http://dx.doi.org/10.1371/journal.pone.0101422			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983375	Green Submitted, Green Published, gold			2022-12-27	WOS:000339635000104
J	Ursing, J; Rombo, L; Rodrigues, A; Aaby, P; Kofoed, PE				Ursing, Johan; Rombo, Lars; Rodrigues, Amabelia; Aaby, Peter; Kofoed, Poul-Erik			Malaria Transmission in Bissau, Guinea-Bissau between 1995 and 2012: Malaria Resurgence Did Not Negatively Affect Mortality	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; UNCOMPLICATED MALARIA; CHILDREN; CHLOROQUINE; AGE; QUININE; AREA; AMODIAQUINE; MORBIDITY; AFRICA	INTRODUCTION: As Plasmodium falciparum prevalence decreases in many parts of Sub-Saharan Africa, so does immunity resulting in larger at risk populations and increased risk of malaria resurgence. In Bissau, malaria prevalence decreased from ?50% to 3% between 1995 and 2003. The epidemiological characteristics of P. falciparum malaria within Bandim health and demographic surveillance site (population similar to 100000) between 1995 and 2012 are described. METHODS AND FINDINGS: The population was determined by census. 3603 children aged <15 years that were enrolled in clinical trials at the Bandim health centre (1995-2012) were considered incident cases. The mean annual malaria incidence per thousand children in 1995-1997, 1999-2003, 2007, 2011, 2012 were as follows; age <5 years 22 -> 29 -> 4 -> 9 -> 3, age 5-9 years 15 -> 28 -> 4 -> 33 -> 12, age 10-14 years 9 -> 15 -> 1 -> 45 -> 19. There were 4 campaigns (2003-2010) to increase use of insecticide treated bed nets (ITN) amongst children <5 years. An efficacious high-dose chloroquine treatment regime was routinely used until artemisinin based combination therapy (ACT) was introduced in 2008. Long lasting insecticide treated bed nets (LLIN) were distributed in 2011. By 2012 there was 1 net per 2 people and 97% usage. All-cause mortality decreased from post-war peaks in 1999 until 2012 in all age groups and was not negatively affected by malaria resurgence. CONCLUSION: The cause of decreasing malaria incidence (1995-2007) was probably multifactorial and coincident with the use of an efficacious high-dose chloroquine treatment regime. Decreasing malaria prevalence created a susceptible group of older children in which malaria resurged, highlighting the need to include all age groups in malaria interventions. ACT did not hinder malaria resurgence. Mass distribution of LLINs probably curtailed malaria epidemics. All-cause mortality was not negatively affected by malaria resurgence.	[Ursing, Johan; Rodrigues, Amabelia; Aaby, Peter; Kofoed, Poul-Erik] Projecto Saude Bandim, Indepth Network, Bissau, Guinea Bissau; [Ursing, Johan; Rombo, Lars] Karolinska Univ Hosp, Dept Med, Infect Dis Unit, Malaria Res Lab, Stockholm, Sweden; [Ursing, Johan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Solna, Sweden; [Rombo, Lars] Malarsjukhuset, Dept Infect Dis, Eskilstuna, Sweden; [Rombo, Lars] Sormland Cty Council, Clin Res Ctr, Eskilstuna, Sweden; [Kofoed, Poul-Erik] Kolding Cty Hosp, Dept Paediat, Kolding, Denmark	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Kolding Hospital	Ursing, J (corresponding author), Projecto Saude Bandim, Indepth Network, Bissau, Guinea Bissau.	johan.ursing@karolinska.se; pekofoed@dadlnet.dk		Aaby, Peter/0000-0001-8331-1389; Ursing, Johan/0000-0002-5508-9327	Anthony Cerami and Ann Dunne Foundation for World Health; Stockholms Lans Landsting [K0603-2010]	Anthony Cerami and Ann Dunne Foundation for World Health; Stockholms Lans Landsting	This work was supported by awards from the Anthony Cerami and Ann Dunne Foundation for World Health and Stockholms Lans Landsting (K0603-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242; Craig MH, 2004, TROP MED INT HEALTH, V9, P1258, DOI 10.1111/j.1365-3156.2004.01341.x; Imbert P, 1997, T ROY SOC TROP MED H, V91, P22, DOI 10.1016/S0035-9203(97)90380-1; Kofoed PE, 2003, T ROY SOC TROP MED H, V97, P429, DOI 10.1016/S0035-9203(03)90078-2; Kofoed PE, 2003, ACTA TROP, V86, P67, DOI 10.1016/S0001-706X(03)00018-4; Kofoed PE, 2002, T ROY SOC TROP MED H, V96, P304, DOI 10.1016/S0035-9203(02)90107-0; Kofoed PE, 2002, T ROY SOC TROP MED H, V96, P185, DOI 10.1016/S0035-9203(02)90298-1; Kofoed PE, 1997, T ROY SOC TROP MED H, V91, P462, DOI 10.1016/S0035-9203(97)90286-8; Kofoed PE, 1999, T ROY SOC TROP MED H, V93, P547, DOI 10.1016/S0035-9203(99)90377-2; Kofoed PE, 2002, AM J TROP MED HYG, V67, P28, DOI 10.4269/ajtmh.2002.67.28; Kofoed PE, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-148; Kofoed PE, 2007, T ROY SOC TROP MED H, V101, P231, DOI 10.1016/j.trstmh.2006.05.008; LISSE IM, 1994, T ROY SOC TROP MED H, V88, P709, DOI 10.1016/0035-9203(94)90242-9; Marsh K, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P241; Modiano D, 1998, AM J TROP MED HYG, V59, P539, DOI 10.4269/ajtmh.1998.59.539; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; O'Meara WP, 2008, AM J TROP MED HYG, V79, P185, DOI 10.4269/ajtmh.2008.79.185; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Okiro EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-285; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Rodrigues A, 2013, AVALIACAO IMPACTO CA; Rodrigues A, 2010, EVALUATION CHANGES M; Rodrigues A, 2008, TROP MED INT HEALTH, V13, P410, DOI 10.1111/j.1365-3156.2008.02016.x; Snow RW, 2004, AM J TROP MED HYG, V71, P16, DOI 10.4269/ajtmh.2004.71.16; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Sodemann M, 1999, AM J TROP MED HYG, V61, P336, DOI 10.4269/ajtmh.1999.61.336; Teklehaimanot HD, 2009, AM J TROP MED HYG, V80, P133, DOI 10.4269/ajtmh.2009.80.133; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3; Ursing J, 2007, INFECT GENET EVOL, V7, P555, DOI 10.1016/j.meegid.2007.03.006; Ursing J, 2007, AM J TROP MED HYG, V76, P844, DOI 10.4269/ajtmh.2007.76.844; Ursing J, 2011, J INFECT DIS, V203, P109, DOI 10.1093/infdis/jiq001; Ursing J, 2009, ANTIMICROB AGENTS CH, V53, P180, DOI 10.1128/AAC.01111-08	35	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101167	10.1371/journal.pone.0101167	http://dx.doi.org/10.1371/journal.pone.0101167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984039	gold, Green Published, Green Submitted			2022-12-27	WOS:000339635000062
J	Cheung, CMG; Li, X; Mathur, R; Lee, SY; Chan, CM; Yeo, I; Loh, BK; Williams, R; Wong, EYM; Wong, D; Wong, TY				Cheung, Chui Ming Gemmy; Li, Xiang; Mathur, Ranjana; Lee, Shu Yen; Chan, Choi Mun; Yeo, Ian; Loh, Boon Kwang; Williams, Rachel; Wong, Edmund Yick-Mun; Wong, Doric; Wong, Tien Yin			A Prospective Study of Treatment Patterns and 1-Year Outcome of Asian Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy	PLOS ONE			English	Article							QUALITY-OF-LIFE; PHOTODYNAMIC THERAPY; RANIBIZUMAB TREATMENT; INTRAVITREAL BEVACIZUMAB; VERTEPORFIN; SAFETY; PREVALENCE; EFFICACY	Objective: To study the treatment patterns and visual outcome over one year in Asian patients with choroidal neovascular membrane secondary to age-related macular degeneration (AMD-CNV) and polypoidal choroidal vasculopathy (PCV). Design: Prospective cohort, non-interventional study. Methods: 132 treatment-naive patients who received treatment for AMD-CNV and PCV were included. All patients underwent standardized examination procedures including retinal imaging at baseline and follow-up. AMD-CNV and PCV were defined on fundus fluorescein angiography and indocyanine green angiography at baseline. Patients were treated according to standard of care. We report the visual acuity (VA) and optical coherence tomography (OCT) measurements at baseline, month 3 and month 12 The factors influencing month 12 outcomes were analyzed. Main Outcome Measure: Type of treatment, number of Anti-vascular endothelial growth factor (VEGF) treatments, visual outcome over one year. Results: Anti-VEGF monotherapy was the initial treatment in 89.1% of AMD-CNV, but only 15.1% of PCV. The mean number of anti-VEGF injections up to month 12 was 3.97 (4.51 AMD-CNV, 3.43 PCV, p = 0.021). Baseline OCT, month 3 OCT and month 3 VA were significant in determining continuation of treatment after month 3. At month12, mean VA improved from 0.82 (similar to 20/132) at baseline to 0.68 (similar to 20/96) at month 12 (mean gain 6.5 ETDRS letters, p = 0.002). 34.2% of eyes (38/113 eyes) gained >= 15 ETDRS letters and 14.4% (16/113 eyes) lost >= 15 ETDRS letters. There were no significant differences in visual outcome between AMD-CNV and PCV (p = 0.51). Factors predictive of month 12 visual outcome were baseline VA, baseline OCT central macular thickness, month 3 VA and age. Conclusions: There is significant variation in treatment patterns in Asian eyes with exudative maculopathy. There is significant visual improvement in all treatment groups at one year. These data highlight the need for high quality clinical trial data to provide evidence-based management of Asian AMD.	[Cheung, Chui Ming Gemmy; Mathur, Ranjana; Lee, Shu Yen; Chan, Choi Mun; Yeo, Ian; Loh, Boon Kwang; Wong, Edmund Yick-Mun; Wong, Doric; Wong, Tien Yin] Singapore Natl Eye Ctr, Vitreoretinal Serv, Singapore, Singapore; [Cheung, Chui Ming Gemmy; Li, Xiang; Wong, Tien Yin] Singapore Eye Res Inst, Singapore, Singapore; [Cheung, Chui Ming Gemmy; Wong, Tien Yin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore; [Cheung, Chui Ming Gemmy; Wong, Tien Yin] Duke NUS Grad Med Sch, Ophthalmol Acad Clin Program, Singapore, Singapore; [Li, Xiang] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Williams, Rachel] GlaxoSmithKline, R&D Projects, Clin Platforms & Sci, Worldwide Epidemiol, Philadelphia, PA USA	Singapore National Eye Center; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; National University of Singapore; GlaxoSmithKline	Cheung, CMG (corresponding author), Singapore Natl Eye Ctr, Vitreoretinal Serv, Singapore, Singapore.	gemmy.cheung.c.m@snec.com.sg	Wong, Tien Yin/AAC-9724-2020	Wong, Tien Yin/0000-0002-8448-1264; Cheung, Chui Ming Gemmy/0000-0003-3358-3516; Wong, Damon/0000-0003-4601-9121	National Medical Research Council [NMRC/NIG/1003/2009]; GlaxoSimthKline [WEUSKOP5855]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); GlaxoSimthKline	This study was supported by National Medical Research Council grant: NMRC/NIG/1003/2009; GlaxoSimthKline Research and Development Protocol WEUSKOP5855. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashshur ZF, 2008, AM J OPHTHALMOL, V145, P249, DOI 10.1016/j.ajo.2007.09.031; Bressler NM, 1999, ARCH OPHTHALMOL-CHIC, V117, P1329; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Chakravarthy U, 2013, LANCET, V382, P1258, DOI 10.1016/S0140-6736(13)61501-9; Chan WM, 2004, OPHTHALMOLOGY, V111, P1576, DOI 10.1016/j.ophtha.2003.12.056; Cheung CMG, 2011, NEW ENGL J MED, V365, P2237, DOI 10.1056/NEJMc1107895; Cheung CMG, 2013, GRAEF ARCH CLIN EXP, V251, P19, DOI 10.1007/s00417-012-2029-1; Cohen SY, 2009, AM J OPHTHALMOL, V148, P409, DOI 10.1016/j.ajo.2009.04.001; Curtis LH, 2012, AM J OPHTHALMOL, V153, P1116, DOI 10.1016/j.ajo.2011.11.032; Finger RP, 2013, ACTA OPHTHALMOL, V91, P540, DOI 10.1111/j.1755-3768.2012.02493.x; Gomi F, 2008, BRIT J OPHTHALMOL, V92, P70, DOI 10.1136/bjo.2007.122283; Gomi F, 2008, OPHTHALMOLOGY, V115, P141, DOI 10.1016/j.ophtha.2007.02.031; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Hjelmqvist L, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/405724; Holz FG, 2013, BRIT J OPHTHALMOL, V97, P1161, DOI 10.1136/bjophthalmol-2013-303232; Japanese Study Group of Polypoidal Choroidal Vasculopathy, 2005, Nippon Ganka Gakkai Zasshi, V109, P417; Kang S, 2011, JPN J OPHTHALMOL, V55, P123, DOI 10.1007/s10384-010-0910-1; Kawasaki R, 2010, OPHTHALMOLOGY, V117, P921, DOI 10.1016/j.ophtha.2009.10.007; Klein R, 2006, OPHTHALMOLOGY, V113, P373, DOI 10.1016/j.ophtha.2005.12.013; Koh A, 2012, RETINA-J RET VIT DIS, V32, P1453, DOI 10.1097/IAE.0b013e31824f91e8; Koh AHC, 2013, RETINA-J RET VIT DIS, V33, P686, DOI 10.1097/IAE.0b013e3182852446; Kurashige Y, 2008, AM J OPHTHALMOL, V146, P513, DOI 10.1016/j.ajo.2008.05.025; Lai TYY, 2008, BRIT J OPHTHALMOL, V92, P661, DOI 10.1136/bjo.2007.135103; Lamoureux EL, 2011, BRIT J OPHTHALMOL, V95, P666, DOI 10.1136/bjo.2010.185207; Laude A, 2010, PROG RETIN EYE RES, V29, P19, DOI 10.1016/j.preteyeres.2009.10.001; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; *MAC PHOT STUD GRO, 1991, ARCH OPHTHALMOL-CHIC, V109, P1219; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Pushpoth S, 2012, BRIT J OPHTHALMOL, V96, P1469, DOI 10.1136/bjophthalmol-2012-302167; Rakic JM, 2013, CLIN OPHTHALMOL, V7, P1849, DOI 10.2147/OPTH.S49385; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481	33	42	43	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101057	10.1371/journal.pone.0101057	http://dx.doi.org/10.1371/journal.pone.0101057			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978485	Green Published, gold, Green Submitted			2022-12-27	WOS:000338506400069
J	Johnson, DC; Bhatta, MP; Smith, JS; Kempf, MC; Broker, TR; Vermund, SH; Chamot, E; Aryal, S; Lhaki, P; Shrestha, S				Johnson, Derek C.; Bhatta, Madhav P.; Smith, Jennifer S.; Kempf, Mirjam-Colette; Broker, Thomas R.; Vermund, Sten H.; Chamot, Eric; Aryal, Shilu; Lhaki, Pema; Shrestha, Sadeep			Assessment of High-Risk Human Papillomavirus Infections Using Clinician- and Self-Collected Cervical Sampling Methods in Rural Women from Far Western Nepal	PLOS ONE			English	Article							HPV DNA; SCREENING METHOD; POOLED ANALYSIS; CANCER; PREVALENCE; SPECIMENS; METAANALYSIS; POPULATION; WORLDWIDE; KNOWLEDGE	Introduction: Nepal has one of the highest cervical cancer rates in South Asia. Only a few studies in populations from urban areas have investigated type specific distribution of human papillomavirus (HPV) in Nepali women. Data on high-risk HPV (HR-HPV) types are not currently available for rural populations in Nepal. We aimed to assess the distribution of HR-HPV among rural Nepali women while assessing self-collected and clinician-collected cervico-vaginal specimens as sample collection methods for HPV screening. Methods: Study participants were recruited during a health camp conducted by Nepal Fertility Care Center in Achham District of rural far western Nepal. Women of reproductive age completed a socio-demographic and clinical questionnaire, and provided two specimens; one cervical-vaginal specimen using a self-collection method and another cervical specimen collected by health camp auxiliary nurse midwives during a pelvic examination. All samples were tested for 14 different HR-HPV mRNA and also specific for HPV16/18/45 mRNA. Results: Of 261 women with both clinician-and self-collected cervical samples, 25 tested positive for HR-HPV, resulting in an overall HR-HPV prevalence of 9.6% (95% confidence Interval [CI]: 6.3-13.8). The overall Kappa value assessing agreement between clinician-and self-collected tests was 0.62 (95% CI: 0.43-0.81), indicating a "good" level of agreement. Abnormal cytology was reported for 8 women. One woman identified with squamous cell carcinoma (SCC), and 7 women with high grade squamous intraepithelial lesions (HSIL). Seven of the 8 women tested positive for HR-HPV (87.5%) in clinician-collected samples and 6 in self-collected samples (75.0%). Conclusion: This is the first study to assess HR-HPV among rural Nepali women. Self-collected sampling methods should be the subject of additional research in Nepal for screening HR-HPV, associated with pre-cancer lesions and cancer, in women in rural areas with limited access to health services.	[Johnson, Derek C.; Chamot, Eric; Shrestha, Sadeep] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [Bhatta, Madhav P.] Kent State Univ, Coll Publ Hlth, Kent, OH 44242 USA; [Smith, Jennifer S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Kempf, Mirjam-Colette] Univ Alabama Birmingham, Sch Nursing, Birmingham, AL USA; [Kempf, Mirjam-Colette] Univ Alabama Birmingham, Dept Hlth Behav, Birmingham, AL USA; [Broker, Thomas R.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL USA; [Vermund, Sten H.] Vanderbilt Univ, Inst Global Hlth, Nashville, TN 37235 USA; [Aryal, Shilu] Nepal Family Hlth Div, Kathmandu, Nepal; [Lhaki, Pema] Nepal Fertil Care Ctr, Kathmandu, Nepal	University of Alabama System; University of Alabama Birmingham; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University of North Carolina; University of North Carolina Chapel Hill; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Vanderbilt University	Shrestha, S (corresponding author), Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA.	sshrestha@uab.edu	Vermund, Sten/AAD-3592-2020	Vermund, Sten/0000-0001-7289-8698	Department of Epidemiology, UAB School of Public Health (EC SS); National Institutes of Health Cancer Prevention and Control Training Grant [R25CA47888]; NATIONAL CANCER INSTITUTE [R25CA047888] Funding Source: NIH RePORTER	Department of Epidemiology, UAB School of Public Health (EC SS); National Institutes of Health Cancer Prevention and Control Training Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported in part by the pilot fund from the Department of Epidemiology, UAB School of Public Health (EC & SS). Derek Johnson was supported by a National Institutes of Health Cancer Prevention and Control Training Grant (R25CA47888). Hologic/GenProbe Inc. (San Diego) donated reagents and kits and provided testing of HPV, STI and liquid cytology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NAT POP HOUS CENS 20; Arbyn M, 2014, LANCET ONCOL, V15, P172, DOI 10.1016/S1470-2045(13)70570-9; Arbyn M, 2013, INT J CANCER, V132, P101, DOI 10.1002/ijc.27636; Baral Y R, 2010, Kathmandu Univ Med J (KUMJ), V8, P325; Bhatla N, 2008, VACCINE, V26, P2811, DOI 10.1016/j.vaccine.2008.03.047; Bhusal CL, 2012, WHO S E ASIA J PUBLI, V1, P4; Binu V, 2007, ASIAN PAC J CANCER P, V8, P183; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Central Bureau of Statistics & UNICEF Nepal., 2012, NEP MULT IND CLUST S; Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9; Cuzick J, 2013, BRIT J CANCER, V108, P908, DOI 10.1038/bjc.2013.22; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Department of Health Services Ministry of Health & Population, 2010, NAT GUID CERV CANC S; Dhakal HP, 2009, J NEPAL MED ASSOC, V48, P301; Franco EL, 2012, VACCINE, V30, pF175, DOI 10.1016/j.vaccine.2012.06.092; Gok M, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1040; International Agency for Research on Cancer (IARC), 2005, IARC HDB CANC PREV C; Johnson D, 2014, KATHMANDU U IN PRESS; Lazcano-Ponce E, 2011, LANCET, V378, P1868, DOI 10.1016/S0140-6736(11)61522-5; Ministry of Health and Population (MOHP) [Nepal] New ERA & ICF International Inc, 2012, NEP DEM HLTH SURV 20; Monsonego J, 2012, GYNECOL ONCOL, V125, P175, DOI 10.1016/j.ygyno.2012.01.002; Nepal Living Standards Survey, 2010, NEP LIV STAND SURV 2; Poertner E, 2011, CRIT ASIAN STUD, V43, P23, DOI 10.1080/14672715.2011.537850; Poudel KC, 2004, TROP MED INT HEALTH, V9, P897, DOI 10.1111/j.1365-3156.2004.01276.x; Pradhan B, 2007, Kathmandu Univ Med J (KUMJ), V5, P461; Rositch AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040766; Salmeron J, 2003, CANCER CAUSE CONTROL, V14, P505, DOI 10.1023/A:1024806707399; Sherpa ATL, 2010, CANCER CAUSE CONTROL, V21, P323, DOI 10.1007/s10552-009-9467-z; Smith JS, 2008, J ADOLESCENT HEALTH, V43, pS5, DOI 10.1016/j.jadohealth.2008.07.009; Snijders PJF, 2013, INT J CANCER, V132, P2223, DOI 10.1002/ijc.27790; Srivastava S, 2012, J BIOSCIENCES, V37, P63, DOI 10.1007/s12038-012-9181-y; Ting J, 2013, SEX TRANSM DIS, V40, P584, DOI 10.1097/OLQ.0b013e31828e5a91; Wheeler CM, 2013, OBSTET GYN CLIN N AM, V40, P165, DOI 10.1016/j.ogc.2013.02.004; WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre), HUM PAP REL CANC NEP; Wright TC, 2000, JAMA-J AM MED ASSOC, V283, P81, DOI 10.1001/jama.283.1.81; Wright TC, 2003, NEW ENGL J MED, V348, P489, DOI 10.1056/NEJMp020178; Zhao FH, 2012, J NATL CANCER I, V104, P178, DOI 10.1093/jnci/djr532	37	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101255	10.1371/journal.pone.0101255	http://dx.doi.org/10.1371/journal.pone.0101255			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978811	Green Submitted, gold, Green Published			2022-12-27	WOS:000338506400106
J	Rego, ROM; Bestor, A; Stefka, J; Rosa, PA				Rego, Ryan O. M.; Bestor, Aaron; Stefka, Jan; Rosa, Patricia A.			Population Bottlenecks during the Infectious Cycle of the Lyme Disease Spirochete Borrelia burgdorferi	PLOS ONE			English	Article							SENSU-STRICTO; PEROMYSCUS-LEUCOPUS; NORTH-AMERICA; TICKS; MICE; HOST; DISSEMINATION; TRANSMISSION; DYNAMICS; STRAINS	Borrelia burgdorferi is a zoonotic pathogen whose maintenance in nature depends upon an infectious cycle that alternates between a tick vector and mammalian hosts. Lyme disease in humans results from transmission of B. burgdorferi by the bite of an infected tick. The population dynamics of B. burgdorferi throughout its natural infectious cycle are not well understood. We addressed this topic by assessing the colonization, dissemination and persistence of B. burgdorferi within and between the disparate mammalian and tick environments. To follow bacterial populations during infection, we generated seven isogenic but distinguishable B. burgdorferi clones, each with a unique sequence tag. These tags resulted in no phenotypic changes relative to wild type organisms, yet permitted highly sensitive and specific detection of individual clones by PCR. We followed the composition of the spirochete population throughout an experimental infectious cycle that was initiated with a mixed inoculum of all clones. We observed heterogeneity in the spirochete population disseminating within mice at very early time points, but all clones displayed the ability to colonize most mouse tissues by 3 weeks of infection. The complexity of clones subsequently declined as murine infection persisted. Larval ticks typically acquired a reduced and variable number of clones relative to what was present in infected mice at the time of tick feeding, and maintained the same spirochete population through the molt to nymphs. However, only a random subset of infectious spirochetes was transmitted to naive mice when these ticks next fed. Our results clearly demonstrate that the spirochete population experiences stochastic bottlenecks during both acquisition and transmission by the tick vector, as well as during persistent infection of its murine host. The experimental system that we have developed can be used to further explore the forces that shape the population of this vector-borne bacterial pathogen throughout its infectious cycle.	[Rego, Ryan O. M.; Bestor, Aaron; Rosa, Patricia A.] NIAID, Lab Zoonot Pathogens, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA; [Stefka, Jan] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Stefka, Jan] ASCR, Ctr Biol, Inst Parasitol, Ceske Budejovice, Czech Republic	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Rego, ROM (corresponding author), NIAID, Lab Zoonot Pathogens, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.	ryanrego@paru.cas.cz	Štefka, Jan/N-3924-2019; Štefka, Jan/G-9267-2014; Rego, Ryan Oliver Marino O. M./G-9773-2014; Rego, Ryan O. M./AAL-1316-2020	Štefka, Jan/0000-0002-1283-9730; Štefka, Jan/0000-0002-1283-9730; Rego, Ryan Oliver Marino O. M./0000-0001-6932-0940; Rego, Ryan O. M./0000-0001-6932-0940	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000917] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2006, APPL ENVIRON MICROB, V72, P5331, DOI 10.1128/AEM.00014-06; ANDERSON JF, 1984, YALE J BIOL MED, V57, P627; Andersson M, 2013, AM NAT, V181, P545, DOI 10.1086/669905; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; BARBOUR AG, 1993, SCIENCE, V260, P1610, DOI 10.1126/science.8503006; Barbour AG, 2010, MBIO, V1, DOI 10.1128/mBio.00153-10; Barnes PD, 2006, J EXP MED, V203, P1591, DOI 10.1084/jem.20060905; Bestor A, 2012, INFECT IMMUN, V80, P3501, DOI 10.1128/IAI.00521-12; Binder SC, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00104; Boonstra R, 2012, OECOLOGIA, V168, P601, DOI 10.1007/s00442-011-2120-z; Brisson D, 2004, GENETICS, V168, P713, DOI 10.1534/genetics.104.028738; Brisson D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022926; Bunikis J, 2004, J INFECT DIS, V189, P1515, DOI 10.1086/382594; Bunikis J, 2004, MICROBIOL-SGM, V150, P1741, DOI 10.1099/mic.0.26944-0; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Coward C, 2008, APPL ENVIRON MICROB, V74, P3857, DOI 10.1128/AEM.02835-07; de Silva AM, 2009, FRONT BIOSCI-LANDMRK, V14, P3051, DOI 10.2741/3434; Derdakova M, 2004, APPL ENVIRON MICROB, V70, P6783, DOI 10.1128/AEM.70.11.6783-6788.2004; Dolan MC, 2004, INFECT IMMUN, V72, P5262, DOI 10.1128/IAI.72.9.5262-5266.2004; DONAHUE JG, 1987, AM J TROP MED HYG, V36, P92, DOI 10.4269/ajtmh.1987.36.92; Dunham-Ems SM, 2009, J CLIN INVEST, V119, P3652, DOI 10.1172/JCI39401; Elias AF, 2003, J MOL MICROB BIOTECH, V6, P29, DOI 10.1159/000073406; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; Ellis TC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003567; Flowerdew JR, 2004, MAMMAL REV, V34, P31, DOI 10.1046/j.0305-1838.2003.00025.x; Forrester NL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002897; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Grant AJ, 2008, PLOS BIOL, V6, P757, DOI 10.1371/journal.pbio.0060074; Grimm D, 2004, INFECT IMMUN, V72, P5938, DOI 10.1128/IAI.72.10.5938-5946.2004; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; Gutierrez S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003009; Hajdusek O, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00026; Herrmann C, 2013, APPL ENVIRON MICROB, V79, P7273, DOI 10.1128/AEM.02158-13; Hunfeld KP, 2006, WIEN KLIN WOCHENSCHR, V118, P659, DOI 10.1007/s00508-006-0693-z; Imai DM, 2013, LAB INVEST, V93, P900, DOI 10.1038/labinvest.2013.81; Imai DM, 2013, INFECT IMMUN, V81, P1663, DOI 10.1128/IAI.01359-12; Jewett MW, 2007, MOL MICROBIOL, V64, P1358, DOI 10.1111/j.1365-2958.2007.05746.x; JOHNSON RC, 1984, INT J SYST BACTERIOL, V34, P496, DOI 10.1099/00207713-34-4-496; Kazimirova M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00043; KELLY R, 1971, SCIENCE, V173, P443, DOI 10.1126/science.173.3995.443; Kim HC, 2013, SYST APPL ACAROL-UK, V18, P201, DOI 10.11158/saa.18.3.1; LANE RS, 1991, ANNU REV ENTOMOL, V36, P587, DOI 10.1146/annurev.en.36.010191.003103; LEVINE JF, 1985, AM J TROP MED HYG, V34, P355, DOI 10.4269/ajtmh.1985.34.355; Liang FT, 2004, AM J PATHOL, V165, P977, DOI 10.1016/S0002-9440(10)63359-7; Liveris D, 2011, J CLIN MICROBIOL, V49, P2166, DOI 10.1128/JCM.00350-11; Mihalca AD, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-266; Nadelman RB, 2012, NEW ENGL J MED, V367, P1883, DOI 10.1056/NEJMoa1114362; Narasimhan S, 2007, CELL HOST MICROBE, V2, P7, DOI 10.1016/j.chom.2007.06.001; Oberle M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001023; Ohnishi J, 2003, J BACTERIOL, V185, P4432, DOI 10.1128/JB.185.15.4432-4441.2003; Ohnishi J, 2001, P NATL ACAD SCI USA, V98, P670, DOI 10.1073/pnas.98.2.670; OLSEN B, 1993, NATURE, V362, P340, DOI 10.1038/362340a0; OLSEN B, 1995, APPL ENVIRON MICROB, V61, P3082; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Rauter C, 2005, APPL ENVIRON MICROB, V71, P7203, DOI 10.1128/AEM.71.11.7203-7216.2005; Restif O, 2009, MICROBE, V4, P176; RIBEIRO JMC, 1987, J MED ENTOMOL, V24, P201, DOI 10.1093/jmedent/24.2.201; Rosa PA, 2005, NAT REV MICROBIOL, V3, P129, DOI 10.1038/nrmicro1086; Samuels D S, 1995, Methods Mol Biol, V47, P253; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; Sarkar A, 2009, ANTIMICROB AGENTS CH, V53, P4490, DOI 10.1128/AAC.00558-09; Schuijt TJ, 2011, CELL HOST MICROBE, V10, P136, DOI 10.1016/j.chom.2011.06.010; Schwartz DJ, 2011, INFECT IMMUN, V79, P4250, DOI 10.1128/IAI.05339-11; Seinost G, 1999, ARCH DERMATOL, V135, P1329, DOI 10.1001/archderm.135.11.1329; SINSKY RJ, 1989, J CLIN MICROBIOL, V27, P1723, DOI 10.1128/JCM.27.8.1723-1727.1989; Stewart PE, 2006, INFECT IMMUN, V74, P3547, DOI 10.1128/IAI.00158-06; Tilly K, 2007, INFECT IMMUN, V75, P1517, DOI 10.1128/IAI.01725-06; Tilly K, 2006, INFECT IMMUN, V74, P3554, DOI 10.1128/IAI.01950-05; Troy EB, 2013, INFECT IMMUN, V81, P2347, DOI 10.1128/IAI.00266-13; Tsao JI, 2009, VET RES, V40, DOI 10.1051/vetres/2009019; Vuong HB, 2013, INFECT GENE IN PRESS; Walters MS, 2012, MBIO, V3, DOI 10.1128/mBio.00303-11; Wormser GP, 2008, J INFECT DIS, V198, P1358, DOI 10.1086/592279	74	37	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101009	10.1371/journal.pone.0101009	http://dx.doi.org/10.1371/journal.pone.0101009			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979342	Green Submitted, Green Published, gold			2022-12-27	WOS:000338506400061
J	Karahalios, A; Simpson, JA; Baglietto, L; MacInnis, RJ; Hodge, AM; Giles, GG; English, DR				Karahalios, Amalia; Simpson, Julie A.; Baglietto, Laura; MacInnis, Robert J.; Hodge, Allison M.; Giles, Graham G.; English, Dallas R.			Change in Body Size and Mortality: Results from the Melbourne Collaborative Cohort Study	PLOS ONE			English	Article							INTENTIONAL WEIGHT-LOSS; ALL-CAUSE MORTALITY; MASS INDEX; OLD-AGE; WAIST CIRCUMFERENCE; RISK; OBESITY; DEATH; ASSOCIATION; HYPERTENSION	Background: The association between change in weight or body mass index, and mortality is widely reported, however, both measures fail to account for fat distribution. Change in waist circumference, a measure of central adiposity, in relation to mortality has not been studied extensively. Methods: We investigated the association between mortality and changes in directly measured waist circumference, hips circumference and weight from baseline (1990-1994) to wave 2 (2003-2007) in a prospective cohort study of people aged 40-69 years at baseline. Cox regression, with age as the time metric and follow-up starting at wave 2, adjusted for confounding variables, was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for change in body size in relation to mortality from all causes, cardiovascular disease and cancer. Results: There were 1465 deaths (109 cancer, 242 cardiovascular disease) identified during an average 7.7 years of follow-up from 21 298 participants. Compared to minimal increase in body size, loss of waist circumference (HR: 1.26; 95% CI: 1.09-1.47), weight (1.80; 1.54-2.11), or hips circumference (1.35; 1.15-1.57) were associated with an increased risk of all-cause mortality, particularly for older adults. Weight loss was associated with cardiovascular disease mortality (2.40; 1.57-3.65) but change in body size was not associated with obesity-related cancer mortality. Conclusion: This study confirms the association between weight loss and increased mortality from all-causes for older adults. Based on evidence from observational cohort studies, weight stability may be the recommended option for most adults, especially older adults.	[Karahalios, Amalia; Simpson, Julie A.; Baglietto, Laura; English, Dallas R.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia; [Karahalios, Amalia; Simpson, Julie A.; Baglietto, Laura; MacInnis, Robert J.; Hodge, Allison M.; Giles, Graham G.; English, Dallas R.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia	University of Melbourne; Cancer Council Victoria	Karahalios, A (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia.	emily.karahalios@unimelb.edu.au	Simpson, Julie A/P-7299-2014; Baglietto, Laura/AAB-9051-2019; English, Dallas/AAH-5005-2019	English, Dallas/0000-0001-7828-8188; Baglietto, Laura/0000-0002-8193-7529; Simpson, Julie/0000-0002-2660-2013; Giles, Graham/0000-0003-4946-9099; MacInnis, Robert/0000-0002-1627-5047; Hodge, Allison/0000-0001-5464-2197	National Health & Medical Research Council (NHMRC) [209057, 251533]; Vic-Health [1998-0406]; NHMRC Centre of Research Excellence [1035261]; Australian Brewers' Foundation; Australian Postgraduate Award	National Health & Medical Research Council (NHMRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)National Health and Medical Research Council (NHMRC) of Australia); Vic-Health; NHMRC Centre of Research Excellence(National Health and Medical Research Council (NHMRC) of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Australian Brewers' Foundation; Australian Postgraduate Award(Australian Government)	This work was supported by National Health & Medical Research Council (NHMRC) [grant numbers 209057, 251533], Vic-Health (grant number 1998-0406), NHMRC Centre of Research Excellence [grant number 1035261]. Further infrastructure support was provided by the Cancer Council Victoria, and funding was received from the Australian Brewers' Foundation to collect alcohol data in wave 2. AK is funded by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bales CW, 2008, J AM MED DIR ASSOC, V9, P302, DOI 10.1016/j.jamda.2008.01.006; Bamia C, 2010, J INTERN MED, V268, P133, DOI 10.1111/j.1365-2796.2010.02219.x; Berentzen T, 2006, NUTR REV, V64, P502, DOI [10.1301/nr.2006.nov.502507, 10.1111/j.1753-4887.2006.tb00183.x]; Berentzen TL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013097; Blanton CA, 1999, P SOC EXP BIOL MED, V221, P153, DOI 10.1046/j.1525-1373.1999.d01-70.x; Breeze E, 2006, INT J EPIDEMIOL, V35, P169, DOI 10.1093/ije/dyi212; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Cameron AJ, 2012, INT J EPIDEMIOL, V41, P484, DOI 10.1093/ije/dyr198; Corrada MM, 2006, AM J EPIDEMIOL, V163, P938, DOI 10.1093/aje/kwj114; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; de Hollander EL, 2013, J AM MED DIR ASSOC, V14, P187, DOI 10.1016/j.jamda.2012.09.023; de Hollander EL, 2012, INT J EPIDEMIOL, V41, P805, DOI 10.1093/ije/dys008; Donini LM, 2012, J NUTR HEALTH AGING, V16, P89, DOI 10.1007/s12603-011-0073-x; Flegal KM, 2011, AM J EPIDEMIOL, V173, P1, DOI 10.1093/aje/kwq341; Giles G G, 2002, IARC Sci Publ, V156, P69; Gregg EW, 2003, ANN INTERN MED, V138, P383, DOI 10.7326/0003-4819-138-5-200303040-00007; Harrington M, 2009, NUTR RES REV, V22, P93, DOI 10.1017/S0954422409990035; Hernan MA, 2002, AM J EPIDEMIOL, V155, P176, DOI 10.1093/aje/155.2.176; Hodge A, 2000, AUST NZ J PUBL HEAL, V24, P576, DOI 10.1111/j.1467-842X.2000.tb00520.x; Ireland P, 1994, Asia Pac J Clin Nutr, V3, P19; Kanaya AM, 2003, AM J EPIDEMIOL, V158, P1161, DOI 10.1093/aje/kwg271; Karahalios A, 2013, EMERG THEMES EPIDEMI, V10, DOI 10.1186/1742-7622-10-6; Landi F, 2013, AGE AGEING, V42, P203, DOI 10.1093/ageing/afs194; Lee CG, 2011, J AM GERIATR SOC, V59, P233, DOI 10.1111/j.1532-5415.2010.03245.x; Lohman T. G., 1998, ANTROPOMETRIC STANDA; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Magliano D, 2003, AUST NZ J PUBL HEAL, V27, P649, DOI 10.1111/j.1467-842X.2003.tb00615.x; Masters RK, 2013, AM J EPIDEMIOL, V177, P431, DOI 10.1093/aje/kws325; McLennan W, 1996, INTRO SOCIO EC INDEX; Myrskyla M, 2009, EPIDEMIOLOGY, V20, P840, DOI 10.1097/EDE.0b013e3181b5f520; Newman AB, 2001, J AM GERIATR SOC, V49, P1309, DOI 10.1046/j.1532-5415.2001.49258.x; Peeters A, 2007, ANN SURG, V246, P1028, DOI 10.1097/SLA.0b013e31814a6929; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Poirier P, 2005, HYPERTENSION, V45, P363, DOI 10.1161/01.HYP.0000155463.90018.dc; Richman EL, 2010, J INTERN MED, V268, P103, DOI 10.1111/j.1365-2796.2010.02227.x; Sauvaget C, 2008, INT J EPIDEMIOL, V37, P990, DOI 10.1093/ije/dyn059; Shrier I, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-70; Simonsen MK, 2008, NUTR REV, V66, P375, DOI 10.1111/j.1753-4887.2008.00047.x; Sjostrom CD, 1999, OBES RES, V7, P477; Somes GW, 2002, AM J EPIDEMIOL, V156, P132, DOI 10.1093/aje/kwf019; StataCorp, 2009, STAT STAT SOFTW REL; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; Trichopoulou A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2337; Yaari S, 1998, AM J EPIDEMIOL, V148, P546, DOI 10.1093/oxfordjournals.aje.a009680	44	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e99672	10.1371/journal.pone.0099672	http://dx.doi.org/10.1371/journal.pone.0099672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BA	24988430	Green Published, Green Submitted, gold			2022-12-27	WOS:000341354100017
J	Lu, MC; Yan, ST; Yin, WY; Koo, M; Lai, NS				Lu, Ming-Chi; Yan, Shih-Tang; Yin, Wen-Yao; Koo, Malcolm; Lai, Ning-Sheng			Risk of Rheumatoid Arthritis in Patients with Type 2 Diabetes: A Nationwide Population-Based Case-Control Study	PLOS ONE			English	Article							INSULIN-RESISTANCE; SMOKING; IMMUNE; INFLAMMATION; PREVALENCE; MARKERS	Objective: Type 2 diabetes is associated with chronic, low-grade inflammation and could potentially trigger the progression of other, more prominent inflammatory diseases such as rheumatoid arthritis (RA). Therefore, we aimed to investigate the risk of incident RA in Taiwanese patients with type 2 diabetes using a population-based health claims database. Methods: This nationwide, population-based, case-control study used administrative data to identify 1,416 patients with RA (age >= 20 years) as cases and 7,080 controls that were frequency-matched for sex, 10-year age group, and year of catastrophic illness certificate application date (index year). All subjects were retrospectively traced back, up to 13 years prior to the index year, for their first diagnosis of type 2 diabetes. Logistic regression analysis was conducted to quantify the association between incident RA and type 2 diabetes. Results: The odds of developing RA were significantly higher in female (odds ratio [OR] 1.46, 95% confidence interval [95% CI] 1.24-1.72) but not in male (OR 1.00, 95% CI 0.72-1.37) patients who had previously diagnosed with type 2 diabetes. Subgroup analysis indicated that the odds of developing RA were more prominent in younger females (20 to 44 years of age) with type 2 diabetes. In addition, the odds of developing RA in female patients with type 2 diabetes were higher in those with a shorter time interval between the diagnosis of type 2 diabetes and RA. Conclusions: This large nationwide, population-based, case-control study showed an elevated risk of RA in female Taiwanese patients with type 2 diabetes. Our findings were consistent with the hypothesis that chronic low-grade inflammation in type 2 diabetes may elicit the development of RA in genetically susceptible individuals.	[Lu, Ming-Chi; Lai, Ning-Sheng] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan; [Lu, Ming-Chi; Yin, Wen-Yao; Lai, Ning-Sheng] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Yan, Shih-Tang] Dalin Tzu Chi Hosp, Div Endocrinol & Metab, Buddhist Tzu Chi Med Fdn, Chiayi, Taiwan; [Yin, Wen-Yao] Dalin Tzu Chi Hosp, Div Gen Surg, Buddhist Tzu Chi Med Fdn, Chiayi, Taiwan; [Koo, Malcolm] Dalin Tzu Chi Hosp, Dept Med Res, Buddhist Tzu Chi Med Fdn, Chiayi, Taiwan; [Koo, Malcolm] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1A1, Canada	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; University of Toronto	Koo, M (corresponding author), Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan.	m.koo@utoronto.ca; tzuchilai@gmail.com	Koo, Malcolm/AAE-5822-2020	Koo, Malcolm/0000-0002-9242-9167				Abdullah A, 2010, DIABETES RES CLIN PR, V89, P309, DOI 10.1016/j.diabres.2010.04.012; [Anonymous], 2013, NAT HLTH INS RES DAT; Aroor AR, 2013, METABOLISM, V62, P1543, DOI 10.1016/j.metabol.2013.07.001; Baka Z, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2751; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CALDWELL JR, 1991, SEMIN ARTHRITIS RHEU, V21, P1, DOI 10.1016/0049-0172(91)90051-Z; Cefalu WT, 2009, DIABETES, V58, P307, DOI 10.2337/db08-1656; Chen MF, 2010, FORMOSAN J RHEUMATOL, V24, P64; Chung SJ, 2011, YONSEI MED J, V52, P113, DOI 10.3349/ymj.2011.52.1.113; Dessein PH, 2004, J RHEUMATOL, V31, P867; Dubreuil M, 2014, RHEUMATOLOGY, V53, P346, DOI 10.1093/rheumatology/ket343; Rodriguez LAG, 2009, SCAND J RHEUMATOL, V38, P173, DOI 10.1080/03009740802448825; Goldberg RB, 2009, J CLIN ENDOCR METAB, V94, P3171, DOI 10.1210/jc.2008-2534; Goldfine AB, 2013, ANN INTERN MED, V159, P1, DOI 10.7326/0003-4819-159-1-201307020-00003; Hemminki K, 2009, DIABETOLOGIA, V52, P1820, DOI 10.1007/s00125-009-1427-3; Kim EJ, 2013, RHEUMATOL INT, V33, P2135, DOI 10.1007/s00296-013-2670-y; Kolb H, 2005, DIABETOLOGIA, V48, P1038, DOI 10.1007/s00125-005-1764-9; Kuo CF, 2013, RHEUMATOL INT, V33, P355, DOI 10.1007/s00296-012-2411-7; Lai NS, 2014, ARTHRIT CARE RES, V66, P371, DOI 10.1002/acr.22146; Lin CC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-318; Mancuso CA, 2007, ARTHRIT RHEUM-ARTHR, V57, P672, DOI 10.1002/art.22689; Mirjafari H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3476; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Solomon DH, 2011, JAMA-J AM MED ASSOC, V305, P2525, DOI 10.1001/jama.2011.878; Solomon DH, 2010, ANN RHEUM DIS, V69, P2114, DOI 10.1136/ard.2009.125476; Stolt P, 2003, ANN RHEUM DIS, V62, P835, DOI 10.1136/ard.62.9.835; Su CC, 2013, J RHEUMATOL, V40, P1513, DOI 10.3899/jrheum.121259; Tsai YW, 2008, J WOMENS HEALTH, V17, P971, DOI 10.1089/jwh.2007.0621; van de Sande MGH, 2011, ANN RHEUM DIS, V70, P772, DOI 10.1136/ard.2010.139527; van Steenbergen HW, 2013, ARTHRITIS RHEUM-US, V65, P2219, DOI 10.1002/art.38013; Vasunilashorn S, 2013, J OBES, V2013; VOIGT LF, 1994, EPIDEMIOLOGY, V5, P525; Wang X, 2013, DIABETES CARE, V36, P166, DOI 10.2337/dc12-0702; Wasko MCM, 2007, JAMA-J AM MED ASSOC, V298, P187, DOI 10.1001/jama.298.2.187	35	33	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101528	10.1371/journal.pone.0101528	http://dx.doi.org/10.1371/journal.pone.0101528			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988532	Green Submitted, Green Published, gold			2022-12-27	WOS:000341354100107
J	Sturtzel, C; Testori, J; Schweighofer, B; Bilban, M; Hofer, E				Sturtzel, Caterina; Testori, Julia; Schweighofer, Bernhard; Bilban, Martin; Hofer, Erhard			The Transcription Factor MEF2C Negatively Controls Angiogenic Sprouting of Endothelial Cells Depending on Oxygen	PLOS ONE			English	Article							VEGF-INDUCED ANGIOGENESIS; GROWTH-FACTOR RECEPTORS; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; ALPHA(2)-MACROGLOBULIN; NOTCH; IDENTIFICATION; DETERMINES; DISEASE; PLASMA	The MADS box transcription factor MEF2C has been detected by us to be upregulated by the angiogenic factors VEGF-A and bFGF in endothelial cells. We have here investigated its potential role for angiogenesis. MEF2C was surprisingly found to strongly inhibit angiogenic sprouting, whereas a dominant negative mutant rather induced sprouting. The factor mainly affected migratory processes of endothelial cells, but not proliferation. In gene profiling experiments we delineated the alpha-2-macroglobulin gene to be highly upregulated by MEF2C. Further data confirmed that MEF2C in endothelial cells indeed induces alpha-2-macroglobulin mRNA as well as the secretion of alpha-2-macroglobulin and that conditioned supernatants of cells overexpressing MEF2C inhibit sprouting. Alpha-2-macroglobulin mediates, at least to a large extent, the inhibitory effects of MEF2C as is shown by knockdown of alpha-2-macroglobulin mRNA by lentiviral shRNA expression which reduces the inhibitory effect. However, under hypoxic conditions the VEGF-A/bFGF-mediated upregulation of MEF2C is reduced and the production of alpha-2-macroglobulin largely abolished. Taken together, this suggests that the MEF2C/alpha-2-macroglobulin axis functions in endothelial cells as a negative feed-back mechanism that adapts sprouting activity to the oxygen concentration thus diminishing inappropriate and excess angiogenesis.	[Sturtzel, Caterina; Testori, Julia; Schweighofer, Bernhard; Hofer, Erhard] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Vienna, Austria; [Bilban, Martin] Med Univ Vienna, Dept Lab Med, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Hofer, E (corresponding author), Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Vienna, Austria.	erhard.hofer@meduniwien.ac.at		Bilban, Martin/0000-0001-7043-7142; Sturtzel, Caterina/0000-0003-1002-5634	Austrian Academy of Sciences [22689]; Austrian Science Fund [P-21291-B11]; European Commission [FP7-Health-2009-222995]; DOC-fFORTE fellowship of the Austrian Academy of Sciences	Austrian Academy of Sciences; Austrian Science Fund(Austrian Science Fund (FWF)); European Commission(European CommissionEuropean Commission Joint Research Centre); DOC-fFORTE fellowship of the Austrian Academy of Sciences	This project was supported by grants of the Austrian Academy of Sciences (22689), the Austrian Science Fund (P-21291-B11) and the European Commission (FP7-Health-2009-222995). CS was a recipient of a DOC-fFORTE fellowship of the Austrian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Bhattacharjee G, 2000, J BIOL CHEM, V275, P26806; Bi WZ, 1999, DEV BIOL, V211, P255, DOI 10.1006/dbio.1999.9307; Cante-Barrett K, 2013, ONCOGENE; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Critser PJ, 2011, CELL PROLIFERAT, V44, P15, DOI 10.1111/j.1365-2184.2010.00719.x; de Lorenc LB, 2005, CLIN CHEM LAB MED, V43, P1183, DOI 10.1515/CCLM.2005.205; del Toro R, 2010, BLOOD, V116, P4025, DOI 10.1182/blood-2010-02-270819; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Fontana V, 2011, BASIC CLIN PHARMACOL, V109, P130, DOI 10.1111/j.1742-7843.2011.00698.x; Green MR, 2012, MOL CLONING LAB MANU, Vxxxiii, P1161; Hayashi M, 2004, J CLIN INVEST, V113, P1138, DOI 10.1172/JCI200419890; Hickey MM, 2006, CURR TOP DEV BIOL, V76, P217, DOI 10.1016/S0070-2153(06)76007-0; Hofer E, 2007, THROMB HAEMOSTASIS, V97, P355, DOI 10.1160/TH06-08-0470; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Liu D, 2008, ONCOGENE, V27, P2989, DOI 10.1038/sj.onc.1210959; Liu D, 2003, ARTERIOSCL THROM VAS, V23, P2002, DOI 10.1161/01.ATV.0000098644.03153.6F; Lucerna M, 2006, CANCER RES, V66, P6708, DOI 10.1158/0008-5472.CAN-05-2732; Maiti D, 2008, INVEST OPHTH VIS SCI, V49, P3640, DOI 10.1167/iovs.08-1760; Mathew S, 2003, BIOCHEM J, V374, P123, DOI 10.1042/BJ20021655; MEHL JW, 1964, SCIENCE, V145, P821, DOI 10.1126/science.145.3634.821; Minucci S, 1997, P NATL ACAD SCI USA, V94, P11295, DOI 10.1073/pnas.94.21.11295; Mocchegiani E, 2011, CURR OPIN PULM MED, V17, pS11, DOI 10.1097/01.mcp.0000410743.98087.12; Pallavi SK, 2012, EMBO J, V31, P2895, DOI 10.1038/emboj.2012.129; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Rivera CG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024887; Schweighofer B, 2009, THROMB HAEMOSTASIS, V102, P544, DOI 10.1160/TH08-12-0830; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Tauber S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-200; Tchetverikov I, 2004, ANN RHEUM DIS, V63, P881, DOI 10.1136/ard.2003.013243; Testori J, 2011, BLOOD, V117, P2735, DOI 10.1182/blood-2010-07-293209; Urbich C, 2009, BLOOD, V113, P5669, DOI 10.1182/blood-2009-01-196485; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Vong LH, 2005, GENESIS, V43, P43, DOI 10.1002/gene.20152; Wang WY, 2010, BLOOD, V115, P2971, DOI 10.1182/blood-2009-05-224824; Wilson-Rawls J, 1999, MOL CELL BIOL, V19, P2853; WOJTA J, 1989, J BIOL CHEM, V264, P2846; Xu ZH, 2012, AM J PATHOL, V180, P2548, DOI 10.1016/j.ajpath.2012.02.021; Young A, 2009, ARTERIOSCL THROM VAS, V29, P1902, DOI 10.1161/ATVBAHA.109.193540; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhao DZ, 2011, INT J CANCER, V128, P2602, DOI 10.1002/ijc.25600	44	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101521	10.1371/journal.pone.0101521	http://dx.doi.org/10.1371/journal.pone.0101521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988463	gold, Green Published, Green Submitted			2022-12-27	WOS:000341354100106
J	Gao, J; Ohtsubo, M; Hotta, Y; Minoshima, S				Gao, Jie; Ohtsubo, Masafumi; Hotta, Yoshihiro; Minoshima, Shinsei			Oligomerization of Optineurin and Its Oxidative Stressor E50K Mutation-Driven Covalent Cross-Linking: Possible Relationship with Glaucoma Pathology	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; RETINAL GANGLION-CELLS; PROTEIN-PROTEIN INTERACTIONS; BLUE NATIVE ELECTROPHORESIS; OPEN-ANGLE GLAUCOMA; ALZHEIMERS-DISEASE; GOLGI-APPARATUS; GLOBAL DATA; TNF-ALPHA	The optineurin gene, OPTN, is one of the causative genes of primary open-angle glaucoma. Although oligomerization of optineurin in cultured cells was previously observed by gel filtration analysis and blue native gel electrophoresis (BNE), little is known about the characteristics of optineurin oligomers. Here, we aimed to analyze the oligomeric state of optineurin and factors affecting oligomerization, such as environmental stimuli or mutations in OPTN. Using BNE or immunoprecipitation followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), we demonstrated that both endogenous and transfected optineurin exist as oligomers, rather than monomers, in NIH3T3 cells. We also applied an in situ proximity ligation assay to visualize the self-interaction of optineurin in fixed HeLaS3 cells and found that the optineurin oligomers were localized diffusely in the cytoplasm. Optineurin oligomers were usually detected as a single band of a size equal to that of the optineurin monomer upon SDS-PAGE, while an additional protein band of a larger size was observed when cells were treated with H2O2. We showed that larger protein complex is optineurin oligomers by immunoprecipitation and termed it covalent optineurin oligomers. In cells expressing OPTN bearing the most common glaucoma-associated mutation, E50K, covalent oligomers were formed even without H2O2 stimulation. Antioxidants inhibited the formation of E50K-induced covalent oligomers to various degrees. A series of truncated constructs of OPTN was used to reveal that covalent oligomers may be optineurin trimers and that the ubiquitin-binding domain is essential for formation of these trimers. Our results indicated that optineurin trimers may be the basic unit of these oligomers. The oligomeric state can be affected by many factors that induce covalent bonds, such as H2O2 or E50K, as demonstrated here; this provides novel insights into the pathogenicity of E50K. Furthermore, regulation of the oligomeric state should be studied in the future.	[Gao, Jie; Ohtsubo, Masafumi; Minoshima, Shinsei] Hamamatsu Univ Sch Med, Med Photon Res Ctr, Basic Med Photon Lab, Dept Photomed Genom, Hamamatsu, Shizuoka 4313192, Japan; [Gao, Jie; Hotta, Yoshihiro] Hamamatsu Univ Sch Med, Dept Ophthalmol, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Ohtsubo, M (corresponding author), Hamamatsu Univ Sch Med, Med Photon Res Ctr, Basic Med Photon Lab, Dept Photomed Genom, Hamamatsu, Shizuoka 4313192, Japan.	masa.oh@hama-med.ac.jp	Hotta, Yoshihiro/O-5115-2019	Hotta, Yoshihiro/0000-0003-4052-5066	JSPS KAKENHI [24592622]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the JSPS KAKENHI Grant Number 24592622. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agou F, 2004, J BIOL CHEM, V279, P27861, DOI 10.1074/jbc.M314278200; Agou F, 2002, J BIOL CHEM, V277, P17464, DOI 10.1074/jbc.M201964200; Anborgh PH, 2005, J BIOL CHEM, V280, P34840, DOI 10.1074/jbc.M504508200; Aung T, 2005, INVEST OPHTH VIS SCI, V46, P2816, DOI 10.1167/iovs.04-1133; Chalasani ML, 2007, INVEST OPHTH VIS SCI, V48, P1607, DOI 10.1167/iovs.06-0834; Chi ZL, 2010, HUM MOL GENET, V19, P2606, DOI 10.1093/hmg/ddq146; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; De Marco N, 2006, J BIOL CHEM, V281, P16147, DOI 10.1074/jbc.M601467200; del Toro D, 2009, MOL BIOL CELL, V20, P1478, DOI 10.1091/mbc.E08-07-0726; FRIGUET B, 1994, J BIOL CHEM, V269, P21639; GRANT AJ, 1992, BIOCHIM BIOPHYS ACTA, V1134, P203, DOI 10.1016/0167-4889(92)90177-D; Hattula K, 2000, CURR BIOL, V10, P1603, DOI 10.1016/S0960-9822(00)00864-2; Hauser MA, 2006, J GLAUCOMA, V15, P358, DOI 10.1097/01.ijg.0000212255.17950.42; HENSLEY K, 1995, J NEUROCHEM, V65, P2146; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Ivins FJ, 2009, BIOCHEM J, V421, P243, DOI 10.1042/BJ20090427; Izzotti A, 2003, AM J MED, V114, P638, DOI 10.1016/S0002-9343(03)00114-1; Korac J, 2013, J CELL SCI, V126, P580, DOI 10.1242/jcs.114926; Krishnan S, 2003, BIOCHEMISTRY-US, V42, P829, DOI 10.1021/bi026528t; Li YG, 1998, MOL CELL BIOL, V18, P1601, DOI 10.1128/MCB.18.3.1601; Mankouri J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000778; Meng QF, 2012, MOL BIOL REP, V39, P5867, DOI 10.1007/s11033-011-1397-7; Minegishi Y, 2013, HUM MOL GENET, V22, P3559, DOI 10.1093/hmg/ddt210; Moreland RJ, 2000, NUCLEIC ACIDS RES, V28, P1986, DOI 10.1093/nar/28.9.1986; Nagabhushana A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017477; Nagabhushana A, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-4; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Nucci C, 2005, NEUROTOXICOLOGY, V26, P935, DOI 10.1016/j.neuro.2005.06.002; Park BC, 2007, GENES CELLS, V12, P969, DOI 10.1111/j.1365-2443.2007.01102.x; Park BC, 2006, AM J PATHOL, V169, P1976, DOI 10.2353/ajpath.2006.060400; Park B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011547; Poppek D, 2006, ANTIOXID REDOX SIGN, V8, P173, DOI 10.1089/ars.2006.8.173; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rezaie T, 2005, GENOMICS, V85, P131, DOI 10.1016/j.ygeno.2004.10.011; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schwamborn K, 2000, J BIOL CHEM, V275, P22780, DOI 10.1074/jbc.M001500200; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Stroissnigg H, 2002, EXP CELL RES, V278, P133, DOI 10.1006/excr.2002.5567; Sudhakar C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005114; Swaab DF, 1998, PROG BRAIN RES, V117, P343; Tanito M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049680; Tegethoff S, 2003, MOL CELL BIOL, V23, P2029, DOI 10.1128/MCB.23.6.2029-2041.2003; Tezel G, 2000, J NEUROSCI, V20, P8693; Tezel G, 2001, INVEST OPHTH VIS SCI, V42, P1787; Tezel G, 2006, PROG RETIN EYE RES, V25, P490, DOI 10.1016/j.preteyeres.2006.07.003; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115; Wang CX, 2013, CELL BIOL I IN PRESS; Wittig I, 2010, MOL CELL PROTEOMICS, V9, P2149, DOI 10.1074/mcp.M900526-MCP200; Ying HY, 2012, INT REV CEL MOL BIO, V294, P223, DOI 10.1016/B978-0-12-394305-7.00005-7; Ying HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009168; Yuan L, 2000, GLIA, V32, P42, DOI 10.1002/1098-1136(200010)32:1<42::AID-GLIA40>3.3.CO;2-V; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	57	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101206	10.1371/journal.pone.0101206	http://dx.doi.org/10.1371/journal.pone.0101206			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983867	Green Published, gold, Green Submitted			2022-12-27	WOS:000339635000068
J	Lecomte, M; Hamama, L; Voisine, L; Gatto, J; Helesbeux, JJ; Seraphin, D; Pena-Rodriguez, LM; Richomme, P; Boedo, C; Yovanopoulos, C; Gyomlai, M; Briard, M; Simoneau, P; Poupard, P; Berruyer, R				Lecomte, Mickael; Hamama, Latifa; Voisine, Linda; Gatto, Julia; Helesbeux, Jean-Jacques; Seraphin, Denis; Pena-Rodriguez, Luis M.; Richomme, Pascal; Boedo, Cora; Yovanopoulos, Claire; Gyomlai, Melvina; Briard, Mathilde; Simoneau, Philippe; Poupard, Pascal; Berruyer, Romain			Partial Resistance of Carrot to Alternaria dauci Correlates with In Vitro Cultured Carrot Cell Resistance to Fungal Exudates	PLOS ONE			English	Article							DISEASE RESISTANCE; BOTRYTIS-CINEREA; KINASE GENE; ZINNIOL; PHYTOTOXIN; ARABIDOPSIS; METABOLISM; RESPONSES; GROWTH	Although different mechanisms have been proposed in the recent years, plant pathogen partial resistance is still poorly understood. Components of the chemical warfare, including the production of plant defense compounds and plant resistance to pathogen-produced toxins, are likely to play a role. Toxins are indeed recognized as important determinants of pathogenicity in necrotrophic fungi. Partial resistance based on quantitative resistance loci and linked to a pathogen-produced toxin has never been fully described. We tested this hypothesis using the Alternaria dauci - carrot pathosystem. Alternaria dauci, causing carrot leaf blight, is a necrotrophic fungus known to produce zinniol, a compound described as a non-host selective toxin. Embryogenic cellular cultures from carrot genotypes varying in resistance against A. dauci were confronted with zinniol at different concentrations or to fungal exudates (raw, organic or aqueous extracts). The plant response was analyzed through the measurement of cytoplasmic esterase activity, as a marker of cell viability, and the differentiation of somatic embryos in cellular cultures. A differential response to toxicity was demonstrated between susceptible and partially resistant genotypes, with a good correlation noted between the resistance to the fungus at the whole plant level and resistance at the cellular level to fungal exudates from raw and organic extracts. No toxic reaction of embryogenic cultures was observed after treatment with the aqueous extract or zinniol used at physiological concentration. Moreover, we did not detect zinniol in toxic fungal extracts by UHPLC analysis. These results suggest that strong phytotoxic compounds are present in the organic extract and remain to be characterized. Our results clearly show that carrot tolerance to A. dauci toxins is one component of its partial resistance.	[Lecomte, Mickael; Hamama, Latifa; Voisine, Linda; Boedo, Cora; Yovanopoulos, Claire; Gyomlai, Melvina; Briard, Mathilde; Simoneau, Philippe; Poupard, Pascal; Berruyer, Romain] Agrocampus Ouest, UMR IRHS 1345, Angers, France; [Lecomte, Mickael; Hamama, Latifa; Voisine, Linda; Boedo, Cora; Yovanopoulos, Claire; Gyomlai, Melvina; Briard, Mathilde; Simoneau, Philippe; Poupard, Pascal; Berruyer, Romain] Univ Angers, UMR IRHS 1345, SFR QUASAV, Angers, France; [Lecomte, Mickael; Hamama, Latifa; Voisine, Linda; Boedo, Cora; Yovanopoulos, Claire; Gyomlai, Melvina; Briard, Mathilde; Simoneau, Philippe; Poupard, Pascal; Berruyer, Romain] INRA, UMR IRHS 1345, F-49000 Angers, France; [Gatto, Julia; Helesbeux, Jean-Jacques; Seraphin, Denis; Richomme, Pascal] Univ Angers, UPRES EA921SONAS, SFR QUASAV 4207, Angers, France; [Pena-Rodriguez, Luis M.] Ctr Invest Cient Yucatan, Unidad Biotecnol, Merida, Yucatan, Mexico	Institut Agro; Agrocampus Ouest; Universite d'Angers; Universite d'Angers; INRAE; Universite d'Angers; Universite d'Angers; Centro de Investigacion Cientifica de Yucatan	Berruyer, R (corresponding author), Agrocampus Ouest, UMR IRHS 1345, Angers, France.	romain.berruyer@univ-angers.fr	martel, celine/O-6651-2016; Simoneau, Philippe/GPG-0546-2022; Simoneau, Philippe/AAV-4324-2021	martel, celine/0000-0002-1800-4558; Simoneau, Philippe/0000-0002-3890-9848; HELESBEUX, Jean-Jacques/0000-0002-1894-8911; SERAPHIN, DENIS/0000-0002-0509-5788	 [SFR 4207 QUASAV]		M. Lecomte was granted a doctoral fellowship by SFR 4207 QUASAV. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen B, 2008, MYCOL RES, V112, P241, DOI 10.1016/j.mycres.2007.09.004; BARASH I, 1981, PHYSIOL PLANT PATHOL, V19, P7; Berestetskii AO, 2010, APPL BIOCHEM MICRO+, V46, P75, DOI 10.1134/S0003683810010138; Berruyer R, 2006, PHYTOPATHOLOGY, V96, P346, DOI 10.1094/PHYTO-96-0346; Bessire M, 2007, EMBO J, V26, P2158, DOI 10.1038/sj.emboj.7601658; Bithell A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010392; Boedo C, 2010, PLANT PATHOL, V59, P368, DOI 10.1111/j.1365-3059.2009.02218.x; Boedo C, 2012, PLANT PATHOL, V121, P55; Boedo C, 2008, EUR J PLANT PATHOL, V121, P55, DOI 10.1007/s10658-007-9241-6; Bohnert HU, 2004, PLANT CELL, V16, P2499, DOI 10.1105/tpc.104.022715; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Boyd LA, 2013, TRENDS GENET, V29, P233, DOI 10.1016/j.tig.2012.10.011; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calmes B, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00131; Cao AH, 2011, P NATL ACAD SCI USA, V108, P7727, DOI 10.1073/pnas.1016981108; COTTY PJ, 1983, PHYTOPATHOLOGY, V73, P1326, DOI 10.1094/Phyto-73-1326; COTTY PJ, 1984, PHYTOPATHOLOGY, V74, P785, DOI 10.1094/Phyto-74-785; Dubouzet JG, 2011, PLANT BIOTECHNOL J, V9, P466, DOI 10.1111/j.1467-7652.2010.00568.x; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; Fu J, 2011, PLANT PHYSIOL, V155, P589, DOI 10.1104/pp.110.163774; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; GAMBORG OL, 1976, IN VITRO CELL DEV B, V12, P473; George EF, 2008, PLANT PROPAGATION TI, V1; Graf E, 2012, INT J FOOD MICROBIOL, V157, P353, DOI 10.1016/j.ijfoodmicro.2012.06.004; Green VS, 2006, SOIL BIOL BIOCHEM, V38, P693, DOI 10.1016/j.soilbio.2005.06.020; Horbach R, 2011, J PLANT PHYSIOL, V168, P51, DOI 10.1016/j.jplph.2010.06.014; JOHAL GS, 1992, SCIENCE, V258, P985, DOI 10.1126/science.1359642; Kliebenstein DJ, 2005, PLANT J, V44, P25, DOI 10.1111/j.1365-313X.2005.02508.x; Kou YJ, 2010, CURR OPIN PLANT BIOL, V13, P181, DOI 10.1016/j.pbi.2009.12.010; Kushalappa AC, 2013, TRENDS PLANT SCI, V18, P522, DOI 10.1016/j.tplants.2013.05.002; Lai ZB, 2013, CURR OPIN PLANT BIOL, V16, P505, DOI 10.1016/j.pbi.2013.06.014; Lecomte M, 2012, PHYSIOL MOL PLANT P, V80, P58, DOI 10.1016/j.pmpp.2012.10.002; Lima MRM, 2012, EUR J PLANT PATHOL, V132, P133, DOI 10.1007/s10658-011-9857-4; MARTIN JA, 1980, TETRAHEDRON, V36, P791, DOI 10.1016/S0040-4020(01)93696-8; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Montemurro N., 1992, ALTERNARIA, P449; Montillet JL, 1986, DOSAGE RADIOIMMUNOLO; Qui JA, 2010, J GEN PLANT PATHOL, V76, P94, DOI 10.1007/s10327-010-0222-9; REINERT J, 1958, NATURWISSENSCHAFTEN, V45, P344, DOI 10.1007/BF00640240; Repka V, 2006, BIOL PLANTARUM, V50, P94, DOI 10.1007/s10535-005-0080-z; ROTMAN B, 1966, P NATL ACAD SCI USA, V55, P134, DOI 10.1073/pnas.55.1.134; Schweizer P, 2011, MOL PLANT MICROBE IN, V24, P1492, DOI 10.1094/MPMI-05-11-0107; Sinha AK, 2002, PLANT PHYSIOL, V128, P1480, DOI 10.1104/pp.010771; Somma S, 2011, INT J FOOD MICROBIOL, V145, P414, DOI 10.1016/j.ijfoodmicro.2011.01.006; Spassieva SD, 2002, PLANT J, V32, P561, DOI 10.1046/j.1365-313X.2002.01444.x; STEWARD FC, 1958, AM J BOT, V45, P705, DOI 10.2307/2439728; Steward N, 1999, PLANT CELL REP, V19, P171, DOI 10.1007/s002990050729; SUGAWARA F, 1986, PLANT SCI, V43, P19, DOI 10.1016/0168-9452(86)90102-0; Thomma BPHJ, 2003, MOL PLANT PATHOL, V4, P225, DOI 10.1046/J.1364-3703.2003.00173.X; THULEAU P, 1988, P NATL ACAD SCI USA, V85, P5932, DOI 10.1073/pnas.85.16.5932; Vitecek J, 2007, SENSORS-BASEL, V7, P222, DOI 10.3390/s7030222; Walton JD, 1996, PLANT CELL, V8, P1723, DOI 10.1105/tpc.8.10.1723; Walz A, 2008, PLANT PATHOL, V57, P453, DOI 10.1111/j.1365-3059.2007.01815.x; Zhang Y, 2013, J GENET GENOMICS, V40, P23, DOI 10.1016/j.jgg.2012.11.003; Zheng L, 2010, PLANT DIS, V94, P1231, DOI 10.1094/PDIS-03-10-0183; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x	58	13	14	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101008	10.1371/journal.pone.0101008	http://dx.doi.org/10.1371/journal.pone.0101008			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983469	Green Published, gold			2022-12-27	WOS:000339635000045
J	Liu, YW; Ni, BX; Lin, Y; Chen, XG; Fang, Z; Zhao, LY; Hu, ZB; Zhang, FX				Liu, Yaowu; Ni, Bixian; Lin, Yuan; Chen, Xin-guang; Fang, Zhen; Zhao, Liyan; Hu, Zhibin; Zhang, Fengxiang			Genetic Polymorphisms in ZFHX3 Are Associated with Atrial Fibrillation in a Chinese Han Population	PLOS ONE			English	Article							RISK-FACTORS; PREVALENCE; VARIANTS; STAT3	Background: The gene zinc finger homeobox 3 (ZFHX3) encodes a transcription factor with cardiac expression and its genetic variants are associated with atrial fibrillation (AF). We aimed to explore the associations between single nucleotide polymorphisms (SNPs) of ZFHX3 and the risk of AF in a Chinese Han population. Methods: We genotyped eight SNPs, including seven potentially functional SNPs and one previously reported SNP by using the middle-throughput iPLEX Sequenom MassARRAY platform. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated in logistic regression models. Results: We enrolled a total of 1,593 Chinese Han origin individuals in the study, including 597 AF patients and 996 non-AF controls. Logistic regression analyses revealed that potentially functional SNPs rs6499600 and rs16971436 were associated with a decreased risk of AF (adjusted OR = 0.73, 95% CI: 0.63-0.86, P = 1.07610(-4); adjusted OR = 0.74, 95% CI: 0.56-0.98, P = 0.039, respectively). In addition, rs2106261 showed a robust association with an increased risk of AF (adjusted OR = 1.71, 95% CI: 1.46-2.00, P = 1.85610(-11)). After multiple comparisons, rs16971436 conferred a borderline significant association with the risk of AF. Stratification analysis indicated that the risks of AF were statistically different among subgroups of age for rs2106261, and the effect for rs16971436 was more evident in subgroups of patients with coronary artery disease. Conclusion: In summary, our study investigated the role of genetic variants of ZFHX3 in AF and two SNPs (rs2106261, rs6499600) showed significant associations while rs16971436 conferred a borderline significant association with AF risk in Chinese Han populations. However, further large and functional studies are warranted to confirm our findings.	[Liu, Yaowu; Chen, Xin-guang; Fang, Zhen; Zhao, Liyan; Zhang, Fengxiang] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Ni, Bixian; Lin, Yuan; Hu, Zhibin] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Hu, ZB (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	zhibin_hu@njmu.edu.cn; njzfx6@163.com	Zhang, Fengxiang/Z-2807-2019		National Natural Science Foundation of China [81170160]; Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University [IRT-004]; Six Peak Talents Foundation of Jiangsu Province [2011-WS-071]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University; Six Peak Talents Foundation of Jiangsu Province	This work was supported by grants from the National Natural Science Foundation of China (Grant 81170160), the Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University (No. IRT-004), and the Six Peak Talents Foundation of Jiangsu Province (No. 2011-WS-071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBARINO CG, 1994, MOL CELL PROBE, V8, P423, DOI 10.1006/mcpr.1994.1060; Arnar DO, 2006, EUR HEART J, V27, P708, DOI 10.1093/eurheartj/ehi727; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Benjamin EJ, 2009, NAT GENET, V41, P879, DOI 10.1038/ng.416; Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/europace/eus305, 10.1093/eurheartj/ehs253]; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P2851, DOI 10.1001/jama.291.23.2851; Fuster V, 2011, J AM COLL CARDIOL, V57, pE101, DOI 10.1016/j.jacc.2010.09.013; Greenwood TA, 2003, GENOMICS, V82, P511, DOI 10.1016/S0888-7543(03)00142-3; Hilfiker-Kleiner D, 2004, CIRC RES, V95, P187, DOI 10.1161/01.RES.0000134921.50377.61; KANNEL WB, 1982, NEW ENGL J MED, V306, P1018, DOI 10.1056/NEJM198204293061703; KOPECKY SL, 1987, NEW ENGL J MED, V317, P669, DOI 10.1056/NEJM198709103171104; Li C, 2011, HUM GENET, V129, P239, DOI 10.1007/s00439-010-0912-6; Lubitz Steven A, 2010, Heart Fail Clin, V6, P239, DOI 10.1016/j.hfc.2009.12.004; Nojiri S, 2004, BIOCHEM BIOPH RES CO, V314, P97, DOI 10.1016/j.bbrc.2003.12.054; Psaty BM, 1997, CIRCULATION, V96, P2455; Ringborg A, 2008, EUROPACE, V10, P403, DOI 10.1093/europace/eun048; Sinner MF, 2011, CARDIOVASC RES, V89, P701, DOI 10.1093/cvr/cvr001; Stefansdottir H, 2011, EUROPACE, V13, P1110, DOI 10.1093/europace/eur132; Toko H, 2010, J MOL CELL CARDIOL, V49, P113, DOI 10.1016/j.yjmcc.2010.03.020; Tsai CT, 2008, HEART RHYTHM, V5, P1285, DOI 10.1016/j.hrthm.2008.05.012; Wilke T, 2013, EUROPACE, V15, P486, DOI 10.1093/europace/eus333	23	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101318	10.1371/journal.pone.0101318	http://dx.doi.org/10.1371/journal.pone.0101318			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983873	Green Submitted, Green Published, gold			2022-12-27	WOS:000339635000088
J	Lundhede, TH; Jacobsen, JB; Hanley, N; Fjeldsa, J; Rahbek, C; Strange, N; Thorsen, BJ				Lundhede, Thomas Hedemark; Jacobsen, Jette Bredahl; Hanley, Nick; Fjeldsa, Jon; Rahbek, Carsten; Strange, Niels; Thorsen, Bo Jellesmark			Public Support for Conserving Bird Species Runs Counter to Climate Change Impacts on Their Distributions	PLOS ONE			English	Article							CHOICE; BIODIVERSITY; PREFERENCES; VALUATION; BENEFITS; VELOCITY; COSTS	There is increasing evidence that global climate change will alter the spatiotemporal occurrences and abundances of many species at continental scales. This will have implications for efficient conservation of biodiversity. We investigate if the general public in Denmark are willing to pay for the preservation of birds potentially immigrating and establishing breeding populations due to climate change to the same extent that they are for native species populations currently breeding in Denmark, but potentially emigrating due to climate change. We find that Danish citizens are willing to pay much more for the conservation of birds currently native to Denmark, than for bird species moving into the country - even when they are informed about the potential range shifts associated with climate change. The only exception is when immigrating species populations are under pressure at European level. Furthermore, people believing climate change to be man-made and people more knowledgeable about birds tended to have higher WTP for conservation of native species, relative to other people, whereas their preferences for conserving immigrant species generally resembled those of other people. Conservation investments rely heavily on public funding and hence on public support. Our results suggest that cross-country coordination of conservation efforts under climate change will be challenging in terms of achieving an appropriate balance between cost-effectiveness in adaptation and the concerns of a general public who seem mostly worried about protecting currently-native species.	[Lundhede, Thomas Hedemark; Jacobsen, Jette Bredahl; Strange, Niels; Thorsen, Bo Jellesmark] Univ Copenhagen, Dept Food & Resource Econ, Copenhagen, Denmark; [Lundhede, Thomas Hedemark; Jacobsen, Jette Bredahl; Fjeldsa, Jon; Rahbek, Carsten; Strange, Niels; Thorsen, Bo Jellesmark] Univ Copenhagen, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark; [Hanley, Nick] Univ St Andrews, Dept Geog & Sustainable Dev, St Andrews, Fife, Scotland; [Fjeldsa, Jon; Rahbek, Carsten] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of St Andrews; University of Copenhagen	Lundhede, TH (corresponding author), Univ Copenhagen, Dept Food & Resource Econ, Copenhagen, Denmark.	thlu@ifro.ku.dk	Thorsen, Bo Jellesmark J/K-8770-2014; Rahbek, Carsten/L-1129-2013; Jacobsen, Jette Bredahl/C-9354-2015; Fjeldså, Jon/A-9699-2013; Strange, Niels/AAB-5155-2020	Thorsen, Bo Jellesmark J/0000-0002-3305-8343; Rahbek, Carsten/0000-0003-4585-0300; Jacobsen, Jette Bredahl/0000-0002-1313-6228; Fjeldså, Jon/0000-0003-0790-3600; Strange, Niels/0000-0002-8842-8022; Lundhede, Thomas/0000-0003-3226-8338; Hanley, Nick/0000-0002-1362-3499	Danish Council for Independent Research, Social Science [75-07-0240]; Danish National Research Foundation	Danish Council for Independent Research, Social Science; Danish National Research Foundation(Danmarks Grundforskningsfond)	The authors acknowledge the Danish Council for Independent Research, Social Science for financial support (Grant no. 75-07-0240) and the Danish National Research Foundation for support to the Centre for Macroecology, Evolution and Climate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; Barbet-Massin M, 2009, BIOL LETTERS, V5, P248, DOI 10.1098/rsbl.2008.0715; Campbell D, J ENV PLANN IN PRESS; CARSON RT, 1993, AM J AGR ECON, V75, P1263, DOI 10.2307/1243469; Christie M, 2006, ECOL ECON, V58, P304, DOI 10.1016/j.ecolecon.2005.07.034; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Cotton PA, 2003, P NATL ACAD SCI USA, V100, P12219, DOI 10.1073/pnas.1930548100; Danish Data Protection Agency, DAN ACT PROC PERS DA; Erasmus BFN, 1999, P ROY SOC B-BIOL SCI, V266, P315, DOI 10.1098/rspb.1999.0640; Greene W.H, 2007, NLOGIT 4 0; Greene W.H., 2007, ECONOMETRIC ANAL; Hanley N., 2009, PRICING NATURE COST; Hanley N, 2009, J ENVIRON MANAGE, V90, P1404, DOI 10.1016/j.jenvman.2008.08.008; Huntley B., 2007, CLIMATIC ATLAS EUROP; Jacobsen JB, 2008, ENVIRON RESOUR ECON, V39, P247, DOI 10.1007/s10640-007-9107-6; KAHNEMAN D, 1990, J POLIT ECON, V98, P1325, DOI 10.1086/261737; Klausmeyer KR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006392; Krutilla J, 1975, EC NATURAL ENV; La Sorte FA, 2010, P ROY SOC B-BIOL SCI, V277, P3401, DOI 10.1098/rspb.2010.0612; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Loomis JB, 1996, ECOL ECON, V18, P197, DOI 10.1016/0921-8009(96)00029-8; Lundhede T, 2012, INT J CULT POLICY, P1; McDonald-Madden E, 2011, NAT CLIM CHANGE, V1, P261, DOI 10.1038/NCLIMATE1170; McFadden D., 1973, FRONTIERS ECONOMETRI, P105, DOI DOI 10.1108/EB028592; Meyerhoff J, 2014, ENVIRON RESOUR ECON, V58, P35, DOI 10.1007/s10640-013-9688-1; Moilanen A, 2011, BIOL CONSERV, V144, P1719, DOI 10.1016/j.biocon.2011.03.007; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Nunes PALD, 2001, ECOL ECON, V39, P203, DOI 10.1016/S0921-8009(01)00233-6; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; Scarpa R, 2008, AUST J AGR RESOUR EC, V52, P253, DOI 10.1111/j.1467-8489.2007.00436.x; The European Society for Opinion and Market Research (ESOMAR), ICC ESOMAR COD MARK; The National Committee for Health Research Ethics, 2012, ACT RES ETH REV HLTH; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Train K., 2005, APPL SIMULATION METH, P1, DOI [10.1007/1-4020-3684-1_1, DOI 10.1007/1-4020-3684-1_1]; Train K. E., 2003, DISCRETE CHOICE METH; TVERSKY A, 1991, Q J ECON, V106, P1039, DOI 10.2307/2937956; von Haefen RH, 2005, AM J AGR ECON, V87, P1061, DOI 10.1111/j.1467-8276.2005.00794.x; Walpole MJ, 2002, BIODIVERS CONSERV, V11, P543, DOI 10.1023/A:1014864708777; Wilhelm-Rechmann A, 2014, ORYX, V48, P71, DOI 10.1017/S0030605312000257; Willis KJ, 2009, SCIENCE, V326, P806, DOI 10.1126/science.1178838	43	14	15	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101281	10.1371/journal.pone.0101281	http://dx.doi.org/10.1371/journal.pone.0101281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1UX	24984055	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000339635000082
J	Montastier, E; Dejean, S; Le Gall, C; Saris, WHM; Langin, D; Viguerie, N				Montastier, Emilie; Dejean, Sebastien; Le Gall, Caroline; Saris, Wim H. M.; Langin, Dominique; Viguerie, Nathalie			Adipose Tissue CIDEA Is Associated, Independently of Weight Variation, to Change in Insulin Resistance during a Longitudinal Weight Control Dietary Program in Obese Individuals	PLOS ONE			English	Article							HOMEOSTASIS MODEL ASSESSMENT; IMPAIRED GLUCOSE-TOLERANCE; GENE-EXPRESSION; LIPID DROPLETS; ENERGY RESTRICTION; MAINTENANCE; SENSITIVITY; HUMANS; STABILIZATION; TRANSCRIPTOME	Aim: Weight loss reduces risk factors associated with obesity. However, long-term metabolic improvement remains a challenge. We investigated quantitative gene expression of subcutaneous adipose tissue in obese individuals and its relationship with low calorie diet and long term weight maintenance induced changes in insulin resistance. Research Design: Three hundred eleven overweight and obese individuals followed a dietary protocol consisting of an 8-week low calorie diet followed by a 6-month ad libitum weight-maintenance diet. Individuals were clustered according to insulin resistance trajectories assessed using homeostasis model assessment of insulin resistance (HOMA-IR) index. Adipose tissue mRNA levels of 267 genes selected for regulation according to obesity, metabolic status and response to dieting was assessed using high throughput RT-qPCR. A combination of discriminant analyses was used to identify genes with regulation according to insulin resistance trajectories. Partial correlation was used to control for change in body mass index. Results: Three different HOMA-IR profile groups were determined. HOMA-IR improved during low calorie diet in the 3 groups. At the end of the 6-month follow-up, groups A and B had reduced HOMA-IR by 50%. In group C, HOMA-IR had returned to baseline values. Genes were differentially expressed in the adipose tissue of individuals according to groups but a single gene, CIDEA, was common to all phases of the dietary intervention. Changes in adipose tissue CIDEA mRNA levels paralleled variations in insulin sensitivity independently of change in body mass index. Overall, CIDEA was up-regulated in adipose tissue of individuals with successful long term insulin resistance relapse and not in adipose tissue of unsuccessful individuals. Conclusion: The concomitant change in adipose tissue CIDEA mRNA levels and insulin sensitivity suggests a beneficial role of adipose tissue CIDEA in long term glucose homeostasis, independently of weight variation.	[Montastier, Emilie; Langin, Dominique; Viguerie, Nathalie] Inst Natl Sante & Rech Med INSERM, Inst Metab & Cardiovasc Dis I2MC, Obes Res Lab, UMR1048, Toulouse, France; [Montastier, Emilie; Langin, Dominique; Viguerie, Nathalie] Univ Toulouse 3, Univ Toulouse, UMR1048, F-31062 Toulouse, France; [Montastier, Emilie; Langin, Dominique] Toulouse Univ Hosp, Dept Clin Biochem, Toulouse, France; [Dejean, Sebastien; Le Gall, Caroline] Toulouse Univ, Inst Math, CNRS, UMR 5219, Toulouse, France; [Saris, Wim H. M.] Maastricht Univ, Med Ctr, Dept Human Biol, NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Universite de Toulouse; Universite Toulouse 1 Capitole; Universite Toulouse III - Paul Sabatier; Universite de Toulouse - Jean Jaures; Institut National des Sciences Appliquees de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Maastricht University; Maastricht University Medical Centre (MUMC)	Viguerie, N (corresponding author), Inst Natl Sante & Rech Med INSERM, Inst Metab & Cardiovasc Dis I2MC, Obes Res Lab, UMR1048, Toulouse, France.	nathalie.viguerie@inserm.fr	; Viguerie, Nathalie/M-2422-2017	Montastier, Emilie/0000-0002-7303-3837; Langin, Dominique/0000-0002-2669-7825; Viguerie, Nathalie/0000-0002-1730-9915	European Communities [EMIF-MET, FP7-115372, DiOGenes, FP6-513946, HEALTH-F2-2008-2011 00]; Fondation pour la Recherche Medicale; Agence Nationale de la Recherche (LIPOB and OBELIP); Region Midi-Pyrenees	European Communities(European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche (LIPOB and OBELIP)(French National Research Agency (ANR)); Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie)	The study was supported by funding from the European Communities (EMIF-MET, FP7-115372, DiOGenes, FP6-513946, HEALTH-F2-2008-2011 00), Fondation pour la Recherche Medicale, Agence Nationale de la Recherche (LIPOB and OBELIP) and Region Midi-Pyrenees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2006, DIABETES, V55, P1430, DOI 10.2337/db05-1200; Alligier M, 2013, J CLIN ENDOCR METAB, V98, P802, DOI 10.1210/jc.2012-3289; Antuna-Puente B, 2011, DIABETES METAB, V37, P179, DOI 10.1016/j.diabet.2011.01.002; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Capel F, 2008, J CLIN ENDOCR METAB, V93, P4315, DOI 10.1210/jc.2008-0814; Capel F, 2009, DIABETES, V58, P1558, DOI 10.2337/db09-0033; Chalmers J, 1999, J HYPERTENS, V17, P151; Christianson JL, 2010, J LIPID RES, V51, P3455, DOI 10.1194/jlr.M009498; Dahlman I, 2005, AM J CLIN NUTR, V81, P1275; de la Fuente A, 2004, BIOINFORMATICS, V20, P3565, DOI 10.1093/bioinformatics/bth445; Girousse A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001485; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Gummesson A, 2007, J CLIN ENDOCR METAB, V92, P4759, DOI 10.1210/jc.2007-1136; Johansson LE, 2012, AM J CLIN NUTR, V96, P196, DOI 10.3945/ajcn.111.020578; Keller MP, 2010, ANNU REV NUTR, V30, P341, DOI 10.1146/annurev.nutr.012809.104747; Klimcakova E, 2011, DIABETOLOGIA, V54, P876, DOI 10.1007/s00125-010-2014-3; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Larsen TM, 2010, OBES REV, V11, P76, DOI 10.1111/j.1467-789X.2009.00603.x; Larsen TM, 2010, NEW ENGL J MED, V363, P2102, DOI 10.1056/NEJMoa1007137; Laurencikiene J, 2008, CANCER RES, V68, P9247, DOI 10.1158/0008-5472.CAN-08-1343; Lin SC, 2004, TRENDS MOL MED, V10, P434, DOI 10.1016/j.molmed.2004.07.005; Marquez-Quinones A, 2010, AM J CLIN NUTR, V92, P975, DOI 10.3945/ajcn.2010.29808; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mutch DM, 2011, AM J CLIN NUTR, V94, P1399, DOI 10.3945/ajcn.110.006858; Nordstrom EA, 2005, DIABETES, V54, P1726, DOI 10.2337/diabetes.54.6.1726; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Viguerie N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002959; Wing RR, 2011, DIABETES CARE, V34, P1481, DOI 10.2337/dc10-2415; Yonezawa T, 2011, MOL BIOSYST, V7, P91, DOI 10.1039/c0mb00099j; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	35	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e98707	10.1371/journal.pone.0098707	http://dx.doi.org/10.1371/journal.pone.0098707			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983748	gold, Green Published, Green Submitted			2022-12-27	WOS:000339635000007
J	Roset, MS; Ibanez, AE; de Souza, JA; Spera, JM; Minatel, L; Oliveira, SC; Giambartolomei, GH; Cassataro, J; Briones, G				Roset, Mara S.; Ibanez, Andres E.; de Souza Filho, Job Alves; Spera, Juan M.; Minatel, Leonardo; Oliveira, Sergio C.; Giambartolomei, Guillermo H.; Cassataro, Juliana; Briones, Gabriel			Brucella Cyclic beta-1,2-Glucan Plays a Critical Role in the Induction of Splenomegaly in Mice	PLOS ONE			English	Article							DENDRITIC CELL MATURATION; VIRULENCE FACTOR; MOLECULAR-CLONING; BALB/C MICE; ABORTUS; MELITENSIS; INFECTION; PROTEIN; INFLAMMATION; SALMONELLA	Brucella, the etiological agent of animal and human brucellosis, is a bacterium with the capacity to modulate the inflammatory response. Cyclic beta-1,2-glucan (C beta G) is a virulence factor key for the pathogenesis of Brucella as it is involved in the intracellular life cycle of the bacteria. Using comparative studies with different C beta G mutants of Brucella, cgs (C beta G synthase), cgt (C beta G transporter) and cgm (C beta G modifier), we have identified different roles for this polysaccharide in Brucella. While anionic C beta G is required for bacterial growth in low osmolarity conditions, the sole requirement for a successful Brucella interaction with mammalian host is its transport to periplasmic space. Our results uncover a new role for C beta G in promoting splenomegaly in mice. We showed that C beta G-dependent spleen inflammation is the consequence of massive cell recruitment (monocytes, dendritics cells and neutrophils) due to the induction of pro-inflammatory cytokines such as IL-12 and TNF-alpha and also that the reduced splenomegaly response observed with the cgs mutant is not the consequence of changes in expression levels of the characterized Brucella PAMPs LPS, flagellin or OMP16/19. Complementation of cgs mutant with purified C beta G increased significantly spleen inflammation response suggesting a direct role for this polysaccharide.	[Roset, Mara S.; Spera, Juan M.; Minatel, Leonardo; Cassataro, Juliana; Briones, Gabriel] Univ Nacl San Martin UNSAM, CONICET, Inst Invest Biotecnol Rodolfo Ugalde, Inst Tecnol Chascomus IIB INTECH, Buenos Aires, DF, Argentina; [Ibanez, Andres E.; Giambartolomei, Guillermo H.] Univ Buenos Aires, Fac Med, Hosp Clin Jose de San Martin, Lab Inmunogenet,INIGEM CONICET, Buenos Aires, DF, Argentina; [de Souza Filho, Job Alves; Oliveira, Sergio C.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Universidade Federal de Minas Gerais	Roset, MS (corresponding author), Univ Nacl San Martin UNSAM, CONICET, Inst Invest Biotecnol Rodolfo Ugalde, Inst Tecnol Chascomus IIB INTECH, Buenos Aires, DF, Argentina.	mroset@iibintech.com.ar; gbriones@iibintech.com.ar	Oliveira, Sergio Costa/AAG-5408-2021	Oliveira, Sergio Costa/0000-0003-4062-5577; Alves de Souza Filho, Job/0000-0002-6592-2378; Cassataro, Juliana/0000-0002-7122-869X; Briones, Gabriel/0000-0002-4500-9848; Roset, Mara/0000-0003-0487-199X	Agencia Nacional de Promocion Cientifica y Tecnologica, Buenos Aires, Argentina [PICT 2006-1208, PICT 2011-1772]; CONICET [PIP1142010010031401]	Agencia Nacional de Promocion Cientifica y Tecnologica, Buenos Aires, Argentina(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica, Buenos Aires, Argentina (PICT 2006-1208, PICT 2011-1772,), CONICET (PIP1142010010031401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dahouk S, 2008, PROTEOMICS, V8, P3862, DOI 10.1002/pmic.200800026; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Arellano-Reynoso B, 2005, NAT IMMUNOL, V6, P618, DOI 10.1038/ni1202; BREEDVELD MW, 1994, MICROBIOL REV, V58, P145, DOI 10.1128/MMBR.58.2.145-161.1994; Briones G, 1997, MICROBIOL-SGM, V143, P1115, DOI 10.1099/00221287-143-4-1115; Briones G, 2001, INFECT IMMUN, V69, P4528, DOI 10.1128/IAI.69.7.4528-4535.2001; CHEERS C, 1980, CELL IMMUNOL, V49, P168, DOI 10.1016/0008-8749(80)90066-0; Crawford RM, 1996, INFECT IMMUN, V64, P2188, DOI 10.1128/IAI.64.6.2188-2192.1996; De Iannino NI, 1998, J BACTERIOL, V180, P4392; DelVecchio VG, 2002, P NATL ACAD SCI USA, V99, P443, DOI 10.1073/pnas.221575398; DOUGLAS CJ, 1982, J BACTERIOL, V152, P1265; ENRIGHT FM, 1990, VET IMMUNOL IMMUNOP, V26, P171, DOI 10.1016/0165-2427(90)90065-Z; Ferguson GP, 2004, P NATL ACAD SCI USA, V101, P5012, DOI 10.1073/pnas.0307137101; Fretin D, 2005, CELL MICROBIOL, V7, P687, DOI 10.1111/j.1462-5822.2005.00502.x; GEREMIA RA, 1987, J BACTERIOL, V169, P880, DOI 10.1128/jb.169.2.880-884.1987; Giambartolomei GH, 2004, J IMMUNOL, V173, P4635, DOI 10.4049/jimmunol.173.7.4635; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Lapaque N, 2006, CELL MICROBIOL, V8, P401, DOI 10.1111/j.1462-5822.2005.00629.x; Larnontagne J, 2009, J PROTEOME RES, V8, P1594, DOI 10.1021/pr800978p; Macedo GC, 2008, J IMMUNOL, V180, P1080, DOI 10.4049/jimmunol.180.2.1080; Martirosyan A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002983; MONTARAZ JA, 1986, INFECT IMMUN, V53, P245, DOI 10.1128/IAI.53.2.245-251.1986; Moreno E, 2002, P NATL ACAD SCI USA, V99, P1, DOI 10.1073/pnas.022622699; Newman RM, 2006, INFECT IMMUN, V74, P594, DOI 10.1128/IAI.74.1.594-601.2006; Pappas G, 2006, EXPERT OPIN INV DRUG, V15, P1141, DOI 10.1517/13543784.15.10.1141; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; Roset MS, 2006, J BACTERIOL, V188, P5003, DOI 10.1128/JB.00086-06; Roset MS, 2004, INFECT IMMUN, V72, P2263, DOI 10.1128/IAI.72.4.2263-2271.2004; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Salcedo SP, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00028; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Verger JM, 1988, TECHNIQUES BRUCELLOS; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; YOUNG EJ, 1995, CLIN INFECT DIS, V21, P283, DOI 10.1093/clinids/21.2.283; Zhan YF, 1996, INFECT IMMUN, V64, P2782, DOI 10.1128/IAI.64.7.2782-2786.1996	35	21	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101279	10.1371/journal.pone.0101279	http://dx.doi.org/10.1371/journal.pone.0101279			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983999	gold, Green Submitted, Green Published			2022-12-27	WOS:000339635000081
J	Aglieri, G; Papetti, C; Zane, L; Milisenda, G; Boero, F; Piraino, S				Aglieri, Giorgio; Papetti, Chiara; Zane, Lorenzo; Milisenda, Giacomo; Boero, Ferdinando; Piraino, Stefano			First Evidence of Inbreeding, Relatedness and Chaotic Genetic Patchiness in the Holoplanktonic Jellyfish Pelagia noctiluca (Scyphozoa, Cnidaria)	PLOS ONE			English	Article							URCHIN STRONGYLOCENTROTUS-PURPURATUS; BARNACLE SEMIBALANUS-BALANOIDES; MICROSATELLITE NULL ALLELES; WESTERN MEDITERRANEAN-SEA; LONG-TERM FLUCTUATIONS; REPRODUCTIVE SUCCESS; PARENTAGE ANALYSIS; MARINE FISH; POPULATION-STRUCTURE; MAXIMUM-LIKELIHOOD	Genetic drift and non-random mating seldom influence species with large breeding populations and high dispersal potential, characterized by unstructured gene pool and panmixia at a scale lower than the minimum dispersal range of individuals. In the present study, a set of nine microsatellite markers was developed and used to investigate the spatio-temporal genetic patterns of the holoplanktonic jellyfish Pelagia noctiluca (Scyphozoa) in the Southern Tyrrhenian Sea. Homozygote excess was detected at eight loci, and individuals exhibited intra-population relatedness higher than expected by chance in at least three samples. This result was supported by the presence of siblings in at least 5 out 8 samples, 4 of which contained full-sib in addition to half-sib dyads. Having tested and ruled out alternative explanations as null alleles, our results suggest the influence of reproductive and behavioural features in shaping the genetic structure of P. noctiluca, as outcomes of population genetics analyses pointed out. Indeed, the genetic differentiation among populations was globally small but highlighted: a) a spatial genetic patchiness uncorrelated with distance between sampling locations, and b) a significant genetic heterogeneity between samples collected in the same locations in different years. Therefore, despite its extreme dispersal potential, P. noctiluca does not maintain a single homogenous population, but rather these jellyfish appear to have intra-bloom localized recruitment and/or individual cohesiveness, whereby siblings more likely swarm together as a single group and remain close after spawning events. These findings provide the first evidence of family structures and consequent genetic patchiness in a species with highly dispersive potential throughout its whole life cycle, contributing to understanding the patterns of dispersal and connectivity in marine environments.	[Aglieri, Giorgio; Milisenda, Giacomo; Boero, Ferdinando; Piraino, Stefano] Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali DiSTe, Lecce, Italy; [Aglieri, Giorgio; Papetti, Chiara; Zane, Lorenzo; Milisenda, Giacomo; Boero, Ferdinando; Piraino, Stefano] Consorzio Nazl Interuniv Sci Mare CoNISMa, Rome, Italy; [Papetti, Chiara; Zane, Lorenzo] Univ Padua, Dipartimento Biol, Padua, Italy; [Papetti, Chiara] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany; [Boero, Ferdinando] Inst Marine Sci CNR ISMAR, Italian Natl Res Council, Genoa, Italy	University of Salento; CoNISMa; University of Padua; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Aglieri, G (corresponding author), Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali DiSTe, Lecce, Italy.	giorgio.aglieri@unisalento.it	Milisenda, Giacomo/L-6882-2019; Piraino, Stefano/J-5234-2012; Aglieri, Giorgio/AAF-1632-2019; Zane, Lorenzo/G-6249-2010; CNR, Ismar/P-1247-2014	Milisenda, Giacomo/0000-0003-1334-9749; Piraino, Stefano/0000-0002-8752-9390; Zane, Lorenzo/0000-0002-6963-2132; Papetti, Chiara/0000-0002-4567-459X; Aglieri, Giorgio/0000-0002-5831-9706; Boero, Ferdinando/0000-0002-6317-2710; CNR, Ismar/0000-0001-5351-1486	European Community [266445]; STFC [ST/K000977/1] Funding Source: UKRI	European Community(European Commission); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement No. 266445 for the project Vectors of Change in Oceans and Seas Marine Life, Impact on Economic Sectors (VECTORS - http://www.marine-vectors.eu). Logistic/technical support was also provided by the FP7 EU projects COCONET, PERSEUS, the ENPI-CBCMED programme MED-JELLYRISK, and by the Italian Flagship project RITMARE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkrim J, 2009, BIOTECHNIQUES, V46, P185, DOI 10.2144/000113084; Amos W, 2007, MOL ECOL NOTES, V7, P10, DOI 10.1111/j.1471-8286.2006.01560.x; AVIAN M, 1986, B ZOOL, V53, P385; Banks SC, 2007, ECOLOGY, V88, P3055, DOI 10.1890/07-0091.1; Belkhir K, 1996, 5000 CNRS UMR; Bernardi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044953; Boero F, 2008, MAR ECOL PROG SER, V356, P299, DOI 10.3354/meps07368; Boero F, 2002, REPRO BIOL, V11, P141; BOERO F, 1994, MAR ECOL-P S Z N I, V15, P3, DOI 10.1111/j.1439-0485.1994.tb00038.x; Boero F., 2013, GFCM STUDIES REV, V92; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Bonferroni C.E, 1936, PUBBL R 1 SUPER SCI, V8, P3; Boudry P, 2002, AQUACULTURE, V204, P283, DOI 10.1016/S0044-8486(01)00841-9; Broquet T, 2013, EVOLUTION, V67, P1660, DOI 10.1111/j.1558-5646.2012.01826.x; Calderon I, 2012, MAR BIOL, V159, P187, DOI 10.1007/s00227-011-1799-z; CALLEN DF, 1993, AM J HUM GENET, V52, P922; Canepa Antonio, 2014, P237; CARGO DAVID G., 1967, CHESAPEAKE SCI, V8, P209, DOI 10.2307/1350339; CARSON HL, 1975, AM NAT, V109, P83, DOI 10.1086/282975; CHAKRABORTY R, 1992, ANN HUM GENET, V56, P45, DOI 10.1111/j.1469-1809.1992.tb01128.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Coombs JA, 2008, MOL ECOL RESOUR, V8, P578, DOI 10.1111/j.1471-8286.2007.02036.x; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; David P, 1997, EVOLUTION, V51, P1318, DOI 10.1111/j.1558-5646.1997.tb03979.x; Dawson MN, 1998, MOL MAR BIOL BIOTECH, V7, P145; Dawson MN, 2001, BIOL BULL, V200, P92, DOI 10.2307/1543089; Della Tommasa L, 2000, HYDROBIOLOGIA, V440, P249, DOI 10.1023/A:1004139715482; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Doyle TK, 2008, J PLANKTON RES, V30, P963, DOI 10.1093/plankt/fbn052; Edmands S, 1996, MAR BIOL, V126, P443, DOI 10.1007/BF00354626; Eldon B, 2006, GENETICS, V172, P2621, DOI 10.1534/genetics.105.052175; Eldon B, 2009, GENETICS, V181, P615, DOI 10.1534/genetics.108.094342; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Flowers JM, 2002, EVOLUTION, V56, P1445, DOI 10.1111/j.0014-3820.2002.tb01456.x; Giorgi R, 1991, JELLYFISH BLOOMS MED, P102; Gorospe KD, 2013, MOL ECOL, V22, P3721, DOI 10.1111/mec.12335; GOUDET J., 2001, FSTAT VERSION 2 9 3; GOY J, 1989, DEEP-SEA RES, V36, P269, DOI 10.1016/0198-0149(89)90138-6; Graham WM, 2001, HYDROBIOLOGIA, V451, P199, DOI 10.1023/A:1011876004427; Graham WM, 2003, MAR ECOL PROG SER, V254, P129, DOI 10.3354/meps254129; Hamner WM, 2009, HYDROBIOLOGIA, V616, P161, DOI 10.1007/s10750-008-9620-9; Hansson LJ, 2003, J MAR BIOL ASSOC UK, V83, P923, DOI 10.1017/S0025315403008063h; Hare MP, 2005, EVOLUTION, V59, P2509, DOI 10.1554/05-150.1; Hay ME, 2009, ANNU REV MAR SCI, V1, P193, DOI 10.1146/annurev.marine.010908.163708; HEDGECOCK D, 1994, GENETICS AND EVOLUTION OF AQUATIC ORGANISMS, P122; Hedgecock D, 2011, B MAR SCI, V87, P971, DOI 10.5343/bms.2010.1051; Hickey B.M, 1995, SOEST SPECIAL PUBLIC, P95; Holleley CE, 2009, BIOTECHNIQUES, V46, P511, DOI 10.2144/000113156; Hood GM, 2010, POPTOLLS VERSION 3 2; Iacchei M, 2013, MOL ECOL, V22, P3476, DOI 10.1111/mec.12341; Ishii Haruto, 2004, Plankton Biology and Ecology, V51, P26; JOHNSON MS, 1984, EVOLUTION, V38, P1371, DOI 10.1111/j.1558-5646.1984.tb05658.x; JOHNSON MS, 1993, MAR BIOL, V117, P91, DOI 10.1007/BF00346429; JOHNSON MS, 1982, MAR BIOL, V70, P157, DOI 10.1007/BF00397680; Jolly MT, 2003, HELGOLAND MAR RES, V56, P238, DOI 10.1007/s10152-002-0123-1; Jones AG, 2010, MOL ECOL RESOUR, V10, P6, DOI 10.1111/j.1755-0998.2009.02778.x; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; KRAMP PL, 1961, J MAR BIOL ASSOC UK, V40, P7, DOI 10.1017/S0025315400007347; Laurent V, 2007, BIOL J LINN SOC, V90, P591, DOI 10.1111/j.1095-8312.2007.00747.x; Lee PLM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0920; LEVITAN DR, 1995, TRENDS ECOL EVOL, V10, P228, DOI 10.1016/S0169-5347(00)89071-0; Li G, 1998, CAN J FISH AQUAT SCI, V55, P1025, DOI 10.1139/cjfas-55-4-1025; Licandro P, 2010, BIOL LETTERS, V6, P688, DOI 10.1098/rsbl.2010.0150; Magalon H, 2005, MOL ECOL, V14, P1861, DOI 10.1111/j.1365-294X.2005.02430.x; Malej A, 2004, NATO SCI S SS IV EAR, V35, P273; MALEJ A, 1993, MAR BIOL, V116, P565, DOI 10.1007/BF00355475; MALEJ A, 1992, OLSEN INT S, P215; MALEJ A, 1989, J EXP MAR BIOL ECOL, V126, P259, DOI 10.1016/0022-0981(89)90191-3; Mariani S, 2006, OECOLOGIA, V149, P174, DOI 10.1007/s00442-006-0429-9; Marino IAM, 2010, ESTUAR COAST SHELF S, V87, P135, DOI 10.1016/j.ecss.2010.01.003; McClintock JB, 2001, MARINE CHEM ECOLOGY; Miller BJ, 2012, AFR J MAR SCI, V34, P425, DOI 10.2989/1814232X.2012.726646; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; MILLOT C, 1991, DYNAM ATMOS OCEANS, V15, P179, DOI 10.1016/0377-0265(91)90020-G; Millot C, 1999, J MARINE SYST, V20, P423, DOI 10.1016/S0924-7963(98)00078-5; Moberg PE, 2000, MAR BIOL, V136, P773, DOI 10.1007/s002270000281; Mokhtar-Jamai K, 2011, MOL ECOL, V20, P3291, DOI 10.1111/j.1365-294X.2011.05176.x; MORAND P, 1992, ANN I OCEANOGR PARIS, V68, P151; O'Leary SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066126; Papetti C, 2013, ICES J MAR SCI, V70, P387, DOI 10.1093/icesjms/fss201; Parrish R.H., 1981, Biological Oceanography, V1, P175; Planes S, 2002, MOL ECOL, V11, P1515, DOI 10.1046/j.1365-294X.2002.01521.x; Puig P, 2000, DEEP-SEA RES PT I, V47, P343, DOI 10.1016/S0967-0637(99)00062-X; Pujolar JM, 2009, J FISH BIOL, V74, P2034, DOI 10.1111/j.1095-8649.2009.02267.x; Pujolar JM, 2011, MOL PHYLOGENET EVOL, V58, P198, DOI 10.1016/j.ympev.2010.11.019; Purcell JE, 2005, J MAR BIOL ASSOC UK, V85, P461, DOI 10.1017/S0025315405011409; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Ravago-Gotanco RG, 2007, MAR ECOL PROG SER, V336, P161, DOI 10.3354/meps336161; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; ROUSSET F, 1995, GENETICS, V140, P1413; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruzzante DE, 1996, CAN J FISH AQUAT SCI, V53, P2695, DOI 10.1139/cjfas-53-12-2695; SANDRINI LR, 1991, HYDROBIOLOGIA, V216, P197, DOI 10.1007/BF00026462; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Schunter C, 2011, MOL ECOL, V20, P5167, DOI 10.1111/j.1365-294X.2011.05355.x; Selkoe KA, 2006, ECOLOGY, V87, P3082, DOI 10.1890/0012-9658(2006)87[3082:CSAKAE]2.0.CO;2; Stopar K, 2010, MOL PHYLOGENET EVOL, V57, P417, DOI 10.1016/j.ympev.2010.07.004; Thorrold SR, 2001, SCIENCE, V291, P297, DOI 10.1126/science.291.5502.297; Toonen RJ, 2011, CRUSTACEAN ISS, V19, P75; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Veliz D, 2006, MOL ECOL, V15, P4193, DOI 10.1111/j.1365-294X.2006.03078.x; VERMEIJ GJ, 1987, EVOLUTION, V41, P1046, DOI 10.1111/j.1558-5646.1987.tb05875.x; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; Waples RS, 2011, MOL ECOL RESOUR, V11, P162, DOI 10.1111/j.1755-0998.2010.02942.x; WATTS RJ, 1990, MAR BIOL, V105, P145, DOI 10.1007/BF01344280; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weir BS, 1996, GENETIC DATA ANAL 2, VII; WRIGHT S, 1922, AM NAT, V56, P836; Zarraonaindia I, 2009, ICES J MAR SCI, V66, P2176, DOI 10.1093/icesjms/fsp187; ZAVODNIK D, 1987, MAR BIOL, V94, P265, DOI 10.1007/BF00392939; Zavodnik D., 1991, JELLYFISH BLOOMS MED, P212	116	34	34	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e99647	10.1371/journal.pone.0099647	http://dx.doi.org/10.1371/journal.pone.0099647			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977703	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400006
J	Mitchell, P; Bressler, N; Doan, QV; Dolan, C; Ferreira, A; Osborne, A; Rochtchina, E; Danese, M; Colman, S; Wong, TY				Mitchell, Paul; Bressler, Neil; Doan, Quan V.; Dolan, Chantal; Ferreira, Alberto; Osborne, Aaron; Rochtchina, Elena; Danese, Mark; Colman, Shoshana; Wong, Tien Y.			Estimated Cases of Blindness and Visual Impairment from Neovascular Age-Related Macular Degeneration Avoided in Australia by Ranibizumab Treatment	PLOS ONE			English	Article							BLUE MOUNTAINS EYE; OLDER-ADULTS; RESOURCE UTILIZATION; INJURIOUS FALLS; LEGAL BLINDNESS; PUBLIC-HEALTH; BURDEN; MACULOPATHY; LIMITATIONS; POPULATION	Intravitreal injections of anti-vascular endothelial growth factor agents, such as ranibizumab, have significantly improved the management of neovascular age-related macular degeneration. This study used patient-level simulation modelling to estimate the number of individuals in Australia who would have been likely to avoid legal blindness or visual impairment due to neovascular age-related macular degeneration over a 2-year period as a result of intravitreal ranibizumab injections. The modelling approach used existing data for the incidence of neovascular age-related macular degeneration in Australia and outcomes from ranibizumab trials. Blindness and visual impairment were defined as visual acuity in the better-seeing eye of worse than 6/60 or 6/12, respectively. In 2010, 14 634 individuals in Australia were estimated to develop neovascular age-related macular degeneration who would be eligible for ranibizumab therapy. Without treatment, 2246 individuals would become legally blind over 2 years. Monthly 0.5 mg intravitreal ranibizumab would reduce incident blindness by 72% (95% simulation interval, 70-74%). Ranibizumab given as needed would reduce incident blindness by 68% (64-71%). Without treatment, 4846 individuals would become visually impaired over 2 years; this proportion would be reduced by 37% (34-39%) with monthly intravitreal ranibizumab, and by 28% (23-33%) with ranibizumab given as needed. These data suggest that intravitreal injections of ranibizumab, given either monthly or as needed, can substantially lower the number of cases of blindness and visual impairment over 2 years after the diagnosis of neovascular age-related macular degeneration.	[Mitchell, Paul; Rochtchina, Elena] Univ Sydney, Dept Ophthalmol, Westmead, NSW 2145, Australia; [Mitchell, Paul; Rochtchina, Elena] Univ Sydney, Westmead Millennium Inst, Westmead, NSW 2145, Australia; [Bressler, Neil] Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21218 USA; [Doan, Quan V.; Danese, Mark] Outcomes Insights Inc, Westlake Village, CA USA; [Dolan, Chantal] CMD Consulting Inc, Sandy, UT USA; [Ferreira, Alberto; Osborne, Aaron] Novartis, Basel, Switzerland; [Colman, Shoshana] Genentech Inc, San Francisco, CA 94080 USA; [Wong, Tien Y.] Natl Univ Singapore, Singapore Eye Res Inst, Singapore 117548, Singapore; [Wong, Tien Y.] Univ Melbourne, Ctr Eye Res Australia, Parkville, Vic 3052, Australia	University of Sydney; University of Sydney; Westmead Institute for Medical Research; Johns Hopkins University; Johns Hopkins Medicine; Roche Holding; Genentech; National University of Singapore; Singapore National Eye Center; Centre for Eye Research Australia; University of Melbourne	Mitchell, P (corresponding author), Univ Sydney, Dept Ophthalmol, Westmead, NSW 2145, Australia.	paul.mitchell@sydney.edu.au	Wong, Tien Yin/AAC-9724-2020; Mitchell, Paul/P-1498-2014	Wong, Tien Yin/0000-0002-8448-1264; 	Novartis AG; Genentech, Inc.	Novartis AG; Genentech, Inc.(Roche HoldingGenentech)	This study was funded by Novartis AG and Genentech, Inc. Novartis AG and Genentech, Inc. participated in the design and conduct of the study, in the distribution of the raw data to Outcomes Insights, in the analysis and interpretation of the data and in the preparation of the manuscript. Novartis AG and Genentech, Inc. reviewed the manuscript before submission. Third-party medical writing assistance, but not editorial content sufficient to meet International Committee of Medical Journal Editors (ICMJE) authorship criteria, was funded by Novartis AG.	Abedi F, 2014, RETINA; Australian Bureau of Statistics, 2010, 33020 AUSTR BUR STAT; Australian Bureau of Statistics, 2010, 32010 AUSTR BUR STAT; Australian Institute of Health and Welfare, 2005, BULLETIN, V27; Bloch SB, 2012, AM J OPHTHALMOL, V153, P209, DOI 10.1016/j.ajo.2011.10.016; Bressler NM, 2011, ARCH OPHTHALMOL-CHIC, V129, P709, DOI 10.1001/archophthalmol.2011.140; Bressler NM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1621; Brown DM, 2009, OPHTHALMOLOGY, V116, P57, DOI 10.1016/j.ophtha.2008.10.018; Campbell JP, 2012, ARCH OPHTHALMOL-CHIC, V130, P794, DOI 10.1001/archophthalmol.2011.2480; Cheung N, 2012, AM J OPHTHALMOL, V153, P193, DOI 10.1016/j.ajo.2011.11.022; Cruess A, 2007, CAN J OPHTHALMOL, V42, P836, DOI 10.3129/i07-153; Gillies MC, 2014, OPHTHALMOLOGY, V121, P676, DOI 10.1016/j.ophtha.2013.09.050; Hochberg C, 2012, INVEST OPHTH VIS SCI, V53, P3201, DOI 10.1167/iovs.12-9469; Ivers RQ, 1998, J AM GERIATR SOC, V46, P58; Kaiser PK, 2007, AM J OPHTHALMOL, V144, P850, DOI 10.1016/j.ajo.2007.08.012; Klein BEK, 2003, OPHTHALMOLOGY, V110, P644, DOI 10.1016/S0161-6420(02)01935-8; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Lotery A, 2007, BRIT J OPHTHALMOL, V91, P1303, DOI 10.1136/bjo.2007.116939; Macular Degeneration Foundation, 2011, EYES FUT; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Mitchell P, 2002, OPHTHALMOLOGY, V109, P1092, DOI 10.1016/S0161-6420(02)01055-2; Popescu ML, 2011, INVEST OPHTH VIS SCI, V52, P7168, DOI 10.1167/iovs.11-7564; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Skaat A, 2012, AM J OPHTHALMOL, V153, P214, DOI 10.1016/j.ajo.2011.08.035; Soubrane G, 2007, ARCH OPHTHALMOL-CHIC, V125, P1249, DOI 10.1001/archopht.125.9.1249; Szabo SM, 2010, OSTEOPOROSIS INT, V21, P855, DOI 10.1007/s00198-009-1025-8; Tufail A, 2014, OPHTHALMOLOGY, V121, P1092, DOI 10.1016/j.ophtha.2013.11.031; Wang JJ, 2007, OPHTHALMOLOGY, V114, P92, DOI 10.1016/j.ophtha.2006.07.017; Wood JM, 2011, INVEST OPHTH VIS SCI, V52, P5088, DOI 10.1167/iovs.10-6644	30	41	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101072	10.1371/journal.pone.0101072	http://dx.doi.org/10.1371/journal.pone.0101072			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979237	Green Published, gold			2022-12-27	WOS:000338506400072
J	Wang, W; Zhang, XL				Wang, Wei; Zhang, Xiulan			Meta-Analysis of Randomized Controlled Trials Comparing EX-PRESS Implantation with Trabeculectomy for Open-Angle Glaucoma	PLOS ONE			English	Article							FILTRATION DEVICE; SCLERAL FLAP; SHUNT	Purpose: To evaluate the efficacy and safety of EX-PRESS implantation compared with trabeculectomy for uncontrolled open-angle glaucoma. Methods: Pertinent randomized controlled trials were identified through systematic searches of the PubMed, EMBASE, and Cochrane Library. The efficacy measures utilized were the weighted mean differences (WMDs) for the intraocular pressure reduction (IOPR), the reduction in glaucoma medications, the change of visual acuity, and the relative risks (RRs) for operative success rates. The safety measures utilized were RRs for postoperative complications. The pooled effects were calculated using the random-effects model. Results: Four randomized controlled trials of 292 eyes were included in this meta-analysis. The WMDs of the IOPR comparing the EX-PRESS with trabeculectomy were -0.25 (95% Cl: -3.61 to 3.11) at 6 month, 0.053 (-4.31 to 4.42) at 12 months, 0.81 (-4.06 to 5.67) at 24 months, and 0.20 (-2.11 to 2.51) at final follow-up. There was no statistically significance for IOPR at any point after surgery. There were also no significant differences in the reduction in glaucoma medications or visual acuity between the groups. The pooled relative risks comparing EX-PRESS with Trabeculectomy were 1.36 (1.11 to 1.66) for the complete operative success rate and 1.05 (0.94 to 1.17) for the qualified operative success rate. EX-PRESS and Trabeculectomy were associated with similar incidences in most complications with the exception of hyphema, with pooled RR being 0.18 (0.046 to 0.66). Conclusions: EX-PRESS implantation and trabeculectomy have similar efficacy in IOP-lowering, medication reduction, vision recovery, and qualified operative success rates. EX-PRESS associated with higher rates of complete operative success and fewer hyphema than with Trabeculectomy. However, these should be interpreted with caution because of the inherent limitations of the included studies.	[Wang, Wei; Zhang, Xiulan] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhang, XL (corresponding author), Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China.	zhangxl2@mail.sysu.edu.cn			National Natural Science Foundation of China [81371008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (81371008). No additional external funding was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed IIK, 2011, CLIN SURG OPHTHALMOL, V29, P156; Beltran-Agullo L, 2013, J GLAUCOMA; Buys YM, 2013, CURR OPIN OPHTHALMOL, V24, P111, DOI 10.1097/ICU.0b013e32835907a6; Chen GH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086045; Dahan E, 2012, EYE, V26, P703, DOI 10.1038/eye.2012.13; de Jong L, 2011, CLIN OPHTHALMOL, V5, P527, DOI 10.2147/OPTH.S18565; de Jong LAMS, 2009, ADV THER, V26, P336, DOI 10.1007/s12325-009-0017-6; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Estermann S, 2013, J GLAUCOMA, V22, P209, DOI 10.1097/IJG.0b013e31824479ce; Francis BA, 2011, OPHTHALMOLOGY, V118, P1466, DOI 10.1016/j.ophtha.2011.03.028; Gallego-Pinazo R., 2009, Arch Soc Esp Oftalmol, V84, P293; Good TJ, 2011, AM J OPHTHALMOL, V151, P507, DOI 10.1016/j.ajo.2010.09.004; Hammel N, 2013, J GLAUCOMA, V22, P565, DOI 10.1097/IJG.0b013e31824d4fa1; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hofmann I, 2008, CLIN SURG OPHTHALMOL, V26, P393; Johnson MS, 2013, J GLAUCOMA; Kanner EM, 2009, J GLAUCOMA, V18, P488, DOI 10.1097/IJG.0b013e31818fb44e; Li TJ, 2013, OPHTHALMOLOGY, V120, P1113, DOI 10.1016/j.ophtha.2012.11.038; Maris PJG, 2007, J GLAUCOMA, V16, P14, DOI 10.1097/01.ijg.0000243479.90403.cd; Marzette L, 2011, OPHTHAL SURG LAS IM, V42, P453, DOI 10.3928/15428877-20111017-03; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Mosaed S, 2010, EXPERT REV MED DEVIC, V7, P661, DOI 10.1586/ERD.10.32; Netland PA, 2014, AM J OPHTHALMOL, V157, P433, DOI 10.1016/j.ajo.2013.09.014; Patel HY, 2012, J GLAUCOMA; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Sarkisian SR, 2011, CLIN EXP OPHTHALMOL, V39, P381, DOI 10.1111/j.1442-9071.2011.02603.x; Seider MI, 2012, J GLAUCOMA, V21, P469, DOI 10.1097/IJG.0b013e3182182bfb; Sugiyama T, 2011, CLIN OPHTHALMOL, V5, P1063, DOI 10.2147/OPTH.S23129; Wang W, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063591, 10.1155/2013/758750, 10.1371/journal.pone.0076538]	30	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100578	10.1371/journal.pone.0100578	http://dx.doi.org/10.1371/journal.pone.0100578			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972022	gold, Green Submitted, Green Published			2022-12-27	WOS:000338512200044
J	Adiredjo, AL; Navaud, O; Munos, S; Langlade, NB; Lamaze, T; Grieu, P				Adiredjo, Afifuddin Latif; Navaud, Olivier; Munos, Stephane; Langlade, Nicolas B.; Lamaze, Thierry; Grieu, Philippe			Genetic Control of Water Use Efficiency and Leaf Carbon Isotope Discrimination in Sunflower (Helianthus annuus L.) Subjected to Two Drought Scenarios	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; QTL ANALYSIS; TRANSPIRATION EFFICIENCY; ENVIRONMENT INTERACTIONS; PHOTOSYNTHETIC CAPACITY; BIOMASS PRODUCTIVITY; STOMATAL CONDUCTANCE; GENOTYPIC VARIATION; PLANT HEIGHT; GAS-EXCHANGE	High water use efficiency (WUE) can be achieved by coordination of biomass accumulation and water consumption. WUE is physiologically and genetically linked to carbon isotope discrimination (CID) in leaves of plants. A population of 148 recombinant inbred lines (RILs) of sunflower derived from a cross between XRQ and PSC8 lines was studied to identify quantitative trait loci (QTL) controlling WUE and CID, and to compare QTL associated with these traits in different drought scenarios. We conducted greenhouse experiments in 2011 and 2012 by using 100 balances which provided a daily measurement of water transpired, and we determined WUE, CID, biomass and cumulative water transpired by plants. Wide phenotypic variability, significant genotypic effects, and significant negative correlations between WUE and CID were observed in both experiments. A total of nine QTL controlling WUE and eight controlling CID were identified across the two experiments. A QTL for phenotypic response controlling WUE and CID was also significantly identified. The QTL for WUE were specific to the drought scenarios, whereas the QTL for CID were independent of the drought scenarios and could be found in all the experiments. Our results showed that the stable genomic regions controlling CID were located on the linkage groups 06 and 13 (LG06 and LG13). Three QTL for CID were co-localized with the QTL for WUE, biomass and cumulative water transpired. We found that CID and WUE are highly correlated and have common genetic control. Interestingly, the genetic control of these traits showed an interaction with the environment (between the two drought scenarios and control conditions). Our results open a way for breeding higher WUE by using CID and marker-assisted approaches and therefore help to maintain the stability of sunflower crop production.	[Adiredjo, Afifuddin Latif; Grieu, Philippe] Univ Toulouse, INP ENSAT, AGIR, INPT INRA,UMR 1248, Castanet Tolosan, France; [Adiredjo, Afifuddin Latif] Brawijaya Univ, Fac Agr, Dept Agron, Plant Breeding Lab, Malang, Indonesia; [Navaud, Olivier; Lamaze, Thierry] Univ Toulouse, UPS Toulouse 3, CESBIO, UMR 5126, Toulouse, France; [Munos, Stephane; Langlade, Nicolas B.] INRA, LIPM, UMR 441, F-31326 Castanet Tolosan, France; [Munos, Stephane; Langlade, Nicolas B.] CNRS, LIPM, UMR 2594, Castanet Tolosan, France	INRAE; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; Brawijaya University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut de Recherche pour le Developpement (IRD); INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse	Grieu, P (corresponding author), Univ Toulouse, INP ENSAT, AGIR, INPT INRA,UMR 1248, Castanet Tolosan, France.	grieu@ensat.fr	Navaud, Olivier/S-1491-2016; MUNOS, STEPHANE/ABE-6062-2020; Langlade, Nicolas/C-6191-2008	Navaud, Olivier/0000-0003-4270-4690; Langlade, Nicolas/0000-0002-5651-1446; Adiredjo, Afifuddin Latif/0000-0002-3297-8439; Munos, Stephane/0000-0003-0261-2759	French Government Scholarship (Bourse du gouvernement Francais, BGF); Directorate general of Higher Education, Ministry of Education and Culture, Republic of Indonesia (Beasiswa Luar Negeri, BLN)	French Government Scholarship (Bourse du gouvernement Francais, BGF); Directorate general of Higher Education, Ministry of Education and Culture, Republic of Indonesia (Beasiswa Luar Negeri, BLN)	The work was supported by a French Government Scholarship (Bourse du gouvernement Francais, BGF) and a co-funding by Directorate general of Higher Education, Ministry of Education and Culture, Republic of Indonesia (Beasiswa Luar Negeri, BLN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chaarani GR, 2004, THEOR APPL GENET, V109, P1353, DOI 10.1007/s00122-004-1770-1; Austin DF, 1996, GENOME, V39, P957, DOI 10.1139/g96-120; Blum A, 1996, PLANT GROWTH REGUL, V20, P135, DOI 10.1007/BF00024010; Brendel O, 2002, PLANT CELL ENVIRON, V25, P945, DOI 10.1046/j.1365-3040.2002.00872.x; Brendel O, 2008, TREE GENET GENOMES, V4, P263, DOI 10.1007/s11295-007-0107-z; Cadic E, 2013, THEOR APPL GENET, V126, P1337, DOI 10.1007/s00122-013-2056-2; Cattivelli L, 2008, FIELD CROP RES, V105, P1, DOI 10.1016/j.fcr.2007.07.004; Ceccarelli M, 2007, GENOME, V50, P429, DOI 10.1139/G07-019; CECCARELLI S, 1991, EUPHYTICA, V56, P169, DOI 10.1007/BF00042061; Chapman S, 2003, AGRON J, V95, P99, DOI 10.2134/agronj2003.0099; Chen J, 2011, PLANT CELL ENVIRON, V34, P2009, DOI 10.1111/j.1365-3040.2011.02397.x; CHURCHILL GA, 1994, GENETICS, V138, P963; Collins NC, 2008, PLANT PHYSIOL, V147, P469, DOI 10.1104/pp.108.118117; Condon AG, 2004, J EXP BOT, V55, P2447, DOI 10.1093/jxb/erh277; CONDON AG, 1992, AUST J AGR RES, V43, P935, DOI 10.1071/AR9920935; Condon AG, 2002, CROP SCI, V42, P122, DOI 10.2135/cropsci2002.0122; CONDON AG, 1990, AUST J PLANT PHYSIOL, V17, P9, DOI 10.1071/PP9900009; CONDON AG, 1993, AUST J AGR RES, V44, P1693, DOI 10.1071/AR9931693; CRAIG H, 1957, GEOCHIM COSMOCHIM AC, V12, P133, DOI 10.1016/0016-7037(57)90024-8; de Givry S, 2005, BIOINFORMATICS, V21, P1703, DOI 10.1093/bioinformatics/bti222; Diab AA, 2004, THEOR APPL GENET, V109, P1417, DOI 10.1007/s00122-004-1755-0; DINGKUHN M, 1991, AUST J AGR RES, V42, P1123, DOI 10.1071/AR9911123; Ehleringer J. R., 1993, Stable isotopes and plant carbon-water relations., P155; Ellis RP, 2002, J EXP BOT, V53, P1163, DOI 10.1093/jexbot/53.371.1163; Erice G, 2011, ENVIRON EXP BOT, V72, P123, DOI 10.1016/j.envexpbot.2011.02.013; Farquhar G. D., 1993, Stable isotopes and plant carbon-water relations., P47; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1984, AUST J PLANT PHYSIOL, V11, P539, DOI 10.1071/PP9840539; Feng JH, 2013, G3-GENES GENOM GENET, V3, P31, DOI 10.1534/g3.112.004846; Forster BP, 2004, ANN APPL BIOL, V144, P157, DOI 10.1111/j.1744-7348.2004.tb00329.x; Hall A. E., 1994, Plant Breeding Reviews, V12, P81; Hao Z, 2009, PLANT BREEDING, V128, P337, DOI 10.1111/j.1439-0523.2009.01642.x; Hausmann NJ, 2005, EVOLUTION, V59, P81; Impa SM, 2005, CROP SCI, V45, P2517, DOI 10.2135/cropsci2005.0119; Jourjon MF, 2005, BIOINFORMATICS, V21, P128, DOI 10.1093/bioinformatics/bth481; Juenger TE, 2005, PLANT CELL ENVIRON, V28, P697, DOI 10.1111/j.1365-3040.2004.01313.x; Julier B., 2010, SUSTAINABLE USE GENE; Kiani SP, 2009, PLANT BREEDING, V128, P363, DOI 10.1111/j.1439-0523.2009.01628.x; Kliebenstein DJ, 2002, GENETICS, V161, P1685; Lambrides CJ, 2004, CROP SCI, V44, P1642, DOI 10.2135/cropsci2004.1642; Lauteri M, 1997, FUNCT ECOL, V11, P675, DOI 10.1046/j.1365-2435.1997.00140.x; Lauteri M., 1993, Stable isotopes and plant carbon-water relations., P93; Laza MR, 2006, CROP SCI, V46, P763, DOI 10.2135/cropsci2005.05.0084; Li CY, 1999, PLANT SOIL, V214, P165, DOI 10.1023/A:1004708815973; LI ZK, 1995, THEOR APPL GENET, V91, P374, DOI 10.1007/BF00220902; Lincoln S.E., 1993, CONSTRUCTING GENETIC, V3; MARTIN B, 1988, PLANT PHYSIOL, V88, P213, DOI 10.1104/pp.88.1.213; MARTIN B, 1989, SCIENCE, V243, P1725, DOI 10.1126/science.243.4899.1725; Mian MAR, 1996, CROP SCI, V36, P1252, DOI 10.2135/cropsci1996.0011183X003600050030x; Misra SC, 2010, AGR WATER MANAGE, V97, P57, DOI 10.1016/j.agwat.2009.08.014; MORGAN JA, 1993, CROP SCI, V33, P178, DOI 10.2135/cropsci1993.0011183X003300010032x; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; Price AH, 2002, J EXP BOT, V53, P989, DOI 10.1093/jexbot/53.371.989; Rebetzke G, 2008, THEOR APPL GENET, V118, P123, DOI 10.1007/s00122-008-0882-4; Rengel D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045249; Reynolds MP, 2000, FIELD CROP RES, V66, P37, DOI 10.1016/S0378-4290(99)00077-5; Ribaut JM, 1997, THEOR APPL GENET, V94, P887, DOI 10.1007/BF00221905; Richards RA, 2002, CROP SCI, V42, P111, DOI 10.2135/cropsci2002.0111; Richards RA, 1996, PLANT GROWTH REGUL, V20, P157, DOI 10.1007/BF00024012; Rizza F, 2012, FIELD CROP RES, V125, P49, DOI 10.1016/j.fcr.2011.09.001; Rytter RM, 2005, J AGRON CROP SCI, V191, P426, DOI 10.1111/j.1439-037X.2005.00162.x; Saranga Y, 2001, GENOME RES, V11, P1988, DOI 10.1101/gr.157201; Saranga Y, 2004, PLANT CELL ENVIRON, V27, P263, DOI 10.1111/j.1365-3040.2003.01134.x; Scheidegger Y, 2000, OECOLOGIA, V125, P350, DOI 10.1007/s004420000466; Schlighting CD, 1998, PHENOTYPIC EVOLUTION; Specht JE, 2001, CROP SCI, V41, P493, DOI 10.2135/cropsci2001.412493x; Teulat B, 2002, THEOR APPL GENET, V106, P118, DOI 10.1007/s00122-002-1028-8; Teulat B, 1998, THEOR APPL GENET, V96, P688, DOI 10.1007/s001220050790; This D, 2010, RICE, V3, P72, DOI 10.1007/s12284-010-9036-9; Ungerer MC, 2003, GENETICS, V165, P353; Upadyayula N, 2006, THEOR APPL GENET, V112, P592, DOI 10.1007/s00122-005-0133-x; Vargas M, 2006, THEOR APPL GENET, V112, P1009, DOI 10.1007/s00122-005-0204-z; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; Vincourt P, 2012, THEOR APPL GENET, V125, P909, DOI 10.1007/s00122-012-1882-y; Wright G. C., 1993, Stable isotopes and plant carbon-water relations., P247; Xu Y, 1997, PLANT ANIMAL GENOME, P149; Xu Yunbi, 2002, P109, DOI 10.1079/9780851996011.0109; Xu YB, 2009, THEOR APPL GENET, V118, P1065, DOI 10.1007/s00122-009-0963-z; Zhang QF, 2007, P NATL ACAD SCI USA, V104, P16402, DOI 10.1073/pnas.0708013104	79	30	35	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101218	10.1371/journal.pone.0101218	http://dx.doi.org/10.1371/journal.pone.0101218			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992022	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000341253400051
J	Vorsino, AE; Fortini, LB; Amidon, FA; Miller, SE; Jacobi, JD				Vorsino, A. E.; Fortini, L. B.; Amidon, F. A.; Miller, S. E.; Jacobi, J. D.			Modeling Hawaiian Ecosystem Degradation due to Invasive Plants under Current and Future Climates (vol 9, e95427, 2014)	PLOS ONE			English	Correction																		Vorsino AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095427	1	4	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e102400	10.1371/journal.pone.0102400	http://dx.doi.org/10.1371/journal.pone.0102400			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991934	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400130
J	Jonas, A; Sumbi, V; Mwinga, S; DeKlerk, M; Tjituka, F; Penney, S; Jordan, MR; Desta, T; Tang, AM; Hong, SY				Jonas, Anna; Sumbi, Victor; Mwinga, Samson; DeKlerk, Michael; Tjituka, Francina; Penney, Scott; Jordan, Michael R.; Desta, Tiruneh; Tang, Alice M.; Hong, Steven Y.			HIV Drug Resistance Early Warning Indicators in Namibia with Updated World Health Organization Guidance	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; TREATMENT INTERRUPTIONS; ADHERENCE; PROTEASE; OUTCOMES; PREDICTORS; MORTALITY; PROGRAMS; SURVIVAL	Background: In response to concerns about the emergence of HIV drug resistance (HIVDR), the World Health Organization (WHO) has developed a comprehensive set of early warning indicators (EWIs) to monitor HIV drug resistance and good programme practice at antiretroviral therapy (ART) sites. Methods: In 2012, Namibia utilized the updated WHO EWI guidance and abstracted data from adult and pediatric patients from 50 ART sites for the following EWIs: 1. On-time Pill Pick-up, 2. Retention in Care, 3. Pharmacy Stock-outs, 4. Dispensing Practices, and 5. Virological Suppression. Results: Data for EWIs one through four were abstracted and validated. EWI 5 - Virological Suppression was not included due to poor data entry at many sites. On-time Pill Pick-up national estimate was 87.9% (87.2-88.7) of patients picking up pills on time for adults and 90.0% (88.9-90.9) picking up pills on time for pediatrics. Retention in Care national estimate was 82% of patients retained on ART after 12 months for adults and 83% for pediatrics. Pharmacy Stock-outs national estimate was 99% of months without a stock-out for adults and 97% for pediatrics. Dispensing Practices national estimate was 0.01% (0.003-0.064) of patients dispensed mono-or dual-therapy for adults and 0.25% (0.092-0.653) for pediatrics. Conclusions: The successful 2012 EWI exercise provides Namibia a solid evidence base, which can be used to make national statements about programmatic functioning and possible HIVDR. This evidence base will serve to contextualize results from Namibia's surveys of HIVDR, which involves genotype testing. EWI abstraction has prompted the national program and its counterparts to engage sites in dialogue regarding the need to strengthen adherence and retention of patients on ART. The EWI collection process and EWI results will serve to optimize patient care and support Namibia in making evidence-based recommendations and take action to minimize the emergence of preventable HIVDR.	[Jonas, Anna; DeKlerk, Michael] Republ Namibia Minist Hlth & Social Serv, Directorate Special Programmes, Windhoek, Namibia; [Sumbi, Victor; Mwinga, Samson; Tjituka, Francina] Management Sci Hlth, Strengthening Pharmaceut Syst, Windhoek, Namibia; [Penney, Scott; Jordan, Michael R.; Tang, Alice M.; Hong, Steven Y.] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA; [Jordan, Michael R.; Hong, Steven Y.] Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA USA; [Desta, Tiruneh] World Hlth Org Namibia, Klein Windhoek, Namibia	Massachusetts Department of Public Health; Tufts University; Tufts Medical Center; World Health Organization	Hong, SY (corresponding author), Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA.	shong@tuftsmedicalcenter.org		Sumbi, Victor/0000-0001-6474-2642	Republic of Namibia Ministry of Health and Social Services; National Institutes of Health [NIH L30 AI080268-02, NIH 1K23AI097010-01A1, NIH K23 AI074423-05, NIH P30 AI42853-10]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853, K23AI097010, K23AI074423] Funding Source: NIH RePORTER	Republic of Namibia Ministry of Health and Social Services; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funding from the Republic of Namibia Ministry of Health and Social Services, National Institutes of Health, NIH L30 AI080268-02 (SYH), NIH 1K23AI097010-01A1 (SYH), NIH K23 AI074423-05 (MRJ), and NIH P30 AI42853-10 (AMT). Travel expenses for this study were supported in part by the Harold Williams Tufts Medical Student Research Fellowship (SP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WORLD FACTB; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Bennett DE, 2008, ANTIVIR THER, V13, P1; Bennett DE, 2012, CLIN INFECT DIS, V54, pS280, DOI 10.1093/cid/cis207; Billong SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036777; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014; Dzangare J, 2012, CLIN INFECT DIS, V54, pS313, DOI 10.1093/cid/cir1014; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; Hong SY, 2010, JAIDS-J ACQ IMM DEF, V55, pE27, DOI 10.1097/QAI.0b013e3181f5376d; Jones A, 2013, PLOS ONE, V8; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; Maggiolo F, 2005, CLIN INFECT DIS, V40, P158, DOI 10.1086/426595; Marcellin F, 2008, TROP MED INT HEALTH, V13, P1470, DOI 10.1111/j.1365-3156.2008.02170.x; Martin M, 2008, AIDS RES HUM RETROV, V24, P1263, DOI 10.1089/aid.2008.0141; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Parienti JJ, 2004, CLIN INFECT DIS, V38, P1311, DOI 10.1086/383572; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Republic of Namibia Ministry of Health and Social Services Directorate of Special Programmes, 2010, NAT GUID ANT THER; Sethi AK, 2003, CLIN INFECT DIS, V37, P1112, DOI 10.1086/378301; Sigaloff KCE, 2012, CLIN INFECT DIS, V54, pS294, DOI 10.1093/cid/cir1015; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; Tweya H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075761; WHO, 2012, REP ASS WHO HIV DRUG; World Health Organization, 2010, WHO IND MON HIV DRUG	30	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100539	10.1371/journal.pone.0100539	http://dx.doi.org/10.1371/journal.pone.0100539			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988387	Green Submitted, Green Published, gold			2022-12-27	WOS:000341354100033
J	Wilson, SC; Eybatov, TM; Amano, M; Jepson, PD; Goodman, SJ				Wilson, Susan C.; Eybatov, Tariel M.; Amano, Masao; Jepson, Paul D.; Goodman, Simon J.			The Role of Canine Distemper Virus and Persistent Organic Pollutants in Mortality Patterns of Caspian Seals (Pusa caspica)	PLOS ONE			English	Article							PHOCA-VITULINA; POLYCHLORINATED-BIPHENYLS; HARBOR SEAL; ENVIRONMENTAL CONTAMINANTS; PHOCOENA-PHOCOENA; COPLANAR PCBS; GROWTH; ORGANOCHLORINE; AGE; INFECTION	Persistent organic pollutants are a concern for species occupying high trophic levels since they can cause immunosuppression and impair reproduction. Mass mortalities due to canine distemper virus (CDV) occurred in Caspian seals (Pusa caspica), in spring of 1997, 2000 and 2001, but the potential role of organochlorine exposure in these epizootics remains undetermined. Here we integrate Caspian seal mortality data spanning 1971-2008, with data on age, body condition, pathology and blubber organochlorine concentration for carcases stranded between 1997 and 2002. We test the hypothesis that summed PCB and DDT concentrations contributed to CDV associated mortality during epizootics. We show that age is the primary factor explaining variation in blubber organochlorine concentrations, and that organochlorine burden, age, sex, and body condition do not account for CDV infection status (positive/negative) of animals dying in epizootics. Most animals (57%, n = 67) had PCB concentrations below proposed thresholds for toxic effects in marine mammals (17 mu g/g lipid weight), and only 3 of 67 animals had predicted TEQ values exceeding levels seen to be associated with immune suppression in harbour seals (200 pg/g lipid weight). Mean organonchlorine levels were higher in CDV-negative animals indicating that organochlorines did not contribute significantly to CDV mortality in epizootics. Mortality monitoring in Azerbaijan 1971-2008 revealed bi-annual stranding peaks in late spring, following the annual moult and during autumn migrations northwards. Mortality peaks comparable to epizootic years were also recorded in the 1970s-1980s, consistent with previous undocumented CDV outbreaks. Gompertz growth curves show that Caspian seals achieve an asymptotic standard body length of 126-129 cm (n = 111). Males may continue to grow slowly throughout life. Mortality during epizootics may exceed the potential biological removal level (PBR) for the population, but the low frequency of epizootics suggest they are of secondary importance compared to anthropogenic sources of mortality such as fishing by-catch.	[Wilson, Susan C.] Tara Seal Res Ctr, Killyleagh, County Down, North Ireland; [Eybatov, Tariel M.] Inst Geol, Baku, Azerbaijan; [Amano, Masao] Nagasaki Univ, Fac Fisheries, Nagasaki 852, Japan; [Jepson, Paul D.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Goodman, Simon J.] Univ Leeds, Sch Biol, Leeds, W Yorkshire, England	Azerbaijan National Academy of Sciences (ANAS); Nagasaki University; Zoological Society of London; University of Leeds	Wilson, SC (corresponding author), Tara Seal Res Ctr, Killyleagh, County Down, North Ireland.	suewilson@sealresearch.org; s.j.goodman@leeds.ac.uk	Amano, Masao/J-9778-2019	Amano, Masao/0000-0001-9495-5315; Goodman, Simon/0000-0003-4118-8575	World Bank ECOTOX project; Darwin Initiative project 'Quantification and Elimination of Threats to the Caspian seal' [165-15-024]; Grants-in-Aid for Scientific Research [25281008] Funding Source: KAKEN	World Bank ECOTOX project; Darwin Initiative project 'Quantification and Elimination of Threats to the Caspian seal'; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Investigation of the mass mortalities, pathology and toxicology analyses were funded by the World Bank ECOTOX project. The Darwin Initiative project 'Quantification and Elimination of Threats to the Caspian seal' (ref: 165-15-024) funded collection of data from Azerbaijan 2006-2009. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDISON RF, 1977, J FISH RES BOARD CAN, V34, P937, DOI 10.1139/f77-146; ADDISON RF, 1973, J FISH RES BOARD CAN, V30, P595, DOI 10.1139/f73-106; Allchin C, 1997, P 1 BION WORKSH BORD, P101; Amano M, 2000, ADV ECOL RES, V31, P449, DOI 10.1016/S0065-2504(00)31024-8; AMOS B, 1995, SCIENCE, V268, P1897, DOI 10.1126/science.268.5219.1897; Anan Y, 2002, ARCH ENVIRON CON TOX, V42, P354, DOI 10.1007/s00244-001-0004-7; Beckmen KB, 1999, SCI TOTAL ENVIRON, V231, P183, DOI 10.1016/S0048-9697(99)00094-7; Brock PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067132; Chabot D, 2002, MAR ECOL PROG SER, V227, P25, DOI 10.3354/meps227025; Chapsky KK, 1965, MARINE MAMMALS, P122; DESWART RL, 1995, INFECT AGENT DIS, V4, P125; DESWART RL, 1995, CHEMOSPHERE, V31, P4289, DOI 10.1016/0045-6535(95)00298-M; deSwart RL, 1996, ENVIRON HEALTH PERSP, V104, P823, DOI 10.2307/3432713; DESWART RL, 1995, CLIN EXP IMMUNOL, V101, P480; Dmitrieva L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067074; Espeland O, 1997, MAR ENVIRON RES, V44, P315, DOI 10.1016/S0141-1136(97)00010-X; Eybatov T, 1997, P 1 BION WORKSH BORD, P95; FITZHUGH HA, 1976, J ANIM SCI, V42, P1036, DOI 10.2527/jas1976.4241036x; Forsyth MA, 1998, VET REC, V143, P662; Giesy JP, 1998, CRIT REV TOXICOL, V28, P511, DOI 10.1080/10408449891344263; Green Nicholas, 1996, Organohalogen Compounds, V29, P453; Hadjiev DB, 1995, MORPHOLOGIA ZYBNOVO; Hall AJ, 2006, BIOL CONSERV, V131, P221, DOI 10.1016/j.biocon.2006.04.008; Hall AJ, 1999, ENVIRON POLLUT, V106, P203, DOI 10.1016/S0269-7491(99)00073-1; Hall AJ, 2006, ENVIRON HEALTH PERSP, V114, P704, DOI 10.1289/ehp.8222; Harder TC, 1997, TRENDS MICROBIOL, V5, P120, DOI 10.1016/S0966-842X(97)01010-X; Harding KC, 2002, ECOL LETT, V5, P727, DOI 10.1046/j.1461-0248.2002.00390.x; Harkonen T, 2008, IUCN 2013 RED LIST T; Harkonen T, 2008, AMBIO, V37, P356, DOI 10.1579/07-R-345.1; Harkonen T, 2006, DIS AQUAT ORGAN, V68, P115, DOI 10.3354/dao068115; Harkonen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043130; Harkonen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000887; HELLE E, 1976, Ambio, V5, P261; HELLE E, 1976, Ambio, V5, P188; Helle E, 1990, AMBIO, V7, P16; Jepson PD, 2005, ENVIRON TOXICOL CHEM, V24, P238, DOI 10.1897/03-663.1; Kajiwara N, 2002, ENVIRON POLLUT, V117, P391, DOI 10.1016/S0269-7491(01)00200-7; Kajiwara N, 2008, ENVIRON POLLUT, V152, P431, DOI 10.1016/j.envpol.2007.06.075; Kannan K, 2000, HUM ECOL RISK ASSESS, V6, P181, DOI 10.1080/10807030091124491; Kennedy S, 2000, EMERG INFECT DIS, V6, P637, DOI 10.3201/eid0606.000613; Kosarev A.N., 1994, CASPIAN SEA, DOI DOI 10.1111/jai.14038; Krylov V.I., 1990, Finnish Game Research, V47, P32; Kuiken T, 2006, VET PATHOL, V43, P321, DOI 10.1354/vp.43-3-321; LAW RJ, 1994, MAR POLLUT BULL, V29, P235, DOI 10.1016/0025-326X(94)90415-4; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Mariner JC, 2003, VET REC, V152, P641, DOI 10.1136/vr.152.21.641; MCLAREN IA, 1993, BIOL REV, V68, P1, DOI 10.1111/j.1469-185X.1993.tb00731.x; Murphy S, 2006, ACTA ZOOL-STOCKHOLM, V87, P315, DOI 10.1111/j.1463-6395.2006.00245.x; Murphy Sinead, 2012, Endangered Species Research, V16, P149, DOI 10.3354/esr00392; Murphy S, 2009, MAR ECOL PROG SER, V388, P273, DOI 10.3354/meps08129; Nilssen K.T., 1997, Journal of Northwest Atlantic Fishery Science, V22, P17; Ohashi K, 2001, VET MICROBIOL, V82, P203, DOI 10.1016/S0378-1135(01)00371-6; OLSSON M, 1994, SCI TOTAL ENVIRON, V154, P217, DOI 10.1016/0048-9697(94)90089-2; Paterson W, 2012, J THERM BIOL, V37, P454, DOI 10.1016/j.jtherbio.2012.03.004; R Core Team, 2013, R LANG ENV STAT COMP; RALLS K, 1977, AM NAT, V111, P917, DOI 10.1086/283223; Reijnders PJH, 2003, N P TOX ENV, P55; REIJNDERS PJH, 1986, NATURE, V324, P456, DOI 10.1038/324456a0; ROSS PS, 1995, ENVIRON HEALTH PERSP, V103, P162, DOI 10.2307/3432272; ROSS PS, 1994, VET IMMUNOL IMMUNOP, V42, P331, DOI 10.1016/0165-2427(94)90077-9; Ross PS, 1996, AQUAT TOXICOL, V34, P71, DOI 10.1016/0166-445X(95)00031-X; Sandland GJ, 2003, TRENDS PARASITOL, V19, P571, DOI 10.1016/j.pt.2003.10.006; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Stolen MK, 2002, MAR MAMMAL SCI, V18, P348, DOI 10.1111/j.1748-7692.2002.tb01042.x; SWART RD, 1994, AMBIO, V23, P155; Swinton J, 1998, J ANIM ECOL, V67, P54, DOI 10.1046/j.1365-2656.1998.00176.x; TANABE S, 1987, INT J ENVIRON AN CH, V29, P199, DOI 10.1080/03067318708079836; TANABE S, 1987, ENVIRON POLLUT, V47, P147, DOI 10.1016/0269-7491(87)90044-3; TANABE S, 1994, SCI TOTAL ENVIRON, V154, P163, DOI 10.1016/0048-9697(94)90086-8; Watanabe M, 1999, ARCH ENVIRON CON TOX, V37, P396, DOI 10.1007/s002449900531; Winship AJ, 2001, J MAMMAL, V82, P500, DOI 10.1644/1545-1542(2001)082<0500:GIBSOT>2.0.CO;2	71	17	17	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e99265	10.1371/journal.pone.0099265	http://dx.doi.org/10.1371/journal.pone.0099265			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987857	Green Published, gold			2022-12-27	WOS:000341354100012
J	Bui, ET; Anderson, NK; Kassem, L; McMahon, FJ				Bui, Elise T.; Anderson, Natalie K.; Kassem, Layla; McMahon, Francis J.			Do Participants in Genome Sequencing Studies of Psychiatric Disorders Wish to Be Informed of Their Results? A Survey Study	PLOS ONE			English	Article							GENETIC RESEARCH; INCIDENTAL FINDINGS; PUBLIC EXPECTATIONS; WORKING GROUP; RETURN; ATTITUDES; RECOMMENDATIONS; PERSPECTIVES; INTENTIONS; AUTONOMY	Objective: As large-scale genome sequencing technology advances, concerns surrounding the reporting of individual findings to study volunteers have grown and fueled controversy. This is especially true in mental health research, where the clinical importance of sequencing results is particularly unclear. The ethical, legal, and social issues are being widely debated, but less is known about the attitudes of actual study volunteers toward sequencing studies or what they wish to team about their DNA sequence and its health implications. This study provides information on psychiatric research volunteers' attitudes, beliefs, and concerns with respect to participation in DNA sequencing studies and reporting of individual results. Method: We conducted a pilot study using a questionnaire that we developed to assess what information volunteers in an ongoing family study of bipolar disorder would like to receive if they underwent genome sequencing, what they would do with that information, and what concerns they may have. Results: Almost all of the respondents were willing to participate in genome sequencing. Most respondents wished to be informed about all their health-related genetic risks, including risks for diseases without known prevention or treatment. However, few respondents felt well informed about the nature of genome sequencing or its implications for their health, insurability, or offspring. Conclusions: Despite generally positive attitudes toward genome sequencing among study volunteers, most are not fully aware of the special issues raised by genome sequencing. The attitudes of study volunteers should be considered in the debate about the reporting of individual findings from genome sequencing.	[Bui, Elise T.; Anderson, Natalie K.; Kassem, Layla; McMahon, Francis J.] NIMH, Human Genet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Kassem, L (corresponding author), NIMH, Human Genet Branch, NIH, Bethesda, MD 20892 USA.	kasseml@mail.nih.gov	McMahon, Francis J/A-7290-2009	McMahon, Francis J/0000-0002-9469-305X; Bui, Elise/0000-0002-0709-7293	NIMH Intramural Research Program; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002843] Funding Source: NIH RePORTER	NIMH Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the NIMH Intramural Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Medical Genetics and Genomics, 2014, ACMG UPD REC OPT OUT; Beskow LM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000952; Bollinger JM, 2012, GENET MED, V14, P451, DOI 10.1038/gim.2011.66; Bookman EB, 2006, AM J MED GENET A, V140A, P1033, DOI 10.1002/ajmg.a.31195; Caulfield T, 2008, PLOS BIOL, V6, P430, DOI 10.1371/journal.pbio.0060073; Christenhusz GM, 2012, EUROPEAN J HUMAN GEN; Christensen K, 2013, ALZHEIMERS DEMENT, V9, pP546; Christensen KD, 2013, PERS MED, V10, P377, DOI [10.2217/PME.13.24, 10.2217/pme.13.24]; Fabsitz RR, 2010, CIRC-CARDIOVASC GENE, V3, P574, DOI 10.1161/CIRCGENETICS.110.958827; Facio FM, 2013, EUR J HUM GENET, V21, P261, DOI 10.1038/ejhg.2012.179; Fernandez C, 2008, AM J BIOETHICS, V8, P46, DOI 10.1080/15265160802513127; Fernandez CV, 2003, J PEDIAT HEMATOL ONC, V25, P704, DOI 10.1097/00043426-200309000-00006; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Hook CC, 2004, MAYO CLIN PROC, V79, P645, DOI 10.4065/79.5.645; Jones I, 2002, J AFFECT DISORDERS, V71, P189, DOI 10.1016/S0165-0327(00)00384-0; Karlawish J, 2013, ALZHEIMERS DEMENT, V9, pP621; Laegsgaard MM, 2009, GENET TEST MOL BIOMA, V13, P57, DOI 10.1089/gtmb.2008.0022; McGowan ML, 2013, PERS MED, V10, P339, DOI 10.2217/PME.13.32; McGuire AL, 2012, PERS MED, V10, P27; McGuire AL, 2008, NAT REV GENET, V9, P152, DOI 10.1038/nrg2302; McGuire AL, 2013, SCIENCE, V340, P1047, DOI 10.1126/science.1240156; Meulenkamp TM, 2010, AM J MED GENET A, V152A, P2482, DOI 10.1002/ajmg.a.33617; Murphy J, 2008, AM J BIOETHICS, V8, P36, DOI 10.1080/15265160802513093; O'Daniel J, 2011, PUBLIC HEALTH GENOM, V14, P346, DOI 10.1159/000324933; Partridge AH, 2002, JAMA-J AM MED ASSOC, V288, P363, DOI 10.1001/jama.288.3.363; Rotimi CN, 2010, GENOME MED, V2, DOI 10.1186/gm141; Tabor HK, 2012, AM J MED GENET A, V158A, P1310, DOI 10.1002/ajmg.a.35328; Townsend A, 2014, EUR J HUM GENET, V22, P6, DOI 10.1038/ejhg.2013.94; Wolf SM, 2013, SCIENCE, V340, P1049, DOI 10.1126/science.1239119	29	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101111	10.1371/journal.pone.0101111	http://dx.doi.org/10.1371/journal.pone.0101111			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983240	Green Submitted, Green Published, gold			2022-12-27	WOS:000339635000053
J	Ramlochansingh, C; Branoner, F; Chagnaud, BP; Straka, H				Ramlochansingh, Carlana; Branoner, Francisco; Chagnaud, Boris P.; Straka, Hans			Efficacy of Tricaine Methanesulfonate (MS-222) as an Anesthetic Agent for Blocking Sensory-Motor Responses in Xenopus laevis Tadpoles	PLOS ONE			English	Article							NEUROACTIVE DRUGS; NEURONS; PAIN; FROG; INPUTS	Anesthetics are drugs that reversibly relieve pain, decrease body movements and suppress neuronal activity. Most drugs only cover one of these effects; for instance, analgesics relieve pain but fail to block primary fiber responses to noxious stimuli. Alternately, paralytic drugs block synaptic transmission at neuromuscular junctions, thereby effectively paralyzing skeletal muscles. Thus, both analgesics and paralytics each accomplish one effect, but fail to singularly account for all three. Tricaine methanesulfonate (MS-222) is structurally similar to benzocaine, a typical anesthetic for anamniote vertebrates, but contains a sulfate moiety rendering this drug more hydrophilic. MS-222 is used as anesthetic in poikilothermic animals such as fish and amphibians. However, it is often argued that MS-222 is only a hypnotic drug and its ability to block neural activity has been questioned. This prompted us to evaluate the potency and dynamics of MS-222-induced effects on neuronal firing of sensory and motor nerves alongside a defined motor behavior in semi-intact in vitro preparations of Xenopus laevis tadpoles. Electrophysiological recordings of extraocular motor discharge and both spontaneous and evoked mechanosensory nerve activity were measured before, during and after administration of MS-222, then compared to benzocaine and a known paralytic, pancuronium. Both MS-222 and benzocaine, but not pancuronium caused a dose-dependent, reversible blockade of extraocular motor and sensory nerve activity. These results indicate that MS-222 as benzocaine blocks the activity of both sensory and motor nerves compatible with the mechanistic action of effective anesthetics, indicating that both caine-derivates are effective as single-drug anesthetics for surgical interventions in anamniotes.	[Ramlochansingh, Carlana; Branoner, Francisco; Chagnaud, Boris P.; Straka, Hans] Univ Munich, Dept Biol 2, Planegg, Germany	University of Munich	Straka, H (corresponding author), Univ Munich, Dept Biol 2, Planegg, Germany.	straka@lmu.de			German Science Foundation [CRC 870, TP B12]; German Federal Ministry of Education and Research [01 EO 0901]; Munich Center for Neurosciences - Brain and Mind (MCN); Graduate School for Systemic Neurosciences (GSN)	German Science Foundation(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Munich Center for Neurosciences - Brain and Mind (MCN); Graduate School for Systemic Neurosciences (GSN)	The authors CR FB BPC and HS acknowledge financial support from the German Science Foundation (CRC 870, TP B12), the German Federal Ministry of Education and Research under the Grant code 01 EO 0901, the Munich Center for Neurosciences - Brain and Mind (MCN) and the Graduate School for Systemic Neurosciences (GSN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnolds DEW, 2002, BIOL BULL, V203, P188, DOI 10.2307/1543388; Bai CX, 2003, NEUROSCI LETT, V337, P41, DOI 10.1016/S0304-3940(02)01288-0; Beck JC, 2004, METHOD CELL BIOL, V76, P385; Biesdorf S, 2008, J NEUROPHYSIOL, V99, P1758, DOI 10.1152/jn.01207.2007; BUTTERWORTH JF, 1990, ANESTHESIOLOGY, V72, P711, DOI 10.1097/00000542-199004000-00022; Cakir Y, 2005, PHARMACOL REP, V57, P467; Combes D, 2004, J PHYSIOL-LONDON, V559, P17, DOI 10.1113/jphysiol.2004.069542; Drexler B, 2010, CURR MED CHEM, V17, P4538, DOI 10.2174/092986710794183042; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Gentz EJ, 2007, ILAR J, V48, P255, DOI 10.1093/ilar.48.3.255; Guenette SA, 2008, J AM ASSOC LAB ANIM, V47, P35; Guenette SA, 2013, EXP ANIM TOKYO, V62, P87; Hasegawa T, 2004, J MEMBRANE BIOL, V199, P119, DOI 10.1007/s00232-004-0677-8; Lafortune M., 2001, Journal of Herpetological Medicine and Surgery, V11, P13; Lalonde-Robert V, 2012, J AM ASSOC LAB ANIM, V51, P464; Lambert FM, 2008, J NEUROSCI, V28, P8086, DOI 10.1523/JNEUROSCI.1288-08.2008; Lambert FM, 2012, CURR BIOL, V22, P1649, DOI 10.1016/j.cub.2012.07.019; LETCHER J, 1995, J AM VET MED ASSOC, V207, P80; LODGE D, 1990, TRENDS PHARMACOL SCI, V11, P81, DOI 10.1016/0165-6147(90)90323-Z; Machin KL, 1999, J ZOO WILDLIFE MED, V30, P2; Nair G, 2011, DOC OPHTHALMOL, V122, P163, DOI 10.1007/s10633-011-9271-4; Palmer LM, 2004, J NEUROPHYSIOL, V92, P1034, DOI 10.1152/jn.01151.2003; Parker Brian M, 2006, Cleve Clin J Med, V73 Suppl 1, pS13; Ramlochansingh C, 2011, NEUROTOX RES, V20, P263, DOI 10.1007/s12640-011-9239-x; Rihel J, 2012, DEV NEUROBIOL, V72, P373, DOI 10.1002/dneu.20910; SIMMONDS MA, 1987, NEUROPHARMACOLOGY, V26, P923, DOI 10.1016/0028-3908(87)90071-2; Sladky KK, 2001, AM J VET RES, V62, P337, DOI 10.2460/ajvr.2001.62.337; Smith JM, 2000, CONTEMP TOP LAB ANIM, V39, P39; STEDMAN TL, 1995, STEDMANS MED DICT; Stevens Craig W., 2011, Veterinary Clinics of North America Exotic Animal Practice, V14, P33, DOI 10.1016/j.cvex.2010.09.007; Stockman J, 2013, VET ANAESTH ANALG, V40, P35, DOI 10.1111/j.1467-2995.2012.00739.x; Stoskopf M, 2008, AM COLL LAB, P519; STOSKOPF MK, 1994, INVEST OPHTH VIS SCI, V35, P775; STRAKA H, 1993, EUR J NEUROSCI, V5, P251, DOI 10.1111/j.1460-9568.1993.tb00491.x; Straka H, 2004, PROG NEUROBIOL, V73, P259, DOI 10.1016/j.pneurobio.2004.05.003; Straka H, 2012, DEV NEUROBIOL, V72, P649, DOI 10.1002/dneu.20965; SU PC, 1979, ANESTHESIOLOGY, V50, P199, DOI 10.1097/00000542-197903000-00006; WASS JA, 1974, LAB ANIM SCI, V24, P669; Wheeler GN, 2009, DEV DYNAM, V238, P1287, DOI 10.1002/dvdy.21967; Zahl IH, 2012, FISH PHYSIOL BIOCHEM, V38, P201, DOI 10.1007/s10695-011-9565-1; Zornik E, 2008, J NEUROSCI, V28, P612, DOI 10.1523/JNEUROSCI.4754-07.2008	41	52	52	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101606	10.1371/journal.pone.0101606	http://dx.doi.org/10.1371/journal.pone.0101606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984086	Green Published, gold, Green Submitted			2022-12-27	WOS:000339635000122
J	Xia, S; Fan, X; Huang, ZG; Xia, L; Xiao, M; Chen, RC; Xu, YC; Zhuo, C				Xia, Shu; Fan, Xin; Huang, Zengguang; Xia, Liang; Xiao, Meng; Chen, Rongchang; Xu, Yingchun; Zhuo, Chao			Dominance of CTX-M-Type Extended-Spectrum beta-Lactamase (ESBL)-Producing Escherichia coli Isolated from Patients with Community-Onset and Hospital-Onset Infection in China	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; BLOOD-STREAM INFECTIONS; FECAL CARRIAGE; ANTIMICROBIAL SUSCEPTIBILITY; KLEBSIELLA-PNEUMONIAE; GENOTYPE DISTRIBUTION; ACQUIRED INFECTIONS; MEDICAL-CENTERS; FOOD ANIMALS; RISK-FACTORS	Objective: To investigate CTX-M genotypes among extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) isolated from patients with community-onset and hospital-onset infections in China, their clonality and the distribution of CTX-M variants in different specimens of community-onset and hospital-onset infections. Methods: ESBL-EC isolates were collected from general hospitals from 2011 to 2012 in China. Broth microdilution method antimicrobial susceptibility testing of 16 antibiotics was performed. Clinical data from community-onset and hospital-onset infections due to ESBL-EC were analyzed. ESBL-encoding genes were amplified by PCR and sequenced, and multilocus sequence typing (MLST) was performed for a random selection of predominant CTX-M type strains identified. Results: A total of 1,168 ESBL-EC isolates were obtained from various clinical specimens, 41.7% of which were responsible for causing community-onset infections. The presence of urinary calculi was higher in community-onset infections, whereas malignancy, cardiovascular and cerebrovascular diseases, dementia, chronic renal disease, diabetes mellitus and surgical treatment were found to have higher proportions in hospital-onset infections. There was no significant difference in trauma between community-onset and hospital-onset infections. 96.2% of the isolates were detected to harbor bla(CTX-M) genes. bla(CTX-M-1) group and bla(CTX-M-9) group were detected at 40.7% and 48.7% respectively, and both positive group accounted for 10.6%. bla(CTX-M-55) (24.8%) and bla(CTX-M-15) (18.2%) were the major genotypes in bla(CTX-M-1) group while bla(CTX-M-14) (46.8%) was predominant in bla(CTX-M-9) group. A comparison of bla(CTX-M) distribution in different specimens between ESBL-EC causing community-onset and hospital-onset infection showed no significant difference. A total of 229 isolates were tested for MLST. ST131 (14%) was the predominant type. ST648, ST405 and ST1193 were also detected. Conclusions: Community-onset ESBL-EC has emerged as a common pathogen in China. CTX-M-14 is the most commonly encountered, CTX-M-55 and CTX-M-15 have spread rapidly. ST131 is the predominant clonal group, and the great diversity of CTX-M-producing isolates of E. coli has emerged in China.	[Xia, Shu; Huang, Zengguang; Chen, Rongchang; Zhuo, Chao] Guangzhou Med Univ, State Key Lab Resp Dis, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Fan, Xin; Xiao, Meng; Xu, Yingchun] Beijing Union Med Coll Hosp, Dept Clin Lab, Beijing, Peoples R China; [Xia, Liang] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chongqing Medical University	Xu, YC (corresponding author), Beijing Union Med Coll Hosp, Dept Clin Lab, Beijing, Peoples R China.	xycpumch@139.com; chao_sheep@263.net	Xiao, Meng/J-6518-2017; Chen, Rong-Chang/HIR-4186-2022	Xiao, Meng/0000-0003-2103-7008; Chen, Rong-Chang/0000-0002-4321-8558	National Natural Science Foundation of China [81271881]; Special Fund for Scientific Research of Public Health Service Industry of China [201002021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Scientific Research of Public Health Service Industry of China	This work was supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal0/default.htm) (grant number: 81271881) and Special Fund for Scientific Research of Public Health Service Industry of China (http://www.nhfpc.gov.cn/) ( grant number: 201002021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aibinu I, 2012, CLIN MICROBIOL INFEC, V18, pE49, DOI 10.1111/j.1469-0691.2011.03730.x; An SC, 2012, FEMS MICROBIOL LETT, V332, P137, DOI 10.1111/j.1574-6968.2012.02586.x; Cao XL, 2011, J CLIN MICROBIOL, V49, P2496, DOI 10.1128/JCM.02503-10; Clinical and Laboratory Standards Institute, 2012, PERF STAND ANT SUS S; D'Andrea MM, 2013, INT J MED MICROBIOL, V303, P305, DOI 10.1016/j.ijmm.2013.02.008; Doi Y, 2013, CLIN INFECT DIS, V56, P641, DOI 10.1093/cid/cis942; Dong LF, 2008, J ANTIMICROB CHEMOTH, V62, P410, DOI 10.1093/jac/dkn153; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; Hawser SP, 2010, ANTIMICROB AGENTS CH, V54, P3043, DOI 10.1128/AAC.00265-10; Hayakawa K, 2013, ANTIMICROB AGENTS CH, V57, P4010, DOI 10.1128/AAC.02516-12; He DD, 2013, ANTIMICROB AGENTS CH, V57, P4068, DOI 10.1128/AAC.00541-13; Jones RN, 2013, DIAGN MICR INFEC DIS, V77, P258, DOI 10.1016/j.diagmicrobio.2013.07.003; Kiratisin P, 2007, DIAGN MICR INFEC DIS, V58, P349, DOI 10.1016/j.diagmicrobio.2007.02.005; Liu WE, 2009, J ANTIMICROB CHEMOTH, V63, P895, DOI 10.1093/jac/dkp068; Luvsansharav UO, 2012, J ANTIMICROB CHEMOTH, V67, P1769, DOI 10.1093/jac/dks118; Lv LC, 2013, ANTIMICROB AGENTS CH, V57, P2824, DOI 10.1128/AAC.02155-12; Ma JY, 2012, APPL ENVIRON MICROB, V78, P3668, DOI 10.1128/AEM.07507-11; Miano R, 2007, UROL INT, V79, P32, DOI 10.1159/000104439; Nicolas-Chanoine MH, 2013, J ANTIMICROB CHEMOTH, V68, P562, DOI 10.1093/jac/dks429; Novais A, 2012, ANTIMICROB AGENTS CH, V56, P3973, DOI 10.1128/AAC.00475-12; Rodriguez-Bano J, 2006, CLIN INFECT DIS, V43, P1407, DOI 10.1086/508877; Rodriguez-Bano J, 2010, CLIN INFECT DIS, V50, P40, DOI 10.1086/649537; Sun Y, 2010, CLIN MICROBIOL INFEC, V16, P1475, DOI 10.1111/j.1469-0691.2010.03127.x; Trecarichi EM, 2012, FUTURE MICROBIOL, V7, P1173, DOI [10.2217/FMB.12.100, 10.2217/fmb.12.100]; Vardakas KZ, 2012, J ANTIMICROB CHEMOTH, V67, P2793, DOI 10.1093/jac/dks301; Woerther PL, 2013, CLIN MICROBIOL REV, V26, P744, DOI 10.1128/CMR.00023-13; Yu YS, 2007, J INFECTION, V54, P53, DOI 10.1016/j.jinf.2006.01.014; Zheng HQ, 2012, INT J ANTIMICROB AG, V39, P305, DOI 10.1016/j.ijantimicag.2011.12.001; Zhuo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052222; [卓超 ZHUO Chao], 2009, [中华检验医学杂志, Chinese Journal of Laboratory Medicine], V32, P1114; Zong ZY, 2008, ANTIMICROB AGENTS CH, V52, P4198, DOI 10.1128/AAC.00107-08	31	56	64	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100707	10.1371/journal.pone.0100707	http://dx.doi.org/10.1371/journal.pone.0100707			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983621	Green Submitted, Green Published, gold			2022-12-27	WOS:000339635000036
J	De Ferrari, A; Gentille, C; Davalos, L; Huayanay, L; Malaga, G				De Ferrari, Aldo; Gentille, Cesar; Davalos, Long; Huayanay, Leandro; Malaga, German			Attitudes and Relationship between Physicians and the Pharmaceutical Industry in a Public General Hospital in Lima, Peru	PLOS ONE			English	Article							GIFTS; REPRESENTATIVES	Background: The interaction between physicians and the pharmaceutical industry influences physicians' attitudes and prescribing behavior. Although largely studied in the US, this topic has not been well studied in resource-poor settings, where a close relationship between physicians and industry still exists. Objective: To describe physician interactions with and attitudes towards the pharmaceutical industry in a public general hospital in Lima, Peru. Design: Descriptive, cross-sectional study through an anonymous, self-filled questionnaire distributed among faculty and trainee physicians of five different clinical departments working in a Peruvian public general hospital. A transcultural validation of an existing Spanish questionnaire was performed. Exposure to marketing activities, motivations to contact pharmaceutical representatives and attitudes towards industry were studied. Collected data was analyzed by degree of training, clinical department, gender and teaching status. Attitudes were measured on a four-point LIKERT scale. Results: 155 physicians completed the survey, of which 148 were included in the study sample. 94.5% of attending physicians reported ongoing encounters with pharmaceutical representatives. The most common industry-related activities were receiving medical samples (91.2%), promotional material (87.8%) and attending meetings in restaurants (81.8%). Respondents considered medical samples and continuing medical education the most ethically acceptable benefits. We found significant differences between attendings and residents, and teaching and non-teaching attendings. An association between the amount of encounters with pharmaceutical representatives, and attitudes towards industry and acceptance of medical samples was found. Conclusions: A close physician-industry relationship exists in the population under study. The contact is established mainly through pharmaceutical representatives. Medical samples are the most received and ethically accepted benefit. The attitudes of physicians on the ethical standards of acceptance of medical samples and other benefits are closely related with their exposure to the pharmaceutical industry. Future studies could explore the motivations of physicians working in resource-poor settings to maintain a close relationship with industry.	[De Ferrari, Aldo; Gentille, Cesar; Davalos, Long; Huayanay, Leandro; Malaga, German] Univ Peruana Cayetano Heredia, Fac Med Alberto Hurtado, Lima, Peru; [Malaga, German] Hosp Nacl Cayetano Heredia, Dept Med, Lima, Peru	Universidad Peruana Cayetano Heredia	De Ferrari, A (corresponding author), Univ Peruana Cayetano Heredia, Fac Med Alberto Hurtado, Lima, Peru.	aldo.de.ferrari@upch.pe	Davalos, Long/AHD-9292-2022; Gentille, Cesar/AAE-6613-2022	Gentille, Cesar/0000-0001-7643-8154; Malaga, German/0000-0002-7828-300X; HUAYANAY, LEANDRO/0000-0001-6239-5157				Adair RF, 2005, AM J MED, V118, P881, DOI 10.1016/j.amjmed.2005.02.031; Alssageer MA, 2012, LIBYAN J MED, V7, DOI 10.3402/ljm.v7i0.18556; Appelbaum PS, 2010, AM J BIOETHICS, V10, P11, DOI 10.1080/15265160903441046; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Birkhahn RH, 2008, ACAD EMERG MED, V15, P819, DOI 10.1111/j.1553-2712.2008.00196.x; Campbell EG, 2007, NEW ENGL J MED, V356, P1742, DOI 10.1056/NEJMsa064508; Chen J., 2013, IEEE T IND INF, P1, DOI DOI 10.1145/2537052.2537057; Chew LD, 2000, J GEN INTERN MED, V15, P478, DOI 10.1046/j.1525-1497.2000.08014.x; Dana J, 2003, JAMA-J AM MED ASSOC, V290, P252, DOI 10.1001/jama.290.2.252; Gagnon MA, 2008, PLOS MED, V5, P29, DOI 10.1371/journal.pmed.0050001; Galan Herrera S, 2004, Aten Primaria, V34, P231, DOI 10.1157/13066401; Katz D, 2003, AM J BIOETHICS, V3, P39, DOI 10.1162/15265160360706552; Kleier J, 2012, UROL NURS, V32, P51; Kleiner Jo Ann, 2012, Urol Nurs, V32, P8; Komesaroff PA, 2010, INTERN MED J, V40, P321, DOI 10.1111/j.1445-5994.2010.02215.x; Korenstein D, 2010, ARCH SURG-CHICAGO, V145, P570, DOI 10.1001/archsurg.2010.75; LEXCHIN J, 1993, CAN MED ASSOC J, V149, P1401; Lieb K, 2010, DTSCH ARZTEBL INT, V107, P392, DOI 10.3238/arztebl.2010.0392; Lo B, 2009, CONFLICT INTEREST ME; Mansfield P, 2009, WHO MANUAL IN PRESS; McNeill PM, 2006, INTERN MED J, V36, P571, DOI 10.1111/j.1445-5994.2006.01151.x; Norris P, 2004, EDM RES SERIES, V032; Saito S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012193; Sergeant MD, 1996, CAN MED ASSOC J, V155, P1243; Valenzuela-Rodriguez G, 2010, REV SOC PERU MED INT, V23, P150; Warrier R, 2010, CLIN REV OPIN, V2, P41; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; Zipkin DA, 2005, J GEN INTERN MED, V20, P777, DOI 10.1111/j.1525-1497.2005.0134.x	28	22	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100114	10.1371/journal.pone.0100114	http://dx.doi.org/10.1371/journal.pone.0100114			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978481	Green Submitted, Green Published, gold			2022-12-27	WOS:000338506400021
J	Kawashima, A; Satta, Y				Kawashima, Ayaka; Satta, Yoko			Substrate-Dependent Evolution of Cytochrome P450: Rapid Turnover of the Detoxification-Type and Conservation of the Biosynthesis-Type	PLOS ONE			English	Article							LANOSTEROL 14-ALPHA-DEMETHYLASE; GENE-CLUSTER; P450; SEQUENCES; FAMILY; RAT	Members of the cytochrome P450 family are important metabolic enzymes that are present in all metazoans. Genes encoding cytochrome P450s form a multi-gene family, and the number of genes varies widely among species. The enzymes are classified as either biosynthesis-or detoxification-type, depending on their substrates, but their origin and evolution have not been fully understood. In order to elucidate the birth and death process of cytochrome P450 genes, we performed a phylogenetic analysis of 710 sequences from 14 vertebrate genomes and 543 sequences from 6 invertebrate genomes. Our results showed that vertebrate detoxification-type genes have independently emerged three times from biosynthesis-type genes and that invertebrate detoxification-type genes differ from vertebrates in their origins. Biosynthetic-type genes exhibit more conserved evolutionary processes than do detoxification-type genes, with regard to the rate of gene duplication, pseudogenization, and amino acid substitution. The differences in the evolutionary mode between biosynthesis- and detoxification-type genes may reflect differences in their respective substrates. The phylogenetic tree also revealed 11 clans comprising an upper category to families in the cytochrome P450 nomenclature. Here, we report novel clan-specific amino acids that may be used for the qualitative definition of clans.	[Kawashima, Ayaka; Satta, Yoko] Grad Univ Adv Studies Sokendai, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa, Japan	Graduate University for Advanced Studies - Japan	Satta, Y (corresponding author), Grad Univ Adv Studies Sokendai, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa, Japan.	satta@soken.ac.jp		Satta, Yoko/0000-0002-5305-493X	Japan Society for the Promotion of Science (JSPS) [21370106]; Center for the Promotion of Integrated Sciences (CPIS) of Sokendai	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Center for the Promotion of Integrated Sciences (CPIS) of Sokendai(Graduate University for Advanced Studies - Japan)	This work was supported by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (B) Grant Number 21370106 and for JSPS Fellows. This work was also supported in part by the Center for the Promotion of Integrated Sciences (CPIS) of Sokendai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama Y, 1998, J BIOCHEM-TOKYO, V124, P694; Debeljak N, 2003, ARCH BIOCHEM BIOPHYS, V409, P159, DOI 10.1016/S0003-9861(02)00418-6; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Feyereisen R, 2011, BBA-PROTEINS PROTEOM, V1814, P19, DOI 10.1016/j.bbapap.2010.06.012; Gotoh O, 2012, BIOL PHARM BULL, V35, P812; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hoffman SMG, 2006, MUTAT RES, V616, P133; Hu SY, 2008, GENETICA, V133, P215, DOI 10.1007/s10709-007-9206-x; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KLINGENBERG M, 1958, ARCH BIOCHEM BIOPHYS, V75, P376, DOI 10.1016/0003-9861(58)90436-3; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Mao GH, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-169; Meunier B, 2004, CHEM REV, V104, P3947, DOI 10.1021/cr020443g; Munro AW, 1996, MOL MICROBIOL, V20, P1115, DOI 10.1111/j.1365-2958.1996.tb02632.x; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Nei M., 2000, MOL EVOLUTION PHYLOG; Nelson DR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0474; Nelson David R., 2009, Human Genomics, V4, P59; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Nelson DR, 1999, ARCH BIOCHEM BIOPHYS, V369, P1, DOI 10.1006/abbi.1999.1352; Nelson DR, 1998, COMP BIOCHEM PHYS C, V121, P15, DOI 10.1016/S0742-8413(98)10027-0; Ohmura T, 2009, MOL BIOL P450; OMURA T, 1962, J BIOL CHEM, V237, P1375; Qi X, 2006, P NATL ACAD SCI USA, V103, P18848, DOI 10.1073/pnas.0607849103; Quaderer R, 2006, J AM CHEM SOC, V128, P13036, DOI 10.1021/ja0639214; Rezen T, 2004, J MOL EVOL, V59, P51, DOI 10.1007/s00239-004-2603-1; RZHETSKY A, 1992, J MOL EVOL, V35, P367, DOI 10.1007/BF00161174; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sawai H, 2008, IMMUNOGENETICS, V60, P295, DOI 10.1007/s00251-008-0291-5; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas JH, 2007, PLOS GENET, V3, P720, DOI 10.1371/journal.pgen.0030067; URABE K, 1990, AM J HUM GENET, V46, P1178; Yasukochi Y, 2011, GENES GENET SYST, V86, P109, DOI 10.1266/ggs.86.109; Yoshida Y, 2000, BIOCHEM BIOPH RES CO, V273, P799, DOI 10.1006/bbrc.2000.3030	37	19	19	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100059	10.1371/journal.pone.0100059	http://dx.doi.org/10.1371/journal.pone.0100059			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977709	Green Submitted, gold, Green Published			2022-12-27	WOS:000338506400018
J	Latombe, G; Parrott, L; Basille, M; Fortin, D				Latombe, Guillaume; Parrott, Lael; Basille, Mathieu; Fortin, Daniel			Uniting Statistical and Individual-Based Approaches for Animal Movement Modelling	PLOS ONE			English	Article							CONDITIONAL LOGISTIC-REGRESSION; RESOURCE SELECTION FUNCTIONS; ADULT FEMALE CARIBOU; STATE-SPACE MODELS; WOODLAND CARIBOU; FUNCTIONAL-RESPONSES; DENALI HERD; HABITAT USE; LANDSCAPE; CONSERVATION	The dynamic nature of their internal states and the environment directly shape animals' spatial behaviours and give rise to emergent properties at broader scales in natural systems. However, integrating these dynamic features into habitat selection studies remains challenging, due to practically impossible field work to access internal states and the inability of current statistical models to produce dynamic outputs. To address these issues, we developed a robust method, which combines statistical and individual-based modelling. Using a statistical technique for forward modelling of the IBM has the advantage of being faster for parameterization than a pure inverse modelling technique and allows for robust selection of parameters. Using GPS locations from caribou monitored in Quebec, caribou movements were modelled based on generative mechanisms accounting for dynamic variables at a low level of emergence. These variables were accessed by replicating real individuals' movements in parallel sub-models, and movement parameters were then empirically parameterized using Step Selection Functions. The final IBM model was validated using both k-fold cross-validation and emergent patterns validation and was tested for two different scenarios, with varying hardwood encroachment. Our results highlighted a functional response in habitat selection, which suggests that our method was able to capture the complexity of the natural system, and adequately provided projections on future possible states of the system in response to different management plans. This is especially relevant for testing the long-term impact of scenarios corresponding to environmental configurations that have yet to be observed in real systems.	[Latombe, Guillaume] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Latombe, Guillaume] Univ Montreal, Dept Geog, Montreal, PQ H3C 3J7, Canada; [Parrott, Lael] Univ British Columbia, Earth & Environm Sci Unit, Kelowna, BC, Canada; [Parrott, Lael] Univ British Columbia, Biol Unit, Kelowna, BC, Canada; [Basille, Mathieu; Fortin, Daniel] Univ Laval, Dept Biol, Chaire Rech Ind CRSNG Univ Laval Sylviculture & F, Quebec City, PQ G1K 7P4, Canada; [Basille, Mathieu] Univ Florida, Ft Lauderdale Res & Educ Ctr, Ft Lauderdale, FL 33314 USA	Monash University; Universite de Montreal; University of British Columbia; University of British Columbia; Laval University; State University System of Florida; University of Florida	Latombe, G (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.	guillaume.latombe@monash.edu	Fortin, Daniel/ABG-3554-2020; Latombe, Guillaume/AAI-1012-2021; Basille, Mathieu/A-6133-2017	Latombe, Guillaume/0000-0002-8589-8387; Basille, Mathieu/0000-0001-9366-7127	Natural Sciences and Engineering Research Council of Canada (NSERC) - Sylviculture and Wildlife Research Chair; Ministere des Ressources Naturelles et de la Faune du Quebec; Canadian Foundation for Innovation; Fondation de la faune du Quebec	Natural Sciences and Engineering Research Council of Canada (NSERC) - Sylviculture and Wildlife Research Chair; Ministere des Ressources Naturelles et de la Faune du Quebec; Canadian Foundation for Innovation(Canada Foundation for Innovation); Fondation de la faune du Quebec	Financial support for field efforts and data analysis were funded by the Natural Sciences and Engineering Research Council of Canada (NSERC) - Sylviculture and Wildlife Research Chair, Ministere des Ressources Naturelles et de la Faune du Quebec, the Canadian Foundation for Innovation, and Fondation de la faune du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babin JS, 2011, ECOLOGY, V92, P240, DOI 10.1890/10-0252.1; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Basille M, 2013, ECOGRAPHY, V36, P220, DOI 10.1111/j.1600-0587.2011.07367.x; BERGERUD AT, 1986, CAN J ZOOL, V64, P1515, DOI 10.1139/z86-226; BOERTJE RD, 1990, J APPL ECOL, V27, P420, DOI 10.2307/2404291; BOERTJE RD, 1985, J RANGE MANAGE, V38, P468, DOI 10.2307/3899725; Borger L, 2006, AM NAT, V168, P471, DOI 10.1086/507883; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Brown GS, 2007, FOREST ECOL MANAG, V245, P137, DOI 10.1016/j.foreco.2007.04.016; Burrough P. A, 1998, PRINCIPLES GEOGRAPHI, V333; COSEWIC, 2006, CAN SPEC RISK; Courbin N, 2009, LANDSCAPE ECOL, V24, P1375, DOI 10.1007/s10980-009-9389-x; COURTOIS R, 2003, THESIS U QUEBEC RIMO; Craiu RV, 2008, BIOMETRICAL J, V50, P97, DOI 10.1002/bimj.200610379; Duchesne T, 2010, J ANIM ECOL, V79, P548, DOI 10.1111/j.1365-2656.2010.01670.x; Forester JD, 2007, ECOL MONOGR, V77, P285, DOI 10.1890/06-0534; Forester JD, 2009, ECOLOGY, V90, P3554, DOI 10.1890/08-0874.1; Fortin D, 2005, OECOLOGIA, V145, P335, DOI 10.1007/s00442-005-0122-4; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Fortin D, 2013, AM NAT, V181, P827, DOI 10.1086/670243; Fortin D, 2009, ANIM BEHAV, V78, P887, DOI 10.1016/j.anbehav.2009.06.026; Fortin D, 2009, ECOLOGY, V90, P2480, DOI 10.1890/08-0345.1; Gautestad AO, 2013, J ANIM ECOL, V82, P572, DOI 10.1111/1365-2656.12027; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Graniero PA, 2006, INT J GEOGR INF SCI, V20, P965, DOI 10.1080/13658810600830541; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V, 2012, PHILOS T R SOC B, V367, P298, DOI 10.1098/rstb.2011.0180; Grunbaum D, 1998, AM NAT, V151, P97, DOI 10.1086/286105; Gustine DD, 2006, WILDLIFE MONOGR, P1, DOI 10.2193/0084-0173(2006)165[1:CSOWCI]2.0.CO;2; Hardin JW, 2012, GEN ESTIMATING EQUAT; Hebblewhite M, 2008, J APPL ECOL, V45, P834, DOI 10.1111/j.1365-2664.2008.01466.x; HOLLEMAN DF, 1979, J WILDLIFE MANAGE, V43, P192, DOI 10.2307/3800651; Houle M, 2010, LANDSCAPE ECOL, V25, P419, DOI 10.1007/s10980-009-9420-2; Howery L. D., 1999, GRAZING BEHAV LIVEST, V3, P91; Johnson CJ, 2001, OECOLOGIA, V127, P590, DOI 10.1007/s004420000573; Johnson CJ, 2004, J APPL ECOL, V41, P238, DOI 10.1111/j.0021-8901.2004.00899.x; Jonsen ID, 2003, ECOLOGY, V84, P3055, DOI 10.1890/02-0670; Keating KA, 2004, J WILDLIFE MANAGE, V68, P774, DOI 10.2193/0022-541X(2004)068[0774:UAIOLR]2.0.CO;2; Latombe G, 2014, J ANIM ECOL, V83, P185, DOI 10.1111/1365-2656.12108; Latombe G, 2011, ECOL MODEL, V222, P1557, DOI 10.1016/j.ecolmodel.2011.02.020; Lenth R., 2019, Journal of Statistical Software, V60, P1; Manly B.F.J., 2002, RESOURCE SELECTION A; McLoughlin PD, 2006, P ROY SOC B-BIOL SCI, V273, P1449, DOI 10.1098/rspb.2006.3486; Morales JM, 2005, LANDSCAPE ECOL, V20, P301, DOI 10.1007/s10980-005-0061-9; Moreau G, 2012, J APPL ECOL, V49, P611, DOI 10.1111/j.1365-2664.2012.02134.x; Mysterud A, 1998, ECOLOGY, V79, P1435, DOI 10.1890/0012-9658(1998)079[1435:FRIHUA]2.0.CO;2; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; NEWMAN JA, 1995, FUNCT ECOL, V9, P255, DOI 10.2307/2390572; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Schaefer JA, 2003, CONSERV BIOL, V17, P1435, DOI 10.1046/j.1523-1739.2003.02288.x; Tang WW, 2010, GEOGR COMPASS, V4, pCP7, DOI 10.1111/j.1749-8198.2010.00337.x; Vanak AT, 2013, ECOLOGY, V94, P2619, DOI 10.1890/13-0217.1; Weclaw P, 2004, ECOL MODEL, V177, P75, DOI 10.1016/j.ecolmodel.2003.12.052; Weclaw P, 2001, THESIS U ALBERTA CAN; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Wiegand T, 2004, BIODIVERS CONSERV, V13, P79, DOI 10.1023/B:BIOC.0000004314.38828.db; Wiegand T, 2003, OIKOS, V100, P209, DOI 10.1034/j.1600-0706.2003.12027.x; Wittmer HU, 2007, J ANIM ECOL, V76, P568, DOI 10.1111/j.1365-2656.2007.01220.x	60	20	20	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e99938	10.1371/journal.pone.0099938	http://dx.doi.org/10.1371/journal.pone.0099938			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979047	Green Submitted, Green Published, gold			2022-12-27	WOS:000338506400011
J	Lotan, D; Cunningham, M; Joel, D				Lotan, Dafna; Cunningham, Madeleine; Joel, Daphna			Antibiotic Treatment Attenuates Behavioral and Neurochemical Changes Induced by Exposure of Rats to Group A Streptococcal Antigen	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; INCREASES GLUTAMATE UPTAKE; BETA-LACTAM ANTIBIOTICS; R6/2 MOUSE MODEL; SYDENHAMS CHOREA; NEUROPSYCHIATRIC DISORDERS; HUNTINGTONS-DISEASE; PSYCHIATRIC-DISORDERS; MULTIPLE-SCLEROSIS; UP-REGULATION	Post-streptococcal A (GAS) sequelae including movement and neuropsychiatric disorders have been associated with improvement in response to antibiotic therapy. Besides eradication of infection, the underlying basis of attenuation of neuropsychiatric symptoms following antibiotic treatment is not known. The aim of the present study was to test the efficacy of antibiotic treatment in a rat model of GAS-related neuropsychiatric disorders. In the model, rats were not infected but were exposed to GAS-antigen or to adjuvants only (Control rats) and treated continuously with the antibiotic ampicillin in their drinking water from the first day of GAS-antigen exposure. Two additional groups of rats (GAS and Control) did not receive ampicillin in their drinking water. Behavior of the four groups was assessed in the forced swim, marble burying and food manipulation assays. We assessed levels of D1 and D2 dopamine receptors and tyrosine hydroxylase in the prefrontal cortex and striatum, and IgG deposition in the prefrontal cortex, striatum and thalamus. Ampicillin treatment prevented emergence of the motor and some of the behavioral alterations induced by GAS-antigen exposure, reduced IgG deposition in the thalamus of GAS-exposed rats, and tended to attenuate the increase in the level of TH and D1 and D2 receptors in their striatum, without concomitantly reducing the level of sera anti-GAS antibodies. Our results reinforce the link between exposure to GAS antigen, dysfunction of central dopaminergic pathways and motor and behavioral alterations. Our data further show that some of these deleterious effects can be attenuated by antibiotic treatment, and supports the latter's possible efficacy as a prophylactic treatment in GAS-related neuropsychiatric disorders.	[Lotan, Dafna; Joel, Daphna] Tel Aviv Univ, Sch Psychol Sci, IL-69978 Tel Aviv, Israel; [Lotan, Dafna; Joel, Daphna] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Cunningham, Madeleine] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA	Tel Aviv University; Tel Aviv University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Joel, D (corresponding author), Tel Aviv Univ, Sch Psychol Sci, IL-69978 Tel Aviv, Israel.	djoel@post.tau.ac.il		Joel, Daphna/0000-0002-2003-4190	Israel Science Foundation [341/07]; National Institutes of Health [HL56267]; National Institutes of Mental Health; Oklahoma Center for the Advancement of Science and Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL056267, R01HL056267] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Oklahoma Center for the Advancement of Science and Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the Israel Science Foundation (grant No. 341/07) to DJ and by the National Institutes of Health grant HL56267, Bench to Bedside grant from the National Institutes of Mental Health, and the Oklahoma Center for the Advancement of Science and Technology grant to MWC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asbahr FR, 2005, BIOL PSYCHIAT, V57, P1073, DOI 10.1016/j.biopsych.2005.01.037; Bercik P, 2012, NEUROGASTROENT MOTIL, V24, P405, DOI 10.1111/j.1365-2982.2012.01906.x; Bonthius Daniel J, 2003, Semin Pediatr Neurol, V10, P11, DOI 10.1016/S1071-9091(02)00004-9; Brimberg L, 2012, NEUROPSYCHOPHARMACOL, V37, P2076, DOI 10.1038/npp.2012.56; Brooks BM, 2005, J ANTIMICROB CHEMOTH, V56, P1122, DOI 10.1093/jac/dki373; Calabro Rocco Salvatore, 2011, Ann Pharmacother, V45, pe65, DOI 10.1345/aph.1Q366; Citak EC, 2004, J CHILD NEUROL, V19, P387, DOI 10.1177/088307380401900513; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P547, DOI 10.1016/j.neubiorev.2005.03.008; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Cunningham MW, 2012, CURR OPIN RHEUMATOL, V24, P408, DOI 10.1097/BOR.0b013e32835461d3; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dale RC, 2005, DEV MED CHILD NEUROL, V47, P785, DOI 10.1017/S0012162205001647; Dale RC, 2004, ARCH DIS CHILD, V89, P604, DOI 10.1136/adc.2003.031856; Dale RC, 2012, BRAIN, V135, P3453, DOI 10.1093/brain/aws256; Demiroren K, 2007, J CHILD NEUROL, V22, P550, DOI 10.1177/0883073807302614; Diamond B, 2011, BIOESSAYS, V33, P588, DOI 10.1002/bies.201100042; Doyle F, 2012, NEUROSCI LETT, V523, P186, DOI 10.1016/j.neulet.2012.06.073; Ganzinelli S, 2006, NEUROPHARMACOLOGY, V50, P362, DOI 10.1016/j.neuropharm.2005.09.013; Goodrich GS, 2013, J NEUROTRAUMA; Gordon N, 2009, BRAIN DEV-JPN, V31, P11, DOI 10.1016/j.braindev.2008.05.001; Hansen N, 2013, EXP NEUROL, V239, P202, DOI 10.1016/j.expneurol.2012.10.013; Hirjak D, 2012, J PSYCHIATR RES, V46, P533, DOI 10.1016/j.jpsychires.2012.01.015; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Hughes EG, 2010, J NEUROSCI, V30, P5866, DOI 10.1523/JNEUROSCI.0167-10.2010; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Kassubek J, 2002, NEUROSCI LETT, V323, P29, DOI 10.1016/S0304-3940(02)00111-8; Kirvan CA, 2006, AUTOIMMUNITY, V39, P21, DOI 10.1080/08916930500484757; Kirvan CA, 2003, NAT MED, V9, P914, DOI 10.1038/nm892; Kirvan CA, 2006, J NEUROIMMUNOL, V179, P173, DOI 10.1016/j.jneuroim.2006.06.017; Kobayashi T, 2008, PSYCHOPHARMACOLOGY, V197, P567, DOI 10.1007/s00213-008-1070-6; KOLB B, 1983, BEHAV NEUROSCI, V97, P697, DOI 10.1037/0735-7044.97.5.697; Lai MZ, 2009, ANN NEUROL, V65, P424, DOI 10.1002/ana.21589; Lee PH, 1999, ARCH NEUROL-CHICAGO, V56, P237, DOI 10.1001/archneur.56.2.237; Lee SJ, 2012, CLIN NUCL MED, V37, P663, DOI 10.1097/RLU.0b013e3182478bf2; Leung TCH, 2012, ACS CHEM NEUROSCI, V3, P22, DOI 10.1021/cn200072h; LINTHICUM DS, 1982, CELL IMMUNOL, V73, P299, DOI 10.1016/0008-8749(82)90457-9; Lotan D., 2014, BRAIN BEHAV IMMUN; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Maling N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044215; Marques-Dias MJ, 1997, PSYCHIAT CLIN N AM, V20, P809, DOI 10.1016/S0193-953X(05)70346-4; Martin Judith M, 2006, Semin Pediatr Infect Dis, V17, P140, DOI 10.1053/j.spid.2006.07.001; Melzer N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003149; Millan MJ, 2000, J PHARMACOL EXP THER, V295, P1206; Miller BR, 2008, NEUROSCIENCE, V153, P329, DOI 10.1016/j.neuroscience.2008.02.004; Miller BR, 2012, J NEUROCHEM, V121, P629, DOI 10.1111/j.1471-4159.2012.07691.x; Murphy TK, 2010, J CHILD ADOL PSYCHOP, V20, P317, DOI 10.1089/cap.2010.0043; Nieuwenhuis EES, 2000, ARTHRITIS RHEUM, V43, P2583, DOI 10.1002/1529-0131(200011)43:11<2583::AID-ANR28>3.0.CO;2-U; Nishino R, 2013, NEUROGASTROENTEROL M; Nizzardo M, 2011, EXP NEUROL, V229, P214, DOI 10.1016/j.expneurol.2011.01.017; Ridel KR, 2010, PEDIATR NEUROL, V42, P243, DOI 10.1016/j.pediatrneurol.2009.12.004; Rorick-Kehn LM, 2007, PSYCHOPHARMACOLOGY, V193, P121, DOI 10.1007/s00213-007-0758-3; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Samadi P, 2013, GENES BRAIN BEHAV, V12, P108, DOI 10.1111/j.1601-183X.2012.00858.x; Saydoff JA, 2003, BRAIN RES, V994, P44, DOI 10.1016/j.brainres.2003.09.049; SCHLIAMSER SE, 1991, J ANTIMICROB CHEMOTH, V27, P405, DOI 10.1093/jac/27.4.405; Snider LA, 2005, BIOL PSYCHIAT, V57, P788, DOI 10.1016/j.biopsych.2004.12.035; Swedo SE, 1998, AM J PSYCHIAT, V155, P264; SWEDO SE, 1993, PEDIATRICS, V91, P706; Takahashi T, 2011, CASE REP NEUROL, V4, P194, DOI 10.1159/000345227; Takeuchi Y, 2002, J NEUROCHEM, V83, P784, DOI 10.1046/j.1471-4159.2002.01180.x; Thone-Reineke C, 2008, J HYPERTENS, V26, P2426, DOI 10.1097/HJH.0b013e328313e403; van Coevorden-Hameete MH, 2014, AUTOIMMUN REV, V13, P299, DOI 10.1016/j.autrev.2013.10.016; Wei J, 2012, J TRAUMA ACUTE CARE, V73, P654, DOI 10.1097/TA.0b013e31825133c0; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yokote H, 2008, AM J PATHOL, V173, P1714, DOI 10.2353/ajpath.2008.080622	66	13	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101257	10.1371/journal.pone.0101257	http://dx.doi.org/10.1371/journal.pone.0101257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979049	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400107
J	Shi, WB; Yang, LJ; Hu, X; Zhou, J; Zhang, Q; Shao, ZM				Shi, Wen-Biao; Yang, Lin-Jun; Hu, Xin; Zhou, Jian; Zhang, Qiang; Shao, Zhi-Ming			Clinico-Pathological Features and Prognosis of Invasive Micropapillary Carcinoma Compared to Invasive Ductal Carcinoma: A Population-Based Study from China	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; BREAST-CARCINOMA; CANCER; SURVIVAL; SUBTYPES; VARIANT	Background: Invasive micropapillary carcinoma (IMPC) of the breast is a rare subtype of breast cancer that is associated with a high incidence of regional lymph node metastases and a poor clinical outcome. However, the clinico-pathological features and prognostic factors of IMPC are not well understood. Patients and Methods: A total of 188 IMPC cases and 1,289 invasive ductal carcinoma (IDC) cases were included. The clinical features, breast cancer-specific survival (BCSS) and recurrence/metastasis-free survival (RFS) of the patients were compared between these two groups. Results: The IMPC patients exhibited more features of aggressive carcinoma than the IDC patients, including larger tumor size, higher tumor stage, a greater proportion of nodal involvement and an increased incidence of lymphovascular invasion. Patients with IMPC had lower 5-year BCSS and RFS rates (75.9% and 67.1%, respectively) than patients with IDC (89.5% and 84.5%, respectively). Compared to IDC patients, the patients with IMPC had a significantly higher percentage of stage III breast cancer (51.3% versus 21.7%). In a stage-matched Kaplan-Meier analysis, the patients with stage III IMPC had lower 5-year BCSS and RFS rates than patients with stage III IDC (BCSS, P = 0.004; RFS, P = 0.034). A multivariate analysis revealed that TNM stage was an independent prognostic factor for patients with IMPC. The proportion of cancers with a luminal-like subtype was significantly higher in IMPC than in IDC (P < 0.001). However, after matching by molecular subtype, the patients with IMPC had significantly worse clinical outcomes than patients with IDC. Conclusions: In Chinese women, IMPCs displayed more aggressive behaviors than IDCs, resulting in poorer clinical outcomes for patients with IMPC, regardless of a favorable molecular subtype. Our findings illustrate that the poorer survival of patients with IMPC might be due to an increased incidence and aggressiveness of tumors in TNM stage III.	[Shi, Wen-Biao; Hu, Xin; Shao, Zhi-Ming] Fudan Univ, Shanghai Canc Ctr, Key Lab Breast Canc Shanghai, Dept Breast Surg, Shanghai 200433, Peoples R China; [Shi, Wen-Biao; Hu, Xin; Shao, Zhi-Ming] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Shi, Wen-Biao; Yang, Lin-Jun; Zhou, Jian; Zhang, Qiang] Taizhou Municipal Hosp, Dept Surg Oncol, Taizhou, Zhejiang, Peoples R China	Fudan University; Fudan University; Taizhou University	Shao, ZM (corresponding author), Fudan Univ, Shanghai Canc Ctr, Key Lab Breast Canc Shanghai, Dept Breast Surg, Shanghai 200433, Peoples R China.	zhimingshao@yahoo.com			National Natural Science Foundation of China [30971143, 30972936, 81001169]; Shanghai Committee of Science and Technology Funds [12ZR1406200, 12DZ2260100, 12140901502]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology Funds(Shanghai Science & Technology Committee)	This research is supported by grants from the National Natural Science Foundation of China (30971143, 30972936, and 81001169) and the Shanghai Committee of Science and Technology Funds (12ZR1406200, 12DZ2260100 and 12140901502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chen AC, 2013, CLIN BREAST CANCER, V13, P133, DOI 10.1016/j.clbc.2012.10.001; Chen L, 2008, INT J SURG PATHOL, V16, P155, DOI 10.1177/1066896907307047; De La Cruz C, 2004, PATHOL INT, V54, P90, DOI 10.1111/j.1440-1827.2004.01590.x; Engstrom MJ, 2013, BREAST CANCER RES TR, V140, P463, DOI 10.1007/s10549-013-2647-2; Gokce H, 2013, BREAST J, V19, P374, DOI 10.1111/tbj.12128; Grimes DA, 2005, LANCET, V365, P1429, DOI 10.1016/S0140-6736(05)66379-9; Guo XJ, 2006, AM J CLIN PATHOL, V126, P740, DOI 10.1309/AXYY4AJTMNW6FRMW; Ide Y, 2011, PATHOL INT, V61, P731, DOI 10.1111/j.1440-1827.2011.02735.x; Kuroda Hajime, 2004, Breast Cancer, V11, P169, DOI 10.1007/BF02968297; Nassar H, 2001, MODERN PATHOL, V14, P836, DOI 10.1038/modpathol.3880399; Paterakos M, 1999, HUM PATHOL, V30, P1459, DOI 10.1016/S0046-8177(99)90168-5; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pettinato G, 2004, AM J CLIN PATHOL, V121, P857, DOI 10.1309/XTJ7VHB49UD78X60; Reyal F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020297; SIRIAUNKGUL S, 1993, MODERN PATHOL, V6, P660; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tavassoli FA, 2003, WHO CLASSIFICATION T; Vargo JA, 2011, ONCOLOGY-BASEL, V80, P341, DOI 10.1159/000330203; Vingiani A, 2013, HISTOPATHOLOGY, V63, P217, DOI 10.1111/his.12147; Yu JI, 2010, BREAST, V19, P231, DOI 10.1016/j.breast.2010.01.020; Zekioglu O, 2004, HISTOPATHOLOGY, V44, P18, DOI 10.1111/j.1365-2559.2004.01757.x	22	28	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101390	10.1371/journal.pone.0101390	http://dx.doi.org/10.1371/journal.pone.0101390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977705	Green Submitted, Green Published, gold			2022-12-27	WOS:000338506400126
J	Das, S; Roy, P; Pal, R; Auddy, RG; Chakraborti, AS; Mukherjee, A				Das, Suvadra; Roy, Partha; Pal, Rajat; Auddy, Runa Ghosh; Chakraborti, Abhay Sankar; Mukherjee, Arup			Engineered Silybin Nanoparticles Educe Efficient Control in Experimental Diabetes	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; STREPTOZOTOCIN; SILYMARIN; ANTIOXIDANT; LIVER; RAT; INSULIN; INHIBITION; HEMOGLOBIN	Silybin, is one imminent therapeutic for drug induced hepatotoxicity, human prostrate adenocarcinoma and other degenerative organ diseases. Recent evidences suggest that silybin influences gluconeogenesis pathways favorably and is beneficial in the treatment of type 1 and type 2 diabetes. The compound however is constrained due to solubility (0.4 mg/mL) and bioavailabilty limitations. Appropriate nanoparticle design for silybin in biocompatible polymers was thus proposed as a probable solution for therapeutic inadequacy. New surface engineered biopolymeric nanoparticles with high silybin encapsulation efficiency of 92.11% and zeta potential of + 21 mV were designed. Both the pure compound and the nanoparticles were evaluated in vivo for the first time in experimental diabetic conditions. Animal health recovered substantially and the blood glucose levels came down to near normal values after 28 days treatment schedule with the engineered nanoparticles. Restoration from hyperglycemic damage condition was traced to serum insulin regeneration. Serum insulin recovered from the streptozotocin induced pancreatic damage levels of 0.17 +/- 0.01 mu g/lit to 0.57 +/- 0.11 mu g/lit after nanoparticle treatment. Significant reduction in glycated hemoglobin level, and restoration of liver glycogen content were some of the other interesting observations. Engineered silybin nanoparticle assisted recovery in diabetic conditions was reasoned due to improved silybin dissolution, passive transport in nanoscale, and restoration of antioxidant status.	[Das, Suvadra; Roy, Partha; Auddy, Runa Ghosh; Mukherjee, Arup] Univ Calcutta, Dept Chem Technol, Kolkata 700073, W Bengal, India; [Pal, Rajat; Chakraborti, Abhay Sankar] Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, Kolkata, W Bengal, India; [Auddy, Runa Ghosh; Chakraborti, Abhay Sankar; Mukherjee, Arup] Univ Calcutta, Ctr Res Nanosci & Nanotechnol, Kolkata, W Bengal, India; [Roy, Partha] Univ Malaysia Pahang, Fac Technol Pharmaceutical, Pekan, Pahang, Malaysia	University of Calcutta; University of Calcutta; University of Calcutta; Universiti Malaysia Pahang	Mukherjee, A (corresponding author), Univ Calcutta, Dept Chem Technol, Kolkata 700073, W Bengal, India.	arupm1234@gmail.com	Roy, Partha/GNP-6565-2022	Roy, Partha/0000-0002-9641-6136	DST PURSE, Govt of India; Center for Research in Nanoscience and Nanotechnology; Technical Education Quality Improvement program (TEQIP) University of Calcutta	DST PURSE, Govt of India; Center for Research in Nanoscience and Nanotechnology; Technical Education Quality Improvement program (TEQIP) University of Calcutta	SD would like to thank DST PURSE, Govt of India for a grant of SRF extended fellowship and PR would like to thank the Council of Scientific and Industrial Research, India for a Research Associateship. Authors would also like to acknowledge the funds made available for the manuscript editing and the related software supports extended by the Center for Research in Nanoscience and Nanotechnology and the Technical Education Quality Improvement program (TEQIP) University of Calcutta. The academic research funding supports had no bearing in the study design, data collection and analysis, preparation of the manuscript and a decision to publish results.	Aebi H, 1984, Methods Enzymol, V105, P121; ARMBRUSTER DA, 1987, CLIN CHEM, V33, P2153; Barwal I, 2013, COLLOID SURFACE B, V101, P510, DOI 10.1016/j.colsurfb.2012.07.005; BELLAMY LJ, 1975, INFRARED SPECTRA COM, P107; BENNETT RA, 1981, CANCER RES, V41, P2786; Bertelsen M, 2001, DIABETOLOGIA, V44, P605, DOI 10.1007/s001250051667; Bhattacharyya J, 1998, INT J BIOL MACROMOL, V23, P11, DOI 10.1016/S0141-8130(98)00006-3; Budhian A, 2008, INT J PHARMACEUT, V346, P151, DOI 10.1016/j.ijpharm.2007.06.011; COHEN MP, 1994, METHOD ENZYMOL, V231, P65; Das S, 2013, CHEM PHARM BULL, V61, P125, DOI 10.1248/cpb.c12-00475; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FALLOUH NA, 1986, INT J PHARM, V28, P125; FESSI H, 1989, INT J PHARM, V55, pR1, DOI 10.1016/0378-5173(89)90281-0; GOLDSTEIN DE, 1986, CLIN CHEM, V32, pB64; Guigas B, 2007, CELL PHYSIOL BIOCHEM, V20, P925, DOI 10.1159/000110453; HII CST, 1985, J ENDOCRINOL, V107, P1, DOI 10.1677/joe.0.1070001; Hoh CSL, 2007, J AGR FOOD CHEM, V55, P2532, DOI 10.1021/jf063156c; Huseini HF, 2006, PHYTOTHER RES, V20, P1036, DOI 10.1002/ptr.1988; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; Jariyapamornkoon N, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-171; JOHNSON RN, 1983, CLIN CHIM ACTA, V127, P87, DOI 10.1016/0009-8981(83)90078-5; Kajimoto Y, 2004, ANN NY ACAD SCI, V1011, P168, DOI 10.1196/annals.1293.017; King GL, 2004, HISTOCHEM CELL BIOL, V122, P333, DOI 10.1007/s00418-004-0678-9; Konrad RJ, 2002, INT J MOL MED, V10, P535; Kvasnicka F, 2003, J CHROMATOGR A, V990, P239, DOI 10.1016/S0021-9673(02)01971-4; Li LJ, 2010, NANO TODAY, V5, P296, DOI 10.1016/j.nantod.2010.06.007; Lirussi F, 2002, DIABETES NUTR METAB, V15, P222; Liu SH, 2010, J AGR FOOD CHEM, V58, P5795, DOI 10.1021/jf100662r; Liu VA, 2002, J BIOMED MATER RES, V60, P126, DOI 10.1002/jbm.10005; LOVEN D, 1986, DIABETES, V35, P503, DOI 10.2337/diabetes.35.5.503; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maghrani M, 2004, J ETHNOPHARMACOL, V91, P309, DOI 10.1016/j.jep.2004.01.008; Malekinejad H, 2012, PHYTOMEDICINE, V19, P583, DOI 10.1016/j.phymed.2012.02.009; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McAnuff MA, 2005, W INDIAN MED J, V54, P97; Merisko-Liversidge EM, 2008, TOXICOL PATHOL, V36, P43, DOI 10.1177/0192623307310946; Mundargi RC, 2008, J CONTROL RELEASE, V125, P193, DOI 10.1016/j.jconrel.2007.09.013; Murali R, 2013, BIOCHIMIE, V95, P1848, DOI 10.1016/j.biochi.2013.06.013; MURAT JC, 1974, CLIN CHEM, V20, P1576; Nielsen SE, 1998, XENOBIOTICA, V28, P389, DOI 10.1080/004982598239498; NUKATSUKA M, 1990, J PHARMACOBIO-DYNAM, V13, P259, DOI 10.1248/bpb1978.13.259; Pillai SI, 2013, EUR J MED CHEM, V63, P109, DOI 10.1016/j.ejmech.2013.02.002; Piskula MK, 1998, J NUTR, V128, P1172, DOI 10.1093/jn/128.7.1172; Pradeep K, 2007, EUR J PHARMACOL, V560, P110, DOI 10.1016/j.ejphar.2006.12.023; Roy P, 2013, PHARM RES-DORDR, V30, P1252, DOI 10.1007/s11095-012-0964-5; Saliou C, 1998, FEBS LETT, V440, P8, DOI 10.1016/S0014-5793(98)01409-4; Saller R, 2001, DRUGS, V61, P2035, DOI 10.2165/00003495-200161140-00003; Sersen F, 2006, FITOTERAPIA, V77, P525, DOI 10.1016/j.fitote.2006.06.005; Shivanna N, 2013, J DIABETES COMPLICAT, V27, P103, DOI 10.1016/j.jdiacomp.2012.10.001; Soto C, 2004, LIFE SCI, V75, P2167, DOI 10.1016/j.lfs.2004.04.019; Soto C, 2010, PHYTOMEDICINE, V17, P1090, DOI 10.1016/j.phymed.2010.04.011; Soto CP, 1998, COMP BIOCHEM PHYS C, V119, P125, DOI 10.1016/S0742-8413(97)00198-9; Sozmen EY, 2001, ARCH MED RES, V32, P283, DOI 10.1016/S0188-4409(01)00285-5; STRANDELL E, 1988, MOL CELL ENDOCRINOL, V59, P83, DOI 10.1016/0303-7207(88)90198-0; TJALVE H, 1976, J ENDOCRINOL, V69, P455, DOI 10.1677/joe.0.0690455; UCHIGATA Y, 1982, J BIOL CHEM, V257, P6084; Velussi M, 1997, J HEPATOL, V26, P871, DOI 10.1016/S0168-8278(97)80255-3; Vengerovskii AI, 2007, B EXP BIOL MED+, V144, P53, DOI 10.1007/s10517-007-0252-2; Vessal M, 2003, COMP BIOCHEM PHYS C, V135, P357, DOI 10.1016/S1532-0456(03)00140-6; VIALETTES B, 1982, DIABETOLOGIA, V22, P264, DOI 10.1007/BF00281303; Wang Q, 2012, J ASIAN NAT PROD RES, V14, P413, DOI 10.1080/10286020.2012.657180; *WHO, 2013, DIABETES; Wu JT, 1996, J CLIN LAB ANAL, V10, P21, DOI 10.1002/(SICI)1098-2825(1996)10:1<21::AID-JCLA5>3.0.CO;2-O; YAGI K, 1987, CHEM PHYS LIPIDS, V45, P337, DOI 10.1016/0009-3084(87)90071-5; Yallapu MM, 2010, J COLLOID INTERF SCI, V351, P19, DOI 10.1016/j.jcis.2010.05.022; Yan H, 1997, BIOCHEM J, V328, P599, DOI 10.1042/bj3280599; Yan SF, 2011, EUR J PHARM BIOPHARM, V78, P336, DOI 10.1016/j.ejpb.2010.12.031; Zhuang J, 2010, INT J NANOMED, V5, P407; Zi ZL, 1999, P NATL ACAD SCI USA, V96, P7490, DOI 10.1073/pnas.96.13.7490	70	34	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101818	10.1371/journal.pone.0101818	http://dx.doi.org/10.1371/journal.pone.0101818			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991800	Green Published, gold, Green Submitted			2022-12-27	WOS:000341253400121
J	Christensen, D; Zubrick, SR; Lawrence, D; Mitrou, F; Taylor, CL				Christensen, Daniel; Zubrick, Stephen R.; Lawrence, David; Mitrou, Francis; Taylor, Catherine L.			Risk Factors for Low Receptive Vocabulary Abilities in the Preschool and Early School Years in the Longitudinal Study of Australian Children	PLOS ONE			English	Article							LATE LANGUAGE EMERGENCE; OUTCOMES; DIFFICULTIES; PREDICTORS; INEQUALITY; HEALTH	Receptive vocabulary development is a component of the human language system that emerges in the first year of life and is characterised by onward expansion throughout life. Beginning in infancy, children's receptive vocabulary knowledge builds the foundation for oral language and reading skills. The foundations for success at school are built early, hence the public health policy focus on reducing developmental inequalities before children start formal school. The underlying assumption is that children's development is stable, and therefore predictable, over time. This study investigated this assumption in relation to children's receptive vocabulary ability. We investigated the extent to which low receptive vocabulary ability at 4 years was associated with low receptive vocabulary ability at 8 years, and the predictive utility of a multivariate model that included child, maternal and family risk factors measured at 4 years. The study sample comprised 3,847 children from the first nationally representative Longitudinal Study of Australian Children (LSAC). Multivariate logistic regression was used to investigate risks for low receptive vocabulary ability from 4-8 years and sensitivity-specificity analysis was used to examine the predictive utility of the multivariate model. In the multivariate model, substantial risk factors for receptive vocabulary delay from 4-8 years, in order of descending magnitude, were low receptive vocabulary ability at 4 years, low maternal education, and low school readiness. Moderate risk factors, in order of descending magnitude, were low maternal parenting consistency, socio-economic area disadvantage, low temperamental persistence, and NESB status. The following risk factors were not significant: One or more siblings, low family income, not reading to the child, high maternal work hours, and Aboriginal or Torres Strait Islander ethnicity. The results of the sensitivity-specificity analysis showed that a well-fitted multivariate model featuring risks of substantive magnitude does not do particularly well in predicting low receptive vocabulary ability from 4-8 years.	[Christensen, Daniel; Zubrick, Stephen R.; Lawrence, David; Mitrou, Francis; Taylor, Catherine L.] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia	Telethon Kids Institute; University of Western Australia	Christensen, D (corresponding author), Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia.	daniel.christensen@telethonkids.org.au	Taylor, Catherine L/H-5943-2014; Zubrick, Stephen R/CAI-1970-2022; Christensen, Daniel/I-2018-2019; Dhungana, Raja Ram/B-3673-2016; Mitrou, Francis/AAF-5727-2020; Lawrence, David/C-8292-2009	Taylor, Catherine L/0000-0001-9061-9162; Zubrick, Stephen R/0000-0002-6369-1713; Christensen, Daniel/0000-0002-9684-5782; Dhungana, Raja Ram/0000-0002-9610-6306; Lawrence, David/0000-0003-4700-1425; Mitrou, Francis/0000-0002-6639-2030	National Health and Medical Research Council [572742]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by a program grant from the National Health and Medical Research Council (Grant Number 572742). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J, 2008, J EDUC BEHAV STAT, V33, P416, DOI 10.3102/1076998607306081; ALTMAN DG, 1994, BRIT MED J, V309, P188, DOI 10.1136/bmj.309.6948.188; Anglin J. M., 1993, MONOGRAPHS SOC RES C, pi; [Anonymous], 2003, AUSTR VERSION ADAPTE; [Anonymous], 2005, 1 LSAC; Australian Bureau of Statistics, 2003, INF PAP CENS POP HOU; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX; Bronfenbrenner U, 2005, MAKING HUMAN BEINGS, P3; Brown B. V., 2008, KEY INDICATORS CHILD; Dale PS, 2003, J SPEECH LANG HEAR R, V46, P544, DOI 10.1044/1092-4388(2003/044); de Lemos M., 1999, WHO AM I; Dollaghan CA, 2013, LATE TALKERS LANGUAG; Duckworth K., 2008, CTR RES WIDER BENEFI; Duncan GJ, 2007, DEV PSYCHOL, V43, P1428, DOI 10.1037/0012-1649.43.6.1428; Dunn L.M., 1981, PEABODY PICTURE VOCA; Edwards B, 2012, FAMILY MATTERS, P7; Farkas G, 2004, SOC SCI RES, V33, P464, DOI 10.1016/j.ssresearch.2003.08.001; Feinstein L, 2003, ECONOMICA, V70, P73, DOI 10.1111/1468-0335.t01-1-00272; Fenson L., 1993, MACARTHUR COMMUNICAT; Haddock CK, 1998, PSYCHOL METHODS, V3, P339, DOI 10.1037/1082-989X.3.3.339; Hancock GR, 2006, QUANT METH EDUC BEHA, P1; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hayiou-thomas ME, 2013, J SPEECH LANGUAGE HE; HOSMER DW, 1989, APPL LOGISTIC REGRES; Keating DP, 1999, DEV HLTH WEALTH NATI; Law J, 2009, J SPEECH LANG HEAR R, V52, P1401, DOI 10.1044/1092-4388(2009/08-0142); Lawrence D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-256; Loong TW, 2003, BMJ-BRIT MED J, V327, P716, DOI 10.1136/bmj.327.7417.716; Matarazzo J. D., 1972, WECHSLERS MEASUREMEN; McCormack J, 2011, J SPEECH LANG HEAR R, V54, P1328, DOI 10.1044/1092-4388(2011/10-0155); Misson S, 2007, 5 LSAC AUSTR I FAM S; NICHD Early Child Care Research Network, 2005, DEV PSYCHOL; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; Reilly S, 2007, PEDIATRICS, V120, pE1441, DOI 10.1542/peds.2007-0045; Reilly S, 2010, PEDIATRICS, V126, pE1530, DOI 10.1542/peds.2010-0254; Rice M, 2001, RICE WAXLER TEST EAR; Rice ML, 2008, J SPEECH LANG HEAR R, V51, P394, DOI 10.1044/1092-4388(2008/029); RICE ML, 2009, INFANT PATHWAYS LANG, P65; Rothman S, 2005, 2 AUSTR COUNC ED RES; SANSON A, 1987, INFANT BEHAV DEV, V10, P97, DOI 10.1016/0163-6383(87)90009-9; Sanson A., 2005, 2 LSAC AUSTR I FAM S; Sanson A, 2002, 1 LSAC AUSTR I FAM S; SAS Institute Inc, 2002, SAS WIND VERS 9 3; Schoon I, 2010, PEDIATRICS, V125, pE459, DOI 10.1542/peds.2008-2111; Shonkoff J. P., 2000, NEURONS NEIGHBORHOOD; Skeat J, 2010, CHILD CARE HLTH DEV, V36, P878, DOI 10.1111/j.1365-2214.2010.01093.x; Skeat J, 2013, CHILD CARE HLTH DEV; Skeat J, 2011, MED J AUSTRALIA, V195, P322, DOI 10.5694/mja11.10254; Soloff C, 2006, 3 LSAC AUSTR I FAM S; Strazdins L., 2007, AUSTR B LABOUR, V33, P202; Strazdins L, 2010, SOC SCI MED, V70, P2052, DOI 10.1016/j.socscimed.2010.02.041; Taylor CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073046; Taylor CL, 2013, LATE TALKERS LANGUAG; Valentine J., 2003, EFFECT SIZE SUBSTANT; Wake M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4741; Wechsler D., 2004, WISC 4 WECHSLER INTE, DOI 10.1037/t15174-000; Zubrick S, 2005, NO TIME LOSE WELLBEI; Zubrick S, PARENTING M IN PRESS; Zubrick SR, 2008, 34 DEP FAM COMM SERV; Zubrick SR, 2007, J SPEECH LANG HEAR R, V50, P1562, DOI 10.1044/1092-4388(2007/106)	60	18	18	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101476	10.1371/journal.pone.0101476	http://dx.doi.org/10.1371/journal.pone.0101476			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BA	24988308	Green Submitted, gold, Green Published			2022-12-27	WOS:000341354100096
J	del Balzo, V; Vitiello, V; Germani, A; Donini, LM; Poggiogalle, E; Pinto, A				del Balzo, Valeria; Vitiello, Valeria; Germani, Alessia; Donini, Lorenzo M.; Poggiogalle, Eleonora; Pinto, Alessandro			A Cross-Sectional Survey on Dietary Supplements Consumption among Italian Teen-Agers	PLOS ONE			English	Article							UNITED-STATES; LIFE-STYLE; VITAMIN; ADOLESCENTS; FOOD; USERS; NONUSERS; CHILDREN; ADULTS; VARIETY	Introduction: In the last decades, dietary supplements consumption has increased in the Western world for all age groups. The long-term potentially dangerous effects related to an indiscriminate consumption of dietary supplements are still unknown and are becoming a matter of public health concern. Therefore, the aims of the present study were: to explore the contribution of dietary supplements to micronutrient daily intake, and to evaluate awareness and knowledge about dietary supplements. Methods: Participants (age ranging from 14 to 18 years) were recruited among students attending 8 high schools in the province of Frosinone (Italy). An anonymous questionnaire, composed of 12 multiple-choice items, was administered to all the participants. T-test and the analysis of variance (ANOVA) were performed to describe differences between means of the groups, while the chi-square test was used to compare observed and expected frequencies. The logistic regression model, aimed at identifying the characteristics of potential consumers of dietary supplements, Results: A total of 686 teenagers (288 males and 398 females, average age: 17,8960,91 years) participated in the study. The 83,6% of participants affirmed to be aware of dietary supplements. 239 participants consumed dietary supplements: 118 males and 121 females. 49,1% of females consumed dietary supplements less than twice a week, whereas 43,6% of males consumed dietary supplements from 2 to 5 times per week. Statistically significant differences emerged between the genders with respect to the source of information regarding dietary supplements, the perceived indications for their use, and the choice of the store/place to purchase them. Discussion: Findings in the present study provide insight into the consumption of dietary supplements among young Italians, highlighting the need to foster further awareness among adolescents about the correct use of dietary supplements, especially in terms of indications and contraindications.	[del Balzo, Valeria; Vitiello, Valeria; Germani, Alessia; Donini, Lorenzo M.; Poggiogalle, Eleonora; Pinto, Alessandro] Univ Roma La Sapienza, Dept Expt Med, Res Unit Food Sci & Human Nutr, I-00185 Rome, Italy	Sapienza University Rome	del Balzo, V (corresponding author), Univ Roma La Sapienza, Dept Expt Med, Res Unit Food Sci & Human Nutr, I-00185 Rome, Italy.	valeria.delbalzo@uniroma1.it	Poggiogalle, Eleonora/AAB-9338-2019; Donini, Lorenzo/AAS-3873-2020	Donini, Lorenzo/0000-0003-4692-4754; Poggiogalle, Eleonora/0000-0003-0862-5892	CLR spa, Rme-Italy [5.2.1.2.9.32]	CLR spa, Rme-Italy	The study has been supported by CLR spa, Rme-Italy and grant number is: 5.2.1.2.9.32 www.centralelattediroma.it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the authors have received any financial support to develop this work.	Alves C, 2009, J PEDIAT-BRAZIL, V85, P287, DOI [10.2223/JPED.1907, 10.1590/S0021-75572009000400004]; Bailey RL, 2012, J PEDIATR-US, V161, P837, DOI 10.1016/j.jpeds.2012.05.009; Bailey RL, 2011, J NUTR, V141, P261, DOI 10.3945/jn.110.133025; BLOCK G, 1994, AM J CLIN NUTR, V59, p232S, DOI 10.1093/ajcn/59.1.232S; Briefel RR, 2004, ANNU REV NUTR, V24, P401, DOI 10.1146/annurev.nutr.23.011702.073349; de Jong N, 2003, BRIT J NUTR, V89, P273, DOI 10.1079/BJN2002772; Dwyer J, 2013, AM J CLIN NUTR, V97, P1331, DOI 10.3945/ajcn.112.052373; Dwyer JT, 2001, J AM DIET ASSOC, V101, P1340, DOI 10.1016/S0002-8223(01)00321-2; Foote JA, 2004, J NUTR, V134, P1779; FUMICH RM, 1983, AM J SPORT MED, V11, P34, DOI 10.1177/036354658301100110; Greenberger PA, 2001, ANN ALLERG ASTHMA IM, V86, P239, DOI 10.1016/S1081-1206(10)62698-1; Institute of Medicine Food and Nutrition Board, 2000, DIETARY REFERENCE IN; Kiely M, 2001, PUBLIC HEALTH NUTR, V4, P1089, DOI 10.1079/PHN2001190; Kim SH, 2001, NUTRITION, V17, P373, DOI 10.1016/S0899-9007(00)00582-7; L'Informatore farmaceutico, 2000, ANN IT MED LAB; Lyle BJ, 1998, J NUTR, V128, P2355, DOI 10.1093/jn/128.12.2355; Murphy SP, 2006, J AM DIET ASSOC, V106, P425, DOI 10.1016/j.jada.2005.12.003; O'Brien MM, 2001, PUBLIC HEALTH NUTR, V4, P1069, DOI 10.1079/PHN2001188; O'Dea JA, 2003, HEALTH EDUC RES, V18, P98, DOI 10.1093/her/18.1.98; Patterson RE, 1998, AM J EPIDEMIOL, V148, P643, DOI 10.1093/aje/148.7.643; Picciano MF, 2007, ARCH PEDIAT ADOL MED, V161, P978, DOI 10.1001/archpedi.161.10.978; Shakur YA, 2012, J NUTR, V142, P534, DOI 10.3945/jn.111.149450; Sichert-Hellert W, 2006, J NUTR, V136, P1329, DOI 10.1093/jn/136.5.1329; Soni MG, 2010, TOXICOL SCI, V118, P348, DOI 10.1093/toxsci/kfq293; Stratton RJ, 2005, P NUTR SOC, V64, P325, DOI 10.1079/PNS2005439; Troppmann L, 2002, J AM DIET ASSOC, V102, P818, DOI 10.1016/S0002-8223(02)90183-5; Zeisel SH, 2000, AM J CLIN NUTR, V72, p507S, DOI 10.1093/ajcn/72.2.507S	27	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100508	10.1371/journal.pone.0100508	http://dx.doi.org/10.1371/journal.pone.0100508			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988073	Green Submitted, gold, Green Published			2022-12-27	WOS:000341354100030
J	Chen, L; Munoz-Antonia, T; Cress, WD				Chen, Lu; Munoz-Antonia, Teresita; Cress, W. Douglas			Trim28 Contributes to EMT via Regulation of E-Cadherin and N-Cadherin in Lung Cancer Cell Lines	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ZINC-FINGER PROTEINS; GROWTH-FACTOR-BETA; GENE-EXPRESSION; TRANSCRIPTION; METASTASIS; COMPLEXES; KAP-1; PHOSPHORYLATION; ADENOCARCINOMA	In previous work, we demonstrated that transcription factor Trim28 (Tripartite motif containing 28) plays a tumor-suppressor role in early-staged adenocarcinoma of the lung due to its ability to restrain transcription of cell cycle-regulating genes. Herein we examine Trim28's role in the epithelial-to-mesenchymal transition (EMT) which is strongly implicated in cancer metastasis. We found that Trim28 plays a role in TGF-beta-induced EMT in non-small cell lung cancer cells. Silencing Trim28 with inhibitory RNAs alters the expression of numerous EMT markers, such as E-cadherin and N-cadherin, whereas overexpression of Trim28 has an opposite effect. Trim28 expression is induced following TGF-beta treatment at both protein and mRNA levels. Trim28 deficiency impairs TGF-beta-induced EMT and decreases cell migration and invasion. Finally, we demonstrate that the expression of Trim28 affects the acetylation and methylation of histones on E-cadherin and N-cadherin promoters. These results suggest that Trim28 contributes to EMT and might be important for tumor metastasis in lung cancer. Taken together with our previous work these results suggest a model in which Trim28 is a tumor suppressor early in the transformation process in lung cancer, but in later stages it functions as an oncogene.	[Chen, Lu; Munoz-Antonia, Teresita; Cress, W. Douglas] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Cress, WD (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA.	Douglas.Cress@moffitt.org			National Cancer Institute [CA119997, CA163068]; Moffitt Cancer Center; NATIONAL CANCER INSTITUTE [P50CA119997, P30CA076292, U54CA163068] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Moffitt Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Cancer Institute (CA119997 and CA163068) and the Moffitt Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Byles V, 2012, ONCOGENE, V31, P4619, DOI 10.1038/onc.2011.612; Chang CJ, 1998, MOL CELL BIOL, V18, P5880, DOI 10.1128/MCB.18.10.5880; Chen L, 2012, J BIOL CHEM, V287, P40106, DOI 10.1074/jbc.M112.380865; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Dong C, 2013, ONCOGENE, V32, P1351, DOI 10.1038/onc.2012.169; Dong CF, 2012, J CLIN INVEST, V122, P1469, DOI 10.1172/JCI57349; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Herquel B, 2011, P NATL ACAD SCI USA, V108, P8212, DOI 10.1073/pnas.1101544108; Ho J, 2009, J PROTEOME RES, V8, P583, DOI 10.1021/pr8007368; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; Javelaud D, 2011, CANCER RES, V71, P5606, DOI 10.1158/0008-5472.CAN-11-1194; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kokura K, 2010, EMBO J, V29, P3673, DOI 10.1038/emboj.2010.239; Kumar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068597; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Lin LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073033; Ma YH, 2010, J BIOL CHEM, V285, P9813, DOI 10.1074/jbc.M109.091496; Moreno-Bueno G, 2009, NAT PROTOC, V4, P1591, DOI 10.1038/nprot.2009.152; Rambaud J, 2009, J BIOL CHEM, V284, P14147, DOI 10.1074/jbc.M809023200; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Seki Y, 2010, P NATL ACAD SCI USA, V107, P10926, DOI 10.1073/pnas.0907601107; Shintani Y, 2008, AM J RESP CELL MOL, V38, P95, DOI 10.1165/rcmb.2007-0071OC; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsuruma R, 2008, ONCOGENE, V27, P3054, DOI 10.1038/sj.onc.1210952; Venkov CD, 2007, J CLIN INVEST, V117, P482, DOI 10.1172/JCI29544; Wang CG, 2007, J BIOL CHEM, V282, P29902, DOI 10.1074/jbc.M704757200; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yokoe T, 2010, ANN SURG ONCOL, V17, P821, DOI 10.1245/s10434-009-0795-8; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	36	62	70	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101040	10.1371/journal.pone.0101040	http://dx.doi.org/10.1371/journal.pone.0101040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983967	Green Submitted, Green Published, gold			2022-12-27	WOS:000339635000050
J	Jackson, R; Togtema, M; Lambert, PF; Zehbe, I				Jackson, Robert; Togtema, Melissa; Lambert, Paul F.; Zehbe, Ingeborg			Tumourigenesis Driven by the Human Papillomavirus Type 16 Asian-American E6 Variant in a Three-Dimensional Keratinocyte Model	PLOS ONE			English	Article							CERVICAL INTRAEPITHELIAL NEOPLASIA; POLYMERASE-CHAIN-REACTION; E2 GENE; ONCOGENE EXPRESSION; PHYSICAL STATUS; LIFE-CYCLE; CELL-LINE; IFN-KAPPA; HPV16 E6; CANCER	Infection with a transforming human papillomavirus (HPV) such as type 16 (of species Alphapapillomavirus 9) causes anogenital and oral tumours via viral persistence in human squamous cell epithelia. Epidemiological studies showed that the naturally occurring HPV16 Asian-American (AA) variant (sublineage D2/D3) is found more often than the European Prototype (EP) (sublineage A1) in high-grade cervical neoplasia and tumours compared to non-cancer controls. Just three amino acid changes within the early gene, E6, of HPV16 AA have been linked to this augmented tumourigenicity. The AAE6 variant's greater immortalizing and transforming potential over EPE6 has recently been confirmed in retrovirally-transduced keratinocytes expressing the E6 gene only. However, the tumourigenic role of the full-length viral genome of HPV16 has not yet been addressed with regard to these E6 variants. To investigate this process in the context of these two HPV16 E6 genotypes, an organotypic tissue culture model was used to simulate the HPV infectious life cycle. The AAE6 variant demonstrated an enhanced ability over EPE6 to drive the viral life cycle toward tumourigenesis, as evidenced phenotypically-by a more severe grade of epithelial dysplasia with higher proliferation and deregulated differentiation, and molecularly-by high viral oncogene E6 and E7 expression, but lack of productive viral life cycle markers. In contrast, EPE6 had low E6 and E7 but high E1<^>E4 expression, indicative of a productive life cycle. We suggest increased viral integration into the host genome for AAE6 as one possible mechanism for these observed differences from EPE6. Additionally, we found downstream effects on immortalization and host innate immune evasion. This study highlights how minor genomic variations in transforming viruses can have a significant affect on their tumourigenic ability.	[Jackson, Robert; Togtema, Melissa; Zehbe, Ingeborg] Thunder Bay Reg Res Inst, Thunder Bay, ON, Canada; [Jackson, Robert; Togtema, Melissa; Zehbe, Ingeborg] Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada; [Lambert, Paul F.] Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, Madison, WI 53706 USA	Northern Ontario School of Medicine; Lakehead University; University of Wisconsin System; University of Wisconsin Madison	Zehbe, I (corresponding author), Thunder Bay Reg Res Inst, Thunder Bay, ON, Canada.	zehbei@tbh.net	Jackson, Robert/AAP-7870-2021	Jackson, Robert/0000-0001-9898-5546	Natural Sciences and Engineering Council (NSERC), Canada [355858-2008]	Natural Sciences and Engineering Council (NSERC), Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a grant from the Natural Sciences and Engineering Council (NSERC, to IZ), Canada (#355858-2008). URL: http://www.nserccrsng.gc.ca/index_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Hoffmann BL, 2000, J INVEST DERMATOL, V114, P444, DOI 10.1046/j.1523-1747.2000.00869.x; ANDROPHY EJ, 1985, SCIENCE, V230, P442, DOI 10.1126/science.2996134; Angiero F, 2008, ANTICANCER RES, V28, P2535; Baay MFD, 1996, J CLIN MICROBIOL, V34, P745, DOI 10.1128/JCM.34.3.745-747.1996; Bernard HU, 2006, INT J CANCER, V118, P1071, DOI 10.1002/ijc.21655; Berumen J, 2001, JNCI-J NATL CANCER I, V93, P1325, DOI 10.1093/jnci/93.17.1325; Bodily JM, 2011, J VIROL, V85, P8852, DOI 10.1128/JVI.00664-11; Buontempo PJ, 2006, J INTERF CYTOK RES, V26, P40, DOI 10.1089/jir.2006.26.40; Burk RD, 2013, VIROLOGY, V445, P232, DOI 10.1016/j.virol.2013.07.018; Burk RD, 2009, PUBLIC HEALTH GENOM, V12, P281, DOI 10.1159/000214919; Cheah PL, 2002, PATHOLOGY, V34, P326, DOI 10.1080/003130202760120472; CHOO KB, 1987, VIROLOGY, V161, P259, DOI 10.1016/0042-6822(87)90195-4; Collins SI, 2009, CANCER RES, V69, P3828, DOI 10.1158/0008-5472.CAN-08-3099; Cornet I, 2012, J VIROL, V86, P6855, DOI 10.1128/JVI.00483-12; CRIPE TP, 1987, EMBO J, V6, P3745, DOI 10.1002/j.1460-2075.1987.tb02709.x; Daniel B, 1997, J GEN VIROL, V78, P1095, DOI 10.1099/0022-1317-78-5-1095; DAS BC, 1992, J GEN VIROL, V73, P2327, DOI 10.1099/0022-1317-73-9-2327; Dayyani F, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-15; DeCarlo CA, 2008, ANAL BIOCHEM, V381, P59, DOI 10.1016/j.ab.2008.06.009; DeCarlo CA, 2010, LAB INVEST, V90, P1482, DOI 10.1038/labinvest.2010.95; Doorbar J, 2005, J CLIN VIROL, V32, pS7, DOI 10.1016/j.jcv.2004.12.006; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Dray M, 2005, PATHOLOGY, V37, P112, DOI 10.1080/00313020500058607; Flores ER, 1999, VIROLOGY, V262, P344, DOI 10.1006/viro.1999.9868; Francis DA, 2000, J VIROL, V74, P2679, DOI 10.1128/JVI.74.6.2679-2686.2000; Genther SM, 2003, J VIROL, V77, P2832, DOI 10.1128/JVI.77.5.2832-2842.2003; Ghittoni R, 2010, VIRUS GENES, V40, P1, DOI 10.1007/s11262-009-0412-8; Goodwin EC, 1998, J VIROL, V72, P3925, DOI 10.1128/JVI.72.5.3925-3934.1998; Hansen LA, 2000, CANCER RES, V60, P3328; Hasan UA, 2013, J EXP MED, V210, P1369, DOI 10.1084/jem.20122394; HAVRE PA, 1995, CANCER RES, V55, P4420; HUITFELDT HS, 1991, CARCINOGENESIS, V12, P2063, DOI 10.1093/carcin/12.11.2063; JEON S, 1995, J VIROL, V69, P2989, DOI 10.1128/JVI.69.5.2989-2997.1995; Kahla S, 2013, INT J BIOL MARKER; Kalantari M, 1998, INT J GYNECOL PATHOL, V17, P146, DOI 10.1097/00004347-199804000-00009; Kessis TD, 1996, ONCOGENE, V13, P427; Klaes R, 2001, INT J CANCER, V92, P276, DOI 10.1002/ijc.1174; Lambert PF, 2005, METH MOLEC MED, V119, P141; Liu HQ, 2011, J VIROL, V85, P9863, DOI 10.1128/JVI.00828-11; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mantovani F, 2001, ONCOGENE, V20, P7874, DOI 10.1038/sj.onc.1204869; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; Nagao S, 2002, J CLIN MICROBIOL, V40, P863, DOI 10.1128/JCM.40.3.863-867.2002; Niccoli S, 2012, J VIROL, V86, P12384, DOI 10.1128/JVI.01512-12; Nishimura A, 2000, J VIROL, V74, P3752, DOI 10.1128/JVI.74.8.3752-3760.2000; O'Brien PM, 2003, TRENDS MICROBIOL, V11, P300, DOI 10.1016/S0966-842X(03)00145-8; PALEFSKY JM, 1991, CANCER RES, V51, P1014; Park RB, 2002, J VIROL, V76, P11359, DOI 10.1128/JVI.76.22.11359-11364.2002; Peitsaro P, 2002, J CLIN MICROBIOL, V40, P886, DOI 10.1128/JCM.40.3.886-891.2002; Pett MR, 2004, CANCER RES, V64, P1359, DOI 10.1158/0008-5472.CAN-03-3214; R Core Team, 2021, R LANGUAGE ENV STAT; Reiser J, 2011, J VIROL, V85, P11372, DOI 10.1128/JVI.05279-11; Richard C, 2010, ONCOGENE, V29, P3435, DOI 10.1038/onc.2010.93; Riley RR, 2003, CANCER RES, V63, P4862; Rincon-Orozco B, 2009, CANCER RES, V69, P8718, DOI 10.1158/0008-5472.CAN-09-0550; Roberts I, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-57; Roman A, 2013, VIROLOGY, V445, P138, DOI 10.1016/j.virol.2013.04.013; ROMANCZUK H, 1992, P NATL ACAD SCI USA, V89, P3159, DOI 10.1073/pnas.89.7.3159; ROMANCZUK H, 1990, J VIROL, V64, P2849, DOI 10.1128/JVI.64.6.2849-2859.1990; Ronco LV, 1998, GENE DEV, V12, P2061, DOI 10.1101/gad.12.13.2061; Ruiz S, 2004, DEVELOPMENT, V131, P2737, DOI 10.1242/dev.01148; Schmitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039632; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHWARZ E, 1985, NATURE, V314, P111, DOI 10.1038/314111a0; SEEDORF K, 1985, VIROLOGY, V145, P181, DOI 10.1016/0042-6822(85)90214-4; Si HX, 2005, J CLIN VIROL, V32, P19, DOI 10.1016/j.jcv.2004.04.004; Sichero L, 2012, VIROLOGY, V432, P127, DOI 10.1016/j.virol.2012.06.011; Smith RH, 2008, GENE THER, V15, P817, DOI 10.1038/gt.2008.55; Stanley MA, 2007, BIOCHEM SOC T, V35, P1456, DOI 10.1042/BST0351456; TAN SH, 1992, NUCLEIC ACIDS RES, V20, P251, DOI 10.1093/nar/20.2.251; Tosun G, 2010, EUR J GYNAECOL ONCOL, V31, P627; Van Doorslaer K, 2012, VIROLOGY, V433, P216, DOI 10.1016/j.virol.2012.08.006; Vande Pol SB, 2013, VIROLOGY, V445, P115, DOI 10.1016/j.virol.2013.04.026; Vassallo J, 2000, INT J GYNECOL OBSTET, V71, P45, DOI 10.1016/S0020-7292(00)00248-4; Vernon SD, 1997, INT J CANCER, V74, P50, DOI 10.1002/(SICI)1097-0215(19970220)74:1<50::AID-IJC9>3.3.CO;2-P; Vicente-Duenas C, 2013, EMBO J, V32, P1502, DOI 10.1038/emboj.2013.97; Villa LL, 2000, J GEN VIROL, V81, P2959, DOI 10.1099/0022-1317-81-12-2959; Wang JL, 2004, CLIN CANCER RES, V10, P2407, DOI 10.1158/1078-0432.CCR-03-0242; Wechsler EI, 2012, J VIROL, V86, P6358, DOI 10.1128/JVI.07069-11; WHITE AE, 1994, GENE DEV, V8, P666, DOI 10.1101/gad.8.6.666; Xi LF, 1997, JNCI-J NATL CANCER I, V89, P796, DOI 10.1093/jnci/89.11.796; Xi LF, 2007, CANCER EPIDEM BIOMAR, V16, P4, DOI 10.1158/1055-9965.EPI-06-0670; YAMADA T, 1995, J VIROL, V69, P7743, DOI 10.1128/JVI.69.12.7743-7753.1995; Zehbe I, 1996, VIRCHOWS ARCH, V428, P151; Zehbe I, 1998, LANCET, V352, P1441, DOI 10.1016/S0140-6736(05)61263-9; Zehbe I, 1998, CANCER RES, V58, P829; Zehbe I, 2001, CANCER RES, V61, P608; Zehbe I, 2009, VIROLOGY, V383, P69, DOI 10.1016/j.virol.2008.09.036; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; zurHausen H, 1996, BBA-REV CANCER, V1288, pF55	90	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101540	10.1371/journal.pone.0101540	http://dx.doi.org/10.1371/journal.pone.0101540			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983759	gold, Green Published			2022-12-27	WOS:000339635000117
J	Komrskova, P; Susor, A; Malik, R; Prochazkova, B; Liskova, L; Supolikova, J; Hladky, S; Kubelka, M				Komrskova, Pavla; Susor, Andrej; Malik, Radek; Prochazkova, Barbora; Liskova, Lucie; Supolikova, Jaroslava; Hladky, Stepan; Kubelka, Michal			Aurora Kinase A Is Not Involved in CPEB1 Phosphorylation and cyclin B1 mRNA Polyadenylation during Meiotic Maturation of Porcine Oocytes	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; CYTOPLASMIC POLYADENYLATION; MOUSE OOCYTES; C-MOS; TRANSLATIONAL REGULATION; CHROMOSOME CONDENSATION; XENOPUS PUMILIO; PIG OOCYTES; MAP KINASE; A KINASE	Regulation of mRNA translation by cytoplasmic polyadenylation is known to be important for oocyte maturation and further development. This process is generally controlled by phosphorylation of cytoplasmic polyadenylation element binding protein 1 (CPEB1). The aim of this study is to determine the role of Aurora kinase A in CPEB1 phosphorylation and the consequent CPEB1-dependent polyadenylation of maternal mRNAs during mammalian oocyte meiosis. For this purpose, we specifically inhibited Aurora kinase A with MLN8237 during meiotic maturation of porcine oocytes. Using poly(A)-test PCR method, we monitored the effect of Aurora kinase A inhibition on poly(A)-tail extension of long and short cyclin B1 encoding mRNAs as markers of CPEB1-dependent cytoplasmic polyadenylation. Our results show that inhibition of Aurora kinase A activity impairs neither cyclin B1 mRNA polyadenylation nor its translation and that Aurora kinase A is unlikely to be involved in CPEB1 activating phosphorylation.	[Komrskova, Pavla; Susor, Andrej; Prochazkova, Barbora; Liskova, Lucie; Supolikova, Jaroslava; Hladky, Stepan; Kubelka, Michal] Acad Sci Czech Republic, Inst Anim Physiol & Genet, Libechov, Czech Republic; [Malik, Radek] Acad Sci Czech Republic, Inst Mol Genet, Libechov, Czech Republic	Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Kubelka, M (corresponding author), Acad Sci Czech Republic, Inst Anim Physiol & Genet, Libechov, Czech Republic.	kubelka@iapg.cas.cz	Prochazkova, Barbora/G-7133-2014; Malik, Radek/G-3578-2014	Malik, Radek/0000-0002-6783-1146	Czech Science Foundation [P502/10/0944, 13- 12291S, P502/12/2201]; IAPG AS CR, v.v.i. [67985904]	Czech Science Foundation(Grant Agency of the Czech Republic); IAPG AS CR, v.v.i.	This work was supported by grant from the Czech Science Foundation P502/10/0944 (http://www.gacr.cz/) and by Institutional Research Concept 67985904 (IAPG AS CR, v.v.i., http://www.iapg.cas.cz/), AS was also supported by grant from the Czech Science Foundation 13- 12291S and MK was also supported by grant from the Czech Science Foundation P502/12/2201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asteriti IA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-131; Atkins CM, 2004, J NEUROSCI, V24, P5193, DOI 10.1523/JNEUROSCI.0854-04.2004; Brunet S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003338; De Luca M, 2006, CELL CYCLE, V5, P296; Do TV, 2014, ONCOGENE, V33, P539, DOI 10.1038/onc.2012.632; Dutertre S, 2004, J CELL SCI, V117, P2523, DOI 10.1242/jcs.01108; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Hodgman R, 2001, DEVELOPMENT, V128, P2815; Hong X, 2014, CANC CHEMOTHER PHARM; Huck JJ, 2010, MOL CANCER RES, V8, P373, DOI 10.1158/1541-7786.MCR-09-0300; Jelinkova L, 2006, BIOL REPROD, V74, P905, DOI 10.1095/biolreprod.105.047886; Karabinova P, 2011, CELL TISSUE RES, V346, P1, DOI 10.1007/s00441-011-1235-1; Keady BT, 2007, J CELL SCI, V120, P1093, DOI 10.1242/jcs.03416; Kim JH, 2007, GENE DEV, V21, P2571, DOI 10.1101/gad.1593007; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; Kim KC, 2013, NEUROCHEM RES, V38, P1960, DOI 10.1007/s11064-013-1102-4; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Kubelka M, 2002, MOL REPROD DEV, V63, P110, DOI 10.1002/mrd.10176; Kunitoku N, 2003, DEV CELL, V5, P853, DOI 10.1016/S1534-5807(03)00364-2; Kuo PW, 2011, DIFFERENTIATION, V81, P133, DOI 10.1016/j.diff.2010.11.001; Lioutas A, 2014, CELL CYCLE, V13, P499, DOI 10.4161/cc.27781; Lioutas A, 2013, EMBO REP, V14, P829, DOI 10.1038/embor.2013.109; Liskova L, 2010, REPROD FERT DEVELOP, V22, P644, DOI 10.1071/RD09068; Manfredi MG, 2011, CLIN CANCER RES, V17, P7614, DOI 10.1158/1078-0432.CCR-11-1536; Marumoto T, 2003, J BIOL CHEM, V278, P51786, DOI 10.1074/jbc.M306275200; MCGREW LL, 1989, GENE DEV, V3, P803, DOI 10.1101/gad.3.6.803; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; Mendez R, 2002, EMBO J, V21, P1833, DOI 10.1093/emboj/21.7.1833; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Motlik J, 1996, ZYGOTE, V4, P247, DOI 10.1017/S0967199400003166; Murai S, 2010, DEV BIOL, V341, P205, DOI 10.1016/j.ydbio.2010.02.027; Nakahata S, 2003, MECH DEVELOP, V120, P865, DOI 10.1016/S0925-4773(03)00160-6; Nakahata S, 2001, J BIOL CHEM, V276, P20945, DOI 10.1074/jbc.M010528200; Nechama M, 2013, MOL CELL BIOL, V33, P48, DOI 10.1128/MCB.00904-12; Nishimura Y, 2010, ANIM SCI J, V81, P444, DOI 10.1111/j.1740-0929.2010.00755.x; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Padmanabhan K, 2006, GENE DEV, V20, P199, DOI 10.1101/gad.1383106; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; Reverte CG, 2001, DEV BIOL, V231, P447, DOI 10.1006/dbio.2001.0153; SALLES FJ, 1995, PCR METH APPL, V4, P317; Saskova A, 2008, CELL CYCLE, V7, P2368, DOI 10.4161/cc.6361; Setoyama D, 2007, P NATL ACAD SCI USA, V104, P18001, DOI 10.1073/pnas.0706952104; SHEETS MD, 1994, GENE DEV, V8, P926, DOI 10.1101/gad.8.8.926; Solc P, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101014; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; StebbinsBoaz B, 1996, EMBO J, V15, P2582, DOI 10.1002/j.1460-2075.1996.tb00616.x; Tay J, 2000, DEV BIOL, V221, P1, DOI 10.1006/dbio.2000.9669; Toji S, 2004, GENES CELLS, V9, P383, DOI 10.1111/j.1356-9597.2004.00732.x; Tremblay K, 2005, BIOL REPROD, V72, P1037, DOI 10.1095/biolreprod.104.034793; Uzbekova S, 2008, BIOL REPROD, V78, P218, DOI 10.1095/biolreprod.107.061036; Walter AO, 2000, ONCOGENE, V19, P4906, DOI 10.1038/sj.onc.1203847; Wu JM, 2013, P NATL ACAD SCI USA, V110, pE1779, DOI 10.1073/pnas.1220523110; Yao LJ, 2004, BIOL REPROD, V70, P1392, DOI 10.1095/biolreprod.103.025155; Zhang DX, 2010, MOL REPROD DEV, V77, P38, DOI 10.1002/mrd.21095	54	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101222	10.1371/journal.pone.0101222	http://dx.doi.org/10.1371/journal.pone.0101222			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983972	Green Published, gold, Green Submitted			2022-12-27	WOS:000339635000070
J	Wu, MM; Xiao, H; Ren, WK; Yin, J; Tan, B; Liu, G; Li, L; Nyachoti, CM; Xiong, X; Wu, GY				Wu, Miaomiao; Xiao, Hao; Ren, Wenkai; Yin, Jie; Tan, Bie; Liu, Gang; Li, Lili; Nyachoti, Charles Martin; Xiong, Xia; Wu, Guoyao			Therapeutic Effects of Glutamic Acid in Piglets Challenged with Deoxynivalenol	PLOS ONE			English	Article							RIBOTOXIC STRESS-RESPONSE; ACTIVATED PROTEIN-KINASE; CELL-CYCLE ARREST; T-2 TOXIN; TRICHOTHECENE MYCOTOXINS; GASTROINTESTINAL-TRACT; SMALL-INTESTINE; AMINO-ACIDS; SUPPLEMENTATION; EXPRESSION	The mycotoxin deoxynivalenol (DON), one of the most common food contaminants, primarily targets the gastrointestinal tract to affect animal and human health. This study was conducted to examine the protective function of glutamic acid on intestinal injury and oxidative stress caused by DON in piglets. Twenty-eight piglets were assigned randomly into 4 dietary treatments (7 pigs/treatment): 1) uncontaminated control diet (NC), 2) NC+DON at 4 mg/kg (DON), 3) NC+2% glutamic acid (GLU), and 4) NC+2% glutamic acid + DON at 4 mg/kg (DG). At day 15, 30 and 37, blood samples were collected to determine serum concentrations of CAT (catalase), T-AOC (total antioxidant capacity), H2O2 (hydrogen peroxide), NO (nitric oxide), MDA (maleic dialdehyde), DAO (diamine oxidase) and D-lactate. Intestinal morphology, and the activation of Akt/mTOR/4EBP1 signal pathway, as well as the concentrations of H2O2, MDA, and DAO in kidney, liver and small intestine, were analyzed at day 37. Results showed that DON significantly (P<0.05) induced oxidative stress in piglets, while this stress was remarkably reduced with glutamic acid supplementation according to the change of oxidative parameters in blood and tissues. Meanwhile, DON caused obvious intestinal injury from microscopic observations and permeability indicators, which was alleviated by glutamic acid supplementation. Moreover, the inhibition of DON on Akt/mTOR/4EBP1 signal pathway was reduced by glutamic acid supplementation. Collectively, these data suggest that glutamic acid may be a useful nutritional regulator for DON-induced damage manifested as oxidative stress, intestinal injury and signaling inhibition.	[Wu, Miaomiao; Xiao, Hao; Ren, Wenkai; Yin, Jie; Tan, Bie; Liu, Gang; Li, Lili; Xiong, Xia; Wu, Guoyao] Chinese Acad Sci, Sci Observing & Expt Stn Anim Nutr & Feed Sci Sou, Minist Agr,Inst Subtrop Agr, Hunan Prov Engn Res Ctr Hlth Livestock,Key Lab Ag, Changsha, Hunan, Peoples R China; [Wu, Miaomiao; Xiao, Hao; Ren, Wenkai; Yin, Jie] Univ Chinese Acad Sci, Beijing, Peoples R China; [Nyachoti, Charles Martin] Univ Manitoba, Dept Anim Sci, Winnipeg, MB R3T 2N2, Canada; [Wu, Guoyao] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA	Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Manitoba; Texas A&M University System; Texas A&M University College Station	Xiong, X (corresponding author), Chinese Acad Sci, Sci Observing & Expt Stn Anim Nutr & Feed Sci Sou, Minist Agr,Inst Subtrop Agr, Hunan Prov Engn Res Ctr Hlth Livestock,Key Lab Ag, Changsha, Hunan, Peoples R China.	xx@isa.ac.cn	YIN, Jie/H-3578-2019; Liu, Gang/G-5283-2017	YIN, Jie/0000-0003-1852-1042; Liu, Gang/0000-0002-9475-5134	National Key Basic Research of China [2009CB118806]; National Natural Science Foundation of China [31272463, 31072042]; Hunan Provincial Natural Science Foundation of China [12JJ2014, 13JJ2034]; Chinese Academy of Sciences [2011T2S15]	National Key Basic Research of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was jointly supported by grants from the National Key Basic Research of China (NO. 2009CB118806), the National Natural Science Foundation of China (NO. 31272463 and NO. 31072042), Hunan Provincial Natural Science Foundation of China (NO. 12JJ2014, 13JJ2034) and Chinese Academy of Sciences Visiting Professorship for Senior International Scientists Grant No. 2011T2S15. Meanwhile, the authors also give their profound admiration and respect to the many researchers in this field and in their lab, whose dedication and hard work make it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARSEN PN, 1964, NATURE, V204, P1195, DOI 10.1038/2041195a0; Abid-Essefi S, 2003, TOXICOLOGY, V192, P237, DOI 10.1016/S0300-483X(03)00329-9; AE D, 2006, FUSARIUM MYCOTOXINS; Beutheu S, 2013, CLIN NUTR; Blachier F, 1999, DIGESTION, V60, P349, DOI 10.1159/000007682; Blachier F, 2009, AM J CLIN NUTR, V90, p814S, DOI 10.3945/ajcn.2009.27462S; BRAGG LE, 1991, J SURG RES, V50, P228, DOI 10.1016/0022-4804(91)90183-M; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; CANNON M, 1976, BIOCHEM J, V160, P137, DOI 10.1042/bj1600137; Eriksen GS, 2004, ANIM FEED SCI TECH, V114, P205, DOI 10.1016/j.anifeedsci.2003.08.008; Felicia W, 2007, ANIM FEED SCI TECHNO, V137, P363; Feng YJ, 2012, ANN NY ACAD SCI, V1258, P71, DOI 10.1111/j.1749-6632.2012.06572.x; Feng ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084533; Frankic T, 2006, FOOD CHEM TOXICOL, V44, P1838, DOI 10.1016/j.fct.2006.06.002; Fujita T, 2007, LIFE SCI, V80, P1846, DOI 10.1016/j.lfs.2007.02.017; Goossens J, 2013, FOOD CHEM TOXICOL, V57, P54, DOI 10.1016/j.fct.2013.03.009; Hou YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060374; Hu CAA, 2008, AMINO ACIDS, V35, P665, DOI 10.1007/s00726-008-0075-0; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Iordanov MS, 1997, MOL CELL BIOL, V17, P3373, DOI 10.1128/MCB.17.6.3373; Kalaiselvi P, 2013, FOOD CHEM TOXICOL, V56, P110, DOI 10.1016/j.fct.2013.01.042; Karihtala P, 2007, APMIS, V115, P81, DOI 10.1111/j.1600-0463.2007.apm_514.x; Klunker LR, 2013, J ANIM SCI, V91, P276, DOI 10.2527/jas.2012-5453; Kolf-Clauw M, 2009, TOXICOL IN VITRO, V23, P1580, DOI 10.1016/j.tiv.2009.07.015; Kuo PL, 2006, MOL CANCER THER, V5, P3209, DOI 10.1158/1535-7163.MCT-06-0478; Li FQ, 1999, NAT TOXINS, V7, P93, DOI 10.1002/(SICI)1522-7189(199905/06)7:3<93::AID-NT45>3.0.CO;2-5; Maresca M, 2002, J NUTR, V132, P2723, DOI 10.1093/jn/132.9.2723; Minervini F, 2004, TOXICOL IN VITRO, V18, P21, DOI 10.1016/S0887-2333(03)00130-9; Namikawa T, 2012, ONCOLOGY-BASEL, V82, P147, DOI 10.1159/000336799; Ngampongsa S, 2013, J TOXICOL SCI, V38, P495, DOI 10.2131/jts.38.495; Nossol C, 2013, MYCOTOXIN RES, V29, P245, DOI 10.1007/s12550-013-0177-8; Obremski K, 2008, POL J VET SCI, V11, P339; Osselaere A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069014; Packer RA, 2012, J VET INTERN MED, V26, P905, DOI 10.1111/j.1939-1676.2012.00936.x; Pestka JJ, 2008, FOOD ADDIT CONTAM A, V25, P1128, DOI 10.1080/02652030802056626; Pestka JJ, 2005, J TOXICOL ENV HEAL B, V8, P39, DOI 10.1080/10937400590889458; Pinton P, 2009, TOXICOL APPL PHARM, V237, P41, DOI 10.1016/j.taap.2009.03.003; Reeds PJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE408, DOI 10.1152/ajpendo.1997.273.2.E408; Ren WK, 2013, AMINO ACIDS, V45, P947, DOI 10.1007/s00726-013-1551-8; Ren WK, 2013, BRIT J NUTR, V110, P1053, DOI 10.1017/S0007114512006101; Ren WK, 2013, AMINO ACIDS, V45, P555, DOI 10.1007/s00726-013-1490-4; Ren WK, 2012, AMINO ACIDS, V42, P2089, DOI 10.1007/s00726-011-0942-y; Rocha O, 2005, FOOD ADDIT CONTAM A, V22, P369, DOI 10.1080/02652030500058403; Ruth MR, 2013, AMINO ACIDS, V45, P581; Sanden C, 2013, INT IMMUNOPHARMACOL, V15, P121, DOI 10.1016/j.intimp.2012.11.012; Shifrin VI, 1999, J BIOL CHEM, V274, P13985, DOI 10.1074/jbc.274.20.13985; van Meijl LEC, 2010, MOL NUTR FOOD RES, V54, P1568, DOI 10.1002/mnfr.200900438; Vandenbroucke V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023871; Watford M, 2008, J NUTR, V138, p2003S, DOI 10.1093/jn/138.10.2003S; Wu GY, 2009, BIOFACTORS, V35, P21, DOI 10.1002/biof.3; WU GY, 1994, J NUTR, V124, P2437, DOI 10.1093/jn/124.12.2437; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Wu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069502; Xiao H, 2013, J ANIM SCI, V91, P4772, DOI 10.2527/jas.2013-6426; Yang HS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050921, 10.1371/journal.pone.0029051]; Yang H, 2008, TOXICOLOGY, V243, P145, DOI 10.1016/j.tox.2007.10.002; Yin YL, 2010, AMINO ACIDS, V39, P1477, DOI 10.1007/s00726-010-0612-5; Zhang J, 2013, AMINO ACIDS, V45, P1169, DOI 10.1007/s00726-013-1573-2; Zhou HR, 2003, TOXICOL SCI, V72, P130, DOI 10.1093/toxsci/kfg006	59	60	68	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100591	10.1371/journal.pone.0100591	http://dx.doi.org/10.1371/journal.pone.0100591			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984001	gold, Green Submitted, Green Published			2022-12-27	WOS:000339635000031
J	Ahkami, A; Scholz, U; Steuernagel, B; Strickert, M; Haensch, KT; Druege, U; Reinhardt, D; Nouri, E; von Wiren, N; Franken, P; Hajirezaei, MR				Ahkami, Amirhossein; Scholz, Uwe; Steuernagel, Burkhard; Strickert, Marc; Haensch, Klaus-Thomas; Druege, Uwe; Reinhardt, Didier; Nouri, Eva; von Wiren, Nicolaus; Franken, Philipp; Hajirezaei, Mohammad-Reza			Comprehensive Transcriptome Analysis Unravels the Existence of Crucial Genes Regulating Primary Metabolism during Adventitious Root Formation in Petunia hybrida	PLOS ONE			English	Article							POSTTRANSLATIONAL REDOX ACTIVATION; S-ADENOSYLMETHIONINE SYNTHETASE; TREHALOSE 6-PHOSPHATE; PROLINE ACCUMULATION; PHOSPHOENOLPYRUVATE CARBOXYLASE; PEROXIDASE-ACTIVITY; STARCH SYNTHESIS; EXPRESSION; CUTTINGS; GROWTH	To identify specific genes determining the initiation and formation of adventitious roots (AR), a microarray-based transcriptome analysis in the stem base of the cuttings of Petunia hybrida (line W115) was conducted. A microarray carrying 24,816 unique, non-redundant annotated sequences was hybridized to probes derived from different stages of AR formation. After exclusion of wound-responsive and root-regulated genes, 1,354 of them were identified which were significantly and specifically induced during various phases of AR formation. Based on a recent physiological model distinguishing three metabolic phases in AR formation, the present paper focuses on the response of genes related to particular metabolic pathways. Key genes involved in primary carbohydrate metabolism such as those mediating apoplastic sucrose unloading were induced at the early sink establishment phase of AR formation. Transcriptome changes also pointed to a possible role of trehalose metabolism and SnRK1 (sucrose non-fermenting 1-related protein kinase) in sugar sensing during this early step of AR formation. Symplastic sucrose unloading and nucleotide biosynthesis were the major processes induced during the later recovery and maintenance phases. Moreover, transcripts involved in peroxisomal beta-oxidation were up-regulated during different phases of AR formation. In addition to metabolic pathways, the analysis revealed the activation of cell division at the two later phases and in particular the induction of G1-specific genes in the maintenance phase. Furthermore, results point towards a specific demand for certain mineral nutrients starting in the recovery phase.	[Ahkami, Amirhossein] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Steuernagel, Burkhard] Sainsbury Lab, Norwich, Norfolk, England; [Strickert, Marc] Univ Marburg, SYNMIKRO, Marburg, Germany; [Haensch, Klaus-Thomas; Druege, Uwe; Franken, Philipp] Leibniz Inst Vegetable & Ornamental Crops IGZ, Grossbeeren, Germany; [Haensch, Klaus-Thomas; Druege, Uwe; Franken, Philipp] Leibniz Inst Vegetable & Ornamental Crops IGZ, Erfurt, Germany; [Reinhardt, Didier; Nouri, Eva] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland; [Scholz, Uwe; von Wiren, Nicolaus; Hajirezaei, Mohammad-Reza] Leibniz Inst Plant Genet & Crop Plant Res, Gatersleben, Germany	Washington State University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Philipps University Marburg; Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ); Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ); University of Fribourg; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Hajirezaei, MR (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res, Gatersleben, Germany.	mohammad@ipk-gatersleben.de	Reinhardt, Didier/M-8508-2014	Reinhardt, Didier/0000-0003-3495-6783; Haensch, Klaus-Thomas/0000-0002-3092-7881; Hajirezaei, Mohammad-Reza/0000-0002-9537-0121; Ahkami, Amir H./0000-0002-0545-1236; Steuernagel, Burkhard/0000-0002-8284-7728; Scholz, Uwe/0000-0001-6113-3518; von Wiren, Nicolaus/0000-0002-4966-425X	DFG (Deutsche Forschungsgemeinschaft)	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by DFG (Deutsche Forschungsgemeinschaft), http://www.dfg.de/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca D., 2011, BMC P S7, V5, pP133, DOI [10.1186/1753-6561-5-s7-p133, DOI 10.1186/1753-6561-5-S7-P133]; Ahkami AH, 2013, PLANTA, V238, P499, DOI 10.1007/s00425-013-1907-z; Ahkami AH, 2009, NEW PHYTOL, V181, P613, DOI 10.1111/j.1469-8137.2008.02704.x; Anbazhagan VR, 2008, IN VITRO CELL DEV-PL, V44, P494, DOI 10.1007/s11627-008-9134-1; Agullo-Anton MA, 2014, PHYSIOL PLANTARUM, V150, P446, DOI 10.1111/ppl.12114; Birnbaum KD, 2008, CELL, V132, P697, DOI 10.1016/j.cell.2008.01.040; Blazich FA, 1988, ADVENTITIOUS ROOT FO, P61; BOOT KJM, 1993, PLANT PHYSIOL, V102, P513, DOI 10.1104/pp.102.2.513; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Breuillin F, 2010, PLANT J, V64, P1002, DOI 10.1111/j.1365-313X.2010.04385.x; Brinker M, 2004, PLANT PHYSIOL, V135, P1526, DOI 10.1104/pp.103.032235; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Butler E, 1998, Symp Soc Exp Biol, V51, P79; Campa A., 1991, PEROXIDASES CHEM BIO, P25; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; Chollet R, 1996, ANNU REV PLANT PHYS, V47, P273, DOI 10.1146/annurev.arplant.47.1.273; da Costa CT, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00133; De Klerk GJ, 1999, IN VITRO CELL DEV-PL, V35, P189, DOI 10.1007/s11627-999-0076-z; DELL B, 1985, PLANT SOIL, V88, P377, DOI 10.1007/BF02197494; Druege U, 2000, ANN BOT-LONDON, V85, P687, DOI 10.1006/anbo.2000.1132; Eastmond PJ, 2003, J EXP BOT, V54, P533, DOI 10.1093/jxb/erg039; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; ELLEDGE SJ, 1992, TRENDS BIOCHEM SCI, V17, P119, DOI 10.1016/0968-0004(92)90249-9; Fang WC, 2000, PLANT SCI, V158, P71, DOI 10.1016/S0168-9452(00)00307-1; Farrar J, 1996, PLANT SOIL, V185, P13, DOI 10.1007/BF02257561; Galston A.W., 1995, PLANT HORMONES PHYSL, P158, DOI DOI 10.1007/978-94-011-0473-9_; Gerats T, 2005, TRENDS PLANT SCI, V10, P251, DOI 10.1016/j.tplants.2005.03.005; Giehl RFH, 2009, CURR OPIN PLANT BIOL, V12, P320, DOI 10.1016/j.pbi.2009.04.006; Goldberg R, 1986, MOL PHYSL ASPECTS PL, P208; GRAMBOW HJ, 1983, PLANTA, V157, P131; Grisebach H., 1981, The biochemistry of plants. A comprehensive treatise. Volume 7. Secondary plant products., P457; Guo FQ, 2001, PLANT CELL, V13, P1761, DOI 10.1105/tpc.13.8.1761; Haensch KT, 2004, PLANT CELL REP, V22, P376, DOI 10.1007/s00299-003-0726-2; Hare PD, 1997, PLANT GROWTH REGUL, V21, P79, DOI 10.1023/A:1005703923347; Himanen K, 2004, P NATL ACAD SCI USA, V101, P5146, DOI 10.1073/pnas.0308702101; Hu CAA, 2007, MOL CELL BIOCHEM, V295, P85, DOI 10.1007/s11010-006-9276-6; Journet EP, 2002, NUCLEIC ACIDS RES, V30, P5579, DOI 10.1093/nar/gkf685; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Kolbe A, 2005, P NATL ACAD SCI USA, V102, P11118, DOI 10.1073/pnas.0503410102; Koyuncu F, 2004, PAKISTAN J BOT, V36, P763; Kunne C, 2005, NUCLEIC ACIDS RES, V33, pD619, DOI 10.1093/nar/gki119; Kuroha T, 2002, J EXP BOT, V53, P2193, DOI 10.1093/jxb/erf077; Lindroth AM, 2001, PLANT PHYSIOL BIOCH, V39, P107, DOI 10.1016/S0981-9428(00)01229-8; Lindroth AM, 2001, PLANT MOL BIOL, V46, P335, DOI 10.1023/A:1010637012528; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; Lorbiecke R, 1999, PLANT PHYSIOL, V119, P21, DOI 10.1104/pp.119.1.21; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Lunn JE, 2006, BIOCHEM J, V397, P139, DOI 10.1042/BJ20060083; Maggio A, 2002, PLANT J, V31, P699, DOI 10.1046/j.1365-313X.2002.01389.x; Marschner H., 1995, MARSCHNERS MINERAL N, DOI DOI 10.1016/B978-0-12-473542-2.X5000-7; Mayne MB, 1996, PLANT CELL ENVIRON, V19, P958, DOI 10.1111/j.1365-3040.1996.tb00460.x; McDonald MS, 2003, IN VITRO CELL DEV-PL, V39, P234, DOI 10.1079/IVP2002390; McKeon Thomas A., 1995, P118; Meijer M, 2000, PLANT MOL BIOL, V43, P621, DOI 10.1023/A:1006482115915; MELZER E, 1987, PLANT PHYSIOL, V84, P58, DOI 10.1104/pp.84.1.58; Metaxas DJ, 2004, PLANT GROWTH REGUL, V44, P257, DOI 10.1007/s10725-004-5931-7; MICHELET B, 1994, PLANT CELL, V6, P1375, DOI 10.1105/tpc.6.10.1375; Negi S, 2010, PLANT J, V61, P3, DOI 10.1111/j.1365-313X.2009.04027.x; Paul M, 2001, TRENDS PLANT SCI, V6, P197, DOI 10.1016/S1360-1385(01)01920-3; Paul M, 2007, CURR OPIN PLANT BIOL, V10, P303, DOI 10.1016/j.pbi.2007.04.001; Plaxton WC, 1996, ANNU REV PLANT PHYS, V47, P185, DOI 10.1146/annurev.arplant.47.1.185; Poirier Y, 2006, BBA-MOL CELL RES, V1763, P1413, DOI 10.1016/j.bbamcr.2006.08.034; Ramon M, 2007, TRENDS PLANT SCI, V12, P185, DOI 10.1016/j.tplants.2007.03.007; Rapaka VK, 2005, PLANT SCI, V168, P1547, DOI 10.1016/j.plantsci.2005.02.006; Raymond MJ, 2002, ANN BOT-LONDON, V89, P813, DOI 10.1093/aob/mcf082; Rout GR, 2006, PLANT GROWTH REGUL, V48, P111, DOI 10.1007/s10725-005-5665-1; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Santos KM, 2009, HORTSCIENCE, V44, P1974, DOI 10.21273/HORTSCI.44.7.1974; Santoso D, 1998, PLANT PHYSIOL, V116, P815, DOI 10.1104/pp.116.2.815; Schluepmann H, 2004, PLANT PHYSIOL, V135, P879, DOI 10.1104/pp.104.039503; Schluepmann H, 2003, P NATL ACAD SCI USA, V100, P6849, DOI 10.1073/pnas.1132018100; Schwacke R, 1999, PLANT CELL, V11, P377, DOI 10.1105/tpc.11.3.377; Schwambach J, 2005, TREE PHYSIOL, V25, P487, DOI 10.1093/treephys/25.4.487; Sorin C, 2006, PLANT PHYSIOL, V140, P349, DOI 10.1104/pp.105.067868; Sorin C, 2005, PLANT CELL, V17, P1343, DOI 10.1105/tpc.105.031625; Stitt M, 1999, CURR OPIN PLANT BIOL, V2, P178, DOI 10.1016/S1369-5266(99)80033-8; STURM A, 1990, PLANT CELL, V2, P1107, DOI 10.1105/tpc.2.11.1107; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; SUZUKI T, 1983, PHYSIOL PLANTARUM, V59, P455, DOI 10.1111/j.1399-3054.1983.tb04229.x; Ticconi CA, 2004, PLANT J, V37, P801, DOI 10.1111/j.1365-313X.2004.02005.x; Tiessen A, 2003, PLANT J, V35, P490, DOI 10.1046/j.1365-313X.2003.01823.x; Truernit E, 1996, PLANT CELL, V8, P2169, DOI 10.1105/tpc.8.12.2169; van Dijken AJH, 2004, PLANT PHYSIOL, V135, P969, DOI 10.1104/pp.104.039743; Verbruggen N, 1996, P NATL ACAD SCI USA, V93, P8787, DOI 10.1073/pnas.93.16.8787; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Wang CX, 2006, PLANT CELL, V18, P350, DOI 10.1105/tpc.105.037044; Zhang HM, 2000, J EXP BOT, V51, P51, DOI 10.1093/jexbot/51.342.51	87	31	33	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100997	10.1371/journal.pone.0100997	http://dx.doi.org/10.1371/journal.pone.0100997			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978694	Green Published, gold			2022-12-27	WOS:000338506400058
J	Burman, MA; Erickson, KJ; Deal, AL; Jacobson, RE				Burman, Michael A.; Erickson, Kristen J.; Deal, Alex L.; Jacobson, Rose E.			Contextual and Auditory Fear Conditioning Continue to Emerge during the Periweaning Period in Rats	PLOS ONE			English	Article							NEONATAL ALCOHOL EXPOSURE; COMORBIDITY SURVEY REPLICATION; HIPPOCAMPAL-FORMATION; POSTNATAL-DEVELOPMENT; ADULT RATS; DIFFERENTIAL CONTRIBUTION; BASOLATERAL AMYGDALA; VENTRAL HIPPOCAMPUS; POTENTIATED STARTLE; LIFETIME PREVALENCE	Anxiety disorders often emerge during childhood. Rodent models using classical fear conditioning have shown that different types of fear depend upon different neural structures and may emerge at different stages of development. For example, some work has suggested that contextual fear conditioning generally emerges later in development (postnatal day 23-24) than explicitly cued fear conditioning (postnatal day 15-17) in rats. This has been attributed to an inability of younger subjects to form a representation of the context due to an immature hippocampus. However, evidence that contextual fear can be observed in postnatal day 17 subjects and that cued fear conditioning continues to emerge past this age raises questions about the nature of this deficit. The current studies examine this question using both the context pre-exposure facilitation effect for immediate single-shock contextual fear conditioning and traditional cued fear conditioning using Sprague-Dawley rats. The data suggest that both cued and contextual fear conditioning are continuing to develop between PD 17 and 24, consistent with development occurring the in essential fear conditioning circuit.	[Burman, Michael A.; Erickson, Kristen J.; Deal, Alex L.] Univ New England, Ctr Excellence Neurosci, Dept Psychol, Biddeford, ME 04005 USA; [Jacobson, Rose E.] Univ New England, Dept Biol, Biddeford, ME USA	University of New England - Maine; University of New England - Maine	Burman, MA (corresponding author), Univ New England, Ctr Excellence Neurosci, Dept Psychol, Biddeford, ME 04005 USA.	mburman@une.edu			National Institute of Mental Health of the National Institutes of Health [R15MH093950]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R15MH093950] Funding Source: NIH RePORTER	National Institute of Mental Health of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research reported in this publication was supported in part by the National Institute of Mental Health of the National Institutes of Health under Award Number R15MH093950 to MAB. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers KG, 2011, DEV PSYCHOBIOL, V53, P1, DOI 10.1002/dev.20480; ALTMAN J, 1975, ANIM BEHAV, V23, P896, DOI 10.1016/0003-3472(75)90114-1; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Anand KJS, 1999, PHYSIOL BEHAV, V66, P627, DOI 10.1016/S0031-9384(98)00338-2; Barnet RC, 2005, LEARN BEHAV, V33, P437, DOI 10.3758/BF03193182; Beane ML, 2002, HORM BEHAV, V41, P33, DOI 10.1006/hbeh.2001.1725; BEKENSTEIN JW, 1991, DEV BRAIN RES, V63, P237, DOI 10.1016/0165-3806(91)90083-U; BEKENSTEIN JW, 1991, DEV BRAIN RES, V63, P245, DOI 10.1016/0165-3806(91)90084-V; Belda X, 2004, BEHAV BRAIN RES, V154, P399, DOI 10.1016/j.bbr.2004.03.011; Bevins RA, 1997, J EXP PSYCHOL ANIM B, V23, P312; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; BLANCHARD RJ, 1969, J COMP PHYSIOL PSYCH, V67, P370, DOI 10.1037/h0026779; Brasser SM, 2004, NEUROBIOL LEARN MEM, V81, P46, DOI 10.1016/S1074-7427(03)00068-6; Brasser SM, 1998, BEHAV NEUROSCI, V112, P126, DOI 10.1037/0735-7044.112.1.126; Burman MA, 2009, BEHAV NEUROSCI, V123, P1148, DOI 10.1037/a0016733; Burman MA, 2006, HIPPOCAMPUS, V16, P103, DOI 10.1002/hipo.20137; Burman MA, 2014, J NEUROSCI METH, V222, P111, DOI 10.1016/j.jneumeth.2013.11.005; CANDLAND DK, 1962, J COMP PHYSIOL PSYCH, V55, P593, DOI 10.1037/h0047206; Chareyron LJ, 2012, J COMP NEUROL, V520, P3745, DOI 10.1002/cne.23132; Claflin D. I., 2013, DEV PSYCHOBIOLOGY; CROWLEY DE, 1966, J COMP PHYSIOL PSYCH, V62, P427, DOI 10.1037/h0023953; DAVIS M, 1992, TRENDS PHARMACOL SCI, V13, P35, DOI 10.1016/0165-6147(92)90014-W; Davis M, 2006, AM PSYCHOL, V61, P741, DOI 10.1037/0003-066X.61.8.741; Ehrlich DE, 2012, J PHYSIOL-LONDON, V590, P4819, DOI 10.1113/jphysiol.2012.237453; Esclassan F, 2009, HIPPOCAMPUS, V19, P33, DOI 10.1002/hipo.20473; Esmoris-Arranz FJ, 2008, BEHAV PROCESS, V78, P340, DOI 10.1016/j.beproc.2008.01.010; FANSELOW MS, 1990, ANIM LEARN BEHAV, V18, P264, DOI 10.3758/BF03205285; Foster JA, 2010, LEARN MEMORY, V17, P259, DOI 10.1101/lm.1755810; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; FRIAUF E, 1992, EUR J NEUROSCI, V4, P798, DOI 10.1111/j.1460-9568.1992.tb00190.x; Hamilton GF, 2011, BRAIN RES, V1412, P88, DOI 10.1016/j.brainres.2011.07.027; Huff NC, 2005, LEARN MEMORY, V12, P456, DOI 10.1101/lm.6705; Huff NC, 2004, BEHAV NEUROSCI, V118, P53, DOI 10.1037/0735-7044.118.1.53; Jablonski SA, 2012, DEV PSYCHOBIOL, V54, P714, DOI 10.1002/dev.20621; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kholodar-Smith DB, 2008, BEHAV NEUROSCI, V122, P1178, DOI 10.1037/a0012902; Kim JH, 2008, J NEUROSCI, V28, P1282, DOI 10.1523/JNEUROSCI.4736-07.2008; Kim JH, 2007, BEHAV NEUROSCI, V121, P131, DOI 10.1037/0735-7044.121.1.131; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Lattal KM, 2001, J NEUROSCI, V21, P5773, DOI 10.1523/JNEUROSCI.21-15-05773.2001; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; Lehmann H, 2010, NEUROSCIENCE, V167, P974, DOI 10.1016/j.neuroscience.2010.03.005; Leonardo ED, 2008, NEUROPSYCHOPHARMACOL, V33, P134, DOI 10.1038/sj.npp.1301569; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; Maren S, 2004, BEHAV NEUROSCI, V118, P97, DOI 10.1037/0735-7044.118.1.97; Maren S, 2001, NEUROBIOL LEARN MEM, V76, P268, DOI 10.1006/nlme.2001.4042; Maren S, 2008, EUR J NEUROSCI, V28, P1661, DOI 10.1111/j.1460-9568.2008.06485.x; Matus-Amat P, 2004, J NEUROSCI, V24, P2431, DOI 10.1523/JNEUROSCI.1598-03.2004; McHugh SB, 2004, BEHAV NEUROSCI, V118, P63, DOI 10.1037/0735-7044.118.1.63; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Murawski NJ, 2012, NEUROSCIENCE, V206, P89, DOI 10.1016/j.neuroscience.2012.01.006; Murawski NJ, 2011, ALCOHOL CLIN EXP RES, V35, P1160, DOI 10.1111/j.1530-0277.2011.01449.x; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pine DS, 2007, J CHILD PSYCHOL PSYC, V48, P631, DOI 10.1111/j.1469-7610.2007.01751.x; Pisano MV, 2012, BEHAV BRAIN RES, V233, P176, DOI 10.1016/j.bbr.2012.04.030; Pugh CR, 1996, DEV PSYCHOBIOL, V29, P87, DOI 10.1002/(SICI)1098-2302(199603)29:2<87::AID-DEV1>3.0.CO;2-H; Raineki C, 2010, HIPPOCAMPUS, V20, P1037, DOI 10.1002/hipo.20702; Raineki C, 2010, BIOL PSYCHIAT, V67, P1137, DOI 10.1016/j.biopsych.2009.12.019; Revillo DA, 2014, DEV PSYCHOBIOL, V56, P713, DOI 10.1002/dev.21140; Revillo DA, 2013, BEHAV BRAIN RES, V253, P173, DOI 10.1016/j.bbr.2013.07.027; Rudy J. W., 1992, ADV INFANCY RES, P247; Rudy JW, 2009, LEARN MEMORY, V16, P573, DOI 10.1101/lm.1494409; Rudy JW, 2005, LEARN MEMORY, V12, P172, DOI 10.1101/lm.84005; RUDY JW, 1993, BEHAV NEUROSCI, V107, P887, DOI 10.1037/0735-7044.107.5.887; RUDY JW, 1994, BEHAV NEUROSCI, V108, P227, DOI 10.1037/0735-7044.108.2.227; Rudy JW, 2002, BEHAV NEUROSCI, V116, P530, DOI 10.1037//0735-7044.116.4.530; Schiffino FL, 2011, NEUROBIOL LEARN MEM, V95, P190, DOI 10.1016/j.nlm.2010.11.011; SELDEN NRW, 1991, NEUROSCIENCE, V42, P335, DOI 10.1016/0306-4522(91)90379-3; Shechner T, 2014, BIOL PSYCHOL; Stanton ME, 2000, BEHAV BRAIN RES, V110, P25, DOI 10.1016/S0166-4328(99)00182-5; Sutherland RJ, 2008, HIPPOCAMPUS, V18, P710, DOI 10.1002/hipo.20431; THOMAS DA, 1983, J COMP PSYCHOL, V97, P201, DOI 10.1037/0735-7036.97.3.201; Treffers PDA, 2001, ANXIETY DISORDERS CH, P1; WILSON DA, 1984, DEV BRAIN RES, V16, P61, DOI 10.1016/0165-3806(84)90063-4; Wiltgen BJ, 2006, J NEUROSCI, V26, P5484, DOI 10.1523/JNEUROSCI.2685-05.2006; Woodcock EA, 2000, NEUROBIOL LEARN MEM, V74, P89, DOI 10.1006/nlme.1999.3949; Yap CSL, 2007, DEV PSYCHOBIOL, V49, P565, DOI 10.1002/dev.20244; Yap CSL, 2005, DEV PSYCHOBIOL, V47, P55, DOI 10.1002/dev.20074; Zhang WN, 2001, BEHAV BRAIN RES, V126, P159, DOI 10.1016/S0166-4328(01)00256-X	79	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100807	10.1371/journal.pone.0100807	http://dx.doi.org/10.1371/journal.pone.0100807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977415	gold, Green Published, Green Submitted			2022-12-27	WOS:000338506400041
J	Decullier, E; Huot, L; Chapuis, FR				Decullier, Evelyne; Huot, Laure; Chapuis, Francois R.			Fate of Protocols Submitted to a French National Funding Scheme: A Cohort Study	PLOS ONE			English	Article							PUBLICATION BIAS; RETROSPECTIVE COHORT; BIOMEDICAL-RESEARCH; CLINICAL-RESEARCH; FOLLOW-UP; IMPACT	Background: The fate of clinical research projects funded by a grant has been investigated, but there is no information on the projects which did not receive funding. The fate of these projects is not known: do they apply for and/or receive funding from other sources or are they carried out without specific funding? Purpose: The aim of the study was to describe all clinical research projects submitted to a French national funding scheme (PHRC 2000) and to assess project initiation, completion and publication status taking into account whether or not they received funding. Methods: This study is a retrospective cohort. The initial project characteristics were retrieved from the submission files and follow-up information was collected from the primary investigator. The percentages of projects started, completed and published were studied. Results: A total of 481 projects were studied. Follow-up information was obtained for 366. Overall, 185 projects were initiated (51%); 139 of them were funded by the PHRC 2000 or other sources. The most commonly cited reason for not initiating a project was a lack of funding. Subsequently, 121 of the projects initiated were completed (65%). Accrual difficulties were the main reason cited to explain why studies were stopped prematurely or were still ongoing. Finally, 88 of the completed projects were published (73%). Amongst the completed projects, the only factor explaining publication was the statistical significance of the results. Conclusions: Obtainment of funding was a determining factor for project initiation. However, once initiated, the funding did not influence completion or publication.	[Decullier, Evelyne; Huot, Laure; Chapuis, Francois R.] Hosp Civils Lyon, Pole Informat Med Evaluat Rech, Unite Rech Clin, Lyon, France; [Decullier, Evelyne; Huot, Laure; Chapuis, Francois R.] Univ Lyon, RECIF, EAM Sante Individu Soc 4128, Lyon, France; [Decullier, Evelyne; Huot, Laure; Chapuis, Francois R.] Univ Lyon 1, F-69365 Lyon, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Decullier, E (corresponding author), Hosp Civils Lyon, Pole Informat Med Evaluat Rech, Unite Rech Clin, Lyon, France.	evelyne.decullier@chu-lyon.fr	decullier, evelyne/AAL-5861-2021; Huot, Laure/GLS-5988-2022	Huot, Laure/0000-0002-7870-9912	French ministry of Health (PHRC, SAFIRE)	French ministry of Health (PHRC, SAFIRE)	The study was supported by a grant from the French ministry of Health (PHRC 2008, SAFIRE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Decullier E, 2005, BMJ-BRIT MED J, V331, P19, DOI 10.1136/bmj.38488.385995.8F; Decullier E, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-165; Devos P, 2006, STUD HEALTH TECHNOL, V124, P543; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; Dickersin K., 1993, ONLINE J CURR CLIN T, pDoc No 50; Druss BG, 2005, AM J MED, V118, P658, DOI 10.1016/j.amjmed.2005.02.015; Duffet J-P, 2001, RAPPORT EVALUATION P; Duffet J-P, 2003, RAPPORT EVALUATION P; Duffet JP, 2004, RAPPORT EVALUATION P; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Magri M, 1996, SCIENTOMETRICS, V35, P93, DOI 10.1007/BF02018235; Neill US, 2005, J CLIN INVEST, V115, P1392, DOI 10.1172/JCI25545; Pich J, 2003, LANCET, V361, P1015, DOI 10.1016/S0140-6736(03)12799-7; Pico F, 1999, ANAL 6 ANS 168 PROJE; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640	15	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e99561	10.1371/journal.pone.0099561	http://dx.doi.org/10.1371/journal.pone.0099561			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977416	Green Published, gold, Green Submitted			2022-12-27	WOS:000338506400005
J	Dewar, ML; Arnould, JPY; Krause, L; Trathan, P; Dann, P; Smith, SC				Dewar, Meagan L.; Arnould, John P. Y.; Krause, Lutz; Trathan, Phil; Dann, Peter; Smith, Stuart C.			Influence of Fasting during Moult on the Faecal Microbiota of Penguins	PLOS ONE			English	Article							GUT MICROBIOTA; EUDYPTULA-MINOR; KING PENGUINS; OBESITY; ENERGY; METABOLISM; ENERGETICS; DIVERSITY; ECOLOGY; CELLS	Many seabirds including penguins are adapted to long periods of fasting, particularly during parts of the reproductive cycle and during moult. However, the influence of fasting on the gastrointestinal (GI) microbiota has not been investigated in seabirds. Therefore, the present study aimed to examine the microbial composition and diversity of the GI microbiota of fasting little (Eudyptula minor) and king penguins (Aptenodytes patagonicus) penguins during early and late moult. The results from this study indicated that there was little change in the abundance of the major phyla during moult, except for a significant increase in the level of Proteobacteria in king penguins. In king penguins the abundance of Fusobacteria increases from 1.73% during early moult to 33.6% by late moult, whilst the abundance of Proteobacteria (35.7% to 17.2%) and Bacteroidetes (19.5% to 11%) decrease from early to late moult. In little penguins, a decrease in the abundances of Firmicutes (44% to 29%) and an increase in the abundance of Bacteroidetes (11% to 20%) were observed from early to late moult respectively. The results from this study indicate that the microbial composition of both king and little penguins alters during fasting. However, it appears that the microbial composition of king penguins is more affected by fasting than little penguins with the length of fast the most probable cause for this difference.	[Dewar, Meagan L.; Smith, Stuart C.] Deakin Univ, Sch Exercise & Nutr Sci, Burwood, Australia; [Arnould, John P. Y.] Deakin Univ, Sch Life & Environm Sci, Burwood, Australia; [Krause, Lutz] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Trathan, Phil] British Antarctic Survey, Cambridge CB3 0ET, England; [Dann, Peter] Phillip Isl Nat Pk, Phillip Isl, Australia; [Smith, Stuart C.] Deakin Univ, Ctr Mol & Med Res, Burwood, Australia	Deakin University; Deakin University; QIMR Berghofer Medical Research Institute; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Deakin University	Smith, SC (corresponding author), Deakin Univ, Sch Exercise & Nutr Sci, Burwood, Australia.	stuart.smith@deakin.edu.au	Dewar, Meagan/AAI-3969-2021; Krause, Lutz/M-7305-2015; Krause, Lutz/G-6283-2013	Krause, Lutz/0000-0003-3806-0845; Krause, Lutz/0000-0003-3806-0845; Dewar, Meagan/0000-0003-0581-2422	Deakin University (Centre for Molecular and Medical Research, Life and Environmental Sciences); Holsworth Wildlife Research Endowment; Phillip Island Nature Parks; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	Deakin University (Centre for Molecular and Medical Research, Life and Environmental Sciences); Holsworth Wildlife Research Endowment; Phillip Island Nature Parks; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project was sponsored by Deakin University (Centre for Molecular and Medical Research, Life and Environmental Sciences), Holsworth Wildlife Research Endowment (http://www.anz.com.au/personal/private-bank-trustees/trustees/granting/granting-programs/small-grants/) and Phillip Island Nature Parks (http://www.penguins.org.au/conservation/research/). The sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bourgeon S, 2007, ECOSCIENCE, V14, P519, DOI 10.2980/1195-6860(2007)14[519:HAILIK]2.0.CO;2; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHEREL Y, 1994, AM J PHYSIOL, V266, pR1182, DOI 10.1152/ajpregu.1994.266.4.R1182; CHEREL Y, 1992, J COMP PHYSIOL B, V162, P305, DOI 10.1007/BF00260757; Claus SP, 2011, MBIO, V2, DOI 10.1128/mBio.00271-10; Costello EK, 2010, ISME J, V4, P1375, DOI 10.1038/ismej.2010.71; Crawford PA, 2009, P NATL ACAD SCI USA, V106, P11276, DOI 10.1073/pnas.0902366106; DANN P, 1992, EMU, V91, P263, DOI 10.1071/MU9910263; Dewar ML, 2013, MICROBIOLOGYOPEN, V2, P195, DOI 10.1002/mbo3.66; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fierer N, 2008, P NATL ACAD SCI; GALES R, 1988, AUST J ZOOL, V36, P159, DOI 10.1071/ZO9880159; Gauthier-Clerc M, 2002, MAR ECOL PROG SER, V237, P291, DOI 10.3354/meps237291; Glad T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-10; Goyache J, 2003, INT J SYST EVOL MICR, V53, P43, DOI 10.1099/ijs.0.02343-0; Green JA, 2004, J AVIAN BIOL, V35, P153, DOI 10.1111/j.0908-8857.2004.03138.x; Groscolas R, 2001, COMP BIOCHEM PHYS A, V128, P645, DOI 10.1016/S1095-6433(00)00341-X; Hosokawa T, 2006, PLOS BIOL, V4, P1841, DOI 10.1371/journal.pbio.0040337; Lavery TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036478; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Marri PR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011835; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Panda AK, 2009, ASIAN AUSTRAL J ANIM, V22, P1026, DOI 10.5713/ajas.2009.80298; Potrykus J, 2008, PROTEOMICS, V8, P2691, DOI 10.1002/pmic.200700437; Razin S, 1999, BIOSCIENCE REP, V19, P367, DOI 10.1023/A:1020204020545; Reilly P., 1994, PENGUINS WORLD; Sen Gupta S, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-7; Smith SC, 2013, FEMS MICROBIOL ECOL, V86, P246, DOI 10.1111/1574-6941.12157; Sonoyama K, 2009, APPL ENVIRON MICROB, V75, P6451, DOI 10.1128/AEM.00692-09; Stone-house Bernard, 1975, BIOL PENGUINS; Sun YZ, 2011, AQUACULT NUTR, V17, pE733, DOI 10.1111/j.1365-2095.2010.00837.x; Tremaroli V, 2010, GUT; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; WILLIAMS AJ, 1977, COMP BIOCHEM PHYS A, V56, P27, DOI 10.1016/0300-9629(77)90437-6; Zaneveld J, 2008, CURR OPIN CHEM BIOL, V12, P109, DOI 10.1016/j.cbpa.2008.01.015; Zoetendal Erwin G, 2004, Curr Issues Intest Microbiol, V5, P31	42	46	47	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e99996	10.1371/journal.pone.0099996	http://dx.doi.org/10.1371/journal.pone.0099996			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979619	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000338506400014
J	Lavinder, JJ; Hoi, KH; Reddy, ST; Wine, Y; Georgioul, G				Lavinder, Jason J.; Hoi, Kam Hon; Reddy, Sai T.; Wine, Yariv; Georgioul, George			Systematic Characterization and Comparative Analysis of the Rabbit Immunoglobulin Repertoire	PLOS ONE			English	Article							GENE CONVERSION-LIKE; ANTIBODY REPERTOIRE; B-CELL; MONOCLONAL-ANTIBODIES; SEQUENCE-ANALYSIS; VH-GENE; HEAVY; DIVERSIFICATION; GENERATION; GERMLINE	Rabbits have been used extensively as a model system for h elucidation of the mechanism of immunoglobulin diversification and for he production of antibodies. We employed Next Generation Sequencing to analyze Ig germline V and J gene usage, CDR3 length and amino acid composition, and gene conversion frequencies within the functional (transcribed) IgG repertoire of he New Zealand white rabbit (Oryctolagus cuniculus). Several previously unannotated rabbit heavy chain variable (VH) and light chain variable (VL) germline elements were deduced bioinformatically using multidimensional scaling and k-means clustering methods. We estimated the gene conversion frequency in the rabbit at 23% of IgG sequences with a mean gene conversion tract length of 59 +/- 6 bp. Sequencing and gene conversion analysis of the chicken, human, and mouse repertoires revealed that gene conversion occurs much more extensively in the chicken (frequency 70%, tract length 79 +/- 57 bp), was observed to a small, yet statistically significant extent in humans, but was virtually absent in mice	[Lavinder, Jason J.; Reddy, Sai T.; Wine, Yariv; Georgioul, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Lavinder, Jason J.; Wine, Yariv; Georgioul, George] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Hoi, Kam Hon; Reddy, Sai T.; Georgioul, George] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Georgioul, George] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Georgioul, G (corresponding author), Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.	gg@che.utexas.edu	; Reddy, Sai/B-4190-2012	Hoi, Kam Hon/0000-0003-4158-0446; Reddy, Sai/0000-0002-9177-0857	Defense Advanced Research Projects Agency (DARPA) [HR0011-10-0052]; Defense Threat Reduction Agency (DTRA) [HDTRA1-12-00007]; Cancer Prevention Research Institute of Texas (CPRIT)	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); Cancer Prevention Research Institute of Texas (CPRIT)	This work was funded by the Defense Advanced Research Projects Agency (DARPA, www.darpa.mil) grant HR0011-10-0052 and the Defense Threat Reduction Agency (DTRA, www.dtra.mil) grant HDTRA1-12-00007. JJL was supported by a postdoctoral fellowship from the Cancer Prevention Research Institute of Texas (CPRIT, www.cprit.state.tx.us). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPELLA E, 1974, IMMUNOCHEMISTRY, V11, P395, DOI 10.1016/0019-2791(74)90072-X; Arakawa H, 2004, DEV DYNAM, V229, P458, DOI 10.1002/dvdy.10495; Arakawa H, 2002, J IMMUNOL, V169, P818, DOI 10.4049/jimmunol.169.2.818; BECKER RS, 1990, CELL, V63, P987, DOI 10.1016/0092-8674(90)90502-6; BERNSTEIN KE, 1985, J IMMUNOL, V134, P3480; Boyd SD, 2010, J IMMUNOL, V184, P6986, DOI 10.4049/jimmunol.1000445; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Castro R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003098; D'Avirro N, 2005, J IMMUNOL, V175, P8133, DOI 10.4049/jimmunol.175.12.8133; Darlow JM, 2006, IMMUNOGENETICS, V58, P511, DOI 10.1007/s00251-006-0113-6; DeKosky BJ, 2013, NAT BIOTECHNOL, V31, P166, DOI 10.1038/nbt.2492; DRAY S, 1963, NATURE, V199, P52, DOI 10.1038/199052a0; DRAY S, 1962, NATURE, V195, P785, DOI 10.1038/195785a0; DUBISKI S, 1967, NATURE, V214, P696, DOI 10.1038/214696a0; Duvvuri B, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00158; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Esteves PJ, 2005, IMMUNOGENETICS, V57, P874, DOI 10.1007/s00251-005-0022-0; Finlay WJJ, 2011, METHODS MOL BIOL, V681, P383, DOI 10.1007/978-1-60761-913-0_21; FITTS MG, 1990, J IMMUNOL, V145, P2713; FRIEDMAN ML, 1994, J IMMUNOL, V152, P632; Gertz EM, 2013, IMMUNOGENETICS, V65, P749, DOI 10.1007/s00251-013-0722-9; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Harris RS, 2002, CURR BIOL, V12, P435, DOI 10.1016/S0960-9822(02)00717-0; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P15; Huston JS, 2012, PROTEIN ENG DES SEL, V25, P483, DOI 10.1093/protein/gzs069; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; KIM BS, 1973, J IMMUNOL, V111, P750; KNIGHT KL, 1992, ANNU REV IMMUNOL, V10, P593, DOI 10.1146/annurev.iy.10.040192.003113; KNIGHT KL, 1990, CELL, V60, P963, DOI 10.1016/0092-8674(90)90344-E; Lanning D, 2000, J IMMUNOL, V165, P2012, DOI 10.4049/jimmunol.165.4.2012; Lanning DK, 2005, TRENDS IMMUNOL, V26, P419, DOI 10.1016/j.it.2005.06.001; Larsen PA, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-52; Lavinder JJ, 2014, P NATL ACAD SCI USA, V111, P2259, DOI 10.1073/pnas.1317793111; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Mage RG, 2006, DEV COMP IMMUNOL, V30, P137, DOI 10.1016/j.dci.2005.06.017; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Pele J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-133; Pele J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019094; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; RAMAN C, 1994, J IMMUNOL, V152, P3935; Reddy ST, 2010, NAT BIOTECHNOL, V28, P965, DOI 10.1038/nbt.1673; REYNAUD CA, 1989, CELL, V59, P171, DOI 10.1016/0092-8674(89)90879-9; Rhee KJ, 2005, J EXP MED, V201, P55, DOI 10.1084/jem.20041849; Ros F, 2004, GENE, V330, P49, DOI 10.1016/j.gene.2003.12.037; ROUX KH, 1991, J IMMUNOL, V146, P2027; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Schroeder HW, 1998, VACCINE, V16, P1383, DOI 10.1016/S0264-410X(98)00096-6; Sehgal D, 1999, IMMUNOGENETICS, V50, P31, DOI 10.1007/s002510050683; TORGERSON WS, 1952, PSYCHOMETRIKA, V17, P401; Wang F, 2013, CELL, V153, P1379, DOI 10.1016/j.cell.2013.04.049; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020; WEINSTEIN PD, 1994, IMMUNITY, V1, P647, DOI 10.1016/1074-7613(94)90036-1; Wine Y, 2013, P NATL ACAD SCI USA, V110, P2993, DOI 10.1073/pnas.1213737110; Wu LY, 2012, J IMMUNOL, V188, P322, DOI 10.4049/jimmunol.1102466; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Zhu XC, 1999, J IMMUNOL, V163, P3313	56	43	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101322	10.1371/journal.pone.0101322	http://dx.doi.org/10.1371/journal.pone.0101322			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978027	gold, Green Published, Green Submitted			2022-12-27	WOS:000338506400115
J	Monson, MS; Settlage, RE; McMahon, KW; Mendoza, KM; Rawal, S; El-Nezami, HS; Coulombe, RA; Reed, KM				Monson, Melissa S.; Settlage, Robert E.; McMahon, Kevin W.; Mendoza, Kristelle M.; Rawal, Sumit; El-Nezami, Hani S.; Coulombe, Roger A.; Reed, Kent M.			Response of the Hepatic Transcriptome to Aflatoxin B-1 in Domestic Turkey (Meleagris gallopavo)	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; LIVER; LACTOBACILLUS; PROPIONIBACTERIUM; PERFORMANCE; METABOLISM; STRAINS; BINDING; MDM2	Dietary exposure to aflatoxin B-1 (AFB(1)) is detrimental to avian health and leads to major economic losses for the poultry industry. AFB(1) is especially hepatotoxic in domestic turkeys (Meleagris gallopavo), since these birds are unable to detoxify AFB(1) by glutathione-conjugation. The impacts of AFB(1) on the turkey hepatic transcriptome and the potential protection from pretreatment with a Lactobacillus-based probiotic mixture were investigated through RNA-sequencing. Animals were divided into four treatment groups and RNA was subsequently recovered from liver samples. Four pooled RNA-seq libraries were sequenced to produce over 322 M reads totaling 13.8 Gb of sequence. Approximately 170,000 predicted transcripts were de novo assembled, of which 803 had significant differential expression in at least one pair-wise comparison between treatment groups. Functional analysis linked many of the transcripts significantly affected by AFB(1) exposure to cancer, apoptosis, the cell cycle or lipid regulation. Most notable were transcripts from the genes encoding E3 ubiquitin-protein ligase Mdm2, osteopontin, S-adenosylmethionine synthase isoform type-2, and lipoprotein lipase. Expression was modulated by the probiotics, but treatment did not completely mitigate the effects of AFB(1). Genes identified through transcriptome analysis provide candidates for further study of AFB(1) toxicity and targets for efforts to improve the health of domestic turkeys exposed to AFB(1).	[Monson, Melissa S.; Mendoza, Kristelle M.; Reed, Kent M.] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Settlage, Robert E.; McMahon, Kevin W.] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Data Anal Core, Blacksburg, VA 24061 USA; [Rawal, Sumit; Coulombe, Roger A.] Utah State Univ, Dept Anim Dairy & Vet Sci, Coll Agr, Logan, UT 84322 USA; [El-Nezami, Hani S.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China	University of Minnesota System; University of Minnesota Twin Cities; Virginia Polytechnic Institute & State University; Utah System of Higher Education; Utah State University; University of Hong Kong	Reed, KM (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	reedx054@umn.edu	Coulombe, Roger A/G-7523-2012	Monson, Melissa/0000-0002-4183-2888; El-Nezami, Hani/0000-0001-6700-4346	USDA-AFRI from the USDA NIFA Animal Genome Program [2007-35205-17880, 2009-35205-05302, 2013-01043]	USDA-AFRI from the USDA NIFA Animal Genome Program	This study was funded by USDA-AFRI Grants #2007-35205-17880, 2009-35205-05302 and 2013-01043 from the USDA NIFA Animal Genome Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2011, BIOCHEM BIOPH RES CO, V414, P664, DOI 10.1016/j.bbrc.2011.09.120; Anders S., 2010, HTSEQ ANAL HIGH THRO; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andrews S., 2010, FASTQC QUALITY CONTR; Blount W.P, 1961, TURKEYS, V9, P52; Blount W. P., 1961, J BRIT TURKEY FEDERA, V9; Blount WP, 1961, TURKEYS, V52, P55; Blout WP, 1961, TURKEYS, V9, P77; CAST, 1989, MYC EC HLTH RISKS; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CORRIER DE, 1991, VET IMMUNOL IMMUNOP, V30, P73, DOI 10.1016/0165-2427(91)90010-A; COULOMBE RA, 1993, J DAIRY SCI, V76, P880, DOI 10.3168/jds.S0022-0302(93)77414-7; Davail S, 2000, COMP BIOCHEM PHYS A, V126, P91, DOI 10.1016/S1095-6433(00)00190-2; EATON DL, 1994, ANNU REV PHARMACOL, V34, P135, DOI 10.1146/annurev.pa.34.040194.001031; El-Nezami H, 1998, FOOD CHEM TOXICOL, V36, P321, DOI 10.1016/S0278-6915(97)00160-9; El-Nezami H, 2000, J FOOD PROTECT, V63, P549, DOI 10.4315/0362-028X-63.4.549; Endo K, 2000, LIVER, V20, P209, DOI 10.1034/j.1600-0676.2000.020003209.x; Farkas D, 2005, CHEM RES TOXICOL, V18, P1132, DOI 10.1021/tx0500225; GIAMBRONE JJ, 1985, POULTRY SCI, V64, P1678, DOI 10.3382/ps.0641678; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gratz S, 2006, APPL ENVIRON MICROB, V72, P7398, DOI 10.1128/AEM.01348-06; Gratz S, 2005, J FOOD PROTECT, V68, P2470, DOI 10.4315/0362-028X-68.11.2470; Han CC, 2008, ASIAN AUSTRAL J ANIM, V21, P590, DOI 10.5713/ajas.2008.70472; Ho AS, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-58; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Inoue J, 2011, MOL ENDOCRINOL, V25, P995, DOI 10.1210/me.2011-0070; Kim CW, 2010, P NATL ACAD SCI USA, V107, P9626, DOI 10.1073/pnas.1001292107; Kim JE, 2011, TOXICOL SCI, V124, P45, DOI 10.1093/toxsci/kfr212; Klein PJ, 2002, TOXICOL APPL PHARM, V182, P11, DOI 10.1006/taap.2002.9433; Klein PJ, 2002, COMP BIOCHEM PHYS C, V132, P193, DOI 10.1016/S1532-0456(02)00065-0; Klein PJ, 2000, TOXICOL APPL PHARM, V165, P45, DOI 10.1006/taap.2000.8926; Lau WY, 2000, ONCOL RES, V12, P59; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lozano MC, 2006, BRIT POULTRY SCI, V47, P734, DOI 10.1080/00071660601084390; Lu SC, 2008, J GASTROEN HEPATOL, V23, pS73, DOI 10.1111/j.1440-1746.2007.05289.x; Luo J, 2010, BENEF MICROBES, V1, P53, DOI 10.3920/BM2009.0017; Mountzouris KC, 2007, POULTRY SCI, V86, P309, DOI 10.1093/ps/86.2.309; Murcia HW, 2011, J XENOBIOTICS, V1, P17, DOI 10.4081/xeno.2011.e4; Nagoshi S, 2014, HEPATOL RES, V44, P22, DOI 10.1111/hepr.12166; NEWBERNE PM, 1969, CANCER RES, V29, P236; Oatley JT, 2000, J FOOD PROTECT, V63, P1133, DOI 10.4315/0362-028X-63.8.1133; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Pandey I, 2007, BRIT POULTRY SCI, V48, P713, DOI 10.1080/00071660701713534; Pardina E, 2009, OBES SURG, V19, P608, DOI 10.1007/s11695-009-9827-5; Qureshi MA, 1998, POULTRY SCI, V77, P812, DOI 10.1093/ps/77.6.812; Ramaiah SK, 2008, TOXICOL SCI, V103, P4, DOI 10.1093/toxsci/kfm246; Rawal S, 2014, RES VET SCI IN PRESS; Rawal S, 2011, TOXICOL APPL PHARM, V254, P349, DOI 10.1016/j.taap.2011.05.010; Rawal S, 2010, RES VET SCI, V89, P325, DOI 10.1016/j.rvsc.2010.04.011; Rustemeyer SM, 2011, J ANIM SCI, V89, P916, DOI 10.2527/jas.2010-3473; Salim HM, 2013, POULTRY SCI, V92, P2084, DOI 10.3382/ps.2012-02947; Schlott T, 1999, BRIT J CANCER, V80, P73, DOI 10.1038/sj.bjc.6690324; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; SIMS WM, 1970, POULTRY SCI, V49, P1082, DOI 10.3382/ps.0491082; Smorenburg SM, 1996, HEPATOLOGY, V23, P560; Van Vleet TR, 2006, TOXICOL SCI, V89, P399, DOI 10.1093/toxsci/kfj039; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Yarru LP, 2009, POULTRY SCI, V88, P360, DOI 10.3382/ps.2008-00258; Yoon YJ, 2008, CARCINOGENESIS, V29, P1192, DOI 10.1093/carcin/bgn090; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	61	29	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100930	10.1371/journal.pone.0100930	http://dx.doi.org/10.1371/journal.pone.0100930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979717	Green Published, gold, Green Submitted			2022-12-27	WOS:000338506400051
J	Real, LM; Ruiz, A; Gayan, J; Gonzalez-Perez, A; Saez, ME; Ramirez-Lorca, R; Moron, FJ; Velasco, J; Marginet-Flinch, R; Musulen, E; Carrasco, JM; Moreno-Rey, C; Vazquez, E; Chaves-Conde, M; Moreno-Nogueira, JA; Hidalgo-Pascual, M; Ferrero-Herrero, E; Castellvi-Bel, S; Castells, A; Fernandez-Rozadilla, C; Ruiz-Ponte, C; Carracedo, A; Gonzalez, B; Alonso, S; Perucho, M				Real, Luis M.; Ruiz, Agustin; Gayan, Javier; Gonzalez-Perez, Antonio; Saez, Maria E.; Ramirez-Lorca, Reposo; Moron, Francisco J.; Velasco, Juan; Marginet-Flinch, Ruth; Musulen, Eva; Carrasco, Jose M.; Moreno-Rey, Concha; Vazquez, Enrique; Chaves-Conde, Manuel; Moreno-Nogueira, Jose A.; Hidalgo-Pascual, Manuel; Ferrero-Herrero, Eduardo; Castellvi-Bel, Sergi; Castells, Antoni; Fernandez-Rozadilla, Ceres; Ruiz-Ponte, Clara; Carracedo, Angel; Gonzalez, Beatriz; Alonso, Sergio; Perucho, Manuel			A Colorectal Cancer Susceptibility New Variant at 4q26 in the Spanish Population Identified by Genome-Wide Association Analysis	PLOS ONE			English	Article							LONG NONCODING RNA; LOCI; SCAN; RISK; METAANALYSIS; EPISTASIS; 8Q24; LD	Background: Non-hereditary colorectal cancer (CRC) is a complex disorder resulting from the combination of genetic and non-genetic factors. Genome-wide association studies (GWAS) are useful for identifying such genetic susceptibility factors. However, the single loci so far associated with CRC only represent a fraction of the genetic risk for CRC development in the general population. Therefore, many other genetic risk variants alone and in combination must still remain to be discovered. The aim of this work was to search for genetic risk factors for CRC, by performing single-locus and two-locus GWAS in the Spanish population. Results: A total of 801 controls and 500 CRC cases were included in the discovery GWAS dataset. 77 single nucleotide polymorphisms (SNP)s from single-locus and 243 SNPs from two-locus association analyses were selected for replication in 423 additional CRC cases and 1382 controls. In the meta-analysis, one SNP, rs3987 at 4q26, reached GWAS significant p-value (p = 4.02x10(-8)), and one SNP pair, rs1100508 CG and rs8111948 AA, showed a trend for two-locus association (p = 4.35x10(-11)). Additionally, our GWAS confirmed the previously reported association with CRC of five SNPs located at 3q36.2 (rs10936599), 8q24 (rs10505477), 8q24.21(rs6983267), 11q13.4 (rs3824999) and 14q22.2 (rs4444235). Conclusions: Our GWAS for CRC patients from Spain confirmed some previously reported associations for CRC and yielded a novel candidate risk SNP, located at 4q26. Epistasis analyses also yielded several novel candidate susceptibility pairs that need to be validated in independent analyses.	[Real, Luis M.; Ruiz, Agustin; Gayan, Javier; Gonzalez-Perez, Antonio; Saez, Maria E.; Ramirez-Lorca, Reposo; Moron, Francisco J.; Velasco, Juan; Marginet-Flinch, Ruth; Carrasco, Jose M.; Moreno-Rey, Concha; Vazquez, Enrique] Neocodex, Dept Struct Genom, Seville, Spain; [Real, Luis M.] Hosp Nuestra Senora de Valme, Infect Dis & Microbiol Unit, Seville, Spain; [Real, Luis M.; Ramirez-Lorca, Reposo; Moron, Francisco J.] Inst Biomed Seville IBIS, Seville, Spain; [Ruiz, Agustin] Fundacio ACE, Inst Catala Neurociencies Aplicades, Barcelona, Spain; [Gayan, Javier] Bioinfosol, Seville, Spain; [Gonzalez-Perez, Antonio; Saez, Maria E.] Andalusian Ctr Bioinformat Studies CAEBI, Seville, Spain; [Velasco, Juan; Gonzalez, Beatriz; Alonso, Sergio; Perucho, Manuel] IMPPC, Barcelona, Spain; [Marginet-Flinch, Ruth; Musulen, Eva] HUGTP, Dept Pathol, Barcelona, Spain; [Moreno-Rey, Concha; Chaves-Conde, Manuel; Moreno-Nogueira, Jose A.] Hosp Virgen del Rocio, Dept Oncol, Seville, Spain; [Hidalgo-Pascual, Manuel; Ferrero-Herrero, Eduardo] Hosp 12 Octubre, Colorectal Surg Unit, E-28041 Madrid, Spain; [Castellvi-Bel, Sergi; Castells, Antoni] Univ Barcelona, CIBEREHD, Hosp Clin, Dept Gastroenterol,IDIBAPS, Barcelona, Spain; [Fernandez-Rozadilla, Ceres; Ruiz-Ponte, Clara; Carracedo, Angel] Hosp Clin, Galician Publ Fdn Genom Med, Ctr Invest Biomed Red Enfermedades Rares, Genom Med Grp, Santiago De Compostela, A Coruna, Spain; [Perucho, Manuel] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Perucho, Manuel] ICREA, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Complexo Hospitalario Universitario de Santiago de Compostela; Sanford Burnham Prebys Medical Discovery Institute; ICREA	Perucho, M (corresponding author), IMPPC, Barcelona, Spain.	mperucho@imppc.org	Ruiz, Agustín/L-4469-2019; Saez, Maria E/C-8093-2012; Ruiz, Agustin/G-5677-2012; Gonzalez, Beatriz/G-5158-2011; González-Pérez, Antonio/AAY-4179-2021; Ruiz-Ponte, Clara/I-3849-2015; Real, Luis M/K-9646-2014; Alonso, Sergio/GVR-8346-2022; Carracedo, Angel/D-4257-2012; Castells, Antoni/ABC-1002-2021; Musulen, Eva/AAI-9169-2020; Reposo, Ramirez-Lorca/D-7907-2014; IBIS, TERAPIA CELULA/P-3297-2015; Alonso, Sergio/G-5145-2011; Gonzalez-Perez, Antonio/A-5247-2010	Ruiz, Agustín/0000-0003-2633-2495; Gonzalez, Beatriz/0000-0002-3699-9392; González-Pérez, Antonio/0000-0001-9771-5982; Ruiz-Ponte, Clara/0000-0002-2200-0162; Real, Luis M/0000-0003-4932-7429; Carracedo, Angel/0000-0003-1085-8986; Castells, Antoni/0000-0001-8431-2033; Musulen, Eva/0000-0002-9667-6464; Alonso, Sergio/0000-0001-6497-892X; Gonzalez-Perez, Antonio/0000-0001-9771-5982; MORON CIVANTO, FRANCISCO J./0000-0002-1961-2723; Fernandez-Rozadilla, Ceres/0000-0001-7330-4804; Saez, Maria/0000-0001-9299-2534; Castellvi-Bel, Sergi/0000-0003-1217-5097; Perucho, Manuel/0000-0002-2169-2662; Ramirez Lorca, Reposo/0000-0002-1594-0404	CENIT program from the Centro Tecnologico Industrial [CEN-20091016]; Spanish Institute of Health Carlos III [ADE10/00026, PI09/02444, PI12/00511]; Fondo de Investigacion Sanitaria/FEDER [08/1276, 08/0024, PS09/02368, 11/00219, 11/00681]; COST office through COST action [BM1206]; Fondo de Investigacion Sanitaria [CP 03-0070]; ICREA Funding Source: Custom	CENIT program from the Centro Tecnologico Industrial; Spanish Institute of Health Carlos III(Instituto de Salud Carlos III); Fondo de Investigacion Sanitaria/FEDER(Instituto de Salud Carlos IIIEuropean Commission); COST office through COST action; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); ICREA(ICREA)	This work was partially supported by the CENIT program from the Centro Tecnologico Industrial (CEN-20091016), grants from the Spanish Institute of Health Carlos III (ADE10/00026, PI09/02444, PI12/00511, Accion Transversal de Cancer) grants from the Fondo de Investigacion Sanitaria/FEDER (08/1276, 08/0024, PS09/02368, 11/00219, 11/00681), and by COST office through COST action BM1206. SCB is supported by contracts from the Fondo de Investigacion Sanitaria (CP 03-0070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; [Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373; Arai Y, 2010, GENE CHROMOSOME CANC, V49, P596, DOI 10.1002/gcc.20770; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barsh GS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002812; Camps J, 2006, CARCINOGENESIS, V27, P419, DOI 10.1093/carcin/bgi244; Dunlop MG, 2013, GUT, V62, P871, DOI 10.1136/gutjnl-2011-300537; Dunlop MG, 2012, NAT GENET, V44, P770, DOI 10.1038/ng.2293; Fernandez-Rozadilla C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-55; Gayan J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-326; Gayan J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-360; Hauptman N, 2013, INT J MOL SCI, V14, P4655, DOI 10.3390/ijms14034655; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeter JM, 2006, ONCOLOGY-NY, V20, P269; Jia WH, 2013, NAT GENET, V45, P191, DOI 10.1038/ng.2505; Jiao S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052535; Li LJ, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-104; Martinez-Mir A, 2013, J ALZHEIMERS DIS, V35, P403, DOI 10.3233/JAD-122257; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Pibouin L, 2002, CANCER GENET CYTOGEN, V133, P55, DOI 10.1016/S0165-4608(01)00634-3; Price AL, 2008, AM J HUM GENET, V83, P132, DOI 10.1016/j.ajhg.2008.06.005; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Shriner D, 2007, SCIENCE, V316, P1840; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; Tzeng ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067040; Wang K, 2008, GENET EPIDEMIOL, V32, P606, DOI 10.1002/gepi.20336; Wrage M, 2009, CLIN CANCER RES, V15, P1566, DOI 10.1158/1078-0432.CCR-08-2188; Yang QH, 1999, EPIDEMIOLOGY, V10, P167, DOI 10.1097/00001648-199903000-00014; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zhang Y, 2007, NAT GENET, V39, P1167, DOI 10.1038/ng2110	43	21	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101178	10.1371/journal.pone.0101178	http://dx.doi.org/10.1371/journal.pone.0101178			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978480	Green Submitted, Green Published, gold			2022-12-27	WOS:000338506400093
J	Chirombo, J; Lowe, R; Kazembe, L				Chirombo, James; Lowe, Rachel; Kazembe, Lawrence			Using Structured Additive Regression Models to Estimate Risk Factors of Malaria: Analysis of 2010 Malawi Malaria Indicator Survey Data	PLOS ONE			English	Article							BURDEN; CLIMATE; WOMEN	Background: After years of implementing Roll Back Malaria (RBM) interventions, the changing landscape of malaria in terms of risk factors and spatial pattern has not been fully investigated. This paper uses the 2010 malaria indicator survey data to investigate if known malaria risk factors remain relevant after many years of interventions. Methods: We adopted a structured additive logistic regression model that allowed for spatial correlation, to more realistically estimate malaria risk factors. Our model included child and household level covariates, as well as climatic and environmental factors. Continuous variables were modelled by assuming second order random walk priors, while spatial correlation was specified as a Markov random field prior, with fixed effects assigned diffuse priors. Inference was fully Bayesian resulting in an under five malaria risk map for Malawi. Results: Malaria risk increased with increasing age of the child. With respect to socio-economic factors, the greater the household wealth, the lower the malaria prevalence. A general decline in malaria risk was observed as altitude increased. Minimum temperatures and average total rainfall in the three months preceding the survey did not show a strong association with disease risk. Conclusions: The structured additive regression model offered a flexible extension to standard regression models by enabling simultaneous modelling of possible nonlinear effects of continuous covariates, spatial correlation and heterogeneity, while estimating usual fixed effects of categorical and continuous observed variables. Our results confirmed that malaria epidemiology is a complex interaction of biotic and abiotic factors, both at the individual, household and community level and that risk factors are still relevant many years after extensive implementation of RBM activities.	[Chirombo, James] Univ Malawi, Chancellor Coll, Zomba, Malawi; [Chirombo, James] UNC Project, Lilongwe, Malawi; [Lowe, Rachel] Inst Catala Ciencies Clima IC3, Barcelona, Spain; [Lowe, Rachel] Abdus Salam Int Ctr Theoret Phys, Trieste, Italy; [Kazembe, Lawrence] Univ Namibia, Dept Stat & Populat Studies, Windhoek, Namibia	University of Malawi; Institut Catala de Ciencies del Clima (IC3); University of Barcelona; Abdus Salam International Centre for Theoretical Physics (ICTP); University of Namibia	Chirombo, J (corresponding author), Univ Malawi, Chancellor Coll, Zomba, Malawi.	jjchirombo@gmail.com	Lowe, Rachel/H-1658-2015; Lowe, Rachel/GXN-3278-2022	Lowe, Rachel/0000-0003-3939-7343; Chirombo, James/0000-0003-3132-3710	Health Research Capacity Strengthening Initiative (HRCSI)	Health Research Capacity Strengthening Initiative (HRCSI)	The study was supported by a grant from the Health Research Capacity Strengthening Initiative (HRCSI) for JC MSc studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, MALAWI MALARIA INDIC; Auta A, 2012, N AM J MED SCI, V4, P40, DOI 10.4103/1947-2714.92903; Belitz C, 2009, BAYESX SOFTW BAYES I; Bennett A, 2013, AM J TROP MED HYG, V89, P840, DOI 10.4269/ajtmh.13-0028; Djinjalamala F, 2006, EPIDEMIOLOGY MALAWI; Fahrmeir L, 2009, J STAT PLAN INFER, V139, P843, DOI 10.1016/j.jspi.2008.05.036; Gage KL, 2008, AM J PREV MED, V35, P436, DOI 10.1016/j.amepre.2008.08.030; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; Gosoniu L, 2006, GEOSPATIAL HEALTH, V1, P127, DOI 10.4081/gh.2006.287; Gosoniu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009322; Haque U, 2014, LANCET GLOB HEALTH, V2, pE98, DOI 10.1016/S2214-109X(13)70176-1; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Howard N, 2003, TROP MED INT HEALTH, V8, P1043, DOI 10.1046/j.1365-3156.2003.01163.x; Kammann EE, 2003, J R STAT SOC C-APPL, V52, P1, DOI 10.1111/1467-9876.00385; Kamuliwo M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-437; Kandala NB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-261; Kazembe Lawrence N, 2006, Int J Health Geogr, V5, P41, DOI 10.1186/1476-072X-5-41; Kazembe LN, 2007, ACTA TROP, V102, P126, DOI 10.1016/j.actatropica.2007.04.012; Kazembe LN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011180; Kazembe Lawrence N, 2007, Int J Equity Health, V6, P5, DOI 10.1186/1475-9276-6-5; Kneib T, 2011, BAYESX R UT ACC SOFT; Lang S, 2004, J COMPUT GRAPH STAT, V13, P183, DOI 10.1198/1061860043010; Lin XH, 1999, J ROY STAT SOC B, V61, P381, DOI 10.1111/1467-9868.00183; Lowe R, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-416; Mathanga DP., 2007, INT J EQUITY HLTH, V6, P22, DOI [10.1186/1475-9276-6-22, DOI 10.1186/1475-9276-6-22]; McCullagh P, 1989, GEN LINEAR MODELS; MEASURE DHS, 2013, MAL IND SURV; National Malaria Control Programme (NMCP), 2011, MAL STRAT PLAN 2011; National Malaria Control Programme (NMCP) [Malawi] and ICE International, 2010, MAL MAL IND SURV MIS; Nkurunziza H, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-234; Nkurunziza H, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-114; Osei FB, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-118; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Riedel N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-37; Riley EM, 2001, PARASITE IMMUNOL, V23, P51, DOI 10.1046/j.1365-3024.2001.00364.x; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Simon C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-458; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Wand H, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-28; Westbrook CJ, 2010, VECTOR-BORNE ZOONOT, V10, P241, DOI 10.1089/vbz.2009.0035	40	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101116	10.1371/journal.pone.0101116	http://dx.doi.org/10.1371/journal.pone.0101116			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991915	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000341253400042
J	Dinis, M; Plainvert, C; Kovarik, P; Longo, M; Fouet, A; Poyart, C				Dinis, Marcia; Plainvert, Celine; Kovarik, Pavel; Longo, Magalie; Fouet, Agnes; Poyart, Claire			The Innate Immune Response Elicited by Group A Streptococcus Is Highly Variable among Clinical Isolates and Correlates with the emm Type	PLOS ONE			English	Article							PYOGENES; HOST; SUPERANTIGEN; SUSCEPTIBILITY; MACROPHAGES; CELLS; RECOGNITION; INFECTION; SURVIVAL; INSIGHT	Group A Streptococcus (GAS) infections remain a significant health care problem due to high morbidity and mortality associated with GAS diseases, along with their increasing worldwide prevalence. Macrophages play a key role in the control and clearance of GAS infections. Moreover, pro-inflammatory cytokines production and GAS persistence and invasion are related. In this study we investigated the correlation between the GAS clinical isolates genotypes, their known clinical history, and their ability to modulate innate immune response. We constituted a collection of 40 independent GAS isolates representative of the emm types currently prevalent in France and responsible for invasive (57.5%) and non-invasive (42.5%) clinical manifestations. We tested phagocytosis and survival in mouse bone marrow-derived macrophages and quantified the pro-inflammatory mediators (IL-6, TNF-alpha) and type I interferon (INF-beta) production. Invasive emm89 isolates were more phagocytosed than their non-invasive counterparts, and emm89 isolates more than the other isolates. Regarding the survival, differences were observed depending on the isolate emm type, but not between invasive and non-invasive isolates within the same emm type. The level of inflammatory mediators produced was also emm type-dependent and mostly invasiveness status independent. Isolates of the emm1 type were able to induce the highest levels of both pro-inflammatory cytokines, whereas emm89 isolates induced the earliest production of IFN-beta. Finally, even within emm types, there was a variability of the innate immune responses induced, but survival and inflammatory mediator production were not linked.	[Dinis, Marcia; Plainvert, Celine; Longo, Magalie; Fouet, Agnes; Poyart, Claire] INSERM, Inst Cochin, Unite FRM Barrieres & Pathogenes, U 1016, Paris, France; [Dinis, Marcia; Plainvert, Celine; Longo, Magalie; Fouet, Agnes; Poyart, Claire] CNRS, UMR 8104, Paris, France; [Dinis, Marcia; Plainvert, Celine; Longo, Magalie; Fouet, Agnes; Poyart, Claire] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Plainvert, Celine; Poyart, Claire] CNRS, Paris, France; [Plainvert, Celine; Poyart, Claire] Hop Univ Paris Ctr, AP HP, Paris, France; [Poyart, Claire] Inst Pasteur, Unite Biol Bacteries Pathogenes Gram Positif, Paris, France; [Poyart, Claire] CNRS 2172, Paris, France; [Kovarik, Pavel] Univ Vienna, Max F Perutz Labs, Vienna, Austria	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Poyart, C (corresponding author), INSERM, Inst Cochin, Unite FRM Barrieres & Pathogenes, U 1016, Paris, France.	claire.poyart@cch.aphp.fr	Kovarik, Pavel/D-1184-2014; POYART, Claire/P-4225-2017; Plainvert, Céline/P-4218-2017	Kovarik, Pavel/0000-0003-2956-0944; POYART, Claire/0000-0003-2158-6293; Fouet, Agnes/0000-0001-7715-9157; Dinis, Marcia/0000-0001-8734-4276	ERA Pathogenomic INSERM [ANR-08-MIEN-015]; CNRS; Universite Paris Descartes; Institut de Veille Sanitaire; Austrian Science Fund (FWF) [P 24540] Funding Source: researchfish	ERA Pathogenomic INSERM; CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris Descartes; Institut de Veille Sanitaire; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by ERA Pathogenomic (Grant No ANR-08-MIEN-015) INSERM, CNRS, Universite Paris Descartes, Institut de Veille Sanitaire. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beall B, 1996, J CLIN MICROBIOL, V34, P953, DOI 10.1128/JCM.34.4.953-958.1996; Bessen DE, 2011, J BACTERIOL, V193, P6651, DOI 10.1128/JB.05263-11; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Commons R, 2008, J MED MICROBIOL, V57, P1238, DOI 10.1099/jmm.0.2008/001156-0; Dinkla K, 2007, MICROBES INFECT, V9, P922, DOI 10.1016/j.micinf.2007.03.011; Fraser JD, 2008, IMMUNOL REV, V225, P226, DOI 10.1111/j.1600-065X.2008.00681.x; Goldmann O, 2004, INDIAN J MED RES, V119, P141; Goldmann O, 2004, INFECT IMMUN, V72, P2956, DOI 10.1128/IAI.72.5.2956-2963.2004; Goldmann O, 2010, J PATHOL, V220, P521, DOI 10.1002/path.2664; Goldmann O, 2009, CELL MICROBIOL, V11, P138, DOI 10.1111/j.1462-5822.2008.01245.x; Gratz N, 2008, J BIOL CHEM, V283, P19879, DOI 10.1074/jbc.M802848200; Gratz N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001345; Gustafsson MCU, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003323; Kotb M, 2002, NAT MED, V8, P1398, DOI 10.1038/nm800; Lintges M, 2007, INT J MED MICROBIOL, V297, P471, DOI 10.1016/j.ijmm.2007.03.015; Lintges M, 2010, J INFECT DIS, V202, P20, DOI 10.1086/653082; Loof TG, 2008, INFECT IMMUN, V76, P2785, DOI 10.1128/IAI.01680-07; Medina E, 2003, J INFECT DIS, V187, P597, DOI 10.1086/373998; Medina E, 2003, INFECT IMMUN, V71, P5376, DOI 10.1128/IAI.71.9.5376-5380.2003; Medina E, 2002, MICROB PATHOGENESIS, V33, P307, DOI 10.1006/mpat.2002.0532; Medina E, 2001, J INFECT DIS, V184, P846, DOI 10.1086/323292; Nelson DC, 2011, BIOL CHEM, V392, P1077, DOI [10.1515/BC-2011-208, 10.1515/BC.2011.208]; Norrby-Teglund A, 2000, EUR J IMMUNOL, V30, P3247, DOI 10.1002/1521-4141(200011)30:11<3247::AID-IMMU3247>3.0.CO;2-D; O'Seaghdha M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003394; Olsen RJ, 2009, CELL MICROBIOL, V11, P1, DOI 10.1111/j.1462-5822.2008.01225.x; Plainvert C, 2011, CLIN MICROBIOL INFEC, P702; Rantala S, 2012, EUR J CLIN MICROBIOL, V31, P859, DOI 10.1007/s10096-011-1385-9; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Smeesters PR, 2010, TRENDS MICROBIOL, V18, P275, DOI 10.1016/j.tim.2010.02.007; Sriskandan S, 2007, INT J BIOCHEM CELL B, V39, P12, DOI 10.1016/j.biocel.2006.08.009; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; Stollerman GH, 2008, CLIN INFECT DIS, V46, P1038, DOI 10.1086/529194; Thulin P, 2006, PLOS MED, V3, P371, DOI 10.1371/journal.pmed.0030053	34	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101464	10.1371/journal.pone.0101464	http://dx.doi.org/10.1371/journal.pone.0101464			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991887	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400074
J	Yu, LL; Tan, XL; Jiang, BJ; Sun, XG; Gu, SL; Han, TF; Hou, WS				Yu, Lili; Tan, Xiaoli; Jiang, Bingjun; Sun, Xuegang; Gu, Shoulai; Han, Tianfu; Hou, Wensheng			A Peroxisomal Long-Chain Acyl-CoA Synthetase from Glycine max Involved in Lipid Degradation	PLOS ONE			English	Article							COENZYME-A SYNTHETASE; DRAFT GENOME SEQUENCE; FATTY-ACID; 1 LACS1; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; STORAGE; OIL; MUTANT; REVEALS	Seed storage oil, in the form of triacylglycerol (TAG), is degraded to provide carbon and energy during germination and early seedling growth by the fatty acid beta-oxidation in the peroxisome. Although the pathways for lipid degradation have been uncovered, understanding of the exact involved enzymes in soybean is still limited. Long-chain acyl-CoA synthetase (ACSL) is a critical enzyme that activates free fatty acid released from TAG to form the fatty acyl-CoA. Recent studies have shown the importance of ACSL in lipid degradation and synthesis, but few studies were focused on soybean. In this work, we cloned a ACSL gene from soybean and designated it as GmACSL2. Sequence analysis revealed that GmACSL2 encodes a protein of 733 amino acid residues, which is highly homologous to the ones in other higher plants. Complementation test showed that GmACSL2 could restore the growth of an ACS-deficient yeast strain (YB525). Co-expression assay in Nicotiana benthamiana indicated that GmACSL2 is located at peroxisome. Expression pattern analysis showed that GmACSL2 is highly expressed in germinating seedling and strongly induced 1 day after imbibition, which indicate that GmACSL2 may take part in the seed germination. GmACSL2 overexpression in yeast and soybean hairy root severely reduces the contents of the lipids and fatty acids, compared with controls in both cells, and enhances the beta-oxidation efficiency in yeast. All these results suggest that GmACSL2 may take part in fatty acid and lipid degradation. In conclusion, peroxisomal GmACSL2 from Glycine max probably be involved in the lipid degradation during seed germination.	[Yu, Lili; Jiang, Bingjun; Sun, Xuegang; Han, Tianfu; Hou, Wensheng] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, MOA Key Lab Soybean Biol Beijing, Beijing 100193, Peoples R China; [Yu, Lili; Tan, Xiaoli; Gu, Shoulai] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China; [Yu, Lili] Xinxiang Med Coll, Immunol Res Ctr, Sch Basic Med Sci, Dept Immunol, Xinxiang, Henan Province, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Jiangsu University; Xinxiang Medical University	Hou, WS (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, MOA Key Lab Soybean Biol Beijing, Beijing 100193, Peoples R China.	houwensheng@caas.cn	Jiang, Bingjun/GWQ-4354-2022	Yu, Lili/0000-0001-5832-1024	Major Science and Technology Projects of China [2013ZX08010-004]; CAAS (Chinease academy of Agriculture Sciences) Innovation Project	Major Science and Technology Projects of China; CAAS (Chinease academy of Agriculture Sciences) Innovation Project	This work was supported by the Major Science and Technology Projects of China (2013ZX08010-004) and the CAAS (Chinease academy of Agriculture Sciences) Innovation Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai Y, 2008, PLANT CELL PHYSIOL, V49, P526, DOI 10.1093/pcp/pcn027; Baker A, 2006, TRENDS PLANT SCI, V11, P124, DOI 10.1016/j.tplants.2006.01.005; Byfield GE, 2006, CROP SCI, V46, P840, DOI 10.2135/cropsci2005.06-0172; Cao D, 2009, PLANT CELL TISS ORG, V96, P45, DOI 10.1007/s11240-008-9458-x; Chan AP, 2010, NAT BIOTECHNOL, V28, P951, DOI 10.1038/nbt.1674; Chen MX, 2012, PLANT CELL ENVIRON, V35, P2155, DOI 10.1111/j.1365-3040.2012.02546.x; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Chia TYP, 2005, J EXP BOT, V56, P1285, DOI 10.1093/jxb/eri129; Cho HJ, 2000, PLANTA, V210, P195, DOI 10.1007/PL00008126; Eastmond PJ, 2001, TRENDS PLANT SCI, V6, P72, DOI 10.1016/S1360-1385(00)01835-5; Fulda M, 2004, PLANT CELL, V16, P394, DOI 10.1105/tpc.019646; Fulda M, 2002, PLANT J, V32, P93, DOI 10.1046/j.1365-313X.2002.01405.x; Groot P H, 1976, Adv Lipid Res, V14, P75; Hayashi M, 2006, BBA-MOL CELL RES, V1763, P1382, DOI 10.1016/j.bbamcr.2006.08.014; Hettema EH, 1996, EMBO J, V15, P3813, DOI 10.1002/j.1460-2075.1996.tb00755.x; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; Jessen D, 2011, PLANT J, V68, P715, DOI 10.1111/j.1365-313X.2011.04722.x; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; JONES EW, 1977, GENETICS, V85, P23; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kelly AA, 2013, PLANT BIOTECHNOL J, V11, P355, DOI 10.1111/pbi.12021; Khurana P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-57; Lardizabal K, 2008, PLANT PHYSIOL, V148, P89, DOI 10.1104/pp.108.123042; Larson TR, 2002, PLANT J, V32, P519, DOI 10.1046/j.1365-313X.2002.01440.x; Lin Y, 2004, PLANT PHYSIOL, V135, P814, DOI 10.1104/pp.103.036772; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SY, 2009, PLANT J, V59, P553, DOI 10.1111/j.1365-313X.2009.03892.x; Mashek DG, 2004, J LIPID RES, V45, P1958, DOI 10.1194/jlr.E400002-JLR200; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Paz MM, 2004, EUPHYTICA, V136, P167, DOI 10.1023/B:EUPH.0000030670.36730.a4; Pongdontri P, 2001, PLANT MOL BIOL, V47, P717, DOI 10.1023/A:1013652014744; Pulsifer IP, 2012, PLANT PHYSIOL BIOCH, V51, P31, DOI 10.1016/j.plaphy.2011.10.003; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Schnurr J, 2004, PLANT CELL, V16, P629, DOI 10.1105/tpc.017608; Schnurr JA, 2002, PLANT PHYSIOL, V129, P1700, DOI 10.1104/pp.003251; Shockey JM, 2002, PLANT PHYSIOL, V129, P1710, DOI 10.1104/pp.003269; Su, 2004, J JINZHOU MED COLL, V25, P43, DOI DOI 10.3969/J.ISSN.1674-0424.2004.06.015; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THAKUR MS, 1989, ENZYME MICROB TECH, V11, P252, DOI 10.1016/0141-0229(89)90101-4; van Roermund CWT, 1998, EMBO J, V17, P677, DOI 10.1093/emboj/17.3.677; Vickers CE, 2007, BIOTECHNOL LETT, V29, P1793, DOI 10.1007/s10529-007-9467-6; Watkins PA, 1998, J BIOL CHEM, V273, P18210, DOI 10.1074/jbc.273.29.18210; Watkins PA, 2012, BBA-MOL BASIS DIS, V1822, P1411, DOI 10.1016/j.bbadis.2012.02.010; Wood CC, 2009, PLANT BIOTECHNOL J, V7, P914, DOI 10.1111/j.1467-7652.2009.00453.x; XiuLan W, 2008, PLANT J, V57, P473; Yu L, 2010, INT J BIOL, V2, pP111; Zhao LF, 2010, PLANT J, V64, P1048, DOI 10.1111/j.1365-313X.2010.04396.x; Zhu F, 2009, CHINESE J OIL CROP S, V3; Zolman BK, 2001, PLANT PHYSIOL, V127, P1266, DOI 10.1104/pp.010550	50	16	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100144	10.1371/journal.pone.0100144	http://dx.doi.org/10.1371/journal.pone.0100144			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992019	Green Submitted, gold, Green Published			2022-12-27	WOS:000341253400019
J	Campisano, CJ; Kirk, EC; Townsend, KEB; Deino, AL				Campisano, Christopher J.; Kirk, E. Christopher; Townsend, K. E. Beth; Deino, Alan L.			Geochronological and Taxonomic Revisions of the Middle Eocene Whistler Squat Quarry (Devil's Graveyard Formation, Texas) and Implications for the Early Uintan in Trans-Pecos Texas	PLOS ONE			English	Article							BASIN; PALEOMAGNETISM; MARSUPIALS; MAMMALIA; FAUNA	The Whistler Squat Quarry (TMM 41372) of the lower Devil's Graveyard Formation in Trans-Pecos Texas is a middle Eocene fossil locality attributed to Uintan biochronological zone Ui1b. Specimens from the Whistler Squat Quarry were collected immediately above a volcanic tuff with prior K/Ar ages ranging from similar to 47-50 Ma and below a tuff previously dated to similar to 44 Ma. New 40Ar/39Ar analyses of both of the original tuff samples provide statistically indistinguishable ages of 44.88 +/- 0.04 Ma for the lower tuff and 45.04 +/- 0.10 Ma for the upper tuff. These dates are compatible with magnetically reversed sediments at the site attributable to C20r (43.505-45.942 Ma) and a stratigraphic position above a basalt dated to 46.80 Ma. Our reanalysis of mammalian specimens from the Whistler Squat Quarry and a stratigraphically equivalent locality significantly revises their faunal lists, confirms the early Uintan designation for the sites, and highlights several biogeographic and biochronological differences when compared to stratotypes in the Bridger and Uinta Formations. Previous suggestions of regional endemism in the early Uintan are supported by the recognition of six endemic taxa (26% of mammalian taxa) from the Whistler Squat Quarry alone, including three new taxa. The revised faunal list for the Whistler Squat Quarry also extends the biostratigraphic ranges of nine non-endemic mammalian taxa to Ui1b.	[Campisano, Christopher J.] Arizona State Univ, Inst Human Origins, Tempe, AZ 85004 USA; [Campisano, Christopher J.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ USA; [Kirk, E. Christopher] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [Kirk, E. Christopher] Univ Texas Austin, Jackson Sch Geosci, Vertebrate Paleontol Lab, Austin, TX 78712 USA; [Townsend, K. E. Beth] Midwestern Univ, Arizona Coll Osteopath Med, Dept Anat, Glendale, AZ USA; [Deino, Alan L.] Berkeley Geochronol Ctr, Berkeley, CA USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Midwestern University; Berkeley Geochronolgy Center	Campisano, CJ (corresponding author), Arizona State Univ, Inst Human Origins, Tempe, AZ 85004 USA.	campisano@asu.edu		Campisano, Christopher/0000-0001-9530-6130; Kirk, Chris/0000-0001-9439-3041	Arizona State University; Midwestern University; University of Texas	Arizona State University; Midwestern University; University of Texas	Funding for this research was provided by Arizona State University to CJC, from Midwestern University to KET, and from the University of Texas to ECK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alston E. R., 1876, Proceedings of the Zoological Society, P61; Best MG, 1995, J GEOPHYS RES-SOL EA, V100, P24593, DOI 10.1029/95JB01690; Bowdich T, 1821, ANAL NATURAL CLASSIF; Cope E. D., 1875, Proceedings of the Academy Philadelphia, P444; Cope E. D., 1873, PALEONTOLOGICAL B, V16, P1; Cope E. D., 1881, AM NAT, V15, P1017; Cope ED, 1880, AM NAT, V14, P745, DOI DOI 10.1086/272667; DEINO A, 1990, J GEOPHYS RES-SOLID, V95, P8453, DOI 10.1029/JB095iB06p08453; Deino AL, 1998, EVOL ANTHROPOL, V6, P63, DOI 10.1002/(SICI)1520-6505(1998)6:2<63::AID-EVAN4>3.0.CO;2-X; Deino AL, 2010, J HUM EVOL, V58, P111, DOI 10.1016/j.jhevol.2009.11.001; Flynn JJ, 1982, AM MUS NOVIT, V2725, P1; Friscia AR, 2010, ANN CARNEGIE MUS, V79, P51, DOI 10.2992/007.079.0104; Gazin C. L., 1955, Smithsonian Miscellaneous Collections, V128, P1; Gazin C. L., 1958, Smithsonian Miscellaneous Collections, V136, P1; Gill T., 1872, SMITHSONIAN MISCELL, P1, DOI DOI 10.5962/BHL.TITLE.14607; Golz D.J., 1976, Science Bull nat Hist Mus Los Ang Cty, VNo. 26, P1; Gray J.E., 1821, LONDON MED REPOSITOR, V15, P296; Gregory W. K., 1910, B AM MUS NAT HIST, V27, P1, DOI DOI 10.1007/S13364-013-0165-6; Gunnell G.F., 2009, PAPERS GEOLOGY VERTE, V65, P279; Gunnell GF., 1989, U MICH PAP PALEONT, V27, P1; Gunnell Gregg F., 1998, P91; Gustafson E.P., 1986, TEXAS MEML MUSEUM B, V33, P1; Haeckel E, 1866, SYSTEMATISCHE EINLEI; Hatcher JB, 1895, AM NAT, V29, P1084; Henry CD, 1998, REPORT INVESTIGATION, V253, P1; Henry CD, 1989, REPORT INVESTIGATION, V183, P1; Henry CD, 1986, COMPILATION POTASSIU, P1; Kirk EC, 2011, J HUM EVOL, V61, P156, DOI 10.1016/j.jhevol.2011.02.014; KORTH W W, 1984, Bulletin of Carnegie Museum of Natural History, P1; Korth W.W., 1994, TERTIARY RECORD RODE; KORTH WW, 1994, J PALEONTOL, V68, P376, DOI 10.1017/S0022336000022952; KRISHTALKA L, 1979, Annals of Carnegie Museum, V48, P377; KRISHTALKA L, 1983, Annals of Carnegie Museum, V52, P229; Krishtalka L., 1976, B CARNEGIE MUSEUM NA, V1, P1; Kuiper KF, 2008, SCIENCE, V320, P500, DOI 10.1126/science.1154339; Leidy J, 1872, P ACAD NAT SCI PHILA, V24, P19; Leidy J., 1870, P ACAD NAT SCI PHILA, V22, P109; Leidy J., 1869, J ACAD NATURAL SCI P, V2, P1, DOI DOI 10.5962/BHL.TITLE.20910; Leidy J, 1871, P ACAD NAT SCI PHILA, V23, P113; Linnaeus C, 1758, SYSTEMA MATURAE REGN; Marsh O. C., 1894, American Journal of Science (3), Vxlviii, P259; Marsh O. C., 1873, American Journal of Science (3), Vv, P485; Marsh O. C., 1873, American Journal of Science (3), Vv, P407; Marsh O. C., 1877, American Journal of Science (3), Vxiv, P249; Marsh O. C., 1891, American Journal of Science (3), Vxli, P82; Marsh O. C., 1872, AM J SCI, V3, P202, DOI DOI 10.2475/AJS.S3-4.21.202; Marsh OC, 1877, AM J SCI, V14, P337, DOI DOI 10.2475/AJS.S3-14.83.337; Marsh OC, 1875, AM J SCI, V9, P239; Matthew W.D., 1909, MEM AM MUS NAT HIST, V9, P291; Matthew WD, 1906, P US NATL MUS, V30, P203, DOI DOI 10.5479/SI.00963801.30-1449.203; McDowell F. W., 1979, CENOZOIC GEOLOGY T P, V19, P10; McGREW PAUL O., 1959, BULL AMER MUS NAT HIST, V117, P117; McGrew PO, 1959, B AM MUS NAT HIST, V117, P148; McKENNA MALCOLM C., 1959, AMER MUS NOVITATES, V1952, P1; Miggins DP, 2009, THESIS U TEXAS EL PA; Mihlbachler MC, 2008, B AM MUS NAT HIST, P1; Miller G.S., 1918, J WASH ACAD SCI, V8, P431, DOI DOI 10.5962/BHL.PART.6490; Morlo Michael, 2003, Contributions from the Museum of Paleontology University of Michigan, V31, P43; Novacek M. J., 1985, AM MUS NOVIT, V2822, P1; Ogg JG, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P85, DOI 10.1016/B978-0-444-59425-9.00005-6; Osborn H. F., 1895, Bulletin of the American Museum, Vvii, P71; Osborn H.F., 1892, B AM MUS NAT HIST, V4, P81; Osborn H.F., 1929, US GEOL SURV MONOGRA, V55, P1, DOI DOI 10.5962/BHL.TITLE.36431; Osman Hill WC, 1953, PRIMATES COMP ANATOM; Owen R., 1848, Q J GEOL SOC LOND, V4, P103, DOI DOI 10.1144/GSL.JGS.1848.004.01-02.21; Prothero DR, 1996, TERRESTRIAL EOCENE O, P189, DOI DOI 10.1017/CBO9780511665431.010; Robinson Peter, 2004, P106; Rose Kenneth D., 2012, Museum of Paleontology Papers on Paleontology, P1; Rothecker J, 1996, J VERTEBR PALEONTOL, V16, P770, DOI 10.1080/02724634.1996.10011365; RUNKEL AC, 1990, J SEDIMENT PETROL, V60, P747; Runkel AC, 1990, GEOLOGY BIG BEND TRA, P117; Scott WB, 1883, CONTRIBUTIONS E M MU, V3, P3; Simons EL, 1972, PRIMATE EVOLUTION IN, P284; Sinclair WJ, 1914, B AM MUS NAT HIST, V33, P267; STEIGER RH, 1977, EARTH PLANET SC LETT, V36, P359, DOI 10.1016/0012-821X(77)90060-7; Stevens JB, 1984, TEXAS MEMORIAL MUSEU, V32, P1; Stock C, 1935, P NATL ACAD SCI USA, V21, P214, DOI 10.1073/pnas.21.4.214; Storer J. E., 1984, NATURAL HIST CONTRIB, V7, P1; Stucky Richard K., 1998, P358; Szalay FS., 1969, B AM MUS NAT HIST, V140, P193; Townsend KEB, 2010, PALAEOGEOGR PALAEOCL, V297, P144, DOI 10.1016/j.palaeo.2010.07.024; Townsend KEB, 2009, 9 N AM PAL CONV, V3, P62; Townsend KEB, 2006, MOUNTAIN GEOL, V43, P115; Trouessart E.L., 1879, INSECTIVORES REV MAG, V7, P219; Troxell EL, 1923, AM J SCI, V5, P507, DOI 10.2475/ajs.s5-5.30.507; Troxell EL, 1923, AM J SCI, V5, P155, DOI 10.2475/ajs.s5-5.26.155; Tsukui K, 2013, J VERTEBR PALEONTOL, V2013, P228; Wall William P., 1998, P583; Walsh Stephen L., 1996, P75, DOI 10.1017/CBO9780511665431.006; Walton A.H., 1992, EOCENE OLIGOCENE CLI, P74, DOI DOI 10.1515/; Walton AH, 1986, THESIS U TEXAS AUSTI; Walton Anne H., 1993, Journal of Vertebrate Paleontology, V13, P243; West RM, 1982, PEARCE SELLARDS SERI, V35, P1; Williams BA, 2008, J HUM EVOL, V55, P927, DOI 10.1016/j.jhevol.2008.07.007; WILSON J A, 1977, Pearce-Sellards Series Texas Memorial Museum, P1; Wilson J.A., 1986, Journal of Vertebrate Paleontology, V6, P350; Wilson JA, 1981, PEARCE SELLARDS SERI, V33, P1; Wilson JA, 1991, TEXAS MEMORIAL MUSEU, V48, P1; Wilson JA, 1974, TEXAS MEMORIAL MUSEU, V23, P1; Wilson RW, 1937, AM J SCI, V34, P447; Wood A.E., 1973, Pearce-Sellards Series Texas Memorial Museum, VNo. 20, P1; Wood A. E., 1959, B AM MUS NAT HIST, V117, P157; WOOD ALBERT E., 1962, TRANS AMER PHIL SOC, V52, P1; Wortman J. L., 1898, Bulletin of the American Museum, Vx, P93; WYSS AR, 1993, MAMMAL PHYLOGENY : PLACENTALS, P32	105	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101516	10.1371/journal.pone.0101516	http://dx.doi.org/10.1371/journal.pone.0101516			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988115	Green Published, Green Submitted, gold			2022-12-27	WOS:000341354100102
J	Fusco, D; Barnum, TJ; Bruno, AE; Luft, JR; Snell, EH; Mukherjee, S; Charbonneau, P				Fusco, Diana; Barnum, Timothy J.; Bruno, Andrew E.; Luft, Joseph R.; Snell, Edward H.; Mukherjee, Sayan; Charbonneau, Patrick			Statistical Analysis of Crystallization Database Links Protein Physico-Chemical Features with Crystallization Mechanisms	PLOS ONE			English	Article							STRUCTURAL GENOMICS; CRYSTAL CONTACTS; PHASE-BEHAVIOR; SEQUENCE; ENTROPY; PREDICTION; INTERFACES; LESSONS; PURIFICATION; PROPENSITY	X-ray crystallography is the predominant method for obtaining atomic-scale information about biological macromolecules. Despite the success of the technique, obtaining well diffracting crystals still critically limits going from protein to structure. In practice, the crystallization process proceeds through knowledge-informed empiricism. Better physico-chemical understanding remains elusive because of the large number of variables involved, hence little guidance is available to systematically identify solution conditions that promote crystallization. To help determine relationships between macromolecular properties and their crystallization propensity, we have trained statistical models on samples for 182 proteins supplied by the Northeast Structural Genomics consortium. Gaussian processes, which capture trends beyond the reach of linear statistical models, distinguish between two main physico-chemical mechanisms driving crystallization. One is characterized by low levels of side chain entropy and has been extensively reported in the literature. The other identifies specific electrostatic interactions not previously described in the crystallization context. Because evidence for two distinct mechanisms can be gleaned both from crystal contacts and from solution conditions leading to successful crystallization, the model offers future avenues for optimizing crystallization screens based on partial structural information. The availability of crystallization data coupled with structural outcomes analyzed through state-of-the-art statistical models may thus guide macromolecular crystallization toward a more rational basis.	[Fusco, Diana] Duke Univ, Program Computat Biol & Bioinformat, Durham, NC USA; [Fusco, Diana; Barnum, Timothy J.; Charbonneau, Patrick] Duke Univ, Dept Chem, Durham, NC 27706 USA; [Barnum, Timothy J.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Bruno, Andrew E.] SUNY Buffalo, Ctr Computat Res, Buffalo, NY 14260 USA; [Luft, Joseph R.; Snell, Edward H.] Hauptman Woodward Med Res Inst, Buffalo, NY USA; [Snell, Edward H.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14260 USA; [Mukherjee, Sayan] Duke Univ, Dept Comp Sci, Dept Stat Sci, Durham, NC 27706 USA; [Mukherjee, Sayan] Duke Univ, Dept Math, Durham, NC 27706 USA; [Charbonneau, Patrick] Duke Univ, Dept Phys, Durham, NC 27706 USA	Duke University; Duke University; Massachusetts Institute of Technology (MIT); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Duke University; Duke University; Duke University	Charbonneau, P (corresponding author), Duke Univ, Dept Chem, Durham, NC 27706 USA.	patrick.charbonneau@duke.edu	Snell, Edward/G-2055-2018; Fusco, Diana/AAU-3915-2020	Snell, Edward/0000-0001-8714-3191; Charbonneau, Patrick/0000-0001-7174-0821; Barnum, Timothy/0000-0002-9363-9844; Mukherjee, Sayan/0000-0002-6715-3920	Protein Structure Initiative of the National Institutes of Health, NIGMS [U54 GM094597]; NIH [R01GM088396]; National Science Foundation [NSF DMR-1055586, NSF CHE-1062607]; Division Of Materials Research [1055586] Funding Source: National Science Foundation; Division Of Mathematical Sciences [1209155] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094597, R01GM088396] Funding Source: NIH RePORTER	Protein Structure Initiative of the National Institutes of Health, NIGMS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Sample preparation and data acquisition were supported in part by the Protein Structure Initiative of the National Institutes of Health, NIGMS grant U54 GM094597. Crystallization screening results and meta data was supplied from the University of Buffalo Center for Computational Resources (CCR) through research supported by NIH R01GM088396 (EHS, JRL, and AEB). DF and PC acknowledge support from National Science Foundation Grant No. NSF DMR-1055586. TJB acknowledges REU support from National Science Foundation Grant NSF CHE-1062607. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banatao DR, 2006, P NATL ACAD SCI USA, V103, P16230, DOI 10.1073/pnas.0607674103; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bianchi E, 2011, PHYS CHEM CHEM PHYS, V13, P6397, DOI 10.1039/c0cp02296a; Boyle AL, 2011, CHEM SOC REV, V40, P4295, DOI 10.1039/c0cs00152j; Carugo O, 1997, PROTEIN SCI, V6, P2261; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Chen L, 2004, BIOINFORMATICS, V20, P2860, DOI 10.1093/bioinformatics/bth300; Cieslik M, 2009, ACTA CRYSTALLOGR D, V65, P500, DOI 10.1107/S0907444909009500; Cooper DR, 2007, ACTA CRYSTALLOGR D, V63, P636, DOI 10.1107/S0907444907010931; Cristianini N, 2000, INTRO SUPPORT VECTOR; Dale GE, 2003, J STRUCT BIOL, V142, P88, DOI 10.1016/S1047-8477(03)00041-8; Dasgupta S, 1997, PROTEINS, V28, P494, DOI 10.1002/(SICI)1097-0134(199708)28:4<494::AID-PROT4>3.0.CO;2-A; Derewenda ZS, 2006, ACTA CRYSTALLOGR D, V62, P116, DOI 10.1107/S0907444905035237; Derewenda ZS, 2004, STRUCTURE, V12, P529, DOI 10.1016/j.str.2004.03.008; Derewenda ZS, 2010, ACTA CRYSTALLOGR D, V66, P604, DOI 10.1107/S090744491000644X; Dijkstra M, 1998, PHYS REV LETT, V81, P2268, DOI 10.1103/PhysRevLett.81.2268; Dill KA, 2005, ANNU REV BIOPH BIOM, V34, P173, DOI 10.1146/annurev.biophys.34.040204.144517; Dill KA, 2012, SCIENCE, V338, P1042, DOI 10.1126/science.1219021; DOIG AJ, 1995, PROTEIN SCI, V4, P2247, DOI 10.1002/pro.5560041101; Eiler S, 2001, PROTEIN EXPRES PURIF, V22, P165, DOI 10.1006/prep.2001.1409; Fusco D, 2014, SOFT MATTER, V10, P290, DOI 10.1039/c3sm52175c; Fusco D, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.012721; GEORGE A, 1994, ACTA CRYSTALLOGR D, V50, P361, DOI 10.1107/S0907444994001216; Janin J, 1995, PROTEINS, V23, P580, DOI 10.1002/prot.340230413; Janin J, 1995, PROG BIOPHYS MOL BIO, V64, P145, DOI 10.1016/S0079-6107(96)00001-6; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kantardjieff KA, 2004, BIOINFORMATICS, V20, P2162, DOI 10.1093/bioinformatics/bth066; Knight R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r171; Kurgan L, 2009, NATURAL SCI, V1, P93; Kurgan L, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-50; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lanci CJ, 2012, P NATL ACAD SCI USA, V109, P7304, DOI [10.1073/pnas.1112595109, 10.1073/pnas.111259510]; Lawrence ND, 2005, LECT NOTES ARTIF INT, V3635, P56, DOI 10.1007/11559887_4; Lee H, 2009, J PHYS CHEM B, V113, P13186, DOI 10.1021/jp9058966; Luft JR, 2011, EXPERT OPIN DRUG DIS, V6, P465, DOI 10.1517/17460441.2011.566857; McPherson A., 1999, CRYSTALLIZATION BIOL; Mizianty MJ, 2011, BIOINFORMATICS, V27, pI24, DOI 10.1093/bioinformatics/btr229; Newman J, 2012, ACTA CRYSTALLOGR F, V68, P253, DOI 10.1107/S1744309112002618; OOSAWA F, 1954, J CHEM PHYS, V22, P1255, DOI 10.1063/1.1740346; Price II WN, 2011, MICROB INFORM EXP, V1, P1; Price WN, 2009, NAT BIOTECHNOL, V27, P51, DOI 10.1038/nbt.1514; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Rodier F, 2005, PROTEINS, V60, P36, DOI 10.1002/prot.20478; Rosenbaum D, 1996, PHYS REV LETT, V76, P150, DOI 10.1103/PhysRevLett.76.150; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rupp B, 2004, METHODS, V34, P390, DOI 10.1016/j.ymeth.2004.03.031; Saven JG, 2010, CURR OPIN COLLOID IN, V15, P13, DOI 10.1016/j.cocis.2009.06.002; Slabinski L, 2007, BIOINFORMATICS, V23, P3403, DOI 10.1093/bioinformatics/btm477; Slabinski L, 2007, PROTEIN SCI, V16, P2472, DOI 10.1110/ps.073037907; Smialowski P, 2006, PROTEINS, V62, P343, DOI 10.1002/prot.20789; Snell EH, 2008, ACTA CRYSTALLOGR D, V64, P1123, DOI 10.1107/S0907444908028047; tenWolde PR, 1997, SCIENCE, V277, P1975, DOI 10.1126/science.277.5334.1975; Terwilliger TC, 2009, ANNU REV BIOPHYS, V38, P371, DOI 10.1146/annurev.biophys.050708.133740; VRIJ A, 1976, PURE APPL CHEM, V48, P471, DOI 10.1351/pac197648040471; Wilkinson Keith D, 2004, Methods Mol Biol, V261, P15; Zhang F, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.148101; Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020; Zhuang TD, 2011, J AM CHEM SOC, V133, P20571, DOI 10.1021/ja208972h; Zucker FH, 2010, J STRUCT BIOL, V171, P64, DOI 10.1016/j.jsb.2010.03.016	60	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101123	10.1371/journal.pone.0101123	http://dx.doi.org/10.1371/journal.pone.0101123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988076	gold, Green Submitted, Green Published			2022-12-27	WOS:000341354100062
J	Gladwin, MT; Barst, RJ; Gibbs, JSR; Hildesheim, M; Sachdev, V; Nouraie, M; Hassell, KL; Little, JA; Schraufnagel, DE; Krishnamurti, L; Novelli, E; Girgis, RE; Morris, CR; Rosenzweig, EB; Badesch, DB; Lanzkron, S; Castro, OL; Taylor, JG; Goldsmith, JC; Kato, GJ; Gordeuk, VR; Machado, RF				Gladwin, Mark T.; Barst, Robyn J.; Gibbs, J. Simon R.; Hildesheim, Mariana; Sachdev, Vandana; Nouraie, Mehdi; Hassell, Kathryn L.; Little, Jane A.; Schraufnagel, Dean E.; Krishnamurti, Lakshmanan; Novelli, Enrico; Girgis, Reda E.; Morris, Claudia R.; Rosenzweig, Erika Berman; Badesch, David B.; Lanzkron, Sophie; Castro, Oswaldo L.; Taylor, James G.; Goldsmith, Jonathan C.; Kato, Gregory J.; Gordeuk, Victor R.; Machado, Roberto F.		Walk-PHaSST Investigators Patients	Risk Factors for Death in 632 Patients with Sickle Cell Disease in the United States and United Kingdom	PLOS ONE			English	Article							NATRIURETIC PEPTIDE LEVELS; PULMONARY-HYPERTENSION; ASSOCIATION; ADOLESCENTS; MORTALITY; ADULTS	Background: The role of pulmonary hypertension as a cause of mortality in sickle cell disease (SCD) is controversial. Methods and Results: We evaluated the relationship between an elevated estimated pulmonary artery systolic pressure and mortality in patients with SCD. We followed patients from the walk-PHaSST screening cohort for a median of 29 months. A tricuspid regurgitation velocity (TRV)>= 3.0 m/s cuttof, which has a 67-75% positive predictive value for mean pulmonary artery pressure >= 25 mm Hg was used. Among 572 subjects, 11.2% had TRV >= 3.0 m/sec. Among 582 with a measured NT-proBNP, 24.1% had values >= 160 pg/mL. Of 22 deaths during follow-up, 50% had a TRV<3.0 m/sec. At 24 months the cumulative survival was 83% with TRV >= 3.0 m/sec and 98% with TRV, 3.0 m/sec (p<0.0001). The hazard ratios for death were 11.1 (95% CI 4.1-30.1; p, 0.0001) for TRV >= 3.0 m/sec, 4.6 (1.8-11.3; p = 0.001) for NT-proBNP >= 160 pg/mL, and 14.9 (5.5-39.9; p<0.0001) for both TRV >= 3.0 m/sec and NT-proBNP >= 160 pg/mL. Age >47 years, male gender, chronic transfusions, WHO class III-IV, increased hemolytic markers, ferritin and creatinine were also associated with increased risk of death. Conclusions: A TRV >= 3.0 m/sec occurs in approximately 10% of individuals and has the highest risk for death of any measured variable.	[Gladwin, Mark T.; Hildesheim, Mariana; Krishnamurti, Lakshmanan; Novelli, Enrico] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15260 USA; [Gladwin, Mark T.; Hildesheim, Mariana] Univ Pittsburgh, Med Ctr, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [Barst, Robyn J.; Rosenzweig, Erika Berman] Columbia Univ, New York, NY USA; [Gibbs, J. Simon R.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Sachdev, Vandana; Taylor, James G.; Kato, Gregory J.] NHLBI, Cardiovasc Branch, Bethesda, MD 20892 USA; [Nouraie, Mehdi; Castro, Oswaldo L.] Howard Univ, Washington, DC 20059 USA; [Hassell, Kathryn L.; Badesch, David B.] Univ Colorado HSC, Denver, CO USA; [Little, Jane A.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Schraufnagel, Dean E.; Gordeuk, Victor R.; Machado, Roberto F.] Univ Illinois, Chicago, IL USA; [Krishnamurti, Lakshmanan] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; [Girgis, Reda E.; Lanzkron, Sophie] Johns Hopkins Univ, Baltimore, MD USA; [Morris, Claudia R.] Emory Univ, Sch Med, Atlanta, GA USA; [Goldsmith, Jonathan C.] NHLBI, NIH, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Columbia University; Imperial College London; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Howard University; University of Colorado System; University of Colorado Anschutz Medical Campus; Case Western Reserve University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Emory University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Gladwin, MT (corresponding author), Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15260 USA.	gladwinmt@upmc.edu	Kato, Gregory J/I-7615-2014; Taylor, James G./AAH-4782-2021; Rosenzweig, Erika/AAC-3680-2019; Nouraie, Seyed Mehdi/O-4071-2018; Lanzkron, Sophie/AFU-9516-2022; Gordeuk, Victor/AAG-6577-2019; Lanzkron, Sophie/AAD-7584-2022	Kato, Gregory J/0000-0003-4465-3217; Taylor, James G./0000-0002-4421-1809; Nouraie, Seyed Mehdi/0000-0001-7465-0581; Lanzkron, Sophie/0000-0002-2878-0251; Lanzkron, Sophie/0000-0002-2878-0251; Schraufnagel, Dean/0000-0003-0063-7223; Rosenzweig, Erika B./0000-0003-4849-214X; Krishnamurti, Lakshmanan/0000-0003-3242-0037; Machado, Roberto/0000-0002-3722-5954	National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services [HHSN268200617182C]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111656, ZIAHL006012, P01HL103455] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project has been founded with federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, under contract HHSN268200617182C. NHLBI was involved in the design and conduct of the original study and their staff had input in the writing of the manuscript.	[Anonymous], 2012, HAEMATOLOGICA; Anthi A, 2007, AM J RESP CRIT CARE, V175, P1272, DOI 10.1164/rccm.200610-1498OC; Ataga KI, 2006, BRIT J HAEMATOL, V134, P109, DOI 10.1111/j.1365-2141.2006.06110.x; De Castro LM, 2008, AM J HEMATOL, V83, P19, DOI 10.1002/ajh.21058; Fonseca GH, 2012, EUR RESP J; Gladwin MT, 2008, NEW ENGL J MED, V359, P2254, DOI 10.1056/NEJMra0804411; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Machado RF, 2009, BLOOD, V114, P1541; Machado RF, 2006, JAMA-J AM MED ASSOC, V296, P310, DOI 10.1001/jama.296.3.310; Machado RF, 2011, BRIT J HAEMATOL, V154, P512, DOI 10.1111/j.1365-2141.2011.08777.x; McLaughlin VV, 2009, CIRCULATION, V119, P2250, DOI 10.1161/CIRCULATIONAHA.109.192230; Mehari A, 2013, AM J RESP CRITICAL C; Mehari A, 2012, JAMA-J AM MED ASSOC, V307, P1254, DOI 10.1001/jama.2012.358; Minniti CR, 2009, HAEMATOL-HEMATOL J, V94, P340, DOI 10.3324/haematol.13812; Nathan DG, 2011, BLOOD, V118, P3758, DOI 10.1182/blood-2011-08-370338; Parent F, 2011, NEW ENGL J MED, V365, P44, DOI 10.1056/NEJMoa1005565; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Sachdev V, 2011, CIRCULATION, V124, P1452, DOI 10.1161/CIRCULATIONAHA.111.032920; Simonneau G, 2012, EUR RESPIR J, V39, P3, DOI 10.1183/09031936.00119811	20	83	84	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e99489	10.1371/journal.pone.0099489	http://dx.doi.org/10.1371/journal.pone.0099489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988120	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000341354100014
J	Stewart, MKG; Plante, I; Bechberger, JF; Naus, CC; Laird, DW				Stewart, Michael K. G.; Plante, Isabelle; Bechberger, John F.; Naus, Christian C.; Laird, Dale W.			Mammary Gland Specific Knockdown of the Physiological Surge in Cx26 during Lactation Retains Normal Mammary Gland Development and Function	PLOS ONE			English	Article							MEDIATED GENE DELETION; JUNCTIONAL COMMUNICATION; CONNEXIN 30; EXPRESSION; MOUSE; PERMEABILITY; CHANNELS	Connexin26 (Cx26) is the major Cx protein expressed in the human mammary gland and is up-regulated during pregnancy while remaining elevated throughout lactation. It is currently unknown if patients with loss-of-function Cx26 mutations that result in hearing loss and skin diseases have a greater susceptibility to impaired breast development. To investigate if Cx26 plays a critical role in mammary gland development and differentiation, a novel Cx26 conditional knockout mouse model was generated by crossing Cx26(fl/fl) mice with mice expressing Cre under the beta-Lactoglobulin promoter. Conditional knockdown of Cx26 from the mammary gland resulted in a dramatic reduction in detectable gap junction plaques confirmed by a significant similar to 65-70% reduction in Cx26 mRNA and protein throughout parturition and lactation. Interestingly, this reduction was accompanied by a decrease in mammary gland Cx30 gap junction plaques at parturition, while no change was observed for Cx32 or Cx43. Whole mount, histological and immunofluorescent assessment of breast tissue revealed comparatively normal lobuloalveolar development following pregnancy in the conditionally knockdown mice compared to control mice. In addition, glands from genetically-modified mice were capable of producing milk proteins that were evident in the lumen of alveoli and ducts at similar levels as controls, suggesting normal gland function. Together, our results suggest that low levels of Cx26 expression throughout pregnancy and lactation, and not the physiological surge in Cx26, is sufficient for normal gland development and function.	[Stewart, Michael K. G.; Laird, Dale W.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Plante, Isabelle] INRS Inst Armand Frappier, Laval, PQ, Canada; [Bechberger, John F.; Naus, Christian C.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada; [Laird, Dale W.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada	Western University (University of Western Ontario); University of Quebec; Institut national de la recherche scientifique (INRS); University of British Columbia; Western University (University of Western Ontario)	Laird, DW (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada.	dale.laird@schulich.uwo.ca	Laird, Dale W/AAL-2407-2020; Laird, Dale w/E-4176-2015; Plante, Isabelle/AAK-5997-2021	Laird, Dale W/0000-0002-4568-3285; Plante, Isabelle/0000-0003-2080-6450	Canadian Breast Cancer Foundation; Ontario Graduate Scholarship; Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit; Canadian Institutes of Health Research (CIHR) Strategic Training Program in Cancer Research and Technology Transfer	Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit; Canadian Institutes of Health Research (CIHR) Strategic Training Program in Cancer Research and Technology Transfer(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Breast Cancer Foundation (CCN and DWL) and the Ontario Graduate Scholarship, Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit and the Canadian Institutes of Health Research (CIHR) Strategic Training Program in Cancer Research and Technology Transfer (MKGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; Bry C, 2004, DEV BIOL, V267, P418, DOI 10.1016/j.ydbio.2003.11.022; Cao YX, 2003, J MAMMARY GLAND BIOL, V8, P215, DOI 10.1023/A:1025905008934; Chanson M, 1998, J CELL BIOL, V141, P1267, DOI 10.1083/jcb.141.5.1267; Chin NP, 2013, J HUM LACT, V29, P564, DOI 10.1177/0890334413476921; Cohen-Salmon M, 2002, CURR BIOL, V12, P1106, DOI 10.1016/S0960-9822(02)00904-1; Crispino G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023279; Dicke N, 2011, J CELL SCI, V124, P2806, DOI 10.1242/jcs.084186; El-Saghir JA, 2011, INT J DEV BIOL, V55, P773, DOI 10.1387/ijdb.113372je; Gabriel HD, 1998, J CELL BIOL, V140, P1453, DOI 10.1083/jcb.140.6.1453; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; HARRIS S, 1991, DEV GENET, V12, P299, DOI 10.1002/dvg.1020120407; Hassiotou F, 2013, CLIN ANAT, V26, P29, DOI 10.1002/ca.22165; Imbeault S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-13; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; LEE SW, 1992, J CELL BIOL, V118, P1213, DOI 10.1083/jcb.118.5.1213; Lee WJ, 2006, BBA-REV CANCER, V1765, P235, DOI 10.1016/j.bbcan.2005.12.001; Locke D, 2004, EXP CELL RES, V298, P643, DOI 10.1016/j.yexcr.2004.05.003; Locke D, 2007, CELL TISSUE RES, V328, P97, DOI 10.1007/s00441-006-0301-6; McLachlan E, 2007, J MEMBRANE BIOL, V218, P107, DOI 10.1007/s00232-007-9052-x; Michon L, 2005, BBA-BIOMEMBRANES, V1719, P82, DOI 10.1016/j.bbamem.2005.11.003; Mittal B., 2003, INDIAN J HUM GENET, V9, P40; Monaghan P, 1996, EXP CELL RES, V223, P29, DOI 10.1006/excr.1996.0055; Nelles E, 1996, P NATL ACAD SCI USA, V93, P9565, DOI 10.1073/pnas.93.18.9565; Ortolano S, 2008, P NATL ACAD SCI USA, V105, P18776, DOI 10.1073/pnas.0800831105; Parmar H, 2004, ENDOCR-RELAT CANCER, V11, P437, DOI 10.1677/erc.1.00659; Plante I, 2008, DEV BIOL, V318, P312, DOI 10.1016/j.ydbio.2008.03.033; Plante I, 2011, JOVE-J VIS EXP, DOI 10.3791/2828; Schutz M, 2010, HUM MOL GENET, V19, P4759, DOI 10.1093/hmg/ddq402; Selbert S, 1998, TRANSGENIC RES, V7, P387, DOI 10.1023/A:1008848304391; Serre-Beinier V, 2002, BIOL CELL, V94, P477, DOI 10.1016/S0248-4900(02)00024-2; Stewart MKG, 2013, BIOCHEM J, V449, P401, DOI 10.1042/BJ20121070; VanderMolen MA, 1996, J BIOL CHEM, V271, P12165, DOI 10.1074/jbc.271.21.12165; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; White TW, 2000, BRAIN RES REV, V32, P181, DOI 10.1016/S0165-0173(99)00079-X; Yuan TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019233	37	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101546	10.1371/journal.pone.0101546	http://dx.doi.org/10.1371/journal.pone.0101546			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988191	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000341354100111
J	Stuit, SM; Paffen, CLE; van der Smagt, MJ; Verstraten, FAJ				Stuit, Sjoerd M.; Paffen, Chris L. E.; van der Smagt, Maarten J.; Verstraten, Frans A. J.			Image-Based Grouping during Binocular Rivalry Is Dictated by Eye-Of-Origin	PLOS ONE			English	Article							FACIAL EXPRESSIONS; ORIENTATION; DEPTH	Prolonged viewing of dichoptically presented images with different content results in perceptual alternations known as binocular rivalry. This phenomenon is thought to be the result of competition at a local level, where local rivalry zones interact to give rise to a single, global dominant percept. Certain perceived combinations that result from this local competition are known to last longer than others, which is referred to as grouping during binocular rivalry. In recent years, the phenomenon has been suggested to be the result of competition at both eye-and image-based processing levels, although the exact contribution from each level remains elusive. Here we use a paradigm designed specifically to quantify the contribution of eye-and image-based processing to grouping during rivalry. In this paradigm we used sine-wave gratings as well as upright and inverted faces, with and without binocular disparity-based occlusion. These stimuli and conditions were used because they are known to result in processing at different stages throughout the visual processing hierarchy. Specifically, more complex images were included in order to maximize the potential contribution of image-based grouping. In spite of this, our results show that increasing image complexity did not lead to an increase in the contribution of image-based processing to grouping during rivalry. In fact, the results show that grouping was primarily affected by the eye-of-origin of the image parts, irrespective of stimulus type. We suggest that image content affects grouping during binocular rivalry at low-level processing stages, where it is intertwined with eye-of-origin information.	[Stuit, Sjoerd M.; Paffen, Chris L. E.; van der Smagt, Maarten J.; Verstraten, Frans A. J.] Univ Utrecht, Helmholtz Inst, Div Expt Psychol, Neurosci & Cognit Utrecht, Utrecht, Netherlands; [Verstraten, Frans A. J.] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia	Utrecht University; University of Sydney	Stuit, SM (corresponding author), Univ Utrecht, Helmholtz Inst, Div Expt Psychol, Neurosci & Cognit Utrecht, Utrecht, Netherlands.	sjoerdstuit@gmail.com		van der Smagt, Maarten/0000-0003-2772-6429; Verstraten, Frans/0000-0002-5487-1755				Alais D, 1999, VISION RES, V39, P4341, DOI 10.1016/S0042-6989(99)00146-7; Alais D, 2000, PERCEPTION, V29, P1437, DOI 10.1068/p3017; Alais D, 1998, VISION RES, V38, P637, DOI 10.1016/S0042-6989(97)00190-9; Alpers GW, 2007, EMOTION, V7, P495, DOI 10.1037/1528-3542.7.3.495; Arnold DH, 2009, J VISION, V9, DOI 10.1167/9.5.4; Bannerman RL, 2008, OPHTHAL PHYSL OPT, V28, P317, DOI 10.1111/j.1475-1313.2008.00568.x; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; Ekman P., 1976, PICTURES FACIAL AFFE; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Freeman AW, 2005, J NEUROPHYSIOL, V94, P4412, DOI 10.1152/jn.00557.2005; HUBEL DH, 1974, J COMP NEUROL, V158, P267, DOI 10.1002/cne.901580304; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kanwisher N, 1998, COGNITION, V68, pB1, DOI 10.1016/S0010-0277(98)00035-3; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Knapen T, 2007, VISION RES, V47, P3269, DOI 10.1016/j.visres.2007.09.005; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; Lee SH, 2004, VISION RES, V44, P983, DOI 10.1016/j.visres.2003.12.007; Lee SH, 2004, TRENDS COGN SCI, V8, P148, DOI 10.1016/j.tics.2004.02.009; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; NAKAYAMA K, 1989, PERCEPTION, V18, P55, DOI 10.1068/p180055; Nguyen VA, 2003, VISION RES, V43, P2003, DOI 10.1016/S0042-6989(03)00314-6; Palmer SE, 1996, PSYCHON B REV, V3, P75, DOI 10.3758/BF03210743; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Silver MA, 2007, VISION RES, V47, P532, DOI 10.1016/j.visres.2006.10.011; Stuit SM, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00117; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; WHITTLE P, 1968, PERCEPT PSYCHOPHYS, V4, P183, DOI 10.3758/BF03210465; Wilson HR, 2003, P NATL ACAD SCI USA, V100, P14499, DOI 10.1073/pnas.2333622100; Yoon KL, 2009, EMOTION, V9, P172, DOI 10.1037/a0014714	35	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e95327	10.1371/journal.pone.0095327	http://dx.doi.org/10.1371/journal.pone.0095327			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987847	Green Published, Green Submitted, gold			2022-12-27	WOS:000341354100004
J	Wu, B; Wu, HX; Liu, XY; Lin, HW; Li, J				Wu, Bin; Wu, Haixiang; Liu, Xiaoyan; Lin, Houwen; Li, Jin			Ranibizumab versus Bevacizumab for Ophthalmic Diseases Related to Neovascularisation: A Meta-Analysis of Randomised Controlled Trials	PLOS ONE			English	Article							INTRAVITREAL BEVACIZUMAB; MACULAR DEGENERATION; THERAPY; ANGIOGENESIS; CANCER; EVENTS	Background: Bevacizumab is believed to be as effective and safe as ranibizumab for ophthalmic diseases; however, its magnitude of effectiveness and safety profile remain controversial. Thus, a meta-analysis and systematic review appears necessary. Methods: PubMed and EMBASE were systematically searched with no restrictions. All relevant citations comparing ranibizumab and bevacizumab were considered for inclusion. Pooled effect estimates were obtained using a fixed-and random-effects meta-analysis. Results: Nine independent randomised-controlled clinical trials (RCTs) involving 2,289 participants were identified. Compared with bevacizumab, the overall combined weighted mean difference (WMD) of the mean change in visual acuity for ranibizumab was 0.52 letters (95% CI 20.11-1.14). The odds ratios (ORs) of gaining >= 15, gaining 5-14, losing 5-14 and losing <= 15 letters were 1.10 (95% CI 0.90-1.33), 0.93 (95% CI 0.77-1.11), 0.89 (95% CI 0.65-1.22) and 0.95 (95% CI 0.73-1.25), respectively. The risk of serious systemic events increased by 17% (95% CI 6%-27%, p = 0.0042) for bevacizumab treatment in comparison with ranibizumab. No statistically significant differences between the two treatments were found for the nonfatal arterial thrombotic events, ocular serious adverse, death from vascular and all causes events. Conclusions: Bevacizumab is not inferior to ranibizumab as a treatment for achieving visual acuity. The use of bevacizumab was associated with an increased risk of developing serious systemic events. Weighing the costs and health outcomes is necessary when selecting between bevacizumab and ranibizumab for ophthalmic diseases. Due to the limitations of the available data, further research is needed.	[Wu, Bin; Liu, Xiaoyan; Lin, Houwen] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Pharm, Shanghai 200030, Peoples R China; [Wu, Haixiang] Fudan Univ, Dept Ophthalmol, Shanghai 200433, Peoples R China; [Wu, Haixiang] Fudan Univ, Visual Sci Eye & ENT Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Li, Jin] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Ophthalmol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Fudan University; Fudan University; Shanghai Jiao Tong University	Li, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Ophthalmol, Shanghai 200030, Peoples R China.	wbwithtg@hotmail.com		Lin, Hou-Wen/0000-0002-7097-0876	National Natural Science Foundation of China [71373160]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Natural Science Foundation of China (NO. 71373160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banfi R, 2013, INT J CLIN PHARM-NET, V35, P507, DOI 10.1007/s11096-013-9779-7; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Brechner RJ, 2011, AM J OPHTHALMOL, V151, P887, DOI 10.1016/j.ajo.2010.11.017; Brown DM, 2009, OPHTHALMOLOGY, V116, P57, DOI 10.1016/j.ophtha.2008.10.018; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chakravarthy U, 2013, LANCET, V382, P1258, DOI 10.1016/S0140-6736(13)61501-9; Chen XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066721; Cheng JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041325; Cho HJ, 2012, EYE, V26, P426, DOI 10.1038/eye.2011.324; Cho Han Joo, 2012, Korean J Ophthalmol, V26, P157, DOI 10.3341/kjo.2012.26.3.157; Curtis LH, 2010, ARCH OPHTHALMOL-CHIC, V128, P1273, DOI 10.1001/archophthalmol.2010.223; Dixon JA, 2009, EXPERT OPIN INV DRUG, V18, P1573, DOI 10.1517/13543780903201684; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Ferrara N, 2006, RETINA-J RET VIT DIS, V26, P859, DOI 10.1097/01.iae.0000242842.14624.e7; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Ford JA, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5182; Gharbiya M, 2010, AM J OPHTHALMOL, V149, P458, DOI 10.1016/j.ajo.2009.10.010; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hufendiek Katerina, 2012, International Ophthalmology, V32, P259, DOI 10.1007/s10792-012-9562-0; Iacono P, 2012, RETINA-J RET VIT DIS, V32, P1539, DOI 10.1097/IAE.0b013e31826956b7; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kim Jin-Hyoung, 2013, Korean J Ophthalmol, V27, P235, DOI 10.3341/kjo.2013.27.4.235; Kodjikian L, 2013, OPHTHALMOLOGY, V120, P2300, DOI 10.1016/j.ophtha.2013.06.020; Krebs I, 2013, BRIT J OPHTHALMOL, V97, P266, DOI 10.1136/bjophthalmol-2012-302391; Li J, 2013, INT J OPHTHALMOL-CHI, V6, P169, DOI 10.3980/j.issn.2222-3959.2013.02.12; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; McCartney M, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6778; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nalluri SR, 2008, JAMA-J AM MED ASSOC, V300, P2277, DOI 10.1001/jama.2008.656; Nepomuceno AB, 2013, AM J OPHTHALMOL, V156, P502, DOI 10.1016/j.ajo.2013.04.026; Ozturk BT, 2011, J OCUL PHARMACOL TH, V27, P373, DOI 10.1089/jop.2010.0195; Park SC, 2012, EXPERT OPIN BIOL TH, V12, P1641, DOI 10.1517/14712598.2012.721772; Parodi MB, 2013, ACTA OPHTHALMOL, V91, P267, DOI 10.1111/j.1755-3768.2011.02265.x; Presta LG, 1997, CANCER RES, V57, P4593; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Scappaticci FA, 2007, JNCI-J NATL CANCER I, V99, P1232, DOI 10.1093/jnci/djm086; Schmucker C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042701; Shams Naveed, 2006, Ophthalmol Clin North Am, V19, P335; Subramanian ML, 2010, EYE, V24, P1708, DOI 10.1038/eye.2010.147; Van der Reis MI, 2011, RETINA-J RET VIT DIS, V31, P1449, DOI 10.1097/IAE.0b013e3182278ab4	42	6	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101253	10.1371/journal.pone.0101253	http://dx.doi.org/10.1371/journal.pone.0101253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983855	Green Published, Green Submitted, gold			2022-12-27	WOS:000339635000078
J	Yang, CC; Yao, CA; Lin, YR; Yang, JC; Chien, CT				Yang, Chih-Ching; Yao, Chien-An; Lin, Yi-Ruu; Yang, Jyh-Chin; Chien, Chiang-Ting			Deep-Sea Water Containing Selenium Provides Intestinal Protection against Duodenal Ulcers through the Upregulation of Bcl-2 and Thioredoxin Reductase 1	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; SHUMIYA CATARACT RAT; OXIDATIVE STRESS; DRINKING-WATER; MAGNESIUM; APOPTOSIS; DISEASE; SEAWATER; MICE; ISCHEMIA/REPERFUSION	Deep-sea water (DSW), which is rich in micronutrients and minerals and with antioxidant and anti-inflammatory qualities, may be developed as marine drugs to provide intestinal protection against duodenal ulcers. We determined several characteristics in the modified DSW. We explored duodenal pressure, oxygenation, microvascular blood flow, and changes in pH and oxidative redox potential (ORP) values within the stomach and duodenum in response to tap water (TW, hardness: 2.48 ppm), DSW600 (hardness: 600 ppm), and DSW1200 (hardness: 1200 ppm) in Wistar rats and analyzed oxidative stress and apoptosis gene expressions by cDNA and RNA microarrays in the duodenal epithelium. We compared the effects of drinking DSW, MgCl2, and selenium water on duodenal ulcers using pathologic scoring, immunohistochemical analysis, and Western blotting. Our results showed DSW has a higher pH value, lower ORP value, higher scavenging H2O2 and HOCl activity, higher Mg2+ concentrations, and micronutrients selenium compared with TW samples. Water infusion significantly increased intestinal pressure, O-2 levels, and microvascular blood flow in DSW and TW groups. Microarray showed DSW600, DSW1200, selenium water upregulated antioxidant and anti-apoptotic genes and downregulated proapoptotic gene expression compared with the TW group. Drinking DSW600, DSW1200, and selenium water but not Mg2+ water significantly enhanced Bcl-2 and thioredoxin reductase 1 expression. Bax/Bcl-2/caspase 3/poly-(ADP-ribose)-polymerase signaling was activated during the pathogenesis of duodenal ulceration. DSW drinking reduced ulcer area as well as apoptotic signaling in acetic acid-induced duodenal ulcers. DSW, which contains selenium, provides intestinal protection against duodenal ulcers through the upregulation of Bcl-2 and thioredoxin reductase 1.	[Yang, Chih-Ching] Execut Yuan, Minist Hlth & Welf, Dept Planning, Taipei, Taiwan; [Yang, Chih-Ching] Natl Yang Ming Univ, Dept Internal Med, Taipei 112, Taiwan; [Yao, Chien-An] Natl Taiwan Univ, Dept Family Med, Hosp & Coll Med, Taipei 10764, Taiwan; [Lin, Yi-Ruu] Stone & Resource Ind Res & Dev Ctr, Div Water Resources, Hualien, Taiwan; [Yang, Jyh-Chin] Natl Taiwan Univ, Dept Internal Med, Hosp & Coll Med, Taipei 10764, Taiwan; [Chien, Chiang-Ting] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University; National Taiwan Normal University	Yang, JC (corresponding author), Natl Taiwan Univ, Dept Internal Med, Hosp & Coll Med, Taipei 10764, Taiwan.	jcyang47@ntu.edu.tw		Yao, Chien-An/0000-0001-8074-6379; YANG, JYH-CHIN/0000-0003-4219-0685	Water Resources Division, Stone & Resource Industry RD Center [SRDC-160-B1-168(101)]; National Science Council of the Republic of China [NSC 102-2320-B-003-001-MY3]	Water Resources Division, Stone & Resource Industry RD Center; National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	Grant support: This work was majorly supported by Water Resources Division, Stone & Resource Industry R&D Center (SRDC-160-B1-168(101)) and partly by the National Science Council of the Republic of China (NSC 102-2320-B-003-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasciano V, 2003, MAGNESIUM RES, V16, P281; Bak JP, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-108; Barkun A, 2010, AM J MED, V123, P358, DOI 10.1016/j.amjmed.2009.09.031; Boehler CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071525; Chen DL, 2011, TRANSL RES, V157, P306, DOI 10.1016/j.trsl.2010.12.012; Chen HW, 2006, FASEB J, V20, P2393, DOI 10.1096/fj.06-6485fje; Chen IS, 2013, J CHIN MED ASSOC, V76, P95, DOI 10.1016/j.jcma.2012.10.008; Cheung Dae Young, 2009, Korean J Gastroenterol, V54, P285; Chien CT, 2005, AM J TRANSPLANT, V5, P1194, DOI 10.1111/j.1600-6143.2005.00826.x; Chien CT, 2001, J AM SOC NEPHROL, V12, P973, DOI 10.1681/ASN.V125973; Chung SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047299; Drago F, 1999, LIFE SCI, V64, P2341, DOI 10.1016/S0024-3205(99)00187-3; Fu ZY, 2012, J MED FOOD, V15, P535, DOI 10.1089/jmf.2011.2007; Garcia-Miranda P, 2010, EXP PHYSIOL, V223, P451; Hataguchi Y, 2005, EUR J CLIN NUTR, V59, P1093, DOI 10.1038/sj.ejcn.1602218; Hein J, 2011, CLIN DRUG INVEST, V31, P655, DOI 10.2165/11590270-000000000-00000; Hoffman-Goetz L, 2007, J NEUROIMMUNOL, V187, P94, DOI 10.1016/j.jneuroim.2007.04.012; Hunt RH, 2011, DIGEST DIS, V29, P465, DOI 10.1159/000332211; Katsuda S, 2008, BIOL PHARM BULL, V31, P38, DOI 10.1248/bpb.31.38; Kawada M, 2012, J MED MICROBIOL DI S, VS1; Kawahara K, 2007, MED HYPOTHESES, V68, P1429, DOI 10.1016/j.mehy.2006.10.025; Kimata Hajime, 2002, Acta Medica (Hradec Kralove), V45, P83; Kohda K, 1999, GUT, V44, P456, DOI 10.1136/gut.44.4.456; KURATA JH, 1985, GASTROENTEROLOGY, V88, P96, DOI 10.1016/S0016-5085(85)80139-6; Lahner E, 2012, HELICOBACTER, V17, P1, DOI 10.1111/j.1523-5378.2011.00892.x; LeonBarua R, 1997, CLIN INFECT DIS, V25, P1013, DOI 10.1086/516079; Lu J, 2009, FASEB J, V23, P2394, DOI 10.1096/fj.08-127662; Malfertheiner P, 2009, LANCET, V374, P1449, DOI 10.1016/S0140-6736(09)60938-7; Miyamura M, 2004, BIOL PHARM BULL, V27, P1784, DOI 10.1248/bpb.27.1784; Nagai N, 2007, CURR EYE RES, V32, P439, DOI 10.1080/02713680701329339; Nagai N, 2006, BIOL PHARM BULL, V29, P1234, DOI 10.1248/bpb.29.1234; Nasri H, 2007, BRATISL MED J, V108, P506; Proksch E, 2005, INT J DERMATOL, V44, P151, DOI 10.1111/j.1365-4632.2005.02079.x; Radhakrishnan G, 2009, BIOCHEM BIOPH RES CO, V387, P25, DOI 10.1016/j.bbrc.2009.06.073; Sheu MJ, 2013, MAR DRUGS, V11, P2183, DOI 10.3390/md11062183; Sieron A, 2001, Pol Merkur Lekarski, V10, P113; Sostek MB, 2011, CURR MED RES OPIN, V27, P847, DOI 10.1185/03007995.2011.555756; SZABO S, 1978, AM J PATHOL, V93, P273; Trigona WL, 2006, BIOCHEM J, V394, P207, DOI 10.1042/BJ20050712; Wang Y, 2013, FOOD CHEM TOXICOL, V58, P61, DOI 10.1016/j.fct.2013.04.013; Yang JC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/248585; Yang LC, 2008, J NUTR, V138, P2084, DOI 10.3945/jn.108.090985; Yang SY, 2013, BIOL TRACE ELEM RES, V153, P237, DOI 10.1007/s12011-013-9649-0; Zhou YJ, 2009, TOXICOL IN VITRO, V23, P288, DOI 10.1016/j.tiv.2008.12.009	44	11	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e96006	10.1371/journal.pone.0096006	http://dx.doi.org/10.1371/journal.pone.0096006			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984066	Green Submitted, gold, Green Published			2022-12-27	WOS:000339635000002
J	Zingg, JM; Libinaki, R; Meydani, M; Azzi, A				Zingg, Jean-Marc; Libinaki, Roksan; Meydani, Mohsen; Azzi, Angelo			Modulation of Phosphorylation of Tocopherol and Phosphatidylinositol by hTAP1/SEC14L2-Mediated Lipid Exchange	PLOS ONE			English	Article							SCAVENGER RECEPTOR EXPRESSION; SUPERNATANT PROTEIN FACTOR; HUMAN SEC14P-LIKE PROTEINS; VITAMIN-E; ALPHA-TOCOPHEROL; GENE-EXPRESSION; ATHEROSCLEROSIS PROGRESSION; CELL-PROLIFERATION; MAMMARY-GLAND; OXIDIZED LDL	The vitamin E derivative, alpha-tocopheryl phosphate (alpha TP), is detectable in cultured cells, plasma and tissues in small amounts, suggesting the existence of enzyme(s) with alpha-tocopherol (alpha T) kinase activity. Here, we characterize the production of alpha TP from alpha T and [gamma-P-32]-ATP in primary human coronary artery smooth muscle cells (HCA-SMC) using separation by thin layer chromatography (TLC) and subsequent analysis by Ultra Performance Liquid Chromatography (UPLC). In addition to alpha T, although to a lower amount, also gamma T is phosphorylated. In THP-1 monocytes, gamma TP inhibits cell proliferation and reduces CD36 scavenger receptor expression more potently than alpha TP. Both alpha TP and gamma TP activate the promoter of the human vascular endothelial growth factor (VEGF) gene with similar potency, whereas alpha T and gamma T had no significant effect. The recombinant human tocopherol associated protein 1 (hTAP1, hSEC14L2) binds both alpha T and alpha TP and stimulates phosphorylation of alpha T possibly by facilitating its transport and presentation to a putative alpha T kinase. Recombinant hTAP1 reduces the in vitro activity of the phosphatidylinositol-3-kinase gamma (PI3K gamma) indicating the formation of a stalled/inactive hTAP1/PI3K gamma heterodimer. The addition of alpha T, beta T, gamma T, delta dT or alpha TP differentially stimulates PI3K gamma, suggesting facilitated egress of sequestered PI from hTAP1 to the enzyme. It is suggested that the continuous competitive exchange of different lipophilic ligands in hTAPs with cell enzymes and membranes may be a way to make these lipophiles more accessible as substrates for enzymes and as components of specific membrane domains.	[Zingg, Jean-Marc; Meydani, Mohsen; Azzi, Angelo] Tufts Univ, JM USDA Human Nutr Res Ctr Aging, Vasc Biol Lab, Boston, MA 02111 USA; [Libinaki, Roksan] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia	Tufts University; United States Department of Agriculture (USDA); Monash University	Zingg, JM (corresponding author), Tufts Univ, JM USDA Human Nutr Res Ctr Aging, Vasc Biol Lab, Boston, MA 02111 USA.	Jean-Marc.Zingg@tufts.edu	Zingg, Jean-Marc/H-6960-2019		Swiss National Science Foundation; US Department of Agriculture [58-1950-0-014]; Phosphagenics, Ltd.	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); US Department of Agriculture(United States Department of Agriculture (USDA)); Phosphagenics, Ltd.	This study was supported in part by the Swiss National Science Foundation (AA, JMZ), by grants from US Department of Agriculture, under Agreement No. 58-1950-0-014 (MM, JMZ) and by a research fellowship from Phosphagenics, Ltd. (JMZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames SR, 1949, ANN NY ACAD SCI, V52; Atkinson J, 2010, MOL NUTR FOOD RES, V54, P641, DOI 10.1002/mnfr.200900439; Bankaitis VA, 2007, ADV ENZYME REGUL, V47, P27, DOI 10.1016/j.advenzreg.2006.12.007; Bankaitis Vytas A, 2012, Adv Biol Regul, V52, P115, DOI 10.1016/j.jbior.2011.11.001; Bankaitis VA, 2010, TRENDS BIOCHEM SCI, V35, P150, DOI 10.1016/j.tibs.2009.10.008; Birringer M, 2010, MOL NUTR FOOD RES, V54, P588, DOI 10.1002/mnfr.200900457; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Cockcroft S, 2011, CRIT REV BIOCHEM MOL, V46, P89, DOI 10.3109/10409238.2010.538664; Cursiefen C, 2011, J EXP MED, V208, P1083, DOI 10.1084/jem.20092277; Curwin AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055388; De Pascale MC, 2006, ARCH BIOCHEM BIOPHYS, V447, P97, DOI 10.1016/j.abb.2006.02.002; Dutra RC, 2011, BR J PHARM; Eyre NS, 2007, J LIPID RES, V48, P528, DOI 10.1194/jlr.M600255-JLR200; Frantz S, 2009, CARDIOVASC RES, V81, P474, DOI 10.1093/cvr/cvn292; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Ghosh R, 2011, BIOFACTORS, V37, P290, DOI 10.1002/biof.180; Gianello R, 2005, FREE RADICAL BIO MED, V39, P970, DOI 10.1016/j.freeradbiomed.2005.05.016; Huang PH, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003816; Ile KE, 2006, NAT CHEM BIOL, V2, P576, DOI 10.1038/nchembio835; Inoue M, 2001, ARTERIOSCL THROM VAS, V21, P560, DOI 10.1161/01.ATV.21.4.560; Isenberg JS, 2007, J BIOL CHEM, V282, P15404, DOI 10.1074/jbc.M701638200; KAGAN VE, 1990, METHOD ENZYMOL, V186, P355; Kearns BG, 1998, TRENDS CELL BIOL, V8, P276, DOI 10.1016/S0962-8924(98)01281-1; Kempna P, 2004, J BIOL CHEM, V279, P50700, DOI 10.1074/jbc.M410800200; Kempna P, 2003, FREE RADICAL BIO MED, V34, P1458, DOI 10.1016/S0891-5849(03)00173-4; Kempna P, 2003, IUBMB LIFE, V55, P103, DOI 10.1080/1521654031000095756; Kono N, 2013, SCIENCE; Lemaire-Ewing S, 2010, MOL NUTR FOOD RES, V54, P631, DOI 10.1002/mnfr.200900445; Libinaki R, 2010, CLIN EXP PHARMACOL P, V37, P587, DOI 10.1111/j.1440-1681.2010.05356.x; Marlier A, 2009, MECH DEVELOP, V126, P91, DOI 10.1016/j.mod.2008.12.003; McCary CA, 2012, BIOCHEM J, V441, P189, DOI 10.1042/BJ20111318; Mokashi V, 2005, ARCH BIOCHEM BIOPHYS, V433, P474, DOI 10.1016/j.abb.2004.10.002; Moldovan L, 2005, EXP SUPPL, V94, P127; Munteanu A, 2006, J BIOL CHEM, V281, P6489, DOI 10.1074/jbc.M508799200; Munteanu A, 2004, BIOCHEM BIOPH RES CO, V318, P311, DOI 10.1016/j.bbrc.2004.04.028; Munteanu A, 2007, IUBMB LIFE, V59, P771, DOI 10.1080/15216540701697420; Nakai K, 2011, EXP DERMATOL, V20, P388, DOI 10.1111/j.1600-0625.2010.01223.x; Nakayama S, 2003, J INVEST DERMATOL, V121, P406, DOI 10.1046/j.1523-1747.2003.12351.x; Negis Y, 2005, IUBMB LIFE, V57, P23, DOI 10.1080/15216540500058980; Negis Y, 2007, BIOCHEM BIOPH RES CO, V359, P348, DOI 10.1016/j.bbrc.2007.05.094; Negis Y, 2006, ARCH BIOCHEM BIOPHYS, V450, P63, DOI 10.1016/j.abb.2006.02.027; Nell S, 2007, FREE RADICAL RES, V41, P930, DOI 10.1080/10715760701416988; Neuzil J, 2006, BIOCHEM BIOPH RES CO, V343, P1113, DOI 10.1016/j.bbrc.2006.03.052; Ni J, 2005, CANCER RES, V65, P9807, DOI 10.1158/0008-5472.CAN-05-1334; Nile AH, 2010, CLIN LIPIDOL, V5, P867, DOI 10.2217/CLP.10.67; Nishio K, 2011, FREE RADICAL BIO MED, V50, P1794, DOI 10.1016/j.freeradbiomed.2011.03.021; Panagabko C, 2003, BIOCHEMISTRY-US, V42, P6467, DOI 10.1021/bi034086v; Pepper MS, 2000, DEV DYNAM, V218, P507, DOI 10.1002/1097-0177(200007)218:3<507::AID-DVDY1012>3.0.CO;2-5; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Prior SJ, 2006, AM J PHYSIOL-HEART C, V290, pH1848, DOI 10.1152/ajpheart.01033.2005; Ren B, 2011, BLOOD, V117, P6036, DOI 10.1182/blood-2010-12-326017; Ricciarelli R, 2000, CIRCULATION, V102, P82, DOI 10.1161/01.CIR.102.1.82; Rigotti A, 2007, MOL ASPECTS MED, V28, P423, DOI 10.1016/j.mam.2007.01.002; Rossiter H, 2007, FASEB J, V21, P3994, DOI 10.1096/fj.07-8720com; Saito K, 2007, BBA-MOL CELL BIOL L, V1771, P719, DOI 10.1016/j.bbalip.2007.02.010; Schaaf G, 2008, MOL CELL, V29, P191, DOI 10.1016/j.molcel.2007.11.026; Schaaf G, 2006, ACTA CRYSTALLOGR F, V62, P1156, DOI 10.1107/S1744309106041728; Shan L, 2011, INFLAMMATION; Shiau CW, 2006, J BIOL CHEM, V281, P11819, DOI 10.1074/jbc.M511015200; Shibata N, 2001, P NATL ACAD SCI USA, V98, P2244, DOI 10.1073/pnas.041620398; Smolarek AK, 2011, NUTRIENTS, V3, P962, DOI 10.3390/nu3110962; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Upadhyay J, 2009, BIOINFORMATION, V3, P326, DOI 10.6026/97320630003326; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Zingg JM, 2007, MINI-REV MED CHEM, V7, P543; Zingg JM, 2012, BIOFACTORS, V38, P24, DOI 10.1002/biof.198; Zingg JM, 2010, FREE RADICAL BIO MED, V49, P1989, DOI 10.1016/j.freeradbiomed.2010.09.034; Zingg JM, 2010, MOL NUTR FOOD RES, V54, P679, DOI 10.1002/mnfr.200900404; Zingg JM, 2008, BIOCHIMIE, V90, P1703, DOI 10.1016/j.biochi.2008.07.008; Zingg JM, 2006, PHYTOCHEMICALS NUTR, P175	70	19	19	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101550	10.1371/journal.pone.0101550	http://dx.doi.org/10.1371/journal.pone.0101550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983950	Green Submitted, gold, Green Published			2022-12-27	WOS:000339635000119
J	Zhang, R; Wan, XJ; Zhang, X; Kang, QX; Bian, JJ; Yu, GF; Wang, JF; Zhu, KM				Zhang, Ran; Wan, Xiao-jian; Zhang, Xu; Kang, Qiu-xiang; Bian, Jin-jun; Yu, Gui-fang; Wang, Jia-feng; Zhu, Ke-ming			Plasma HSPA12B Is a Potential Predictor for Poor Outcome in Severe Sepsis	PLOS ONE			English	Article							COMMUNITY-ACQUIRED SEPSIS; C-REACTIVE PROTEIN; ATRIAL-FIBRILLATION; EPIDEMIOLOGY; INTERLEUKIN-10; BIOMARKERS; MORTALITY; PROCALCITONIN; DYSFUNCTION; THERAPY	Introduction: Endothelium-derived molecules may be predictive to organ injury. Heat shock protein (HSP) A12B is mainly located in endothelial cells, which can be detected in the plasma of septic patients. Whether it is correlated with prognosis of sepsis remains unclear. Methods: Extracellular HSPA12B (eHSPA12B) was determined in plasma of septic mice at 6h, 12h, 24h and 48h after cecal ligation and puncture (CLP). It was also detected in plasma of patients with severe sepsis, sepsis, systemic inflammatory response syndrome and healthy volunteers. The predictive value for prognosis of severe sepsis was assessed by receiver operating curve (ROC) and Cox regression analyses. Results: eHSPA12B was elevated in plasma of CLP mice at 6h and peaked at 24h after surgery. A total of 118 subjects were included in the clinical section, including 66 patients with severe sepsis, 21 patients with sepsis, 16 patients with SIRS and 15 volunteers. Plasma eHSPA12B was significantly higher in patients with severe sepsis than in patients with sepsis, SIRS and volunteers. The level of eHSPA12B was also higher in non-survivals than survivals with severe sepsis. The area under the curve (AUC) of eHSPA12B in predicting death among patients with severe sepsis was 0.782 (0.654-0.909) in ROC analysis, much higher than that of IL-6 and IL-10. Cox regression analysis showed that cardiovascular diseases, IL-6 and eHSPA12B were risk factors for mortality in patients with severe sepsis. Survival curve demonstrated a strikingly significant difference between 28-day survival rates of patients with an eHSPA12B lower or not lower than 1.466ng/ml. Conclusions: Plasma eHSPA12B is elevated in both septic mice and patients. It may be a good predictor for poor outcome in patients with severe sepsis.	[Zhang, Ran; Wan, Xiao-jian; Zhang, Xu; Kang, Qiu-xiang; Bian, Jin-jun; Wang, Jia-feng; Zhu, Ke-ming] Second Mil Med Univ, Dept Anesthesiol & Intens Care Med, Changhai Hosp, Shanghai, Peoples R China; [Yu, Gui-fang] Shanghai Jiao Tong Univ, Dept Anesthesiol, Peoples Hosp 3, Shanghai 200030, Peoples R China	Naval Medical University; Shanghai Jiao Tong University	Wang, JF (corresponding author), Second Mil Med Univ, Dept Anesthesiol & Intens Care Med, Changhai Hosp, Shanghai, Peoples R China.	jfwang@smmu.edu.cn; kmzhu@aliyun.com		Wang, Jia-feng/0000-0002-1753-6499	National Natural Science Foundation of China [81270128, 81201493]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (81270128 to Dr. KM Zhu and 81201493 to Dr. JF Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Brun-Buisson C, 2004, INTENS CARE MED, V30, P580, DOI 10.1007/s00134-003-2121-4; Cardoso T, 2010, CRIT CARE, V14, DOI 10.1186/cc9008; Cheng BL, 2007, CRIT CARE MED, V35, P2538, DOI 10.1097/01.CCM.0000284492.30800.00; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Engel C, 2007, INTENS CARE MED, V33, P606, DOI 10.1007/s00134-006-0517-7; Gibot S, 2012, AM J RESP CRIT CARE, V186, P65, DOI 10.1164/rccm.201201-0037OC; Gouel-Cheron A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033095; Guitton C, 2011, INTENS CARE MED, V37, P950, DOI 10.1007/s00134-011-2171-y; Han ZH, 2003, P NATL ACAD SCI USA, V100, P1256, DOI 10.1073/pnas.252764399; Harrison DA, 2006, CRIT CARE, V10, DOI 10.1186/cc4854; Heper Y, 2006, EUR J CLIN MICROBIOL, V25, P481, DOI 10.1007/s10096-006-0168-1; Hu G, 2006, J CELL SCI, V119, P4117, DOI 10.1242/jcs.03179; Jacob ST, 2012, CRIT CARE MED, V40, P2050, DOI 10.1097/CCM.0b013e31824e65d7; Lefrant JY, 2010, ANN FR ANESTH, V29, P621, DOI 10.1016/j.annfar.2010.04.007; Levy MM, 2012, LANCET INFECT DIS, V12, P919, DOI 10.1016/S1473-3099(12)70239-6; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Ma YJ, 2013, BBA-MOL BASIS DIS, V1832, P57, DOI 10.1016/j.bbadis.2012.10.003; Manley MO, 2005, SHOCK, V23, P521, DOI 10.1097/01.shk.0000161386.23817.7f; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Miguel-Bayarri V, 2012, MED INTENSIVA, V36, P556, DOI 10.1016/j.medin.2012.01.014; Ogawa K, 2012, CELL STRESS CHAPERON, V17, P349, DOI 10.1007/s12192-011-0310-6; Ricciuto DR, 2011, CRIT CARE MED, V39, P702, DOI 10.1097/CCM.0b013e318206d285; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rivers EP, 2013, SHOCK, V39, P127, DOI 10.1097/SHK.0b013e31827dafa7; Rose WE, 2012, J INFECT DIS, V206, P1604, DOI 10.1093/infdis/jis552; Sands Kenneth E., 1997, JAMA (Journal of the American Medical Association), V278, P234, DOI 10.1001/jama.278.3.234; Seymour CW, 2010, CHEST, V137, P1289, DOI 10.1378/chest.09-2661; Skibsted S, 2013, SHOCK, V39, P427, DOI 10.1097/SHK.0b013e3182903f0d; Suarez D, 2011, INTENS CARE MED, V37, P444, DOI 10.1007/s00134-010-2102-3; Walkey AJ, 2013, AM HEART J, V165, P949, DOI 10.1016/j.ahj.2013.03.020; Walkey AJ, 2011, JAMA-J AM MED ASSOC, V306, P2248, DOI 10.1001/jama.2011.1615; Wang HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048307; Wang JF, 2010, BIOCHEM BIOPH RES CO, V394, P184, DOI 10.1016/j.bbrc.2010.02.145; Ware LB, 2004, AM J RESP CRIT CARE, V170, P766, DOI 10.1164/rccm.200310-1434OC; Yeh CH, 2009, LEUKEMIA RES, V33, P212, DOI 10.1016/j.leukres.2008.07.012; Zhou HM, 2011, CARDIOVASC RES, V89, P109, DOI 10.1093/cvr/cvq268; Zhu JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035523	38	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101215	10.1371/journal.pone.0101215	http://dx.doi.org/10.1371/journal.pone.0101215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977412	Green Published, gold, Green Submitted			2022-12-27	WOS:000338506400101
J	Zhang, W; Song, W; Zhang, ZQ; Wang, HD; Yang, MM; Guo, RJ; Li, ML				Zhang, Wei; Song, Wang; Zhang, Zhengqing; Wang, Haidong; Yang, Miaomiao; Guo, Ruijian; Li, Menglou			Transcriptome Analysis of Dastarcus helophoroides (Coleoptera: Bothrideridae) Using Illumina HiSeq Sequencing	PLOS ONE			English	Article							RNA-SEQ; GENOME; TOOL; INFECTION; DATABASE	Background: Dastarcus helophoroides is known as the most valuable natural enemy insect against many large-body longhorned beetles. The molecular mechanism of its long lifespan and reproduction makes it a unique resource for genomic research. However, molecular biological studies on this parasitic beetle are scarce, and genomic information for D. helophoroides is not currently available. Thus, transcriptome information for this species is an important resource that is required for a better understanding of the molecular mechanisms of D. helophoroides. In this study, we obtained transcriptome information of D. helophoroides using high-throughput RNA sequencing. Results: Using Illumina HiSeq 2000 sequencing, 27,543,746 clean reads corresponding to a total of 2.48 Gb nucleotides were obtained from a single run. These reads were assembled into 42,810 unigenes with a mean length of 683 bp. Using a sequence similarity search against the five public databases (NR, Swiss-Prot, GO, COG, KEGG) with a cut-off E-value of 10(-5) using Blastx, a total of 31,293 unigenes were annotated with gene description, gene ontology terms, or metabolic pathways. Conclusions: To the best of our knowledge, this is the first study on the transcriptome information of D. helophoroides. The transcriptome data presented in this study provide comprehensive information for future studies in D. helophoroides, particularly for functional genomic studies in this parasitic beetle.	[Zhang, Wei; Song, Wang; Zhang, Zhengqing; Guo, Ruijian; Li, Menglou] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China; [Wang, Haidong] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Lab Agrozool, B-9000 Ghent, Belgium; [Yang, Miaomiao] Shaanxi Inst Zool, Xian, Shaanxi, Peoples R China	Northwest A&F University - China; Ghent University	Li, ML (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China.	limenglou@hotmail.com	Sunny, QI/M-5188-2019	Sunny, QI/0000-0002-5817-1609	National Natural Sciences Foundation of China [31170608]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the National Natural Sciences Foundation of China (No. 31170608). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1971, INSECT SOC; Attardo GM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-160; BENNETT MD, 2003, ANN BOT, V91, P1; BOZINA K. D., 1961, PCHELOVODSTVO, V38, P13; Burke GR, 2011, INSECT MOL BIOL, V20, P357, DOI 10.1111/j.1365-2583.2011.01070.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hollodobler B., 1990, ANTS; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jiang SN, 1989, LONGHORNED BEETLES C; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; [雷琼 Lei Qiong], 2003, [西北农林科技大学学报. 自然科学版, Journal of northwest sci-tech university of agriculture and forestry], V31, P62; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Mittapalli O, 2011, PLOS ONE, V5; Miura K., 2003, Journal of the Japanese Forestry Society, V85, P12; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Pu FJ, 1980, EC INSECT FAUNA CHIN, VXIX; Qin X.-x., 1988, Entomological Knowledge, V25, P109; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Urano Tadahisa, 2003, Bulletin of the Forestry and Forest Products Research Institute, V2, P255; Wang HD, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.28; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang Ximeng, 1996, Acta Agriculturae Boreali-Occidentalis Sinica, V5, P75; Wang YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018644; Wei JR, 2009, BIOCONTROL, V54, P733, DOI 10.1007/s10526-009-9224-y; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; [张翌楠 Zhang Yinan], 2006, [植物保护, Plant Protection], V32, P9	35	15	16	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100673	10.1371/journal.pone.0100673	http://dx.doi.org/10.1371/journal.pone.0100673			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979346	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400037
J	Zhang, WQ; Han, XX; An, MH; Zhao, B; Hu, QH; Chu, ZX; Xu, JC; Cai, WP; Chen, X; Fu, JH; Wang, Z; Wu, JJ; Lu, L; Zhuang, MH; Wu, H; Yan, HJ; Liao, C; Takebe, Y; Shang, H				Zhang, Weiqing; Han, Xiaoxu; An, Minghui; Zhao, Bin; Hu, Qinghai; Chu, Zhenxing; Xu, Jiancheng; Cai, Weiping; Chen, Xi; Fu, Jihua; Wang, Zhe; Wu, Jianjun; Lu, Lin; Zhuang, Minghua; Wu, Hao; Yan, Hongjing; Liao, Christina; Takebe, Yutaka; Shang, Hong			Identification and Characterization of a Novel HIV-1 Circulating Recombinant Form (CRF59_01B) Identified among Men-Who-Have-Sex-with-Men in China	PLOS ONE			English	Article							LENGTH SEQUENCE-ANALYSIS; INJECTING DRUG-USERS; SUBTYPE B; TYPE-1; THAILAND; GENOME; MSM; INFECTION; MALAYSIA; ASIA	The HIV-1 epidemic among men-who-have-sex-with-men (MSM) continues to expand in China. A large-scale national survey we conducted on HIV-1 strains among MSM in 11 provinces in China from 2008 to 2013 (n = 920) identified a novel transmission cluster consisting of six strains (0.7%) that belonged to a new circulating recombinant form (designated CRF59_01B). CRF59_01B contains two subtype B segments of U.S.-European origin (in the pol and vpu-env regions) in a CRF01_AE backbone. CRF59_01B is the second CRF (after CRF55_01B) circulating primarily among MSM in China. CRF59_01B occurs at a low frequency (less than 1%), but it was detected in four different provinces/regions in China: Liaoning (northeast China) (n = 3); Hunan (central China) (n = 1); Guangdong (south China) (n = 1); Yunnan (southwest China) (n = 1). One additional recombinant strain was detected in a heterosexual individual in Liaoning province but is not the focus of this paper. Bayesian molecular clock analyses indicate that CRF59_01B emerged as a result of recombination between CRF01_AE and subtype B around the year 2001. The emergence of multiple forms of recombinants and CRFs reflects the ever-increasing contribution of homosexual transmission in China's HIV epidemic and indicates an active HIV transmission network among MSM in China.	[Zhang, Weiqing; Han, Xiaoxu; An, Minghui; Zhao, Bin; Hu, Qinghai; Chu, Zhenxing; Xu, Jiancheng; Liao, Christina; Takebe, Yutaka; Shang, Hong] China Med Univ, Hosp 1, Dept Lab Med, Key Lab AIDS Immunol Natl Hlth & Family Planning, Shenyang, Peoples R China; [Zhang, Weiqing; Han, Xiaoxu; An, Minghui; Zhao, Bin; Hu, Qinghai; Chu, Zhenxing; Xu, Jiancheng; Liao, Christina; Takebe, Yutaka; Shang, Hong] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Takebe, Yutaka] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan; [Cai, Weiping] Guangzhou 8 Renmin Hosp, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China; [Chen, Xi] Hunan Prov Ctr Dis Control & Prevent, AIDS STIs Prevent & Control Dept, Changsha, Hunan, Peoples R China; [Fu, Jihua] Shandong Prov Ctr Dis Control & Prevent, Sexually Transmitted Dis & AIDS Dept, Jinan, Peoples R China; [Wang, Zhe] Henan Prov Ctr Dis Control & Prevent, Zhengzhou, Peoples R China; [Wu, Jianjun] Anhui Prov Ctr Dis Control & Prevent, Sexually Transmitted Dis & AIDS Dept, Hefei, Peoples R China; [Lu, Lin] Yunnan Prov Ctr Dis Control & Prevent, Kunming, Peoples R China; [Zhuang, Minghua] Shanghai Municipal Ctr Dis Control & Prevent, Sexually Transmitted Dis & AIDS Dept, Shanghai, Peoples R China; [Wu, Hao] Capital Med Univ, Beijing Youan Hosp, Dept Infect Dis, Beijing, Peoples R China; [Yan, Hongjing] Jiangsu Prov Ctr Dis Control & Prevent, Sexually Transmitted Dis & AIDS Prevent & Control, Nanjing, Jiangsu, Peoples R China	China Medical University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; National Institute of Infectious Diseases (NIID); Shanghai Center for Disease Control & Prevention; Capital Medical University; Jiangsu Provincial Center for Disease Control & Prevention	Takebe, Y (corresponding author), China Med Univ, Hosp 1, Dept Lab Med, Key Lab AIDS Immunol Natl Hlth & Family Planning, Shenyang, Peoples R China.	takebe@nih.go.jp; hongshang100@hotmail.com	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	Mega-projects of National Science Research for the 12th Five-Year Plan [2012ZX10001-006]; Liaoning Province Department of Higher Education Programme for Excellence in Research [LJQ2012068]; Bill and Melinda Gates Foundation; Development Programme of the innovative group by Ministry of Education, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China	Mega-projects of National Science Research for the 12th Five-Year Plan; Liaoning Province Department of Higher Education Programme for Excellence in Research; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Development Programme of the innovative group by Ministry of Education, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China	This work was supported by Mega-projects of National Science Research for the 12th Five-Year Plan (2012ZX10001-006), Liaoning Province Department of Higher Education Programme for Excellence in Research 2012 (LJQ2012068), Bill and Melinda Gates Foundation, Development Programme of the innovative group by Ministry of Education, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An MH, 2012, J VIROL, V86, P12402, DOI 10.1128/JVI.00262-12; [Anonymous], GENOME ANNOUNC; China. MoHotPsRo, 2010, CHIN 2010 UNGASS COU; Chow WZ, 2012, J VIROL, V86, P11398, DOI 10.1128/JVI.01932-12; Guo HX, 2009, SEX TRANSM DIS, V36, P120, DOI 10.1097/OLQ.0b013e31818d3fa0; Han X., 2013, J ACQUIR IMMUNE DEFI; He X., 2012, PLOS ONE, V7; KALISH ML, 1995, AIDS, V9, P851, DOI 10.1097/00002030-199508000-00004; Kirchherr JL, 2007, J VIROL METHODS, V143, P104, DOI 10.1016/j.jviromet.2007.02.015; Li Y, 2010, JAIDS-J ACQ IMM DEF, V54, P129, DOI 10.1097/QAI.0b013e3181d82ce5; Li Y, 2010, VIROLOGY, V402, P223, DOI 10.1016/j.virol.2010.03.048; Liu YJ, 2012, AIDS RES HUM RETROV, V28, P1357, DOI 10.1089/aid.2011.0376; Liu YJ, 2011, AIDS RES HUM RETROV, V27, P445, DOI 10.1089/aid.2010.0212; Ministry of Health PsRoC HIV/AIDS JUNPo Organization WH, 2011, 2011 EST HIV AIDS EP; [Ministry of Health PsRoCJUNPoHAWHO CDC C], 2006, 2005 UPD HIV AIDS EP; Ng KT, 2012, J VIROL, V86, P11405, DOI 10.1128/JVI.01949-12; Ng OT, 2012, AIDS RES HUM RETROV, V28, P527, DOI [10.1089/aid.2011.0177, 10.1089/AID.2011.0177]; OU CY, 1993, LANCET, V341, P1171, DOI 10.1016/0140-6736(93)91001-3; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; SahBandar IN, 2011, AIDS RES HUM RETROV, V27, P97, DOI 10.1089/aid.2010.0163; Shang H, 2012, NATURE, V485, P576, DOI 10.1038/485576a; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Tovanabutra S, 2003, AIDS RES HUM RETROV, V19, P561, DOI 10.1089/088922203322230923; Tovanabutra S, 2007, AIDS RES HUM RETROV, V23, P829, DOI 10.1089/aid.2006.0300; van Griensven F, 2010, AIDS, V24, pS30, DOI 10.1097/01.aids.0000390087.22565.b4; Van Heuverswyn F, 2006, NATURE, V444, P164, DOI 10.1038/444164a; Wang WH, 2008, AIDS RES HUM RETROV, V24, P1245, DOI 10.1089/aid.2008.0095; Wang WH, 2012, AIDS RES HUM RETROV, V28, P411, DOI [10.1089/aid.2011.0196, 10.1089/AID.2011.0196]; Wu JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054322; Xu JJ, 2010, SEX TRANSM DIS, V37, P432, DOI 10.1097/OLQ.0b013e3181d13eed; Zhang BC, 2005, CELL RES, V15, P858, DOI 10.1038/sj.cr.7290359; Zhang L. R., 2013, PLOS ONE, V8; Zhang XY, 2007, AIDS, V21, pS59, DOI 10.1097/01.aids.0000304698.47261.b1	34	22	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e99693	10.1371/journal.pone.0099693	http://dx.doi.org/10.1371/journal.pone.0099693			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978029	Green Published, gold, Green Submitted			2022-12-27	WOS:000338506400007
J	Puhl, HL; Lu, VB; Won, YJ; Sasson, Y; Hirsch, JA; Ono, F; Ikeda, SR				Puhl, Henry L., III; Lu, Van B.; Won, Yu-Jin; Sasson, Yehezkel; Hirsch, Joel A.; Ono, Fumihito; Ikeda, Stephen R.			Ancient Origins of RGK Protein Function: Modulation of Voltage-Gated Calcium Channels Preceded the Protostome and Deuterostome Split	PLOS ONE			English	Article							GTP-BINDING PROTEINS; BETA-SUBUNIT; RAS-SUPERFAMILY; CA2+ CHANNELS; FAMILY; EXPRESSION; REM2; MEMBER; SURFACE; GENE	RGK proteins, Gem, Rad, Rem1, and Rem2, are members of the Ras superfamily of small GTP-binding proteins that interact with Ca2+ channel beta subunits to modify voltage-gated Ca2+ channel function. In addition, RGK proteins affect several cellular processes such as cytoskeletal rearrangement, neuronal dendritic complexity, and synapse formation. To probe the phylogenetic origins of RGK protein-Ca2+ channel interactions, we identified potential RGK-like protein homologs in genomes for genetically diverse organisms from both the deuterostome and protostome animal superphyla. RGK-like protein homologs cloned from Danio rerio (zebrafish) and Drosophila melanogaster (fruit flies) expressed in mammalian sympathetic neurons decreased Ca2+ current density as reported for expression of mammalian RGK proteins. Sequence alignments from evolutionarily diverse organisms spanning the protostome/deuterostome divide revealed conservation of residues within the RGK G-domain involved in RGK protein - Ca-v beta subunit interaction. In addition, the C-terminal eleven residues were highly conserved and constituted a signature sequence unique to RGK proteins but of unknown function. Taken together, these data suggest that RGK proteins, and the ability to modify Ca2+ channel function, arose from an ancestor predating the protostomes split from deuterostomes approximately 550 million years ago.	[Puhl, Henry L., III; Lu, Van B.; Won, Yu-Jin; Ikeda, Stephen R.] NIAAA, Lab Mol Physiol, Sect Transmitter Signaling, NIH, Rockville, MD 20852 USA; [Ono, Fumihito] NIAAA, Lab Mol Physiol, Sect Model Synapt Syst, NIH, Rockville, MD 20852 USA; [Sasson, Yehezkel; Hirsch, Joel A.] Tel Aviv Univ, Fac Life Sci, Inst Biol Struct, Dept Biochem & Mol Biol, Ramat Aviv, Israel	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Tel Aviv University	Ikeda, SR (corresponding author), NIAAA, Lab Mol Physiol, Sect Transmitter Signaling, NIH, Rockville, MD 20852 USA.	sikeda@mail.nih.gov	Hirsch, Joel/AAC-8000-2021	Hirsch, Joel/0000-0001-7544-8668; Puhl, Henry/0000-0003-3095-7201; Lu, Van/0000-0002-4880-6455; ono, fumihito/0000-0001-7532-5262; Ikeda, Stephen/0000-0002-4088-9508	National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism; Israel Science Foundation [1519/12]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000430, ZIAAA000437] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Israel Science Foundation(Israel Science Foundation); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the intramural program at the National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism. YS and JAH were supported by the Israel Science Foundation (grant 1519/12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Beguin P, 2007, J BIOL CHEM, V282, P11509, DOI 10.1074/jbc.M606423200; Chen HM, 2005, J NEUROSCI, V25, P9762, DOI 10.1523/JNEUROSCI.3111-05.2005; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Correll RN, 2008, CELL SIGNAL, V20, P400, DOI 10.1016/j.cellsig.2007.10.029; Correll RN, 2008, CELL SIGNAL, V20, P292, DOI 10.1016/j.cellsig.2007.10.028; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DelVillar K, 1996, BIOCHEM SOC T, V24, P709; Dorin D, 1995, ONCOGENE, V11, P2267; Edel MJ, 2010, CELL CYCLE, V9, P3414, DOI 10.4161/cc.9.17.12719; Fan MM, 2010, P NATL ACAD SCI USA, V107, P14887, DOI 10.1073/pnas.1007543107; de Velasco EMF, 2009, ZEBRAFISH, V6, P259, DOI 10.1089/zeb.2009.0594; Finlin BS, 2006, J BIOL CHEM, V281, P23557, DOI 10.1074/jbc.M604867200; Finlin BS, 1997, J BIOL CHEM, V272, P21982, DOI 10.1074/jbc.272.35.21982; Finlin BS, 2000, BIOCHEM J, V347, P223, DOI 10.1042/0264-6021:3470223; Fischer R, 1996, J BIOL CHEM, V271, P25067, DOI 10.1074/jbc.271.41.25067; Flynn R, 2010, CHANNELS, V4, P434, DOI 10.4161/chan.4.6.12865; Ghiretti AE, 2011, DEV NEUROBIOL, V71, P374, DOI 10.1002/dneu.20868; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hollis DM, 2012, COMP BIOCHEM PHYS B, V161, P93, DOI 10.1016/j.cbpb.2011.09.011; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Ikeda SR, 2004, METHOD ENZYMOL, V389, P170; Ikeda Stephen R, 2004, Methods Mol Biol, V259, P167; Kelly K, 2005, TRENDS CELL BIOL, V15, P640, DOI 10.1016/j.tcb.2005.10.002; Krey JF, 2013, NAT NEUROSCI, V16, P201, DOI 10.1038/nn.3307; Leung YF, 2005, ZEBRAFISH, V2, P269, DOI 10.1089/zeb.2005.2.269; Leyris JP, 2009, FASEB J, V23, P2627, DOI 10.1096/fj.08-122135; Lu Van B, 2009, J Vis Exp, DOI 10.3791/1614; MAGUIRE J, 1994, SCIENCE, V265, P241, DOI 10.1126/science.7912851; Manning JR, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000459; Rojas AM, 2012, J CELL BIOL, V196, P189, DOI 10.1083/jcb.201103008; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Moore AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074751; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012; REYNET C, 1993, SCIENCE, V262, P1441, DOI 10.1126/science.8248782; Sasson Y, 2011, J MOL BIOL, V413, P372, DOI 10.1016/j.jmb.2011.08.017; Shimizu-Nishikawa K, 2001, DEV DYNAM, V220, P74, DOI 10.1002/1097-0177(20010101)220:1<74::AID-DVDY1090>3.0.CO;2-Q; Veldman MB, 2007, DEV BIOL, V312, P596, DOI 10.1016/j.ydbio.2007.09.019; Ward Y, 2004, MOL CELL BIOL, V24, P651, DOI 10.1128/MCB.24.2.651-661.2004; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Yang T, 2007, NAT CHEM BIOL, V3, P795, DOI 10.1038/nchembio.2007.42; Yang TT, 2013, BBA-BIOMEMBRANES, V1828, P1644, DOI 10.1016/j.bbamem.2012.10.005; Yang TT, 2010, J PHYSIOL-LONDON, V588, P1665, DOI 10.1113/jphysiol.2010.187203; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029; Zhang J, 2011, CARDIOVASC RES, V91, P90, DOI 10.1093/cvr/cvr068; Zhou WB, 2008, DEV DYNAM, V237, P3842, DOI 10.1002/dvdy.21776; ZHU Y, 1993, J NEUROPHYSIOL, V70, P610, DOI 10.1152/jn.1993.70.2.610	51	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100694	10.1371/journal.pone.0100694	http://dx.doi.org/10.1371/journal.pone.0100694			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992013	gold, Green Submitted, Green Published			2022-12-27	WOS:000341253400027
J	Foster, SD; Griffin, DA; Dunstan, PK				Foster, Scott D.; Griffin, David A.; Dunstan, Piers K.			Twenty Years of High-Resolution Sea Surface Temperature Imagery around Australia: Inter-Annual and Annual Variability	PLOS ONE			English	Article							CLIMATE-CHANGE; MARINE ECOSYSTEMS; SMOOTHING SPLINES; LEEUWIN CURRENT; TRENDS; ICE	The physical climate defines a significant portion of the habitats in which biological communities and species reside. It is important to quantify these environmental conditions, and how they have changed, as this will inform future efforts to study many natural systems. In this article, we present the results of a statistical summary of the variability in sea surface temperature (SST) time-series data for the waters surrounding Australia, from 1993 to 2013. We partition variation in the SST series into annual trends, inter-annual trends, and a number of components of random variation. We utilise satellite data and validate the statistical summary from these data to summaries of data from long-term monitoring stations and from the global drifter program. The spatially dense results, available as maps from the Australian Oceanographic Data Network's data portal (http://www.cmar.csiro.au/geonetwork/srv/en/metadata.show?id = 51805), show clear trends that associate with oceanographic features. Noteworthy oceanographic features include: average warming was greatest off southern West Australia and off eastern Tasmania, where the warming was around 0.60C per decade for a twenty year study period, and insubstantial warming in areas dominated by the East Australian Current, but this area did exhibit high levels of inter-annual variability (long-term trend increases and decreases but does not increase on average). The results of the analyses can be directly incorporated into (biogeographic) models that explain variation in biological data where both biological and environmental data are on a fine scale.	[Foster, Scott D.; Dunstan, Piers K.] CSIROs Wealth Oceans Flagship, Hobart, Tas, Australia; [Griffin, David A.] CSIROs Marine & Atmospher Res, Hobart, Tas, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Foster, SD (corresponding author), CSIROs Wealth Oceans Flagship, Hobart, Tas, Australia.	scott.foster@csiro.au	Foster, Scott D/E-9311-2010; Dunstan, Piers K/B-7309-2016	Foster, Scott D/0000-0002-6719-8002; Dunstan, Piers K/0000-0002-2568-5945	Marine Biodiversity Hub through Australian Government's National Environmental Research Program (NERP)	Marine Biodiversity Hub through Australian Government's National Environmental Research Program (NERP)	SDF and PKD were supported by the Marine Biodiversity Hub, a collaborative partnership supported through funding from the Australian Government's National Environmental Research Program (NERP). NERP Marine Biodiversity Hub partners include the Institute for Marine and Antarctic Studies, University of Tasmania; CSIRO Wealth from Oceans National Flagship, Geoscience Australia, Australian Institute of Marine Science, Museum Victoria, Charles Darwin University and the University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban NC, 2012, CONSERV BIOL, V26, P799, DOI 10.1111/j.1523-1739.2012.01894.x; Baumann H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067596; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Cane MA, 1997, SCIENCE, V275, P957, DOI 10.1126/science.275.5302.957; Chollett I, 2012, MAR POLLUT BULL, V64, P956, DOI 10.1016/j.marpolbul.2012.02.016; Cresswell GR, 2004, MAR FRESHWATER RES, V55, P267, DOI 10.1071/MF03115; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Dunn JR, 2002, DEEP-SEA RES PT I, V49, P591, DOI 10.1016/S0967-0637(01)00069-3; Feng M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01277; Gordon C, 2000, CLIM DYNAM, V16, P147, DOI 10.1007/s003820050010; Griffn D, 2004, DECADE SST SATELLITE; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hobday AJ, 2013, REV FISH BIOL FISHER; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Huber P. H., 1981, ROBUST STAT; Lough J., 2008, GEOPHYS RES LETT, V35; Lough JM, 2011, MAR FRESHWATER RES, V62, P984, DOI 10.1071/MF10272; Maslin M, 2012, NATURE, V486, P183, DOI 10.1038/486183a; Morton R, 2009, ENVIRONMETRICS, V20, P249, DOI 10.1002/env.925; Neter J., 1996, APPL LINEAR STAT MOD; O'Kane TJ, 2011, OCEAN MODEL, V38, P251, DOI 10.1016/j.ocemod.2011.04.003; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; Payne MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030105; Pearce A, 2007, MAR FRESHWATER RES, V58, P914, DOI 10.1071/MF07082; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Pinheiro J, 2001, MIXED EFFECTS MODELS; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Ridgway K., 2007, GEOPHYS RES LETT, V34; Rochford D, 1988, CSIRO SEA, P45; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rousseeuw P, 2011, WIRES DATA MINING KN, V1; SAUNDERS RW, 1988, INT J REMOTE SENS, V9, P123, DOI 10.1080/01431168808954841; Suthers IM, 2011, DEEP-SEA RES PT II, V58, P538, DOI 10.1016/j.dsr2.2010.09.029; van Sebille E, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051004; Venables WN., 2002, MODERN APPL STAT S 4; Verbyla AP, 1999, J ROY STAT SOC C-APP, V48, P269, DOI 10.1111/1467-9876.00154; Weatherhead EC, 1998, J GEOPHYS RES-ATMOS, V103, P17149, DOI 10.1029/98JD00995; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wu LX, 2012, NAT CLIM CHANGE, V2, P161, DOI 10.1038/NCLIMATE1353	40	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100762	10.1371/journal.pone.0100762	http://dx.doi.org/10.1371/journal.pone.0100762			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988444	Green Published, gold, Green Submitted			2022-12-27	WOS:000341354100042
J	Gourraud, PA; Khankhanian, P; Cereb, N; Yang, SY; Feolo, M; Maiers, M; Rioux, JD; Hauser, S; Oksenberg, J				Gourraud, Pierre-Antoine; Khankhanian, Pouya; Cereb, Nezih; Yang, Soo Young; Feolo, Michael; Maiers, Martin; Rioux, John D.; Hauser, Stephen; Oksenberg, Jorge			HLA Diversity in the 1000 Genomes Dataset	PLOS ONE			English	Article							HIGH-RESOLUTION HLA; EXTENDED HUMAN MHC; MULTIPLE-SCLEROSIS; LINKAGE DISEQUILIBRIUM; LOCI; ASSOCIATION; ALLELES; MAP; IMMUNOGENETICS; INFORMATION	The 1000 Genomes Project aims to provide a deep characterization of human genome sequence variation by sequencing at a level that should allow the genome-wide detection of most variants with frequencies as low as 1%. However, in the major histocompatibility complex (MHC), only the top 10 most frequent haplotypes are in the 1% frequency range whereas thousands of haplotypes are present at lower frequencies. Given the limitation of both the coverage and the read length of the sequences generated by the 1000 Genomes Project, the highly variable positions that define HLA alleles may be difficult to identify. We used classical Sanger sequencing techniques to type the HLA-A, HLA-B, HLA-C, HLA-DRB1 and HLA-DQB1 genes in the available 1000 Genomes samples and combined the results with the 103,310 variants in the MHC region genotyped by the 1000 Genomes Project. Using pairwise identity-by-descent distances between individuals and principal component analysis, we established the relationship between ancestry and genetic diversity in the MHC region. As expected, both the MHC variants and the HLA phenotype can identify the major ancestry lineage, informed mainly by the most frequent HLA haplotypes. To some extent, regions of the genome with similar genetic or similar recombination rate have similar properties. An MHC-centric analysis underlines departures between the ancestral background of the MHC and the genome-wide picture. Our analysis of linkage disequilibrium (LD) decay in these samples suggests that overestimation of pairwise LD occurs due to a limited sampling of the MHC diversity. This collection of HLA-specific MHC variants, available on the dbMHC portal, is a valuable resource for future analyses of the role of MHC in population and disease studies.	[Gourraud, Pierre-Antoine; Khankhanian, Pouya; Hauser, Stephen; Oksenberg, Jorge] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Cereb, Nezih; Yang, Soo Young] Histogenetics Inc, Ossining, NY USA; [Feolo, Michael] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA; [Maiers, Martin] Natl Marrow Donor Program, Minneapolis, MN USA; [Rioux, John D.] Univ Montreal, Inst Cardiol Montreal, Montreal, PQ, Canada	University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Marrow Donor Program; Universite de Montreal; Institut de Cardiologie de Montreal	Gourraud, PA (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	pierreantoine.gourraud@ucsf.edu	Rioux, John D/A-9599-2015; Gourraud, Pierre-Antoine FD/O-3024-2015	Rioux, John D/0000-0001-7560-8326; Maiers, Martin/0000-0002-0198-2064; Gourraud, Pierre-Antoine/0000-0003-1131-9554	National Institute of Health [U19AI067152, RO1NS076492, RO1NS046297]; Office of Naval Research [N00014-11-1-0339]; Race to erase MS Junior Investigator Award; European Federation for Immunogenetics Julia Bodmer Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046297, R01NS076492] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); Race to erase MS Junior Investigator Award; European Federation for Immunogenetics Julia Bodmer Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institute of Health U19AI067152 (ARRA administrative supplement), RO1NS076492, RO1NS046297, and from the Office of Naval Research N00014-11-1-0339. PAG is a recipient of the Race to erase MS Junior Investigator Award and the European Federation for Immunogenetics Julia Bodmer Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, NATURE, V467, P1061, DOI DOI 10.1038/NATURE09534; Browning SR, 2010, AM J HUM GENET, V86, P526, DOI 10.1016/j.ajhg.2010.02.021; Bugawan TL, 2000, TISSUE ANTIGENS, V56, P392, DOI 10.1034/j.1399-0039.2000.560502.x; Cano P, 2007, HUM IMMUNOL, V68, P392, DOI 10.1016/j.humimm.2007.01.014; Chaix R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000184; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Cozen W, 2012, BLOOD, V119, P469, DOI 10.1182/blood-2011-03-343921; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; Genome C, 2014, LIST SAMPL PHAS 1 IN; Genome C, 2014, 1000 GEN FTP DAT REL; Genome C, 2014, REF GEN SEQ 1000 GEN; Gourraud PA, 2005, HUM IMMUNOL, V66, P563, DOI 10.1016/j.humimm.2005.01.011; Gourraud PA, 2012, STEM CELLS, V30, P180, DOI 10.1002/stem.772; Gragert L, 2013, HUM IMMUNOL, V74, P1313, DOI 10.1016/j.humimm.2013.06.025; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Iqbal Z, 2012, NAT GENET, V44, P226, DOI 10.1038/ng.1028; Khankhanian P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-626; Maiers M, 2007, HUM IMMUNOL, V68, P779, DOI 10.1016/j.humimm.2007.04.005; Major E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078410; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Marsh SGE, 2012, TISSUE ANTIGENS, V80, P72, DOI 10.1111/j.1399-0039.2012.01882.x; McCormack M, 2011, NEW ENGL J MED, V364, P1134, DOI 10.1056/NEJMoa1013297; McElroy JP, 2010, HUM MOL GENET, V19, P3080, DOI 10.1093/hmg/ddq197; Meyer D, 2007, P 13 INT HIST WORKSH, V1, P653; Meyer D, 2006, GENETICS, V173, P2121, DOI 10.1534/genetics.105.052837; NCBI, 2014, DBMHC IMM PORT; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Petersdorf EW, 2008, CURR OPIN IMMUNOL, V20, P588, DOI 10.1016/j.coi.2008.06.014; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; Robinson J, 2011, NUCLEIC ACIDS RES, V39, pD1171, DOI 10.1093/nar/gkq998; Sanchez-Mazas A, 2011, IMMUNOLOGY, V133, P143, DOI 10.1111/j.1365-2567.2011.03438.x; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Software B, 2014, BEAGL FORM DAT; Susal Caner, 2012, Methods Mol Biol, V882, P267, DOI 10.1007/978-1-61779-842-9_15; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; van Rood J, 2008, BONE MARROW TRANSPL, V41, P1, DOI 10.1038/sj.bmt.1705866; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1	41	113	114	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e97282	10.1371/journal.pone.0097282	http://dx.doi.org/10.1371/journal.pone.0097282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988075	Green Published, gold, Green Submitted			2022-12-27	WOS:000341354100006
J	Hurtado-Gonzales, JL; Loew, ER; Uy, JAC				Hurtado-Gonzales, Jorge L.; Loew, Ellis R.; Uy, J. Albert C.			Variation in the Visual Habitat May Mediate the Maintenance of Color Polymorphism in a Poeciliid Fish	PLOS ONE			English	Article							ALTERNATIVE MATING STRATEGIES; DIVERGENT SEXUAL SELECTION; LAKE VICTORIA CICHLIDS; BLUEFIN KILLIFISH; ENVIRONMENTAL VARIATION; INTRASPECIFIC VARIATION; LIGHTING ENVIRONMENT; AMBIENT LIGHT; MATE CHOICE; REEF FISH	The conspicuousness of animal signals is influenced by their contrast against the background. As such, signal conspicuousness will tend to vary in nature because habitats are composed of a mosaic of backgrounds. Variation in attractiveness could result in variation in conspecific mate choice and risk of predation, which, in turn, may create opportunities for balancing selection to maintain distinct polymorphisms. We quantified male coloration, the absorbance spectrum of visual pigments and the photic environment of Poecilia parae, a fish species with five distinct male color morphs: a drab (i.e., grey), a striped, and three colorful (i.e., blue, red and yellow) morphs. Then, using physiological models, we assessed how male color patterns can be perceived in their natural visual habitats by conspecific females and a common cichlid predator, Aequidens tetramerus. Our estimates of chromatic and luminance contrasts suggest that the three most colorful morphs were consistently the most conspicuous across all habitats. However, variation in the visual background resulted in variation in which morph was the most conspicuous to females at each locality. Likewise, the most colorful morphs were the most conspicuous morphs to cichlid predators. If females are able to discriminate between conspicuous prospective mates and those preferred males are also more vulnerable to predation, variable visual habitats could influence the direction and strength of natural and sexual selection, thereby allowing for the persistence of color polymorphisms in natural environments.	[Hurtado-Gonzales, Jorge L.; Uy, J. Albert C.] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA; [Loew, Ellis R.] Cornell Univ, Dept Biomed Sci, Ithaca, NY USA; [Uy, J. Albert C.] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA	Syracuse University; Cornell University; University of Miami	Hurtado-Gonzales, JL (corresponding author), Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA.	hurtadje@ucmail.uc.edu		Uy, J. Albert C./0000-0002-8437-5525	NSF CAREER [1137624]; College of Arts and Sciences at Syracuse University	NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); College of Arts and Sciences at Syracuse University	This work was funded by a NSF CAREER grant (1137624) to JACU and the College of Arts and Sciences at Syracuse University to JACU and JLHG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; ARCHER SN, 1990, VISION RES, V30, P225, DOI 10.1016/0042-6989(90)90038-M; ARCHER SN, 1987, VISION RES, V27, P1243, DOI 10.1016/0042-6989(87)90200-8; Banks AN, 2001, TRENDS ECOL EVOL, V16, P473, DOI 10.1016/S0169-5347(01)02245-5; Blows MW, 2003, EVOLUTION, V57, P1622, DOI 10.1111/j.0014-3820.2003.tb00369.x; Bond AB, 2007, ANNU REV ECOL EVOL S, V38, P489, DOI 10.1146/annurev.ecolsys.38.091206.095728; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Bourne GR, 2003, NATURWISSENSCHAFTEN, V90, P402, DOI 10.1007/s00114-003-0444-1; Carleton KL, 2005, MOL ECOL, V14, P4341, DOI 10.1111/j.1365-294X.2005.02735.x; Cheney KL, 2009, BEHAV ECOL, V20, P459, DOI 10.1093/beheco/arp017; Chiao CC, 2011, P NATL ACAD SCI USA, V108, P9148, DOI 10.1073/pnas.1019090108; Chunco AJ, 2007, EVOLUTION, V61, P2504, DOI 10.1111/j.1558-5646.2007.00213.x; Cummings ME, 2003, P ROY SOC B-BIOL SCI, V270, P897, DOI 10.1098/rspb.2003.2334; Dalton BE, 2010, J EXP BIOL, V213, P2243, DOI 10.1242/jeb.037671; Darwin C., 1871, P423; ENDLER JA, 1991, VISION RES, V31, P587, DOI 10.1016/0042-6989(91)90109-I; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Endler JA, 1996, AM NAT, V148, P421, DOI 10.1086/285934; Fuller RC, 2005, J EVOLUTION BIOL, V18, P516, DOI 10.1111/j.1420-9101.2005.00886.x; Fuller RC, 2003, J COMP PHYSIOL A, V189, P609, DOI 10.1007/s00359-003-0435-x; Fuller RC, 2004, EVOLUTION, V58, P1086; Fuller RC, 2002, P ROY SOC B-BIOL SCI, V269, P1457, DOI 10.1098/rspb.2002.2042; Fuller RC, 2011, MOL ECOL, V20, P3321, DOI 10.1111/j.1365-294X.2011.05180.x; Fuller RC, 2010, ANIM BEHAV, V80, P23, DOI 10.1016/j.anbehav.2010.03.017; Gamble S, 2003, ECOL LETT, V6, P463, DOI 10.1046/j.1461-0248.2003.00449.x; Gomez D, 2012, PROGRAM ANAL SPECTRO; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Gray SM, 2008, P ROY SOC B-BIOL SCI, V275, P1785, DOI 10.1098/rspb.2008.0283; Hastad O, 2005, P NATL ACAD SCI USA, V102, P6391, DOI 10.1073/pnas.0409228102; HESTER FJ, 1968, VISION RES, V8, P1315, DOI 10.1016/0042-6989(68)90053-9; Hoffmann M, 2007, P ROY SOC B-BIOL SCI, V274, P33, DOI 10.1098/rspb.2006.3707; HOUDE AE, 1987, EVOLUTION, V41, P1, DOI 10.1111/j.1558-5646.1987.tb05766.x; Hurtado-Gonzales JL, 2010, J EVOLUTION BIOL, V23, P1293, DOI 10.1111/j.1420-9101.2010.01995.x; Hurtado-Gonzales JL, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-391; Hurtado-Gonzales JL, 2009, ANIM BEHAV, V77, P1187, DOI 10.1016/j.anbehav.2008.12.032; Kemp DJ, 2008, BIOL J LINN SOC, V95, P734, DOI 10.1111/j.1095-8312.2008.01112.x; KIRSCH M, 1989, VISION RES, V29, P389, DOI 10.1016/0042-6989(89)90003-5; Kroger RHH, 1999, VISION RES, V39, P2441, DOI 10.1016/S0042-6989(98)00256-9; Lackey ACR, 2013, J EVOLUTION BIOL, V26, P1611, DOI 10.1111/jeb.12173; Laver CRJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-81; Leal M, 2002, P ROY SOC B-BIOL SCI, V269, P351, DOI 10.1098/rspb.2001.1904; Lettieri L, 2009, J EXP BIOL, V212, P2194, DOI 10.1242/jeb.025478; LEVINE JS, 1979, SENS PROCESS, V3, P95; LEVINE JS, 1979, SCIENCE, V204, P523, DOI 10.1126/science.432658; Liley N. R., 1966, Behaviour Suppl, V13, P1; Lindholm AK, 2004, HEREDITY, V92, P156, DOI 10.1038/sj.hdy.6800386; LIPETZ LE, 1988, VISION RES, V28, P1083, DOI 10.1016/0042-6989(88)90135-6; LOEW ER, 1994, VISION RES, V34, P1427, DOI 10.1016/0042-6989(94)90143-0; Loew ER, 2002, J EXP BIOL, V205, P927; Lythgoe J.N., 1979, ECOLOGY VISION; Maan ME, 2006, AM NAT, V167, P947, DOI 10.1086/503532; MACNICHOL EF, 1986, VISION RES, V26, P1543, DOI 10.1016/0042-6989(86)90174-4; Mansfield RJW, 1985, VIS SYST P S HON EF; Marshall N. Justin, 2003, P194, DOI 10.1007/978-0-387-22628-6_10; MCDONALD CG, 1995, J COMP PHYSIOL A, V176, P255; MCFARLAND WN, 1975, VISION RES, V15, P1063, DOI 10.1016/0042-6989(75)90002-4; Morehouse NI, 2010, AM NAT, V176, P768, DOI 10.1086/657043; MUNTZ WRA, 1970, VISION RES, V10, P281, DOI 10.1016/0042-6989(70)90100-8; Owens GL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005970; Pignatelli V, 2010, BIOL LETTERS, V6, P537, DOI 10.1098/rsbl.2009.1010; PRESS WH, 1986, NUMERICAL RECIPES AR; Rennison DJ, 2011, J EXP BIOL, V214, P3248, DOI 10.1242/jeb.057836; Rosenthal GG, 2001, AM NAT, V158, P146, DOI 10.1086/321309; Seehausen O, 1998, BEHAV ECOL SOCIOBIOL, V42, P1, DOI 10.1007/s002650050405; Thery M, 2002, NATURE, V415, P133, DOI 10.1038/415133a; Uy JAC, 2007, J EVOLUTION BIOL, V20, P1847, DOI 10.1111/j.1420-9101.2007.01378.x; Uy JAC, 2004, BEHAV ECOL, V15, P1003, DOI 10.1093/beheco/arh106; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Ward MN, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-210; Watson CT, 2011, J MOL EVOL, V72, P240, DOI 10.1007/s00239-010-9426-z; Watson CT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-87; Weadick CJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S11; Weadick CJ, 2012, MOL BIOL EVOL, V29, P3045, DOI 10.1093/molbev/mss115; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412	76	15	17	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101497	10.1371/journal.pone.0101497	http://dx.doi.org/10.1371/journal.pone.0101497			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987856	Green Submitted, Green Published, gold			2022-12-27	WOS:000341354100100
J	Rinne, LF; Mazzocco, MMM				Rinne, Luke F.; Mazzocco, Michele M. M.			Knowing Right from Wrong in Mental Arithmetic Judgments: Calibration of Confidence Predicts the Development of Accuracy	PLOS ONE			English	Article							ERROR-RELATED NEGATIVITY; INDIVIDUAL-DIFFERENCES; LEARNING-DISABILITIES; WORKING-MEMORY; SCHOOL; ACHIEVEMENT; STUDENTS; CHILDREN; MATH; OVERCONFIDENCE	Does knowing when mental arithmetic judgments are right-and when they are wrong-lead to more accurate judgments over time? We hypothesize that the successful detection of errors (and avoidance of false alarms) may contribute to the development of mental arithmetic performance. Insight into error detection abilities can be gained by examining the "calibration" of mental arithmetic judgments-that is, the alignment between confidence in judgments and the accuracy of those judgments. Calibration may be viewed as a measure of metacognitive monitoring ability. We conducted a developmental longitudinal investigation of the relationship between the calibration of children's mental arithmetic judgments and their performance on a mental arithmetic task. Annually between Grades 5 and 8, children completed a problem verification task in which they rapidly judged the accuracy of arithmetic expressions (e. g., 25+50 = 75) and rated their confidence in each judgment. Results showed that calibration was strongly related to concurrent mental arithmetic performance, that calibration continued to develop even as mental arithmetic accuracy approached ceiling, that poor calibration distinguished children with mathematics learning disability from both low and typically achieving children, and that better calibration in Grade 5 predicted larger gains in mental arithmetic accuracy between Grades 5 and 8. We propose that good calibration supports the implementation of cognitive control, leading to long-term improvement in mental arithmetic accuracy. Because mental arithmetic "fluency" is critical for higher-level mathematics competence, calibration of confidence in mental arithmetic judgments may represent a novel and important developmental predictor of future mathematics performance.	[Rinne, Luke F.] Johns Hopkins Univ, Sch Educ, Baltimore, MD USA; [Mazzocco, Michele M. M.] Univ Minnesota, Inst Child Dev, Minneapolis, MN 55455 USA	Johns Hopkins University; University of Minnesota System; University of Minnesota Twin Cities	Mazzocco, MMM (corresponding author), Univ Minnesota, Inst Child Dev, 51 E River Rd, Minneapolis, MN 55455 USA.	mazzocco@umn.edu	Mazzocco, Michele/AAI-5597-2021		Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01 HD34061]	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The original study for which data were collected was funded by grant R01 HD34061 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (https://www.nichd.nih.gov). MM was the recipient of this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P., 2000, CLIN NEUROPSYCHOL AS, V1, P247; Ansari D, 2011, LEARN INDIVID DIFFER, V21, P636, DOI 10.1016/j.lindif.2011.07.013; BEGG IM, 1992, EUR J COGN PSYCHOL, V4, P195, DOI 10.1080/09541449208406182; Bol L., 2010, J RES ED, V21, P81; Bol L, 2012, CONTEMP EDUC PSYCHOL, V37, P280, DOI 10.1016/j.cedpsych.2012.02.004; Braet W, 2009, NEUROPSYCHOLOGIA, V47, P3143, DOI 10.1016/j.neuropsychologia.2009.07.018; Brenner LA, 1996, ORGAN BEHAV HUM DEC, V65, P212, DOI 10.1006/obhd.1996.0021; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Butler AC, 2008, J EXP PSYCHOL LEARN, V34, P918, DOI 10.1037/0278-7393.34.4.918; BUTLER DL, 1995, REV EDUC RES, V65, P245, DOI 10.3102/00346543065003245; Butterfield B., 2006, METACOGN LEARN, V1, P69, DOI [10.1007/s11409-006-6894-z, DOI 10.1007/S11409-006-6894-Z, https://doi.org/10.1007/s11409-006-6894-z]; Desmet C, 2012, Q J EXP PSYCHOL, V65, P1059, DOI 10.1080/17470218.2011.648943; Dunlosky J, 2013, LEARN INSTR, V24, P58, DOI 10.1016/j.learninstruc.2012.05.002; Dunlosky J, 2012, LEARN INSTR, V22, P271, DOI 10.1016/j.learninstruc.2011.08.003; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Garrett Adia J, 2006, Learn Disabil Res Pract, V21, P77, DOI 10.1111/j.1540-5826.2006.00208.x; Geary DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054651; GIGERENZER G, 1991, PSYCHOL REV, V98, P506, DOI 10.1037/0033-295X.98.4.506; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; HYDE JS, 1990, PSYCHOL BULL, V107, P139, DOI 10.1037/0033-2909.107.2.139; Jordan NC, 2009, DEV PSYCHOL, V45, P850, DOI 10.1037/a0014939; KEREN G, 1991, ACTA PSYCHOL, V77, P217, DOI 10.1016/0001-6918(91)90036-Y; Lachance JA, 2006, LEARN INDIVID DIFFER, V16, P195, DOI 10.1016/j.lindif.2005.12.001; LICHTENSTEIN S, 1977, ORGAN BEHAV HUM PERF, V20, P159, DOI 10.1016/0030-5073(77)90001-0; Lichtenstein S., 1982, JUDGMENT UNCERTAINTY, P306, DOI [DOI 10.1017/CBO9780511809477, DOI 10.1017/CBO9780511809477.023]; Luna B, 2010, BRAIN COGNITION, V72, P101, DOI 10.1016/j.bandc.2009.08.005; Mazzocco MMM, 2008, DEVELOPMENTAL SCI, V11, P681, DOI 10.1111/j.1467-7687.2008.00717.x; Mazzocco Michele M M, 2005, Learn Disabil Res Pract, V20, P142, DOI 10.1111/j.1540-5826.2005.00129.x; Mazzocco MMM, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00486; Mazzocco MMM, 2003, ANN DYSLEXIA, V53, P218, DOI 10.1007/s11881-003-0011-7; Mazzocco MMM, 2002, J APPL SOC PSYCHOL, V32, P1577, DOI 10.1111/j.1559-1816.2002.tb02763.x; Miller AE, 2012, J EXP PSYCHOL LEARN, V38, P757, DOI 10.1037/a0026595; Murphy MM, 2008, J LEARN DISABIL-US, V41, P29, DOI 10.1177/0022219407311038; Nietfeld J.L., 2006, METACOGN LEARN, V1, P159, DOI [10.1007/s10409-006-9595-6, DOI 10.1007/S10409-006-9595-6]; Pieschl S, 2009, METACOGN LEARN, V4, P3, DOI 10.1007/s11409-008-9030-4; Price GR, 2013, J NEUROSCI, V33, P156, DOI 10.1523/JNEUROSCI.2936-12.2013; Rabe-Hesketh S., 2012, MULTILEVEL LONGITUDI; Rosenzweig C, 2011, J LEARN DISABIL-US, V44, P508, DOI 10.1177/0022219410378445; Schneider W, 2008, MIND BRAIN EDUC, V2, P114, DOI 10.1111/j.1751-228X.2008.00041.x; Schoenfeld A. H., 1992, HDB RES MATH TEACHIN, P334; Siegler RS, 2012, PSYCHOL SCI, V23, P691, DOI 10.1177/0956797612440101; Themanson JR, 2012, BRAIN COGNITION, V80, P257, DOI 10.1016/j.bandc.2012.07.003; Veenman M.V.J., 2006, METACOGN LEARN, V1, P3, DOI [DOI 10.1007/S11409-006-6893-0, 10.1007/s11409-006-6893-0]; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wessel JR, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00088; Woodcock R.W., 1989, WOODCOCK JOHNSON PSY; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI 10.1037/0033-295x.111.4.931; Zbrodoff N. J., 2004, HDB MATH COGNITION, P331	48	38	38	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e98663	10.1371/journal.pone.0098663	http://dx.doi.org/10.1371/journal.pone.0098663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BA	24988539	Green Published, gold			2022-12-27	WOS:000341354100011
J	Armstrong, D; Dregan, A				Armstrong, David; Dregan, Alex			A Population-Based Investigation into the Self-Reported Reasons for Sleep Problems	PLOS ONE			English	Article							INSOMNIA; DISTURBANCES; EPIDEMIOLOGY; PREVALENCE; PREDICTORS; COHORT	Typologies of sleep problems have usually relied on identifying underlying causes or symptom clusters. In this study the value of using the patient's own reasons for sleep disturbance are explored. Using secondary data analysis of a nationally representative psychiatric survey the patterning of the various reasons respondents provided for self-reported sleep problems were examined. Over two thirds (69.3%) of respondents could identify a specific reason for their sleep problem with worry (37.9%) and illness (20.1%) representing the most commonly reported reasons. And while women reported more sleep problems for almost every reason compared with men, the patterning of reasons by age showed marked variability. Sleep problem symptoms such as difficulty getting to sleep or waking early also showed variability by different reasons as did the association with major correlates such as worry, depression, anxiety and poor health. While prevalence surveys of 'insomnia' or 'poor sleep' often assume the identification of an underlying homogeneous construct there may be grounds for recognising the existence of different sleep problem types particularly in the context of the patient's perceived reason for the problem.	[Armstrong, David; Dregan, Alex] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London, England; [Dregan, Alex] Guys & St Thomas Natl Hlth Serv Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr, London, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Dregan, A (corresponding author), Kings Coll London, Dept Primary Care & Publ Hlth Sci, London, England.	alexandru.dregan@kcl.ac.uk	Armstrong, David/AAI-4476-2021	Armstrong, David/0000-0003-3652-9662; Dregan, Alex/0000-0002-7620-4902	AHRC; BBSRC; EPSRC; ESRC; MRC [RES-339-25-009]	AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	AHRC, BBSRC, EPSRC, ESRC, and MRC Grant no. RES-339-25-009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders MP, 2013, EUR J PUBLIC HLTH; Billiard M, 2004, SLEEP MED, V5, pS35, DOI 10.1016/S1389-9457(04)90006-8; Bultmann U, 2013, EUR J PUBLIC HEALTH, V23, P123, DOI 10.1093/eurpub/ckr207; Dregan A, 2011, INT PSYCHOGERIATR, V23, P1413, DOI 10.1017/S1041610211000664; Dregan A, 2010, J ADOLESCENT HEALTH, V46, P482, DOI 10.1016/j.jadohealth.2009.11.197; Dregan A, 2009, SOC SCI MED, V69, P1432, DOI 10.1016/j.socscimed.2009.08.041; Foley DJ, 1999, SLEEP, V22, pS366; Hislop Jenny, 2006, AGE MATTERS REALIGNI, P225, DOI DOI 10.4324/9780203943434; Leger D, 2005, CURR MED RES OPIN, V21, P1785, DOI 10.1185/030079905X65637; MORGAN K, 1988, AGE AGEING, V17, P1, DOI 10.1093/ageing/17.1.1; Ohayon MM, 2010, SLEEP MED, V11, P980, DOI 10.1016/j.sleep.2010.07.012; Ohayon MM, 2009, SLEEP MED, V10, P952, DOI 10.1016/j.sleep.2009.07.008; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Ohayon MM, 2001, J PSYCHOSOM RES, V51, P745, DOI 10.1016/S0022-3999(01)00285-9; Roberts RE, 1999, PSYCHOSOM MED, V61, P188, DOI 10.1097/00006842-199903000-00011; Singleton N., 2000, TECHNICAL REPORT; Tang NKY, 2004, BEHAV RES THER, V42, P27, DOI 10.1016/S0005-7967(03)00068-8; Taylor DJ, 2005, SLEEP, V28, P1457, DOI 10.1093/sleep/28.11.1457; Voderholzer U, 2003, DEPRESS ANXIETY, V17, P162, DOI 10.1002/da.10101; WEYERER S, 1991, SLEEP, V14, P392	20	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101368	10.1371/journal.pone.0101368	http://dx.doi.org/10.1371/journal.pone.0101368			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1UX	24983754	gold, Green Published, Green Submitted			2022-12-27	WOS:000339635000097
J	Craig, DPA; Varnon, CA; Sokolowski, MBC; Wells, H; Abramson, CI				Craig, David Philip Arthur; Varnon, Christopher A.; Sokolowski, Michel B. C.; Wells, Harrington; Abramson, Charles I.			An Assessment of Fixed Interval Timing in Free-Flying Honey Bees (Apis mellifera ligustica): An Analysis of Individual Performance	PLOS ONE			English	Article							FORAGING BUMBLEBEES; FLOWER CONSTANCY; MEMORY DYNAMICS; REINFORCEMENT; SCHEDULES; BEHAVIOR; ECOLOGY; TIME; HUMMINGBIRDS; INVERTEBRATE	Interval timing is a key element of foraging theory, models of predator avoidance, and competitive interactions. Although interval timing is well documented in vertebrate species, it is virtually unstudied in invertebrates. In the present experiment, we used free-flying honey bees (Apis mellifera ligustica) as a model for timing behaviors. Subjects were trained to enter a hole in an automated artificial flower to receive a nectar reinforcer (i.e. reward). Responses were continuously reinforced prior to exposure to either a fixed interval (FI) 15-sec, FI 30-sec, FI 60-sec, or FI 120-sec reinforcement schedule. We measured response rate and post-reinforcement pause within each fixed interval trial between reinforcers. Honey bees responded at higher frequencies earlier in the fixed interval suggesting subject responding did not come under traditional forms of temporal control. Response rates were lower during FI conditions compared to performance on continuous reinforcement schedules, and responding was more resistant to extinction when previously reinforced on FI schedules. However, no "scalloped" or "break-and-run" patterns of group or individual responses reinforced on FI schedules were observed; no traditional evidence of temporal control was found. Finally, longer FI schedules eventually caused all subjects to cease returning to the operant chamber indicating subjects did not tolerate the longer FI schedules.	[Craig, David Philip Arthur; Varnon, Christopher A.; Abramson, Charles I.] Oklahoma State Univ, Dept Psychol, Stillwater, OK 74078 USA; [Sokolowski, Michel B. C.] Univ Picardie Jules Verne, Dept Psychol, Amiens, Picardy, France; [Wells, Harrington] Univ Tulsa, Dept Biol, Tulsa, OK 74104 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Picardie Universites; Universite de Picardie Jules Verne (UPJV); University of Tulsa	Abramson, CI (corresponding author), Oklahoma State Univ, Dept Psychol, Stillwater, OK 74078 USA.	charles.abramson@okstate.edu	Abramson, Charles/AAD-5709-2019	Abramson, Charles/0000-0001-8961-3089; Sokolowski, Michel/0000-0003-0357-1629	National Science Foundation [OISE-1043057]	National Science Foundation(National Science Foundation (NSF))	Parts of this work and its publication have been supported by a grant from the National Science Foundation (OISE-1043057). No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson C. I., 1990, INVERTEBRATE LEARNIN; Abramson CI, 2010, ETHOLOGY, V116, P843, DOI 10.1111/j.1439-0310.2010.01796.x; ABRAMSON CI, 1988, J EXP ANAL BEHAV, V50, P483, DOI 10.1901/jeab.1988.50-483; ABRAMSON CI, 1995, J COMP PSYCHOL, V109, P390, DOI 10.1037/0735-7036.109.4.390; ABRAMSON CI, 1986, J COMP PSYCHOL, V100, P108, DOI 10.1037/0735-7036.100.2.108; Agostino PV, 2011, FRONTIERS INTEGRATIV, V5, P1; AMBLER S, 1976, J MATH PSYCHOL, V14, P53, DOI 10.1016/0022-2496(76)90014-6; BARRETT JE, 1974, J EXP ANAL BEHAV, V22, P561, DOI 10.1901/jeab.1974.22-561; BITTERMAN ME, 1965, AM PSYCHOL, V20, P396, DOI 10.1037/h0022328; BOGDANY FJ, 1978, BEHAV ECOL SOCIOBIOL, V3, P323, DOI 10.1007/BF00303198; Boisvert MJ, 2006, CURR BIOL, V16, P1636, DOI 10.1016/j.cub.2006.06.064; BUTLER CG, 1945, J EXP BIOL, V21, P5; CHENG K, 1993, J EXP PSYCHOL ANIM B, V19, P56, DOI 10.1037/0097-7403.19.1.56; Chittka Lars, 2004, P165; Cnaani J, 2006, ETHOLOGY, V112, P278, DOI 10.1111/j.1439-0310.2006.01174.x; Craig DPA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046729; DEWS PB, 1969, J EXP ANAL BEHAV, V12, P191, DOI 10.1901/jeab.1969.12-191; DEWS PB, 1978, J EXP ANAL BEHAV, V29, P67, DOI 10.1901/jeab.1978.29-67; Dinges CW, 2013, J EXP BIOL, V216, P4124, DOI 10.1242/jeb.090100; DUKICH TD, 1973, J EXP ANAL BEHAV, V20, P281, DOI 10.1901/jeab.1973.20-281; Edgington E.S., 2007, RANDOMIZATION TESTS; ELSMORE TF, 1971, PSYCHON SCI, V23, P371, DOI 10.3758/BF03336158; Endress P. K., 1994, DIVERSITY EVOLUTIONA; ESKIN RM, 1960, AM J PSYCHOL, V73, P417, DOI 10.2307/1420180; Farina WM, 2005, P ROY SOC B-BIOL SCI, V272, P1923, DOI 10.1098/rspb.2005.3172; Ferster C.B., 1957, SCHEDULES REINFORCEM, DOI 10.1037/10627-000; Gegear RJ, 2004, CAN J ZOOL, V82, P587, DOI 10.1139/Z04-029; GILL FB, 1988, ECOLOGY, V69, P1933, DOI 10.2307/1941170; Greggers U, 1997, ANIM LEARN BEHAV, V25, P458, DOI 10.3758/BF03209852; GREGGERS U, 1993, BEHAV ECOL SOCIOBIOL, V32, P17, DOI 10.1007/BF00172219; Grice JW, 2011, OBSERVATION ORIENTED MODELING: ANALYSIS OF CAUSE IN THE BEHAVIORAL SCIENCES, P1; Grice JW, 2012, BEHAV SCI-BASEL, V2, P1, DOI 10.3390/bs2010001; GROSSMANN KE, 1973, J EXP ANAL BEHAV, V20, P105, DOI 10.1901/jeab.1973.20-105; HEINRICH B, 1979, ECOLOGY, V60, P245, DOI 10.2307/1937652; Henderson J, 2006, CURR BIOL, V16, P512, DOI 10.1016/j.cub.2006.01.054; Higa JJ, 2004, BEHAV PROCESS, V67, P501, DOI 10.1016/j.beproc.2004.08.007; Hill PSM, 2001, ANIM BEHAV, V62, P729, DOI 10.1006/anbe.2001.1775; HILLS TT, 2003, METH NE FRO NEUROSCI, P77; Hut RA, 2011, PHILOS T R SOC B, V366, P2141, DOI 10.1098/rstb.2010.0409; JOHNSON DL, 1966, ANIM BEHAV, V14, P261, DOI 10.1016/S0003-3472(66)80081-7; Kleniginna P. R., 1979, BIOL PSYCHOL, V21, P14; KOLTERMANN R, 1971, Z VERGL PHYSIOL, V75, P49, DOI 10.1007/BF00335137; LAURENT E, 1985, BEHAV PROCESS, V10, P159, DOI 10.1016/0376-6357(85)90128-7; LEJEUNE H, 1991, LEARN MOTIV, V22, P84, DOI 10.1016/0023-9690(91)90018-4; Lihoreau M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001392; Lihoreau M, 2010, AM NAT, V176, P744, DOI 10.1086/657042; Linnaeus C, 1756, CALENDARIUM FLORAE; LOWE CF, 1977, J EXP ANAL BEHAV, V28, P189, DOI 10.1901/jeab.1977.28-189; MacDonald CJ, 2005, FUNCTIONAL NEURAL ME, P401; MARDEN JH, 1981, PHYSIOL ENTOMOL, V6, P431, DOI 10.1111/j.1365-3032.1981.tb00658.x; MECHNER F, 1963, J EXP ANAL BEHAV, V6, P323, DOI 10.1901/jeab.1963.6-323; MORSE WH, 1956, ANN NY ACAD SCI, V65, P303, DOI 10.1111/j.1749-6632.1956.tb49641.x; PARKER GA, 1990, NATURE, V348, P27, DOI 10.1038/348027a0; Percival MS., 1965, FLORAL BIOL; Perry CJ, 2013, WIRES COGN SCI, V4, P561, DOI 10.1002/wcs.1248; Raine NE, 2007, ENTOMOL GEN, V29, P179; Reinhard J, 2004, NATURE, V427, P411, DOI 10.1038/427411a; Richelle M., 1980, TIME ANIMAL BEHAV; Rosbash M, 2009, PLOS BIOL, V7, P421, DOI 10.1371/journal.pbio.1000062; Sanderson CE, 2006, ETHOLOGY, V112, P937, DOI 10.1111/j.1439-0310.2006.01245.x; Saunders D.S., 1976, INSECT CLOCKS; SCHNEIDE.BA, 1969, J EXP ANAL BEHAV, V12, P677, DOI 10.1901/jeab.1969.12-677; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; Skinner B. F., 1938, BEHAV ORGAN EXP ANAL; Skorupski P, 2006, CURR BIOL, V16, pR851, DOI 10.1016/j.cub.2006.08.069; Sokolowski MBC, 2010, J NEUROSCI METH, V188, P235, DOI 10.1016/j.jneumeth.2010.02.013; Stephens D.W., 1986, pi; Talton LE, 1999, BEHAV PROCESS, V45, P193, DOI 10.1016/S0376-6357(99)00018-2; VISSCHER PK, 1982, ECOLOGY, V63, P1790, DOI 10.2307/1940121; WADDINGTON KD, 1979, AM NAT, V114, P179, DOI 10.1086/283467; Wagner AE, 2013, J EXP BIOL, V216, P1131, DOI 10.1242/jeb.064881; Wainselboim AJ, 2003, J COMP PHYSIOL A, V189, P39, DOI 10.1007/s00359-002-0373-z; WELLS H, 1994, J APICULT RES, V33, P219, DOI 10.1080/00218839.1994.11100875; WELLS H, 1992, ECOL ENTOMOL, V17, P280, DOI 10.1111/j.1365-2311.1992.tb01059.x; WELLS H, 1983, J ANIM ECOL, V52, P829, DOI 10.2307/4457; WELLS H, 1986, J ANIM ECOL, V55, P881, DOI 10.2307/4422; WENNER AM, 1969, SCIENCE, V164, P84, DOI 10.1126/science.164.3875.84; Woelfle MA, 2004, CURR BIOL, V14, P1481, DOI 10.1016/j.cub.2004.08.023; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660	79	25	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101262	10.1371/journal.pone.0101262	http://dx.doi.org/10.1371/journal.pone.0101262			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983960	Green Published, Green Submitted, gold			2022-12-27	WOS:000339635000080
J	Dewland, TA; Glidden, DV; Marcus, GM				Dewland, Thomas A.; Glidden, David V.; Marcus, Gregory M.			Healthcare Utilization and Clinical Outcomes after Catheter Ablation of Atrial Flutter	PLOS ONE			English	Article							SOCIETY-OF-CARDIOLOGY; RADIOFREQUENCY ABLATION; FIBRILLATION; REHOSPITALIZATIONS; ARRHYTHMIAS; MANAGEMENT; CONVERSION; STROKE; RISK	Atrial flutter ablation is associated with a high rate of acute procedural success and symptom improvement. The relationship between ablation and other clinical outcomes has been limited to small studies primarily conducted at academic centers. We sought to determine if catheter ablation of atrial flutter is associated with reductions in healthcare utilization, atrial fibrillation, or stroke in a large, real world population. California Healthcare Cost and Utilization Project databases were used to identify patients undergoing atrial flutter ablation between 2005 and 2009. The adjusted association between atrial flutter ablation and healthcare utilization, atrial fibrillation, or stroke was investigated using Cox proportional hazards models. Among 33,004 patients with a diagnosis of atrial flutter observed for a median of 2.1 years, 2,733 (8.2%) underwent catheter ablation. Atrial flutter ablation significantly lowered the adjusted risk of inpatient hospitalization (HR 0.88, 95% CI 0.84-0.92, p<0.001), emergency department visits (HR 0.60, 95% CI 0.54-0.65, p<0.001), and overall hospital-based healthcare utilization (HR 0.94, 95% CI 0.90-0.98, p = 0.001). Atrial flutter ablation was also associated with a statistically significant 11% reduction in the adjusted hazard of atrial fibrillation (HR 0.89, 95% CI 0.81-0.97, p = 0.01). Risk of acute stroke was not significantly reduced after ablation (HR 1.09, 95% CI 0.81-1.45, p = 0.57). In a large, real world population, atrial flutter ablation was associated with significant reductions in hospital-based healthcare utilization and a reduced risk of atrial fibrillation. These findings support the early use of catheter ablation for the treatment of atrial flutter.	[Dewland, Thomas A.; Marcus, Gregory M.] Univ Calif San Francisco, Div Cardiol, Dept Internal Med, Electrophysiol Sect, San Francisco, CA 94117 USA; [Glidden, David V.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Marcus, GM (corresponding author), Univ Calif San Francisco, Div Cardiol, Dept Internal Med, Electrophysiol Sect, San Francisco, CA 94117 USA.	marcusg@medicine.ucsf.edu	Glidden, David/AAD-4730-2020; Marcus, Gregory/AAN-8584-2021	Marcus, Gregory/0000-0001-5197-7696; Glidden, David/0000-0001-5888-1419	American Heart Association [12POST11810036, 12GRNT11780061]; Joseph Drown Foundation [12POST11810036, 12GRNT11780061]	American Heart Association(American Heart Association); Joseph Drown Foundation	This work was made possible by grant numbers 12POST11810036 (TAD) and 12GRNT11780061 (GMM) from the American Heart Association, and by the Joseph Drown Foundation (GMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blomstrom-Lundqvist C, 2003, CIRCULATION, V108, P1871, DOI 10.1161/01.CIR.0000091380.04100.84; Brousseau DC, 2010, JAMA-J AM MED ASSOC, V303, P1288, DOI 10.1001/jama.2010.378; Calkins H, 2004, AM J CARDIOL, V94, P437, DOI 10.1016/j.amjcard.2004.04.058; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Da Costa A, 2006, CIRCULATION, V114, P1676, DOI 10.1161/CIRCULATIONAHA.106.638395; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Lee SH, 1999, AM J CARDIOL, V84, P278, DOI 10.1016/S0002-9149(99)00276-3; Morton JB, 2002, CIRCULATION, V105, P258, DOI 10.1161/hc0202.102012; Natale A, 2000, J AM COLL CARDIOL, V35, P1898, DOI 10.1016/S0735-1097(00)00635-5; O'Callaghan PA, 2001, HEART, V86, P167, DOI 10.1136/heart.86.2.167; Roithinger FX, 1997, CIRCULATION, V96, P3484; Saoudi N, 2001, J CARDIOVASC ELECTR, V12, P852, DOI 10.1046/j.1540-8167.2001.00852.x; Scheinman MM, 2000, PACE, V23, P1020, DOI 10.1111/j.1540-8159.2000.tb00891.x; Shah RU, 2012, J AM COLL CARDIOL, V59, P143, DOI 10.1016/j.jacc.2011.08.068; Tomson TT, 2012, HEART RHYTHM, V9, P1779, DOI 10.1016/j.hrthm.2012.07.013; Waldo AL, 2002, CARDIOVASC RES, V54, P217, DOI 10.1016/S0008-6363(01)00549-1	17	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100509	10.1371/journal.pone.0100509	http://dx.doi.org/10.1371/journal.pone.0100509			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983868	gold, Green Published, Green Submitted			2022-12-27	WOS:000339635000028
J	Fan, J; He, RL; Zhang, YB; Jin, XH				Fan, Jie; He, Runli; Zhang, Yinbo; Jin, Xiaohua			Systematic Significance of Leaf Epidermal Features in Holcoglossum (Orchidaceae)	PLOS ONE			English	Article							COMPARATIVE VEGETATIVE ANATOMY; MOLECULAR PHYLOGENETICS; AERIDINAE; EVOLUTION; TAXONOMY; VANDEAE; PLANTS; WAXES	Determining the generic delimitations within Aeridinae has been a significant issue in the taxonomy of Orchidaceae, and Holcoglossum is a typical case. We investigated the phylogenetic utility of the morphological traits of leaf epidermis in the taxonomy of Holcoglossum s.l. by using light and scanning electron microscopy to analyze 38 samples representing 12 species of Holcoglossum, with five species from five closely related genera, such as Ascocentrum, Luisia, Papilionanthe, Rhynchostylis and Vanda. Our results indicated that Holcoglossum can be distinguished from the related genera based on cuticular wax characteristics, and the inclusion of Holcoglossum himalaicum in Holcoglossum is supported by the epidermis characteristics found by LM and SEM. The percentage of the tetracytic, brachyparacytic, and laterocytic stomata types as well as the stomata index and certain combinations of special wax types support infrageneric clades and phylogenetic relationships that have been inferred from molecular data. Laterocytic and polarcytic stomata are perhaps ecological adaptations to the strong winds and ample rains in the alpine region of the Hengduanshan Mountains.	[Fan, Jie; He, Runli] Shanxi Univ Tradit Chinese Med, Coll Chinese Med, Taiyuan, Peoples R China; [Zhang, Yinbo] Shanxi Univ, Coll Environm Sci & Resources, Taiyuan, Peoples R China; [Jin, Xiaohua] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China	Shanxi University; Chinese Academy of Sciences; Institute of Botany, CAS	Jin, XH (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	xiaohuajin@ibcas.ac.cn						BARANOVA M, 1992, BOT REV, V58, P49, DOI 10.1007/BF02858543; Barthlott W, 1998, BOT J LINN SOC, V126, P237, DOI 10.1111/j.1095-8339.1998.tb02529.x; Carlsward BS, 2006, BOT J LINN SOC, V151, P165, DOI 10.1111/j.1095-8339.2006.00502.x; Carlsward BS, 2006, AM J BOT, V93, P770, DOI 10.3732/ajb.93.5.770; Carpenter KJ, 2005, AM J BOT, V92, P1595, DOI 10.3732/ajb.92.10.1595; CHRISTENSON E A, 1987, Notes from the Royal Botanic Garden Edinburgh, V44, P249; Christenson EA, 1987, P 12 WORLD ORCH C TO, P35; Christenson Eric A., 1998, Lindleyana, V13, P121; DAS S, 1992, BANGLADESH J BOTANY, V21, P65; Dressler R.L., 1981, ORCHIDS NATURAL HIST; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Fan J, 2009, TAXON, V58, P849, DOI 10.1002/tax.583013; Gan Y, 2010, BOT STUD, V51, P325; GARAY L A, 1974, Botanical Museum Leaflets Harvard University, V23, P369; GARAY L A, 1972, BOT MUS LEAFL HARV UNIV, V23, P149; Gardiner LM, 2013, BOT J LINN SOC, V173, P549, DOI 10.1111/boj.12102; Gardiner LM, 2012, PHYTOTAXA, V61, P47, DOI 10.11646/phytotaxa.61.1.4; Hidayat T, 2005, J PLANT RES, V118, P271, DOI 10.1007/s10265-005-0217-3; Jin XH, 2005, BOT J LINN SOC, V149, P465, DOI 10.1111/j.1095-8339.2005.00463.x; Jin XH, 2004, NOVON, V14, P178; Jin XH, 2007, NORD J BOT, V25, P125, DOI 10.1111/j.2007.0107-055X.00018.x; Jin XiaoHua, 2004, Kew Bulletin, V59, P633, DOI 10.2307/4110926; Kaushik P, 1978, THESIS PANJAB U CHAN; Liu ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024864; Pansarin Emerson R., 2008, Boletim de Botanica da Universidade de Sao Paulo, V26, P79; Pridgeon A.M., 2014, GENERA ORCHIDACEARUM, V6; Schlechter R., 1919, FEDDES REPERT SPEC N, V4; Seidenfaden G., 1988, OPERA BOT, V95, P304; SEIDENFADEN G, 1992, OPERA BOT, V114, P441; Stern WL, 2006, BOT J LINN SOC, V152, P91, DOI 10.1111/j.1095-8339.2006.00548.x; TOMLINSON P B, 1974, Taxon, V23, P109, DOI 10.2307/1218094; Tsi Z.H., 1982, ACTA PHYTOTAX SINICA, V20, P439; TSI ZH, 1999, FLORA REIPUBLICAE PO, V19, P269; Wayne MM, 1996, BOT J LINN SOC, V120, P89; Wilkinson, 1979, PLANT SURFACE MAINLY, P97; WILLIAMS NH, 1979, BOT J LINN SOC, V78, P41, DOI 10.1111/j.1095-8339.1979.tb02185.x; Xiang XG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052050; Yang Y, 2012, SYST BOT, V37, P861, DOI 10.1600/036364412X656518	38	6	11	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101557	10.1371/journal.pone.0101557	http://dx.doi.org/10.1371/journal.pone.0101557			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983996	gold, Green Published, Green Submitted			2022-12-27	WOS:000339635000120
J	Osugi, T; Okamura, T; Son, YL; Ohkubo, M; Ubuka, T; Henmi, Y; Tsutsui, K				Osugi, Tomohiro; Okamura, Tomoki; Son, You Lee; Ohkubo, Makoto; Ubuka, Takayoshi; Henmi, Yasuhisa; Tsutsui, Kazuyoshi			Evolutionary Origin of GnIH and NPFF in Chordates: Insights from Novel Amphioxus RFamide Peptides	PLOS ONE			English	Article							GONADOTROPIN-INHIBITORY HORMONE; GROWTH-HORMONE; HYPOTHALAMIC NEUROPEPTIDE; LPXRFAMIDE PEPTIDES; PQRFAMIDE PEPTIDES; MESSENGER-RNA; CDNA CLONING; IDENTIFICATION; LOCALIZATION; RECEPTOR	Gonadotropin-inhibitory hormone (GnIH) is a newly identified hypothalamic neuropeptide that inhibits pituitary hormone secretion in vertebrates. GnIH has an LPXRFamide (X = L or Q) motif at the C-terminal in representative species of gnathostomes. On the other hand, neuropeptide FF (NPFF), a neuropeptide characterized as a pain-modulatory neuropeptide, in vertebrates has a PQRFamide motif similar to the C-terminal of GnIH, suggesting that GnIH and NPFF have diverged from a common ancestor. Because GnIH and NPFF belong to the RFamide peptide family in vertebrates, protochordate RFamide peptides may provide important insights into the evolutionary origin of GnIH and NPFF. In this study, we identified a novel gene encoding RFamide peptides and two genes of their putative receptors in the amphioxus Branchiostoma japonicum. Molecular phylogenetic analysis and synteny analysis indicated that these genes are closely related to the genes of GnIH and NPFF and their receptors of vertebrates. We further identified mature RFamide peptides and their receptors in protochordates. The identified amphioxus RFamide peptides inhibited forskolin induced cAMP signaling in the COS-7 cells with one of the identified amphioxus RFamide peptide receptors expressed. These results indicate that the identified protochordate RFamide peptide gene is a common ancestral form of GnIH and NPFF genes, suggesting that the origin of GnIH and NPFF may date back to the time of the emergence of early chordates. GnIH gene and NPFF gene may have diverged by whole-genome duplication in the course of vertebrate evolution.	[Osugi, Tomohiro; Okamura, Tomoki; Son, You Lee; Ohkubo, Makoto; Ubuka, Takayoshi; Tsutsui, Kazuyoshi] Waseda Univ, Lab Integrat Brain Sci, Dept Biol, Tokyo, Japan; [Osugi, Tomohiro; Okamura, Tomoki; Son, You Lee; Ohkubo, Makoto; Ubuka, Takayoshi; Tsutsui, Kazuyoshi] Waseda Univ, Ctr Med Life Sci, Tokyo, Japan; [Henmi, Yasuhisa] Kumamoto Univ, Ctr Marine Environm Studies, Aitsu Marine Stn, Kumamoto, Japan	Waseda University; Waseda University; Kumamoto University	Tsutsui, K (corresponding author), Waseda Univ, Lab Integrat Brain Sci, Dept Biol, Tokyo, Japan.	k-tsutsui@waseda.jp	Son, You Lee/AAM-3859-2020	Ubuka, Takayoshi/0000-0002-4731-8118; Osugi, Tomohiro/0000-0001-6987-9576; Son, You Lee/0000-0002-3429-5324	Ministry of Education, Science and Culture, Japan [18107002, 22132004, 22227002]; Grants-in-Aid for Scientific Research [22227002] Funding Source: KAKEN	Ministry of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Science and Culture, Japan (18107002, 22132004 and 22227002 to K. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 2006, J ENDOCRINOL, V188, P417, DOI 10.1677/joe.1.06494; Anko ML, 2006, J NEUROCHEM, V96, P573, DOI 10.1111/j.1471-4159.2005.03581.x; Bentley GE, 2010, BRAIN RES, V1364, P62, DOI 10.1016/j.brainres.2010.10.001; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chartrel N, 2002, J COMP NEUROL, V448, P111, DOI 10.1002/cne.10253; Chowdhury VS, 2011, J ENDOCRINOL, V209, P211, DOI 10.1530/JOE-10-0494; Daukss D, 2012, GEN COMP ENDOCR, V177, P215, DOI 10.1016/j.ygcen.2012.04.024; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Dos Santos S, 2009, ENDOCRINOLOGY, V150, P3815, DOI 10.1210/en.2008-1743; Elshourbagy NA, 2000, J BIOL CHEM, V275, P25965, DOI 10.1074/jbc.M004515200; Henmi Y, 2003, ZOOL SCI, V20, P897, DOI 10.2108/zsj.20.897; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Ikemoto T, 2005, J REPROD DEVELOP, V51, P359, DOI 10.1262/jrd.16087; Koda A, 2002, ENDOCRINOLOGY, V143, P411, DOI 10.1210/en.143.2.411; Kuraku S, 2009, INT J DEV BIOL, V53, P765, DOI 10.1387/ijdb.072533km; Larsson TA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-184; Lemons D, 2006, SCIENCE, V313, P1918, DOI 10.1126/science.1132040; McVeigh P, 2009, INT J PARASITOL, V39, P1243, DOI 10.1016/j.ijpara.2009.03.005; Osugi T, 2006, FEBS J, V273, P1731, DOI 10.1111/j.1742-4658.2006.05187.x; Osugi T, 2004, J ENDOCRINOL, V182, P33, DOI 10.1677/joe.0.1820033; Osugi T, 2012, ENDOCRINOLOGY, V153, P2362, DOI 10.1210/en.2011-2046; Osugi T, 2011, ENDOCRINOLOGY, V152, P4252, DOI 10.1210/en.2011-1375; Satake H, 2001, BIOCHEM J, V354, P79; Sawada K, 2002, EUR J BIOCHEM, V269, P6000, DOI 10.1046/j.1432-1033.2002.03351.x; Sawada K, 2002, J ENDOCRINOL, V174, P395, DOI 10.1677/joe.0.1740395; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Shahjahan M, 2011, J NEUROENDOCRINOL, V23, P39, DOI 10.1111/j.1365-2826.2010.02081.x; Son YL, 2012, ENDOCRINOLOGY, V153, P2332, DOI 10.1210/en.2011-1904; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tando Y, 2009, ZOOL SCI, V26, P409, DOI 10.2108/zsj.26.409; Tando Y, 2009, GEN COMP ENDOCR, V162, P329, DOI 10.1016/j.ygcen.2009.04.015; Tobari Y, 2010, PEPTIDES, V31, P816, DOI 10.1016/j.peptides.2010.01.015; Tsutsui K, 2000, BIOCHEM BIOPH RES CO, V275, P661, DOI 10.1006/bbrc.2000.3350; Tsutsui K, 2010, FRONT NEUROENDOCRIN, V31, P284, DOI 10.1016/j.yfrne.2010.03.001; Tsutsui K, 2009, PROG NEUROBIOL, V88, P76, DOI 10.1016/j.pneurobio.2009.02.003; Ubuka T, 2008, ENDOCRINOLOGY, V149, P268, DOI 10.1210/en.2007-0983; Ubuka T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4061; Ubuka T, 2012, ENDOCRINOLOGY, V153, P373, DOI 10.1210/en.2011-1110; Ubuka T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008400; Ubuka T, 2009, J COMP NEUROL, V517, P841, DOI 10.1002/cne.22191; Ukena K, 2002, FEBS LETT, V512, P255, DOI 10.1016/S0014-5793(02)02275-5; Ukena K, 2005, MASS SPECTROM REV, V24, P469, DOI 10.1002/mas.20031; Ukena K, 2003, ENDOCRINOLOGY, V144, P3879, DOI 10.1210/en.2003-0359; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; Yang HYT, 2006, PEPTIDES, V27, P943, DOI 10.1016/j.peptides.2005.06.030; Zhang Y, 2010, PEPTIDES, V31, P1034, DOI 10.1016/j.peptides.2010.03.003	47	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100962	10.1371/journal.pone.0100962	http://dx.doi.org/10.1371/journal.pone.0100962			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983238	Green Published, gold, Green Submitted			2022-12-27	WOS:000339635000043
J	Pesce, M; Sergi, MR; Rizzuto, A; Tatangelo, R; Tommasi, M; Picconi, L; Balsamo, M; Gatta, V; Stuppia, L; Siegling, AB; Gokcen, E; Grilli, A; Saggino, A				Pesce, Mirko; Sergi, Maria R.; Rizzuto, Alessia; Tatangelo, Raffaella; Tommasi, Marco; Picconi, Laura; Balsamo, Michela; Gatta, Valentina; Stuppia, Liborio; Siegling, Alexander B.; Goekcen, Elif; Grilli, Alfredo; Saggino, Aristide			Associations between the Antioxidant Network and Emotional Intelligence: A Preliminary Study	PLOS ONE			English	Article							OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; GLUTATHIONE-PEROXIDASE; COGNITIVE IMPAIRMENT; PSYCHOLOGICAL STRESS; VALIDATION; DAMAGE; EXPRESSION; EXERCISE; ANXIETY	Background: Emotional intelligence (EI) can be broadly defined as the ability to cope with environmental demands. In the scientific research, however, there is not a univocal precise definition of EI and recent articles have underlined the necessity to explore its biological basis to advance understanding of the construct. The aim of study was to investigate if the antioxidant network may be associated with typical-performance or trait EI. Methods: The study group consisted of 50 women (age, M = 25.10, SD = 3.87). Super Oxide Dismutase (SOD), Catalase (CAT), Glutathione Reductase (GR), and Glutathione Peroxidase (GPx) activities were evaluated on proteins extracted from Peripheral Blood Mononuclear Cells. Participants completed the Italian version of the EQ-i (Bar-On, 1997) as a measure of trait EI. Results: We observed positive and significant correlations between some biological variables and EQ-i scores, and a significant predictive effect of CAT activity when controlling for related biological variables, age, and smoking. Conclusions: Our preliminary study suggests that the antioxidant network may constitute some of trait EI's biological basis. In particular, CAT and the SOD/CAT ratio could be two biological variables involved in some specific components of EI.	[Pesce, Mirko; Sergi, Maria R.; Rizzuto, Alessia; Tatangelo, Raffaella; Tommasi, Marco; Picconi, Laura; Balsamo, Michela; Gatta, Valentina; Stuppia, Liborio; Grilli, Alfredo; Saggino, Aristide] Univ G DAnnunzio, Dept Psychol Humanist & Terr Sci, Chieti, Italy; [Siegling, Alexander B.; Goekcen, Elif] UCL, London Psychometr Lab, London, England	G d'Annunzio University of Chieti-Pescara; University of London; University College London	Pesce, M (corresponding author), Univ G DAnnunzio, Dept Psychol Humanist & Terr Sci, Chieti, Italy.	mirkopesce@unich.it	Siegling, Alex/O-2327-2019; Tommasi, Marco/G-4917-2013; Balsamo, Michela/AAP-1182-2020; Gatta, Valentina/G-5765-2014	Tommasi, Marco/0000-0002-4876-0530; Balsamo, Michela/0000-0001-5396-3853; SERGI, MARIA RITA/0000-0002-8821-3304; Pesce, Mirko/0000-0001-8836-2564; Stuppia, Liborio/0000-0002-6232-0996; Siegling, Alex/0000-0003-2411-9826; grilli, alfredo/0000-0002-5746-5007; GATTA, Valentina/0000-0002-9999-5823	Italian ministry of University and Research	Italian ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	The Italian ministry of University and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablij Hans, 2002, Eur J Intern Med, V13, P412, DOI 10.1016/S0953-6205(02)00132-2; Aebi H., 1974, CATALASE METHODS ENZ; Bar-On R, 2009, EMOTIONAL QUOTIENT I; Behr GA, 2012, CELL BIOL TOXICOL, V28, P317, DOI 10.1007/s10565-012-9226-x; Biasucci LM, 2004, CIRCULATION, V110, pE560, DOI 10.1161/01.CIR.0000148983.88334.80; Di Fabio A, 2010, EMPOWERING EMOTIONAL; DIILIO C, 1986, J MOL CELL CARDIOL, V18, P983; Dulewicz V, 2003, J MANAGERIAL PSYCHOL, V18, P405, DOI DOI 10.1108/02683940310484017; Gidron Y, 2006, BIOL PSYCHOL, V72, P291, DOI 10.1016/j.biopsycho.2005.11.011; Grewal D, 2008, JAMA-J AM MED ASSOC, V300, P1200, DOI 10.1001/jama.300.10.1200; Huang G, 2006, EMOTIONAL INTELLIGEN; Jordan PJ, 2009, J MANAGE ORGAN, V15, P452, DOI 10.5172/jmo.15.4.452; Kupper N, 2009, PSYCHOSOM MED, V71, P973, DOI 10.1097/PSY.0b013e3181bee6dc; Landy FJ, 2005, J ORGAN BEHAV, V26, P411, DOI 10.1002/job.317; Li Q, 2011, PHYSIOL BEHAV, V104, P365, DOI 10.1016/j.physbeh.2011.04.012; Liu RL, 2003, P NATL ACAD SCI USA, V100, P8526, DOI 10.1073/pnas.1332809100; Locke EA, 2005, J ORGAN BEHAV, V26, P425, DOI 10.1002/job.318; Lopes PN, 2004, PERS SOC PSYCHOL B, V30, P1018, DOI 10.1177/0146167204264762; Lucca G, 2009, NEUROCHEM INT, V54, P358, DOI 10.1016/j.neuint.2009.01.001; Matsushita M, 2010, PSYCHIAT CLIN NEUROS, V64, P435, DOI 10.1111/j.1440-1819.2010.02109.x; Matthews G, 2002, EMOTIONAL INTELLIGENCE: SCIENCE AND MYTH, P1; Moller P, 1996, CHEM-BIOL INTERACT, V102, P17, DOI 10.1016/0009-2797(96)03729-5; Nagai T, 2002, FASEB J, V16, P50, DOI 10.1096/fj.02-0448fje; Olsen RHJ, 2013, J NEUROCHEM, V125, P303, DOI 10.1111/jnc.12187; Ozcan ME, 2004, INT CLIN PSYCHOPHARM, V19, P89, DOI 10.1097/01.yic.0000110796.97676.89; Ozdemir O, 2012, NEUROPSYCHOBIOLOGY, V66, P244, DOI 10.1159/000341880; Patruno A, 2012, NITRIC OXIDE-BIOL CH, V27, P143, DOI 10.1016/j.niox.2012.06.002; Petrides KV, 2001, EUR J PERSONALITY, V15, P425, DOI 10.1002/per.416; PRITCHARD KA, 1995, CIRC RES, V77, P510, DOI 10.1161/01.RES.77.3.510; Radak Z, 2007, APPL PHYSIOL NUTR ME, V32, P942, DOI 10.1139/H07-081; Rawdin BJ, 2013, BRAIN BEHAV IMMUN, V31, P143, DOI 10.1016/j.bbi.2012.11.011; Reale M, 2012, CNS NEUROL DISORD-DR, V11, P430, DOI 10.2174/187152712800792875; Salovey P., 1995, EMOTION DISCLOSURE H, P125; Scapagnini G, 2012, CNS DRUGS, V26, P477, DOI 10.2165/11633190-000000000-00000; Schutte NS, 1998, PERS INDIV DIFFER, V25, P167, DOI 10.1016/S0191-8869(98)00001-4; Siegling AB, 2012, PERS INDIV DIFFER, V52, P776, DOI 10.1016/j.paid.2012.01.003; Speranza L, 2008, INT J IMMUNOPATH PH, V21, P879, DOI 10.1177/039463200802100412; SUN M, 1978, ANAL BIOCHEM, V90, P81, DOI 10.1016/0003-2697(78)90010-6; Tapia M, 2006, PSICOTHEMA, V18, P55; Tett RP, 2005, PERS SOC PSYCHOL B, V31, P859, DOI 10.1177/0146167204272860; Torres LL, 2011, J ALZHEIMERS DIS, V26, P59, DOI 10.3233/JAD-2011-110284; Van Rooy DL, 2004, J VOCAT BEHAV, V65, P71, DOI 10.1016/S0001-8791(03)00076-9; Williams LM, 2003, COGNITION EMOTION, V17, P747, DOI 10.1080/02699930302284; Zhang XY, 2013, J PSYCHIATR RES, V47, P1049, DOI 10.1016/j.jpsychires.2013.03.014	44	1	1	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101247	10.1371/journal.pone.0101247	http://dx.doi.org/10.1371/journal.pone.0101247			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1UX	24983620	Green Submitted, Green Published, gold			2022-12-27	WOS:000339635000076
J	Pyne, S; Lee, SX; Wang, K; Irish, J; Tamayo, P; Nazaire, MD; Duong, T; Ng, SK; Hafler, D; Levy, R; Nolan, GP; Mesirov, J; McLachlan, GJ				Pyne, Saumyadipta; Lee, Sharon X.; Wang, Kui; Irish, Jonathan; Tamayo, Pablo; Nazaire, Marc-Danie; Duong, Tarn; Shu-Kay Ng; Hafler, David; Levy, Ronald; Nolan, Garry P.; Mesirov, Jill; McLachlan, Geoffrey J.			Joint Modeling and Registration of Cell Populations in Cohorts of High-Dimensional Flow Cytometric Data	PLOS ONE			English	Article							SIGNALING NETWORKS; IMMUNE; COMPONENTS; INNOVATION	In biomedical applications, an experimenter encounters different potential sources of variation in data such as individual samples, multiple experimental conditions, and multivariate responses of a panel of markers such as from a signaling network. In multiparametric cytometry, which is often used for analyzing patient samples, such issues are critical. While computational methods can identify cell populations in individual samples, without the ability to automatically match them across samples, it is difficult to compare and characterize the populations in typical experiments, such as those responding to various stimulations or distinctive of particular patients or time-points, especially when there are many samples. Joint Clustering and Matching (JCM) is a multi-level framework for simultaneous modeling and registration of populations across a cohort. JCM models every population with a robust multivariate probability distribution. Simultaneously, JCM fits a random-effects model to construct an overall batch template - used for registering populations across samples, and classifying new samples. By tackling systems-level variation, JCM supports practical biomedical applications involving large cohorts. Software for fitting the JCM models have been implemented in an R package EMMIX-JCM, available from http://www.maths.uq.edu.au/,gjm/mix_soft/EMMIX-JCM/.	[Pyne, Saumyadipta] CR Rao Adv Inst Math Stat & Comp Sci, Hyderabad, Andhra Pradesh, India; [Lee, Sharon X.; Wang, Kui; McLachlan, Geoffrey J.] Univ Queensland, Dept Math, St Lucia, Qld, Australia; [Irish, Jonathan; Levy, Ronald] Stanford Med Sch, Div Oncol, Stanford, CA USA; [Irish, Jonathan; Nolan, Garry P.] Stanford Sch Med, Baxter Lab Stem Cell Biol, Dept Microbiol & Immunol, Stanford, CA USA; [Irish, Jonathan] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37235 USA; [Tamayo, Pablo; Nazaire, Marc-Danie; Mesirov, Jill] Broad Inst MIT & Harvard Univ, Cambridge, MA USA; [Duong, Tarn] Inst Curie, CNRS, UMR 144, F-75231 Paris, France; [Shu-Kay Ng] Griffith Univ, Sch Med, Meadowbrook, Qld 4131, Australia; [Hafler, David] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA	University of Queensland; Stanford University; Stanford University; Vanderbilt University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Griffith University; Yale University	McLachlan, GJ (corresponding author), Univ Queensland, Dept Math, St Lucia, Qld, Australia.	g.mclachlan@uq.edu.au	Nolan, Garry/AAE-7903-2019; Duong, Tarn/G-1296-2013; McLachlan, Geoffrey J/A-1491-2008; Irish, Jonathan M/E-1180-2013; Mesirov, Jill/AGF-7626-2022; Leemaqz, Sharon/P-4663-2014	Duong, Tarn/0000-0002-1198-3482; McLachlan, Geoffrey J/0000-0002-5921-3145; Irish, Jonathan M/0000-0001-9428-8866; Levy, Ronald/0000-0003-2061-0650; Nolan, Garry/0000-0002-8862-9043; Leemaqz, Sharon/0000-0002-6391-135X; Ng, Shu Kay/0000-0002-6865-9384	Australian Research Council (ARC) [DP120104327]; NATIONAL CANCER INSTITUTE [R00CA143231, K99CA143231] Funding Source: NIH RePORTER	Australian Research Council (ARC)(Australian Research Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	GJM, S-KN, KW, and SXL acknowledge support of the Australian Research Council (ARC). Grant number DP120104327. ARC URL http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaeepour N, 2013, NAT METHODS, V10, P228, DOI [10.1038/NMETH.2365, 10.1038/nmeth.2365]; Baudry JP, 2010, J COMPUT GRAPH STAT, V19, P332, DOI 10.1198/jcgs.2010.08111; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Cron A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003130; DEMERS S, 1992, CYTOMETRY, V13, P291, DOI 10.1002/cyto.990130311; Fruhwirth-Schnatter S, 2010, BIOSTATISTICS, V11, P317, DOI 10.1093/biostatistics/kxp062; Gaffney SJ, 2007, CLIM DYNAM, V29, P423, DOI 10.1007/s00382-007-0235-z; Hahne F, 2010, CYTOM PART A, V77A, P121, DOI 10.1002/cyto.a.20823; Irish JM, 2006, NAT REV CANCER, V6, P146, DOI 10.1038/nrc1804; Irish JM, 2010, P NATL ACAD SCI USA, V107, P12747, DOI 10.1073/pnas.1002057107; Kotecha N, 2008, CANCER CELL, V14, P335, DOI 10.1016/j.ccr.2008.08.014; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Liu XL, 2009, COMPUT STAT DATA AN, V53, P1361, DOI 10.1016/j.csda.2008.11.019; Lo K, 2009, CYTOM PART A, V73, P321; Lo K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-145; Lugli E, 2010, CYTOM PART A, V77A, P705, DOI 10.1002/cyto.a.20901; Maier LM, 2007, P NATL ACAD SCI USA, V104, P18607, DOI 10.1073/pnas.0706409104; McLachlan G. J., 2008, EM ALGORITHM EXTENSI; McLachlan GJ, 1998, LECT NOTES COMPUTER, P658; Naim I, 2010, INT CONF ACOUST SPEE, P509, DOI 10.1109/ICASSP.2010.5495653; Ng SK, 2006, BIOINFORMATICS, V22, P1745, DOI 10.1093/bioinformatics/btl165; Oved K, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.15; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Pyne S, 2013, ARXIV13057344; Pyne S, 2009, P NATL ACAD SCI USA, V106, P8519, DOI 10.1073/pnas.0903028106; Sahu SK, 2003, CAN J STAT, V31, P129, DOI 10.2307/3316064; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamayo P, 2011, J CLIN ONCOL, V29, P1415, DOI 10.1200/JCO.2010.28.1675; Tanner SD, 2008, PURE APPL CHEM, V80, P2627, DOI 10.1351/pac200880122627	29	29	29	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100334	10.1371/journal.pone.0100334	http://dx.doi.org/10.1371/journal.pone.0100334			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983991	gold, Green Published, Green Submitted			2022-12-27	WOS:000339635000020
J	Wang, CQ; Yang, SL; Zhang, NB; Mu, YL; Ren, HY; Wang, YF; Li, K				Wang, Chaoqun; Yang, Shulin; Zhang, Ningbo; Mu, Yulian; Ren, Hongyan; Wang, Yefu; Li, Kui			Long-Term Supranutritional Supplementation with Selenate Decreases Hyperglycemia and Promotes Fatty Liver Degeneration by Inducing Hyperinsulinemia in Diabetic db/db Mice	PLOS ONE			English	Article							HEREDITARY FRUCTOSE INTOLERANCE; INSULIN-RESISTANCE; HUMAN HEALTH; SKELETAL-MUSCLE; GENE-EXPRESSION; DBDB MICE; SELENIUM; METABOLISM; CALRETICULIN; CELLS	There are conflicting reports on the link between the micronutrient selenium and the prevalence of diabetes. To investigate the possibility that selenium acts as a "double-edged sword" in diabetes, cDNA microarray profiling and two-dimensional differential gel electrophoresis coupled with mass spectrometry were used to determine changes in mRNA and protein expression in pancreatic and liver tissues of diabetic db/db mice in response to dietary selenate supplementation. Fasting blood glucose levels increased continuously in db/db mice administered placebo (DMCtrl), but decreased gradually in selenate-supplemented db/db mice (DMSe) and approached normal levels after termination of the experiment. Pancreatic islet size was increased in DMSe mice compared with DMCtrl mice, resulting in a clear increase in insulin production and a doubling of plasma insulin concentration. Genes that encode proteins involved in key pancreatic beta-cell functions, including regulation of beta-cell proliferation and differentiation and insulin synthesis, were found to be specifically upregulated in DMSe mice. In contrast, apoptosis-associated genes were downregulated, indicating that islet function was protected by selenate treatment. Conversely, liver fat accumulation increased in DMSe mice together with significant upregulation of lipogenic and inflammatory genes. Genes related to detoxification were downregulated and antioxidant enzymatic activity was reduced, indicating an unexpected reduction in antioxidant defense capacity and exacerbation of fatty liver degeneration. Moreover, proteomic analysis of the liver showed differential expression of proteins involved in glucolipid metabolism and the endoplasmic reticulum assembly pathway. Taken together, these results suggest that dietary selenate supplementation in db/db mice decreased hyperglycemia by increasing insulin production and secretion; however, long-term hyperinsulinemia eventually led to reduced antioxidant defense capacity, which exacerbated fatty liver degeneration.	[Wang, Chaoqun; Wang, Yefu] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Wang, Chaoqun; Yang, Shulin; Zhang, Ningbo; Mu, Yulian; Ren, Hongyan; Li, Kui] Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing 100193, Peoples R China	Wuhan University; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Wang, YF (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.	wangyefu@whu.edu.cn; likui@caas.cn			national high technology research and development program 863 [2012AA020603]; State Key Laboratory of Animal Nutrition of China, Independent Research Project [2004DA125184G1109]; Agricultural Science and Technology Innovation Program [ASTIP-IAS05]	national high technology research and development program 863; State Key Laboratory of Animal Nutrition of China, Independent Research Project; Agricultural Science and Technology Innovation Program	This research was supported by grants from the national high technology research and development program 863 (2012AA020603), the State Key Laboratory of Animal Nutrition of China, Independent Research Project (2004DA125184G1109) and the Agricultural Science and Technology Innovation Program (ASTIP-IAS05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksunes LM, 2007, TOXICOL PATHOL, V35, P459, DOI 10.1080/01926230701311344; Becker DJ, 1996, DIABETOLOGIA, V39, P3, DOI 10.1007/BF00400407; Bleys J, 2007, DIABETES CARE, V30, P829, DOI 10.2337/dc06-1726; Bouteldja N, 2010, J INHERIT METAB DIS, V33, P105, DOI 10.1007/s10545-010-9053-2; Burk Raymond F, 2002, Nutr Clin Care, V5, P75, DOI 10.1046/j.1523-5408.2002.00006.x; Bystrom J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026591; Campbell SC, 2008, FEBS LETT, V582, P2333, DOI 10.1016/j.febslet.2008.05.038; Coffee EM, 2010, J INHERIT METAB DIS, V33, P715, DOI 10.1007/s10545-010-9192-5; Dalby AR, 2001, ACTA CRYSTALLOGR D, V57, P1526, DOI 10.1107/S0907444901012719; Del Cid N, 2010, J BIOL CHEM, V285, P4520, DOI 10.1074/jbc.M109.085407; Faghihi T, 2013, AM J THER; Fairweather-Tait SJ, 2011, ANTIOXID REDOX SIGN, V14, P1337, DOI 10.1089/ars.2010.3275; Faure P, 2004, EUR J CLIN INVEST, V34, P475, DOI 10.1111/j.1365-2362.2004.01362.x; Fu Z, 2013, CURR DIABETES REV, V9, P25, DOI 10.2174/157339913804143225; Gosmain Y, 2012, MOL ENDOCRINOL, V26, P696, DOI 10.1210/me.2011-1256; Iizuka Y, 2010, BIOL TRACE ELEM RES, V138, P265, DOI 10.1007/s12011-010-8622-4; Karkoulias G, 2006, CELL SIGNAL, V18, P729, DOI 10.1016/j.cellsig.2005.06.014; Koh HJ, 2004, J BIOL CHEM, V279, P39968, DOI 10.1074/jbc.M402260200; Labunskyy VM, 2011, ANTIOXID REDOX SIGN, V14, P2327, DOI 10.1089/ars.2010.3526; Laclaustra M, 2009, ENVIRON HEALTH PERSP, V117, P1409, DOI 10.1289/ehp.0900704; Leyva A, 2008, BIOLOGICALS, V36, P134, DOI 10.1016/j.biologicals.2007.09.001; Li RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038716; LIAW SH, 1995, PROTEIN SCI, V4, P2358, DOI 10.1002/pro.5560041114; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mueller AS, 2006, J NUTR BIOCHEM, V17, P548, DOI 10.1016/j.jnutbio.2005.10.006; Mueller AS, 2009, FREE RADICAL RES, V43, P1029, DOI 10.1080/10715760903196925; Mueller AS, 2003, J NUTR BIOCHEM, V14, P637, DOI 10.1016/j.jnutbio.2003.08.001; Muller AS, 2005, J ANIM PHYSIOL AN N, V89, P94, DOI 10.1111/j.1439-0396.2005.00559.x; OLDFIELD JE, 1987, J NUTR, V117, P2002, DOI 10.1093/jn/117.12.2002; Perfield JW, 2013, J OBES, V2013, DOI 10.1155/2013/296537; Pinto A, 2012, J INORG BIOCHEM, V114, P47, DOI 10.1016/j.jinorgbio.2012.04.011; Pinto A, 2011, J INORG BIOCHEM, V105, P812, DOI 10.1016/j.jinorgbio.2011.03.010; Rayman MP, 2008, BRIT J NUTR, V100, P254, DOI 10.1017/S0007114508939830; Rayman MP, 2013, FREE RADICAL BIO MED, V65, P1557, DOI 10.1016/j.freeradbiomed.2013.04.003; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Rios JJ, 2010, J SCI FOOD AGR, V90, P1914, DOI 10.1002/jsfa.4032; Rocourt CRB, 2013, NUTRIENTS, V5, P1349, DOI 10.3390/nu5041349; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Shechter I, 2003, J LIPID RES, V44, P2169, DOI 10.1194/jlr.M300285-JLR200; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200; Stapleton SR, 2000, CELL MOL LIFE SCI, V57, P1874, DOI 10.1007/PL00000669; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stranges S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-564; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Zeng MS, 2012, FREE RADICAL BIO MED, V52, P1335, DOI 10.1016/j.freeradbiomed.2012.01.017; Zhang Y, 2009, J BIOL CHEM, V284, P10160, DOI 10.1074/jbc.M808356200; Zhao G, 2012, J LIPID RES, V53, P456, DOI 10.1194/jlr.M017319; Zimmerman KA, 2013, J BIOL CHEM, V288, P14584, DOI 10.1074/jbc.M112.447243	48	25	25	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101315	10.1371/journal.pone.0101315	http://dx.doi.org/10.1371/journal.pone.0101315			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983750	Green Published, gold, Green Submitted			2022-12-27	WOS:000339635000087
J	Beyer, F; Munte, TF; Wiechert, J; Heldmann, M; Kramer, UM				Beyer, Frederike; Muente, Thomas F.; Wiechert, Juliana; Heldmann, Marcus; Kraemer, Ulrike M.			Trait Aggressiveness Is Not Related to Structural Connectivity between Orbitofrontal Cortex and Amygdala	PLOS ONE			English	Article							WHITE-MATTER INTEGRITY; PREFRONTAL CORTEX; CONDUCT DISORDER; BRAIN; PSYCHOPATHY; EMOTION; ANXIETY; LOBE	Studies in both pathological and healthy samples have suggested altered functional connectivity between orbitofrontal cortex (OFC) and amygdala as a possible cause of anger and aggression. In patient populations presenting with pathological aggression, there is also evidence for changes in structural connectivity between OFC and amygdala. In healthy samples, however, the relationship between white matter integrity and aggression has not been studied to date. Here, we investigated the relationship between trait aggressiveness and structural OFC-amygdala connectivity in a large sample (n = 93) of healthy young men. Using diffusion tensor imaging, we measured the distribution of fractional anisotropy and mean diffusivity along the uncinate fascicle bilaterally. We found no differences in either measure between participants high and low in physical aggressiveness, or between those high and low in trait anger. Our results therefore argue against a direct relationship between structural OFC-amygdala connectivity and normal-range trait aggressiveness.	[Beyer, Frederike; Muente, Thomas F.; Wiechert, Juliana; Heldmann, Marcus; Kraemer, Ulrike M.] Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany	University of Lubeck	Kramer, UM (corresponding author), Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany.	umkraemer@gmail.com	Krämer, Ulrike/AAF-2966-2020; Krämer, Ulrike M./A-8871-2019	Krämer, Ulrike M./0000-0002-3841-1812	German Research Foundation [KR3691/5-1]; University of Lubeck [E36-2011]	German Research Foundation(German Research Foundation (DFG)); University of Lubeck	This study was supported by the German Research Foundation (KR3691/5-1) and through intramural funding by the University of Lubeck (E36-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bava S, 2010, BRAIN RES, V1327, P38, DOI 10.1016/j.brainres.2010.02.066; Beyer F, 2014, CEREBRAL CO IN PRESS; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Coccaro EF, 2007, BIOL PSYCHIAT, V62, P168, DOI 10.1016/j.biopsych.2006.08.024; Craig MC, 2009, MOL PSYCHIATR, V14, P946, DOI 10.1038/mp.2009.40; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; Decety J, 2009, BIOL PSYCHOL, V80, P203, DOI 10.1016/j.biopsycho.2008.09.004; Finger EC, 2012, PSYCHIAT RES-NEUROIM, V202, P239, DOI 10.1016/j.pscychresns.2011.11.002; Ghashghaei H, 2007, NEUROIMAGE, V34, P905, DOI 10.1016/j.neuroimage.2006.09.046; Herzberg P. Y., 2003, J DIFFERENTIAL DIAGN, V24, P311; Hoptman MJ, 2002, BIOL PSYCHIAT, V52, P9, DOI 10.1016/S0006-3223(02)01311-2; Inano S, 2011, AM J NEURORADIOL, V32, P2103, DOI 10.3174/ajnr.A2785; Kim MJ, 2011, BEHAV BRAIN RES, V223, P403, DOI 10.1016/j.bbr.2011.04.025; KLINGLER J, 1960, J COMP NEUROL, V115, P333, DOI 10.1002/cne.901150305; Koolschijn PCMP, 2013, DEV COGN NEUROS-NETH, V5, P106, DOI 10.1016/j.dcn.2013.02.003; Montag C, 2012, NEUROSCIENCE, V217, P77, DOI 10.1016/j.neuroscience.2012.05.017; Motzkin JC, 2011, J NEUROSCI, V31, P17348, DOI 10.1523/JNEUROSCI.4215-11.2011; Passamonti L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048789; Passamonti L, 2008, NEUROIMAGE, V43, P562, DOI 10.1016/j.neuroimage.2008.07.045; Perrin JS, 2008, J NEUROSCI, V28, P9519, DOI 10.1523/JNEUROSCI.1212-08.2008; Sisti HM, 2012, LEARN MEMORY, V19, P351, DOI 10.1101/lm.026534.112; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Soares JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00031; Sundram F, 2012, CORTEX, V48, P216, DOI 10.1016/j.cortex.2011.06.005; TAYLOR SP, 1967, J PERS, V35, P297, DOI 10.1111/j.1467-6494.1967.tb01430.x; Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094; Xu JS, 2012, HUM BRAIN MAPP, V33, P994, DOI 10.1002/hbm.21275; Yeatman JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049790	28	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101105	10.1371/journal.pone.0101105	http://dx.doi.org/10.1371/journal.pone.0101105			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977414	Green Submitted, gold, Green Published			2022-12-27	WOS:000338506400077
J	Galal, IF; Zakaria, Z; Allam, WR; Mahmoud, MA; Ezzat, AR; Osman, A; Waked, I; Strickland, GT; Abdelwahab, SF				Galal, Iman F.; Zakaria, Zainab; Allam, Walaa R.; Mahmoud, Mohamed A.; Ezzat, Ahmed R.; Osman, Ahmed; Waked, Imam; Strickland, G. Thomas; Abdelwahab, Sayed F.			Cross Reactive Cellular Immune Response to HCV Genotype 1 and 4 Antigens among Genotype 4 Exposed Subjects	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HEALTH-CARE WORKERS; INFECTION; MEMORY; PROTECTION; VACCINE; CD4(+); EGYPT; REPLICATION; RECHALLENGE	Background: Hepatitis C Virus (HCV) infection is a global health burden particularly in Egypt, where HCV genotype 4a (GT-4a) predominates. The prevention and control of HCV infection will remain a challenge until the development of an effective vaccine that protects against different genotypes. Several HCV GT-1-based vaccines are in different stages of clinical trials, but antigenic differences could make protection against other genotypes problematic. In this regard, data comparing the cell-mediated immune (CMI) response to different HCV genotypes are limited. We aimed to ex vivo investigate whether GT-1-based vaccine may protect against HCV GT-4 infections. This was carried out on samples collected from genotype 4 infected/exposed subjects. Methods/Principal Findings: The CMI responses of 35 subjects; infected with HCV GT-4/or who had spontaneously-resolved the infection and 10 healthy control subjects; to two sets of seven HCV overlapping 15-mer peptide pools derived from both genotypes; and covering most of the viral proteins; were evaluated. This was carried out using an interferon gamma (IFN gamma) enzyme-linked immunospot (ELISpot) assay. Peripheral blood mononuclear cells (PBMC) from 17 subjects (48%) responded to at least one peptide pool derived from GT-1b/GT-4a with 13 subjects responding to peptide pools from both genotypes. A strong correlation was found in the responses to both genotypes (r = 0.82, p<0.001; 95% confidence interval = 0.562-0.933). The average IFNc total spot forming cells (SFC)/10(6) PBMC (+/- SE) from the responding subjects for GT-1b and GT-4a was 216 +/- 56 and 199 +/- 55, respectively (p = 0.833). Also, there were no significant differences between those who cleared their HCV infection or who remained HCV-RNA positive (p = 0.8). Conclusion/Significance: Our data suggest that an effective GT-1b vaccine could protect from GT-4a infection. These data could help in HCV rationale vaccine design and efficacy studies and further our understanding of HCV cross protection against different genotypes.	[Galal, Iman F.; Zakaria, Zainab; Allam, Walaa R.; Abdelwahab, Sayed F.] Egyptian Co Blood Transfus Serv Egyblood VACSERA, Giza, Egypt; [Mahmoud, Mohamed A.; Waked, Imam] Menoufiya Univ, Dept Hepatol, Natl Liver Inst, Menoufia, Egypt; [Ezzat, Ahmed R.] Ain Shams Univ, Fac Sci, Dept Zool, Cairo, Egypt; [Osman, Ahmed] Ain Shams Univ, Fac Sci, Dept Biochem, Cairo, Egypt; [Strickland, G. Thomas] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Abdelwahab, Sayed F.] Menia Univ, Dept Microbiol & Immunol, Fac Med, Al Minya, Egypt	Egyptian Knowledge Bank (EKB); Menofia University; Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Ain Shams University; University System of Maryland; University of Maryland Baltimore; Egyptian Knowledge Bank (EKB); Minia University	Abdelwahab, SF (corresponding author), Egyptian Co Blood Transfus Serv Egyblood VACSERA, Giza, Egypt.	sayed.awahab@mu.edu.eg	Waked/V-1221-2018; Abdelwahab, Sayed F./P-1481-2016; Zakaria, Zainab/ABC-3220-2020; Galal, Iman/AAK-6415-2020; Ali, Zainab/HHD-2051-2022	Waked/0000-0002-9857-8972; Abdelwahab, Sayed F./0000-0002-9636-7485; Zakaria, Zainab/0000-0003-4987-3649; Ali, Zainab/0000-0002-7792-7985; Abdel-Samiee, Mohamed/0000-0002-8970-0286	6th Framework Program [0374435]; Okairos; Egyptian Company for Blood Transfusion Services (Egyblood)	6th Framework Program(European Commission); Okairos; Egyptian Company for Blood Transfusion Services (Egyblood)	This work was supported by the 6th Framework Program, Contract# 0374435 to the HEPACIVAC Consortium; by Okairos, and by the Egyptian Company for Blood Transfusion Services (Egyblood). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hamid M, 2007, J GEN VIROL, V88, P1526, DOI 10.1099/vir.0.82626-0; Abdelwahab S, 2012, T ROY SOC TROP MED H, V106, P98, DOI 10.1016/j.trstmh.2011.10.003; Abdelwahab SF, 2012, CLIN VACCINE IMMUNOL, V19, P780, DOI 10.1128/CVI.00050-12; Abdelwahab SF, 2013, J CLIN VIROL; Al-Sherbiny M, 2005, AM J TROP MED HYG, V73, P44; Barnes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003155; Cox AL, 2005, J EXP MED, V201, P1741, DOI 10.1084/jem.20050121; Day CL, 2002, J VIROL, V76, P12584, DOI 10.1128/JVI.76.24.12584-12595.2002; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; El Khayat Hisham R, 2012, Trop Gastroenterol, V33, P112; El-Kamary SS, 2013, J PEDIATR-US, V162, P148, DOI 10.1016/j.jpeds.2012.06.057; El-Zanaty F, 2008, EGYPT DEMOGRAPHIC HL; El-Zayadi A, 1994, J Egypt Public Health Assoc, V69, P327; Elrefaei M, 2004, J HEPATOL, V40, P313, DOI 10.1016/j.jhep.2003.10.007; Esmat G, 2013, LIVER INT, V33, P41, DOI 10.1111/liv.12059; FARCI P, 1991, NEW ENGL J MED, V325, P98, DOI 10.1056/NEJM199107113250205; Farid A, 2005, PARASITE IMMUNOL, V27, P189, DOI 10.1111/j.1365-3024.2005.00762.x; Folgori A, 2006, NAT MED, V12, P190, DOI 10.1038/nm1353; Fytili P, 2008, VACCINE, V26, P3818, DOI 10.1016/j.vaccine.2008.05.045; Guerra J, 2012, J VIRAL HEPATITIS, V19, P560, DOI 10.1111/j.1365-2893.2011.01576.x; Houghton M, 2005, NATURE, V436, P961, DOI 10.1038/nature04081; Kamal SM, 2004, J VIROL, V78, P12252, DOI 10.1128/JVI.78.22.12252-12258.2004; Kamal SM, 2004, J INFECT DIS, V189, P1140, DOI 10.1086/382278; Kamal SM, 2001, J INFECT DIS, V184, P972, DOI 10.1086/323352; Khattab MA, 2011, J HEPATOL, V54, P1250, DOI 10.1016/j.jhep.2010.11.016; Lanford RE, 2004, J VIROL, V78, P1575, DOI 10.1128/JVI.78.3.1575-1581.2004; Lauer GM, 2002, J VIROL, V76, P6104, DOI 10.1128/JVI.76.12.6104-6113.2002; Major ME, 2002, J VIROL, V76, P6586, DOI 10.1128/JVI.76.13.6586-6595.2002; Martin NK, 2012, HEPATOLOGY, V55, P49, DOI 10.1002/hep.24656; MCOMISH F, 1994, J CLIN MICROBIOL, V32, P884, DOI 10.1128/JCM.32.4.884-892.1994; Nascimbeni M, 2003, J VIROL, V77, P4781, DOI 10.1128/JVI.77.8.4781-4793.2003; Nelson DR, 1997, J IMMUNOL, V158, P1473; Ohno T, 1997, J CLIN MICROBIOL, V35, P201, DOI 10.1128/JCM.35.1.201-207.1997; Park SH, 2012, GASTROENTEROLOGY, V143, P1048, DOI 10.1053/j.gastro.2012.06.005; Prince AM, 2005, J INFECT DIS, V192, P1701, DOI 10.1086/496889; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Shata MT, 2007, J IMMUNOL METHODS, V328, P152, DOI 10.1016/j.jim.2007.08.014; Shoukry NH, 2003, J EXP MED, V197, P1645, DOI 10.1084/jem.20030239; SIMMONDS P, 1994, J GEN VIROL, V75, P1053, DOI 10.1099/0022-1317-75-5-1053; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Strickland GT, 2008, LANCET INFECT DIS, V8, P379, DOI 10.1016/S1473-3099(08)70126-9; Von Hahn T, 2007, GASTROENTEROLOGY, V132, P667, DOI 10.1053/j.gastro.2006.12.008; Ward S, 2002, CLIN EXP IMMUNOL, V128, P195, DOI 10.1046/j.1365-2249.2002.01840.x; Welsh RM, 2006, CURR TOP MICROBIOL, V311, P117; Youn JW, 2008, J VIROL, V82, P10896, DOI 10.1128/JVI.01179-08	46	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101264	10.1371/journal.pone.0101264	http://dx.doi.org/10.1371/journal.pone.0101264			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979366	Green Published, gold, Green Submitted			2022-12-27	WOS:000338506400109
J	Kandala, NB; Stranges, S				Kandala, Ngianga-Bakwin; Stranges, Saverio			Geographic Variation of Overweight and Obesity among Women in Nigeria: A Case for Nutritional Transition in Sub-Saharan Africa	PLOS ONE			English	Article							NORTH-WEST PROVINCE; SOUTH-AFRICA; PREVALENCE; HEALTH; URBANIZATION; PERSPECTIVE; MODELS	Background: Nutritional research in sub-Saharan Africa has primarily focused on under-nutrition. However, there is evidence of an ongoing nutritional transition in these settings. This study aimed to examine the geographic variation of overweight and obesity prevalence at the state-level among women in Nigeria, while accounting for individual-level risk factors. Methods: The analysis was based on the 2008 Nigerian Demographic and Health Survey (NDHS), including 27,967 women aged 15-49 years. Individual data were collected on socio-demographics, but were aggregated to the country's states. We used a Bayesian geo-additive mixed model to map the geographic distribution of overweight and obesity at the state-level, accounting for individual-level risk factors. Results: The overall prevalence of combined overweight and obesity (body mass index >= 25) was 20.9%. In multivariate Bayesian geo-additive models, higher education [odds ratio (OR) & 95% Credible Region (CR): 1.68 (1.38, 2.00)], higher wealth index [3.45 (2.98, 4.05)], living in urban settings [1.24 (1.14, 1.36)] and increasing age were all significantly associated with a higher prevalence of overweight/obesity. There was also a striking variation in overweight/obesity prevalence across ethnic groups and state of residence, the highest being in Cross River State, in south-eastern Nigeria [2.32 (1.62, 3.40)], the lowest in Osun State in south-western Nigeria [0.48 (0.36, 0.61)]. Conclusions: This study suggests distinct geographic patterns in the combined prevalence of overweight and obesity among Nigerian women, as well as the role of demographic, socio-economic and environmental factors in the ongoing nutritional transition in these settings.	[Kandala, Ngianga-Bakwin; Stranges, Saverio] Univ Warwick, Div Hlth Sci, Sch Med, Coventry CV4 7AL, W Midlands, England; [Kandala, Ngianga-Bakwin] Univ Witwatersrand, Sch Publ Hlth, Epidemiol & Biostat Div, Johannesburg, South Africa; [Kandala, Ngianga-Bakwin] Univ Oxford, KEMRI Univ Oxford Wellcome Trust Collaborat Progr, Malaria Publ Hlth & Epidemiol Grp, Ctr Geog Med, Nairobi, Kenya	University of Warwick; University of Witwatersrand	Stranges, S (corresponding author), Univ Warwick, Div Hlth Sci, Sch Med, Coventry CV4 7AL, W Midlands, England.	S.Stranges@warwick.ac.uk		Stranges, Saverio/0000-0001-5226-8373	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West Midlands at University Hospitals Birmingham NHS Foundation Trust	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West Midlands at University Hospitals Birmingham NHS Foundation Trust	Ngianga-Bakwin Kandala is also supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West Midlands at University Hospitals Birmingham NHS Foundation Trust. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	Abubakari AR, 2008, OBES REV, V9, P297, DOI 10.1111/j.1467-789X.2007.00462.x; Abubakari AR, 2008, PUBLIC HEALTH, V122, P173, DOI 10.1016/j.puhe.2007.06.012; Adedoyin Rufus A, 2009, Nig Q J Hosp Med, V19, P100; AmiraCO SokunbiDOB, 2011, NIG MED J, V52, P110; Arnuna P, 2008, P NUTR SOC, V67, P82, DOI 10.1017/S0029665108006058; Ayopo Olotu O., 2011, INT J MARKETING STUD, V3, P162, DOI 10.5539/ijms.v3n1p162; Brezger A, 2012, BAYESX SOFTWARE BAYE; Brezger A, 2005, J STAT SOFTWARE, V14, P11; BROWN PJ, 1987, ANN NY ACAD SCI, V499, P29, DOI 10.1111/j.1749-6632.1987.tb36195.x; Chigbu CO, 2011, ANN MED HEALTH SCI R, V1, P135; Chukwuonye II, 2013, DIABET METAB SYND OB, V6, P285, DOI 10.2147/DMSO.S43545; Chukwuonye II, 2013, DIABET METAB SYND OB, V6, P43, DOI 10.2147/DMSO.S38626; Collinson MA, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5080; Desalu OO, 2008, SAHEL MED J, V11, P61; Fahrmeir L, 2001, J ROY STAT SOC C-APP, V50, P201, DOI 10.1111/1467-9876.00229; Griffiths PL, 2001, J NUTR, V131, P2692, DOI 10.1093/jn/131.10.2692; Kandala NB, 2006, QUAL QUANT, V40, P935, DOI 10.1007/s11135-005-3268-6; Kandala NB, 2013, AM J HYPERTENS, V26, P382, DOI 10.1093/ajh/hps063; Kennedy Gina, 2004, FAO Food Nutr Pap, V83, P1; Kimani-Murage EW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-158; Loaiza E, 1997, DHS COMPARATIVE STUD; Martorell R, 2000, EUR J CLIN NUTR, V54, P247, DOI 10.1038/sj.ejcn.1600931; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; NPC and ICF Macro, 2009, NIG DEM HLTH SURV 20; Oyeyemi AL, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-32; Popkin BM, 1998, PUBLIC HEALTH NUTR, V1, P5, DOI 10.1079/PHN19980004; POPKIN BM, 1993, POPUL DEV REV, V19, P138, DOI 10.2307/2938388; Popkin BM, 2003, DEV POLICY REV, V21, P581, DOI DOI 10.1111/J.1467-8659.2003.00225.X; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; Raschke V, 2008, PUBLIC HEALTH NUTR, V11, P662, DOI 10.1017/S1368980007001140; RK Udo, 1975, POPULATION GROWTH SO, P298; Salomon JA, 2002, POPUL DEV REV, V28, P205, DOI 10.1111/j.1728-4457.2002.00205.x; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; United Nations Population Division, 1999, WORLD URB PROSP 1999; Vorster HH, 2005, PUBLIC HEALTH NUTR, V8, P480, DOI 10.1079/PHN2005784; Vorster HH, 2000, S AFR J SCI, V96, P505; WHO, 1995, WORLD HLTH ORG WHO E, V854; World Health Organization, 2000, WHO TECHN REP SERIES, V894; World Health Organization Regional Committee for Africa, 2005, CARD DIS AFR REG CUR; World Reference Base for Soil Resources, 2006, 84 FAO	40	58	58	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101103	10.1371/journal.pone.0101103	http://dx.doi.org/10.1371/journal.pone.0101103			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK5ZO	24979753	Green Submitted, Green Published, gold			2022-12-27	WOS:000338506400076
J	Mesquita, M; Fintelman-Rodrigues, N; Sacramento, CQ; Abrantes, JL; Costa, E; Temerozo, JR; Siqueira, MM; Bou-Habib, DC; Souza, TML				Mesquita, Milene; Fintelman-Rodrigues, Natalia; Sacramento, Carolina Q.; Abrantes, Juliana L.; Costa, Eduardo; Temerozo, Jairo R.; Siqueira, Marilda M.; Bou-Habib, Dumith Chequer; Souza, Thiago Moreno L.			HIV-1 and Its gp120 Inhibits the Influenza A(H1N1)pdm09 Life Cycle in an IFITM3-Dependent Fashion	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ALVEOLAR EPITHELIAL-CELLS; PANDEMIC H1N1 2009; A H1N1; ALPHA-INTERFERON; REPLICATION; INFECTION; LUNG; MACROPHAGES; RESPONSES	HIV-1-infected patients co-infected with A(H1N1)pdm09 surprisingly presented benign clinical outcome. The knowledge that HIV-1 changes the host homeostatic equilibrium, which may favor the patient resistance to some co-pathogens, prompted us to investigate whether HIV-1 infection could influence A(H1N1)pdm09 life cycle in vitro. We show here that exposure of A(H1N1)pdm09-infected epithelial cells to HIV-1 viral particles or its gp120 enhanced by 25% the IFITM3 content, resulting in a decrease in influenza replication. This event was dependent on toll-like receptor 2 and 4. Moreover, knockdown of IFITM3 prevented HIV-1 ability to inhibit A(H1N1)pdm09 replication. HIV-1 infection also increased IFITM3 levels in human primary macrophages by almost 100%. Consequently, the arrival of influenza ribonucleoproteins (RNPs) to nucleus of macrophages was inhibited, as evaluated by different approaches. Reduction of influenza RNPs entry into the nucleus tolled A(H1N1) pdm09 life cycle in macrophages earlier than usual, limiting influenza's ability to induce TNF-alpha. As judged by analysis of the influenza hemagglutin (HA) gene from in vitro experiments and from samples of HIV-1/A(H1N1)pdm09 co-infected individuals, the HIV-1-induced reduction of influenza replication resulted in delayed viral evolution. Our results may provide insights on the mechanisms that may have attenuated the clinical course of Influenza in HIV-1/A(H1N1)pdm09 co-infected patients during the recent influenza form 2009/2010.	[Mesquita, Milene; Fintelman-Rodrigues, Natalia; Sacramento, Carolina Q.; Abrantes, Juliana L.; Costa, Eduardo; Siqueira, Marilda M.; Souza, Thiago Moreno L.] Fiocruz MS, Inst Oswaldo Cruz, WHO, Resp Viruses Lab,NIC, BR-21045900 Rio De Janeiro, RJ, Brazil; [Temerozo, Jairo R.; Bou-Habib, Dumith Chequer] Fiocruz MS, Inst Oswaldo Cruz, Lab Thymus Res, BR-21045900 Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; World Health Organization; Fundacao Oswaldo Cruz	Souza, TML (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, WHO, Resp Viruses Lab,NIC, BR-21045900 Rio De Janeiro, RJ, Brazil.	tmoreno@ioc.fiocruz.br	Miranda, Milene/ABD-8472-2021; Bou-Habib, Dumith/GPP-1624-2022; Temerozo, Jairo R/K-4894-2012; Souza, Thiago Moreno L./G-2900-2012	Miranda, Milene/0000-0003-0037-059X; Bou-Habib, Dumith/0000-0003-0552-9045; Temerozo, Jairo R/0000-0002-8092-2149; Souza, Thiago Moreno L./0000-0003-2212-3899	PAPES/Fiocruz; CNPq; Faperj	PAPES/Fiocruz; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faperj(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This study was supported by grants from PAPES/Fiocruz (www.ioc.fiocruz.br), CNPq (www.cnpq.br), and Faperj (www.faperj.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes JL, 2012, BBA-MOL BASIS DIS, V1822, P1198, DOI 10.1016/j.bbadis.2012.04.011; [Anonymous], 2012, GLOB REP UNAIDS REP; Baillie GJ, 2012, J VIROL, V86, P11, DOI 10.1128/JVI.05347-11; Barchi E, 2010, EMERG INFECT DIS, V16, P1643, DOI 10.3201/eid1610.100341; Basu S, 2004, AM J PHYSIOL-LUNG C, V286, pL887, DOI 10.1152/ajplung.00323.2003; Bergmann JH, 2014, CURR OPIN CELL BIOL, V26, P10, DOI 10.1016/j.ceb.2013.08.005; Blachere FM, 2007, INFLUENZA OTHER RESP, V1, P113, DOI 10.1111/j.1750-2659.2007.00020.x; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Camp JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056602; Chua PK, 2009, J GEN VIROL, V90, P2929, DOI 10.1099/vir.0.013128-0; Cline TD, 2013, J VIROL, V87, P1411, DOI 10.1128/JVI.02682-12; Cohen SS, 1999, P NATL ACAD SCI USA, V96, P10842, DOI 10.1073/pnas.96.19.10842; Cordero E, 2012, EUR J CLIN MICROBIOL, V31, P547, DOI 10.1007/s10096-011-1346-3; Damjanovic D, 2012, CLIN IMMUNOL, V144, P57, DOI 10.1016/j.clim.2012.05.005; Douek Daniel, 2007, Top HIV Med, V15, P114; Elton D, 2005, BIOL LETTERS, V1, P113, DOI 10.1098/rsbl.2004.0253; ERIKSSON B, 1977, ANTIMICROB AGENTS CH, V11, P946, DOI 10.1128/AAC.11.6.946; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; Feiterna-Sperling C, 2010, CLIN INFECT DIS, V51, pE90, DOI 10.1086/657121; Friesenhagen J, 2012, J LEUKOCYTE BIOL, V92, P11, DOI 10.1189/jlb.0911479; Garcia-Verdugo I, 2010, BIOCHIMIE, V92, P1608, DOI 10.1016/j.biochi.2010.05.010; Goujon C, 2010, J VIROL, V84, P9254, DOI 10.1128/JVI.00854-10; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Guilliams M, 2013, MUCOSAL IMMUNOL, V6, P464, DOI 10.1038/mi.2013.14; Heath L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006949; Herold S, 2006, J IMMUNOL, V177, P1817, DOI 10.4049/jimmunol.177.3.1817; Hollenhorst MI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/174306; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Iwata K, 2010, J INFECT CHEMOTHER, V16, P298, DOI 10.1007/s10156-010-0054-8; Julkunen I, 2000, VACCINE, V19, pS32, DOI 10.1016/S0264-410X(00)00275-9; Karaivanova G M, 1995, Afr J Med Med Sci, V24, P1; Lee N, 2012, ANTIVIR THER, V17, P143, DOI 10.3851/IMP2059; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Lima RG, 2002, J INFECT DIS, V185, P1561, DOI 10.1086/340412; Lisco A, 2009, CELL HOST MICROBE, V6, P403, DOI 10.1016/j.chom.2009.10.010; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Martinez E, 2011, HIV MED, V12, P236, DOI 10.1111/j.1468-1293.2010.00905.x; Mayer KH, 2011, CLIN INFECT DIS, V52, pS205, DOI 10.1093/cid/ciq043; MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455; Montaner LJ, 2006, J LEUKOCYTE BIOL, V80, P961, DOI 10.1189/jlb.0806488; Monteerarat Y, 2010, ARCH VIROL, V155, P1273, DOI 10.1007/s00705-010-0716-y; Nazli A, 2013, J IMMUNOL, V191, P4246, DOI 10.4049/jimmunol.1301482; Ormsby CE, 2011, AIDS, V25, P435, DOI 10.1097/QAD.0b013e3283434844; Perez CM, 2010, AIDS, V24, P2867, DOI 10.1097/QAD.0b013e32833e92d5; PESCHKE T, 1993, IMMUNOBIOLOGY, V189, P340, DOI 10.1016/S0171-2985(11)80365-7; Pomerantz RJ, 2003, HIV CLIN TRIALS, V4, P137, DOI 10.1310/80JH-148K-NADQ-U927; Qian C, 2013, ANN NY ACAD SCI, V1283, P67, DOI 10.1111/j.1749-6632.2012.06786.x; RODGERS B, 1981, INFECT IMMUN, V31, P751, DOI 10.1128/IAI.31.2.751-757.1981; Sakabe S, 2011, VIRUS RES, V158, P124, DOI 10.1016/j.virusres.2011.03.022; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Short KR, 2013, LANCET INFECT DIS; Siegrist F, 2011, J INTERF CYTOK RES, V31, P183, DOI 10.1089/jir.2010.0112; Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853; Balish Amanda L, 2013, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/0471729256.mc15g01s3, 10.1002/9780471729259.mc15g01s29]; Tang JW, 2010, INFECT DIS CLIN N AM, V24, P603, DOI 10.1016/j.idc.2010.04.001; Upham JP, 2010, J VIROL, V84, P3730, DOI 10.1128/JVI.02148-09; Wagner TA, 2009, AIDS, V23, P923, DOI 10.1097/QAD.0b013e328329f964; Wahl SM, 2003, J LEUKOCYTE BIOL, V74, P726, DOI 10.1189/jlb.0503220; Woo PCY, 2010, J INFECT DIS, V201, P346, DOI 10.1086/649785; Yu WCL, 2011, J VIROL, V85, P6844, DOI 10.1128/JVI.02200-10	63	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101056	10.1371/journal.pone.0101056	http://dx.doi.org/10.1371/journal.pone.0101056			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978204	Green Published, gold			2022-12-27	WOS:000338506400068
J	O'Dwyer, L; Tanner, C; van Dongen, EV; Greven, CU; Braten, J; Zwiersl, MP; Franke, B; Oosterlaan, J; Heslenfeld, D; Hoekstra, P; Hartman, CA; Rommelse, N; Buitelaar, JK				O'Dwyer, Laurence; Tanner, Colby; van Dongen, Eelco V.; Greven, Corina U.; Braten, Janita; Zwiersl, Marcel P.; Franke, Barbara; Oosterlaan, Jaap; Heslenfeld, Dirk; Hoekstra, Pieter; Hartman, Catharina A.; Rommelse, Nanda; Buitelaar, Jan K.			Brain Volumetric Correlates of Autism Spectrum Disorder Symptoms in Attention Deficit/Hyperactivity Disorder	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; PERVASIVE DEVELOPMENTAL DISORDERS; BEHAVIOR QUESTIONNAIRE CSBQ; LARGE MULTICENTER ADHD; REPETITIVE BEHAVIORS; DIAGNOSTIC-APPROACH; LANGUAGE DISORDER; CORPUS-CALLOSUM; CAUDATE-NUCLEUS; FAMILIAL TRAIT	Autism spectrum disorder (ASD) symptoms frequently occur in subjects with attention deficit/hyperactivity disord (ADHD). While there is evidence that both ADHD and ASD have differential structural correlates, no study to date has nvestigated these structural correlates within a framework that robustly accounts for the phenotypic overlap between the two disorders. The presence of ASD symptoms was measured by the parent-reported Children's Social and Behavioural Questionnaire (CSBQ) in ADHD subject n = 180) their unaffected siblings (n = 118) and healthy controls (n = 146). ADHD symptoms were assessed by a structured interview K-SADS-PL) and the Conners' ADHD questionnaires. Whole brain T1 Weighted MPRAGE images were acquired and the structural MRI correlates of ASD symptom scores were analysed by modelling ASD symptom scores against white matter (WM) and grey matter (GM) volumes using mixed effects models which controlled for ADHD symptom levels. ASD symptoms were significantly elevated in ADHD subjects relative to bot h controls and unaffected siblings. ASD scores were predicted by the interaction between WM and GM volumes. Increasing ASD score was associated with greater GM volume. Equivocal results from previous structural studies in ADHD and ASD may be due to the fact that comorbidity has not been taken into account in studies to date. The current findings stress he need. to account for issues of ASD comorbidity ADHD.	[O'Dwyer, Laurence; van Dongen, Eelco V.; Greven, Corina U.; Braten, Janita; Zwiersl, Marcel P.; Buitelaar, Jan K.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands; [Tanner, Colby] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Greven, Corina U.] Kings Coll London, Social Genet & Dev Psychiat Ctr, Inst Psychiat, London WC2R 2LS, England; [Braten, Janita; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Franke, Barbara; Rommelse, Nanda] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Psychiat, NL-6525 ED Nijmegen, Netherlands; [Oosterlaan, Jaap; Heslenfeld, Dirk] Vrije Univ Amsterdam, Dept Clin Neuropsychol, Amsterdam, Netherlands; [Heslenfeld, Dirk] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands; [Hoekstra, Pieter; Hartman, Catharina A.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Rommelse, Nanda; Buitelaar, Jan K.] Karakter Child & Adolescent Psychiat Univ Ctr Nij, Nijmegen, Netherlands	Radboud University Nijmegen; University of Lausanne; University of London; King's College London; Radboud University Nijmegen; Radboud University Nijmegen; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Groningen; Radboud University Nijmegen	O'Dwyer, L (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands.	larodwyer@gmail.com	Bralten, Janita/D-4647-2011; Buitelaar, J.K./AAY-7522-2020; Lambregts-Rommelse, N.N.J./L-4470-2015; Zwiers, Marcel P/D-2968-2009; Rommelse, Nanda NJ/D-4872-2009; Franke, Barbara/D-4836-2009; Hassan, Randa/AAW-3624-2021; Greven, Corina/GRS-7921-2022; Greven, Corina U/F-9729-2010	Zwiers, Marcel P/0000-0001-5483-2935; Rommelse, Nanda NJ/0000-0002-1711-0359; Franke, Barbara/0000-0003-4375-6572; Greven, Corina U/0000-0002-5433-7878; Greven, Corina U./0000-0003-2402-3074	National Institutes of Health [RO1MH62873]; NWO Large Investment Grant [1750102007010]; Radboud University Nijmegen Medical Center; University Medical Center Groningen and Accare; Vrije Universiteit Amsterdam; European Community's Seventh Framework Programme [278948]; Innovative Medicines Initiative Joint Undertaking (IMI) under (EU-AIMS) [115300-01]; Irish Research Council for Science, Engineering and Technology (IRCSET); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062873] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NWO Large Investment Grant; Radboud University Nijmegen Medical Center; University Medical Center Groningen and Accare; Vrije Universiteit Amsterdam; European Community's Seventh Framework Programme(European Commission); Innovative Medicines Initiative Joint Undertaking (IMI) under (EU-AIMS); Irish Research Council for Science, Engineering and Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The NeuroIMAGE study was supported by National Institutes of Health grant RO1MH62873 (to Stephen V. Faraone), NWO Large Investment Grant 1750102007010 (to Jan Buitelaar) and matching grants from Radboud University Nijmegen Medical Center, University Medical Center Groningen and Accare, and Vrije Universiteit Amsterdam. The research leading to these results also received support from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 278948 (TACTICS), and from the Innovative Medicines Initiative Joint Undertaking (IMI) under grant agreement number 115300-01 (EU-AIMS). CT was supported by a fellowship from the Irish Research Council for Science, Engineering and Technology (IRCSET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1979, BIOMETRIKA, V66, P237, DOI 10.1093/biomet/66.2.237; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Ames CS, 2011, J AUTISM DEV DISORD, V41, P357, DOI 10.1007/s10803-010-1049-0; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2002, MODEL SELECTION MULT; Asato MR, 2010, CEREB CORTEX, V20, P2122, DOI 10.1093/cercor/bhp282; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Association AP, 2000, DIAGNOTIC STAT MANUA; Bates D, IME4 LINEAR MIXED EF; Booth R, 2010, J EXP CHILD PSYCHOL, V107, P377, DOI 10.1016/j.jecp.2010.06.003; Brieber S, 2007, J CHILD PSYCHOL PSYC, V48, P1251, DOI 10.1111/j.1469-7610.2007.01799.x; Bussing Regina, 2002, World J Biol Psychiatry, V3, P216, DOI 10.3109/15622970209150624; Carmona S, 2005, NEUROSCI LETT, V389, P88, DOI 10.1016/j.neulet.2005.07.020; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Chabernaud C, 2012, BIOL PSYCHIAT, V71, P434, DOI 10.1016/j.biopsych.2011.08.013; Chung MK, 2004, NEUROIMAGE, V23, P242, DOI 10.1016/j.neuroimage.2004.04.037; Corbett BA, 2009, PSYCHIAT RES, V166, P210, DOI 10.1016/j.psychres.2008.02.005; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101; Crawley M.J., 2007, R BOOK; Dawson G, 2008, DEV PSYCHOPATHOL, V20, P775, DOI 10.1017/S0954579408000370; de Bildt A, 2009, J AUTISM DEV DISORD, V39, P1464, DOI 10.1007/s10803-009-0764-x; DIVAC I, 1967, J COMP PHYSIOL PSYCH, V63, P184, DOI 10.1037/h0024348; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Durston S, 2004, J AM ACAD CHILD PSY, V43, P332, DOI 10.1097/00004583-200403000-00016; Esbensen AJ, 2009, J AUTISM DEV DISORD, V39, P57, DOI 10.1007/s10803-008-0599-x; Fine JG, 2008, J AUTISM DEV DISORD, V38, P1797, DOI 10.1007/s10803-008-0570-x; Freitag CM, 2009, BIOL PSYCHIAT, V66, P316, DOI 10.1016/j.biopsych.2009.03.011; Frodl T, 2012, ACTA PSYCHIAT SCAND, V125, P114, DOI 10.1111/j.1600-0447.2011.01786.x; Geluk CAML, 2012, J CHILD PSYCHOL PSYC, V53, P160, DOI 10.1111/j.1469-7610.2011.02456.x; Geurts HM, 2008, J CHILD PSYCHOL PSYC, V49, P848, DOI 10.1111/j.1469-7610.2008.01916.x; Geurts HM, 2013, J AUTISM DEV DISORD, V43, P1630, DOI 10.1007/s10803-012-1708-4; Grahn JA, 2009, BEHAV BRAIN RES, V199, P53, DOI 10.1016/j.bbr.2008.11.020; Greaves-Lord K, 2013, J AUTISM DEV DISORD, V43, P1784, DOI 10.1007/s10803-012-1724-4; Happe F, 2006, BRAIN COGNITION, V61, P25, DOI 10.1016/j.bandc.2006.03.004; Hartman CA, 2006, J AUTISM DEV DISORD, V36, P325, DOI 10.1007/s10803-005-0072-z; Heimer L, 2003, AM J PSYCHIAT, V160, P1726, DOI 10.1176/appi.ajp.160.10.1726; Helt M, 2008, NEUROPSYCHOL REV, V18, P339, DOI 10.1007/s11065-008-9075-9; Herbert MR, 2005, NEUROSCIENTIST, V11, P417, DOI 10.1177/0091270005278866; Herbert MR, 2004, ANN NEUROL, V55, P530, DOI 10.1002/ana.20032; Herbert MR, 2003, BRAIN, V126, P1182, DOI 10.1093/brain/awg110; Hesslinger B, 2002, NEUROSCI LETT, V328, P319, DOI 10.1016/S0304-3940(02)00554-2; Hollander E, 2003, NEUROPSYCHOPHARMACOL, V28, P193, DOI 10.1038/sj.npp.1300021; Howlin P, 2000, J CHILD PSYCHOL PSYC, V41, P561, DOI 10.1017/S0021963099005806; HYND GW, 1990, ARCH NEUROL-CHICAGO, V47, P919, DOI 10.1001/archneur.1990.00530080107018; Jaspers M, 2013, J ABNORM CHILD PSYCH, V41, P71, DOI 10.1007/s10802-012-9653-4; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; KIRKBY RJ, 1969, PHYSIOL BEHAV, V4, P451, DOI 10.1016/0031-9384(69)90135-8; Kleinhans NM, 2012, BRAIN RES, V1479, P1, DOI 10.1016/j.brainres.2012.07.056; KRUG DA, 1980, J CHILD PSYCHOL PSYC, V21, P221, DOI 10.1111/j.1469-7610.1980.tb01797.x; Langen M, 2009, BIOL PSYCHIAT, V66, P327, DOI 10.1016/j.biopsych.2009.03.017; Leyfer OT, 2006, J AUTISM DEV DISORD, V36, P849, DOI 10.1007/s10803-006-0123-0; Luteijn EF, 2000, EUR CHILD ADOLES PSY, V9, P168, DOI 10.1007/s007870070040; Lyoo IK, 1996, BIOL PSYCHIAT, V40, P1060; Matson JL, 2007, RES DEV DISABIL, V28, P341, DOI 10.1016/j.ridd.2005.12.004; Mostofsky SH, 2002, BIOL PSYCHIAT, V52, P785, DOI 10.1016/S0006-3223(02)01412-9; Muller UC, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-55; Muller UC, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-54; Mulligan A, 2009, J AUTISM DEV DISORD, V39, P197, DOI 10.1007/s10803-008-0621-3; Nakao T, 2011, AM J PSYCHIAT, V168, P1154, DOI 10.1176/appi.ajp.2011.11020281; Nickl-Jockschat T, 2012, HUM BRAIN MAPP, V33, P1470, DOI 10.1002/hbm.21299; Nijmeijer JS, 2009, J ABNORM CHILD PSYCH, V37, P443, DOI 10.1007/s10802-008-9282-0; Nijmeijer JS, 2014, J AUTISM DEV DISORD, V44, P1671, DOI 10.1007/s10803-014-2039-4; O'Dwyer L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048895; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Piven J, 1996, J AM ACAD CHILD PSY, V35, P530, DOI 10.1097/00004583-199604000-00020; Radua J, 2011, PSYCHOL MED, V41, P1539, DOI 10.1017/S0033291710002187; Redcay E, 2005, BIOL PSYCHIAT, V58, P1, DOI 10.1016/j.biopsych.2005.03.026; Reiersen AM, 2007, J CHILD PSYCHOL PSYC, V48, P464, DOI 10.1111/j.1469-7610.2006.01720.x; Rommelse NNJ, 2011, NEUROSCI BIOBEHAV R, V35, P1363, DOI 10.1016/j.neubiorev.2011.02.015; Rommelse NNJ, 2010, EUR CHILD ADOLES PSY, V19, P281, DOI 10.1007/s00787-010-0092-x; Ronald A, 2008, J CHILD PSYCHOL PSYC, V49, P535, DOI 10.1111/j.1469-7610.2007.01857.x; Scarpa A, 2011, BEHAV COGN PSYCHOTH, V39, P495, DOI 10.1017/S1352465811000063; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Seidman LJ, 2011, BIOL PSYCHIAT, V69, P857, DOI 10.1016/j.biopsych.2010.09.053; Seltzer MM, 2004, MENT RETARD DEV D R, V10, P234, DOI 10.1002/mrdd.20038; Shaw P, 2011, AM J PSYCHIAT, V168, P143, DOI 10.1176/appi.ajp.2010.10030385; Shaw P, 2010, HUM BRAIN MAPP, V31, P917, DOI 10.1002/hbm.21028; Shea S, 2004, PEDIATRICS, V114, pE634, DOI 10.1542/peds.2003-0264-F; STETTNER LJ, 1967, SCIENCE, V155, P1689, DOI 10.1126/science.155.3770.1689; Sze KM, 2008, BEHAV COGNITIVE PSYC, V36; 't Hart-Kerkhoffs LA, 2009, J CLIN PSYCHIAT, V70, P266, DOI 10.4088/JCP.08m04635; Taylor JL, 2010, J AUTISM DEV DISORD, V40, P1431, DOI 10.1007/s10803-010-1005-z; THOMPSON RL, 1959, J COMP PHYSIOL PSYCH, V52, P650, DOI 10.1037/h0038893; Vaccarino FM, 2009, J AUTISM DEV DISORD, V39, P511, DOI 10.1007/s10803-008-0653-8; Valera EM, 2007, BIOL PSYCHIAT, V61, P1361, DOI 10.1016/j.biopsych.2006.06.011; van der Meer JMJ, 2012, J AM ACAD CHILD PSY, V51, P1160, DOI 10.1016/j.jaac.2012.08.024; van Steijn DJ, 2012, J CHILD PSYCHOL PSYC, V53, P954, DOI 10.1111/j.1469-7610.2012.02556.x; Via E, 2011, ARCH GEN PSYCHIAT, V68, P409, DOI 10.1001/archgenpsychiatry.2011.27; Waiter GD, 2005, NEUROIMAGE, V24, P455, DOI 10.1016/j.neuroimage.2004.08.049	91	14	15	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101130	10.1371/journal.pone.0101130	http://dx.doi.org/10.1371/journal.pone.0101130			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979066	Green Published, gold, Green Submitted			2022-12-27	WOS:000338506400083
J	Zhang, HY; Zhang, Q; Yang, B; Wang, JF				Zhang, Huyuan; Zhang, Qing; Yang, Bo; Wang, Jinfang			Compacted Sewage Sludge as a Barrier for Tailings: The Heavy Metal Speciation and Total Organic Carbon Content in the Compacted Sludge Specimen	PLOS ONE			English	Article							MINE DRAINAGE; SORPTION; SOIL	Acid mine drainage (AMD) was the main environmental problem facing the mining industry. For AMD had high heavy metals content and low pH, the compacted sewage sludge might be a barrier for tailings whose oxidation and weathering produced AMD, with its own carbon source, microorganism reduction ability and impermeability. To study the heavy metals environmental risk, under the simulate AMD, the deionized water (DW), and the pH 2.1 sulfuric acid water (SA) seepage conditions, respectively, the changes of the chemical speciation of heavy metals Cd, Cu, Fe, Ni, Zn and total organic carbon (TOC) content in the compacted sewage sludge were assessed in the different periods. The results indicated according to the distribution of heavy metals, the potential mobility was for Cd: 6.08 under AMD, 7.48 under SA, infinity under DW; for Cu: 0.08 under AMD, 0.17 under SA, 0.59 under DW; for Fe: 0.15 under AMD, 0.22 under SA, 0.22 under DW; for Ni: 2.60 under AMD, 1.69 under SA, 1.67 under DW; and for Zn: 0.15 under AMD, 0.23 under SA and 0.21 under DW at the second checking time. TOC content firstly decreased from 67.62 +/- 0% to 66.29 +/- 0.35%, then increased to 67.74 +/- 0.65% under the AMD seepage while TOC decreased to 63.30 +/- 0.53%, then to 61.33 +/- 0.37% under the DW seepage, decreased to 63.86 +/- 0.41%, then to 63.28 +/- 0.49% under SA seepage. That indicated under the AMD seepage, the suitable microorganisms communities in the compacted sewage sludge were activated. And the heavy metals environmental risk of compacted sewage sludge was lower with AMD condition than with other two. So the compacted sewage sludge as a barrier for tailings was feasible as the aspect of environmental risk assessment.	[Zhang, Huyuan; Zhang, Qing; Yang, Bo; Wang, Jinfang] Lanzhou Univ, Minist Educ, Key Lab Mech Disaster & Environm Western China, Lanzhou 730000, Peoples R China; [Zhang, Huyuan; Zhang, Qing; Wang, Jinfang] Lanzhou Univ, Coll Earth & Environm Sci, Lanzhou 730000, Peoples R China; [Zhang, Qing] Lanzhou City Univ, Sch Chem & Environm Sci, Lanzhou, Peoples R China	Lanzhou University; Lanzhou University; Lanzhou City University	Zhang, Q (corresponding author), Lanzhou Univ, Minist Educ, Key Lab Mech Disaster & Environm Western China, Lanzhou 730000, Peoples R China.	m35t@163.com		ZHANG, Qing/0000-0002-4997-2586	Doctoral Program of Higher Education of China [20110211110025]; National Natural Science Foundation of China [31160118, 30960060]	Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Doctoral Program of Higher Education of China (No. 20110211110025) and National Natural Science Foundation of China (No. 31160118 & No. 30960060), http://www.nsfc.gov.cn/publish/portal0/default.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLOWAY BJ, 1991, SCI TOTAL ENVIRON, V100, P151, DOI 10.1016/0048-9697(91)90377-Q; Ashworth DJ, 2004, ENVIRON POLLUT, V127, P137, DOI 10.1016/S0269-7491(03)00237-9; Brown M., 2002, MINEWATER TREATMENT; China EPA, 2002, WAT WAST MON AN METH; Clemente R, 2007, J ENVIRON QUAL, V36, P1137, DOI 10.2134/jeq2006.0304; Domene X, 2010, J SOIL SEDIMENT, V10, P30, DOI 10.1007/s11368-009-0073-1; ELLIOTT HA, 1990, J ENVIRON QUAL, V19, P330, DOI 10.2134/jeq1990.00472425001900020021x; Gibert O, 2005, WATER RES, V39, P2827, DOI 10.1016/j.watres.2005.04.056; Gibert O, 2005, APPL GEOCHEM, V20, P1648, DOI 10.1016/j.apgeochem.2005.04.012; Gibert O, 2010, ENVIRON GEOCHEM HLTH, V32, P373, DOI 10.1007/s10653-010-9290-1; Gulec S, 2003, EFFECT ACID MINE DRA; Gulec SB, 2005, J GEOTECH GEOENVIRON, V131, P937, DOI 10.1061/(ASCE)1090-0241(2005)131:8(937); Jiang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071176; Kamon M, 2002, SOILS FOUND, V42, P79, DOI 10.3208/sandf.42.6_79; Lin CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091981; Lottermoser BG, 2007, MINE WASTES CHARACTE; Miller S, 1998, THEORY DESIGN OPERAT, P115; Munk L, 2002, APPL GEOCHEM, V17, P421, DOI 10.1016/S0883-2927(01)00098-1; Nason P, 2014, MINE WATER ENVIRON, V33, P66, DOI 10.1007/s10230-013-0244-6; Nason P, 2013, ENVIRON EARTH SCI, V70, P3093, DOI 10.1007/s12665-013-2369-0; Singh AK, 1999, ENVIRON GEOL, V39, P90, DOI 10.1007/s002540050439; Smith SR, 2009, ENVIRON INT, V35, P142, DOI 10.1016/j.envint.2008.06.009; TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017; Wang B, 2010, ENVIRON EARTH SCI, V61, P931, DOI 10.1007/s12665-009-0410-0; Zhang Hu-yuan, 2010, Huanjing Kexue, V31, P2705; Zhou YF, 2010, CRIT REV ENV SCI TEC, V40, P909, DOI 10.1080/10643380802586857; Zufiaurre R, 1998, ANALYST, V123, P255, DOI 10.1039/a705168i	27	5	6	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100932	10.1371/journal.pone.0100932	http://dx.doi.org/10.1371/journal.pone.0100932			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979755	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400052
J	Kumar, A; Sahu, SK; Mohanty, S; Chakrabarti, S; Maji, S; Reddy, RR; Jha, AK; Goswami, C; Kundu, CN; Rajasubramaniam, S; Verma, SC; Choudhuri, T				Kumar, Amit; Sahu, Sushil Kumar; Mohanty, Suchitra; Chakrabarti, Sudipta; Maji, Santanu; Reddy, R. Rajendra; Jha, Asutosh K.; Goswami, Chandan; Kundu, Chanakya N.; Rajasubramaniam, Shanmugam; Verma, Subhash C.; Choudhuri, Tathagata			Kaposi Sarcoma Herpes Virus Latency Associated Nuclear Antigen Protein Release the G2/M Cell Cycle Blocks by Modulating ATM/ATR Mediated Checkpoint Pathway	PLOS ONE			English	Article							MULTICENTRIC CASTLEMANS-DISEASE; PRIMARY EFFUSION LYMPHOMA; REVERSE-TRANSCRIPTASE PROMOTER; DNA-SEQUENCES; HUMAN PAPILLOMAVIRUSES; BINDING PROTEIN; GENE-EXPRESSION; TUMOR-VIRUSES; LANA PROTEIN; HUMAN-HERPESVIRUS-8	The Kaposi's sarcoma-associated herpesvirus infects the human population and maintains latency stage of viral life cycle in a variety of cell types including cells of epithelial, mesenchymal and endothelial origin. The establishment of latent infection by KSHV requires the expression of an unique repertoire of genes among which latency associated nuclear antigen (LANA) plays a critical role in the replication of the viral genome. LANA regulates the transcription of a number of viral and cellular genes essential for the survival of the virus in the host cell. The present study demonstrates the disruption of the host G2/M cell cycle checkpoint regulation as an associated function of LANA. DNA profile of LANA expressing human B-cells demonstrated the ability of this nuclear antigen in relieving the drug (Nocodazole) induced G2/M checkpoint arrest. Caffeine suppressed nocodazole induced G2/M arrest indicating involvement of the ATM/ATR. Notably, we have also shown the direct interaction of LANA with Chk2, the ATM/ATR signalling effector and is responsible for the release of the G2/M cell cycle block.	[Kumar, Amit; Sahu, Sushil Kumar; Mohanty, Suchitra; Chakrabarti, Sudipta; Maji, Santanu; Reddy, R. Rajendra; Choudhuri, Tathagata] Inst Life Sci, Div Infect Dis Biol, Bhubaneswar, Orissa, India; [Choudhuri, Tathagata] Dept Biotechnol, Santini Ketan, Bolpur, India; [Kundu, Chanakya N.] KIIT Univ, Sch Biotechnol, Bhubaneswar, Orissa, India; [Verma, Subhash C.] Univ Nevada, Sch Med, Dept Microbiol & Immunol, Reno, NV 89557 USA; [Jha, Asutosh K.; Goswami, Chandan] Natl Inst Sci Educ & Res, Sch Biol Sci, Bhubaneswar, Orissa, India; [Rajasubramaniam, Shanmugam] Reg Med Res Ctr Tribals, Dept Biotechnol, Jabalpur, India	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Kalinga Institute of Industrial Technology (KIIT); Nevada System of Higher Education (NSHE); University of Nevada Reno; National Institute of Science Education & Research (NISER); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tribal Health (NIRTH)	Choudhuri, T (corresponding author), Inst Life Sci, Div Infect Dis Biol, Bhubaneswar, Orissa, India.	tatha@ils.res.in	Choudhuri, Tathagata/F-8139-2011; maji, santanu/HCH-0463-2022; Chakrabarti, Sudipta/ABG-5682-2021; Kumar, Ashutosh/AFX-7442-2022; Mohanty, Suchitra/ABG-6763-2020; Kumar, Amit/AAO-4055-2020	maji, santanu/0000-0002-8939-0636; Chakrabarti, Sudipta/0000-0002-4867-160X; Mohanty, Suchitra/0000-0002-8154-6093; Kundu, Chanakya/0000-0003-0297-1030	Council of Scientific and Industrial Research, Government of India; DBT through RGYI grant, Department of Biotechnology, Government of India	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); DBT through RGYI grant, Department of Biotechnology, Government of India	AK, SKS, SM was supported by Council of Scientific and Industrial Research, Government of India. This work was supported by DBT through its RGYI grant, Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal C, 2006, MOL CANCER THER, V5, P3294, DOI 10.1158/1535-7163.MCT-06-0483; An FQ, 2005, J BIOL CHEM, V280, P3862, DOI 10.1074/jbc.M407435200; Barbera AJ, 2006, CELL CYCLE, V5, P1048, DOI 10.4161/cc.5.10.2768; Bechtel JT, 2003, J VIROL, V77, P6474, DOI 10.1128/JVI.77.11.6474-6481.2003; Ben-Israel H, 2002, FRONT BIOSCI-LANDMRK, V7, pD1369, DOI 10.2741/ben; Borgne A, 1996, J BIOL CHEM, V271, P27847, DOI 10.1074/jbc.271.44.27847; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chen L, 2005, J VIROL, V79, P14383, DOI 10.1128/JVI.79.22.14383-14391.2005; Chen WG, 2010, J VIROL, V84, P3898, DOI 10.1128/JVI.01321-09; Choudhuri T, 2007, J VIROL, V81, P6718, DOI 10.1128/JVI.00053-07; Cotter MA, 1999, VIROLOGY, V264, P254, DOI 10.1006/viro.1999.9999; Darbon JM, 2000, J BIOL CHEM, V275, P15363, DOI 10.1074/jbc.275.20.15363; Dupin N, 1999, P NATL ACAD SCI USA, V96, P4546, DOI 10.1073/pnas.96.8.4546; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; ENOCH T, 1990, CELL, V60, P665, DOI 10.1016/0092-8674(90)90669-6; Friborg J, 1999, NATURE, V402, P889, DOI 10.1038/47266; Fujimuro M, 2003, J VIROL, V77, P8019, DOI 10.1128/JVI.77.14.8019-8030.2003; Gabrielli B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00009; Godfrey A, 2005, BLOOD, V105, P2510, DOI 10.1182/blood-2004-08-3052; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Howe AK, 1998, J VIROL, V72, P9637, DOI 10.1128/JVI.72.12.9637-9644.1998; Kaul R, 2007, VIROLOGY, V364, P317, DOI 10.1016/j.virol.2007.03.010; Knight JS, 2001, J BIOL CHEM, V276, P22971, DOI 10.1074/jbc.M101890200; Krauer KG, 2004, ONCOGENE, V23, P1342, DOI 10.1038/sj.onc.1207253; Krithivas A, 2000, J VIROL, V74, P9637, DOI 10.1128/JVI.74.20.9637-9645.2000; KUMAGAI A, 1991, CELL, V64, P903, DOI 10.1016/0092-8674(91)90315-P; Lan K, 2005, J VIROL, V79, P3468, DOI 10.1128/JVI.79.6.3468-3478.2005; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Lavia P, 2003, ONCOGENE, V22, P6508, DOI 10.1038/sj.onc.1206861; Lim C, 2000, J GEN VIROL, V81, P2645, DOI 10.1099/0022-1317-81-11-2645; Lim C, 2001, J BIOL CHEM, V276, P31016, DOI 10.1074/jbc.M102431200; Liu JY, 2007, J VIROL, V81, P10451, DOI 10.1128/JVI.00804-07; Liu L, 2002, J BIOL CHEM, V277, P13745, DOI 10.1074/jbc.M110480200; Lu F, 2012, J VIROL, V86, P5752, DOI 10.1128/JVI.07216-11; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Murakami Y, 2006, J BIOL CHEM, V281, P28113, DOI 10.1074/jbc.M602026200; Ottinger M, 2006, J VIROL, V80, P10772, DOI 10.1128/JVI.00804-06; Parravicini C, 2000, AM J PATHOL, V156, P743, DOI 10.1016/S0002-9440(10)64940-1; Qiu L, 2000, MOL BIOL CELL, V11, P2069, DOI 10.1091/mbc.11.6.2069; Radkov SA, 2000, NAT MED, V6, P1121, DOI 10.1038/80459; Rainbow L, 1997, J VIROL, V71, P5915, DOI 10.1128/JVI.71.8.5915-5921.1997; Saha A, 2010, CANCER BIOL THER, V10, P961, DOI 10.4161/cbt.10.10.13923; SCHOLLER A, 1994, MOL PHARMACOL, V45, P944; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Southern SA, 2000, INT J GYNECOL CANCER, V10, P263, DOI 10.1046/j.1525-1438.2000.010004263.x; Spiller OB, 2003, J VIROL, V77, P592, DOI 10.1128/JVI.77.1.592-599.2003; Tang J, 2003, J VIROL, V77, P5975, DOI 10.1128/JVI.77.10.5975-5984.2003; Vahteristo P, 2001, CANCER RES, V61, P5718; Vazquez ED, 2011, J VIROL, V85, P7622, DOI 10.1128/JVI.00304-11; Verma SC, 2004, J VIROL, V78, P10348, DOI 10.1128/JVI.78.19.10348-10359.2004; Verschuren EW, 2004, J GEN VIROL, V85, P1347, DOI 10.1099/vir.0.79812-0; Villa LL, 1997, ADV CANCER RES, V71, P321, DOI 10.1016/S0065-230X(08)60102-5; Warrener R, 2003, FASEB J, V17, P1550, DOI 10.1096/fj.02-1003fje; Zhong WD, 1996, P NATL ACAD SCI USA, V93, P6641, DOI 10.1073/pnas.93.13.6641	57	13	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100228	10.1371/journal.pone.0100228	http://dx.doi.org/10.1371/journal.pone.0100228			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972086	gold, Green Submitted, Green Published			2022-12-27	WOS:000338512200021
J	Sharp, SJ; Poulaliou, M; Thompson, SG; White, IR; Wood, AM				Sharp, Stephen J.; Poulaliou, Manon; Thompson, Simon G.; White, Ian R.; Wood, Angela M.			A Review of Published Analyses of Case-Cohort Studies and Recommendations for Future Reporting	PLOS ONE			English	Review								The case-cohort study design combines the advantages of a cohort study with the efficiency of a nested case-control study. However, unlike more standard observational study designs, there are currently no guidelines for reporting results from case-cohort studies. Our aim was to review recent practice in reporting these studies, and develop recommendations for the future. By searching papers published in 24 major medical and epidemiological journals between January 2010 and March 2013 using PubMed, Scopus and Web of Knowledge, we identified 32 papers reporting case-cohort studies. The median subcohort sampling fraction was 4.1% (interquartile range 3.7% to 9.1%). The papers varied in their approaches to describing the numbers of individuals in the original cohort and the subcohort, presenting descriptive data, and in the level of detail provided about the statistical methods used, so it was not always possible to be sure that appropriate analyses had been conducted. Based on the findings of our review, we make recommendations about reporting of the study design, subcohort definition, numbers of participants, descriptive information and statistical methods, which could be used alongside existing STROBE guidelines for reporting observational studies.	[Sharp, Stephen J.] Univ Cambridge, Sch Clin Med, Med Res Council Epidemiol Unit, Cambridge, England; [Poulaliou, Manon] Ecole Natl Stat & Adm Econ Paris Tech, Paris, France; [Thompson, Simon G.; Wood, Angela M.] Univ Cambridge, Sch Clin Med, Dept Publ Hlth & Primary Care, Cambridge, England; [White, Ian R.] Cambridge Inst Publ Hlth, Med Res Council Biostat Unit, Cambridge, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; Institut Polytechnique de Paris; University of Cambridge; MRC Biostatistics Unit; University of Cambridge	Sharp, SJ (corresponding author), Univ Cambridge, Sch Clin Med, Med Res Council Epidemiol Unit, Cambridge, England.	stephen.sharp@mrc-epid.cam.ac.uk	Wood, Angela/GZA-5762-2022	Wood, Angela/0000-0002-7937-304X; White, Ian/0000-0002-6718-7661	Medical Research Council [MC_UU_12015/1, U105260558]; British Heart Foundation [CH/12/2/29428]; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MC_U106179471, MC_U105260558, MR/L003120/1, G0701619, G0800270] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165] Funding Source: researchfish; MRC [MC_U105260558, MR/L003120/1, G0800270, G0701619, MC_UU_12015/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	SJS was supported by the Medical Research Council www.mrc.ac.uk [Unit Programme number MC_UU_12015/1]. IRW was supported by the Medical Research Council www.mrc.ac.uk [Unit Programme number U105260558]. MP, SGT and AMW were supported by the British Heart Foundation www.bhf.org.uk [grant number CH/12/2/29428]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Borgan O, 2000, LIFETIME DATA ANAL, V6, P39, DOI 10.1023/A:1009661900674; Collett, 2003, MODELLING SURVIVAL D; Coviello V, 2001, STATA TECHNICAL B, V10, P12; Ganna A, 2012, AM J EPIDEMIOL, V175, P715, DOI 10.1093/aje/kwr374; Onland-Moret NC, 2007, J CLIN EPIDEMIOL, V60, P350, DOI 10.1016/j.jclinepi.2006.06.022; Ploner M, 2013, COXPHW WEIGHTED COX; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; Sanderson J, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-113; Thompson S, 2010, INT J EPIDEMIOL, V39, P1345, DOI 10.1093/ije/dyq063; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; White IR, 2010, STAT MED, V29, P2920, DOI 10.1002/sim.3944; Xue XN, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-88	14	47	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101176	10.1371/journal.pone.0101176	http://dx.doi.org/10.1371/journal.pone.0101176			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972092	Green Published, gold, Green Submitted			2022-12-27	WOS:000338512200101
J	Schneider, KA; Escalante, AA				Schneider, Kristan A.; Escalante, Ananias A.			A Likelihood Approach to Estimate the Number of Co-Infections	PLOS ONE			English	Article							MULTIPLE INFECTIONS; PYRIMETHAMINE RESISTANCE; STAPHYLOCOCCUS-AUREUS; EVOLUTION; VIRULENCE; HITCHHIKING; SULFADOXINE; EXPRESSION; MUTATIONS; ECOLOGY	The number of co-infections of a pathogen (multiplicity of infection or MOI) is a relevant parameter in epidemiology as it relates to transmission intensity. Notably, such quantities can be built into a metric in the context of disease control and prevention. Having applications to malaria in mind, we develop here a maximum-likelihood (ML) framework to estimate the quantities of interest at low computational and no additional costs to study designs or data collection. We show how the ML estimate for the quantities of interest and corresponding confidence-regions are obtained from multiple genetic loci. Assuming specifically that infections are rare and independent events, the number of infections per host follows a conditional Poisson distribution. Under this assumption, we show that a unique ML estimate for the parameter (l) describing MOI exists which is found by a simple recursion. Moreover, we provide explicit formulas for asymptotic confidence intervals, and show that profile-likelihood-based confidence intervals exist, which are found by a simple two-dimensional recursion. Based on the confidence intervals we provide alternative statistical tests for the MOI parameter. Finally, we illustrate the methods on three malaria data sets. The statistical framework however is not limited to malaria.	[Schneider, Kristan A.] Univ Appl Sci Mittweida, Dept MNI, Mittweida, Germany; [Escalante, Ananias A.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Escalante, Ananias A.] Arizona State Univ, Biodesign Inst, Ctr Evolutionary Med & Informat, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Schneider, KA (corresponding author), Univ Appl Sci Mittweida, Dept MNI, Mittweida, Germany.	kristan.schneider@hs-mittweida.de		Escalante, Ananias/0000-0002-1532-3430; Schneider, Kristan/0000-0003-4138-1180	U.S. National Institutes of Health [1U19AI089702, R01GM084320]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084320] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research is supported by U.S. National Institutes of Health grants 1U19AI089702 and R01GM084320 to AAE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2013, ECOL LETT, V16, P556, DOI 10.1111/ele.12076; Balmer O, 2011, LANCET INFECT DIS, V11, P868, DOI 10.1016/S1473-3099(11)70241-9; Ben-Ami F, 2008, EVOLUTION, V62, P1700, DOI 10.1111/j.1558-5646.2008.00391.x; Ben-Ami F, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-97; Cohen T, 2012, CLIN MICROBIOL REV, V25, P708, DOI 10.1128/CMR.00021-12; Davison A., 2003, STAT MODELS; Durbin R., 1998, BIOL SEQUENCE ANAL P; FRANK SA, 1992, P ROY SOC B-BIOL SCI, V250, P195, DOI 10.1098/rspb.1992.0149; Hill WG, 1995, P ROY SOC B-BIOL SCI, V262, P249, DOI 10.1098/rspb.1995.0203; Klein EY, 2012, P ROY SOC B-BIOL SCI, V279, P3834, DOI 10.1098/rspb.2012.1064; Lindstrom I, 2008, PARASITOLOGY, V135, P39, DOI 10.1017/S0031182007003654; Lively CM, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-64; Matussek A, 2011, J CLIN MICROBIOL, V49, P3647, DOI 10.1128/JCM.00389-11; McCollum AM, 2008, ANTIMICROB AGENTS CH, V52, P4089, DOI 10.1128/AAC.00623-08; McCollum AM, 2007, ANTIMICROB AGENTS CH, V51, P2085, DOI 10.1128/AAC.01228-06; McCollum AM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-77; Poon AFY, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002753; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Schjorring S, 2003, P ROY SOC B-BIOL SCI, V270, P189, DOI 10.1098/rspb.2002.2233; Schneider KA, 2011, J MATH BIOL, V62, P789, DOI 10.1007/s00285-010-0353-9; Schneider KA, 2010, THEOR POPUL BIOL, V78, P93, DOI 10.1016/j.tpb.2010.06.005; Thanapongpichat S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-275; Theron A, 2004, PARASITOLOGY, V129, P571, DOI 10.1017/S0031182004005943; Tognazzo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049137; VENZON DJ, 1988, J R STAT SOC C-APPL, V37, P87, DOI 10.2307/2347496; Vu-Thien H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-24; Wacker Mark A, 2012, Malar J, V11, P180, DOI 10.1186/1475-2875-11-180	27	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e97899	10.1371/journal.pone.0097899	http://dx.doi.org/10.1371/journal.pone.0097899			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988302	Green Published, gold, Green Submitted			2022-12-27	WOS:000341354100008
J	Goller, CC; Arshad, M; Noah, JW; Ananthan, S; Evans, CW; Nebane, NM; Rasmussen, L; Sosa, M; Tower, NA; White, EL; Neuenswander, B; Porubsky, P; Maki, BE; Rogers, SA; Schoenen, F; Seed, PC				Goller, Carlos C.; Arshad, Mehreen; Noah, James W.; Ananthan, Subramaniam; Evans, Carrie W.; Nebane, N. Miranda; Rasmussen, Lynn; Sosa, Melinda; Tower, Nichole A.; White, E. Lucile; Neuenswander, Benjamin; Porubsky, Patrick; Maki, Brooks E.; Rogers, Steven A.; Schoenen, Frank; Seed, Patrick C.			Lifting the Mask: Identification of New Small Molecule Inhibitors of Uropathogenic Escherichia coli Group 2 Capsule Biogenesis	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; ACUTE UNCOMPLICATED CYSTITIS; ANTIBIOTIC-RESISTANCE; GENE-CLUSTER; POLYSACCHARIDE; K5; EPIDEMIOLOGY; LIBRARIES; VIRULENCE; WOMEN	Uropathogenic Escherichia coli (UPEC) is the leading cause of community-acquired urinary tract infections (UTIs), with over 100 million UTIs occurring annually throughout the world. Increasing antimicrobial resistance among UPEC limits ambulatory care options, delays effective treatment, and may increase overall morbidity and mortality from complications such as urosepsis. The polysaccharide capsules of UPEC are an attractive target a therapeutic, based on their importance in defense against the host immune responses; however, the large number of antigenic types has limited their incorporation into vaccine development. The objective of this study was to identify small-molecule inhibitors of UPEC capsule biogenesis. A large-scale screening effort entailing 338,740 compounds was conducted in a cell-based, phenotypic screen for inhibition of capsule biogenesis in UPEC. The primary and concentration-response assays yielded 29 putative inhibitors of capsule biogenesis, of which 6 were selected for further studies. Secondary confirmatory assays identified two highly active agents, named DU003 and DU011, with 50% inhibitory concentrations of 1.0 mu M and 0.69 mu M, respectively. Confirmatory assays for capsular antigen and biochemical measurement of capsular sugars verified the inhibitory action of both compounds and demonstrated minimal toxicity and off-target effects. Serum sensitivity assays demonstrated that both compounds produced significant bacterial death upon exposure to active human serum. DU011 administration in mice provided near complete protection against a lethal systemic infection with the prototypic UPEC K1 isolate UTI89. This work has provided a conceptually new class of molecules to combat UPEC infection, and future studies will establish the molecular basis for their action along with efficacy in UTI and other UPEC infections.	[Goller, Carlos C.; Arshad, Mehreen; Seed, Patrick C.] Duke Univ, Dept Pediat, Sch Med, Durham, NC 27706 USA; [Noah, James W.; Ananthan, Subramaniam; Evans, Carrie W.; Nebane, N. Miranda; Rasmussen, Lynn; Sosa, Melinda; Tower, Nichole A.; White, E. Lucile] So Res Inst, Southern Res Specialized Biocontainment Screening, Birmingham, AL 35255 USA; [Neuenswander, Benjamin; Porubsky, Patrick; Maki, Brooks E.; Rogers, Steven A.; Schoenen, Frank] Univ Kansas, Specialized Chem Ctr, Lawrence, KS 66045 USA; [Seed, Patrick C.] Duke Univ, Dept Mol Genet & Microbiol, Sch Med, Durham, NC 27706 USA; [Seed, Patrick C.] Duke Univ, Ctr Microbial Pathogenesis, Sch Med, Durham, NC 27706 USA	Duke University; University of Kansas; Duke University; Duke University	Seed, PC (corresponding author), Duke Univ, Dept Pediat, Sch Med, Durham, NC 27706 USA.	patrick.seed@duke.edu	Goller, Carlos C./AAJ-9924-2021	Schoenen, Frank/0000-0003-2711-1117; Arshad, Mehreen/0000-0002-7517-9274; Goller, Carlos/0000-0002-2013-0334	NIH [R03MH090791]; NIH Molecular Libraries Probe Production Centers Network [5U54HG005031]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG005031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH090791] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Molecular Libraries Probe Production Centers Network; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH grant R03MH090791 (PI, Seed) and the NIH Molecular Libraries Probe Production Centers Network grant 5U54HG005031 (PI, Jeffrey Aube). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali ASM, 2009, J UROLOGY, V182, P21, DOI 10.1016/j.juro.2009.02.124; Anderson GG, 2010, INFECT IMMUN, V78, P963, DOI 10.1128/IAI.00925-09; [Anonymous], 2014, MOL LIB PROGRAM PATH; Baell JB, 2010, FUTURE MED CHEM, V2, P1529, DOI [10.4155/fmc.10.237, 10.4155/FMC.10.237]; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Buckles EL, 2009, J INFECT DIS, V199, P1689, DOI 10.1086/598524; Edlin RS, 2013, J UROLOGY, V190, P222, DOI 10.1016/j.juro.2013.01.069; Foxman B, 2003, INFECT DIS CLIN N AM, V17, P227, DOI 10.1016/S0891-5520(03)00005-9; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Fritsch E.F., 1989, MOL CLONING LAB MANU; Gaschignard J, 2011, PEDIATR INFECT DIS J, V30, P212, DOI 10.1097/INF.0b013e3181fab1e7; Goller CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011642; GUPTA DS, 1982, FEMS MICROBIOL LETT, V14, P75, DOI 10.1111/j.1574-6968.1982.tb08638.x; Gupta K, 2005, J ANTIMICROB CHEMOTH, V56, P243, DOI 10.1093/jac/dki169; Gupta K, 1999, JAMA-J AM MED ASSOC, V281, P736, DOI 10.1001/jama.281.8.736; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; HACKER J, 1990, MICROB PATHOGENESIS, V8, P213, DOI 10.1016/0882-4010(90)90048-U; Hang L, 1998, J UROLOGY, V159, P2185, DOI 10.1016/S0022-5347(01)63303-2; HEDGES S, 1991, INFECT IMMUN, V59, P421, DOI 10.1128/IAI.59.1.421-427.1991; Hooton TM, 2000, NEW ENGL J MED, V343, P992, DOI 10.1056/NEJM200010053431402; JOHNSON JR, 1991, CLIN MICROBIOL REV, V4, P80, DOI 10.1128/CMR.4.1.80-128.1991; Karlowsky JA, 2006, ANTIMICROB AGENTS CH, V50, P2251, DOI 10.1128/AAC.00123-06; King T, 2012, BJU INT, V110, P300, DOI 10.1111/j.1464-410X.2012.11142.x; Li K, 2008, MOL IMMUNOL, V45, P954, DOI 10.1016/j.molimm.2007.07.037; Litwin MS, 2007, UROLOGIC DIS AM, P3; Llobet E, 2008, MICROBIOL-SGM, V154, P3877, DOI 10.1099/mic.0.2008/022301-0; Ma JF, 2004, UROL CLIN N AM, V31, P517, DOI 10.1016/j.ucl.2004.04.016; MOBLEY HLT, 1993, MOL MICROBIOL, V10, P143, DOI 10.1111/j.1365-2958.1993.tb00911.x; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Mushtaq N, 2005, J ANTIMICROB CHEMOTH, V56, P160, DOI 10.1093/jac/dki177; NKUDIC, 2005, UR TRACT INF AD; Noah JW, 2007, ANTIVIR RES, V73, P50, DOI 10.1016/j.antiviral.2006.07.006; Noah JW, 2013, 3 2 6 DIFLUOROBENZAM; Noah JW, 2013, N PYRIDIN 4 YL BENZO; Olson RP, 2009, ANTIMICROB AGENTS CH, V53, P1285, DOI 10.1128/AAC.01188-08; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; ROBERTS IS, 1995, MICROBIOL-SGM, V141, P2023, DOI 10.1099/13500872-141-9-2023; Roberts JA, 1997, J UROLOGY, V158, P1610, DOI 10.1016/S0022-5347(01)64290-3; Rowe S, 2000, J BACTERIOL, V182, P2741, DOI 10.1128/JB.182.10.2741-2745.2000; Schappert S, 2011, VITAL HLTH STAT SERI, V13; Schilling JD, 2003, P NATL ACAD SCI USA, V100, P4203, DOI 10.1073/pnas.0736473100; Schilling JD, 2001, J IMMUNOL, V166, P1148, DOI 10.4049/jimmunol.166.2.1148; Scholl D, 2005, J BACTERIOL, V187, P8499, DOI 10.1128/JB.187.24.8499-8503.2005; Scholl D, 2005, APPL ENVIRON MICROB, V71, P4872, DOI 10.1128/AEM.71.8.4872-4874.2005; SERWER P, 1974, VIROLOGY, V59, P70, DOI 10.1016/0042-6822(74)90207-4; Singh N, 2009, J CHEM INF MODEL, V49, P1010, DOI 10.1021/ci800426u; Stevens MP, 1997, MOL MICROBIOL, V24, P1001, DOI 10.1046/j.1365-2958.1997.4241780.x; SVANBORG C, 1993, ZBL BAKT-INT J MED M, V278, P359, DOI 10.1016/S0934-8840(11)80852-2; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; VIMR ER, 1985, J BACTERIOL, V164, P854, DOI 10.1128/JB.164.2.854-860.1985; VIMR ER, 1984, P NATL ACAD SCI-BIOL, V81, P1971, DOI 10.1073/pnas.81.7.1971; Vimr ER, 2009, MICROBIOL-SGM, V155, P9, DOI 10.1099/mic.0.023564-0; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; YAMADA K, 1963, NATURE, V198, P799, DOI 10.1038/198799a0; Yang QW, 2013, J MED MICROBIOL, V62, P1343, DOI 10.1099/jmm.0.059816-0	56	8	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e96054	10.1371/journal.pone.0096054	http://dx.doi.org/10.1371/journal.pone.0096054			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983234	Green Published, Green Submitted, gold			2022-12-27	WOS:000339635000003
J	Inouye, H; Liu, JL; Makowski, L; Palmisano, M; Burghammer, M; Riekel, C; Kirschner, DA				Inouye, Hideyo; Liu, Jiliang; Makowski, Lee; Palmisano, Marilena; Burghammer, Manfred; Riekel, Christian; Kirschner, Daniel A.			Myelin Organization in the Nodal, Paranodal, and Juxtaparanodal Regions Revealed by Scanning X-Ray Microdiffraction	PLOS ONE			English	Article							LAEVIS PERIPHERAL-NERVE; MEMBRANE-STRUCTURE; PROTEIN ZERO; INTERNODAL MYELIN; BASIC-PROTEIN; P0 PROTEIN; SHEATH; SCATTERING; MICROSCOPE; DISORDER	X-ray diffraction has provided extensive information about the arrangement of lipids and proteins in multilamellar myelin. This information has been limited to the abundant inter-nodal regions of the sheath because these regions dominate the scattering when x-ray beams of 100 mm diameter or more are used. Here, we used a 1 mm beam, raster-scanned across a single nerve fiber, to obtain detailed information about the molecular architecture in the nodal, paranodal, and juxtaparanodal regions. Orientation of the lamellar membrane stacks and membrane periodicity varied spatially. In the juxtaparanode-internode, 198-202 angstrom-period membrane arrays oriented normal to the nerve fiber axis predominated, whereas in the paranode-node, 205-208 angstrom-period arrays oriented along the fiber direction predominated. In parts of the sheath distal to the node, multiple sets of lamellar reflections were observed at angles to one another, suggesting that the myelin multilayers are deformed at the Schmidt-Lanterman incisures. The calculated electron density of myelin in the different regions exhibited membrane bilayer profiles with varied electron densities at the polar head groups, likely due to different amounts of major myelin proteins (P0 glycoprotein and myelin basic protein). Scattering from the center of the nerve fibers, where the x-rays are incident en face (perpendicular) to the membrane planes, provided information about the lateral distribution of protein. By underscoring the heterogeneity of membrane packing, microdiffraction analysis suggests a powerful new strategy for understanding the underlying molecular foundation of a broad spectrum of myelinopathies dependent on local specializations of myelin structure in both the PNS and CNS.	[Inouye, Hideyo; Liu, Jiliang; Makowski, Lee] Northeastern Univ, Dept Elect & Comp Engn, Boston, MA 02115 USA; [Makowski, Lee] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Palmisano, Marilena] Univ Vita Salute San Raffaele, Div Cell Biol & Genet, Milan, Italy; [Burghammer, Manfred; Riekel, Christian] European Synchrotron Res Facil, Grenoble, France; [Kirschner, Daniel A.] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA	Northeastern University; Northeastern University; Vita-Salute San Raffaele University; Boston College	Kirschner, DA (corresponding author), Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA.	kirschnd@bc.edu		Liu, Jiliang/0000-0002-3491-3452; Kirschner, Daniel/0000-0003-3498-1452	Fondation pour l'Aide a la Recherche sur la Sclerose en Plaques (ARSEP Foundation); L'Association Europeenne contre les Leucodystrophies -ELA (ELA Foundation) [ELA2008-009C4, ELA2010-042C5]; Boston College Institutional Research Funds; Northeastern University	Fondation pour l'Aide a la Recherche sur la Sclerose en Plaques (ARSEP Foundation); L'Association Europeenne contre les Leucodystrophies -ELA (ELA Foundation); Boston College Institutional Research Funds; Northeastern University	This research was supported by the Fondation pour l'Aide a la Recherche sur la Sclerose en Plaques (ARSEP Foundation), L'Association Europeenne contre les Leucodystrophies -ELA (ELA Foundation, grant numbers ELA2008-009C4, ELA2010-042C5), Boston College Institutional Research Funds (DAK), and Northeastern University (LM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardo A, 2011, LANGMUIR, V27, P8216, DOI 10.1021/la2014336; Arroyo EJ, 1999, J NEUROCYTOL, V28, P333, DOI 10.1023/A:1007009613484; Avila RL, 2005, J NEUROPATH EXP NEUR, V64, P976, DOI 10.1097/01.jnen.0000186925.95957.dc; Avila RL, 2010, J BIOL CHEM, V285, P42001, DOI 10.1074/jbc.M110.166967; Banerjee S, 2006, CELL BIOCHEM BIOPHYS, V46, P65, DOI 10.1385/CBB:46:1:65; Bear RS, 1936, J OPT SOC AM, V26, P363, DOI 10.1364/JOSA.26.000363; Bear RS, 1936, J OPT SOC AM, V26, P206, DOI 10.1364/JOSA.26.000206; Blanton TN, 1995, POWDER DIFFR, V10, P91, DOI DOI 10.1017/S0885715600014421; BLAUROCK AE, 1976, J MOL BIOL, V103, P421, DOI 10.1016/0022-2836(76)90321-1; BLAUROCK AE, 1966, BIOPHYS J, V6, P305, DOI 10.1016/S0006-3495(66)86658-4; CASPAR DLD, 1971, NATURE-NEW BIOL, V231, P46, DOI 10.1038/newbio231046a0; Cifuentes-Diaz C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014533; De Felici M, 2008, PHYS MED BIOL, V53, P5675, DOI 10.1088/0031-9155/53/20/007; DeBruin LS, 2005, J NEUROSCI RES, V80, P211, DOI 10.1002/jnr.20452; Ducic T, 2011, J STRUCT BIOL, V173, P202, DOI 10.1016/j.jsb.2010.10.001; Fasano A, 2008, J NEUROCHEM, V107, P291, DOI 10.1111/j.1471-4159.2008.05598.x; FERNANDEZMORAN H, 1957, J BIOPHYS BIOCHEM CY, V3, P725, DOI 10.1083/jcb.3.5.725; Hammersley A. P., 1997, ESRF97HA02T; Hasse B, 2002, J NEUROSCI RES, V69, P227, DOI 10.1002/jnr.10287; HIRANO A, 1982, J NEUROCYTOL, V11, P861, DOI 10.1007/BF01148304; HOLLINGSHEAD CJ, 1981, J CELL BIOL, V89, P631, DOI 10.1083/jcb.89.3.631; INOUYE H, 1989, BIOPHYS J, V56, P129, DOI 10.1016/S0006-3495(89)82658-X; Inouye H, 1999, BIOPHYS J, V76, P423, DOI 10.1016/S0006-3495(99)77209-7; Inouye H, 2009, MOL AGGREGATION NUCL, P75; Kirschner D., 1984, MYELIN, P51; KIRSCHNER DA, 1980, NATURE, V283, P207, DOI 10.1038/283207a0; KIRSCHNER DA, 1989, J NEUROCHEM, V53, P1599, DOI 10.1111/j.1471-4159.1989.tb08558.x; KIRSCHNER DA, 1980, J ULTRA MOL STRUCT R, V73, P211, DOI 10.1016/S0022-5320(80)90125-2; Kirschner DA, 2004, MYELIN BIOL DISORDER, V1, P523; Kirschner Daniel A., 1992, P3; KOSARAS B, 1990, J NEUROCYTOL, V19, P187, DOI 10.1007/BF01217297; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; MACKENZIE ML, 1984, J NEUROCYTOL, V13, P1043, DOI 10.1007/BF01148601; MUGNAINI E, 1977, J NEUROCYTOL, V6, P647, DOI 10.1007/BF01176378; NELANDER JC, 1978, J MOL BIOL, V118, P497, DOI 10.1016/0022-2836(78)90287-5; Peters A, 1991, FINE STRUCTURE NERVO, pxviii; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; RAND RP, 1979, NATURE, V279, P258, DOI 10.1038/279258a0; RITCHIE JM, 1977, P NATL ACAD SCI USA, V74, P211, DOI 10.1073/pnas.74.1.211; ROBERTSON JD, 1958, J BIOPHYS BIOCHEM CY, V4, P39, DOI 10.1083/jcb.4.1.39; Salem M, 2010, ACTA CRYSTALLOGR F, V66, P225, DOI 10.1107/S1744309109054037; Schmitt FO, 1935, RADIOLOGY, V25, P131; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schroer CG, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.090801; Shapiro L, 1996, NEURON, V17, P435, DOI 10.1016/S0896-6273(00)80176-2; Smith JL, 2012, CURR OPIN STRUC BIOL, V22, P602, DOI 10.1016/j.sbi.2012.09.001; SUZUKI M, 1969, LAB INVEST, V20, P444; Thompson AJ, 2002, J NEUROSCI RES, V67, P766, DOI 10.1002/jnr.10167; Trapp BD, 2004, MYELIN BIOL DISORDER, P3; VAN MEER G, 1982, EMBO J, V1, P847, DOI 10.1002/j.1460-2075.1982.tb01258.x; Xie B, 2007, INT J MASS SPECTROM, V268, P304, DOI 10.1016/j.ijms.2007.08.007; Yagi N, 2009, J PHYS C SER, V272, P1	52	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100592	10.1371/journal.pone.0100592	http://dx.doi.org/10.1371/journal.pone.0100592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984037	Green Published, Green Submitted, gold			2022-12-27	WOS:000339635000032
J	Kivikangas, JM; Katsyri, J; Jarvela, S; Ravaja, N				Kivikangas, J. Matias; Katsyri, Jari; Jarvela, Simo; Ravaja, Niklas			Gender Differences in Emotional Responses to Cooperative and Competitive Game Play	PLOS ONE			English	Article							SEX-DIFFERENCES; BEHAVIORAL ACTIVATION; INTRINSIC MOTIVATION; NEGATIVE AFFECT; PSYCHOPHYSIOLOGY; PERFORMANCE; INHIBITION; PSYCHOLOGY; FEMALES; SYSTEMS	Previous research indicates that males prefer competition over cooperation, and it is sometimes suggested that females show the opposite behavioral preference. In the present article, we investigate the emotions behind the preferences: Do males exhibit more positive emotions during competitive than cooperative activities, and do females show the opposite pattern? We conducted two experiments where we assessed the emotional responses of same-gender dyads (in total 130 participants, 50 female) during intrinsically motivating competitive and cooperative digital game play using facial electromyography (EMG), skin conductance, heart rate measures, and self-reported emotional experiences. We found higher positive emotional responses (as indexed by both physiological measures and self-reports) during competitive than cooperative play for males, but no differences for females. In addition, we found no differences in negative emotions, and heart rate, skin conductance, and self-reports yielded contradictory evidence for arousal. These results support the hypothesis that males not only prefer competitive over cooperative play, but they also exhibit more positive emotional responses during them. In contrast, the results suggest that the emotional experiences of females do not differ between cooperation and competition, which implies that less competitiveness does not mean more cooperativeness. Our results pertain to intrinsically motivated game play, but might be relevant also for other kinds of activities.	[Kivikangas, J. Matias; Jarvela, Simo; Ravaja, Niklas] Aalto Univ, Sch Business, Dept Informat & Serv Econ, Helsinki, Finland; [Katsyri, Jari] Aalto Univ, Sch Sci, Dept Media Technol, Espoo, Finland; [Ravaja, Niklas] Univ Helsinki, Dept Social Res, Helsinki, Finland; [Ravaja, Niklas] Univ Helsinki, Helsinki Inst Informat Technol, Helsinki, Finland	Aalto University; Aalto University; University of Helsinki; University of Helsinki	Kivikangas, JM (corresponding author), Aalto Univ, Sch Business, Dept Informat & Serv Econ, Helsinki, Finland.	matias.kivikangas@aalto.fi	Ravaja, Niklas/D-1532-2013	Ravaja, Niklas/0000-0003-1876-8731	Finnish graduate school for User-Centered Technology; EU [NEST-PATH-028765]; Tekes; Finnish Funding Agency for Technology and Innovation [425/10]	Finnish graduate school for User-Centered Technology; EU(European Commission); Tekes(Finnish Funding Agency for Technology & Innovation (TEKES)); Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES))	This study was partly supported by Finnish graduate school for User-Centered Technology. Experiment 1 of this research was funded by EU under the project "FUGA," Contract Number NEST-PATH-028765, and Experiment 2 was funded by Tekes, the Finnish Funding Agency for Technology and Innovation (www.tekes.fi/eng/), grant "Next Media", Decision Number 425/10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLGREN A, 1979, DEV PSYCHOL, V15, P45, DOI 10.1037/h0078076; [Anonymous], 2007, P PRESENCE 2007 10 I; [Anonymous], 2005, HDB EVOLUTIONARY PSY; Anthony D, 2003, SOC PSYCHOL QUART, V66, P293, DOI 10.2307/1519827; Balliet D, 2011, PSYCHOL BULL, V137, P881, DOI 10.1037/a0025354; Bartsch A, 2008, MEDIA PSYCHOL, V11, P7, DOI 10.1080/15213260701813447; Benedek M, 2010, PSYCHOPHYSIOLOGY, V47, P647, DOI 10.1111/j.1469-8986.2009.00972.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biocca F., 2003, MEASURES COPRESENCE, P1; Bolls PD, 2001, COMMUN RES, V28, P627, DOI 10.1177/009365001028005003; Bradley MM, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P581, DOI 10.1017/CBO9780511546396.025; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Conti R, 2001, PERS INDIV DIFFER, V31, P1273, DOI 10.1016/S0191-8869(00)00217-8; CROCKER PRE, 1995, SPORT PSYCHOL, V9, P325, DOI 10.1123/tsp.9.3.325; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; Dawson M.E., 2000, HDB PSYCHOPHYSIOLOGY, V2, P200; De Kort YAW, 2009, P DIGRA 2009; Decety J, 2004, NEUROIMAGE, V23, P744, DOI 10.1016/j.neuroimage.2004.05.025; Deci EL, 1985, INTRINSIC MOTIVATION; Fischer A.H., 2001, APPRAISAL PROCESSES, P221; FRANKEN RE, 1995, PERS INDIV DIFFER, V19, P175, DOI 10.1016/0191-8869(95)00035-5; Fredricks JA, 2002, DEV PSYCHOL, V38, P519, DOI 10.1037/0012-1649.38.4.519; Fridlund A.J., 1994, HUMAN FACIAL EXPRESS; FUJITA F, 1991, J PERS SOC PSYCHOL, V61, P427, DOI 10.1037/0022-3514.61.3.427; Gajadhar BJ, 2009, INT J GAMING COMPUT-, V1, P14, DOI 10.4018/jgcms.2009070102; Gajadhar BJ, 2008, LECT NOTES COMPUT SC, V5294, P106, DOI 10.1007/978-3-540-88322-7_11; Gill D, 1996, J SPORT BEHAV, V19; Gill D, 1988, SPORT PSYCHOL, V2, P212, DOI DOI 10.1123/TSP.2.3.212; Gladstone EC, 2013, ACAD MANAG P, V2013; Gneezy U, 2009, ECONOMETRICA, V77, P1637, DOI 10.3982/ECTA6690; Greenberg BS, 2010, SIMULAT GAMING, V41, P238, DOI 10.1177/1046878108319930; Gupta ND, 2005, MALE FEMALE COMPETIT; Harrison LK, 2001, PSYCHOPHYSIOLOGY, V38, P601, DOI 10.1017/S0048577201000890; Hartmann T, 2006, J COMPUT-MEDIAT COMM, V11, P910, DOI 10.1111/j.1083-6101.2006.00301.x; Hazlett R. L., 2006, Conference on Human Factors in Computing Systems. CHI2006, P1023; Heponiemi T, 2003, PERS INDIV DIFFER, V34, P943, DOI 10.1016/S0191-8869(02)00079-X; Jarvela S, 2014, SIMULAT GAMING, V45, P24, DOI 10.1177/1046878113513080; Jorm AF, 1999, PERS INDIV DIFFER, V26, P49; Kenny D. A., 2006, DYADIC DATA ANAL; Kivikangas JM, 2013, IEEE T AFFECT COMPUT, V4, P173, DOI 10.1109/T-AFFC.2013.12; Kivikangas JM, 2011, J GAMING VIRTUAL WOR, V3, P181, DOI 10.1386/jgvw.3.3.181_1; Knight J, 2002, NATURE, V415, P254, DOI 10.1038/415254a; LaFrance M, 2003, PSYCHOL BULL, V129, P305, DOI 10.1037/0033-2909.129.2.305; Lang P, 1980, TECHNOLOGY MENTAL HL, P119, DOI DOI 10.1016/J.LINDIF.2013.01.005; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Larsen JT, 2011, J PERS SOC PSYCHOL, V100, P1095, DOI 10.1037/a0021846; Larsen JT, 2003, PSYCHOPHYSIOLOGY, V40, P776, DOI 10.1111/1469-8986.00078; Lee S, 2009, MEDIA PSYCHOL, V12, P148, DOI 10.1080/15213260902849927; Lessiter J, 2001, PRESENCE-TELEOP VIRT, V10, P282, DOI 10.1162/105474601300343612; Loch CH, 2006, MANAG DECIS ECON, V27, P217, DOI 10.1002/mde.1294; Mandryk RL, 2007, INT J HUM-COMPUT ST, V65, P329, DOI 10.1016/j.ijhcs.2006.11.011; Mandryk Regan L., 2008, MEAS BEHAV, V2008, P93, DOI [10.1016/j.ijhcs.2006.11.011, DOI 10.1016/J.IJHCS.2006.11.011]; MCAULEY E, 1989, J SPORT EXERCISE PSY, V11, P84, DOI 10.1123/jsep.11.1.84; Nacke LE, 2010, SIMUL GAMING; Niederle M, 2007, Q J ECON, V122, P1067, DOI 10.1162/qjec.122.3.1067; Petersen MB, 2012, POLIT PSYCHOL, V33, P395, DOI 10.1111/j.1467-9221.2012.00883.x; Poels K, 2008, ANN M INT COMM ASS S; Przybylski AK, 2009, CYBERPSYCHOL BEHAV, V12, P485, DOI 10.1089/cpb.2009.0083; Ravaja N, 2004, MEDIA PSYCHOL, V6, P193, DOI 10.1207/s1532785xmep0602_4; Ravaja N, 2008, EMOTION, V8, P114, DOI 10.1037/1528-3542.8.1.114; Ravaja N, 2006, PRESENCE-TELEOP VIRT, V15, P381, DOI 10.1162/pres.15.4.381; Ravaja N, 2009, MEDIA PSYCHOL, V12, P268, DOI 10.1080/15213260903052240; Reeves B, 1994, MEASURING PSYCHOL RE, P165; Ryan RM, 2006, MOTIV EMOTION, V30, P347, DOI 10.1007/s11031-006-9051-8; Salen Katie., 2004, RULES PLAY GAME DESI; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; SCANLAN TK, 1986, J SPORT EXERCISE PSY, V8, P25, DOI 10.1123/jsp.8.1.25; Scherer KR, 2005, SOC SCI INFORM, V44, P695, DOI 10.1177/0539018405058216; Schmierbach M, 2010, COMMUN RES, V37, P256, DOI 10.1177/0093650209356394; Sherman LW, 1986, TEACH TEACH EDUC, V2, P283; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Simons RF, 1999, PSYCHOPHYSIOLOGY, V36, P619, DOI 10.1017/S0048577299980976; Simpson B, 2003, SOC FORCES, V82, P35, DOI 10.1353/sof.2003.0081; Small DA, 2007, J PERS SOC PSYCHOL, V93, P600, DOI 10.1037/0022-3514.93.4.600; Spape MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078795; Takatalo J, 2011, SIMULAT GAMING, V42, P656, DOI 10.1177/1046878110378353; Tauer JM, 2004, J PERS SOC PSYCHOL, V86, P849, DOI 10.1037/0022-3514.86.6.849; Taylor SE, 2000, PSYCHOL REV, V107, P411, DOI 10.1037/0033-295X.107.3.411; Vallerand RJ, 1999, J APPL SPORT PSYCHOL, V11, P142, DOI 10.1080/10413209908402956; van den Hoogen W, 2012, MEDIA PSYCHOL, V15, P443, DOI 10.1080/15213269.2012.723117; Van Vugt M, 2007, PSYCHOL SCI, V18, P19, DOI 10.1111/j.1467-9280.2007.01842.x; Vorderer P., 2003, P 2 INT C ENT COMP P, P1, DOI DOI 10.1145/958720.958735; Walters AE, 1998, ORGAN BEHAV HUM DEC, V76, P1, DOI 10.1006/obhd.1998.2797; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Weaver AJ, 2011, MEDIA PSYCHOL, V14, P49, DOI 10.1080/15213269.2010.547829; WEIDNER G, 1995, INT J BEHAV MED, V2, P66, DOI 10.1207/s15327558ijbm0201_6; Williams D, 2006, LEA COMMUN SER, P197; Wright RA, 1997, J PERS SOC PSYCHOL, V73, P405, DOI 10.1037/0022-3514.73.2.405; Yamasue H, 2008, CEREB CORTEX, V18, P2331, DOI 10.1093/cercor/bhm254	91	36	38	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100318	10.1371/journal.pone.0100318	http://dx.doi.org/10.1371/journal.pone.0100318			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1UX	24983952	Green Published, gold, Green Submitted			2022-12-27	WOS:000339635000019
J	Obermeier, A; Schneider, J; Wehner, S; Matl, FD; Schieker, M; von Eisenhart-Rothe, R; Stemberger, A; Burgkart, R				Obermeier, Andreas; Schneider, Jochen; Wehner, Steffen; Matl, Florian Dominik; Schieker, Matthias; von Eisenhart-Rothe, Ruediger; Stemberger, Axel; Burgkart, Rainer			Novel High Efficient Coatings for Anti-Microbial Surgical Sutures Using Chlorhexidine in Fatty Acid Slow-Release Carrier Systems	PLOS ONE			English	Article							SITE INFECTION; COATED SUTURES; ANTIINFECTIVE COATINGS; BACTERIAL ADHERENCE; RANDOMIZED-TRIAL; POVIDONE-IODINE; IN-VITRO; TRICLOSAN; PREVENTION; EFFICACY	Sutures can cause challenging surgical site infections, due to capillary effects resulting in bacteria permeating wounds. Antimicrobial sutures may avoid these complications by inhibiting bacterial pathogens. Recently, first triclosan-resistances were reported and therefore alternative substances are becoming clinically relevant. As triclosan alternative chlorhexidine, the "gold standard'' in oral antiseptics was used. The aim of the study was to optimize novel slow release chlorhexidine coatings based on fatty acids in surgical sutures, to reach a high anti-microbial efficacy and simultaneously high biocompatibility. Sutures were coated with chlorhexidine laurate and chlorhexidine palmitate solutions leading to 11, 22 or 33 mu g/cm drug concentration per length. Drug release profiles were determined in aqueous elutions. Antibacterial efficacy against Staphylococcus aureus was assessed in agar diffusion tests. Biocompatibility was evaluated via established cytotoxicity assay (WST-1). A commercially triclosan-containing suture (Vicryl Plus), was used as anti-microbial reference. All coated sutures fulfilled European Pharmacopoeia required tensile strength and proved continuous slow drug release over 96 hours without complete wash out of the coated drug. High anti-microbial efficacy for up to 5 days was observed. Regarding biocompatibility, sutures using 11 mg/cm drug content displayed acceptable cytotoxic levels according to ISO 10993-5. The highest potential for human application were shown by the 11 mg/cm chlorhexidine coated sutures with palmitic acid. These novel coated sutures might be alternatives to already established anti-microbial sutures such as Vicryl Plus in case of triclosan-resistance. Chlorhexidine is already an established oral antiseptic, safety and efficacy should be proven for clinical applications in anti-microbial sutures.	[Obermeier, Andreas; Wehner, Steffen; Matl, Florian Dominik; von Eisenhart-Rothe, Ruediger; Stemberger, Axel; Burgkart, Rainer] Tech Univ Munich, Klinikum Rechts Isar, Klin Orthopadie & Sportorthopadie, D-80290 Munich, Bavaria, Germany; [Schneider, Jochen] Tech Univ Munich, Klinikum Rechts Isar, Inst Mikrobiol Immunol & Hyg, D-80290 Munich, Bavaria, Germany; [Schieker, Matthias] Klinikum Univ Munchen, Chirurg Klin, Munich, Bavaria, Germany	Technical University of Munich; Technical University of Munich; University of Munich	Obermeier, A (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Klin Orthopadie & Sportorthopadie, D-80290 Munich, Bavaria, Germany.	aobermeier@tum.de	von Eisenhart-Rothe, Ruediger/E-4839-2017; Schieker, Matthias/J-6511-2015; Schieker, Matthias/AGZ-2030-2022; Obermeier, Andreas/B-3020-2016	Schieker, Matthias/0000-0002-1230-3653; Schieker, Matthias/0000-0002-1230-3653; Obermeier, Andreas/0000-0002-1774-5194; Schneider, Jochen/0000-0002-0300-0159	Heraeus Medical GmbH, Wehrheim, Germany; Klinikum rechts der Isar, Technische Universitat Munchen [8895117_HeraeusCoating]; German Research Foundation (DFG); Technische Universitat Munchen	Heraeus Medical GmbH, Wehrheim, Germany; Klinikum rechts der Isar, Technische Universitat Munchen; German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen	This work was financially supported by the Heraeus Medical GmbH, Wehrheim, Germany (http://www.heraeus-medical.com/de/home_15.html). Within the Klinikum rechts der Isar, Technische Universitat Munchen the external funding number was 8895117_HeraeusCoating. This work was supported by the German Research Foundation (DFG) and the Technische Universitat Munchen within the funding programme Open Access Publishing. The funder's financial support does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The funding organization didn't play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support and research materials.	Aiello AE, 2007, CLIN INFECT DIS, V45, pS137, DOI 10.1086/519255; Baracs J, 2011, SURG INFECT, V12, P483, DOI 10.1089/sur.2011.001; Barnett Todd E, 2007, AORN J, V86, P249, DOI 10.1016/j.aorn.2007.03.012; Chang WK, 2012, ANN SURG, V255, P854, DOI 10.1097/SLA.0b013e31824e7005; Clinical and Laboratory Standards Institute, 2012, METHODS DILUTION ANT, V32; Cooney CM, 2010, ENVIRON HEALTH PERSP, V118, pA242, DOI 10.1289/ehp.118-a242; Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130; Edmiston CE, 2006, J AM COLL SURGEONS, V203, P481, DOI 10.1016/j.jamcollsurg.2006.06.026; Ethicon, 2010, IHR ZUS SCHUTZ VOR P; Fujita T, 2010, SURGERY, V147, P464, DOI 10.1016/j.surg.2009.04.019; Geiger Dieter, 2005, Surg Infect (Larchmt), V6, P377, DOI 10.1089/sur.2005.6.377; Hranjec T, 2010, SURG INFECT, V11, P289, DOI 10.1089/sur.2010.021; Hubner NO, 2010, SKIN PHARMACOL PHYS, V23, P28, DOI 10.1159/000318265; Justinger C, 2011, LANGENBECK ARCH SURG, P1; Justinger C, 2013, SURGERY, V154, P589, DOI 10.1016/j.surg.2013.04.011; Kathju S, 2009, SURG INFECT, V10, P457, DOI 10.1089/sur.2008.062; KATZ S, 1981, ANN SURG, V194, P35, DOI 10.1097/00000658-198107000-00007; Leaper DJ, 2010, BRIT J SURG, V97, P1601, DOI 10.1002/bjs.7275; Leaper D, 2011, INT WOUND J, V8, P556, DOI 10.1111/j.1742-481X.2011.00841.x; Matl FD, 2008, ANTIMICROB AGENTS CH, V52, P1957, DOI 10.1128/AAC.01438-07; Matl FD, 2009, J BIOMAT SCI-POLYM E, V20, P1439, DOI 10.1163/092050609X12457418973107; Menderes G, 2012, OBSTET GYNECOL, V120, P1037, DOI [10.1097/AOG.0b013e31826f3bd9, http://10.1097/AOG.0b013e31826f3bd9]; Ming XT, 2008, SURG INFECT, V9, P451, DOI 10.1089/sur.2007.061; Mingmalairak, 2011, SCI MICROBIAL PATHOG, V313, P23; Mingmalairak Chatchai, 2009, Journal of the Medical Association of Thailand, V92, P770; Obermeier A, 2012, J MATER SCI-MATER M, V23, P1675, DOI 10.1007/s10856-012-4631-5; Rupp ME, 2005, ANN INTERN MED, V143, P570, DOI 10.7326/0003-4819-143-8-200510180-00007; Sanders D, 2013, HERNIA, V17, P779, DOI 10.1007/s10029-013-1124-5; Schierholz JM, 2001, J HOSP INFECT, V49, P87, DOI 10.1053/jhin.2001.1052; Segers P, 2006, JAMA-J AM MED ASSOC, V296, P2460, DOI 10.1001/jama.296.20.2460; Stone J, 2010, PEDIATR NEUROSURG, V46, P19, DOI 10.1159/000314053; Suwanpimolkul G, 2008, J INFECTION, V56, P354, DOI 10.1016/j.jinf.2008.03.001; Timsit JF, 2012, AM J RESP CRIT CARE, V186, P1272, DOI 10.1164/rccm.201206-1038OC; von Eiff C, 2005, DRUGS, V65, P179, DOI 10.2165/00003495-200565020-00003; Wang ZX, 2013, BRIT J SURG, V100, P465, DOI 10.1002/bjs.9062; Williams N, 2011, SURG INFECT, V12, P469, DOI 10.1089/sur.2011.045; Yazdankhah SP, 2006, MICROB DRUG RESIST, V12, P83, DOI 10.1089/mdr.2006.12.83; Young B, 2011, ANTIMICROB AGENTS CH, V55, P4659, DOI 10.1128/AAC.00562-11	38	54	55	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101426	10.1371/journal.pone.0101426	http://dx.doi.org/10.1371/journal.pone.0101426			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983633	gold, Green Published, Green Submitted			2022-12-27	WOS:000339635000106
J	Trairatphisan, P; Mizera, A; Pang, J; Tantar, AA; Sauter, T				Trairatphisan, Panuwat; Mizera, Andrzej; Pang, Jun; Tantar, Alexandru Adrian; Sauter, Thomas			optPBN: An Optimisation Toolbox for Probabilistic Boolean Networks	PLOS ONE			English	Article							MODELS	Background: There exist several computational tools which allow for the optimisation and inference of biological networks using a Boolean formalism. Nevertheless, the results from such tools yield only limited quantitative insights into the complexity of biological systems because of the inherited qualitative nature of Boolean networks. Results: We introduce optPBN, a Matlab-based toolbox for the optimisation of probabilistic Boolean networks (PBN) which operates under the framework of the BN/PBN toolbox. optPBN offers an easy generation of probabilistic Boolean networks from rule-based Boolean model specification and it allows for flexible measurement data integration from multiple experiments. Subsequently, optPBN generates integrated optimisation problems which can be solved by various optimisers. In term of functionalities, optPBN allows for the construction of a probabilistic Boolean network from a given set of potential constitutive Boolean networks by optimising the selection probabilities for these networks so that the resulting PBN fits experimental data. Furthermore, the optPBN pipeline can also be operated on large-scale computational platforms to solve complex optimisation problems. Apart from exemplary case studies which we correctly inferred the original network, we also successfully applied optPBN to study a large-scale Boolean model of apoptosis where it allows identifying the inverse correlation between UVB irradiation, NFkB and Caspase 3 activations, and apoptosis in primary hepatocytes quantitatively. Also, the results from optPBN help elucidating the relevancy of crosstalk interactions in the apoptotic network. Summary: The optPBN toolbox provides a simple yet comprehensive pipeline for integrated optimisation problem generation in the PBN formalism that can readily be solved by various optimisers on local or grid-based computational platforms. optPBN can be further applied to various biological studies such as the inference of gene regulatory networks or the identification of the interaction's relevancy in signal transduction networks.	[Trairatphisan, Panuwat; Sauter, Thomas] Univ Luxembourg, Syst Biol Grp, Life Sci Res Unit, Luxembourg, Luxembourg; [Mizera, Andrzej; Pang, Jun] Univ Luxembourg, Comp Sci & Commun Res Unit, Luxembourg, Luxembourg; [Pang, Jun; Tantar, Alexandru Adrian] Univ Luxembourg, Interdisciplinary Ctr Secur Reliabil & Trust, Luxembourg, Luxembourg	University of Luxembourg; University of Luxembourg; University of Luxembourg	Sauter, T (corresponding author), Univ Luxembourg, Syst Biol Grp, Life Sci Res Unit, Luxembourg, Luxembourg.	thomas.sauter@uni.lu		Pang, Jun/0000-0002-4521-4112; Trairatphisan, Panuwat/0000-0001-9015-5855; Sauter, Thomas/0000-0001-8225-2954	Fonds National de la Recherche (FNR) Luxembourg [1233900]	Fonds National de la Recherche (FNR) Luxembourg(Luxembourg National Research Fund)	We acknowledge with thanks financial support from the Fonds National de la Recherche (FNR) Luxembourg (grant 1233900), http://www.fnr.lu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender C, 2012, BIOINFORMATICS, V26, pi596; Bornholdt S, 2008, J R SOC INTERFACE, V5, pS85, DOI 10.1098/rsif.2008.0132.focus; Cahon S, 2004, J HEURISTICS, V10, P357, DOI 10.1023/B:HEUR.0000026900.92269.ec; Cullen SP, 2013, MOL CELL, V49, P1034, DOI 10.1016/j.molcel.2013.01.025; Fertig Elana J., 2011, Frontiers in Genetics, V2, P77, DOI 10.3389/fgene.2011.00077; Flottmann M, 2012, FRONT PHYSIOL, V3, P1; HASHIMOTO R. F., 2009, P IEEE INT WORKSHOP, P1, DOI DOI 10.1109/GENSIPS.2009.5174356; Holland J. H., 1992, ADAPTATION NATURAL A; Imamura R, 2004, J BIOL CHEM, V279, P46415, DOI 10.1074/jbc.M403226200; Kaderali L, 2009, BIOINFORMATICS, V25, P2229, DOI 10.1093/bioinformatics/btp375; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Klamt S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-56; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Ma Z, 2008, IEEE J-STSP, V2, P975, DOI 10.1109/JSTSP.2008.2007816; MIRANDA EN, 1989, EUROPHYS LETT, V10, P293, DOI 10.1209/0295-5075/10/4/002; Pal R, 2005, BIOINFORMATICS, V21, P1211, DOI 10.1093/bioinformatics/bti131; Raftery AE., 1992, BAYESIAN STAT, V4, P763; Saez-Rodriguez J, 2007, PLOS COMPUT BIOL, V3, P1580, DOI 10.1371/journal.pcbi.0030163; Saez-Rodriguez J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.87; Schlatter R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000595; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Shmulevich I, 2003, COMP FUNCT GENOM, V4, P601, DOI 10.1002/cfg.342; Shmulevich I, 2002, P IEEE, V90, P1778, DOI 10.1109/JPROC.2002.804686; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; Shmulevich I., 2010, PROB BOOL NETW; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Tay Joc C, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P5315; Terfve C, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-133; Trairatphisan P, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-46; Vaz AIF, 2007, J GLOBAL OPTIM, V39, P197, DOI 10.1007/s10898-007-9133-5; Yu L, 2006, IEEE INT WORK GENOM, P45, DOI 10.1109/GENSIPS.2006.353148	31	18	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e98001	10.1371/journal.pone.0098001	http://dx.doi.org/10.1371/journal.pone.0098001			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983623	gold, Green Published, Green Submitted			2022-12-27	WOS:000339635000006
J	Cho, HK; Kim, KW; Jeong, YM; Lee, HS; Lee, YJ; Hwang, SH				Cho, Hye Kyung; Kim, Kyu Won; Jeong, Yeon Min; Lee, Ho Seok; Lee, Yeon Ji; Hwang, Se Hwan			Efficacy of Ketamine in Improving Pain after Tonsillectomy in Children: Meta-Analysis	PLOS ONE			English	Article							PREINCISIONAL PERITONSILLAR INFILTRATION; POSTOPERATIVE PAIN; ANALGESIA; TRAMADOL; MORPHINE; RELIEF; ADENOTONSILLECTOMY; SEDATION; MANAGEMENT	Background and objectives: The goal of this meta-analysis study was to perform a systematic review of the literature on the effects of ketamine on postoperative pain following tonsillectomy and adverse effects in children. Subjects and Methods: Two authors independently searched three databases (MEDLINE, SCOPUS, Cochrane) from their inception of article collection to February 2014. Studies that compared preoperative ketamine administration (ketamine groups) with no treatment (control group) or opioid administration (opioid group) where the outcomes of interest were postoperative pain intensity, rescue analgesic consumption, or adverse effects (sedation, nausea and vomiting, bad dream, worsening sleep pattern, and hallucination) 0-24 hours after leaving the operation room were included in the analysis. Results: The pain score reported by the physician during first 4 hours and need for analgesics during 24 hours postoperatively was significantly decreased in the ketamine group versus control group and was similar with the opioid group. In addition, there was no significant difference between ketamine and control groups for adverse effects during 24 hours postoperatively. In the subgroup analyses (systemic and local administration) regarding pain related measurements, peritonsillar infiltration of ketamine was more effective in reducing the postoperative pain severity and need for analgesics. Conclusion: Preoperative administration of ketamine systemically or locally could provide pain relief without side-effects in children undergoing tonsillectomy. However, considering the insufficient evaluation of efficacy of ketamine according to the administration methods and high heterogeneity in some parameters, further clinical trials with robust research methodology should be conducted to confirm the results of this study.	[Cho, Hye Kyung; Kim, Kyu Won] Gachon Univ, Dept Pediat, Grad Sch Med, Inchon, South Korea; [Jeong, Yeon Min; Lee, Ho Seok; Lee, Yeon Ji; Hwang, Se Hwan] Catholic Univ Korea, Dept Otolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea	Gachon University; Catholic University of Korea	Hwang, SH (corresponding author), Catholic Univ Korea, Dept Otolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea.	yellobird@catholic.ac.kr	Kim, Kyu Won/AAJ-7213-2020	Hwang, Se Hwan/0000-0002-2838-7820	Otorhinolaryngology Alumni Fund of the Catholic University of Korea; Catholic Medical Center Research Foundation	Otorhinolaryngology Alumni Fund of the Catholic University of Korea; Catholic Medical Center Research Foundation	This research was supported by the Otorhinolaryngology Alumni Fund of the Catholic University of Korea made in the program year of 2013, the Catholic Medical Center Research Foundation made in the program year of 2013, and the Catholic Medical Center Research Foundation made in the program year of 2014. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acion L, 2006, STAT MED, V25, P591, DOI 10.1002/sim.2256; Aspinall RL, 2001, PAEDIATR ANAESTH, V11, P333, DOI 10.1046/j.1460-9592.2001.00676.x; Ayatollahi V, 2012, CROAT MED J, V53, P155, DOI 10.3325/cmj.2012.53.155; Bameshki Ali Reza, 2013, Iran J Otorhinolaryngol, V25, P209; Batra YK, 2007, INT J CLIN PHARM TH, V45, P155; Canbay O, 2008, EUR J ANAESTH, V25, P287, DOI 10.1017/S026502150700316X; Da Conceicao MJ, 2006, PEDIATR ANESTH, V16, P962, DOI 10.1111/j.1460-9592.2006.01893.x; Dahmani S, 2011, PEDIATR ANESTH, V21, P636, DOI 10.1111/j.1460-9592.2011.03566.x; Dal D, 2007, PEDIATR ANESTH, V17, P263, DOI 10.1111/j.1460-9592.2006.02095.x; Eghbal Mohammad Hossein, 2013, Middle East Journal of Anesthesiology, V22, P155; El Sonbaty Mohamed Ibrahim, 2011, Middle East Journal of Anesthesiology, V21, P43; Elhakim M, 2003, ACTA ANAESTH SCAND, V47, P604, DOI 10.1034/j.1399-6576.2003.00111.x; Elshammaa N, 2011, PEDIATR ANESTH, V21, P1009, DOI 10.1111/j.1460-9592.2011.03604.x; EPSTEIN FB, 1993, AM J EMERG MED, V11, P180, DOI 10.1016/0735-6757(93)90115-R; Erhan OL, 2007, INT J PEDIATR OTORHI, V71, P735, DOI 10.1016/j.ijporl.2007.01.008; Genc E, 2006, INT J PEDIATR OTORHI, V70, P725, DOI 10.1016/j.ijporl.2005.12.005; Green SM, 2011, ANN EMERG MED, V57, P449, DOI 10.1016/j.annemergmed.2010.11.030; Hamunen K, 2005, PAIN, V117, P40, DOI 10.1016/j.pain.2005.05.012; Hasnain F, 2012, PAK J PHARM SCI, V25, P599; Honarmand A, 2013, RES PHARM SCI, V8, P177; Honarmand A, 2008, PEDIATR ANESTH, V18, P508, DOI 10.1111/j.1460-9592.2008.02461.x; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Khademi S, 2011, MED PRIN PRACT, V20, P433, DOI 10.1159/000327657; Laskowski K, 2011, CAN J ANESTH, V58, P911, DOI 10.1007/s12630-011-9560-0; Levanen J, 2000, MIL MED, V165, P450, DOI 10.1093/milmed/165.6.450; Marcus RJ, 2000, BRIT J ANAESTH, V84, P739, DOI 10.1093/oxfordjournals.bja.a013585; McGlone RG, 2004, EMERG MED J, V21, P290, DOI 10.1136/emj.2002.003772; Mistry RB, 2005, PHARMACOTHERAPY, V25, P1104, DOI 10.1592/phco.2005.25.8.1104; O'Flaherty JE, 2003, PAEDIATR ANAESTH, V13, P413, DOI 10.1046/j.1460-9592.2003.01049.x; Ozlugedik S, 2006, INT J PEDIATR OTORHI, V70, P1929, DOI 10.1016/j.ijporl.2006.07.001; Pirzadeh Akbar, 2012, Iran J Otorhinolaryngol, V24, P23; Safavi Mohammadreza, 2012, Med Arh, V66, P111; Siddiqui AS, 2013, JCPSP-J COLL PHYSICI, V23, P533, DOI 08.2013/JCPSP.533537; Taheri R, 2011, Pak J Biol Sci, V14, P572; Tekelioglu UY, 2013, PEDIATR ANESTH, V23, P496, DOI 10.1111/pan.12148; Ugur KS, 2013, INT J PEDIATR OTORHI, V77, P1825, DOI 10.1016/j.ijporl.2013.08.018; Umuroglu T, 2004, PEDIATR ANESTH, V14, P568, DOI 10.1111/j.1460-9592.2004.01223.x	37	33	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101259	10.1371/journal.pone.0101259	http://dx.doi.org/10.1371/journal.pone.0101259			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979227	gold, Green Published, Green Submitted			2022-12-27	WOS:000338506400108
J	David, MS; Kelly, E; Cheung, I; Xaymardan, M; Moore, MAS; Zoellner, H				David, Manu S.; Kelly, Elizabeth; Cheung, Ivan; Xaymardan, Munira; Moore, Malcolm A. S.; Zoellner, Hans			SAOS-2 Osteosarcoma Cells Bind Fibroblasts via ICAM-1 and This Is Increased by Tumour Necrosis Factor-alpha	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; ENDOTHELIAL-CELLS; ADHESION MOLECULE-1; MEDIATED APOPTOSIS; CARCINOMA CELLS; POLYMYXIN-B; TNF-ALPHA; CYTOKINES; CANCER; METASTASIS	We recently reported exchange of membrane and cytoplasmic markers between SAOS-2 osteosarcoma cells and human gingival fibroblasts (h-GF) without comparable exchange of nuclear markers, while similar h-GF exchange was seen for melanoma and ovarian carcinoma cells. This process of "cellular sipping'' changes phenotype such that cells sharing markers of both SAOS-2 and h-GF have morphology intermediate to that of either cell population cultured alone, evidencing increased tumour cell diversity without genetic change. TNF-alpha increases cellular sipping between h-GF and SAOS-2, and we here study binding of SAOS-2 to TNF-alpha treated h-GF to determine if increased cellular sipping can be accounted for by cytokine stimulated SAOS-2 binding. More SAOS-2 bound h-GF pe-seeded wells than culture plastic alone (p<0.001), and this was increased by h-GF pre-treatment with TNF-alpha (p<0.001). TNF-alpha stimulated binding was dose dependent and maximal at 1.16nM (p<0.05) with no activity below 0.006 nM. SAOS-2 binding to h-GF was independent of serum, while the lipopolysaccharide antagonist Polymyxin B did not affect results, and TNF-alpha activity was lost on boiling. h-GF binding of SAOS-2 started to increase after 30min TNF-alpha stimulation and was maximal by 1.5hr pre-treatment (p<0.001). h-GF retained maximal binding up to 6hrs after TNF-alpha stimulation, but this was lost by 18hrs (p<0.001). FACS analysis demonstrated increased ICAM-1 consistent with the time course of SAOS-2 binding, while antibody against ICAM-1 inhibited SAOS-2 adhesion (p<0.04). Pre-treating SAOS-2 with TNF-alpha reduced h-GF binding to background levels (p<0.003), and this opposite effect to h-GF cytokine stimulation suggests that the history of cytokine exposure of malignant cells migrating across different microenvironments can influence subsequent interactions with fibroblasts. Since cytokine stimulated binding was comparable in magnitude to earlier reported TNF-alpha stimulated cellular sipping, we conclude that TNF-alpha stimulated cellular sipping likely reflects increased SAOS-2 binding as opposed to enhanced exchange mechanisms.	[David, Manu S.; Kelly, Elizabeth; Cheung, Ivan; Xaymardan, Munira; Zoellner, Hans] Univ Sydney, Westmead Hosp, Dept Oral Pathol & Oral Med, Cellular & Mol Pathol Res Unit,Fac Dent,Westmead, Westmead, NSW 2145, Australia; [Moore, Malcolm A. S.; Zoellner, Hans] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	University of Sydney; Memorial Sloan Kettering Cancer Center	Zoellner, H (corresponding author), Univ Sydney, Westmead Hosp, Dept Oral Pathol & Oral Med, Cellular & Mol Pathol Res Unit,Fac Dent,Westmead, Westmead, NSW 2145, Australia.	hans.zoellner@sydney.edu.au	Zoellner, Hans/GWQ-7168-2022	Zoellner, Hans/0000-0003-4804-2464; Xaymardan, Munira/0000-0003-0078-0863	Australian Dental Research Fund; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Australian Dental Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by the Australian Dental Research Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Bendall LJ, 1997, EXP HEMATOL, V25, P132; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; CAVAILLON JM, 1986, MOL IMMUNOL, V23, P965, DOI 10.1016/0161-5890(86)90127-6; David MS, 2013, CYTOKINE, V62, P48, DOI 10.1016/j.cyto.2013.02.028; David MS, 2012, J PATHOL, V228, P495, DOI 10.1002/path.4063; de Sampaio PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030753; Duda DG, 2010, P NATL ACAD SCI USA, V107, P21677, DOI 10.1073/pnas.1016234107; Emmanuel C, 2002, CYTOKINE, V18, P237, DOI 10.1006/cyto.2002.1042; FIDLER IJ, 1982, SCIENCE, V217, P998, DOI 10.1126/science.7112116; Hayashi S, 2007, ARTHRITIS RHEUM, V56, P1067, DOI 10.1002/art.22494; Hess S, 1998, EUR J IMMUNOL, V28, P3594, DOI 10.1002/(SICI)1521-4141(199811)28:11<3594::AID-IMMU3594>3.3.CO;2-4; HONN KV, 1992, CANCER METAST REV, V11, P353, DOI 10.1007/BF01307187; Hosokawa Y, 2006, CLIN EXP IMMUNOL, V144, P494, DOI 10.1111/j.1365-2249.2006.03064.x; Kim Se Jong, 1993, Journal of Korean Medical Science, V8, P41; Klein CL, 1995, PATHOBIOLOGY, V63, P204, DOI 10.1159/000163953; Kumar V, 2005, ROBBINS COTRAN PATHO, Vxv; LAURI D, 1991, JNCI-J NATL CANCER I, V83, P1321, DOI 10.1093/jnci/83.18.1321; Loeb LA, 2008, CANCER RES, V68, P6863, DOI 10.1158/0008-5472.CAN-08-2852; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; LYNN WA, 1992, IMMUNOL TODAY, V13, P271, DOI 10.1016/0167-5699(92)90009-V; MALIK STA, 1990, EUR J CANCER, V26, P1031, DOI 10.1016/0277-5379(90)90044-T; MARLOR CW, 1992, AM J PATHOL, V140, P1055; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; McEwen A, 2003, J PATHOL, V201, P395, DOI 10.1002/path.1457; Mohan RR, 2000, INVEST OPHTH VIS SCI, V41, P1327; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; MORRISON DC, 1976, INFECT IMMUN, V13, P298, DOI 10.1128/IAI.13.1.298-301.1976; Okamoto K, 2002, APOPTOSIS, V7, P77, DOI 10.1023/A:1013569029907; RICE GE, 1988, AM J PATHOL, V133, P204; Steinbach F, 1996, J UROLOGY, V155, P743, DOI 10.1016/S0022-5347(01)66513-3; Tanaka T, 2002, EUR RESPIR J, V20, P359, DOI 10.1183/09031936.02.00252602; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; TSUTSUI T, 1973, JPN J MED SCI BIOL, V26, P169, DOI 10.7883/yoken1952.26.169; van Grevenstein WMU, 2007, DIGEST DIS SCI, V52, P2775, DOI 10.1007/s10620-007-9778-4; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; ZOELLNER H, 1992, BLOOD, V80, P2805; ZOELLNER H, 1993, LYMPHOKINE CYTOK RES, V12, P93; ZOELLNER HFA, 1989, J HISTOCHEM CYTOCHEM, V37, P1893, DOI 10.1177/37.12.2584695	40	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101202	10.1371/journal.pone.0101202	http://dx.doi.org/10.1371/journal.pone.0101202			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979620	Green Submitted, gold, Green Published			2022-12-27	WOS:000338506400098
J	Liu, JL; Ke, F; Xu, ZY; Liu, ZY; Zhang, LY; Yan, S; Wang, Z; Wang, H; Wang, HL				Liu, Jinlin; Ke, Fang; Xu, Zhenyao; Liu, Zhaoyuan; Zhang, Lingyun; Yan, Sha; Wang, Zhe; Wang, Hong; Wang, Honglin			CCR6 Is a Prognostic Marker for Overall Survival in Patients with Colorectal Cancer, and Its Overexpression Enhances Metastasis In Vivo	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CCR6; MACROPHAGE INFLAMMATORY PROTEIN-3-ALPHA/CCL20; LYMPH-NODE METASTASIS; MOLECULAR-CLONING; E-CADHERIN; EXPRESSION; CELLS; LIVER; LOCALIZATION; ACTIVATION	The chemokine receptor CCR6 has been recently shown to be associated with colorectal cancer (CRC) progression. However, the direct evidence for whether CCR6 in tumors is a prognostic marker for the survival of patients with CRC and whether it plays a critical role in CRC metastasis in vivo is lacking. Here we show that the levels of CCR6 were upregulated in CRC cell lines and primary CRC clinical samples. CCR6 upregulation was closely correlated with disease stages and the survival time of CRC patients. Knockdown of CCR6 inhibited the migration of CRC cells in vitro. Overexpression of CCR6 in CRC cells increased their proliferation, migration, and colony formation in vitro and promoted their metastatic potential in vivo. CCR6 activated Akt signaling, upregulated metastasis genes and downregulated metastasis suppressor genes. Selective targeting of CCR6 in tumors dramatically inhibited the growth of CRC in mice. Thus, the tumor expression of CCR6 plays a critical role in CRC metastasis, upregulated CCR6 predicts poor survival in CRC patients, and targeting CCR6 expression in tumors may be a potential therapeutic strategy for CRC.	[Liu, Jinlin; Ke, Fang; Xu, Zhenyao; Liu, Zhaoyuan; Zhang, Lingyun; Yan, Sha; Wang, Zhe; Wang, Hong; Wang, Honglin] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai Inst Immunol, Shanghai 200030, Peoples R China; [Wang, Honglin] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Tumor Microenvironm & Inflammat, Shanghai 200030, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, HL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai Inst Immunol, Shanghai 200030, Peoples R China.	honglin.wang@sjtu.edu.cn	WANG, Honglin/AAJ-2708-2020	WANG, Honglin/0000-0001-6302-6927	National Natural Science Foundation of China; 973 Program [91029730, 81202304, 2012CB917100, 2010CB529700, 30972787]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Science and Technology Commission of Shanghai Municipality [09140902600]; Leading Academic Discipline Project of the Shanghai Municipal Education Commission [J50208, J50207]; Shanghai Pujiang Program [10PJ407300]; Shanghai Committee of Science and Technology [11DZ2260200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Leading Academic Discipline Project of the Shanghai Municipal Education Commission; Shanghai Pujiang Program(Shanghai Pujiang Program); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This work is supported by grants from National Natural Science Foundation of China and 973 Program (No: 91029730, No: 81202304, No: 2012CB917100, No: 2010CB529700 and No: 30972787), by the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, by the Science and Technology Commission of Shanghai Municipality (No: 09140902600), by the Leading Academic Discipline Project of the Shanghai Municipal Education Commission (No: J50208 and No: J50207), by Shanghai Pujiang Program (No: 10PJ407300), and by Shanghai Committee of Science and Technology (11DZ2260200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbero S, 2003, CANCER RES, V63, P1969; Brand S, 2006, J CELL BIOCHEM, V97, P709, DOI 10.1002/jcb.20672; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; Dellacasagrande J, 2003, SCAND J IMMUNOL, V57, P534, DOI 10.1046/j.1365-3083.2003.01263.x; Dillon RL, 2010, CANCER RES, V70, P4260, DOI 10.1158/0008-5472.CAN-10-0266; Ding YZ, 2003, CLIN CANCER RES, V9, P3406; Fitzhugh DJ, 2000, J IMMUNOL, V165, P6677, DOI 10.4049/jimmunol.165.12.6677; Ghadjar P, 2006, J CLIN ONCOL, V24, P1910, DOI 10.1200/JCO.2005.04.1822; Hieshima K, 1997, J BIOL CHEM, V272, P5846, DOI 10.1074/jbc.272.9.5846; Homey B, 2000, J IMMUNOL, V164, P6621, DOI 10.4049/jimmunol.164.12.6621; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Kleeff J, 1999, INT J CANCER, V81, P650, DOI 10.1002/(SICI)1097-0215(19990517)81:4<650::AID-IJC23>3.0.CO;2-#; Krzysiek R, 2000, BLOOD, V96, P2338, DOI 10.1182/blood.V96.7.2338.h8002338_2338_2345; Li Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016483; Liao F, 1997, BIOCHEM BIOPH RES CO, V236, P212, DOI 10.1006/bbrc.1997.6936; Liu JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019495; Luangdilok S, 2007, CANCER RES, V67, P7907, DOI 10.1158/0008-5472.CAN-07-0331; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mashino K, 2002, CANCER RES, V62, P2937; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murphy PM, 2001, NEW ENGL J MED, V345, P833, DOI 10.1056/NEJM200109133451113; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Rescigno M, 2006, IMMUNITY, V24, P508, DOI 10.1016/j.immuni.2006.05.005; Robledo MM, 2001, J BIOL CHEM, V276, P45098, DOI 10.1074/jbc.M106912200; Rubie C, 2006, TUMOR BIOL, V27, P166, DOI 10.1159/000092777; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Schutyser E, 2000, J IMMUNOL, V165, P4470, DOI 10.4049/jimmunol.165.8.4470; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Shimamura T, 2003, J CLIN ONCOL, V21, P659, DOI 10.1200/JCO.2003.06.179; Smith SC, 2009, NAT REV CANCER, V9, P253, DOI 10.1038/nrc2594; Taichman RS, 2002, CANCER RES, V62, P1832; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Varona R, 1998, FEBS LETT, V440, P188, DOI 10.1016/S0014-5793(98)01450-1; Yamashiro S, 2000, BLOOD, V96, P3958, DOI 10.1182/blood.V96.12.3958.h8003958_3958_3963; Yu M, 2012, THER ADV GASTROENTER, V5, P319, DOI 10.1177/1756283X12448456	37	22	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101137	10.1371/journal.pone.0101137	http://dx.doi.org/10.1371/journal.pone.0101137			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979261	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400084
J	de Alencar, MCN; Rocha, MOD; Lima, MMD; Costa, HS; Sousa, GR; Carneiro, RDB; Silva, GCR; Brandao, FV; Kreuser, LJ; Ribeiro, ALP; Nunes, MCP				Noman de Alencar, Maria Clara; da Costa Rocha, Manoel Otavio; de Oliveira Lima, Marcia Maria; Costa, Henrique Silveira; Sousa, Giovane Rodrigo; Carneiro, Renata de Carvalho Bicalho; Rodrigues Silva, Guilherme Canabrava; Brandao, Fernando Vieira; Kreuser, Lucas Jordan; Pinho Ribeiro, Antonio Luiz; Pereira Nunes, Maria Carmo			Heart Rate Recovery in Asymptomatic Patients with Chagas Disease	PLOS ONE			English	Article							CHRONOTROPIC RESPONSE; TRYPANOSOMA-CRUZI; EXERCISE; DYSFUNCTION; PREDICTOR; MORTALITY; RECOMMENDATIONS; AUTOANTIBODIES; DYSAUTONOMIA; MODULATION	Background: Chagas disease patients with right bundle-branch block (RBBB) have diverse clinical presentation and prognosis, depending on left ventricular (LV) function. Autonomic disorder can be an early marker of heart involvement. The heart rate recovery (HRR) after exercise may identify autonomic dysfunction, with impact on therapeutic strategies. This study was designed to assess the HRR after symptom-limited exercise testing in asymptomatic Chagas disease patients with RBBB without ventricular dysfunction compared to patients with indeterminate form of Chagas disease and healthy controls. Methods: One hundred and forty-nine subjects divided into 3 groups were included. A control group was comprised of healthy individuals; group 1 included patients in the indeterminate form of Chagas disease; and group 2 included patients with complete RBBB with or without left anterior hemiblock, and normal ventricular systolic function. A symptom-limited exercise test was performed and heart rate (HR) response to exercise was assessed. HRR was defined as the difference between HR at peak exercise and 1 min following test termination. Results: There were no differences in heart-rate profile during exercise between healthy individuals and patients in indeterminate form, whereas patients with RBBB had more prevalence of chronotropic incompetence, lower exercise capacity and lower HRR compared with patients in indeterminate form and controls. A delayed decrease in the HR after exercise was found in 17 patients (15%), 9% in indeterminate form and 24% with RBBB, associated with older age, worse functional capacity, impaired chronotropic response, and ventricular arrhythmias during both exercise and recovery. By multivariable analysis, the independent predictors of a delayed decrease in the HRR were age (odds ratio [OR] 1.11; 95% confidence interval [CI] 1.03 to 1.21; p = 0.010) and presence of RBBB (OR 3.97; 95% CI 1.05 to 15.01; p = 0.042). Conclusions: A small proportion (15%) of asymptomatic Chagas patients had attenuated HRR after exercise, being more prevalent in patients with RBBB compared with patients in indeterminate form and controls.	[Noman de Alencar, Maria Clara; da Costa Rocha, Manoel Otavio; de Oliveira Lima, Marcia Maria; Costa, Henrique Silveira; Sousa, Giovane Rodrigo; Carneiro, Renata de Carvalho Bicalho; Pinho Ribeiro, Antonio Luiz; Pereira Nunes, Maria Carmo] Univ Fed Minas Gerais, Sch Med, Postgrad Program Infect Dis & Trop Med, Belo Horizonte, MG, Brazil; [Rodrigues Silva, Guilherme Canabrava; Brandao, Fernando Vieira] Univ Fed Minas Gerais, Sch Med, Belo Horizonte, MG, Brazil; [Kreuser, Lucas Jordan] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; University of Minnesota System; University of Minnesota Twin Cities	Nunes, MCP (corresponding author), Univ Fed Minas Gerais, Sch Med, Postgrad Program Infect Dis & Trop Med, Belo Horizonte, MG, Brazil.	mcarmo@waymail.com.br	Costa, Henrique Silveira/H-8286-2014; Sousa, Giovane R./H-6102-2016; Ribeiro, Antonio L/C-2707-2009; Ribeiro, Ana Cristina/HHN-7466-2022; Nunes, Maria Carmo/AAV-5185-2020	Costa, Henrique Silveira/0000-0002-1426-7246; Sousa, Giovane R./0000-0003-0085-3882; Ribeiro, Antonio L/0000-0002-2740-0042; Ribeiro, Ana Cristina/0000-0002-0493-8376; 				Azarbal B, 2004, J AM COLL CARDIOL, V44, P423, DOI 10.1016/j.jacc.2004.02.060; Bern C, 2011, CLIN MICROBIOL REV, V24, P655, DOI 10.1128/CMR.00005-11; Cahalin LP, 2013, EUR J HEART FAIL, V15, P519, DOI 10.1093/eurjhf/hfs216; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; FLETCHER GF, 1995, CIRCULATION, V91, P580, DOI 10.1161/01.CIR.91.2.580; Frolkis JP, 2003, NEW ENGL J MED, V348, P781, DOI 10.1056/NEJMoa022353; IMAI K, 1994, J AM COLL CARDIOL, V24, P1529, DOI 10.1016/0735-1097(94)90150-3; Jouven X, 2005, NEW ENGL J MED, V352, P1951, DOI 10.1056/NEJMoa043012; Junqueira LF, 2012, REV SOC BRAS MED TRO, V45, P243, DOI 10.1590/S0037-86822012000200020; JUNQUEIRA LF, 1992, CARDIOVASC RES, V26, P324, DOI 10.1093/cvr/26.4.324; Kligfield P, 2006, CIRCULATION, V114, P2070, DOI 10.1161/CIRCULATIONAHA.105.561944; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lauer Michael S, 2009, Cleve Clin J Med, V76 Suppl 2, pS18, DOI 10.3949/ccjm.76.s2.04; Lauer MS, 2004, J AM COLL CARDIOL, V44, P431, DOI 10.1016/j.jacc.2004.05.001; Lauer MS, 1999, JAMA-J AM MED ASSOC, V281, P524, DOI 10.1001/jama.281.6.524; Maddox TM, 2008, AM HEART J, V156, P736, DOI 10.1016/j.ahj.2008.05.025; MAGUIRE JH, 1987, CIRCULATION, V75, P1140, DOI 10.1161/01.CIR.75.6.1140; Meluzin J, 2001, EUR HEART J, V22, P340, DOI 10.1053/euhj.2000.2296; Molina RBG, 2006, INT J CARDIOL, V113, P188, DOI 10.1016/j.ijcard.2005.11.010; Myers J, 2007, EUR J CARDIOV PREV R, V14, P215, DOI 10.1097/HJR.0b013e328088cb92; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Nunes MCP, 2011, INT J CARDIOL, V147, P294, DOI 10.1016/j.ijcard.2010.12.044; Nunes MCP, 2013, J AM COLL CARDIOL, V62, P767, DOI 10.1016/j.jacc.2013.05.046; Nunes MCP, 2012, EXPERT REV CARDIOVAS, V10, P1173, DOI [10.1586/erc.12.111, 10.1586/ERC.12.111]; Pierpont GL, 2000, J AUTONOM NERV SYST, V80, P169, DOI 10.1016/S0165-1838(00)00090-4; Ribeiro ALP, 2007, INT J CARDIOL, V117, P59, DOI 10.1016/j.ijcard.2006.04.053; Ramos RP, 2012, AM HEART J, V163, P580, DOI 10.1016/j.ahj.2012.01.023; Rassi A, 2007, CIRCULATION, V115, P1101, DOI 10.1161/CIRCULATIONAHA.106.627265; Ribeiro A L, 1998, Rev Soc Bras Med Trop, V31, P301, DOI 10.1590/S0037-86821998000300008; Ribeiro ALP, 2005, INT J CARDIOL, V103, P225, DOI 10.1016/j.ijcard.2004.11.007; Ribeiro ALP, 2001, AM HEART J, V141, P260, DOI 10.1067/mhj.2001.111406; Ribeiro AL, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002078; Ribeiro AL, 2012, NAT REV CARDIOL, V9, P576, DOI 10.1038/nrcardio.2012.109; Rocha ALL, 2006, ANN NONINVAS ELECTRO, V11, P3, DOI 10.1111/j.1542-474X.2006.00054.x; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Shetler K, 2001, J AM COLL CARDIOL, V38, P1980, DOI 10.1016/S0735-1097(01)01652-7; Surawicz B, 2009, CIRCULATION, V119, pE235, DOI 10.1161/CIRCULATIONAHA.108.191095; Talvani A, 2006, MICROBES INFECT, V8, P2459, DOI 10.1016/j.micinf.2006.06.006; Tang Yi-Da, 2009, J Card Fail, V15, P850, DOI 10.1016/j.cardfail.2009.06.437; Villar JC, 2004, INT J CARDIOL, V93, P189, DOI 10.1016/j.ijcard.2003.03.002; Vivekananthan DP, 2003, J AM COLL CARDIOL, V42, P831, DOI 10.1016/S0735-1097(03)00833-7; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Zaim S, 2010, ANN NONINVAS ELECTRO, V15, P43, DOI 10.1111/j.1542-474X.2009.00338.x	43	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100753	10.1371/journal.pone.0100753	http://dx.doi.org/10.1371/journal.pone.0100753			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979699	Green Submitted, gold, Green Published			2022-12-27	WOS:000338506400039
J	Su, XJ; Yuan, W; Tan, H; Liu, XY; Li, D; Li, DK; Huang, GY; Zhang, LW; Miao, MH				Su, Xiu-Juan; Yuan, Wei; Tan, Hui; Liu, Xiang-Yun; Li, Dan; Li, De-Kun; Huang, Guo-Ying; Zhang, Li-Wen; Miao, Mao-Hua			Correlation between Exposure to Magnetic Fields and Embryonic Development in the First Trimester	PLOS ONE			English	Article							LEGHORN CHICKEN EMBRYOS; ELECTROMAGNETIC-FIELDS; SPONTANEOUS-ABORTION; PERSONAL EXPOSURE; APOPTOSIS; GROWTH; RISK; RATS	Objective: To explore the correlation between maternal magnetic field (MF) exposure in daily life and embryonic development. Methods: A cross-sectional study was conducted among 149 pregnant women who were seeking induced abortion of unwanted pregnancies. Participating women were asked to wear an EMDEX Lite magnetic field meter for a 24-h period to obtain MF exposure level within 4 weeks following the abortion. Embryonic bud and sac lengths were measured through B-mode ultrasound before the surgical abortion. Embryo sections were prepared and examined for histological changes, and the apoptosis status of the deciduas was examined using the TUNEL apoptosis assay. Results: Embryonic bud length was inversely associated with maternal daily MF exposure level; the association was statistically significant at the time-weighted-average and 75th percentile of MF exposure levels, with coefficients of -3.09 (P = 0.0479) and -3.07(P = 0.0228), respectively. Logistic regression for examining the risk of higher MF exposure indicated that women with her 75th percentile of daily MF measurements >= 0.82 mG had a 3.95-fold risk of having a fetus with a shorter embryonic bud length than those whose daily MF exposure were <0.82 mG. MF exposure was associated with a higher degree of apoptosis, but the association was not statistically significant. We failed to find a statistical correlation between MF exposure and embryonic sac length and histological changes in the first trimester. Conclusion: Prenatal MF exposure may have an adverse effect on embryonic development.	[Su, Xiu-Juan] Tongji Univ Sch Med, Shanghai Matern & Infant Hosp 1, Clin & Translat Res Ctr, Shanghai, Peoples R China; [Yuan, Wei; Liu, Xiang-Yun; Miao, Mao-Hua] Shanghai Inst Planned Parenthood Res, Dept Reprod Epidemiol & Social Sci, Natl Populat & Family Planning Key Lab Contracept, Shanghai, Peoples R China; [Tan, Hui] Fudan Univ, Dept Child & Adolescent Hlth, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Li, Dan] Maternal & Child Hosp Xuhui Dist, Dept Obstet & Gynecol, Shanghai, Peoples R China; [Li, De-Kun] Kaiser Permanente, Kaiser Fdn Res Inst, Div Res, Oakland, CA USA; [Huang, Guo-Ying] Fudan Univ, Childrens Hosp, Shanghai 200433, Peoples R China; [Zhang, Li-Wen] Fudan Univ, Peoples Hosp Shanghai 5, Dept Obstet & Gynecol, Sch Med, Shanghai 200433, Peoples R China	Tongji University; Fudan University; Kaiser Permanente; Fudan University; Fudan University	Zhang, LW (corresponding author), Fudan Univ, Peoples Hosp Shanghai 5, Dept Obstet & Gynecol, Sch Med, Shanghai 200433, Peoples R China.	zhlw902@gmail.com; miaomaohua@163.com			National Basic Research Program of China (973 program) [2010CB529504]	National Basic Research Program of China (973 program)(National Basic Research Program of China)	This work is supported by the National Basic Research Program of China (973 program), 2010CB529504, (URL: http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Akhras MA, 2001, BIOELECTROMAGNETICS, V22, P340, DOI 10.1002/bem.59; Bayat PD, 2011, INDIAN J EXP BIOL, V49, P634; Belanger K, 1998, EPIDEMIOLOGY, V9, P36, DOI 10.1097/00001648-199801000-00009; Bliss Robin, 2012, J Biom Biostat, V3, P142; Cao Xing-wu, 2009, Zhonghua Nan Ke Xue, V15, P530; Cho SI, 2012, BIOELECTROMAGNETICS, V33, P568, DOI 10.1002/bem.21715; Choi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035464; Costa EVL, 2013, BIOELECTROMAGNETICS, V34, P114, DOI 10.1002/bem.21759; Davis S, 2006, ANN EPIDEMIOL, V16, P622, DOI 10.1016/j.annepidem.2005.11.005; Fadel Raouf A. R., 2006, Anthropologischer Anzeiger, V64, P211; GOLDSTEIN I, 1991, OBSTET GYNECOL, V77, P885; Ilijin L, 2011, INT J RADIAT BIOL, V87, P461, DOI 10.3109/09553002.2011.542544; Kaczmarek E, 2004, Rocz Akad Med Bialymst, V49 Suppl 1, P155; Khaki A. A., 2006, Folia Morphologica, V65, P188; Kokawa K, 1998, PLACENTA, V19, P21, DOI 10.1016/S0143-4004(98)90094-7; Lahijani MS, 2011, ELECTROMAGN BIOL MED, V30, P146, DOI 10.3109/15368378.2011.596250; Lahijani MS, 2011, ELECTROMAGN BIOL MED, V30, P158, DOI [10.3109/15368378.2011.596603, 10.3109/15368378.2011.596250]; Lahijani MS, 2009, ELECTROMAGN BIOL MED, V28, P391, DOI 10.3109/15368370903287689; Lee GM, 2002, EPIDEMIOLOGY, V13, P21, DOI 10.1097/00001648-200201000-00005; Li DK, 2010, REPROD TOXICOL, V29, P86, DOI 10.1016/j.reprotox.2009.09.004; Li DK, 2002, EPIDEMIOLOGY, V13, P9, DOI 10.1097/00001648-200201000-00004; Marcilio Izabel, 2011, Rev. bras. epidemiol., V14, P580, DOI 10.1590/S1415-790X2011000400005; McDevitt JJ, 2002, J EXPO ANAL ENV EPID, V12, P1, DOI 10.1038/sj.jea.7500194; Nishimura I, 2012, REGUL TOXICOL PHARM, V64, P394, DOI 10.1016/j.yrtph.2012.10.005; Reichenbach A, 2011, NEUROIMAGE, V54, P1375, DOI 10.1016/j.neuroimage.2010.08.047; Roda O, 2011, HISTOL HISTOPATHOL, V26, P873, DOI 10.14670/HH-26.873; Simko M, 2001, MUTAT RES-GEN TOX EN, V495, P43, DOI 10.1016/S1383-5718(01)00192-9; WERTHEIMER N, 1979, AM J EPIDEMIOL, V109, P273, DOI 10.1093/oxfordjournals.aje.a112681; Xu You-Qiong, 2008, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V26, P332; Zhao TY, 2007, NEUROSCI LETT, V412, P34, DOI 10.1016/j.neulet.2006.09.092	30	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101050	10.1371/journal.pone.0101050	http://dx.doi.org/10.1371/journal.pone.0101050			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977708	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400066
J	Yumnam, S; Park, HS; Kim, MK; Nagappan, A; Hong, GE; Lee, HJ; Lee, WS; Kim, EH; Cho, JH; Shin, SC; Kim, GS				Yumnam, Silvia; Park, Hyeon Soo; Kim, Mun Ki; Nagappan, Arulkumar; Hong, Gyeong Eun; Lee, Ho Jeong; Lee, Won Sup; Kim, Eun Hee; Cho, Jae Hyeon; Shin, Sung Chul; Kim, Gon Sup			Hesperidin Induces Paraptosis Like Cell Death in Hepatoblatoma, HepG2 Cells: Involvement of ERK1/2 MAPK	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; CANCER-CELLS; ANTICANCER AGENTS; BREAST-CANCER; APOPTOSIS; FLAVONOIDS; MICE; CARCINOGENESIS; INHIBITION; CASPASES	Hesperidin, a natural flavonoid abundantly present in Citrus is known for its anti-cancer, anti-oxidant and anti-inflammatory properties. In this study we examined the effect of hesperidin on HepG2 cells. HepG2 cells treated with various concentration of hesperidin undergo a distinct type of programed cell death. Cytoplasmic vacuolization, mitochondria and endoplasmic reticulum swelling and uncondensed chromatin were observed in hesperidin treated cells. DNA electrophoresis show lack of DNA fragmentation and western blot analysis demonstrates lack of caspase activation and PARP cleavage. It was observed that hesperidin induced cell death is nonautophagic and also activate mitogen activated protein kinase ERK1/2. Taken together, the data indicate that hesperidin induces paraptosis like cell death in HepG2 cells with the activation of ERK1/2. Thus our finding suggests that hesperidin inducing paraptosis may offer an alternative tool in human liver carcinoma therapy.	[Yumnam, Silvia; Park, Hyeon Soo; Kim, Mun Ki; Nagappan, Arulkumar; Hong, Gyeong Eun; Lee, Ho Jeong; Cho, Jae Hyeon; Kim, Gon Sup] Gyeongsang Natl Univ, Life Sci Res Inst, Coll Vet Med, Plus Project BK21, Gazwa, Jinju, South Korea; [Lee, Won Sup] Gyeongsang Natl Univ, Dept Internal Med, Inst Hlth Sci, Sch Med,Gyeongnam Reg Canc Ctr,Gyeongsang Natl Un, Jinju, South Korea; [Kim, Eun Hee] Int Univ Korea, Dept Nursing Sci, Jinju, South Korea; [Shin, Sung Chul] Gyeongsang Natl Univ, Dept Chem, Life Sci Res Inst, Jinju, South Korea	Gyeongsang National University; Gyeongsang National University; International University Korea; Gyeongsang National University	Kim, GS (corresponding author), Gyeongsang Natl Univ, Life Sci Res Inst, Coll Vet Med, Plus Project BK21, Gazwa, Jinju, South Korea.	gonskim@gnu.ac.kr		Yumnam, Silvia/0000-0002-4518-2464	National Research Foundation (NRF) of Korea - Ministry of Science, ICT & Future Planning [2012M3A9B8019303, 2012R1A2A2A06045015]; National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea [0820050]	National Research Foundation (NRF) of Korea - Ministry of Science, ICT & Future Planning; National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a grant from the National Research Foundation (NRF) of Korea funded by the Ministry of Science, ICT & Future Planning (No. 2012M3A9B8019303 and No. 2012R1A2A2A06045015) and National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea (No. 0820050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Androutsopoulos VP, 2010, PHARMACOL THERAPEUT, V126, P9, DOI 10.1016/j.pharmthera.2010.01.009; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Chen TS, 2008, CANCER LETT, V270, P164, DOI 10.1016/j.canlet.2008.05.008; Constantinou C, 2009, CURR CANCER DRUG TAR, V9, P717, DOI 10.2174/156800909789271512; Cragg GM, 2009, CHEM REV, V109, P3012, DOI 10.1021/cr900019j; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GALATI EM, 1994, FARMACO, V49, P709; Jambrina E, 2003, J BIOL CHEM, V278, P14134, DOI 10.1074/jbc.M211388200; Justesen U, 1998, J CHROMATOGR A, V799, P101, DOI 10.1016/S0021-9673(97)01061-3; Kamaraj S, 2009, INVEST NEW DRUG, V27, P214, DOI 10.1007/s10637-008-9159-7; Kar R, 2009, ONCOGENE, V28, P2556, DOI 10.1038/onc.2009.118; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim SO, 2001, J ENDOTOXIN RES, V7, P292, DOI 10.1179/096805101101532873; Korsnes MS, 2011, TOXICOL IN VITRO, V25, P1764, DOI 10.1016/j.tiv.2011.09.005; Lee CJ, 2010, PHYTOTHER RES, V24, pS15, DOI 10.1002/ptr.2856; Lee DH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/515901; Lee KH, 2010, J NAT PROD, V73, P500, DOI 10.1021/np900821e; Lee KH, 2010, TOXICOL LETT, V194, P42, DOI 10.1016/j.toxlet.2010.01.021; Lee KA, 2012, BIOMOL THER, V20, P273, DOI 10.4062/biomolther.2012.20.3.273; Li BH, 2011, CANCER LETT, V301, P185, DOI 10.1016/j.canlet.2010.11.015; Liaudet-Coopman E, 2006, CANCER LETT, V237, P167, DOI 10.1016/j.canlet.2005.06.007; Liu HL, 2010, RECENT PAT ANTI-CANC, V5, P152, DOI 10.2174/157489210790936261; Palmeri CM, 2009, TOXICOL APPL PHARM, V240, P55, DOI 10.1016/j.taap.2009.07.002; Natarajan N., 2011, BIOMEDICINE PREVENTI, V1, P207, DOI DOI 10.1016/j.bionut.2011.07.001; Park HJ, 2008, PHYTOMEDICINE, V15, P147, DOI 10.1016/j.phymed.2007.07.061; Park HS, 2012, FOOD CHEM TOXICOL, V50, P2407, DOI 10.1016/j.fct.2012.04.034; Park KI, 2011, J ETHNOPHARMACOL, V133, P634, DOI 10.1016/j.jep.2010.10.057; Ren WY, 2003, MED RES REV, V23, P519, DOI 10.1002/med.10033; Souza LC, 2013, PROG NEURO-PSYCHOPH, V40, P103, DOI 10.1016/j.pnpbp.2012.09.003; Sperandio S, 2004, CELL DEATH DIFFER, V11, P1066, DOI 10.1038/sj.cdd.4401465; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Sun QR, 2010, J CELL PHYSIOL, V222, P421, DOI 10.1002/jcp.21982; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Wang Y, 2004, J CELL SCI, V117, P1525, DOI 10.1242/jcs.00994; Wang Y, 2013, BIOCHEM BIOPH RES CO, V430, P876, DOI 10.1016/j.bbrc.2012.12.063; Wyllie AH, 2001, P NATL ACAD SCI USA, V98, P11, DOI 10.1073/pnas.98.1.11; Yang MZ, 1997, INT J CANCER, V73, P719, DOI 10.1002/(SICI)1097-0215(19971127)73:5<719::AID-IJC18>3.0.CO;2-0; Yeh MH, 2009, TOXICOL LETT, V184, P204, DOI 10.1016/j.toxlet.2008.11.018; Yoon MJ, 2012, CANCER LETT, V324, P197, DOI 10.1016/j.canlet.2012.05.018; Zhang FJ, 2010, PHARM BIOL, V48, P883, DOI 10.3109/13880200903311102; Zhang JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057779; Zhang Y, 2014, EUR REV MED PHARMACO, V18, P1018	43	41	44	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101321	10.1371/journal.pone.0101321	http://dx.doi.org/10.1371/journal.pone.0101321			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977707	gold, Green Published, Green Submitted			2022-12-27	WOS:000338506400114
J	De Marco, MA; Delogu, M; Sivay, M; Sharshov, K; Yurlov, A; Cotti, C; Shestopalov, A				De Marco, Maria A.; Delogu, Mauro; Sivay, Mariya; Sharshov, Kirill; Yurlov, Alexander; Cotti, Claudia; Shestopalov, Alexander			Virological Evaluation of Avian Influenza Virus Persistence in Natural and Anthropic Ecosystems of Western Siberia (Novosibirsk Region, Summer 2012)	PLOS ONE			English	Article							WILD BIRDS; A VIRUSES; H5N1 VIRUSES; SURVEILLANCE; WATERFOWL; POULTRY; RUSSIA; PCR	Background: Wild aquatic birds, reservoir of low-pathogenicity (LP) avian influenza viruses (AIVs), congregate in huge numbers in Western Siberia wetlands, where major intra- and inter-continental bird flyways overlap. In 2005 and 2006, highly pathogenic (HP) AIV H5N1 epizootics affected wild and domestic birds in the Novosibirsk Region. In 2012, we evaluated AIV persistence in Siberian natural and anthropic ecosystems. Methodology/Principal Findings: In Novosibirsk Region, 166 wild birds ecologically linked to aquatic environments and 152 domestic waterfowl were examined for AIV isolation in embryonating chicken eggs. Biological samples were obtained by integrating the conventional cloacal swab collection with the harvesting of samples from birds' plumage. Haemagglutinating allantoic fluids were further characterized by serological and molecular methods. In August-September 2012, 17 AIVs, including three H3N8, eight H4N6, two H4N?, one H2N?, one H?N2, and two unsubtyped LPAIVs, were isolated from 15 wild ducks. Whereas comparable proportions of wild Anseriformes (n.118) tested virus isolation (VI)-positive from cloaca and feathers (5.9% vs 8.5%) were detected, the overall prevalence of virus isolation, obtained from both sampling methods, was 2.4 times higher than that calculated on results from cloacal swab examination only (14.4% vs 5.9%). Unlike previously described in this area, the H4N6 antigenic subtype was found to be the prevalent one in 2012. Both cloacal and feather samples collected from domestic waterfowl tested VI-negative. Conclusion/Significance: We found lack of evidence for the H5N1 HPAIV circulation, explainable by the poor environmental fitness of HPAIVs in natural ecosystems. Our LPAIV isolation data emphasise the importance of Siberia wetlands in influenza A virus ecology, providing evidence of changes in circulation dynamics of HN antigenic subtypes harboured in wild bird reservoirs. Further studies of isolates, based on bioinformatic approaches to virus molecular evolution and phylogenesis, will be needed to better elucidate mechanisms involved in AIV perpetuation in this area.	[De Marco, Maria A.] ISPRA, Genet Lab, Ozzano Dell Emilia, BO, Italy; [Delogu, Mauro; Cotti, Claudia] Univ Bologna, Dept Vet Med Sci, Ozzano Dell Emilia, BO, Italy; [Sivay, Mariya; Sharshov, Kirill; Shestopalov, Alexander] Russian Acad Med Sci, Siberian Div, Res Ctr Clin & Expt Med, Novosibirsk, Russia; [Yurlov, Alexander] RAS, Inst Systemat & Ecol Anim, Siberian Branch, Novosibirsk, Russia; [Shestopalov, Alexander] Novosibirsk State Univ, Div Res, Novosibirsk 630090, Russia	Italian Institute for Environmental Protection & Research (ISPRA); University of Bologna; Russian Academy of Medical Sciences; Russian Academy of Sciences; Russian Academy of Sciences; Novosibirsk State University	De Marco, MA (corresponding author), ISPRA, Genet Lab, Ozzano Dell Emilia, BO, Italy.	mariaalessandra.demarco@isprambiente.it	Yurlov, Alexander/R-4483-2016; Sivay, Mariya/AAI-2085-2020; Shestopalov, Alexander/AAO-5569-2020		RFBR [13-04-91179- GFEN-a]; USDA [58-0210-2-040F]	RFBR(Russian Foundation for Basic Research (RFBR)); USDA(United States Department of Agriculture (USDA))	RFBR project No. 13-04-91179- GFEN-a, and USDA grant no. 58-0210-2-040F provided financial and logistical support in sample collection and analysis. The funders had no role in study design, decision to publish, or preparation of the manuscript.	BAKER K, 1993, BTO GUIDES, V24; BECKER WB, 1966, J HYG-CAMB, V64, P309, DOI 10.1017/S0022172400040596; Bourouiba L, 2010, J R SOC INTERFACE, V7, P1627, DOI 10.1098/rsif.2010.0126; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Cannon R.M., 1982, LIVESTOCK DIS SURVEY; De Marco MA, 2003, AVIAN DIS, V47, P861, DOI 10.1637/0005-2086-47.s3.861; Delogu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011315; [ДОНЧЕНКО А.С. DONCHENKO A.S.], 2012, [Сибирский вестник сельскохозяйственной науки, Sibirskii vestnik sel'skokhozyaistvennoi nauki], P84; Ely CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057614; GILBERT M, 2012, PLOS ONE, V7, DOI DOI 10.1371/ANNOTATION/2CED0370-4F34-4380-9CA9-954BA328E160; Gilbert M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044097; Ilyicheva T, 2013, INFECT GENET EVOL, V20, P177, DOI 10.1016/j.meegid.2013.08.025; Iushkov Iu G, 2006, Zh Mikrobiol Epidemiol Immunobiol, P59; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Lebarbenchon C, 2013, AVIAN DIS, V57, P677, DOI 10.1637/10455-112512-ResNote.1; Lebarbenchon C, 2010, EMERG INFECT DIS, V16, P1057, DOI 10.3201/eid1607.090389; Lipatov AS, 2007, EMERG INFECT DIS, V13, P539, DOI 10.3201/eid1304.061266; Lvov D. K., 2006, Voprosy Virusologii, V51, P15; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; PRILIPOV AG, 2005, DIRECT SUBMISSION SU; Qiu BF, 2009, J VIROL METHODS, V155, P193, DOI 10.1016/j.jviromet.2008.10.001; Razumova Yu. V., 2006, Voprosy Virusologii, V51, P32; Sharshov K. A., 2007, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P53; Sharshov K, 2010, ARCH VIROL, V155, P1145, DOI 10.1007/s00705-010-0676-2; Sharshov K, 2010, EMERG INFECT DIS, V16, P349, DOI 10.3201/eid1602.090974; Shestopalov AM, 2006, EMERG INFECT DIS, V12, P1167, DOI 10.3201/eid1207.051338; Sivay MV, 2013, J VIROL, V87, P3578, DOI 10.1128/JVI.02521-12; Sivay MV, 2012, AVIAN DIS, V56, P456, DOI 10.1637/9868-080111-Reg.1; Stallknecht DE, 2010, AVIAN DIS, V54, P461, DOI 10.1637/8760-033109-Reg.1; Svensson L., 1992, IDENTIFICATION GUIDE; Tsukamoto K, 2008, J CLIN MICROBIOL, V46, P3048, DOI 10.1128/JCM.02386-07; Veen J., 2005, ATLAS MOVEMENTS SW S; *WAHID, 2014, COUNTR INF; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, 2012, H5N1 AV INFL TIM MAJ; World Health Organization (WHO), 2002, MAN AN INFL DIAGN SU; Zhang G, 2006, J VIROL, V80, P12229, DOI 10.1128/JVI.00986-06; 2001, NATL TRAINING COURSE	40	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100859	10.1371/journal.pone.0100859	http://dx.doi.org/10.1371/journal.pone.0100859			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972026	Green Published, gold, Green Submitted			2022-12-27	WOS:000338512200069
J	Liu, F; Wang, W; Xu, Y; Wang, Y; Chen, LF; Fang, Q; Yan, XW				Liu, Fang; Wang, Wei; Xu, Yan; Wang, Yu; Chen, Lian-Feng; Fang, Quan; Yan, Xiao-Wei			ABCG1 rs57137919G > A Polymorphism Is Functionally Associated with Varying Gene Expression and Apoptosis of Macrophages	PLOS ONE			English	Article							REVERSE CHOLESTEROL TRANSPORT; DEFICIENT MICE; LESION STAGE; BONE-MARROW; FOAM CELL; ATHEROSCLEROSIS; EFFLUX; ACCUMULATION; DISEASE; ABCA1	ATP-binding cassette transporter G1 (ABCG1) is a transmembrane cholesterol transporter involved in macrophage sterol homeostasis, reverse cholesterol transport (RCT), and atherosclerosis. The role of ABCG1 in atherosclerosis remains controversial, especially in animal models. Our previous study showed that single nucleotide polymorphism rs57137919 (-367G>A) in the ABCG1 promoter region was associated with reduced risk for atherosclerotic coronary artery disease (CAD). This study was designed to provide functional evidence for the role of rs57137919G>A in atherosclerosis in humans. We combined in vitro and ex vivo studies using cell lines and human monocyte-derived macrophages to investigate the functional consequences of the promoter polymorphism by observing the effects of the rs57137919A allele on promoter activity, transcription factor binding, gene expression, cholesterol efflux, and apoptosis levels. The results showed that the rs57137919A allele was significantly associated with decreased ABCG1 gene expression possibly due to the impaired ability of protein-DNA binding. ABCG1-mediated cholesterol efflux decreased by 23% with rs57137919 A/A versus the G/G genotype. Cholesterol-loaded macrophage apoptosis was induced 2-fold with the A/A genotype compared with the G/G genotype. Proapoptotic genes Bok and Bid mRNA levels were significantly increased in macrophages from the A/A genotype compared with those from the G/G genotype. These findings demonstrated that the ABCG1 promoter rs57137919G>A variant had an allele-specific effect on ABCG1 expression and was associated with an increased apoptosis in cholesterol-loaded macrophages, providing functional evidence to explain the reduced risk for atherosclerosis in subjects with the ABCG1 promoter rs57137919A allele as reported in our previous study.	[Yan, Xiao-Wei] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Cardiol, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yan, XW (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Cardiol, Beijing 100730, Peoples R China.	xwy_pumc@163.com			National Natural Sciences Foundation of China [81270381]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Sciences Foundation of China (81270381). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai S, 2005, CELL METAB, V1, P201, DOI 10.1016/j.cmet.2005.02.002; Baldan A, 2006, J BIOL CHEM, V281, P29401, DOI 10.1074/jbc.M606597200; Baldan A, 2006, ARTERIOSCL THROM VAS, V26, P2301, DOI 10.1161/01.ATV.0000240051.22944.dc; Basso F, 2006, BIOCHEM BIOPH RES CO, V351, P398, DOI 10.1016/j.bbrc.2006.10.044; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Burgess B, 2008, ARTERIOSCL THROM VAS, V28, P1731, DOI 10.1161/ATVBAHA.108.168542; Cordell HJ, 2005, LANCET, V366, P1121, DOI 10.1016/S0140-6736(05)67424-7; Engel T, 2007, FEBS LETT, V581, P1673, DOI 10.1016/j.febslet.2007.03.038; Fitzgerald ML, 2010, ATHEROSCLEROSIS, V211, P361, DOI 10.1016/j.atherosclerosis.2010.01.011; Gautier EL, 2009, CIRCULATION, V119, P1795, DOI 10.1161/CIRCULATIONAHA.108.806158; Heinloth A, 2002, ATHEROSCLEROSIS, V162, P93, DOI 10.1016/S0021-9150(01)00687-6; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Kyriakou T, 2005, ARTERIOSCL THROM VAS, V25, P418, DOI 10.1161/01.ATV.0000149379.72018.20; Le Goff W, 2011, ATHEROSCLEROSIS, V219, P393, DOI 10.1016/j.atherosclerosis.2011.07.015; Li AC, 2002, NAT MED, V8, P1235, DOI 10.1038/nm1102-1235; Lusis AJ, 2004, CIRCULATION, V110, P2066, DOI 10.1161/01.CIR.0000143098.98869.F8; Natunen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080700; Ohashi R, 2005, QJM-INT J MED, V98, P845, DOI 10.1093/qjmed/hci136; Out R, 2006, ARTERIOSCL THROM VAS, V26, P2295, DOI 10.1161/01.ATV.0000237629.29842.4c; Ranalletta M, 2006, ARTERIOSCL THROM VAS, V26, P2308, DOI 10.1161/01.ATV.0000242275.92915.43; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schou J, 2012, ARTERIOSCL THROM VAS, V32, P506, DOI 10.1161/ATVBAHA.111.234872; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Tarling EJ, 2013, CURR OPIN LIPIDOL, V24, P138, DOI 10.1097/MOL.0b013e32835da122; Tarling EJ, 2010, ARTERIOSCL THROM VAS, V30, P1174, DOI 10.1161/ATVBAHA.110.205617; Tarr PT, 2008, J LIPID RES, V49, P169, DOI 10.1194/jlr.M700364-JLR200; Terasaka N, 2008, J CLIN INVEST, V118, P3701, DOI 10.1172/JCI35470; Terasaka N, 2007, P NATL ACAD SCI USA, V104, P15093, DOI 10.1073/pnas.0704602104; Terasaka N, 2010, ARTERIOSCL THROM VAS, V30, P2219, DOI 10.1161/ATVBAHA.110.213215; Venkateswaran A, 2000, J BIOL CHEM, V275, P14700, DOI 10.1074/jbc.275.19.14700; Wang W, 2013, J CARDIOVASC PHARM, V62, P90, DOI 10.1097/FJC.0b013e3182927e7c; Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JCI32057; Whetzel AM, 2010, ARTERIOSCL THROM VAS, V30, P809, DOI 10.1161/ATVBAHA.109.199166; Xu Y, 2011, ATHEROSCLEROSIS, V219, P648, DOI 10.1016/j.atherosclerosis.2011.05.043; Xue JH, 2013, J PHYSIOL SCI, V63, P435, DOI 10.1007/s12576-013-0281-8; Ye D, 2011, CURR DRUG TARGETS, V12, P647, DOI 10.2174/138945011795378522; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Zhang J, 2011, ASSAY DRUG DEV TECHN, V9, P136, DOI 10.1089/adt.2010.0288	38	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e97044	10.1371/journal.pone.0097044	http://dx.doi.org/10.1371/journal.pone.0097044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972087	gold, Green Submitted, Green Published			2022-12-27	WOS:000338512200004
J	Skaug, EA; Madssen, E; Aspenes, ST; Wisloff, U; Ellingsen, O				Skaug, Eli-Anne; Madssen, Erik; Aspenes, Stian Thoresen; Wisloff, Ulrik; Ellingsen, Oyvind			Cardiovascular Risk Factors Have Larger Impact on Endothelial Function in Self-Reported Healthy Women than Men in the HUNT3 Fitness Study	PLOS ONE			English	Article							FLOW-MEDIATED DILATION; PEAK OXYGEN-UPTAKE; METABOLIC SYNDROME; MYOCARDIAL-INFARCTION; GENDER-DIFFERENCES; SEX-DIFFERENCES; BLOOD-PRESSURE; HEART-DISEASE; MORTALITY; ARTERY	Background: Several studies suggest that cardiovascular risk factors comprising the metabolic syndrome have larger effects on the development of cardiovascular disease in women than in men. A recent study in self-reported healthy subjects demonstrated a marked gender difference in endothelial dysfunction that may be an important precursor of manifest cardiovascular disease. The aim of the present study was to determine whether the association between endothelial function and cardiovascular risk factors is different in self-reported healthy women compared to self-reported healthy men. Methods and Results: Associations between endothelial function (flow mediated dilation, FMD, of the brachial artery measured by ultrasound), anthropometric variables, peak oxygen uptake (VO2peak), blood pressure, serum lipids, blood glucose and a questionnaire on general health and lifestyle including smoking status were studied by logistic and linear regression in 2 528 women and 2 211 men aged 20-89 years, free from self-reported cardiovascular disease. In women with hyperglycemia, endothelial dysfunction (FMD <= 0%) occurred twice as frequently as in male counterparts. The presence of the metabolic syndrome, high blood pressure and low VO2peak increased the prevalence of endothelial dysfunction more in women than in men. Conclusion: Endothelial dysfunction is more strongly associated with cardiovascular risk factors in self-reported healthy women than in self-reported healthy men. This finding could explain why the metabolic syndrome, and especially hyperglycemia, is associated with higher cardiovascular risk and a worse prognosis in women.	[Skaug, Eli-Anne; Madssen, Erik; Aspenes, Stian Thoresen; Wisloff, Ulrik; Ellingsen, Oyvind] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway; [Skaug, Eli-Anne; Madssen, Erik; Aspenes, Stian Thoresen; Wisloff, Ulrik; Ellingsen, Oyvind] Norwegian Univ Sci & Technol, KG Jebsen Ctr Exercise Med, N-7034 Trondheim, Norway; [Madssen, Erik; Ellingsen, Oyvind] St Olavs Hosp, Dept Cardiol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Skaug, EA (corresponding author), Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway.	eli-anne.skaug@ntnu.no	Wisloff, Ulrik/K-2899-2012	Wisloff, Ulrik/0000-0002-7211-3587	K.G. Jebsen Foundation; Norwegian Council on Cardiovascular Disease, Norwegian Research Council Funding for Outstanding Young Investigators; Foundation for Cardiovascular Research at St. Olavs Hospital; Norwegian State Railways	K.G. Jebsen Foundation; Norwegian Council on Cardiovascular Disease, Norwegian Research Council Funding for Outstanding Young Investigators; Foundation for Cardiovascular Research at St. Olavs Hospital; Norwegian State Railways	The study was supported with grants from the K.G. Jebsen Foundation, the Norwegian Council on Cardiovascular Disease, Norwegian Research Council Funding for Outstanding Young Investigators, the Foundation for Cardiovascular Research at St. Olavs Hospital, and Norwegian State Railways. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Aspenes ST, 2011, MED SCI SPORT EXER, V43, P1675, DOI 10.1249/MSS.0b013e318216ea50; Aspenes ST, 2011, MED SCI SPORT EXER, V43, P1465, DOI 10.1249/MSS.0b013e31820ca81c; Blum A, 2009, GENDER MED, V6, P410, DOI 10.1016/j.genm.2009.09.005; Borch-Johnsen K, 1999, LANCET, V354, P617; Caballero AE, 1999, DIABETES, V48, P1856, DOI 10.2337/diabetes.48.9.1856; Chan SY, 2003, J AM COLL CARDIOL, V42, P1037, DOI 10.1016/S0735-1097(03)00927-6; Ciambrone G, 2011, CURR PHARM DESIGN, V17, P1079, DOI 10.2174/138161211795656945; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cordero A, 2009, PREV MED, V48, P134, DOI 10.1016/j.ypmed.2008.10.024; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Dei Cas A, 2011, NUTR METAB CARDIOVAS, V21, P512, DOI 10.1016/j.numecd.2009.11.011; Engberding N, 2012, HYPERTENS RES, V35, P251, DOI 10.1038/hr.2011.210; Goel A, 2007, CARDIOVASC RES, V76, P351, DOI 10.1016/j.cardiores.2007.06.029; Haring R, 2010, EXP CLIN ENDOCR DIAB, V118, P685, DOI 10.1055/s-0030-1261876; Held C, 2007, CIRCULATION, V115, P1371, DOI 10.1161/CIRCULATIONAHA.106.661405; Hu R, 2008, CLIN CARDIOL, V31, P525, DOI 10.1002/ClC.20314; Iglseder B, 2005, STROKE, V36, P1212, DOI 10.1161/01.STR.0000166196.31227.91; Kip KE, 2004, CIRCULATION, V109, P706, DOI 10.1161/01.CIR.0000115514.44135.A8; Kuk JL, 2010, DIABETES CARE, V33, P2457, DOI 10.2337/dc10-0942; Lanas F, 2007, CIRCULATION, V115, P1067, DOI 10.1161/CIRCULATIONAHA.106.633552; Levit RD, 2011, CARDIOL REV, V19, P60, DOI 10.1097/CRD.0b013e31820987b5; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Mellbin LG, 2010, EUR J CARDIOV PREV R, V17, pS9, DOI 10.1097/01.hjr.0000368192.24732.2f; MORRIS JN, 1953, LANCET, V265, P1053; O'Brien E, 2005, J HYPERTENS, V23, P697, DOI 10.1097/01.hjh.0000163132.84890.c4; PANZA JA, 1990, NEW ENGL J MED, V323, P22, DOI 10.1056/NEJM199007053230105; Peretz Alon, 2007, BMC Cardiovasc Disord, V7, P11, DOI 10.1186/1471-2261-7-11; Petersen JL, 2010, CIRC-CARDIOVASC QUAL, V3, P165, DOI 10.1161/CIRCOUTCOMES.109.864447; Poredos P, 1999, ANGIOLOGY, V50, P201, DOI 10.1177/000331979905000304; Regitz-Zagrosek V, 2007, GENDER MED, V4, pS162, DOI 10.1016/S1550-8579(07)80056-8; Rossi R, 2008, HYPERTENSION, V52, P865, DOI 10.1161/HYPERTENSIONAHA.108.110478; Rudnicka AR, 2011, J THROMB HAEMOST, V9, P2337, DOI 10.1111/j.1538-7836.2011.04517.x; Skaug EA, 2013, EUR J PREV CARDIOL, V20, P531, DOI 10.1177/2047487312444234; Smilowitz NR, 2011, AM HEART J, V161, P681, DOI 10.1016/j.ahj.2010.12.022; Strehlow K, 2003, CIRCULATION, V107, P3059, DOI 10.1161/01.CIR.0000077911.81151.30; Suzuki T, 2008, AM HEART J, V156, P405, DOI 10.1016/j.ahj.2008.02.022; Tjonna AE, 2010, J EPIDEMIOL COMMUN H, V64, P690, DOI 10.1136/jech.2008.084467; Tuomilehto J, 1999, NEW ENGL J MED, V340, P677, DOI 10.1056/NEJM199903043400902; Wannamethee SG, 2012, DIABETOLOGIA, V55, P80, DOI 10.1007/s00125-011-2284-4; Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X; Yeboah J, 2007, CIRCULATION, V115, P2390, DOI 10.1161/CIRCULATIONAHA.106.678276; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714	45	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101371	10.1371/journal.pone.0101371	http://dx.doi.org/10.1371/journal.pone.0101371			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991924	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400066
J	Gilman, JM; Curran, MT; Calderon, V; Stoeckel, LE; Evins, AE				Gilman, Jodi M.; Curran, Max T.; Calderon, Vanessa; Stoeckel, Luke E.; Evins, A. Eden			Impulsive Social Influence Increases Impulsive Choices on a Temporal Discounting Task in Young Adults	PLOS ONE			English	Article							PROTECTIVE FACTORS; PHYSICAL-ACTIVITY; PEER INFLUENCE; RISK-TAKING; FOOD-INTAKE; DELAY; REWARDS; NORMS; IMMEDIATE; ALCOHOL	Adolescents and young adults who affiliate with friends who engage in impulsive behavior are more likely to engage in impulsive behaviors themselves, and those who associate with prosocial (i.e. more prudent, future oriented) peers are more likely to engage in prosocial behavior. However, it is difficult to disentangle the contribution of peer influence vs. peer selection (i.e., whether individuals choose friends with similar traits) when interpreting social behaviors. In this study, we combined a novel social manipulation with a well-validated delay discounting task assessing impulsive behavior to create a social influence delay discounting task, in which participants were exposed to both impulsive (smaller, sooner or SS payment) and non-impulsive (larger, later or LL payment) choices from their peers. Young adults in this sample, n = 51, aged 18-25 had a higher rate of SS choices after exposure to impulsive peer influence than after exposure to non-impulsive peer influence. Interestingly, in highly susceptible individuals, the rate of non-impulsive choices did not increase after exposure to non-impulsive influence. There was a positive correlation between self-reported suggestibility and degree of peer influence on SS choices. These results suggest that, in young adults, SS choices appear to be influenced by the choices of same-aged peers, especially for individuals who are highly susceptible to influence.	[Gilman, Jodi M.; Curran, Max T.; Calderon, Vanessa; Stoeckel, Luke E.; Evins, A. Eden] Harvard Univ, Sch Med, Dept Psychiat, Ctr Addict Med,Massachusetts Gen Hosp, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Gilman, JM (corresponding author), Harvard Univ, Sch Med, Dept Psychiat, Ctr Addict Med,Massachusetts Gen Hosp, Boston, MA 02115 USA.	jgilman1@partners.org	Gilman, Jodi/P-3864-2018; Stoeckel, Luke/AAT-1742-2020	Gilman, Jodi/0000-0001-5180-6694; Stoeckel, Luke/0000-0002-7837-7487; Curran, Max/0000-0002-3712-8572	Harvard Medical School Norman E. Zinberg Fellowship in Addiction Psychiatry Research; NIDA [K01 DA034093, K24 DA030443]; Charles A. King Trust; NIH [K23DA032612]; NATIONAL INSTITUTE ON DRUG ABUSE [K23DA032612, K01DA034093, K24DA030443] Funding Source: NIH RePORTER	Harvard Medical School Norman E. Zinberg Fellowship in Addiction Psychiatry Research; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Charles A. King Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Harvard Medical School Norman E. Zinberg Fellowship in Addiction Psychiatry Research (JMG), NIDA K01 DA034093 (JMG), NIDA K24 DA030443 (AEE), the Charles A. King Trust (LES), and NIH K23DA032612 (LES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert D, 2011, INHIBITORY CONTROL AND DRUG ABUSE PREVENTION: FROM RESEARCH TO TRANSLATION, P211, DOI 10.1007/978-1-4419-1268-8_11; [Anonymous], 1999, J Am Acad Child Adolesc Psychiatry, V38, P235; [Anonymous], 2008, UNDERSTANDING PEER I; Asch, 1957, SOC PSYCHOL-GERMANY; Asch S.E., 1951, GROUPS LEADERSHIP ME, P177, DOI DOI 10.1037/10025-01; Asch SE, 1956, PSYCHOL MONOGRAM, V70; Baker F, 2003, J ABNORM PSYCHOL, V112, P382, DOI 10.1037/0021-843X.112.3.382; Bandura Albert, 1977, SOCIAL LEARNING THEO; Bickel WK, 2011, PSYCHOPHARMACOLOGY, V217, P177, DOI 10.1007/s00213-011-2272-x; Bickel WK, 2001, ADDICTION, V96, P73, DOI 10.1046/j.1360-0443.2001.961736.x; Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010; Chein J, 2011, DEVELOPMENTAL SCI, V14, pF1, DOI 10.1111/j.1467-7687.2010.01035.x; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; Dahlberg LL, 1998, AM J PREV MED, V14, P259, DOI 10.1016/S0749-3797(98)00009-9; Davis C, 2010, APPETITE, V54, P208, DOI 10.1016/j.appet.2009.11.002; Donaldson S., 2002, J BUSINESS PSYCHOL, V17; EAGLY AH, 1966, J PERS SOC PSYCHOL, V3, P483, DOI 10.1037/h0023045; EAGLY AH, 1978, ANNU REV PSYCHOL, V29, P517, DOI 10.1146/annurev.ps.29.020178.002505; Falk EB, 2012, PSYCHOL SCI, V23, P439, DOI 10.1177/0956797611434964; First MB, 2002, STRUCTURED CLIN INTE; Gardner M, 2005, DEV PSYCHOL, V41, P625, DOI 10.1037/0012-1649.41.4.625; Goldstein NJ, 2008, J CONSUM RES, V35, P472, DOI 10.1086/586910; HAWKINS JD, 1992, PSYCHOL BULL, V112, P64, DOI 10.1037/0033-2909.112.1.64; Hermans RCJ, 2008, APPETITE, V51, P512, DOI 10.1016/j.appet.2008.03.016; Hermans RCJ, 2012, BRIT J NUTR, V107, P588, DOI 10.1017/S0007114511003278; Hull C.L., 1943, PRINCIPLES BEHAV INT, DOI DOI 10.2307/1416955; Humbert ML, 2006, QUAL HEALTH RES, V16, P467, DOI 10.1177/1049732305286051; Johnson MW, 2002, J EXP ANAL BEHAV, V77, P129, DOI 10.1901/jeab.2002.77-129; Kirby KN, 1996, PSYCHON B REV, V3, P100, DOI 10.3758/BF03210748; Kirby KN, 2009, PSYCHON B REV, V16, P457, DOI 10.3758/PBR.16.3.457; Koffarnus MN, 2013, J EXP ANAL BEHAV, V99, P32, DOI 10.1002/jeab.2; Kotov R. I., 2004, MULTIDIMENSIONAL IOW; Lazarsfeld PF, 1954, FRIENDSHIP SOCIAL PR; Lynskey MT, 1998, J CHILD PSYCHOL PSYC, V39, P995, DOI 10.1017/S0021963098002960; Madden GJ, 2003, EXP CLIN PSYCHOPHARM, V11, P139, DOI 10.1037/1064-1297.11.2.139; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; O'Brien L, 2011, J RES ADOLESCENCE, V21, P747, DOI 10.1111/j.1532-7795.2011.00738.x; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Perry JL, 2008, PSYCHOPHARMACOLOGY, V200, P1, DOI 10.1007/s00213-008-1173-0; Petry NM, 1999, DRUG ALCOHOL DEPEN, V56, P25, DOI 10.1016/S0376-8716(99)00010-1; Petty R. E., 1986, COMMUN PERSUATION, P1; Petty R.E., 1986, ADV EXPT SOCIAL PSYC, V19, P123, DOI [10.1016/S0065-2601(08)60214-2, DOI 10.1016/S0065-2601(08)60214-2, https://doi.org/10.1016/S0065-2601(08)60214-2]; Pliner P, 2004, APPETITE, V42, P227, DOI 10.1016/j.appet.2003.12.001; Polonec LD, 2006, HEALTH COMMUN, V20, P23, DOI 10.1207/s15327027hc2001_3; Salvy SJ, 2008, J PEDIATR PSYCHOL, V33, P39, DOI 10.1093/jpepsy/jsm039; Spoth R, 1996, AM J COMMUN PSYCHOL, V24, P749, DOI 10.1007/BF02511033; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Steinberg L, 2009, CHILD DEV, V80, P28, DOI 10.1111/j.1467-8624.2008.01244.x; Troje NF, 1996, VISION RES, V36, P1761, DOI 10.1016/0042-6989(95)00230-8; Weigard A, 2013, EFFECTS ANONYMOUS PE, P1; Weller RE, 2008, APPETITE, V51, P563, DOI 10.1016/j.appet.2008.04.010; Wills TA, 1996, J PERS SOC PSYCHOL, V71, P937, DOI 10.1037/0022-3514.71.5.937	53	20	20	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101570	10.1371/journal.pone.0101570	http://dx.doi.org/10.1371/journal.pone.0101570			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BA	24988440	Green Published, Green Submitted, gold			2022-12-27	WOS:000341354100114
J	Huang, CL; Xue, M; Chen, HL; Jiao, J; Herschman, HR; O'Keefe, RJ; Zhang, XP				Huang, Chunlan; Xue, Ming; Chen, Hongli; Jiao, Jing; Herschman, Harvey R.; O'Keefe, Regis J.; Zhang, Xinping			The Spatiotemporal Role of COX-2 in Osteogenic and Chondrogenic Differentiation of Periosteum-Derived Mesenchymal Progenitors in Fracture Repair	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; CHONDROCYTE DIFFERENTIATION; BONE-FORMATION; OSTEOBLAST DIFFERENTIATION; PROSTAGLANDIN E-2; STEM-CELLS; BMP2 ACTIVITY; PATHWAY; MICE	Periosteum provides a major source of mesenchymal progenitor cells for bone fracture repair. Combining cell-specific targeted Cox-2 gene deletion approaches with in vitro analyses of the differentiation of periosteum-derived mesenchymal progenitor cells (PDMPCs), here we demonstrate a spatial and temporal role for Cox-2 function in the modulation of osteogenic and chondrogenic differentiation of periosteal progenitors in fracture repair. Prx1Cre-targeted Cox-2 gene deletion in mesenchyme resulted in marked reduction of intramembraneous and endochondral bone repair, leading to accumulation of poorly differentiated mesenchyme and immature cartilage in periosteal callus. In contrast, Col2Cre-targeted Cox-2 gene deletion in cartilage resulted in a deficiency primarily in cartilage conversion into bone. Further cell culture analyses using Cox-2 deficient PDMPCs demonstrated reduced osteogenic differentiation in monolayer cultures, blocked chondrocyte differentiation and hypertrophy in high density micromass cultures. Gene expression microarray analyses demonstrated downregulation of a key set of genes associated with bone/cartilage formation and remodeling, namely Sox9, Runx2, Osx, MMP9, VDR and RANKL. Pathway analyses demonstrated dysregulation of the HIF-1, PI3K-AKT and Wnt pathways in Cox-2 deficient cells. Collectively, our data highlight a crucial role for Cox-2 from cells of mesenchymal lineages in modulating key pathways that control periosteal progenitor cell growth, differentiation, and angiogenesis in fracture repair.	[Huang, Chunlan; Xue, Ming; Chen, Hongli; O'Keefe, Regis J.; Zhang, Xinping] Univ Rochester, Sch Med & Dent, Ctr Musculoskeletal Res, Rochester, NY 14627 USA; [Jiao, Jing; Herschman, Harvey R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	University of Rochester; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zhang, XP (corresponding author), Univ Rochester, Sch Med & Dent, Ctr Musculoskeletal Res, Rochester, NY 14627 USA.	Xinping_Zhang@URMC.rochester.edu	Jiao, Jing/F-5354-2015		Musculoskeletal Transplant Foundation; NYSTEM [N08G-495, N09G346]; National Institutes of Health [R21 DE021513, RC1 AR058435, AR R01 AR048681, P50 AR054041]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048681, P50AR054041, RC1AR058435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE021513] Funding Source: NIH RePORTER	Musculoskeletal Transplant Foundation; NYSTEM; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study is supported by grants from the Musculoskeletal Transplant Foundation (XPZ), NYSTEM N08G-495 (XPZ) and N09G346 (XPZ), and the National Institutes of Health (R21 DE021513 to XPZ, RC1 AR058435 to XPZ, AR R01 AR048681 to XPZ and RJO, P50 AR054041 to RJO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2009, EXPERT REV CLIN IMMU, V5, P145, DOI 10.1586/1744666X.5.2.145; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; ALLEN HL, 1980, ACTA ORTHOP SCAND, V51, P595, DOI 10.3109/17453678008990848; ALTMAN RD, 1995, J ORTHOP TRAUMA, V9, P392, DOI 10.1097/00005131-199505000-00006; Barnes GL, 1999, J BONE MINER RES, V14, P1805, DOI 10.1359/jbmr.1999.14.11.1805; Chappuis V, 2012, BONE, V51, P800, DOI 10.1016/j.bone.2012.07.017; Chen Y, 2007, PLOS MED, V4, P1216, DOI 10.1371/journal.pmed.0040249; Chen Y, 2009, J CELL BIOCHEM, V106, P353, DOI 10.1002/jcb.22020; Colnot C, 2012, J ORTHOP RES, V30, P1869, DOI 10.1002/jor.22181; Dao DY, 2012, J BONE MINER RES, V27, P1680, DOI 10.1002/jbmr.1639; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; EYREBROOK AL, 1984, CLIN ORTHOP RELAT R, P300; Gaur T, 2009, J CELL PHYSIOL, V220, P174, DOI 10.1002/jcp.21747; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Gerstenfeld LC, 2003, J ORTHOP RES, V21, P670, DOI 10.1016/S0736-0266(03)00003-2; Gerstenfeld Louis C, 2004, Expert Opin Drug Saf, V3, P131, DOI 10.1517/14740338.3.2.131; Huang C, 2013, MOL THER; Ishikawa T, 2006, GENESIS, V44, P143, DOI 10.1002/gene.20192; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kellinsalmi M, 2007, EUR J PHARMACOL, V572, P102, DOI 10.1016/j.ejphar.2007.06.030; Lau KHW, 2013, BONE, V53, P369, DOI 10.1016/j.bone.2013.01.003; Lee CM, 2007, J CELL PHYSIOL, V212, P182, DOI 10.1002/jcp.21017; Lee CM, 2010, J BONE MINER METAB, V28, P8, DOI 10.1007/s00774-009-0096-0; Li CJ, 2011, BONE, V48, P286, DOI 10.1016/j.bone.2010.09.020; Li X, 2002, BONE, V30, P567, DOI 10.1016/S8756-3282(02)00683-X; Malizos KN, 2005, INJURY, V36, P13, DOI 10.1016/j.injury.2005.07.030; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MCKIBBIN B, 1978, J BONE JOINT SURG BR, V60, P150, DOI 10.1302/0301-620X.60B2.350882; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Mukherjee A, 2010, MOL CELL BIOL, V30, P1018, DOI 10.1128/MCB.01401-09; Mukherjee A, 2009, J CELL SCI, V122, P716, DOI 10.1242/jcs.042770; Naik AA, 2009, J BONE MINER RES, V24, P251, DOI 10.1359/JBMR.081002; Ninomiya T, 2011, EUR J PHARMACOL, V650, P396, DOI 10.1016/j.ejphar.2010.10.021; Paralkar VM, 2003, P NATL ACAD SCI USA, V100, P6736, DOI 10.1073/pnas.1037343100; Regard J. B., 2012, COLD SPRING HARB PER, V4; Riley EH, 1996, CLIN ORTHOP RELAT R, P39, DOI 10.1097/00003086-199603000-00006; Robertson G, 2006, BONE, V39, P767, DOI 10.1016/j.bone.2006.04.006; Schipani E, 2001, GENE DEV, V15, P2865; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Wallace DC, 2005, COLD SH Q B, V70, P363, DOI 10.1101/sqb.2005.70.035; Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105; Wang JH, 2013, BONE, V57, P311, DOI 10.1016/j.bone.2013.08.015; Wang Q, 2011, BONE, V48, P524, DOI 10.1016/j.bone.2010.10.178; Wang Q, 2010, AM J PATHOL, V177, P3100, DOI 10.2353/ajpath.2010.100060; Wang YJ, 2005, J BONE MINER RES, V20, P1624, DOI 10.1359/JBMR.050516; Xie C, 2009, AM J PATHOL, V175, P772, DOI 10.2353/ajpath.2009.081099; Yaqub Sheraz, 2008, Critical Reviews in Oncogenesis, V14, P57; Zhang QZ, 2009, J IMMUNOL, V183, P7787, DOI 10.4049/jimmunol.0902318; Zhang XP, 2004, BONE, V34, P809, DOI 10.1016/j.bone.2003.12.026; Zhang XP, 2005, J BONE MINER RES, V20, P2124, DOI 10.1359/JBMR.050806; Zhao LX, 2012, J CELL MOL MED, V16, P1840, DOI 10.1111/j.1582-4934.2011.01479.x; Zou DH, 2011, STEM CELLS, V29, P1380, DOI 10.1002/stem.693; Zuscik MJ, 2008, J CLIN INVEST, V118, P429, DOI 10.1172/JCI34174	56	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100079	10.1371/journal.pone.0100079	http://dx.doi.org/10.1371/journal.pone.0100079			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988184	gold, Green Published, Green Submitted			2022-12-27	WOS:000341354100023
J	Mariani, M; He, SQ; McHugh, M; Andreoli, M; Pandya, D; Sieber, S; Wu, ZY; Fiedler, P; Shahabi, S; Ferlini, C				Mariani, Marisa; He, Shiquan; McHugh, Mark; Andreoli, Mirko; Pandya, Deep; Sieber, Steven; Wu, Zheyang; Fiedler, Paul; Shahabi, Shohreh; Ferlini, Cristiano			Integrated Multidimensional Analysis Is Required for Accurate Prognostic Biomarkers in Colorectal Cancer	PLOS ONE			English	Article							COLON-CANCER; SIGNALING PATHWAYS; METASTASIS; EXPRESSION; PROTEOMICS; DISCOVERY; GENOMICS; SURVIVAL; IGFBP-3; CELLS	CRC cancer is one of the deadliest diseases in Western countries. In order to develop prognostic biomarkers for CRC (colorectal cancer) aggressiveness, we analyzed retrospectively 267 CRC patients via a novel, multidimensional biomarker platform. Using nanofluidic technology for qPCR analysis and quantitative fluorescent immunohistochemistry for protein analysis, we assessed 33 microRNAs, 124 mRNAs and 9 protein antigens. Analysis was conducted in each single dimension (microRNA, gene or protein) using both the multivariate Cox model and Kaplan-Meier method. Thereafter, we simplified the censored survival data into binary response data (aggressive vs. non aggressive cancer). Subsequently, we integrated the data into a diagnostic score using sliced inverse regression for sufficient dimension reduction. Accuracy was assessed using area under the receiver operating characteristic curve (AUC). Single dimension analysis led to the discovery of individual factors that were significant predictors of outcome. These included seven specific microRNAs, four genes, and one protein. When these factors were quantified individually as predictors of aggressive disease, the highest demonstrable area under the curve (AUC) was 0.68. By contrast, when all results from single dimensions were combined into integrated biomarkers, AUCs were dramatically increased with values approaching and even exceeding 0.9. Single dimension analysis generates statistically significant predictors, but their predictive strengths are suboptimal for clinical utility. A novel, multidimensional integrated approach overcomes these deficiencies. Newly derived integrated biomarkers have the potential to meaningfully guide the selection of therapeutic strategies for individual patients while elucidating molecular mechanisms driving disease progression.	[Mariani, Marisa; He, Shiquan; McHugh, Mark; Andreoli, Mirko; Pandya, Deep; Sieber, Steven; Fiedler, Paul; Shahabi, Shohreh; Ferlini, Cristiano] Danbury Hosp, Res Inst, Danbury, CT 06810 USA; [Wu, Zheyang] Worcester Polytech Inst, Dept Math Sci, Worcester, MA 01609 USA	Worcester Polytechnic Institute	Ferlini, C (corresponding author), Danbury Hosp, Res Inst, Danbury, CT 06810 USA.	cristiano.ferlini@danhosp.org			Ruth C. Donovan Cancer Research Program	Ruth C. Donovan Cancer Research Program	This work was partially supported by a Grant from the Ruth C. Donovan Cancer Research Program and by a liberal donation from Mr. and Mrs. Ruggles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter RC, 2001, J CLIN PATHOL-MOL PA, V54, P145, DOI 10.1136/mp.54.3.145; Baxter RC, 2013, J CELL COMMUN SIGNAL, V7, P179, DOI 10.1007/s12079-013-0203-9; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Georges RB, 2011, CANCER BIOL THER, V12, P69, DOI 10.4161/cbt.12.1.15719; Gonzalez-Gonzalez M, 2013, CANCER GENOM PROTEOM, V10, P19; Gray RG, 2011, J CLIN ONCOL, V29, P4611, DOI 10.1200/JCO.2010.32.8732; Held-Feindt J, 2006, INT J CANCER, V118, P55, DOI 10.1002/ijc.21258; Hogan NM, 2012, CANCER BIOMARK, V11, P239, DOI 10.3233/CBM-2012-00278; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Kansra S, 2000, INT J CANCER, V87, P373, DOI 10.1002/1097-0215(20000801)87:3<373::AID-IJC10>3.0.CO;2-X; Kim YH, 2011, ANN SURG ONCOL, V18, P2338, DOI 10.1245/s10434-011-1573-y; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee H, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-54; Lemos C, 2013, CURR PHARM DESIGN, V19, P841, DOI 10.2174/138161213804547277; Li LX, 2008, BIOMETRICS, V64, P124, DOI 10.1111/j.1541-0420.2007.00836.x; Li LX, 2004, BIOINFORMATICS, V20, P3406, DOI 10.1093/bioinformatics/bth415; Ma YL, 2012, ANN SURG, V255, P720, DOI 10.1097/SLA.0b013e31824a9a8b; Mariani M, 2012, CLIN CANC RES; Matteucci E, 2009, CARCINOGENESIS, V30, P937, DOI 10.1093/carcin/bgp080; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Newton KF, 2012, COLORECTAL DIS, V14, P3, DOI 10.1111/j.1463-1318.2010.02439.x; Pfeiffer RM, 2008, BIOMETRICAL J, V50, P558, DOI 10.1002/bimj.200710428; Prislei S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-72; Sanz-Pamplona R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048877; Srivastava S, 2002, J NUTR, V132, p2471S, DOI 10.1093/jn/132.8.2471S; Tejpar S, 2010, ONCOLOGIST, V15, P390, DOI 10.1634/theoncologist.2009-0233; Trovato M, 2004, EUR J HISTOCHEM, V48, P291; Wingo PA, 1998, CANCER EPIDEM BIOMAR, V7, P271	29	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101065	10.1371/journal.pone.0101065	http://dx.doi.org/10.1371/journal.pone.0101065			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988459	Green Submitted, Green Published, gold			2022-12-27	WOS:000341354100058
J	White, MR; Kandel, R; Tripathi, S; Condon, D; Qi, L; Taubenberger, J; Hartshorn, KL				White, Mitchell R.; Kandel, Ruth; Tripathi, Shweta; Condon, David; Qi, Li; Taubenberger, Jeffrey; Hartshorn, Kevan L.			Alzheimer's Associated beta-Amyloid Protein Inhibits Influenza A Virus and Modulates Viral Interactions with Phagocytes	PLOS ONE			English	Article							HUMAN NEUTROPHIL DEFENSINS; DISEASE; PEPTIDE; RESPONSES; RECEPTOR	Accumulation of beta-Amyloid (beta A) is a key pathogenetic factor in Alzheimer's disease; however, the normal function of beta A is unknown. Recent studies have shown that beta A can inhibit growth of bacteria and fungi. In this paper we show that beta A also inhibits replication of seasonal and pandemic strains of H3N2 and H1N1 influenza A virus (IAV) in vitro. The 42 amino acid fragment of beta A (beta A42) had greater activity than the 40 amino acid fragment. Direct incubation of the virus with beta A42 was needed to achieve optimal inhibition. Using quantitative PCR assays beta A42 was shown to reduce viral uptake by epithelial cells after 45 minutes and to reduce supernatant virus at 24 hours post infection. beta A42 caused aggregation of IAV particles as detected by light transmission assays and electron and confocal microscopy. beta A42 did not stimulate neutrophil H2O2 production or extracellular trap formation on its own, but it increased both responses stimulated by IAV. In addition, beta A42 increased uptake of IAV by neutrophils. beta A42 reduced viral protein synthesis in monocytes and reduced IAV-induced interleukin-6 production by these cells. Hence, we demonstrate for the first time that beta A has antiviral activity and modulates viral interactions with phagocytes.	[White, Mitchell R.; Tripathi, Shweta; Condon, David; Hartshorn, Kevan L.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Kandel, Ruth] Harvard Univ, Sch Med, Hebrew Senior Life, Boston, MA USA; [Qi, Li; Taubenberger, Jeffrey] NIAID, Bethesda, MD 20892 USA	Boston University; Harvard University; Harvard Medical School; Hebrew SeniorLife; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hartshorn, KL (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	khartsho@bu.edu	Taubenberger, Jeffery/AAQ-1407-2021		National Institutes of Health [AI-83222, HL 069031]; NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000986, P01AI083222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding came from the National Institutes of Health Grant numbers AI-83222 (KLH)and HL 069031 (KLH) and NIH intramural funds (JKT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo EPC, 2012, J BIOL CHEM, V287, P37206, DOI 10.1074/jbc.M112.369942; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; De Chiara G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013989; Doss M, 2009, J IMMUNOL, V182, P7878, DOI 10.4049/jimmunol.0804049; Hartshorn KL, 2006, J IMMUNOL, V176, P6962, DOI 10.4049/jimmunol.176.11.6962; HARTSHORN KL, 1988, J IMMUNOL, V141, P1295; HARTSHORN KL, 1990, BLOOD, V75, P218; Jana M, 2008, J IMMUNOL, V181, P7254, DOI 10.4049/jimmunol.181.10.7254; Jang H, 2008, BIOPHYS J, V95, P4631, DOI 10.1529/biophysj.108.134551; Job ER, 2010, J IMMUNOL, V185, P4284, DOI 10.4049/jimmunol.1001613; Larvie M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/929803; Lee RM, 2006, SCAND J IMMUNOL, V63, P81, DOI 10.1111/j.1365-3083.2005.01714.x; Lurain NS, 2013, J INFECT DIS, V208, P564, DOI 10.1093/infdis/jit210; Masters CL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006262; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Papareddy P, 2012, J PEPT SCI, V18, P183, DOI 10.1002/psc.1439; Qi L, 2011, VIROLOGY, V412, P426, DOI 10.1016/j.virol.2011.01.029; Richard KL, 2008, J NEUROSCI, V28, P5784, DOI 10.1523/JNEUROSCI.1146-08.2008; Selkoe Dennis J, 2008, Handb Clin Neurol, V89, P245, DOI 10.1016/S0072-9752(07)01223-7; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Shinya K, 2011, J VIROL, V85, P4673, DOI 10.1128/JVI.00148-11; Slowik A, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-55; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Tecle T, 2007, J IMMUNOL, V178, P8046, DOI 10.4049/jimmunol.178.12.8046; Tripathi S, 2013, J GEN VIROL, V94, P40, DOI 10.1099/vir.0.045013-0; Verma A, 2012, J IMMUNOL, V189, P2478, DOI 10.4049/jimmunol.1103786; Wozniak MA, 2007, NEUROSCI LETT, V429, P95, DOI 10.1016/j.neulet.2007.09.077; Zhang JD, 2011, J NEUROIMMUNE PHARM, V6, P650, DOI 10.1007/s11481-011-9259-6	28	119	120	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101364	10.1371/journal.pone.0101364	http://dx.doi.org/10.1371/journal.pone.0101364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988208	Green Submitted, Green Published, gold			2022-12-27	WOS:000341354100079
J	Aznar, I; Frankena, K; More, SJ; Whelan, C; Martin, W; Gormley, E; Corner, LAL; Murphy, D; De Jong, MCM				Aznar, Inma; Frankena, Klaas; More, Simon J.; Whelan, Clare; Martin, Wayne; Gormley, Eamonn; Corner, Leigh A. L.; Murphy, Denise; De Jong, Mart C. M.			Optimising and Evaluating the Characteristics of a Multiple Antigen ELISA for Detection of Mycobacterium bovis Infection in a Badger Vaccine Field Trial	PLOS ONE			English	Article							GAMMA-INTERFERON ASSAY; MELES-MELES; ENDOBRONCHIAL INOCULATION; EXPERIMENTAL TUBERCULOSIS; PROTECTIVE IMMUNITY; CATTLE HERDS; BCG; CHALLENGE; PATHOLOGY; CULTURE	A long-term research programme has been underway in Ireland to evaluate the usefulness of badger vaccination as part of the national bTB (bovine tuberculosis) control strategy. This culminated in a field trial which commenced in county Kilkenny in 2009 to determine the effects of badger vaccination on Mycobacterium bovis transmission in badgers under field conditions. In the present study, we sought to optimise the characteristics of a multiplex chemiluminescent assay for detection of M. bovis infection in live badgers. Our goal was to maximise specificity, and therefore statistical power, during evaluation of the badger vaccine trial data. In addition, we also aimed to explore the effects of vaccination on test characteristics. For the test optimisation, we ran a stepwise logistic regression with analytical weights on the converted Relative Light Units (RLU) obtained from testing blood samples from 215 badgers captured as part of culling operations by the national Department of Agriculture, Food and the Marine (DAFM). The optimised test was applied to two other datasets obtained from two captive badger studies (Study 1 and Study 2), and the sensitivity and specificity of the test was attained separately for vaccinated and non-vaccinated badgers. During optimisation, test sensitivity was maximised (30.77%), while retaining specificity at 99.99%. When the optimised test was then applied to the captive badger studies data, we observed that test characteristics did not vary greatly between vaccinated and non-vaccinated badgers. However, a different time lag between infection and a positive test result was observed in vaccinated and non-vaccinated badgers. We propose that the optimized multiplex immunoassay be used to analyse the vaccine trial data. In relation to the difference in the time lag observed for vaccinated and non-vaccinated badgers, we also present a strategy to enable the test to be used during trial evaluation.	[Aznar, Inma; More, Simon J.] Univ Coll Dublin, Sch Vet Med, Ctr Vet Epidemiol & Risk Anal, Dublin 2, Ireland; [Aznar, Inma; Frankena, Klaas; De Jong, Mart C. M.] Wageningen Univ, Quantitat Vet Epidemiol Grp, Wageningen Inst Anim Sci, NL-6700 AP Wageningen, Netherlands; [Whelan, Clare] Enfer Sci, Naas, Kildare, Ireland; [Martin, Wayne] Univ Guelph, Guelph, ON N1G 2W1, Canada; [Gormley, Eamonn; Corner, Leigh A. L.] Univ Coll Dublin, Sch Vet Med, Dublin 2, Ireland; [Murphy, Denise] Dept Agr Food & Marine, Athlone Reg Vet Lab, Athlone, Ireland	University College Dublin; Wageningen University & Research; University of Guelph; University College Dublin	Aznar, I (corresponding author), Univ Coll Dublin, Sch Vet Med, Ctr Vet Epidemiol & Risk Anal, Dublin 2, Ireland.	inma.aznar@ucd.ie	FRANKENA, KLAAS/K-6920-2012; whelan, clare/I-4129-2019; de Jong, Mart C.M./GQQ-0825-2022; Gormley, Eamonn/AAU-6678-2020	de Jong, Mart C.M./0000-0002-5339-1995; Gormley, Eamonn/0000-0003-3900-0393; More, Simon/0000-0002-4270-0385				Aznar I, 2013, PREV VET MED, V111, P297, DOI 10.1016/j.prevetmed.2013.05.007; Aznar I, 2011, VET MICROBIOL, V151, P104, DOI 10.1016/j.vetmic.2011.02.032; Chambers MA, 2008, J CLIN MICROBIOL, V46, P1498, DOI 10.1128/JCM.02117-07; Chambers MA, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-42; Corner LAL, 2008, RES VET SCI, V85, P481, DOI 10.1016/j.rvsc.2008.03.003; Corner LAL, 2007, RES VET SCI, V83, P53, DOI 10.1016/j.rvsc.2006.10.016; Corner LAL, 2012, VET J, V194, P166, DOI 10.1016/j.tvjl.2012.03.013; Corner LAL, 2010, VACCINE, V28, P6265, DOI 10.1016/j.vaccine.2010.06.120; Corner LAL, 2008, TUBERCULOSIS, V88, P601, DOI 10.1016/j.tube.2008.03.002; Crawshaw TR, 2008, VET REC, V163, P473, DOI 10.1136/vr.163.16.473; Dalley D, 2008, TUBERCULOSIS, V88, P235, DOI 10.1016/j.tube.2007.11.001; Dalley DJ, 2004, VET IMMUNOL IMMUNOP, V101, P19, DOI 10.1016/j.vetimm.2004.04.010; Drewe JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011196; GOODGER J, 1994, VET IMMUNOL IMMUNOP, V40, P243, DOI 10.1016/0165-2427(94)90023-X; Gormley E, 2004, VET IMMUNOL IMMUNOP, V102, P413, DOI 10.1016/j.vetimm.2004.08.002; Greenwald R, 2003, DIAGN MICR INFEC DIS, V46, P197, DOI 10.1016/S0732-8893(03)00046-4; Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X; Griffin JM, 2005, PREV VET MED, V67, P237, DOI 10.1016/j.prevetmed.2004.10.009; Hewinson RG, 1996, SCAND J IMMUNOL, V43, P490, DOI 10.1046/j.1365-3083.1996.d01-78.x; More SJ, 2009, VET J, V180, P275, DOI 10.1016/j.tvjl.2009.01.027; Murphy D, 2011, VET MICROBIOL, V151, P120, DOI 10.1016/j.vetmic.2011.02.034; Murphy D, 2010, RES VET SCI, V88, P1, DOI 10.1016/j.rvsc.2009.05.020; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Waters WR, 2007, VET MICROBIOL, V119, P277, DOI 10.1016/j.vetmic.2006.08.014; Whelan C, 2009, M BOV 5 INT C AUG 25; Whelan C, 2010, CLIN VACCINE IMMUNOL, V17, P813, DOI 10.1128/CVI.00489-09; Whelan C, 2008, CLIN VACCINE IMMUNOL, V15, P1834, DOI 10.1128/CVI.00238-08	27	7	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100139	10.1371/journal.pone.0100139	http://dx.doi.org/10.1371/journal.pone.0100139			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983473	Green Published, Green Submitted, gold			2022-12-27	WOS:000339635000015
J	Diao, DM; Wang, Z; Cheng, Y; Zhang, H; Guo, Q; Song, YC; Zhu, K; Li, K; Liu, D; Dang, CX				Diao, Dongmei; Wang, Zhe; Cheng, Yao; Zhang, Hao; Guo, Qi; Song, Yongchun; Zhu, Kun; Li, Kang; Liu, Di; Dang, Chengxue			D-Dimer: Not Just an Indicator of Venous Thrombosis but a Predictor of Asymptomatic Hematogenous Metastasis in Gastric Cancer Patients	PLOS ONE			English	Article							ELEVATED D-DIMER; PROGNOSTIC-SIGNIFICANCE; COLORECTAL-CANCER; ESOPHAGEAL CANCER; PLASMA-LEVELS; LUNG-CANCER; TUMOR-CELLS; PLATELETS; THROMBOEMBOLISM; DIAGNOSIS	Background: Plasma D-dimer levels have been shown to be high in advanced tumor stage patients and can be used to predict clinical outcome in cancer patients. As most advanced tumor stage patients exhibit asymptomatic metastasis, which contributes to early tumor recurrence after surgery, we hypothesized that plasma D-dimer levels can be used to predict patients with potential metastasis. Methods: We enrolled 1042 primary gastric cancer patients in three multiple cancer centers in Northwest China and examined plasma D-dimer levels using the latex-enhanced immunoturbidimetric assay (LEA) method. Plasma D-dimer levels were compared with the clinicopathological characteristics in this large-scale case-control study with follow up. We also performed regular follow-up studies for 395 patients to analyze the 2-year survival rate and early tumor recurrence. Results: In this large-scale clinical study, we found that plasma D-dimer levels were increased in patients with distant metastasis and especially hematogenous metastasis patients. The cut-off value of the D-dimer levels was determined to be 1.5 mg/ml based on the ROC curve, and the sensitivity and specificity for metastasis prediction were 61.9% and 86.6%, respectively. Additionally, patients with high D-dimer levels displayed early tumor recurrence and poor outcome during the follow-up study. Conclusion: Plasma D-dimer may represent an easy to measure and lower cost marker for the testing of gastric cancer patients to predict asymptomatic hematogenous metastasis.	[Diao, Dongmei; Cheng, Yao; Zhang, Hao; Guo, Qi; Song, Yongchun; Zhu, Kun; Li, Kang; Dang, Chengxue] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Surg Oncol, Xian, Peoples R China; [Wang, Zhe] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Thorac Surg, Xian, Peoples R China; [Liu, Di] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Surg Oncol, Xian, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Dang, CX (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Surg Oncol, Xian, Peoples R China.	dangchengxue@mail.xjtu.edu.cn	diao, dongmei/HGD-6807-2022		National Natural Scientific Foundation of China [30973489]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Scientific Foundation of China (No. 30973489 (to CD)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HS, 2012, BRIT J CANCER, V106, P733, DOI 10.1038/bjc.2011.592; Altiay G, 2007, CLIN ONCOL-UK, V19, P494, DOI 10.1016/j.clon.2007.04.002; Antoniou D, 2006, LUNG CANCER, V53, P205, DOI 10.1016/j.lungcan.2006.03.015; Ay C, 2012, HAEMATOL-HEMATOL J, V97, P1158, DOI 10.3324/haematol.2011.054718; Ay C, 2009, J CLIN ONCOL, V27, P4124, DOI 10.1200/JCO.2008.21.7752; Batschauer APB, 2010, ANN ONCOL, V21, P1267, DOI 10.1093/annonc/mdp474; Biggerstaff JP, 2006, THROMB J, V4, DOI 10.1186/1477-9560-4-12; Diao DM, 2013, J SURG ONCOL, V108, P34, DOI 10.1002/jso.23339; Dompmartin A, 2009, ARCH DERMATOL, V145, P1239, DOI 10.1001/archdermatol.2009.296; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Horowitz NA, 2011, BLOOD, V118, P2889, DOI 10.1182/blood-2011-03-341222; Im JH, 2004, CANCER RES, V64, P8613, DOI 10.1158/0008-5472.CAN-04-2078; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kilic M, 2008, COLORECTAL DIS, V10, P238, DOI 10.1111/j.1463-1318.2007.01374.x; Kwon HC, 2008, JPN J CLIN ONCOL, V38, P2, DOI 10.1093/jjco/hym157; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Lippi G, 2007, Haematologica, V92, pe53, DOI 10.3324/haematol.12237; MIRSHAHI SS, 1992, CANCER, V69, P2289, DOI 10.1002/1097-0142(19920501)69:9<2289::AID-CNCR2820690914>3.0.CO;2-A; Palumbo JS, 2000, BLOOD, V96, P3302, DOI 10.1182/blood.V96.10.3302; Palumbo JS, 2005, BLOOD, V105, P178, DOI 10.1182/blood-2004-06-2272; Palumbo JS, 2002, CANCER RES, V62, P6966; Raj SD, 2012, AM J CLIN ONCOL-CANC, V35, P462, DOI 10.1097/COC.0b013e31821d4529; Righini M, 2008, J THROMB HAEMOST, V6, P1059, DOI 10.1111/j.1538-7836.2008.02981.x; Stender MT, 2012, J THROMB HAEMOST, V10, P2027, DOI 10.1111/j.1538-7836.2012.04887.x; Tas F, 2012, MELANOMA RES, V22, P368, DOI 10.1097/CMR.0b013e328357be7c; Tomimaru Y, 2006, J AM COLL SURGEONS, V202, P139, DOI 10.1016/j.jamcollsurg.2005.08.008; van den Berg YW, 2012, BLOOD, V119, P924, DOI 10.1182/blood-2011-06-317685; Yamamoto M, 2012, ONCOLOGY-BASEL, V83, P10, DOI 10.1159/000338329; Zhang W, 2012, BLOOD, V120, P2889, DOI 10.1182/blood-2012-04-425207	31	34	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101125	10.1371/journal.pone.0101125	http://dx.doi.org/10.1371/journal.pone.0101125			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983619	Green Published, gold, Green Submitted			2022-12-27	WOS:000339635000056
J	Amico, E; Gomez, F; Di Perri, C; Vanhaudenhuyse, A; Lesenfants, D; Boveroux, P; Bonhomme, V; Brichant, JF; Marinazzo, D; Laureys, S				Amico, Enrico; Gomez, Francisco; Di Perri, Carol; Vanhaudenhuyse, Audrey; Lesenfants, Damien; Boveroux, Pierre; Bonhomme, Vincent; Brichant, Jean-Francois; Marinazzo, Daniele; Laureys, Steven			Posterior Cingulate Cortex-Related Co-Activation Patterns: A Resting State fMRI Study in Propofol-Induced Loss of Consciousness	PLOS ONE			English	Article							DEFAULT MODE NETWORK; FUNCTIONAL CONNECTIVITY; BRAIN; STIMULATION; MECHANISMS; RESPONSES; SEDATION; NEURONS; HUMANS	Background: Recent studies have been shown that functional connectivity of cerebral areas is not a static phenomenon, but exhibits spontaneous fluctuations over time. There is evidence that fluctuating connectivity is an intrinsic phenomenon of brain dynamics that persists during anesthesia. Lately, point process analysis applied on functional data has revealed that much of the information regarding brain connectivity is contained in a fraction of critical time points of a resting state dataset. In the present study we want to extend this methodology for the investigation of resting state fMRI spatial pattern changes during propofol-induced modulation of consciousness, with the aim of extracting new insights on brain networks consciousness-dependent fluctuations. Methods: Resting-state fMRI volumes on 18 healthy subjects were acquired in four clinical states during propofol injection: wakefulness, sedation, unconsciousness, and recovery. The dataset was reduced to a spatio-temporal point process by selecting time points in the Posterior Cingulate Cortex (PCC) at which the signal is higher than a given threshold (i.e., BOLD intensity above 1 standard deviation). Spatial clustering on the PCC time frames extracted was then performed (number of clusters = 8), to obtain 8 different PCC co-activation patterns (CAPs) for each level of consciousness. Results: The current analysis shows that the core of the PCC-CAPs throughout consciousness modulation seems to be preserved. Nonetheless, this methodology enables to differentiate region-specific propofol-induced reductions in PCC-CAPs, some of them already present in the functional connectivity literature (e. g., disconnections of the prefrontal cortex, thalamus, auditory cortex), some others new (e. g., reduced co-activation in motor cortex and visual area). Conclusion: In conclusion, our results indicate that the employed methodology can help in improving and refining the characterization of local functional changes in the brain associated to propofol-induced modulation of consciousness.	[Amico, Enrico; Gomez, Francisco; Vanhaudenhuyse, Audrey; Lesenfants, Damien; Boveroux, Pierre; Bonhomme, Vincent; Laureys, Steven] Univ Liege, Cyclotron Res Ctr, Coma Sci Grp, Liege, Belgium; [Amico, Enrico; Marinazzo, Daniele] Univ Ghent, Dept Data Anal, Fac Psychol & Educ Sci, B-9000 Ghent, Belgium; [Laureys, Steven] Univ Liege, Dept Neurol, Liege, Belgium; [Boveroux, Pierre; Bonhomme, Vincent; Brichant, Jean-Francois] Univ Liege, CHU Sart Tilman Hosp, Dept Anesthesia & Intens Care Med, Liege, Belgium; [Bonhomme, Vincent] Univ Liege, CHR Citadelle, Dept Anesthesia & Intens Care Med, Liege, Belgium; [Vanhaudenhuyse, Audrey] Univ Liege, CHU Sart Tilman Hosp, Dept Algol & Palliat Care, Liege, Belgium; [Di Perri, Carol] Natl Neurol Inst C Mondino, Dept Neuroradiol, Pavia, Italy	University of Liege; Ghent University; University of Liege; University of Liege; University of Liege; University of Liege; IRCCS Istituto Neurologico Besta	Amico, E (corresponding author), Univ Liege, Cyclotron Res Ctr, Coma Sci Grp, Liege, Belgium.	eamico@ulg.ac.be	Bonhomme, Vincent/J-7144-2019; Marinazzo, Daniele/H-4793-2019; Laureys, Steven/AAN-2097-2021; Laureys, Steven/A-3349-2011; Vanhaudenhuyse, Audrey/AAP-2455-2020; Amico, Enrico/AAB-2581-2019	Bonhomme, Vincent/0000-0001-6356-547X; Marinazzo, Daniele/0000-0002-9803-0122; Laureys, Steven/0000-0002-3096-3807; Amico, Enrico/0000-0001-6705-9689; Di Perri, Carol/0000-0003-0284-770X	Belgian Funds for Scientific Research (FRS); European Commission (DECODER); Belgian Science Policy (CEREBNET); McDonnell Foundation; European Space Agency; Wallonia-Brussels Federation Concerted Research Action Mind Science Foundation; University of Liege	Belgian Funds for Scientific Research (FRS)(Fonds de la Recherche Scientifique - FNRS); European Commission (DECODER); Belgian Science Policy (CEREBNET); McDonnell Foundation; European Space Agency(European Space AgencyEuropean Commission); Wallonia-Brussels Federation Concerted Research Action Mind Science Foundation; University of Liege(University of Liege)	This research was supported by the Belgian Funds for Scientific Research (FRS), European Commission (DECODER), Belgian Science Policy (CEREBNET), McDonnell Foundation, European Space Agency, Wallonia-Brussels Federation Concerted Research Action Mind Science Foundation, University of Liege. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Allen E. A., 2012, CEREBRAL CORTEX; Boly M, 2009, HUM BRAIN MAPP, V30, P2393, DOI 10.1002/hbm.20672; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Boveroux P, 2008, INT ANESTHESIOL CLIN, V46, P131, DOI 10.1097/AIA.0b013e318181a8b3; Chang C, 2010, FILM COMMENT, V46, P81; Deshpande G, 2010, BRAIN RES, V1318, P110, DOI 10.1016/j.brainres.2009.12.075; Dueck MH, 2005, ACTA ANAESTH SCAND, V49, P784, DOI 10.1111/j.1399-6576.2005.00703.x; Fiset P, 1999, J NEUROSCI, V19, P5506; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Gaese BH, 2001, J NEUROPHYSIOL, V86, P1062, DOI 10.1152/jn.2001.86.2.1062; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Guldenmund P, 2013, BRAIN CONNECT, V3, P273, DOI 10.1089/brain.2012.0117; Hastie T., 2009, ELEMENTS STAT LEARNI, DOI [10.1007/b94608, DOI 10.1007/B94608]; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Hutchison RM, 2013, HUM BRAIN MAPP, V34, P2154, DOI 10.1002/hbm.22058; John ER, 2005, ANESTHESIOLOGY, V102, P447, DOI 10.1097/00000542-200502000-00030; KALKMAN CJ, 1992, ANESTHESIOLOGY, V76, P502, DOI 10.1097/00000542-199204000-00003; Lamme VAF, 1998, P NATL ACAD SCI USA, V95, P3263, DOI 10.1073/pnas.95.6.3263; Lee U, 2009, CONSCIOUS COGN, V18, P56, DOI 10.1016/j.concog.2008.10.005; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Liu X, 2013, P NATL ACAD SCI USA, V110, P4392, DOI 10.1073/pnas.1216856110; MacLaren R, 2000, PHARMACOTHERAPY, V20, P662, DOI 10.1592/phco.20.7.662.35172; Martuzzi R, 2010, NEUROIMAGE, V49, P823, DOI 10.1016/j.neuroimage.2009.07.028; Peigneux P, 2006, PLOS BIOL, V4, P647, DOI 10.1371/journal.pbio.0040100; Plourde G, 2006, ANESTHESIOLOGY, V104, P448, DOI 10.1097/00000542-200603000-00011; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Sanders RD, 2012, ANESTHESIOLOGY, V116, P946, DOI 10.1097/ALN.0b013e318249d0a7; Schrouff J, 2011, NEUROIMAGE, V57, P198, DOI 10.1016/j.neuroimage.2011.04.020; Tagliazucchi E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00015; Tenenbein PK, 2006, J NEUROSURGICAL ANES, V18, P310; Untergehrer G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087498; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Vijayan S, 2013, J NEUROSCI, V33, P11070, DOI 10.1523/JNEUROSCI.5670-12.2013; Wu GR, 2013, MED IMAGE ANAL, V17, P365, DOI 10.1016/j.media.2013.01.003; Ying SW, 2005, J NEUROPHYSIOL, V93, P1935, DOI 10.1152/jn.01058.2004; Ziemann U, 1996, ANN NEUROL, V40, P367, DOI 10.1002/ana.410400306	41	72	74	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100012	10.1371/journal.pone.0100012	http://dx.doi.org/10.1371/journal.pone.0100012			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979748	Green Published, gold			2022-12-27	WOS:000338506400016
J	Sun, FL; Wang, W; Cheng, H; Wang, Y; Li, L; Xue, JL; Wang, XF; Ai, HX; Zhang, L; Xu, JD; Wang, XM; Ji, XM				Sun, Fang-Ling; Wang, Wen; Cheng, Hua; Wang, Ying; Li, Lei; Xue, Jin-Long; Wang, Xiao-feng; Ai, Hou-Xi; Zhang, Li; Xu, Jing-dong; Wang, Xiao-Min; Ji, Xun-Ming			Morroniside Improves Microvascular Functional Integrity of the Neurovascular Unit after Cerebral Ischemia	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; ENDOTHELIAL GROWTH-FACTOR; TIGHT JUNCTION PROTEINS; MCA-OCCLUSION MODEL; UP-REGULATION; RAT-BRAIN; CD34(+) CELLS; STROKE; ANGIOGENESIS; EXPRESSION	Treating the vascular elements within the neurovascular unit is essential for protecting and repairing the brain after stroke. Acute injury on endothelial systems results in the disruption of blood-brain barrier (BBB), while post-ischemic angiogenesis plays an important role in delayed functional recovery. Here, we considered alterations in microvessel integrity to be targets for brain recovery, and tested the natural compound morroniside as a therapeutic approach to restore the vascular elements of injured tissue in a rat model of focal cerebral ischemia. Sprague-Dawley rats were subjected to middle cerebral artery occlusion (MCAO) model, and morroniside was then administered intragastrically once a day at doses of 30, 90, and 270 mg/kg. BBB integrity and associated factors were analyzed to identify cerebrovascular permeability 3 days after MCAO. The recruitment of endothelial progenitor cells (EPCs), the expression of angiogenic factors and the new vessel formation in the peri-infarct cortex of rats were examined 7 days after MCAO to identify the angiogenesis. We demonstrated that at 3 days post-ischemia, morroniside preserved neurovascular unit function by ameliorating BBB injury. By 7 days post-ischemia, morroniside amplified angiogenesis, in part by enhancing endothelial progenitor cell proliferation and expression of angiogenic factors. Morever, the increase in the amount of vWF(+) vessels induced by ischemia could be extended to 28 days after administration of morroniside, indicating the crucial role of morroniside in angiogenesis during the chronic phase. Taken together, our findings suggested that morroniside might offer a novel therapeutic approach for promoting microvascular integrity recovery and provide a thoroughly new direction for stroke therapy.	[Sun, Fang-Ling; Wang, Wen; Cheng, Hua; Wang, Ying; Li, Lei; Xue, Jin-Long; Wang, Xiao-feng; Ai, Hou-Xi; Zhang, Li] Capital Med Univ, Xuanwu Hosp, Dept Pharmacol, Beijing, Peoples R China; [Xu, Jing-dong] Capital Med Univ, Dept Physiol, Sch Basic Med Sci, Beijing, Peoples R China; [Wang, Xiao-Min] Capital Med Univ, Dept Neurobiol, Sch Basic Med Sci, Beijing, Peoples R China; [Ji, Xun-Ming] Capital Med Univ, Dept Neurosurg, Xuanwu Hosp, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University	Wang, W (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Pharmacol, Beijing, Peoples R China.	lzwwang@163.com; xmwang@ccmu.edu.cn; robertjixm@hotmail.com	xu, jing/GRR-8698-2022; Ji, Xunming/AAN-3370-2021		National Science and Technology Major Project [2012ZX09102201-106, 2009ZX09103-366]; National Natural Science Foundation of China [81173575, 30973893, 81274173]; China Postdoctoral Science Foundation [106455]; Beijing Natural Science Foundation [7102077, 7211017]; Beijing Municipal Commission of Education & Capital Medical University Base-Technological Innovation Platform Fund [111219]; Beijing Health System Experts of High-level [2011-3-097]; Beijing Municipal Commission of Education [KM201010025004]; Beijing Postdoctoral Science Foundation [106455]	National Science and Technology Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Municipal Commission of Education & Capital Medical University Base-Technological Innovation Platform Fund; Beijing Health System Experts of High-level; Beijing Municipal Commission of Education(Beijing Municipal Commission of Education); Beijing Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Science and Technology Major Project (2012ZX09102201-106 and 2009ZX09103-366); National Natural Science Foundation of China (81173575, 30973893 and 81274173); China Postdoctoral Science Foundation funded project (106455); Beijing Natural Science Foundation (7102077 and 7211017); Beijing Municipal Commission of Education & Capital Medical University Base-Technological Innovation Platform Fund (111219); a grant of Beijing Health System Experts of High-level (2011-3-097); Beijing Municipal Commission of Education (KM201010025004); Beijing Postdoctoral Science Foundation funded project (106455). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Alfieri A, 2011, J PHYSIOL-LONDON, V589, P4125, DOI 10.1113/jphysiol.2011.210294; Anthony DC, 1997, NEUROPATH APPL NEURO, V23, P406, DOI 10.1111/j.1365-2990.1997.tb01315.x; Arai K, 2011, J CHILD NEUROL, V26, P1193, DOI 10.1177/0883073811408610; Beck H, 2002, J NEUROPATH EXP NEUR, V61, P339, DOI 10.1093/jnen/61.4.339; Beck H, 2009, ACTA NEUROPATHOL, V117, P481, DOI 10.1007/s00401-009-0483-6; Blamire AM, 2000, J NEUROSCI, V20, P8153; Boutin H, 2001, J NEUROSCI, V21, P5528, DOI 10.1523/JNEUROSCI.21-15-05528.2001; Cao GD, 2001, J CEREBR BLOOD F MET, V21, P321, DOI 10.1097/00004647-200104000-00001; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; del Zoppo GJ, 2009, NEUROSCIENCE, V158, P972, DOI 10.1016/j.neuroscience.2008.08.028; Gale NW, 1999, GENE DEV, V13, P1055, DOI 10.1101/gad.13.9.1055; Gasche Y, 2001, J CEREBR BLOOD F MET, V21, P1393, DOI 10.1097/00004647-200112000-00003; Gasche Y, 1999, J CEREBR BLOOD F MET, V19, P1020, DOI 10.1097/00004647-199909000-00010; Goldman SA, 2011, NAT NEUROSCI, V14, P1382, DOI 10.1038/nn.2963; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Guo XB, 2009, J NEUROTRAUM, V26, P1337, DOI [10.1089/neu.2008.0733, 10.1089/neu.2008-0733]; Gursoy-Ozdemir Y, 2004, STROKE, V35, P1449, DOI 10.1161/01.STR.0000126044.83777.f4; Hansen TM, 2008, CURR NEUROVASC RES, V5, P236, DOI 10.2174/156720208786413433; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P166, DOI 10.1097/00004647-200302000-00004; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Hoang MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013612; Issa Razao, 2005, Angiogenesis, V8, P53, DOI 10.1007/s10456-005-5613-8; KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794; Liu WB, 2005, CYTOKINE, V32, P206, DOI 10.1016/j.cyto.2005.09.009; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; Ma XL, 2013, CURR NEUROVASC RES, V10, P103, DOI 10.2174/1567202611310020003; Maier CM, 2006, ANN NEUROL, V59, P929, DOI 10.1002/ana.20850; Mey L, 2013, NEUROBIOL DIS, V59, P111, DOI 10.1016/j.nbd.2013.06.009; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Nag S, 2009, ACTA NEUROPATHOL, V118, P197, DOI 10.1007/s00401-009-0541-0; Navarro-Sobrino M, 2011, ATHEROSCLEROSIS, V216, P205, DOI 10.1016/j.atherosclerosis.2011.01.030; Parry-Jones AR, 2008, MAGN RESON MED, V59, P1239, DOI 10.1002/mrm.21531; Plate KH, 1999, J NEUROPATH EXP NEUR, V58, P654, DOI 10.1097/00005072-199906000-00010; Qin D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061831; Rosell A, 2006, STROKE, V37, P1399, DOI 10.1161/01.STR.0000223001.06264.af; Rosell A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073244; Rosenberg GA, 2001, BRAIN RES, V893, P104, DOI 10.1016/S0006-8993(00)03294-7; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Wang L, 2008, J CEREBR BLOOD F MET, V28, P1361, DOI 10.1038/jcbfm.2008.32; Wang W, 2008, CELL MOL NEUROBIOL, V28, P293, DOI 10.1007/s10571-007-9168-7; Wang W, 2010, BRAIN RES BULL, V83, P196, DOI 10.1016/j.brainresbull.2010.07.003; Wang W, 2009, EUR J PHARMACOL, V613, P19, DOI 10.1016/j.ejphar.2009.04.013; YAMASAKI Y, 1992, NEUROSCI LETT, V142, P45, DOI 10.1016/0304-3940(92)90616-F; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yang Y, 2013, J CEREBR BLOOD F MET, V33, P1104, DOI 10.1038/jcbfm.2013.56; Yao RQ, 2009, BRAIN RES BULL, V79, P69, DOI 10.1016/j.brainresbull.2008.12.010; Zhang ZG, 2001, J CEREBR BLOOD F MET, V21, P541, DOI 10.1097/00004647-200105000-00008; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4; Zhao BQ, 2007, STROKE, V38, P748, DOI 10.1161/01.STR.0000253500.32979.d1; Zheng QP, 2011, TOHOKU J EXP MED, V224, P221, DOI 10.1620/tjem.224.221; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	54	18	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101194	10.1371/journal.pone.0101194	http://dx.doi.org/10.1371/journal.pone.0101194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979385	Green Published, gold, Green Submitted			2022-12-27	WOS:000338506400097
J	Zhang, PW; Xie, LN; Balliet, JW; Casimiro, DR; Yao, F				Zhang, Pengwei; Xie, Lining; Balliet, John W.; Casimiro, Danilo R.; Yao, Feng			A Herpes Simplex Virus 2 (HSV-2) Glycoprotein D-expressing Nonreplicating Dominant-Negative HSV-2 Virus Vaccine Is Superior to a gD2 Subunit Vaccine against HSV-2 Genital Infection in Guinea Pigs	PLOS ONE			English	Article							CONFERS PROTECTIVE IMMUNITY; CD8(+) T-CELLS; ANTIGEN PRESENTATION; VIRAL REPLICATION; TYPE-1 PROTECTS; UNITED-STATES; FC-RECEPTOR; RECOMBINANT; DISEASE; IMMUNIZATION	We recently constructed a novel non-replicating dominant-negative HSV-2 recombinant viral vaccine (CJ2-gD2) capable of expressing various HSV-2 antigens that are dominant targets of HSV-2-specific CD8 T-cell response. Importantly, CJ2-gD2 expresses gD2, the HSV-2 major antigen glycoprotein D, as efficiently as wild-type HSV-2 infection and can lead to a nearly 500-fold reduction in wild-type HSV-2 viral replication in cells co-infected with CJ2-gD2 and wild-type HSV-2. In this report, we show that CJ2-gD2 elicits a strong antibody response to various HSV-2 antigens and is highly effective in the prevention of primary and recurrent HSV-2 genital infection and disease in the immunized guinea pigs. The direct comparison study between CJ2-gD2 and a gD2 subunit vaccine (gD2-alum/MPL) with a formulation akin to a vaccine tested in phase III clinical trials shows that CJ2-gD2 is 8 times more effective than the gD2-alum/MPL subunit vaccine in eliciting an anti-HSV-2 specific neutralizing antibody response and offers significantly superior protection against primary and recurrent HSV-2 genital infections. Importantly, no challenge wild-type HSV-2 viral DNA was detectable in dorsal root ganglia DNA isolated from CJ2-gD2-immunized guinea pigs on day 60 post-challenge. CJ2-gD2 should be an excellent HSV-2 vaccine candidate for protection against HSV-2 genital infection and disease in humans.	[Zhang, Pengwei; Xie, Lining; Yao, Feng] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Zhang, Pengwei; Xie, Lining; Yao, Feng] Harvard Univ, Sch Med, Boston, MA USA; [Balliet, John W.; Casimiro, Danilo R.] Merck & Co Inc, Vaccine Res, Merck Res Labs, West Point, PA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Merck & Company	Yao, F (corresponding author), Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA.	fyao@rics.bwh.harvard.edu			Department of Surgery, Brigham and Women's Hospital; NIH from the National Institutes of Health [1R56AI93738-01]; Partners Innovation Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI093738] Funding Source: NIH RePORTER	Department of Surgery, Brigham and Women's Hospital; NIH from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Partners Innovation Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Partners Innovation Fund, Partners Health Care, Intramural Fund from the Department of Surgery, Brigham and Women's Hospital, and NIH 1R56AI93738-01 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhrameyeva NV, 2011, J VIROL, V85, P5036, DOI 10.1128/JVI.02548-10; Augustinova H, 2004, J VIROL, V78, P5756, DOI 10.1128/JVI.78.11.5756-5765.2004; Awasthi S, 2014, J VIROL, V88, P2000, DOI 10.1128/JVI.03163-13; Awasthi S, 2012, J VIROL, V86, P4586, DOI 10.1128/JVI.07203-11; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Bernstein DI, 2011, VACCINE, V29, P2071, DOI 10.1016/j.vaccine.2011.01.005; Blaney JE, 1998, J VIROL, V72, P9567, DOI 10.1128/JVI.72.12.9567-9574.1998; Bourne N, 2005, J INFECT DIS, V192, P2117, DOI 10.1086/498247; Bourne N, 2003, J INFECT DIS, V187, P542, DOI 10.1086/374002; Brans R, 2008, J INVEST DERMATOL, V128, P2825, DOI 10.1038/jid.2008.142; Brans R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-163; Brans R, 2009, J INVEST DERMATOL, V129, P2470, DOI 10.1038/jid.2009.86; Chentoufi AA, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/187585; Cohen J, 2010, SCIENCE, V330, P304, DOI 10.1126/science.330.6002.304; Daubeuf S, 2009, BLOOD, V113, P3264, DOI 10.1182/blood-2008-07-168203; DUBIN G, 1991, J VIROL, V65, P7046, DOI 10.1128/JVI.65.12.7046-7050.1991; Dudek T, 2006, VIROLOGY, V344, P230, DOI 10.1016/j.virol.2005.09.020; Eidson KM, 2002, J VIROL, V76, P2180, DOI 10.1128/JVI.76.5.2180-2191.2002; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; FRUH K, 1995, NATURE, V375, P415, DOI 10.1038/375415a0; Halford WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065523; Halford WP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017748; He B, 1997, J VIROL, V71, P6049, DOI 10.1128/JVI.71.8.6049-6054.1997; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; Hoshino Y, 2005, J VIROL, V79, P410, DOI 10.1128/JVI.79.1.410-418.2005; Hoshino Y, 2009, J INFECT DIS, V200, P1088, DOI 10.1086/605645; Hosken N, 2006, J VIROL, V80, P5509, DOI 10.1128/JVI.02659-05; Johnston C, 2011, J CLIN INVEST, V121, P4600, DOI 10.1172/JCI57148; Knickelbein JE, 2008, SCIENCE, V322, P268, DOI 10.1126/science.1164164; Koelle DM, 2008, ANNU REV MED, V59, P381, DOI 10.1146/annurev.med.59.061606.095540; Lu ZM, 2009, J INVEST DERMATOL, V129, P1174, DOI 10.1038/jid.2008.349; Mikloska Z, 2000, J IMMUNOL, V164, P5167, DOI 10.4049/jimmunol.164.10.5167; Milligan GN, 1998, J IMMUNOL, V160, P6093; Mossman KL, 2002, J VIROL, V76, P1995, DOI 10.1128/JVI.76.4.1995-1998.2002; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Orr MT, 2007, J IMMUNOL, V178, P4731, DOI 10.4049/jimmunol.178.8.4731; Paul WE, 2011, CELL, V147, P1212, DOI 10.1016/j.cell.2011.11.036; Posavad CM, 2010, J IMMUNOL, V184, P3250, DOI 10.4049/jimmunol.0900722; Posavad CM, 1998, J CLIN INVEST, V101, P1500; Schillinger JA, 2004, SEX TRANSM DIS, V31, P753, DOI 10.1097/01.olq.0000145852.43262.c3; Sievers E, 2002, IMMUNOLOGY, V107, P129, DOI 10.1046/j.1365-2567.2002.01472.x; Stanberry Lawrence R, 2004, Herpes, V11 Suppl 3, p161A; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915; STANBERRY LR, 1985, INTERVIROLOGY, V24, P226, DOI 10.1159/000149647; STANBERRY LR, 1982, J INFECT DIS, V146, P397, DOI 10.1093/infdis/146.3.397; Tengvall S, 2006, J VIROL, V80, P5283, DOI 10.1128/JVI.02013-05; Tirabassi RS, 2011, VACCINE, V29, P1090, DOI 10.1016/j.vaccine.2010.11.076; van Lint A, 2004, J IMMUNOL, V172, P392, DOI 10.4049/jimmunol.172.1.392; Wakim LM, 2008, IMMUNOL CELL BIOL, V86, P666, DOI 10.1038/icb.2008.47; Whitley RJ, FIELDS VIROLOGY FIEL, V2, P297; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964; Yao F, 1999, HUM GENE THER, V10, P419, DOI 10.1089/10430349950018869; Yao F, 2002, ANTIVIR RES, V53, P127, DOI 10.1016/S0166-3542(01)00207-8; YAO F, 1995, J VIROL, V69, P6249, DOI 10.1128/JVI.69.10.6249-6258.1995; Yao F, 1999, HUM GENE THER, V10, P1811, DOI 10.1089/10430349950017491; Yao F, 1998, HUM GENE THER, V9, P1939, DOI 10.1089/hum.1998.9.13-1939; Ye LL, 2011, NAT BIOTECHNOL, V29, P158, DOI 10.1038/nbt.1742; YORK IA, 1994, CELL, V77, P525, DOI 10.1016/0092-8674(94)90215-1; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792	59	11	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101373	10.1371/journal.pone.0101373	http://dx.doi.org/10.1371/journal.pone.0101373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979708	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400123
J	Liu, QS; Wang, HF; Sun, AK; Huo, XP; Liu, JL; Ma, SH; Peng, N; Hu, J				Liu, Qin-she; Wang, Hai-fang; Sun, An-ke; Huo, Xue-ping; Liu, Jin-lian; Ma, Shu-hui; Peng, Ning; Hu, Jun			A Comparative Study on Inhibition of Total Astragalus Saponins and Astragaloside IV on TNFR1-Mediated Signaling Pathways in Arterial Endothelial Cells	PLOS ONE			English	Article							TNF-ALPHA; ACTIVATION; RATS; INFLAMMATION; OSTEOBLASTS; EXPRESSION; MECHANISM; INJURY	Background: Both total astragalus saponins (AST) and it's main component astragaloside IV (ASIV) have been used in China as cardiovascular protective medicines. However, the anti-inflammatory activities that are beneficial for cardiovascular health have never been compared directly and the molecular mechanisms remain unresolved. This study was conducted to compare the inhibitory effects of these drugs on TNF alpha-induced cell responses, related signaling pathways, and the underlying mechanisms in mouse arterial endothelial cells. Methodology/Principal Findings: Real-time qRT-PCR was performed to determine the expression of cell adhesion molecule (CAM) genes. Immunofluorescent staining was used to detect the nuclear translocation of transcription factor NF-kappa B-p65. Western Blot analysis was used to identify TNF alpha-induced NF-kappa B-p65 phosphorylation, I kappa B alpha degradation, and caspase-3 cleavage. Cell surface proteins were isolated and TNF alpha receptor-1(TNFR1) expression was determined. The results suggest that both AST and ASIV attenuate TNF alpha-induced up-regulation of CAMs mRNA and upstream nuclear translocation and phosphorylation of NF-kappa B-p65. However, TNFR1-mediated I kappa B alpha degradation, cleavage of caspase-3 and apoptosis were inhibited only by AST. These differences in the actions of AST and ASIV could be explained by the presence of other components in AST, such as ASII and ASIII, which also had an inhibitory effect on TNFR1-induced I kappa B alpha degradation. Moreover, AST, but not ASIV, was able to reduce TNFR1 protein level on the cell surface. Furthermore, mechanistic investigation demonstrated that TNFR1-mediated I kappa B alpha degradation was reversed by the use of TAPI-0, an inhibitor of TNF alpha converting enzyme (TACE), suggesting the involvement of TACE in the modulation of surface TNFR1 level by AST. Conclusion: ASIV was not a better inhibitor than AST, at least on the inhibition of TNF alpha-induced inflammatory responses and TNFR1-mediated signaling pathways in AECs. The inhibitory effect of AST was caused by the reduction of cell surface TNFR1 level, and TACE could be involved in this action.	[Liu, Qin-she] Xi An Jiao Tong Univ, Sch Med, Dept Publ Hlth, Xian 710049, Peoples R China; [Liu, Qin-she; Wang, Hai-fang; Huo, Xue-ping; Peng, Ning; Hu, Jun] Shaanxi Prov Peoples Hosp, Lab Ctr, Xian, Peoples R China; [Liu, Qin-she] Shaanxi Prov Inst Chinese Med & Med Herbs, Xian, Peoples R China; [Sun, An-ke] Gen Hosp Shenyang Mil Command, Dept Otolaryngol, Shenyang, Peoples R China; [Liu, Jin-lian; Ma, Shu-hui] Xi An Jiao Tong Univ, Sch Med, Dept Clin Tradit Chinese Med Western Med, Xian 710049, Peoples R China	Xi'an Jiaotong University; Xi'an Medical University; Xi'an Jiaotong University	Liu, QS (corresponding author), Xi An Jiao Tong Univ, Sch Med, Dept Publ Hlth, Xian 710049, Peoples R China.	lqsspph@126.com			National Key Technology R&D Program of China [2008BAI51B01]; Basic Research Program of Shaanxi Province [13-JC028]	National Key Technology R&D Program of China(National Key Technology R&D Program); Basic Research Program of Shaanxi Province	This study was supported, in parts, by grants from the National Key Technology R&D Program of China (http://kjzc.jhgl.org/default.aspx) (grant no. 2008BAI51B01 to QS Liu), and the Basic Research Program of Shaanxi Province (http://www.sxhealth.gov.cn/index.asp) (grant no. 13-JC028 to HF Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	'Alessio AD, 2012, J CELL MOL MED, V16, P627, DOI 10.1111/j.1582-4934.2011.01353.x; Choi J, 2005, J MED FOOD, V8, P78, DOI 10.1089/jmf.2005.8.78; Duerschmied D, 2009, J THROMB HAEMOST, V7, P1163, DOI 10.1111/j.1538-7836.2009.03476.x; Francis G, 2002, BRIT J NUTR, V88, P587, DOI 10.1079/BJN2002725; Gui DK, 2013, CYTOKINE, V61, P970, DOI 10.1016/j.cyto.2013.01.008; Hassan HS, 2012, AFR J TRADIT COMPLEM, V9, P250, DOI 10.4314/ajtcam.v9i2.10; Hu JY, 2009, CLIN EXP PHARMACOL P, V36, P351, DOI 10.1111/j.1440-1681.2008.05059.x; Huang X, 2009, TALANTA, V78, P1090, DOI 10.1016/j.talanta.2009.01.021; Kim YS, 2007, J CARDIOVASC PHARM, V50, P41, DOI 10.1097/FJC.0b013e31805559b9; Kong XH, 2012, INT J MOL MED, V29, P1090, DOI 10.3892/ijmm.2012.941; Kyula JN, 2010, CLIN CANCER RES, V16, P3378, DOI 10.1158/1078-0432.CCR-10-0014; Lee DY, 2013, MOLECULES, V18, P3725, DOI 10.3390/molecules18043725; Lei H, 2003, ACTA PHARMACOL SIN, V24, P230; Li X, 2006, UROL RES, V34, P277, DOI 10.1007/s00240-006-0057-1; Liu MJ, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-141; Liu QY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019811; POLUNOVSKY VA, 1994, EXP CELL RES, V214, P584, DOI 10.1006/excr.1994.1296; Rowlands DJ, 2011, J CLIN INVEST, V121, P1986, DOI 10.1172/JCI43839; Wang HF, 2011, J CELL PHYSIOL, V226, P1044, DOI 10.1002/jcp.22427; Wu K, 2013, BIOCHEM PHARMACOL, V85, P1753, DOI 10.1016/j.bcp.2013.04.009; Zhang HR, 2009, CLIN SCI, V116, P219, DOI 10.1042/CS20080196; Zhang WJ, 2003, THROMB HAEMOSTASIS, V90, P904, DOI 10.1160/TH03-03-0136; Zhao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044938	23	8	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101504	10.1371/journal.pone.0101504	http://dx.doi.org/10.1371/journal.pone.0101504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991819	gold, Green Published, Green Submitted			2022-12-27	WOS:000341253400081
J	Tseng, CH				Tseng, Chin-Hsiao			Diabetes but Not Insulin Increases the Risk of Lung Cancer: A Taiwanese Population-Based Study	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; PANCREATIC-CANCER; PROSTATE-CANCER; NATIONAL COHORT; MORTALITY; SMOKING; EPIDEMIOLOGY; PREVALENCE	Background: The trend of lung cancer incidence in Taiwan is unknown, and the association between type 2 diabetes/insulin use and lung cancer is rarely studied. Methods: The trends of lung cancer incidence in 1979-2007 in the Taiwanese general population were calculated. A random sample of 1,000,000 subjects covered by the National Health Insurance in 2005 was recruited. A total of 494,002 men and 502,948 women and without lung cancer were followed for the annual cumulative incidence of lung cancer in 2005, with calculation of the risk ratios between diabetic and non-diabetic subjects. Logistic regression estimated the adjusted odds ratios for risk factors. Results: The trends increased significantly in both sexes (P<0.0001). The sex-specific annual cumulative incidence increased with age in either the diabetic or non-diabetic subjects, but the risk ratios attenuated with age. In logistic regressions, diabetes was associated with a significantly higher risk, with odds ratios (95% confidence interval) for diabetes duration <1, 1-3, 3-5 and >= 5 years versus non-diabetes of 2.189 (1.498-3.200), 1.420 (1.014-1.988), 1.545 (1.132-2.109), and 1.329 (1.063-1.660), respectively. Such an association was not related to a higher detection with chest X-ray examination. Insulin use and medications including oral anti-diabetic drugs, statin, fibrate, and anti-hypertensive agents were not significantly associated with lung cancer. Age, male sex, and chronic obstructive pulmonary disease were positively; but dyslipidemia, stroke and higher socioeconomic status were negatively associated with lung cancer. Conclusions: Diabetes is significantly associated with a higher risk of lung cancer, but insulin use does not increase the risk.	[Tseng, Chin-Hsiao] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan; [Tseng, Chin-Hsiao] Natl Taiwan Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei 100, Taiwan; [Tseng, Chin-Hsiao] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Health Research Institutes - Taiwan	Tseng, CH (corresponding author), Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan.	ccktsh@ms6.hinet.net		TSENG, CHIN-HSIAO/0000-0001-9545-7123	National Science Council of Taiwan [NSC102-2314-B-002-067]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	The study was supported by the National Science Council (NSC102-2314-B-002-067) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bureau of Health Promotion, 2010, CANC REG ANN REP 200; Carstensen B, 2012, DIABETOLOGIA, V55, P948, DOI 10.1007/s00125-011-2381-4; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Dela Cruz CS, 2011, CLIN CHEST MED, V32, P605, DOI 10.1016/j.ccm.2011.09.001; Ehrlich SF, 2010, DIABETES CARE, V33, P55, DOI 10.2337/dc09-0880; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Hall GC, 2005, DIABETES CARE, V28, P590, DOI 10.2337/diacare.28.3.590; Hemminki K, 2010, ONCOLOGIST, V15, P548, DOI 10.1634/theoncologist.2009-0300; Klabunde CN, 2012, ANN FAM MED, V10, P102, DOI 10.1370/afm.1340; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR, P298; Lai SW, 2012, CLIN LUNG CANCER, V13, P143, DOI 10.1016/j.cllc.2011.10.002; Lee MY, 2012, METABOLISM, V61, P242, DOI 10.1016/j.metabol.2011.06.020; Reddy Chakravarthy, 2011, Hosp Pract (1995), V39, P107, DOI 10.3810/hp.2011.10.929; Tseng CH, 2006, DIABETOLOGIA, V49, P1755, DOI 10.1007/s00125-006-0314-4; Tseng CH, 2012, ANN ONCOL, V23, P153, DOI 10.1093/annonc/mdr334; Tseng CH, 2009, OPEN DIABETES J, V2, P18; Tseng CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086517; Tseng CH, 2014, CLIN GENITOURIN CANC, V12, pE7, DOI 10.1016/j.clgc.2013.08.004; Tseng CH, 2013, DIABETES RES CLIN PR, V102, P193, DOI 10.1016/j.diabres.2013.10.019; Tseng CH, 2013, ACTA DIABETOL, V50, P879, DOI 10.1007/s00592-013-0471-0; Tseng CH, 2013, CLIN GENITOURIN CANC, V11, P508, DOI 10.1016/j.clgc.2013.04.019; Tseng CH, 2013, DIABETES-METAB RES, V29, P515, DOI 10.1002/dmrr.2422; Tseng CH, 2013, HEPATOL INT, V7, P693, DOI 10.1007/s12072-012-9405-0; Tseng CH, 2013, J CLIN GASTROENTEROL, V47, pE60, DOI 10.1097/MCG.0b013e31827245eb; Tseng CH, 2013, PANCREAS, V42, P42, DOI 10.1097/MPA.0b013e3182571ba9; Tseng CH, 2012, METABOLISM, V61, P1003, DOI 10.1016/j.metabol.2011.11.015; Tseng CH, 2011, ANN MED, V43, P142, DOI 10.3109/07853890.2010.530683; Tseng CH, 2011, DIABETES CARE, V34, P616, DOI 10.2337/dc10-1640; Tseng CH, 2011, GUT, V60, P774, DOI 10.1136/gut.2010.226522; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	30	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101553	10.1371/journal.pone.0101553	http://dx.doi.org/10.1371/journal.pone.0101553			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991802	gold, Green Published, Green Submitted			2022-12-27	WOS:000341253400089
J	Zhou, J; Qu, XD; Li, ZY; Wei-Ji; Liu, Q; Ma, YH; He, JJ				Zhou, Jie; Qu, Xiao-Dong; Li, Zhi-Yun; Wei-Ji; Liu, Qi; Ma, Yi-Hui; He, Jiao-Jiang			Salvianolic Acid B Attenuates Toxin-Induced Neuronal Damage via Nrf2-Dependent Glial Cells-Mediated Protective Activity in Parkinson's Disease Models	PLOS ONE			English	Article							NATURAL-PRODUCTS; INFLAMMATORY PROCESS; DOPAMINE NEURONS; ACTIVATION; MICROGLIA; BRAIN; ANTIOXIDANT; ASTROCYTES; EXPRESSION; MPTP	Salvianolic acid B (SalB), a bioactive compound isolated from the plant-derived medicinal herb Danshen, has been shown to exert various anti-oxidative and anti-inflammatory activities in several neurological disorders. In this study, we sought to investigate the potential protective effects and associated molecular mechanisms of SalB in Parkinson's disease (PD) models. To determine the neuroprotective effects of SalB in vitro, MPP+-or lipopolysaccharide (LPS)-induced neuronal injury was achieved using primary cultures with different compositions of neurons, microglia and astrocytes. Our results showed that SalB reduced both LPS- and MPP+-induced toxicity of dopamine neurons in a dose-dependent manner. Additionally, SalB treatment inhibited the release of microglial pro-inflammatory cytokines and resulted in an increase in the expression and release of glial cell line-derived neurotrophic factor (GDNF) from astrocytes. Western blot analysis illustrated that SalB increased the expression and nuclear translocation of nuclear factor (erythroid-derived 2)-like 2 (Nrf2). The knockdown of Nrf2 using specific small interfering RNA (siRNA) partially reversed the SalB-induced GDNF expression and anti-inflammatory activity. Moreover, SalB treatment significantly attenuated dopaminergic (DA) neuronal loss, inhibited neuroinflammation, increased GDNF expression and improved the neurological function in MPTP-treated mice. Collectively, these findings demonstrated that SalB protects DA neurons by an Nrf-2 -mediated dual action: reducing microglia activation-mediated neuroinflammation and inducing astrocyte activation-dependent GDNF expression. Importantly the present study also highlights critical roles of glial cells as targets for developing new strategies to alter the progression of neurodegenerative disorders.	[Zhou, Jie; Qu, Xiao-Dong; Li, Zhi-Yun; Wei-Ji; Liu, Qi; Ma, Yi-Hui; He, Jiao-Jiang] Lanzhou Gen Hosp, Lanzhou Command PLA, Dept Neurosurg, Lanzhou, Gansu, Peoples R China		Li, ZY (corresponding author), Lanzhou Gen Hosp, Lanzhou Command PLA, Dept Neurosurg, Lanzhou, Gansu, Peoples R China.	lizy_lzpla@163.com						Campos HC, 2011, CNS NEUROL DISORD-DR, V10, P239; Cao W, 2012, CHIN J INTEGR MED, V18, P316, DOI [10.1007/s11655-012-1052-8, 10.1007/s11655-011-012-1052-8]; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; Chen SC, 2011, THROMB RES, V128, P560, DOI 10.1016/j.thromres.2011.08.032; Chen T, 2013, CELL SIGNAL, V25, P2863, DOI 10.1016/j.cellsig.2013.09.004; Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Ciesielska A, 2009, INFLAMM RES, V58, P747, DOI 10.1007/s00011-009-0026-6; Clark J, 2009, ANTIOXID REDOX SIGN, V11, P509, DOI 10.1089/ARS.2008.2241; Darlington Cynthia L, 2005, Curr Opin Investig Drugs, V6, P700; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Deguil J, 2007, J NEUROSCI RES, V85, P2017, DOI 10.1002/jnr.21318; Dhakshinamoorthy S, 2001, ONCOGENE, V20, P3906, DOI 10.1038/sj.onc.1204506; Di Stefano A, 2011, CURR PHARM DESIGN, V17, P3482, DOI 10.2174/138161211798194495; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Gao HM, 2002, J NEUROSCI, V22, P782, DOI 10.1523/JNEUROSCI.22-03-00782.2002; Gao HM, 2002, J NEUROCHEM, V81, P1285, DOI 10.1046/j.1471-4159.2002.00928.x; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Halliday GM, 2011, MOVEMENT DISORD, V26, P6, DOI 10.1002/mds.23455; Heneka MT, 2010, BRAIN RES REV, V63, P189, DOI 10.1016/j.brainresrev.2009.11.004; Ho JHC, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-30; Houghton PJ, 2005, NEUROSIGNALS, V14, P6, DOI 10.1159/000085382; Iannaccone S, 2013, PARKINSONISM RELAT D, V19, P47, DOI 10.1016/j.parkreldis.2012.07.002; Imanshahidi M, 2006, PHYTOTHER RES, V20, P427, DOI 10.1002/ptr.1898; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Kalivendi SV, 2003, BIOCHEM J, V371, P151, DOI 10.1042/BJ20021525; Katagiri N, 2010, BRAIN RES, V1321, P133, DOI 10.1016/j.brainres.2010.01.049; Kim YS, 2006, EXP MOL MED, V38, P333, DOI 10.1038/emm.2006.40; KOPIN IJ, 1988, MT SINAI J MED, V55, P43; KOPIN IJ, 1988, ANNU REV NEUROSCI, V11, P81, DOI 10.1146/annurev.neuro.11.1.81; Kumar H, 2014, NAT PROD REP, V31, P109, DOI 10.1039/c3np70065h; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Lipski J, 2011, PROG NEUROBIOL, V94, P389, DOI 10.1016/j.pneurobio.2011.06.005; Long-Smith CM, 2009, PROG NEUROBIOL, V89, P277, DOI 10.1016/j.pneurobio.2009.08.001; Marchetti B, 2005, TRENDS PHARMACOL SCI, V26, P517, DOI 10.1016/j.tips.2005.08.007; MARZATICO F, 1993, NEUROCHEM RES, V18, P1101, DOI 10.1007/BF00966691; Min KJ, 2006, J NEUROSCI, V26, P1880, DOI 10.1523/JNEUROSCI.3696-05.2006; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Mythri RB, 2012, RECENT PATENTS ENDOC, V6, P181, DOI 10.2174/187221412802481793; Nagatsu T, 2005, CURR PHARM DESIGN, V11, P999, DOI 10.2174/1381612053381620; Ossola B, 2011, NEUROPHARMACOLOGY, V61, P574, DOI 10.1016/j.neuropharm.2011.04.030; Ramsey CP, 2007, J NEUROPATH EXP NEUR, V66, P75, DOI 10.1097/nen.0b013e31802d6da9; Rojas P, 2011, J NUTR BIOCHEM, V22, P937, DOI 10.1016/j.jnutbio.2010.08.005; Sawada M, 2006, J NEURAL TRANSM-SUPP, P373; Slevin JT, 2005, J NEUROSURG, V102, P216, DOI 10.3171/jns.2005.102.2.0216; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Stanic D, 2004, BRAIN RES, V1023, P83, DOI 10.1016/j.brainres.2004.07.012; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Tang MK, 2002, PHYTOMEDICINE, V9, P405, DOI 10.1078/09447110260571634; Tian LL, 2008, INT J BIOCHEM CELL B, V40, P409, DOI 10.1016/j.biocel.2007.08.005; TIPTON KF, 1993, J NEUROCHEM, V61, P1191, DOI 10.1111/j.1471-4159.1993.tb13610.x; Tsai MK, 2010, TOXICOL APPL PHARM, V242, P155, DOI 10.1016/j.taap.2009.10.002; Tufekci K. U., 2011, PARKINSONS DIS, V2011; Wang ZS, 2013, CELL MOL NEUROBIOL, V33, P921, DOI 10.1007/s10571-013-9958-z; Wilms H, 2003, FASEB J, V17, P500, DOI 10.1096/fj.02-0314fje; Wolosker H, 2008, FEBS J, V275, P3514, DOI 10.1111/j.1742-4658.2008.06515.x; Yacoubian TA, 2009, BBA-MOL BASIS DIS, V1792, P676, DOI 10.1016/j.bbadis.2008.09.009; Zeng G, 2010, BIOL PHARM BULL, V33, P1337, DOI 10.1248/bpb.33.1337; Zhang H, 2014, FREE RADICAL BIO MED, V69, P219, DOI 10.1016/j.freeradbiomed.2014.01.025; Zhao Y, 2011, J ONCOL, V2011, DOI 10.1155/2011/534548; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	62	28	35	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101668	10.1371/journal.pone.0101668	http://dx.doi.org/10.1371/journal.pone.0101668			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991814	Green Submitted, Green Published, gold			2022-12-27	WOS:000341253400105
J	Frost, CL; Pollock, SW; Smith, JE; Hughes, WOH				Frost, Crystal L.; Pollock, Steven W.; Smith, Judith E.; Hughes, William O. H.			Wolbachia in the Flesh: Symbiont Intensities in Germ-Line and Somatic Tissues Challenge the Conventional View of Wolbachia Transmission Routes	PLOS ONE			English	Article							HORIZONTAL TRANSFER; CASTE DIFFERENTIATION; STRAINS; ANTS; INFECTIONS; PREVALENCE; EXPRESSION; PIPIENTIS; DYNAMICS; INVASION	Symbionts can substantially affect the evolution and ecology of their hosts. The investigation of the tissue-specific distribution of symbionts (tissue tropism) can provide important insight into host-symbiont interactions. Among other things, it can help to discern the importance of specific transmission routes and potential phenotypic effects. The intracellular bacterial symbiont Wolbachia has been described as the greatest ever panzootic, due to the wide array of arthropods that it infects. Being primarily vertically transmitted, it is expected that the transmission of Wolbachia would be enhanced by focusing infection in the reproductive tissues. In social insect hosts, this tropism would logically extend to reproductive rather than sterile castes, since the latter constitute a dead-end for vertically transmission. Here, we show that Wolbachia are not focused on reproductive tissues of eusocial insects, and that non-reproductive tissues of queens and workers of the ant Acromyrmex echinatior, harbour substantial infections. In particular, the comparatively high intensities of Wolbachia in the haemolymph, fat body, and faeces, suggest potential for horizontal transmission via parasitoids and the faecal-oral route, or a role for Wolbachia modulating the immune response of this host. It may be that somatic tissues and castes are not the evolutionary dead-end for Wolbachia that is commonly thought.	[Frost, Crystal L.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Pollock, Steven W.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Smith, Judith E.] Univ Salford, Sch Environm & Life Sci, Salford M5 4WT, Lancs, England; [Hughes, William O. H.] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	University of Liverpool; University of York - UK; University of Salford; University of Sussex	Frost, CL (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	clfrost@liv.ac.uk		Smith, Judith/0000-0002-2206-3534	Biotechnology and Biological Sciences Research Council; Natural Environment Research Council; Natural Environment Research Council [NE/F000677/1] Funding Source: researchfish; NERC [NE/F000677/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding for this study was provided by the Biotechnology and Biological Sciences Research Council (awarded to CLF and WOHH) and the Natural Environment Research Council (awarded to WOHH). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andersen SB, 2012, J EVOLUTION BIOL, V25, P1340, DOI 10.1111/j.1420-9101.2012.02521.x; Anderson CL, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-10; Armitage SAO, 2010, J INSECT PHYSIOL, V56, P780, DOI 10.1016/j.jinsphys.2010.01.009; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Azad AF, 1998, EMERG INFECT DIS, V4, P179, DOI 10.3201/eid0402.980205; Baer B, 2005, INSECT SOC, V52, P298, DOI 10.1007/s00040-005-0809-x; Baldo L, 2008, MOL ECOL, V17, P557, DOI 10.1111/j.1365-294X.2007.03608.x; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Barchuk AR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-70; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Braquart-Varnier C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003286; Cheng Q, 2000, MED VET ENTOMOL, V14, P44, DOI 10.1046/j.1365-2915.2000.00202.x; Cornette R, 2008, J INSECT PHYSIOL, V54, P922, DOI 10.1016/j.jinsphys.2008.04.017; Cornman RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000466; Dedeine F, 2005, MOL ECOL, V14, P1543, DOI 10.1111/j.1365-294X.2005.02499.x; Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2; Douglas AE, 1998, HEREDITY, V81, P599, DOI 10.1038/sj.hdy.6884550; Fehlner-Gardiner C, 2002, J BIOL CHEM, V277, P26893, DOI 10.1074/jbc.M203937200; Frost CL, 2010, MOL ECOL, V19, P4077, DOI 10.1111/j.1365-294X.2010.04764.x; Frydman HM, 2006, NATURE, V441, P509, DOI 10.1038/nature04756; Fytrou A, 2006, P R SOC B, V273, P791, DOI 10.1098/rspb.2005.3383; Graff J, 2007, MOL ECOL, V16, P675, DOI 10.1111/j.1365-294X.2007.03162.x; Guidugli KR, 2005, FEBS LETT, V579, P4961, DOI 10.1016/j.febslet.2005.07.085; Heath BD, 1999, CURR BIOL, V9, P313, DOI 10.1016/S0960-9822(99)80139-0; Holldobler B., 1990, pi; Holldobler B., 2008, SUPERORGANISM BEAUTY; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001296; Hughes WOH, 2010, P ROY SOC B-BIOL SCI, V277, P609, DOI 10.1098/rspb.2009.1415; Huigens ME, 2000, NATURE, V405, P178, DOI 10.1038/35012066; Huigens ME, 2004, P ROY SOC B-BIOL SCI, V271, P509, DOI 10.1098/rspb.2003.2640; Ijichi N, 2002, APPL ENVIRON MICROB, V68, P4074, DOI 10.1128/AEM.68.8.4074-4080.2002; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Mueller AK, 2010, INT J PARASITOL, V40, P1229, DOI 10.1016/j.ijpara.2010.05.005; Paterson S, 2011, MOL ECOL, V20, P869, DOI 10.1111/j.1365-294X.2010.04991.x; Rasgon JL, 2006, APPL ENVIRON MICROB, V72, P6934, DOI 10.1128/AEM.01673-06; Raychoudhury R, 2009, EVOLUTION, V63, P165, DOI 10.1111/j.1558-5646.2008.00533.x; SACCHI L, 1985, J INVERTEBR PATHOL, V46, P139, DOI 10.1016/0022-2011(85)90142-9; SACCHI L, 1988, INT J INSECT MORPHOL, V17, P437, DOI 10.1016/0020-7322(88)90023-2; Sacchi L, 2010, TISSUE CELL, V42, P328, DOI 10.1016/j.tice.2010.07.009; Schiott M, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-156; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sintupachee S, 2006, MICROB ECOL, V51, P294, DOI 10.1007/s00248-006-9036-x; Socolovschi C, 2009, VET RES, V40, DOI 10.1051/vetres/2009017; Stahlhut JK, 2010, MOL ECOL, V19, P1940, DOI 10.1111/j.1365-294X.2010.04572.x; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Taylor MJ, 2005, ADV PARASIT, V60, P245, DOI 10.1016/S0065-308X(05)60004-8; Team R. D. C., 2005, LANG ENV STAT COMP; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Tsakas S, 2010, ISJ-INVERT SURVIV J, V7, P228; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Van Borm S, 2003, MOL PHYLOGENET EVOL, V26, P102, DOI 10.1016/S1055-7903(02)00298-1; Van Borm S, 2001, J EVOLUTION BIOL, V14, P805, DOI 10.1046/j.1420-9101.2001.00321.x; Wenseleers T, 2002, P ROY SOC B-BIOL SCI, V269, P623, DOI 10.1098/rspb.2001.1927; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Werren JH, 1997, P NATL ACAD SCI USA, V94, P11154, DOI 10.1073/pnas.94.21.11154; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969	58	26	26	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e95122	10.1371/journal.pone.0095122	http://dx.doi.org/10.1371/journal.pone.0095122			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988478	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000341354100003
J	Giannoni-Guzman, MA; Giray, T; Agosto-Rivera, JL; Stevison, BK; Freeman, B; Ricci, P; Brown, EA; Abramson, CI				Giannoni-Guzman, Manuel A.; Giray, Tugrul; Agosto-Rivera, Jose Luis; Stevison, Blake K.; Freeman, Brett; Ricci, Paige; Brown, Erika A.; Abramson, Charles I.			Ethanol-Induced Effects on Sting Extension Response and Punishment Learning in the Western Honey Bee (Apis mellifera)	PLOS ONE			English	Article							PRIMER PHEROMONE; SOCIAL INSECTS; BEHAVIORAL DISINHIBITION; INHIBITORY CONTROL; INDUCED ANALGESIA; CARNICA POLL.; ETHYL OLEATE; ALCOHOL; PAIN; L.	Acute ethanol administration is associated with sedation and analgesia as well as behavioral disinhibition and memory loss but the mechanisms underlying these effects remain to be elucidated. During the past decade, insects have emerged as important model systems to understand the neural and genetic bases of alcohol effects. However, novel assays to assess ethanol's effects on complex behaviors in social or isolated contexts are necessary. Here we used the honey bee as an especially relevant model system since bees are typically exposed to ethanol in nature when collecting standing nectar crop of flowers, and there is recent evidence for independent biological significance of this exposure for social behavior. Bee's inhibitory control of the sting extension response (SER) and a conditioned-place aversion assay were used to study ethanol effects on analgesia, behavioral disinhibition, and associative learning. Our findings indicate that although ethanol, in a dose-dependent manner, increases SER thresholds (analgesic effects), it disrupts the ability of honey bees to inhibit SER and to associate aversive stimuli with their environment. These results suggest that ethanol's effects on analgesia, behavioral disinhibition and associative learning are common across vertebrates and invertebrates. These results add to the use of honey bees as an ethanol model to understand ethanol's effects on complex, socially relevant behaviors.	[Stevison, Blake K.; Freeman, Brett; Ricci, Paige; Brown, Erika A.; Abramson, Charles I.] Oklahoma State Univ, Lab Behav Biol & Comparat Psychol, Stillwater, OK 74078 USA; [Giannoni-Guzman, Manuel A.; Giray, Tugrul; Agosto-Rivera, Jose Luis] Univ Puerto Rico Rio Piedras, Dept Biol, San Juan, PR USA	Oklahoma State University System; Oklahoma State University - Stillwater; University of Puerto Rico; University of Puerto Rico Rio Piedras	Abramson, CI (corresponding author), Oklahoma State Univ, Lab Behav Biol & Comparat Psychol, Stillwater, OK 74078 USA.	charles.abramson@okstate.edu		, Charles/0000-0001-8961-3089; Giray, Tugrul/0000-0003-4383-4681	NSF [DBI 0552717, DBI 1263327]; FIPI [2012-0051]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061151] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1263327] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); FIPI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported in part by NSF grants DBI 0552717 and DBI 1263327 to CIA and by FIPI grant 2012-0051 to TG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson CI, 2013, BEHAV SCI-BASEL, V3, P55, DOI 10.3390/bs3010055; Abramson CI, 2004, PSYCHOL REP, V94, P1107, DOI 10.2466/pr0.94.3c.1107-1115; ABRAMSON CI, 1986, J COMP PSYCHOL, V100, P108, DOI 10.1037/0735-7036.100.2.108; Abramson CI, 2000, ALCOHOL CLIN EXP RES, V24, P1153, DOI 10.1111/j.1530-0277.2000.tb02078.x; Abramson CI, 2007, TRENDS ALCOHOL ABUSE, P197; Agarwal M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025371; Alaux C, 2009, P NATL ACAD SCI USA, V106, P15400, DOI 10.1073/pnas.0907043106; Avalos A, 2014, BEHAV ECOLOGY SOCIOB; Balderrama N., 1987, P121; BOADA J, 1981, PHARMACOL RES COMMUN, V13, P673, DOI 10.1016/S0031-6989(81)80055-0; Bozic J, 2006, ALCOHOL, V38, P179, DOI 10.1016/j.alcohol.2006.01.005; Breed MD, 2004, ANNU REV ENTOMOL, V49, P271, DOI 10.1146/annurev.ento.49.061802.123155; BROWN RA, 1977, J ABNORM PSYCHOL, V86, P179, DOI 10.1037/0021-843X.86.2.179; BUSHMAN BJ, 1990, PSYCHOL BULL, V107, P341, DOI 10.1037/0033-2909.107.3.341; Cakmak I, 2009, B INSECTOL, V62, P99; Cakmak I, 2009, ANIM BEHAV, V77, P1273, DOI 10.1016/j.anbehav.2009.01.032; Castillo C, 2012, J INSECT PHYSIOL, V58, P1112, DOI 10.1016/j.jinsphys.2012.05.010; Castillo C, 2012, INSECT BIOCHEM MOLEC, V42, P404, DOI 10.1016/j.ibmb.2012.02.002; Caswell AJ, 2013, EXP PSYCHOL, V60, P324, DOI 10.1027/1618-3169/a000202; Charlet K, 2013, ADDICT BIOL, DOI 10.1111/adb.12045; Cingolani P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-666; Curran HV, 1999, CONSCIOUS COGN, V8, P497, DOI 10.1006/ccog.1999.0417; CUTTER HSG, 1976, J STUD ALCOHOL, V37, P273, DOI 10.15288/jsa.1976.37.273; de Vega C, 2009, S AFR J BOT, V75, P798, DOI 10.1016/j.sajb.2009.07.016; Dinges CW, 2013, J EXP BIOL, V216, P4124, DOI 10.1242/jeb.090100; Dudley R, 2004, INTEGR COMP BIOL, V44, P315, DOI 10.1093/icb/44.4.315; Field M, 2010, ALCOHOL CLIN EXP RES, V34, P1346, DOI 10.1111/j.1530-0277.2010.01218.x; Galindo-Cardona A, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-65; Gameiro GH, 2003, LIFE SCI, V73, P3351, DOI 10.1016/j.lfs.2003.06.024; Ganeshina O, 2001, J COMP NEUROL, V437, P335, DOI 10.1002/cne.1287; Garfinkel SN, 2006, PSYCHOPHARMACOLOGY, V188, P498, DOI 10.1007/s00213-006-0480-6; Garland EL, 2012, PRIMARY CARE, V39, P561, DOI 10.1016/j.pop.2012.06.013; Giray T, 2000, BEHAV ECOL, V11, P44, DOI 10.1093/beheco/11.1.44; Giray T, 2007, J INSECT PHYSIOL, V53, P691, DOI 10.1016/j.jinsphys.2007.03.016; Grant NK, 2005, ALCOHOL ALCOHOLISM, V40, P373, DOI 10.1093/alcalc/agh177; Gulick D, 2007, ALCOHOL CLIN EXP RES, V31, P1528, DOI 10.1111/j.1530-0277.2007.00458.x; Hawes JJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1864, DOI 10.1038/sj.npp.1301579; Heinz AJ, 2011, NAT REV NEUROSCI, V12, P400, DOI 10.1038/nrn3042; Hendler RA, 2013, CURR TOP BEHAV NEURO, V13, P489, DOI 10.1007/7854_2011_135; Hicklin TR, 2011, P NATL ACAD SCI USA, V108, P6650, DOI 10.1073/pnas.1017856108; Hranitz JM, 2010, ALCOHOL, V44, P275, DOI 10.1016/j.alcohol.2010.02.003; Ikeda K, 2002, NEUROSCI RES, V44, P121, DOI 10.1016/S0168-0102(02)00094-9; Johansson AK, 2000, PHYSIOL BEHAV, V70, P453, DOI 10.1016/S0031-9384(00)00284-5; KEVAN PG, 1988, J APICULT RES, V27, P26, DOI 10.1080/00218839.1988.11100777; Keys TE, 1963, HIST SURG ANESTHESIA, pxxx; KOLMES SA, 1989, J NEW YORK ENTOMOL S, V97, P218; Kraus FB, 2011, BEHAV GENET, V41, P323, DOI 10.1007/s10519-010-9382-9; Lee H, 2009, INT J ENV RES PUB HE, V6, P2783, DOI 10.3390/ijerph6112783; Leoncini I, 2004, P NATL ACAD SCI USA, V101, P17559, DOI 10.1073/pnas.0407652101; Melis M, 2002, J NEUROSCI, V22, P2074, DOI 10.1523/JNEUROSCI.22-06-02074.2002; Mixson TA, 2010, PSYCHOL REP, V106, P701, DOI 10.2466/PR0.106.3.701-717; MOGIL JS, 1993, BRAIN RES, V602, P126, DOI 10.1016/0006-8993(93)90251-H; Morozova TV, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-239; Moss HB, 2013, SOC WORK PUBLIC HLTH, V28, P175, DOI 10.1080/19371918.2013.758987; Mussig L, 2010, J NEUROSCI, V30, P7817, DOI 10.1523/JNEUROSCI.5543-09.2010; Mullin F. J., 1934, AM J PHYSIOL, V109, P77; NUNEZ J, 1983, PHARMACOL BIOCHEM BE, V19, P921, DOI 10.1016/0091-3057(83)90391-X; Perrino AC, 2008, ALCOHOL CLIN EXP RES, V32, P952, DOI 10.1111/j.1530-0277.2008.00653.x; POHORECKY LA, 1987, LIFE SCI, V41, P1289, DOI 10.1016/0024-3205(87)90208-6; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Rivera-Marchand B, 2012, EVOLUTIONARY APPL; Rivera-Marchand B, 2008, ENTOMOL EXP APPL, V129, P1, DOI 10.1111/j.1570-7458.2008.00747.x; RYAN C, 1980, ALCOHOL CLIN EXP RES, V4, P288, DOI 10.1111/j.1530-0277.1980.tb04816.x; Sanders SH, 1985, ANN BEHAV MED, V7, P3; Scholz H, 2013, CURR TOP BEHAV NEURO, V13, P433, DOI 10.1007/7854_2011_128; Sokolowski MBC, 2012, ALCOHOL CLIN EXP RES, V36, P1568, DOI 10.1111/j.1530-0277.2012.01770.x; STEWART SH, 1995, PSYCHOPHARMACOLOGY, V119, P261, DOI 10.1007/BF02246289; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; Tedjakumala SR, 2014, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00221; Tedjakumala SR, 2013, J EXP BIOL, V216, P2985, DOI 10.1242/jeb.086629; Tokuda K, 2013, NEUROSCI LETT, V537, P40, DOI 10.1016/j.neulet.2013.01.018; Tracy JI, 1999, NEUROPSYCHOLOGY, V13, P282, DOI 10.1037/0894-4105.13.2.282; Uribe-Rubio J. L., 2013, Open Journal of Ecology, V3, P279; van Gaalen MM, 2006, PSYCHOPHARMACOLOGY, V187, P73, DOI 10.1007/s00213-006-0396-1; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; Wang J, 2010, J NEUROSCI, V30, P10187, DOI 10.1523/JNEUROSCI.2268-10.2010; Wiens F, 2008, P NATL ACAD SCI USA, V105, P10426, DOI 10.1073/pnas.0801628105; Wolff HG, 1942, J PHARMACOL EXP THER, V75, P38	78	15	15	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100894	10.1371/journal.pone.0100894	http://dx.doi.org/10.1371/journal.pone.0100894			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988309	Green Published, gold, Green Submitted			2022-12-27	WOS:000341354100048
J	Stoeckle, MY; Thaler, DS				Stoeckle, Mark Y.; Thaler, David S.			DNA Barcoding Works in Practice but Not in (Neutral) Theory	PLOS ONE			English	Article							MITOCHONDRIAL GENETIC DIVERSITY; POPULATION-SIZE; MUTATIONS; EVOLUTION; SELECTION; PHYLOGEOGRAPHY; INTROGRESSION; DYNAMICS; PATTERNS; CLOCK	Background: DNA barcode differences within animal species are usually much less than differences among species, making it generally straightforward to match unknowns to a reference library. Here we aim to better understand the evolutionary mechanisms underlying this usual "barcode gap'' pattern. We employ avian barcode libraries to test a central prediction of neutral theory, namely, intraspecific variation equals 2 N mu, where N is population size and mu is mutations per site per generation. Birds are uniquely suited for this task: they have the best-known species limits, are well represented in barcode libraries, and, most critically, are the only large group with documented census population sizes. In addition, we ask if mitochondrial molecular clock measurements conform to neutral theory prediction of clock rate equals mu. Results: Intraspecific COI barcode variation was uniformly low regardless of census population size (n = 142 species in 15 families). Apparent outliers reflected lumping of reproductively isolated populations or hybrid lineages. Re-analysis of a published survey of cytochrome b variation in diverse birds (n = 93 species in 39 families) further confirmed uniformly low intraspecific variation. Hybridization/gene flow among species/populations was the main limitation to DNA barcode identification. Conclusions/Significance: To our knowledge, this is the first large study of animal mitochondrial diversity using actual census population sizes and the first to test outliers for population structure. Our finding of universally low intraspecific variation contradicts a central prediction of neutral theory and is not readily accounted for by commonly proposed ad hoc modifications. We argue that the weight of evidence-low intraspecific variation and the molecular clock-indicates neutral evolution plays a minor role in mitochondrial sequence evolution. As an alternate paradigm consistent with empirical data, we propose extreme purifying selection, including at synonymous sites, limits variation within species and continuous adaptive selection drives the molecular clock.	[Stoeckle, Mark Y.] Rockefeller Univ, Program Human Environm, New York, NY 10021 USA; [Thaler, David S.] Columbia Univ, Dept Earth & Environm Engn, New York, NY USA; [Thaler, David S.] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY USA	Rockefeller University; Columbia University; Columbia University	Stoeckle, MY (corresponding author), Rockefeller Univ, Program Human Environm, 1230 York Ave, New York, NY 10021 USA.	mark.stoeckle@rockefeller.edu; david.thaler@gmail.com	Stoeckle, Mark/D-3729-2011	Stoeckle, Mark/0000-0002-8280-4795	Alfred P. Sloan Foundation	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	This work was supported by The Alfred P. Sloan Foundation (www.sloan.org) (MYS, DST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Barker FK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046403; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Bedford T, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-220; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Bortolotto E, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-32; Chesser RT, 2013, AUK, V130, P558, DOI 10.1525/auk.2013.130.3.1; Consortium for the Barcode of Life Database Working Group, 2009, DAT STAND BARCODE RE; Coyne J.A., 2004, SPECIATION; Crow J. F., 2009, INTRO POPULATION GEN; Dabrowski A, 2005, CONSERV GENET, V6, P843, DOI 10.1007/s10592-005-9028-2; del Hoyo J, 2013, HDB BIRDS WORLD; Duret L, 2008, NAT ED, V1, P218; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Galtier N, 2006, GENOME RES, V16, P215, DOI 10.1101/gr.4305906; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Gill F, 2014, IOC WORLD BIRD LIST; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hartl Daniel L., 1997; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hedrick P.W., 2011, GENETICS POPULATIONS; Hill GE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1314; Ho, 2008, NATURE ED, V1, P168; Jinbo U, 2011, ENTOMOL SCI, V14, P107, DOI 10.1111/j.1479-8298.2011.00449.x; Johnsen A, 2010, J ORNITHOL, V151, P565, DOI 10.1007/s10336-009-0490-3; Kazancioglu E, 2014, ECOL LETT, V17, P22, DOI 10.1111/ele.12195; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Kerr KCR, 2011, MOL ECOL RESOUR, V11, P1045, DOI 10.1111/j.1755-0998.2011.03049.x; Kerr KCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004379; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kondrashov FA, 2010, PHILOS T R SOC B, V365, P1169, DOI 10.1098/rstb.2009.0286; Kuhn TS, 1962, STRUCTURE SCI REVOLU; Kumar S, 2005, NAT REV GENET, V6, P654, DOI 10.1038/nrg1659; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lanfear R, 2014, TRENDS ECOL EVOL, V29, P33, DOI 10.1016/j.tree.2013.09.009; Leffler EM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001388; Levin L, 2013, GENOME BIOL EVOL, V5, P876, DOI 10.1093/gbe/evt058; Lewontin R. C., 1974, The genetic basis of evolutionary change.; Lohman DJ, 2010, BIOL CONSERV, V143, P1885, DOI 10.1016/j.biocon.2010.04.042; Meiklejohn CD, 2007, TRENDS GENET, V23, P259, DOI 10.1016/j.tig.2007.03.008; Mila B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040541; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Nabholz B, 2008, GENETICS, V178, P351, DOI 10.1534/genetics.107.073346; Nabholz B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-54; Neher RA, 2013, ANNU REV ECOL EVOL S, V44, P195, DOI 10.1146/annurev-ecolsys-110512-135920; Newton I., 2003, SPECIATION BIOGEOGRA; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Parmakelis A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061970; Partners in Flight Science Committee, 2013, POP EST DAT VERS 201; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Piganeau G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004396; Pyle P, 1997, IDENTIFICATION GUIDE; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rheindt FE, 2011, AUK, V128, P620, DOI 10.1525/auk.2011.128.4.620; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; Sonsthagen SA, 2012, ECOL EVOL, V2, P1278, DOI 10.1002/ece3.240; Stergachis AB, 2013, SCIENCE, V342, P1367, DOI 10.1126/science.1243490; Stoeckle MY, 2013, SCI REP-UK, V3, DOI 10.1038/srep02635; Stoeckle MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043992; Tavares ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028543; Thompson J., 2013, RELENTLESS EVOLUTION, DOI DOI 10.7208/CHICAGO/9780226018898.001.0001; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Wares JP, 2010, EVOLUTION, V64, P1136, DOI 10.1111/j.1558-5646.2009.00870.x; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Wetlands International, 2002, WETL INT GLOB SER, V12; Zhang FF, 2013, GENOME BIOL EVOL, V5, P1781, DOI 10.1093/gbe/evt129; Zhang RY, 2012, MOL PHYLOGENET EVOL, V65, P562, DOI 10.1016/j.ympev.2012.07.011	71	34	36	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100755	10.1371/journal.pone.0100755	http://dx.doi.org/10.1371/journal.pone.0100755			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988408	Green Published, Green Submitted, gold			2022-12-27	WOS:000341354100041
J	Tracey, JA; Sheppard, J; Zhu, J; Wei, FW; Swaisgood, RR; Fisher, RN				Tracey, Jeff A.; Sheppard, James; Zhu, Jun; Wei, Fuwen; Swaisgood, Ronald R.; Fisher, Robert N.			Movement-Based Estimation and Visualization of Space Use in 3D for Wildlife Ecology and Conservation	PLOS ONE			English	Article							GLOBAL POSITIONING SYSTEM; HOME-RANGE; 3-DIMENSIONAL MOVEMENTS; CLASSIFICATION; PATTERNS; SEAGRASS; BEHAVIOR; AREA	Advances in digital biotelemetry technologies are enabling the collection of bigger and more accurate data on the movements of free-ranging wildlife in space and time. Although many biotelemetry devices record 3D location data with x, y, and z coordinates from tracked animals, the third z coordinate is typically not integrated into studies of animal spatial use. Disregarding the vertical component may seriously limit understanding of animal habitat use and niche separation. We present novel movement-based kernel density estimators and computer visualization tools for generating and exploring 3D home ranges based on location data. We use case studies of three wildlife species - giant panda, dugong, and California condor - to demonstrate the ecological insights and conservation management benefits provided by 3D home range estimation and visualization for terrestrial, aquatic, and avian wildlife research.	[Tracey, Jeff A.; Fisher, Robert N.] US Geol Survey, Western Ecol Res Ctr, San Diego Field Stn, San Diego, CA 92101 USA; [Sheppard, James; Swaisgood, Ronald R.] San Diego Zoo Inst Conservat Res, Escondido, CA USA; [Zhu, Jun] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA; [Zhu, Jun] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Wei, Fuwen] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China	United States Department of the Interior; United States Geological Survey; Zoological Society of San Diego; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Chinese Academy of Sciences; Institute of Zoology, CAS	Tracey, JA (corresponding author), US Geol Survey, Western Ecol Res Ctr, San Diego Field Stn, San Diego, CA 92101 USA.	jatracey@usgs.gov	Fisher, Robert/AAA-7301-2022; Swaisgood, Ronald R/AAL-3198-2020	Fisher, Robert/0000-0002-2956-3240; Swaisgood, Ronald R/0000-0001-5353-2148	Sempra Energy; U.S. Geological Survey	Sempra Energy; U.S. Geological Survey(United States Geological Survey)	This research was funded by Sempra Energy and the U.S. Geological Survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot EA, 2007, FLATLAND ROMANCE MAN; [Anonymous], 2014, REG EARTH SYST PRED; ASTER GDEM Validation Team, 2011, ASTER GLOBAL DIGITAL; Bailleul F, 2010, ECOL MODEL, V221, P1665, DOI 10.1016/j.ecolmodel.2010.04.001; Belant JL, 2012, FRONT ECOL ENVIRON, V10, P11, DOI 10.1890/12.WB.003; Benhamou S, 2014, ANIM BEHAV, V90, P171, DOI 10.1016/j.anbehav.2014.01.030; Benhamou S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014592; Berg HC, 1983, RANDOM WALKS BIOL, Vix; Bhattacharyya A., 1943, B CALCUTTA MATH SOC, V35, P99; Brashares JS, 2003, CONSERV BIOL, V17, P733, DOI 10.1046/j.1523-1739.2003.01592.x; Burt W. H., 1943, Journal of Mammalogy, V24, P346, DOI 10.2307/1374834; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Cogan Christopher B., 2012, Open Ornithology Journal, V5, P82; Davis RW, 2013, DEEP-SEA RES PT II, V88-89, P65, DOI 10.1016/j.dsr2.2012.07.006; Davis RW, 2003, MAR ECOL PROG SER, V264, P109, DOI 10.3354/meps264109; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; Fieberg J, 2012, J MAMMAL, V93, P890, DOI 10.1644/11-MAMM-S-172.1; GOMPPER ME, 1991, OECOLOGIA, V87, P343, DOI 10.1007/BF00634589; Grech A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017993; Hagihara R, 2014, MAR MAMMAL SCI, V30, P348, DOI 10.1111/mms.12041; Hagihara R, 2011, J EXP MAR BIOL ECOL, V399, P173, DOI 10.1016/j.jembe.2011.01.001; Hansen MC, 2008, J WILDLIFE MANAGE, V72, P518, DOI 10.2193/2006-493; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; Hijmans RJ, 2012, RASTER GEOGRAPHIC AN; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; IUCN, 2013, IUCN RED LIST THREAT; Jenness JS, 2004, WILDLIFE SOC B, V32, P829, DOI 10.2193/0091-7648(2004)032[0829:CLSAFD]2.0.CO;2; Jetz W, 2004, SCIENCE, V306, P266, DOI 10.1126/science.1102138; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; Lanyon Janet M., 2006, Aquatic Mammals, V32, P196, DOI 10.1578/AM.32.2.2006.196; Lewis JS, 2011, LANDSCAPE URBAN PLAN, V101, P99, DOI 10.1016/j.landurbplan.2011.01.008; Manly B.F.J., 2002, RESOURCE SELECTION A; Marsh H., 2011, ECOLOGY CONSERVATION, DOI DOI 10.1017/CBO9781139013277; Marsh H, 2002, DUGONG STATUS REPORT; MESERVE PL, 1977, J MAMMAL, V58, P549, DOI 10.2307/1380003; Microwave Telemetry Inc., 2014, VERT GPS ACC HOR GPS; National Renewable Energy Laboratory, 2004, INT WIND RES MAPS; Nie YG, 2012, ANIM BEHAV, V84, P39, DOI 10.1016/j.anbehav.2012.03.026; North American Development Bank, 2013, 201335 BD N AM DEV B; Pollock KH, 2006, J WILDLIFE MANAGE, V70, P255, DOI 10.2193/0022-541X(2006)70[255:EAAIHE]2.0.CO;2; Powell RA, 2012, J MAMMAL, V93, P948, DOI 10.1644/11-MAMM-S-177.1; Rideout BA, 2012, J WILDLIFE DIS, V48, P95, DOI 10.7589/0090-3558-48.1.95; Rogers D, 2012, ECOL INFORM, V7, P1, DOI 10.1016/j.ecoinf.2011.10.003; SCHROEDER W, 2003, VISUALIZATION TOOLKI; Sheppard JK, 2007, ESTUAR COAST SHELF S, V71, P117, DOI 10.1016/j.ecss.2006.07.006; Sheppard JK, 2010, MAR MAMMAL SCI, V26, P855, DOI 10.1111/j.1748-7692.2010.00374.x; Sheppard JK, 2009, J WILDLIFE MANAGE, V73, P45, DOI 10.2193/2007-468; Silverman B.W., 1986, DENSITY ESTIMATION S; Simpfendorfer CA, 2012, CAN J FISH AQUAT SCI, V69, P565, DOI 10.1139/F2011-179; Snyder N, 2000, CALIFORNIA CONDOR; Spencer WD, 2012, J MAMMAL, V93, P929, DOI 10.1644/12-MAMM-S-061.1; Swaisgood RR, 2010, BIOL LETTERS, V6, P143, DOI 10.1098/rsbl.2009.0786; Tachikawa T, 2011, INT GEOSCI REMOTE SE, P3657, DOI 10.1109/IGARSS.2011.6050017; Terborgh J, 1992, DIVERSITY TROPICAL R; Tomkiewicz SM, 2010, PHILOS T R SOC B, V365, P2163, DOI 10.1098/rstb.2010.0090; VANWINKLE W, 1975, J WILDLIFE MANAGE, V39, P118; Wang K, 2010, SENSORS-BASEL, V10, P9647, DOI 10.3390/s101109647; Wedding LM, 2011, MAR ECOL PROG SER, V427, P219, DOI 10.3354/meps09119; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Zhang ZJ, 2014, INTEGR ZOOL, V9, P46, DOI 10.1111/1749-4877.12030; [No title captured]; [No title captured]	64	37	38	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101205	10.1371/journal.pone.0101205	http://dx.doi.org/10.1371/journal.pone.0101205			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988114	Green Published, Green Submitted, gold			2022-12-27	WOS:000341354100070
J	Weiss, GJ; Ganeshan, B; Miles, KA; Campbell, DH; Cheung, PY; Frank, S; Korn, RL				Weiss, Glen J.; Ganeshan, Balaji; Miles, Kenneth A.; Campbell, David H.; Cheung, Philip Y.; Frank, Samuel; Korn, Ronald L.			Noninvasive Image Texture Analysis Differentiates K-ras Mutation from Pan-Wildtype NSCLC and Is Prognostic	PLOS ONE			English	Article							CELL LUNG-CANCER; CT TEXTURE; STAGE; HETEROGENEITY; SURVIVAL	Background: Non-invasive characterization of a tumor's molecular features could enhance treatment management. Quantitative computed tomography (CT) based texture analysis (QTA) has been used to derive tumor heterogeneity information, and the appearance of the tumors has been shown to relate to patient outcome in non-small cell lung cancer (NSCLC) and other cancers. In this study, we examined the potential of tumoral QTA to differentiate K-ras mutant from pan-wildtype tumors and its prognostic potential using baseline pre-treatment non-contrast CT imaging in NSCLC. Methods: Tumor DNA from patients with early-stage NSCLC was analyzed on the LungCarta Panel. Cases with a K-ras mutation or pan-wildtype for 26 oncogenes and tumor suppressor genes were selected for QTA. QTA was applied to regions of interest in the primary tumor. Non-parametric Mann Whitney test assessed the ability of the QTA, clinical and patient characteristics to differentiate between K-ras mutation from pan-wildtype. A recursive decision tree was developed to determine whether the differentiation of K-ras mutant from pan-wildtype tumors could be improved by sequential application of QTA parameters. Kaplan-Meier survival analysis assessed the ability of these markers to predict survival. Results: QTA was applied to 48 cases identified, 27 had a K-ras mutation and 21 cases were pan-wildtype. Positive skewness and lower kurtosis were significantly associated with the presence of a K-ras mutation. A five node decision tree had sensitivity, specificity, and accuracy values (95% CI) of 96.3% (78.1-100), 81.0% (50.5-97.4), and 89.6% (72.9-97.0); respectively. Kurtosis was a significant predictor of OS and DFS, with a lower kurtosis value linked with poorer survival. Conclusions: Lower kurtosis and positive skewness are significantly associated with K-ras mutations. A QTA feature such as kurtosis is prognostic for OS and DFS. Non-invasive QTA can differentiate the presence of K-ras mutation from pan-wildtype NSCLC and is associated with patient survival.	[Weiss, Glen J.] Canc Treatment Ctr Amer, Goodyear, AZ 85338 USA; [Weiss, Glen J.; Cheung, Philip Y.] Translat Genom Res Inst TGen, Phoenix, AZ USA; [Ganeshan, Balaji; Miles, Kenneth A.] UCL, Inst Nucl Med, London WC1E 6BT, England; [Campbell, David H.; Korn, Ronald L.] Imaging Endpoints Core Lab, Scottsdale, AZ USA; [Frank, Samuel; Korn, Ronald L.] Scottsdale Healthcare, Virginia G Piper Canc Ctr Clin Trials, Scottsdale, AZ USA	Translational Genomics Research Institute; University of London; University College London; Scottsdale Healthcare Osborn	Weiss, GJ (corresponding author), Canc Treatment Ctr Amer, Goodyear, AZ 85338 USA.	glen.weiss@ctca-hope.com		Miles, Kenneth/0000-0002-5920-381X	TGen Foundation; SHC Foundation; Flinn Foundation; Sequenom, Inc.; UK Department of Health's NIHR Biomedical Research Centre	TGen Foundation; SHC Foundation; Flinn Foundation; Sequenom, Inc.; UK Department of Health's NIHR Biomedical Research Centre	The authors would like to acknowledge the funding sources for this work including TGen Foundation (GJW), SHC Foundation (GJW), Flinn Foundation (GJW) and Sequenom, Inc. for providing the LungCarta Panel assay analysis. The work undertaken by two of the co-authors (BG and KAM) based at University College London in UK, which receives a proportion of funding from the UK Department of Health's NIHR Biomedical Research Centre's funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, GLOBOCAN 2008 V2 0 C; Bakken S, 2009, J AM MED INFORM ASSN, V16, P889, DOI 10.1197/jamia.M3085; Choi Pil Jo, 2013, Korean J Thorac Cardiovasc Surg, V46, P449, DOI 10.5090/kjtcs.2013.46.6.449; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Ferlay J., 2010, GLOBOCAN 2008 V20 CA; Ferlay J, 2008, GLOBOCAN 2008 V2 0 C, DOI [10.1002/ijc.27711, DOI 10.1002/IJC.27711]; Ganeshan B, 2012, EUR RADIOL, V22, P796, DOI 10.1007/s00330-011-2319-8; Ganeshan B, 2010, CANCER IMAGING, V10, P137, DOI 10.1102/1470-7330.2010.0021; Goh V, 2011, RADIOLOGY, V261, P165, DOI 10.1148/radiol.11110264; Karachaliou N, 2013, CLIN LUNG CANCER, V14, P205, DOI 10.1016/j.cllc.2012.09.007; Maeshima AM, 2002, CANCER, V95, P2546, DOI 10.1002/cncr.11006; Maeshima AM, 1999, PATHOL INT, V49, P411, DOI 10.1046/j.1440-1827.1999.00888.x; Miles KA, 2013, CANCER IMAGING, V13, P400, DOI 10.1102/1470-7330.2013.9045; Ng F, 2013, RADIOLOGY, V266, P177, DOI 10.1148/radiol.12120254; Raz G, 2012, LUNG CANCER, V76, P191, DOI 10.1016/j.lungcan.2011.10.015; Riley RD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001380; Shepherd FA, 2013, J CLIN ONCOL, V31, P2173, DOI 10.1200/JCO.2012.48.1390; Sieren JC, 2011, LUNG CANCER, V74, P61, DOI 10.1016/j.lungcan.2011.01.023; Takahashi Y, 2011, J THORAC ONCOL, V6, P1460, DOI 10.1097/JTO.0b013e318229189d; Win T, 2013, CLIN CANC RES	20	88	92	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100244	10.1371/journal.pone.0100244	http://dx.doi.org/10.1371/journal.pone.0100244			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987838	Green Published, Green Submitted, gold			2022-12-27	WOS:000341354100028
J	Zhang, YN; Qiu, ZP; Wei, L; Tang, RQ; Lian, BF; Zhao, YJ; He, XH; Xie, L				Zhang, Yuannv; Qiu, Zhaoping; Wei, Lin; Tang, Ruqi; Lian, Baofeng; Zhao, Yingjun; He, Xianghuo; Xie, Lu			Integrated Analysis of Mutation Data from Various Sources Identifies Key Genes and Signaling Pathways in Hepatocellular Carcinoma	PLOS ONE			English	Article							FACTOR-KAPPA-B; RECURRENT MUTATIONS; SOMATIC MUTATIONS; DOWN-REGULATION; LIVER-CANCER; METASTASIS; INVASION; STEATOSIS; DISCOVERY; GENOMICS	Background: Recently, a number of studies have performed genome or exome sequencing of hepatocellular carcinoma (HCC) and identified hundreds or even thousands of mutations in protein-coding genes. However, these studies have only focused on a limited number of candidate genes, and many important mutation resources remain to be explored. Principal Findings: In this study, we integrated mutation data obtained from various sources and performed pathway and network analysis. We identified 113 pathways that were significantly mutated in HCC samples and found that the mutated genes included in these pathways contained high percentages of known cancer genes, and damaging genes and also demonstrated high conservation scores, indicating their important roles in liver tumorigenesis. Five classes of pathways that were mutated most frequently included (a) proliferation and apoptosis related pathways, (b) tumor microenvironment related pathways, (c) neural signaling related pathways, (d) metabolic related pathways, and (e) circadian related pathways. Network analysis further revealed that the mutated genes with the highest betweenness coefficients, such as the well-known cancer genes TP53, CTNNB1 and recently identified novel mutated genes GNAL and the ADCY family, may play key roles in these significantly mutated pathways. Finally, we highlight several key genes (e.g., RPS6KA3 and PCLO) and pathways (e.g., axon guidance) in which the mutations were associated with clinical features. Conclusions: Our workflow illustrates the increased statistical power of integrating multiple studies of the same subject, which can provide biological insights that would otherwise be masked under individual sample sets. This type of bioinformatics approach is consistent with the necessity of making the best use of the ever increasing data provided in valuable databases, such as TCGA, to enhance the speed of deciphering human cancers.	[Zhang, Yuannv; Qiu, Zhaoping; Wei, Lin; Tang, Ruqi; Zhao, Yingjun; He, Xianghuo] Shanghai Jiao Tong Univ Sch Med, Shanghai Canc Inst, Renji Hosp, State Key Lab Oncogenes & Related Genes, Shanghai, Peoples R China; [Lian, Baofeng; Xie, Lu] Shanghai Acad Sci & Technol, Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences	He, XH (corresponding author), Shanghai Jiao Tong Univ Sch Med, Shanghai Canc Inst, Renji Hosp, State Key Lab Oncogenes & Related Genes, Shanghai, Peoples R China.	xhhe@shsci.org; xielu@scbit.org	He, Xianghuo/I-1497-2014	He, Xianghuo/0000-0001-8872-668X	National 973 Key Basic Research Program [2013CB910504]; National Natural Science Foundation of China [81125016]; Key Infectious Disease Project [2012ZX10002-009013]; State Key Laboratory of Oncogenes and Related Genes [90-13-01]	National 973 Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Infectious Disease Project; State Key Laboratory of Oncogenes and Related Genes	This work was supported by grants obtained from the National 973 Key Basic Research Program (2013CB910504); National Natural Science Foundation of China (81125016); Key Infectious Disease Project (2012ZX10002-009013); and State Key Laboratory of Oncogenes and Related Genes (90-13-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Bai J, 2011, HUM PATHOL, V42, P375, DOI 10.1016/j.humpath.2010.09.003; Belinsky SA, 2004, NAT REV CANCER, V4, P707, DOI 10.1038/nrc1432; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cefalu AB, 2013, ARTERIOSCL THROM VAS, V33, P2021, DOI 10.1161/ATVBAHA.112.301101; Chan CF, 2004, CLIN CANCER RES, V10, P4140, DOI 10.1158/1078-0432.CCR-03-0574; Chew V, 2012, GUT, V61, P427, DOI 10.1136/gutjnl-2011-300509; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Elsharkawy AM, 2007, HEPATOLOGY, V46, P590, DOI 10.1002/hep.21802; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gasper G, 2004, BASIC HYPERGEOMETRIC, Vxxvi; Ge CQ, 2013, J INT MED RES, V41, P284, DOI 10.1177/0300060513476436; Gong X, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-76; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Ho M, 2011, BIODRUGS, V25, P275, DOI 10.2165/11595360-000000000-00000; Hoshida Y, 2010, SEMIN LIVER DIS, V30, P35, DOI 10.1055/s-0030-1247131; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Ikeda A, 2014, GASTROENTEROLOGY, V146, P222, DOI 10.1053/j.gastro.2013.09.025; Kan ZY, 2013, GENOME RES, V23, P1422, DOI 10.1101/gr.154492.113; Kanda M, 2008, J SURG ONCOL, V98, P190, DOI 10.1002/jso.21095; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Katoh M, 2012, INT J ONCOL, V41, P1913, DOI 10.3892/ijo.2012.1669; Leonardi GC, 2012, INT J ONCOL, V40, P1733, DOI 10.3892/ijo.2012.1408; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Molloy Niamh H, 2011, Cancers (Basel), V3, P510, DOI 10.3390/cancers3010510; Nault JC, 2012, J HEPATOL, V56, P184, DOI 10.1016/j.jhep.2011.07.018; Nault JC, 2014, J HEPATOL, V60, P224, DOI 10.1016/j.jhep.2013.08.019; Okamoto H, 2003, HEPATOLOGY, V38, P1242, DOI 10.1053/jhep.2003.50457; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rydzanicz M, 2013, CANCER LETT, V341, P111, DOI 10.1016/j.canlet.2013.08.006; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Tanaka N, 2008, J CLIN INVEST, V118, P683, DOI 10.1172/JCI33594; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang YH, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-51; Wei RC, 2011, HUM GENE THER, V22, P1109, DOI 10.1089/hum.2010.219; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007; Yang YM, 2003, BIOINFORMATICS, V19, P2311, DOI 10.1093/bioinformatics/btg300; Yoon YJ, 2008, CARCINOGENESIS, V29, P1192, DOI 10.1093/carcin/bgn090; Zender L, 2010, J HEPATOL, V52, P921, DOI 10.1016/j.jhep.2009.12.034; Zhang GW, 2012, J INVEST SURG, V25, P93, DOI 10.3109/08941939.2011.606875; Zhao P, 2011, HEPATOLOGY, V54, P2012, DOI 10.1002/hep.24592; Zhou L, 2012, ONCOL REP, V28, P874, DOI 10.3892/or.2012.1880	56	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100854	10.1371/journal.pone.0100854	http://dx.doi.org/10.1371/journal.pone.0100854			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988079	Green Submitted, Green Published, gold			2022-12-27	WOS:000341354100046
J	Joy, A; Ramesh, A; Smirnov, I; Reiser, M; Misra, A; Shapiro, WR; Mills, GB; Kim, S; Feuerstein, BG				Joy, Anna; Ramesh, Archana; Smirnov, Ivan; Reiser, Mark; Misra, Anjan; Shapiro, William R.; Mills, Gordon B.; Kim, Seungchan; Feuerstein, Burt G.			AKT Pathway Genes Define 5 Prognostic Subgroups in Glioblastoma	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; MOLECULAR SUBTYPES; IDH1; ACTIVATION; CANCER; MTOR; PHOSPHORYLATION; DEGRADATION; ABERRATIONS; SUBCLASSES	Activity of GFR/PI3K/AKT pathway inhibitors in glioblastoma clinical trials has not been robust. We hypothesized variations in the pathway between tumors contribute to poor response. We clustered GBM based on AKT pathway genes and discovered new subtypes then characterized their clinical and molecular features. There are at least 5 GBM AKT subtypes having distinct DNA copy number alterations, enrichment in oncogenes and tumor suppressor genes and patterns of expression for PI3K/AKT/mTOR signaling components. Gene Ontology terms indicate a different cell of origin or dominant phenotype for each subgroup. Evidence suggests one subtype is very sensitive to BCNU or CCNU ( median survival 5.8 vs. 1.5 years; BCNU/CCNU vs other treatments; respectively). AKT subtyping advances previous approaches by revealing additional subgroups with unique clinical and molecular features. Evidence indicates it is a predictive marker for response to BCNU or CCNU and PI3K/AKT/mTOR pathway inhibitors. We anticipate Akt subtyping may help stratify patients for clinical trials and augment discovery of class-specific therapeutic targets.	[Joy, Anna; Misra, Anjan; Shapiro, William R.; Feuerstein, Burt G.] St Josephs Hosp, Barrow Neurol Inst, Dept Neurol, Phoenix, AZ 85013 USA; [Ramesh, Archana] Univ Washington, Tacoma, WA USA; [Smirnov, Ivan] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Reiser, Mark] Arizona State Univ, Dept Math & Stat Sci, Tempe, AZ USA; [Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Kim, Seungchan] Translat Genom Res Inst, Integrated Canc Genom Div, Phoenix, AZ USA; [Feuerstein, Burt G.] Univ Arizona, Coll Med, Phoenix, AZ USA	Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; University of Washington; University of Washington Tacoma; University of California System; University of California San Francisco; Arizona State University; Arizona State University-Tempe; University of Texas System; UTMD Anderson Cancer Center; Translational Genomics Research Institute; University of Arizona	Joy, A (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Dept Neurol, Phoenix, AZ 85013 USA.	anna.joy@dignityhealth.org	Feuerstein, Burt G/A-5186-2015	Feuerstein, Burt G/0000-0001-7276-8842; Kim, Seungchan/0000-0003-4183-4338	NIH [1 K01 NS064952-01A1]; Barrow Neurological Foundation; Diane and Bruce Halle Fund; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K01NS064952] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barrow Neurological Foundation; Diane and Bruce Halle Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH 1 K01 NS064952-01A1 (AJ); Barrow Neurological Foundation and Diane and Bruce Halle Fund (BJF, AJ, AM). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Banerjee S, 2011, P NATL ACAD SCI USA, V108, P15996, DOI 10.1073/pnas.1019012108; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Bredel M, 2009, JAMA-J AM MED ASSOC, V302, P261, DOI 10.1001/jama.2009.997; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Burton EC, 2002, CANCER RES, V62, P6205; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Coons SW, 1997, CANCER, V79, P1381, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W; Dasgupta B, 2005, CANCER RES, V65, P2755, DOI 10.1158/0008-5472.CAN-04-4058; DeAngelis LM, 2011, J CLIN ONCOL, V29, P4473, DOI 10.1200/JCO.2011.37.5873; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Everitt B. S., 2006, CAMBRIDGE DICT STAT; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; French PEL, 2012, NEURO-ONCOLOGY, V14; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Han EKH, 2007, ONCOGENE, V26, P5655, DOI 10.1038/sj.onc.1210343; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hartley D, 2002, J CELL BIOCHEM, V85, P304, DOI 10.1002/jcb.10135; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Huang TT, 2009, NEUROTHERAPEUTICS, V6, P500, DOI 10.1016/j.nurt.2009.04.008; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johannessen CM, 2005, P NATL ACAD SCI USA, V102, P8573, DOI 10.1073/pnas.0503224102; Kutner M., 2005, APPL LINEAR STAT MOD; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mischel PS, 2003, ONCOGENE, V22, P2361, DOI 10.1038/sj.onc.1206344; Misra A, 2005, CLIN CANCER RES, V11, P2907, DOI 10.1158/1078-0432.CCR-04-0708; Mittler MA, 1996, J NEUROSURG, V85, P1091, DOI 10.3171/jns.1996.85.6.1091; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Nigro JM, 2005, CANCER RES, V65, P1678, DOI 10.1158/0008-5472.CAN-04-2921; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sakai D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002566; Shen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035236; Singh B, 2002, GENE DEV, V16, P984, DOI 10.1101/gad.973602; Sinor AD, 2004, J NEUROSCI, V24, P8531, DOI 10.1523/JNEUROSCI.1470-04.2004; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wen PY, 2012, NEURO-ONCOLOGY, V14, P819, DOI 10.1093/neuonc/nos117; West KA, 2002, DRUG RESIST UPDATE, V5, P234, DOI 10.1016/S1368-7646(02)00120-6; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	54	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100827	10.1371/journal.pone.0100827	http://dx.doi.org/10.1371/journal.pone.0100827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984002	gold, Green Published			2022-12-27	WOS:000339635000041
J	Kroeker, KJ; Gaylord, B; Hill, TM; Hosfelt, JD; Miller, SH; Sanford, E				Kroeker, Kristy J.; Gaylord, Brian; Hill, Tessa M.; Hosfelt, Jessica D.; Miller, Seth H.; Sanford, Eric			The Role of Temperature in Determining Species' Vulnerability to Ocean Acidification: A Case Study Using Mytilus galloprovincialis	PLOS ONE			English	Article							CLIMATE-CHANGE; SEAWATER ACIDIFICATION; FILTRATION-RATE; BLUE MUSSELS; IMPACTS; PH; CALCIFICATION; OYSTER; CO2; LIMITATION	Ocean acidification (OA) is occurring across a backdrop of concurrent environmental changes that may in turn influence species' responses to OA. Temperature affects many fundamental biological processes and governs key reactions in the seawater carbonate system. It therefore has the potential to offset or exacerbate the effects of OA. While initial studies have examined the combined impacts of warming and OA for a narrow range of climate change scenarios, our mechanistic understanding of the interactive effects of temperature and OA remains limited. Here, we use the blue mussel, Mytilus galloprovincialis, as a model species to test how OA affects the growth of a calcifying invertebrate across a wide range of temperatures encompassing their thermal optimum. Mussels were exposed in the laboratory to a factorial combination of low and high pCO(2) (400 and 1200 mu atm CO2) and temperatures (12, 14, 16, 18, 20, and 24 degrees C) for one month. Results indicate that the effects of OA on shell growth are highly dependent on temperature. Although high CO2 significantly reduced mussel growth at 14 degrees C, this effect gradually lessened with successive warming to 20 degrees C, illustrating how moderate warming can mediate the effects of OA through temperature's effects on both physiology and seawater geochemistry. Furthermore, the mussels grew thicker shells in warmer conditions independent of CO2 treatment. Together, these results highlight the importance of considering the physiological and geochemical interactions between temperature and carbonate chemistry when interpreting species' vulnerability to OA.	[Kroeker, Kristy J.; Gaylord, Brian; Hill, Tessa M.; Hosfelt, Jessica D.; Miller, Seth H.; Sanford, Eric] Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA 94923 USA; [Gaylord, Brian; Sanford, Eric] Univ Calif Davis, Dept Evolut & Ecol, Davis, CA 95616 USA; [Hill, Tessa M.] Univ Calif Davis, Dept Geol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Kroeker, KJ (corresponding author), Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA 94923 USA.	kjkroeker@ucdavis.edu	Hill, Tessa Michelle/P-3401-2019	Hill, Tessa Michelle/0000-0003-4159-9104; Kroeker, Kristy/0000-0002-5766-1999	UC Multicampus Research Programs & Initiatives Grant; NSF [OCE-0927255, OCE-1220648]; Directorate For Geosciences [1220648, 1041089] Funding Source: National Science Foundation	UC Multicampus Research Programs & Initiatives Grant; NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by a UC Multicampus Research Programs & Initiatives Grant (to TMH, BG, ES, ADR) and NSF (OCE-0927255 to BG, TMH, ES, ADR; OCE-1220648 to ES, BG, TMH, ADR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anestis A, 2007, AM J PHYSIOL-REG I, V293; Baayen RH, 2010, LANGUAGER DATA SETS; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; BARRY JP, 1995, SCIENCE, V267, P672, DOI 10.1126/science.267.5198.672; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Braby CE, 2006, J EXP BIOL, V209, P2554, DOI 10.1242/jeb.02259; Braby CE, 2006, MAR BIOL, V148, P1249, DOI 10.1007/s00227-005-0177-0; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; BURTON EA, 1987, GEOLOGY, V15, P111, DOI 10.1130/0091-7613(1987)15<111:RPROAA>2.0.CO;2; Chan VBS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078945; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Dickson A., 2007, PICES SPECIAL PUBLIC, V3, DOI 10.25607/OBP-1342; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dowd WW, 2013, J EXP BIOL, V216, P502, DOI 10.1242/jeb.076620; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Fields PA, 2012, J EXP BIOL, V215, P1106, DOI 10.1242/jeb.062273; Frieder CA, 2014, GLOBAL CHANGE BIOL, V20, P754, DOI 10.1111/gcb.12485; Gaylord B, 2011, J EXP BIOL, V214, P2586, DOI 10.1242/jeb.055939; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gillooly JF, 2002, NATURE, V417, P70, DOI 10.1038/417070a; GRAUS RR, 1974, LETHAIA, V7, P303, DOI 10.1111/j.1502-3931.1974.tb00906.x; GREENAWAY P, 1971, J EXP BIOL, V54, P609; Helmuth B, 2002, SCIENCE, V298, P1015, DOI 10.1126/science.1076814; Hettinger A, 2012, ECOLOGY, V93, P2758, DOI 10.1890/12-0567.1; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Jokiel PL, 2011, B MAR SCI, V87, P639, DOI 10.5343/bms.2010.1107; JORGENSEN CB, 1990, MAR ECOL PROG SER, V64, P89, DOI 10.3354/meps064089; Fernandez-Reiriz MJ, 2012, MAR ECOL PROG SER, V454, P65, DOI 10.3354/meps09660; Kittner C, 2005, MAR ECOL PROG SER, V305, P147, DOI 10.3354/meps305147; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Lannig G, 2010, MAR DRUGS, V8, P2318, DOI 10.3390/md8082318; Lewis CN, 2013, P NATL ACAD SCI USA, V110, pE4960, DOI 10.1073/pnas.1315162110; Lockwood BL, 2011, J EXP MAR BIOL ECOL, V400, P167, DOI 10.1016/j.jembe.2011.02.022; Logan CA, 2012, MAR ECOL PROG SER, V450, P93, DOI 10.3354/meps09491; McCulloch M, 2012, NAT CLIM CHANGE, V2, P623, DOI 10.1038/NCLIMATE1473; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Melzner F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024223; Michaelidis B, 2005, MAR ECOL PROG SER, V293, P109, DOI 10.3354/meps293109; Miller GM, 2012, NAT CLIM CHANGE, V2, P858, DOI 10.1038/NCLIMATE1599; Millero FJ, 2007, CHEM REV, V107, P308, DOI 10.1021/cr0503557; MUCCI A, 1983, AM J SCI, V283, P780, DOI 10.2475/ajs.283.7.780; Mulvaney R, 2012, NATURE, V489, P141, DOI 10.1038/nature11391; O'Connor MI, 2009, ECOLOGY, V90, P388, DOI 10.1890/08-0034.1; O'Donnell MJ, 2013, NAT CLIM CHANGE, V3, P587, DOI 10.1038/NCLIMATE1846; Pansch C, 2014, GLOBAL CHANGE BIOL, V20, P765, DOI 10.1111/gcb.12478; Parker LM, 2012, GLOBAL CHANGE BIOL, V18, P82, DOI 10.1111/j.1365-2486.2011.02520.x; Parker LM, 2009, GLOBAL CHANGE BIOL, V15, P2123, DOI 10.1111/j.1365-2486.2009.01895.x; Pearson GA, 1998, ECOLOGY, V79, P1725; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; RAO KP, 1953, BIOL BULL, V104, P171, DOI 10.2307/1538791; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Riisgard HU, 2007, MAR ECOL PROG SER, V343, P141, DOI 10.3354/meps06930; Roleda MY, 2012, J PHYCOL, V48, P840, DOI 10.1111/j.1529-8817.2012.01195.x; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sanford E, 1999, SCIENCE, V283, P2095, DOI 10.1126/science.283.5410.2095; Sanford E, 2002, INTEGR COMP BIOL, V42, P881, DOI 10.1093/icb/42.4.881; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Thomsen J, 2013, GLOBAL CHANGE BIOL, V19, P1017, DOI 10.1111/gcb.12109; Thomsen J, 2010, MAR BIOL, V157, P2667, DOI 10.1007/s00227-010-1527-0; Venn AA, 2013, P NATL ACAD SCI USA, V110, P1634, DOI 10.1073/pnas.1216153110; Vermeij G.J., 1978, BIOGEOGRAPHY ADAPTAT; Waldbusser GG, 2013, GEOPHYS RES LETT, V40, P2171, DOI 10.1002/grl.50449; WALSH C., 2013, HIER PART HIERARCHIC; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105	73	52	52	4	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100353	10.1371/journal.pone.0100353	http://dx.doi.org/10.1371/journal.pone.0100353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984016	Green Published, gold			2022-12-27	WOS:000339635000021
J	Stone, SF; Bosco, A; Jones, A; Cotterell, CL; van Eeden, PE; Arendts, G; Fatovich, DM; Brown, SGA				Stone, Shelley F.; Bosco, Anthony; Jones, Anya; Cotterell, Claire L.; van Eeden, Pauline E.; Arendts, Glenn; Fatovich, Daniel M.; Brown, Simon G. A.			Genomic Responses during Acute Human Anaphylaxis Are Characterized by Upregulation of Innate Inflammatory Gene Networks	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; MAST-CELLS; DENDRITIC CELLS; ASTHMA EXACERBATIONS; PERIPHERAL-BLOOD; ACTIVATION; EXPRESSION; RECEPTOR; DISEASE; SEPSIS	Background: Systemic spread of immune activation and mediator release is required for the development of anaphylaxis in humans. We hypothesized that peripheral blood leukocyte (PBL) activation plays a key role. Objective: To characterize PBL genomic responses during acute anaphylaxis. Methods: PBL samples were collected at three timepoints from six patients presenting to the Emergency Department (ED) with acute anaphylaxis and six healthy controls. Gene expression patterns were profiled on microarrays, differentially expressed genes were identified, and network analysis was employed to explore underlying mechanisms. Results: Patients presented with moderately severe anaphylaxis after oral aspirin (2), peanut (2), bee sting (1) and unknown cause (1). Two genes were differentially expressed in patients compared to controls at ED arrival, 67 genes at 1 hour post-arrival and 2,801 genes at 3 hours post-arrival. Network analysis demonstrated that three inflammatory modules were upregulated during anaphylaxis. Notably, these modules contained multiple hub genes, which are known to play a central role in the regulation of innate inflammatory responses. Bioinformatics analyses showed that the data were enriched for LPS-like and TNF activation signatures. Conclusion: PBL genomic responses during human anaphylaxis are characterized by dynamic expression of innate inflammatory modules. Upregulation of these modules was observed in patients with different reaction triggers. Our findings indicate a role for innate immune pathways in the pathogenesis of human anaphylaxis, and the hub genes identified in this study represent logical candidates for follow-up studies.	[Stone, Shelley F.; Cotterell, Claire L.; van Eeden, Pauline E.; Arendts, Glenn; Fatovich, Daniel M.; Brown, Simon G. A.] Harry Perkins Inst Med Res, Ctr Clin Res Emergency Med, Perth, WA, Australia; [Stone, Shelley F.; Cotterell, Claire L.; van Eeden, Pauline E.; Arendts, Glenn; Fatovich, Daniel M.; Brown, Simon G. A.] Univ Western Australia, Perth, WA 6009, Australia; [Stone, Shelley F.; Cotterell, Claire L.; van Eeden, Pauline E.; Arendts, Glenn; Fatovich, Daniel M.; Brown, Simon G. A.] Royal Perth Hosp, Dept Emergency Med, Perth, WA 6001, Australia; [Bosco, Anthony; Jones, Anya] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia; [Bosco, Anthony; Jones, Anya] Univ Western Australia, Ctr Child Hlth Res, Perth, WA 6009, Australia	Harry Perkins Institute of Medical Research; University of Western Australia; Royal Perth Hospital; University of Western Australia; Telethon Kids Institute; University of Western Australia; University of Western Australia	Stone, SF (corresponding author), Harry Perkins Inst Med Res, Ctr Clin Res Emergency Med, Perth, WA, Australia.	shelley.stone@uwa.edu.au	van Eeden, Pauline/O-8713-2014; Jones, Anya/AAE-8029-2021; Bosco, Anthony/AAC-6900-2022; Fatovich, Daniel/J-5510-2013	Jones, Anya/0000-0002-6649-4977; Fatovich, Daniel/0000-0001-9414-6905; Bosco, Anthony/0000-0002-4335-615X; Arendts, Glenn/0000-0001-7830-7756	Food Allergy Research and Education; NHMRC Career Development Fellowship Award [ID1023265]; BrightSpark Foundation McCusker Fellowship; Royal Perth Hospital Medical Research Foundation	Food Allergy Research and Education; NHMRC Career Development Fellowship Award(National Health and Medical Research Council (NHMRC) of Australia); BrightSpark Foundation McCusker Fellowship; Royal Perth Hospital Medical Research Foundation	The study was supported by a grant received by SFS and SGAB from the US Food Allergy and Anaphylaxis Network, now called Food Allergy Research and Education (www.foodallergy.org). SGAB is supported by a NHMRC Career Development Fellowship Award ID1023265. AB is supported by a BrightSpark Foundation McCusker Fellowship. Additional funding was received from the Royal Perth Hospital Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Arendts G, 2012, EMERG MED AUSTRALAS, V24, P31, DOI 10.1111/j.1742-6723.2011.01500.x; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Bae JS, 2012, ARCH PHARM RES, V35, P1511, DOI 10.1007/s12272-012-0901-5; Baghestanian M, 1997, BLOOD, V90, P4438; Bode JG, 2012, CELL SIGNAL, V24, P1185, DOI 10.1016/j.cellsig.2012.01.018; Bosco A, 2010, MUCOSAL IMMUNOL, V3, P399, DOI 10.1038/mi.2010.13; Bosco A, 2012, J ALLERGY CLIN IMMUN, V129, P88, DOI 10.1016/j.jaci.2011.10.038; Bosco A, 2009, J IMMUNOL, V182, P6011, DOI 10.4049/jimmunol.0804125; Boyce JA, 2007, IMMUNOL REV, V217, P168, DOI 10.1111/j.1600-065X.2007.00512.x; Brown SGA, 2004, J ALLERGY CLIN IMMUN, V114, P371, DOI 10.1016/j.jaci.2004.04.029; Brown SGA, 2013, J ALLERGY CLIN IMMUN, V132, P1141, DOI 10.1016/j.jaci.2013.06.015; Burke SM, 2008, BLOOD, V111, P5467, DOI 10.1182/blood-2007-10-118547; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chan CW, 2006, NAT MED, V12, P207, DOI 10.1038/nm1352; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Golden DBK, 2007, CURR OPIN ALLERGY CL, V7, P331, DOI 10.1097/ACI.0b013e3281f8290c; Grayson MH, 2007, J EXP MED, V204, P2759, DOI 10.1084/jem.20070360; Hochreiter S, 2006, BIOINFORMATICS, V22, P943, DOI 10.1093/bioinformatics/btl033; Holt PG, 2011, CHEST, V139, P1165, DOI 10.1378/chest.10-2397; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Jonsson F, 2012, BLOOD, V119, P2533, DOI 10.1182/blood-2011-07-367334; Jonsson F, 2011, J CLIN INVEST, V121, P1484, DOI 10.1172/JCI45232; Kajiwara N, 2010, J ALLERGY CLIN IMMUN, V125, P1137, DOI 10.1016/j.jaci.2010.01.056; Kang YJ, 2008, J IMMUNOL, V180, P5075, DOI 10.4049/jimmunol.180.7.5075; Kawasaki T, 2011, IMMUNOL REV, V243, P61, DOI 10.1111/j.1600-065X.2011.01048.x; Kobayashi SD, 2003, J LEUKOCYTE BIOL, V73, P315, DOI 10.1189/jlb.1002481; Krause K, 2012, CURR OPIN ALLERGY CL, V12, P477, DOI 10.1097/ACI.0b013e3283574d0c; Kulka M, 2004, J ALLERGY CLIN IMMUN, V114, P174, DOI 10.1016/j.jaci.2004.03.049; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Madonna R, 2012, THROMB HAEMOSTASIS, V107, P656, DOI 10.1160/TH11-10-0711; Mancardi DA, 2013, BLOOD, V121, P1563, DOI 10.1182/blood-2012-07-442541; Matsumori A, 1996, BIOCHEM BIOPH RES CO, V221, P391, DOI 10.1006/bbrc.1996.0606; MOLLER A, 1993, J IMMUNOL, V151, P3261; Moretta A, 2005, TRENDS IMMUNOL, V26, P668, DOI 10.1016/j.it.2005.09.008; Nakamura Y, 2009, J EXP MED, V206, P1037, DOI 10.1084/jem.20082179; Oh SH, 2012, J NEUROIMMUNOL, V249, P60, DOI 10.1016/j.jneuroim.2012.04.005; Okayama Y, 2005, CHEM IMMUNOL ALLERGY, V87, P101, DOI 10.1159/000087574; Oppenheim JJ, 2007, ADV EXP MED BIOL, V601, P185; Page K, 2009, J IMMUNOL, V183, P3400, DOI 10.4049/jimmunol.0900838; Prince LR, 2011, CURR OPIN PHARMACOL, V11, P397, DOI 10.1016/j.coph.2011.06.007; Sala V, 2011, CELL MOL LIFE SCI, V68, P1703, DOI 10.1007/s00018-011-0633-6; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Schreibelt G, 2010, CANCER IMMUNOL IMMUN, V59, P1573, DOI 10.1007/s00262-010-0833-1; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stone SF, 2012, CURR ALLERGY ASTHM R, V12, P33, DOI 10.1007/s11882-011-0231-6; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Supajatura V, 2002, J CLIN INVEST, V109, P1351, DOI 10.1172/JCI200214704; Talloen W, 2007, BIOINFORMATICS, V23, P2897, DOI 10.1093/bioinformatics/btm478; Venereau E, 2013, MOL IMMUNOL, V55, P76, DOI 10.1016/j.molimm.2012.10.037; Ward PA, 2012, EMBO MOL MED, V4, P1234, DOI 10.1002/emmm.201201375; Williams CMM, 2000, J ALLERGY CLIN IMMUN, V105, P847, DOI 10.1067/mai.2000.106485; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yang D, 2009, TRENDS IMMUNOL, V30, P531, DOI 10.1016/j.it.2009.07.004; Yazdan-Ashoori P, 2011, J CRIT CARE, V26, P556, DOI 10.1016/j.jcrc.2011.01.008	60	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101409	10.1371/journal.pone.0101409	http://dx.doi.org/10.1371/journal.pone.0101409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983946	gold, Green Published, Green Submitted			2022-12-27	WOS:000339635000099
J	Xiao, ZJ; Zhang, AW; Lin, JW; Zheng, ZY; Shi, XL; Di, W; Qi, WW; Zhu, YT; Zhou, GJ; Fang, YN				Xiao, Zijian; Zhang, Aiwu; Lin, Jianwen; Zheng, Zhenyang; Shi, Xiaolei; Di, Wei; Qi, Weiwei; Zhu, Yingting; Zhou, Guijuan; Fang, Yannan			Telomerase: A Target for Therapeutic Effects of Curcumin and a Curcumin Derivative in A beta 1-42 Insult In Vitro	PLOS ONE			English	Article							OXIDATIVE STRESS; INHIBITS TELOMERASE; ALZHEIMERS-DISEASE; AMYLOID PATHOLOGY; BRAIN; ANTIOXIDANT; DAMAGE; PROTEINS	This study was designed to investigate whether telomerase was involved in the neuroprotective effect of curcumin and Cur1. Alzheimer's disease is a consequence of an imbalance between the generation and clearance of amyloid-beta peptide in the brain. In this study, we used A beta 1-42 (10 mu g/ml) to establish a damaged cell model, and curcumin and Cur1 were used in treatment groups. We measured cell survival and cell growth, intracellular oxidative stress and hTERT expression. After RNA interference, the effects of curcumin and Cur1 on cells were verified. Exposure to A beta 1-42 resulted in significant oxidative stress and cell toxicity, and the expression of hTERT was significantly decreased. Curcumin and Cur1 both protected SK-N-SH cells from A beta 1-42 and up-regulated the expression of hTERT. Furthermore, Cur1 demonstrated stronger protective effects than curcumin. However, when telomerase was inhibited by TERT siRNA, the neuroprotection by curcumin and Cur1 were ceased. Our study indicated that the neuroprotective effects of curcumin and Cur1 depend on telomerase, and thus telomerase may be a target for therapeutic effects of curcumin and Cur1.	[Xiao, Zijian; Zhang, Aiwu; Lin, Jianwen; Zheng, Zhenyang; Shi, Xiaolei; Di, Wei; Qi, Weiwei; Zhou, Guijuan; Fang, Yannan] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Yingting] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Fang, YN (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China.	fangyannan@21cn.com						Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372; Ancelin ML, 2007, DEMENT GERIATR COGN, V24, P1, DOI 10.1159/000102567; Atzmon G, 2010, P NATL ACAD SCI USA, V107, P1710, DOI 10.1073/pnas.0906191106; Axelsen PH, 2011, PHYSIOLOGY, V26, P54, DOI 10.1152/physiol.00024.2010; Begum AN, 2008, J PHARMACOL EXP THER, V326, P196, DOI 10.1124/jpet.108.137455; de Jesus BB, 2012, EMBO MOL MED, V4, P691, DOI 10.1002/emmm.201200245; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Chiu WT, 2011, J CELL PHYSIOL, V226, P2041, DOI 10.1002/jcp.22536; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Franco Sonia, 2006, Alzheimers Dement, V2, P164, DOI 10.1016/j.jalz.2006.03.001; Frautschy SA, 2001, NEUROBIOL AGING, V22, P993, DOI 10.1016/S0197-4580(01)00300-1; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; Gonzalez-Reyes S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/801418; Kant V, 2014, INT IMMUNOPHARMACOL, V20, P322, DOI 10.1016/j.intimp.2014.03.009; Khaw AK, 2013, J CELL BIOCHEM, V114, P1257, DOI 10.1002/jcb.24466; Kim E, 2003, HUM GENE THER, V14, P1415, DOI 10.1089/104303403769211637; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Massard C, 2006, ONCOGENE, V25, P4505, DOI 10.1038/sj.onc.1209487; Mollazade M, 2013, ASIAN PAC J CANCER P, V14, P6925, DOI 10.7314/APJCP.2013.14.11.6925; Ramachandran C, 2002, CANCER LETT, V184, P1, DOI 10.1016/S0304-3835(02)00192-1; Sattayasai J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085053; Satyanarayana A, 2004, MOL CELL BIOL, V24, P5459, DOI 10.1128/MCB.24.12.5459-5474.2004; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sharma S, 2010, EXP NEUROL, V226, P191, DOI 10.1016/j.expneurol.2010.08.027; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Sultana R, 2010, J ALZHEIMERS DIS, V19, P341, DOI 10.3233/JAD-2010-1222; Swomley AM, 2013, BIOCH BIOPHYS ACTA; Tichon A, 2013, CURR MOL MED, V13, P1010, DOI 10.2174/1566524011313060013; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Xiao ZJ, 2010, BRAIN RES, V1361, P115, DOI 10.1016/j.brainres.2010.09.019; Yang KY, 2007, J CHROMATOGR B, V853, P183, DOI 10.1016/j.jchromb.2007.03.010; Zhu HY, 2000, J NEUROCHEM, V75, P117, DOI 10.1046/j.1471-4159.2000.0750117.x	34	81	87	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101251	10.1371/journal.pone.0101251	http://dx.doi.org/10.1371/journal.pone.0101251			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983737	Green Published, gold, Green Submitted			2022-12-27	WOS:000339635000077
J	de Barra, M; Islam, MS; Curtis, V				de Barra, Micheal; Islam, M. Sirajul; Curtis, Val			Disgust Sensitivity Is Not Associated with Health in a Rural Bangladeshi Sample	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; DISEASE; INTERVIEWER; DOMAINS; ILLNESS	Disgust can be considered a psychological arm of the immune system that acts to prevent exposure to infectious agents. High disgust sensitivity is associated with greater behavioral avoidance of disease vectors and thus may reduce infection risk. A cross-sectional survey in rural Bangladesh provided no strong support for this hypothesis. In many species, the expression of pathogen- and predator-avoidance mechanisms is contingent on early life exposure to predators and pathogens. Using childhood health data collected in the 1990s, we examined if adults with more infectious diseases in childhood showed greater adult disgust sensitivity: no support for this association was found. Explanations for these null finding and possible directions for future research are discussed.	[de Barra, Micheal; Curtis, Val] London Sch Hyg & Trop Med, Environm Hlth Grp, London WC1, England; [Islam, M. Sirajul] ICDDR B, Environm Microbiol Lab, Dhaka, Bangladesh	University of London; London School of Hygiene & Tropical Medicine; International Centre for Diarrhoeal Disease Research (ICDDR)	de Barra, M (corresponding author), London Sch Hyg & Trop Med, Environm Hlth Grp, London WC1, England.	mdebarra@gmail.com			Hindustan Unilever Ltd	Hindustan Unilever Ltd(Unilever)	This research was supported by a grant from Hindustan Unilever Ltd to Valerie A. Curtis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1974, AUTOM CONTROL IEEE T; Albers R, 2005, BRIT J NUTR, V94, P452, DOI 10.1079/BJN20051469; Baqui AH, 1998, B WORLD HEALTH ORGAN, V76, P161; Bayliss AP, 2007, COGNITION, V104, P644, DOI 10.1016/j.cognition.2006.07.012; Curtis V, 2004, P ROY SOC B-BIOL SCI, V271, pS131, DOI 10.1098/rsbl.2003.0144; Curtis V, 2001, PERSPECT BIOL MED, V44, P17, DOI 10.1353/pbm.2001.0001; Curtis V., 2013, DONT LOOK DONT TOUCH; Curtis V, 2011, PHILOS T R SOC B, V366, P389, DOI 10.1098/rstb.2010.0117; Davey GCL, 2006, J BEHAV THER EXP PSY, V37, P4, DOI 10.1016/j.jbtep.2005.09.001; De Barra M, 2013, FIGSHARE, DOI [10.6084/m9.figshare.839646, DOI 10.6084/M9.FIGSHARE.839646]; de Barra M, 2013, EVOL HUM BEHAV, V34, P384, DOI 10.1016/j.evolhumbehav.2013.07.001; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Fessler DMT, 2003, EVOL HUM BEHAV, V24, P406, DOI 10.1016/S1090-5138(03)00054-0; FREEMAN J, 1976, PUBLIC OPIN QUART, V40, P79, DOI 10.1086/268269; HAIDT J, 1994, PERS INDIV DIFFER, V16, P701, DOI 10.1016/0191-8869(94)90212-7; Hart BL, 2011, PHILOS T R SOC B, V366, P3406, DOI 10.1098/rstb.2011.0092; Hayton JC, 2004, ORGAN RES METHODS, V7, P191, DOI 10.1177/1094428104263675; Hoefling A, 2009, EMOTION, V9, P50, DOI 10.1037/a0014449; HOX JJ, 1994, SOCIOL METHOD RES, V22, P300, DOI 10.1177/0049124194022003002; Hutchings MR, 2006, MAMMAL REV, V36, P1, DOI 10.1111/j.1365-2907.2006.00080.x; Janeway CA, 2001, IMMUNOBIOLOGY; LIVELY CM, 1986, EVOLUTION, V40, P232, DOI 10.1111/j.1558-5646.1986.tb00466.x; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Nettle D, 2011, P ROY SOC B-BIOL SCI, V278, P1721, DOI 10.1098/rspb.2010.1726; Nettle D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013371; Oaten M, 2009, PSYCHOL BULL, V135, P303, DOI 10.1037/a0014823; Olatunji BO, 2007, J ANXIETY DISORD, V21, P918, DOI 10.1016/j.janxdis.2006.12.005; Olatunji BO, 2009, J CROSS CULT PSYCHOL, V40, P234, DOI 10.1177/0022022108328918; Rahman MM, 2012, HLTH DEMOGRAPHIC SUR, V44; Rahman O, 1999, 1996 MATLAB HLTH SOC; Rozin P, 1999, J RES PERS, V33, P330, DOI 10.1006/jrpe.1999.2251; Rozin P, 2008, JUDGM DECIS MAK, V3, P191; Stevenson RJ, 2009, EVOL HUM BEHAV, V30, P363, DOI 10.1016/j.evolhumbehav.2009.02.005; Tybur JM, 2011, PERS INDIV DIFFER, V51, P343, DOI 10.1016/j.paid.2011.04.003; Tybur JM, 2009, J PERS SOC PSYCHOL, V97, P103, DOI 10.1037/a0015474; Waynforth D, 2012, P ROY SOC B-BIOL SCI, V279, P2998, DOI 10.1098/rspb.2012.0220; Wisenden BD, 2003, FISH DEFENSES, V2, P151	37	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100444	10.1371/journal.pone.0100444	http://dx.doi.org/10.1371/journal.pone.0100444			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK5ZO	24977418	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000338506400029
J	Majumder, R; Koklic, T; Sengupta, T; Cole, D; Chattopadhyay, R; Biswas, S; Monroe, D; Lentz, BR				Majumder, Rinku; Koklic, Tilen; Sengupta, Tanusree; Cole, Daud; Chattopadhyay, Rima; Biswas, Subir; Monroe, Dougald; Lentz, Barry R.			Soluble Phosphatidylserine Binds to Two Sites on Human Factor IXa in a Ca2+ Dependent Fashion to Specifically Regulate Structure and Activity	PLOS ONE			English	Article							FACTOR X-A; COAGULATION FACTOR-X; BOVINE FACTOR-X; FACTOR V-A; BLOOD-COAGULATION; PROTHROMBIN ACTIVATION; SODIUM DEOXYCHOLATE; MEMBRANE-SURFACE; FACTOR-VIIIA; FACTOR XASE	Clinical studies have demonstrated a correlation between elevated levels of FIX and the risk of coronary heart disease, while reduced plasma FIX causes hemophilia B. FIXa interacts with FVIIIa in the presence of Ca2+ and phosphatidylserine (PS)-containing membranes to form a factor X-activating complex (Xase) that is key to propagation of the initiated blood coagulation process in human. We test the hypothesis that PS in these membranes up-regulates the catalytic activity of this essential enzyme. We used a soluble form of phosphatidylserine, 1, 2-dicaproyl-sn-glycero-3-phospho-L-serine (C6PS), as a tool to do so. C6PS and PS in membranes are reported to regulate the homologous FXa nearly identically. FIXa binds a molecule of C6PS at each of with two sites with such different affinities (similar to 100-fold) that these appear to be independent. A high affinity C6PS binding site (K-d similar to 1.4 mu M) regulates structure, whereas a low-affinity binding site (K-d similar to 140 mu M) regulates activity. Equilibrium dialysis experiments were analyzed globally with four other data sets (proteolytic and amidolytic activities, intrinsic fluorescence, ellipticity) to unequivocally demonstrate stoichiometries of one for both sites. Michaelis-Menten parameters for FIXa proteolytic activity were the same in the presence of C6PS or PS/PC membranes. We conclude that the PS molecule and not a membrane surface is the key regulator of both factors Xa and IXa. Despite some minor differences in the details of regulation of factors Xa and IXa, the similarities we found suggest that lipid regulation of these two proteases may be similar, a hypothesis that we continue to test.	[Majumder, Rinku; Koklic, Tilen; Sengupta, Tanusree; Cole, Daud; Chattopadhyay, Rima; Biswas, Subir; Lentz, Barry R.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27514 USA; [Monroe, Dougald] Univ N Carolina, Dept Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Majumder, R (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27514 USA.	rinku_majumder@med.unc.edu	S, Tanusree/AAI-8680-2021; Majumder, Rinku/J-7512-2019	S, Tanusree/0000-0002-6828-667X; Lentz, Barry/0000-0001-9685-8690; Monroe, Dougald/0000-0002-0493-2943; majumder, Rinku/0000-0002-1727-7220	National Institute of Health USPHS [HL 45916]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045916] Funding Source: NIH RePORTER	National Institute of Health USPHS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by National Institute of Health USPHS Grant HL 45916 to BRL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardoin SP, 2007, SCAND J IMMUNOL, V66, P159, DOI 10.1111/j.1365-3083.2007.01984.x; Banerjee M, 2002, BIOCHEMISTRY-US, V41, P7751, DOI 10.1021/bi020017p; Chattopadhyay R, 2009, BIOPHYS J, V96, P974, DOI 10.1016/j.bpj.2008.10.013; Fay PJ, 1996, J BIOL CHEM, V271, P6027, DOI 10.1074/jbc.271.11.6027; FURIE B, 1982, J BIOL CHEM, V257, P3875; HAQUE ME, 1995, J PHYS CHEM-US, V99, P14032, DOI 10.1021/j100038a039; Haque ME, 1999, J COLLOID INTERF SCI, V217, P1, DOI 10.1006/jcis.1999.6267; Hockin MF, 2002, J BIOL CHEM, V277, P18322, DOI 10.1074/jbc.M201173200; JACOBS M, 1994, J BIOL CHEM, V269, P25494; Koppaka V, 1996, BIOCHEMISTRY-US, V35, P7482, DOI 10.1021/bi952063d; LAWSON JH, 1991, J BIOL CHEM, V266, P11317; Majumder R, 2005, BIOCHEMISTRY-US, V44, P16998, DOI 10.1021/bi051469f; Majumder R, 2003, BIOPHYS J, V84, P1238, DOI 10.1016/S0006-3495(03)74939-X; Majumder R, 2002, J BIOL CHEM, V277, P29765, DOI 10.1074/jbc.M200893200; Majumder R, 2013, BIOCHEMISTRY-US, V52, P143, DOI 10.1021/bi301239z; Majumder R, 2011, J BIOL CHEM, V286, P35535, DOI 10.1074/jbc.M111.260141; Mann KG, 1999, THROMB HAEMOSTASIS, V82, P165; Mann KG, 2003, ARTERIOSCL THROM VAS, V23, P17, DOI 10.1161/01.ATV.0000046238.23903.FC; Monroe DM, 1996, BLOOD COAGUL FIBRIN, V7, P459, DOI 10.1097/00001721-199606000-00005; Rand MD, 1996, BLOOD, V88, P3432, DOI 10.1182/blood.V88.9.3432.bloodjournal8893432; Rautou PE, 2011, CIRC RES, V109, P593, DOI 10.1161/CIRCRESAHA.110.233163; RAWALASHEIKH R, 1990, BIOCHEMISTRY-US, V29, P2606, DOI 10.1021/bi00462a025; RAWALASHEIKH R, 1992, BLOOD, V79, P398; Saenko EL, 1999, TRENDS CARDIOVAS MED, V9, P185, DOI 10.1016/S1050-1738(00)00019-0; Srivastava A, 2002, J BIOL CHEM, V277, P1855, DOI 10.1074/jbc.M105697200; VANDIEIJEN G, 1981, J BIOL CHEM, V256, P3433; Venkateswarlu D, 2002, BIOPHYS J, V82, P1190, DOI 10.1016/S0006-3495(02)75476-3; Weinreb GE, 2003, J BIOL CHEM, V278, P5679, DOI 10.1074/jbc.M208423200; Zhai X, 2002, BIOCHEMISTRY-US, V41, P5675, DOI 10.1021/bi011844d	29	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100006	10.1371/journal.pone.0100006	http://dx.doi.org/10.1371/journal.pone.0100006			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979705	Green Published, gold, Green Submitted			2022-12-27	WOS:000338506400015
J	Najafi, A; Masoudi-Nejad, A; Ghanei, M; Nourani, MR; Moeini, A				Najafi, Ali; Masoudi-Nejad, Ali; Ghanei, Mostafa; Nourani, Mohamad-Reza; Moeini, Ali			Pathway Reconstruction of Airway Remodeling in Chronic Lung Diseases: A Systems Biology Approach	PLOS ONE			English	Article							SULFUR MUSTARD; BRONCHIOLITIS OBLITERANS; GENE-EXPRESSION; PROTEIN; APOPTOSIS; DATABASE; EXPOSURE; CELLS; TRANSCRIPTOME; INTEGRATION	Airway remodeling is a pathophysiologic process at the clinical, cellular, and molecular level relating to chronic obstructive airway diseases such as chronic obstructive pulmonary disease (COPD), asthma and mustard lung. These diseases are associated with the dysregulation of multiple molecular pathways in the airway cells. Little progress has so far been made in discovering the molecular causes of complex disease in a holistic systems manner. Therefore, pathway and network reconstruction is an essential part of a systems biology approach to solve this challenging problem. In this paper, multiple data sources were used to construct the molecular process of airway remodeling pathway in mustard lung as a model of airway disease. We first compiled a master list of genes that change with airway remodeling in the mustard lung disease and then reconstructed the pathway by generating and merging the protein-protein interaction and the gene regulatory networks. Experimental observations and literature mining were used to identify and validate the master list. The outcome of this paper can provide valuable information about closely related chronic obstructive airway diseases which are of great importance for biologists and their future research. Reconstructing the airway remodeling interactome provides a starting point and reference for the future experimental study of mustard lung, and further analysis and development of these maps will be critical to understanding airway diseases in patients.	[Najafi, Ali; Masoudi-Nejad, Ali; Moeini, Ali] Univ Tehran, Inst Biochem & Biophys, Lab Syst Biol & Bioinformat LBB, Tehran, Iran; [Ghanei, Mostafa; Nourani, Mohamad-Reza] Baqiyatallah Univ Med Sci, Genom Div, Chem Injury Res Ctr, Tehran, Iran; [Moeini, Ali] Univ Tehran, Dept Algorithms & Computat, Coll Engn, Tehran, Iran	University of Tehran; Baqiyatallah University of Medical Sciences (BMSU); University of Tehran	Masoudi-Nejad, A (corresponding author), Univ Tehran, Inst Biochem & Biophys, Lab Syst Biol & Bioinformat LBB, Tehran, Iran.	amasoudin@ibb.ut.ac.ir	Najafi, Ali/K-1113-2015; Ghanei, Mostafa/V-1975-2019; Masoudi-Nejad, Ali/ABH-2078-2021	Najafi, Ali/0000-0001-7700-2053; Ghanei, Mostafa/0000-0001-9372-0928; Najafi, Ali/0000-0002-2540-4955				Adelipour M, 2011, IRAN J ALLERGY ASTHM, V10, P147, DOI 010.03/ijaai.147154; Agusti A, 2011, AM J RESP CRIT CARE, V183, P1129, DOI 10.1164/rccm.201009-1414PP; Bader GD, 2006, NUCLEIC ACIDS RES, V34, pD504, DOI 10.1093/nar/gkj126; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bugrim A, 2004, DRUG DISCOV TODAY, V9, P127, DOI 10.1016/S1359-6446(03)02971-4; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chen L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024495; Cheung AKL, 2011, P NATL ACAD SCI USA, V108, P8390, DOI 10.1073/pnas.1101747108; Dillman JF, 2005, CHEM RES TOXICOL, V18, P28, DOI 10.1021/tx049745z; Fernandez JM, 2007, NUCLEIC ACIDS RES, V35, pW21, DOI 10.1093/nar/gkm298; Fischer BM, 2002, AM J RESP CELL MOL, V26, P447, DOI 10.1165/ajrcmb.26.4.4473; Ghabili K, 2010, J APPL TOXICOL, V30, P627, DOI 10.1002/jat.1581; Ghanei M, 2004, EUR J RADIOL, V52, P164, DOI 10.1016/j.ejrad.2004.03.018; Ghanei M, 2008, Chron Respir Dis, V5, P95, DOI 10.1177/1479972307087191; Ghanei M, 2007, INHAL TOXICOL, V19, P451, DOI 10.1080/08958370601174990; Ghanei M, 2011, INHAL TOXICOL, V23, P363, DOI 10.3109/08958378.2011.576278; Greeley MA, 2010, TOXICOL SCI, V113, P453, DOI 10.1093/toxsci/kfp268; Hallock P, 2012, OMICS, V16, P37, DOI 10.1089/omi.2011.0054; Junker B. H., 2011, ANAL BIOL NETWORKS; Kann MG, 2007, BRIEF BIOINFORM, V8, P333, DOI 10.1093/bib/bbm031; Kim HJ, 2010, AM J RESP CELL MOL, V43, P349, DOI 10.1165/rcmb.2009-0205OC; King JY, 2005, PHYSIOL GENOMICS, V23, P103, DOI 10.1152/physiolgenomics.00101.2005; Kitano H, 2005, NAT BIOTECHNOL, V23, P961, DOI 10.1038/nbt1111; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Lo PHY, 2012, CANCER LETT, V316, P39, DOI 10.1016/j.canlet.2011.10.020; Loscalzo Joseph, 2011, Proc Am Thorac Soc, V8, P196, DOI 10.1513/pats.201006-041MS; Matsui A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044080; Mishra NC, 2012, INT IMMUNOPHARMACOL, V13, P101, DOI 10.1016/j.intimp.2012.03.010; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Najafi A, 2014, J RECEPT SIG TRANSD, P1; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Rebane A, 2012, J ALLERGY CLIN IMMUN, V129, P1297, DOI 10.1016/j.jaci.2012.02.020; Rogers JV, 2004, J BIOCHEM MOL TOXIC, V18, P289, DOI 10.1002/jbt.20043; Royce SG, 2013, AM J RESP CELL MOL, V48, P135, DOI 10.1165/rcmb.2011-0320OC; Sato M, 2002, AM J RESP CELL MOL, V26, P127, DOI 10.1165/ajrcmb.26.1.4319; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Snyder JC, 2009, AM J RESP CELL MOL, V40, P633, DOI 10.1165/rcmb.2008-0334OC; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Thomason JWW, 2003, JAMA-J AM MED ASSOC, V290, P598, DOI 10.1001/jama.290.5.598; Tschumperlin DJ, 2001, AM J RESP CRIT CARE, V164, pS90, DOI 10.1164/ajrccm.164.supplement_2.2106060; Uchida T, 2004, J BIOL CHEM, V279, P14871, DOI 10.1074/jbc.M400461200; Wachi S, 2005, BIOINFORMATICS, V21, P4205, DOI 10.1093/bioinformatics/bti688; Werneburg NW, 2012, J BIOL CHEM, V287, P24427, DOI 10.1074/jbc.M112.342238; Wheelock CE, 2009, MOL BIOSYST, V5, P588, DOI 10.1039/b902356a; Willems-Widyastuti A, 2011, TRANSFORMING GROWTH; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Yazdani S, 2011, J RECEPT SIG TRANSD, V31, P367, DOI 10.3109/10799893.2011.602415; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	52	9	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100094	10.1371/journal.pone.0100094	http://dx.doi.org/10.1371/journal.pone.0100094			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978043	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400019
J	Schriever, VA; Mori, E; Petters, W; Boerner, C; Smitka, M; Hummel, T				Schriever, Valentin A.; Mori, Eri; Petters, Wenke; Boerner, Carolin; Smitka, Martin; Hummel, Thomas			The "Sniffin' Kids" Test - A 14-Item Odor Identification Test for Children	PLOS ONE			English	Article							OLFACTORY FUNCTION; NORMATIVE DATA; SMELL; DISCRIMINATION; THRESHOLDS; AGE; POPULATION; TASTE	Tools for measuring olfactory function in adults have been well established. Although studies have shown that olfactory impairment in children may occur as a consequence of a number of diseases or head trauma, until today no consensus on how to evaluate the sense of smell in children exists in Europe. Aim of the study was to develop a modified "Sniffin' Sticks" odor identification test, the "Sniffin' Kids" test for the use in children. In this study 537 children between 6-17 years of age were included. Fourteen odors, which were identified at a high rate by children, were selected from the "Sniffin' Sticks" 16-item odor identification test. Normative date for the 14-item "Sniffin' Kids" odor identification test was obtained. The test was validated by including a group of congenital anosmic children. Results show that the "Sniffin' Kids" test is able to discriminate between normosmia and anosmia with a cutoff value of >7 points on the odor identification test. In addition the test-retest reliability was investigated in a group of 31 healthy children and shown to be rho = 0.44. With the 14-item odor identification "Sniffin' Kids" test we present a valid and reliable test for measuring olfactory function in children between ages 6-17 years.	[Schriever, Valentin A.; Petters, Wenke; Boerner, Carolin; Hummel, Thomas] Tech Univ TU Dresden, Univ Hosp Carl Gustav Carus, Dept Otorhinolaryngol, Smell & Taste Clin, Dresden, Germany; [Smitka, Martin] Tech Univ TU Dresden, Univ Hosp Carl Gustav Carus, Dept Neuropediat, Dresden, Germany; [Mori, Eri] Jikei Univ, Sch Med, Dept Otorhinolaryngol, Tokyo, Japan	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Jikei University	Schriever, VA (corresponding author), Tech Univ TU Dresden, Univ Hosp Carl Gustav Carus, Dept Otorhinolaryngol, Smell & Taste Clin, Dresden, Germany.	valentin.schriever@mac.com	Mori, Eri/AAB-8544-2022		department of otolaryngology, TU Dresden	department of otolaryngology, TU Dresden	This study received no external support. Internal funding was provided by the department of otolaryngology, TU Dresden. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker K, 2013, J NEUROTRAUMA; Cameron EL, 2013, INT J PEDIATR OTORHI, V77, P346, DOI 10.1016/j.ijporl.2012.11.022; Chopra A, 2008, NEUROIMAGE, V40, P1257, DOI 10.1016/j.neuroimage.2008.01.015; Dalton P, 2011, LARYNGOSCOPE, V121, P1843, DOI 10.1002/lary.21928; Davidson TM, 1998, ANN NY ACAD SCI, V855, P787, DOI 10.1111/j.1749-6632.1998.tb10659.x; DOTY RL, 1984, SCIENCE, V226, P1441, DOI 10.1126/science.6505700; Doty RL, 1996, LARYNGOSCOPE, V106, P353, DOI 10.1097/00005537-199603000-00021; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Dzaman K, 2013, INT J PEDIATR OTORHI, V77, P418, DOI 10.1016/j.ijporl.2012.12.001; Moura RGF, 2014, CODAS, V26, P96, DOI 10.1590/s2317-17822014000100014; Gudziol V, 2006, LARYNGOSCOPE, V116, P1858, DOI 10.1097/01.mlg.0000234915.51189.cb; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Hummel T, 2011, EXP BRAIN RES, V214, P285, DOI 10.1007/s00221-011-2832-7; Hummel T, 2001, ANN OTO RHINOL LARYN, V110, P976, DOI 10.1177/000348940111001015; Hummel T, 2007, BEHAV BRAIN RES, V180, P133, DOI 10.1016/j.bbr.2007.02.040; JACOBI G, 1986, Acta Paediatrica Hungarica, V27, P173; Kobal G., 1996, Rhinology (Utrecht), V34, P222; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; Kondo H, 1998, AM J RHINOL, V12, P353, DOI 10.2500/105065898780182390; Konstantinidis I, 2005, INT J PEDIATR OTORHI, V69, P1343, DOI 10.1016/j.ijporl.2005.03.022; Laing DG, 2008, OTOLARYNG HEAD NECK, V139, P74, DOI 10.1016/j.otohns.2006.11.058; Monnery-Patris S, 2009, Dev Psychobiol, V51, P268, DOI 10.1002/dev.20363; Murphy C., 1994, PSYCHOPHYSICAL ASSES, P609; Obrebowski A, 2000, INT J PEDIATR OTORHI, V55, P191, DOI 10.1016/S0165-5876(00)00397-9; Oozeer NB, 2011, CLIN OTOLARYNGOL, V36, P494, DOI 10.1111/j.1749-4486.2011.02327.x; Roberts M A, 1996, Appl Neuropsychol, V3, P86, DOI 10.1207/s15324826an0302_7; Roessner V, 2005, EUR ARCH PSY CLIN N, V255, P6, DOI 10.1007/s00406-004-0525-y; Schecklmann M, 2013, J NEURAL TRANSM, V120, P121, DOI 10.1007/s00702-012-0855-2; Schriever VA, 2014, CHEM SENSES; van Spronsen E, 2013, AM J RHINOL ALLERGY, V27, P197, DOI 10.2500/ajra.2013.27.3865	31	49	52	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101086	10.1371/journal.pone.0101086	http://dx.doi.org/10.1371/journal.pone.0101086			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979650	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400074
J	Akbas, SD				Akbas, Seref Doguscan			Wave Propagation Analysis of Edge Cracked Circular Beams under Impact Force	PLOS ONE			English	Article							SPECTRAL FINITE-ELEMENT; FREE-VIBRATION ANALYSIS; MODEL	This paper presents responses of an edge circular cantilever beam under the effect of an impact force. The beam is excited by a transverse triangular force impulse modulated by a harmonic motion. The Kelvin-Voigt model for the material of the beam is used. The cracked beam is modelled as an assembly of two sub-beams connected through a massless elastic rotational spring. The considered problem is investigated within the Bernoulli-Euler beam theory by using energy based finite element method. The system of equations of motion is derived by using Lagrange's equations. The obtained system of linear differential equations is reduced to a linear algebraic equation system and solved in the time domain by using Newmark average acceleration method. In the study, the effects of the location of crack, the depth of the crack, on the characteristics of the reflected waves are investigated in detail. Also, the positions of the cracks are calculated by using reflected waves.	Bursa Tech Univ, Dept Civil Engn, Bursa, Turkey	Bursa Technical University	Akbas, SD (corresponding author), Bursa Tech Univ, Dept Civil Engn, Bursa, Turkey.	serefda@yahoo.com	Akbaş, Şeref Doğuşcan/AAW-3318-2020	Akbaş, Şeref Doğuşcan/0000-0001-5327-3406				Akbas S.D., 2014, INT J ENG APPL SCI, V6, P40, DOI [10.24107/ijeas.251218, DOI 10.24107/IJEAS.251218]; Chakraborty A, 2005, COMPUT MECH, V36, P1, DOI 10.1007/s00466-004-0637-2; Chouvion B, 2010, J SOUND VIB, V329, P5087, DOI 10.1016/j.jsv.2010.05.023; EIE, 2020, ENG IS ELEMENTARY; FARRIS TN, 1989, J SOUND VIB, V130, P137, DOI 10.1016/0022-460X(89)90524-5; Frikha A, 2011, WAVE MOTION, V48, P83, DOI 10.1016/j.wavemoti.2010.08.001; GOPALAKRISHNAN S, 1995, COMPUT METHOD APPL M, V121, P77, DOI 10.1016/0045-7825(94)00686-H; Kang B, 2003, J SOUND VIB, V260, P19, DOI 10.1016/S0022-460X(02)00898-2; Kisa M, 2007, INT J ENG SCI, V45, P364, DOI 10.1016/j.ijengsci.2007.03.014; Kocaturk T, 2011, INT J PHYS SCI, V6, P4013; Kocaturk T, 2013, STRUCT ENG MECH, V46, P417, DOI 10.12989/sem.2013.46.3.417; Krawczuk M, 2003, J SOUND VIB, V264, P1139, DOI 10.1016/S0022-460X(02)01387-1; Krawczuk M, 2002, FINITE ELEM ANAL DES, V38, P537, DOI 10.1016/S0168-874X(01)00084-1; Kumar DS, 2004, FINITE ELEM ANAL DES, V40, P1729, DOI 10.1016/j.finel.2004.01.001; LEE SY, 1990, J SOUND VIB, V142, P203, DOI 10.1016/0022-460X(90)90552-B; Newmark N., 1959, J ENG MECH DIV, V85, P67, DOI [10.1061/JMCEA3.0000098, DOI 10.1061/JMCEA3.0000098]; Ostachowicz W, 2004, COMPUT STRUCT, V82, P475, DOI 10.1016/j.compstruc.2003.11.001; Palacz M, 2005, COMPOS STRUCT, V68, P45, DOI 10.1016/j.compstruct.2004.02.013; Palacz M, 2005, COMPOS STRUCT, V68, P37, DOI 10.1016/j.compstruct.2004.02.012; Palacz M, 2002, COMPUT STRUCT, V80, P1809, DOI 10.1016/S0045-7949(02)00219-5; Park J, 2008, J SOUND VIB, V318, P820, DOI 10.1016/j.jsv.2008.05.008; Sridhar R, 2006, INT J SOLIDS STRUCT, V43, P4997, DOI 10.1016/j.ijsolstr.2005.10.005; Tada H., 1985, STRESS ANAL CRACKS H; TEH KK, 1981, FIBRE SCI TECHNOL, V14, P301, DOI 10.1016/0015-0568(81)90021-X; Tian JY, 2003, J SOUND VIB, V261, P715, DOI 10.1016/S0022-460X(02)01001-5; Usuki T, 2003, INT J SOLIDS STRUCT, V40, P3737, DOI 10.1016/S0020-7683(03)00142-2; Vinod KG, 2007, INT J SOLIDS STRUCT, V44, P5875, DOI 10.1016/j.ijsolstr.2007.02.002; Watanabe Y, 2005, WAVE MOTION, V42, P155, DOI 10.1016/j.wavemoti.2005.01.001; Yokoyama T, 1982, TECHNOLOGY REPORTS O, V32, P103; Zhu HP, 2013, ADV STRUCT ENG, V16, P1513, DOI 10.1260/1369-4332.16.9.1513	30	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100496	10.1371/journal.pone.0100496	http://dx.doi.org/10.1371/journal.pone.0100496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972050	gold, Green Published, Green Submitted			2022-12-27	WOS:000338512200037
J	Zheng, FP; Zhang, SF; Lu, WN; Wu, F; Yin, XY; Yu, D; Pan, QQ; Li, H				Zheng, Fenping; Zhang, Saifei; Lu, Weina; Wu, Fang; Yin, Xueyao; Yu, Dan; Pan, Qianqian; Li, Hong			Regulation of Insulin Resistance and Adiponectin Signaling in Adipose Tissue by Liver X Receptor Activation Highlights a Cross-Talk with PPAR gamma	PLOS ONE			English	Article							FATTY-ACID-METABOLISM; PHARMACOLOGICAL ACTIVATION; NUTRITIONAL REGULATION; GLUCOSE-UPTAKE; LXR; ADIPOCYTES; INHIBITION; MICE; LIPOGENESIS; ALPHA	Liver X receptors (LXRs) have been recognized as a promising therapeutic target for atherosclerosis; however, their role in insulin sensitivity is controversial. Adiponectin plays a unique role in maintaining insulin sensitivity. Currently, no systematic experiments elucidating the role of LXR activation in insulin function based on adiponectin signaling have been reported. Here, we investigated the role of LXR activation in insulin resistance based on adiponectin signaling, and possible mechanisms. C57BL/6 mice maintained on a regular chow received the LXR agonist, T0901317 (30 mg/kg.d) for 3 weeks by intraperitoneal injection, and differentiated 3T3-L1 adipocytes were treated with T0901317 or GW3965. T0901317 treatment induced significant insulin resistance in C57BL/6 mice. It decreased adiponectin gene transcription in epididymal fat, as well as serum adiponectin levels. Activity of AMPK, a key mediator of adiponectin signaling, was also decreased, resulting in decreased Glut-4 membrane translocation in epididymal fat. In contrast, adiponectin activity was not changed in the liver of T0901317 treated mice. In vitro, both T0901317 and GW3965 decreased adiponectin expression in adipocytes in a dose-dependent manner, an effect which was diminished by LXR alpha silencing. ChIP-qPCR studies demonstrated that T0901317 decreased the binding of PPAR gamma to the PPAR-responsive element (PPRE) of the adiponectin promoter in a dose-dependent manner. Furthermore, T0901317 exerted an antagonistic effect on the expression of adiponectin in adipocytes co-treated with 3 mu M Pioglitazone. In luciferase reporter gene assays, T0901317 dose-dependently inhibited PPRE-Luc activity in HEK293 cells co-transfected with LXR alpha and PPAR gamma. These results suggest that LXR activation induces insulin resistance with decreased adiponectin signaling in epididymal fat, probably due to negative regulation of PPAR gamma signaling. These findings indicate that the potential of LXR activation as a therapeutic target for atherosclerosis may be limited by the possibility of exacerbating insulin resistance-related disease.	[Zheng, Fenping; Zhang, Saifei; Lu, Weina; Wu, Fang; Yin, Xueyao; Yu, Dan; Li, Hong] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Endocrinol, Hangzhou 310003, Zhejiang, Peoples R China; [Pan, Qianqian] Zhejiang Univ, Sir Run Run Shaw Hosp, Biomed Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Pan, Qianqian] Zhejiang Univ, Sir Run Run Shaw Hosp, Key Lab Biotherapy Zhejiang Provapw, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Li, H (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Endocrinol, Hangzhou 310003, Zhejiang, Peoples R China.	lihongheyi@126.com			National Natural Science Foundation of China [81270924]; Science and Technology Project of Zhejiang Province [2012C33131]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Zhejiang Province	This study was supported by grant of National Natural Science Foundation of China (81270924, http://www.nsfc.gov.cn) and grant of Science and Technology Project of Zhejiang Province (2012C33131, http://www.zjkjt.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer A, 2013, J LIPID RES, V54, P1300, DOI 10.1194/jlr.M033977; Beaven SW, 2013, CELL METAB, V18, P106, DOI 10.1016/j.cmet.2013.04.021; Bouskila M, 2005, INT J OBESITY, V29, pS17, DOI 10.1038/sj.ijo.0802908; Cao GQ, 2003, J BIOL CHEM, V278, P1131, DOI 10.1074/jbc.M210208200; Chen JL, 2010, J CEREBR BLOOD F MET, V30, P102, DOI 10.1038/jcbfm.2009.187; Commerford SR, 2007, MOL ENDOCRINOL, V21, P3002, DOI 10.1210/me.2007-0156; Dalen KT, 2003, J BIOL CHEM, V278, P48283, DOI 10.1074/jbc.M302287200; Darimont C, 2006, BIOCHIMIE, V88, P309, DOI 10.1016/j.biochi.2005.08.010; Dib L, 2014, J LIPID RES, V55, P247, DOI 10.1194/jlr.M043422; Fritah A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032520; Gaidhu MP, 2010, MOL ENDOCRINOL, V24, P1434, DOI 10.1210/me.2009-0502; Gao M, 2013, PLOS ONE, V8; Ge Q, 2011, AM J PHYSIOL-ENDOC M, V301, pE326, DOI 10.1152/ajpendo.00153.2011; Grefhorst A, 2005, AM J PHYSIOL-ENDOC M, V289, pE829, DOI 10.1152/ajpendo.00165.2005; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Griesel BA, 2010, DIABETES, V59, P800, DOI 10.2337/db09-1542; Guerre-Millo M, 2004, DIABETES METAB, V30, P13, DOI 10.1016/S1262-3636(07)70084-8; Hong C, 2011, J LIPID RES, V52, P531, DOI 10.1194/jlr.M010686; Ide T, 2003, MOL ENDOCRINOL, V17, P1255, DOI 10.1210/me.2002-0191; Im SS, 2011, CIRC RES, V108, P996, DOI 10.1161/CIRCRESAHA.110.226878; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Korach-Andre M, 2011, P NATL ACAD SCI USA, V108, P403, DOI 10.1073/pnas.1017884108; Kudoh A, 2011, LIFE SCI, V88, P1055, DOI 10.1016/j.lfs.2011.04.001; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Liu Y, 2007, J CLIN ENDOCR METAB, V92, P4313, DOI 10.1210/jc.2007-0890; Liu Y, 2013, DIABETES, V62, P743, DOI 10.2337/db12-0687; Meng ZX, 2012, DIABETOLOGIA, V55, P1733, DOI 10.1007/s00125-012-2516-2; Naik SU, 2006, CIRCULATION, V113, P90, DOI 10.1161/CIRCULATIONAHA.105.560177; Pettersson AML, 2013, DIABETOLOGIA, V56, P2044, DOI 10.1007/s00125-013-2954-5; Ronti T, 2006, CLIN ENDOCRINOL, V64, P355, DOI 10.1111/j.1365-2265.2006.02474.x; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Ross SE, 2002, MOL CELL BIOL, V22, P5989, DOI 10.1128/MCB.22.16.5989-5999.2002; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Seo JB, 2004, MOL CELL BIOL, V24, P3430, DOI 10.1128/MCB.24.8.3430-3444.2004; Stenson BM, 2011, J BIOL CHEM, V286, P370, DOI 10.1074/jbc.M110.179499; Stohr R, 2013, BIOCHEM J, V454, P1, DOI 10.1042/BJ20130121; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Wang FF, 2013, P NATL ACAD SCI USA, V110, P18656, DOI 10.1073/pnas.1314863110; Yamauchi T, 2013, CELL METAB, V17, P185, DOI 10.1016/j.cmet.2013.01.001; Yoshikawa T, 2003, MOL ENDOCRINOL, V17, P1240, DOI 10.1210/me.2002-0190	42	17	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101269	10.1371/journal.pone.0101269	http://dx.doi.org/10.1371/journal.pone.0101269			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972069	gold, Green Submitted, Green Published			2022-12-27	WOS:000338512200109
J	Bai, YS; Hassler, J; Ziyar, A; Li, P; Wright, Z; Menon, R; Omenn, GS; Cavalcoli, JD; Kaufman, RJ; Sartor, MA				Bai, Yongsheng; Hassler, Justin; Ziyar, Ahdad; Li, Philip; Wright, Zachary; Menon, Rajasree; Omenn, Gilbert S.; Cavalcoli, James D.; Kaufman, Randal J.; Sartor, Maureen A.			Novel Bioinformatics Method for Identification of Genome-Wide Non-Canonical Spliced Regions Using RNA-Seq Data	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; XBP1 MESSENGER-RNA; ER STRESS; HEPATIC STEATOSIS; READ ALIGNMENT; BREAST-CANCER; IRE1-ALPHA; EXPRESSION; ULTRAFAST	Setting: During endoplasmic reticulum (ER) stress, the endoribonuclease (RNase) Ire1 alpha initiates removal of a 26 nt region from the mRNA encoding the transcription factor Xbp1 via an unconventional mechanism (atypically within the cytosol). This causes an open reading frame-shift that leads to altered transcriptional regulation of numerous downstream genes in response to ER stress as part of the unfolded protein response (UPR). Strikingly, other examples of targeted, unconventional splicing of short mRNA regions have yet to be reported. Objective: Our goal was to develop an approach to identify non-canonical, possibly very short, splicing regions using RNA-Seq data and apply it to ER stress-induced Ire1 alpha heterozygous and knockout mouse embryonic fibroblast (MEF) cell lines to identify additional Ire1 alpha targets. Results: We developed a bioinformatics approach called the Read-Split-Walk (RSW) pipeline, and evaluated it using two Ire1 alpha heterozygous and two Ire1 alpha-null samples. The 26 nt non-canonical splice site in Xbp1 was detected as the top hit by our RSW pipeline in heterozygous samples but not in the negative control Ire1 alpha knockout samples. We compared the Xbp1 results from our approach with results using the alignment program BWA, Bowtie2, STAR, Exonerate and the Unix "grep" command. We then applied our RSW pipeline to RNA-Seq data from the SKBR3 human breast cancer cell line. RSW reported a large number of non-canonical spliced regions for 108 genes in chromosome 17, which were identified by an independent study. Conclusions: We conclude that our RSW pipeline is a practical approach for identifying non-canonical splice junction sites on a genome-wide level. We demonstrate that our pipeline can detect novel splice sites in RNA-Seq data generated under similar conditions for multiple species, in our case mouse and human.	[Bai, Yongsheng; Wright, Zachary; Menon, Rajasree; Omenn, Gilbert S.; Cavalcoli, James D.; Sartor, Maureen A.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Bai, Yongsheng; Wright, Zachary; Menon, Rajasree; Omenn, Gilbert S.; Cavalcoli, James D.; Sartor, Maureen A.] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Hassler, Justin; Ziyar, Ahdad; Li, Philip; Kaufman, Randal J.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Sartor, Maureen A.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Bai, Yongsheng] Univ Wisconsin, Morgridge Inst Res, Madison, WI USA; [Omenn, Gilbert S.] Univ Michigan, Dept Internal Med & Human Genet, Ann Arbor, MI 48109 USA; [Omenn, Gilbert S.] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Omenn, Gilbert S.] Inst Syst Biol, Seattle, WA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Sanford Burnham Prebys Medical Discovery Institute; University of Michigan System; University of Michigan; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Institute for Systems Biology (ISB)	Kaufman, RJ (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA.	rkaufman@sanfordburnham.org; sartorma@umich.edu	Sartor, Maureen/L-2902-2019	Omenn, Gilbert S./0000-0002-8976-6074; Menon, Rajasree/0000-0001-6280-9639	National Institutes of Health [DK042394, DK088227, HL052173]; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042394, R37DK042394, R01DK088227] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Portions of this work were supported by National Institutes of Health grants DK042394, DK088227 and HL052173 (RJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril JF, 2005, GENOME RES, V15, P111, DOI 10.1101/gr.3108805; Aebersold R, 2013, J PROTEOME RES, V12, P23, DOI 10.1021/pr301151m; Aschoff M, 2013, BIOINFORMATICS, V29, P1141, DOI 10.1093/bioinformatics/btt101; Back SH, 2006, J BIOL CHEM, V281, P18691, DOI 10.1074/jbc.M602030200; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1311; Liu SL, 2013, J PROTEOME RES, V12, P45, DOI 10.1021/pr300985j; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Marko-Varga G, 2013, J PROTEOME RES, V12, P1, DOI [10.1021/pr301183aIJ, 10.1021/pr301183a]; Menon R, 2014, J PROTEOME RES, V13, P212, DOI 10.1021/pr400773v; Niwa M, 2005, GENOME BIOL, V6; Oikawa D, 2010, NUCLEIC ACIDS RES, V38, P6265, DOI 10.1093/nar/gkq452; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Tang SJ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-116; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang EY, 2013, J PROTEOME RES, V12, P2805, DOI 10.1021/pr4001527; Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52; Zhou A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S10	28	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100864	10.1371/journal.pone.0100864	http://dx.doi.org/10.1371/journal.pone.0100864			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991935	gold, Green Published, Green Submitted			2022-12-27	WOS:000341253400034
J	Bargerstock, E; Puvenna, V; Iffland, P; Falcone, T; Hossain, M; Vetter, S; Man, SM; Dickstein, L; Marchi, N; Ghosh, C; Carvalho-Tavares, J; Janigro, D				Bargerstock, Erin; Puvenna, Vikram; Iffland, Philip; Falcone, Tatiana; Hossain, Mohammad; Vetter, Stephen; Man, Shumei; Dickstein, Leah; Marchi, Nicola; Ghosh, Chaitali; Carvalho-Tavares, Juliana; Janigro, Damir			Is Peripheral Immunity Regulated by Blood-Brain Barrier Permeability Changes?	PLOS ONE			English	Article							DENDRITIC CELLS; CEREBROSPINAL-FLUID; POSSIBLE MARKER; S-100B PROTEIN; SERUM S-100B; IN-VIVO; S100B; DISRUPTION; AUTOANTIBODIES; S100-BETA	S100B is a reporter of blood-brain barrier (BBB) integrity which appears in blood when the BBB is breached. Circulating S100B derives from either extracranial sources or release into circulation by normal fluctuations in BBB integrity or pathologic BBB disruption (BBBD). Elevated S100B matches the clinical presence of indices of BBBD (gadolinium enhancement or albumin coefficient). After repeated sub-concussive episodes, serum S100B triggers an antigen-driven production of anti-S100B autoantibodies. We tested the hypothesis that the presence of S100B in extracranial tissue is due to peripheral cellular uptake of serum S100B by antigen presenting cells, which may induce the production of auto antibodies against S100B. To test this hypothesis, we used animal models of seizures, enrolled patients undergoing repeated BBBD, and collected serum samples from epileptic patients. We employed a broad array of techniques, including immunohistochemistry, RNA analysis, tracer injection and serum analysis. mRNA for S100B was segregated to barrier organs (testis, kidney and brain) but S100B protein was detected in immunocompetent cells in spleen, thymus and lymph nodes, in resident immune cells (Langerhans, satellite cells in heart muscle, etc.) and BBB endothelium. Uptake of labeled S100B by rat spleen CD4+ or CD8+ and CD86+ dendritic cells was exacerbated by pilocarpine-induced status epilepticus which is accompanied by BBBD. Clinical seizures were preceded by a surge of serum S100B. In patients undergoing repeated therapeutic BBBD, an autoimmune response against S100B was measured. In addition to its role in the central nervous system and its diagnostic value as a BBBD reporter, S100B may integrate blood-brain barrier disruption to the control of systemic immunity by a mechanism involving the activation of immune cells. We propose a scenario where extravasated S100B may trigger a pathologic autoimmune reaction linking systemic and CNS immune responses.	[Bargerstock, Erin; Puvenna, Vikram; Iffland, Philip; Falcone, Tatiana; Hossain, Mohammad; Vetter, Stephen; Man, Shumei; Dickstein, Leah; Marchi, Nicola; Ghosh, Chaitali; Carvalho-Tavares, Juliana; Janigro, Damir] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Puvenna, Vikram; Hossain, Mohammad; Ghosh, Chaitali; Janigro, Damir] Cleveland Clin, Lerner Coll Med, Dept Neurosurg, Cleveland, OH 44106 USA; [Puvenna, Vikram; Hossain, Mohammad; Ghosh, Chaitali; Janigro, Damir] Cleveland Clin, Lerner Coll Med, Dept Biomed Engn, Cleveland, OH 44106 USA; [Janigro, Damir] Flocel Inc, Cleveland, OH USA; [Iffland, Philip] Kent State Univ, Kent, OH 44242 USA; [Falcone, Tatiana] Cleveland Clin, Lerner Coll Med, Dept Psychiat, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Case Western Reserve University; Cleveland Clinic Foundation	Janigro, D (corresponding author), Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA.	janigrd@ccf.org	Dickstein, Leah/CAF-1892-2022; Marchi, Nicola/J-8607-2016	Marchi, Nicola/0000-0001-9124-0226; Falcone, Tatiana/0000-0002-4431-6782; Ghosh, Chaitali/0000-0003-4078-0278; Dickstein, Leah/0000-0002-4779-4122; Iffland, Philip/0000-0003-2203-188X	National Institutes of Health [R01NS078307, R01NS43284, R41MH093302, R21NS077236, R42MH093302, R21HD057256]; American Heart Association [13SDG13950015]; Brain Behavior Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD057256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R41MH093302, R42MH093302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078307, R21NS077236, R01NS043284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Brain Behavior Research Foundation(NARSAD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by: National Institutes of Health (R01NS078307, R01NS43284, R41MH093302, R21NS077236, R42MH093302, and R21HD057256 to DJ), a Scientist Development Grant from the American Heart Association (13SDG13950015), and a Brain Behavior Research Foundation grant to CG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DJ is employed by Flocel, Inc. Cleveland. Flocel, Inc. Cleveland provided support in the form of salary for author DJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Ajmo CT, 2008, J NEUROSCI RES, V86, P2227, DOI 10.1002/jnr.21661; Akirav EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034698; Albuerne M, 1998, ANAT REC, V251, P351, DOI 10.1002/(SICI)1097-0185(199807)251:3<351::AID-AR11>3.0.CO;2-N; Angelov L, 2009, J CLIN ONCOL, V27, P3503, DOI 10.1200/JCO.2008.19.3789; Bazarian JJ, 2006, BRAIN INJURY, V20, P759, DOI 10.1080/02699050500488207; Bechmann I, 2007, TRENDS IMMUNOL, V28, P5, DOI 10.1016/j.it.2006.11.007; Bianchi R, 2010, NEUROBIOL AGING, V31, P665, DOI 10.1016/j.neurobiolaging.2008.05.017; Bitsch A, 2004, J NEUROL, V251, P1498, DOI 10.1007/s00415-004-0580-3; Blyth BJ, 2008, ANN EMERG MED, V51, P538, DOI 10.1016/j.annemergmed.2008.01.193; Blyth BJ, 2011, J NEUROTRAUM, V28, P2453, DOI 10.1089/neu.2010.1653; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Cavalheiro EA, 2006, MODELS OF SEIZURES AND EPILEPSY, P433, DOI 10.1016/B978-012088554-1/50037-2; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Fabene PF, 2008, NAT MED, V14, P1377, DOI 10.1038/nm.1878; Falcone T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011089; Fazio V, 2004, ANN THORAC SURG, V78, P46, DOI 10.1016/j.athoracsur.2003.11.042; FIESCHI C, 1980, LIFE SCI, V27, P239, DOI 10.1016/0024-3205(80)90143-5; Fraser PA, 2011, FREE RADICAL BIO MED, V51, P967, DOI 10.1016/j.freeradbiomed.2011.06.003; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Gruden MA, 2007, J NEUROIMMUNOL, V186, P181, DOI 10.1016/j.jneuroim.2007.03.023; Hattori T, 2011, INVEST OPHTH VIS SCI, V52, P4598, DOI 10.1167/iovs.10-6741; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Huston JM, 2009, J IMMUNOL, V183, P552, DOI 10.4049/jimmunol.0802684; Iffland PH, 2013, NEUROBIOL DIS, V59, P206, DOI 10.1016/j.nbd.2013.07.006; Janigro D, 2012, EPILEPSIA, V53, P26, DOI 10.1111/j.1528-1167.2012.03472.x; John J, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-14; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Kroll RA, 1998, NEUROSURGERY, V42, P1083, DOI 10.1097/00006123-199805000-00082; Maetzler W, 2011, J ALZHEIMERS DIS, V26, P171, DOI 10.3233/JAD-2011-110221; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.cccn.2003.12.008; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; Marchi N, 2003, J NEUROSCI, V23, P1949; Marchi N, 2011, EPILEPSIA IN PRESS; Marchi N, 2007, EPILEPSIA, V48, P1934, DOI 10.1111/j.1528-1167.2007.01185.x; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Marchi N, 2012, EPILEPSIA, V53, P1877, DOI 10.1111/j.1528-1167.2012.03637.x; Marchi N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018200; Marchi N, 2010, BRAIN RES, V1353, P176, DOI 10.1016/j.brainres.2010.06.051; Marchi N, 2009, NEUROBIOL DIS, V33, P171, DOI 10.1016/j.nbd.2008.10.002; McIlroy D, 2001, BLOOD, V97, P3470, DOI 10.1182/blood.V97.11.3470; Metz CN, 2005, NAT IMMUNOL, V6, P756, DOI 10.1038/ni0805-756; Michalak Z, 2012, J NEUROPATH EXP NEUR, V71, P826, DOI 10.1097/NEN.0b013e31826809a6; Mrak RE, 2001, NEUROBIOL AGING, V22, P915, DOI 10.1016/S0197-4580(01)00293-7; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; Nishikawa Y, 2009, J CLIN EXP HEMATOP, V49, P23, DOI 10.3960/jslrt.49.23; Olivecrona M, 2009, J NEUROL NEUROSUR PS, V80, P1241, DOI 10.1136/jnnp.2008.158196; Osuna M, 2012, J ENDOCRINOL, V213, P231, DOI 10.1530/JOE-12-0043; Perrone L, 2008, J CELL PHYSIOL, V217, P60, DOI 10.1002/jcp.21474; Pham N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012691; Poletaev AB, 2000, AUTOIMMUNITY, V32, P33, DOI 10.3109/08916930008995985; Ponath G, 2007, J NEUROIMMUNOL, V184, P214, DOI 10.1016/j.jneuroim.2006.12.011; Raabe A, 2004, NEUROL RES, V26, P440, DOI 10.1179/016164104225015958; Raabe A, 2003, RESTOR NEUROL NEUROS, V21, P159; Reiber H, 1998, MULT SCLER, V4, P99, DOI 10.1177/135245859800400302; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; ROMANGOLDSTEIN S, 1994, AM J NEURORADIOL, V15, P581; Rook GAW, 1999, BEST PRACT RES CL EN, V13, P567, DOI 10.1053/beem.1999.0044; Rosas-Ballina M, 2009, J INTERN MED, V265, P663, DOI 10.1111/j.1365-2796.2009.02098.x; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Ruan S, 2009, J NEUROTRAUM, V26, P1655, DOI [10.1089/neu.2009.0928, 10.1089/neu.2009-0928]; Sarker MH, 1998, J PHYSIOL-LONDON, V507, P909, DOI 10.1111/j.1469-7793.1998.909bs.x; Sarkis RA, 2012, EPILEPTIC DISORD, V14, P57, DOI 10.1684/epd.2012.0493; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Schmidt S, 1997, BRAIN, V120, P1437, DOI 10.1093/brain/120.8.1437; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Sorci G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001315; Sorokina EG, 2010, ZH NEVROL PSIKHIATR, V110, P30; Steiner J, 2010, PSYCHONEUROENDOCRINO, V35, P321, DOI 10.1016/j.psyneuen.2009.07.012; Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x; Tomkins O, 2007, NEUROBIOL DIS, V25, P367, DOI 10.1016/j.nbd.2006.10.006; Tsoporis JN, 1998, J CLIN INVEST, V102, P1609, DOI 10.1172/JCI3077; Tsoporis JN, 2003, AM J PHYSIOL-HEART C, V284, pH193, DOI 10.1152/ajpheart.00161.2002; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; Vernino S, 2007, NEUROTHERAPEUTICS, V4, P305, DOI 10.1016/j.nurt.2007.01.007; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Vezzani A, 2008, EPILEPSY COMPREHENSI, P267; Vincent A, 2011, LANCET NEUROL, V10, P759, DOI 10.1016/S1474-4422(11)70096-5; Vogelbaum MA, 2005, CANCER-AM CANCER SOC, V104, P817, DOI 10.1002/cncr.21220; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027; Zuo Y, 2004, J NEUROSCI, V24, P10999, DOI 10.1523/JNEUROSCI.3934-04.2004	85	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101477	10.1371/journal.pone.0101477	http://dx.doi.org/10.1371/journal.pone.0101477			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988410	Green Published, Green Submitted, gold			2022-12-27	WOS:000341354100097
J	Coetzee, V; Greeff, JM; Stephen, ID; Perrett, DI				Coetzee, Vinet; Greeff, Jaco M.; Stephen, Ian D.; Perrett, David I.			Cross-Cultural Agreement in Facial Attractiveness Preferences: The Role of Ethnicity and Gender	PLOS ONE			English	Article							MATE PREFERENCES; PHYSICAL ATTRACTIVENESS; WOMENS PREFERENCES; FACE RECOGNITION; RACE; HEALTH; BEAUTY; COLOR; JUDGMENTS; IDENTIFICATION	Previous work showed high agreement in facial attractiveness preferences within and across cultures. The aims of the current study were twofold. First, we tested cross-cultural agreement in the attractiveness judgements of White Scottish and Black South African students for own-and other-ethnicity faces. Results showed significant agreement between White Scottish and Black South African observers' attractiveness judgements, providing further evidence of strong cross-cultural agreement in facial attractiveness preferences. Second, we tested whether cross-cultural agreement is influenced by the ethnicity and/or the gender of the target group. White Scottish and Black South African observers showed significantly higher agreement for Scottish than for African faces, presumably because both groups are familiar with White European facial features, but the Scottish group are less familiar with Black African facial features. Further work investigating this discordance in cross-cultural attractiveness preferences for African faces show that Black South African observers rely more heavily on colour cues when judging African female faces for attractiveness, while White Scottish observers rely more heavily on shape cues. Results also show higher cross-cultural agreement for female, compared to male faces, albeit not significantly higher. The findings shed new light on the factors that influence cross-cultural agreement in attractiveness preferences.	[Coetzee, Vinet; Greeff, Jaco M.] Univ Pretoria, Dept Genet, ZA-0002 Pretoria, South Africa; [Stephen, Ian D.] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia; [Perrett, David I.] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland	University of Pretoria; Macquarie University; University of St Andrews	Coetzee, V (corresponding author), Univ Pretoria, Dept Genet, ZA-0002 Pretoria, South Africa.	vinet.coetzee@up.ac.za	Greeff, Jaco M/A-5582-2011; Stephen, Ian/ABA-6218-2021; Coetzee, Vinet/F-2155-2011	Coetzee, Vinet/0000-0003-1716-0804; Stephen, Ian/0000-0001-9714-8295; Greeff, Jaco/0000-0003-2951-6791; Perrett, David/0000-0002-6025-0939	South African National Research Foundation Scarce Skills Postdoctoral Fellowship [76454]	South African National Research Foundation Scarce Skills Postdoctoral Fellowship	VC was supported by a South African National Research Foundation Scarce Skills Postdoctoral Fellowship (Grant nr: 76454). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez L, 2004, EVOLUTIONARY PSYCHOL, V2, P177, DOI DOI 10.1177/1474704904002001223; [Anonymous], 2007, USING MULTIVARIATE S; ANTHONY T, 1992, PERS SOC PSYCHOL B, V18, P296, DOI 10.1177/0146167292183005; Bar-Haim Y, 2006, PSYCHOL SCI, V17, P159, DOI 10.1111/j.1467-9280.2006.01679.x; BENSON PJ, 1993, PERCEPTION, V22, P257, DOI 10.1068/p220257; Bereczkei T, 2004, P ROY SOC B-BIOL SCI, V271, P1129, DOI 10.1098/rspb.2003.2672; Bereczkei T, 2002, PERS INDIV DIFFER, V33, P677, DOI 10.1016/S0191-8869(01)00182-9; BOTHWELL RK, 1989, PERS SOC PSYCHOL B, V15, P19, DOI 10.1177/0146167289151002; Brand A, 2012, J GEN PSYCHOL, V139, P260, DOI 10.1080/00221309.2012.703711; Brooks R, 2011, P ROY SOC B-BIOL SCI, V278, P810, DOI 10.1098/rspb.2010.0964; BURT DM, 1995, P ROY SOC B-BIOL SCI, V259, P137, DOI 10.1098/rspb.1995.0021; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; Coetzee V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048116; Coetzee V, 2011, EAT BEHAV, V12, P72, DOI 10.1016/j.eatbeh.2010.09.006; Coetzee V, 2009, PERCEPTION, V38, P1700, DOI 10.1068/p6423; CUNNINGHAM MR, 1995, J PERS SOC PSYCHOL, V68, P261, DOI 10.1037/0022-3514.68.2.261; Darwin C., 1871, P423; DeBruine LM, 2011, P ROY SOC B-BIOL SCI, V278, P813, DOI 10.1098/rspb.2010.2200; DeBruine LM, 2010, P ROY SOC B-BIOL SCI, V277, P2405, DOI 10.1098/rspb.2009.2184; Garbin C. P, 2012, FZT COMPUTATOR; JONES D, 1993, HUM NATURE-INT BIOS, V4, P271, DOI 10.1007/BF02692202; JONES D, 1995, CURR ANTHROPOL, V36, P723, DOI 10.1086/204427; Kelly DJ, 2007, PSYCHOL SCI, V18, P1084, DOI 10.1111/j.1467-9280.2007.02029.x; Kurzban R, 2005, EVOL HUM BEHAV, V26, P227, DOI 10.1016/j.evolhumbehav.2004.08.012; Laeng B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068395; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Lewin R, 2004, PRINCIPLES HUMAN EVO, P400; Little AC, 2007, EVOL HUM BEHAV, V28, P18, DOI 10.1016/j.evolhumbehav.2006.09.002; Little AC, 2011, PHILOS T R SOC B, V366, P1638, DOI 10.1098/rstb.2010.0404; Lowry R, 2012, SIGNIFICANCE CORRELA; Lowry R, 2012, Z P CALCULATOR; MARTIN JG, 1964, J SOC PSYCHOL, V63, P59, DOI 10.1080/00224545.1964.9922213; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Monin B, 2005, SOC COGNITION, V23, P257, DOI 10.1521/soco.2005.23.3.257; Pascalis O, 2002, SCIENCE, V296, P1321, DOI 10.1126/science.1070223; Penton-Voak IS, 2004, EVOL HUM BEHAV, V25, P355, DOI 10.1016/j.evolhumbehav.2004.06.002; Perrett DI, 2002, P ROY SOC B-BIOL SCI, V269, P873, DOI 10.1098/rspb.2002.1971; Pizzagalli DA, 2002, NEUROIMAGE, V16, P663, DOI 10.1006/nimg.2002.1126; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; ROWLAND DA, 1995, IEEE COMPUT GRAPH, V15, P70, DOI 10.1109/38.403830; Sangrigoli S, 2005, PSYCHOL SCI, V16, P440; Schmitt N, 1996, PSYCHOL ASSESSMENT, V8, P350, DOI 10.1037/1040-3590.8.4.350; Scott IML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013585; Scottish Government, 2004, AN ETHN 2001 CENS SU; SHEPHERD JW, 1973, AM J PSYCHOL, V86, P627, DOI 10.2307/1421948; Silva AS, 2012, EVOL HUM BEHAV, V33, P491, DOI 10.1016/j.evolhumbehav.2012.01.002; Statistics South Africa, 2010, MID YEAR POP EST; Stephen ID, 2012, EVOL HUM BEHAV, V33, P260, DOI 10.1016/j.evolhumbehav.2011.10.003; Stephen ID, 2011, EVOL HUM BEHAV, V32, P216, DOI 10.1016/j.evolhumbehav.2010.09.003; Stephen ID, 2009, INT J PRIMATOL, V30, P845, DOI 10.1007/s10764-009-9380-z; Stephen ID, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005083; Strom MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041193; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Wilkinson C, 2012, CRANIOFACIAL IDENTIFICATION, P1, DOI 10.1017/CBO9781139049566; Zebrowitz L. A., 2011, SCI SOCIAL VISION, P3, DOI [DOI 10.1093/ACPROF:OSO/9780195333176.003.0002, 10.1093/acprof:oso/9780195333176.003.0002]; ZEBROWITZ LA, 1993, J PERS SOC PSYCHOL, V65, P85, DOI 10.1037/0022-3514.65.1.85; Zebrowitz LA, 2012, J CROSS CULT PSYCHOL, V43, P119, DOI 10.1177/0022022111411386	57	56	57	4	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e99629	10.1371/journal.pone.0099629	http://dx.doi.org/10.1371/journal.pone.0099629			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BA	24988325	gold, Green Published			2022-12-27	WOS:000341354100016
J	Vorpahl, M; Schonhofer-Merl, S; Michaelis, C; Flotho, A; Melchior, F; Wessely, R				Vorpahl, Marc; Schoenhofer-Merl, Sabine; Michaelis, Cornelia; Flotho, Annette; Melchior, Frauke; Wessely, Rainer			The Ran GTPase-Activating Protein (RanGAP1) Is Critically Involved in Smooth Muscle Cell Differentiation, Proliferation and Migration following Vascular Injury: Implications for Neointima Formation and Restenosis	PLOS ONE			English	Article							NUCLEOCYTOPLASMIC TRANSPORT; COMPLEX; EXPRESSION; IMPORT; ATHEROSCLEROSIS; NUCLEOPORIN; MECHANISMS; INHIBITORS; MYOCARDIN; GROWTH	Differentiation and dedifferentiation, accompanied by proliferation play a pivotal role for the phenotypic development of vascular proliferative diseases (VPD), such as restenosis. Increasing evidence points to an essential role of regulated nucleoporin expression in the choice between differentiation and proliferation. However, whether components of the Ran GTPase cycle, which is of pivotal importance for both nucleocytoplasmic transport and for mitotic progression, are subject to similar regulation in VPD is currently unknown. Here, we show that differentiation of human coronary artery smooth muscle cell (CASMC) to a contractile phenotype by stepwise serum depletion leads to significant reduction of RanGAP1 protein levels. The inverse event, dedifferentiation of cells, was assessed in the rat carotid artery balloon injury model, a well-accepted model for neointima formation and restenosis. As revealed by temporospatial analysis of RanGAP1 expression, neointima formation in rat carotid arteries was associated with a significant upregulation of RanGAP1 expression at 3 and 7 days after balloon injury. Of note, neointimal cells located at the luminal surface revealed persistent RanGAP1 expression, as opposed to cells in deeper layers of the neointima where RanGAP1 expression was less or not detectable at all. To gain first evidence for a direct influence of RanGAP1 levels on differentiation, we reduced RanGAP1 in human coronary artery smooth muscle cells by siRNA. Indeed, downregulation of the essential RanGAP1 protein by 50% induced a differentiated, spindle-like smooth muscle cell phenotype, accompanied by an upregulation of the differentiation marker desmin. Reduction of RanGAP1 levels also resulted in a reduction of mitogen induced cellular migration and proliferation as well as a significant upregulation of the cyclin-dependent kinase inhibitor p27(KIP1), without evidence for cellular necrosis. These findings suggest that RanGAP1 plays a critical role in smooth muscle cell differentiation, migration and proliferation in vitro and in vivo. Appropriate modulation of RanGAP1 expression may thus be a strategy to modulate VPD development such as restenosis.	[Vorpahl, Marc] Univ Witten Herdecke, Dept Cardiol, HELIOS Klinikum Wuppertal, Witten, Germany; [Schoenhofer-Merl, Sabine; Michaelis, Cornelia; Wessely, Rainer] Tech Univ Munich, Deutsch Herzzentrum Muenchen, D-80290 Munich, Germany; [Schoenhofer-Merl, Sabine; Michaelis, Cornelia; Wessely, Rainer] Tech Univ Munich, Med Klin 1, Klinikum Rechts Isar, D-80290 Munich, Germany; [Flotho, Annette; Melchior, Frauke] Univ Heidelberg ZMBH, Zentrum Mol Biol, DKFZ ZMBH Alliance, Heidelberg, Germany; [Wessely, Rainer] Zentrum Herz Gefaess Lungenmed, Cologne, Germany	Helios Kliniken; Witten Herdecke University; German Heart Centre Munich; Technical University of Munich; Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Vorpahl, M (corresponding author), Univ Witten Herdecke, Dept Cardiol, HELIOS Klinikum Wuppertal, Witten, Germany.	marc.vorpahl@helios-kliniken.de; rwessely@web.de	Melchior, Frauke/E-2014-2014	Melchior, Frauke/0000-0001-9546-8797				Asally M, 2011, FEBS J, V278, P610, DOI 10.1111/j.1742-4658.2010.07982.x; CLOWES AW, 1983, LAB INVEST, V49, P208; D'Angelo MA, 2012, DEV CELL, V22, P446, DOI 10.1016/j.devcel.2011.11.021; Diez-Juan Antonio, 2003, Current Vascular Pharmacology, V1, P99; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; Faustino RS, 2007, MOL PHARMACOL, V71, P438, DOI 10.1124/mol.105.021667; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; GORDON D, 1990, P NATL ACAD SCI USA, V87, P4600, DOI 10.1073/pnas.87.12.4600; Goukassian D, 2001, FASEB J, V15, P1877, DOI 10.1096/fj.01-0065com; Hall MN, 2011, DEV BIOL, V357, P248, DOI 10.1016/j.ydbio.2011.06.032; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Jaschke B, 2004, FASEB J, V18, P1285, DOI 10.1096/fj.04-1646fje; Kiyan Y, 2012, ARTERIOSCL THROM VAS, V32, P110, DOI 10.1161/ATVBAHA.111.234369; LIBBY P, 1984, J CELL PHYSIOL, V118, P317, DOI 10.1002/jcp.1041180315; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; LIBBY P, 1983, J CELL PHYSIOL, V115, P217, DOI 10.1002/jcp.1041150217; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Melchior F, 1998, TRENDS CELL BIOL, V8, P175, DOI 10.1016/S0962-8924(98)01252-5; Okamoto E, 1996, LAB INVEST, V74, P120; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; ROSS R, 1973, SCIENCE, V180, P1332, DOI 10.1126/science.180.4093.1332; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Sartore S, 1999, Rev Physiol Biochem Pharmacol, V134, P235; Shi WY, 2004, DEV BIOL, V270, P106, DOI 10.1016/j.ydbio.2004.02.011; Stevenson AS, 2001, EXP CELL RES, V263, P118, DOI 10.1006/excr.2000.5107; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Swaminathan S, 2004, J CELL BIOL, V164, P965, DOI 10.1083/jcb.200309126; Tanner FC, 1998, CIRC RES, V82, P396, DOI 10.1161/01.RES.82.3.396; Vidal A, 2000, GENE, V247, P1, DOI 10.1016/S0378-1119(00)00092-5; Wei GL, 1997, CIRC RES, V80, P418, DOI 10.1161/01.res.0000435858.35902.ea; Werner A, 2012, MOL CELL, V46, P287, DOI 10.1016/j.molcel.2012.02.017; Wessely R, 2003, HUM MOL GENET, V12, P177, DOI 10.1093/hmg/ddg018; Yoshida T, 2004, ARTERIOSCL THROM VAS, V24, P1596, DOI 10.1161/01.ATV.0000137190.63214.c5	36	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101519	10.1371/journal.pone.0101519	http://dx.doi.org/10.1371/journal.pone.0101519			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988324	Green Submitted, Green Published, gold			2022-12-27	WOS:000341354100104
J	Hintsala, H; Kentta, TV; Tulppo, M; Kiviniemi, A; Huikuri, HV; Mantysaari, M; Keinanen-Kiukaannemi, S; Bloigu, R; Herzig, KH; Antikainen, R; Rintamaki, H; Jaakkola, JJK; Ikaheimo, TM				Hintsala, Heidi; Kentta, Tuomas V.; Tulppo, Mikko; Kiviniemi, Antti; Huikuri, Heikki V.; Mantysaari, Matti; Keinanen-Kiukaannemi, Sirkka; Bloigu, Risto; Herzig, Karl-Heinz; Antikainen, Riitta; Rintamaki, Hannu; Jaakkola, Jouni J. K.; Ikaheimo, Tiina M.			Cardiac Repolarization and Autonomic Regulation during Short-Term Cold Exposure in Hypertensive Men: An Experimental Study	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; HEART-RATE-VARIABILITY; BLOOD-PRESSURE; VENTRICULAR REPOLARIZATION; ELECTROCARDIOGRAPHIC MANIFESTATIONS; ATRIAL-FIBRILLATION; SEASONAL-VARIATION; EUROPEAN-SOCIETY; WATER IMMERSION; NERVOUS-SYSTEM	Objectives: The aim of our study was to assess the effect of short-term cold exposure, typical in subarctic climate, on cardiac electrical function among untreated middle-aged hypertensive men. Methods: We conducted a population-based recruitment of 51 hypertensive men and a control group of 32 men without hypertension (age 55-65 years) who underwent whole-body cold exposure (15 min exposure to temperature -10 degrees C, wind 3 m/s, winter clothes). Conduction times and amplitudes, vectorcardiography, arrhythmias, and heart rate variability (autonomic nervous function) were assessed. Results: Short-term cold exposure increased T-peak to T-end interval from 67 to 72 ms (p<0.001) and 71 to 75 ms (p<0.001) and T-wave amplitude from 0.12 to 0.14 mV (p<0.001) and from 0.17 to 0.21 mV (p<0.001), while QTc interval was shortened from 408 to 398 ms (p<0.001) and from 410 to 401 ms (p<0.001) among hypertensive men and controls, respectively. Cold exposure increased both low (from 390 to 630 ms(2) (p<0.001) and 380 to 700 ms(2) (p<0.001), respectively) and high frequency heart rate variability (from 90 to 190 ms(2) (p<0.001) and 150 to 300 ms(2) (p<0.001), respectively), while low-to-high frequency-ratio was reduced. In addition, the frequency of ventricular ectopic beats increased slightly during cold exposure. The cold induced changes were similar between untreated hypertensive men and controls. Conclusions: Short-term cold exposure with moderate facial and mild whole body cooling resulted in prolongation of T-peak to T-end interval and higher T-wave amplitude while QTc interval was shortened. These changes of ventricular repolarization may have resulted from altered cardiac autonomic regulation and were unaffected by untreated hypertension.	[Hintsala, Heidi; Jaakkola, Jouni J. K.; Ikaheimo, Tiina M.] Univ Oulu, Ctr Environm & Resp Hlth Res, Oulu, Finland; [Hintsala, Heidi; Kentta, Tuomas V.; Huikuri, Heikki V.; Antikainen, Riitta; Jaakkola, Jouni J. K.; Ikaheimo, Tiina M.] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Hintsala, Heidi; Kentta, Tuomas V.; Huikuri, Heikki V.; Antikainen, Riitta; Jaakkola, Jouni J. K.; Ikaheimo, Tiina M.] Univ Oulu, Oulu, Finland; [Kentta, Tuomas V.; Huikuri, Heikki V.] Univ Oulu, Dept Internal Med, Inst Clin Med, SF-90220 Oulu, Finland; [Tulppo, Mikko; Kiviniemi, Antti] Verve Res, Dept Exercise & Med Physiol, Oulu, Finland; [Mantysaari, Matti; Keinanen-Kiukaannemi, Sirkka; Antikainen, Riitta; Jaakkola, Jouni J. K.; Ikaheimo, Tiina M.] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Keinanen-Kiukaannemi, Sirkka] Oulu Univ Hosp, Unit Gen Practice, Oulu, Finland; [Bloigu, Risto] Univ Oulu, Med Informat & Stat Res Grp, Oulu, Finland; [Herzig, Karl-Heinz; Rintamaki, Hannu] Univ Oulu, Dept Physiol, Inst Biomed, Oulu, Finland; [Herzig, Karl-Heinz; Rintamaki, Hannu] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Herzig, Karl-Heinz] Kuopio Univ Hosp, Dept Psychiat, SF-70210 Kuopio, Finland; [Antikainen, Riitta] Oulu City Hosp, Oulu, Finland; [Rintamaki, Hannu] Finnish Inst Occupat Hlth, Oulu, Finland; [Jaakkola, Jouni J. K.] Oulu Univ Hosp, Dept Med, Oulu, Finland; [Tulppo, Mikko] London S Bank Univ, Dept Appl Sci, London, England	University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; Kuopio University Hospital; University of Eastern Finland; Finnish Institute of Occupational Health; University of Oulu; London South Bank University	Ikaheimo, TM (corresponding author), Univ Oulu, Ctr Environm & Resp Hlth Res, Oulu, Finland.	tiina.ikaheimo@oulu.fi	Kiviniemi, Antti M/D-5288-2015; Jaakkola, Jouni J.K./G-4314-2012	Kiviniemi, Antti M/0000-0002-1160-493X; Kentta, Tuomas/0000-0003-2943-7188; Tulppo, Mikko/0000-0001-5598-9109; Hintsala, Heidi/0000-0002-0910-0847; Jaakkola, Jouni/0000-0003-4168-4683; Ikaheimo, Tiina Maria/0000-0002-2763-6004	National Institute for Health and Welfare; Paavo Nurmi Foundation; Emil Aaltonen Foundation; Ida Montin Foundation	National Institute for Health and Welfare; Paavo Nurmi Foundation; Emil Aaltonen Foundation; Ida Montin Foundation	The study was funded through grants from the National Institute for Health and Welfare as well as Paavo Nurmi, Emil Aaltonen and Ida Montin Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand K, 2007, AM J CARDIOL, V100, P1134, DOI 10.1016/j.amjcard.2007.04.063; Andersen MP, 2008, J ELECTROCARDIOL, V41, P557, DOI 10.1016/j.jelectrocard.2008.07.021; Arai K, 2013, AUTON NEUROSCI-BASIC, V173, P53, DOI 10.1016/j.autneu.2012.11.006; Aslam AF, 2006, AM J MED, V119, P297, DOI 10.1016/j.amjmed.2005.09.062; Backman C, 1991, ARCTIC MED RES S, P526; Barnett AG, 2007, BLOOD PRESS MONIT, V12, P195, DOI 10.1097/MBP.0b013e3280b083f4; Bernardo D, 2000, NATURE, V403, P40; Chen PS, 2007, HEART RHYTHM, V4, pS61, DOI 10.1016/j.hrthm.2006.12.006; Conrath CE, 2006, PROG BIOPHYS MOL BIO, V92, P269, DOI 10.1016/j.pbiomolbio.2005.05.009; Daskalov IK, 1999, MED ENG PHYS, V21, P37, DOI 10.1016/S1350-4533(99)00016-8; de Souza D, 2007, J ELECTROCARDIOL, V40, P47, DOI 10.1016/j.jelectrocard.2006.08.094; Dilaveris P, 2000, CLIN CARDIOL, V23, P600, DOI 10.1002/clc.4960230811; EDENBRANDT L, 1988, J ELECTROCARDIOL, V21, P361, DOI 10.1016/0022-0736(88)90113-6; Fares Auda, 2013, N Am J Med Sci, V5, P266, DOI 10.4103/1947-2714.110430; Gallerani M, 2011, CLIN CARDIOL, V34, P389, DOI 10.1002/clc.20895; Grassi G, 2010, AM J HYPERTENS, V23, P1052, DOI 10.1038/ajh.2010.154; Hintsala H, 2014, AM J HYPERTENS, V27, P656, DOI 10.1093/ajh/hpt136; HUIKURI HV, 1993, CIRCULATION, V87, P1220, DOI 10.1161/01.CIR.87.4.1220; ISO, 1995, 105511995 ISO; ISO, 2007, 99202007 ISO; KARJALAINEN J, 1994, J AM COLL CARDIOL, V23, P1547, DOI 10.1016/0735-1097(94)90654-8; Keatinge WR, 1997, LANCET, V349, P1341, DOI 10.1016/S0140-6736(96)12338-2; Kentta T, 2010, ANN NONINVAS ELECTRO, V15, P264, DOI 10.1111/j.1542-474X.2010.00374.x; Khurana RK, 2006, CLIN AUTON RES, V16, P202, DOI 10.1007/s10286-006-0332-9; Komulainen S, 2000, EUR J CLIN PHARMACOL, V56, P637, DOI 10.1007/s002280000208; KRALIOS FA, 1975, AM J PHYSIOL, V228, P1621, DOI 10.1152/ajplegacy.1975.228.5.1621; Leppaluoto J, 2005, ACTA PHYSIOL SCAND, V184, P255, DOI 10.1111/j.1365-201X.2005.01464.x; Makinen TM, 2006, INT J BIOMETEOROL, V51, P27, DOI 10.1007/s00484-006-0040-0; Manfredini R, 2009, AM J EMERG MED, V27, P1097, DOI 10.1016/j.ajem.2008.08.009; Manolis AJ, 2012, J HYPERTENS, V30, P239, DOI 10.1097/HJH.0b013e32834f03bf; Mattu A, 2002, AM J EMERG MED, V20, P314, DOI 10.1053/ajem.2002.32633; Mehta RH, 2002, CIRCULATION, V106, P1110, DOI 10.1161/01.CIR.0000027568.39540.4B; Murphy BP, 2009, MED CLIN N AM, V93, P681, DOI 10.1016/j.mcna.2009.02.003; Page RL, 2004, HEART RHYTHM, V1, P435, DOI 10.1016/j.hrthm.2004.06.001; Palm F, 2013, EUR J EPIDEMIOL, V28, P373, DOI 10.1007/s10654-013-9772-4; Parati G, 2008, J HYPERTENS, V26, P1505, DOI 10.1097/HJH.0b013e328308da66; Parati G, 2012, EUR HEART J, V33, P1058, DOI 10.1093/eurheartj/ehs041; Pardey J, 2004, COMPUT CARDIOL, V31, P373, DOI 10.1109/CIC.2004.1442950; Sanchez-Gonzalez MA, 2013, AUTON NEUROSCI-BASIC, V176, P95, DOI 10.1016/j.autneu.2013.02.002; Schmid JP, 2009, EUR J HEART FAIL, V11, P903, DOI 10.1093/eurjhf/hfp114; Shattock MJ, 2012, J PHYSIOL-LONDON, V590, P3219, DOI 10.1113/jphysiol.2012.229864; Sundaram S, 2008, AM J PHYSIOL-HEART C, V294, pH490, DOI 10.1152/ajpheart.00046.2007; Tulppo MP, 2011, CLIN PHYSIOL FUNCT I, V31, P272, DOI 10.1111/j.1475-097X.2011.01012.x; Tulppo MP, 2005, CIRCULATION, V112, P314, DOI 10.1161/CIRCULATIONAHA.104.523712; Vaseghi M, 2008, PROG CARDIOVASC DIS, V50, P404, DOI 10.1016/j.pcad.2008.01.003; Vaseghi M, 2013, AM J PHYSIOL-HEART C, V305, pH1020, DOI 10.1152/ajpheart.00056.2013; Wierzba T, 2011, GEORGIAN MED NEWS, V196-197, P28; Wu JS, 2008, J AM COLL CARDIOL, V51, P1896, DOI 10.1016/j.jacc.2007.12.053	48	26	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e99973	10.1371/journal.pone.0099973	http://dx.doi.org/10.1371/journal.pone.0099973			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983379	Green Published, Green Submitted, gold			2022-12-27	WOS:000339635000014
J	Robinson, BG; Franke, A; Derocher, AE				Robinson, Barry G.; Franke, Alastair; Derocher, Andrew E.			The Influence of Weather and Lemmings on Spatiotemporal Variation in the Abundance of Multiple Avian Guilds in the Arctic	PLOS ONE			English	Article							CLIMATE-CHANGE; REPRODUCTIVE SUCCESS; BREEDING PHENOLOGY; ELLESMERE-ISLAND; ALEXANDRA FJORD; NESTING SUCCESS; TESHEKPUK LAKE; BYLOT ISLAND; HABITAT USE; SNOW COVER	Climate change is occurring more rapidly in the Arctic than other places in the world, which is likely to alter the distribution and abundance of migratory birds breeding there. A warming climate can provide benefits to birds by decreasing spring snow cover, but increases in the frequency of summer rainstorms, another product of climate change, may reduce foraging opportunities for insectivorous birds. Cyclic lemming populations in the Arctic also influence bird abundance because Arctic foxes begin consuming bird eggs when lemmings decline. The complex interaction between summer temperature, precipitation, and the lemming cycle hinder our ability to predict how Arctic-breeding birds will respond to climate change. The main objective of this study was to investigate the relationship between annual variation in weather, spring snow cover, lemming abundance and spatiotemporal variation in the abundance of multiple avian guilds in a tundra ecosystem in central Nunavut, Canada: songbirds, shorebirds, gulls, loons, and geese. We spatially stratified our study area based on vegetation productivity, terrain ruggedness, and freshwater abundance, and conducted distance sampling to estimate strata-specific densities of each guild during the summers of 2010-2012. We also monitored temperature, rainfall, spring snow cover, and lemming abundance each year. Spatial variation in bird abundance matched what was expected based on previous ecological knowledge, but weather and lemming abundance also significantly influenced the abundance of some guilds. In particular, songbirds were less abundant during the cool, wet summer with moderate snow cover, and shorebirds and gulls declined with lemming abundance. The abundance of geese did not vary over time, possibly because benefits created by moderate spring snow cover were offset by increased fox predation when lemmings were scarce. Our study provides an example of a simple way to monitor the correlation between weather, spring snow cover, lemming abundance, and spatiotemporal variations in Arctic-breeding birds.	[Robinson, Barry G.; Derocher, Andrew E.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Franke, Alastair] Univ Alberta, Canadian Circumpolar Inst, Edmonton, AB, Canada	University of Alberta; University of Alberta	Robinson, BG (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	bgrobi@gmail.com	Robinson, Barry/O-4406-2014; Derocher, Andrew/J-4469-2012	Robinson, Barry/0000-0002-2646-2508; Derocher, Andrew/0000-0002-1104-7774	Government of Nunavut; Nunavut Wildlife Management Board; Wilson Ornithological Society; Canadian Wildlife Federation; Canadian Circumpolar Institute; Aboriginal and Northern Affairs Canada; Arctic Net; Peregrine Fund; Natural Sciences and Engineering Research Council of Canada [305472-2008, 261231-2008]; Alberta Innovates Technology Futures; W. Garfield Weston Fountain	Government of Nunavut; Nunavut Wildlife Management Board; Wilson Ornithological Society; Canadian Wildlife Federation; Canadian Circumpolar Institute; Aboriginal and Northern Affairs Canada; Arctic Net; Peregrine Fund; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates Technology Futures; W. Garfield Weston Fountain	This project was funded by the Government of Nunavut (www.gov.nu.ca; grant to A. Franke), the Nunavut Wildlife Management Board (www.nwmb.com; grant to A. Franke), the Wilson Ornithological Society (www.wilsonsociety.org; Paul A. Stewart Award to B. Robinson), the Canadian Wildlife Federation (www.cwf-fcf.org/; Foundation Grant to B. Robinson), the Canadian Circumpolar Institute (www.cci.ualberta.ca; Circumpolar/Boral Alberta Research grant to B. Robinson), Aboriginal and Northern Affairs Canada (www.aadnc-aandc.gc.c; Northern Science Training Program grant to B. Robinson), Arctic Net (www.arcticnet.ulaval.ca; grant to A. Franke), The Peregrine Fund (www.peregrinefund.org; grant to A. Franke) the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca; Canadian Graduate Scholarship, Doctoral, to B. Robinson; Discovery Grant no. 305472-2008 and Northern Research Supplement no. 261231-2008 to A. Derocher), Alberta Innovates Technology Futures (www.albertatechfutures.ca; Graduate Student Scholarship to B. Robinson), and the W. Garfield Weston Fountain (Award for Northern Research to B. Robinson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anctil A, 2013, OECOLOGIA, P1; Andres BA, 2012, ARCTIC, V65, P411; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; Ashley NT, 2012, J EXPT ZOOLOGY A, V319A, P10; Aubry LM, 2013, GLOBAL CHANGE BIOL, V19, P149, DOI 10.1111/gcb.12013; Barr JF, 2000, BIRDS N AM ONLINE; Bety J, 2002, J ANIM ECOL, V71, P88, DOI 10.1046/j.0021-8790.2001.00581.x; Bety J, 2001, OIKOS, V93, P388, DOI 10.1034/j.1600-0706.2001.930304.x; Bliss L.C., 1973, Annual Res Ecol Syst, V4, P359, DOI 10.1146/annurev.es.04.110173.002043; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Blomqvist S, 2002, OECOLOGIA, V133, P146, DOI 10.1007/s00442-002-1017-2; Boelman NT, 2003, OECOLOGIA, V135, P414, DOI 10.1007/s00442-003-1198-3; Bolduc E, 2013, CAN ENTOMOL, V145, P155, DOI 10.4039/tce.2013.4; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; Brommer JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043648; Brown RD, 2011, CRYOSPHERE, V5, P219, DOI 10.5194/tc-5-219-2011; Buckland S.T., 2001, pi; Buckland ST, 2009, J AGR BIOL ENVIR ST, V14, P432, DOI 10.1198/jabes.2009.08030; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Callaghan Terry V., 2005, P243; Carlson TN, 1997, REMOTE SENS ENVIRON, V62, P241, DOI 10.1016/S0034-4257(97)00104-1; CUSHING DH, 1969, J CONSEIL, V33, P81; CUSTER TW, 1978, CONDOR, V80, P295, DOI 10.2307/1368039; Dickey MH, 2008, GLOBAL CHANGE BIOL, V14, P1973, DOI 10.1111/j.1365-2486.2008.01622.x; Earnst SL, 2006, HYDROBIOLOGIA, V567, P227, DOI 10.1007/s10750-006-0042-2; FORBES G, 1992, ARCTIC, V45, P295; Fortin D, 2000, CONDOR, V102, P163, DOI 10.1650/0010-5422(2000)102[0163:BTARBO]2.0.CO;2; FREEDMAN B, 1982, CAN FIELD NAT, V96, P56; Gaston AJ, 2012, ICES J MAR SCI, V69, P1218, DOI 10.1093/icesjms/fss040; Gaston AJ, 2012, POLAR BIOL, V35, P1221, DOI 10.1007/s00300-012-1168-5; Gauthier G, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0482; Gilg O, 2006, OIKOS, V113, P193, DOI 10.1111/j.2006.0030-1299.14125.x; Gilg O, 2009, GLOBAL CHANGE BIOL, V15, P2634, DOI 10.1111/j.1365-2486.2009.01927.x; Grabowski MM, 2013, POLAR BIOL, V36, P1097, DOI 10.1007/s00300-013-1332-6; Gruyer N, 2008, CAN J ZOOL, V86, P910, DOI 10.1139/Z08-059; Hall D. K., 2006, MODIS TERRA SNOW COV, DOI 10.5067/ACYTYZB9BEOS; HATCH JJ, 2002, BIRDS N AM ONLINE; Hendricks P, 2012, BIRDS N AM ONLINE; Hoye TT, 2007, CURR BIOL, V17, pR449, DOI 10.1016/j.cub.2007.04.047; Huemmrich KF, 2010, REMOTE SENS ENVIRON, V114, P481, DOI 10.1016/j.rse.2009.10.003; HUGHES RJ, 1994, J WILDLIFE MANAGE, V58, P536, DOI 10.2307/3809326; Hussell DJT, 2002, BIRDS N AM ONLINE; Ims RA, 2005, BIOSCIENCE, V55, P311, DOI 10.1641/0006-3568(2005)055[0311:TICITE]2.0.CO;2; Jensen GH, 2014, POLAR BIOL, V37, P1, DOI 10.1007/s00300-013-1404-7; Johnson O. W., 2010, BIRDS N AM ONLINE; Kattsov V. M., 2005, ARCTIC CLIMATE IMPAC, P101; Kausrud KL, 2008, NATURE, V456, P93, DOI 10.1038/nature07442; Kendall S, 2011, GYRFALCONS PTARMIGAN; Krebs CJ, 2006, CLIM RES, V32, P143, DOI 10.3354/cr032143; Latour PB, 2005, ARCTIC, V58, P55; Lecomte N, 2009, ECOLOGY, V90, P465, DOI 10.1890/08-0215.1; Liebezeit JR, 2011, ARCTIC, V64, P32, DOI 10.14430/arctic4078; LINDHOLM A, 1994, CONDOR, V96, P898, DOI 10.2307/1369100; Madsen J, 2007, POLAR BIOL, V30, P1363, DOI 10.1007/s00300-007-0296-9; Marques FFC, 2003, BIOMETRICS, V59, P924, DOI 10.1111/j.0006-341X.2003.00107.x; Marshall IB, 1996, ENVIRON MONIT ASSESS, V39, P25, DOI 10.1007/BF00396133; McKinnon L, 2012, CAN J ZOOL, V90, P961, DOI 10.1139/Z2012-064; McKinnon L, 2013, SCI REPORTS, V3, P6; McKinnon L, 2013, OIKOS, V122, P1042, DOI 10.1111/j.1600-0706.2012.20708.x; Meltofte H., 2007, EFFECTS CLIMATE VARI; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; Montgomerie R., 2011, BIRDS N AM ONLINE; Moody AT, 2012, J ORNITHOL, V153, P1067, DOI 10.1007/s10336-012-0836-0; Morrison RIG, 1997, ARCTIC, V50, P55; Mowbray Thomas B., 2002, BIRDS N AM ONLINE; Nol E, 1999, BIRDS N AM ONLINE; Nolet BA, 2013, J ANIM ECOL, V82, P804, DOI 10.1111/1365-2656.12060; Parmelee D.F., 1992, BIRDS N AM ONLINE; Pearce-Higgins JW, 2005, OECOLOGIA, V143, P470, DOI 10.1007/s00442-004-1820-z; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Perkins DE, 2007, POLAR REC, V43, P135, DOI 10.1017/S0032247407006092; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; Pokrovsky I, 2012, POLAR RES, V31, DOI 10.3402/polar.v31i0.17294; Post E, 2008, PHILOS T R SOC B, V363, P2369, DOI 10.1098/rstb.2007.2207; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Provencher JF, 2012, MARINE; RCoreTeam, 2012, R LANG ENV STAT COMP; Russell RW, 2002, BIRDS N AM ONLINE; Sammler JE, 2008, CONDOR, V110, P325, DOI 10.1525/cond.2008.8438; Schekkerman H, 2003, OECOLOGIA, V134, P332, DOI 10.1007/s00442-002-1124-0; Schekkerman H, 2001, AUK, V118, P944, DOI 10.1642/0004-8038(2001)118[0944:PERISE]2.0.CO;2; Skinner WR, 1998, GLOB CHANGE BIOL, V4, P3, DOI 10.1046/j.1365-2486.1998.00097.x; Smith PA, 2010, J AVIAN BIOL, V41, P292, DOI 10.1111/j.1600-048X.2009.04815.x; Sokolov V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050335; Steiger SS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1016; Stenhouse IJ, 2001, CONDOR, V103, P98, DOI 10.1650/0010-5422(2001)103[0098:RBOSSG]2.0.CO;2; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; Therrien JF, 2014, ECOLOGY, V95, P56, DOI 10.1890/13-0458.1; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Tracy D. M., 2002, BIRDS N AM ONLINE; Trefry SA, 2010, ARCTIC, V63, P308; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; Tulp I, 2008, ARCTIC, V61, P48; Tulp I, 2009, AUK, V126, P155, DOI 10.1525/auk.2009.07181; UNDERHILL LG, 1993, IBIS, V135, P277, DOI 10.1111/j.1474-919X.1993.tb02845.x; Van der Putten WH, 2010, PHILOS T R SOC B, V365, P2025, DOI 10.1098/rstb.2010.0037; Weiser E, 2012, BIRDS N AM ONLINE; Weiser EL, 2011, ARCTIC, V64, P220; Wiley R. H., 1998, BIRDS N AM ONLINE; [No title captured]; [No title captured]	102	19	20	5	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101495	10.1371/journal.pone.0101495	http://dx.doi.org/10.1371/journal.pone.0101495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983471	gold, Green Submitted, Green Published			2022-12-27	WOS:000339635000115
J	Yu, MF; Ast, S; Yu, Q; Lo, ATS; Flehr, R; Todd, MH; Rutledge, PJ				Yu, Mingfeng; Ast, Sandra; Yu, Qun; Lo, Anthony T. S.; Flehr, Roman; Todd, Matthew H.; Rutledge, Peter J.			Incorporating a Piperidinyl Group in the Fluorophore Extends the Fluorescence Lifetime of Click-Derived Cyclam-Naphthalimide Conjugates	PLOS ONE			English	Article							PHOTOINDUCED ELECTRON-TRANSFER; TRANSITION-METAL IONS; RATIOMETRIC FLUORESCENT; ARYL AZIDES; CHEMOSENSORS; RECOGNITION; SENSORS; COMPLEXES; MECHANISM; AMINES	Ligands incorporating a tetraazamacrocycle receptor, a 'click'-derived triazole and a 1,8-naphthalimide fluorophore have proven utility as probes for metal ions. Three new cyclam-based molecular probes are reported, in which a piperidinyl group has been introduced at the 4-position of the naphthalimide fluorophore. These compounds have been synthesized using the copper(I)-catalyzed azide-alkyne Huisgen cycloaddition and their photophysical properties studied in detail. The alkylamino group induces the expected red-shift in absorption and emission spectra relative to the simple naphthalimide derivatives and gives rise to extended fluorescence lifetimes in aqueous buffer. The photophysical properties of these systems are shown to be highly solvent-dependent. Screening the fluorescence responses of the new conjugates to a wide variety of metal ions reveals significant and selective fluorescence quenching in the presence of copper(II), yet no fluorescence enhancement with zinc(II) as observed previously for the simple naphthalimide derivatives. Reasons for this different behaviour are proposed. Cytotoxicity testing shows that these new cyclam-triazole-dye conjugates display little or no toxicity against either DLD-1 colon carcinoma cells or MDA-MB-231 breast carcinoma cells, suggesting a potential role for these and related systems in biological sensing applications.	[Yu, Mingfeng; Ast, Sandra; Yu, Qun; Lo, Anthony T. S.; Todd, Matthew H.; Rutledge, Peter J.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia; [Flehr, Roman] Univ Potsdam, Inst Chem, Potsdam, Brandenburg, Germany	University of Sydney; University of Potsdam	Todd, MH (corresponding author), Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia.	matthew.todd@sydney.edu.au; peter.rutledge@sydney.edu.au	Rutledge, Peter J/D-6253-2012; Yu, Mingfeng/F-4325-2013; Todd, Matthew/S-2678-2018	Yu, Mingfeng/0000-0002-0860-4816; Rutledge, Peter/0000-0002-0767-5196; Lo, Anthony/0000-0002-5921-9854; Todd, Matthew/0000-0001-7096-4751	National Breast Cancer Fund [NC-10-69]; Australian Research Council [DP120104035]; University of Sydney	National Breast Cancer Fund; Australian Research Council(Australian Research Council); University of Sydney(University of Sydney)	This work was supported by the National Breast Cancer Fund (http://www.nbcf.org.au/) with Novel Concept Grant NC-10-69, the Australian Research Council (http://www.arc.gov.au/) with Discovery Project Grant DP120104035, and the University of Sydney, with a University of Sydney International Scholarship (USydIS) to Mingfeng Yu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen J, 2005, SYNLETT, P2209, DOI 10.1055/s-2005-872248; Ast S, 2012, EUR J INORG CHEM, P5611, DOI 10.1002/ejic.201201072; Baier MC, 2009, J AM CHEM SOC, V131, P14267, DOI 10.1021/ja905077c; Dai HL, 2012, CHEM-EUR J, V18, P11188, DOI 10.1002/chem.201201604; Dai HL, 2012, CHINESE J CHEM, V30, P267, DOI 10.1002/cjoc.201180481; Dai HL, 2011, BIOORG MED CHEM LETT, V21, P5141, DOI 10.1016/j.bmcl.2011.07.085; De Costa MDP, 2004, J PHOTOCH PHOTOBIO A, V162, P591, DOI 10.1016/S1010-6030(03)00419-2; DE SILVA AP, 1995, ANGEW CHEM INT EDIT, V34, P1728, DOI 10.1002/anie.199517281; Dean KM, 2012, BBA-MOL CELL RES, V1823, P1406, DOI 10.1016/j.bbamcr.2012.04.001; Ding GH, 2008, RES CHEM INTERMEDIAT, V34, P299, DOI 10.1163/156856708783623401; Fegley MEA, 2012, INORG CHIM ACTA, V381, P78, DOI 10.1016/j.ica.2011.11.040; Filarowski A, 2010, PHOTOCH PHOTOBIO SCI, V9, P996, DOI 10.1039/c0pp00035c; Grabchev I, 2012, CURR MED CHEM, V19, P4976; Gunnlaugsson T, 2003, TETRAHEDRON LETT, V44, P6575, DOI 10.1016/S0040-4039(03)01699-X; Huang JH, 2009, ORG BIOMOL CHEM, V7, P1299, DOI 10.1039/b818611a; Hyman LM, 2012, COORDIN CHEM REV, V256, P2333, DOI 10.1016/j.ccr.2012.03.009; Jeong Y, 2012, INORG CHIM ACTA, V381, P2, DOI 10.1016/j.ica.2011.09.011; Jobe K, 2011, CHEM COMMUN, V47, P6036, DOI 10.1039/c1cc11213a; Kim BJ, 2011, CHEM SCI, V2, P2135, DOI 10.1039/c1sc00337b; KRONICK MN, 1983, CLIN CHEM, V29, P1582; Lau YH, 2011, CHEM-EUR J, V17, P2850, DOI 10.1002/chem.201002477; LIPPERT E, 1955, Z NATURFORSCH PT A, V10, P541, DOI 10.1515/zna-1955-0707; Markiewicz JT, 2010, J ORG CHEM, V75, P4887, DOI 10.1021/jo101002p; MASUHARA H, 1984, J PHYS CHEM-US, V88, P5868, DOI 10.1021/j150668a026; MATAGA N, 1956, B CHEM SOC JPN, V29, P465, DOI 10.1246/bcsj.29.465; MATAGA N, 1955, B CHEM SOC JPN, V28, P690, DOI 10.1246/bcsj.28.690; Mbatia HW, 2012, BIOCHEMISTRY-US, V51, P7212, DOI 10.1021/bi3001769; MCCLURE DS, 1952, J CHEM PHYS, V20, P682, DOI 10.1063/1.1700516; Mednykh YA, 2004, RUSS J GEN CHEM+, V74, P1728, DOI 10.1007/s11176-005-0091-7; Parkesh R, 2007, ORG BIOMOL CHEM, V5, P310, DOI 10.1039/b614529a; Schaferling M, 2012, ANGEW CHEM INT EDIT, V51, P3532, DOI 10.1002/anie.201105459; Singh N, 2010, TETRAHEDRON LETT, V51, P3385, DOI 10.1016/j.tetlet.2010.04.099; Tagg T, 2008, ACTA CRYSTALLOGR C, V64, pO388, DOI 10.1107/S0108270108016120; Tamanini E, 2010, INORG CHEM, V49, P3789, DOI 10.1021/ic901939x; Tamanini E, 2009, CHEM-EUR J, V15, P3720, DOI 10.1002/chem.200802425; Tamanini E, 2009, INORG CHEM, V48, P319, DOI 10.1021/ic8017634; VARNES AW, 1972, J AM CHEM SOC, V94, P946, DOI 10.1021/ja00758a037; Wang DH, 2010, ORG BIOMOL CHEM, V8, P2923, DOI 10.1039/c004148c; WERNER TC, 1973, J PHYS CHEM-US, V77, P1611, DOI 10.1021/j100632a003; Xu H, 2011, CHINESE J CHEM, V29, P2165, DOI 10.1002/cjoc.201180375; Xu ZC, 2005, ORG LETT, V7, P3029, DOI 10.1021/ol051131d; Xu ZC, 2005, ORG LETT, V7, P889, DOI 10.1021/ol0473445; Xu Z, 2007, TETRAHEDRON LETT, V48, P9151, DOI 10.1016/j.tetlet.2007.10.109; Xu ZC, 2010, TETRAHEDRON, V66, P1678, DOI 10.1016/j.tet.2010.01.008; Yang YM, 2013, CHEM REV, V113, P192, DOI 10.1021/cr2004103; Yu MF, 2013, CHEMSTRYOPEN, V2, P99, DOI 10.1002/open.201300014; Yu MF, 2013, CHEMBIOCHEM, V14, P224, DOI 10.1002/cbic.201200637; Yu MF, 2011, INORG CHEM, V50, P12823, DOI 10.1021/ic2020012; Zhang JZ, 2012, METALLOMICS, V4, P1209, DOI 10.1039/c2mt20168b; Zhu W, 2004, CHEM COMMUN, P888, DOI 10.1039/b400878b	50	11	11	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100761	10.1371/journal.pone.0100761	http://dx.doi.org/10.1371/journal.pone.0100761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983863	Green Published, gold, Green Submitted			2022-12-27	WOS:000339635000038
J	Zhang, DD; Liu, YZ; Zhou, CL; Chen, YM; Luo, YJ				Zhang, Dandan; Liu, Yunzhe; Zhou, Chenglin; Chen, Yuming; Luo, Yuejia			Spatial Attention Effects of Disgusted and Fearful Faces	PLOS ONE			English	Article							TOP-DOWN MODULATION; FACIAL EXPRESSION; DISEASE-AVOIDANCE; BRAIN POTENTIALS; VISUAL-ATTENTION; TIME-COURSE; EMOTION; THREAT; FMRI; BIAS	Effective processing of threat-related stimuli is of significant evolutionary advantage. Given the intricate relationship between attention and the neural processing of threat-related emotions, this study manipulated attention allocation and emotional categories of threat-related stimuli as independent factors and investigated the time course of spatial-attention-modulated processing of disgusting and fearful stimuli. The participants were instructed to direct their attention either to the two vertical or to the two horizontal locations, where two faces and two houses would be presented. The task was to respond regarding the physical identity of the two stimuli at cued locations. Event-related potentials (ERP) evidences were found to support a two-stage model of attention-modulated processing of threat-related emotions. In the early processing stage, disgusted faces evoked larger P1 component at right occipital region despite the attention allocation while larger N170 component was elicited by fearful faces at right occipito-temporal region only when participants attended to houses. In the late processing stage, the amplitudes of the parietal P3 component enhanced for both disgusted and fearful facial expressions only when the attention was focused on faces. According to the results, we propose that the temporal dynamics of the emotion-by-attention interaction consist of two stages. The early stage is characterized by quick and specialized neural encoding of disgusting and fearful stimuli irrespective of voluntary attention allocation, indicating an automatic detection and perception of threat-related emotions. The late stage is represented by attention-gated separation between threat-related stimuli and neutral stimuli; the similar ERP pattern evoked by disgusted and fearful faces suggests a more generalized processing of threat-related emotions via top-down attentional modulation, based on which the defensive behavior in response to threat events is largely facilitated.	[Zhang, Dandan; Chen, Yuming; Luo, Yuejia] Shenzhen Univ, Inst Affect & Social Neurosci, Shenzhen, Peoples R China; [Zhang, Dandan; Liu, Yunzhe] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zhou, Chenglin] Shanghai Univ Sport, Sch Kinesiol, Shanghai, Peoples R China	Shenzhen University; Beijing Normal University; Shanghai University of Sport	Zhou, CL (corresponding author), Shanghai Univ Sport, Sch Kinesiol, Shanghai, Peoples R China.	chenglin_600@126.com			National Natural Science Foundation of China [31300867]; National Basic Research Program of China (973 Program) [2014CB744600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was funded by the National Natural Science Foundation of China (31300867) and the National Basic Research Program of China (973 Program, 2014CB744600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SK, 2011, J COGNITIVE NEUROSCI, V23, P238, DOI 10.1162/jocn.2009.21328; Anderson AK, 2003, J NEUROSCI, V23, P5627; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bishop SJ, 2007, CEREB CORTEX, V17, P1595, DOI 10.1093/cercor/bhl070; Bledowski C, 2004, J NEUROSCI, V24, P9353, DOI 10.1523/JNEUROSCI.1897-04.2004; Capotosto P, 2009, J NEUROSCI, V29, P5863, DOI 10.1523/JNEUROSCI.0539-09.2009; Charash M, 2002, J ANXIETY DISORD, V16, P529, DOI 10.1016/S0887-6185(02)00171-8; Charash M, 2006, ANXIETY STRESS COPIN, V19, P353, DOI 10.1080/10615800601055915; Cheng YW, 2012, J COGNITIVE NEUROSCI, V24, P1411, DOI 10.1162/jocn_a_00214; Chong H, 2008, J COGNITIVE NEUROSCI, V20, P120, DOI 10.1162/jocn.2008.20003; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Devlin JT, 2000, NEUROIMAGE, V11, P589, DOI 10.1006/nimg.2000.0595; Eimer M, 2000, NEUROREPORT, V11, P2319, DOI 10.1097/00001756-200007140-00050; Eimer M, 2007, NEUROPSYCHOLOGIA, V45, P15, DOI 10.1016/j.neuropsychologia.2006.04.022; Eimer M, 2003, COGN AFFECT BEHAV NE, V3, P97, DOI 10.3758/CABN.3.2.97; EKMAN P, 1983, SCIENCE, V221, P1208, DOI 10.1126/science.6612338; Ewbank MP, 2009, NEUROIMAGE, V44, P1144, DOI 10.1016/j.neuroimage.2008.09.056; Furey ML, 2006, P NATL ACAD SCI USA, V103, P1065, DOI 10.1073/pnas.0510124103; Galfano G, 2011, SOC NEUROSCI-UK, V6, P257, DOI 10.1080/17470919.2010.515722; [龚栩 Gong Xu], 2011, [中国心理卫生杂志, Chinese Mental Health Journal], V25, P40; Hajcak G, 2009, CLIN NEUROPHYSIOL, V120, P505, DOI 10.1016/j.clinph.2008.11.028; Herrmann CS, 2001, NEUROSCI BIOBEHAV R, V25, P465, DOI 10.1016/S0149-7634(01)00027-6; Holmes A, 2003, COGNITIVE BRAIN RES, V16, P174, DOI 10.1016/S0926-6410(02)00268-9; Krusemark EA, 2013, J NEUROSCI, V33, P587, DOI [10.1523/JNEUROSCI.1379-12.2013, 10.1523/JNEUROSCI.1835-13.2013]; Krusemark EA, 2011, J NEUROSCI, V31, P3429, DOI 10.1523/JNEUROSCI.4394-10.2011; Langton SRH, 2008, COGNITION, V107, P330, DOI 10.1016/j.cognition.2007.07.012; Neuberg SL, 2011, NEUROSCI BIOBEHAV R, V35, P1042, DOI 10.1016/j.neubiorev.2010.08.011; Oaten M, 2009, PSYCHOL BULL, V135, P303, DOI 10.1037/a0014823; Ohman A, 2005, PSYCHONEUROENDOCRINO, V30, P953, DOI 10.1016/j.psyneuen.2005.03.019; Pessoa L, 2005, NEUROIMAGE, V28, P249, DOI 10.1016/j.neuroimage.2005.05.048; Pourtois G, 2005, HUM BRAIN MAPP, V26, P65, DOI 10.1002/hbm.20130; Schupp HT, 2007, J NEUROSCI, V27, P1082, DOI 10.1523/JNEUROSCI.3223-06.2007; Schupp HT, 2003, PSYCHOL SCI, V14, P7, DOI 10.1111/1467-9280.01411; Schyns PG, 2007, CURR BIOL, V17, P1580, DOI 10.1016/j.cub.2007.08.048; Siegel M, 2008, NEURON, V60, P709, DOI 10.1016/j.neuron.2008.09.010; Smith ML, 2012, CEREB CORTEX, V22, P1748, DOI 10.1093/cercor/bhr250; Susskind JM, 2008, NAT NEUROSCI, V11, P843, DOI 10.1038/nn.2138; Vaish A, 2008, PSYCHOL BULL, V134, P383, DOI 10.1037/0033-2909.134.3.383; Vermeulen N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007924; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Vuilleumier P, 2002, CURR OPIN PSYCHIATR, V15, P291, DOI 10.1097/00001504-200205000-00011; Vuilleumier P, 2001, NEUROLOGY, V56, P153, DOI 10.1212/WNL.56.2.153; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Weymar M, 2011, NEUROIMAGE, V58, P946, DOI 10.1016/j.neuroimage.2011.06.061; Williams Leanne M., 2006, Journal of Integrative Neuroscience, V5, P1, DOI 10.1142/S0219635206001082; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574; Zanto TP, 2010, NEUROIMAGE, V53, P736, DOI 10.1016/j.neuroimage.2010.06.012; Zhang DD, 2013, NEUROPSYCHOLOGIA, V51, P1397, DOI 10.1016/j.neuropsychologia.2013.04.014; Zhang DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049517	49	5	6	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101608	10.1371/journal.pone.0101608	http://dx.doi.org/10.1371/journal.pone.0101608			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1UX	24983360	Green Published, gold, Green Submitted			2022-12-27	WOS:000339635000124
J	Martins, VDA; Bastos, MD; Ramasawmy, R; de Figueiredo, RP; Gimaque, JBL; Braga, WSM; Nogueira, ML; Nozawa, S; Naveca, FG; Figueiredo, LTM; Mourao, MPG				Alves Martins, Valquiria do Carmo; Bastos, Michele de Souza; Ramasawmy, Rajendranath; de Figueiredo, Regina Pinto; Lima Gimaque, Joao Bosco; Miranda Braga, Wornei Silva; Nogueira, Mauricio Lacerda; Nozawa, Sergio; Naveca, Felipe Gomes; Moraes Figueiredo, Luiz Tadeu; Gomes Mourao, Maria Paula			Clinical and Virological Descriptive Study in the 2011 Outbreak of Dengue in the Amazonas, Brazil	PLOS ONE			English	Article							NEUROLOGICAL MANIFESTATIONS; MOLECULAR EPIDEMIOLOGY; VIRUS TYPE-2; INFECTION; CIRCULATION; SEROTYPES; PARAGUAY; MANAUS; STATE; PCR	Background: Dengue is a vector-borne disease in the tropical and subtropical region of the world and is transmitted by the mosquito Aedes aegypti. In the state of Amazonas, Brazil during the 2011 outbreak of dengue all the four Dengue virus (DENV) serotypes circulating simultaneously were observed. The aim of the study was to describe the clinical epidemiology of dengue in Manaus, the capital city of the state of the Amazonas, where all the four DENV serotypes were co-circulating simultaneously. Methodology: Patients with acute febrile illness during the 2011 outbreak of dengue, enrolled at the Fundacao de Medicina Tropical Dr. Heitor Viera Dourado (FMT-HVD), a referral centre for tropical and infectious diseases in Manaus, were invited to participate in a clinical and virological descriptive study. Sera from 677 patients were analyzed by RT-nested-PCRs for flaviviruses (DENV 1-4, Saint Louis encephalitis virus-SLEV, Bussuquara virus-BSQV and Ilheus virus-ILHV), alphavirus (Mayaro virus-MAYV) and orthobunyavirus (Oropouche virus-OROV). Principal Findings: Only dengue viruses were detected in 260 patients (38.4%). Thirteen patients were co-infected with more than one DENV serotype and six (46.1%) of them had a more severe clinical presentation of the disease. Nucleotide sequencing showed that DENV-1 belonged to genotype V, DENV-2 to the Asian/American genotype, DENV-3 to genotype III and DENV-4 to genotype II. Conclusions: Co-infection with more than one DENV serotype was observed. This finding should be warning signs to health authorities in situations of the large dispersal of serotypes that are occurring in the world.	[Bastos, Michele de Souza; Ramasawmy, Rajendranath; de Figueiredo, Regina Pinto; Lima Gimaque, Joao Bosco; Miranda Braga, Wornei Silva; Nogueira, Mauricio Lacerda; Moraes Figueiredo, Luiz Tadeu; Gomes Mourao, Maria Paula] Fundacao Med Trop Dr Heitor Viera Dourado FMT HVD, Manaus, Amazonas, Brazil; [Alves Martins, Valquiria do Carmo; Bastos, Michele de Souza; Ramasawmy, Rajendranath; Miranda Braga, Wornei Silva; Gomes Mourao, Maria Paula] Univ Estado Amazonas, Manaus, Amazonas, Brazil; [Ramasawmy, Rajendranath; Nozawa, Sergio; Gomes Mourao, Maria Paula] Univ Nilton Lins, Manaus, Amazonas, Brazil; [Nogueira, Mauricio Lacerda] Fac Med Sao Jose Rio Preto FAMERP, Sao Paulo, Brazil; [Naveca, Felipe Gomes] Fundacao Oswaldo Cruz FIOCRUZ, Inst Leonidas & Maria Deane ILMD, Manaus, Amazonas, Brazil; [Moraes Figueiredo, Luiz Tadeu] Fac Med Ribeirao Preto FMRP USP, Ctr Pesquisas Virol, Sao Paulo, Brazil	Universidade do Estado do Amazonas; Centro Universitario Nilton Lins; Fundacao Oswaldo Cruz	Martins, VDA (corresponding author), Univ Estado Amazonas, Manaus, Amazonas, Brazil.	alvesvalquiria@yahoo.com.br; mariapaula.mourao@gmail.com	Mourao, Maria/AAW-5989-2021; Nogueira, Mauricio L/B-7599-2012; Bastos, Michele/AAS-7386-2020; Ramasawmy, Rajendranath/V-4926-2019; Naveca, Felipe/H-1130-2012	Nogueira, Mauricio L/0000-0003-1102-2419; Bastos, Michele/0000-0003-3450-666X; Naveca, Felipe/0000-0002-2888-1060; Mourao, Maria Paula/0000-0002-6458-0900	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Ampara a Pesquisa do Estado do Amazonas (FAPEAM) [887/2010]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Ampara a Pesquisa do Estado do Amazonas (FAPEAM)	This research was financed by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Ampara a Pesquisa do Estado do Amazonas (FAPEAM) through grant 887/2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso HL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-124; Aquino VH, 2006, AM J TROP MED HYG, V75, P710, DOI 10.4269/ajtmh.2006.75.710; Bastos MD, 2012, REV SOC BRAS MED TRO, V45, P393, DOI 10.1590/S0037-86822012000300022; Bharaj P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-1; Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005; Bronzoni RVM, 2004, T ROY SOC TROP MED H, V98, P456, DOI 10.1016/j.trstmh.2003.09.002; Chao DY, 2007, J CLIN MICROBIOL, V45, P584, DOI 10.1128/JCM.00842-06; Bona ACD, 2012, REV SOC BRAS MED TRO, V45, P297, DOI 10.1590/S0037-86822012000300003; Araujo FMD, 2006, MEM I OSWALDO CRUZ, V101, P925, DOI 10.1590/S0074-02762006000800017; de Figueiredo RMP, 2011, REV INST MED TROP SP, V53, P321, DOI 10.1590/S0036-46652011000600004; de Melo FL, 2009, PLOS NEGLECT TROP D, V3, P28; Domingues RB, 2008, J NEUROL SCI, V267, P36, DOI 10.1016/j.jns.2007.09.040; Santos Cecília Luiza Simões dos, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P11; Drumond BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059422; Drumond BP, 2012, ARCH VIROL, V157, P2061, DOI 10.1007/s00705-012-1393-9; de Figueiredo MLG, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-60; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lorono-Pino MA, 1999, AM J TROP MED HYG, V61, P725, DOI 10.4269/ajtmh.1999.61.725; Misra UK, 2006, J NEUROL SCI, V244, P117, DOI 10.1016/j.jns.2006.01.011; Figueiredo LTM, 2012, REV SOC BRAS MED TRO, V45, P285, DOI 10.1590/S0037-86822012000300001; Moreli ML, 2002, J MED VIROL, V66, P139, DOI 10.1002/jmv.2122; Naveca FG, 2012, J VIROL, V86, P1897, DOI 10.1128/JVI.06731-11; Oliveira MF, 2010, EMERG INFECT DIS, V16, P576, DOI 10.3201/eid1603.090996; Peng WM, 2005, J CLIN VIROL, V32, P194, DOI 10.1016/j.jcv.2004.04.010; de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Rocco Iray Maria, 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P151, DOI 10.1590/S0036-46651998000300004; Rocha LA, 2009, REV SOC BRAS MED TRO, V42, P18; Soares CN, 2006, J NEUROL SCI, V249, P19, DOI 10.1016/j.jns.2006.05.068; Soares CN, 2010, INT J INFECT DIS, V14, pE150, DOI 10.1016/j.ijid.2009.03.016; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; WHO/TDR, 2012, HDB CLIN MAN DENG, P124; Wu WL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-322; Yu Man, 2004, Weishengwu Xuebao, V44, P717	37	26	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100535	10.1371/journal.pone.0100535	http://dx.doi.org/10.1371/journal.pone.0100535			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978469	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400033
J	Benjamin, CFA; Saling, MM; Wood, AG; Reutens, DC				Benjamin, Christopher F. A.; Saling, Michael M.; Wood, Amanda G.; Reutens, David C.			Elemental Spatial and Temporal Association Formation in Left Temporal Lobe Epilepsy	PLOS ONE			English	Article							MEMORY FORMATION; FUNCTIONAL MRI; HIPPOCAMPAL PATHOLOGY; EPISODIC MEMORY; WORKING-MEMORY; BRAIN; FMRI; PARAHIPPOCAMPAL; ACTIVATION; RESECTION	The mesial temporal lobe (MTL) is typically understood as a memory structure in clinical settings, with the sine qua non of MTL damage in epilepsy being memory impairment. Recent models, however, understand memory as one of a number of higher cognitive functions that recruit the MTL through their reliance on more fundamental processes, such as "self-projection'' or "association formation''. We examined how damage to the left MTL influences these fundamental processes through the encoding of elemental spatial and temporal associations. We used a novel fMRI task to image the encoding of simple visual stimuli, either rich or impoverished, in spatial or spatial plus temporal information. Participants included 14 typical adults (36.4 years, sd. 10.5 years) and 14 patients with left mesial temporal lobe damage as evidenced by a clinical diagnosis of left temporal lobe epilepsy (TLE) and left MTL impairment on imaging (34.3 years, sd. 6.6 years). In-scanner behavioral performance was equivalent across groups. In the typical group whole-brain analysis revealed highly significant bilateral parahippocampal activation (right. left) during spatial associative processing and left hippocampal/parahippocampal deactivation in joint spatial-temporal associative processing. In the left TLE group identical analyses indicated patients used MTL structures contralateral to the seizure focus differently and relied on extra-MTL regions to a greater extent. These results are consistent with the notion that epileptogenic MTL damage is followed by reorganization of networks underlying elemental associative processes. In addition, they provide further evidence that task-related fMRI deactivation can meaningfully index brain function. The implications of these findings for clinical and cognitive neuropsychological models of MTL function in TLE are discussed.	[Benjamin, Christopher F. A.] Univ Calif Los Angeles, Dept Psychiat, Semel Inst, Los Angeles, CA 90095 USA; [Benjamin, Christopher F. A.] Harvard Univ, Sch Med, Computat Radiol Lab, Boston, MA USA; [Saling, Michael M.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Wood, Amanda G.] Univ Birmingham, Dept Psychol, Birmingham, England; [Wood, Amanda G.] Monash Univ, Southern Clin Sch, Clayton, Vic, Australia; [Reutens, David C.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia	University of California System; University of California Los Angeles; Harvard University; Harvard Medical School; University of Melbourne; University of Birmingham; Monash University; University of Queensland	Benjamin, CFA (corresponding author), Univ Calif Los Angeles, Dept Psychiat, Semel Inst, Los Angeles, CA 90095 USA.	cbenjamin@mednet.ucla.edu	Reutens, David/C-7226-2018; Benjamin, Christopher/Z-2728-2019; Wood, Amanda/K-9595-2013	Benjamin, Christopher/0000-0002-2000-9016; Reutens, David/0000-0002-1652-9369; Wood, Amanda/0000-0002-1537-6858	NH&MRC Program Grant [400121]; National Academy of Neuropsychology Clinical Research Grant	NH&MRC Program Grant; National Academy of Neuropsychology Clinical Research Grant	This research was supported by NH&MRC Program Grant 400121 and in part by a National Academy of Neuropsychology Clinical Research Grant (PI: Benjamin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Alessio A, 2013, HUM BRAIN MAPP, V34, P186, DOI 10.1002/hbm.21432; Aminoff E, 2007, CEREB CORTEX, V17, P1493, DOI 10.1093/cercor/bhl078; [Anonymous], 2007, MATL R2007B; Astur RS, 2004, BEHAV NEUROSCI, V118, P667, DOI 10.1037/0735-7044.118.4.667; Bar M, 2008, J NEUROSCI, V28, P8539, DOI 10.1523/JNEUROSCI.0987-08.2008; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Benjamin CFA, 2014, HUM BRAIN MAPP, V35, P683, DOI 10.1002/hbm.22204; Binder JR, 2011, EPILEPSY BEHAV, V20, P214, DOI 10.1016/j.yebeh.2010.08.004; Blakemore SJ, 2001, NAT REV NEUROSCI, V2, P561, DOI 10.1038/35086023; Bonelli SB, 2013, BRAIN, V136, P1889, DOI 10.1093/brain/awt105; Bonelli SB, 2010, BRAIN, V133, P1186, DOI 10.1093/brain/awq006; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Cameron KA, 2001, NEURON, V30, P289, DOI 10.1016/S0896-6273(01)00280-X; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Daselaar SM, 2006, J NEUROPHYSIOL, V96, P1902, DOI 10.1152/jn.01029.2005; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; Diana RA, 2007, TRENDS COGN SCI, V11, P379, DOI 10.1016/j.tics.2007.08.001; Diaz-Asper CM, 2006, J CLIN EXP NEUROPSYC, V28, P1462, DOI 10.1080/13803390500434359; Doucet G, 2013, HUM BRAIN MAPP, V34, P2202, DOI 10.1002/hbm.22059; EICHENBAUM H, 1995, CURR DIR PSYCHOL SCI, V4, P19, DOI 10.1111/1467-8721.ep10770954; EICHENBAUM H, 1990, J NEUROSCI, V10, P3531; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Fell J, 2006, NEUROSCI LETT, V407, P37, DOI 10.1016/j.neulet.2006.07.074; Glikmann-Johnston Y, 2008, BRAIN, V131, P3006, DOI 10.1093/brain/awn213; Haag A, 2008, EPILEPSY BEHAV, V13, P83, DOI 10.1016/j.yebeh.2008.02.012; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Hayes SM, 2004, BEHAV NEUROSCI, V118, P885, DOI 10.1037/0735-7044.118.5.885; King JA, 2002, HIPPOCAMPUS, V12, P811, DOI 10.1002/hipo.10070; Lehn H, 2009, J NEUROSCI, V29, P3475, DOI 10.1523/JNEUROSCI.5370-08.2009; Mayes A, 2007, TRENDS COGN SCI, V11, P126, DOI 10.1016/j.tics.2006.12.003; McAndrews Mary Pat, 2012, Epilepsy Res Treat, V2012, P925238, DOI 10.1155/2012/925238; Meltzer JA, 2008, HUM BRAIN MAPP, V29, P385, DOI 10.1002/hbm.20391; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; Neurobehavioral Systems, 2007, PRESENTATION; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Powell HWR, 2007, EPILEPSIA, V48, P1512, DOI 10.1111/j.1528-1167.2007.01053.x; Raichle ME, 1998, P NATL ACAD SCI USA, V95, P765, DOI 10.1073/pnas.95.3.765; Saling MM, 2005, MAGNETIC RESONANCE IN EPILEPSY: NEUROIMAGING TECHNIQUES, 2ND EDITION, P271, DOI 10.1016/B978-012431152-7/50013-6; Saling MM, 2009, BRAIN, V132, P570, DOI 10.1093/brain/awp012; SMITH ML, 1981, NEUROPSYCHOLOGIA, V19, P781, DOI 10.1016/0028-3932(81)90090-7; Spiers HJ, 2001, HIPPOCAMPUS, V11, P715, DOI 10.1002/hipo.1087; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; St Jacques P, 2008, J COGNITIVE NEUROSCI, V20, P1327, DOI 10.1162/jocn.2008.20091; Staresina BP, 2010, J NEUROSCI, V30, P9890, DOI 10.1523/JNEUROSCI.0826-10.2010; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Tomasi D, 2006, HUM BRAIN MAPP, V27, P694, DOI 10.1002/hbm.20211; Treyer V, 2005, HIPPOCAMPUS, V15, P684, DOI 10.1002/hipo.20093; Tsukiura T, 2002, HUM BRAIN MAPP, V17, P203, DOI 10.1002/hbm.10068; Tulving E., 1972, ORG MEMORY, DOI DOI 10.1017/S0140525X00047257; Tulving E, 2002, EPISODIC MEMORY MIND; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Voets NL, 2009, HUM BRAIN MAPP, V30, P4070, DOI 10.1002/hbm.20830; Yonelinas AP, 2013, BEHAV BRAIN RES, V254, P34, DOI 10.1016/j.bbr.2013.05.030; Zeidman P, 2012, NEUROREPORT, V23, P503, DOI 10.1097/WNR.0b013e328353766a	58	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100891	10.1371/journal.pone.0100891	http://dx.doi.org/10.1371/journal.pone.0100891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978828	Green Published, Green Accepted, gold			2022-12-27	WOS:000338506400046
J	Cohen, M; Hamilton, J; Narang, I				Cohen, Michal; Hamilton, Jill; Narang, Indra			Clinically Important Age-Related Differences in Sleep Related Disordered Breathing in Infants and Children with Prader-Willi Syndrome	PLOS ONE			English	Article							GROWTH-HORMONE THERAPY; POLYSOMNOGRAPHIC VALUES; BODY-COMPOSITION; APNEA; MANAGEMENT; CHILDHOOD; ADOLESCENTS; DIAGNOSIS; TODDLERS; OBESITY	Background: Sleep related disordered breathing (SDB) in pediatric Prader-Willi Syndrome is gaining increased attention due to the possible association of growth hormone therapy, SDB and sudden death. However data on the patterns of SDB and their management, particularly in infants in this population, is lacking. Objective: The aim of this study was to 1) describe patterns of SDB in growth hormone naive infants with PWS and the management of these disorders in our institution 2) Compare the patterns of sleep disorders between infants and children with PWS. Methods and Design: Polysomnograms of infants and children (0-18 years of age) with Prader-Willi Syndrome were reviewed. Age, sex, anthropometrics, sleep architecture, obstructive and central apnea indices and oxygen saturations were recorded. Data of infants with central sleep apnea treated with oxygen were analyzed to evaluate the efficacy of this treatment. The main outcome measures were obstructive and central apnea indices on a polysomnogram. Results: Data of 44 patients, 23 under 2 years of age and 21 older children were included. Infants when compared with older children were more likely to experience central sleep apnea (43% vs. 5%; p = 0.003). In older children obstructive was significantly more prevalent than central sleep apnea. Supplemental oxygen was used to treat 9/23 infants with central sleep apnea. Oxygen therapy resulted in a significant decrease in the median central apnea index from 14 (5,68) to 1 (0,6; p = 0.008) events/hour and an improvement in the oxygen saturation nadir from 70% (52, 92) to 81% (64, 95; p = 0.080). Conclusions: Central sleep apnea with associated oxygen desaturations is more prevalent in infants compared with older children with Prader-Willi Syndrome. Supplemental oxygen was efficacious in treating central sleep apnea in infants. Routine sleep surveillance for all children with Prader-Willi Syndrome and treatment with oxygen for central sleep apnea should be considered.	[Cohen, Michal; Hamilton, Jill] Hosp Sick Children, Div Endocrinol, Toronto, ON M5G 1X8, Canada; [Cohen, Michal; Hamilton, Jill; Narang, Indra] Univ Toronto, Toronto, ON, Canada; [Narang, Indra] Hosp Sick Children, Div Resp Med, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Cohen, M (corresponding author), Hosp Sick Children, Div Endocrinol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	indra.narang@sickkids.ca						ARENS R, 1994, J APPL PHYSIOL, V77, P2224, DOI 10.1152/jappl.1994.77.5.2224; Barbera Joseph VI, 2010, SLEEP MENTAL ILLNESS; Bass JL, 2004, PEDIATRICS, V114, P805, DOI 10.1542/peds.2004-0227; Beck SE, 2009, SLEEP MED CLIN, V4, P393, DOI 10.1016/j.jsmc.2009.04.007; Bekx MT, 2003, J PEDIATR-US, V143, P372, DOI 10.1067/S0022-3476(03)00386-X; Bruni O, 2010, CURR OPIN PULM MED, V16, P568, DOI 10.1097/MCP.0b013e32833ef547; Capdevila Oscar Sans, 2008, Proc Am Thorac Soc, V5, P274, DOI 10.1513/pats.200708-138MG; Carrel AL, 2004, J PEDIATR-US, V145, P744, DOI 10.1016/j.jpeds.2004.08.002; Cassidy SB, 2012, GENET MED, V14, P10, DOI 10.1038/gim.0b013e31822bead0; Eiholzer U, 1999, J PEDIATR-US, V134, P222, DOI 10.1016/S0022-3476(99)70419-1; Festen DAM, 2008, CLIN ENDOCRINOL, V68, P919, DOI 10.1111/j.1365-2265.2007.03126.x; Festen DAM, 2006, J CLIN ENDOCR METAB, V91, P4911, DOI 10.1210/jc.2006-0765; Festen DAM, 2007, PEDIATR RES, V62, P221, DOI 10.1203/PDR.0b013e31809871dd; Goldstone AP, 2008, J CLIN ENDOCR METAB, V93, P4183, DOI 10.1210/jc.2008-0649; Gozal D, 1998, PEDIATRICS, V102, P616, DOI 10.1542/peds.102.3.616; HELBINGZWANENBURG B, 1993, J INTELL DISABIL RES, V37, P533; HERTZ G, 1995, AM J MED GENET, V56, P188, DOI 10.1002/ajmg.1320560215; Iber C., 2007, AASM MANUAL SCORING; Lin HY, 2007, PEDIATR PULM, V42, P881, DOI 10.1002/ppul.20673; Marcus CL, 2012, PEDIATRICS, V130, pE714, DOI 10.1542/peds.2012-1672; MARCUS CL, 1992, AM REV RESPIR DIS, V146, P1235, DOI 10.1164/ajrccm/146.5_Pt_1.1235; Mary Cataletto GH, 2010, ROMANIAN J RARE DIS; McCandless SE, 2011, PEDIATRICS, V127, P195, DOI 10.1542/peds.2010-2820; Miller JL, 2012, J CLIN ENDOCR METAB, V97, P3837, DOI 10.1210/jc.2012-2543; Miller JL, 2011, AM J MED GENET A, V155A, P1040, DOI 10.1002/ajmg.a.33951; Miller JL, 2009, J CLIN SLEEP MED, V5, P448; Montgomery-Downs HE, 2006, PEDIATRICS, V117, P741, DOI 10.1542/peds.2005-1067; Nixon GM, 2002, PEDIATR PULM, V34, P209, DOI 10.1002/ppul.10152; O'Donoghue FJ, 2005, J PEDIATR-US, V147, P823, DOI 10.1016/j.jpeds.2005.07.021; RICHARDS A, 1994, CLIN OTOLARYNGOL, V19, P193, DOI 10.1111/j.1365-2273.1994.tb01213.x; Sacco M, 2005, HORM RES, V63, P29, DOI 10.1159/000082525; Scholle S, 2011, SLEEP MED, V12, P988, DOI 10.1016/j.sleep.2011.05.006; Tapia IE, 2008, SLEEP, V31, P1737, DOI 10.1093/sleep/31.12.1737; Tauber M, 2008, AM J MED GENET A, V146A, P881, DOI 10.1002/ajmg.a.32131; Traeger N, 2005, PEDIATR PULM, V40, P22, DOI 10.1002/ppul.20236; Urquhart DS, 2013, ARCH DIS CHILD, V98, P592, DOI 10.1136/archdischild-2012-303441; Vandeleur M, 2013, J PAEDIATR CHILD H, V49, P238, DOI 10.1111/jpc.12109; Williams K, 2008, J CLIN SLEEP MED, V4, P111	38	63	63	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101012	10.1371/journal.pone.0101012	http://dx.doi.org/10.1371/journal.pone.0101012			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979549	gold, Green Submitted, Green Published			2022-12-27	WOS:000338506400062
J	de Bruin, M; Smeulders, MJ; Kreulen, M; Huijing, PA; Jaspers, RT				de Bruin, Marije; Smeulders, Mark J.; Kreulen, Michiel; Huijing, Peter A.; Jaspers, Richard T.			Intramuscular Connective Tissue Differences in Spastic and Control Muscle: A Mechanical and Histological Study	PLOS ONE			English	Article							MYOFASCIAL FORCE TRANSMISSION; CHRONIC ELECTRICAL-STIMULATION; FLEXOR CARPI ULNARIS; CEREBRAL-PALSY; SKELETAL-MUSCLE; FIBER TYPES; SARCOMERE-LENGTH; EXTRACELLULAR-MATRIX; COMPUTED-TOMOGRAPHY; MEASUREMENTS REVEAL	Cerebral palsy (CP) of the spastic type is a neurological disorder characterized by a velocity-dependent increase in tonic stretch reflexes with exaggerated tendon jerks. Secondary to the spasticity, muscle adaptation is presumed to contribute to limitations in the passive range of joint motion. However, the mechanisms underlying these limitations are unknown. Using biopsies, we compared mechanical as well as histological properties of flexor carpi ulnaris muscle (FCU) from CP patients (n = 29) and healthy controls (n = 10). The sarcomere slack length (mean 2.5 mu m, SEM 0.05) and slope of the normalized sarcomere length-tension characteristics of spastic fascicle segments and single myofibre segments were not different from those of control muscle. Fibre type distribution also showed no significant differences. Fibre size was significantly smaller (1933 mu m(2), SEM 190) in spastic muscle than in controls (2572 mu m(2), SEM 322). However, our statistical analyses indicate that the latter difference is likely to be explained by age, rather than by the affliction. Quantities of endomysial and perimysial networks within biopsies of control and spastic muscle were unchanged with one exception: a significant thickening of the tertiary perimysium (3-fold), i.e. the connective tissue reinforcement of neurovascular tissues penetrating the muscle. Note that this thickening in tertiary perimysium was shown in the majority of CP patients, however a small number of patients (n = 4 out of 23) did not have this feature. These results are taken as indications that enhanced myofascial loads on FCU is one among several factors contributing in a major way to the aetiology of limitation of movement at the wrist in CP and the characteristic wrist position of such patients.	[de Bruin, Marije; Smeulders, Mark J.; Kreulen, Michiel] Univ Amsterdam, Acad Med Ctr, Dept Plast Reconstruct & Hand Surg, NL-1105 AZ Amsterdam, Netherlands; [Kreulen, Michiel] Red Cross Hosp, Dept Plast Reconstruct & Hand Surg, Beverwijk, Netherlands; [Huijing, Peter A.; Jaspers, Richard T.] Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Lab Myol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Jaspers, RT (corresponding author), Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Lab Myol, Amsterdam, Netherlands.	r.t.jaspers@vu.nl		Jaspers, Richard/0000-0002-6951-0952	Phelps Stichting voor Spastici [2006009]	Phelps Stichting voor Spastici	This study was supported by the Phelps Stichting voor Spastici (Grant No. 2006009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHERNE W, 1971, J NEUROL SCI, V14, P171, DOI 10.1016/0022-510X(71)90085-2; ALNAQEEB MA, 1984, J ANAT, V139, P677; Barber L, 2011, DEV MED CHILD NEUROL, V53, P543, DOI 10.1111/j.1469-8749.2011.03913.x; Benard MR, 2010, CLIN BIOMECH, V25, P802, DOI 10.1016/j.clinbiomech.2010.04.010; BLINKS JR, 1965, J PHYSIOL-LONDON, V177, P42, DOI 10.1113/jphysiol.1965.sp007574; Booth CM, 2001, DEV MED CHILD NEUROL, V43, P314, DOI 10.1017/S0012162201000597; BORG TK, 1980, TISSUE CELL, V12, P197, DOI 10.1016/0040-8166(80)90061-0; BROOKE MH, 1970, ARCH NEUROL-CHICAGO, V23, P369, DOI 10.1001/archneur.1970.00480280083010; Burkholder TJ, 2001, J APPL PHYSIOL, V91, P2466, DOI 10.1152/jappl.2001.91.6.2466; CASTLE ME, 1979, CLIN ORTHOP RELAT R, P223; de Bruin M, 2011, CLIN BIOMECH, V26, P725, DOI 10.1016/j.clinbiomech.2011.03.007; Friden J, 2003, MUSCLE NERVE, V27, P157, DOI 10.1002/mus.10247; Fry NR, 2003, GAIT POSTURE, V17, P119, DOI 10.1016/S0966-6362(02)00059-0; Gollapudi SK, 2009, J BIOMECH, V42, P2011, DOI 10.1016/j.jbiomech.2009.06.013; Haus JM, 2007, J APPL PHYSIOL, V103, P2068, DOI 10.1152/japplphysiol.00670.2007; HESLINGA JW, 1995, EUR J APPL PHYSIOL, V70, P49, DOI 10.1007/BF00601808; HOFFER MM, 1993, CLIN ORTHOP RELAT R, P135; Huijing PA, 2005, SCAND J MED SCI SPOR, V15, P349, DOI 10.1111/j.1600-0838.2005.00457.x; Huijing PA, 2003, J MORPHOL, V256, P306, DOI 10.1002/jmor.10097; Huijing PA, 2007, J ELECTROMYOGR KINES, V17, P708, DOI 10.1016/j.jelekin.2007.02.003; Ito J, 1996, BRAIN DEV-JPN, V18, P299, DOI 10.1016/0387-7604(96)00006-X; Jaspers RT, 2006, CELL TISSUE RES, V326, P795, DOI 10.1007/s00441-006-0227-z; JUNQUEIRA LCU, 1979, ANAL BIOCHEM, V94, P96, DOI 10.1016/0003-2697(79)90795-4; LEXELL J, 1991, J ANAT, V174, P239; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; Lieber RL, 1997, J EXP BIOL, V200, P19; Lieber RL, 2004, MUSCLE NERVE, V29, P615, DOI 10.1002/mus.20059; Lieber RL, 2003, MUSCLE NERVE, V28, P464, DOI 10.1002/mus.10446; Lieber RL, 1997, J BIOMECH ENG-T ASME, V119, P386, DOI 10.1115/1.2798283; LIEBER RL, 1986, DEV MED CHILD NEUROL, V28, P662; Maas H, 2005, CELLS TISSUES ORGANS, V181, P38, DOI 10.1159/000089967; Marbini A, 2002, BRAIN DEV-JPN, V24, P63, DOI 10.1016/S0387-7604(01)00394-1; MARSHALL PA, 1989, MUSCLE NERVE, V12, P528, DOI 10.1002/mus.880120703; Meijer HJM, 2007, J ELECTROMYOGR KINES, V17, P698, DOI 10.1016/j.jelekin.2007.02.006; Nishimura T, 2009, ANIM SCI J, V80, P85, DOI 10.1111/j.1740-0929.2008.00600.x; OERTEL G, 1988, J NEUROL SCI, V88, P303, DOI 10.1016/0022-510X(88)90227-4; OVEREND TJ, 1992, CLIN PHYSIOL, V12, P629, DOI 10.1111/j.1475-097X.1992.tb00366.x; Pette D, 1999, MUSCLE NERVE, V22, P666, DOI 10.1002/(SICI)1097-4598(199906)22:6<666::AID-MUS3>3.0.CO;2-Z; Pette D, 2001, HISTOCHEM CELL BIOL, V115, P359, DOI 10.1007/s004180100268; Ponten E, 2005, DEV MED CHILD NEUROL, V47, P384, DOI 10.1017/S0012162205000757; Ponten EM, 2007, J NEUROL SCI, V253, P25, DOI 10.1016/j.jns.2006.11.006; Ponten E, 2007, MUSCLE NERVE, V36, P47, DOI 10.1002/mus.20780; Prado LG, 2005, J GEN PHYSIOL, V126, P461, DOI 10.1085/jgp.200509364; PURSLOW PP, 1989, J BIOMECH, V22, P21, DOI 10.1016/0021-9290(89)90181-4; Ramaswamy KS, 2011, J PHYSIOL-LONDON, V589, P1195, DOI 10.1113/jphysiol.2010.201921; Ranatunga KW, 1996, BIOPHYS J, V71, P1905, DOI 10.1016/S0006-3495(96)79389-X; RICE CL, 1989, CLIN PHYSIOL, V9, P207, DOI 10.1111/j.1475-097X.1989.tb00973.x; Rivero JLL, 1998, J MUSCLE RES CELL M, V19, P733, DOI 10.1023/A:1005482816442; ROMANINI L, 1989, Italian Journal of Orthopaedics and Traumatology, V15, P87; ROSE J, 1994, J ORTHOP RES, V12, P758, DOI 10.1002/jor.1100120603; ROWE RWD, 1981, TISSUE CELL, V13, P681, DOI 10.1016/S0040-8166(81)80005-5; Schiaffino S, 2010, ACTA PHYSIOL, V199, P451, DOI 10.1111/j.1748-1716.2010.02130.x; SINKJAER T, 1994, BRAIN, V117, P355, DOI 10.1093/brain/117.2.355; Smeulders MJC, 2005, MUSCLE NERVE, V32, P208, DOI 10.1002/mus.20360; Smeulders MJC, 2004, J ORTHOP RES, V22, P1331, DOI 10.1016/j.orthres.2004.04.006; Smith LR, 2011, J PHYSIOL-LONDON, V589, P2625, DOI 10.1113/jphysiol.2010.203364; Smith LR, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-44; TARDIEU C, 1979, Journal of the Neurological Sciences, V42, P357, DOI 10.1016/0022-510X(79)90169-2; TARDIEU C, 1974, J PHYSIOL-PARIS, V68, P205; van Wessel T, 2010, EUR J APPL PHYSIOL, V110, P665, DOI 10.1007/s00421-010-1545-0; VOGLER C, 1985, ARCH PATHOL LAB MED, V109, P238; WILLIAMS PE, 1978, J ANAT, V127, P459; ZANCOLLI EA, 1987, CLIN ORTHOP RELAT R, P14	63	60	62	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101038	10.1371/journal.pone.0101038	http://dx.doi.org/10.1371/journal.pone.0101038			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977410	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400065
J	Duftner, C; Seiler, R; Dejaco, C; Chemelli-Steingruber, I; Schennach, H; Klotz, W; Rieger, M; Herold, M; Falkensammer, J; Fraedrich, G; Schirmer, M				Duftner, Christina; Seiler, Ruediger; Dejaco, Christian; Chemelli-Steingruber, Iris; Schennach, Harald; Klotz, Werner; Rieger, Michael; Herold, Manfred; Falkensammer, Juergen; Fraedrich, Gustav; Schirmer, Michael			Antiphospholipid Antibodies Predict Progression of Abdominal Aortic Aneurysms	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; GIANT-CELL ARTERITIS; INTERNATIONAL CONSENSUS STATEMENT; ANTICARDIOLIPIN ANTIBODIES; INTRALUMINAL THROMBUS; CLASSIFICATION CRITERIA; POLYARTERITIS-NODOSA; WALL STRESS; MATRIX-METALLOPROTEINASE-9; PREVALENCE	Antiphospholipid antibodies (aPLs) frequently occur in autoimmune and cardiovascular diseases and correlate with a worse clinical outcome. In the present study, we evaluated the association between antiphospholipid antibodies (aPLs), markers of inflammation, disease progression and the presence of an intra-aneurysmal thrombus in abdominal aortic aneurysm (AAA) patients. APLs ELISAs were performed in frozen serum samples of 96 consecutive AAA patients and 48 healthy controls yielding positive test results in 13 patients (13.5%) and 3 controls (6.3%; n.s.). Nine of the 13 aPL-positive AAA patients underwent a second antibody testing >12 weeks apart revealing a positive result in 6 cases. APL-positive patients had increased levels of inflammatory markers compared to aPL-negative patients. Disease progression was defined as an increase of the AAA diameter >0.5 cm/year measured by sonography. Follow-up was performed in 69 patients identifying 41 (59.4%) patients with progressive disease. Performing multipredictor logistic regression analysis adjusting for classical AAA risk factors as confounders, the presence of aPLs at baseline revealed an odds ratio of 9.4 (95% CI 1.0-86.8, p = 0.049) to predict AAA progression. Fifty-five patients underwent a computed tomography in addition to ultrasound assessment indicating intra-aneurysmal thrombus formation in 82.3%. Median thrombus volume was 46.7 cm(3) (1.9-377.5). AAA diameter correlated with the size of the intra-aneurysmal thrombus (corr(coeff) = 0.721, p<0.001), however neither the presence nor the size of the intra-aneurysmal thrombus were related to the presence of aPLs. In conclusion, the presence of aPLs is associated with elevated levels of inflammatory markers and is an independent predictor of progressive disease in AAA patients.	[Duftner, Christina; Dejaco, Christian; Klotz, Werner; Herold, Manfred; Schirmer, Michael] Med Univ Innsbruck, Dept Internal Med, Clin Internal Med 6, A-6020 Innsbruck, Austria; [Seiler, Ruediger; Falkensammer, Juergen; Fraedrich, Gustav] Med Univ Innsbruck, Dept Operat Med, Clin Vasc Surg, A-6020 Innsbruck, Austria; [Chemelli-Steingruber, Iris; Rieger, Michael] Med Univ Innsbruck, Dept Radiol, A-6020 Innsbruck, Austria; [Schennach, Harald] Med Univ Innsbruck, Inst Blood Transfus & Immunol, A-6020 Innsbruck, Austria; [Duftner, Christina] Gen Hosp Kufstein, Dept Internal Med, Kufstein, Austria; [Dejaco, Christian] Med Univ Graz, Dept Rheumatol, Graz, Austria; [Falkensammer, Juergen] Wilhelminenhospital, Dept Vasc & Endovasc Surg, Vienna, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Graz; Wilhelminenspital	Schirmer, M (corresponding author), Med Univ Innsbruck, Dept Internal Med, Clin Internal Med 6, A-6020 Innsbruck, Austria.	michael.schirmer@i-med.ac.at	Klotz, Werner/L-2803-2019; Schirmer, Michael/B-1893-2012	Schirmer, Michael/0000-0001-9208-7809; Dejaco, Christian/0000-0002-0173-0668; Klotz, Werner/0000-0002-1104-5613	Research Fund of the Austrian National Bank (ONB), Innsbruck Medical University [8825, 9715]; Tyrolean Medical Research Fund (MFF); Verein zur Forderung der Hamatologie, Onkologie und Immunologie	Research Fund of the Austrian National Bank (ONB), Innsbruck Medical University; Tyrolean Medical Research Fund (MFF); Verein zur Forderung der Hamatologie, Onkologie und Immunologie	This study was funded by the Research Fund of the Austrian National Bank (ONB, project 8825 and 9715), Innsbruck Medical University, the Tyrolean Medical Research Fund (MFF) and the Verein zur Forderung der Hamatologie, Onkologie und Immunologie. The funders had no role in study design, data collection and anlaysis, decision to publish or preparation of the manuscript.	Baxter BT, 2008, CIRCULATION, V117, P1883, DOI 10.1161/CIRCULATIONAHA.107.735274; Carrell TWG, 2006, VASCULAR, V14, P9, DOI 10.2310/6670.2006.00008; Cervera R, 2003, IMMUNOBIOLOGY, V207, P5, DOI 10.1078/0171-2985-00213; Chaikof EL, 2002, J VASC SURG, V35, P1048, DOI 10.1067/mva.2002.123763; Chew DKW, 2003, J SURG RES, V114, P25, DOI 10.1016/S0022-4804(03)00208-7; Czermak BV, 2001, J ENDOVASC THER, V8, P380, DOI 10.1583/1545-1550(2001)008<0380:SCVMAE>2.0.CO;2; Dasgupta B, 1997, BRIT J RHEUMATOL, V36, P1210; Dawson JA, 2011, EUR J VASC ENDOVASC, V41, P28, DOI 10.1016/j.ejvs.2010.08.023; Di Martino E, 1998, EUR J VASC ENDOVASC, V15, P290, DOI 10.1016/S1078-5884(98)80031-2; Di Martino ES, 2003, ANN BIOMED ENG, V31, P804, DOI 10.1114/1.1581880; Duftner C, 2005, ARTERIOSCL THROM VAS, V25, P1347, DOI 10.1161/01.ATV.0000167520.41436.c0; Duhaut P, 1998, ARTHRITIS RHEUM-US, V41, P701, DOI 10.1002/1529-0131(199804)41:4<701::AID-ART18>3.0.CO;2-P; Espinosa G, 2001, SEMIN ARTHRITIS RHEU, V31, P12, DOI 10.1053/sarh.2001.23499; Faber-Elmann A, 2002, CLIN EXP IMMUNOL, V127, P393, DOI 10.1046/j.1365-2249.2002.01758.x; Fontaine V, 2002, AM J PATHOL, V161, P1701, DOI 10.1016/S0002-9440(10)64447-1; Golledge J, 2008, EUR RADIOL, V18, P1987, DOI 10.1007/s00330-008-0956-3; Greco TP, 2009, AM J CLIN PATHOL, V132, P613, DOI 10.1309/AJCP2FJUT2YZGITK; Hans SS, 2005, J VASC SURG, V41, P584, DOI 10.1016/j.jvs.2005.01.004; Hans SS, 2003, J VASC SURG, V37, P949, DOI 10.1067/mva.2003.256; HULL RG, 1984, ANN RHEUM DIS, V43, P746, DOI 10.1136/ard.43.5.746; Kazi M, 2003, J VASC SURG, V38, P1283, DOI 10.1016/S0741-5214(03)00791-2; Levine JS, 2002, NEW ENGL J MED, V346, P752, DOI 10.1056/NEJMra002974; LEVINE SR, 1992, STROKE, V23, pI29; Liozon E, 2000, RHEUMATOLOGY, V39, P1089, DOI 10.1093/rheumatology/39.10.1089; MCHUGH NJ, 1990, J RHEUMATOL, V17, P916; Merkel PA, 1996, AM J MED, V101, P576, DOI 10.1016/S0002-9343(96)00335-X; Meroni PL, 2004, EXP GERONTOL, V39, P1459, DOI 10.1016/j.exger.2004.08.003; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Motoki Y, 2012, THROMB RES, V130, P667, DOI 10.1016/j.thromres.2011.11.048; Mower WR, 1997, J VASC SURG, V26, P602, DOI 10.1016/S0741-5214(97)70058-2; Petri M, 2000, J AUTOIMMUN, V15, P145, DOI 10.1006/jaut.2000.0409; Pyo R, 2000, J CLIN INVEST, V105, P1641, DOI 10.1172/JCI8931; Roberts WC, 2006, AM J CARDIOL, V98, P1519, DOI 10.1016/j.amjcard.2006.06.057; Ruiz-Irastorza G, 2004, ARCH INTERN MED, V164, P77, DOI 10.1001/archinte.164.1.77; Satta J, 1996, J VASC SURG, V23, P737, DOI 10.1016/S0741-5214(96)80062-0; Schoonjans R, 1996, CLIN RHEUMATOL, V15, P410, DOI 10.1007/BF02230368; Stenbaek J, 2000, EUR J VASC ENDOVASC, V20, P466, DOI 10.1053/ejvs.2000.1217; Szyper-Kravitz M, 2008, ISR MED ASSOC J, V10, P48; Thompson RW, 1996, ANN NY ACAD SCI, V800, P157, DOI 10.1111/j.1749-6632.1996.tb33307.x; VAARALA O, 1995, CIRCULATION, V91, P23, DOI 10.1161/01.CIR.91.1.23; Wilson WA, 1999, ARTHRITIS RHEUM, V42, P1309, DOI 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F; WOLF YG, 1994, J VASC SURG, V20, P529, DOI 10.1016/0741-5214(94)90277-1; Yokoi K, 1996, ANGIOLOGY, V47, P315, DOI 10.1177/000331979604700317	43	12	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e99302	10.1371/journal.pone.0099302	http://dx.doi.org/10.1371/journal.pone.0099302			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979700	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400004
J	Jang, HC; Choi, SM; Kim, HK; Kim, SE; Kang, SJ; Park, KH; Ryu, PY; Lee, TH; Kim, YR; Rhee, JH; Jung, SI; Choy, HE				Jang, Hee-Chang; Choi, Su-Mi; Kim, Hee Kyung; Kim, Sung-Eun; Kang, Seung-Ji; Park, Kyung-Hwa; Ryu, Phil Youl; Lee, Tae-Hoon; Kim, Young Ran; Rhee, Joon Haeng; Jung, Sook-In; Choy, Hyon E.			In Vivo Efficacy of the Combination of Ciprofloxacin and Cefotaxime against Vibrio vulnificus Sepsis	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; SUBINHIBITORY CONCENTRATIONS; PATHOGENIC SIGNIFICANCE; PROGNOSTIC-FACTORS; VITRO SYNERGISM; ANTIBIOTICS; INFECTION; THERAPY; GENE; MINOCYCLINE	Objectives: The in vivo efficacy of a cefotaxime-ciprofloxacin combination against Vibrio vulnificus and the effects on rtxA1 expression of commonly used antibiotics are unknown. Methods: In vitro time-kill studies were performed to evaluate synergism. Female BALB/c mice were injected subcutaneously with 1x10(7) or 1x10(8) cfu of V. vulnificus. Antibiotic therapy was initiated at 2 h after inoculation in the following four therapy groups: cefotaxime; ciprofloxacin; cefotaxime-plus-ciprofloxacin; and cefotaxime-plus-minocycline. The cytotoxicity of V. vulnificus for HeLa cells was measured using the lactate dehydrogenase assay; rtxA1 transcription was measured in a transcriptional reporter strain using a beta-galactosidase assay. Results: In vitro time-kill assays exhibited synergism between cefotaxime and ciprofloxacin. In the animal experiments, the 96-h survival rate for the cefotaxime-plus-ciprofloxacin group (85%; 17/20) was significantly higher than that of the cefotaxime-plus-minocycline (35%; 7/20) and cefotaxime alone (0%; 0/20) groups (P<0.05 for both). Bacterial counts in the liver and spleen were significantly lower in the cefotaxime-plus-ciprofloxacin group 24 and 48 h after treatment, relative to the other groups. At sub-inhibitory concentrations, ciprofloxacin inhibited more effectively rtxA1 transcription and mammalian cell cytotoxicity than either minocycline or cefotaxime (P<0.05 for both). Conclusions: Ciprofloxacin is more effective at reducing rtxA1 transcription and subsequent cytotoxicity than either minocycline or cefotaxime, and the combination of ciprofloxacin and cefotaxime was more effective in clearing V. vulnificus in vivo than previously used regimens. These data suggest that the combination of ciprofloxacin and cefotaxime is an effective option for the treatment of V. vulnificus sepsis in humans.	[Jang, Hee-Chang; Choi, Su-Mi; Kim, Hee Kyung; Kim, Sung-Eun; Kang, Seung-Ji; Park, Kyung-Hwa; Jung, Sook-In] Chonnam Natl Univ, Dept Infect Dis, Sch Med, Kwangju, South Korea; [Jang, Hee-Chang; Rhee, Joon Haeng; Choy, Hyon E.] Res Inst Vibrio Infect, Kwangju, South Korea; [Jang, Hee-Chang; Rhee, Joon Haeng; Choy, Hyon E.] Genome Res Ctr Enteropathogen Bacteria, Kwangju, South Korea; [Ryu, Phil Youl; Rhee, Joon Haeng; Choy, Hyon E.] Chonnam Natl Univ, Sch Med, Kwangju, South Korea; [Lee, Tae-Hoon] Chonnam Natl Univ, Sch Dent, Dept Biochem, Kwangju, South Korea; [Kim, Young Ran] Dongshin Univ, Dept Pharmaceut Engn, Naju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Dongshin University	Jung, SI (corresponding author), Chonnam Natl Univ, Dept Infect Dis, Sch Med, Kwangju, South Korea.	sijung@chonnam.ac.kr; hyonchoy@chonnam.ac.kr	Lee, Tae-Hoon/AAR-3708-2021; Ryu, Pan Dong/AGX-5700-2022	Lee, Tae-Hoon/0000-0003-0105-1750; Jang, Hee-Chang/0000-0002-3407-8493; Kang, Seung ji/0000-0002-3298-0520; Ryu, Pan Dong/0000-0003-4130-2251	Research Institute of Medical Sciences, Chonnam National University [2011-CURIMS-DR005]	Research Institute of Medical Sciences, Chonnam National University	This work was supported by a grant from the Research Institute of Medical Sciences, Chonnam National University (2011-CURIMS-DR005). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang CM, 2009, INT J ANTIMICROB AG, V33, P593, DOI 10.1016/j.ijantimicag.2008.10.027; CHAPMAN JS, 1988, ANTIMICROB AGENTS CH, V32, P438, DOI 10.1128/AAC.32.4.438; Chen SC, 2012, J ANTIMICROB CHEMOTH, V67, P488, DOI 10.1093/jac/dkr476; Chen SC, 2010, CRIT CARE MED, V38, P1984, DOI 10.1097/CCM.0b013e3181eeda2c; Chuang YC, 1998, ANTIMICROB AGENTS CH, V42, P1319, DOI 10.1128/AAC.42.6.1319; Chuang YC, 1997, ANTIMICROB AGENTS CH, V41, P2214, DOI 10.1128/AAC.41.10.2214; Chung KJ, 2010, J INFECT DIS, V201, P97, DOI 10.1086/648612; Clinical and Laboratory Standards Institute, 2009, M07A8 CLIN LAB STAND; Dechet AM, 2008, CLIN INFECT DIS, V46, P970, DOI 10.1086/529148; Dumitrescu O, 2007, ANTIMICROB AGENTS CH, V51, P1515, DOI 10.1128/AAC.01201-06; Gemmell CG, 2002, J ANTIMICROB CHEMOTH, V50, P665, DOI 10.1093/jac/dkf192; Jeong KC, 2000, INFECT IMMUN, V68, P5096, DOI 10.1128/IAI.68.9.5096-5106.2000; Kim CM, 2007, J INFECT DIS, V195, P90, DOI 10.1086/509822; Kim DM, 2005, ANTIMICROB AGENTS CH, V49, P3489, DOI 10.1128/AAC.49.8.3489-3491.2005; Kim DM, 2010, INT J ANTIMICROB AG, V36, P155, DOI 10.1016/j.ijantimicag.2010.03.022; Kim DM, 2008, J INFECTION, V57, P489, DOI 10.1016/j.jinf.2008.08.003; Kim HU, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.115; Kim JR, 2010, EUR J PHARMACOL, V642, P163, DOI 10.1016/j.ejphar.2010.05.037; Kim SY, 2003, MOL MICROBIOL, V48, P1647, DOI 10.1046/j.1365-2958.2003.03536.x; Kim YR, 2008, CELL MICROBIOL, V10, P848, DOI 10.1111/j.1462-5822.2007.01088.x; Kim YR, 2003, INFECT IMMUN, V71, P5461, DOI 10.1128/IAI.71.10.5461-5471.2003; Kim YR, 2013, J INFECT DIS; KLONTZ KC, 1988, ANN INTERN MED, V109, P318, DOI 10.7326/0003-4819-109-4-318; Korea Food and Drug Administration, 2011, GUID AN EXP IACUC ST; Kwak JS, 2011, P NATL ACAD SCI USA, V108, P1645, DOI 10.1073/pnas.1014339108; Lee SE, 2004, BIOCHEM BIOPH RES CO, V324, P86, DOI 10.1016/j.bbrc.2004.09.020; Lee SE, 2007, INFECT IMMUN, V75, P2795, DOI 10.1128/IAI.01499-06; Liu JW, 2006, ARCH INTERN MED, V166, P2117, DOI 10.1001/archinte.166.19.2117; Lo HR, 2011, J INFECT DIS, V203, P1866, DOI 10.1093/infdis/jir070; Morrison SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037553; Na HS, 2011, FEMS IMMUNOL MED MIC, V63, P355, DOI 10.1111/j.1574-695X.2011.00855.x; Neupane GP, 2012, EUR J CLIN MICROBIOL, V31, P2461, DOI 10.1007/s10096-012-1592-z; Neupane GP, 2010, ANTIMICROB AGENTS CH, V54, P3696, DOI 10.1128/AAC.00988-09; Ohlsen K, 1998, ANTIMICROB AGENTS CH, V42, P2817, DOI 10.1128/AAC.42.11.2817; Otsuki M, 1996, J ANTIMICROB CHEMOTH, V38, P771; Piccoli L, 2005, J CHEMOTHERAPY, V17, P355, DOI 10.1179/joc.2005.17.4.355; Saleh-Mghir A, 2012, ANTIMICROB AGENTS CH, V56, P6291, DOI 10.1128/AAC.00926-12; Sugiyama H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026018; Tang HJ, 2002, ANTIMICROB AGENTS CH, V46, P3580, DOI 10.1128/AAC.46.11.3580-3584.2002; Yokochi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055219	40	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101118	10.1371/journal.pone.0101118	http://dx.doi.org/10.1371/journal.pone.0101118			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978586	Green Published, gold, Green Submitted			2022-12-27	WOS:000338506400081
J	Jiang, JX; Zhang, YF; Wei, L; Sun, ZY; Liu, ZM				Jiang, Jianxin; Zhang, Yanfei; Wei, Liang; Sun, Zhiyang; Liu, Zhongmin			Association between MTHFD1 G1958A Polymorphism and Neural Tube Defects Susceptibility: A Meta-Analysis	PLOS ONE			English	Article							DEHYDROGENASE-METHENYLTETRAHYDROFOLATE-CYCLOHYDROLASE; MOLECULAR-GENETIC-ANALYSIS; RISK-FACTOR; METHYLENETETRAHYDROFOLATE REDUCTASE; TRIFUNCTIONAL ENZYME; 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE; R653Q POLYMORPHISM; MATERNAL RISK; SPINA-BIFIDA; VARIANT	Objectives: The methylenetetrahydrofolate dehydrogenase (MTHFD1) gene, as one of the key genes involved in the folate pathway, has been reported to play a critical role in the pathogenesis of neural tube defects (NTDs). However, the results of published studies are contradictory and inconclusive. Thus, this meta-analysis aimed to evaluate the effect of the common polymorphism in the MTHFD1 gene, the G1958A (R653Q, dbSNP ID: rs2236225) variant, on the risk of NTDs in all eligible studies. Methods: Relevant literature published before January 3, 2014 was retrieved from the MEDLINE, EMBASE, Cochrane Library, and CBM databases. Pooled crude odds ratios (ORs) and their corresponding 95% confidence intervals (CIs) were calculated to evaluate the association between the MTHFD1 G1958A polymorphism and NTDs risk. Results: We performed a meta-analysis of nine studies with a total of 4,302 NTDs patients and 4,238 healthy controls. Our results demonstrated a significant correlation between the MTHFD1 G1958A polymorphism and NTDs in an overall meta-analysis. For family-based studies, the study subjects were classified as NTD cases, mothers with NTDs offspring, and fathers with NTDs offspring. We found no association between any of the fathers' genotypes and NTDs, whereas there was a clear excess of the 1958A allele in the mothers of children with NTDs compared with controls individuals. Conclusions: In summary, our meta-analysis strongly suggests that the MTHFD1 G1958A polymorphism might be associated with maternal risk for NTDs in Caucasian populations. However, the evidence of this association should be interpreted with caution due to the selective nature of publication of genetic association studies.	[Jiang, Jianxin; Liu, Zhongmin] Tongji Univ, Sch Med, East Hosp, Res Ctr Translat Med, Shanghai 200092, Peoples R China; [Jiang, Jianxin; Zhang, Yanfei; Wei, Liang; Sun, Zhiyang; Liu, Zhongmin] Tongji Univ, Sch Med, East Hosp, Dept Neurosurg, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Sun, ZY (corresponding author), Tongji Univ, Sch Med, East Hosp, Dept Neurosurg, Shanghai 200092, Peoples R China.	zhiyangsun@126.com; zhongmliu@163.com						Amorim MR, 2007, AM J MED GENET A, V143A, P1726, DOI 10.1002/ajmg.a.31812; BARLOWE CK, 1990, MOL CELL BIOL, V10, P5679, DOI 10.1128/MCB.10.11.5679; Bhaskar LVKS, 2011, ARCH ORAL BIOL, V56, P723, DOI 10.1016/j.archoralbio.2011.01.007; Botto LD, 2000, AM J EPIDEMIOL, V151, P862; Brody LC, 2002, AM J HUM GENET, V71, P1207, DOI 10.1086/344213; Busby A, 2005, REPROD TOXICOL, V20, P393, DOI 10.1016/j.reprotox.2005.03.009; Carroll N, 2009, HUM GENET, V125, P247, DOI 10.1007/s00439-008-0616-3; Chen XL, 2010, BIRTH DEFECTS RES A, V88, P575, DOI 10.1002/bdra.20670; Christensen KE, 2009, HUM MUTAT, V30, P212, DOI 10.1002/humu.20830; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; De Marco P, 2006, J HUM GENET, V51, P98, DOI 10.1007/s10038-005-0329-6; Deb R, 2011, METAB BRAIN DIS, V26, P241, DOI 10.1007/s11011-011-9256-8; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Etheredge AJ, 2012, AM J MED GENET A, V158A, P2439, DOI 10.1002/ajmg.a.35552; Green Ridgely Fisk, 2013, Frontiers in Genetics, V4, P223, DOI 10.3389/fgene.2013.00223; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hol FA, 1998, CLIN GENET, V53, P119; Houcher B, 2009, PEDIATR NEUROSURG, V45, P472, DOI 10.1159/000283086; HUM DW, 1988, J BIOL CHEM, V263, P15946; Jackson D, 2012, STAT MED, V31, P3805, DOI 10.1002/sim.5453; Junker R, 2001, CARDIOVASC RES, V51, P251, DOI 10.1016/S0008-6363(01)00286-3; Liu J, 2014, J NEUROL SCI, V337, P61, DOI 10.1016/j.jns.2013.11.017; Marini NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028408; Mostowska A, 2010, J MED GENET, V47, P809, DOI 10.1136/jmg.2009.070029; Ouyang SR, 2014, GENE, V535, P119, DOI 10.1016/j.gene.2013.11.052; Pangilinan F, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-62; Parle-McDermott A, 2005, MOL HUM REPROD, V11, P477, DOI 10.1093/molehr/gah204; Parle-McDermott A, 2005, AM J MED GENET A, V132A, P365, DOI 10.1002/ajmg.a.30354; Parle-McDermott A, 2006, EUR J HUM GENET, V14, P768, DOI 10.1038/sj.ejhg.5201603; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; SACKS HS, 1987, NEW ENGL J MED, V316, P450, DOI 10.1056/NEJM198702193160806; Shaw GM, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-49; Shields DC, 1999, AM J HUM GENET, V64, P1045, DOI 10.1086/302310; SMITHELLS RW, 1976, ARCH DIS CHILD, V51, P944, DOI 10.1136/adc.51.12.944; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; van der Linden IJM, 2007, CLIN GENET, V72, P599, DOI 10.1111/j.1399-0004.2007.00904.x; Van der Linden IJM, 2006, J MOL MED, V84, P1047, DOI 10.1007/s00109-006-0093-x; VANDERPUT NMJ, 1995, LANCET, V346, P1070, DOI 10.1016/S0140-6736(95)91743-8; Wang HG, 2012, GENE, V510, P180, DOI 10.1016/j.gene.2012.02.020; Wang XW, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.021; Wolff T, 2009, ANN INTERN MED, V150, P632, DOI 10.7326/0003-4819-150-9-200905050-00010; Yan LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041689; Yang M, 2013, GENE, V520, P7, DOI 10.1016/j.gene.2013.02.005; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059570	44	29	33	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101169	10.1371/journal.pone.0101169	http://dx.doi.org/10.1371/journal.pone.0101169			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977710	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400090
J	Li, T; Blande, JD; Gundel, PE; Helander, M; Saikkonen, K				Li, Tao; Blande, James D.; Gundel, Pedro E.; Helander, Marjo; Saikkonen, Kari			Epichloe Endophytes Alter Inducible Indirect Defences in Host Grasses	PLOS ONE			English	Article							FUNGAL ENDOPHYTES; INDUCED RESISTANCE; INSECT HERBIVORES; METHYL SALICYLATE; SYMBIOTIC FUNGI; TALL FESCUE; VOLATILES; DIVERSITY; EMISSION; PLANTS	Epichloe endophytes are common symbionts living asymptomatically in pooid grasses and may provide chemical defences against herbivorous insects. While the mechanisms underlying these fungal defences have been well studied, it remains unknown whether endophyte presence affects the host's own defences. We addressed this issue by examining variation in the impact of Epichloe on constitutive and herbivore-induced emissions of volatile organic compounds (VOC), a well-known indirect plant defence, between two grass species, Schedonorus phoenix (ex. Festuca arundinacea; tall fescue) and Festuca pratensis (meadow fescue). We found that feeding by a generalist aphid species, Rhopalosiphum padi, induced VOC emissions by uninfected plants of both grass species but to varying extents, while mechanical wounding failed to do so in both species after one day of damage. Interestingly, regardless of damage treatment, Epichloe uncinata-infected F. pratensis emitted significantly lower quantities of VOCs than their uninfected counterparts. In contrast, Epichloe coenophiala-infected S. phoenix did not differ from their uninfected counterparts in constitutive VOC emissions but tended to increase VOC emissions under intense aphid feeding. A multivariate analysis showed that endophyte status imposed stronger differences in VOC profiles of F. pratensis than damage treatment, while the reverse was true for S. phoenix. Additionally, both endophytes inhibited R. padi population growth as measured by aphid dry biomass, with the inhibition appearing greater in E. uncinata-infected F. pratensis. Our results suggest, not only that Epichloe endophytes may play important roles in mediating host VOC responses to herbivory, but also that the magnitude and direction of such responses may vary with the identity of the Epichloe-grass symbiosis. Whether Epichloe-mediated host VOC responses will eventually translate into effects on higher trophic levels merits future investigation.	[Li, Tao; Blande, James D.] Univ Eastern Finland, Dept Environm Sci, Kuopio, Finland; [Gundel, Pedro E.; Saikkonen, Kari] MTT Agrifood Res Finland, Plant Prod Res, Jokioinen, Finland; [Helander, Marjo] Univ Turku, Dept Biol, SF-20500 Turku, Finland	University of Eastern Finland; Natural Resources Institute Finland (Luke); University of Turku	Li, T (corresponding author), Univ Eastern Finland, Dept Environm Sci, Kuopio, Finland.	tao.li@uef.fi	Gundel, Pedro/A-5314-2013; Blande, James/Q-9611-2019	Gundel, Pedro/0000-0003-3246-0282; Li, Tao/0000-0003-1462-5135; Helander, Marjo/0000-0002-9759-4321; Blande, James/0000-0001-6822-0649	Academy of Finland [256050, 251898, 137909]	Academy of Finland(Academy of Finland)	This research was funded by the Academy of Finland (Project nos. 256050, 251898 and 137909). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkhami ME, 2009, ENVIRON ENTOMOL, V38, P1086, DOI 10.1603/022.038.0416; Aharoni A, 2003, PLANT CELL, V15, P2866, DOI 10.1105/tpc.016253; Ali JG, 2012, TRENDS PLANT SCI, V17, P293, DOI 10.1016/j.tplants.2012.02.006; Babikova Z, 2014, FUNCT ECOL, V28, P375, DOI 10.1111/1365-2435.12181; Ballhorn DJ, 2013, OECOLOGIA, V172, P833, DOI 10.1007/s00442-012-2539-x; Blande JD, 2010, TREE PHYSIOL, V30, P404, DOI 10.1093/treephys/tpp124; Bultman TL, 2004, ECOLOGY, V85, P679, DOI 10.1890/03-0073; Clay K, 2002, AM NAT, V160, pS99, DOI 10.1086/342161; CLAY K, 1988, ECOLOGY, V69, P10, DOI 10.2307/1943155; Clement SL, 2001, CROP SCI, V41, P570, DOI 10.2135/cropsci2001.412570x; de Sassi C, 2006, P R SOC B, V273, P1301, DOI 10.1098/rspb.2005.3442; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Du YJ, 1998, J CHEM ECOL, V24, P1355, DOI 10.1023/A:1021278816970; Eriksson L, 2006, MULTI MEGAVARIATE 1, V2nd; Estrada C, 2013, NEW PHYTOL, V198, P241, DOI 10.1111/nph.12140; Faeth SH, 2012, FUNGAL ECOL, V5, P364, DOI 10.1016/j.funeco.2011.09.003; Fontana A, 2009, J CHEM ECOL, V35, P833, DOI 10.1007/s10886-009-9654-0; Glinwood RT, 2000, ENTOMOL EXP APPL, V94, P325, DOI 10.1023/A:1003902321787; Guerrieri E, 2004, ECOL ENTOMOL, V29, P753, DOI 10.1111/j.0307-6946.2004.00644.x; Halbert SE, 2009, ANN APPL BIOL, V154, P303, DOI 10.1111/j.1744-7348.2008.00300.x; Hare JD, 2011, ANNU REV ENTOMOL, V56, P161, DOI 10.1146/annurev-ento-120709-144753; Hartley SE, 2009, ANNU REV ENTOMOL, V54, P323, DOI 10.1146/annurev.ento.54.110807.090614; Jallow MFA, 2008, ARTHROPOD-PLANT INTE, V2, P53, DOI 10.1007/s11829-008-9033-8; Karban R, 1997, SERIES INTERSPECIFIC; Kessler A, 2011, FUNCT ECOL, V25, P348, DOI 10.1111/j.1365-2435.2010.01818.x; Kigathi RN, 2009, J CHEM ECOL, V35, P1335, DOI 10.1007/s10886-009-9716-3; Leitner M, 2010, MYCORRHIZA, V20, P89, DOI 10.1007/s00572-009-0264-z; Leuchtmann A, 2014, MYCOLOGIA, V106, P202, DOI 10.3852/106.2.202; Li T, 2012, FUNCT ECOL, V26, P1176, DOI 10.1111/j.1365-2435.2012.01984.x; Mithofer A, 2005, PLANT PHYSIOL, V137, P1160, DOI 10.1104/pp.104.054460; Mucciarelli M, 2007, MICROB ECOL, V54, P685, DOI 10.1007/s00248-007-9227-0; Muller CB, 2005, CURR OPIN PLANT BIOL, V8, P450, DOI 10.1016/j.pbi.2005.05.007; Omacini M, 2001, NATURE, V409, P78, DOI 10.1038/35051070; Panaccione DG, 2014, FUNCT ECOL, V28, P299, DOI 10.1111/1365-2435.12076; Panka D, 2013, J PLANT PHYSIOL, V170, P1010, DOI 10.1016/j.jplph.2013.02.009; Pareja M, 2007, J CHEM ECOL, V33, P695, DOI 10.1007/s10886-007-9260-y; Pineda A, 2013, FUNCT ECOL, V27, P574, DOI 10.1111/1365-2435.12050; Rapparini F, 2008, PLANT BIOLOGY, V10, P108, DOI 10.1055/s-2007-964963; Rudgers JA, 2004, ECOL LETT, V7, P42, DOI 10.1046/j.1461-0248.2003.00543.x; Rudgers JA, 2009, ECOLOGY, V90, P1531, DOI 10.1890/08-0116.1; Saikkonen K, 2006, TRENDS PLANT SCI, V11, P428, DOI 10.1016/j.tplants.2006.07.001; Saikkonen K, 2013, J CHEM ECOL, V39, P962, DOI 10.1007/s10886-013-0310-3; Saikkonen K, 2010, FUNGAL DIVERS, V41, P101, DOI 10.1007/s13225-010-0023-7; Sasso R, 2009, CHEMOECOLOGY, V19, P195, DOI 10.1007/s00049-009-0023-9; Schardl CL, 2012, FUNGAL ECOL, V5, P331, DOI 10.1016/j.funeco.2011.04.005; Schausberger P, 2012, FUNCT ECOL, V26, P441, DOI 10.1111/j.1365-2435.2011.01947.x; Simons L, 2008, J CHEM ECOL, V34, P1511, DOI 10.1007/s10886-008-9551-y; Stout MJ, 2006, ANNU REV ENTOMOL, V51, P663, DOI 10.1146/annurev.ento.51.110104.151117; Sullivan TJ, 2007, NEW PHYTOL, V176, P673, DOI 10.1111/j.1469-8137.2007.02201.x; Tabata J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023799; Van Oosten VR, 2008, MOL PLANT MICROBE IN, V21, P919, DOI 10.1094/MPMI-21-7-0919; Wali PR, 2011, PROSPECTS APPL PLANT, P64; Wilkinson HH, 2000, MOL PLANT MICROBE IN, V13, P1027, DOI 10.1094/MPMI.2000.13.10.1027; Yue Q, 2001, PHYTOCHEMISTRY, V58, P935, DOI 10.1016/S0031-9422(01)00353-3; Zhu JW, 2005, J CHEM ECOL, V31, P1733, DOI 10.1007/s10886-005-5923-8; [No title captured]	56	30	33	5	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101331	10.1371/journal.pone.0101331	http://dx.doi.org/10.1371/journal.pone.0101331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978701	Green Published, gold, Green Submitted			2022-12-27	WOS:000338506400118
J	Lyle, S; Hoover, K; Colpan, C; Zhu, ZQ; Matijasevic, Z; Jones, SN				Lyle, Stephen; Hoover, Kathleen; Colpan, Cansu; Zhu, Zhiqing; Matijasevic, Zdenka; Jones, Stephen N.			Dicer Cooperates with p53 to Suppress DNA Damage and Skin Carcinogenesis in Mice	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ENZYME DICER; MORPHOGENESIS; BIOGENESIS; DEFICIENT; MICRORNA; TISSUE; SPECTRUM; CANCER; TUMORS	Dicer is required for the maturation of microRNA, and loss of Dicer and miRNA processing has been found to alter numerous biological events during embryogenesis, including the development of mammalian skin and hair. We have previously examined the role of miRNA biogenesis in mouse embryonic fibroblasts and found that deletion of Dicer induces cell senescence regulated, in part, by the p53 tumor suppressor. Although Dicer and miRNA molecules are thought to have either oncogenic or tumor suppressing roles in various types of cancer, a role for Dicer and miRNAs in skin carcinogenesis has not been established. Here we show that perinatal ablation of Dicer in the skin of mice leads to loss of fur in adult mice, increased epidermal cell proliferation and apoptosis, and the accumulation of widespread DNA damage in epidermal cells. Co- ablation of Dicer and p53 did not alter the timing or extent of fur loss, but greatly reduced survival of Dicer-skin ablated mice, as these mice developed multiple and highly aggressive skin carcinomas. Our results describe a new mouse model for spontaneous basal and squamous cell tumorigenesis. Furthermore, our findings reveal that loss of Dicer in the epidermis induces extensive DNA damage, activation of the DNA damage response and p53-dependent apoptosis, and that Dicer and p53 cooperate to suppress mammalian skin carcinogenesis.	[Lyle, Stephen; Zhu, Zhiqing; Jones, Stephen N.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01655 USA; [Hoover, Kathleen; Colpan, Cansu; Zhu, Zhiqing; Matijasevic, Zdenka; Jones, Stephen N.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Jones, SN (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01655 USA.	stephen.jones@umassmed.edu			NIH from the National Cancer Institute [CA077735]; NATIONAL CANCER INSTITUTE [R56CA077735, R01CA077735] Funding Source: NIH RePORTER	NIH from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by NIH grant CA077735 from the National Cancer Institute to SNJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Bcnjamin CL, 2008, ADV EXP MED BIOL, V624, P265, DOI 10.1007/978-0-387-77574-6_21; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Di Leva G, 2013, ANN REV PATHOL  0925; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Gannon HS, 2012, CANCER CELL, V21, P668, DOI 10.1016/j.ccr.2012.04.011; Gannon HS, 2011, DEV BIOL, V353, P1, DOI 10.1016/j.ydbio.2011.02.007; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; HARVEY M, 1993, FASEB J, V7, P938, DOI 10.1096/fasebj.7.10.8344491; Hill DA, 2009, SCIENCE, V325, P965, DOI 10.1126/science.1174334; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kim J, 2012, P NATL ACAD SCI USA, V109, P3921, DOI 10.1073/pnas.1117135109; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Ma ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020494; Marino S, 2000, GENE DEV, V14, P994; Mudhasani R, 2008, J CELL BIOL, V181, P1055, DOI 10.1083/jcb.200802105; Mudhasani R, 2011, J CELL PHYSIOL, V226, P1399, DOI 10.1002/jcp.22475; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; Ramirez A, 2004, GENESIS, V39, P52, DOI 10.1002/gene.20025; Ravi A, 2012, CANCER CELL, V21, P848, DOI 10.1016/j.ccr.2012.04.037; Sand M, 2012, CANCER BIOMARK, V11, P253, DOI 10.3233/CBM-2012-0274; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Teta M, 2012, DEVELOPMENT, V139, P1405, DOI 10.1242/dev.070920; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yi R, 2009, P NATL ACAD SCI USA, V106, P498, DOI 10.1073/pnas.0810766105; Zhang Z, 2011, DEV BIOL, V351, P254, DOI 10.1016/j.ydbio.2011.01.005; Zhou MJ, 2013, CARCINOGENESIS, V34, P1653, DOI 10.1093/carcin/bgt097	34	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100920	10.1371/journal.pone.0100920	http://dx.doi.org/10.1371/journal.pone.0100920			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979267	gold, Green Published			2022-12-27	WOS:000338506400048
J	Rojo-Martinez, G; Maymo-Masip, E; Rodriguez, MM; Solano, E; Goday, A; Soriguer, F; Valdes, S; Chaves, FJ; Delgado, E; Colomo, N; Hernandez, P; Vendrell, J; Chacon, MR				Rojo-Martinez, Gemma; Maymo-Masip, Elsa; Mar Rodriguez, M.; Solano, Esther; Goday, Albert; Soriguer, Federico; Valdes, Sergio; Javier Chaves, Felipe; Delgado, Elias; Colomo, Natalia; Hernandez, Pilar; Vendrell, Joan; Chacon, Matilde R.			Serum sCD163 Levels Are Associated with Type 2 Diabetes Mellitus and Are Influenced by Coffee and Wine Consumption: Results of the Di@bet.es Study	PLOS ONE			English	Article							HIGH CARDIOVASCULAR RISK; MEDITERRANEAN DIET; WEAK INDUCER; METABOLIC SYNDROME; SOLUBLE CD163; WEIGHT-LOSS; TNF-ALPHA; TWEAK; INFLAMMATION; OBESITY	Objective: Serum levels of soluble TNF-like weak inducer of apoptosis (sTWEAK) and its scavenger receptor CD163 (sCD163) have been linked to insulin resistance. We analysed the usefulness of these cytokines as biomarkers of type 2 diabetes in a Spanish cohort, together with their relationship to food consumption in the setting of the Di@bet.es study. Research Design and Methods: This is a cross-sectional, matched case-control study of 514 type 2 diabetes subjects and 517 controls with a Normal Oral Glucose Tolerance Test (NOGTT), using data from the Di@bet.es study. Study variables included clinical and demographic structured survey, food frequency questionnaire and physical examination. Serum concentrations of sTWEAK and sCD163 were measured by ELISA. Linear regression analysis determined which variables were related to sTWEAK and sCD163 levels. Logistic regression analysis was used to estimate odd ratios of presenting type 2 diabetes. Results: sCD163 concentrations and sCD163/sTWEAK ratio were 11.0% and 15.0% higher, respectively, (P<0.001) in type 2 diabetes than in controls. Following adjustment for various confounders, the OR for presenting type 2 diabetes in subjects in the highest vs the lowest tertile of sCD163 was [(OR), 2,01 (95% CI, 1,46-2,97); P for trend <0.001]. Coffee and red wine consumption was negatively associated with serum levels of sCD163 (P = 0.0001 and; P = 0.002 for coffee and red wine intake, respectively). Conclusions: High circulating levels of sCD163 are associated with type 2 diabetes in the Spanish population. The association between coffee and red wine intake and these biomarkers deserves further study to confirm its potential role in type 2 diabetes.	[Rojo-Martinez, Gemma; Soriguer, Federico; Valdes, Sergio; Colomo, Natalia] Hosp Reg Univ, UGCI Endocrinol & Nutr, Inst Biomed Malaga IBIMA, Malaga, Spain; [Rojo-Martinez, Gemma; Maymo-Masip, Elsa; Solano, Esther; Soriguer, Federico; Valdes, Sergio; Javier Chaves, Felipe; Colomo, Natalia; Vendrell, Joan; Chacon, Matilde R.] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona, Spain; [Maymo-Masip, Elsa; Solano, Esther; Hernandez, Pilar; Vendrell, Joan; Chacon, Matilde R.] Univ Rovira & Virgili, Hosp Univ Tarragona Joan 23, IISPV, E-43007 Tarragona, Spain; [Mar Rodriguez, M.] Inst Invest Biomed Girona Dr Josep Trueta, CIBERObn Fisiopatol Obesidad & Nutr, Girona, Spain; [Goday, Albert] Univ Autonoma Barcelona, Dept Endocrinol & Nutr, Hosp del Mar, E-08193 Barcelona, Spain; [Javier Chaves, Felipe] Fdn Invest Hosp Clin Valencia INCLIVA, Genotyping & Genet Diag Unit, Valencia, Spain; [Delgado, Elias] Univ Oviedo, Dept Med Endocrinol & Nutr, HUCA, Oviedo, Spain	Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Central University Hospital Asturias; University of Oviedo	Rojo-Martinez, G (corresponding author), Hosp Reg Univ, UGCI Endocrinol & Nutr, Inst Biomed Malaga IBIMA, Malaga, Spain.	gemma.rojo.m@gmail.com; mrodriguez.hj23.ics@gencat.cat	Chacón, Matilde R./E-5574-2019; Rojo-martínez, Gemma/E-3351-2010; Chaves-Martinez, Felipe Javier/ABC-3294-2021; Maymó Masip, Elsa/T-1828-2017; Delgado, Elias/B-2634-2013; Vendrell, Joan j/V-4034-2018	Chacón, Matilde R./0000-0003-1531-2165; Rojo-martínez, Gemma/0000-0003-2179-2134; Chaves-Martinez, Felipe Javier/0000-0001-8009-3689; Maymó Masip, Elsa/0000-0002-9133-3120; Delgado, Elias/0000-0001-6114-9712; Vendrell, Joan j/0000-0002-6994-6115	Fondo de Investigacion Sanitaria (FIS) [PI 11/00049, PI 11/0085, PI 11/02755]; European Regional Development Fund (ERDF); Research Stabilization Programme of the Instituto de Salud Carlos III (ISCIII); Institut Catala de Salut (ICS) in Catalonia; CIBER in Diabetes and Associated Metabolic Disorders - CIBERDEM (ISCIII - Ministerio de Ciencia e Innovacion); Spanish Society of Diabetes - SED; Ministerio de Sanidad	Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); European Regional Development Fund (ERDF)(European Commission); Research Stabilization Programme of the Instituto de Salud Carlos III (ISCIII); Institut Catala de Salut (ICS) in Catalonia; CIBER in Diabetes and Associated Metabolic Disorders - CIBERDEM (ISCIII - Ministerio de Ciencia e Innovacion); Spanish Society of Diabetes - SED; Ministerio de Sanidad(Instituto de Salud Carlos IIISpanish Government)	This study was supported by projects from the Fondo de Investigacion Sanitaria (FIS): PI 11/00049 (M. R. CH.), PI 11/0085 (J.V.) and PI 11/02755 (F. S.) co-financed by the European Regional Development Fund (ERDF). M. R. CH. is supported by the Research Stabilization Programme of the Instituto de Salud Carlos III (ISCIII) co-financed by Institut Catala de Salut (ICS) in Catalonia. Di@bet.es study was supported by CIBER in Diabetes and Associated Metabolic Disorders - CIBERDEM (ISCIII - Ministerio de Ciencia e Innovacion), Ministerio de Sanidad and Spanish Society of Diabetes - SED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Blanco-Colio LM, 2007, ARTERIOSCL THROM VAS, V27, P916, DOI 10.1161/01.ATV.0000258972.10109.ff; Burkly LC, 2007, CYTOKINE, V40, P1, DOI 10.1016/j.cyto.2007.09.007; Chacon MR, 2006, CYTOKINE, V33, P129, DOI 10.1016/j.cyto.2005.12.005; Dharmapatni AASSK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3294; Diaz-Lopez A, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-51; Diaz-Lopez A, 2013, J CLIN ENDOCR METAB, V98, P3482, DOI 10.1210/jc.2013-1848; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Estruch R, 2010, P NUTR SOC, V69, P333, DOI 10.1017/S0029665110001539; Fick A, 2012, J BIOL CHEM, V287, P484, DOI 10.1074/jbc.M111.287656; Fjeldborg K, 2013, OBESITY, V21, P2437, DOI 10.1002/oby.20376; Goncalves RB, 2011, INFLAMM RES, V60, P409, DOI 10.1007/s00011-011-0308-7; Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548; Kralisch S, 2008, ATHEROSCLEROSIS, V199, P440, DOI 10.1016/j.atherosclerosis.2007.10.022; Lakhan SE, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-129; Llaurado G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043919; Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888, DOI 10.1093/ajcn/84.4.888; Martinez-Gonzalez MA, 2008, BMJ-BRIT MED J, V336, P1348, DOI 10.1136/bmj.39561.501007.BE; Maymo-Masip E, 2013, J CLIN ENDOCR METAB, V98, pE1323, DOI 10.1210/jc.2012-4177; Meksawan K, 2004, J AM COLL NUTR, V23, P331, DOI 10.1080/07315724.2004.10719376; Mercer JR, 2012, ARTERIOSCL THROM VAS, V32, P2461, DOI 10.1161/ATVBAHA.112.251322; Michaelson JS, 2012, J AUTOIMMUN, V39, P130, DOI 10.1016/j.jaut.2012.05.003; Moller HJ, 2011, CLIN CHEM, V57, P291, DOI 10.1373/clinchem.2010.154724; Moreno JA, 2009, ATHEROSCLEROSIS, V207, P103, DOI 10.1016/j.atherosclerosis.2009.04.033; Ortega E, 2013, ANN NUTR METAB, V62, P339, DOI 10.1159/000346553; Rebello SA, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-61; Richard C, 2013, OBESITY, V21, P51, DOI 10.1002/oby.20239; Soriguer F, 2012, DIABETOLOGIA, V55, P88, DOI 10.1007/s00125-011-2336-9; Spranger J, 2003, DIABETES, V52; Uddin MJ, 2013, FREE RADICAL BIO MED, V65, P1331, DOI 10.1016/j.freeradbiomed.2013.09.027; Vazquez-Carballo A, 2013, AM J PHYSIOL-ENDOC M, V305, pE101, DOI 10.1152/ajpendo.00589.2012; Vendrell J, 2010, J CLIN ENDOCR METAB, V95, P2983, DOI 10.1210/jc.2009-2481; Wang X, 2013, DIABETES CARE, V36, P166, DOI 10.2337/dc12-0702; Yamauchi R, 2010, J AGR FOOD CHEM, V58, P5597, DOI 10.1021/jf904062c; Yilmaz MI, 2009, CLIN J AM SOC NEPHRO, V4, P1716, DOI 10.2215/CJN.02760409; Zanni MV, 2012, CLIN ENDOCRINOL, V77, P385, DOI 10.1111/j.1365-2265.2011.04284.x	36	10	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101250	10.1371/journal.pone.0101250	http://dx.doi.org/10.1371/journal.pone.0101250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978196	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400104
J	Yang, YL; Chen, MW; Xian, L				Yang, Yan-Long; Chen, Ming-Wu; Xian, Lei			Prognostic and Clinicopathological Significance of Downregulated E-Cadherin Expression in Patients with Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ENDOTHELIAL GROWTH-FACTOR; STAGE-I NSCLC; CLINICAL-SIGNIFICANCE; FACTOR RECEPTOR; POOR-PROGNOSIS; BETA-CATENIN; ADENOCARCINOMA; CARCINOMA; VIMENTIN	Background: Many studies have investigated the prognostic role of E-cadherin in patients with NSCLC; however, the result still remains inconclusive. An up-to data system review and meta-analysis was necessary to give a comprehensive evaluation of prognostic role of E-cadherin in NSCLC. Methods: Eligible studies were searched in Pubmed, Embase and Web of Science databases. The inclusion criteria were studies that assessed the relationship between E-cadherin expression detected by immunohistochemistry (IHC) and the prognosis or clinicopathological features in patients with NSCLC. Subgroup analysis according to race, percentage of reduced/negative E-cadherin expression, histological type, and sample size were also conducted. Odds ratio (OR) or hazard ratio (HR) with 95% confidence interval (CI) were calculated to examine the risk or hazard association. Results: A total of 29 studies including 4010 patients were qualified for analysis. The analysis suggested that downregulated E-cadherin expression was significant associated with unfavorable overall survival (OS) and disease-free survival/progression-free survival (DFS/PFS) in patients with NSCLC. Subgroup analysis by race, percentage of reduced/negative E-cadherin expression, sample size also found the significant association in OS. When only the stage I NSCLC were considered, downregulated E-cadherin expression still had an unfavorable impact on OS. Additionally, downregulated E-cadherin expression was significantly associated with differentiation grade, lymphnode metastasis, vascular invasion, and TNM stage. Conclusion: Downregulated E-cadherin expression detected by IHC seems to correlate with tumour progression and could serve as an important prognostic factor in patients with NSCLC.	[Yang, Yan-Long; Chen, Ming-Wu; Xian, Lei] Guangxi Med Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Nanning, Guangxi Zhuang, Peoples R China	Guangxi Medical University	Xian, L (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Nanning, Guangxi Zhuang, Peoples R China.	xianlei59@163.com			Guangxi Scientific Research and Technology Development projects [10124001A-47]	Guangxi Scientific Research and Technology Development projects	This work was supported by the Guangxi Scientific Research and Technology Development projects (grant no. 10124001A-47). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saad S, 2008, BRIT J CANCER, V99, P1476, DOI 10.1038/sj.bjc.6604713; Arias AM, 2001, CELL, V105, P425, DOI 10.1016/S0092-8674(01)00365-8; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chansky K, 2009, J THORAC ONCOL, V4, P792, DOI 10.1097/JTO.0b013e3181a7716e; Cho S, 2008, LUNG, V186, P411, DOI 10.1007/s00408-008-9116-4; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Deeb G, 2004, MODERN PATHOL, V17, P430, DOI 10.1038/modpathol.3800041; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feng J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039937; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hirata T, 2001, Clin Lung Cancer, V3, P134, DOI 10.3816/CLC.2001.n.024; Huang C, 2005, BRIT J CANCER, V92, P1231, DOI 10.1038/sj.bjc.6602481; International Agency for Research on Cancer, 2012, GLOBOCAN 2012 EST CA; Jin SD, 2012, MED ONCOL, V29, P3157, DOI 10.1007/s12032-012-0229-5; Kase S, 2000, CLIN CANCER RES, V6, P4789; Kim H, 2013, KOREAN J PATHOL, V47, P44, DOI 10.4132/KoreanJPathol.2013.47.1.44; Kimura K, 2000, INT J ONCOL, V16, P1125; Lee YC, 2000, THORAC CARDIOV SURG, V48, P294, DOI 10.1055/s-2000-7885; Lim SC, 2000, J KOREAN MED SCI, V15, P501, DOI 10.3346/jkms.2000.15.5.501; Lin QA, 2010, JPN J CLIN ONCOL, V40, P670, DOI 10.1093/jjco/hyq041; MANTEL N, 1959, J NATL CANCER I, V22, P719; Morgensztern D, 2010, J THORAC ONCOL, V5, P29, DOI 10.1097/JTO.0b013e3181c5920c; Ono K, 2010, ANTICANCER RES, V30, P3273; Pagaki E, 2010, DIAGN CYTOPATHOL, V38, P419, DOI 10.1002/dc.21188; Paredes J, 2012, BBA-REV CANCER, V1826, P297, DOI 10.1016/j.bbcan.2012.05.002; Richardson F, 2012, ANTICANCER RES, V32, P537; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Shi YL, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-89; Sterlacci W, 2010, J THORAC ONCOL, V5, P1325, DOI 10.1097/JTO.0b013e3181e77efc; Tamura M, 2005, J THORAC CARDIOV SUR, V130, P740, DOI 10.1016/j.jtcvs.2004.12.051; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Ucvet A, 2011, ARCH BRONCONEUMOL, V47, P397, DOI 10.1016/j.arbres.2011.04.010; Vincan E, 2008, CLIN EXP METASTAS, V25, P657, DOI 10.1007/s10585-008-9156-4; Wells GA., 2003, NEWCASTLE OTTAWA SCA; Wu SW, 2012, ARCH IRAN MED, V15, P707, DOI 0121511/AIM.0012; Wu Y, 2012, MOL BIOL REP, V39, P9621, DOI 10.1007/s11033-012-1827-1; Yamashita T, 2010, LUNG CANCER, V70, P320, DOI 10.1016/j.lungcan.2010.02.013; Ye J, 2012, MOL MED REP, V6, P507, DOI 10.3892/mmr.2012.938; Yu JH, 2011, VIRCHOWS ARCH, V458, P99, DOI 10.1007/s00428-010-1016-3; Zhang H, 2013, J CLIN PATHOL, V66, P937, DOI 10.1136/jclinpath-2013-201467; Zhang X, 2014, CLIN TRANSL ONCOL, V16, P178, DOI 10.1007/s12094-013-1057-6; Zhao C, 2013, BIOSCI TRENDS, V7, P264, DOI 10.5582/bst.2013.v7.6.264; Zhao JQ, 2013, ASIAN PAC J CANCER P, V14, P639, DOI 10.7314/APJCP.2013.14.2.639; Zhu ZH, 2009, J CLIN ONCOL, V27, P1091, DOI 10.1200/JCO.2008.16.6991	48	42	48	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e99763	10.1371/journal.pone.0099763	http://dx.doi.org/10.1371/journal.pone.0099763			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978478	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400009
J	Schlamann, A; von Bueren, AO; Hagel, C; Zwiener, I; Seidel, C; Kortmann, RD; Muller, K				Schlamann, Annika; von Bueren, Andre O.; Hagel, Christian; Zwiener, Isabella; Seidel, Clemens; Kortmann, Rolf-Dieter; Mueller, Klaus			An Individual Patient Data Meta-Analysis on Characteristics and Outcome of Patients with Papillary Glioneuronal Tumor, Rosette Glioneuronal Tumor with Neuropil-Like Islands and Rosette Forming Glioneuronal Tumor of the Fourth Ventricle	PLOS ONE			English	Article							DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD; ENTITY; CLASSIFICATION; DISSEMINATION; FEATURES; VARIANT; ADULT	Background and Purpose: In 2007, the WHO classification of brain tumors was extended by three new entities of glioneuronal tumors: papillary glioneuronal tumor (PGNT), rosette-forming glioneuronal tumor of the fourth ventricle (RGNT) and glioneuronal tumor with neuropil-like islands (GNTNI). Focusing on clinical characteristics and outcome, the authors performed a comprehensive individual patient data (IPD) meta-analysis of the cases reported in literature until December 2012. Methods: PubMed, Embase and Web of Science were searched for peer-reviewed articles reporting on PGNT, RGNT, and GNTNI using predefined keywords. Results: 95 publications reported on 182 patients (PGNT, 71; GNTNI, 26; RGNT, 85). Median age at diagnosis was 23 years (range 4-75) for PGNT, 27 years (range 6-79) for RGNT, and 40 years (range 2-65) for GNTNI. Ninety-seven percent of PGNT and 69% of GNTNI were located in the supratentorial region, 23% of GNTNI were in the spinal cord, and 80% of RGNT were localized in the posterior fossa. Complete resection was reported in 52 PGNT (73%), 36 RGNT (42%), and 7 GNTNI (27%) patients. Eight PGNT, 3 RGNT, and 12 GNTNI patients were treated with chemo- and/or radiotherapy as the primary postoperative treatment. Follow-up data were available for 132 cases. After a median follow-up time of 1.5 years (range 0.2-25) across all patients, 1.5-year progression-free survival rates were 52 +/- 12% for GNTNI, 86 +/- 5% for PGNT, and 100% for RGNT. The 1.5-year overall-survival were 95 +/- 5%, 98 +/- 2%, and 100%, respectively. Conclusions: The clinical understanding of the three new entities of glioneuronal tumors, PGNT, RGNT and GNTNI, is currently emerging. The present meta-analysis will hopefully contribute to a delineation of their diagnostic, therapeutic, and prognostic profiles. However, the available data do not provide a solid basis to define the optimum treatment approach. Hence, a central register should be established.	[Schlamann, Annika; Seidel, Clemens; Kortmann, Rolf-Dieter; Mueller, Klaus] Univ Leipzig, Med Ctr, Dept Radiat Oncol, D-04109 Leipzig, Saxony, Germany; [von Bueren, Andre O.] Univ Gottingen, Med Ctr, Dept Pediat & Adolescent Med, Div Pediat Hematol & Oncol, D-37073 Gottingen, Lower Saxony, Germany; [Hagel, Christian] Univ Hamburg Eppendorf, Med Ctr, Dept Neuropathol, Hamburg, Germany; [Zwiener, Isabella] Johannes Gutenberg Univ Mainz, Med Ctr, Inst Med Biostat Epidemiol & Informat, D-55122 Mainz, Rhineland Palat, Germany	Leipzig University; University of Gottingen; University of Hamburg; University Medical Center Hamburg-Eppendorf; Johannes Gutenberg University of Mainz	Muller, K (corresponding author), Univ Leipzig, Med Ctr, Dept Radiat Oncol, D-04109 Leipzig, Saxony, Germany.	klaus.muller@medizin.uni-leipzig.de	von Bueren, Andre/AAF-2065-2020	von Bueren, Andre/0000-0003-4197-6264	German Research Foundation (DFG); Leipzig University	German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University	We acknowledge support from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 2005, SURG NEUROL, V63, P375, DOI 10.1016/j.surneu.2004.05.039; Agarwal S, 2012, CHILD NERV SYST, V28, P1897, DOI 10.1007/s00381-012-1860-3; Allende DS, 2009, ADV ANAT PATHOL, V16, P33, DOI 10.1097/PAP.0b013e3181915e3b; Amemiya S, 2008, J COMPUT ASSIST TOMO, V32, P279, DOI 10.1097/RCT.0b013e31814ce981; Anan M, 2009, HUM PATHOL, V40, P898, DOI 10.1016/j.humpath.2008.11.010; Atri S, 2007, CHILD NERV SYST, V23, P349, DOI 10.1007/s00381-006-0196-2; Barnes NP, 2002, PEDIATR NEUROSURG, V36, P266, DOI 10.1159/000058431; Benesch M, 2006, PEDIATR NEUROSURG, V42, P159, DOI 10.1159/000091859; Bisson EF, 2005, J NEURO-ONCOL, V72, P89, DOI 10.1007/s11060-004-2277-y; Bouvier-Labit C, 2000, ACTA NEUROPATHOL, V99, P321, DOI 10.1007/PL00007445; Broholm H, 2002, CLIN NEUROPATHOL, V21, P1; Buccoliero AM, 2012, PEDIATR DEVEL PATHOL, V15, P352, DOI 10.2350/12-01-1147-OA.1; Celli P, 2006, J NEURO-ONCOL, V80, P185, DOI 10.1007/s11060-006-9170-9; Collett, 2003, MODELLING SURVIVAL D; Ellezam B, 2012, ACTA NEUROPATHOL, V123, P285, DOI 10.1007/s00401-011-0886-z; Epelbaum S, 2006, BRIT J NEUROSURG, V20, P90, DOI 10.1080/02688690600682465; Fraum TJ, 2012, J NEURO-ONCOL, V107, P421, DOI 10.1007/s11060-011-0760-9; Friedrich C, 2014, J NEURO-ONCOL, V116, P567, DOI 10.1007/s11060-013-1327-8; Frydenberg E, 2010, J CLIN NEUROSCI, V17, P1326, DOI 10.1016/j.jocn.2010.03.003; Gelpi E, 2007, NEUROPATHOLOGY, V27, P468, DOI 10.1111/j.1440-1789.2007.00802.x; Harris BT, 2000, ACTA NEUROPATHOL, V100, P575, DOI 10.1007/s004010000217; Ishizawa T, 2006, HUM PATHOL, V37, P627, DOI 10.1016/j.humpath.2005.12.014; Javahery RJ, 2009, J NEUROSURG-PEDIATR, V3, P46, DOI 10.3171/2008.10.PEDS08242; Komori T, 2002, AM J SURG PATHOL, V26, P582, DOI 10.1097/00000478-200205000-00004; Komori T, 1998, AM J SURG PATHOL, V22, P1171, DOI 10.1097/00000478-199810000-00002; KUCHELMEISTER K, 1995, ACTA NEUROPATHOL, V89, P385; Lamszus K, 2003, BRAIN PATHOL, V13, P115; Lavrnic S, 2012, J NEUROL SURG PART A, V73, P224, DOI 10.1055/s-0032-1313636; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lu JQ, 2009, NEUROSURGERY, V64, P1193, DOI 10.1227/01.NEU.0000345640.40566.48; Malats W, 2005, LANCET ONCOL, V6, P678; Mazloom A, 2012, INT J RADIAT ONCOL, V84, P350, DOI 10.1016/j.ijrobp.2011.12.044; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Newton HB, 2008, CLIN NEUROPATHOL, V27, P317; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Poliani PL, 2009, NEUROPATHOLOGY, V29, P574, DOI 10.1111/j.1440-1789.2008.00988.x; Prayson RA, 2000, ARCH PATHOL LAB MED, V124, P1820; Rainov NG, 2010, CENT EUR NEUROSURG, V71, P219, DOI 10.1055/s-0029-1242760; Rosenblum MK, 2007, BRAIN PATHOL, V17, P308, DOI 10.1111/j.1750-3639.2007.00079.x; Ruppert B, 2011, J NEURO-ONCOL, V104, P529, DOI 10.1007/s11060-010-0505-1; Scheithauer BW, 2009, NEUROSURGERY, V64, P771, DOI 10.1227/01.NEU.0000340979.81362.F3; Shah MN, 2010, J NEUROSURG-PEDIATR, V5, P98, DOI 10.3171/2009.7.PEDS09113; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; Solis OE, 2011, J NEURO-ONCOL, V102, P477, DOI 10.1007/s11060-010-0335-1; Teo JGC, 1999, AM J SURG PATHOL, V23, P502, DOI 10.1097/00000478-199905000-00002; The WHO, 2020, CLASSIFICATION TUMOU; Vaquero J, 2007, J NEURO-ONCOL, V83, P319, DOI 10.1007/s11060-007-9333-3; Wang Y, 2009, ACTA NEUROPATHOL, V118, P813, DOI 10.1007/s00401-009-0569-1; Williams SR, 2008, ANN CLIN LAB SCI, V38, P287; Xiao H, 2011, J NEUROIMAGING, V21, P297, DOI 10.1111/j.1552-6569.2010.00478.x; Xiong J, 2012, NEUROPATHOLOGY, V32, P301, DOI 10.1111/j.1440-1789.2011.01261.x; Zhang J, 2013, J CLIN NEUROSCI, V20, P335, DOI 10.1016/j.jocn.2012.09.003; Zwiener I, 2011, DTSCH ARZTEBL INT, V108, P163, DOI [10.3238/arztebl.2011.0163, 10.3238/arztebl.2010.0163]	53	40	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101211	10.1371/journal.pone.0101211	http://dx.doi.org/10.1371/journal.pone.0101211			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991807	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400049
J	Wang, HB; Zhu, SL; Zheng, JS; Gou, AL; Cui, H; Zhang, Y; Ning, GJ; Fan, CX; Chen, YS; Li, KL; Yuan, P; Ma, C; Ma, J; Zheng, H; Fan, XC; Li, XL; Tang, HS; Li, XL; Zhang, F; Yan, DM; Wang, DY; Cui, ZQ; Ren, LP; Zhu, H; Wang, HL; Jiang, XH; An, HQ; Liu, Y; Li, J; Xu, WB; Wen, N; Xu, AQ; Luo, HM				Wang, Hai-Bo; Zhu, Shuang-Li; Zheng, Jing-Shan; Gou, Ai-Li; Cui, Hui; Zhang, Yong; Ning, Gui-Jun; Fan, Chun-Xiang; Chen, Yuan-Sheng; Li, Ke-Li; Yuan, Ping; Ma, Chao; Ma, Jing; Zheng, Hui; Fan, Xin-Chun; Li, Xin-Lan; Tang, Hai-Shu; Li, Xiao-Lei; Zhang, Fan; Yan, Dong-Mei; Wang, Dong-Yan; Cui, Zhi-Qiang; Ren, Li-Ping; Zhu, Hui; Wang, Hui-Ling; Jiang, Xiao-Hong; An, Hong-Qiu; Liu, Yang; Li, Jing; Xu, Wen-Bo; Wen, Ning; Xu, Ai-Qiang; Luo, Hui-Ming			Sero-Survey of Polio Antibodies during Wild Poliovirus Outbreak in Southern Xinjiang Uygur Autonomous Region, China	PLOS ONE			English	Article							POLIOMYELITIS OUTBREAK; IMMUNITY STATUS; NEUTRALIZING ANTIBODIES; POINTE-NOIRE; VACCINE; SEROPREVALENCE; POPULATION; CONGO	Background: After being polio free for more than 10 years, an outbreak following importation of wild poliovirus (WPV) was confirmed in Xinjiang Uygur Autonomous Region, China, in 2011. Methods: A cross-sectional study was conducted prior to supplementary immunization activities (SIAs), immediately after the confirmation of the WPV outbreak. In selected prefectures, participants aged <= 60 years old who visited hospitals at county-level or above to have their blood drawn for reasons not related to the study, were invited to participate in our study. Antibody titers >= 8 were considered positive. Results: Among the 2,611 participants enrolled, 2,253 (86.3%), 2,283 (87.4%), and 1,989 (76.2%) were seropositive to P1, P2 and P3 respectively, and 1744 (66.8%) participants were seropositive to all the three serotypes. Lower antibody seropositivities and geometric mean titers were observed in children <1 year of age and in adults aged 15-39 years. Conclusion: Serosurveys to estimate population immunity in districts at high risk of polio importation might be useful to gauge underlying population immunity gaps to polio and possibly to guide preparedness and response planning. Consideration should be given to older children and adults during polio risk assessment planning and outbreak response.	[Wang, Hai-Bo; Zheng, Jing-Shan; Ning, Gui-Jun; Fan, Chun-Xiang; Chen, Yuan-Sheng; Li, Ke-Li; Yuan, Ping; Ma, Chao; Ma, Jing; Zheng, Hui; Wen, Ning; Luo, Hui-Ming] Chinese Ctr Dis Control & Prevent, Expanded Program Immunizat, Beijing, Peoples R China; [Zhu, Shuang-Li; Zhang, Yong; Li, Xiao-Lei; Yan, Dong-Mei; Wang, Dong-Yan; Zhu, Hui; Wang, Hui-Ling; Jiang, Xiao-Hong; An, Hong-Qiu; Li, Jing; Xu, Wen-Bo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Gou, Ai-Li; Cui, Hui; Fan, Xin-Chun; Li, Xin-Lan; Tang, Hai-Shu] Xinjiang Uygur Autonomous Reg Ctr Dis Control & P, Expanded Program Immunizat, Urumqi city, Xinjiang Uygur, Peoples R China; [Zhang, Fan] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Cui, Zhi-Qiang] Hebei Prov Ctr Dis Control & Prevent, Shijiazhuang, Peoples R China; [Ren, Li-Ping] Liaoning Prov Ctr Dis Control & Prevent, Shenyang, Peoples R China; [Liu, Yang] Tianjin Ctr Dis Control & Prevent, Tianjin, Peoples R China; [Xu, Ai-Qiang] Shandong Univ, Shandong Ctr Dis Control & Prevent, Inst Prevent Med, Shandong Prov Key Lab Infect Dis Control & Preven, Jinan, Shandong, Peoples R China	Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Tianjin Center for Disease Control & Prevention; Shandong University	Wen, N (corresponding author), Chinese Ctr Dis Control & Prevent, Expanded Program Immunizat, Beijing, Peoples R China.	ning_wen@163.com; aqxuepi@163.com; Hmluo@vip.sina.com		Zhang, Yong/0000-0002-2692-5437				[Anonymous], 2000, JAMA, V283, P1414; Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P357; [Anonymous], 2000, Wkly Epidemiol Rec, V75, P401; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P545; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P425; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P489; BASS JW, 1978, JAMA-J AM MED ASSOC, V239, P2252, DOI 10.1001/jama.239.21.2252; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P967; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P1198; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P145; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P113; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P1070; Chiba Y, 2000, JPN J INFECT DIS, V53, P135; Conyn-van Spaendonck MAE, 2001, AM J EPIDEMIOL, V153, P207, DOI 10.1093/aje/153.3.207; Cowling DW, 2000, JAMA-J AM MED ASSOC, V284, P3121; Diedrich S, 2000, DEUT MED WOCHENSCHR, V125, P584, DOI 10.1055/s-2007-1024365; Diedrich S, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-2; Frantzidou F, 2005, CLIN MICROBIOL INFEC, V11, P68, DOI 10.1111/j.1469-0691.2004.00998.x; Gregory CJ, 2012, CLIN INFECT DIS, V55, P1299, DOI 10.1093/cid/cis715; Lamy M E, 1979, Dev Biol Stand, V43, P207; Le Menach A, 2011, EMERG INFECT DIS, V17, P1506, DOI 10.3201/eid1708.110195; Liang XF, 2006, J INFECT DIS, V194, P545, DOI 10.1086/506359; Luchs A, 2010, T ROY SOC TROP MED H, V104, P625, DOI 10.1016/j.trstmh.2010.05.004; Luo HM, 2013, NEW ENGL J MED, V369, P1981, DOI 10.1056/NEJMoa1303368; Mastroeni I, 1997, VACCINE, V15, P747, DOI 10.1016/S0264-410X(96)00208-3; Nates SV, 2007, VIRAL IMMUNOL, V20, P3, DOI 10.1089/vim.2006.0071; PATRIARCA PA, 1991, REV INFECT DIS, V13, P926; Pires de Miranda M, 2007, Euro Surveill, V12, pE7; Prevots DR, 1998, CLIN INFECT DIS, V26, P419, DOI 10.1086/516312; REALI D, 1990, EUR J EPIDEMIOL, V6, P309, DOI 10.1007/BF00150438; Schoub BD, 2001, J INFECTION, V43, P128, DOI 10.1053/jinf.2001.0867; TRIVELLO R, 1994, ANN CLIN LAB SCI, V24, P542; TRIVELLO R, 1988, EPIDEMIOL INFECT, V101, P605, DOI 10.1017/S0950268800029472; Wang HB, 2013, CLIN VACCINE IMMUNOL, V20, P1070, DOI 10.1128/CVI.00092-13; Wassilak Steve, 2012, Morbidity and Mortality Weekly Report, V61, P353; World Health Organization, 1997, EPIGEN9701EPI WHO; 2010, EURO SURVEILL, V15	37	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e80069	10.1371/journal.pone.0080069	http://dx.doi.org/10.1371/journal.pone.0080069			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991811	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400001
J	Bhinder, B; Shum, D; Li, M; Ibanez, G; Vlassov, AV; Magdaleno, S; Djaballah, H				Bhinder, Bhavneet; Shum, David; Li, Mu; Ibanez, Glorymar; Vlassov, Alexander V.; Magdaleno, Susan; Djaballah, Hakim			Discovery of a Dicer-Independent, Cell-Type Dependent Alternate Targeting Sequence Generator: Implications in Gene Silencing & Pooled RNAi Screens	PLOS ONE			English	Article							MICRORNA BIOGENESIS; SYSTEMATIC ANALYSIS; INTERFERING RNAS; MAMMALIAN-CELLS; REVEALS; PATHWAY; HAIRPIN; SIRNAS; SHRNAS; EXPRESSION	There is an acceptance that plasmid-based delivery of interfering RNA always generates the intended targeting sequences in cells, making it as specific as its synthetic counterpart. However, recent studies have reported on cellular inefficiencies of the former, especially in light of emerging gene discordance at inter-screen level and across formats. Focusing primarily on the TRC plasmid-based shRNA hairpins, we reasoned that alleged specificities were perhaps compromised due to altered processing; resulting in a multitude of random interfering sequences. For this purpose, we opted to study the processing of hairpin TRCN#40273 targeting CTTN; which showed activity in a miRNA-21 gain-of-function shRNA screen, but inactive when used as an siRNA duplex. Using a previously described walk-through method, we identified 36 theoretical cleavage variants resulting in 78 potential siRNA duplexes targeting 53 genes. We synthesized and tested all of them. Surprisingly, six duplexes targeting ASH1L, DROSHA, GNG7, PRKCH, THEM4, and WDR92 scored as active. QRT-PCR analysis on hairpin transduced reporter cells confirmed knockdown of all six genes, besides CTTN; revealing a surprising 7 gene-signature perturbation by this one single hairpin. We expanded our qRT-PCR studies to 26 additional cell lines and observed unique knockdown profiles associated with each cell line tested; even for those lacking functional DICER1 gene suggesting no obvious dependence on dicer for shRNA hairpin processing; contrary to published models. Taken together, we report on a novel dicer independent, cell-type dependent mechanism for non-specific RNAi gene silencing we coin Alternate Targeting Sequence Generator (ATSG). In summary, ATSG adds another dimension to the already complex interpretation of RNAi screening data, and provides for the first time strong evidence in support of arrayed screening, and questions the scientific merits of performing pooled RNAi screens, where deconvolution of up to genome-scale pools is indispensable for target identification.	[Bhinder, Bhavneet; Shum, David; Ibanez, Glorymar; Djaballah, Hakim] Mem Sloan Kettering Canc Ctr, HTS Core Facil, New York, NY 10021 USA; [Li, Mu; Vlassov, Alexander V.; Magdaleno, Susan] Thermo Fisher Sci, Austin, TX USA	Memorial Sloan Kettering Cancer Center; Thermo Fisher Scientific	Djaballah, H (corresponding author), Mem Sloan Kettering Canc Ctr, HTS Core Facil, 1275 York Ave, New York, NY 10021 USA.	djaballh@mskcc.org		Djaballah, Hakim/0000-0002-6039-0181	Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center; William Randolph Hearst Fund in Experimental Therapeutics; Lillian S Wells Foundation; NIH/NCI Cancer Center Support Grant [5 P30 CA008748-44]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center; William Randolph Hearst Fund in Experimental Therapeutics; Lillian S Wells Foundation; NIH/NCI Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The HTS Core Facility is partially supported by Mr. William H. Goodwin and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research, the Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center, the William Randolph Hearst Fund in Experimental Therapeutics, the Lillian S Wells Foundation and by an NIH/NCI Cancer Center Support Grant 5 P30 CA008748-44. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Beronja S, 2013, NATURE, V501, P185, DOI 10.1038/nature12464; Bhinder B, 2013, DRUG DISC WORLD, V14, P31; Bhinder B, 2014, COMB CHEM HIGH T SCR, V17, P98, DOI 10.2174/1386207317666140117101852; Bhinder B, 2013, COMB CHEM HIGH T SCR, V16, P665; Bhinder B, 2013, ASSAY DRUG DEV TECHN, V11, P173, DOI 10.1089/adt.2012.475; Bhinder B, 2012, COMB CHEM HIGH T SCR, V15, P686, DOI 10.2174/138620712803519671; Blainey PC, 2014, NAT METHODS, V11, P19, DOI 10.1038/nmeth.2783; Boettcher M, 2010, CURR GENOMICS, V11, P162, DOI 10.2174/138920210791110988; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chu C, 2014, PESTIC BIOC IN PRESS; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Demir Kubilay, 2012, Methods Mol Biol, V910, P1, DOI 10.1007/978-1-61779-965-5_1; Gu S, 2012, CELL, V151, P900, DOI 10.1016/j.cell.2012.09.042; Heintze Jacob, 2013, Frontiers in Genetics, V4, P193, DOI 10.3389/fgene.2013.00193; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jackson AL, 2004, TRENDS GENET, V20, P521, DOI 10.1016/j.tig.2004.08.006; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lavery KS, 2003, CURR OPIN DRUG DI DE, V6, P561; Liu YP, 2013, NUCLEIC ACIDS RES, V41, P3723, DOI 10.1093/nar/gkt036; Marine S, 2012, J BIOMOL SCREEN, V17, P370, DOI 10.1177/1087057111427348; Maurin T, 2012, RNA, V18, P2166, DOI 10.1261/rna.036194.112; Naik G, 2011, WSJ, VCCLVIII, pA1; Naik G, 2011, WSJ, VCCLVIII, pA16; Naito Yuki, 2013, Methods Mol Biol, V942, P57, DOI 10.1007/978-1-62703-119-6_3; Pache L, 2011, METHODS, V53, P3, DOI 10.1016/j.ymeth.2010.07.009; Pennisi E, 2013, SCIENCE, V341, P833, DOI 10.1126/science.341.6148.833; Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904; Ramji K, 2013, MOL BIOL REP, V40, P6977, DOI 10.1007/s11033-013-2817-7; Rao DD, 2009, ADV DRUG DELIVER REV, V61, P746, DOI 10.1016/j.addr.2009.04.004; Sachse C, 2004, ONCOGENE, V23, P8384, DOI 10.1038/sj.onc.1208072; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Schultz Nikolaus, 2011, Silence, V2, P3, DOI 10.1186/1758-907X-2-3; Shum D, 2013, COMB CHEM HIGH T SCR, V16, P791, DOI 10.2174/1386207311301010004; Shum D, 2013, ASSAY DRUG DEV TECHN, V11, P191, DOI 10.1089/adt.2012.477; Sigoillot FD, 2012, NAT METHODS, V9, P363, DOI [10.1038/NMETH.1898, 10.1038/nmeth.1898]; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Snove O, 2004, BIOCHEM BIOPH RES CO, V319, P256, DOI 10.1016/j.bbrc.2004.04.175; Sudbery I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-175; Wang XW, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp864; Zumbansen Markus, 2009, J RNAi Gene Silencing, V6, P354	44	6	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100676	10.1371/journal.pone.0100676	http://dx.doi.org/10.1371/journal.pone.0100676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987961	Green Published, Green Submitted, gold			2022-12-27	WOS:000341354100037
J	Manez, KS; Holm, P; Blight, L; Coll, M; MacDiarmid, A; Ojaveer, H; Poulsen, B; Tull, M				Manez, Kathleen Schwerdtner; Holm, Poul; Blight, Louise; Coll, Marta; MacDiarmid, Alison; Ojaveer, Henn; Poulsen, Bo; Tull, Malcolm			The Future of the Oceans Past: Towards a Global Marine Historical Research Initiative	PLOS ONE			English	Article							SOUTH-AFRICA; BASE-LINES; EMERYVILLE SHELLMOUND; TOP-DOWN; FISHERIES; COLLAPSE; IMPACTS; FISH; RECOVERY; COASTAL	Historical research is playing an increasingly important role in marine sciences. Historical data are also used in policy making and marine resource management, and have helped to address the issue of shifting baselines for numerous species and ecosystems. Although many important research questions still remain unanswered, tremendous developments in conceptual and methodological approaches are expected to contribute to a comprehensive understanding of the global history of human interactions with life in the seas. Based on our experiences and knowledge from the "History of Marine Animal Populations'' project, this paper identifies the emerging research topics for future historical marine research. It elaborates on concepts and tools which are expected to play a major role in answering these questions, and identifies geographical regions which deserve future attention from marine environmental historians and historical ecologists.	[Manez, Kathleen Schwerdtner] Leibniz Ctr Trop Marine Ecol, Dept Social Sci, Bremen, Germany; [Manez, Kathleen Schwerdtner] Murdoch Univ, Asia Res Ctr, Murdoch, WA 6150, Australia; [Holm, Poul] Univ Dublin Trinity Coll, Trinity Long Room Hub Arts & Humanities Res Inst, Dublin 2, Ireland; [Blight, Louise] World Wildlife Fund WWF Canada, Vancouver, BC, Canada; [Coll, Marta] Inst Marine Sci, Renewable Marine Resources Dept, Barcelona, Spain; [Coll, Marta] Lab Ecosyst Marins Exploites, Sete, France; [MacDiarmid, Alison] Natl Inst Water & Atmospher Res, Wellington, New Zealand; [Ojaveer, Henn] Univ Tartu, Estonian Marine Inst, EE-50090 Tartu, Estonia; [Poulsen, Bo] Aalborg Univ, Fac Social Sci, Aalborg O, Denmark; [Tull, Malcolm] Murdoch Univ, Murdoch Business Sch, Murdoch, WA 6150, Australia	Leibniz Zentrum fur Marine Tropenforschung (ZMT); Murdoch University; Trinity College Dublin; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Tartu; Estonian Marine Institute; Aalborg University; Murdoch University	Manez, KS (corresponding author), Leibniz Ctr Trop Marine Ecol, Dept Social Sci, Bremen, Germany.	kathleen.schwerdtner@zmt-bremen.de	Ojaveer, Henn/K-2160-2016; Holm, Poul/E-8100-2012; Coll, Marta/A-9488-2012	Ojaveer, Henn/0000-0003-2742-6063; Holm, Poul/0000-0003-3927-3308; Coll, Marta/0000-0001-6235-5868; Poulsen, Bo/0000-0002-6759-2341	Spanish National Program 'Ramon y Cajal'; Estonian Ministry of Education and Research [SF0180005s10]; HMAP	Spanish National Program 'Ramon y Cajal'; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); HMAP	Fellowships to the BIOWEB project and by the Spanish National Program 'Ramon y Cajal'. HO was funded by the Estonian Ministry of Education and Research (grant SF0180005s10). We thank HMAP for paying the publication costs of this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth CH, 2008, ECOL MODEL, V216, P354, DOI 10.1016/j.ecolmodel.2008.05.005; Ainsworth CH, 2008, BIOL CONSERV, V141, P848, DOI 10.1016/j.biocon.2008.01.006; Alheit J, 1997, FISH OCEANOGR, V6, P130, DOI 10.1046/j.1365-2419.1997.00035.x; Allison E. H., 2013, C PEOPLE SEA 7; Alter SE, 2007, P NATL ACAD SCI USA, V104, P15162, DOI 10.1073/pnas.0706056104; Attwood CG, 1999, S AFR J MARINE SCI, V21, P415; Bailey G, 2008, HUMAN IMPACTS ON ANCIENT MARINE ECOSYSTEMS: A GLOBAL PERSPECTIVE, P215; Barnes DKA, 2009, PHILOS T R SOC B, V364, P1985, DOI 10.1098/rstb.2008.0205; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Bennett E, 2005, MAR POLICY, V29, P451, DOI 10.1016/j.marpol.2004.07.003; Blamey LK, 2012, PROG OCEANOGR, V106, P80, DOI 10.1016/j.pocean.2012.07.001; Boomgaard P, 2005, MUDDIED WATERS HIST, P98; Broughton JM, 1997, ANTIQUITY, V71, P845, DOI 10.1017/S0003598X0008577X; Broughton JM, 2002, WORLD ARCHAEOL, V34, P60, DOI 10.1080/00438240220134269; Bunce M, 2008, OCEAN COAST MANAGE, V51, P285, DOI 10.1016/j.ocecoaman.2007.09.006; Butcher J., 2004, CLOSING FRONTIER HIS, P1850; Campana SE, 2001, CAN J FISH AQUAT SCI, V58, P30, DOI 10.1139/f00-177; CAMPANA SE, 1995, MAR ECOL PROG SER, V122, P115, DOI 10.3354/meps122115; Caroll EL, 2006, DEMOGRAPHIC GENETIC; Carpenter SR, 2006, ECOL SOC, V11; Chilvers BL, 2008, WILDLIFE RES, V35, P463, DOI 10.1071/WR07053; Choo P. S., 2008, Development (London), V51, P176; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Cinner JE, 2012, MAR POLICY, V36, P278, DOI 10.1016/j.marpol.2011.06.005; Coll M, PERSPECTIVES OCEANS; Coll M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085670; Conversi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010633; Cortes-Sanchez M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024026; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Cushmann GT, 2003, THESIS U TEXAS AUSTI; Dambacher JM, 2003, ECOL MODEL, V161, P79, DOI 10.1016/S0304-3800(02)00295-8; Day JA, 2000, T ROY SOC S AFR, V55, P101, DOI 10.1080/00359190009520436; del Monte-Luna P, 2007, FISH FISH, V8, P107; delaMare WK, 1997, NATURE, V389, P57, DOI 10.1038/37956; Drinkwater KF, 2006, PROG OCEANOGR, V68, P134, DOI 10.1016/j.pocean.2006.02.011; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; Eddy TD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013670; Emslie SD, 2007, P NATL ACAD SCI USA, V104, P11666, DOI 10.1073/pnas.0608477104; Erlandson JM, 2008, HUMAN IMPACTS ON ANCIENT MARINE ECOSYSTEMS: A GLOBAL PERSPECTIVE, P1; Fabinyi Michael., 2007, PHILIPP STUD, V55, P509; FAO Fisheries Department, 2003, FAO TECHN GUID RESP; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; Finney BP, 2010, J MARINE SYST, V79, P316, DOI 10.1016/j.jmarsys.2008.12.010; Fontaine MC, 2012, P NATL ACAD SCI USA, V109, pE2569, DOI 10.1073/pnas.1201258109; Fulton EA, 2010, J MARINE SYST, V81, P171, DOI 10.1016/j.jmarsys.2009.12.012; Ghazoul J, 2007, GAIA, V16, P215, DOI 10.14512/gaia.16.3.13; Glaser M, 2012, CURR OPIN ENV SUST, V4, P300, DOI 10.1016/j.cosust.2012.05.004; Griffiths MH, 2000, S AFR J MARINE SCI, V22, P81, DOI 10.2989/025776100784125663; Hacquebord L., 2001, ENVIRON HIST-UK, V7, P169; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harper S, 2013, MAR POLICY, V39, P56, DOI 10.1016/j.marpol.2012.10.018; Hauser L, 2008, FISH FISH, V9, P333, DOI 10.1111/j.1467-2979.2008.00299.x; Hauzer M, 2013, FISH RES, V140, P28, DOI 10.1016/j.fishres.2012.12.001; Holm P, 2010, MARINE ANIMAL POPULA, P1; Hufthammer AK, 2010, J ARCHAEOL SCI, V37, P78, DOI 10.1016/j.jas.2009.09.001; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Johannes RE., 2007, FISHERSKNOWLEDGE FIS, P41; Josephson Elizabeth A., 2008, P133; Kittinger JN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025460; Klais R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021567; Kleiber D, 2014, CAN J FISH AQUAT SCI, V71, P656, DOI 10.1139/cjfas-2013-0177; Lalas C, 2008, CONS VIS C; Lotze HK, 2007, FISH RES, V87, P208, DOI 10.1016/j.fishres.2006.12.009; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lotze HK, 2011, TRENDS ECOL EVOL, V26, P595, DOI 10.1016/j.tree.2011.07.008; Lotze HK, 2011, ECOSYSTEMS, V14, P198, DOI 10.1007/s10021-010-9404-8; Lotze HK, 2009, TRENDS ECOL EVOL, V24, P254, DOI 10.1016/j.tree.2008.12.004; Lybolt M, 2011, FRONT ECOL ENVIRON, V9, P154, DOI 10.1890/090176; MacDiarmid AB, 2013, ECOSYSTEM SERVICES; Manez KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011346; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; Maxwell K, 2014, ORAL HIST M IN PRESS; McCay B.J., 1993, REV ANTHR, V22, P77, DOI [10.1080/00988157.1993.9978054, DOI 10.1080/00988157.1993.9978054]; McKenzie MJ, 1946, HIST DEV HARBOURS FI; Meltzoff SK, 1995, J POLIT ECOL, V2, P20, DOI [10.2458/v2i1.20129, DOI 10.2458/V2I1.20129]; Menge BA, 2000, J EXP MAR BIOL ECOL, V250, P257, DOI 10.1016/S0022-0981(00)00200-8; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Nadal-Klein J, 1988, SOCIAL EC PAPERS; Nelson GC, 2006, ECOL SOC, V11; Neubauer P, 2013, SCIENCE, V340, P347, DOI 10.1126/science.1230441; Nicol S, 2010, FISH FISH, V11, P203, DOI 10.1111/j.1467-2979.2010.00356.x; Ojaveer H, 2007, FISH RES, V87, P102, DOI 10.1016/j.fishres.2007.08.011; Oliver GP, 2004, J NAT HIST, V38, P2927, DOI 10.1080/00222930410001695006; Orton DC, 2014, ANTIQUITY, V88, P516, DOI 10.1017/S0003598X00101152; Orton DC, 2014, PERSPECTIVE IN PRESS; Osterblom H, 2007, ECOSYSTEMS, V10, P877, DOI 10.1007/s10021-007-9069-0; Page G., 2009, ANAL GOVERNANCE RESP; Palomares MLD, 2006, ENVIRON HIST, V11, P835, DOI 10.1093/envhis/11.4.835; Palumbi SR, 2011, SHIFTING BASELINES F, P163; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Perkol-Finkel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010791; Perri Michael, 2009, ENVIRON HIST-UK, V15, P129; Philippart CJM, 2007, ECOSYSTEMS, V10, P95, DOI 10.1007/s10021-006-9006-7; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Pitcher TJ, 2005, PHILOS T R SOC B, V360, P107, DOI 10.1098/rstb.2004.1575; PITCHER TJ, 2002, ECOSYSTEM MODELS NEW; Plaganyi EE, 2012, FISH FISH; Poulsen B, 2008, DUTCH HERRING ENV HI, P1600; Poulsen B, 2007, FISH RES, V87, P181, DOI 10.1016/j.fishres.2007.07.014; Powell A. M. Jr., 2011, Atmospheric and Climate Sciences, V1, P33, DOI 10.4236/acs.2011.12004; Ramirez-Llodra E, 2010, BIOGEOSCIENCES, V7, P2851, DOI 10.5194/bg-7-2851-2010; Richards J. F, 2006, UNENDING FRONTIER EN; Rick TC, 2008, HUMAN IMPACTS ON ANCIENT MARINE ECOSYSTEMS: A GLOBAL PERSPECTIVE, P77; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Roelke LA, 1997, FISH B-NOAA, V95, P540; Roff G, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2100; Roman J, 2003, SCIENCE, V301, P508, DOI 10.1126/science.1084524; Saenz-Arroyo A, 2005, P ROY SOC B-BIOL SCI, V272, P1957, DOI 10.1098/rspb.2005.3175; SANGER C W, 1991, Polar Record, V27, P77; Schwerdtner Manez K, 2014, PERSPECTIVES OCEANS; Seitz RD, 2001, ICES J MAR SCI, V58, P689, DOI 10.1006/jmsc.2001.1054; Smith I, 2005, EXPLOITATION AND CULTURAL IMPORTANCE OF SEA MAMMALS, P6; Southward AJ, 1998, J MAR BIOL ASSOC UK, V68, P423; Steneck RS, 2004, ECOSYSTEMS, V7, P323, DOI 10.1007/s10021-004-0240-6; Taning AV, 1929, SCIENCE, V69, P191, DOI 10.1126/science.69.1781.191-a; Thurstan RH, 2014, PERSPECTIVES OCEANS; Thurstan RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011767; Vunisea A, 2005, PACIFIC VOICES EQUIT, P89; Williams M. J., 2008, Development (London), V51, P180, DOI 10.1057/dev.2008.2; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yodanis CL, 2000, QUAL SOCIOL, V23, P267, DOI DOI 10.1023/A:1005515926536; Zeldis JR, 2008, MAR ECOL PROG SER, V371, P131, DOI 10.3354/meps07668; ZERNER C, 1994, LAW SOC REV, V28, P1079, DOI 10.2307/3054024	126	48	48	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101466	10.1371/journal.pone.0101466	http://dx.doi.org/10.1371/journal.pone.0101466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988080	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000341354100094
J	Sharma, VK; Das, SK; Dhar, P; Hota, KB; Mahapatra, BB; Vashishtha, V; Kumar, A; Hota, SK; Norboo, T; Srivastava, RB				Sharma, Vijay K.; Das, Saroj K.; Dhar, Priyanka; Hota, Kalpana B.; Mahapatra, Bidhu B.; Vashishtha, Vivek; Kumar, Ashish; Hota, Sunil K.; Norboo, Tsering; Srivastava, Ravi B.			Domain Specific Changes in Cognition at High Altitude and Its Correlation with Hyperhomocysteinemia	PLOS ONE			English	Article							HYPOBARIC HYPOXIA; TOTAL HOMOCYSTEINE; IMPAIRMENT; PERFORMANCE; FOLATE; MEMORY	Though acute exposure to hypobaric hypoxia is reported to impair cognitive performance, the effects of prolonged exposure on different cognitive domains have been less studied. The present study aimed at investigating the time dependent changes in cognitive performance on prolonged stay at high altitude and its correlation with electroencephalogram (EEG) and plasma homocysteine. The study was conducted on 761 male volunteers of 25-35 years age who had never been to high altitude and baseline data pertaining to domain specific cognitive performance, EEG and homocysteine was acquired at altitude <= 240 m mean sea level (MSL). The volunteers were inducted to an altitude of 4200-4600 m MSL and longitudinal follow-ups were conducted at durations of 03, 12 and 18 months. Neuropsychological assessment was performed for mild cognitive impairment (MCI), attention, information processing rate, visuo-spatial cognition and executive functioning. Total homocysteine (tHcy), vitamin B-12 and folic acid were estimated. Mini Mental State Examination (MMSE) showed temporal increase in the percentage prevalence of MCI from 8.17% on 03 months of stay at high altitude to 18.54% on 18 months of stay. Impairment in visuo-spatial executive, attention, delayed recall and procedural memory related cognitive domains were detected following prolonged stay in high altitude. Increase in alpha wave amplitude in the T3, T4 and C3 regions was observed during the follow-ups which was inversely correlated (r = -0.68) to MMSE scores. The tHcy increased proportionately with duration of stay at high altitude and was correlated with MCI. No change in vitamin B-12 and folic acid was observed. Our findings suggest that cognitive impairment is progressively associated with duration of stay at high altitude and is correlated with elevated tHcy in the plasma. Moreover, progressive MCI at high altitude occurs despite acclimatization and is independent of vitamin B-12 and folic acid.	[Sharma, Vijay K.; Das, Saroj K.; Dhar, Priyanka; Hota, Kalpana B.; Vashishtha, Vivek; Kumar, Ashish; Hota, Sunil K.; Srivastava, Ravi B.] Def Res & Dev Org, Def Inst High Altitude Res, Leh Ladakh, India; [Mahapatra, Bidhu B.] Populat Council, Dept Stat, New Delhi, India; [Norboo, Tsering] Ladakh Inst Prevent, Dambuchan, Leh Ladakh, India	Defence Research & Development Organisation (DRDO); Defence Institute of High Altitude Research (DIHAR)	Hota, SK (corresponding author), Def Res & Dev Org, Def Inst High Altitude Res, 56 APO, Leh Ladakh, India.	drsunilhota@hotmail.com	Mahapatra, Bidhubhusan/M-1411-2019; Das, Saroj Kumar/W-5452-2019	Mahapatra, Bidhubhusan/0000-0003-0240-7026; Das, Saroj Kumar/0000-0002-5717-5333; Sharma, Vijay Kumar/0000-0002-9327-0397; Srivastava, Rakesh/0000-0003-3112-4252; Srivastava, Rakesh/0000-0002-0065-4069	DRDO	DRDO(Defence Research & Development Organisation (DRDO))	Financial support for the study was provided by DRDO. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraini JH, 1998, PFLUG ARCH EUR J PHY, V436, P553, DOI 10.1007/s004240050671; Barncord S W, 2001, Appl Neuropsychol, V8, P99, DOI 10.1207/S15324826AN0802_4; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bender L., 1938, AM ORTHOPSYCHIATRIC, V3; Bonnon M, 2000, AVIAT SPACE ENVIR MD, V71, P678; Curro M, 2014, NEUROCHEM R IN PRESS; Fayed N., 2006, AM J MED, V119, p168., DOI [10.1016/j.amjmed.2005.07.062, DOI 10.1016/J.AMJMED.2005.07.062]; FOLSTEIN MF, 1983, ARCH GEN PSYCHIAT, V40, P812; GARRIDO E, 1995, EUR J APPL PHYSIOL O, V70, P477, DOI 10.1007/BF00634375; Hota SK, 2007, NEUROCHEM INT, V51, P384, DOI 10.1016/j.neuint.2007.04.003; Hota SK, 2012, INDIAN J MED RES, V136, P411; Karakas Hakki Muammer, 2006, Diagn Interv Radiol, V12, P9; Kinoshita M, 2013, EPIGENETICS-US, V8, P584, DOI 10.4161/epi.24621; Kloppenborg RP, 2011, ATHEROSCLEROSIS, V216, P461, DOI 10.1016/j.atherosclerosis.2011.02.027; Leifflen D, 1997, AVIAT SPACE ENVIR MD, V68, P993; Lezak M.D, 1995, NEUROPSYCHOLOGICAL A; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; MARGOLIS RB, 1989, J PSYCHOL, V123, P179, DOI 10.1080/00223980.1989.10542974; Miller A. L., 1997, ALTERN MED REV, V2, P234; Morris MS, 2012, ADV NUTR, V3, P801, DOI 10.3945/an.112.002535; Obeid R, 2007, CLIN CHEM LAB MED, V45, P1590, DOI 10.1515/CCLM.2007.356; Paola MD, 2008, EUR J NEUROL, V15, P1050, DOI [10.1111/j.1468-1331.2008.02243.x, 10.1111/j.1468-1331.2008.02137.x]; Peng QQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079346; Raven JC, 1992, MANUAL RAVENS STANDA; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; REGARD M, 1989, NEUROLOGY, V39, P210, DOI 10.1212/WNL.39.2.210; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; SHUKITTHALE B, 1994, BEHAV NEURAL BIOL, V62, P244, DOI 10.1016/S0163-1047(05)80023-8; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; Singh S B, 2003, Indian J Physiol Pharmacol, V47, P52; Singh SB, 2004, INDIAN J MED RES, V120, P94; Siuda J, 2009, NEUROL NEUROCHIR POL, V43, P321; Skaiaa SC, 2006, WILD ENVIRON MED, V17, P132, DOI 10.1580/PR19-04.1; Sudduth TL, 2013, J CEREBR BLOOD F MET, V33, P708, DOI 10.1038/jcbfm.2013.1; Tu Min-Chien, 2010, Acta Neurol Taiwan, V19, P168; Vidal JS, 2008, NEUROEPIDEMIOLOGY, V30, P207, DOI 10.1159/000126914; WEST JB, 1986, FASEB J, V45, P2953; Wheatley K, 2011, J ROY ARMY MED CORPS, V157, P38, DOI 10.1136/jramc-157-01-07; World Health Organization Switzerland, 2008, WHO STEPS SURV; Wright CB, 2004, NEUROLOGY, V63, P254, DOI 10.1212/01.WNL.0000129986.19019.5D; Yelmen N, 2011, GEN PHYSIOL BIOPHYS, V30, P389, DOI 10.4149/gpb_2011_04_389; Zhang JX, 2011, HIGH ALT MED BIOL, V12, P37, DOI 10.1089/ham.2009.1085	42	25	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101448	10.1371/journal.pone.0101448	http://dx.doi.org/10.1371/journal.pone.0101448			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988417	Green Submitted, Green Published, gold			2022-12-27	WOS:000341354100089
J	Dee, DR; Horimoto, Y; Yada, RY				Dee, Derek R.; Horimoto, Yasumi; Yada, Rickey Y.			Conserved Prosegment Residues Stabilize a Late-Stage Folding Transition State of Pepsin Independently of Ground States	PLOS ONE			English	Article							ALPHA-LYTIC PROTEASE; FYN SH3 DOMAIN; NONNATIVE INTERACTIONS; NATIVE-STATE; MULTIDOMAIN PROTEINS; KINETIC STABILITY; PHI-VALUES; ENERGY LANDSCAPES; HYDROPHOBIC CORE; CONTACT ORDER	The native folding of certain zymogen-derived enzymes is completely dependent upon a prosegment domain to stabilize the folding transition state, thereby catalyzing the folding reaction. Generally little is known about how the prosegment accomplishes this task. It was previously shown that the prosegment catalyzes a late-stage folding transition between a stable misfolded state and the native state of pepsin. In this study, the contributions of specific prosegment residues to catalyzing pepsin folding were investigated by introducing individual Ala substitutions and measuring the effects on the bimolecular folding reaction between the prosegment peptide and pepsin. The effects of mutations on the free energies of the individual misfolded and native ground states and the transition state were compared using measurements of prosegment-pepsin binding and folding kinetics. Five out of the seven prosegment residues examined yielded relatively large kinetic effects and minimal ground state perturbations upon mutation, findings which indicate that these residues form strengthened and/or non-native contacts in the transition state. These five residues are semi-to strictly conserved, while only a non-conserved residue had no kinetic effect. One conserved residue was shown to form native structure in the transition state. These results indicated that the prosegment, which is only 44 residues long, has evolved a high density of contacts that preferentially stabilize the folding transition state over the ground states. It is postulated that the prosegment forms extensive non-native contacts during the process of catalyzing correct inter-and intra-domain contacts during the final stages of folding. These results have implications for understanding the folding of multi-domain proteins and for the evolution of prosegment-catalyzed folding.	[Dee, Derek R.; Yada, Rickey Y.] Univ Guelph, Biophys Interdept Grp, Guelph, ON N1G 2W1, Canada; [Horimoto, Yasumi; Yada, Rickey Y.] Univ Guelph, Dept Food Sci, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Guelph	Yada, RY (corresponding author), Univ Guelph, Biophys Interdept Grp, Guelph, ON N1G 2W1, Canada.	ryada@uoguelph.ca	Dee, Derek/AAK-5892-2020	Yada, Rickey/0000-0002-8648-2156	National Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chairs (CRC) Program; Ontario Graduate Scholarship	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs (CRC) Program(Canada Research Chairs); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by the National Sciences and Engineering Research Council of Canada (NSERC) (http://www.nserc-crsng.gc.ca/index_eng.a?sp) and the Canada Research Chairs (CRC) Program (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx). DRD was also supported by an Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BAKER D, 1992, NATURE, V356, P263, DOI 10.1038/356263a0; Baker D, 1993, CURR OPIN CELL BIOL, V5, P966, DOI 10.1016/0955-0674(93)90078-5; Bolinger D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000731; Borgia MB, 2011, NATURE, V474, P662, DOI 10.1038/nature10099; Bryan PN, 2002, CHEM REV, V102, P4805, DOI 10.1021/cr010190b; Chan HS, 2011, ANNU REV PHYS CHEM, V62, P301, DOI 10.1146/annurev-physchem-032210-103405; Clementi C, 2004, PROTEIN SCI, V13, P1750, DOI 10.1110/ps.03580104; Cunningham EL, 2002, BIOCHEMISTRY-US, V41, P8860, DOI 10.1021/bi020214o; Dee D, 2006, BIOCHEMISTRY-US, V45, P13982, DOI 10.1021/bi061270i; Dee DR, 2011, BIOPHYS J, V101, P1699, DOI 10.1016/j.bpj.2011.08.002; Dee DR, 2010, BIOCHEMISTRY-US, V49, P365, DOI 10.1021/bi9014055; Di Nardo AA, 2004, P NATL ACAD SCI USA, V101, P7954, DOI 10.1073/pnas.0400550101; EDER J, 1995, MOL MICROBIOL, V16, P609, DOI 10.1111/j.1365-2958.1995.tb02423.x; Fersht AR, 2004, P NATL ACAD SCI USA, V101, P7976, DOI 10.1073/pnas.0402684101; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; Fersht AR, 1997, CURR OPIN STRUC BIOL, V7, P3, DOI 10.1016/S0959-440X(97)80002-4; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fisher KE, 2007, BIOCHEMISTRY-US, V46, P640, DOI 10.1021/bi061600z; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Grantcharova VP, 1998, NAT STRUCT BIOL, V5, P714, DOI 10.1038/1412; Gromiha MM, 2006, NUCLEIC ACIDS RES, V34, pW70, DOI 10.1093/nar/gkl043; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; HARTSUCK JA, 1992, PROTEINS, V13, P1, DOI 10.1002/prot.340130102; Itoh K, 2008, P NATL ACAD SCI USA, V105, P13865, DOI 10.1073/pnas.0804512105; ITZHAKI LS, 1995, J MOL BIOL, V254, P260, DOI 10.1006/jmbi.1995.0616; Ivankov DN, 2003, PROTEIN SCI, V12, P2057, DOI 10.1110/ps.0302503; Jaswal SS, 2005, J MOL BIOL, V347, P355, DOI 10.1016/j.jmb.2005.01.032; Jaswal SS, 2002, NATURE, V415, P343, DOI 10.1038/415343a; Kelch BA, 2012, P NATL ACAD SCI USA, V109, P9414, DOI 10.1073/pnas.1119274109; Li L, 2000, NAT STRUCT BIOL, V7, P336; Manning M, 2004, BIOCHEMISTRY-US, V43, P11248, DOI 10.1021/bi0491898; Morton VL, 2007, J MOL BIOL, V371, P554, DOI 10.1016/j.jmb.2007.05.010; Naganathan AN, 2010, P NATL ACAD SCI USA, V107, P8611, DOI 10.1073/pnas.1000988107; Northey JGB, 2002, NAT STRUCT BIOL, V9, P126, DOI 10.1038/nsb748; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Ozkan SB, 2001, NAT STRUCT BIOL, V8, P765, DOI 10.1038/nsb0901-765; Parry-Smith DJ, 1997, GENE, V211, pGC45; Pauwels K, 2007, MOL MICROBIOL, V64, P917, DOI 10.1111/j.1365-2958.2007.05718.x; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Plotkin SS, 2003, P NATL ACAD SCI USA, V100, P4417, DOI 10.1073/pnas.0330720100; Plotkin SS, 2001, PROTEINS, V45, P337, DOI 10.1002/prot.1154; Raleigh DP, 2005, PROTEIN PEPTIDE LETT, V12, P117, DOI 10.2174/0929866053005809; Riddle DS, 1999, NAT STRUCT BIOL, V6, P1016; Sanchez IE, 2003, J MOL BIOL, V334, P1077, DOI 10.1016/j.jmb.2003.10.016; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; SERRANO L, 1992, J MOL BIOL, V224, P805, DOI 10.1016/0022-2836(92)90563-Y; Sohl JL, 1998, NATURE, V395, P817, DOI 10.1038/27470; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Truhlar SME, 2004, PROTEIN SCI, V13, P381, DOI 10.1110/ps.03336804; Ventura S, 2002, NAT STRUCT BIOL, V9, P485, DOI 10.1038/nsb799; Wang SL, 2014, J BIOL CHEM, V289, P697, DOI 10.1074/jbc.M113.505891; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD222, DOI 10.1093/nar/gkm800; Xia K, 2007, P NATL ACAD SCI USA, V104, P17329, DOI 10.1073/pnas.0705417104; Zarrine-Afsar A, 2004, METHODS, V34, P41, DOI 10.1016/j.ymeth.2004.03.013; Zarrine-Afsar A, 2008, P NATL ACAD SCI USA, V105, P9999, DOI 10.1073/pnas.0801874105; Zarrine-Afsar A, 2007, J MOL BIOL, V373, P764, DOI 10.1016/j.jmb.2007.07.059; Zarrine-Afsar A, 2012, PROTEINS, V80, P858, DOI 10.1002/prot.23243	61	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101339	10.1371/journal.pone.0101339	http://dx.doi.org/10.1371/journal.pone.0101339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983988	Green Published, Green Submitted, gold			2022-12-27	WOS:000339635000090
J	Jiang, B; Song, Y; Wei, S; Liu, JH; McLoughlin, IV; Dai, LR				Jiang, Bing; Song, Yan; Wei, Si; Liu, Jun-Hua; McLoughlin, Ian Vince; Dai, Li-Rong			Deep Bottleneck Features for Spoken Language Identification	PLOS ONE			English	Article							SPEAKER; DIMENSIONALITY; SPEECH; LVCSR	A key problem in spoken language identification (LID) is to design effective representations which are specific to language information. For example, in recent years, representations based on both phonotactic and acoustic features have proven their effectiveness for LID. Although advances in machine learning have led to significant improvements, LID performance is still lacking, especially for short duration speech utterances. With the hypothesis that language information is weak and represented only latently in speech, and is largely dependent on the statistical properties of the speech content, existing representations may be insufficient. Furthermore they may be susceptible to the variations caused by different speakers, specific content of the speech segments, and background noise. To address this, we propose using Deep Bottleneck Features (DBF) for spoken LID, motivated by the success of Deep Neural Networks (DNN) in speech recognition. We show that DBFs can form a low-dimensional compact representation of the original inputs with a powerful descriptive and discriminative capability. To evaluate the effectiveness of this, we design two acoustic models, termed DBF-TV and parallel DBF-TV (PDBF-TV), using a DBF based i-vector representation for each speech utterance. Results on NIST language recognition evaluation 2009 (LRE09) show significant improvements over state-of-the-art systems. By fusing the output of phonotactic and acoustic approaches, we achieve an EER of 1.08%, 1.89% and 7.01% for 30 s, 10 s and 3 s test utterances respectively. Furthermore, various DBF configurations have been extensively evaluated, and an optimal system proposed.	[Jiang, Bing; Song, Yan; McLoughlin, Ian Vince; Dai, Li-Rong] Univ Sci & Technol China, Natl Engn Lab Speech & Language Informat Proc, Hefei 230026, Anhui, Peoples R China; [Wei, Si; Liu, Jun-Hua] Anhui USTC iFlytek Co Ltd, iFlytek Res, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Song, Y (corresponding author), Univ Sci & Technol China, Natl Engn Lab Speech & Language Informat Proc, Hefei 230026, Anhui, Peoples R China.	songy@ustc.edu.cn	McLoughlin, Ian/AAS-9081-2020; McLoughlin, Ian V/A-3674-2011	McLoughlin, Ian/0000-0001-7111-2008; McLoughlin, Ian V/0000-0001-7111-2008	National Nature Science Foundation of China [61273264]; National 973 program of China [2012CB326405]; Chinese Universities Scientific Fund [Wk2100060008]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 program of China(National Basic Research Program of China); Chinese Universities Scientific Fund	This work was partially funded by the National Nature Science Foundation of China (Grant No. 61273264), the National 973 program of China (Grant No. 2012CB326405) and Chinese Universities Scientific Fund (Grant No. Wk2100060008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YB, 2012, INT CONF SIGN PROCES, P562, DOI 10.1109/ICoSP.2012.6491550; Bielefeld B., 1994, P 14 ANN SPEECH RES; Burget L, 2006, INT CONF ACOUST SPEE, P209; Campbell WM, 2007, INT CONF ACOUST SPEE, P989; Campbell WM, 2006, COMPUT SPEECH LANG, V20, P210, DOI 10.1016/j.csl.2005.06.003; Campbell WM, 2004, 2004 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH, AND SIGNAL PROCESSING, VOL I, PROCEEDINGS, P73; Campbell WM, 2006, P IEEE INT C AC SPEE, V1; Castaldo F., 2007, P ANN C INT SPEECH C, V7, P346; Castaldo F, 2007, IEEE T AUDIO SPEECH, V15, P1969, DOI 10.1109/TASL.2007.901823; Dehak N., 2009, THESIS ECOLE TECHNOL; Dehak N, 2011, 12TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2011 (INTERSPEECH 2011), VOLS 1-5, P864; Dehak N, 2011, IEEE T AUDIO SPEECH, V19, P788, DOI 10.1109/TASL.2010.2064307; Diez M, 2013, P ANN C INT SPEECH C; Diez M, 2012, IEEE W SP LANG TECH, P274, DOI 10.1109/SLT.2012.6424235; EADY SJ, 1982, LANG SPEECH, V25, P29, DOI 10.1177/002383098202500103; Fontaine V., 1997, P EUR C SPEECH COMM; Freund Y., 1994, UNSUPERVISED LEARNIN; Grezl F, 2007, INT CONF ACOUST SPEE, P757; Hazen T. J., 1993, P EUR BERL SEP, V2, P1303; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hinton GE, 2002, NEURAL COMPUT, V14, P1771, DOI 10.1162/089976602760128018; Hinton G, 2012, IEEE SIGNAL PROC MAG, V29, P82, DOI 10.1109/MSP.2012.2205597; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Hubeika V, 2008, INTERSPEECH 2008: 9TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2008, VOLS 1-5, P301; Jancik Z, 2010, ODYSSEY 2010: THE SPEAKER AND LANGUAGE RECOGNITION WORKSHOP, P215; Kenny P, 2005, IEEE T SPEECH AUDI P, V13, P345, DOI 10.1109/TSA.2004.840940; Kenny P, 2007, IEEE T AUDIO SPEECH, V15, P1435, DOI 10.1109/TASL.2006.881693; Kirchhoff K, 2002, INT CONF ACOUST SPEE, P761; Kohler MA, 2002, 2002 45TH MIDWEST SYMPOSIUM ON CIRCUITS AND SYSTEMS, VOL III, CONFERENCE PROCEEDINGS, P69; Martin A., 1997, P EUR C SPEECH COMM; Martin AF, 2008, P OD 2008 SPEAK LANG; Martin A, 2010, ODYSSEY 2010: THE SPEAKER AND LANGUAGE RECOGNITION WORKSHOP, P165; Matejka P, 2005, INTERSPEECH, P2237; Matrouf D, 1998, P INT C SPOK LANG PR, V98, P181; Qu Dan, 2003, P ISCA IEEE WORKSH S; Schwarz P, 2000, THESIS BRNO U TECHNO; Seide F., 2011, 2011 IEEE Workshop on Automatic Speech Recognition & Understanding (ASRU), P24, DOI 10.1109/ASRU.2011.6163899; Siniscalchi SM, 2009, INTERSPEECH 2009: 10TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2009, VOLS 1-5, P168; Song Y, 2013, ELECTRON LETT, V49, P1569, DOI 10.1049/el.2013.1721; SUGIYAMA M, 1991, INT CONF ACOUST SPEE, P813, DOI 10.1109/ICASSP.1991.150461; Torres-Carrasquillo P.A., 2012, OD 2012 SPEAK LANG R, P209; Torres-Carrasquillo P. A., 2002, P ANN C INT SPEECH C; Torres-Carrasquillo PA, 2010, INT CONF ACOUST SPEE, P4994, DOI 10.1109/ICASSP.2010.5495080; Vair Claudio, 2006, P OD SPEAK LANG REC, P1; Ying Xu, 2010, Proceedings 7th International Symposium on Chinese Spoken Language Processing (ISCSLP 2010), P157, DOI 10.1109/ISCSLP.2010.5684492; Yu D., 2010, P NEUR INF PROC SYST; Zissman MA, 1996, IEEE T SPEECH AUDI P, V4, P31, DOI 10.1109/TSA.1996.481450	48	36	42	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100795	10.1371/journal.pone.0100795	http://dx.doi.org/10.1371/journal.pone.0100795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983963	Green Published, Green Submitted, gold			2022-12-27	WOS:000339635000040
J	Nass, N; Bromme, HJ; Hartig, R; Korkmaz, S; Sel, S; Hirche, F; Ward, A; Simm, A; Wiemann, S; Lykkesfeldt, AE; Roessner, A; Kalinski, T				Nass, Norbert; Broemme, Hans-Juergen; Hartig, Roland; Korkmaz, Sevil; Sel, Saadettin; Hirche, Frank; Ward, Aoife; Simm, Andreas; Wiemann, Stefan; Lykkesfeldt, Anne E.; Roessner, Albert; Kalinski, Thomas			Differential Response to alpha-Oxoaldehydes in Tamoxifen Resistant MCF-7 Breast Cancer Cells	PLOS ONE			English	Article							METHYLGLYOXAL INDUCES APOPTOSIS; GLYCATION END-PRODUCTS; OXIDATIVE STRESS; ACTIVATION; EXPRESSION; RECEPTOR; PROTEIN; GLYOXAL; KINASE; ACCUMULATION	Tamoxifen is the standard adjuvant endocrine therapy for estrogen-receptor positive premenopausal breast cancer patients. However, tamoxifen resistance is frequently observed under therapy. A tamoxifen resistant cell line has been generated from the estrogen receptor positive mamma carcinoma cell line MCF-7 and was analyzed for putative differences in the aldehyde defence system and accumulation of advanced glycation end products (AGE). In comparison to wt MCF-7 cells, these tamoxifen resistant cells were more sensitive to the dicarbonyl compounds glyoxal and methylglyoxal and displayed increased caspase activity, p38-MAPK- and I kappa B alpha-phosphorylation. However, mRNA accumulation of the aldehyde-and AGE-defence enzymes glyoxalase-1 and -2 (GLO1, GLO2) as well as fructosamine-3-kinase (FN3K) was not significantly altered. Tamoxifen resistant cells contained less free sulfhydryl-groups (glutathione) suggesting that the increased sensitivity towards the dicarbonyls was due to a higher sensitivity towards reactive oxygen species which are associated with dicarbonyl stress. To further analyse, if these data are of more general importance, key experiments were replicated with tamoxifen resistant MCF-7 cell lines from two independent sources. These cell lines were also more sensitive to aldehydes, especially glyoxal, but were different in their cellular signalling responses to the aldehydes. In conclusion, glyoxalases and other aldehyde defence enzymes might represent a promising target for the therapy of tamoxifen resistant breast cancers.	[Nass, Norbert; Roessner, Albert; Kalinski, Thomas] Univ Magdeburg, Dept Pathol, D-39106 Magdeburg, Germany; [Broemme, Hans-Juergen; Simm, Andreas] Univ Halle Wittenberg, Ctr Basic Med Res ZMG, D-06108 Halle, Germany; [Hartig, Roland] Otto Von Guericke Univ, Fac Med, Magdeburg, Germany; [Korkmaz, Sevil] Heidelberg Univ, Dept Cardiac Surg, Heidelberg, Germany; [Sel, Saadettin] Heidelberg Univ, Dept Ophthalmol, Heidelberg, Germany; [Hirche, Frank] Univ Halle Wittenberg, Inst Agr & Nutr Sci, D-06108 Halle, Germany; [Ward, Aoife; Wiemann, Stefan] German Canc Res Ctr, Div Mol Genome Anal, Heidelberg, Germany; [Lykkesfeldt, Anne E.] Danish Canc Soc, Res Ctr, Breast Canc Grp, Copenhagen, Denmark	Otto von Guericke University; Martin Luther University Halle Wittenberg; Otto von Guericke University; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Martin Luther University Halle Wittenberg; Helmholtz Association; German Cancer Research Center (DKFZ); Danish Cancer Society	Nass, N (corresponding author), Univ Magdeburg, Dept Pathol, D-39106 Magdeburg, Germany.	norbert.nass@med.ovgu.de	Wiemann, Stefan/E-4424-2013; Nass, Norbert/A-5592-2011	Wiemann, Stefan/0000-0003-4683-3174; Nass, Norbert/0000-0003-2563-0386; Hartig, Roland/0000-0002-3706-7458; Sel, Prof. Dr. med. Saadettin/0000-0003-3307-3305; Ward Gahlawat, Aoife/0000-0001-7854-7207	Danish Cancer Society Research Center; Federal Ministry of Education and Research [BMBF - e:Bio FKZ 0316168C]; German Cancer Research Center DKFZ; Otto von Guericke University Magdeburg; Martin-Luther University Halle-Wittenberg	Danish Cancer Society Research Center; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Cancer Research Center DKFZ; Otto von Guericke University Magdeburg; Martin-Luther University Halle-Wittenberg	The study was funded by the Danish Cancer Society Research Center, the Federal Ministry of Education and Research (BMBF - e:Bio FKZ 0316168C), German Cancer Research Center DKFZ, Otto von Guericke University Magdeburg, Martin-Luther University Halle-Wittenberg and Otto von Guericke University Magdeburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2005, J BIOL CHEM, V280, P5724, DOI 10.1074/jbc.M410973200; Akhand AA, 2001, FREE RADICAL BIO MED, V31, P20, DOI 10.1016/S0891-5849(01)00550-0; Akhand AA, 1999, J CELL BIOCHEM, V72, P1, DOI 10.1002/(SICI)1097-4644(19990101)72:1<1::AID-JCB1>3.0.CO;2-Y; Bachmeier BE, 2008, ANN NY ACAD SCI, V1126, P283, DOI 10.1196/annals.1433.057; Bansode SB, 2013, MOL CELL PROTEOMICS, V12, P228, DOI 10.1074/mcp.M112.020651; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Bierhaus A, 2012, NAT MED, V18, P926, DOI 10.1038/nm.2750; Cai WJ, 2008, AM J PATHOL, V173, P327, DOI 10.2353/ajpath.2008.080152; Chan WH, 2007, J CELL BIOCHEM, V100, P1056, DOI 10.1002/jcb.21114; Chang TJ, 2011, FASEB J, V25, P1746, DOI 10.1096/fj.10-178053; Clemons M, 2002, CANCER TREAT REV, V28, P165, DOI 10.1016/S0305-7372(02)00036-1; Creighton DJ, 2003, BIOCHEM SOC T, V31, P1378; Droog M, 2013, EUR J PHARMACOL, V717, P47, DOI 10.1016/j.ejphar.2012.11.071; Du J, 2003, J CELL BIOCHEM, V88, P1235, DOI 10.1002/jcb.10478; Fonseca-Sanchez MA, 2012, INT J ONCOL, V41, P670, DOI 10.3892/ijo.2012.1478; Fukunaga M, 2004, BIOCHEM BIOPH RES CO, V320, P689, DOI 10.1016/j.bbrc.2004.06.011; Germanova A, 2009, CANCER INVEST, V27, P655, DOI 10.1080/07357900802350822; Ghosh M, 2006, TOXICOL APPL PHARM, V212, P45, DOI 10.1016/j.taap.2005.07.003; Glomb MA, 2001, J BIOL CHEM, V276, P41638, DOI 10.1074/jbc.M103557200; Hunter SJ, 2003, DIABETES, V52, P492, DOI 10.2337/diabetes.52.2.492; Ignatov A, 2011, BREAST CANCER RES TR, V128, P457, DOI 10.1007/s10549-011-1584-1; Ignatov A, 2010, BREAST CANCER RES TR, V123, P87, DOI 10.1007/s10549-009-0624-6; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Jia XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036610; Jiang Q, 2013, FUTURE MED CHEM, V5, P1023, DOI 10.4155/fmc.13.63; Knowlden JM, 2003, ENDOCRINOLOGY, V144, P1032, DOI 10.1210/en.2002-220620; Kuntz S, 2010, MOL NUTR FOOD RES, V54, P1458, DOI 10.1002/mnfr.200900408; Kurebayashi J, 2005, CANCER CHEMOTH PHARM, V56, pS39, DOI 10.1007/s00280-005-0099-z; Liu BF, 2003, KIDNEY INT, V63, P947, DOI 10.1046/j.1523-1755.2003.00829.x; LYKKESFELDT AE, 1994, CANCER RES, V54, P1587; Nass N, 2007, Z GERONTOL GERIATR, V40, P349, DOI 10.1007/s00391-007-0484-9; Nass N, 2010, INT J BIOCHEM CELL B, V42, P749, DOI 10.1016/j.biocel.2010.01.012; Nass N, 2009, BIOL CHEM, V390, P915, DOI 10.1515/BC.2009.083; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Oya T, 1999, J BIOL CHEM, V274, P18492, DOI 10.1074/jbc.274.26.18492; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; POURMOTABBED T, 1986, J BIOL CHEM, V261, P14240; Rabbani N, 2014, BIOCHEM SOC T, V42, P419, DOI 10.1042/BST20140008; Rabbani N, 2012, AMINO ACIDS, V42, P1133, DOI 10.1007/s00726-010-0783-0; Roepke TA, 2009, J NEUROENDOCRINOL, V21, P263, DOI 10.1111/j.1365-2826.2009.01846.x; Sakamoto H, 2001, CLIN CANCER RES, V7, P2513; Santen RJ, 2009, STEROIDS, V74, P586, DOI 10.1016/j.steroids.2008.11.020; Sato T, 2006, CURR MOL MED, V6, P351, DOI 10.2174/156652406776894536; Schleicher ED, 1997, J CLIN INVEST, V99, P457, DOI 10.1172/JCI119180; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Thornalley PJ, 2011, SEMIN CELL DEV BIOL, V22, P318, DOI 10.1016/j.semcdb.2011.02.006; Thornalley PJ, 2000, BIOCHEM PHARMACOL, V60, P55, DOI 10.1016/S0006-2952(00)00287-2; Thrane S, 2013, BREAST CANCER RES TR, V139, P71, DOI 10.1007/s10549-013-2485-2; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Upadhyay M, 2012, PHARMACOL THERAPEUT, V137, P318; van Heerebeek L, 2008, CIRCULATION, V117, P43, DOI 10.1161/CIRCULATIONAHA.107.728550; Veiga-Da-Cunha M, 2006, BIOCHEM J, V399, P257, DOI 10.1042/BJ20060684; Vienonen A, 2003, EUR J ENDOCRINOL, V148, P469, DOI 10.1530/eje.0.1480469; Vivacqua A, 2009, MOL ENDOCRINOL, V23, P1815, DOI 10.1210/me.2009-0120; Ward A, 2013, ONCOGENE, V32, P1173, DOI 10.1038/onc.2012.128; WEINER LM, 1991, FEBS LETT, V290, P243, DOI 10.1016/0014-5793(91)81270-I; Zhou YM, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-59	57	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101473	10.1371/journal.pone.0101473	http://dx.doi.org/10.1371/journal.pone.0101473			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983248	Green Published, Green Submitted, gold			2022-12-27	WOS:000339635000113
J	Powolny, T; Bretagnolle, V; Aguilar, A; Eraud, C				Powolny, Thibaut; Bretagnolle, Vincent; Aguilar, Astrid; Eraud, Cyril			Sex-Related Differences in the Trade-Off between Foraging and Vigilance in a Granivorous Forager	PLOS ONE			English	Article							13-LINED GROUND-SQUIRRELS; SKYLARKS ALAUDA-ARVENSIS; PREDATION RISK; GROUP-SIZE; ANTIPREDATOR VIGILANCE; FUNCTIONAL-RESPONSE; HABITAT STRUCTURE; FARMLAND BIRDS; STUBBLE FIELDS; SPERMOPHILUS-TRIDECEMLINEATUS	The relationship between intake rate and food density can provide the foundation for models that predict the spatiotemporal distribution of organisms across a range of resource densities. The functional response, describing the relationship between resource density and intake rate is often interpreted mechanistically as the relationships between times spend searching and handling. While several functional response models incorporate anti-predator vigilance (defined here as an interruption of feeding or some other activity to visually scan the environment, directed mainly towards detecting potential predators), the impacts of environmental factors influencing directly anti-predator vigilance remains unclear. We examined the combined effects of different scenarios of predation risk and food density on time allocation between foraging and anti-predator vigilance in a granivorous species. We experimentally exposed Skylarks to various cover heights and seed densities, and measured individual time budget and pecking and intake rates. Our results indicated that time devoted to different activities varied as a function of both seed density and cover height. Foraging time increased with seed density for all cover heights. Conversely, an increased cover height resulted in a decreased foraging time. Contrary to males, the decreased proportion of time spent foraging did not translate into a foraging disadvantage for females. When vegetation height was higher, females maintained similar pecking and intake rates compared to intermediate levels, while males consistently decreased their energy gain. This difference in anti-predator responses suggests a sexually mediated strategy in the food-safety trade-off: when resource density is high a females would adopt a camouflage strategy while an escape strategy would be adopted by males. In other words, males would leave risky-areas, whereas females would stay when resource density is high. Our results suggest that increased predation risk might generate sexually mediated behavioural responses that functional response models should perhaps better consider in the future.	[Powolny, Thibaut; Eraud, Cyril] Off Natl Chasse & Faune Sauvage, Villiers En Bois, France; [Powolny, Thibaut; Bretagnolle, Vincent; Aguilar, Astrid] CNRS, Ctr Etud Biol Chize, Villiers En Bois, France	Centre National de la Recherche Scientifique (CNRS)	Powolny, T (corresponding author), Off Natl Chasse & Faune Sauvage, Villiers En Bois, France.	thibaut.powolny@yahoo.fr			French Agence Nationale de la Recherche; Office National de la Chasse et de la Faune Sauvage	French Agence Nationale de la Recherche(French National Research Agency (ANR)); Office National de la Chasse et de la Faune Sauvage	Funding was provided by the French Agence Nationale de la Recherche to V.B. and PhD grant from the Office National de la Chasse et de la Faune Sauvage to T.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenz CL, 1997, ETHOLOGY, V103, P945; Arenz CL, 1997, BEHAVIOUR, V134, P1101, DOI 10.1163/156853997X00421; Arenz CL, 2000, ANIM BEHAV, V59, P535, DOI 10.1006/anbe.1999.1345; Baker DJ, 2010, FUNCT ECOL, V24, P1281, DOI 10.1111/j.1365-2435.2010.01735.x; Baker DJ, 2009, IBIS, V151, P547, DOI 10.1111/j.1474-919X.2009.00941.x; Beauchamp G, 2009, ANIM BEHAV, V78, P223, DOI 10.1016/j.anbehav.2009.04.029; Bednekoff PA, 2005, ANIM BEHAV, V69, P1165, DOI 10.1016/j.anbehav.2004.07.020; Berger J, 1999, P ROY SOC B-BIOL SCI, V266, P2261, DOI 10.1098/rspb.1999.0917; Boukal DS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002687; BRABRAND A, 1993, OECOLOGIA, V95, P38, DOI 10.1007/BF00649504; Breitwisch R, 1988, AUK, V106, P150; Burger Joanna, 2000, Acta Ethologica, V2, P97, DOI 10.1007/s102119900013; Butler SJ, 2005, J APPL ECOL, V42, P469, DOI 10.1111/j.1365-2664.2005.01027.x; Butler SJ, 2005, ANIM BEHAV, V69, P337, DOI 10.1016/j.anbehav.2004.06.006; Cameron EZ, 2005, ANIM BEHAV, V69, P1337, DOI 10.1016/j.anbehav.2004.08.015; Chamberlain DE, 1999, J APPL ECOL, V36, P856, DOI 10.1046/j.1365-2664.1999.00453.x; Chamberlain DE, 1999, IBIS, V141, P38, DOI 10.1111/j.1474-919X.1999.tb04261.x; Cramp S., 1988, BIRDS W PALEARCTIC; Crawley M.J., 1993, GLIM ECOLOGISTS; CRESSWELL W, 1994, J ANIM ECOL, V63, P589, DOI 10.2307/5225; CRESSWELL W, 1994, ANIM BEHAV, V47, P433, DOI 10.1006/anbe.1994.1057; Cresswell W, 2003, P ROY SOC B-BIOL SCI, V270, P1069, DOI 10.1098/rspb.2003.2353; De Roos AM, 2003, ECOL LETT, V6, P473, DOI 10.1046/j.1461-0248.2003.00458.x; Devereux CL, 2006, BEHAV ECOL, V17, P303, DOI 10.1093/beheco/arj032; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; EKMAN J, 1987, ANIM BEHAV, V35, P445, DOI 10.1016/S0003-3472(87)80269-5; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; Eraud C, 2006, BIRD STUDY, V53, P319, DOI 10.1080/00063650609461448; Fernandez G, 2010, J ORNITHOL, V151, P665, DOI 10.1007/s10336-010-0507-y; Fernandez-Juricic E, 2004, BEHAV ECOL, V15, P371, DOI 10.1093/beheco/arh017; Fernandez-Juricic E, 2004, BEHAV ECOL SOCIOBIOL, V55, P502, DOI 10.1007/s00265-003-0698-9; Fernandez-Juricic E, 2008, ETHOLOGY, V114, P105, DOI 10.1111/j.1439-0310.2007.01433.x; FITZGIBBON CD, 1990, ANIM BEHAV, V40, P837, DOI 10.1016/S0003-3472(05)80984-4; FOSTER WA, 1981, NATURE, V293, P466, DOI 10.1038/293466a0; Frid A, 1997, ANIM BEHAV, V53, P799, DOI 10.1006/anbe.1996.0345; Ginnett TF, 1997, OECOLOGIA, V110, P291, DOI 10.1007/s004420050162; Griesser M, 2009, BEHAV ECOL, V20, P709, DOI 10.1093/beheco/arp045; Heithaus MR, 2002, ECOLOGY, V83, P480, DOI 10.1890/0012-9658(2002)083[0480:FAATSP]2.0.CO;2; Krause J, 2002, LIVING GROUPS; Lazarus Symond M, 1992, ANIM BEHAV, V43, P519; LIMA S. L., 1990, INTERPRETATION EXPLA, V2, P246; LIMA SL, 1987, J THEOR BIOL, V124, P303, DOI 10.1016/S0022-5193(87)80118-2; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; MCGOWAN KJ, 1989, ANIM BEHAV, V37, P1000, DOI 10.1016/0003-3472(89)90144-9; MCNAMARA JM, 1990, EVOL ECOL, V4, P298, DOI 10.1007/BF02270929; Meldrum GE, 2009, ANIM BEHAV, V77, P919, DOI 10.1016/j.anbehav.2008.12.023; METCALFE NB, 1984, ANIM BEHAV, V32, P981, DOI 10.1016/S0003-3472(84)80210-9; Mills GL, 1997, CONSERV BIOL, V11, P1397; Moorcroft D, 2002, J APPL ECOL, V39, P535, DOI 10.1046/j.1365-2664.2002.00730.x; Nystrand M, 2006, BEHAV ECOL, V17, P503, DOI 10.1093/beheco/arj055; Ottoni EB, 1996, BEHAV RES METH INSTR, V28, P472, DOI 10.3758/BF03200529; Powolny T, 2012, J ORNITHOL, V153, P485, DOI 10.1007/s10336-011-0764-4; PRAVOSUDOV VV, 1995, CONDOR, V97, P1064, DOI 10.2307/1369547; Reboreda JC, 1997, ETHOLOGY, V103, P198; Roberts G, 1996, ANIM BEHAV, V51, P1077, DOI 10.1006/anbe.1996.0109; Robinson RA, 1999, ECOGRAPHY, V22, P447, DOI 10.1111/j.1600-0587.1999.tb00581.x; Sharpe PB, 1998, J MAMMAL, V79, P906, DOI 10.2307/1383098; Siriwardena GM, 1998, BIRD STUDY, V45, P276, DOI 10.1080/00063659809461099; Smart SL, 2008, J ANIM ECOL, V77, P687, DOI 10.1111/j.1365-2656.2008.01375.x; Steenbeek R, 1999, BEHAV ECOL SOCIOBIOL, V45, P137, DOI 10.1007/s002650050547; Sutherland W.J., 1996, INDIVIDUAL BEHAV POP; Treves A, 2000, ANIM BEHAV, V60, P711, DOI 10.1006/anbe.2000.1528; Van Buskirk J, 1999, OIKOS, V85, P31, DOI 10.2307/3546789; Verdolin JL, 2006, BEHAV ECOL SOCIOBIOL, V60, P457, DOI 10.1007/s00265-006-0172-6; Whittingham MJ, 2006, J APPL ECOL, V43, P640, DOI 10.1111/j.1365-2664.2006.01186.x; Whittingham MJ, 2002, OECOLOGIA, V130, P637, DOI 10.1007/s00442-001-0850-z; Wilson JD, 1997, J APPL ECOL, V34, P1462, DOI 10.2307/2405262	69	18	18	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101598	10.1371/journal.pone.0101598	http://dx.doi.org/10.1371/journal.pone.0101598			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984028	gold, Green Published, Green Submitted			2022-12-27	WOS:000339635000121
J	Goktas, O; Solmaz, M; Goktas, G; Olze, H				Goektas, Oender; Solmaz, Mustafa; Goektas, Goekhan; Olze, Heidi			Long-Term Results in Obstructive Sleep Apnea Syndrome (OSAS) after Laser-Assisted Uvulopalatoplasty (LAUP)	PLOS ONE			English	Article							UPPER AIRWAY; SURGICAL MODIFICATIONS; ADULTS; MANAGEMENT	Obstructive sleep apnea syndrome (OSAS) is a serious disease. The etiology of and optimum therapy options for this disorder have been much discussed and have been the subject of many publications. One much discussed therapy option is laser-assisted uvulopalatoplasty (LAUP). Despite conflicting opinions and guidelines which recommend that it should not be used, it remains in use. Patients who had previously undergone this procedure were invited for follow-up appointments, at which they were asked to complete a questionnaire, underwent an ENT examination and underwent sleep laboratory analysis using a portable sleep lab device. The average time since LAUP treatment was 11 years. The cohort comprised 25 patients. The average preoperative apnea-hypopnea-index (AHI) score was 25.25/h; the average postoperative AHI score 23.62/h. Closer examination of our data enabled us to identify 10 responders (40%) and 15 non-responders (60%). 12% (3/25) of non-responders experienced either no reduction in their AHI score or an increase compared to their preoperative AHI score of less than 5/h. In the remaining 48% (12/25), AHI increased by more than 5/h compared to the preoperative figure. Our questionnaire showed that 40% (10/25) of patients suffered from dry mouth and 20% (5/25) from foreign body sensation. The data led us to conclude that laser-assisted uvulopalatoplasty can indeed result in a reduction in AHI score comparable to other mucosal resection methods. Also in common with these methods, the efficacy of the therapy reduces with time and the procedure carries a high risk of bringing about an increase in the patient's AHI score.	[Goektas, Oender; Solmaz, Mustafa; Goektas, Goekhan; Olze, Heidi] Charite, CCM, Dept Otorhinolaryngol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Goktas, O (corresponding author), Charite, CCM, Dept Otorhinolaryngol, Berlin, Germany.	oender.goektas@charite.de		Olze, Heidi/0000-0001-9987-6392				Berger G, 1999, ARCH OTOLARYNGOL, V125, P786, DOI 10.1001/archotol.125.7.786; Berger G, 2003, ARCH OTOLARYNGOL, V129, P447, DOI 10.1001/archotol.129.4.447; Caples SM, 2010, SLEEP, V33, P1396, DOI 10.1093/sleep/33.10.1396; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Ferguson KA, 2003, AM J RESP CRIT CARE, V167, P15, DOI 10.1164/rccm.2108050; Finkelstein Y, 2002, ARCH OTOLARYNGOL, V128, P429, DOI 10.1001/archotol.128.4.429; Iyngkaran T, 2006, J LARYNGOL OTOL, V120, P932, DOI 10.1017/S002221510600209X; Kamami Y V, 1994, J Clin Laser Med Surg, V12, P215; KAMAMI Y-V, 1990, Acta Oto-Rhino-Laryngologica Belgica, V44, P451; Kotecha B, 1998, CLIN OTOLARYNGOL, V23, P354, DOI 10.1046/j.1365-2273.1998.00162.x; Littner M, 2001, SLEEP, V24, P603, DOI 10.1093/sleep/24.5.603; Rombaux P, 2003, LARYNGOSCOPE, V113, P2169, DOI 10.1097/00005537-200312000-00023; Sher AE, 1996, SLEEP, V19, P156, DOI 10.1093/sleep/19.2.156; Tishler PV, 2003, JAMA-J AM MED ASSOC, V289, P2230, DOI 10.1001/jama.289.17.2230; Verse T, 2009, HNO, V57, P1136, DOI 10.1007/s00106-009-2013-1; Won Christine H J, 2008, Proc Am Thorac Soc, V5, P193, DOI 10.1513/pats.200708-121MG	16	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100211	10.1371/journal.pone.0100211	http://dx.doi.org/10.1371/journal.pone.0100211			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979228	gold, Green Published, Green Submitted			2022-12-27	WOS:000338506400024
J	Morris, P; Buys, L; Vine, D				Morris, Peter; Buys, Laurie; Vine, Desley			Moving from Outsider to Insider: Peer Status and Partnerships between Electricity Utilities and Residential Consumers	PLOS ONE			English	Article							ENERGY-CONSERVATION; CONSUMPTION; FEEDBACK; BEHAVIOR; POLICY	An electricity demand reduction project based on comprehensive residential consumer engagement was established within an Australian community in 2008. By 2011, both the peak demand and grid supplied electricity consumption had decreased to below pre-intervention levels. This case study research explored the relationship developed between the utility, community and individual consumer from the residential customer perspective through qualitative research of 22 residential households. It is proposed that an energy utility can be highly successful at peak demand reduction by becoming a community member and a peer to residential consumers and developing the necessary trust, access, influence and partnership required to create the responsive environment to change. A peer-community approach could provide policymakers with a pathway for implementing pro-environmental behaviour for low carbon communities, as well as peak demand reduction, thereby addressing government emission targets while limiting the cost of living increases from infrastructure expenditure.	[Morris, Peter; Buys, Laurie] Queensland Univ Technol, Sch Design, Creat Ind Fac, Brisbane, Qld 4001, Australia; [Vine, Desley] Queensland Univ Technol, Fac Sci & Engn, Sch Elect Engineer & Comp Sci, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Vine, D (corresponding author), Queensland Univ Technol, Fac Sci & Engn, Sch Elect Engineer & Comp Sci, Brisbane, Qld 4001, Australia.	d.vine@qut.edu.au		Buys, Laurie/0000-0001-8917-0863; Vine, Desley/0000-0002-8414-9210	Australian Research Council [LP110201139]	Australian Research Council(Australian Research Council)	This research was supported under Australian Research Council's Linkage Project funding scheme (http://www.arc.gov.au/ncgp/lp/lp_default.htm), project number LP110201139. The findings and views expressed in this article are those of the authors and are not necessarily those of the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamse W, 2005, J ENVIRON PSYCHOL, V25, P273, DOI 10.1016/j.jenvp.2005.08.002; Alexander B.R., 2010, ELECT J, V23, P39, DOI [DOI 10.1016/J.TEJ.2010.05.014, 10.1016/j.tej.2010.05.014]; Allcott H, 2011, J PUBLIC ECON, V95, P1082, DOI 10.1016/j.jpubeco.2011.03.003; Allcott H, 2010, SCIENCE, V327, P1204, DOI 10.1126/science.1180775; Aronson, 1994, QUALITATIVE REPORT, V2, P1, DOI [10.46743/2160-3715/1995.2069, DOI 10.46743/2160-3715/1995.2069]; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bomberg E, 2012, ENERG POLICY, V51, P435, DOI 10.1016/j.enpol.2012.08.045; Bord RJ, 1998, CLIMATE RES, V11, P75, DOI 10.3354/cr011075; Bouwen R, 2004, J COMMUNITY APPL SOC, V14, P137, DOI 10.1002/casp.777; Brandon G, 1999, J ENVIRON PSYCHOL, V19, P75, DOI 10.1006/jevp.1998.0105; Buller DB, 2007, HEALTH EDUC RES, V22, P609, DOI 10.1093/her/cyl130; Burt RS, 2000, RES ORGAN BEHAV, V22, P345, DOI 10.1016/S0191-3085(00)22009-1; Churchman A., 2002, HDB ENV PSYCHOL, P525; Cockerell L., 2008, CREATING MAGIC 10 CO; COSTANZO M, 1986, AM PSYCHOL, V41, P521, DOI 10.1037/0003-066X.41.5.521; Darby S, 2006, ENERG POLICY, V34, P2929, DOI 10.1016/j.enpol.2005.04.013; Davis MA, 1997, NATL CIVIC REV, V86, P227, DOI DOI 10.1002/(ISSN)1542-7811; Eilbert A, 2013, HOME ENERGY AUDIT RE; Faruqui A., 2007, ELECT J, V20, P68, DOI DOI 10.1016/J.TEJ.2007.08.003; Faruqui A, 2011, J REGUL ECON, V40, P82, DOI 10.1007/s11149-011-9152-5; Gardner G.T., 1996, ENV PROBLEMS HUMAN B; GELLER ES, 1981, J CONSUM RES, V8, P331, DOI 10.1086/208872; Giesecke J, 2012, J LIBR ADM, V52, P36, DOI 10.1080/01930826.2012.629964; Gillingham K, 2009, SSRN WORKING PAPER S; Godfrey BJ, 1984, INNER CITY NEIGHBORH; Gram-Hanssen K, 2007, ENERG POLICY, V35, P2879, DOI 10.1016/j.enpol.2006.10.017; Gyamfi S, 2011, ENERG POLICY, V39, P2993, DOI 10.1016/j.enpol.2011.03.012; Hausman A, 2001, J BUS IND MARK, V16, P600, DOI 10.1108/EUM0000000006194; Heiskanen E, 2010, ENERG POLICY, V38, P7586, DOI 10.1016/j.enpol.2009.07.002; HIRST E, 1981, ENERGY, V6, P621, DOI 10.1016/0360-5442(81)90017-7; Holstein J. A., 1995, ACTIVE INTERVIEW; KATZEV R, 1981, J ENVIRON SYST, V10, P215; Leighty W, 2011, ENERG POLICY, V39, P2299, DOI 10.1016/j.enpol.2011.01.041; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; LUTZENHISER L, 1993, ANNU REV ENERG ENV, V18, P247, DOI 10.1146/annurev.energy.18.1.247; Marechal K, 2009, J ECON ISSUES, V43, P69, DOI 10.2753/JEI0021-3624430104; McKenzie-Mohr D., 2011, FOSTERING SUSTAINABL, Vthird; McMakin AH, 2002, ENVIRON BEHAV, V34, P848, DOI 10.1177/001391602237252; Miller R. D., 1985, SHARED SAVINGS RESID; MOORMAN C, 1993, J MARKETING, V57, P81, DOI 10.2307/1252059; Morris A.D., 1992, FRONTIERS SOCIAL MOV; Murray C., 2006, CHILD SOC, V20, P273, DOI [https://doi.org/10.1002/CHI.892, DOI 10.1002/CHI.892]; Polatidis H, 2004, ENERG SOURCE, V26, P1253, DOI 10.1080/00908310490441584; Roussopoulos D, 1999, PUBLIC PLACE CITIZEN; SANSTAD AH, 1994, ENERG POLICY, V22, P811, DOI 10.1016/0301-4215(94)90139-2; SELIGMAN C, 1977, J APPL PSYCHOL, V62, P363, DOI 10.1037/0021-9010.62.4.363; Shove E., 2004, CHANGING HUMAN BEHAV; Simon H, 2005, DARWINISM ALTRUISM E; Speer PW, 2001, HEALTH EDUC BEHAV, V28, P716, DOI 10.1177/109019810102800605; Spees K., 2007, ELECT J, V20, P69, DOI [DOI 10.1016/J.TEJ.2007.01.006, 10.1016/j.tej.2007.01.006]; Stern P., 1999, J CONSUM POLICY, V22, P461, DOI [DOI 10.1023/A:1006211709570, 10.1023/A:1006211709570]; Stern P.C., 1984, ENERGY USE HUMAN DIM; Thumann A., 2008, HDB ENERGY AUDITS, Vsixth; Tindall JA, 2008, PEER POWER BOOK ONE; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; VANHOUWELINGEN JH, 1989, J CONSUM RES, V16, P98, DOI 10.1086/209197; WINETT RA, 1983, J ECON PSYCHOL, V3, P203, DOI 10.1016/0167-4870(83)90003-X; Wiser R. H., 1998, Utilities Policy, V7, P107, DOI 10.1016/S0957-1787(98)00005-8; Yin R. K., 2012, APPL CASE STUDY RES, V3rd; Yoeli E, 2009, DOES SOCIAL APPROVAL	60	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101189	10.1371/journal.pone.0101189	http://dx.doi.org/10.1371/journal.pone.0101189			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK5ZO	24979234	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400096
J	Penzkofer, D; Bonauer, A; Fischer, A; Tups, A; Brandes, RP; Zeiher, AM; Dimmeler, S				Penzkofer, Daniela; Bonauer, Angelika; Fischer, Ariane; Tups, Alexander; Brandes, Ralf P.; Zeiher, Andreas M.; Dimmeler, Stefanie			Phenotypic Characterization of miR-92a(-/-) Mice Reveals an Important Function of miR-92a in Skeletal Development	PLOS ONE			English	Article							CLUSTER; PROLIFERATION; INHIBITION; ANGIOGENESIS; DELETION; FAMILY; CANCER	MicroRNAs (miRNAs, miRs) emerged as key regulators of gene expression. Germline hemizygous deletion of the gene that encodes the miR-17 similar to 92 miRNA cluster was associated with microcephaly, short stature and digital abnormalities in humans. Mice deficient for the miR-17 similar to 92 cluster phenocopy several features such as growth and skeletal development defects and exhibit impaired B cell development. However, the individual contribution of miR-17 similar to 92 cluster members to this phenotype is unknown. Here we show that germline deletion of miR-92a in mice is not affecting heart development and does not reduce circulating or bone marrow-derived hematopoietic cells, but induces skeletal defects. MiR-92a(-/-) mice are born at a reduced Mendelian ratio, but surviving mice are viable and fertile. However, body weight of miR-92a(-/-) mice was reduced during embryonic and postnatal development and adulthood. A significantly reduced body and skull length was observed in miR-92a(-/-) mice compared to wild type littermates. mu CT analysis revealed that the length of the 5th mesophalanx to 5th metacarpal bone of the forelimbs was significantly reduced, but bones of the hindlimbs were not altered. Bone density was not affected. These findings demonstrate that deletion of miR-92a is sufficient to induce a developmental skeletal defect.	[Penzkofer, Daniela; Bonauer, Angelika; Fischer, Ariane; Dimmeler, Stefanie] Goethe Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, D-60054 Frankfurt, Germany; [Tups, Alexander] Univ Marburg, Dept Anim Physiol, Fac Biol, Marburg, Germany; [Brandes, Ralf P.] Goethe Univ Frankfurt, Inst Cardiovasc Physiol, D-60054 Frankfurt, Germany; [Zeiher, Andreas M.] JW Goethe Univ Hosp Frankfurt, Dept Cardiol, Frankfurt, Germany; [Brandes, Ralf P.; Zeiher, Andreas M.; Dimmeler, Stefanie] Partner Site RheinMain, German Ctr Cardiovasc Res DZHK, Frankfurt, Germany	Goethe University Frankfurt; Philipps University Marburg; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt Hospital; German Centre for Cardiovascular Research	Dimmeler, S (corresponding author), Goethe Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, D-60054 Frankfurt, Germany.	dimmeler@em.uni-frankfurt.de	Brandes, Ralf P/L-3058-2017	Brandes, Ralf P/0000-0002-8035-0048; Dimmeler, Stefanie/0000-0002-1045-2436	European Union (ERC); German Center of Cardiovascular Research (BMBF)	European Union (ERC)(European Research Council (ERC)European Commission); German Center of Cardiovascular Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The study was supported by the European Union (ERC advanced grant "AngiomiR"). The mu CT core facility is supported by the German Center of Cardiovascular Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonauer A, 2009, CELL CYCLE, V8, P3866, DOI 10.4161/cc.8.23.9994; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Celli J, 2003, AM J MED GENET A, V122A, P294, DOI 10.1002/ajmg.a.20471; Concepcion CP, 2012, CANCER J, V18, P262, DOI 10.1097/PPO.0b013e318258b60a; Daniel J-M, 2014, CARDIOVAS R IN PRESS; de Pontual L, 2011, NAT GENET, V43, P1026, DOI 10.1038/ng.915; Dimmeler S, 2013, EMBO MOL MED, V5, P180, DOI 10.1002/emmm.201201986; Fang Y, 2012, ARTERIOSCL THROM VAS, V32, P979, DOI 10.1161/ATVBAHA.111.244053; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Hinkel R, 2013, CIRCULATION, V128, P1066, DOI 10.1161/CIRCULATIONAHA.113.001904; Iaconetti C, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0296-y; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Kumarswamy R, 2013, CIRC RES, V113, P676, DOI 10.1161/CIRCRESAHA.113.300226; Li FF, 2012, GENE, V495, P95, DOI 10.1016/j.gene.2011.12.057; Liu XS, 2013, J BIOL CHEM, V288, P12478, DOI 10.1074/jbc.M112.449025; Loyer X, 2014, CIRC RES, V114, P434, DOI 10.1161/CIRCRESAHA.114.302213; Murata K, 2014, J BONE MINER RES, V29, P316, DOI 10.1002/jbmr.2040; Ning GZ, 2013, DEV CELL, V24, P283, DOI 10.1016/j.devcel.2012.12.016; Sengul A, 2013, PHYSIOL RES, V62, P221, DOI 10.33549/physiolres.932410; Sharifi M, 2014, MOL BIOL REP, V41, P2799, DOI 10.1007/s11033-014-3134-5; Tsuchida A, 2011, CANCER SCI, V102, P2264, DOI 10.1111/j.1349-7006.2011.02081.x; Uziel T, 2009, P NATL ACAD SCI USA, V106, P2812, DOI 10.1073/pnas.0809579106; van Bokhoven H, 2001, AM J HUM GENET, V69, P481, DOI 10.1086/323123; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wu W, 2011, CIRCULATION; Zhang GJ, 2014, DIGEST DIS SCI, V59, P98, DOI 10.1007/s10620-013-2858-8; Zhou M., 2013, ENDOCRINE	27	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101153	10.1371/journal.pone.0101153	http://dx.doi.org/10.1371/journal.pone.0101153			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979655	gold, Green Published, Green Submitted			2022-12-27	WOS:000338506400086
J	Tian, DQ; Zheng, T				Tian, Deqiao; Zheng, Tao			Comparison and Analysis of Biological Agent Category Lists Based On Biosafety and Biodefense	PLOS ONE			English	Article								Biological agents pose a serious threat to human health, economic development, social stability and even national security. The classification of biological agents is a basic requirement for both biosafety and biodefense. We compared and analyzed the Biological Agent Laboratory Biosafety Category list and the defining criteria according to the World Health Organization (WHO), the National Institutes of Health (NIH), the European Union (EU) and China. We also compared and analyzed the Biological Agent Biodefense Category list and the defining criteria according to the Centers for Disease Control and Prevention (CDC) of the United States, the EU and Russia. The results show some inconsistencies among or between the two types of category lists and criteria. We suggest that the classification of biological agents based on laboratory biosafety should reduce the number of inconsistencies and contradictions. Developing countries should also produce lists of biological agents to direct their development of biodefense capabilities. To develop a suitable biological agent list should also strengthen international collaboration and cooperation.	[Tian, Deqiao; Zheng, Tao] Beijing Inst Biotechnol, Ctr Biosecur Strategy Management, Beijing, Peoples R China		Zheng, T (corresponding author), Beijing Inst Biotechnol, Ctr Biosecur Strategy Management, Beijing, Peoples R China.	zt19721@hotmail.com			National Natural Science Foundation of China [70573120, 70773118]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by grants from the National Natural Science Foundation of China (70573120, 70773118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, LIST HUMAN TRANSMISS; [Anonymous], 2005, TECHNICAL GUIDANCE G; Frischknecht F, 2003, EMBO REP, V4, pS47, DOI 10.1038/sj.embor.embor849; Gaudioso J, 2004, SCIENCE, V304, P687, DOI 10.1126/science.1096911; Gottron F, 2011, PROJECT BIOSHIELD AU; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Morse SA, 2003, ASM NEWS, V69, P433; Tegnell A, 2006, CELL MOL LIFE SCI, V63, P2223, DOI 10.1007/s00018-006-6310-5; Westerdahl KS, 2006, ROLE NEW RUSSIAN BIO; World Health Organization, 2004, LAB BIOS MAN, V3rd	10	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101163	10.1371/journal.pone.0101163	http://dx.doi.org/10.1371/journal.pone.0101163			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979754	Green Submitted, Green Published, gold			2022-12-27	WOS:000338506400088
J	Wan, Q; Pal, R				Wan, Qian; Pal, Ranadip			An Ensemble Based Top Performing Approach for NCI-DREAM Drug Sensitivity Prediction Challenge	PLOS ONE			English	Article							CHEMOSENSITIVITY; INTERVENTION	We consider the problem of predicting sensitivity of cancer cell lines to new drugs based on supervised learning on genomic profiles. The genetic and epigenetic characterization of a cell line provides observations on various aspects of regulation including DNA copy number variations, gene expression, DNA methylation and protein abundance. To extract relevant information from the various data types, we applied a random forest based approach to generate sensitivity predictions from each type of data and combined the predictions in a linear regression model to generate the final drug sensitivity prediction. Our approach when applied to the NCI-DREAM drug sensitivity prediction challenge was a top performer among 47 teams and produced high accuracy predictions. Our results show that the incorporation of multiple genomic characterizations lowered the mean and variance of the estimated bootstrap prediction error. We also applied our approach to the Cancer Cell Line Encyclopedia database for sensitivity prediction and the ability to extract the top targets of an anti-cancer drug. The results illustrate the effectiveness of our approach in predicting drug sensitivity from heterogeneous genomic datasets.	[Wan, Qian; Pal, Ranadip] Texas Tech Univ, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	Pal, R (corresponding author), Texas Tech Univ, Lubbock, TX 79409 USA.	ranadip.pal@ttu.edu	Pal, Ranadip/F-3905-2012	Pal, Ranadip/0000-0002-9311-5901	National Science Foundation [CCF0953366]; Direct For Computer & Info Scie & Enginr [0953366] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported in part by National Science Foundation grant CCF0953366. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Shalabi L., 2006, Journal of Computer Sciences, V2, P735, DOI 10.3844/jcssp.2006.735.739; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Biau G, 2012, J MACH LEARN RES, V13, P1063; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cai XD, 2007, IEEE SIGNAL PROC MAG, V24, P27; Consortium D, NCI DREAM DRUG SENSI; DrugKiNET, COMPR INF 800 COMP H; EFRON B, 1992, J ROY STAT SOC B MET, V54, P83; Jaiantilal A, CLASSIFICATION REGRE; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Krzanowski WJ, 2001, J APPL STAT, V28, P585, DOI 10.1080/02664760120047915; Kuo WL, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-77; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Meinshausen N, 2006, J MACH LEARN RES, V7, P983; Mitsos A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000591; Pal R, 2012, BIOCOMPUT-PAC SYM, P351; Pal R, 2012, IEEE INT WORK GENOM, P9, DOI 10.1109/GENSIPS.2012.6507714; Pal R, 2012, IEEE SIGNAL PROC MAG, V29, P66, DOI 10.1109/MSP.2011.942818; Pal R, 2010, IEEE T SIGNAL PROCES, V58, P3341, DOI 10.1109/TSP.2010.2043970; Riddick G, 2011, BIOINFORMATICS, V27, P220, DOI 10.1093/bioinformatics/btq628; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Szallasi Z, 2006, SYST MOD CELL BIOL, DOI 10.7551/mitpress/9780262195485.001.0001.; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Venkatesan K., 2010, AACR M, V16, pPR2, DOI DOI 10.1158/DIAG-10-PR2; Walther Z, 2011, CANCER J, V17, P71, DOI 10.1097/PPO.0b013e318212dd6d; Zarrinkar PP, 2009, BLOOD, V114, P2984, DOI 10.1182/blood-2009-05-222034	27	54	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101183	10.1371/journal.pone.0101183	http://dx.doi.org/10.1371/journal.pone.0101183			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978814	Green Published, gold, Green Submitted			2022-12-27	WOS:000338506400094
J	Tsujiura, M; Mazack, V; Sudol, M; Kaspar, HG; Nash, J; Carey, DJ; Gogoi, R				Tsujiura, Masahiro; Mazack, Virginia; Sudol, Marius; Kaspar, Hanna G.; Nash, John; Carey, David J.; Gogoi, Radhika			Yes-Associated Protein (YAP) Modulates Oncogenic Features and Radiation Sensitivity in Endometrial Cancer	PLOS ONE			English	Article							HIPPO PATHWAY; CANDIDATE ONCOGENE; UTERINE CORPUS; CARCINOMA; OVEREXPRESSION; IDENTIFICATION; COACTIVATOR; EXPRESSION; MUTATIONS; INDUCTION	Background: Yes-associated protein (YAP) is a transcriptional co-activator and regulates cell proliferation and apoptosis. We investigated the clinical and biological significance of YAP in endometrial cancer (EMCA). Methods: YAP expression in 150 primary tumor tissues from patients with EMCA was evaluated by immunohistochemistry and its association with clinicopathological data was assessed. The biological functions of YAP were determined in EMCA cell lines through knockdown/overexpression of YAP. The role of YAP in modulating radiation sensitivity was also investigated in EMCA cells. Results: Increased nuclear YAP expression was significantly associated with higher grade, stage, lympho-vascular space invasion, postoperative recurrence/metastasis and overall survival in estrogen mediated EMCA, called type 1 cancer (p = 0.019, = 0.028, = 0.0008, = 0.046 and = 0.015, respectively). In multivariate analysis, nuclear YAP expression was confirmed as an independent prognostic factor for overall survival in type 1 EMCA. YAP knockdown by siRNA resulted in a significant decrease in cell proliferation (p < 0.05), anchorage-dependent growth (p = 0.015) and migration/invasion (p < 0.05), and a significant increase in the number of cells in G0/G1 phase (p = 0.002). Conversely, YAP overexpression promoted cell proliferation. Clonogenic assay demonstrated enhanced radiosensitivity by approximately 36% in YAP inhibited cells. Conclusions: Since YAP functions as a transcriptional co-activator, its differential localization in the nucleus of cancer cells and subsequent impact on cell proliferation could have important consequences with respect to its role as an oncogene in EMCA. Nuclear YAP expression could be useful as a prognostic indicator or therapeutic target and predict radiation sensitivity in patients with EMCA.	[Tsujiura, Masahiro; Mazack, Virginia; Sudol, Marius; Carey, David J.; Gogoi, Radhika] Geisinger Med Ctr, Weis Ctr Res, Danville, PA 17822 USA; [Sudol, Marius] Icahn Sch Med Mt Sinai, New York, NY USA; [Kaspar, Hanna G.] Geisinger Med Labs, Wilkes Barre, PA USA; [Nash, John; Gogoi, Radhika] Geisinger Med Ctr, Div Obstet & Gynecol, Danville, PA 17822 USA	Geisinger Medical Center; Icahn School of Medicine at Mount Sinai; Geisinger Medical Center; Geisinger Medical Center	Gogoi, R (corresponding author), Geisinger Med Ctr, Weis Ctr Res, Danville, PA 17822 USA.	rpgogoi@geisinger.edu			Geisinger Medical Center; Rice Cancer Foundation; Clinic Research Fund [SRC-075]	Geisinger Medical Center; Rice Cancer Foundation; Clinic Research Fund	Funding for work done in this publication was from Grant SRC-075 Clinic Research Fund, Geisinger Medical Center and the Rice Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albitar L, 2007, GYNECOL ONCOL, V106, P52, DOI 10.1016/j.ygyno.2007.02.033; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; Byron SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030801; Clement PB, 2002, ADV ANAT PATHOL, V9, P145, DOI 10.1097/00125480-200205000-00001; Clement PB, 2004, ADV ANAT PATHOL, V11, P117, DOI 10.1097/00125480-200405000-00001; Cochrane DR, 2009, MOL CANCER THER, V8, P1055, DOI 10.1158/1535-7163.MCT-08-1046; Creasman W, 1989, GYNECOL ONCOL, V35, P7; Creutzberg CL, 2000, LANCET, V355, P1404, DOI 10.1016/S0140-6736(00)02139-5; Creutzberg CL, 2003, GYNECOL ONCOL, V89, P201, DOI 10.1016/S0090-8258(03)00126-4; Dhananjayan SC, 2006, MOL ENDOCRINOL, V20, P2343, DOI 10.1210/me.2005-0533; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Fader AN, 2009, GYNECOL ONCOL, V114, P121, DOI 10.1016/j.ygyno.2009.03.039; Fernandez A, 2012, ONCOGENE, V31, P1923, DOI 10.1038/onc.2011.379; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hall CA, 2010, CANCER RES, V70, P8517, DOI 10.1158/0008-5472.CAN-10-1242; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Howlader N, 2013, SEER CANC STAT REV 1; Kang W, 2011, CLIN CANCER RES, V17, P2130, DOI 10.1158/1078-0432.CCR-10-2467; Keys HM, 2004, GYNECOL ONCOL, V92, P744, DOI 10.1016/j.ygyno.2003.11.048; Modena P, 2006, J CLIN ONCOL, V24, P5223, DOI 10.1200/JCO.2006.06.3701; MORROW CP, 1991, GYNECOL ONCOL, V40, P55, DOI 10.1016/0090-8258(91)90086-K; Muramatsu T, 2011, CARCINOGENESIS, V32, P389, DOI 10.1093/carcin/bgq254; Mutch DG., 2009, GYNECOL ONCOL, V115, P325, DOI [10.1016/j.ygyno.2009.10.050, DOI 10.1016/J.YGYNO.2009.10.050, DOI 10.1016/J.YGYN0.2009.10.050]; Nishimura Y, 2013, BRIT J CANCER, V108, P1324, DOI 10.1038/bjc.2013.65; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pajonk F, 2010, STEM CELLS, V28, P639, DOI 10.1002/stem.318; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Rudd ML, 2011, CLIN CANCER RES, V17, P1331, DOI 10.1158/1078-0432.CCR-10-0540; Salvesen HB, 2009, P NATL ACAD SCI USA, V106, P4834, DOI 10.1073/pnas.0806514106; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Singh M, 2008, MODERN PATHOL, V21, P912, DOI 10.1038/modpathol.2008.82; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; SUDOL M, 1994, ONCOGENE, V9, P2145; Sudol M, 2013, ONCOGENE, V32, P3922, DOI 10.1038/onc.2012.520; Sudol M, 2013, HIPPO SIGNALING PATH, P53; Tashiro H, 1997, CANCER RES, V57, P3935; Tschop K, 2011, GENE DEV, V25, P814, DOI 10.1101/gad.2000211; Wang H, 2013, CANC METASTASIS REV; Wang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065539; Wang Y, 2010, CANCER SCI, V101, P1279, DOI 10.1111/j.1349-7006.2010.01511.x; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yokoyama T, 2008, CARCINOGENESIS, V29, P2139, DOI 10.1093/carcin/bgn200; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang X, 2011, ONCOGENE, V30, P2810, DOI 10.1038/onc.2011.8; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	50	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100974	10.1371/journal.pone.0100974	http://dx.doi.org/10.1371/journal.pone.0100974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972085	Green Submitted, Green Published, gold			2022-12-27	WOS:000338512200077
J	Khedkar, GD; Jamdade, R; Naik, S; David, L; Haymer, D				Khedkar, Gulab Dattarao; Jamdade, Rahul; Naik, Suresh; David, Lior; Haymer, David			DNA Barcodes for the FIshes of the Narmada, One of India's Longest Rivers	PLOS ONE			English	Article							SPECIES DISCOVERY; GENETIC-DIVERGENCE; DIVERSITY; GAP; DELIMITATION; SPECIATION; DISTANCES; INSIGHTS; RATES	This study describes the species diversity of fishes of the Narmada River in India. A total of 820 fish specimens were collected from 17 sampling locations across the whole river basin. Fish were taxonomically classified into one of 90 possible species based on morphological characters, and then DNA barcoding was employed using COI gene sequences as a supplemental identification method. A total of 314 different COI sequences were generated, and specimens were confirmed to belong to 85 species representing 63 genera, 34 families and 10 orders. Findings of this study include the identification of five putative cryptic or sibling species and 43 species not previously known from the Narmada River basin. Five species are endemic to India and three are introduced species that had not been previously reported to occur in the Narmada River. Conversely, 43 species previously reported to occur in the Narmada were not found. Genetic diversity and distance values were generated for all of the species within genera, families and orders using Kimura's 2 parameter distance model followed by the construction of a Neighbor Joining tree. High resolution clusters generated in NJ trees aided the groupings of species corresponding to their genera and families which are in confirmation to the values generated by Automatic Barcode Gap Discovery bioinformatics platform. This aided to decide a threshold value for the discrimination of species boundary from the Narmada River. This study provides an important validation of the use of DNA barcode sequences for monitoring species diversity and changes within complex ecosystems such as the Narmada River.	[Khedkar, Gulab Dattarao; Jamdade, Rahul] Dr Babasaheb Ambedkar Marathwada Univ, Paul Hebert Ctr DNA Barcoding & Biodivers Studies, Aurangabad, Maharashtra, India; [Naik, Suresh] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [David, Lior] Hebrew Univ Jerusalem, RH Smith Fac Agr Food & Environm, Dept Anim Sci, IL-76100 Rehovot, Israel; [Haymer, David] Univ Hawaii, Dept Cell & Mol Biol, Honolulu, HI 96822 USA	Dr. Babasaheb Ambedkar Marathwada University (BAMU); University of Guelph; Hebrew University of Jerusalem; University of Hawaii System	Khedkar, GD (corresponding author), Dr Babasaheb Ambedkar Marathwada Univ, Paul Hebert Ctr DNA Barcoding & Biodivers Studies, Aurangabad, Maharashtra, India.	gdkhedkar@gmail.com	Jamdade, Rahul Arvind/G-2947-2017; Khedkar, Gualb/AAG-9394-2021; David, Lior/G-8754-2012	Jamdade, Rahul Arvind/0000-0001-8413-7319; David, Lior/0000-0002-6555-0594	Ministry of Food Processing Industries, Government of India, New Delhi [24/MFPI/RD/2007]	Ministry of Food Processing Industries, Government of India, New Delhi	This work is supported by Ministry of Food Processing Industries, Government of India, New Delhi under grant code 24/MFPI/R&D/2007 dated Dec 28, 2011.(www.mofpi.nic.in). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	April J, 2011, P NATL ACAD SCI USA, V108, P10602, DOI 10.1073/pnas.1016437108; Aquilino SVL, 2011, MOL ECOL RESOUR, V11, P612, DOI 10.1111/j.1755-0998.2011.03000.x; Arya SC, 2001, AGR POLLUTION S ASIA, P108; Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; Ayala FJ, 1997, P NATL ACAD SCI USA, V94, P7776, DOI 10.1073/pnas.94.15.7776; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Bhattacharjee MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049950; Bichain JM, 2007, MALACOLOGIA, V49, P293, DOI 10.4002/0076-2997-49.2.293; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bond JE, 2008, SYST BIOL, V57, P628, DOI 10.1080/10635150802302443; Chakraborty M, 2014, GENE, V537, P20, DOI 10.1016/j.gene.2013.12.047; CIFRI (Central Inland Fisheries Research Institute), 1993, STUD FISH CONS NARM; Damm S, 2010, MOL ECOL, V19, P3881, DOI 10.1111/j.1365-294X.2010.04720.x; Depraz A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-171; DeSalle R, 2006, CONSERV BIOL, V20, P1545, DOI 10.1111/j.1523-1739.2006.00543.x; Doria RS, 1990, ENV IMPACT NARMADA S; Dubey GP., 1984, NARMADA BASIN DEV 1; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; Fausch KD, 2002, BIOSCIENCE, V52, P483, DOI 10.1641/0006-3568(2002)052[0483:LTRBTG]2.0.CO;2; Ferguson JWH, 2002, BIOL J LINN SOC, V75, P509, DOI 10.1046/j.1095-8312.2002.00042.x; Fregin S, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-157; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Giraud T, 2008, FUNGAL GENET BIOL, V45, P791, DOI 10.1016/j.fgb.2008.02.001; Gleick PH, 1993, WATER CRISIS GUIDE W; Goetze E, 2010, MOL ECOL, V19, P952, DOI 10.1111/j.1365-294X.2009.04520.x; Gomez A, 2007, P ROY SOC B-BIOL SCI, V274, P199, DOI 10.1098/rspb.2006.3718; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Holland BS, 2004, MAR BIOL, V145, P1119, DOI 10.1007/s00227-004-1409-4; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Johns GC, 1998, MOL BIOL EVOL, V15, P1481, DOI 10.1093/oxfordjournals.molbev.a025875; Khedkar GD, 2014, ECOHYDROLOGY, V7, P1560, DOI 10.1002/eco.1470; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kottelat M., 1996, 343 WORLD BANK; Laikre L, 2010, CONSERV GENET, V11, P349, DOI 10.1007/s10592-009-0037-4; Lakra WS, 2011, MOL ECOL RESOUR, V11, P60, DOI 10.1111/j.1755-0998.2010.02894.x; Lakra W. S., 2010, THREATENED FRESHWATE; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miller SE, 2007, P NATL ACAD SCI USA, V104, P4775, DOI 10.1073/pnas.0700466104; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Paz A, 2012, J BIOSCIENCES, V37, P887, DOI 10.1007/s12038-012-9255-x; Persis M, 2009, MOL BIOL REP, V36, P1733, DOI 10.1007/s11033-008-9375-4; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rao K.S., 1991, Journal of the Inland Fisheries Society of India, V23, P34; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ross KG, 2010, SYST BIOL, V59, P162, DOI 10.1093/sysbio/syp089; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Singh SN, 1993, STUDIES FISH CONSERV, P1; Smith MA, 2008, MOL ECOL RESOUR, V8, P235, DOI 10.1111/j.1471-8286.2007.01964.x; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Stoeckle M, 2003, BIOSCIENCE, V53, P796, DOI 10.1641/0006-3568(2003)053[0796:TDATBC]2.0.CO;2; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teletchea F, 2010, J FISH BIOL, V77, P257, DOI 10.1111/j.1095-8649.2010.02689.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Vogler AP, 2007, J ZOOL SYST EVOL RES, V45, P1, DOI 10.1111/j.1439-0469.2006.00384.x; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x	60	43	54	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101460	10.1371/journal.pone.0101460	http://dx.doi.org/10.1371/journal.pone.0101460			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991801	Green Published, gold, Green Submitted			2022-12-27	WOS:000341253400073
J	Michel, C; Herzog, S; de Capitani, C; Burkhardt-Holm, P; Pietsch, C				Michel, Christian; Herzog, Simon; de Capitani, Christian; Burkhardt-Holm, Patricia; Pietsch, Constanze			Natural Mineral Particles Are Cytotoxic to Rainbow Trout Gill Epithelial Cells In Vitro	PLOS ONE			English	Article							METAL-OXIDE NANOPARTICLES; SUSPENDED CLAY KAOLIN; ONCORHYNCHUS-MYKISS; RISK-ASSESSMENT; CLIMATE-CHANGE; COHO SALMON; TOXICITY; SEDIMENT; EXPOSURE; SIZE	Worldwide increases in fluvial fine sediment are a threat to aquatic animal health. Fluvial fine sediment is always a mixture of particles whose mineralogical composition differs depending on the sediment source and catchment area geology. Nonetheless, whether particle impact in aquatic organisms differs between mineral species remains to be investigated. This study applied an in vitro approach to evaluate cytotoxicity and uptake of four common fluvial mineral particles (quartz, feldspar, mica, and kaolin; concentrations: 10, 50, 250 mg L-1) in the rainbow trout epithelial gill cell line RTgill-W1. Cells were exposed for 24, 48, 72, and 96 h. Cytotoxicity assays for cell membrane integrity (propidium iodide assay), oxidative stress (H2DCF-DA assay), and metabolic activity (MTT assay) were applied. These assays were complemented with cell counts and transmission electron microscopy. Regardless of mineral species, particles <= 2 mu m in diameter were taken up by the cells, suggesting that particles of all mineral species came into contact and interacted with the cells. Not all particles, however, caused strong cytotoxicity: Among all assays the tectosilicates quartz and feldspar caused sporadic maximum changes of 0.8-1.2-fold compared to controls. In contrast, cytotoxicity of the clay particles was distinctly stronger and even differed between the two particle types: mica induced concentration-dependent increases in free radicals, with consistent 1.6-1.8-fold-changes at the 250 mg L-1 concentration, and a dilated endoplasmic reticulum. Kaolin caused concentration-dependent increases in cell membrane damage, with consistent 1.3-1.6-fold increases at the 250 mg L-1 concentration. All effects occurred in the presence or absence of 10% fetal bovine serum. Cell numbers per se were marginally affected. Results indicate that (i.) natural mineral particles can be cytotoxic to gill epithelial cells, (ii.) their cytotoxic potential differs between mineral species, with clay particles being more cytotoxic, and (iii.) some clays might induce effects comparable to engineered nanoparticles.	[Michel, Christian; Herzog, Simon; Burkhardt-Holm, Patricia; Pietsch, Constanze] Univ Basel, Dept Environm Sci, Man Soc Environm, Programm MGU, Basel, Switzerland; [de Capitani, Christian] Univ Basel, Dept Environm Sci, Basel, Switzerland; [Burkhardt-Holm, Patricia] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Basel; University of Basel; University of Alberta	Burkhardt-Holm, P (corresponding author), Univ Basel, Dept Environm Sci, Man Soc Environm, Programm MGU, Basel, Switzerland.	patricia.holm@unibas.ch	Pietsch, Constanze/K-7243-2012	Pietsch, Constanze/0000-0002-3572-8945; Herzog, Simon David/0000-0003-2504-8070; Higgs, Dennis/0000-0002-0771-4642	University of Basel; Swiss National Science Foundation [K-32K1-120486, CR23I2_138025]	University of Basel; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by the University of Basel (www.unibas.ch) and two Swiss National Science Foundation grants (www.snsf.ch, projects K-32K1-120486 and CR23I2_138025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselman NEM, 2003, HYDROL PROCESS, V17, P3225, DOI 10.1002/hyp.1384; Atteia O, 1998, ENVIRON GEOL, V34, P257, DOI 10.1007/s002540050277; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bernhardt ES, 2010, J ENVIRON QUAL, V39, P1954, DOI 10.2134/jeq2009.0479; Bilotta GS, 2008, WATER RES, V42, P2849, DOI 10.1016/j.watres.2008.03.018; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BOLS NC, 1994, J FISH DIS, V17, P601, DOI 10.1111/j.1365-2761.1994.tb00258.x; Borm Paul J. A., 2007, P1; Brunner TJ, 2006, ENVIRON SCI TECHNOL, V40, P4374, DOI 10.1021/es052069i; Busch W, 2011, J NANOPART RES, V13, P293, DOI 10.1007/s11051-010-0030-3; Cakmak GD, 2004, INT J HYG ENVIR HEAL, V207, P105, DOI 10.1078/1438-4639-00276; Camatini M, 2012, ENVIRON TOXICOL, V27, P63, DOI 10.1002/tox.20611; Christian P, 2008, ECOTOXICOLOGY, V17, P326, DOI 10.1007/s10646-008-0213-1; Dayeh VR, 2005, SMALL -SCALE FRESHWATER TOXICITY INVESTIGATIONS, VOL 1 - TOXICITY TEST METHODS, P473, DOI 10.1007/1-4020-3120-3_16; Debes PV, 2012, MOL ECOL, V21, P2574, DOI 10.1111/j.1365-294X.2012.05567.x; Delay M, 2012, ANAL BIOANAL CHEM, V402, P583, DOI 10.1007/s00216-011-5443-z; Dore MHI, 2005, ENVIRON INT, V31, P1167, DOI 10.1016/j.envint.2005.03.004; Doshi N, 2010, J R SOC INTERFACE, V7, pS403, DOI 10.1098/rsif.2010.0134.focus; Evans DJ, 2006, GEOMORPHOLOGY, V79, P93, DOI 10.1016/j.geomorph.2005.09.018; Federici G, 2007, AQUAT TOXICOL, V84, P415, DOI 10.1016/j.aquatox.2007.07.009; Foster KA, 2001, J PHARM PHARMACOL, V53, P57, DOI 10.1211/0022357011775190; Fubini B, 1997, ENVIRON HEALTH PERSP, V105, P1013, DOI 10.2307/3433502; Gao N., 2002, ANN OCCUP HYG, V46, P50; Gehr P, 2011, ENDOCYTOSIS ENV ENG; GEORGE SG, 1976, J EXP MAR BIOL ECOL, V23, P71, DOI 10.1016/0022-0981(76)90086-1; Gerbersdorf SU, 2011, J SOIL SEDIMENT, V11, P1099, DOI 10.1007/s11368-011-0373-0; GILLER PS, 1998, BIOL STREAMS RIVERS; GOLDES SA, 1988, J FISH DIS, V11, P23, DOI 10.1111/j.1365-2761.1988.tb00520.x; GOLDES SA, 1986, J FISH DIS, V9, P147, DOI 10.1111/j.1365-2761.1986.tb00996.x; Goldes SA, 1983, HISTOLOGICAL ULTRAST; Griffitt RJ, 2009, TOXICOL SCI, V107, P404, DOI 10.1093/toxsci/kfn256; Gstraunthaler G, 2003, ALTEX-ALTERN TIEREXP, V20, P275; Guthrie GD, 1997, ENVIRON HEALTH PERSP, V105, P1003, DOI 10.2307/3433501; Handy RD, 2007, HEALTH RISK SOC, V9, P125, DOI 10.1080/13698570701306807; Handy RD, 2008, ECOTOXICOLOGY, V17, P287, DOI 10.1007/s10646-008-0199-8; HERBERT DWM, 1961, INT J AIR WATER POLL, V5, P46; Hetland RB, 2000, J TOXICOL ENV HEAL A, V60, P47, DOI 10.1080/009841000156583; Hildebrand H, 2010, ENVIRON POLLUT, V158, P65, DOI 10.1016/j.envpol.2009.08.021; Hitomi J, 2004, NEUROSCI LETT, V357, P127, DOI 10.1016/j.neulet.2003.12.080; Holder AL, 2012, CHEM RES TOXICOL, V25, P1885, DOI 10.1021/tx3001708; HUBBARD CR, 1976, J APPL CRYSTALLOGR, V9, P169, DOI 10.1107/S0021889876010807; Irion G, 1991, BIOGEOCHEMISTRY MAJO, P265; Jentsch A, 2008, CR GEOSCI, V340, P621, DOI 10.1016/j.crte.2008.07.002; Jiang JK, 2009, J NANOPART RES, V11, P77, DOI 10.1007/s11051-008-9446-4; Karlsson HL, 2009, TOXICOL LETT, V188, P112, DOI 10.1016/j.toxlet.2009.03.014; Keller AA, 2010, ENVIRON SCI TECHNOL, V44, P1962, DOI 10.1021/es902987d; Kemp P, 2011, HYDROL PROCESS, V25, P1800, DOI 10.1002/hyp.7940; Kiama SG, 2008, J ANAT, V213, P452, DOI 10.1111/j.1469-7580.2008.00951.x; Kroll A, 2012, ARCH TOXICOL, V86, P1123, DOI 10.1007/s00204-012-0837-z; Kuhnel D, 2009, AQUAT TOXICOL, V93, P91, DOI 10.1016/j.aquatox.2009.04.003; Kupcsik L, 2011, MAMMALIAN CELL VIABI; Lead J.R., 2007, ENV COLLOIDS PARTICL, V10, P1, DOI DOI 10.1002/9780470024539.CH1; Long JF, 2005, ENVIRON HEALTH PERSP, V113, P170, DOI 10.1289/ehp.7389; MARTENS DW, 1993, CAN J FISH AQUAT SCI, V50, P586, DOI 10.1139/f93-067; MCLEAY DJ, 1987, CAN J FISH AQUAT SCI, V44, P658, DOI 10.1139/f87-080; Michel C, 2013, CAN J FISH AQUAT SCI, V70, P630, DOI 10.1139/cjfas-2012-0376; Moller P, 2010, FREE RADICAL RES, V44, P1, DOI 10.3109/10715760903300691; Moore MN, 2006, ENVIRON INT, V32, P967, DOI 10.1016/j.envint.2006.06.014; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Newcombe Charles P., 1996, North American Journal of Fisheries Management, V16, P693, DOI 10.1577/1548-8675(1996)016<0693:CSSAFA>2.3.CO;2; Owen R, 2007, ENVIRON SCI TECHNOL, V41, P5582; Owens PN, 2005, RIVER RES APPL, V21, P693, DOI 10.1002/rra.878; Pietsch C, 2011, TOXICOL APPL PHARM, V256, P24, DOI 10.1016/j.taap.2011.07.004; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; REDDING JM, 1987, T AM FISH SOC, V116, P737, DOI 10.1577/1548-8659(1987)116<737:PEOCSA>2.0.CO;2; Roco MC, 2003, CURR OPIN BIOTECH, V14, P337, DOI 10.1016/S0958-1669(03)00068-5; Schaetzl RJ, 2005, SOILS: GENESIS AND GEOMORPHOLOGY, P1, DOI 10.1017/CBO9780511815560; Scheurer K, 2009, ENVIRON SCI POLLUT R, V16, P232, DOI 10.1007/s11356-008-0075-3; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schins RPF, 2002, CHEM RES TOXICOL, V15, P1166, DOI 10.1021/tx025558u; Schulze C, 2008, NANOTOXICOLOGY, V2, P51, DOI 10.1080/17435390802018378; Schwarze PE, 2007, INHAL TOXICOL, V19, P17, DOI 10.1080/08958370701490445; Scown TM, 2010, TOXICOL SCI, V115, P521, DOI 10.1093/toxsci/kfq076; SERVIZI JA, 1991, CAN J FISH AQUAT SCI, V48, P493, DOI 10.1139/f91-063; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Stringer B, 1998, J TOXICOL ENV HEAL A, V55, P31; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; Van Hoecke K, 2013, NANOTOXICOLOGY, V7, P37, DOI 10.3109/17435390.2011.626566; Venables W.N., 2013, MODERN APPL STAT S; von Moos N, 2012, ENVIRON SCI TECHNOL, V46, P11327, DOI 10.1021/es302332w; Wang SG, 2011, TOXICOL IN VITRO, V25, P2147, DOI 10.1016/j.tiv.2011.07.007; Warheit DB, 2006, TOXICOL SCI, V91, P227, DOI 10.1093/toxsci/kfj140; Waters T. F., 1995, SEDIMENT STREAMS SOU; Wiesner MR, 2009, ENVIRON SCI TECHNOL, V43, P6458, DOI 10.1021/es803621k; Wilber DH, 2001, N AM J FISH MANAGE, V21, P855, DOI 10.1577/1548-8675(2001)021<0855:BEOSSA>2.0.CO;2; Zhang Y, 2008, WATER RES, V42, P2204, DOI 10.1016/j.watres.2007.11.036; Zuur Alain F., 2009, P1	88	14	15	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100856	10.1371/journal.pone.0100856	http://dx.doi.org/10.1371/journal.pone.0100856			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991818	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000341253400033
J	Rodrigues, H; Figueira, I; Lopes, A; Goncalves, R; Mendlowicz, MV; Coutinho, ESF; Ventura, P				Rodrigues, Helga; Figueira, Ivan; Lopes, Alessandra; Goncalves, Raquel; Mendlowicz, Mauro Vitor; Coutinho, Evandro Silva Freire; Ventura, Paula			Does D-Cycloserine Enhance Exposure Therapy for Anxiety Disorders in Humans? A Meta-Analysis	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; PLACEBO-CONTROLLED TRIAL; OBSESSIVE-COMPULSIVE SCALE; FEAR EXTINCTION; PANIC DISORDER; AUGMENTATION STRATEGY; DROPOUT RATES; SOCIAL PHOBIA; PSYCHOTHERAPY; COMBINATION	The treatment of anxiety is on the edge of a new era of combinations of pharmacologic and psychosocial interventions. A new wave of translational research has focused on the use of pharmacological agents as psychotherapy adjuvants using neurobiological insights into the mechanism of the action of certain psychological treatments such as exposure therapy. Recently, d-cycloserine (DCS) an antibiotic used to treat tuberculosis has been applied to enhance exposure-based treatment for anxiety and has proved to be a promising, but as yet unproven intervention. The present study aimed to evaluate the efficacy of DCS in the enhancement of exposure therapy in anxiety disorders. A systematic review/meta-analysis was conducted. Electronic searches were conducted in the databases ISI-Web of Science, Pubmed and PsycINFO. We included only randomized, double-blind, placebo-controlled trials with humans, focusing on the role of DCS in enhancing the action of exposure therapy for anxiety disorders. We identified 328 references, 13 studies were included in our final sample: 4 on obsessive-compulsive disorder, 2 on panic disorder, 2 on social anxiety disorder, 2 on posttraumatic stress disorder, one on acrophobia, and 2 on snake phobia. The results of the present meta-analysis show that DCS enhances exposure therapy in the treatment of anxiety disorders (Cohen d = -0.34; CI: -0.54 to -0.14), facilitating the specific process of extinction of fear. DCS seems to be effective when administered at a time close to the exposure therapy, at low doses and a limited number of times. DCS emerges as a potential new therapeutic approach for patients with refractory anxiety disorders that are unresponsive to the conventional treatments available. When administered correctly, DCS is a promising strategy for augmentation of CBT and could reduce health care costs, drop-out rates and bring faster relief to patients.	[Rodrigues, Helga; Figueira, Ivan; Lopes, Alessandra; Goncalves, Raquel] Univ Fed Rio Janeiro IPUB UFRJ, Inst Psychiat, Rio De Janeiro, Brazil; [Mendlowicz, Mauro Vitor] Univ Fed Fluminense MSM UFF, Dept Psychiat & Mental Hlth, Niteroi, RJ, Brazil; [Coutinho, Evandro Silva Freire] Escola Nacl Saude Publ ENSP FIOCRUZ, Dept Epidemiol, Rio De Janeiro, Brazil; [Ventura, Paula] Univ Fed Rio Janeiro IPUB UFRJ, Inst Psychol, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal Fluminense; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Rodrigues, H (corresponding author), Univ Fed Rio Janeiro IPUB UFRJ, Inst Psychiat, Rio De Janeiro, Brazil.	helga_rodrigues@hotmail.com	Gonçalves, Raquel M/M-2423-2018	Coutinho, Evandro/0000-0002-4649-7353	National Council for Scientific and Technological Development (CNPq); Carlos Chagas Filho Foundation for Research Support in Rio de Janeiro (FAPERJ)	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlos Chagas Filho Foundation for Research Support in Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was partially supported by the National Council for Scientific and Technological Development (CNPq) and the Carlos Chagas Filho Foundation for Research Support in Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; BANDELOW B, 1995, INT CLIN PSYCHOPHARM, V10, P73, DOI 10.1097/00004850-199506000-00003; Barlow DH, 2000, JAMA-J AM MED ASSOC, V283, P2529, DOI 10.1001/jama.283.19.2529; BOJE KM, 1993, BRAIN RES, V603, P207, DOI 10.1016/0006-8993(93)91239-O; Bontempo A, 2012, J CLIN PSYCHIAT, V73, P533, DOI 10.4088/JCP.11r07356; Brown T. A., 1994, ANXIETY DISORDERS IN; Byrne SP, 2011, CLIN PSYCHOL-UK, V15, P1, DOI 10.1111/j.1742-9552.2011.00005.x; Bystritsky A, 2006, MOL PSYCHIATR, V11, P805, DOI 10.1038/sj.mp.4001852; Chasson GS, 2010, BEHAV RES THER, V48, P675, DOI 10.1016/j.brat.2010.03.007; Clark DM, 2003, J CONSULT CLIN PSYCH, V71, P1058, DOI 10.1037/0022-006X.71.6.1058; COHEN DC, 1977, BEHAV THER, V8, P17, DOI 10.1016/S0005-7894(77)80116-0; D'Souza DC, 2000, BIOL PSYCHIAT, V47, P450, DOI 10.1016/S0006-3223(99)00133-X; de Kleine RA, 2012, BIOL PSYCHIAT, V71, P962, DOI 10.1016/j.biopsych.2012.02.033; DiNardo P.A., 1994, ANXIETY DISORDER INT; Fava M, 1996, PSYCHIAT CLIN N AM, V19, P179, DOI 10.1016/S0193-953X(05)70283-5; Foa EB, 2005, AM J PSYCHIAT, V162, P151, DOI 10.1176/appi.ajp.162.1.151; Foa EB, 2002, BIOL PSYCHIAT, V52, P987, DOI 10.1016/S0006-3223(02)01552-4; Ganasen KA, 2010, PSYCHIAT CLIN N AM, V33, P687, DOI 10.1016/j.psc.2010.04.008; Goff DC, 1999, ARCH GEN PSYCHIAT, V56, P21, DOI 10.1001/archpsyc.56.1.21; Goncalves R, 2011, REV PSIQ CLIN-BRAZIL, V38, P155; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Greenberg PE, 1999, J CLIN PSYCHIAT, V60, P427, DOI 10.4088/JCP.v60n0702; Guastella AJ, 2008, BIOL PSYCHIAT, V63, P544, DOI 10.1016/j.biopsych.2007.11.011; Guy W., 1970, CLIN GLOBAL IMPRESSI; Hembree EA, 2003, J TRAUMA STRESS, V16, P555, DOI 10.1023/B:JOTS.0000004078.93012.7d; Heresco-Levy U, 2002, INT J NEUROPSYCHOPH, V5, P301, DOI 10.1017/S1461145702003061; Higgins JP, 2008, COCHRANE HDB SYSTEMA, P188; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hofmann SG, 2006, ARCH GEN PSYCHIAT, V63, P298, DOI 10.1001/archpsyc.63.3.298; Hofmann SG, 2008, J CLIN PSYCHIAT, V69, P621, DOI 10.4088/jcp.v69n0415; Hofmann SG, 2006, CNS DRUG REV, V12, P208, DOI 10.1111/j.1527-3458.2006.00208.x; Hofmann SG, 2013, BIOL MOOD ANXIETY DI, V3, DOI 10.1186/2045-5380-3-11; Hofmann SG, 2012, CURR PHARM DESIGN, V18, P5659; Javitt DC, 2013, AM J PSYCHIAT, V170, P699, DOI 10.1176/appi.ajp.2013.13040503; Kessler R.C., 2002, NEUROPSYCHOPHARMACOL, P981; KLORMAN R, 1974, BEHAV THER, V5, P401, DOI 10.1016/S0005-7894(74)80008-0; Kushner MG, 2007, BIOL PSYCHIAT, V62, P835, DOI 10.1016/j.biopsych.2006.12.020; Ledgerwood L, 2003, BEHAV NEUROSCI, V117, P341, DOI 10.1037/0735-7044.117.2.341; Lepine JP, 2002, J CLIN PSYCHIAT, V63, P4; Liebowitz M R, 1987, Mod Probl Pharmacopsychiatry, V22, P141; Litz BT, 2012, J PSYCHIATR RES, V46, P1184, DOI 10.1016/j.jpsychires.2012.05.006; Lurie I, 2010, J NERV MENT DIS, V198, P116, DOI 10.1097/NMD.0b013e3181cc41b6; Mendlowicz MV, 2000, AM J PSYCHIAT, V157, P669, DOI 10.1176/appi.ajp.157.5.669; Nave AM, 2012, J CLIN PSYCHIAT, V73, P1179, DOI 10.4088/JCP.11m07564; Norberg MM, 2008, BIOL PSYCHIAT, V63, P1118, DOI 10.1016/j.biopsych.2008.01.012; Otto MW, 2007, CNS SPECTRUMS, V12, P51, DOI 10.1017/S1092852900020526; Otto MW, 2010, BIOL PSYCHIAT, V67, P365, DOI 10.1016/j.biopsych.2009.07.036; Otto MW, 2004, J CLIN PSYCHIAT, V65, P34; Pollack MH, 2008, DEPRESS ANXIETY, V25, P467, DOI 10.1002/da.20329; Popik P, 2000, NEUROPHARMACOLOGY, V39, P2278, DOI 10.1016/S0028-3908(00)00090-3; QUARTERMAIN D, 1994, EUR J PHARMACOL, V257, P7, DOI 10.1016/0014-2999(94)90687-4; Rapee RM, 2007, BRIT J PSYCHIAT, V191, P246, DOI 10.1192/bjp.bp.106.028167; REGIER DA, 1988, ARCH GEN PSYCHIAT, V45, P977; Ressler KJ, 2004, ARCH GEN PSYCHIAT, V61, P1136, DOI 10.1001/archpsyc.61.11.1136; Santini E, 2001, J NEUROSCI, V21, P9009, DOI 10.1523/JNEUROSCI.21-22-09009.2001; Scahill L, 1997, J AM ACAD CHILD PSY, V36, P844, DOI 10.1097/00004583-199706000-00023; Schottenbauer MA, 2008, PSYCHIATRY, V71, P134, DOI 10.1521/psyc.2008.71.2.134; Shear MK, 1997, AM J PSYCHIAT, V154, P1571, DOI 10.1176/ajp.154.11.1571; Sheerin CM, 2012, J CONTEMP PSYCHOTHER, V42, P69, DOI 10.1007/s10879-011-9195-z; Siegmund A, 2011, J PSYCHIATR RES, V45, P1042, DOI 10.1016/j.jpsychires.2011.01.020; Smits JAJ, 2013, BIOL PSYCHIAT, V73, P1054, DOI 10.1016/j.biopsych.2012.12.009; Storch EA, 2007, INT CLIN PSYCHOPHARM, V22, P230, DOI 10.1097/YIC.0b013e32819f8480; Storch EA, 2010, BIOL PSYCHIAT, V68, P1073, DOI 10.1016/j.biopsych.2010.07.015; Storch EA, 2010, CHILD YOUTH CARE FOR, V39, P101, DOI 10.1007/s10566-010-9094-6; Tart CD, 2013, J PSYCHIATR RES, V47, P168, DOI 10.1016/j.jpsychires.2012.09.024; Tsai GE, 1999, AM J PSYCHIAT, V156, P467; Turner S. M., 1989, PSYCHOL ASSESSMENT J, V1, P35, DOI [10.1037/1040-3590.1.1.35, DOI 10.1037/1040-3590.1.1.35]; Walker DL, 2002, J NEUROSCI, V22, P2343, DOI 10.1523/JNEUROSCI.22-06-02343.2002; WHO, 2001, WORLD HLTH REPORT 20; Wilhelm S, 2008, AM J PSYCHIAT, V165, P335, DOI 10.1176/appi.ajp.2007.07050776	71	81	82	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e93519	10.1371/journal.pone.0093519	http://dx.doi.org/10.1371/journal.pone.0093519			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991926	Green Published, gold, Green Submitted			2022-12-27	WOS:000341253400002
J	Ye, YS; Liang, XQ; Chen, YX; Li, L; Ji, YJ; Zhu, CY				Ye, Yushi; Liang, Xinqiang; Chen, Yingxu; Li, Liang; Ji, Yuanjing; Zhu, Chunyan			Carbon, Nitrogen and Phosphorus Accumulation and Partitioning, and C:N:P Stoichiometry in Late-Season Rice under Different Water and Nitrogen Managements	PLOS ONE			English	Article							CO2 ENRICHMENT FACE; N-P STOICHIOMETRY; PLANT-GROWTH; DRY-MATTER; NUTRIENT LIMITATION; TERRESTRIAL PLANTS; ELEVATED CO2; LOWLAND RICE; SOIL CARBON; RATIOS	Water and nitrogen availability plays an important role in the biogeochemical cycles of essential elements, such as carbon (C), nitrogen (N) and phosphorus (P), in agricultural ecosystems. In this study, we investigated the seasonal changes of C, N and P concentrations, accumulation, partitioning, and C:N:P stoichiometric ratios in different plant tissues (root, stem-leaf, and panicle) of late-season rice under two irrigation regimes (continuous flooding, CF; alternate wetting and drying, AWD) and four N managements (control, N0; conventional urea at 240 kg N ha(-1), UREA; controlled-release bulk blending fertilizer at 240 kg N ha(-1), BBF; polymer-coated urea at 240 kg N ha 21, PCU). We found that water and N treatments had remarkable effects on the measured parameters in different plant tissues after transplanting, but the water and N interactions had insignificant effects. Tissue C:N, N:P and C:P ratios ranged from 14.6 to 52.1, 3.1 to 7.8, and 76.9 to 254.3 over the rice growing seasons, respectively. The root and stem-leaf C:N:P and panicle C:N ratios showed overall uptrends with a peak at harvest whereas the panicle N:P and C:P ratios decreased from filling to harvest. The AWD treatment did not affect the concentrations and accumulation of tissue C and N, but greatly decreased those of P, resulting in enhanced N:P and C:P ratios. N fertilization significantly increased tissue N concentration, slightly enhanced tissue P concentration, but did not affect tissue C concentration, leading to a significant increase in tissue N:P ratio but a decrease in C:N and C:P ratios. Our results suggested that the growth of rice in the Taihu Lake region was co-limited by N and P. These findings broadened our understanding of the responses of plant C:N:P stoichiometry to simultaneous water and N managements in subtropical high-yielding rice systems.	[Ye, Yushi; Liang, Xinqiang; Li, Liang; Ji, Yuanjing] Zhejiang Univ, Coll Environm & Resource Sci, Inst Environm Sci & Technol, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Yingxu; Zhu, Chunyan] Zhejiang Prov Key Lab Water Pollut Control & Envi, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Liang, XQ (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Inst Environm Sci & Technol, Hangzhou 310003, Zhejiang, Peoples R China.	liang410@zju.edu.cn	chen, ying/HHS-8254-2022		National Natural Science Foundation of China [41271314, 21077088]; National Key Science and Technology Project: Water Pollution Control and Treatment [2014ZX07101-012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Science and Technology Project: Water Pollution Control and Treatment	This work was funded by the National Natural Science Foundation of China (No. 41271314, 21077088) and the National Key Science and Technology Project: Water Pollution Control and Treatment (2014ZX07101-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058179; Agren GI, 2008, ANNU REV ECOL EVOL S, V39, P153, DOI 10.1146/annurev.ecolsys.39.110707.173515; Agren GI, 2012, NEW PHYTOL, V194, P953, DOI 10.1111/j.1469-8137.2012.04116.x; Agren GI, 2012, NEW PHYTOL, V194, P944, DOI 10.1111/j.1469-8137.2012.04114.x; Aulakh MS, 2005, ADV AGRON, V86, P341, DOI 10.1016/S0065-2113(05)86007-9; Bao SD, 2000, SOIL AGR CHEM ANAL, P268; Belanger G, 2012, FIELD CROP RES, V126, P1, DOI 10.1016/j.fcr.2011.09.016; Dordas C, 2009, EUR J AGRON, V30, P129, DOI 10.1016/j.eja.2008.09.001; Elser JJ, 2010, NEW PHYTOL, V186, P593, DOI 10.1111/j.1469-8137.2010.03214.x; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Gan YT, 2011, CROP PASTURE SCI, V62, P496, DOI 10.1071/CP10360; Gifford RM, 2000, PLANT SOIL, V224, P1, DOI 10.1023/A:1004790612630; Greenwood DJ, 2008, ANN BOT-LONDON, V102, P967, DOI 10.1093/aob/mcn188; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; HAYNES RJ, 1989, J SOIL SCI, V40, P773, DOI 10.1111/j.1365-2389.1989.tb01317.x; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Kerkhoff AJ, 2006, AM NAT, V168, pE103, DOI 10.1086/507879; Kim HY, 2011, PLANT SOIL, V342, P59, DOI 10.1007/s11104-010-0665-y; Knecht MR, 2004, TREE PHYSIOL, V24, P447, DOI 10.1093/treephys/24.4.447; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lu XT, 2012, OECOLOGIA, V168, P301, DOI 10.1007/s00442-011-2097-7; Mahajan G, 2012, FIELD CROP RES, V134, P59, DOI 10.1016/j.fcr.2012.04.011; Mao Z, 2001, WATER EFFICIENT IRRI; Matzek V, 2009, ECOL LETT, V12, P765, DOI 10.1111/j.1461-0248.2009.01310.x; Ning P, 2013, FIELD CROP RES, V144, P19, DOI 10.1016/j.fcr.2013.01.020; Pampolino MF, 2008, SOIL SCI SOC AM J, V72, P798, DOI 10.2136/sssaj2006.0334; Rentsch D, 2007, FEBS LETT, V581, P2281, DOI 10.1016/j.febslet.2007.04.013; [阮新民 RUAN Xinmin], 2011, [中国土壤与肥料, Soil and Fertilizer Sciences in China], P35; Sadras VO, 2006, FIELD CROP RES, V95, P13, DOI 10.1016/j.fcr.2005.01.020; Sardans J, 2012, PERSPECT PLANT ECOL, V14, P33, DOI 10.1016/j.ppees.2011.08.002; Sardans J, 2012, PLANT PHYSIOL, V160, P1741, DOI 10.1104/pp.112.208785; Seneweera S, 2011, J PLANT INTERACT, V6, P35, DOI 10.1080/17429145.2010.513483; Sterner R.W., 2002, ECOLOGICAL STOICHIOM; Tessier JT, 2003, J APPL ECOL, V40, P523, DOI 10.1046/j.1365-2664.2003.00820.x; Witt C, 1999, FIELD CROP RES, V63, P113, DOI 10.1016/S0378-4290(99)00031-3; Yang LX, 2007, FIELD CROP RES, V102, P141, DOI 10.1016/j.fcr.2007.03.004; Yang LX, 2007, FIELD CROP RES, V100, P189, DOI 10.1016/j.fcr.2006.07.003; Yang YH, 2011, PLANT SOIL, V343, P393, DOI 10.1007/s11104-011-0736-8; Ye YS, 2013, FIELD CROP RES, V144, P212, DOI 10.1016/j.fcr.2012.12.003; Yu Q, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032162, 10.1371/journal.pone.0050902]; Zhang HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060360; Zheng SX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051750; Ziadi N, 2007, AGRON J, V99, P833, DOI 10.2134/agronj2006.0199	44	49	54	5	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101776	10.1371/journal.pone.0101776	http://dx.doi.org/10.1371/journal.pone.0101776			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992006	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400115
J	Eliassen, S; Jorgensen, C				Eliassen, Sigrunn; Jorgensen, Christian			Extra-Pair Mating and Evolution of Cooperative Neighbourhoods	PLOS ONE			English	Article							RED-WINGED BLACKBIRDS; POLYGYNANDROUS ALPINE ACCENTORS; INCREASE OFFSPRING HETEROZYGOSITY; REPRODUCTIVE SUCCESS; LEAST FLYCATCHERS; SPERM COMPETITION; SEXUAL SELECTION; FEMALE CONTROL; RECIPROCAL ALTRUISM; FITNESS BENEFITS	Although females commonly solicit extra-pair copulations, the adaptive reason has remained elusive. We use evolutionary modelling of breeding ecology to show that females benefit because extra-pair paternity incentivizes males to shift focus from a single brood towards the entire neighbourhood, as they are likely to have offspring there. Male-male cooperation towards public goods and dear enemy effects of reduced territorial aggression evolve from selfish interests, and lead to safer and more productive neighbourhoods. The mechanism provides adaptive explanations for the common empirical observations that females engage in extra-pair copulations, that neighbours dominate as extra-pair sires, and that extra-pair mating correlates with predation mortality and breeding density. The models predict cooperative behaviours at breeding sites where males cooperate more towards public goods than females. Where maternity certainty makes females care for offspring at home, paternity uncertainty and a potential for offspring in several broods make males invest in communal benefits and public goods. The models further predict that benefits of extra-pair mating affect whole nests or neighbourhoods, and that cuckolding males are often cuckolded themselves. Derived from ecological mechanisms, these new perspectives point towards the evolution of sociality in birds, with relevance also for mammals and primates including humans.	[Eliassen, Sigrunn] Univ Bergen, Dept Biol, Bergen, Norway; [Jorgensen, Christian] Uni Res, Bergen, Norway	University of Bergen	Eliassen, S (corresponding author), Univ Bergen, Dept Biol, Bergen, Norway.	sigrunn.eliassen@bio.uib.no	Jørgensen, Christian/B-4453-2009	Jørgensen, Christian/0000-0001-7087-4625	Research Council of Norway	Research Council of Norway(Research Council of Norway)	The study was funded by the Research Council of Norway. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay E, 2007, EVOL ECOL RES, V9, P855; ARCESE P, 1987, ANIM BEHAV, V35, P773, DOI 10.1016/S0003-3472(87)80114-8; Arnold KE, 2002, P ROY SOC B-BIOL SCI, V269, P1263, DOI 10.1098/rspb.2002.2013; Arnqvist G, 2005, AM NAT, V165, pS26, DOI 10.1086/429350; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Avise JC, 2011, P NATL ACAD SCI USA, V108, P7091, DOI 10.1073/pnas.1103329108; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Beckerman S., 2002, CULTURES MULTIPLE FA, P42; BELETSKY LD, 1989, P NATL ACAD SCI USA, V86, P7933, DOI 10.1073/pnas.86.20.7933; BELETSKY LD, 1986, BEHAV ECOL SOCIOBIOL, V18, P221, DOI 10.1007/BF00290826; Boesch C, 2009, REAL CHIMPANZEE: SEX STRATEGIES IN THE FOREST, P1; Boonekamp JJ, 2014, ECOL LETT, V17, P599, DOI 10.1111/ele.12263; Bouwman KM, 2006, MOL ECOL, V15, P2589, DOI 10.1111/j.1365-294X.2006.02955.x; Briefer E, 2008, ANIM BEHAV, V76, P1319, DOI 10.1016/j.anbehav.2008.06.017; Brown J. L., 1964, Wilson Bulletin, V76, P160; Charmantier A, 2004, BEHAV ECOL SOCIOBIOL, V56, P360, DOI 10.1007/s00265-004-0794-5; Clark CW, 2000, OX ECOL EV; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; Cohas A, 2008, ANIM BEHAV, V76, P87, DOI 10.1016/j.anbehav.2008.01.012; Cornwallis CK, 2010, NATURE, V466, P969, DOI 10.1038/nature09335; Crocker J.G., 2004, CANELA KINSHIP RITUA; CURIO E, 1980, Z TIERPSYCHOL, V53, P139; CURIO E, 1978, Z TIERPSYCHOL, V48, P175; Darwin C., 1871, P423; Davies N. B., 1992, DUNNOCK BEHAV SOCIAL; Davies NB, 1996, ANIM BEHAV, V51, P27, DOI 10.1006/anbe.1996.0003; Delhey K, 2003, P ROY SOC B-BIOL SCI, V270, P2057, DOI 10.1098/rspb.2003.2460; DeWoody JA, 2001, J HERED, V92, P167, DOI 10.1093/jhered/92.2.167; Dieckmann U, 1996, J MATH BIOL, V34, P579, DOI 10.1007/BF02409751; Dunn PO, 2009, BEHAV ECOL SOCIOBIOL, V63, P911, DOI 10.1007/s00265-009-0734-5; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Foerster K, 2003, NATURE, V425, P714, DOI 10.1038/nature01969; Garcia-Navas V, 2014, BEHAV ECOL, V25, P228, DOI 10.1093/beheco/art111; Gavrilets S, 2012, P NATL ACAD SCI USA, V109, P9923, DOI 10.1073/pnas.1200717109; Gerlach NM, 2012, P ROY SOC B-BIOL SCI, V279, P860, DOI 10.1098/rspb.2011.1547; GIBBS HL, 1990, SCIENCE, V250, P1394, DOI 10.1126/science.250.4986.1394; Grabowska-Zhang AM, 2012, BIOL LETTERS, V8, P544, DOI 10.1098/rsbl.2012.0183; Grabowska-Zhang AM, 2012, BEHAV ECOL, V23, P322, DOI 10.1093/beheco/arr189; Gray EM, 1996, BEHAV ECOL SOCIOBIOL, V38, P267, DOI 10.1007/s002650050242; Gray EM, 1997, ANIM BEHAV, V53, P625, DOI 10.1006/anbe.1996.0336; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Gurven M, 2009, CURR ANTHROPOL, V50, P51, DOI 10.1086/595620; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1964, J THEOR BIOL, V7, P17, DOI 10.1016/0022-5193(64)90039-6; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; HEGNER RE, 1987, AUK, V104, P462, DOI 10.2307/4087545; Hill CE, 2011, BEHAV ECOL, V22, P73, DOI 10.1093/beheco/arq171; HOOGLAND JL, 1981, ECOLOGY, V62, P252, DOI 10.2307/1936685; HOOGLAND JL, 1976, ECOL MONOGR, V46, P33, DOI 10.2307/1942393; Hoogland JL, 1998, ANIM BEHAV, V55, P351, DOI 10.1006/anbe.1997.0575; Houston AI, 2005, TRENDS ECOL EVOL, V20, P33, DOI 10.1016/j.tree.2004.10.008; Houston AI, 1999, MODELS ADAPTIVE BEHA; Hrdy SarahBlaffer., 2009, MOTHERS OTHERS EVOLU; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; Jacquet J, 2011, BIOL LETTERS, V7, P899, DOI 10.1098/rsbl.2011.0367; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Johnsen A, 2000, NATURE, V406, P296, DOI 10.1038/35018556; Johnsen A, 1998, P ROY SOC B-BIOL SCI, V265, P1313, DOI 10.1098/rspb.1998.0435; KAPLAN H, 1985, CURR ANTHROPOL, V26, P131, DOI 10.1086/203235; Kempenaers B, 1996, ANIM BEHAV, V51, P1165, DOI 10.1006/anbe.1996.0118; KEMPENAERS B, 1992, NATURE, V357, P494, DOI 10.1038/357494a0; Kempenaers B, 2007, ADV STUD BEHAV, V37, P189, DOI 10.1016/S0065-3454(07)37005-8; Kirkpatrick M, 1997, P NATL ACAD SCI USA, V94, P1282, DOI 10.1073/pnas.94.4.1282; Kohda M, 2009, P R SOC B, V276, P4207, DOI 10.1098/rspb.2009.1175; Kokko H, 1999, ECOL LETT, V2, P247, DOI 10.1046/j.1461-0248.1999.00075.x; Kowalewski MM, 2010, AM J PRIMATOL, V72, P734, DOI 10.1002/ajp.20838; Krams I, 2008, BEHAV ECOL SOCIOBIOL, V62, P599, DOI 10.1007/s00265-007-0484-1; Krams I, 2010, P ROY SOC B-BIOL SCI, V277, P513, DOI 10.1098/rspb.2009.1614; Krams I, 2009, ANIM BEHAV, V77, P513, DOI 10.1016/j.anbehav.2008.11.007; KREBS JR, 1981, ANIM BEHAV, V29, P918, DOI 10.1016/S0003-3472(81)80029-2; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lima SL, 2009, BIOL REV, V84, P485, DOI 10.1111/j.1469-185X.2009.00085.x; LINDEN M, 1989, TRENDS ECOL EVOL, V4, P367, DOI 10.1016/0169-5347(89)90101-8; Magrath MJL, 2009, CURR BIOL, V19, P792, DOI 10.1016/j.cub.2009.03.068; Malinowski B, 1929, SEXAL LIFE SAVAGES N; Mauck RA, 1999, AM NAT, V154, P99, DOI 10.1086/303216; May RM, 2006, NOTES REC ROY SOC, V60, P109, DOI 10.1098/rsnr.2005.0134; Mayer C, 2013, ECOL EVOL, V3, P694, DOI 10.1002/ece3.489; McNamara JM, 2008, NATURE, V451, P189, DOI 10.1038/nature06455; METZ JAJ, 1992, TRENDS ECOL EVOL, V7, P198, DOI 10.1016/0169-5347(92)90073-K; Moller AP, 2000, BEHAV ECOL, V11, P161, DOI 10.1093/beheco/11.2.161; MOLLER AP, 1993, AM NAT, V142, P118, DOI 10.1086/285531; Moller AP, 1998, BEHAV ECOL SOCIOBIOL, V43, P345, DOI 10.1007/s002650050501; Nakamura M, 1998, ANIM BEHAV, V55, P259, DOI 10.1006/anbe.1997.0725; Nakamura M, 1998, ANIM BEHAV, V55, P277, DOI 10.1006/anbe.1997.0599; NOE R, 1994, BEHAV ECOL SOCIOBIOL, V35, P1; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak MA, 2010, NATURE, V466, P1057, DOI 10.1038/nature09205; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Olendorf R, 2004, P ROY SOC B-BIOL SCI, V271, P177, DOI 10.1098/rspb.2003.2586; Opie C, 2013, P NATL ACAD SCI USA, V110, P13328, DOI 10.1073/pnas.1307903110; Ostrom E., 1990, GOVERNING COMMONS EV; Parker GA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0335; PEEK FW, 1971, WILSON BULL, V83, P383; Perry EF, 2003, CONDOR, V105, P756, DOI 10.1650/7162; Perry EF, 2008, AUK, V125, P643, DOI 10.1525/auk.2008.07001; Pfeiffer T, 2005, P ROY SOC B-BIOL SCI, V272, P1115, DOI 10.1098/rspb.2004.2988; Rankin DJ, 2009, EVOLUTION, V63, P1913, DOI 10.1111/j.1558-5646.2009.00656.x; Reid JM, 2011, P ROY SOC B-BIOL SCI, V278, P1114, DOI 10.1098/rspb.2010.1704; Reid JM, 2011, AM NAT, V177, P177, DOI 10.1086/657977; Reznick D, 2000, TRENDS ECOL EVOL, V15, P421, DOI 10.1016/S0169-5347(00)01941-8; Roberts G, 1998, P ROY SOC B-BIOL SCI, V265, P427, DOI 10.1098/rspb.1998.0312; Robertson RJ, 2001, J ANIM ECOL, V70, P1014, DOI 10.1046/j.0021-8790.2001.00555.x; Sardell RJ, 2012, AM NAT, V179, P779, DOI 10.1086/665665; Sardell RJ, 2010, MOL ECOL, V19, P4352, DOI 10.1111/j.1365-294X.2010.04805.x; SCHOENER TW, 1987, AM ZOOL, V27, P259; Searcy WA, 1995, POLYGYNY SEXUAL SELE; SHELDON BC, 1994, ANIM BEHAV, V47, P163, DOI 10.1006/anbe.1994.1018; SHELDON BC, 1994, P ROY SOC B-BIOL SCI, V257, P25, DOI 10.1098/rspb.1994.0089; Shultz S, 2011, NATURE, V479, P219, DOI 10.1038/nature10601; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; Slatyer RA, 2012, BIOL REV, V87, P1, DOI 10.1111/j.1469-185X.2011.00182.x; SMITH J. MAYNARD, 1965, AMER NATUR, V99, P59, DOI 10.1086/282349; SMUTS BB, 1993, ADV STUD BEHAV, V22, P1, DOI 10.1016/S0065-3454(08)60404-0; Solomon NG, 2008, RODENT SOC ECOLOGICA, P59; Soltis J, 2001, AM NAT, V158, P519, DOI 10.1086/323117; STACEY PB, 1982, AM NAT, V120, P51, DOI 10.1086/283969; STAMPS JA, 1988, AM NAT, V131, P329, DOI 10.1086/284793; Stapleton MK, 2007, BEHAV ECOL SOCIOBIOL, V61, P1725, DOI 10.1007/s00265-007-0404-4; Stutchbury Bridget J.M., 1998, Ornithological Monographs, V49, P103; Suter SM, 2007, P ROY SOC B-BIOL SCI, V274, P2865, DOI 10.1098/rspb.2007.0799; Suter SM, 2009, BEHAV ECOL, V20, P601, DOI 10.1093/beheco/arp037; Taborsky M, 2001, J HERED, V92, P100, DOI 10.1093/jhered/92.2.100; TABORSKY M, 1994, ADV STUD BEHAV, V23, P1, DOI 10.1016/S0065-3454(08)60351-4; Taborsky M, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P251, DOI 10.1017/CBO9780511542602.011; Taff CC, 2013, J EVOLUTION BIOL, V26, P1392, DOI 10.1111/jeb.12141; Tarof SA, 2005, BEHAV ECOL, V16, P207, DOI 10.1093/beheco/arh155; Tarof SA, 2004, AUK, V121, P877, DOI 10.1642/0004-8038(2004)121[0877:HCANPD]2.0.CO;2; TEMELES EJ, 1994, ANIM BEHAV, V47, P339, DOI 10.1006/anbe.1994.1047; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Trivers R, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P67; Tryjanowski P, 2005, ANIM BEHAV, V69, P529, DOI 10.1016/j.anbehav.2004.06.009; van Schaik C.P., 1983, Primates, V24, P211; Wagner Richard H., 1998, Ornithological Monographs, V49, P123; West RJD, BIOL J LINN IN PRESS; Westneat DF, 2013, BEHAV ECOL, V24, P598, DOI 10.1093/beheco/ars207; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Westneat DF, 1997, BEHAV ECOL SOCIOBIOL, V41, P205, DOI 10.1007/s002650050381; Wetzel DP, 2009, MOL ECOL, V18, P2010, DOI 10.1111/j.1365-294X.2009.04114.x; Whittingham LA, 2010, MOL ECOL, V19, P2328, DOI 10.1111/j.1365-294X.2010.04640.x; WICKLER W, 1985, Z TIERPSYCHOL, V69, P250; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wilson DS, 2007, Q REV BIOL, V82, P327, DOI 10.1086/522809; Wilson RS, 2014, J EXP BIOL, V217, P545, DOI 10.1242/jeb.092056; Wink Michael, 1999, Acta Ornithologica (Warsaw), V34, P91; Wolff J.O., 2007, RODENT SOC ECOLOGICA; Wolff JO, 2004, TRENDS ECOL EVOL, V19, P127, DOI 10.1016/j.tree.2003.12.009; Yezerinac SM, 1996, ANIM BEHAV, V52, P821, DOI 10.1006/anbe.1996.0227; YEZERINAC SM, 1995, BEHAV ECOL SOCIOBIOL, V37, P179, DOI 10.1007/BF00176715; Yezerinac SM, 1999, J AVIAN BIOL, V30, P234, DOI 10.2307/3677135	154	34	34	2	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e99878	10.1371/journal.pone.0099878	http://dx.doi.org/10.1371/journal.pone.0099878			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987839	Green Published, Green Submitted, gold			2022-12-27	WOS:000341354100020
J	Fiorentino, F; Rogers, CA; Bryan, AJ; Angelini, GD; Reeves, BC				Fiorentino, Francesca; Rogers, Chris A.; Bryan, Alan J.; Angelini, Gianni D.; Reeves, Barnaby C.			Implications of Using Different Methods to Characterise Anticoagulant Control in Patients with Second Generation Mechanical Heart Valve Prostheses	PLOS ONE			English	Article							SELF-MANAGEMENT; REPLACEMENT; CARBOMEDICS; INTENSITY; THERAPY	Objective: Characterisation of anticoagulant control is fundamental to investigations of its association with clinical outcome. Anticoagulant control depends on several factors. This paper aims to illustrate the implications of different methods for measuring and analysing anticoagulant control in patients with second generation mechanical heart valve prostheses. Methods: International normalised ratio (INR) data collected during the 10-year follow-up of a randomised controlled trial were analysed. We considered the influence of: 3 different target INR ranges; anticoagulant control expressed as the proportion of INR readings (PoR) vs. anticoagulant control follow-up time (PoT); 3 ways of describing the profile of anticoagulant control over time. Results: Different target INR ranges dramatically influenced derived measures of anticoagulant control; the PoT within the target range varied from 88% for the widest to 28% for narrowest range. Overall distributions of PoR and PoT observations were similar but differed by up to +/- 20% for individuals; PoT exceeded PoR when control was good but was less than PoR when control was poor. Classifying PoT outside the target range showed that widely varying combinations of PoT too high and too low are possible across individuals. Conclusions: Researchers' choices about methods for measuring and quantifying anticoagulant control markedly influence the values derived from INR readings. The use of different methods across studies makes it difficult or impossible to compare findings and to establish an evidence base for clinical practice. Methods for quantifying anticoagulant control should be standardised.	[Rogers, Chris A.; Bryan, Alan J.; Angelini, Gianni D.; Reeves, Barnaby C.] Univ Bristol, Bristol Heart Inst, Bristol Royal Infirm, Bristol, Avon, England; [Fiorentino, Francesca; Angelini, Gianni D.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Natl Heart & Lung Inst, London, England	Bristol Royal Infirmary; University of Bristol; Imperial College London	Reeves, BC (corresponding author), Univ Bristol, Bristol Heart Inst, Bristol Royal Infirm, Bristol, Avon, England.	barney.reeves@bristol.ac.uk		angelini, gianni/0000-0002-1753-3730; Reeves, Barnaby/0000-0002-5101-9487	United Kingdom National Institute for Health Research; British Heart Foundation; UK National Institute for Health Research Bristol Cardiovascular Biomedical Research Unit; National Institute for Health Research [NF-SI-0611-10022] Funding Source: researchfish	United Kingdom National Institute for Health Research(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); UK National Institute for Health Research Bristol Cardiovascular Biomedical Research Unit; National Institute for Health Research(National Institute for Health Research (NIHR))	The research reported in this paper was supported by the United Kingdom National Institute for Health Research and the British Heart Foundation. FF is funded in part, CR and GDA in full, by the British Heart Foundation. BCR is supported in part by the UK National Institute for Health Research Bristol Cardiovascular Biomedical Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar J, 1996, CIRCULATION, V94, P2107, DOI 10.1161/01.CIR.94.9.2107; [Anonymous], 1998, Br J Haematol, V101, P374; AZAR AJ, 1994, THROMB HAEMOSTASIS, V72, P347; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bryan AJ, 2007, J THORAC CARDIOV SUR, V133, P614, DOI 10.1016/j.jtcvs.2006.08.075; Butchart EG, 2002, J THORAC CARDIOV SUR, V123, P715, DOI 10.1067/mtc.2002.121162; CANNEGIETER SC, 1995, NEW ENGL J MED, V333, P11, DOI 10.1056/NEJM199507063330103; Grunkemeier GL, 2003, J THORAC CARDIOV SUR, V125, P290, DOI 10.1067/mtc.2003.53; Hering D, 2005, CHEST, V127, P53, DOI 10.1378/chest.127.1.53; Hirsh J, 2001, CHEST, V119, p8S, DOI 10.1378/chest.119.1_suppl.8S; Koertke H, 2003, CIRCULATION, V108, P75, DOI 10.1161/01.cir.0000089185.80318.3f; Koertke H, 2000, J THROMB THROMBOLYS, V9, pS41; Kortke H, 2001, ANN THORAC SURG, V72, P44, DOI 10.1016/S0003-4975(01)02656-X; Leiria TLL, 2011, J THROMB THROMBOLYS, V31, P514, DOI 10.1007/s11239-011-0574-9; Lim KHH, 2002, J THORAC CARDIOV SUR, V123, P21, DOI 10.1067/mtc.2002.119703; LOELIGER EA, 1985, THROMB HAEMOSTASIS, V53, P155; Morgan CL, 2009, THROMB RES, V124, P37, DOI 10.1016/j.thromres.2008.09.016; Oake N, 2008, CAN MED ASSOC J, V179, P235, DOI 10.1503/cmaj.080171	18	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e98323	10.1371/journal.pone.0098323	http://dx.doi.org/10.1371/journal.pone.0098323			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988447	Green Published, gold, Green Submitted			2022-12-27	WOS:000341354100010
J	Floyd, CN; Ellis, BH; Ferro, A				Floyd, Christopher N.; Ellis, Benjamin H.; Ferro, Albert			The PlA1/A2 Polymorphism of Glycoprotein IIIa as a Risk Factor for Stroke: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							HUMAN PLATELET ALLOANTIGENS; ISCHEMIC-STROKE; MYOCARDIAL-INFARCTION; ATHEROTHROMBOTIC STROKE; PL(A1/A2) POLYMORPHISM; CEREBROVASCULAR EVENTS; GPIIIA GENE; ASSOCIATION; HPA-1; IIB/IIIA	Background: The PlA1/A2 polymorphism of glycoprotein IIIa (GPIIIa) has been reported to be associated with risk of stroke in some studies, although other studies suggest no such association. This meta-analysis and systematic review was conducted to investigate the hypothesis that carriage of the PlA2 allele is a risk factor for stroke. Methods: Electronic databases (MEDLINE and EMBASE) were searched for all articles evaluating carriage of the PlA2 allele and the incidence of stroke. Pooled odds ratios (ORs) were calculated using fixed-effect and random-effect models. Findings: A total of 35 articles were eligible for inclusion, of which 25 studies were suitable for statistical analysis. For carriage of the PlA2 allele, OR 1.12 (n = 11,873; 95% CI = 1.03-1.22; p = 0.011) was observed for the incidence of stroke in adults, with subgroup analyses identifying the association driven by stroke of an ischaemic (n = 10,494; OR = 1.15, 95% CI = 1.05-1.27; p = 0.003) but not haemorrhagic aetiology (n = 2,470; OR = 0.90, 95% CI = 0.71-1.14; p = 0.398). This association with ischaemic stroke was strongest in individuals homozygous for the PlA2 allele compared to those homozygous for wild-type PlA1 (n = 5,906; OR = 1.74, 95% CI = 1.34-2.26; p < 0.001). Subgroup analysis of ischaemic stroke subtypes revealed an increased association with stroke of cardioembolic (n = 1,271; OR 1.56, 95% CI 1.14-2.12; p = 0.005) and large vessel (n = 1,394; OR = 1.76, 95% CI 1.34-2.31; p<0.001) aetiology, but not those of small vessel origin (n = 1,356; OR = 0.99, 95% CI 0.74-1.33; p = 0.950). Egger's regression test suggested a low probability of publication bias for all analyses (p>0.05). Conclusions: The totality of published data supports the hypothesis that carriage of the PlA2 polymorphism of GPIIIa is a risk factor for ischaemic strokes, and specifically those of cardioembolic and large vessel origin.	[Floyd, Christopher N.; Ellis, Benjamin H.; Ferro, Albert] Kings Coll London, Dept Clin Pharmacol, Cardiovasc Div, British Heart Fdn Ctr Res Excellence, London WC2R 2LS, England	University of London; King's College London	Ferro, A (corresponding author), Kings Coll London, Dept Clin Pharmacol, Cardiovasc Div, British Heart Fdn Ctr Res Excellence, London WC2R 2LS, England.	albert.ferro@kcl.ac.uk	Floyd, christopher/AAF-2979-2020	Floyd, Christopher/0000-0001-9359-6381; Ferro, Albert/0000-0002-5486-9145	Guy's & St Thomas' Charity	Guy's & St Thomas' Charity	This work was funded by Guy's & St Thomas' Charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamski MG, 2009, BIOCHEM BIOPH RES CO, V383, P228, DOI 10.1016/j.bbrc.2009.03.156; Addad F, 2010, BLOOD COAGUL FIBRIN, V21, P674, DOI 10.1097/MBC.0b013e32833e47c1; Bennett JS, 2005, J CLIN INVEST, V115, P3363, DOI 10.1172/JCI26989; Bennett JS, 2001, BLOOD, V97, P3093, DOI 10.1182/blood.V97.10.3093; Bentley P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009136; Berge E, 2007, STROKE, V38, P1069, DOI 10.1161/01.STR.0000258076.04860.8e; Biswas A, 2009, THROMB RES, V124, P397, DOI 10.1016/j.thromres.2009.02.015; Borenstein M., 2009, INTRO METAANALYSIS; Broos K, 2011, BLOOD REV, V25, P155, DOI 10.1016/j.blre.2011.03.002; Carlsson LE, 1997, STROKE, V28, P1392, DOI 10.1161/01.STR.28.7.1392; Carter AM, 1998, ARTERIOSCL THROM VAS, V18, P1124, DOI 10.1161/01.ATV.18.7.1124; Carter AM, 1999, STROKE, V30, P2606, DOI 10.1161/01.STR.30.12.2606; Castro V, 2004, VOX SANG, V87, P118, DOI 10.1111/j.1423-0410.2004.00536.x; Chen CH, 2004, J NEUROL SCI, V227, P1, DOI 10.1016/j.jns.2004.07.019; Cheng C, 2007, ATHEROSCLEROSIS, V195, P225, DOI 10.1016/j.atherosclerosis.2006.11.019; Cheng YC, 2012, STROKE, V43, P980, DOI 10.1161/STROKEAHA.111.632075; Coelho FF, 2009, ANAL ASS POLYMORPHIS, P434; Corral J, 1997, BLOOD COAGUL FIBRIN, V8, P284, DOI 10.1097/00001721-199707000-00004; De Rosa R, 2010, CARDIOVASC RES, V87, pS74; Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dichgans M, 2007, LANCET NEUROL, V6, P149, DOI 10.1016/S1474-4422(07)70028-5; Duan H, 2012, MED SCI MONITOR, V18, pCR19, DOI 10.12659/MSM.882195; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elalamy I, 2009, J THROMBOSIS HAEMOST; Feng DL, 1999, ARTERIOSCL THROM VAS, V19, P1142, DOI 10.1161/01.ATV.19.4.1142; Floyd CN, 2012, JRSM CARDIOVASC DIS, V1, DOI 10.1258/cvd.2012.012007; Floyd CN, 2014, J AM COLL CARDIOL, V63, pA261, DOI 10.1016/S0735-1097(14)60261-8; Floyd CN, 2013, BR J CLIN PHARM; Galasso G, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-41; Golenia A, 2009, EUR J NEUROL, V16, P289; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Iniesta JA, 2004, STROKE, V35, P2282, DOI 10.1161/01.STR.0000141978.33388.eb; Iniesta JA, 1999, HEADACHE, V39, P486, DOI 10.1046/j.1526-4610.1999.3907486.x; Iniesta JA, 2003, CEREBROVASC DIS, V15, P51, DOI 10.1159/000067126; Ishii Keiko, 2004, Rinsho Byori, V52, P22; Kannel W B, 1994, J Cardiovasc Risk, V1, P333, DOI 10.1097/00043798-199412000-00009; Kekomaki S, 1999, J CARDIOVASC RISK, V6, P13; Kim WJ, 2010, STROKE, V41, P1200, DOI 10.1161/STROKEAHA.110.580225; Komarov AL, 2009, 22 C INT SOC THROMB; Lalouschek W, 2007, CLIN CHEM, V53, P600, DOI 10.1373/clinchem.2006.073494; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lanni F, 2007, J HYPERTENS, V25, P551, DOI 10.1097/HJH.0b013e328013cd67; Li Q, 2007, PHARMACOGENOMICS, V8, P577, DOI 10.2217/14622416.8.6.577; Maguire J, 2011, J STROKE CEREBROVASC, V20, P134, DOI 10.1016/j.jstrokecerebrovasdis.2009.10.011; MANTEL N, 1959, J NATL CANCER I, V22, P719; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Meiklejohn DJ, 1999, BRIT J HAEMATOL, V105, P664, DOI 10.1046/j.1365-2141.1999.01413.x; Meiklejohn DJ, 2001, BRIT J HAEMATOL, V112, P621, DOI 10.1046/j.1365-2141.2001.02620.x; Mikkelsson J, 2000, J AM COLL CARDIOL, V36, P1317, DOI 10.1016/S0735-1097(00)00871-8; Morawski W, 2005, J THORAC CARDIOV SUR, V130, P791, DOI 10.1016/j.jtcvs.2005.02.041; Mustaffa R, 2009, VOX SANG, V97, P128; NEWMAN PJ, 1995, THROMB HAEMOSTASIS, V74, P234; Oksala NKJ, 2007, STROKE, V38, P50, DOI 10.1161/01.STR.0000251719.59141.36; Park HJ, 2009, EUR J NEUROL, V16, P582, DOI 10.1111/j.1468-1331.2009.02538.x; Pongracz E, 2001, Orv Hetil, V142, P781; Pongracz Endre, 2007, Turk J Haematol, V24, P155; Pruissen DMO, 2009, ATHEROSCLEROSIS, V204, P191, DOI 10.1016/j.atherosclerosis.2008.08.033; Reiner AP, 2000, STROKE, V31, P1628, DOI 10.1161/01.STR.31.7.1628; Reuner KH, 1997, THROMB HAEMOSTASIS, V78, P964; Ridker PM, 1997, LANCET, V349, P385, DOI 10.1016/S0140-6736(97)80010-4; Roldan V, 2008, ANN MED, V40, P553, DOI 10.1080/07853890802108412; Rubattu S, 2005, EUR J NEUROL, V12, P989, DOI 10.1111/j.1468-1331.2005.01136.x; Rubattu S, 2005, THROMB HAEMOSTASIS, V93, P1095, DOI 10.1160/TH04-07-0457; Saidi S, 2008, AM J HEMATOL, V83, P570, DOI 10.1002/ajh.21171; Saidi S, 2008, CEREBROVASC DIS, V25, P81, DOI 10.1159/000111995; Sato Y, 2012, THROMB RES, V130, P278, DOI 10.1016/j.thromres.2012.04.008; Slowik A, 2004, STROKE, V35, P1589, DOI 10.1161/01.STR.0000132194.24663.3d; Streifler JY, 2001, STROKE, V32, P2753, DOI 10.1161/hs1201.099650; Szczeklik A, 2000, BRIT J HAEMATOL, V110, P965, DOI 10.1046/j.1365-2141.2000.02267.x; Szolnoki Z, 2003, THROMB RES, V109, P265, DOI 10.1016/S0049-3848(03)00258-5; Tsai NW, 2009, THROMB RES, V124, P213, DOI 10.1016/j.thromres.2009.01.012; Undas A, 2001, CIRCULATION, V104, P2666, DOI 10.1161/hc4701.099787; van Goor MLPJ, 2002, THROMB RES, V108, P63, DOI 10.1016/S0049-3848(02)00356-0; Vijayan KV, 2003, FEBS LETT, V540, P41, DOI 10.1016/S0014-5793(03)00170-4; Wagner KR, 1998, STROKE, V29, P581, DOI 10.1161/01.STR.29.3.581; Wei Ye-sheng, 2009, Zhonghua Yixue Yichuanxue Zazhi, V26, P211, DOI 10.3760/cma.j.issn.1003-9406.2009.02.021; Weiss EJ, 1996, NEW ENGL J MED, V334, P1090, DOI 10.1056/NEJM199604253341703; Yeh PS, 2004, THROMB HAEMOSTASIS, V92, P583, DOI 10.1160/TH04-03-0099; Zhang Y, 2007, CLIN CHIM ACTA, V378, P99, DOI 10.1016/j.cca.2006.11.001	80	25	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100239	10.1371/journal.pone.0100239	http://dx.doi.org/10.1371/journal.pone.0100239			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988537	Green Published, gold, Green Submitted			2022-12-27	WOS:000341354100027
J	Hobbs, CV; Neal, J; Conteh, S; Donnelly, L; Chen, JY; Marsh, K; Lambert, L; Orr-Gonzalez, S; Hinderer, J; Healy, S; Borkowsky, W; Penzak, SR; Chakravarty, S; Hoffman, SL; Duffy, PE				Hobbs, Charlotte V.; Neal, Jillian; Conteh, Solomon; Donnelly, Liam; Chen, Jingyang; Marsh, Kennan; Lambert, Lynn; Orr-Gonzalez, Sachy; Hinderer, Jessica; Healy, Sara; Borkowsky, William; Penzak, Scott R.; Chakravarty, Sumana; Hoffman, Stephen L.; Duffy, Patrick E.			HIV Treatments Reduce Malaria Liver Stage Burden in a Non-Human Primate Model of Malaria Infection at Clinically Relevant Concentrations In Vivo	PLOS ONE			English	Article							PLASMODIUM-CYNOMOLGI; PROTEASE INHIBITORS; SULFAMETHOXAZOLE; TRANSMISSION; FALCIPARUM; PROGUANIL; KNOWLESI	We have previously shown that the HIV protease inhibitor lopinavir-ritonavir (LPV-RTV) and the antibiotic trimethoprim sulfamethoxazole (TMP-SMX) inhibit Plasmodium liver stages in rodent malarias and in vitro in P. falciparum. Since clinically relevant levels are better achieved in the non-human-primate model, and since Plasmodium knowlesi is an accepted animal model for the study of liver stages of malaria as a surrogate for P. falciparum infection, we investigated the antimalarial activity of these drugs on Plasmodium knowlesi liver stages in rhesus macaques. We demonstrate that TMP-SMX and TMP-SMX+LPV-RTV (in combination), but not LPV-RTV alone, inhibit liver stage parasite development. Because drugs that inhibit the clinically silent liver stages target parasites when they are present in lower numbers, these results may have implications for eradication efforts.	[Hobbs, Charlotte V.; Neal, Jillian; Conteh, Solomon; Donnelly, Liam; Chen, Jingyang; Lambert, Lynn; Orr-Gonzalez, Sachy; Hinderer, Jessica; Healy, Sara; Duffy, Patrick E.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD 20852 USA; [Marsh, Kennan] AbbVie Inc, N Chicago, IL USA; [Borkowsky, William] NYU, Sch Med, Dept Pediat, Div Infect Dis & Immunol, New York, NY USA; [Penzak, Scott R.] NIAID, Ctr Clin, Dept Pharm, Clin Pharmacokinet Res Lab,NIH, Bethesda, MD 20892 USA; [Chakravarty, Sumana; Hoffman, Stephen L.] Sanaria Inc, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); AbbVie; New York University; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Institute of Allergy & Infectious Diseases (NIAID); Sanaria Inc.	Hobbs, CV (corresponding author), NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD 20852 USA.	charlotte.hobbs@nih.gov		Hobbs, Charlotte/0000-0003-4829-0791	National Institutes of Health Division of Intramural Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001149, ZIAAI001135, ZIGAI001047] Funding Source: NIH RePORTER	National Institutes of Health Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Division of Intramural Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1978, RODENT MALARIA; Birkett DJ., 2010, PHARMACOKINETICS MAD; Bray R. S., 1959, Bulletin of the World Health Organization, V21, P233; Carpenter J.W., 2005, EXOTIC ANIMAL FORMUL, V3; Coatney G. Robert, 1971, PRIMATE MALARIAS, Vix; Craig WA, 1973, J INFECT DIS S, V128; DAVIDSON DE, 1976, AM J TROP MED HYG, V25, P26, DOI 10.4269/ajtmh.1976.25.26; Divis PCS, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-344; Eastman RT, 2013, ANTIMICROB AGENTS CH, V57, P425, DOI 10.1128/AAC.00920-12; FISK TL, 1989, AM J TROP MED HYG, V40, P235, DOI 10.4269/ajtmh.1989.40.235; Flateau C, 2011, LANCET INFECT DIS, V11, P541, DOI 10.1016/S1473-3099(11)70031-7; Gantt SM, 1998, ANTIMICROB AGENTS CH, V42, P2731, DOI 10.1128/AAC.42.10.2731; Gwadz R W, 1979, Bull World Health Organ, V57 Suppl 1, P165; Hobbs CV, 2013, AIDS, V27, P1674, DOI 10.1097/QAD.0b013e3283621dd4; Hobbs CV, 2012, J INFECT DIS, V206, P1706, DOI 10.1093/infdis/jis602; Hobbs CV, 2009, J INFECT DIS, V199, P134, DOI 10.1086/594369; JIANG JB, 1988, T ROY SOC TROP MED H, V82, P56, DOI 10.1016/0035-9203(88)90262-3; Li YJ, 2011, ANTIMICROB AGENTS CH, V55, P3039, DOI 10.1128/AAC.00085-11; Nsanzabana C, 2011, ANTIMICROB AGENTS CH; Parikh S, 2005, ANTIMICROB AGENTS CH, V49, P2983, DOI 10.1128/AAC.49.7.2983-2985.2005; RIECKMAN.KH, 1971, T ROY SOC TROP MED H, V65, P533, DOI 10.1016/0035-9203(71)90170-2; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Sandison TG, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1617; SHANKS GD, 1994, AM J TROP MED HYG, V50, P641, DOI 10.4269/ajtmh.1994.50.641; Vanderberg JP, 2014, PARASITOL INT, V63, P150, DOI 10.1016/j.parint.2013.09.010; WHO, 2013, USE ANT DRUGS TREAT	26	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100138	10.1371/journal.pone.0100138	http://dx.doi.org/10.1371/journal.pone.0100138			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988386	gold, Green Submitted, Green Published			2022-12-27	WOS:000341354100025
J	Li, XL; Li, JJ; Guo, YL; Zhu, CG; Xu, RX; Li, S; Qing, P; Wu, NQ; Jiang, LX; Xu, B; Gao, RL				Li, Xiao-Lin; Li, Jian-Jun; Guo, Yuan-Lin; Zhu, Cheng-Gang; Xu, Rui-Xia; Li, Sha; Qing, Ping; Wu, Na-Qiong; Jiang, Li-Xin; Xu, Bo; Gao, Run-Lin			Relationship of Glycated Hemoglobin Levels with Myocardial Injury following Elective Percutaneous Coronary Intervention in Patients with Type 2 Diabetes Mellitus	PLOS ONE			English	Article							3RD UNIVERSAL DEFINITION; TROPONIN-T; PROGNOSTIC VALUE; GLUCOSE CONTROL; ELEVATION; COMPLICATIONS; ASSOCIATION; PROGRESSION; PREDICTORS; INFARCTION	Background: Glycated hemoglobin (HbA1c) predicts clinical cardiovascular disease or cardiovascular mortality. However, the relationship between HbA1c and myocardial injury following elective percutaneous coronary intervention (PCI) in patients with type 2 diabetes mellitus (DM) has not been investigated. Objectives: The study sought to assess the relationship between HbA1c and myocardial injury following elective PCI in patients with type 2 DM. Methods: We studied a cohort of consecutive 994 diabetic patients with coronary artery disease (CAD) undergoing elective PCI. Periprocedural myocardial injury was evaluated by analysis of troponin I (cTnI). The association between preprocedural HbA1c levels and the peak values of cTnI within 24 hours after PCI was evaluated. Results: Peak postprocedural cTnI>1 x upper limit of normal (ULN), >3 x ULN and >5 x ULN were detected in 543 (54.6%), 337 (33.9%) and 245 (24.6%) respectively. In the multivariate model, higher HbA1c levels were associated with less risk of postprocedural cTnI >1 x ULN (odds ratio [OR], 0.85; 95% confidence interval [CI], 0.76-0.95; P = 0.005). There was a trend that higher HbA1c levels were associated with less risk of postprocedural cTnI >3 x ULN (OR, 0.90; 95% CI, 0.81-1.02; P = 0.088). HbA1c was not associated with the risk of postprocedural cTnI elevation above 5 x ULN (OR, 0.95; 95% CI, 0.84-1.08; P = 0.411). Conclusions: The present study provided the first line of evidence that higher preprocedural HbA1c levels were associated with less risk of myocardial injury following elective PCI in diabetic patients.	[Li, Xiao-Lin; Li, Jian-Jun; Guo, Yuan-Lin; Zhu, Cheng-Gang; Xu, Rui-Xia; Li, Sha; Qing, Ping; Wu, Na-Qiong; Jiang, Li-Xin; Xu, Bo; Gao, Run-Lin] Chinese Acad Med Sci, Div Dyslipidemia, State Key Lab Cardiovasc Dis, Fu Wai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [Li, Xiao-Lin; Li, Jian-Jun; Guo, Yuan-Lin; Zhu, Cheng-Gang; Xu, Rui-Xia; Li, Sha; Qing, Ping; Wu, Na-Qiong; Jiang, Li-Xin; Xu, Bo; Gao, Run-Lin] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, JJ (corresponding author), Chinese Acad Med Sci, Div Dyslipidemia, State Key Lab Cardiovasc Dis, Fu Wai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China.	lijianjun938@yahoo.com	xu, rui/GRX-5734-2022; Guo, Yuan-Lin/K-4887-2019	Guo, Yuan-Lin/0000-0002-7159-0189	National Natural Scientific Foundation [81070171, 81241121]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20111106110013]; Capital Special Foundation of Clinical Application Research [Z121107001012015]; Capital Health Development Fund [2011400302]; Beijing Natural Science Foundation [7131014]	National Natural Scientific Foundation(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Capital Special Foundation of Clinical Application Research; Capital Health Development Fund; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study is partly supported by National Natural Scientific Foundation (81070171, 81241121), Specialized Research Fund for the Doctoral Program of Higher Education of China (20111106110013), Capital Special Foundation of Clinical Application Research (Z121107001012015), Capital Health Development Fund (2011400302), and Beijing Natural Science Foundation (7131014) awarded to Dr. Jian-Jun Li, MD, PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; Anand DV, 2007, J AM COLL CARDIOL, V50, P2218, DOI 10.1016/j.jacc.2007.08.032; Cai QJ, 2007, AM J CARDIOL, V99, P616, DOI 10.1016/j.amjcard.2006.09.108; Colayco DC, 2011, DIABETES CARE, V34, P77, DOI 10.2337/dc10-1318; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Eshaghian S, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.10.008; Feldman DN, 2011, CATHETER CARDIO INTE, V77, P1020, DOI 10.1002/ccd.22962; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Herrmann J, 2005, EUR HEART J, V26, P2493, DOI 10.1093/eurheartj/ehi455; LIBBY P, 1975, CIRCULATION, V51, P621, DOI 10.1161/01.CIR.51.4.621; Madani M, 2013, TEX HEART I J, V40, P410; Moussa ID, 2013, J AM COLL CARDIOL, V62, P1563, DOI 10.1016/j.jacc.2013.08.720; Nathan DM, 2008, DIABETES CARE, V31, P173, DOI [10.2337/dc08-9016, 10.2337/dc08-0545]; NEELY JR, 1974, ANNU REV PHYSIOL, V36, P413, DOI 10.1146/annurev.ph.36.030174.002213; Nicholls SJ, 2008, J AM COLL CARDIOL, V52, P255, DOI 10.1016/j.jacc.2008.03.051; Nienhuis MB, 2008, CATHETER CARDIO INTE, V71, P318, DOI 10.1002/ccd.21345; Nusca A, 2012, CATHETER CARDIO INTE, V80, P377, DOI 10.1002/ccd.23185; Park DW, 2013, EUR HEART J, V34, P1662, DOI 10.1093/eurheartj/eht048; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Prasad A, 2008, CIRC-CARDIOVASC INTE, V1, P10, DOI 10.1161/CIRCINTERVENTIONS.108.765610; Prasad A, 2006, J AM COLL CARDIOL, V48, P1765, DOI 10.1016/j.jacc.2006.04.102; Prasad A, 2013, EUR HEART J, V34, P1615, DOI 10.1093/eurheartj/eht103; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; Skyler JS, 2009, CIRCULATION, V119, P351, DOI 10.1161/CIRCULATIONAHA.108.191305; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Thygesen K, 2012, GLOB HEART, V7, DOI 10.1016/j.gheart.2012.08.001; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Yang DJ, 2013, J INVASIVE CARDIOL, V25, P137; Zhao WH, 2014, DIABETES CARE, V37, P428, DOI 10.2337/dc13-1525	30	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101719	10.1371/journal.pone.0101719	http://dx.doi.org/10.1371/journal.pone.0101719			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988213	Green Submitted, Green Published, gold			2022-12-27	WOS:000341354100127
J	Napolitano, A; Miller, S; Nicholls, AW; Baker, D; Van Horn, S; Thomas, E; Rajpal, D; Spivak, A; Brown, JR; Nunez, DJ				Napolitano, Antonella; Miller, Sam; Nicholls, Andrew W.; Baker, David; Van Horn, Stephanie; Thomas, Elizabeth; Rajpal, Deepak; Spivak, Aaron; Brown, James R.; Nunez, Derek J.			Novel Gut-Based Pharmacology of Metformin in Patients with Type 2 Diabetes Mellitus	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; BILE-ACID; ORAL METFORMIN; IV ACTIVITY; MICROBIOTA; GLUCOSE; METABOLISM; OBESITY; DEGRADATION; INHIBITION	Metformin, a biguanide derivate, has pleiotropic effects beyond glucose reduction, including improvement of lipid profiles and lowering microvascular and macrovascular complications associated with type 2 diabetes mellitus (T2DM). These effects have been ascribed to adenosine monophosphate-activated protein kinase (AMPK) activation in the liver and skeletal muscle. However, metformin effects are not attenuated when AMPK is knocked out and intravenous metformin is less effective than oral medication, raising the possibility of important gut pharmacology. We hypothesized that the pharmacology of metformin includes alteration of bile acid recirculation and gut microbiota resulting in enhanced enteroendocrine hormone secretion. In this study we evaluated T2DM subjects on and off metformin monotherapy to characterize the gut-based mechanisms of metformin. Subjects were studied at 4 time points: (i) at baseline on metformin, (ii) 7 days after stopping metformin, (iii) when fasting blood glucose (FBG) had risen by 25% after stopping metformin, and (iv) when FBG returned to baseline levels after restarting the metformin. At these timepoints we profiled glucose, insulin, gut hormones (glucagon-like peptide-1 (GLP-1), peptide tyrosine-tyrosine (PYY) and glucose-dependent insulinotropic peptide (GIP) and bile acids in blood, as well as duodenal and faecal bile acids and gut microbiota. We found that metformin withdrawal was associated with a reduction of active and total GLP-1 and elevation of serum bile acids, especially cholic acid and its conjugates. These effects reversed when metformin was restarted. Effects on circulating PYY were more modest, while GIP changes were negligible. Microbiota abundance of the phylum Firmicutes was positively correlated with changes in cholic acid and conjugates, while Bacteroidetes abundance was negatively correlated. Firmicutes and Bacteroidetes representation were also correlated with levels of serum PYY. Our study suggests that metformin has complex effects due to gut-based pharmacology which might provide insights into novel therapeutic approaches to treat T2DM and associated metabolic diseases.	[Napolitano, Antonella] GlaxoSmithKline Res & Dev Ltd, Immunoinflammat Unit, Stevenage, Herts, England; [Miller, Sam] GlaxoSmithKline Res & Dev Ltd, Quantitat Sci, Stevenage, Herts, England; [Nicholls, Andrew W.; Baker, David] GlaxoSmithKline Res & Dev Ltd, Safety Assessment, Ware, Herts, England; [Van Horn, Stephanie; Thomas, Elizabeth] GlaxoSmithKline Res & Dev Ltd, Target & Pathways Validat, Upper Providence, PA USA; [Rajpal, Deepak; Spivak, Aaron; Brown, James R.] GlaxoSmithKline Res & Dev Ltd, Computat Biol, Upper Providence, PA USA; [Nunez, Derek J.] GlaxoSmithKline Res & Dev Ltd, GlaxoSmithKline R&D, Enteroendocrine Discovery Unit, Res Triangle Pk, NC USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Napolitano, A (corresponding author), GlaxoSmithKline Res & Dev Ltd, Immunoinflammat Unit, Stevenage, Herts, England.	antonella.2.napolitano@gsk.com		Brown, James/0000-0002-9368-627X	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	The study has been fully funded by GlaxoSmithKline. The funder provided support in the form of salaries for authors [AN, SM, AWN, DB, SVH, ET, DR, AS, JRB and DJN], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BONORA E, 1984, CURR MED RES OPIN, V9, P47, DOI 10.1185/03007998409109558; Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035; Cani PD, 2012, GUT MICROBES, V3, P279, DOI 10.4161/gmic.19625; Cani PD, 2011, PHARMACOL THERAPEUT, V130, P202, DOI 10.1016/j.pharmthera.2011.01.012; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carter D, 2003, DIABETES OBES METAB, V5, P120, DOI 10.1046/j.1463-1326.2003.00252.x; Chen XS, 2011, EXP DIABETES RES, DOI 10.1155/2011/853501; Cho KW, 2010, J NUTR BIOCHEM, V21, P841, DOI 10.1016/j.jnutbio.2009.06.012; Cuthbertson J, 2009, DIABETIC MED, V26, P649, DOI 10.1111/j.1464-5491.2009.02748.x; Deacon CF, 2004, HORM METAB RES, V36, P761, DOI 10.1055/s-2004-826160; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Galman C, 2005, GASTROENTEROLOGY, V129, P1445, DOI 10.1053/j.gastro.2005.09.009; GIUGLIANO D, 1993, DIABETES CARE, V16, P1387, DOI 10.2337/diacare.16.10.1387; Green BD, 2006, EUR J PHARMACOL, V547, P192, DOI 10.1016/j.ejphar.2006.07.043; Greenway F, 2013, BENEF MICROBES, V17, P1; Gui J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064585; Guiney WJ, 2010, DRUG METAB DISPOS, V38, P851, DOI 10.1124/dmd.109.031062; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hinke SA, 2002, BIOCHEM BIOPH RES CO, V291, P1302, DOI 10.1006/bbrc.2002.6607; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH, 1996, ICH HARM TRIP GUID G; Islam KBMS, 2011, GASTROENTEROLOGY, V141, P1773, DOI 10.1053/j.gastro.2011.07.046; Karlsson F, 2013, DIABETES, V62, P3341, DOI 10.2337/db13-0844; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; le Roux CW, 2006, ENDOCRINOLOGY, V147, P3, DOI 10.1210/en.2005-0972; Legro R., 2013, J CLIN ENDOCRINOL ME; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lindsay JR, 2005, DIABETIC MED, V22, P654, DOI 10.1111/j.1464-5491.2005.01461.x; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Maruo T, 2008, INT J SYST EVOL MICR, V58, P1221, DOI 10.1099/ijs.0.65404-0; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; Migoya EM, 2010, CLIN PHARMACOL THER, V88, P801, DOI 10.1038/clpt.2010.184; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Mulherin AJ, 2011, ENDOCRINOLOGY, V152, P4610, DOI 10.1210/en.2011-1485; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; Proctor WR, 2008, DRUG METAB DISPOS, V36, P1650, DOI 10.1124/dmd.107.020180; Quinn BJ, 2013, TRENDS ENDOCRINOL ME, V24; Rena G, 2013, DIABETOLOGIA, V56, P1898, DOI 10.1007/s00125-013-2991-0; Schwen RJ, 2012, FOOD CHEM TOXICOL, V50, P2074, DOI 10.1016/j.fct.2012.03.048; Shields William W, 2009, Therap Adv Gastroenterol, V2, P157, DOI 10.1177/1756283X09105462; Standard of Medical Care in Diabetes -American Diabetes Association, 2013, DIABETES CARE S1, V36; Stepensky D, 2002, DRUG METAB DISPOS, V30, P861, DOI 10.1124/dmd.30.8.861; Tharakan G, 2011, TRENDS PHARMACOL SCI, V32, P8, DOI 10.1016/j.tips.2010.10.003; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Thondam SK, 2012, DIABETIC MED, V29, pE205, DOI 10.1111/j.1464-5491.2012.03675.x; Toh H, 2013, GENOME ANNOUNC, V24; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vardarli I, 2014, DIABETES, V63, P663, DOI 10.2337/db13-0805; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	55	175	178	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100778	10.1371/journal.pone.0100778	http://dx.doi.org/10.1371/journal.pone.0100778			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988476	Green Published, Green Submitted, gold			2022-12-27	WOS:000341354100043
J	Kovrigin, EL				Kovrigin, Evgenii L.			Fluorescence2D: Software for Accelerated Acquisition and Analysis of Two-Dimensional Fluorescence Spectra	PLOS ONE			English	Article							SPECTROSCOPY; BIOPROCESS; RAS	The Fluorescence2D is free software that allows analysis of two-dimensional fluorescence spectra obtained using the accelerated "triangular" acquisition schemes. The software is a combination of Python and MATLAB-based programs that perform conversion of the triangular data, display of the two-dimensional spectra, extraction of 1D slices at different wavelengths, and output in various graphic formats.	Marquette Univ, Dept Chem, Milwaukee, WI 53233 USA	Marquette University	Kovrigin, EL (corresponding author), Marquette Univ, Dept Chem, Milwaukee, WI 53233 USA.	evgueni.kovriguine@mu.edu			Marquette University	Marquette University	The author acknowledges COR Summer Faculty Fellowship from Marquette University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockhinke A, 2000, APPL PHYS B-LASERS O, V71, P755, DOI 10.1007/s003400000384; Brockhinke A, 2003, PHYS CHEM CHEM PHYS, V5, P3498, DOI 10.1039/b303262k; Haass-Koffler CL, 2012, ANAL TOOL QUANTIFIES, pe4233; Knuttel T, 2005, ANAL CHEM, V77, P6184, DOI 10.1021/ac050747d; Knuttel T, 2001, ENZYME MICROB TECH, V29, P150, DOI 10.1016/S0141-0229(01)00369-6; Lakowicz J.R., 2010, PRINCIPLES FLUORESCE, VThird; Marose S, 1998, BIOTECHNOL PROGR, V14, P63, DOI 10.1021/bp970124o; O'Connor C, 2008, BIOCHEMISTRY-US, V47, P10244, DOI 10.1021/bi801076c; Riccio Massimo, 2004, Methods Mol Biol, V285, P171; Rossi DM, 2012, J IND MICROBIOL BIOT, V39, P701, DOI 10.1007/s10295-011-1075-8; Sydor JR, 1998, BIOCHEMISTRY-US, V37, P14292, DOI 10.1021/bi980764f; Widom JR, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/2/025028	12	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101227	10.1371/journal.pone.0101227	http://dx.doi.org/10.1371/journal.pone.0101227			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984078	Green Published, Green Submitted, gold			2022-12-27	WOS:000339635000072
J	Lyashchenko, AK; Redd, KJ; Goldstein, PA; Tibbs, GR				Lyashchenko, Alex K.; Redd, Kacy J.; Goldstein, Peter A.; Tibbs, Gareth R.			cAMP Control of HCN2 Channel Mg2+ Block Reveals Loose Coupling between the Cyclic Nucleotide-Gating Ring and the Pore	PLOS ONE			English	Article							ACTIVATED PACEMAKER CHANNELS; VOLTAGE-SENSING MECHANISM; I-F CHANNELS; GATED CHANNELS; TERMINAL REGION; CATION CHANNELS; ION CHANNELS; MOLECULAR CHARACTERIZATION; CONFORMATIONAL-CHANGES; POTASSIUM CHANNELS	Hyperpolarization-activated cyclic nucleotide-regulated HCN channels underlie the Na+-K+ permeable I-H pacemaker current. As with other voltage-gated members of the 6-transmembrane K-V channel superfamily, opening of HCN channels involves dilation of a helical bundle formed by the intracellular ends of S6 albeit this is promoted by inward, not outward, displacement of S4. Direct agonist binding to a ring of cyclic nucleotide-binding sites, one of which lies immediately distal to each S6 helix, imparts cAMP sensitivity to HCN channel opening. At depolarized potentials, HCN channels are further modulated by intracellular Mg2+ which blocks the open channel pore and blunts the inhibitory effect of outward K+ flux. Here, we show that cAMP binding to the gating ring enhances not only channel opening but also the kinetics of Mg2+ block. A combination of experimental and simulation studies demonstrates that agonist acceleration of block is mediated via acceleration of the blocking reaction itself rather than as a secondary consequence of the cAMP enhancement of channel opening. These results suggest that the activation status of the gating ring and the open state of the pore are not coupled in an obligate manner (as required by the often invoked Monod-Wyman-Changeux allosteric model) but couple more loosely (as envisioned in a modular model of protein activation). Importantly, the emergence of second messenger sensitivity of open channel rectification suggests that loose coupling may have an unexpected consequence: it may endow these erstwhile "slow" channels with an ability to exert voltage and ligand-modulated control over cellular excitability on the fastest of physiologically relevant time scales.	[Lyashchenko, Alex K.; Tibbs, Gareth R.] Columbia Univ, Dept Anesthesiol, New York, NY 10027 USA; [Redd, Kacy J.] Columbia Univ, Dept Neurosci, New York, NY USA; [Goldstein, Peter A.; Tibbs, Gareth R.] Weill Cornell Med Coll, Dept Anesthesiol, New York, NY USA	Columbia University; Columbia University; Cornell University	Tibbs, GR (corresponding author), Columbia Univ, Dept Anesthesiol, New York, NY 10027 USA.	gareth.r.tibbs@gmail.com		Redd, Kacy/0000-0002-2024-741X; Goldstein, Peter/0000-0002-5973-9104	Department of Anesthesiology of Columbia University; Weill Cornell Medical College	Department of Anesthesiology of Columbia University; Weill Cornell Medical College	This work was supported by the Department of Anesthesiology of Columbia University and Weill Cornell Medical College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare C, 2001, J GEN PHYSIOL, V117, P519, DOI 10.1085/jgp.117.6.519; Azene EM, 2005, CARDIOVASC RES, V67, P263, DOI 10.1016/j.cardiores.2005.03.006; Azene EM, 2005, BIOCHEM BIOPH RES CO, V327, P1131, DOI 10.1016/j.bbrc.2004.12.127; Azene EM, 2003, J PHYSIOL-LONDON, V547, P349, DOI 10.1113/jphysiol.2003.039768; Baruscotti M, 2005, PHARMACOL THERAPEUT, V107, P59, DOI 10.1016/j.pharmthera.2005.01.005; Becchetti A, 1999, J GEN PHYSIOL, V114, P377, DOI 10.1085/jgp.114.3.377; Becchetti A, 2000, PFLUG ARCH EUR J PHY, V440, P556, DOI 10.1007/s004240050006; Bell DC, 2004, J GEN PHYSIOL, V123, P5, DOI 10.1085/jgp.200308918; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; Biel M, 1999, REV PHYSIOL BIOCH P, V136, P165, DOI 10.1007/BFb0032324; Bruening-Wright A, 2007, J GEN PHYSIOL, V130, P71, DOI 10.1085/jgp.200709769; Bruening-Wright A, 2007, J NEUROSCI, V27, P270, DOI 10.1523/JNEUROSCI.3801-06.2007; Bucchi A, 2002, J GEN PHYSIOL, V120, P1, DOI 10.1085/jgp.20028593; Chaplan SR, 2003, J NEUROSCI, V23, P1169, DOI 10.1523/JNEUROSCI.23-04-01169.2003; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Chen S, 2007, J GEN PHYSIOL, V129, P175, DOI 10.1085/jgp.200609585; Chow SS, 2012, J BIOL CHEM, V287, P600, DOI 10.1074/jbc.M111.269563; Contreras JE, 2006, J GEN PHYSIOL, V127, P481, DOI 10.1085/jgp.200509440; Contreras JE, 2008, P NATL ACAD SCI USA, V105, P3310, DOI 10.1073/pnas.0709809105; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Craven KB, 2008, J BIOL CHEM, V283, P14728, DOI 10.1074/jbc.M710463200; D'Avanzo N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007712; Dekker JP, 2006, J GEN PHYSIOL, V128, P561, DOI 10.1085/jgp.200609599; DIFRANCESCO D, 1984, J PHYSIOL-LONDON, V348, P341, DOI 10.1113/jphysiol.1984.sp015114; DiFrancesco D, 1999, J PHYSIOL-LONDON, V515, P367, DOI 10.1111/j.1469-7793.1999.367ac.x; Elinder F, 2006, J PHYSIOL-LONDON, V575, P417, DOI 10.1113/jphysiol.2006.110437; Flynn GE, 2007, STRUCTURE, V15, P671, DOI 10.1016/j.str.2007.04.008; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; Flynn GE, 2001, NAT REV NEUROSCI, V2, P643, DOI 10.1038/35090015; Fodor AA, 1997, J GEN PHYSIOL, V110, P591, DOI 10.1085/jgp.110.5.591; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; Griguoli M, 2010, J NEUROSCI, V30, P10773, DOI 10.1523/JNEUROSCI.2446-10.2010; Heginbotham L, 2004, BIOPHYS J, V86, P3663, DOI 10.1529/biophysj.103.039412; HEINEMANN SH, 1992, METHOD ENZYMOL, V207, P131; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Hua L, 2005, J GEN PHYSIOL, V125, P335, DOI 10.1085/jgp.200409187; Ishii TM, 1999, J BIOL CHEM, V274, P12835, DOI 10.1074/jbc.274.18.12835; Johnson JP, 2005, P NATL ACAD SCI USA, V102, P2742, DOI 10.1073/pnas.0408323102; Johnson JP, 2001, NATURE, V412, P917, DOI 10.1038/35091089; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kubo Y, 2001, J PHYSIOL-LONDON, V531, P645, DOI 10.1111/j.1469-7793.2001.0645h.x; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kusch J, 2012, NAT CHEM BIOL, V8, P162, DOI 10.1038/nchembio.747; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Liu J, 2000, NEURON, V28, P899, DOI 10.1016/S0896-6273(00)00162-8; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Ludwig A, 1999, EMBO J, V18, P2323, DOI 10.1093/emboj/18.9.2323; Lyashchenko AK, 2008, J GEN PHYSIOL, V131, P227, DOI 10.1085/jgp.200709868; Lyashchenko AK, 2007, J PHYSIOL-LONDON, V583, P37, DOI 10.1113/jphysiol.2007.136465; Macri V, 2009, J BIOL CHEM, V284, P15659, DOI 10.1074/jbc.M809164200; Mannikko R, 2005, J GEN PHYSIOL, V125, P305, DOI 10.1085/jgp.200409130; Mannikko R, 2002, NATURE, V419, P837, DOI 10.1038/nature01038; Martinez-Francois JR, 2009, J GEN PHYSIOL, V134, P151, DOI 10.1085/jgp.200910240; Michels G, 2005, CIRCULATION, V111, P399, DOI 10.1161/01.CIR.0000153799.65783.3A; Michels G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001511; Michels G, 2008, CARDIOVASC RES, V78, P466, DOI 10.1093/cvr/cvn032; Mistrik P, 2005, J BIOL CHEM, V280, P27056, DOI 10.1074/jbc.M502696200; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Postea O, 2011, NAT REV DRUG DISCOV, V10, P903, DOI 10.1038/nrd3576; Proenza C, 2006, J GEN PHYSIOL, V127, P183, DOI 10.1085/jgp.200509389; Prole DL, 2006, J GEN PHYSIOL, V128, P273, DOI 10.1085/jgp.200609590; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Rothberg BS, 2003, J GEN PHYSIOL, V122, P501, DOI 10.1085/jgp.200308928; Rothberg BS, 2002, J GEN PHYSIOL, V119, P83, DOI 10.1085/jgp.119.1.83; Ryu S, 2012, J GEN PHYSIOL, V140, P469, DOI 10.1085/jgp.201210850; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Santoro B, 2011, J NEUROSCI, V31, P4074, DOI 10.1523/JNEUROSCI.5707-10.2011; Santoro B, 2009, NEURON, V62, P802, DOI 10.1016/j.neuron.2009.05.009; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; Sesti F, 2003, NAT NEUROSCI, V6, P353, DOI 10.1038/nn1028; Shin KS, 2004, NEURON, V41, P737, DOI 10.1016/S0896-6273(04)00083-2; Shin KS, 2001, J GEN PHYSIOL, V117, P91, DOI 10.1085/jgp.117.2.91; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Steffan R, 1997, J NEUROSCI METH, V78, P51, DOI 10.1016/S0165-0270(97)00139-8; Stieber J, 2005, J BIOL CHEM, V280, P34635, DOI 10.1074/jbc.M502508200; Sun ZP, 1996, NEURON, V16, P141, DOI 10.1016/S0896-6273(00)80031-8; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; Swartz KJ, 2004, NAT REV NEUROSCI, V5, P905, DOI 10.1038/nrn1559; Swartz KJ, 2004, NAT STRUCT MOL BIOL, V11, P499, DOI 10.1038/nsmb0604-499; Tibbs GR, 1997, NATURE, V386, P612, DOI 10.1038/386612a0; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Trudeau MC, 2012, J GEN PHYSIOL, V140, P457, DOI 10.1085/jgp.201210898; Ulens C, 2003, NEURON, V40, P959, DOI 10.1016/S0896-6273(03)00753-0; Vemana S, 2003, J GEN PHYSL; Vemana S, 2008, AM J PHYSIOL-CELL PH, V295, pC557, DOI 10.1152/ajpcell.00154.2008; Wang J, 2002, NEURON, V36, P451, DOI 10.1016/S0896-6273(02)00968-6; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; Wu SJ, 2012, J GEN PHYSIOL, V140, P29, DOI 10.1085/jgp.201110749; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Yu X, 2004, P NATL ACAD SCI USA, V101, P1051, DOI 10.1073/pnas.0305167101; Yu X, 2007, AM J PHYSIOL-CELL PH, V292, pC1147, DOI 10.1152/ajpcell.00598.2005; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; Zhou L, 2004, NEURON, V44, P823, DOI 10.1016/j.neuron.2004.11.012; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012; Zhou L, 2012, NAT CHEM BIOL, V8, P136, DOI 10.1038/nchembio.776; Zolles G, 2009, NEURON, V62, P814, DOI 10.1016/j.neuron.2009.05.008	107	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101236	10.1371/journal.pone.0101236	http://dx.doi.org/10.1371/journal.pone.0101236			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983358	Green Published, Green Submitted, gold			2022-12-27	WOS:000339635000074
J	Numico, G; Pinto, C; Gori, S; Ucci, G; Di Maio, M; Cancian, M; De Lorenzo, F; Silvestris, N				Numico, Gianmauro; Pinto, Carmine; Gori, Stefania; Ucci, Giovanni; Di Maio, Massimo; Cancian, Maurizio; De Lorenzo, Francesco; Silvestris, Nicola			Clinical and Organizational Issues in the Management of Surviving Breast and Colorectal Cancer Patients: Attitudes and Feelings of Medical Oncologists	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; SURVIVORSHIP CARE PLANS; FOLLOW-UP; TIME; HEALTH	Background: The fast growing demand and the shortage of resources are pushing toward more efficient models of survivorship care delivery. The Associazione ltaliana di Oncologia Medica (AIOM) established an interdisciplinary working group with the purpose of promoting organizational improvements at the national level. A survey aimed at assessing attitudes and feelings of oncologists was considered preliminary to further initiatives. Methods: A 25-item questionnaire, sent to the mailing list of the Society, explored the following issues on the practice of breast and colorectal cancer patients' follow up: 1) organization; 2) clinical features; 3) feelings about the different meanings of follow-up. Results: Ninety-one oncologists of 160 institutions (57%) answered to the questionnaire. Although follow up is considered a distinct oncological activity in 68%, a fully shared organization between specialists is not common and communications with Primary Care Physicians are not structured in the majority of the cases. Fifty-five and 30% of the oncologists follow breast and colorectal cancer patients indefinitely. In case of discharge a survivorship care plan is delivered in only 9%. The majority of respondents do not hold a role of follow up in mortality reduction. Conclusions: Although survivorship care represents a significant part of the oncologists' workload, an "oncology-centered" model is largely adopted and established care pathways are still incomplete. Survivorship care needs to be put at the center of an educational policy and of a widespread organizational effort, directed at improving appropriateness and quality.	[Numico, Gianmauro] Azienda USL Valle Aosta, Med Oncol Unit, Aosta, Italy; [Pinto, Carmine] St Orsola Marcello Malpighi Hosp, Med Oncol Unit, Bologna, Italy; [Gori, Stefania] Sacro Cuore Don Calabria Hosp, Verona, Italy; [Ucci, Giovanni] Azienda Osped Lodi, Dept Oncol, Lodi, Italy; [Di Maio, Massimo] Natl Canc Inst G Pascale Fdn, Clin Trial Unit, Naples, Italy; [Cancian, Maurizio] SIMG, Conegliano, Italy; [De Lorenzo, Francesco] FAVO, Rome, Italy; [Silvestris, Nicola] Natl Canc Res Ctr Giovanni Paolo II, Med Oncol Unit, Bari, Italy	Azienda USL della Valle d'Aosta; IRCCS Azienda Ospedaliero-Universitaria di Bologna; IRCCS Sacro Cuore Don Calabria; IRCCS Fondazione Pascale; IRCCS Istituto Tumori Bari Giovanni Paolo II	Numico, G (corresponding author), Azienda USL Valle Aosta, Med Oncol Unit, Aosta, Italy.	gnumico@ausl.vda.it	Numico, Gianmauro/AAE-4489-2020; GORI, Stefania/N-8827-2016; Silvestris, Nicola/K-5889-2012; DI MAIO, Massimo/AAB-6074-2019; Di Maio, Massimo/K-9990-2016; Pinto, Carmine/AAC-2184-2020; GORI, Stefania/AAB-4802-2022	Numico, Gianmauro/0000-0003-3253-2960; GORI, Stefania/0000-0001-6320-405X; Silvestris, Nicola/0000-0001-7814-7318; DI MAIO, Massimo/0000-0001-8906-3785; Di Maio, Massimo/0000-0001-8906-3785; Pinto, Carmine/0000-0002-3159-5268; GORI, Stefania/0000-0001-6320-405X				Azim HA, 2011, ANN ONCOL, V22, P1939, DOI 10.1093/annonc/mdq683; Beaver K, 2009, BMJ-BRIT MED J, V338, P1; Bunnell CA, 2010, ONCOLOGY-NY, V24, P1343; Colzani E, 2011, J CLIN ONCOL, V29, P4014, DOI 10.1200/JCO.2010.32.6462; Debono D, 2010, J ONCOL PRACT, V6, P203, DOI 10.1200/JOP.777005; DELTURCO MR, 1994, JAMA-J AM MED ASSOC, V271, P1593, DOI 10.1001/jama.1994.03510440053032; Desch CE, 2005, J CLIN ONCOL, V23, P8512, DOI 10.1200/JCO.2005.04.0063; Earle CC, 2006, J CLIN ONCOL, V24, P5112, DOI 10.1200/JCO.2006.06.5284; Erikson C, 2007, J ONCOL PRACT, V3, P79, DOI 10.1200/JOP.0723601; Fasola G, 2012, J ONCOL PRACT, V8, P13, DOI 10.1200/JOP.2011.000326; Ganz PA, 2008, J CLIN ONCOL, V26, P759, DOI 10.1200/JCO.2007.14.2851; GHEZZI P, 1994, JAMA-J AM MED ASSOC, V271, P1587, DOI 10.1001/jama.1994.03510440047031; Grunfeld E, 2006, J CLIN ONCOL, V24, P848, DOI 10.1200/JCO.2005.03.2235; Grunfeld E, 1996, BMJ-BRIT MED J, V313, P665; Grunfeld E, 2006, J CLIN ONCOL, V24, P5166, DOI 10.1200/JCO.2006.06.5953; Grunfeld E, 2011, J CLIN ONCOL, V29, P4755, DOI 10.1200/JCO.2011.36.8373; Grunfeld Eva, 2010, Journal of the National Cancer Institute Monographs, P25, DOI 10.1093/jncimonographs/lgq002; Grunfeld E, 2010, J ONCOL PRACT, V6, P174, DOI 10.1200/JOP.200009; Gulliford T, 1997, BRIT MED J, V314, P171; Harrison SE, 2011, J CLIN ONCOL, V29, P2091, DOI 10.1200/JCO.2010.32.5167; Institute of Medicine, 2005, CANC PATIENT CANC SU; Jacobs HJM, 2001, ANN ONCOL, V12, P1107, DOI 10.1023/A:1011624829512; Jacobs LA, 2009, CA-CANCER J CLIN, V59, P391, DOI 10.3322/caac.20040; Jatoi I, 2011, J CLIN ONCOL, V29, P2301, DOI 10.1200/JCO.2010.32.3550; Oeffinger KC, 2006, J CLIN ONCOL, V24, P5117, DOI 10.1200/JCO.2006.07.0474; Schairer C, 2004, JNCI-J NATL CANCER I, V96, P1311, DOI 10.1093/jnci/djh253; Smith TJ, 2011, J CLIN ONCOL, V29, P4740, DOI 10.1200/JCO.2011.38.8397; Turner RM, 2011, J CLIN ONCOL, V29, P4641, DOI 10.1200/JCO.2010.34.2956; Virgo KS, 2013, J CLIN ONCOL, V31, P2322, DOI 10.1200/JCO.2012.45.6954; Wattchow DA, 2006, BRIT J CANCER, V94, P1116, DOI 10.1038/sj.bjc.6603052; Wheeler T, 1999, CLIN ONCOL-UK, V11, P169, DOI 10.1053/clon.1999.9035	31	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101170	10.1371/journal.pone.0101170	http://dx.doi.org/10.1371/journal.pone.0101170			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983237	Green Submitted, Green Published, gold			2022-12-27	WOS:000339635000063
J	Neuman, Y; Marwan, N; Cohen, Y				Neuman, Yair; Marwan, Norbert; Cohen, Yohai			Change in the Embedding Dimension as an Indicator of an Approaching Transition	PLOS ONE			English	Article							EARLY-WARNING SIGNALS; SYSTEMS; CLIMATE	Predicting a transition point in behavioral data should take into account the complexity of the signal being influenced by contextual factors. In this paper, we propose to analyze changes in the embedding dimension as contextual information indicating a proceeding transitive point, called OPtimal Embedding tRANsition Detection (OPERAND). Three texts were processed and translated to time-series of emotional polarity. It was found that changes in the embedding dimension proceeded transition points in the data. These preliminary results encourage further research into changes in the embedding dimension as generic markers of an approaching transition point.	[Neuman, Yair] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel; [Marwan, Norbert] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Cohen, Yohai] Gilasio Coding, Tel Aviv, Israel	Ben Gurion University; Potsdam Institut fur Klimafolgenforschung	Neuman, Y (corresponding author), Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel.	yneuman@bgu.ac.il	Marwan, Norbert/D-9576-2011	Marwan, Norbert/0000-0003-1437-7039	Potsdam Research Cluster for Georisk Analysis, Environmental Change and Sustainability (PROGRESS) [03IS2191B]	Potsdam Research Cluster for Georisk Analysis, Environmental Change and Sustainability (PROGRESS)	Part of this work has been supported by the Potsdam Research Cluster for Georisk Analysis, Environmental Change and Sustainability (PROGRESS, support code 03IS2191B; http://www.earth-in-progress.de/). No additional funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Bateson Gregory, 2000, STEPS ECOLOGY MIND; Boettiger C, 2013, NATURE, V493, P157, DOI 10.1038/493157a; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Dakos V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041010, 10.1371/journal.pone.0045586]; Donner RV, 2011, EUR PHYS J B, V84, P653, DOI 10.1140/epjb/e2011-10899-1; Donner RV, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/033025; Kefi S, 2013, OIKOS, V122, P641, DOI 10.1111/j.1600-0706.2012.20838.x; KENNEL MB, 1992, PHYS REV A, V45, P3403, DOI 10.1103/PhysRevA.45.3403; Kennett DJ, 2012, SCIENCE, V338, P788, DOI 10.1126/science.1226299; Lagi Marco, 2011, FOOD CRISES POLITICA; Marwan N, 2007, PHYS REP, V438, P237, DOI 10.1016/j.physrep.2006.11.001; Marwan N, 2009, PHYS LETT A, V373, P4246, DOI 10.1016/j.physleta.2009.09.042; Neuman Y, 2011, COMPLEXITY, V16, P58, DOI 10.1002/cplx.20347; PACKARD NH, 1980, PHYS REV LETT, V45, P712, DOI 10.1103/PhysRevLett.45.712; Roth D., 1998, 17 INT C COMP LING, P1136; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Sinclair Upton., 1906, JUNGLE; Slater D, 2013, EARLY WARNING SIGNAL; Turney PD, 2003, ACM T INFORM SYST, V21, P315, DOI 10.1145/944012.944013	22	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101014	10.1371/journal.pone.0101014	http://dx.doi.org/10.1371/journal.pone.0101014			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979691	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400063
J	Shimizu, M; Iwano, S; Uno, Y; Uehara, S; Inoue, T; Murayama, N; Onodera, J; Sasaki, E; Yamazaki, H				Shimizu, Makiko; Iwano, Shunsuke; Uno, Yasuhiro; Uehara, Shotaro; Inoue, Takashi; Murayama, Norie; Onodera, Jun; Sasaki, Erika; Yamazaki, Hiroshi			Qualitative De Novo Analysis of Full Length cDNA and Quantitative Analysis of Gene Expression for Common Marmoset (Callithrix jacchus) Transcriptomes Using Parallel Long-Read Technology and Short-Read Sequencing	PLOS ONE			English	Article							FLAVIN-CONTAINING MONOOXYGENASES; DRUG-METABOLISM SYSTEMS-2009; FLX TITANIUM PLATFORM; HUMAN CYTOCHROME-P450; CYNOMOLGUS MONKEYS; LIVER-MICROSOMES; ANIMAL-MODEL; RNA-SEQ; BIOMEDICAL-RESEARCH; ENZYMATIC FUNCTIONS	The common marmoset (Callithrix jacchus) is a non-human primate that could prove useful as human pharmacokinetic and biomedical research models. The cytochromes P450 (P450s) are a superfamily of enzymes that have critical roles in drug metabolism and disposition via monooxygenation of a broad range of xenobiotics; however, information on some marmoset P450s is currently limited. Therefore, identification and quantitative analysis of tissue-specific mRNA transcripts, including those of P450s and flavin-containing monooxygenases (FMO, another monooxygenase family), need to be carried out in detail before the marmoset can be used as an animal model in drug development. De novo assembly and expression analysis of marmoset transcripts were conducted with pooled liver, intestine, kidney, and brain samples from three male and three female marmosets. After unique sequences were automatically aligned by assembling software, the mean contig length was 718 bp (with a standard deviation of 457 bp) among a total of 47,883 transcripts. Approximately 30% of the total transcripts were matched to known marmoset sequences. Gene expression in 18 marmoset P450- and 4 FMO-like genes displayed some tissue-specific patterns. Of these, the three most highly expressed in marmoset liver were P450 2D-, 2E-, and 3A-like genes. In extrahepatic tissues, including brain, gene expressions of these monooxygenases were lower than those in liver, although P450 3A4 (previously P450 3A21) in intestine and P450 4A11- and FMO1-like genes in kidney were relatively highly expressed. By means of massive parallel long-read sequencing and short-read technology applied to marmoset liver, intestine, kidney, and brain, the combined next-generation sequencing analyses reported here were able to identify novel marmoset drug-metabolizing P450 transcripts that have until now been little reported. These results provide a foundation for mechanistic studies and pave the way for the use of marmosets as model animals for drug development in the future.	[Shimizu, Makiko; Iwano, Shunsuke; Uehara, Shotaro; Murayama, Norie; Yamazaki, Hiroshi] Showa Pharmaceut Univ, Lab Drug Metab & Pharmacokinet, Machida, Tokyo, Japan; [Iwano, Shunsuke] Novartis Pharma KK, Tokyo, Japan; [Uno, Yasuhiro] Shin Nippon Biomed Labs Ltd, Pharmacokinet & Bioanal Ctr, Wakayama, Japan; [Inoue, Takashi; Sasaki, Erika] Cent Inst Expt Anim, Dept Appl Dev Biol, Kawasaki, Kanagawa, Japan; [Onodera, Jun] Eurofins Genom, Ohta Ku, Tokyo, Japan; [Sasaki, Erika] Keio Univ, Adv Res Ctr, Tokyo, Japan	Showa Pharmaceutical University; Novartis; Shin Nippon Biomedical Laboratories Ltd.; Keio University	Yamazaki, H (corresponding author), Showa Pharmaceut Univ, Lab Drug Metab & Pharmacokinet, Machida, Tokyo, Japan.	hyamazak@ac.shoyaku.ac.jp	Yamazaki, Hiroshi/A-6081-2011	Yamazaki, Hiroshi/0000-0002-1068-4261; Inoue, Takashi/0000-0003-4691-7255; Uno, Yasuhiro/0000-0001-9040-1681; Shimizu, Makiko/0000-0002-2508-4031; Uehara, Shotaro/0000-0002-1359-8828	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-Aid for Scientific Research and Strategic Research Program for Brain Science of the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2003, COMPARATIVE MED, V53, P339; Carrion R, 2012, CURR OPIN VIROL, V2, P357, DOI 10.1016/j.coviro.2012.02.007; Ding XX, 2003, ANNU REV PHARMACOL, V43, P149, DOI 10.1146/annurev.pharmtox.43.100901.140251; Edwards CE, 2012, DNA RES, V19, P1, DOI 10.1093/dnares/dsr037; Garzon-Martinez GA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-151; Groer C, 2013, J PHARMACEUT BIOMED, V85, P253, DOI 10.1016/j.jpba.2013.07.031; Guengerich FP, 2010, CURR DRUG METAB, V11, P1; Guo SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-454; Hagenbuch B, 2010, CLIN PHARMACOL THER, V87, P39, DOI 10.1038/clpt.2009.235; Hichiya H, 2004, BIOCHEM PHARMACOL, V68, P165, DOI 10.1016/j.bcp.2004.03.018; Hsu MH, 2007, DRUG METAB REV, V39, P515, DOI 10.1080/03602530701468573; Iwasaki K, 2010, DRUG METAB PHARMACOK, V25, P388, DOI 10.2133/dmpk.DMPK-10-NT-022; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Liyou NE, 2003, J HISTOCHEM CYTOCHEM, V51, P1655, DOI 10.1177/002215540305101209; Mansfield K, 2003, COMPARATIVE MED, V53, P383; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mayumi K, 2013, BIOCHEM PHARMACOL, V85, P1182, DOI 10.1016/j.bcp.2013.01.024; MERKER HJ, 1988, ARCH TOXICOL, V61, P165, DOI 10.1007/BF00316631; Nakanishi Y, 2010, DRUG METAB PHARMACOK, V25, P290, DOI 10.2133/dmpk.25.290; Narimatsu S, 2005, CHEM-BIOL INTERACT, V152, P1, DOI 10.1016/j.cbi.2005.01.006; Narimatsu S, 2006, BIOCHEM PHARMACOL, V72, P1738, DOI 10.1016/j.bcp.2006.08.025; Natarajan P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-191; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Neubert R, 1999, NATURE, V400, P419, DOI 10.1038/22685; Nicol P, 2012, INT J PARASITOL, V42, P225, DOI 10.1016/j.ijpara.2011.11.010; Nies AT, 2013, GENOME MED, V5, DOI 10.1186/gm405; Niwa T, 2011, CURR DRUG METAB, V12, P549; Okano H, 2012, SEMIN FETAL NEONAT M, V17, P336, DOI 10.1016/j.siny.2012.07.002; Paine MF, 2006, DRUG METAB DISPOS, V34, P880, DOI 10.1124/dmd.105.008672; Peng YH, 2010, PEST MANAG SCI, V66, P1053, DOI 10.1002/ps.2004; Phillips IR, 2008, TRENDS PHARMACOL SCI, V29, P294, DOI 10.1016/j.tips.2008.03.004; POSWILLO DE, 1972, NATURE, V239, P460, DOI 10.1038/239460a0; Qiu H, 2008, PHARMACOGENET GENOM, V18, P53, DOI 10.1097/FPC.0b013e3282f313f8; Ramayo-Caldas Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-547; Rendic S, 2010, CURR DRUG METAB, V11, P4, DOI 10.2174/138920010791110917; Sanchez CC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-626; Schwartz TS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-694; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; SHIMADA T, 1992, MOL PHARMACOL, V41, P856; Smith D, 2001, LAB ANIM-UK, V35, P117, DOI 10.1258/0023677011911444; Smith RM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-571; Strittmatter AW, 2011, BIOSPEKTRUM, V17, P434; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Tatsumoto S, 2013, DNA RES, V20, P255, DOI 10.1093/dnares/dst007; Tokuno H, 2012, EXP ANIM TOKYO, V61, P389, DOI 10.1538/expanim.61.389; Uehara S, 2011, J PHARMACOL EXP THER, V339, P654, DOI 10.1124/jpet.111.185009; Uno Y, 2007, ARCH BIOCHEM BIOPHYS, V466, P98, DOI 10.1016/j.abb.2007.07.003; Uno Y, 2006, MOL PHARMACOL, V70, P477, DOI 10.1124/mol.106.022673; Uno Y, 2013, BIOCHEM PHARMACOL, V85, P1837, DOI 10.1016/j.bcp.2013.04.012; Uno Y, 2011, DRUG METAB REV, V43, P346, DOI 10.3109/03602532.2010.549492; Wang R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060449; Wang XW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-458; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; Wolbold R, 2003, HEPATOLOGY, V38, P978, DOI 10.1053/jhep.2003.50393; YAMAZAKI H, 1995, CARCINOGENESIS, V16, P2167, DOI 10.1093/carcin/16.9.2167; Yamazaki H, 2013, BIOCHEM PHARMACOL, V85, P1588, DOI 10.1016/j.bcp.2013.03.020; Yang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069168; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang XW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-565	62	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100936	10.1371/journal.pone.0100936	http://dx.doi.org/10.1371/journal.pone.0100936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977701	Green Submitted, Green Published, gold			2022-12-27	WOS:000338506400054
J	Mendy, VL; Azevedo, MJ; Sarpong, DF; Rosas, SE; Ekundayo, OT; Sung, JH; Bhuiyan, AR; Jenkins, BC; Addison, C				Mendy, Vincent L.; Azevedo, Mario J.; Sarpong, Daniel F.; Rosas, Sylvia E.; Ekundayo, Olugbemiga T.; Sung, Jung Hye; Bhuiyan, Azad R.; Jenkins, Brenda C.; Addison, Clifton			The Association between Individual and Combined Components of Metabolic Syndrome and Chronic Kidney Disease among African Americans: The Jackson Heart Study	PLOS ONE			English	Article							UNITED-STATES; PREVALENCE; RISK; POPULATION; GUIDELINES	Introduction: Approximately 26.3 million people in the United States have chronic kidney disease and many more are at risk of developing the condition. The association between specific metabolic syndrome components and chronic kidney disease in African American individuals is uncertain. Methods: Baseline data from 4,933 participants of the Jackson Heart Study were analyzed. Logistic regression models were used to estimate the odds and 95% confidence intervals of chronic kidney disease associated with individual components, metabolic syndrome, the number of components, and specific combinations of metabolic syndrome components. Results: Metabolic syndrome was common with a prevalence of 42.0%. Chronic kidney disease was present in 19.4% of participants. The prevalence of metabolic components was high: elevated blood pressure (71.8%), abdominal obesity (65.8%), low fasting high density lipoprotein cholesterol (37.3%), elevated fasting glucose (32.2%) and elevated triglycerides (16.2%). Elevated blood pressure, triglycerides, fasting blood glucose, and abdominal obesity were significantly associated with increased odds of chronic kidney disease. Participants with metabolic syndrome had a 2.22-fold (adjusted odds ratio (AOR) 2.22; 95% CI, 1.78-2.78) increase in the odds of chronic kidney disease compared to participants without metabolic syndrome. The combination of elevated fasting glucose, elevated triglycerides, and abdominal obesity was associated with the highest odds for chronic kidney disease (AOR 25.11; 95% CI, 6.94-90.90). Conclusion: Metabolic syndrome as well as individual or combinations of metabolic syndrome components are independently associated with chronic kidney disease in African American adults.	[Mendy, Vincent L.; Azevedo, Mario J.; Sarpong, Daniel F.; Ekundayo, Olugbemiga T.; Sung, Jung Hye; Bhuiyan, Azad R.] Jackson State Univ, Coll Publ Serv, Sch Hlth Sci, Dept Epidemiol & Biostat, Jackson, MS 39217 USA; [Sarpong, Daniel F.] Jackson State Univ, RTRN Data Coordinating Ctr, Jackson, MS USA; [Rosas, Sylvia E.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Kidney & Hypertens Sect, Boston, MA 02115 USA; [Jenkins, Brenda C.; Addison, Clifton] Jackson State Univ, Jackson Heart Study, Jackson, MS USA	Jackson State University; Jackson State University; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Jackson State University	Mendy, VL (corresponding author), Jackson State Univ, Coll Publ Serv, Sch Hlth Sci, Dept Epidemiol & Biostat, Jackson, MS 39217 USA.	vinsluther@hotmail.com	Addison, Clifton/AAG-6181-2020	Addison, Clifton/0000-0001-8949-4980; Ekundayo, Olugbemiga/0000-0003-4538-918X; Bhuiyan, Azad/0000-0002-3631-5296	National Heart, Lung, and Blood Institute [HHSN268201300046C, HHSN268201300047C, HHSN268201300048C, HHSN268201300049C, HHSN268201300050C]; National Institute on Minority Health and Health Disparities; National Institute on Biomedical Imaging and Bioengineering; National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The Jackson Heart Study is supported by contracts HHSN268201300046C, HHSN268201300047C, HHSN268201300048C, HHSN268201300049C, HHSN268201300050C from the National Heart, Lung, and Blood Institute and the National Institute on Minority Health and Health Disparities, with additional support from the National Institute on Biomedical Imaging and Bioengineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, L MORRIS CHRONIC KID; Bruce MA, 2010, AM J KIDNEY DIS, V55, P1001, DOI 10.1053/j.ajkd.2010.01.016; Carpenter MA, 2004, AM J MED SCI, V328, P131, DOI 10.1097/00000441-200409000-00001; Centers for Disease Control and Prevention National Center for Health Statistics, 2013, DAT AR COMP COMPR MO, V20, P2013; Chang IH, 2009, NEPHROLOGY, V14, P321, DOI 10.1111/j.1440-1797.2009.01091.x; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Flessner MF, 2009, AM J KIDNEY DIS, V53, P238, DOI 10.1053/j.ajkd.2008.08.035; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; Fuqua SR, 2005, ETHNIC DIS, V15, pS18; Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hall YN, 2010, CLIN J AM SOC NEPHRO, V5, P828, DOI 10.2215/CJN.09011209; Harman J, 2013, J CLIN HYPERTENS, V15, P367, DOI 10.1111/jch.12088; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Kitiyakara C, 2007, KIDNEY INT, V71, P693, DOI 10.1038/sj.ki.5002128; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Norris KC, 2005, KIDNEY INT, V68, P914, DOI 10.1111/j.1523-1755.2005.00485.x; Nugent RA, 2011, NEPHRON CLIN PRACT, V118, pC269, DOI 10.1159/000321382; Plantinga LC, 2010, CLIN J AM SOC NEPHRO, V5, P673, DOI 10.2215/CJN.07891109; Satirapoj B, 2011, SE ASIAN J TROP MED, V42, P176; Saydah S., 2007, Morbidity and Mortality Weekly Report, V56, P161; Schoolwerth Anton C, 2006, Prev Chronic Dis, V3, pA57; Sempos CT, 1999, AM J MED SCI, V317, P142, DOI 10.1097/00000441-199903000-00002; Shuval K, 2011, PREV CHRONIC DIS, V8; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Tarver-Carr ME, 2002, J AM SOC NEPHROL, V13, P2363, DOI 10.1097/01.ASN.0000026493.18542.6A; Taylor HA, 2005, ETHNIC DIS, V15, pS4; Taylor H, 2008, DIABETES CARE, V31, P1248, DOI 10.2337/dc07-1810; Thomas G, 2011, CLIN J AM SOC NEPHRO, V6, P2364, DOI 10.2215/CJN.02180311; U. S. Department of Health and Human Services. Office of Disease Prevention and Health Promotion. Healthy People 2020, 2013, HLTH PEOPL 2020; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Wyatt SB, 2003, ETHNIC DIS, V13, P438	34	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101610	10.1371/journal.pone.0101610	http://dx.doi.org/10.1371/journal.pone.0101610			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991817	Green Published, gold, Green Submitted			2022-12-27	WOS:000341253400097
J	Grdovic, N; Dinic, S; Mihailovic, M; Uskokovic, A; Jovanovic, JA; Poznanovic, G; Wagner, L; Vidakovic, M				Grdovic, Nevena; Dinic, Svetlana; Mihailovic, Mirjana; Uskokovic, Aleksandra; Jovanovic, Jelena Arambasic; Poznanovic, Goran; Wagner, Ludwig; Vidakovic, Melita			CXC Chemokine Ligand 12 Protects Pancreatic beta-Cells from Necrosis through Akt Kinase-Mediated Modulation of Poly(ADP-ribose) Polymerase-1 Activity	PLOS ONE			English	Article							REPERFUSION INJURY; ANTAGONIST AMD3100; PROGENITOR CELLS; STEM-CELLS; RAT-LIVER; IN-VITRO; SURVIVAL; RECEPTOR; DEATH; ACTIVATION	The diabetes prevention paradigm envisages the application of strategies that support the maintenance of appropriate beta-cell numbers. Herein we show that overexpression of CXC chemokine ligand12 (CXCL12) considerably improves the viability of isolated rat Langerhans islet cells and Rin-5F pancreatic beta-cells after hydrogen peroxide treatment. In rat islets and wt cells hydrogen peroxide treatment induced necrotic cell death that was mediated by the rapid and extensive activation of poly(ADP-ribose) polymerase-1 (PARP-1). In contrast, CXCL12-overexpressing cells were protected from necrotic cell death as a result of significantly reduced PARP-1 activity. CXCL12 downstream signalling through Akt kinase was responsible for the reduction of PARP-1 activity which switched cell death from necrosis to apoptosis, providing increased protection to cells from oxidative stress. Our results offer a novel aspect of the CXCL12-mediated improvement of b-cell viability which is based on its antinecrotic action through modulation of PARP-1 activity.	[Grdovic, Nevena; Dinic, Svetlana; Mihailovic, Mirjana; Uskokovic, Aleksandra; Jovanovic, Jelena Arambasic; Poznanovic, Goran; Vidakovic, Melita] Univ Belgrade, Inst Biol Res, Dept Mol Biol, Belgrade, Serbia; [Wagner, Ludwig] Med Univ Vienna, Dept Med 3, Div Nephrol & Dialysis, Vienna, Austria	University of Belgrade; Medical University of Vienna	Vidakovic, M (corresponding author), Univ Belgrade, Inst Biol Res, Dept Mol Biol, Belgrade, Serbia.	melita@ibiss.bg.ac.rs	Vidaković, Melita/G-6747-2016; Mihailovic, Mirjana/E-6308-2015; Poznanovic, Goran/E-6349-2015; Dinic, Svetlana/C-8348-2017; Arambasic Jovanovic, Jelena/L-1415-2016	Vidaković, Melita/0000-0001-8410-6264; Mihailovic, Mirjana/0000-0002-8097-1186; Poznanovic, Goran/0000-0003-0839-7017; Dinic, Svetlana/0000-0002-7612-3117; Grdovic, Nevena/0000-0003-1504-4578; Uskokovic, Aleksandra/0000-0002-9616-1102; Arambasic Jovanovic, Jelena/0000-0002-8810-0668	Ministry of Education, Science and Technological Development of the Republic of Serbia [173020]	Ministry of Education, Science and Technological Development of the Republic of Serbia	This work was financed by the Ministry of Education, Science and Technological Development of the Republic of Serbia (Grant No. 173020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariumi Y, 1999, ONCOGENE, V18, P4616, DOI 10.1038/sj.onc.1202823; Broxmeyer HE, 2003, J LEUKOCYTE BIOL, V73, P630, DOI 10.1189/jlb.1002495; Burkart V, 1999, NAT MED, V5, P314, DOI 10.1038/6535; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Collier JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022485; Fehsel K, 2003, LAB INVEST, V83, P549, DOI 10.1097/01.LAB.0000063927.68605.FF; Galluzzi L, 2011, INT REV CEL MOL BIO, V289, P1, DOI 10.1016/B978-0-12-386039-2.00001-8; Guo Y, 2005, STEM CELLS, V23, P1324, DOI 10.1634/stemcells.2005-0085; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Habener JF, 2012, ISLETS, V4, P188, DOI 10.4161/isl.20500; Harada N, 2004, J SURG RES, V121, P159, DOI 10.1016/j.jss.2004.04.016; Hegedus C, 2008, FEBS LETT, V582, P1672, DOI 10.1016/j.febslet.2008.04.023; Heinrich EL, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-68; Ilhan A, 2009, MOL CELL ENDOCRINOL, V298, P1, DOI 10.1016/j.mce.2008.10.015; Jorns A, 2002, VIRCHOWS ARCH, V440, P63, DOI 10.1007/s004280100490; Juarez J, 2004, CURR PHARM DESIGN, V10, P1245, DOI 10.2174/1381612043452640; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Kauppinen TM, 2006, P NATL ACAD SCI USA, V103, P7136, DOI 10.1073/pnas.0508606103; Kayali AG, 2003, J CELL BIOL, V163, P859, DOI 10.1083/jcb.200304153; Kayali AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038721; Kim Ha-Yon, 2011, Korean J Hematol, V46, P244, DOI 10.5045/kjh.2011.46.4.244; Kim HY, 2010, CANCER RES TREAT, V42, P225, DOI 10.4143/crt.2010.42.4.225; Li L, 2005, DIABETOLOGIA, V48, P1339, DOI 10.1007/s00125-005-1787-2; Liesveld JL, 2007, LEUKEMIA RES, V31, P1553, DOI 10.1016/j.leukres.2007.02.017; Liu LL, 2012, HUM IMMUNOL, V73, P439, DOI 10.1016/j.humimm.2012.02.002; Liu Z, 2011, DIABETOLOGIA, V54, P2067, DOI 10.1007/s00125-011-2181-x; Majka M, 2000, EUR J HAEMATOL, V64, P164, DOI 10.1034/j.1600-0609.2000.90112.x; Mochizuki T, 2002, J BIOL CHEM, V277, P2790, DOI 10.1074/jbc.M106361200; Muller C, 2003, AM J PHYSIOL-GASTR L, V285, pG769, DOI 10.1152/ajpgi.00009.2003; Murphy PM, 2000, PHARMACOL REV, V52, P145; Nadal A, 1998, FASEB J, V12, P1341, DOI 10.1096/fasebj.12.13.1341; Nagasawa T, 1996, P NATL ACAD SCI USA, V93, P14726, DOI 10.1073/pnas.93.25.14726; Pieper AA, 1999, P NATL ACAD SCI USA, V96, P3059, DOI 10.1073/pnas.96.6.3059; Rajesh KG, 2005, J MOL CELL CARDIOL, V39, P766, DOI 10.1016/j.yjmcc.2005.07.014; Ratajczak MZ, 2006, LEUKEMIA, V20, P1915, DOI 10.1038/sj.leu.2404357; Shaik ZP, 2007, AM J PHYSIOL-RENAL, V292, pF292, DOI 10.1152/ajprenal.00082.2006; Sosna J, 2014, CELL MOL LIFE SCI, V71, P331, DOI 10.1007/s00018-013-1381-6; Steer SA, 2006, PLOS MED, V3, P253, DOI 10.1371/journal.pmed.0030017; Tavor S, 2008, LEUKEMIA, V22, P2151, DOI 10.1038/leu.2008.238; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Walker JW, 2006, BIOCHEM BIOPH RES CO, V342, P336, DOI 10.1016/j.bbrc.2006.01.145; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Yano T, 2007, DIABETES, V56, P2946, DOI 10.2337/db07-0291; Zhang S, 2007, CELL DEATH DIFFER, V14, P1001, DOI 10.1038/sj.cdd.4402088; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200	46	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101172	10.1371/journal.pone.0101172	http://dx.doi.org/10.1371/journal.pone.0101172			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988468	Green Published, Green Submitted, gold			2022-12-27	WOS:000341354100067
J	Jonas, JB; Wang, NL; Wang, YX; You, QS; Yang, DY; Xu, L				Jonas, Jost B.; Wang, Ningli; Wang, Ya Xing; You, Qi Sheng; Yang, Diya; Xu, Liang			Ocular Hypertension: General Characteristics and Estimated Cerebrospinal Fluid Pressure. The Beijing Eye Study 2011	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; CENTRAL CORNEAL THICKNESS; BODY-MASS INDEX; INTRAOCULAR-PRESSURE; LAMINA-CRIBROSA; INTRACRANIAL-PRESSURE; OPTIC DISC; POPULATION; SPACE; CHINA	Purpose: To examine characteristics of ocular hypertensive subjects and potential associations with estimated cerebrospinal fluid pressure (estCSFP). Methods: The population-based Beijing Eye Study 2011 included 3468 individuals with a mean age of 64.6 +/- 9.8 years. Ocular hypertension was defined as intraocular pressure (IOP) > 21 mmHg, normal optic nerve head appearance and normal retinal nerve fiber layer thickness. IOP was corrected for its dependence on central corneal thickness (CCT) and corneal curvature radius. Estimated CSFP was calculated as CSFP [mmHg] = 0.44xBody Mass Index [kg/m(2)]+0.16xDiastolic Blood Pressure [mmHg]-0.18xAge [Years]-1.91. Estimated trans-lamina cribrosa pressure difference (estTLCPD) was IOP-estCSFP. Results: EstCSFP (10.5 +/- 3.6 mmHg versus 9.0 +/- 3.7 mmHg; P = 0.003) and estTLCPD (12.0 +/- 4.4 mmHg versus 5.4 +/- 3.8 mmHg; P<0.001) were higher in the ocular hypertensive group than in the normotensive group. In binary regression analysis, ocular hypertension was associated with increased estCSFP (P = 0.03; odds ratio (OR): 1.08; 95% confidence interval (CI): 1.01, 1.17) after adjusting for prevalence of arterial hypertension (P = 0.07; OR: 1.79; 95% CI: 0.96, 3.34), retinal nerve fiber layer thickness (P = 0.03; OR: 0.97; 95% CI: 0.95, 0.997) and blood glucose concentration (P = 0.006; OR: 1.17; 95% CI: 1.04, 1.30). Conclusions: Ocular hypertensive subjects (with IOP correction for CCT and corneal curvature) as compared to ocular normotensive subjects had a significantly higher estCSFP in univariate analysis and in multivariate analysis. Despite of a higher estCSFP, estTLCPD was still markedly higher in ocular hypertensive eyes than in ocular normotensive eyes.	[Jonas, Jost B.; Wang, Ya Xing; You, Qi Sheng; Xu, Liang] Capital Med Univ, Beijing Inst Ophthalmol, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Eye Ctr,Beijing Tongren Hosp, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Mannheim, Germany; [Wang, Ningli; Yang, Diya] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China	Capital Medical University; Ruprecht Karls University Heidelberg; Capital Medical University	Xu, L (corresponding author), Capital Med Univ, Beijing Inst Ophthalmol, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Eye Ctr,Beijing Tongren Hosp, Beijing, Peoples R China.	xlbio@yahoo.cn	You, Qisheng/AAG-7153-2020; wang, YA XING/K-9671-2016	You, Qisheng/0000-0003-0743-7320; wang, YA XING/0000-0003-2749-7793	National Natural Science Foundation of China [81170890]; National Key Technology R&D Program of the Ministry of Science and Technology [2012BAH05F05, 2013BAH19F04]; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program of the Ministry of Science and Technology(National Key Technology R&D Program); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	Supported by the National Natural Science Foundation of China (81170890) and by the National Key Technology R&D Program of the Ministry of Science and Technology (No. 2012BAH05F05 and 2013BAH19F04). The authors acknowledge the financial support of the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing. The sponsor or funding organization had no role in the design or conduct of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdahl JP, 2008, OPHTHALMOLOGY, V115, P763, DOI 10.1016/j.ophtha.2008.01.013; Berdahl JP, 2012, INVEST OPHTH VIS SCI, V53, P1422, DOI 10.1167/iovs.11-8220; Berdahl JP, 2008, INVEST OPHTH VIS SCI, V49, P5412, DOI 10.1167/iovs.08-2228; DIELEMANS I, 1995, OPHTHALMOLOGY, V102, P54; Eysteinsson T, 2002, ACTA OPHTHALMOL SCAN, V80, P11, DOI 10.1034/j.1600-0420.2002.800103.x; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Foster PJ, 2003, INVEST OPHTH VIS SCI, V44, P3885, DOI 10.1167/iovs.03-0012; JONAS JB, 1991, INVEST OPHTH VIS SCI, V32, P401; JONAS JB, 1988, INVEST OPHTH VIS SCI, V29, P1151; Jonas JB, 2003, INVEST OPHTH VIS SCI, V44, P5189, DOI 10.1167/iovs.03-0174; JONAS JB, 1994, AM J OPHTHALMOL, V117, P732, DOI 10.1016/S0002-9394(14)70316-2; Jonas JB, 1999, J GLAUCOMA, V8, P227; Jonas JB, 2014, AM J HYPERTENS; Jonas JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096273; Jonas JB, 2014, INVEST OPHTH VIS SCI, V55, P1292, DOI 10.1167/iovs.13-13351; Jonas JB, 2014, ACTA OPHTHALMOL, V92, pE194, DOI 10.1111/aos.12297; Jonas JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086678; Jonas JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082284; Jonas JB, 2012, INVEST OPHTH VIS SCI, V53, P6045, DOI 10.1167/iovs.12-10623; Jonas JB, 2011, J GLAUCOMA, V20, P405, DOI 10.1097/IJG.0b013e3181f7af9b; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kohlhaas M, 2006, ARCH OPHTHALMOL-CHIC, V124, P471, DOI 10.1001/archopht.124.4.471; MORGAN WH, 1995, INVEST OPHTH VIS SCI, V36, P1163; Morgan WH, 2013, INVEST OPHTH VIS SCI, V53, P4676; Morgan WH, 2008, J GLAUCOMA, V17, P408, DOI 10.1097/IJG.0b013e31815c5f7c; Morgan WH, 2008, CLIN EXP OPHTHALMOL, V36, P802, DOI 10.1111/j.1442-9071.2008.01881.x; Ren RJ, 2012, GRAEF ARCH CLIN EXP, V250, P445, DOI 10.1007/s00417-011-1746-1; Ren RJ, 2011, GRAEF ARCH CLIN EXP, V249, P1057, DOI 10.1007/s00417-011-1657-1; Ren RJ, 2011, ACTA OPHTHALMOL, V89, pE142, DOI 10.1111/j.1755-3768.2010.02015.x; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Tezel G, 2000, ARCH OPHTHALMOL-CHIC, V118, P511, DOI 10.1001/archopht.118.4.511; Wang NL, 2012, OPHTHALMOLOGY, V119, P2065, DOI 10.1016/j.ophtha.2012.03.054; Wang Y, 2006, BRIT J OPHTHALMOL, V90, P353, DOI 10.1136/bjo.2005.081521; Wang YX, 2010, AM J OPHTHALMOL, V150, P917, DOI 10.1016/j.ajo.2010.06.037; Wolfs RC, 1997, AM J OPHTHALMOL, V123, P767, DOI 10.1016/S0002-9394(14)71125-0; Xie XB, 2013, CRIT CARE, V17, DOI 10.1186/cc12841; Xu L, 2006, BRIT J OPHTHALMOL, V90, P1087, DOI 10.1136/bjo.2006.096123; Xu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030104; Yablonski M, 1979, INVEST OPHTHALMOL  S, V18, P165	40	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100533	10.1371/journal.pone.0100533	http://dx.doi.org/10.1371/journal.pone.0100533			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988292	gold, Green Published, Green Submitted			2022-12-27	WOS:000341354100032
J	Shamay-Tsoory, SG; Ahronberg-Kirschenbaum, D; Bauminger-Zviely, N				Shamay-Tsoory, Simone G.; Ahronberg-Kirschenbaum, Dorin; Bauminger-Zviely, Nirit			There Is No Joy like Malicious Joy: Schadenfreude in Young Children	PLOS ONE			English	Article							JEALOUSY; CONTEXT; ENVY; 3RD-PARTY	Human emotions are strongly shaped by the tendency to compare the relative state of oneself to others. Although social comparison based emotions such as jealousy and schadenfreude (pleasure in the other misfortune) are important social emotions, little is known about their developmental origins. To examine if schadenfreude develops as a response to inequity aversion, we assessed the reactions of children to the termination of unequal and equal triadic situations. We demonstrate that children as early as 24 months show signs of schadenfreude following the termination of an unequal situation. Although both conditions involved the same amount of gains, the children displayed greater positive expressions following the disruption of the unequal as compared to the equal condition, indicating that inequity aversion can be observed earlier than reported before. These results support an early evolutionary origin of inequity aversion and indicate that schadenfreude has evolved as a response to unfairness.	[Shamay-Tsoory, Simone G.; Ahronberg-Kirschenbaum, Dorin] Univ Haifa, Dept Psychol, IL-31999 Haifa, Israel; [Bauminger-Zviely, Nirit] Bar Ilan Univ Haifa, Sch Educ, Haifa, Israel	University of Haifa	Shamay-Tsoory, SG (corresponding author), Univ Haifa, Dept Psychol, IL-31999 Haifa, Israel.	sshamay@psy.haifa.ac.il						BATSON CD, 1994, PERS SOC PSYCHOL B, V20, P603, DOI 10.1177/0146167294205016; Bauminger N, 2004, DEV PSYCHOPATHOL, V16, P157, DOI 10.1017/S0954579404044451; Bauminger N, 2008, COGNITION EMOTION, V22, P595, DOI 10.1080/02699930701439986; Bauminger-Zvieli N, 2013, J ABNORM CHILD PSYCH, V41, P253, DOI 10.1007/s10802-012-9664-1; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Buss D.M., 2000, DANGEROUS PASSION WH; BUSS DM, 1990, J SOC PERS RELAT, V7, P395, DOI 10.1177/0265407590073006; CASH KJ, 1986, BEHAV ECOL SOCIOBIOL, V18, P413, DOI 10.1007/BF00300515; Colyn LA, 2012, PERSONAL RELATIONSHI; Colyn LA, 2013, PERS RELATIONSHIP, V20, P524, DOI 10.1111/j.1475-6811.2012.01422.x; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Decety J, 2008, NEUROPSYCHOLOGIA, V46, P2607, DOI 10.1016/j.neuropsychologia.2008.05.026; DeSteno DA, 1996, PERS SOC PSYCHOL B, V22, P920, DOI 10.1177/0146167296229006; Feather N.T., 2006, EUROPEAN REV PSYCHOL, V17, P38, DOI [10.1080/10463280600662321, https://doi.org/10.1080/10463280600662321, DOI 10.1080/10463280600662321]; Feather NT., 1999, VALUES ACHIEVEMENT J; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Hareli S, 2002, MOTIV EMOTION, V26, P257, DOI 10.1023/A:1022818803399; Hart S, 2002, INFANCY, V3, P395, DOI 10.1207/S15327078IN0303_6; Heider F., 1958, PSYCHOL INTERPERSONA, DOI DOI 10.1037/14200-000; Joung SJ, 2005, ZOOL STUD, V44, P487; LoBue V, 2011, SOC DEV, V20, P154, DOI 10.1111/j.1467-9507.2009.00560.x; LOEWENSTEIN GF, 1989, J PERS SOC PSYCHOL, V57, P426, DOI 10.1037/0022-3514.57.3.426; MASCIUCH S, 1993, J SOC PERS RELAT, V10, P421, DOI 10.1177/0265407593103008; Miller AL, 2000, SOC DEV, V9, P433, DOI 10.1111/1467-9507.00137; Parrott W. G, 1991, PSYCHOL JEALOUSY ENV, P3; PARROTT WG, 1993, J PERS SOC PSYCHOL, V64, P906, DOI 10.1037/0022-3514.64.6.906; Paulus M, 2013, J EXP CHILD PSYCHOL, V116, P78, DOI 10.1016/j.jecp.2012.12.014; Powell C. A. J., 2012, SELF IDENTITY, P1; Range F, 2009, P NATL ACAD SCI USA, V106, P340, DOI 10.1073/pnas.0810957105; SALOVEY P, 1986, J PERS SOC PSYCHOL, V50, P1100, DOI 10.1037/0022-3514.50.6.1100; Schmidt MFH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023223; Smetana JG, 2006, ANNU REV PSYCHOL, V57, P255, DOI 10.1146/annurev.psych.57.102904.190124; Smith RH, 2007, PSYCHOL BULL, V133, P46, DOI 10.1037/0033-2909.133.1.46; Smith RH, 2009, SOC PERSONAL PSYCHOL, V3, P530, DOI 10.1111/j.1751-9004.2009.00181.x; Steinbeis N, 2013, J EXP CHILD PSYCHOL, V115, P198, DOI 10.1016/j.jecp.2012.11.009; TAYLOR SE, 1991, PSYCHOL BULL, V110, P67, DOI 10.1037/0033-2909.110.1.67; Turiel E, 2007, HDB CHILD PSYCHOL; Van Dijk W, 2008, WHY PEOPLE ENJ UNPUB; Volling BL, 2002, CHILD DEV, V73, P581, DOI 10.1111/1467-8624.00425; Wainryb C, 2006, ADV CHILD DEV BEHAV, V34, P131, DOI 10.1016/S0065-2407(06)80006-6; Ze'ev AB, 2001, SUBTLETY EMOTIONS	42	16	17	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100233	10.1371/journal.pone.0100233	http://dx.doi.org/10.1371/journal.pone.0100233			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BA	24988446	Green Published, gold			2022-12-27	WOS:000341354100026
J	Sidharthan, NP; Butcher, NJ; Mitchell, DJ; Minchin, RF				Sidharthan, Neelima P.; Butcher, Neville J.; Mitchell, Deanne J.; Minchin, Rodney F.			Expression of the Orphan Cytosolic Sulfotransferase SULT4A1 and Its Major Splice Variant in Human Tissues and Cells: Dimerization, Degradation and Polyubiquitination	PLOS ONE			English	Article							PSYCHOPATHOLOGY; IDENTIFICATION; PROTEASOME; PROTECTS; BINDING	The cytosolic sulfotransferase SULT4A1 is highly conserved between mammalian species but its function remains unknown. Polymorphisms in the SULT4A1 gene have been linked to susceptibility to schizophrenia. There are 2 major SULT4A1 transcripts in humans, one that encodes full length protein (wild-type) and one that encodes a truncated protein (variant). Here, we investigated the expression of SULT4A1 in human tissues by RT-PCR and found the wild-type mRNA to be expressed mainly in the brain, gastrointestinal tract and prostate while the splice variant was more widely expressed. In human cell-lines, the wild-type transcript was found in neuronal cells, but the variant transcript was expressed in nearly all other lines examined. Western blot analysis only identified SULT4A1 protein in cells that expressed the wild-type mRNA. No variant protein was detected in cells that expressed the variant mRNA. Ectopically expressed full length SULT4A1 protein was stable while the truncated protein was not, having a half-life of approximately 3 hr. SULT4A1 was also shown to homodimerize, consistent with other SULTs that contain the consensus dimerization motif. Mutation of the dimerization motif resulted in a monomeric form of SULT4A1 that was rapidly degraded by polyubiquitination on the lysine located within the dimerization motif. These results show that SULT4A1 is widely expressed in human tissues, but mostly as a splice variant that produces a rapidly degraded protein. Dimerization protects the protein from degradation. Since many other cytosolic sulfotransferases possess the conserved lysine within the dimerization motif, homodimerization may serve, in part, to stabilize these enzymes in vivo.	[Sidharthan, Neelima P.; Butcher, Neville J.; Mitchell, Deanne J.; Minchin, Rodney F.] Univ Queensland, Lab Mol & Cellular Pharmacol, Sch Biomed Sci, Brisbane, Qld, Australia	University of Queensland	Minchin, RF (corresponding author), Univ Queensland, Lab Mol & Cellular Pharmacol, Sch Biomed Sci, Brisbane, Qld, Australia.	r.minchin@uq.edu.au		Minchin, Rodney/0000-0002-3178-4835; Nair, Neelima/0000-0003-1729-2575; Butcher, Neville/0000-0002-0709-5589	National Health and Medical research Council of Australia [APP1005899]	National Health and Medical research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical research Council of Australia grant # APP1005899. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnouti Y, 2006, TOXICOL SCI, V93, P242, DOI 10.1093/toxsci/kfl050; Alnouti Y, 2011, XENOBIOTICA, V41, P187, DOI 10.3109/00498254.2010.535923; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butcher NJ, 2010, MOL PHARMACOL, V78, P503, DOI 10.1124/mol.110.063404; Caffrey TM, 2006, HUM MOL GENET, V15, P3529, DOI 10.1093/hmg/ddl429; Cook IT, 2010, HORM MOL BIOL CLIN I, V3, P367, DOI 10.1515/HMBCI.2010.041; Domingues SC, 2011, J NEUROCHEM, V119, P1086, DOI 10.1111/j.1471-4159.2011.07420.x; Dunbar AY, 2004, MOL PHARMACOL, V66, P964, DOI 10.1124/mol.104.000125; FALANY CN, 1995, J STEROID BIOCHEM, V52, P529, DOI 10.1016/0960-0760(95)00015-R; Falany CN, 2000, BIOCHEM J, V346, P857, DOI 10.1042/0264-6021:3460857; Gabut M, 2011, CELL, V147, P132, DOI 10.1016/j.cell.2011.08.023; Gamage N, 2006, TOXICOL SCI, V90, P5, DOI 10.1093/toxsci/kfj061; Gregersen N, 2000, J INHERIT METAB DIS, V23, P441, DOI 10.1023/A:1005663728291; Hattori T, 2003, ONCOGENE, V22, P1273, DOI 10.1038/sj.onc.1206204; Huang G, 2001, EMBO J, V20, P723, DOI 10.1093/emboj/20.4.723; Liu Q, 2012, PRIM CARE COMPANION, V14; Long J, 2010, J MOL BIOL, V396, P178, DOI 10.1016/j.jmb.2009.11.032; Lu LY, 2009, DRUG METAB DISPOS, V37, P1083, DOI 10.1124/dmd.108.025395; Meltzer HY, 2008, SCHIZOPHR RES, V106, P258, DOI 10.1016/j.schres.2008.08.029; Minchin RF, 2008, INT J BIOCHEM CELL B, V40, P2686, DOI 10.1016/j.biocel.2007.11.010; Mitchell DJ, 2011, BBA-MOL CELL RES, V1813, P231, DOI 10.1016/j.bbamcr.2010.09.011; Mitchell DJ, 2009, MOL PHARMACOL, V76, P388, DOI 10.1124/mol.109.055442; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Pal S, 2011, GENOME RES, V21, P1260, DOI 10.1101/gr.120535.111; Petrotchenko EV, 2001, FEBS LETT, V490, P39, DOI 10.1016/S0014-5793(01)02129-9; Ramsey TL, 2011, PHARMACOGENOMICS, V12, P471, DOI [10.2217/pgs.10.205, 10.2217/PGS.10.205]; Ross HH, 2007, FEBS LETT, V581, P5923, DOI 10.1016/j.febslet.2007.11.074; Runge-Morris M, 2013, DRUG METAB REV, V45, P15, DOI 10.3109/03602532.2012.748794; Stjernschantz E, 2010, MOL CELL ENDOCRINOL, V317, P127, DOI 10.1016/j.mce.2009.12.001; Sun MH, 2010, BIOCHEMISTRY-US, V49, P4779, DOI 10.1021/bi902190r; Thomae B. A., 2002, Pharmacogenomics Journal, V2, P48, DOI 10.1038/sj.tpj.6500089; Weitzner B, 2009, PROTEINS, V75, P289, DOI 10.1002/prot.22347	32	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101520	10.1371/journal.pone.0101520	http://dx.doi.org/10.1371/journal.pone.0101520			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988429	Green Published, gold, Green Submitted			2022-12-27	WOS:000341354100105
J	Wang, YB; Zhang, WJ; Lin, YS; Cao, WQ; Zheng, LM; Yang, J				Wang, Yibo; Zhang, Wenjing; Lin, Yuanshao; Cao, Wenqing; Zheng, Lianming; Yang, Jun			Phosphorus, Nitrogen and Chlorophyll-a Are Significant Factors Controlling Ciliate Communities in Summer in the Northern Beibu Gulf, South China Sea	PLOS ONE			English	Article							MESODINIUM-RUBRUM; PLANKTONIC CILIATE; YELLOW SEA; CILIOPHORA; CARBON; SONG	Ciliates (protozoa) are ubiquitous components of plankton community and play important roles in aquatic ecosystems in regards of their abundance, biomass, diversity and energy turnover. Based on the stratified samples collected from the northern Beibu Gulf in August 2011, species composition, abundance, biomass, diversity and spatial pattern of planktonic ciliates were studied. Furthermore the main environmental factors controlling ciliate communities were determined. A total of 101 species belonging to 44 genera and 7 orders (i.e., Oligotrichida, Haptorida, Euplotida, Sessilida, Pleurostomatida, Scuticociliatida and Tintinnida) were identified. The variation of ciliate communities was significant at horizontal level, but that was not at vertical level. Based on cluster analysis, ciliate communities were divided into three main groups. Redundancy analysis (RDA) revealed that Group A, existing in the waters with higher concentration of phosphorus and nitrogen, was dominated by Tintinnidium primitivum. Group B in the waters with lower temperature and chlorophyll-a concentration, was dominated by Leegaardiella ovalis. Group C, existing in the waters with higher temperature and chlorophyll-a concentration, was dominated by large Strombidium spp. and Mesodinium rubrum. Combining multiple analytic methods, our results strongly supported that phosphorus, nitrogen and chlorophyll-a were the most significant factors affecting the ciliate communities in the northern Beibu Gulf in summer. Concentration of phosphorus and nitrogen primarily influenced ciliate biomass, implying a potential impact of eutrophication on ciliate growth. The correlation with chlorophyll-a concentration, on one hand indicate the response of ciliates to the food availability, and on the other hand, the ciliates containing chloroplasts or endosymbionts may contribute greatly to the chlorophyll-a.	[Wang, Yibo; Zhang, Wenjing; Lin, Yuanshao; Cao, Wenqing; Zheng, Lianming] Xiamen Univ, Lab Marine Biodivers & Global Change MBiGC, Coll Ocean & Earth Sci, Xiamen, Peoples R China; [Yang, Jun] Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Aquat Ecohlth Grp, Xiamen, Peoples R China	Xiamen University; Chinese Academy of Sciences; Institute of Urban Environment, CAS	Zhang, WJ (corresponding author), Xiamen Univ, Lab Marine Biodivers & Global Change MBiGC, Coll Ocean & Earth Sci, Xiamen, Peoples R China.	zhangwenjing@xmu.edu.cn	CAS, KLUEH-Cooperation/E-1148-2017; Zhang, Wenjing/H-5057-2012; CAS, KLUEH/T-5743-2019; Wang, Yibo/AAU-5681-2021; Yang, Jun/E-6680-2011; YANG, Jun/J-2819-2014; 郑, 连明/GZL-5449-2022	Zhang, Wenjing/0000-0002-2600-5040; Yang, Jun/0000-0002-7920-2777; YANG, Jun/0000-0002-5069-507X; 	National Natural Science Foundation of China [41276133]; special Research Foundation for Public Welfare Marine Program [201005012];  [GASI-03-01-02-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); special Research Foundation for Public Welfare Marine Program; 	This study was supported by the National Natural Science Foundation of China (No. 41276133), the special Research Foundation for Public Welfare Marine Program (No. 201005012), and GASI-03-01-02-03 Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, FREE LIVING CILIATES; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Chen S, 2008, COLLECTION RES PAPER, V1, P88; Chen SL, 2011, J OCEANOGR, V67, P709, DOI 10.1007/s10872-011-0071-y; Clarke K.R., 2001, PRIMER V5 USERMANUAL; CRAWFORD DW, 1989, MAR ECOL PROG SER, V58, P161, DOI 10.3354/meps058161; Dolan JR, 2000, FRESHWATER BIOL, V45, P227, DOI 10.1046/j.1365-2427.2000.00659.x; Feng Mei-ping, 2010, Journal of Tropical Oceanography, V29, P141; Gomez F, 2007, ACTA OECOL, V32, P188, DOI 10.1016/j.actao.2007.04.002; Gustafson DE, 2000, NATURE, V405, P1049, DOI 10.1038/35016570; Hada Y., 1938, Journal of the Faculty of Science Hokkaido University Zoology, V6, P87; Hada Y., 1937, Journal of the Faculty of Science Hokkaido University Zoology, V5, P143; Hada Y., 1932, J FS HOKKAIDO U 4, V2, P37; Jiang Y, 2011, J MAR BIOL ASSOC UK, V91, P97, DOI 10.1017/S002531541000175X; Jiang Y, 2011, MAR POLLUT BULL, V62, P227, DOI 10.1016/j.marpolbul.2010.11.008; Johnson MD, 2013, J PLANKTON RES, V35, P877, DOI 10.1093/plankt/fbt028; Kim Young-Ok, 2012, Ocean Science Journal, V47, P161, DOI 10.1007/s12601-012-0016-4; Kofoid C. A., 1939, B MUS COMP ZOOL HARV, V84, P1; KOFOID CHARLES A., 1929, UNIV CALIF PUBL ZOOL, V34, P1; Leegaard C, 1915, NYTT MAG NATURV, V53, P1; [刘华雪 Liu Huaxue], 2010, [生态学报, Acta Ecologica Sinica], V30, P2340; Lynn D.H., 2008, CHARACTERIZATION CLA; McManus GB, 2004, LIMNOL OCEANOGR, V49, P308, DOI 10.4319/lo.2004.49.1.0308; MONTAGNES DJS, 1988, MAR BIOL, V99, P21, DOI 10.1007/BF00644973; Montagnes DJS, 1998, J EUKARYOT MICROBIOL, V45, P502, DOI 10.1111/j.1550-7408.1998.tb05108.x; Nie D., 1934, Report of the Marine Biological Association of China, V3, P71; Office of the State Oceanic Administration, 2006, COMPR SURV ASS TECHN; PUTT M, 1989, LIMNOL OCEANOGR, V34, P1097, DOI 10.4319/lo.1989.34.6.1097; Sanders RW, 1995, AQUAT MICROB ECOL, V9, P237, DOI 10.3354/ame009237; SMITH WO, 1979, J PHYCOL, V15, P27, DOI 10.1111/j.0022-3646.1979.00027.x; Song WB, 2000, EUR J PROTISTOL, V36, P327, DOI 10.1016/S0932-4739(00)80010-3; STOECKER DK, 1991, MAR ECOL PROG SER, V73, P245, DOI 10.3354/meps073245; STOECKER DK, 1987, ANN NY ACAD SCI, V503, P562, DOI 10.1111/j.1749-6632.1987.tb40646.x; Su Qiang, 2007, Marine Science Bulletin (Beijing), V9, P43; Sun X, 2005, HYDROGRAPHY CHINA CO, P285; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Utermohl H, 1958, MITT INT VER LIMNOL, V9, P1; WILHM JL, 1970, J WATER POLLUT CON F, V42, pR221; Xu DP, 2006, ACTA PROTOZOOL, V45, P17; Xu HL, 2008, J MAR BIOL ASSOC UK, V88, P1353, DOI 10.1017/S0025315408002129; Xu Runlin, 1998, Tropic Oceanology, V17, P40; [张翠霞 ZHANG Cuixia], 2010, [生态学报, Acta Ecologica Sinica], V30, P867; Zhang WC, 2002, AQUAT MICROB ECOL, V27, P249, DOI 10.3354/ame027249	43	27	29	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101121	10.1371/journal.pone.0101121	http://dx.doi.org/10.1371/journal.pone.0101121			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987960	Green Submitted, Green Published, gold			2022-12-27	WOS:000341354100061
J	Wu, JJ; Zhou, TT; Du, GC; Zhou, JW; Chen, J				Wu, Junjun; Zhou, Tiantian; Du, Guocheng; Zhou, Jingwen; Chen, Jian			Modular Optimization of Heterologous Pathways for De Novo Synthesis of (2S)-Naringenin in Escherichia coli	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; EFFICIENT PRODUCTION; METABOLIC NETWORK; GENE-CLUSTER; L-TYROSINE; NARINGENIN; BIOSYNTHESIS; RESVERATROL; FLAVANONES; FLAVONOIDS	Due to increasing concerns about food safety and environmental issues, bio-based production of flavonoids from safe, inexpensive, and renewable substrates is increasingly attracting attention. Here, the complete biosynthetic pathway, consisting of 3-deoxy-D-arabinoheptulosonate 7-phosphate synthase (DAHPS), chorismate mutase/prephenate dehydrogenase (CM/PDH), tyrosine ammonia lyase (TAL), 4-coumarate: CoA ligase (4CL), chalcone synthase (CHS), chalcone isomerase (CHI), malonate synthetase, and malonate carrier protein, was constructed using pre-made modules to overproduce (2S)-naringenin from D-glucose. Modular pathway engineering strategies were applied to the production of the flavonoid precursor (2S)-naringenin from L-tyrosine to investigate the metabolic space for efficient conversion. Modular expression was combinatorially tuned by modifying plasmid gene copy numbers and promoter strengths to identify an optimally balanced pathway. Furthermore, a new modular pathway from D-glucose to L-tyrosine was assembled and re-optimized with the identified optimal modules to enable de novo synthesis of (2S)-naringenin. Once this metabolic balance was achieved, the optimum strain was capable of producing 100.64 mg/L (2S)-naringenin directly from D-glucose, which is the highest production titer from D-glucose in Escherichia coli. The fermentation system described here paves the way for the development of an economical process for microbial production of flavonoids.	[Wu, Junjun; Zhou, Tiantian; Du, Guocheng; Zhou, Jingwen; Chen, Jian] Jiangnan Univ, Sch Biotechnol, Wuxi, Jiangsu, Peoples R China; [Du, Guocheng; Zhou, Jingwen; Chen, Jian] Synerget Innovat Ctr Food Safety & Nutr, Wuxi, Jiangsu, Peoples R China	Jiangnan University	Zhou, JW (corresponding author), Jiangnan Univ, Sch Biotechnol, Wuxi, Jiangsu, Peoples R China.	zhoujw1982@jiangnan.edu.cn; jchen@jiangnan.edu.cn			Major State Basic Research Development Program of China (973 Program) [2012CB720806]; National Natural Science Foundation of China [31000807]; Natural Science Foundation of Jiangsu Province [BK2011004, BK2010150]; Fundamental Research Funds for the Central Universities [JUSRP51307A]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China (FANEDD) [2011046]; Program for New Century Excellent Talents in University [NCET-12-0876]; 111 Project [111-2-06]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Foundation for the Author of National Excellent Doctoral Dissertation of PR China (FANEDD)(Foundation for the Author of National Excellent Doctoral Dissertation of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); 111 Project(Ministry of Education, China - 111 Project)	This work was supported by the Major State Basic Research Development Program of China (973 Program, 2012CB720806), National Natural Science Foundation of China (31000807), the Natural Science Foundation of Jiangsu Province (BK2011004, BK2010150), the Fundamental Research Funds for the Central Universities (JUSRP51307A), the Foundation for the Author of National Excellent Doctoral Dissertation of PR China (FANEDD, 2011046), the Program for New Century Excellent Talents in University (NCET-12-0876), and the 111 Project (111-2-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Bhan N, 2013, CURR OPIN BIOTECH, V24, P1137, DOI 10.1016/j.copbio.2013.02.019; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fowler ZL, 2009, APPL ENVIRON MICROB, V75, P5831, DOI 10.1128/AEM.00270-09; Fowler ZL, 2009, APPL MICROBIOL BIOT, V83, P799, DOI 10.1007/s00253-009-2039-z; Hermenean A, 2013, CHEM-BIOL INTERACT, V205, P138, DOI 10.1016/j.cbi.2013.06.016; Hwang EI, 2003, APPL ENVIRON MICROB, V69, P2699, DOI 10.1128/AEM.69.5.2699-2706.2003; Kikuchi Y, 1997, APPL ENVIRON MICROB, V63, P761, DOI 10.1128/AEM.63.2.761-762.1997; Koopman F, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-155; Lee JS, 2005, RAPID COMMUN MASS SP, V19, P3539, DOI 10.1002/rcm.2230; Leonard E, 2008, MOL PHARM, V5, P257, DOI 10.1021/mp7001472; Leonard E, 2007, APPL ENVIRON MICROB, V73, P3877, DOI 10.1128/AEM.00200-07; Lim CG, 2011, APPL ENVIRON MICROB, V77, P3451, DOI 10.1128/AEM.02186-10; Lutke-Eversloh T, 2005, APPL ENVIRON MICROB, V71, P7224, DOI 10.1128/AEM.71.11.7224-7228.2005; Miyahisa I, 2005, APPL MICROBIOL BIOT, V68, P498, DOI 10.1007/s00253-005-1916-3; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Santos CNS, 2012, P NATL ACAD SCI USA, V109, P13538, DOI 10.1073/pnas.1206346109; Santos CNS, 2011, METAB ENG, V13, P392, DOI 10.1016/j.ymben.2011.02.002; Schroeder AC, 2008, PHYTOCHEMISTRY, V69, P1496, DOI 10.1016/j.phytochem.2008.02.007; Vannelli T, 2007, METAB ENG, V9, P142, DOI 10.1016/j.ymben.2006.11.001; Wang YC, 2011, APPL MICROBIOL BIOT, V91, P949, DOI 10.1007/s00253-011-3449-2; Wu JJ, 2013, J BIOTECHNOL, V167, P404, DOI 10.1016/j.jbiotec.2013.07.030; Wu JJ, 2013, METAB ENG, V16, P48, DOI 10.1016/j.ymben.2012.11.009; Xu CW, 2013, BIOL PHARM BULL, V36, P1549, DOI 10.1248/bpb.b13-00247; Xu P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2425; Xu P, 2011, METAB ENG, V13, P578, DOI 10.1016/j.ymben.2011.06.008	26	60	68	3	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101492	10.1371/journal.pone.0101492	http://dx.doi.org/10.1371/journal.pone.0101492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988485	Green Published, Green Submitted, gold			2022-12-27	WOS:000341354100099
J	Catenacci, DVT; Liao, WL; Thyparambil, S; Henderson, L; Xu, P; Zhao, L; Rambo, B; Hart, J; Xiao, SY; Bengali, K; Uzzell, J; Darfler, M; Krizman, DB; Cecchi, F; Bottaro, DP; Karrison, T; Veenstra, TD; Hembrough, T; Burrows, J				Catenacci, Daniel V. T.; Liao, Wei-Li; Thyparambil, Sheeno; Henderson, Les; Xu, Peng; Zhao, Lei; Rambo, Brittany; Hart, John; Xiao, Shu-Yuan; Bengali, Kathleen; Uzzell, Jamar; Darfler, Marlene; Krizman, David B.; Cecchi, Fabiola; Bottaro, Donald P.; Karrison, Theodore; Veenstra, Timothy D.; Hembrough, Todd; Burrows, Jon			Absolute Quantitation of Met Using Mass Spectrometry for Clinical Application: Assay Precision, Stability, and Correlation with MET Gene Amplification in FFPE Tumor Tissue	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; STORED PARAFFIN SLIDES; CELL LUNG-CANCER; C-MET; GASTRIC-CANCER; SIGNALING PATHWAY; KINASE INHIBITOR; THERAPEUTIC TARGET; PROTEIN EXPRESSION; ADENOCARCINOMA	Background: Overexpression of Met tyrosine kinase receptor is associated with poor prognosis. Overexpression, and particularly MET amplification, are predictive of response to Met-specific therapy in preclinical models. Immunohistochemistry (IHC) of formalin-fixed paraffin-embedded (FFPE) tissues is currently used to select for 'high Met' expressing tumors for Met inhibitor trials. IHC suffers from antibody non-specificity, lack of quantitative resolution, and, when quantifying multiple proteins, inefficient use of scarce tissue. Methods: After describing the development of the Liquid-Tissue-Selected Reaction Monitoring-mass spectrometry (LT-SRM-MS) Met assay, we evaluated the expression level of Met in 130 FFPE gastroesophageal cancer (GEC) tissues. We assessed the correlation of SRM Met expression to IHC and mean MET gene copy number (GCN)/nucleus or MET/CEP7 ratio by fluorescence in situ hybridization (FISH). Results: Proteomic mapping of recombinant Met identified (418)TEFTTALQR(426) as the optimal SRM peptide. Limits of detection (LOD) and quantitation (LOQ) for this peptide were 150 and 200 amol/mu g tumor protein, respectively. The assay demonstrated excellent precision and temporal stability of measurements in serial sections analyzed one year apart. Expression levels of 130 GEC tissues ranged (<150 amol/mu g to 4669.5 amol/mu g. High correlation was observed between SRM Met expression and both MET GCN and MET/CEP7 ratio as determined by FISH (n = 30; R-2 = 0.898). IHC did not correlate well with SRM (n = 44; R-2 = 0.537) nor FISH GCN (n = 31; R-2 = 0.509). A Met SRM level of >= 1500 amol/mu g was 100% sensitive (95% CI 0.69-1) and 100% specific (95% CI 0.92-1) for MET amplification. Conclusions: The Met SRM assay measured the absolute Met levels in clinical tissues with high precision. Compared to IHC, SRM provided a quantitative and linear measurement of Met expression, reliably distinguishing between non-amplified and amplified MET tumors. These results demonstrate a novel clinical tool for efficient tumor expression profiling, potentially leading to better informed therapeutic decisions for patients with GEC.	[Catenacci, Daniel V. T.; Henderson, Les; Xu, Peng; Rambo, Brittany] Univ Chicago, Dept Med, Sect Hematol & Oncol, Chicago, IL 60637 USA; [Liao, Wei-Li; Thyparambil, Sheeno; Bengali, Kathleen; Uzzell, Jamar; Darfler, Marlene; Krizman, David B.; Veenstra, Timothy D.; Hembrough, Todd; Burrows, Jon] OncoPlex Diagnost Inc, Rockville, MD USA; [Zhao, Lei; Hart, John; Xiao, Shu-Yuan] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Cecchi, Fabiola; Bottaro, Donald P.] NCI, Urol Oncol Branch, NIH, Bethesda, MD 20892 USA; [Karrison, Theodore] Univ Chicago, Dept Hlth Sci, Chicago, IL 60637 USA	University of Chicago; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Chicago	Catenacci, DVT (corresponding author), Univ Chicago, Dept Med, Sect Hematol & Oncol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	dcatenac@medicine.bsd.uchicago.edu	Bottaro, Donald P/AAF-3853-2020; Bottaro, Donald P/F-8550-2010; Xiao, Shu-Yuan/AAR-7167-2020; Catenacci, Daniel/K-4177-2019	Bottaro, Donald P/0000-0002-5057-5334; Bottaro, Donald P/0000-0002-5057-5334; Xiao, Shu-Yuan/0000-0003-0484-932X; zhao, lei/0000-0003-4322-6475	NIH [CA139160-01A]; CALGB/ALLIANCE YIA Award; Live Like Katie Foundation Award; Oncoplex Dx Research Collaboration; UCCCC (University of Chicago Comprehensive Cancer Center) Award in Precision Oncology (DVTC); NIH, National Cancer Institute, Center for Cancer Research; Oncoplex; University of Chicago; Oncoplex Dx; NATIONAL CANCER INSTITUTE [K12CA139160, ZIABC011124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CALGB/ALLIANCE YIA Award; Live Like Katie Foundation Award; Oncoplex Dx Research Collaboration; UCCCC (University of Chicago Comprehensive Cancer Center) Award in Precision Oncology (DVTC); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Oncoplex; University of Chicago(University of Chicago); Oncoplex Dx; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research was supported in part by NIH K12 award (CA139160-01A), CALGB/ALLIANCE YIA Award, Live Like Katie Foundation Award, Oncoplex Dx Research Collaboration, and UCCCC (University of Chicago Comprehensive Cancer Center) Award in Precision Oncology (DVTC); the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research (DB). A scientific research collaborative agreement between Oncoplex and University of Chicago allowed funding for reagents, expenses towards tissue acquisition and processing, and salaries of laboratory members. The role of each individual author at Oncoplex is as previously indicated, and as employees they received salaries from Oncoplex Dx. The specific roles of each author is outlined in the author contributions section.	ARCHIDIACONO N, 1995, GENOMICS, V25, P477, DOI 10.1016/0888-7543(95)80048-Q; Athauda G, 2006, CLIN CANCER RES, V12, P4154, DOI 10.1158/1078-0432.CCR-06-0250; Bart K, 2014, ROCHE HALTS STUDY EX; Catenacci DVT, 2011, CANCER DISCOV, V1, P573, DOI 10.1158/2159-8290.CD-11-0175; Catenacci DVT, 2011, CANCER BIOL THER, V12, P9, DOI 10.4161/cbt.12.1.15747; Catenacci DVT XP, 2012, 24 EORTC NCI AACR S; Cecchi F, 2012, EXPERT OPIN THER TAR, V16, P553, DOI 10.1517/14728222.2012.680957; Dai Y, 2010, MOL CANCER THER, V9, P1554, DOI 10.1158/1535-7163.MCT-10-0359; Eathiraj S, 2011, J BIOL CHEM, V286, P20666, DOI 10.1074/jbc.M110.213801; Eder JP, 2009, CLIN CANCER RES, V15, P2207, DOI 10.1158/1078-0432.CCR-08-1306; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Gatenacci DVT, 2014, PERSONALIZED TREATME; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Gomez-Martin C, 2013, J CLIN ONCOL, V31, P4445, DOI 10.1200/JCO.2013.48.9070; Graziano F, 2011, J CLIN ONCOL, V29, P4789, DOI 10.1200/JCO.2011.36.7706; Gry M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-365; Hembrough T, 2014, QUANTIFICATION MET E; Hembrough T, 2013, J MOL DIAGN, V15, P454, DOI 10.1016/j.jmoldx.2013.03.002; Hembrough Todd, 2012, Clin Proteomics, V9, P5, DOI 10.1186/1559-0275-9-5; Herrera LJ, 2005, NEOPLASIA, V7, P75, DOI 10.1593/neo.04367; Jacobs T, 1996, LAB INVEST, V74, P88; Khoury J, 2014, ARCH PATHOL IN PRESS; Lee HE, 2012, BRIT J CANCER, V107, P325, DOI 10.1038/bjc.2012.237; Lennerz JK, 2011, J CLIN ONCOL, V29, P4803, DOI 10.1200/JCO.2011.35.4928; Liebler DC, 2013, BIOCHEMISTRY-US, V52, P3797, DOI 10.1021/bi400110b; Liu XD, 2008, EXPERT OPIN INV DRUG, V17, P997, DOI [10.1517/13543784.17.7.997, 10.1517/13543784.17.7.997 ]; Ma PC, 2008, GENE CHROMOSOME CANC, V47, P1025, DOI 10.1002/gcc.20604; Meng ZJ, 2011, J PROTEOMICS, V74, P2650, DOI 10.1016/j.jprot.2011.04.011; Mirlacher M, 2004, MODERN PATHOL, V17, P1414, DOI 10.1038/modpathol.3800208; Oliner KS, 2012, J CLIN ONCOL, V30; Pan BS, 2010, CANCER RES, V70, P1524, DOI 10.1158/0008-5472.CAN-09-2541; Peters S, 2012, NAT REV CLIN ONCOL, V9, P314, DOI 10.1038/nrclinonc.2012.71; PRIOLEAU J, 1995, NEW ENGL J MED, V332, P1521, DOI 10.1056/NEJM199506013322217; Puri N, 2007, CANCER RES, V67, P3529, DOI 10.1158/0008-5472.CAN-06-4416; Raghav KP, 2012, CLIN CANCER RES, V18, P2269, DOI 10.1158/1078-0432.CCR-11-2830; Rickert KW, 2011, J BIOL CHEM, V286, P11218, DOI 10.1074/jbc.M110.204404; Sadiq AA, 2013, J CLIN ONCOL, V31, P1089, DOI 10.1200/JCO.2012.43.9422; Sauter G, 2003, NAT REV DRUG DISCOV, V2, P962, DOI 10.1038/nrd1254; Sehdev A, 2013, DISCOV MED, V16, P103; Shah MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054014; Sharma Neelesh, 2011, Ther Adv Med Oncol, V3, pS37, DOI 10.1177/1758834011423403; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; Spigel DR, 2013, J CLIN ONCOL, V31, P4105, DOI 10.1200/JCO.2012.47.4189; Stabile LP, 2008, MOL CANCER THER, V7, P1913, DOI 10.1158/1535-7163.MCT-07-2169; Stricker T, 2011, SEMIN ONCOL, V38, P173, DOI 10.1053/j.seminoncol.2011.01.013; Toiyama Y, 2012, INT J CANCER, V130, P2912, DOI 10.1002/ijc.26330; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; von Ahlfen S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001261; Zhao J, 2011, HISTOL HISTOPATHOL, V26, P1111, DOI 10.14670/HH-26.1111	50	46	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100586	10.1371/journal.pone.0100586	http://dx.doi.org/10.1371/journal.pone.0100586			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983965	Green Published, Green Submitted, gold			2022-12-27	WOS:000339635000030
J	Choy, E; MacConaill, LE; Cote, GM; Le, LP; Shen, JK; Nielsen, GP; Iafrate, AJ; Garraway, LA; Hornicek, FJ; Duan, ZF				Choy, Edwin; MacConaill, Laura E.; Cote, Gregory M.; Le, Long P.; Shen, Jacson K.; Nielsen, Gunnlaugur P.; Iafrate, Anthony J.; Garraway, Levi A.; Hornicek, Francis J.; Duan, Zhenfeng			Genotyping Cancer-Associated Genes in Chordoma Identifies Mutations in Oncogenes and Areas of Chromosomal Loss Involving CDKN2A, PTEN, and SMARCB1	PLOS ONE			English	Article							MALIGNANT RHABDOID TUMORS; SWI/SNF COMPLEXES; LUNG-CANCER; INHIBITION; REEXPRESSION; COMBINATION; EFFICACY; IMPACT; GROWTH; SPINE	The molecular mechanisms underlying chordoma pathogenesis are unknown. We therefore sought to identify novel mutations to better understand chordoma biology and to potentially identify therapeutic targets. Given the relatively high costs of whole genome sequencing, we performed a focused genetic analysis using matrix-assisted laser desorption/ionization-time of flight mass spectrometer (Sequenom iPLEX genotyping). We tested 865 hotspot mutations in 111 oncogenes and selected tumor suppressor genes (OncoMap v.3.0) of 45 human chordoma tumor samples. Of the analyzed samples, seven were identified with at least one mutation. Six of these were from fresh frozen samples, and one was from a paraffin embedded sample. These observations were validated using an independent platform using homogeneous mass extend MALDI-TOF (Sequenom hME Genotyping). These genetic alterations include: ALK (A877S), CTNNB1 (T41A), NRAS (Q61R), PIK3CA (E545K), PTEN (R130), CDKN2A (R58*), and SMARCB1 (R40*). This study reports on the largest comprehensive mutational analysis of chordomas performed to date. To focus on mutations that have the greatest chance of clinical relevance, we tested only oncogenes and tumor suppressor genes that have been previously implicated in the tumorigenesis of more common malignancies. We identified rare genetic changes that may have functional significance to the underlying biology and potential therapeutics for chordomas. Mutations in CDKN2A and PTEN occurred in areas of chromosomal copy loss. When this data is paired with the studies showing 18 of 21 chordoma samples displaying copy loss at the locus for CDKN2A, 17 of 21 chordoma samples displaying copy loss at PTEN, and 3 of 4 chordoma samples displaying deletion at the SMARCB1 locus, we can infer that a loss of heterozygosity at these three loci may play a significant role in chordoma pathogenesis.	[Choy, Edwin; Cote, Gregory M.] Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA; [Choy, Edwin; Cote, Gregory M.; Shen, Jacson K.; Hornicek, Francis J.; Duan, Zhenfeng] Massachusetts Gen Hosp, Ctr Sarcoma & Connect Tissue Oncol, Sarcoma Biol Lab, Boston, MA 02114 USA; [MacConaill, Laura E.; Garraway, Levi A.] Harvard Univ, Sch Med, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [MacConaill, Laura E.; Garraway, Levi A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Le, Long P.; Nielsen, Gunnlaugur P.; Iafrate, Anthony J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts General Hospital	Choy, E (corresponding author), Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA.	echoy@partners.org		Cote, Gregory/0000-0003-0181-886X	Jennifer Hunter Yates Foundation; Stephan L. Harris Chordoma Fund; Cassandra Moseley Berry Sarcoma Endowed Fund; Gategno Fund; Wechsler Fund; KL2 Medical Research Investigator Training (MeRIT) grant (National Institutes of Health) [1KL2RR025757-01]; Harvard University; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025757] Funding Source: NIH RePORTER	Jennifer Hunter Yates Foundation; Stephan L. Harris Chordoma Fund; Cassandra Moseley Berry Sarcoma Endowed Fund; Gategno Fund; Wechsler Fund; KL2 Medical Research Investigator Training (MeRIT) grant (National Institutes of Health); Harvard University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This project was supported in part by the Jennifer Hunter Yates Foundation, the Stephan L. Harris Chordoma Fund, the Cassandra Moseley Berry Sarcoma Endowed Fund, the Gategno and Wechsler Funds, and the KL2 Medical Research Investigator Training (MeRIT) grant awarded to E.C. through Harvard Catalyst/The Harvard Clinical and Translational Science Center (National Institutes of Health grant 1KL2RR025757-01), and by financial contributions from Harvard University and its affiliated academic health care centers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimova I, 2013, NEURO-ONCOLOGY, V15, P149, DOI 10.1093/neuonc/nos285; Biermann JS, 2013, J NATL COMPR CANC NE, V11, P688, DOI 10.6004/jnccn.2013.0088; Bydon M, 2012, EXPERT OPIN THER TAR, V16, P1139, DOI 10.1517/14728222.2012.714772; Chen YL, 2013, SPINE, V38, pE930, DOI 10.1097/BRS.0b013e318296e7d7; Choy E, 2012, CANCER-AM CANCER SOC, V118, P2905, DOI 10.1002/cncr.26617; Dalpra L, 1999, INT J CANCER, V81, P24, DOI 10.1002/(SICI)1097-0215(19990331)81:1<24::AID-IJC5>3.3.CO;2-F; de Castro CV, 2013, HUM PATHOL, V44, P1747, DOI 10.1016/j.humpath.2012.11.024; DeLaney TF, 2009, INT J RADIAT ONCOL, V74, P732, DOI 10.1016/j.ijrobp.2008.08.058; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Di Maio S, 2012, NEUROSURGERY, V70, P1355, DOI 10.1227/NEU.0b013e3182446783; Diaz RJ, 2012, NEOPLASIA, V14, P788, DOI 10.1593/neo.12526; El-Khoueiry AB, 2013, J CLIN ONCOL, V31; Fernandez-Miranda JC, 2014, HEAD NECK-J SCI SPEC, V36, P892, DOI 10.1002/hed.23415; Housari G, 2013, CLIN TRANSL ONCOL, V15, P327, DOI 10.1007/s12094-012-0919-7; Imbalzano AN, 2005, CANCER CELL, V7, P294, DOI 10.1016/j.ccr.2005.04.001; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kadoch C, 2013, CELL, V153, P71, DOI 10.1016/j.cell.2013.02.036; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Knutson SK, 2013, P NATL ACAD SCI USA, V110, P7922, DOI 10.1073/pnas.1303800110; Koutourousiou M, 2011, OTOLARYNG CLIN N AM, V44, P1155, DOI 10.1016/j.otc.2011.06.002; Kuwahara Y, 2013, MOL CANCER RES, V11, P251, DOI 10.1158/1541-7786.MCR-12-0390; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Le LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018846; Lewandrowski KU, 2004, SPINE, V29, P1150, DOI 10.1097/00007632-200405150-00019; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Mobley BC, 2010, ACTA NEUROPATHOL, V120, P745, DOI 10.1007/s00401-010-0767-x; Nibu Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/826435; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Park L, 2006, INT J RADIAT ONCOL, V65, P1514, DOI 10.1016/j.ijrobp.2006.02.059; Scheil S, 2001, GENE CHROMOSOME CANC, V32, P203, DOI 10.1002/gcc.1184; Schwab J, 2009, ANTICANCER RES, V29, P1867; Schwab JH, 2012, J BONE JOINT SURG AM, V94A, P1913, DOI 10.2106/JBJS.L.00955; Seward S, 2013, CANCER LETT, V336, P53, DOI 10.1016/j.canlet.2013.04.012; Smoll NR, 2013, CANCER-AM CANCER SOC, V119, P2029, DOI 10.1002/cncr.28032; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Wagner TD, 2009, INT J RADIAT ONCOL, V73, P259, DOI 10.1016/j.ijrobp.2008.03.074; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; Xia MH, 2013, CANCER BIOL THER, V14, P638, DOI 10.4161/cbt.24596; Yang C, 2009, MOL CANCER THER, V8, P2597, DOI 10.1158/1535-7163.MCT-09-0504	42	59	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101283	10.1371/journal.pone.0101283	http://dx.doi.org/10.1371/journal.pone.0101283			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983247	gold, Green Published, Green Submitted			2022-12-27	WOS:000339635000083
J	Gonzaga, AD; Albuquerque, MR; Malloy-Diniz, LF; Greco, PJ; da Costa, IT				Gonzaga, Adeilton dos Santos; Albuquerque, Maicon Rodrigues; Malloy-Diniz, Leandro Fernandes; Greco, Pablo Juan; da Costa, Israel Teoldo			Affective Decision-Making and Tactical Behavior of Under-15 Soccer Players	PLOS ONE			English	Article							IOWA GAMBLING TASK; EXECUTIVE FUNCTIONS; DYNAMICS; EMOTION; SKILLS; MIND; HOT	Affective decision-making is a type of Executive Function related to cost benefit analysis in situations where gains and losses imply direct consequences for the subject. The purpose of this study was to explore the influence of the affective decision-making on tactical behavior in soccer players under the age of 15 years old. The System of Tactical Assessment in Soccer (FUT-SAT) was used to assess tactical behavior. To evaluate affective decision-making, we used the neuropsychological test called The Iowa Gambling Task (IGT). The values of the offensive, defensive and game tactical behavior of participants were used to create performance groups. The low (<= 25%) and high (>= 75%) groups, according to offensive, defensive and game tactical behavior, were compared and shown to be different. The values of the IGT net score of the participants with low and high tactical behavior were compared using the non-parametric Mann-Whitney test. Statistically significant differences between the groups were observed for Defensive Tactical Behavior (Z = -3.133; p = 0.002; r = -0.355) and Game Tactical Behavior (Z = -2.267; p = 0.023; r = -0.260). According to these results, it is possible to state that affective decision-making can influence the tactical behavior of under-15 soccer players.	[Gonzaga, Adeilton dos Santos; Albuquerque, Maicon Rodrigues; da Costa, Israel Teoldo] Univ Fed Vicosa, Dept Phys Educ, Vicosa, MG, Brazil; [Malloy-Diniz, Leandro Fernandes] Univ Fed Minas Gerais, Dept Mental Hlth, Belo Horizonte, MG, Brazil; [Greco, Pablo Juan] Univ Fed Minas Gerais, Sports Dept, Belo Horizonte, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Albuquerque, MR (corresponding author), Univ Fed Vicosa, Dept Phys Educ, Vicosa, MG, Brazil.	maicon@ufv.br	Malloy-Diniz, Leandro Fernandes/AAR-4025-2021; Albuquerque, Maicon Rodrigues/I-6227-2013; Teoldo, Israel IT/J-8510-2016; Malloy-Diniz, Leandro/D-7829-2013	Malloy-Diniz, Leandro Fernandes/0000-0002-6606-1354; Albuquerque, Maicon Rodrigues/0000-0001-6021-8480; Malloy-Diniz, Leandro/0000-0002-6606-1354	State Department of Sport and Youth of Minas Gerais (SEEJMG) through the State Act of Incentive to Sports; FAPEMIG; CAPES; CNPQ; FUNARBE; Dean's Office for Graduate and Research Studies; Center of Life and Health Sciences from the Federal University of Vicosa, Brazil	State Department of Sport and Youth of Minas Gerais (SEEJMG) through the State Act of Incentive to Sports; FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FUNARBE; Dean's Office for Graduate and Research Studies; Center of Life and Health Sciences from the Federal University of Vicosa, Brazil	This study was funded by the State Department of Sport and Youth of Minas Gerais (SEEJMG) through the State Act of Incentive to Sports; by FAPEMIG, CAPES, CNPQ, FUNARBE, the Dean's Office for Graduate and Research Studies and the Center of Life and Health Sciences from the Federal University of Vicosa, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; [Anonymous], 2017, INT J PERFOMANCE ANA, DOI [10.1080/24748668.2007.11868383, DOI 10.1080/24748668.2007.11868383]; Araujo D, 2006, PSYCHOL SPORT EXERC, V7, P653, DOI 10.1016/j.psychsport.2006.07.002; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 2004, BRAIN COGNITION, V55, P30, DOI 10.1016/j.bandc.2003.04.001; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Costa I.T., 2011, MOTRICIDADE, V7, P69, DOI [DOI 10.6063/MOTRICIDADE.7(1).121, 10.6063/motricidade.121, DOI 10.6063/MOTRICIDADE.121]; da Costa IT, 2010, INT J PERF ANAL SPOR, V10, P82, DOI 10.1080/24748668.2010.11868504; EKBLOM B, 1986, SPORTS MED, V3, P50, DOI 10.2165/00007256-198603010-00005; Elferink-Gemser MT, 2004, PERCEPT MOTOR SKILL, V99, P883, DOI 10.2466/PMS.99.7.883-895; Ernst M, 2006, PSYCHOL MED, V36, P299, DOI 10.1017/S0033291705005891; Ernst M, BRAIN COGNI IN PRESS; Garganta J., 2009, REV PORTUGUESA CIENC, V9, P115, DOI [DOI 10.5628/RPCD.09.01.115, 10.5628/rpcd.09.01.115]; Garon N, 2004, BRAIN COGNITION, V55, P158, DOI 10.1016/s0278-2626(03)00272-0; Grehaigne JF, 2011, REV PSICOL DEPORTE, V20, P747; Grehaigne JF, 1997, J SPORT SCI, V15, P137, DOI 10.1080/026404197367416; Grehaigne JF, 2001, QUEST, V53, P59, DOI 10.1080/00336297.2001.10491730; GREHAIGNE JF, 1995, QUEST, V47, P490, DOI 10.1080/00336297.1995.10484171; Kannekens R, 2009, J SPORT SCI, V27, P807, DOI 10.1080/02640410902894339; Kerr A, 2004, BRAIN COGNITION, V55, P148, DOI 10.1016/s0278-2626(03)00275-6; Lees A, 1998, J SPORT SCI, V16, P211, DOI 10.1080/026404198366740; Malloy-Diniz, 2011, PSYCHOLOGY, V02, P721, DOI [10.4236/psych.2011.27110, DOI 10.4236/PSYCH.2011.27110]; Malloy-Diniz LF, 2008, REV BRAS PSIQUIATR, V30, P144, DOI 10.1590/S1516-44462008005000009; MCPHERSON SL, 1994, QUEST, V46, P223, DOI 10.1080/00336297.1994.10484123; Prencipe A, 2011, J EXP CHILD PSYCHOL, V108, P621, DOI 10.1016/j.jecp.2010.09.008; Roca A, 2011, COGN PROCESS, V12, P301, DOI 10.1007/s10339-011-0392-1; Sampaio J, 2012, INT J SPORTS MED, V33, P395, DOI 10.1055/s-0031-1301320; Shephard RJ, 1999, J SPORT SCI, V17, P757, DOI 10.1080/026404199365498; Smith DG, 2012, DEV PSYCHOL, V48, P1180, DOI 10.1037/a0026342; Steinberg L, 2005, TRENDS COGN SCI, V9, P69, DOI 10.1016/j.tics.2004.12.005; Stuss DT, 2004, BRAIN COGNITION, V55, P69, DOI 10.1016/s0278-2626(03)00271-9; STUSS DT, 1992, BRAIN COGNITION, V20, P8, DOI 10.1016/0278-2626(92)90059-U; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Torralva T, 2007, NEUROPSYCHOLOGIA, V45, P342, DOI 10.1016/j.neuropsychologia.2006.05.031; Vestberg T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034731; WILLIAMS M, 1995, J SPORT EXERCISE PSY, V17, P259, DOI 10.1123/jsep.17.3.259; Zelazo P. D., 2002, HDB CHILDHOOD COGNIT, P445, DOI [10.1002/9780470996652.ch20, DOI 10.1002/9780470996652.CH20]	38	27	32	4	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101231	10.1371/journal.pone.0101231	http://dx.doi.org/10.1371/journal.pone.0101231			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK5ZO	24978030	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400103
J	Romas, LM; Hasselrot, K; Aboud, LG; Birse, KD; Ball, TB; Broliden, K; Burgener, AD				Romas, Laura M.; Hasselrot, Klara; Aboud, Lindsay G.; Birse, Kenzie D.; Ball, T. Blake; Broliden, Kristina; Burgener, Adam D.			A Comparative Proteomic Analysis of the Soluble Immune Factor Environment of Rectal and Oral Mucosa	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LEUKOCYTE PROTEASE INHIBITOR; PROLINE-RICH PROTEINS; UNINFECTED INDIVIDUALS; HIV-1 INFECTIVITY; NEUTRALIZING IGA; IMMUNOGLOBULIN-A; ALPHA-DEFENSINS; EARLY STEPS; SERPIN A1	Objective: Sexual transmission of HIV occurs across a mucosal surface, which contains many soluble immune factors important for HIV immunity. Although the composition of mucosal fluids in the vaginal and oral compartments has been studied extensively, the knowledge of the expression of these factors in the rectal mucosa has been understudied and is very limited. This has particular relevance given that the highest rates of HIV acquisition occur via the rectal tract. To further our understanding of rectal mucosa, this study uses a proteomics approach to characterize immune factor components of rectal fluid, using saliva as a comparison, and evaluates its antiviral activity against HIV. Methods: Paired salivary fluid (n = 10) and rectal lavage fluid (n = 10) samples were collected from healthy, HIV seronegative individuals. Samples were analyzed by label-free tandem mass spectrometry to comprehensively identify and quantify mucosal immune protein abundance differences between saliva and rectal fluids. The HIV inhibitory capacity of these fluids was further assessed using a TZM-bl reporter cell line. Results: Of the 315 proteins identified in rectal lavage fluid, 72 had known immune functions, many of which have described anti-HIV activity, including cathelicidin, serpins, cystatins and antileukoproteinase. The majority of immune factors were similarly expressed between fluids, with only 21 differentially abundant (p<0.05, multiple comparison corrected). Notably, rectal mucosa had a high abundance of mucosal immunoglobulins and antiproteases relative to saliva, Rectal lavage limited HIV infection by 40-50% in vitro (p<0.05), which is lower than the potent anti-HIV effect of oral mucosal fluid (70-80% inhibition, p<0.005). Conclusions: This study reveals that rectal mucosa contains many innate immune factors important for host immunity to HIV and can limit viral replication in vitro. This indicates an important role for this fluid as the first line of defense against HIV.	[Romas, Laura M.; Aboud, Lindsay G.; Birse, Kenzie D.; Ball, T. Blake; Burgener, Adam D.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Hasselrot, Klara] Karolinska Univ Hosp, Ctr Mol Med, Karolinska Inst, Dept Med Solna,Unit Infect Dis, Stockholm, Sweden; [Ball, T. Blake; Broliden, Kristina; Burgener, Adam D.] Publ Hlth Agcy Canada, Natl Lab HIV Immunol, Winnipeg, MB, Canada; [Ball, T. Blake] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada	University of Manitoba; Karolinska Institutet; Karolinska University Hospital; Public Health Agency of Canada; University of Manitoba	Burgener, AD (corresponding author), Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada.	burgener@cc.umanitoba.ca			Canadian Institute for Health Research [CIHR HOP123802]; Public Health Agency of Canada; Swedish Research Council; Swedish Physicians against AIDS foundation	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Public Health Agency of Canada; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Physicians against AIDS foundation	This work is funded through the Canadian Institute for Health Research (www.cihr-irsc.gc.ca; CIHR HOP123802), the Public Health Agency of Canada (www.phac-aspc.gc.ca), the Swedish Research Council (www.vr.se), and the Swedish Physicians against AIDS foundation (www.aidsfond.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboud L, 2014, AM J REPROD IMMUNOL, V71, P12, DOI 10.1111/aji.12166; Amado F, 2010, EXPERT REV PROTEOMIC, V7, P709, DOI [10.1586/epr.10.48, 10.1586/EPR.10.48]; ARCHIBALD DW, 1990, AIDS RES HUM RETROV, V6, P1425, DOI 10.1089/aid.1990.6.1425; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Baggaley RF, 2008, INT J EPIDEMIOL, V37, P1255, DOI 10.1093/ije/dyn151; Berbee JFP, 2005, J ENDOTOXIN RES, V11, P97, DOI 10.1179/096805105X35215; BERGEY EJ, 1994, J ACQ IMMUN DEF SYND, V7, P995; Bingle L, 1996, THORAX, V51, P1273, DOI 10.1136/thx.51.12.1273; Bolscher JGM, 2002, EUR J ORAL SCI, V110, P149, DOI 10.1034/j.1600-0722.2002.11175.x; Burgener A, 2013, J VIROL; Burgener A, 2012, AIDS, V26, P1857, DOI 10.1097/QAD.0b013e328357f79c; Butler MW, 2006, J BIOL CHEM, V281, P34730, DOI 10.1074/jbc.M604844200; Campo J, 2006, ORAL DIS, V12, P219, DOI 10.1111/j.1601-0825.2005.01187.x; Congote LF, 2006, BIOCHEM BIOPH RES CO, V343, P617, DOI 10.1016/j.bbrc.2006.02.190; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Devito C, 2000, J IMMUNOL, V165, P5170, DOI 10.4049/jimmunol.165.9.5170; Devito C, 2002, J ACQ IMMUN DEF SYND, V30, P413, DOI [10.1097/00042560-200208010-00007, 10.1097/01.QAI.0000021664.20213.5A]; Edwards S, 1998, SEX TRANSM INFECT, V74, P6, DOI 10.1136/sti.74.1.6; ELLISON RT, 1990, J GEN MICROBIOL, V136, P1437, DOI 10.1099/00221287-136-7-1437; Fahey JV, 2011, AM J REPROD IMMUNOL, V65, P334, DOI 10.1111/j.1600-0897.2010.00949.x; Furci L, 2007, BLOOD, V109, P2928, DOI 10.1182/blood-2006-05-024489; Furci L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045208; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; GOLDMAN AS, 1973, J PEDIATR-US, V82, P1082, DOI 10.1016/S0022-3476(73)80453-6; GU M, 1995, ORAL MICROBIOL IMMUN, V10, P54, DOI 10.1111/j.1399-302X.1995.tb00118.x; HARMSEN MC, 1995, J INFECT DIS, V172, P380, DOI 10.1093/infdis/172.2.380; Hasselrot K, 2009, AIDS, V23, P329, DOI 10.1097/QAD.0b013e32831f924c; Hasselrot K, 2010, AIDS, V24, P1569, DOI 10.1097/QAD.0b013e32833ac646; Hasselrot K, 2010, AIDS, V24, P35, DOI 10.1097/QAD.0b013e3283329853; Henriksen PA, 2004, J IMMUNOL, V172, P4535, DOI 10.4049/jimmunol.172.7.4535; Heo SM, 2013, INFECT IMMUN; Heutinck KM, 2010, MOL IMMUNOL, V47, P1943, DOI 10.1016/j.molimm.2010.04.020; Hirbod T, 2008, AIDS, V22, P727, DOI 10.1097/QAD.0b013e3282f56b64; Hur EM, 2012, BLOOD, V120, P4571, DOI 10.1182/blood-2012-04-422303; Janeway CA., 2001, IMMUNOBIOLOGY IMMUNE; Kang SS, 2012, COMP IMMUNOL MICROB, V35, P345, DOI 10.1016/j.cimid.2012.02.003; Kopitar-Jerala N, 2006, FEBS LETT, V580, P6295, DOI 10.1016/j.febslet.2006.10.055; Lamm ME, 1997, ANNU REV MICROBIOL, V51, P311, DOI 10.1146/annurev.micro.51.1.311; Levinson P, 2009, AIDS, V23, P309, DOI 10.1097/QAD.0b013e328321809c; Luciano-Montalvo C, 2009, PLACENTA, V30, P464, DOI 10.1016/j.placenta.2009.03.003; Ma G, 2004, J EXP MED, V200, P1337, DOI 10.1084/jem.20041115; Malamud D, 1997, Oral Dis, V3 Suppl 1, pS58; Mangan MSJ, 2008, TISSUE ANTIGENS, V72, P1, DOI 10.1111/j.1399-0039.2008.01059.x; Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41; MCNEELY TB, 1995, J CLIN INVEST, V96, P456, DOI 10.1172/JCI118056; Moriuchi H, 2000, J VIROL, V74, P6849, DOI 10.1128/JVI.74.15.6849-6855.2000; Munch J, 2007, CELL, V129, P263, DOI 10.1016/j.cell.2007.02.042; Newman F, 1996, ELECTROPHORESIS, V17, P266, DOI 10.1002/elps.1150170146; Ogawa Y, 2013, CELL HOST MICROBE, V13, P77, DOI 10.1016/j.chom.2012.12.002; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Platt EJ, 2009, J VIROL, V83, P8289, DOI 10.1128/JVI.00709-09; Purchiaroni F, 2013, EUR REV MED PHARMACO, V17, P323; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Rahman S, 2013, AM J REPROD IMMUNOL, V69, P64, DOI 10.1111/aji.12014; Rapista A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-45; Rivera-Rivera L, 2012, J NEUROVIROL, V18, P20, DOI 10.1007/s13365-011-0061-2; Robinovitch MR, 2001, ORAL DIS, V7, P86, DOI 10.1034/j.1601-0825.2001.0070204.x; Rodriguez-Garcia M, 2013, J REPROD IMMUNOL, V97, P74, DOI 10.1016/j.jri.2012.10.010; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Shapiro L, 2001, FASEB J, V15, P115, DOI 10.1096/fj.00-0311com; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Sheng YH, 2012, MUCOSAL IMMUNOL; Shugars DC, 1999, J INFECT DIS, V179, pS431, DOI 10.1086/314799; Shugars DC, 1999, ARCH ORAL BIOL, V44, P445, DOI 10.1016/S0003-9969(99)00003-5; Simpson AJ, 1999, FEBS LETT, V452, P309, DOI 10.1016/S0014-5793(99)00670-5; Steinstraesser L, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-2; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; UNAIDS, 2011, CRIM HIV NOND EXP TR; UNAIDS, 2009, REP GLOB AIDS EP; Verani Alessia, 2002, Current Molecular Medicine (Hilversum), V2, P691, DOI 10.2174/1566524023361862; Viani RM, 1999, AIDS, V13, P1273, DOI 10.1097/00002030-199907090-00018; Wang LH, 2012, GENET MOL RES, V11, P3766, DOI 10.4238/2012.October.15.8; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weinberg A, 1998, CRIT REV ORAL BIOL M, V9, P399, DOI 10.1177/10454411980090040201; WHITE SH, 1995, CURR OPIN STRUC BIOL, V5, P521, DOI 10.1016/0959-440X(95)80038-7; Williams SE, 2006, CLIN SCI, V110, P21, DOI 10.1042/CS20050115; Wingens M, 1998, J INVEST DERMATOL, V111, P996, DOI 10.1046/j.1523-1747.1998.00425.x; Wittek Natalia, 2010, Przegl Lek, V67, P484; Wong JH, 2011, PEPTIDES, V32, P1117, DOI 10.1016/j.peptides.2011.04.017; Woof JM, 2006, J PATHOL, V208, P270, DOI 10.1002/path.1877; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zhou XY, 2011, J IMMUNOL, V186, P3148, DOI 10.4049/jimmunol.1001358	83	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100820	10.1371/journal.pone.0100820	http://dx.doi.org/10.1371/journal.pone.0100820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978053	Green Published, gold, Green Submitted			2022-12-27	WOS:000338506400043
J	Wan, X; Liu, JM; Cheung, WK; Tong, TJ				Wan, Xiang; Liu, Jiming; Cheung, William K.; Tong, Tiejun			Inferring Epidemic Network Topology from Surveillance Data	PLOS ONE			English	Article							INTERNATIONAL SPREAD; INFECTIOUS-DISEASES; POPULATION BIOLOGY; TRANSMISSION; INFLUENZA; FORECAST; DYNAMICS; MODELS; SEIR	The transmission of infectious diseases can be affected by many or even hidden factors, making it difficult to accurately predict when and where outbreaks may emerge. One approach at the moment is to develop and deploy surveillance systems in an effort to detect outbreaks as timely as possible. This enables policy makers to modify and implement strategies for the control of the transmission. The accumulated surveillance data including temporal, spatial, clinical, and demographic information, can provide valuable information with which to infer the underlying epidemic networks. Such networks can be quite informative and insightful as they characterize how infectious diseases transmit from one location to another. The aim of this work is to develop a computational model that allows inferences to be made regarding epidemic network topology in heterogeneous populations. We apply our model on the surveillance data from the 2009 H1N1 pandemic in Hong Kong. The inferred epidemic network displays significant effect on the propagation of infectious diseases.	[Wan, Xiang; Liu, Jiming; Cheung, William K.] Hong Kong Baptist Univ, Dept Comp Sci, Kowloon, Hong Kong, Peoples R China; [Wan, Xiang; Tong, Tiejun] Hong Kong Baptist Univ, Inst Theoret & Computat Study, Kowloon, Hong Kong, Peoples R China; [Tong, Tiejun] Hong Kong Baptist Univ, Dept Math, Kowloon, Hong Kong, Peoples R China	Hong Kong Baptist University; Hong Kong Baptist University; Hong Kong Baptist University	Wan, X (corresponding author), Hong Kong Baptist Univ, Dept Comp Sci, Kowloon, Hong Kong, Peoples R China.	xwan@comp.hkbu.edu.hk; jiming@comp.hkbu.edu.hk	Tong, Tiejun/F-3880-2010	Tong, Tiejun/0000-0003-0947-3990; Liu, Jiming/0000-0002-8669-9064; Cheung, William Kwok Wai/0000-0002-7428-2050	Hong Kong Baptist University [FRG1/13-14/021]	Hong Kong Baptist University	This study was supported by grants (FRG1/13-14/021) from Hong Kong Baptist University, who also supported the publication costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allen LJS, 2008, LECT NOTES MATH, V1945, P81, DOI 10.1007/978-3-540-78911-6_3; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; Bailey NTJ, 1975, MATH THEORY INFECT D; Becker N, 2002, J ROYAL STAT SOC B, V61, P287; Boguna M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.028701; Chen ZS, 2005, IEEE T NEURAL NETWOR, V16, P1291, DOI 10.1109/TNN.2005.853425; Cohen J, 2009, SCIENCE, V324, P572, DOI 10.1126/science.324_572; Colizza V, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-34; Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Gustafsson L, 2007, MATH BIOSCI, V209, P361, DOI 10.1016/j.mbs.2007.02.004; HETHCOTE H W, 1976, Mathematical Biosciences, V28, P335, DOI 10.1016/0025-5564(76)90132-2; Hollingsworth TD, 2006, NAT MED, V12, P497, DOI 10.1038/nm0506-497; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Kermack WO, 1932, P R SOC LOND A-CONTA, V138, P55, DOI 10.1098/rspa.1932.0171; Kuperman M, 2001, PHYS REV LETT, V86, P2909, DOI 10.1103/PhysRevLett.86.2909; KUZNETSOV YA, 1994, J MATH BIOL, V32, P109, DOI 10.1007/BF00163027; LI MY, 1995, MATH BIOSCI, V125, P155, DOI 10.1016/0025-5564(95)92756-5; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Luke DA, 2007, ANNU REV PUBL HEALTH, V28, P69, DOI 10.1146/annurev.publhealth.28.021406.144132; MAY RM, 1979, NATURE, V280, P455, DOI 10.1038/280455a0; Mitchell Melanie, 1994, Artificial Life, V1, P267, DOI 10.1162/artl.1994.1.3.267; Newman MEJ, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.021904; Opper M, 2001, ADV MEAN FIELD METHO; Papoulis A., 1991, PROBABILITY RANDOM V; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.035108; Pastor-Satorras R, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066117; Pastor-Satorras R, 2002, CONDMAT0205260 ARXIV; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Riley S, 2006, P NATL ACAD SCI USA, V103, P12637, DOI 10.1073/pnas.0510873103; Rogers E.M., 1995, DIFFUSION INNOVATION; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Tizzoni M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-165; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; West JD, 2010, COLL RES LIBR, V71, P236, DOI 10.5860/0710236	38	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100661	10.1371/journal.pone.0100661	http://dx.doi.org/10.1371/journal.pone.0100661			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979215	gold, Green Published, Green Submitted			2022-12-27	WOS:000338506400036
J	Harbi, D; Harrison, PM				Harbi, Djamel; Harrison, Paul M.			Interaction Networks of Prion, Prionogenic and Prion-Like Proteins in Budding Yeast, and Their Role in Gene Regulation	PLOS ONE			English	Article							COILED COILS; COMPOSITIONAL BIAS; RICH DOMAINS; PREDICTION; SEQUENCES; PSI+; IDENTIFICATION; AGGREGATION; PROTEOMES; REGIONS	Prions are transmissible, propagating alternative states of proteins. Prions in budding yeast propagate heritable phenotypes and can function in large-scale gene regulation, or in some cases occur as diseases of yeast. Other 'prionogenic' proteins are likely prions that have been determined experimentally to form amyloid in vivo, and to have prion-like domains that are able to propagate heritable states. Furthermore, there are over 300 additional 'prion-like' yeast proteins that have similar amino-acid composition to prions (primarily a bias for asparagines and glutamines). Here, we examine the protein functional and interaction networks that involve prion, prionogenic and prion-like proteins. Set against a marked overall preference for N/Q-rich prion-like proteins not to interact with each other, we observe a significant tendency of prion/prionogenic proteins to interact with other, N/Q-rich prion-like proteins. This tendency is mostly due to a small number of networks involving the proteins NUP100p, LSM4p and PUB1p. In general, different data analyses of functional and interaction networks converge to indicate a strong linkage of prionogenic and prion-like proteins, to stress-granule assembly and related biological processes. These results further elucidate how prions may impact gene regulation, and reveal a broader horizon for the functional relevance of N/Q-rich prion-like domains.	[Harbi, Djamel; Harrison, Paul M.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Harrison, PM (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	paul.harrison@mcgill.ca			National Science and Engineering Research Council of Canada	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Discovery grant from the National Science and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ader C, 2010, P NATL ACAD SCI USA, V107, P6281, DOI 10.1073/pnas.0910163107; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Brown JCS, 2009, GENE DEV, V23, P2320, DOI 10.1101/gad.1839109; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Angarica VE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-316; Fiumara F, 2010, CELL, V143, P1121, DOI 10.1016/j.cell.2010.11.042; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Gsponer J, 2009, PROG BIOPHYS MOL BIO, V99, P94, DOI 10.1016/j.pbiomolbio.2009.03.001; Halfmann R, 2012, PRION, V6, P391, DOI 10.4161/pri.20199; Harbi D, 2014, PRION, V8, P161, DOI 10.4161/pri.27960; Harbi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031785; Harbi D, 2011, DATABASE-OXFORD, DOI 10.1093/database/baq031; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Harrison LB, 2007, J MOL BIOL, V368, P273, DOI 10.1016/j.jmb.2007.01.070; Harrison PM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-441; Harrison PM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r40; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Hiramatsu N, 2012, PROTEIN SCI, V21, P1481, DOI 10.1002/pro.2137; Holmes DL, 2013, CELL, V153, P153, DOI 10.1016/j.cell.2013.02.026; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Kim DH, 2008, MOL CELL BIOL, V28, P913, DOI 10.1128/MCB.01140-07; Klucevsek KM, 2012, GENETICS, V191, P1107, DOI 10.1534/genetics.112.141713; Kryndushkin D, 2013, PRION, V7, P464, DOI 10.4161/pri.27503; Kryndushkin D, 2013, J BIOL CHEM, V288, P27100, DOI 10.1074/jbc.M113.485359; Kurahashi H, 2011, PRION, V5, P305, DOI [10.4161/pri.18307, 10.4161/pri.5.4.18307]; LACROUTE F, 1971, J BACTERIOL, V106, P519, DOI 10.1128/JB.106.2.519-522.1971; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Malinovska L, 2013, BBA-PROTEINS PROTEOM, V1834, P918, DOI 10.1016/j.bbapap.2013.01.003; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Medina EM, 2011, J MOL EVOL, V73, P116, DOI 10.1007/s00239-011-9461-4; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Ohte S, 2012, J CELL BIOCHEM, V113, P808, DOI 10.1002/jcb.23408; Oishi K, 2013, MICROBIOLOGYOPEN, V2, P415, DOI 10.1002/mbo3.83; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; Ross Eric D, 2013, Methods Mol Biol, V1017, P219, DOI 10.1007/978-1-62703-438-8_16; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shimizu K, 2009, J MOL BIOL, V392, P1253, DOI 10.1016/j.jmb.2009.07.088; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Suzuki G, 2012, SCIENCE, V336, P355, DOI 10.1126/science.1219491; Toombs JA, 2012, P NATL ACAD SCI USA, V109, P6519, DOI 10.1073/pnas.1119366109; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 2004, GENE DEV, V18, P470, DOI 10.1101/gad.1177104	50	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100615	10.1371/journal.pone.0100615	http://dx.doi.org/10.1371/journal.pone.0100615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972093	gold, Green Published, Green Submitted			2022-12-27	WOS:000338512200045
J	Qin, L; Peng, D; Hu, CP; Xiang, Y; Zhou, YG; Tan, YR; Qin, XQ				Qin, Ling; Peng, Dan; Hu, Chengping; Xiang, Yang; Zhou, Yigang; Tan, Yurong; Qin, Xiaoqun			Differentiation of Th Subsets Inhibited by Nonstructural Proteins of Respiratory Syncytial Virus Is Mediated by Ubiquitination	PLOS ONE			English	Article							PEPTIDERGIC INNERVATION; EPITHELIAL-CELLS; UP-REGULATION; INFECTION; EXPRESSION; ASTHMA	Human respiratory syncytial virus (RSV), a major cause of severe respiratory diseases, constitutes an important risk factor for the development of subsequent asthma. However, the mechanism underlying RSV-induced asthma is poorly understood. Viral non-structural proteins NS1 and NS2 are critically required for RSV virulence; they strongly suppress IFN-mediated innate immunity of the host cells. In order to understand the effects of NS1 and NS2 on differentiation of Th subsets, we constructed lentiviral vectors of NS1 or NS2 to infect 16 HBE and analyzed the expression of HLA-DR, CD80 and CD86 and differentiation of Th1, Th2 and Th17 by Flow Cytometric Analysis and real-time PCR. The results showed that NS1 inhibited expression of HLA-DR, CD80 and CD86 and differentiation of Th1, Th2 and Th17 lymphocytes, which could be reversed by deleting elongin C binding domain. NS2 inhibited the differentiation of Th2 and Th17, which was reversed by proteasome inhibitors of PS-341. Our results indicated that NS1 inhibited the differentiation of T lymphocytes through its monoubiquitination to interacted proteins, while NS2 inhibited differentiation of Th2 and Th17 through ubiquitin-proteasome pathway, which may be related with the susceptibility to asthma after RSV infection.	[Qin, Ling; Hu, Chengping] Cent S Univ, Xiangya Hosp, Resp Dept, Changsha, Hunan, Peoples R China; [Peng, Dan; Xiang, Yang; Zhou, Yigang; Tan, Yurong; Qin, Xiaoqun] Cent S Univ, Xiangya Sch Med, Dept Basic Med, Changsha, Hunan, Peoples R China	Central South University; Central South University	Tan, YR (corresponding author), Cent S Univ, Xiangya Sch Med, Dept Basic Med, Changsha, Hunan, Peoples R China.	hope7@126.com			National Natural Science Foundation of China [81270065]; open platform innovation fund of Hunan universities [12K003, 13K001]; Young Teacher Fund of Central South University [2013JSJJ059, 2012QNZT111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); open platform innovation fund of Hunan universities; Young Teacher Fund of Central South University	This work was supported by grant #81270065 (Yang Xiang) from National Natural Science Foundation of China; grants t #12K003 (Yang Xiang) and #13K001 (Yurong Tan) from open platform innovation fund of Hunan universities; and grants #2013JSJJ059 (Yurong Tan) and #2012QNZT111 (Qin Ling) from Young Teacher Fund of Central South University. All funders are involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Bertorelli G, 1998, CLIN EXP ALLERGY, V28, P551; Finn Patricia W, 2009, Proc Am Thorac Soc, V6, P260, DOI 10.1513/pats.200807-064RM; Guo-Parke H, 2013, AM J RESP CRIT CARE, V188, P842, DOI 10.1164/rccm.201304-0750OC; Holgate Stephen T, 2008, Allergol Int, V57, P1, DOI 10.2332/allergolint.R-07-154; Jin H, 2000, VIROLOGY, V273, P210, DOI 10.1006/viro.2000.0393; Kokuho T, 2003, VET IMMUNOL IMMUNOP, V91, P155, DOI 10.1016/S0165-2427(02)00288-X; Kurosawa S, 2003, AM J RESP CELL MOL, V28, P563, DOI 10.1165/rcmb.2002-0199OC; Mendoza L, 2010, THEOR BIOSCI, V129, P283, DOI 10.1007/s12064-010-0112-x; Munir S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001336; Nakajima Hiroshi, 2010, Immune Netw, V10, P1, DOI 10.4110/in.2010.10.1.1; Niedzwiedzka-Rystwej P, 2013, POSTEP HIG MED DOSW, V67, P371, DOI 10.5604/17322693.1048814; Papi A, 2000, J INFECT DIS, V181, P1780, DOI 10.1086/315463; Qin L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027113; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Swedan S, 2009, J VIROL, V83, P9682, DOI 10.1128/JVI.00715-09; Tan YR, 2008, PEPTIDES, V29, P47, DOI 10.1016/j.peptides.2007.10.020; Tan YR, 2013, MOL BIOL REP, V40, P675, DOI 10.1007/s11033-012-2107-9; Tan Y, 2008, EXP PHYSIOL, V93, P1284, DOI 10.1113/expphysiol.2008.043521; Zhou L, 2009, CURR OPIN IMMUNOL, V21, P146, DOI 10.1016/j.coi.2009.03.001; Zomer-Kooijker K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087162	20	16	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101469	10.1371/journal.pone.0101469	http://dx.doi.org/10.1371/journal.pone.0101469			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992002	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400075
J	Wang, CZ; Li, TJ; Zheng, YP				Wang, Cong-Zhi; Li, Tian-Jie; Zheng, Yong-Ping			Shear Modulus Estimation on Vastus Intermedius of Elderly and Young Females over the Entire Range of Isometric Contraction	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; DISPERSION ULTRASOUND VIBROMETRY; DYNAMIC STABILITY CONTROL; HUMAN SKELETAL-MUSCLE; IN-VIVO; TRANSIENT ELASTOGRAPHY; MECHANICAL-PROPERTIES; TISSUE ELASTICITY; MR ELASTOGRAPHY; STIFFNESS	Elderly people often suffer from sarcopenia in their lower extremities, which gives rise to the increased susceptibility of fall. Comparing the mechanical properties of the knee extensor/flexors on elderly and young subjects is helpful in understanding the underlying mechanisms of the muscle aging process. However, although the stiffness of skeletal muscle has been proved to be positively correlated to its non-fatiguing contraction intensity by some existing methods, this conclusion has not been verified above 50% maximum voluntary contraction (MVC) due to the limitation of their measurement range. In this study, a vibro-ultrasound system was set up to achieve a considerably larger measurement range on muscle stiffness estimation. Its feasibility was verified on self-made silicone phantoms by comparing with the mechanical indentation method. The system was then used to assess the stiffness of vastus intermedius (VI), one of the knee extensors, on 10 healthy elderly female subjects (56.7 +/- 4.9 yr) and 10 healthy young female subjects (27.6 +/- 5.0 yr). The VI stiffness in its action direction was confirmed to be positively correlated to the % MVC level (R-2 = 0.999) over the entire range of isometric contraction, i.e. from 0% MVC (relaxed state) to 100% MVC. Furthermore, it was shown that there was no significant difference between the mean VI shear modulus of the elderly and young subjects in a relaxed state (p>0.1). However, when performing step isometric contraction, the VI stiffness of young female subjects was found to be larger than that of elderly participants (p<0.001), especially at the relatively higher contraction levels. The results expanded our knowledge on the mechanical property of the elderly's skeletal muscle and its relationship with intensity of active contraction. Furthermore, the vibro-ultrasound system has a potential to become a powerful tool for investigating the elderly's muscle diseases.	[Wang, Cong-Zhi] Chinese Acad Sci, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Shenzhen, Peoples R China; [Wang, Cong-Zhi; Li, Tian-Jie; Zheng, Yong-Ping] Hong Kong Polytech Univ, Interdisciplinary Div Biomed Engn, Hong Kong, Hong Kong, Peoples R China; [Wang, Cong-Zhi] Beijing Ctr Math & Informat Interdisciplinary Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Hong Kong Polytechnic University	Wang, CZ (corresponding author), Chinese Acad Sci, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Shenzhen, Peoples R China.	cz.wang@siat.ac.cn; ypzheng@ieee.org	Wang, Congzhi/AAS-9082-2021; Zheng, Yong-Ping/M-1197-2015	Zheng, Yong-Ping/0000-0002-3407-9226	Research Grant Council of Hong Kong [PolyU 5331/06E]; Hong Kong Innovation and Technology Fund [UI213]; National Natural Science Found of China [11228411]	Research Grant Council of Hong Kong(Hong Kong Research Grants Council); Hong Kong Innovation and Technology Fund; National Natural Science Found of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Research Grant Council of Hong Kong (PolyU 5331/06E), Hong Kong Innovation and Technology Fund (UI213), and the National Natural Science Found of China (11228411). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy B, 2005, BIOPHYSICAL FDN HUMA, P169; Arampatzis A, 2008, J BIOMECH, V41, P1754, DOI 10.1016/j.jbiomech.2008.02.022; Bamber J, 2013, ULTRASCHALL MED, V34, P169, DOI 10.1055/s-0033-1335205; Bensamoun SF, 2008, J MAGN RESON IMAGING, V27, P1083, DOI 10.1002/jmri.21307; Bensamoun SF, 2006, J MAGN RESON IMAGING, V23, P242, DOI 10.1002/jmri.20487; Blazevich AJ, 2006, J ANAT, V209, P289, DOI 10.1111/j.1469-7580.2006.00619.x; Bouillard K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029261; Brown SHM, 2009, J ELECTROMYOGR KINES, V19, P727, DOI 10.1016/j.jelekin.2008.04.009; Catheline S, 1999, IEEE T ULTRASON FERR, V46, P1013, DOI 10.1109/58.775668; CESPEDES I, 1995, ULTRASONIC IMAGING, V17, P142, DOI 10.1006/uimg.1995.1007; Chen SG, 2008, ULTRASON, P654, DOI 10.1109/ULTSYM.2008.0157; Chen SG, 2009, IEEE T ULTRASON FERR, V56, P55, DOI 10.1109/TUFFC.2009.1005; Chino K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045764; Deffieux T, 2009, IEEE T MED IMAGING, V28, P313, DOI 10.1109/TMI.2008.925077; Dela F, 2006, ESSAYS BIOCHEM, V42, P75, DOI 10.1042/bse0420075; Domire ZJ, 2009, J APPL BIOMECH, V25, P93, DOI 10.1123/jab.25.1.93; Dresner MA, 2001, J MAGN RESON IMAGING, V13, P269, DOI 10.1002/1522-2586(200102)13:2<269::AID-JMRI1039>3.3.CO;2-T; Fung Y.C., 1993, BIOMECHANICS MECH PR, P392; Gennisson JL, 2010, ULTRASOUND MED BIOL, V36, P789, DOI 10.1016/j.ultrasmedbio.2010.02.013; Gennisson JL, 2005, J BIOMECH, V38, P1543, DOI 10.1016/j.jbiomech.2004.07.013; Giresi PG, 2005, PHYSIOL GENOMICS, V21, P253, DOI 10.1152/physiolgenomics.00249.2004; Grabiner MD, 2005, J GERONTOL A-BIOL, V60, P1447, DOI 10.1093/gerona/60.11.1447; HAYES WC, 1972, J BIOMECH, V5, P541, DOI 10.1016/0021-9290(72)90010-3; Heers G, 2003, CLIN BIOMECH, V18, P537, DOI 10.1016/S0268-0033(03)00070-6; Hoyt K, 2008, PHYS MED BIOL, V53, P4063, DOI 10.1088/0031-9155/53/15/004; Karamanidis K, 2008, J ELECTROMYOGR KINES, V18, P980, DOI 10.1016/j.jelekin.2007.04.003; Klein CS, 2001, J APPL PHYSIOL, V91, P1341, DOI 10.1152/jappl.2001.91.3.1341; Kot BCW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044348; Kruse SA, 2000, PHYS MED BIOL, V45, P1579, DOI 10.1088/0031-9155/45/6/313; LARSSON L, 1978, ACTA PHYSIOL SCAND, V103, P31, DOI 10.1111/j.1748-1716.1978.tb06187.x; Leonard CT, 2003, ARCH PHYS MED REHAB, V84, P928, DOI 10.1016/S0003-9993(03)00006-6; Leong HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067199; LEVINSON SF, 1995, J BIOMECH, V28, P1145, DOI 10.1016/0021-9290(94)00173-2; LEXELL J, 1983, MUSCLE NERVE, V6, P588, DOI 10.1002/mus.880060809; Morse CI, 2005, ACTA PHYSIOL SCAND, V183, P291, DOI 10.1111/j.1365-201X.2004.01404.x; Murayama M, 2000, EUR J APPL PHYSIOL, V82, P361, DOI 10.1007/s004210000242; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Narici MV, 2008, DISABIL REHABIL, V30, P1548, DOI 10.1080/09638280701831058; Narici MV, 2003, J APPL PHYSIOL, V95, P2229, DOI 10.1152/japplphysiol.00433.2003; Nordez A, 2009, J ELECTROMYOGR KINES, V19, P484, DOI 10.1016/j.jelekin.2007.11.005; Nordez A, 2010, J APPL PHYSIOL, V108, P1389, DOI 10.1152/japplphysiol.01323.2009; Ochala J, 2004, J GERONTOL A-BIOL, V59, P441; PARKER KJ, 1990, ULTRASOUND MED BIOL, V16, P241, DOI 10.1016/0301-5629(90)90003-U; Sack I, 2002, MAGN RESON IMAGING, V20, P95, DOI 10.1016/S0730-725X(02)00474-5; Sandrin L, 2002, IEEE T ULTRASON FERR, V49, P426, DOI 10.1109/58.996560; Shinohara M, 2010, MUSCLE NERVE, V42, P438, DOI 10.1002/mus.21723; Uffmann K, 2004, NMR BIOMED, V17, P181, DOI 10.1002/nbm.887; Urban MW, 2009, IEEE T ULTRASON FERR, V56, P748, DOI 10.1109/TUFFC.2009.1097; Wang CZ, 2010, BLOOD PRESS MONIT, V15, P213, DOI 10.1097/MBP.0b013e328338aada; WILSON GJ, 1994, J APPL PHYSIOL, V76, P2714, DOI 10.1152/jappl.1994.76.6.2714; Zheng YP, 2006, MED ENG PHYS, V28, P405, DOI 10.1016/j.medengphy.2005.07.012; Zheng YP, 1999, J REHABIL RES DEV, V36, P71; Zheng YP, 1998, 10 ANN INT C IEEE EM	53	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101769	10.1371/journal.pone.0101769	http://dx.doi.org/10.1371/journal.pone.0101769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991890	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400114
J	Manokhina, I; Singh, TK; Penaherrera, MS; Robinson, WP				Manokhina, Irina; Singh, Tanjot K.; Penaherrera, Maria S.; Robinson, Wendy P.			Quantification of Cell-Free DNA in Normal and Complicated Pregnancies: Overcoming Biological and Technical Issues	PLOS ONE			English	Article							FREE FETAL DNA; MATERNAL PLASMA; HYPERMETHYLATED RASSF1A; SERUM; RISK; BLOOD; ONSET; QUANTITATION; RESTRICTION; SEQUENCES	The characterization of cell-free DNA (cfDNA) originating from placental trophoblast in maternal plasma provides a powerful tool for non-invasive diagnosis of fetal and obstetrical complications. Due to its placental origin, the specific epigenetic features of this DNA (commonly known as cell-free fetal DNA) can be utilized in creating universal 'fetal' markers in maternal plasma, thus overcoming the limitations of gender-or rhesus-specific ones. The goal of this study was to compare the performance of relevant approaches and assays evaluating the amount of cfDNA in maternal plasma throughout gestation (7.2-39.5 weeks). Two fetal- or placental-specific duplex assays (RPP30/SRY and RASSF1A/beta-Actin) were applied using two technologies, real-time quantitative PCR (qPCR) and droplet digital PCR (ddPCR). Both methods revealed similar performance parameters within the studied dynamic range. Data obtained using qPCR and ddPCR for these assays were positively correlated (total cfDNA (RPP30): R = 0.57, p = 0.001/placental cfDNA (SRY): R = 0.85, p<0.0001; placental cfDNA (RASSF1A): R = 0.75, p<0.0001). There was a significant correlation in SRY and RASSF1A results measured with qPCR (R = 0.68, p = 0.013) and ddPCR (R = 0.56, p = 0.039). Different approaches also gave comparable results with regard to the correlation of the placental cfDNA concentration with gestational age and pathological outcome. We conclude that ddPCR is a practical approach, adaptable to existing qPCR assays and well suited for analysis of cell-free DNA in plasma. However, it may need further optimization to surpass the performance of qPCR.	[Manokhina, Irina; Singh, Tanjot K.; Penaherrera, Maria S.; Robinson, Wendy P.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Manokhina, Irina; Singh, Tanjot K.; Penaherrera, Maria S.; Robinson, Wendy P.] Child & Family Res Inst, Vancouver, BC, Canada	University of British Columbia; Child & Family Research Institute	Manokhina, I (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada.	ikmanokhina@gmail.com	Robinson, Wendy P/I-9590-2014; Robinson, Wendy/AAB-6420-2020	Robinson, Wendy P/0000-0002-2010-6174; Robinson, Wendy/0000-0002-2010-6174	Canada Institutes of Health Research [257450]; Child and Family Research Institutes Summer Student Fellowship	Canada Institutes of Health Research; Child and Family Research Institutes Summer Student Fellowship	This study is funded by Canada Institutes of Health Research operating grant #257450 to WPR and Child and Family Research Institutes Summer Student Fellowship for TKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashoor G, 2012, FETAL DIAGN THER, V31, P237, DOI 10.1159/000337373; Bartha JL, 2003, OBSTET GYNECOL, V101, P1135, DOI 10.1016/S0029-7844(03)00064-4; Bianchi DW, 2004, PLACENTA, V25, pS93, DOI 10.1016/j.placenta.2004.01.005; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Caramelli E, 2003, PRENATAL DIAG, V23, P367, DOI 10.1002/pd.596; Chan KCA, 2006, CLIN CHEM, V52, P2211, DOI 10.1373/clinchem.2006.074997; Chiu RWK, 2007, AM J PATHOL, V170, P941, DOI 10.2353/ajpath.2007.060641; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Farina A, 2005, AM J OBSTET GYNECOL, V193, P421, DOI 10.1016/j.ajog.2004.12.023; Farina A, 2004, PRENATAL DIAG, V24, P293, DOI 10.1002/pd.863; Fernando MR, 2010, PRENATAL DIAG, V30, P418, DOI 10.1002/pd.2484; Henrich TJ, 2012, J VIROL METHODS, V186, P68, DOI 10.1016/j.jviromet.2012.08.019; Hidestrand M, 2012, FETAL DIAGN THER, V31, P122, DOI 10.1159/000335020; Hill M, 2011, CLIN GENET, V80, P68, DOI 10.1111/j.1399-0004.2010.01533.x; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Holmberg RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073068; Hromadnikova I, 2010, DNA CELL BIOL, V29, P295, DOI 10.1089/dna.2009.0971; Hyland CA, 2009, MED J AUSTRALIA, V191, P21, DOI 10.5694/j.1326-5377.2009.tb02668.x; Jakobsen TR, 2012, PRENATAL DIAG, V32, P840, DOI 10.1002/pd.3917; Jin SN, 2012, CLIN CHEM, V58, P465, DOI 10.1373/clinchem.2011.174417; Jung M, 2003, CLIN CHEM, V49, P1028, DOI 10.1373/49.6.1028; Kolialexi A, 2012, EUR J OBSTET GYN R B, V161, P34, DOI 10.1016/j.ejogrb.2011.12.025; Levine RJ, 2004, AM J OBSTET GYNECOL, V190, P707, DOI 10.1016/j.ajog.2003.12.019; Lim JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056787; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lo YMD, 1999, CLIN CHEM, V45, P184; Lun FMF, 2008, P NATL ACAD SCI USA, V105, P19920, DOI 10.1073/pnas.0810373105; Muller SP, 2011, PRENATAL DIAG, V31, P1300, DOI 10.1002/pd.2889; Papandreaou Nikolaos, 2013, 2013 18 INT C DIG SI, P1; Repiska G, 2013, CLIN CHEM LAB MED, V51, P1185, DOI 10.1515/cclm-2012-0418; Stein W, 2013, EUR J OBSTET GYN R B, V166, P10, DOI 10.1016/j.ejogrb.2012.09.006; Tsui NBY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048319; Tynan JA, 2011, J MOL DIAGN, V13, P382, DOI 10.1016/j.jmoldx.2011.02.001; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Vora NL, 2012, PRENATAL DIAG, V32, P912, DOI 10.1002/pd.3919; Wang E, 2013, PRENAT DIAGN, V33, P1; White HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045073; Wong D, 2013, CLIN BIOCH; Yu H, 2013, INT J MOL SCI, V14, P7571, DOI 10.3390/ijms14047571; Zejskova L, 2010, EXP MOL PATHOL, V89, P241, DOI 10.1016/j.yexmp.2010.09.002; Zeybek YG, 2013, J OBSTET GYNAECOL RE, V39, P632, DOI 10.1111/j.1447-0756.2012.02011.x; Ziegler A, 2002, CANCER TREAT REV, V28, P255, DOI 10.1016/S0305-7372(02)00077-4	44	32	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101500	10.1371/journal.pone.0101500	http://dx.doi.org/10.1371/journal.pone.0101500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987984	Green Published, gold, Green Submitted			2022-12-27	WOS:000341354100101
J	Miao, YL; Guo, WZ; Shi, WZ; Fang, WW; Liu, Y; Liu, J; Li, BW; Wu, W; Li, YF				Miao, Yu-Liang; Guo, Wen-Zhi; Shi, Wen-Zhu; Fang, Wei-Wu; Liu, Yan; Liu, Ji; Li, Bao-Wei; Wu, Wei; Li, Yun-Feng			Midazolam Ameliorates the Behavior Deficits of a Rat Posttraumatic Stress Disorder Model through Dual 18 kDa Translocator Protein and Central Benzodiazepine Receptor and Neurosteroidogenesis	PLOS ONE			English	Article							GABA(A) RECEPTORS; CONTEXTUAL FEAR; MOUSE MODEL; ALLOPREGNANOLONE; AMYGDALA; AC-5216; ANXIETY; LIGAND; ANXIOLYTICS; ACTIVATION	Post-traumatic stress disorder (PTSD) is a debilitating anxiety disorder that may develop after an individual has experienced or witnessed a severe traumatic event. It has been shown that the 18 kDa translocator protein (TSPO) may be correlated with PTSD and that the TSPO ligand improved the behavioral deficits in a mouse model of PTSD. Midazolam, a ligand for TSPO and central benzodiazepine receptor (CBR), induces anxiolytic- and anti-depressant-like effects in animal models. The present study aimed to determine whether midazolam ameliorates PTSD behavior in rats as assessed by the single prolonged stress (SPS) model. The SPS rats received daily Sertraline (Ser) (15 mg/kg, p.o.) and midazolam (0.125, 0.25, 0.5, and 1 mg/kg, p.o.) during the exposure to SPS and behavioral assessments, which included the open field (OF) test, the contextual fear paradigm (CFP), and the elevated plus-maze (EPM). The results showed that, like Ser (15 mg/kg, p.o.), midazolam (0.25 and 0.5 mg/kg, p.o.) significantly reversed the behavioral deficiencies of the SPS rats, including PTSD-associated freezing and anxiety-like behavior but not the effects on spontaneous locomotor activity. In addition, the anti-PTSD effects of midazolam (0.5 mg/kg, p.o.) were antagonized by the TSPO antagonist PK11195 (3 mg/kg, i.p.), the CBR antagonist flumazenil (15 mg/kg, p.o.) and the inhibitor of steroidogenic enzymes finasteride (30 mg/kg, p.o.), which by themselves had no effect on PTSD-associated freezing and anxiety-like behavior. In summary, this study demonstrated that midazolam improves the behavioral deficits in the SPS model through dual TSPO and CBR and neurosteroidogenesis.	[Miao, Yu-Liang; Fang, Wei-Wu; Liu, Yan; Liu, Ji] Chinese PLA 306 Hosp, Dept Anesthesiol, Beijing, Peoples R China; [Guo, Wen-Zhi] PLA, Beijing Mil Gen Hosp, Dept Anesthesiol, Beijing, Peoples R China; [Shi, Wen-Zhu] Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Anesthesia & Operat Ctr, Sanya, Peoples R China; [Li, Bao-Wei; Wu, Wei] Chinese PLA 306 Hosp, Dept Head & Neck Surg Otolaryngol, Beijing, Peoples R China; [Li, Yun-Feng] Acad Mil Med Sci, Inst Pharmacol & Toxicol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Academy of Military Medical Sciences - China	Wu, W (corresponding author), Chinese PLA 306 Hosp, Dept Head & Neck Surg Otolaryngol, Beijing, Peoples R China.	wwzwgk@163.com; lyf0619@aiyun.com			National Natural Science Foundation of China [81371204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from National Natural Science Foundation of China (Grant No. 81371204). This foundation helped us in study design and performance of the experiment.	Akk G, 2005, J NEUROSCI, V25, P11605, DOI 10.1523/JNEUROSCI.4173-05.2005; Anagnostaras SG, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00158; Armario A, 2008, NEUROSCI BIOBEHAV R, V32, P1121, DOI 10.1016/j.neubiorev.2008.04.003; Bai M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046921; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Brady KT, 2003, COMPR PSYCHIAT, V44, P360, DOI 10.1016/S0010-440X(03)00111-1; Brot MD, 1997, EUR J PHARMACOL, V325, P1, DOI 10.1016/S0014-2999(97)00096-4; Cao JP, 2009, BIOSCI TRENDS, V3, P115; Chang FC, 2001, NEUROSCI BIOBEHAV R, V25, P445, DOI 10.1016/S0149-7634(01)00024-0; Costa B, 2012, CURR TOP MED CHEM, V12, P270, DOI 10.2174/156802612799078720; Davidson JRT, 1998, INT CLIN PSYCHOPHARM, V13, P111, DOI 10.1097/00004850-199805000-00003; Debiec J, 2004, NEUROSCIENCE, V129, P267, DOI 10.1016/j.neuroscience.2004.08.018; Dell'Osso L, 2010, PSYCHIAT RES, V177, P139, DOI 10.1016/j.psychres.2008.07.019; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; GABR RW, 1995, NEUROENDOCRINOLOGY, V62, P333, DOI 10.1159/000127022; Guidotti A, 2001, BRAIN RES REV, V37, P110, DOI 10.1016/S0165-0173(01)00129-1; Hopper JW, 2007, J TRAUMA STRESS, V20, P713, DOI 10.1002/jts.20284; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Imanaka A, 2006, BEHAV BRAIN RES, V173, P129, DOI 10.1016/j.bbr.2006.06.012; Kain ZN, 2007, ANESTHESIOLOGY, V107, P545, DOI 10.1097/01.anes.0000281895.81168.c3; Khan S, 2004, PSYCHOPHARMACOLOGY, V172, P225, DOI 10.1007/s00213-003-1634-4; Kita A, 2004, BRIT J PHARMACOL, V142, P1059, DOI 10.1038/sj.bjp.0705681; Kita A, 2008, PHARMACOL BIOCHEM BE, V89, P171, DOI 10.1016/j.pbb.2007.12.006; Kita A, 2009, PROG NEURO-PSYCHOPH, V33, P1040, DOI 10.1016/j.pnpbp.2009.05.018; Lambert Jeremy J, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS48, DOI 10.1016/j.psyneuen.2009.08.009; LAMBERT JJ, 1995, TRENDS PHARMACOL SCI, V16, P295, DOI 10.1016/S0165-6147(00)89058-6; Leskin LP, 2007, NEUROPSYCHOLOGY, V21, P275, DOI 10.1037/0894-4105.21.3.275; Li S, 2006, PHARMACOL BIOCHEM BE, V85, P324, DOI 10.1016/j.pbb.2006.08.015; Liberzon I, 1997, PSYCHONEUROENDOCRINO, V22, P443, DOI 10.1016/S0306-4530(97)00044-9; Maeda J, 2007, BRAIN RES, V1157, P100, DOI 10.1016/j.brainres.2007.04.054; MAIER SF, 1990, J EXP PSYCHOL ANIM B, V16, P137, DOI 10.1037/0097-7403.16.2.137; Nothdurfter C, 2012, J NEUROENDOCRINOL, V24, P82, DOI 10.1111/j.1365-2826.2011.02166.x; Paez-Martinez N, 2013, EUR J PHARMACOL, V698, P178, DOI 10.1016/j.ejphar.2012.10.004; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Pibiri F, 2008, P NATL ACAD SCI USA, V105, P5567, DOI 10.1073/pnas.0801853105; Pinna G, 2009, CURR OPIN PHARMACOL, V9, P24, DOI 10.1016/j.coph.2008.12.006; Qiu ZK, 2013, PROG NEURO-PSYCHOPH, V45, P40, DOI 10.1016/j.pnpbp.2013.04.010; Rasmusson AM, 2006, BIOL PSYCHIAT, V60, P704, DOI 10.1016/j.biopsych.2006.03.026; Ravindran LN, 2009, BRAIN RES, V1293, P24, DOI 10.1016/j.brainres.2009.03.037; Rosenkranz JA, 2003, J NEUROSCI, V23, P11054; Rupprecht R, 2009, SCIENCE, V325, P490, DOI 10.1126/science.1175055; Senses Elif, 2013, Middle East Journal of Anesthesiology, V22, P35; Suenaga T, 2004, INT J NEUROPSYCHOPH, V7, P299, DOI 10.1017/S1461145704004304; Szabo ST, 1999, BRIT J PHARMACOL, V126, P568, DOI 10.1038/sj.bjp.0702343; Takahashi T, 2006, PSYCHOPHARMACOLOGY, V189, P165, DOI 10.1007/s00213-006-0545-6; Tokuda K, 2010, J NEUROSCI, V30, P16788, DOI 10.1523/JNEUROSCI.4101-10.2010; TreggiariVenzi M, 1996, INTENS CARE MED, V22, P1186, DOI 10.1007/BF01709334; Wang HN, 2009, PROG NEURO-PSYCHOPH, V33, P1458, DOI 10.1016/j.pnpbp.2009.07.031; Xue R, 2013, EUR NEUROPSYCHOPHARM, V23, P728, DOI 10.1016/j.euroneuro.2012.06.001; Yamada J, 1999, NEUROPHARMACOLOGY, V38, P1743, DOI 10.1016/S0028-3908(99)00126-4; Zhang LM, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/623753	51	38	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101450	10.1371/journal.pone.0101450	http://dx.doi.org/10.1371/journal.pone.0101450			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988461	Green Submitted, gold, Green Published			2022-12-27	WOS:000341354100090
J	Pavlovic, DM; Vertes, PE; Bullmore, ET; Schafer, WR; Nichols, TE				Pavlovic, Dragana M.; Vertes, Petra E.; Bullmore, Edward T.; Schafer, William R.; Nichols, Thomas E.			Stochastic Blockmodeling of the Modules and Core of the Caenorhabditis elegans Connectome	PLOS ONE			English	Article							COMMUNITY STRUCTURE; MODEL; GRAPHS; ORGANIZATION; LOCOMOTION; MODULARITY; REVEALS	Recently, there has been much interest in the community structure or mesoscale organization of complex networks. This structure is characterised either as a set of sparsely inter-connected modules or as a highly connected core with a sparsely connected periphery. However, it is often difficult to disambiguate these two types of mesoscale structure or, indeed, to summarise the full network in terms of the relationships between its mesoscale constituents. Here, we estimate a community structure with a stochastic blockmodel approach, the Erdos-Renyi Mixture Model, and compare it to the much more widely used deterministic methods, such as the Louvain and Spectral algorithms. We used the Caenorhabditis elegans (C. elegans) nervous system (connectome) as a model system in which biological knowledge about each node or neuron can be used to validate the functional relevance of the communities obtained. The deterministic algorithms derived communities with 4-5 modules, defined by sparse inter-connectivity between all modules. In contrast, the stochastic Erdos Renyi Mixture Model estimated a community with 9 blocks or groups which comprised a similar set of modules but also included a clearly defined core, made of 2 small groups. We show that the "core-in-modules" decomposition of the worm brain network, estimated by the Erdos-Renyi Mixture Model, is more compatible with prior biological knowledge about the C. elegans nervous system than the purely modular decomposition defined deterministically. We also show that the blockmodel can be used both to generate stochastic realisations (simulations) of the biological connectome, and to compress network into a small number of super-nodes and their connectivity. We expect that the Erdos-Renyi Mixture Model may be useful for investigating the complex community structures in other (nervous) systems.	[Pavlovic, Dragana M.; Nichols, Thomas E.] Univ Warwick, Dept Stat, Coventry CV4 7AL, W Midlands, England; [Pavlovic, Dragana M.; Nichols, Thomas E.] Univ Warwick, Warwick Mfg Grp, Coventry CV4 7AL, W Midlands, England; [Vertes, Petra E.; Bullmore, Edward T.] Univ Cambridge, Dept Psychiat, Behav & Clin Neurosci Inst, Brain Mapping Unit, Cambridge, England; [Bullmore, Edward T.] Addenbrookes Hosp, GlaxoSmithKline, Clin Unit Cambridge, Cambridge, England; [Bullmore, Edward T.] Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England; [Schafer, William R.] MRC, Mol Biol Lab, Div Cell Biol, Cambridge CB2 2QH, England	University of Warwick; University of Warwick; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; GlaxoSmithKline; University of Cambridge; MRC Laboratory Molecular Biology	Pavlovic, DM (corresponding author), Univ Warwick, Dept Stat, Coventry CV4 7AL, W Midlands, England.	d.pavlovic@warwick.ac.uk	Nichols, Thomas E./N-9902-2017; Bullmore, Ed/C-1706-2012	Nichols, Thomas E./0000-0002-4516-5103; Bullmore, Ed/0000-0002-8955-8283; Schafer, William/0000-0002-6676-8034; Vertes, Petra E./0000-0002-0992-3210	MRC Industrial CASE award; GlaxoSmithKline's Clinical Unit Cambridge (UK) PhD studentship; Medical Research Council [MR/K020706/1]; Medical Research Council (UK); Wellcome Trust; NIH [U54MH091657-03]; MRC [MR/K020706/1, MC_U105185857] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657] Funding Source: NIH RePORTER; Medical Research Council [G0001354B, G1000183B, G0001354, 1198744, MC_U105185857] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10051] Funding Source: researchfish; Wellcome Trust [103784/Z/14/Z] Funding Source: researchfish	MRC Industrial CASE award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); GlaxoSmithKline's Clinical Unit Cambridge (UK) PhD studentship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)	DMP is supported by the MRC Industrial CASE award with GlaxoSmithKline's Clinical Unit Cambridge (UK) PhD studentship. PEV is supported by Medical Research Council (grant number MR/K020706/1). ETB is employed half-time by the University of Cambridge and half-time by GlaxoSmithKline (GSK); he holds stock in GSK. The Behavioural and Clinical Neuroscience Institute is supported by the Medical Research Council (UK) and Wellcome Trust. TEN is supported by NIH U54MH091657-03 and Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albert R, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.025103; Alexander-Bloch AF, 2013, CEREB CORTEX, V23, P127, DOI 10.1093/cercor/bhr388; Altun Z, 2005, HDB C ELEGANS ANATOM; Altun ZF HD, 2009, NERVOUS SYSTEM GEN D; ANDERSON CJ, 1992, SOC NETWORKS, V14, P137, DOI 10.1016/0378-8733(92)90017-2; Bates D., 2012, IME4 LINEAR MIXED EF; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Borgatti SP, 1999, SOC NETWORKS, V21, P375; BRENNER S, 1974, GENETICS, V77, P71; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Daudin JJ, 2008, STAT COMPUT, V18, P173, DOI 10.1007/s11222-007-9046-7; Dicken P, 2002, GLOBAL NETW, V1, P89; Dobson A., 2001, INTRO GEN LINEAR MOD, DOI 10.1201/9781420057683; Doreian P, 2005, GEN BLOCKMODELING, V25; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; FRALEY C, 2006, 504 U WASH DEP STAT; GILBERT EN, 1959, ANN MATH STAT, V30, P1141, DOI 10.1214/aoms/1177706098; Handl J, 2005, BIOINFORMATICS, V21, P3201, DOI 10.1093/bioinformatics/bti517; HARVILLE DA, 1977, J AM STAT ASSOC, V72, P320, DOI 10.2307/2286796; Haspel G, 2011, J NEUROSCI, V31, P14611, DOI 10.1523/JNEUROSCI.2186-11.2011; Haspel G, 2010, J NEUROSCI, V30, P11151, DOI 10.1523/JNEUROSCI.2244-10.2010; HOLLAND PW, 1981, J AM STAT ASSOC, V76, P33, DOI 10.2307/2287037; Holme P, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046111; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Jaakkola TS, 2001, NEU INF PRO, P129; Jordan MI, 1999, MACH LEARN, V37, P183, DOI 10.1023/A:1007665907178; Karrer B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.016107; Latouche P, 2008, BAYESIAN METHODS GRA; Latouche P, 2011, ANN APPL STAT, V5, P309, DOI 10.1214/10-AOAS382; Lorrain F., 1971, J MATH SOCIOL, V1, P49, DOI [10.1080/0022250X.1971.9989788, DOI 10.1080/0022250X.1971.9989788, 10.1080/0022250x.1971.9989788]; Luczak T., 1989, PROC S RANDOM GRAPHS, P165; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; MOREY LC, 1984, EDUC PSYCHOL MEAS, V44, P33, DOI 10.1177/0013164484441003; Mukherjee S, 2011, BIOINFORMATICS, V27, P994, DOI 10.1093/bioinformatics/btr070; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, EUR PHYS J B, V38, P321, DOI 10.1140/epjb/e2004-00124-y; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Newman MEJ, 2002, P NATL ACAD SCI USA, V99, P2566, DOI 10.1073/pnas.012582999; Pan RK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009240; Pattison P, 2007, HDB PROBABILITY THEO; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Royer L, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000108; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Snijders TAB, 1997, J CLASSIF, V14, P75, DOI 10.1007/s003579900004; Sporns O., 2010, NETWORKS BRAIN; Towlson EK, 2013, J NEUROSCI, V33, P6380, DOI 10.1523/JNEUROSCI.3784-12.2013; Ulanowicz RE, 2004, COMPUT BIOL CHEM, V28, P321, DOI 10.1016/j.compbiolchem.2004.09.001; Varier S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001044; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Von Stetina Stephen E, 2006, Int Rev Neurobiol, V69, P125; Vu DQ, 2012, ARXIV12070188; WHITE HC, 1981, AM J SOCIOL, V87, P517, DOI 10.1086/227495; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wood W. B., 1987, NEMATODE CAENORHABDI; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; Zanghi H, 2008, STRATEGIES ONLINE IN; Zanghi H, 2008, PATTERN RECOGN, V41, P3592, DOI 10.1016/j.patcog.2008.06.019	69	34	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e97584	10.1371/journal.pone.0097584	http://dx.doi.org/10.1371/journal.pone.0097584			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988196	Green Published, Green Submitted, gold			2022-12-27	WOS:000341354100007
J	Shi, L; Yang, AC; Meng, DW; Li, SW; Liu, HG; Li, JJ; Wang, X; Zhang, X; Zhang, JG				Shi, Lin; Yang, An-Chao; Meng, Da-Wei; Li, Shao-Wu; Liu, Huan-Guang; Li, Jun-Ju; Wang, Xiu; Zhang, Xin; Zhang, Jian-Guo			Pathological Alterations and Stress Responses near DBS Electrodes after MRI Scans at 7.0T, 3.0T and 1.5T: An In Vivo Comparative Study	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; HEAT-SHOCK-PROTEIN; NEUROSTIMULATION SYSTEMS; INTRACRANIAL-PRESSURE; ABSORPTION RATE; INJURY; IMPLANTS; SAFETY; LEAD; SAR	Objective: The purpose of this study was to investigate the pathological alterations and the stress responses around deep brain stimulation (DBS) electrodes after magnetic resonance imaging (MRI) scans at 7.0T, 3.0T and 1.5T. Materials and Methods: DBS devices were stereotactically implanted into the brains of New Zealand rabbits, targeting the left nucleus ventralis posterior thalami, while on the right side, a puncture passage pointing to the same target was made. MRI scans at 7.0T, 3.0T and 1.5T were performed using transmit/receive head coils. The pathological alterations of the surrounding tissue were evaluated by hematoxylin and eosin staining (H&E staining) and transmission electron microscopy (TEM). The levels of the 70 kDa heat shock protein (HSP-70), Neuronal Nuclei (NeuN) and Caspase-3 were determined by western-blotting and quantitative polymerase chain reaction (QPCR) to assess the stress responses near the DBS electrodes. Results: H&E staining and TEM showed that the injury around the DBS electrodes was featured by a central puncture passage with gradually weakened injurious alterations. Comparisons of the injury across the groups manifested similar pathological alterations near the DBS electrodes in each group. Moreover, western-blotting and QPCR assay showed that the level of HSP-70 was not elevated by MRI scans (p>0.05), and the levels of NeuN and Caspase-3 were equal in each group, regardless of the field strengths applied (p<0.05). Conclusions: Based on these findings, it is reasonable to conclude that in this study the MRI scans at multiple levels failed to induce additional tissue injury around the DBS electrodes. These preliminary data furthered our understanding of MRI-related DBS heating and encouraged revisions of the current MRI guidelines for patients with DBS devices.	[Shi, Lin; Li, Shao-Wu; Zhang, Xin; Zhang, Jian-Guo] Capital Med Univ, Beijing Neurosurg Inst, Dept Funct Neurosurg, Beijing, Peoples R China; [Yang, An-Chao; Meng, Da-Wei; Liu, Huan-Guang; Li, Jun-Ju; Wang, Xiu; Zhang, Jian-Guo] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Li, Jun-Ju] Peoples Hosp Hainan Prov, Dept Neurosurg, Haikou, Hainan Province, Peoples R China	Beijing Neurosurgical Institute; Capital Medical University; Capital Medical University	Zhang, JG (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Dept Funct Neurosurg, Beijing, Peoples R China.	zjguo73@126.com		Meng, Dawei/0000-0002-3529-3873	National Natural Science Funds for Distributed Young Scholars [81200997]	National Natural Science Funds for Distributed Young Scholars	This project is supported by the National Natural Science Funds for Distributed Young Scholars, Grant No. 81200997. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker KB, 2004, J MAGN RESON IMAGING, V20, P315, DOI 10.1002/jmri.20103; Baker KB, 2005, NEUROSURGERY, V57, P392, DOI 10.1227/01.NEU.0000176877.26994.0C; Ballweg V, 2011, MED PHYS, V38, P5522, DOI 10.1118/1.3637495; Candas F, 2012, THORAC CARDIOV SURG, V60, P280, DOI 10.1055/s-0031-1299573; Carmichael DW, 2007, NEUROIMAGE, V37, P508, DOI 10.1016/j.neuroimage.2007.04.058; Chhabra V, 2010, J NEUROSURG, V112, P497, DOI 10.3171/2009.7.JNS09572; Dempsey MF, 2001, CLIN RADIOL, V56, P457, DOI 10.1053/crad.2000.0688; EKE A, 1990, STROKE, V21, P299, DOI 10.1161/01.STR.21.2.299; Erickson KM, 2003, ANESTH ANALG, V96, P1460, DOI 10.1213/01.ANE.0000061221.23197.CE; Feng QQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091512; Fraix V, 2010, J NEUROSURG, V113, P1242, DOI 10.3171/2010.1.JNS09951; Gorny KR, 2013, MAGN RESON IMAGING, V31, P783, DOI 10.1016/j.mri.2012.11.005; Henderson JM, 2005, NEUROSURGERY, V57, P414, DOI 10.1093/neurosurgery/57.2.414b; Huang Qi-jin, 2005, Di Yi Jun Yi Da Xue Xue Bao, V25, P1270; Huang QJ, 2005, ACAD J 1 MED COLL PL, V25, P1275; Ideta Takahiro, 2013, Nihon Hoshasen Gijutsu Gakkai Zasshi, V69, P521; Joo E, 2006, ELECTROMAGN BIOL MED, V25, P103, DOI 10.1080/15368370600719042; Kahveci FS, 2001, SURG NEUROL, V56, P206, DOI 10.1016/S0090-3019(01)00555-9; Kainz W, 2002, BIOMED ENG ONLINE, V1, DOI 10.1186/1475-925X-1-2; Kalay S, 2013, PEDIATR NEUROL, V49, P319, DOI 10.1016/j.pediatrneurol.2013.05.011; Kharlamov EA, 2011, EPILEPSY RES, V95, P20, DOI 10.1016/j.eplepsyres.2011.02.008; Kostal V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004546; Laakso I, 2010, PHYS MED BIOL, V55, pN421, DOI 10.1088/0031-9155/55/15/N03; Larson PS, 2008, STEREOT FUNCT NEUROS, V86, P92, DOI 10.1159/000112430; Liu HG, 2013, NEUROMODULATION, V16, P212, DOI 10.1111/ner.12050; Liu Y, 2013, J MAGN RESON IMAGING, V37, P491, DOI 10.1002/jmri.23764; Magland JF, 2010, MAGN RESON MED, V63, P719, DOI 10.1002/mrm.22213; MANZERRA P, 1990, NEUROCHEM RES, V15, P53, DOI 10.1007/BF00969184; Mao WH, 2007, CONCEPT MAGN RESON B, V31B, P127, DOI 10.1002/cmr.b.20085; McGee KP, 2004, J MAGN RESON IMAGING, V19, P291, DOI 10.1002/jmri.20015; Mohsin SA, 2008, PHYS MED BIOL, V53, P5745, DOI 10.1088/0031-9155/53/20/012; Muranaka H, 2011, MAGN RESON MED SCI, V10, P11, DOI 10.2463/mrms.10.11; Nazzaro JM, 2014, INT J NEUROSCI, V124, P166, DOI 10.3109/00207454.2013.840303; Newcombe VFJ, 2008, J NEUROSURG, V109, P159, DOI 10.3171/JNS/2008/109/7/0159; Nutt JG, 2001, NEUROLOGY, V56, P1384, DOI 10.1212/WNL.56.10.1384; Panagopoulos DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062663; Rahmani-Cherati Tavoos, 2012, J Tehran Heart Cent, V7, P128; Rejdak K, 2012, EPILEPSIA, V53, P922, DOI 10.1111/j.1528-1167.2012.03459.x; Rezai AR, 2005, NEUROSURGERY, V57, P1056, DOI 10.1227/01.NEU.0000186935.87971.2a; Rezai AR, 2002, J MAGN RESON IMAGING, V15, P241, DOI 10.1002/jmri.10069; RINK A, 1995, AM J PATHOL, V147, P1575; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Sammet CL, 2013, MAGN RESON IMAGING, V31, P1029, DOI 10.1016/j.mri.2012.10.025; Shellock FG, 2000, J MAGN RESON IMAGING, V12, P30, DOI 10.1002/1522-2586(200007)12:1<30::AID-JMRI4>3.0.CO;2-S; Shellock FG, 2000, AM J SPORT MED, V28, P720, DOI 10.1177/03635465000280051701; Shrivastava D, 2010, J MAGN RESON IMAGING, V32, P600, DOI 10.1002/jmri.22292; Spiegel J, 2003, J NEUROSURG, V99, P772, DOI 10.3171/jns.2003.99.4.0772; Tagliati M, 2009, NEUROIMAGE, V47, pT53, DOI 10.1016/j.neuroimage.2009.04.044; Umschwief G, 2010, J CEREBR BLOOD F MET, V30, P616, DOI 10.1038/jcbfm.2009.234; Wang CS, 2005, PHYS MEDICA, V21, P61, DOI 10.1016/S1120-1797(05)80020-1; Wang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053158; Wang YQ, 2010, INJURY, V41, P707, DOI 10.1016/j.injury.2009.12.003; Yildirim E, 2004, EUR J CARDIO-THORAC, V25, P523, DOI 10.1016/j.ejcts.2003.12.021; Yoshida, 2009, ONCOLOGY REPORTS, V22; Ziegelberger G, 2009, HEALTH PHYS, V97, P257, DOI 10.1097/HP.0b013e3181aff9db	56	7	7	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101624	10.1371/journal.pone.0101624	http://dx.doi.org/10.1371/journal.pone.0101624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988329	Green Submitted, gold, Green Published			2022-12-27	WOS:000341354100121
J	Sowa, JP; Atmaca, O; Kahraman, A; Schlattjan, M; Lindner, M; Sydor, S; Scherbaum, N; Lackner, K; Gerken, G; Heider, D; Arteel, GE; Erim, Y; Canbay, A				Sowa, Jan-Peter; Atmaca, Ozgur; Kahraman, Alisan; Schlattjan, Martin; Lindner, Marion; Sydor, Svenja; Scherbaum, Norbert; Lackner, Karoline; Gerken, Guido; Heider, Dominik; Arteel, Gavin E.; Erim, Yesim; Canbay, Ali			Non-Invasive Separation of Alcoholic and Non-Alcoholic Liver Disease with Predictive Modeling	PLOS ONE			English	Article							CONSUMPTION	Background & Objective: Currently, a major clinical challenge is to distinguish between chronic liver disease caused by metabolic syndrome (non-alcoholic fatty liver disease, NAFLD) from that caused by long term or excessive alcohol consumption (ALD). The etiology of severe liver disease affects treatment options and priorities for liver transplantation and organ allocation. Thus we compared physiologically similar NAFLD and ALD patients to detect biochemical differences for improved separation of these mechanistically overlapping etiologies. Methods: In a cohort of 31 NAFLD patients with BMI below 30 and a cohort of ALD patient with (ALDC n = 51) or without cirrhosis (ALDNC n = 51) serum transaminases, cell death markers and (adipo-) cytokines were assessed. Groups were compared with One-way ANOVA and Tukey's correction. Predictive models were built by machine learning techniques. Results: NAFLD, ALDNC or ALDC patients did not differ in demographic parameters. The ratio of alanine aminotransferase/aspartate aminotransferase - common serum parameters for liver damage - was significantly higher in the NAFLD group compared to both ALD groups (each p<0.0001). Adiponectin and tumor necrosis factor(TNF)-alpha were significantly lower in NAFLD than in ALDNC (p<0.05) or ALDC patients (p<0.0001). Significantly higher serum concentrations of cell death markers, hyaluronic acid, adiponectin, and TNF-alpha (each p<0.0001) were found in ALDC compared to ALDNC. Using machine learning techniques we were able to discern NAFLD and ALDNC (up to an AUC of 0.9118+/-0.0056) or ALDC and ALDNC (up to an AUC of 0.9846+/-0.0018), respectively. Conclusions: Machine learning techniques relying on ALT/AST ratio, adipokines and cytokines distinguish NAFLD and ALD. In addition, severity of ALD may be non-invasively diagnosed via serum cytokine concentrations.	[Sowa, Jan-Peter; Atmaca, Ozgur; Kahraman, Alisan; Schlattjan, Martin; Sydor, Svenja; Gerken, Guido; Canbay, Ali] Univ Duisburg Essen, Univ Hosp, Dept Gastroenterol & Hepatol, Essen, Germany; [Atmaca, Ozgur] Hacettepe Univ, Fac Med, TR-06100 Ankara, Turkey; [Lindner, Marion; Scherbaum, Norbert; Erim, Yesim] Univ Duisburg Essen, Univ Hosp, LVR Clin, Essen, Germany; [Lackner, Karoline] Med Univ Graz, Inst Pathol, Graz, Austria; [Heider, Dominik] Straubing Ctr Sci, Dept Bioinformat, Straubing, Germany; [Arteel, Gavin E.] Univ Louisville, Hlth Sci Ctr, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [Erim, Yesim] Univ Hosp Erlangen, Psychosomat & Psychotherapeut Dept, Erlangen, Germany	University of Duisburg Essen; Hacettepe University; University of Duisburg Essen; Medical University of Graz; University of Louisville; University of Erlangen Nuremberg	Canbay, A (corresponding author), Univ Duisburg Essen, Univ Hosp, Dept Gastroenterol & Hepatol, Essen, Germany.	ali.canbay@uni-due.de	Sydor, Svenja/ABG-6622-2020; Heider, Dominik/F-8545-2010; Canbay, Ali/AAL-9620-2020; Sydor, Svenja/AAV-9951-2021; Arteel, Gavin/AAE-2440-2022; Sowa, Jan-Peter/AAQ-6318-2020	Heider, Dominik/0000-0002-3108-8311; Sydor, Svenja/0000-0002-1349-8309; Arteel, Gavin/0000-0002-2253-5984; Canbay, Ali/0000-0001-6069-7899; Sowa, Jan-Peter/0000-0003-2943-0015	Deutsche Forschungsgemeinschaft (DFG) [267/8-1]; Wilhelm Laupitz Foundation; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA021978] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Wilhelm Laupitz Foundation; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, grant 267/8-1), and the Wilhelm Laupitz Foundation to A. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025; Beier JI, 2012, EXP BIOL MED, V237, P1, DOI 10.1258/ebm.2011.011255; Bhala N, 2013, CURR PHARM DESIGN, V19, P5169, DOI 10.2174/13816128113199990336; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cawley GC, 2004, NEURAL NETWORKS, V17, P1467, DOI 10.1016/j.neunet.2004.07.002; Cello JP, 2013, CLIN TRANSL GASTROEN, V4, DOI 10.1038/ctg.2013.6; COHEN JA, 1979, DIGEST DIS SCI, V24, P835, DOI 10.1007/BF01324898; Dunn W, 2012, J HEPATOL, V57, P384, DOI 10.1016/j.jhep.2012.03.024; Erim Y, 2007, LIVER TRANSPLANT, V13, P757, DOI 10.1002/lt.21163; Erim Y, 2006, Z PSYCHOSOM MED PSYC, V52, P341, DOI 10.13109/zptm.2006.52.4.341; Ertle J, 2011, INT J CANCER, V128, P2436, DOI 10.1002/ijc.25797; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; FREBOURG T, 1986, HEPATOLOGY, V6, P392, DOI 10.1002/hep.1840060310; GUECHOT J, 1995, J HEPATOL, V22, P103; Kramer G, 2004, CANCER RES, V64, P1751, DOI 10.1158/0008-5472.CAN-03-2455; Meyer D, 2003, NEUROCOMPUTING, V55, P169, DOI 10.1016/S0925-2312(03)00431-4; Ruhl CE, 2005, CLIN GASTROENTEROL H, V3, P1260, DOI 10.1016/S1542-3565(05)00743-3; Sagir A, 2008, HEPATOLOGY, V47, P592, DOI 10.1002/hep.22056; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sowa JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062439; Verrijken A, 2014, HEPATOLOGY, V59, P121, DOI 10.1002/hep.26510; Vizzutti F, 2009, ANN HEPATOL, V8, P89; Wederneyer I, 2009, J HEPATOL, V50, P140, DOI 10.1016/j.jhep.2008.08.023; Zakhari S, 2007, HEPATOLOGY, V46, P2032, DOI 10.1002/hep.22010	24	40	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101444	10.1371/journal.pone.0101444	http://dx.doi.org/10.1371/journal.pone.0101444			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988316	Green Published, gold, Green Submitted			2022-12-27	WOS:000341354100088
J	Wang, Y; Li, H; Wang, P; Song, F; Cai, WZ				Wang, Ying; Li, Hu; Wang, Pei; Song, Fan; Cai, Wanzhi			Comparative Mitogenomics of Plant Bugs (Hemiptera: Miridae): Identifying the AGG Codon Reassignments between Serine and Lysine	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; PHYLOGENETIC ANALYSIS; GENETIC-CODE; MOLECULAR PHYLOGENY; MULTIPLE ALIGNMENT; CONTROL REGION; EVOLUTION; INSECTA; HETEROPTERA; SEQUENCES	Insect mitochondrial genomes are very important to understand the molecular evolution as well as for phylogenetic and phylogeographic studies of the insects. The Miridae are the largest family of Heteroptera encompassing more than 11,000 described species and of great economic importance. For better understanding the diversity and the evolution of plant bugs, we sequence five new mitochondrial genomes and present the first comparative analysis of nine mitochondrial genomes of mirids available to date. Our result showed that gene content, gene arrangement, base composition and sequences of mitochondrial transcription termination factor were conserved in plant bugs. Intra-genus species shared more conserved genomic characteristics, such as nucleotide and amino acid composition of protein-coding genes, secondary structure and anticodon mutations of tRNAs, and non-coding sequences. Control region possessed several distinct characteristics, including: variable size, abundant tandem repetitions, and intra-genus conservation; and was useful in evolutionary and population genetic studies. The AGG codon reassignments were investigated between serine and lysine in the genera Adelphocoris and other cimicomorphans. Our analysis revealed correlated evolution between reassignments of the AGG codon and specific point mutations at the antidocons of tRNA(Lys) and tRNA(Ser(AGN)). Phylogenetic analysis indicated that mitochondrial genome sequences were useful in resolving family level relationship of Cimicomorpha. Comparative evolutionary analysis of plant bug mitochondrial genomes allowed the identification of previously neglected coding genes or non-coding regions as potential molecular markers. The finding of the AGG codon reassignments between serine and lysine indicated the parallel evolution of the genetic code in Hemiptera mitochondrial genomes.	[Wang, Ying; Li, Hu; Song, Fan; Cai, Wanzhi] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Li, Hu] China Agr Univ, Dept Ornamental Hort, Beijing 100094, Peoples R China; [Wang, Pei] Fujian Entry Exit Inspect & Quarantine Bur, AQSIQ, Key Lab Molluscan Quarantine & Identificat, Fuzhou, Fujian, Peoples R China	China Agricultural University; China Agricultural University	Li, H (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	tigerleecau@hotmail.com; caiwz@cau.edu.cn			Special Fund for Agroscientific Research in the Public Interest [201103012]; National Basic Research Program of China [2013CB127600]; National Natural Science Foundation of China [31372229]; National Key Technology R & D Program of the Ministry of Science and Technology [2012BAD19B00]; Special Fund for Scientific Research [2012FY111100]; China Postdoctoral Science Foundation [2013M540167]; Chinese Universities Scientific Fund [2014BH021]; Beijing Natural Science Foundation [6144027]	Special Fund for Agroscientific Research in the Public Interest; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R & D Program of the Ministry of Science and Technology(National Key Technology R&D Program); Special Fund for Scientific Research; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chinese Universities Scientific Fund; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This research is supported by grants from the Special Fund for Agroscientific Research in the Public Interest (No. 201103012), the National Basic Research Program of China (No. 2013CB127600), the National Natural Science Foundation of China (No. 31372229), the National Key Technology R & D Program of the Ministry of Science and Technology (2012BAD19B00) and the Special Fund for Scientific Research (No. 2012FY111100) for Wanzhi Cai; and the China Postdoctoral Science Foundation (No. 2013M540167), the Chinese Universities Scientific Fund (No.2014BH021) and the Beijing Natural Science Foundation (No. 6144027) for Hu Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2006, PLOS BIOL, V4, P711, DOI 10.1371/journal.pbio.0040127; Abascal F, 2006, NUCLEIC ACIDS RES, V34, pW389, DOI 10.1093/nar/gkl044; Abascal F, 2012, MITOCHONDR DNA, V23, P84, DOI 10.3109/19401736.2011.653801; Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Abascal F, 2009, METHODS MOL BIOL, V537, P233, DOI 10.1007/978-1-59745-251-9_11; Beckenbach AT, 2012, GENOME BIOL EVOL, V4, P89, DOI 10.1093/gbe/evr131; Beckenbach AT, 2009, GENOME, V52, P31, DOI 10.1139/G08-098; Boore JL, 2006, TRENDS ECOL EVOL, V21, P439, DOI 10.1016/j.tree.2006.05.009; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; Cameron SL, 2004, CLADISTICS, V20, P534, DOI 10.1111/j.1096-0031.2004.00040.x; Cameron SL, 2008, GENE, V408, P112, DOI 10.1016/j.gene.2007.10.023; Cameron SL, 2007, SYST ENTOMOL, V32, P40, DOI 10.1111/j.1365-3113.2006.00355.x; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; Cassis G, 2012, ANNU REV ENTOMOL, V57, P377, DOI 10.1146/annurev-ento-121510-133533; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Curole JP, 1999, TRENDS ECOL EVOL, V14, P394, DOI 10.1016/S0169-5347(99)01660-2; Dai X, 2012, ZOOTAXA, P30, DOI 10.11646/zootaxa.3554.1.2; Delsuc F, 2003, SCIENCE, V301, P1482; Dotson EM, 2001, INSECT MOL BIOL, V10, P205, DOI 10.1046/j.1365-2583.2001.00258.x; Gao JY, 2013, ZOOTAXA, V3669, P1; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Haran J, 2013, MOL PHYLOGENET EVOL, V67, P156, DOI 10.1016/j.ympev.2012.12.022; Hua JM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-134; Hua JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-610; Jung S, 2012, CLADISTICS, V28, P50, DOI 10.1111/j.1096-0031.2011.00365.x; Knight RD, 2001, NAT REV GENET, V2, P49, DOI 10.1038/35047500; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Li H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061685; Li H, 2015, MITOCHONDR DNA, V26, P674, DOI 10.3109/19401736.2013.840602; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045925; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029419; Li H, 2012, INT J BIOL SCI, V8, P93, DOI 10.7150/ijbs.8.93; Li H, 2011, INT J BIOL SCI, V7, P792, DOI 10.7150/ijbs.7.792; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Ma C, 2012, MOL ECOL, V21, P4344, DOI 10.1111/j.1365-294X.2012.05684.x; Miller M.A., 2010, P GAT COMP ENV WORKS; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Rawlings TA, 2003, P NATL ACAD SCI USA, V100, P15700, DOI 10.1073/pnas.2535036100; Roberti M, 2003, NUCLEIC ACIDS RES, V31, P1597, DOI 10.1093/nar/gkg272; Roehrdanz R, 2016, MITOCHONDRIAL DNA A, V27, P48, DOI 10.3109/19401736.2013.869689; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rota-Stabelli O, 2010, GENOME BIOL EVOL, V2, P425, DOI 10.1093/gbe/evq030; Sadowska-Woda I, 2008, INSECT SYST EVOL, V39, P407, DOI 10.1163/187631208788784291; Schaefer CW., 2000, HETEROPTERA EC IMPOR, V1; Schuh R.T, 1995, TRUE BUGS WORLD; Schuh RT, 2009, SYST ENTOMOL, V34, P15, DOI 10.1111/j.1365-3113.2008.00436.x; SCHUH RT, 1991, J NEW YORK ENTOMOL S, V99, P298; Sengupta S, 2007, J MOL EVOL, V64, P662, DOI 10.1007/s00239-006-0284-7; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Simon S, 2013, MOL PHYLOGENET EVOL, V69, P393, DOI 10.1016/j.ympev.2013.03.033; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Tabei Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-33; Talavera G, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-315; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tian Y, 2008, MOL PHYLOGENET EVOL, V47, P581, DOI 10.1016/j.ympev.2008.01.034; Timmermans MJTN, 2012, MOL PHYLOGENET EVOL, V63, P299, DOI 10.1016/j.ympev.2011.12.021; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Wang P, 2014, INSECT SCI, V21, P159, DOI 10.1111/1744-7917.12029; Wang Y, 2016, MITOCHONDRIAL DNA A, V27, P222, DOI 10.3109/19401736.2014.880898; Wei SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012708; Wei SJ, 2010, MOL BIOL REP, V37, P1931, DOI 10.1007/s11033-009-9640-1; Weirauch C, 2011, ANNU REV ENTOMOL, V56, P487, DOI 10.1146/annurev-ento-120709-144833; Yang WY, 2013, GENE, V532, P27, DOI 10.1016/j.gene.2013.08.087; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7; ZHANG DX, 1995, J MOL EVOL, V40, P382, DOI 10.1007/BF00164024; Zhao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062943	72	17	19	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101375	10.1371/journal.pone.0101375	http://dx.doi.org/10.1371/journal.pone.0101375			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988409	Green Published, Green Submitted, gold			2022-12-27	WOS:000341354100081
J	Zaiss, AK; Zuber, J; Chu, C; Machado, HB; Jiao, J; Catapang, AB; Ishikawa, TO; Gil, JS; Lowe, SW; Herschman, HR				Zaiss, Anne K.; Zuber, Johannes; Chu, Chun; Machado, Hidevaldo B.; Jiao, Jing; Catapang, Arthur B.; Ishikawa, Tomo-o; Gil, Jose S.; Lowe, Scott W.; Herschman, Harvey R.			Reversible Suppression of Cyclooxygenase 2 (COX-2) Expression In Vivo by Inducible RNA Interference	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; TRANSGENIC MICE; ARACHIDONIC-ACID; GENE-EXPRESSION; MAMMALIAN-CELLS; POLYMERASE-II; MOUSE SKIN; INFLAMMATION; HYPERALGESIA; MESSENGER	Prostaglandin-endoperoxide synthase 2 (PTGS2), also known as cyclooxygenase 2 (COX-2), plays a critical role in many normal physiological functions and modulates a variety of pathological conditions. The ability to turn endogenous COX-2 on and off in a reversible fashion, at specific times and in specific cell types, would be a powerful tool in determining its role in many contexts. To achieve this goal, we took advantage of a recently developed RNA interference system in mice. An shRNA targeting the Cox2 mRNA 3'untranslated region was inserted into a microRNA expression cassette, under the control of a tetracycline response element (TRE) promoter. Transgenic mice containing the COX-2-shRNA were crossed with mice encoding a CAG promoter-driven reverse tetracycline transactivator, which activates the TRE promoter in the presence of tetracycline/doxycycline. To facilitate testing the system, we generated a knockin reporter mouse in which the firefly luciferase gene replaces the Cox2 coding region. Cox2 promoter activation in cultured cells from triple transgenic mice containing the luciferase allele, the shRNA and the transactivator transgene resulted in robust luciferase and COX-2 expression that was reversibly down-regulated by doxycycline administration. In vivo, using a skin inflammation-model, both luciferase and COX-2 expression were inhibited over 80% in mice that received doxycycline in their diet, leading to a significant reduction of infiltrating leukocytes. In summary, using inducible RNA interference to target COX-2 expression, we demonstrate potent, reversible Cox2 gene silencing in vivo. This system should provide a valuable tool to analyze cell type-specific roles for COX-2.	[Zaiss, Anne K.; Chu, Chun; Machado, Hidevaldo B.; Jiao, Jing; Catapang, Arthur B.; Ishikawa, Tomo-o; Gil, Jose S.; Herschman, Harvey R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med & Mol Pharmacol, Los Angeles, CA 90095 USA; [Zaiss, Anne K.; Chu, Chun; Machado, Hidevaldo B.; Jiao, Jing; Catapang, Arthur B.; Ishikawa, Tomo-o; Gil, Jose S.; Herschman, Harvey R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Zuber, Johannes; Lowe, Scott W.] Cold Spring Harbor Lab, New York, NY USA; [Zuber, Johannes; Lowe, Scott W.] Howard Hughes Med Inst, New York, NY USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Herschman, HR (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.	hherschman@mednet.ucla.edu	Jiao, Jing/F-5354-2015; Zuber, Johannes/E-7517-2011	Zuber, Johannes/0000-0001-8810-6835	National Institutes of Health [P50 CA086306-08]; American Society of Hematology (ASH); NATIONAL CANCER INSTITUTE [P50CA086306, P30CA008748, P30CA016042] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Hematology (ASH); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant P50 CA086306-08 (HRH). AKZ is the recipient of an American Society of Hematology (ASH) Scholar Award. SWL is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahler E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064561; Araldi D, 2013, P NATL ACAD SCI USA, V110, P3603, DOI 10.1073/pnas.1220668110; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; CALHOUN W, 1987, AGENTS ACTIONS, V21, P306, DOI 10.1007/BF01966499; Cawthorne Christopher, 2007, J Biomol Tech, V18, P120; Contag PR, 1998, NAT MED, V4, P245, DOI 10.1038/nm0298-245; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Dickins RA, 2007, NAT GENET, V39, P914, DOI 10.1038/ng2045; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; Dixon Dan A, 2013, Recent Results Cancer Res, V191, P7, DOI 10.1007/978-3-642-30331-9_2; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; Doyle T, 2011, FASEB J, V25, P2782, DOI 10.1096/fj.10-178095; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Eakin GS, 2006, NAT PROTOC, V1, P1145, DOI 10.1038/nprot.2006.173; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; FISHER S.M, 1997, FRONT BIOSCI, V2, P482, DOI d482-500; Gabor Miklos, 2003, Methods Mol Biol, V225, P129; Garcia Rodriguez Luis A, 2013, Recent Results Cancer Res, V191, P67, DOI 10.1007/978-3-642-30331-9_4; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Hay C, 1997, NEUROREPORT, V8, P1249, DOI 10.1097/00001756-199703240-00038; Herschman Harvey R, 2003, Mol Imaging Biol, V5, P286; Hirata T, 2012, ADV IMMUNOL, V116, P143, DOI 10.1016/B978-0-12-394300-2.00005-3; Ishikawa TO, 2006, MOL IMAGING BIOL, V8, P171, DOI 10.1007/s11307-006-0034-7; Ishikawa T, 2010, MOL ONCOL, V4, P347, DOI 10.1016/j.molonc.2010.06.004; Jain NK, 2008, PROSTAG LEUKOTR ESS, V79, P183, DOI 10.1016/j.plefa.2008.08.001; Kadoshima-Yamaoka K, 2009, EUR J PHARMACOL, V613, P163, DOI 10.1016/j.ejphar.2009.04.014; Kirkby NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069524; Kirkby NS, 2013, BIOCHEM BIOPH RES CO, V438, P249, DOI 10.1016/j.bbrc.2013.07.006; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; Lazarus M, 2002, ENDOCRINOLOGY, V143, P2410, DOI 10.1210/en.143.6.2410; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Menezes GB, 2008, EUR J PHARMACOL, V598, P118, DOI 10.1016/j.ejphar.2008.08.037; Minghetti L, 2004, J NEUROPATH EXP NEUR, V63, P901, DOI 10.1093/jnen/63.9.901; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakamura Y, 2003, FREE RADICAL BIO MED, V35, P997, DOI 10.1016/S0891-5849(03)00440-4; Oshima M, 2005, BIOCHEM BIOPH RES CO, V330, P928, DOI 10.1016/j.bbrc.2005.03.060; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Puignero V, 1997, INFLAMMATION, V21, P431, DOI 10.1023/A:1027370504822; Ristimaki A, 1996, BIOCHEM J, V318, P325, DOI 10.1042/bj3180325; Seibler J, 1998, BIOCHEMISTRY-US, V37, P6229, DOI 10.1021/bi980288t; Seluanov A., 2010, J VIS EXP; Steer SA, 2003, VIRAL IMMUNOL, V16, P447, DOI 10.1089/088282403771926283; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; TARAYRE JP, 1989, PHARMACOL RES, V21, P385, DOI 10.1016/1043-6618(89)90156-4; Tiano HF, 2002, CANCER RES, V62, P3395; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Zeng Y, 2005, METHOD ENZYMOL, V392, P371, DOI 10.1016/S0076-6879(04)92022-8; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhao XY, 2010, NAT PROTOC, V5, P963, DOI 10.1038/nprot.2010.61	54	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101263	10.1371/journal.pone.0101263	http://dx.doi.org/10.1371/journal.pone.0101263			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988319	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000341354100072
J	Abdelli, S; Papas, KK; Mueller, KR; Murtaugh, MP; Hering, BJ; Bonny, C				Abdelli, Saida; Papas, Klearchos K.; Mueller, Kate R.; Murtaugh, Mike P.; Hering, Bernhard J.; Bonny, Christophe			Regulation of the JNK3 Signaling Pathway during Islet Isolation: JNK3 and c-fos as New Markers of Islet Quality for Transplantation	PLOS ONE			English	Article							OXYGEN-CONSUMPTION RATE; MEDIATED INFLAMMATORY REACTION; HUMAN PANCREATIC-ISLETS; CELL-DEATH; EDMONTON PROTOCOL; INDUCED APOPTOSIS; GENE-EXPRESSION; MAP-KINASES; NUDE-MICE; BETA	Stress conditions generated throughout pancreatic islet processing initiate the activation of pro-inflammatory pathways and beta-cell destruction. Our goal is to identify relevant and preferably beta-specific markers to assess the activation of beta-cell stress and apoptotic mechanisms, and therefore the general quality of the islet preparation prior to transplantation. Protein expression and activation were analyzed by Western blotting and kinase assays. ATP measurements were performed by a luminescence-based assay. Oxygen consumption rate (OCR) was measured based on standard protocols using fiber optic sensors. Total RNA was used for gene expression analyzes. Our results indicate that pancreas digestion initiates a potent stress response in the islets by activating two stress kinases, c-Jun N-terminal Kinase (JNK) and p38. JNK1 protein levels remained unchanged between different islet preparations and following culture. In contrast, levels of JNK3 increased after islet culture, but varied markedly, with a subset of preparations bearing low JNK3 expression. The observed changes in JNK3 protein content strongly correlated with OCR measurements as determined by the Spearman's rank correlation coefficient rho (rho = 0: 7853) in the matching islet samples, while inversely correlating with c-fos mRNA expression (rho = 0: 885). In conclusion, pancreas digestion recruits JNK and p38 kinases that are known to participate to beta- cell apoptosis. Concomitantly, the islet isolation alters JNK3 and c-fos expression, both strongly correlating with OCR. Thus, a comparative analysis of JNK3 and c-fos expression before and after culture may provide for novel markers to assess islet quality prior to transplantation. JNK3 has the advantage over all other proposed markers to be islet-specific, and thus to provide for a marker independent of non-beta cell contamination.	[Abdelli, Saida; Bonny, Christophe] Ctr Hosp Univ Vaudois CHUV, Dept Med Genet, Lausanne, Switzerland; [Abdelli, Saida; Bonny, Christophe] Univ Lausanne, Lausanne, Switzerland; [Papas, Klearchos K.; Mueller, Kate R.] Univ Arizona, Dept Surg, Inst Cellular Transplantat, Tucson, AZ USA; [Murtaugh, Mike P.] Univ Minnesota, Dept Vet & Biomed Sci, Minneapolis, MN USA; [Hering, Bernhard J.] Univ Minnesota, Dept Surg, Schulze Diabet Inst, Minneapolis, MN 55455 USA	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Arizona; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bonny, C (corresponding author), Ctr Hosp Univ Vaudois CHUV, Dept Med Genet, Lausanne, Switzerland.	christophe.bonny@chuv.ch	Bonny, Christophe/AAV-7214-2021		Swiss National Science Foundation [FNS 310030_133018]; National Institute of Health, National Diabetes and Kidney Diseases (NIH/NIDDK) SBIR [R44DK069865]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R44DK069865] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institute of Health, National Diabetes and Kidney Diseases (NIH/NIDDK) SBIR; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grant from the Swiss National Science Foundation (FNS 310030_133018) and a National Institute of Health, National Diabetes and Kidney Diseases (NIH/NIDDK) SBIR grant (R44DK069865). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelli S, 2004, DIABETES, V53, P2815, DOI 10.2337/diabetes.53.11.2815; Abdelli S, 2009, DIABETOLOGIA, V52, P1871, DOI 10.1007/s00125-009-1431-7; Abdelli S, 2007, DIABETOLOGIA; Abdelli S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035997; Bertuzzi F, 2007, DIABETES CARE, V30, P410, DOI 10.2337/dc06-1233; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Caumo A, 2008, DIABETES CARE, V31, P301, DOI 10.2337/dc07-0975; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Fornoni A, 2008, DIABETOLOGIA, V51, P298, DOI 10.1007/s00125-007-0889-4; Fraker C, 2006, CELL TRANSPLANT, V15, P745, DOI 10.3727/000000006783981440; Froud T, 2005, AM J TRANSPLANT, V5, P2037, DOI 10.1111/j.1600-6143.2005.00957.x; Goto M, 2008, XENOTRANSPLANTATION, V15, P225, DOI 10.1111/j.1399-3089.2008.00482.x; GOTO S, 1994, TRANSPLANTATION, V58, P840, DOI 10.1097/00007890-199410150-00016; Hering BJ, 2005, TRANSPLANTATION, V79, P1296, DOI 10.1097/01.TP.0000157321.55375.86; Ilieva A, 1999, J ENDOCRINOL, V161, P357, DOI 10.1677/joe.0.1610357; Keesler GA, 1998, PROTEIN EXPRES PURIF, V14, P221, DOI 10.1006/prep.1998.0947; Kim DS, 2001, PIGM CELL RES, V14, P110, DOI 10.1034/j.1600-0749.2001.140206.x; Mellert J, 1999, J MOL MED-JMM, V77, P126, DOI 10.1007/s001090050319; Mueller KR, 2013, XENOTRANSPLANTATION; NAGATA M, 1990, TRANSPLANT P, V22, P855; Nilsson B, 2011, CURR OPIN ORGAN TRAN, V16, P620, DOI 10.1097/MOT.0b013e32834c2393; Papas KK, 2007, AM J TRANSPLANT, V7, P707, DOI 10.1111/j.1600-6143.2006.01655.x; Papas KK, 2007, BIOTECHNOL BIOENG, V98, P1071, DOI 10.1002/bit.21486; Papas KK, 2010, J INVEST SURG, V23, P28, DOI 10.3109/08941930903410825; Papas KK, 2009, CURR OPIN ORGAN TRAN, V14, P674, DOI 10.1097/MOT.0b013e328332a489; Paraskevas S, 1999, FEBS LETT, V455, P203, DOI 10.1016/S0014-5793(99)00882-0; Paraskevas S, 2000, PANCREAS, V20, P270, DOI 10.1097/00006676-200004000-00008; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; RICORDI C, 1991, PANCREAS, V6, P242, DOI 10.1097/00006676-199103000-00018; RICORDI C, 1988, TRANSPLANTATION, V45, P994, DOI 10.1097/00007890-198805000-00035; Rosenberg L, 1999, SURGERY, V126, P393, DOI 10.1067/msy.1999.98783; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2005, TRANSPLANTATION, V79, P1304, DOI 10.1097/01.TP.0000157300.53976.2A; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Srinivasan S, 2005, DIABETES, V54, P968, DOI 10.2337/diabetes.54.4.968; Street CN, 2004, DIABETES, V53, P3107, DOI 10.2337/diabetes.53.12.3107; Susini S, 1998, FASEB J, V12, P1173, DOI 10.1096/fasebj.12.12.1173; Suszynski TM, 2008, TRANSPL P, V40, P346, DOI 10.1016/j.transproceed.2008.01.061; Sweet IR, 2008, AM J TRANSPLANT, V8, P183, DOI 10.1111/j.1600-6143.2007.02041.x; Wang RN, 1999, J ENDOCRINOL, V163, P181, DOI 10.1677/joe.0.1630181; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Yasuda J, 1999, MOL CELL BIOL, V19, P7245; Zhang SP, 2002, J MOL BIOL, V324, P271, DOI 10.1016/S0022-2836(02)01044-6; Ziolkowski AF, 2012, J CLIN INVEST, V122, P132, DOI 10.1172/JCI46177	49	8	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e99796	10.1371/journal.pone.0099796	http://dx.doi.org/10.1371/journal.pone.0099796			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983249	Green Published, gold, Green Submitted			2022-12-27	WOS:000339635000013
J	Galan, A; Dergham, P; Escoll, P; de-la-Hera, A; D'Onofrio, PM; Magharious, MM; Koeberle, PD; Frade, JM; Saragovi, HU				Galan, Alba; Dergham, Pauline; Escoll, Pedro; de-la-Hera, Antonio; D'Onofrio, Philippe M.; Magharious, Mark M.; Koeberle, Paulo D.; Maria Frade, Jose; Saragovi, H. Uri			Neuronal Injury External to the Retina Rapidly Activates Retinal Glia, Followed by Elevation of Markers for Cell Cycle Re-Entry and Death in Retinal Ganglion Cells	PLOS ONE			English	Article							OPTIC-NERVE TRANSECTION; PROTEINS; EXPRESSION; ISCHEMIA; SURVIVAL; GLAUCOMA; KINASE; NEUROPROTECTION; INVOLVEMENT; INHIBITION	Retinal ganglion cells (RGCs) are neurons that relay visual signals from the retina to the brain. The RGC cell bodies reside in the retina and their fibers form the optic nerve. Full transection (axotomy) of the optic nerve is an extra-retinal injury model of RGC degeneration. Optic nerve transection permits time-kinetic studies of neurodegenerative mechanisms in neurons and resident glia of the retina, the early events of which are reported here. One day after injury, and before atrophy of RGC cell bodies was apparent, glia had increased levels of phospho-Akt, phospho-S6, and phospho-ERK1/2; however, these signals were not detected in injured RGCs. Three days after injury there were increased levels of phospho-Rb and cyclin A proteins detected in RGCs, whereas these signals were not detected in glia. DNA hyperploidy was also detected in RGCs, indicative of cell cycle re-entry by these post-mitotic neurons. These events culminated in RGC death, which is delayed by pharmacological inhibition of the MAPK/ERK pathway. Our data show that a remote injury to RGC axons rapidly conveys a signal that activates retinal glia, followed by RGC cell cycle re-entry, DNA hyperploidy, and neuronal death that is delayed by preventing glial MAPK/ERK activation. These results demonstrate that complex and variable neuro-glia interactions regulate healthy and injured states in the adult mammalian retina.	[Galan, Alba; Dergham, Pauline; Saragovi, H. Uri] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Escoll, Pedro; de-la-Hera, Antonio] Alcala Univ, Sch Med, Dept Med, Mol Med Inst IMMPA CSIC UAH, Madrid, Spain; [D'Onofrio, Philippe M.; Magharious, Mark M.] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada; [Koeberle, Paulo D.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Maria Frade, Jose] CSIC, Inst Cajal, Dept Mol Cellular & Dev Neurobiol, E-28002 Madrid, Spain; [Saragovi, H. Uri] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Saragovi, H. Uri] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Saragovi, H. Uri] McGill Univ, Ctr Canc, Montreal, PQ H3G 1Y6, Canada	Lady Davis Institute; McGill University; Universidad de Alcala; University of Toronto; University of Toronto; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); McGill University; McGill University; McGill University	Saragovi, HU (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada.	uri.saragovi@mcgill.ca	Frade, Jose M/E-7913-2013; Escoll, Pedro/H-9517-2019; Escoll, Pedro/B-2034-2017	Frade, Jose M/0000-0001-7067-2505; Escoll, Pedro/0000-0002-5933-094X	A King Carlos III Award; Canadian Institute of Health Research; Spanish Ministry of Science and Innovation (MICINN); FUNDALUCE; MICINN (DENDRIA) [SAF 2011-29405]	A King Carlos III Award; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FUNDALUCE; MICINN (DENDRIA)	A King Carlos III Award to HUS allowed travel between Spain and Canada. This work was partially supported by grants from the Canadian Institute of Health Research to HUS, and to PDK; the Spanish Ministry of Science and Innovation (MICINN) and FUNDALUCE to JMF; and MICINN (DENDRIA, SAF 2011-29405) to ADLH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo M, 2009, INVEST OPHTH VIS SCI, V50, P424, DOI 10.1167/iovs.08-2404; Bai YJ, 2010, J BIOL CHEM, V285, P39392, DOI 10.1074/jbc.M110.147801; Bai YJ, 2010, INVEST OPHTH VIS SCI, V51, P6639, DOI 10.1167/iovs.10-5431; Bai YJ, 2010, INVEST OPHTH VIS SCI, V51, P4722, DOI 10.1167/iovs.09-5032; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Byrnes KR, 2007, BRAIN, V130, P2977, DOI 10.1093/brain/awm179; Byrnes KR, 2007, NEUROCHEM RES, V32, P1799, DOI 10.1007/s11064-007-9312-2; CARMIGNOTO G, 1989, J NEUROSCI, V9, P1263; Copani A, 2001, TRENDS NEUROSCI, V24, P25, DOI 10.1016/S0166-2236(00)01663-5; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Danias J, 2006, EXP EYE RES, V82, P219, DOI 10.1016/j.exer.2005.06.013; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Frade Jose Maria, 2010, Commun Integr Biol, V3, P201; Garcia M, 2003, HISTOL HISTOPATHOL, V18, P1205, DOI 10.14670/HH-18.1205; GLOVINSKY Y, 1991, INVEST OPHTH VIS SCI, V32, P484; Hollander A, 2012, INVEST OPHTH VIS SCI, V53, P3973, DOI 10.1167/iovs.11-8350; Ivanov D, 2008, J NEUROSCI METH, V174, P10, DOI 10.1016/j.jneumeth.2008.06.016; Janssen A, 2011, NAT CELL BIOL, V13, P199, DOI 10.1038/ncb0311-199; Jiang H, 2010, CANCER RES, V70, P7882, DOI 10.1158/0008-5472.CAN-10-1604; Kikuchi M, 2000, J NEUROSCI, V20, P5037; Kingsbury MA, 2006, CELL MOL LIFE SCI, V63, P2626, DOI 10.1007/s00018-006-6169-5; Kirsch M, 2010, GLIA, V58, P768, DOI 10.1002/glia.20961; Lacroix B, 2012, J PATHOL, V226, P338, DOI 10.1002/path.3013; Lebrun-Julien F, 2010, P NATL ACAD SCI USA, V107, P3817, DOI 10.1073/pnas.0909276107; Lebrun-Julien F, 2009, MOL CELL NEUROSCI, V40, P410, DOI 10.1016/j.mcn.2008.12.005; Magharious MM, 2011, J VIS EXP; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; Mehta SL, 2007, BRAIN RES REV, V54, P34, DOI 10.1016/j.brainresrev.2006.11.003; Morillo SM, 2010, P NATL ACAD SCI USA, V107, P109, DOI 10.1073/pnas.0906121107; Nguyen MD, 2002, CELL DEATH DIFFER, V9, P1294, DOI 10.1038/sj.cdd.4401108; OKANO HJ, 1993, J NEUROSCI, V13, P2930; Padmanabhan J, 1999, J NEUROSCI, V19, P8747, DOI 10.1523/JNEUROSCI.19-20-08747.1999; Pajalunga D, 2008, CELL MOL LIFE SCI, V65, P8, DOI 10.1007/s00018-007-7425-z; Park DS, 2000, J NEUROSCI, V20, P3104, DOI 10.1523/JNEUROSCI.20-09-03104.2000; Sakamoto K, 2011, J OCUL PHARMACOL TH, V27, P419, DOI 10.1089/jop.2010.0141; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Shi ZH, 2008, J BIOL CHEM, V283, P29156, DOI 10.1074/jbc.M802365200; Shi Z, 2007, DEV NEUROBIOL, V67, P884, DOI 10.1002/dneu.20360; Shibuki H, 2000, INVEST OPHTH VIS SCI, V41, P3607; Swiss VA, 2010, GLIA, V58, P377, DOI 10.1002/glia.20933; Wang W, 2009, PROG NEUROBIOL, V89, P1, DOI 10.1016/j.pneurobio.2009.01.007; Wartiovaara K, 2002, J NEUROSCI, V22, P815, DOI 10.1523/JNEUROSCI.22-03-00815.2002; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Yoshimura N, 2003, INVEST OPHTH VIS SCI, V44, P2211, DOI 10.1167/iovs.02-0704; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	47	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101349	10.1371/journal.pone.0101349	http://dx.doi.org/10.1371/journal.pone.0101349			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983470	Green Published, Green Submitted, gold			2022-12-27	WOS:000339635000095
J	Nemeth, K; Zimmer, M; Schweinberger, SR; Vakli, P; Kovacs, G				Nemeth, Kornel; Zimmer, Marta; Schweinberger, Stefan R.; Vakli, Pal; Kovacs, Gyula			The Background of Reduced Face Specificity of N170 in Congenital Prosopagnosia	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; TRIAL EEG DYNAMICS; DEVELOPMENTAL PROSOPAGNOSIA; HEREDITARY PROSOPAGNOSIA; ACQUIRED PROSOPAGNOSIA; BRAIN POTENTIALS; IMPAIRED FACE; SINGLE-TRIAL; ALPHA-OSCILLATIONS; FACIAL EXPRESSION	Congenital prosopagnosia is lifelong face-recognition impairment in the absence of evidence for structural brain damage. To study the neural correlates of congenital prosopagnosia, we measured the face-sensitive N170 component of the event-related potential in three members of the same family (father (56 y), son (25 y) and daughter (22 y)) and in age-matched neurotypical participants (young controls: n = 14; 24.5 y +/- 2.1; old controls: n = 6; 57.3 y +/- 5.4). To compare the face sensitivity of N170 in congenital prosopagnosic and neurotypical participants we measured the event-related potentials for faces and phase-scrambled random noise stimuli. In neurotypicals we found significantly larger N170 amplitude for faces compared to noise stimuli, reflecting normal early face processing. The congenital prosopagnosic participants, by contrast, showed reduced face sensitivity of the N170, and this was due to a larger than normal noise-elicited N170, rather than to a smaller face-elicited N170. Interestingly, single-trial analysis revealed that the lack of face sensitivity in congenital prosopagnosia is related to a larger oscillatory power and phase-locking in the theta frequency-band (4-7 Hz, 130-190 ms) as well as to a lower intertrial jitter of the response latency for the noise stimuli. Altogether, these results suggest that congenital prosopagnosia is due to the deficit of early, structural encoding steps of face perception in filtering between face and non-face stimuli.	[Nemeth, Kornel; Zimmer, Marta; Vakli, Pal; Kovacs, Gyula] Budapest Univ Technol & Econ, Dept Cognit Sci, Budapest, Hungary; [Schweinberger, Stefan R.; Kovacs, Gyula] Univ Jena, Inst Psychol, Jena, Germany; [Schweinberger, Stefan R.; Kovacs, Gyula] Univ Jena, DFG Res Unit Person Percept, Jena, Germany	Budapest University of Technology & Economics; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Kovacs, G (corresponding author), Budapest Univ Technol & Econ, Dept Cognit Sci, Budapest, Hungary.	gkovacs@cogsci.bme.hu	Kovacs, Gyula/E-4781-2010; Schweinberger, Stefan/A-1860-2009	Schweinberger, Stefan/0000-0001-5762-0188	Hungarian Scientific Research Fund (OTKA) [PD 101499]; Deutsche Forschungsgemeinschaft [KO 3918/1-2, KO 3918/2-1]	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Hungarian Scientific Research Fund (OTKA; http://www.otka.hu/; PD 101499 (Marta Zimmer)) and by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/; KO 3918/1-2, 2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiloni F, 1996, ELECTROEN CLIN NEURO, V98, P363, DOI 10.1016/0013-4694(96)00284-2; Baddeley AD, 2004, DOORS PEOPLE TEST VI; Banko EM, 2011, J NEUROSCI, V31, P2663, DOI 10.1523/JNEUROSCI.2725-10.2011; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Behrmann M, 2005, TRENDS COGN SCI, V9, P180, DOI 10.1016/j.tics.2005.02.011; Behrmann M, 2010, PERCEPTUAL EXPERTISE, P167; Bentin S, 2000, COGN NEUROPSYCHOL, V17, P35, DOI 10.1080/026432900380472; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bentin S, 1999, NEUROREPORT, V10, P823, DOI 10.1097/00001756-199903170-00029; Bentin S, 2007, NAT NEUROSCI, V10, P801, DOI 10.1038/nn0707-801; Bentin S, 2007, J COGNITIVE NEUROSCI, V19, P132, DOI 10.1162/jocn.2007.19.1.132; BODAMER J, 1947, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V118, P6, DOI 10.1007/BF00352849; Boehm SG, 2011, NEUROPSYCHOLOGIA, V49, P2082, DOI 10.1016/j.neuropsychologia.2011.03.039; Bottger D, 2002, INT J PSYCHOPHYSIOL, V45, P245, DOI 10.1016/S0167-8760(02)00031-4; Bowles DC, 2009, COGN NEUROPSYCHOL, V26, P423, DOI 10.1080/02643290903343149; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Busigny T, 2011, J NEUROPSYCHOL, V5, P1, DOI 10.1348/174866410X500116; Busigny T, 2010, NEUROPSYCHOLOGIA, V48, P2051, DOI 10.1016/j.neuropsychologia.2010.03.026; Calder AJ, 2005, NAT REV NEUROSCI, V6, P641, DOI 10.1038/nrn1724; Chatrian G. E., 1985, American Journal of EEG Technology, V25, P83; Dakin SC, 2002, CURR BIOL, V12, pR476, DOI 10.1016/S0960-9822(02)00960-0; Dalrymple KA, 2011, NEUROPSYCHOLOGIA, V49, P2553, DOI 10.1016/j.neuropsychologia.2011.05.003; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; de Gelder B, 2005, NEUROSCI LETT, V376, P40, DOI 10.1016/j.neulet.2004.11.047; De Haan EHF, 1999, J CLIN EXP NEUROPSYC, V21, P312, DOI 10.1076/jcen.21.3.312.917; DeGutis JM, 2007, J COGNITIVE NEUROSCI, V19, P1790, DOI 10.1162/jocn.2007.19.11.1790; DEHAAN EHF, 1991, CORTEX, V27, P489, DOI 10.1016/S0010-9452(13)80001-9; Della Sala S, 2003, CORTEX, V39, P533; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Duchaine B, 2006, NEUROPSYCHOLOGIA, V44, P576, DOI 10.1016/j.neuropsychologia.2005.07.001; Duchaine B, 2005, J COGNITIVE NEUROSCI, V17, P249, DOI 10.1162/0898929053124857; Duchaine B., 2011, OXFORD HDB FACE PERC; Duchaine BC, 2006, CURR OPIN NEUROBIOL, V16, P166, DOI 10.1016/j.conb.2006.03.003; Duchaine BC, 2003, PERCEPTION, V32, P827, DOI 10.1068/p5067; Duchaine BC, 2000, NEUROREPORT, V11, P79, DOI 10.1097/00001756-200001170-00016; Duchaine B, 2007, COGN NEUROPSYCHOL, V24, P419, DOI 10.1080/02643290701380491; Duchaine BC, 2006, COGN NEUROPSYCHOL, V23, P714, DOI 10.1080/02643290500441296; Eimer M, 2000, COGNITIVE BRAIN RES, V10, P145, DOI 10.1016/S0926-6410(00)00038-0; Eimer M, 2000, CLIN NEUROPHYSIOL, V111, P694, DOI 10.1016/S1388-2457(99)00285-0; Eimer M, 2000, NEUROREPORT, V11, P2319, DOI 10.1097/00001756-200007140-00050; Eimer M, 1999, NEUROREPORT, V10, P255, DOI 10.1097/00001756-199902050-00010; Eimer M, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00119; Ganel T, 2005, NEUROPSYCHOLOGIA, V43, P1645, DOI 10.1016/j.neuropsychologia.2005.01.012; Gao L, 2009, PSYCHOPHYSIOLOGY, V46, P970, DOI 10.1111/j.1469-8986.2009.00853.x; Gobbini MI, 2006, BRAIN RES BULL, V71, P76, DOI 10.1016/j.brainresbull.2006.08.003; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Grueter M, 2007, CORTEX, V43, P734, DOI 10.1016/S0010-9452(08)70502-1; Gunji A, 2009, BRAIN DEV-JPN, V31, P139, DOI 10.1016/j.braindev.2008.04.011; Harris AM, 2005, NEUROPSYCHOLOGIA, V43, P2125, DOI 10.1016/j.neuropsychologia.2005.03.017; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; HECAEN H, 1962, ARCH NEUROL-CHICAGO, V7, P92, DOI 10.1001/archneur.1962.04210020014002; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; Jemel B, 2003, NEUROREPORT, V14, P2035, DOI 10.1097/00001756-200311140-00006; Jones RD, 2001, J CLIN EXP NEUROPSYC, V23, P265, DOI 10.1076/jcen.23.3.265.1183; Kennerknecht I, 2008, AM J MED GENET A, V146A, P2863, DOI 10.1002/ajmg.a.32552; Kennerknecht I, 2007, J HUM GENET, V52, P230, DOI 10.1007/s10038-006-0101-6; Kennerknecht I, 2006, AM J MED GENET A, V140A, P1617, DOI 10.1002/ajmg.a.31343; Klimesch W, 2004, COGNITIVE BRAIN RES, V19, P302, DOI 10.1016/j.cogbrainres.2003.11.016; Klimesch W, 2008, BRAIN RES, V1235, P31, DOI 10.1016/j.brainres.2008.06.049; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Kress T, 2003, NEUROSCI LETT, V352, P133, DOI 10.1016/j.neulet.2003.08.047; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Le Grand R, 2006, BRAIN COGNITION, V61, P139, DOI 10.1016/j.bandc.2005.11.005; Lee Y, 2010, CORTEX, V46, P949, DOI 10.1016/j.cortex.2009.07.012; Linkenkaer-Hansen K, 1998, NEUROSCI LETT, V253, P147, DOI 10.1016/S0304-3940(98)00586-2; Liu J, 2000, NEUROREPORT, V11, P337, DOI 10.1097/00001756-200002070-00023; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; MCCONACHIE HR, 1976, CORTEX, V12, P76, DOI 10.1016/S0010-9452(76)80033-0; MEADOWS JC, 1974, J NEUROL NEUROSUR PS, V37, P489, DOI 10.1136/jnnp.37.5.489; Melloni L, 2009, TRENDS COGN SCI, V13, P239, DOI 10.1016/j.tics.2009.03.007; Minnebusch DA, 2007, EUR J NEUROSCI, V25, P2234, DOI 10.1111/j.1460-9568.2007.05451.x; Mohamed TN, 2009, NEUROREPORT, V20, P782, DOI 10.1097/WNR.0b013e32832b7e24; Navajas J, 2013, J NEUROSCI, V33, P1337, DOI 10.1523/JNEUROSCI.1226-12.2013; Nemeth K, CLIN NEUROS IN PRESS, V67; Nunn JA, 2001, NEUROCASE, V7, P15, DOI 10.1093/neucas/7.1.15; Palermo R, 2011, NEUROPSYCHOLOGIA, V49, P3801, DOI 10.1016/j.neuropsychologia.2011.09.039; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pfutze EM, 2002, PSYCHOL AGING, V17, P140, DOI 10.1037//0882-7974.17.1.140; Polich J, 1997, EVOKED POTENTIAL, V104, P244, DOI 10.1016/S0168-5597(97)96139-6; Ramon M, 2010, NEUROPSYCHOLOGIA, V48, P933, DOI 10.1016/j.neuropsychologia.2009.11.014; Raven J, 2000, RAVEN MAUAL SECTION; Regan D., 1989, HUMAN BRAIN ELECTROP; Righart R, 2007, P NATL ACAD SCI USA, V104, P17234, DOI 10.1073/pnas.0707753104; Rivolta D, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00045; Rivolta D, 2012, CORTEX, V48, P344, DOI 10.1016/j.cortex.2011.01.005; Rivolta D, 2010, J CLIN EXP NEUROPSYC, V32, P1002, DOI 10.1080/13803391003662710; Rossion B., 2012, OXFORD HDB ERP COMPO, P115, DOI [10.1093/oxfordhb/9780195374148.013.0064, DOI 10.1093/OXFORDHB/9780195374148.013.0064]; Rossion B, 2008, NEUROIMAGE, V40, P423, DOI 10.1016/j.neuroimage.2007.10.047; Rossion B, 2008, NEUROIMAGE, V39, P1959, DOI 10.1016/j.neuroimage.2007.10.011; Rossion B, 2011, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00225; Rousselet GA, 2007, NEUROIMAGE, V36, P843, DOI 10.1016/j.neuroimage.2007.02.052; Rousselet GA, 2008, J VISION, V8, DOI 10.1167/8.12.3; Rousselet GA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-98; Sagiv N, 2001, J COGNITIVE NEUROSCI, V13, P937, DOI 10.1162/089892901753165854; Sakihara K, 2012, CLIN NEUROPHYSIOL, V123, P270, DOI 10.1016/j.clinph.2011.06.023; Sauseng P, 2007, NEUROSCIENCE, V146, P1435, DOI 10.1016/j.neuroscience.2007.03.014; Sauseng P, 2008, NEUROSCI BIOBEHAV R, V32, P1001, DOI 10.1016/j.neubiorev.2008.03.014; Schiltz C, 2006, CEREB CORTEX, V16, P574, DOI 10.1093/cercor/bhj005; Schmalzl L, 2008, J NEUROPSYCHOL, V2, P99, DOI 10.1348/174866407X256554; Schneider BL, 2007, J VISION, V7, DOI 10.1167/7.4.4; Schweinberger SR, 2003, CORTEX, V39, P9, DOI 10.1016/S0010-9452(08)70071-6; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Tang YY, 2008, IEEE ENG MED BIO, P4114, DOI 10.1109/IEMBS.2008.4650114; Thomas AL, 2008, ARCH CLIN NEUROPSYCH, V23, P175, DOI 10.1016/j.acn.2007.10.003; Towler J, 2012, COGN NEUROPSYCHOL, V29, P503, DOI 10.1080/02643294.2012.716757; Towler J, 2012, NEUROPSYCHOLOGIA, V50, P3588, DOI 10.1016/j.neuropsychologia.2012.10.017; Wilcox RR, 2005, INTRO ROBOUST ESTIMA; Wolff N, 2012, PSYCHOL AGING, V27, P1066, DOI 10.1037/a0029112	110	19	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101393	10.1371/journal.pone.0101393	http://dx.doi.org/10.1371/journal.pone.0101393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983881	gold, Green Submitted, Green Published			2022-12-27	WOS:000339635000098
J	Shu, HF; Yang, T; Yu, SX; Huang, HD; Jiang, LL; Gu, JW; Kuang, YQ				Shu, Hai-Feng; Yang, Tao; Yu, Si-Xun; Huang, Hai-Dong; Jiang, Ling-Li; Gu, Jian-Wen; Kuang, Yong-Qin			Aerobic Exercise for Parkinson's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Review							TAI-CHI; REHABILITATION TREATMENT; GAIT; PEOPLE; PERFORMANCE; MOTOR; NEUROPLASTICITY; PROGRAM; BALANCE; HEALTH	Background: Although some trials assessed the effectiveness of aerobic exercise for Parkinson's disease (PD), the role of aerobic exercise in the management of PD remained controversial. Objective: The purpose of this systematic review is to evaluate the evidence about whether aerobic exercise is effective for PD. Methods: Seven electronic databases, up to December 2013, were searched to identify relevant studies. Two reviewers independently extracted data and assessed methodological quality based on PEDro scale. Standardised mean difference (SMD) and 95% confidence intervals (CI) of random-effects model were calculated. And heterogeneity was assessed based on the I 2 statistic. Results: 18 randomized controlled trials (RCTs) with 901 patients were eligible. The aggregated results suggested that aerobic exercise should show superior effects in improving motor actions (SMD, -0.57; 95% CI -0.94 to -0.19; p = 0.003), balance (SMD, 2.02; 95% CI 0.45 to 3.59; p = 0.01), and gait (SMD, 0.33; 95% CI 0.17 to 0.49; p<0.0001) in patients with PD, but not in quality of life (SMD, 0.11; 95% CI -0.23 to 0.46; p = 0.52). And there was no valid evidence on follow-up effects of aerobic exercise for PD. Conclusion: Aerobic exercise showed immediate beneficial effects in improving motor action, balance, and gait in patients with PD. However, given no evidence on follow-up effects, large-scale RCTs with long follow-up are warrant to confirm the current findings.	[Shu, Hai-Feng; Yang, Tao; Yu, Si-Xun; Huang, Hai-Dong; Jiang, Ling-Li; Gu, Jian-Wen; Kuang, Yong-Qin] Gen Hosp Peoples Liberat Army Chengdu Mil Reg, Dept Neurosurg, Chengdu, Sichuan, Peoples R China		Kuang, YQ (corresponding author), Gen Hosp Peoples Liberat Army Chengdu Mil Reg, Dept Neurosurg, Chengdu, Sichuan, Peoples R China.	yongqinkuangdr@163.com	Northcote, Matthew/L-1135-2019; Northcote, Matthew/B-8209-2019		National Natural Science Foundation of China [81100975, 81371430]; China Postdoctoral Science Foundation [2012T50850]; Research Foundation of General Hospital of Chengdu Military Region [424121H3]; Science Foundation of Health Office of Sichuan Province [42412D16]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Research Foundation of General Hospital of Chengdu Military Region; Science Foundation of Health Office of Sichuan Province	This work was supported by National Natural Science Foundation of China (No. 81100975, 81371430), China Postdoctoral Science Foundation (No. 2012T50850), Research Foundation of General Hospital of Chengdu Military Region (No. 424121H3), and Science Foundation of Health Office of Sichuan Province (No. 42412D16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano S, 2013, PARKINSONISM RELAT D, V19, P955, DOI 10.1016/j.parkreldis.2013.06.007; Ashburn A, 2007, J NEUROL NEUROSUR PS, V78, P678, DOI 10.1136/jnnp.2006.099333; Bloomer RJ, 2008, MED SCI SPORT EXER, V40, P1385, DOI 10.1249/MSS.0b013e31816f1550; Bridgewater KJ, 1998, PHYS THER, V78, P566, DOI 10.1093/ptj/78.6.566; Burini D, 2006, Eura Medicophys, V42, P231; Cakit BD, 2007, CLIN REHABIL, V21, P698, DOI 10.1177/0269215507077269; Canning CG, 2012, CLIN REHABIL, V26, P817, DOI 10.1177/0269215511432652; Combs SA, 2013, NEUROREHABILITATION, V32, P117, DOI 10.3233/NRE-130828; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; de Dreu M J, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS114, DOI 10.1016/S1353-8020(11)70036-0; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Ellis T, 2005, ARCH PHYS MED REHAB, V86, P626, DOI 10.1016/j.apmr.2004.08.008; Fisher BE, 2008, ARCH PHYS MED REHAB, V89, P1221, DOI 10.1016/j.apmr.2008.01.013; Frazzitta G, 2013, AM J PHYS MED REHAB, V92, P523, DOI 10.1097/PHM.0b013e31828cd254; Frazzitta G, 2012, NEUROREHAB NEURAL RE, V26, P144, DOI 10.1177/1545968311416990; Frazzitta G, 2009, MOVEMENT DISORD, V24, P1139, DOI 10.1002/mds.22491; Goodwin VA, 2008, MOVEMENT DISORD, V23, P631, DOI 10.1002/mds.21922; Hackney ME, 2008, GAIT POSTURE, V28, P456, DOI 10.1016/j.gaitpost.2008.02.005; Hackney ME, 2009, J REHABIL MED, V41, P475, DOI 10.2340/16501977-0362; Hall EE, 2002, BRIT J HEALTH PSYCH, V7, P47, DOI 10.1348/135910702169358; Herman T, 2009, J NEURAL TRANSM, V116, P307, DOI 10.1007/s00702-008-0139-z; Hirsch MA, 2009, EUR J PHYS REHAB MED, V45, P215; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Kurtais Y, 2008, CLIN J SPORT MED, V18, P289, DOI 10.1097/JSM.0b013e318170626d; Lee KS, 2011, AM J PHYS MED REHAB, V90, P380, DOI 10.1097/PHM.0b013e31820b15cd; Lehman David A, 2005, J Neurol Phys Ther, V29, P2; Li FZ, 2012, NEW ENGL J MED, V366, P511, DOI 10.1056/NEJMoa1107911; Lopane G, 2010, CLIN NEUROPHARMACOL, V33, P254, DOI 10.1097/WNF.0b013e3181f5328c; Macedo LG, 2010, J CLIN EPIDEMIOL, V63, P920, DOI 10.1016/j.jclinepi.2009.10.005; Maher CG, 2003, PHYS THER, V83, P713, DOI 10.1093/ptj/83.8.713; Mak MKY, 2008, MOVEMENT DISORD, V23, P501, DOI 10.1002/mds.21509; Mehrholz J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007830.pub2; Miyai I, 2002, ARCH PHYS MED REHAB, V83, P1370, DOI 10.1053/apmr.2002.34603; Miyai I, 2000, ARCH PHYS MED REHAB, V81, P849, DOI 10.1053/apmr.2000.4439; Nadeau A, 2013, MED SCI SPO IN PRESS; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Pelosin E, 2010, NEUROREHAB NEURAL RE, V24, P746, DOI 10.1177/1545968310368685; Petzinger GM, 2013, LANCET NEUROL, V12, P716, DOI 10.1016/S1474-4422(13)70123-6; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Picelli A, 2012, PARKINSONISM RELAT D, V18, P990, DOI 10.1016/j.parkreldis.2012.05.010; Protas EJ, 2005, NEUROREHABILITATION, V20, P183; Reuter I, 2011, J Aging Res, V2011, P232473, DOI 10.4061/2011/232473; Roy IS, 2012, JAHSP, V10, P1; Sage MD, 2009, MOVEMENT DISORD, V24, P1132, DOI 10.1002/mds.22469; Schenkman M, 2012, PHYS THER, V92, P1395, DOI 10.2522/ptj.20110472; Schmitz-Hubsch T, 2006, MOVEMENT DISORD, V21, P543, DOI 10.1002/mds.20705; Shulman LM, 2013, JAMA NEUROL, V70, P183, DOI 10.1001/jamaneurol.2013.646; Thaut MH, 1996, MOVEMENT DISORD, V11, P193, DOI 10.1002/mds.870110213; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; Van Den Eeden SK, 2003, AM J EPIDEMIOL, V157, P1015, DOI 10.1093/aje/kwg068; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Visser JE, 2010, NEUROSCIENCE, V168, P387, DOI 10.1016/j.neuroscience.2010.03.068; Yousefi Bahram, 2009, Trials, V10, P67, DOI 10.1186/1745-6215-10-67; Zhang ZX, 2005, LANCET, V365, P595, DOI 10.1016/S0140-6736(05)70801-1	54	74	73	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100503	10.1371/journal.pone.0100503	http://dx.doi.org/10.1371/journal.pone.0100503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983753	Green Submitted, Green Published, gold			2022-12-27	WOS:000339635000027
J	Chen, D; Zhang, LQ; Huang, JF; Liu, K; Chuai, ZR; Yang, Z; Wang, YX; Shi, DC; Liu, Q; Huang, Q; Fu, WL				Chen, Dong; Zhang, Li-Qun; Huang, Jun-Fu; Liu, Kai; Chuai, Zheng-Ran; Yang, Zhao; Wang, Yun-Xia; Shi, Da-Chuan; Liu, Qian; Huang, Qing; Fu, Wei-Ling			BRAF Mutations in Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							COLORECTAL-CANCER; CLINICAL CHARACTERISTICS; SOMATIC MUTATIONS; FEATURES; MELANOMA; ADENOCARCINOMAS; GENE	Background: BRAF mutations have been well described in non-small cell lung cancer (NSCLC) for several years, but the clinical features of patients harboring BRAF mutations are still not well described. We performed a meta-analysis to identify common clinical features in NSCLC patients carrying BRAF mutations. Methods: We identified clinical studies that examined the association between BRAF mutations and features of NSCLC within PubMed, Embase and ISI Science Citation Index database up to October 2013. The effect size of clinical features was estimated by odds ratios (ORs) with 95% confidence interval (CI) for each study, using a fixed-effects or random-effects model. Results: Ten studies with a total of 5599 NSCLC patients were included. There was a 3% (170/5599) BRAF mutation rate. BRAF mutations in NSCLC were significantly associated with adenocarcinomas (ADCs) (compared with non-ADCs, OR = 4.96, 95% CI = 2.29-10.75). There were no significant differences in gender, smoking and stage in patients with and without BRAF mutations. The BRAF(V600E) mutation was more frequent in women than non-BRAF(V600E) mutations (OR = 0.27, 95% CI = 0.12-0.59), and was closely related to never smokers (OR = 0.14, 95% CI = 0.05-0.42). Conclusions: These findings have important implications for the prediction of the NSCLC sub-types more accurately combined with other genetic changes.	[Chen, Dong; Zhang, Li-Qun; Huang, Jun-Fu; Chuai, Zheng-Ran; Yang, Zhao; Wang, Yun-Xia; Shi, Da-Chuan; Liu, Qian; Huang, Qing; Fu, Wei-Ling] Third Mil Med Univ, Dept Lab Med, Southwest Hosp, Chongqing, Peoples R China; [Liu, Kai] Third Mil Med Univ, Inst Mil Prevent Med, Res Ctr Nutr & Food Safety, Chongqing, Peoples R China	Army Medical University; Army Medical University	Huang, Q (corresponding author), Third Mil Med Univ, Dept Lab Med, Southwest Hosp, Chongqing, Peoples R China.	Dr.Q.Huang@gmail.com; weiling_fu@sina.com	Zhang, Li/GWM-7501-2022; Huang, Qing/E-1872-2017; fu, weiling/AAX-3286-2021	Huang, Qing/0000-0002-0140-8978; fu, weiling/0000-0002-5768-6563	National High Technology Research and Development Program of China (National 863 Program) [2011AA02A121, 2013AA020204]; Preferential Foundation of Science and Technology Activities for Students Studying Abroad of Chongqing [YuLiuZhu201201]; Scientific Research Foundation for Returned Overseas Chinese Scholars of the State Education Ministry	National High Technology Research and Development Program of China (National 863 Program)(National High Technology Research and Development Program of China); Preferential Foundation of Science and Technology Activities for Students Studying Abroad of Chongqing; Scientific Research Foundation for Returned Overseas Chinese Scholars of the State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported in part by grants from the National High Technology Research and Development Program of China (National 863 Program, No. 2011AA02A121 and 2013AA020204) the Preferential Foundation of Science and Technology Activities for Students Studying Abroad of Chongqing (No. YuLiuZhu201201), the Project Sponsored by the Scientific Research Foundation for Returned Overseas Chinese Scholars of the State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040109; Ardekani GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047054; Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301; Cardarella S, 2013, CLIN CANCER RES, V19, P4532, DOI 10.1158/1078-0432.CCR-13-0657; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ilie M, 2013, ANN ONCOL, V24, P742, DOI 10.1093/annonc/mds534; Kalady MF, 2012, DIS COLON RECTUM, V55, P128, DOI 10.1097/DCR.0b013e31823c08b3; Kim TH, 2012, CANCER-AM CANCER SOC, V118, P1764, DOI 10.1002/cncr.26500; Kobayashi M, 2011, ANTICANCER RES, V31, P4619; Lee JH, 2011, BRIT J DERMATOL, V164, P776, DOI 10.1111/j.1365-2133.2010.10185.x; Lee SY, 2010, J THORAC ONCOL, V5, P1734, DOI 10.1097/JTO.0b013e3181f0beca; Li C, 2012, J CLIN ENDOCR METAB, V97, P4559, DOI 10.1210/jc.2012-2104; Mao C, 2010, LUNG CANCER, V69, P272, DOI 10.1016/j.lungcan.2009.11.020; Marchetti A, 2011, J CLIN ONCOL, V29, P3574, DOI 10.1200/JCO.2011.35.9638; Paik PK, 2011, J CLIN ONCOL, V29, P2046, DOI 10.1200/JCO.2010.33.1280; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Pendharkar D, 2013, INDIA J SURG ONCOL, V4, P120, DOI 10.1007/s13193-013-0213-3; Pratilas CA, 2008, CANCER RES, V68, P9375, DOI 10.1158/0008-5472.CAN-08-2223; Roth AD, 2010, J CLIN ONCOL, V28, P466, DOI 10.1200/JCO.2009.23.3452; Sasaki H, 2012, EXP THER MED, V3, P771, DOI 10.3892/etm.2012.500; Schmid K, 2009, CLIN CANCER RES, V15, P4554, DOI 10.1158/1078-0432.CCR-09-0089; Sclafani F, 2013, CRIT REV ONCOL HEMAT, V87, P55, DOI 10.1016/j.critrevonc.2012.11.003; Seidel D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006802; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tie J, 2011, INT J CANCER, V128, P2075, DOI 10.1002/ijc.25555; Tol J, 2009, NEW ENGL J MED, V361, P98, DOI 10.1056/NEJMc0904160; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Xing M, 2005, ENDOCR-RELAT CANCER, V12, P245, DOI 10.1677/erc.1.0978	32	66	69	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101354	10.1371/journal.pone.0101354	http://dx.doi.org/10.1371/journal.pone.0101354			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979348	gold, Green Published, Green Submitted			2022-12-27	WOS:000338506400121
J	d'Adhemar, CJ; Spillane, CD; Gallagher, MF; Bates, M; Costello, KM; Barry-O'Crowley, J; Haley, K; Kernan, N; Murphy, C; Smyth, PC; O'Byrne, K; Pennington, S; Cooke, AA; Ffrench, B; Martin, CM; O'Donnell, D; Hennessy, B; Stordal, B; Finn, S; McCann, A; Gleeson, N; D'Arcy, T; Flood, B; O'Neill, LAJ; Sheils, O; O'Toole, S; O'Leary, JJ				d'Adhemar, Charles J.; Spillane, Cathy D.; Gallagher, Michael F.; Bates, Mark; Costello, Katie M.; Barry-O'Crowley, Jacqui; Haley, Kathryn; Kernan, Niamh; Murphy, Ciara; Smyth, Paul C.; O'Byrne, Ken; Pennington, Stephen; Cooke, Aoife A.; Ffrench, Brendan; Martin, Cara M.; O'Donnell, Dearbhaile; Hennessy, Bryan; Stordal, Britta; Finn, Stephen; McCann, Amanda; Gleeson, Noreen; D'Arcy, Tom; Flood, Brian; O'Neill, Luke A. J.; Sheils, Orla; O'Toole, Sharon; O'Leary, John J.			The MyD88+Phenotype Is an Adverse Prognostic Factor in Epithelial Ovarian Cancer	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; NF-KAPPA-B; TUMOR-GROWTH; STEM-CELLS; EXPRESSION; CARCINOMA; BREAST; DIFFERENTIATION; CHEMORESISTANCE; RESISTANCE	The prognosis of epithelial ovarian cancer is poor in part due to the high frequency of chemoresistance. Recent evidence points to the Toll-like receptor-4 (TLR4), and particularly its adaptor protein MyD88, as one potential mediator of this resistance. This study aims to provide further evidence that MyD88 positive cancer cells are clinically significant, stem-like and reproducibly detectable for the purposes of prognostic stratification. Expression of TLR4 and MyD88 was assessed immunohistochemically in 198 paraffin-embedded ovarian tissues and in an embryonal carcinoma model of cancer stemness. In parallel, expression of TLR4 and MyD88 mRNA and regulatory microRNAs (miR-21 and miR-146a) was assessed, as well as in a series of chemosensitive and resistant cancer cells lines. Functional analysis of the pathway was assessed in chemoresistant SKOV-3 ovarian cancer cells. TLR4 and MyD88 expression can be reproducibly assessed via immunohistochemistry using a semi-quantitative scoring system. TLR4 expression was present in all ovarian epithelium (normal and neoplastic), whereas MyD88 was restricted to neoplastic cells, independent of tumour grade and associated with reduced progression-free and overall survival, in an immunohistological specific subset of serous carcinomas, p<0.05. MiR-21 and miR-146a expression was significantly increased in MyD88 negative cancers (p<0.05), indicating their participation in regulation. Significant alterations in MyD88 mRNA expression were observed between chemosensitive and chemoresistant cells and tissue. Knockdown of TLR4 in SKOV-3 ovarian cells recovered chemosensitivity. Knockdown of MyD88 alone did not. MyD88 expression was down-regulated in differentiated embryonal carcinoma (NTera2) cells, supporting the MyD88+ cancer stem cell hypothesis. Our findings demonstrate that expression of MyD88 is associated with significantly reduced patient survival and altered microRNA levels and suggest an intact/functioning TLR4/MyD88 pathway is required for acquisition of the chemoresistant phenotype. Ex vivo manipulation of ovarian cancer stem cell (CSC) differentiation can decrease MyD88 expression, providing a potentially valuable CSC model for ovarian cancer.	[d'Adhemar, Charles J.; Spillane, Cathy D.; Gallagher, Michael F.; Bates, Mark; Smyth, Paul C.; Cooke, Aoife A.; Ffrench, Brendan; Martin, Cara M.; Stordal, Britta; Finn, Stephen; Flood, Brian; Sheils, Orla; O'Toole, Sharon; O'Leary, John J.] Univ Dublin Trinity Coll, Dept Histopathol, Dublin 2, Ireland; [Costello, Katie M.; Barry-O'Crowley, Jacqui; Kernan, Niamh; Murphy, Ciara; O'Leary, John J.] Coombe Womens & Infants Univ Hosp, Dept Pathol, Dublin, Ireland; [Haley, Kathryn; Gleeson, Noreen; D'Arcy, Tom; O'Toole, Sharon] Univ Dublin Trinity Coll, Dept Obstet & Gynaecol, Dublin 2, Ireland; [O'Byrne, Ken] Princess Alexandra Hosp, Translat Res Inst, Brisbane, Qld 4102, Australia; [Pennington, Stephen; McCann, Amanda] Univ Coll Dublin, Coll Hlth Sci, Dublin 2, Ireland; [O'Donnell, Dearbhaile] St James Hosp, Dept Med Oncol, Dublin 8, Ireland; [Hennessy, Bryan] Royal Coll Surgeons Ireland, Dept Med Oncol, Dublin 2, Ireland; [O'Neill, Luke A. J.] Univ Dublin Trinity Coll, Dept Biochem, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; University College Dublin; Trinity College Dublin; Royal College of Surgeons - Ireland; Trinity College Dublin	O'Toole, S (corresponding author), Univ Dublin Trinity Coll, Dept Histopathol, Dublin 2, Ireland.	shotoole@tcd.ie	Finn, Stephen/V-3236-2019; Pennington, Stephen R/C-7505-2015; Sheils, Orla Sheils M/B-8461-2015	Finn, Stephen/0000-0002-8628-5814; Sheils, Orla Sheils M/0000-0002-4493-9496; Martin, Cara/0000-0001-8411-8564; Pennington, Stephen/0000-0001-7529-1015; O'Neill, Luke/0000-0002-4333-2748; Cooke, Aoife/0000-0002-1618-1972; O'Byrne, Kenneth/0000-0002-6754-5633; Bates, Mark/0000-0002-5916-5403; McCann, Amanda/0000-0003-1911-3307; Gallagher, Michael/0000-0003-1636-2404; O'Leary, John/0000-0001-7311-9326; Hennessy, Bryan/0000-0002-7871-6477; o toole, sharon/0000-0002-9260-3225; Ffrench, Brendan/0000-0002-5647-3734; Stordal, Britta/0000-0002-7892-951X	Cancer Research Ireland [ICS CRP09OLE]; Meath foundation; Royal City of Dublin Hospital Trust; Emer Casey foundation; Irish Cancer Society; Marie Curie European Union grant;  [BDI-2 (10/CE/B1821)]	Cancer Research Ireland; Meath foundation; Royal City of Dublin Hospital Trust; Emer Casey foundation; Irish Cancer Society; Marie Curie European Union grant; 	This work was supported by Cancer Research Ireland (grant reference number ICS CRP09OLE), the Meath foundation, The Royal City of Dublin Hospital Trust, BDI-2 (10/CE/B1821), the Emer Casey foundation, the Irish Cancer Society, and a Marie Curie European Union grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvero AB, 2006, AM J REPROD IMMUNOL, V55, P399; Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Andrews PW, 2005, BIOCHEM SOC T, V33, P1526, DOI 10.1042/BST0331526; Andrews PW, 2002, PHILOS T R SOC B, V357, P405, DOI 10.1098/rstb.2002.1058; ANDREWS PW, 1987, INT J ANDROL, V10, P95, DOI 10.1111/j.1365-2605.1987.tb00170.x; ANDREWS PW, 1984, LAB INVEST, V50, P147; Armstrong D, 2008, ABELOFFS CLIN ONCOLO, P1827; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beachy PA, 2004, NATURE, V431, P402, DOI 10.1038/431402a; Bell DA, 2005, MODERN PATHOL, V18, pS19, DOI 10.1038/modpathol.3800306; Chen R, 2008, ONCOGENE, V27, P225, DOI 10.1038/sj.onc.1210907; Conroy H, 2008, ONCOGENE, V27, P168, DOI 10.1038/sj.onc.1210910; Gallagher MF, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-19; Geisler S, 2001, CANCER RES, V61, P2505; Kamsteeg M, 2003, ONCOGENE, V22, P2611, DOI 10.1038/sj.onc.1206422; Kelly MG, 2006, CANCER RES, V66, P3859, DOI 10.1158/0008-5472.CAN-05-3948; Lee KR, 2003, WHO CLASSIFICATION T, P117; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liston A, 2010, J CLIN IMMUNOL, V30, P339, DOI 10.1007/s10875-010-9378-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma JG, 1998, CANCER CHEMOTH PHARM, V41, P186; Marsden DE, 2000, SEMIN SURG ONCOL, V19, P11, DOI 10.1002/1098-2388(200007/08)19:1<11::AID-SSU3>3.0.CO;2-3; Mohsin SK, 2004, MODERN PATHOL, V17, P1545, DOI 10.1038/modpathol.3800229; Nisolle M, 1999, HUM REPROD, V14, P2844, DOI 10.1093/humrep/14.11.2844; O'Lorcain P, 2006, INT J GYNECOL CANCER, V16, P1, DOI 10.1111/j.1525-1438.2006.00479.x; O'Lorcain P, 2007, EUR J CANCER PREV, V16, P167, DOI 10.1097/01.cej.0000228408.68353.ba; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Piver MS, 1998, CLIN OBSTET GYNECOL, V41, P215, DOI 10.1097/00003081-199803000-00026; Pommier Y, 2004, ONCOGENE, V23, P2934, DOI 10.1038/sj.onc.1207515; Schwartz Peter E, 2002, Cancer Treat Res, V107, P99; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; SHEN DW, 1986, SCIENCE, V232, P643, DOI 10.1126/science.3457471; Silasi Dan-Arin, 2006, Yale J Biol Med, V79, P153; Stewart JJ, 2006, MOL CELL PROTEOMICS, V5, P433, DOI 10.1074/mcp.M500140-MCP200; Stordal B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040717; Szajnik M, 2009, ONCOGENE, V28, P4353, DOI 10.1038/onc.2009.289; Szajnik ME, 2009, J CLIN ONCOL, V27; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tsan MF, 2006, SEMIN CANCER BIOL, V16, P32, DOI 10.1016/j.semcancer.2005.07.004; Zeromski J, 2008, CANCER MICROENVIRON, V1, P37, DOI 10.1007/s12307-008-0005-4; Zhu Y, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-77	42	36	38	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100816	10.1371/journal.pone.0100816	http://dx.doi.org/10.1371/journal.pone.0100816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977712	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000338506400042
J	Jiang, ZB; Hu, P; Liu, JX; Wang, DJ; Jin, LY; Hong, C				Jiang, Zhibin; Hu, Ping; Liu, Jianxin; Wang, Dianjun; Jin, Longyu; Hong, Chao			Screening Preoperative Peptide Biomarkers for Predicting Postoperative Myocardial Infarction after Coronary Artery Bypass Grafting	PLOS ONE			English	Article							CARDIAC-SURGERY; RISK; DIAGNOSIS	Postoperative myocardial infarction (PMI) is one of the most serious complications of cardiac surgeries. No preoperative biomarker is currently available for predicting PMI after cardiac surgeries. In the present study, we used a phage display peptide library to screen potential preoperative peptide biomarkers for predicting PMI after coronary artery bypass grafting (CABG) surgery. Twenty patients who developed PMI after CABG and 20 age-, sex-, and body mass index-matched patients without PMI after CABG were enrolled as a discovery cohort. Another 50 patients who developed PMI after CABG and 50 randomly selected patients without PMI after CABG were enrolled as a validation cohort to validate the potential peptide biomarkers identified in the discovery cohort. Fifty randomly selected healthy volunteers were also enrolled in the validation phase as a healthy control group. In the discovery/screening phase, 17 out of 20 randomly selected phage clones exhibited specific reaction with purified sera IgG from the PMI group, among which 11 came from the same phage clone with inserted peptide sequence GVIMVIAVSCVF (named PMI-1). In the validation phase, phage ELISA showed that serum IgG from 90% of patients in the PMI group had a positive reaction with PMI-1; in contrast, only 14% and 6% of patients in the non-PMI group and the healthy control group had a positive reaction with PMI-1, respectively. The sensitivity, specificity, positive predictive value, negative predictive value and accuracy of the PMI-1 phage clone to preoperatively identify patients who would develop PMI after CABG were 90.0%, 86.0%, 86.5, 89.5% and 88.0%, respectively. The absorbance value of the PMI-1 phage clone showed statistically significant correlation with the peak postoperative serum cardiac troponin I level (r = 0.349, p = 0.012) in the PMI group. In conclusion, we for the first time identified a mimic peptide (PMI-1) with high validity in preoperative prediction of PMI after CABG.	[Jiang, Zhibin; Liu, Jianxin; Wang, Dianjun; Jin, Longyu; Hong, Chao] Cent S Univ, Xiangya Hosp 3, Dept Cardiothorac Surg, Changsha, Hunan, Peoples R China; [Hu, Ping] Cent S Univ, Xiangya Hosp, Dept Cardiothorac Surg, Changsha, Hunan, Peoples R China	Central South University; Central South University	Hu, P (corresponding author), Cent S Univ, Xiangya Hosp, Dept Cardiothorac Surg, Changsha, Hunan, Peoples R China.	pingping_cpb@163.com			Hunan Provincial Development and Reform Commission [[2013]1199]	Hunan Provincial Development and Reform Commission	This work was supported by Hunan Provincial Development and Reform Commission grant No. [2013]1199. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JE, 1994, NEW ENGL J MED, V330, P670, DOI 10.1056/NEJM199403103301003; Bucerius J, 2003, ANN THORAC SURG, V75, P472, DOI 10.1016/S0003-4975(02)04370-9; Goffinet M, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-34; Landesberg G, 2009, CIRCULATION, V119, P2936, DOI 10.1161/CIRCULATIONAHA.108.828228; Lim CCS, 2011, ANN THORAC SURG, V92, P2046, DOI 10.1016/j.athoracsur.2011.05.019; Molek P, 2011, MOLECULES, V228, P1315; Nalysnyk L, 2003, HEART, V89, P767, DOI 10.1136/heart.89.7.767; Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775; Nizak C, 2003, SCIENCE, V300, P984, DOI 10.1126/science.1083911; Podgoreanu MV, 2006, CIRCULATION, V114, pI275, DOI 10.1161/CIRCULATIONAHA.105.001032; Samoylova T. I., 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P9, DOI 10.2174/187152006774755492; Sergeeva A, 2006, ADV DRUG DELIVER REV, V58, P1622, DOI 10.1016/j.addr.2006.09.018; Simple English Wikipedia, 2005, HAN CHIN; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Wang M, 2011, RHEUMATOL INT, V31, P1009, DOI 10.1007/s00296-010-1403-8; Weng XJ, 2012, CLIN BIOCHEM, V45, P303, DOI 10.1016/j.clinbiochem.2011.12.018	16	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100149	10.1371/journal.pone.0100149	http://dx.doi.org/10.1371/journal.pone.0100149			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979051	Green Submitted, gold, Green Published			2022-12-27	WOS:000338506400023
J	Kaushik, R; Balasubramanian, R; Dunstan, H				Kaushik, Rajni; Balasubramanian, Rajasekhar; Dunstan, Hugh			Microbial Quality and Phylogenetic Diversity of Fresh Rainwater and Tropical Freshwater Reservoir	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; ESCHERICHIA-COLI; DRINKING-WATER; BACTERIOPLANKTON COMMUNITY; BACTERIAL PATHOGENS; AIRBORNE PARTICLES; DISEASE OUTBREAKS; ABUNDANT GROUP; SARGASSO SEA; HUMIC LAKE	The impact of rainwater on the microbial quality of a tropical freshwater reservoir through atmospheric wet deposition of microorganisms was studied for the first time. Reservoir water samples were collected at four different sampling points and rainwater samples were collected in the immediate vicinity of the reservoir sites for a period of four months (January to April, 2012) during the Northeast monsoon period. Microbial quality of all fresh rainwater and reservoir water samples was assessed based on the counts for the microbial indicators: Escherichia coli (E. coli), total coliforms, and Enterococci along with total heterotrophic plate counts (HPC). The taxonomic richness and phylogenetic relationship of the freshwater reservoir with those of the fresh rainwater were also assessed using 16 S rRNA gene clone library construction. The levels of E. coli were found to be in the range of 0 CFU/100 mL - 75 CFU/100 mL for the rainwater, and were 10-94 CFU/100 mL for the reservoir water. The sampling sites that were influenced by highway traffic emissions showed the maximum counts for all the bacterial indicators assessed. There was no significant increase in the bacterial abundances observed in the reservoir water immediately following rainfall. However, the composite fresh rainwater and reservoir water samples exhibited broad phylogenetic diversity, including sequences representing Betaproteobacteria, Alphaproteobacteria, Gammaproteobacteria, Actinobacteria, Lentisphaerae and Bacteriodetes. Members of the Betaproteobacteria group were the most dominant in both fresh rainwater and reservoir water, followed by Alphaproteobacteria, Sphingobacteria, Actinobacteria and Gammaproteobacteria.	[Kaushik, Rajni; Balasubramanian, Rajasekhar] Natl Univ Singapore, Singapore Delft Water Alliance, Singapore 117548, Singapore; [Kaushik, Rajni; Balasubramanian, Rajasekhar] Natl Univ Singapore, Dept Civil & Environm Engn, Singapore 117548, Singapore; [Dunstan, Hugh] Univ Newcastle, Sch Environm & Life Sci, Callahan, NSW, Australia	National University of Singapore; National University of Singapore; University of Newcastle	Balasubramanian, R (corresponding author), Natl Univ Singapore, Singapore Delft Water Alliance, Singapore 117548, Singapore.	ceerbala@nus.edu.sg	Balasubramanian, Rajasekhar/C-2243-2011	Balasubramanian, Rajasekhar/0000-0002-5627-3628	Singapore-Delft Water Alliance, National University of Singapore (NUS); SDWA	Singapore-Delft Water Alliance, National University of Singapore (NUS); SDWA	This study was financially supported by Singapore-Delft Water Alliance, National University of Singapore (NUS). Rajni Kaushik thanks SDWA for supporting her Ph.D. study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed W, 2012, ENVIRON SCI TECHNOL, V46, P11370, DOI 10.1021/es302222b; Ahmed W, 2013, AWA WATER, V40, P88; Altmann D, 2003, ENVIRON MICROBIOL, V5, P798, DOI 10.1046/j.1469-2920.2003.00469.x; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Amato P, 2005, ATMOS ENVIRON, V39, P4143, DOI 10.1016/j.atmosenv.2005.04.002; Ariya PA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015637; Auld H, 2004, J TOXICOL ENV HEAL A, V67, P1879, DOI 10.1080/15287390490493475; Brierley EDR, 2001, SOIL BIOL BIOCHEM, V33, P1403, DOI 10.1016/S0038-0717(01)00045-1; Brookes JD, 2004, ENVIRON INT, V30, P741, DOI 10.1016/j.envint.2003.11.006; Burkert U, 2003, APPL ENVIRON MICROB, V69, P6550, DOI 10.1128/AEM.69.11.6550-6559.2003; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Crump BC, 1999, APPL ENVIRON MICROB, V65, P3192; Curriero FC, 2001, AM J PUBLIC HEALTH, V91, P1194, DOI 10.2105/AJPH.91.8.1194; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DIMMICK RL, 1979, APPL ENVIRON MICROB, V37, P924, DOI 10.1128/AEM.37.5.924-927.1979; EDBERG SC, 1990, APPL ENVIRON MICROB, V56, P366, DOI 10.1128/AEM.56.2.366-369.1990; Edberg SC, 2000, J APPL MICROBIOL, V88, p106S, DOI 10.1111/j.1365-2672.2000.tb05338.x; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Elifantz H, 2005, APPL ENVIRON MICROB, V71, P7799, DOI 10.1128/AEM.71.12.7799-7805.2005; Evans CA, 2006, WATER RES, V40, P37, DOI 10.1016/j.watres.2005.10.034; Evans CA, 2009, SCI TOTAL ENVIRON, V407, P5206, DOI 10.1016/j.scitotenv.2009.06.009; Ferguson C, 2003, CRIT REV ENV SCI TEC, V33, P299, DOI 10.1080/10643380390814497; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; Glockner FO, 2000, APPL ENVIRON MICROB, V66, P5053, DOI 10.1128/AEM.66.11.5053-5065.2000; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; He ZL, 2010, ECOL LETT, V13, P564, DOI 10.1111/j.1461-0248.2010.01453.x; Hiorns WD, 1997, APPL ENVIRON MICROB, V63, P2957, DOI 10.1128/AEM.63.7.2957-2960.1997; Hofle MG, 1999, APPL ENVIRON MICROB, V65, P3164; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Kaushik R, 2013, SCI TOTAL ENVIRON, V449, P237, DOI 10.1016/j.scitotenv.2013.01.065; Kaushik R, 2012, APPL ENVIRON MICROB, V78, P2813, DOI 10.1128/AEM.07695-11; Kaushik R, 2012, ATMOS ENVIRON, V46, P131, DOI 10.1016/j.atmosenv.2011.10.013; LECHEVALLIER MW, 1987, APPL ENVIRON MICROB, V53, P2714, DOI 10.1128/AEM.53.12.2714-2724.1987; Lemke MJ, 2009, MICROB ECOL, V57, P94, DOI 10.1007/s00248-008-9398-3; Liu ZH, 2012, FEMS MICROBIOL ECOL, V80, P30, DOI 10.1111/j.1574-6941.2011.01268.x; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Martin AR, 2010, J ENVIRON MONITOR, V12, P255, DOI [10.1039/b904042k, 10.1039/B904042K]; Mason OU, 2009, ISME J, V3, P231, DOI 10.1038/ismej.2008.92; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Meera V, 2006, J WATER SUPPLY RES T, V55, P257, DOI 10.2166/aqua.2006.0010; Merz J, 2006, J HYDROL, V331, P446, DOI 10.1016/j.jhydrol.2006.05.030; National Health and Medical Research Council, 2004, GUID DRINK WAT QUAL; Newton RJ, 2006, ENVIRON MICROBIOL, V8, P956, DOI 10.1111/j.1462-2920.2005.00979.x; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Oliver JD, 2000, NONCULTURABLE MICROORGANISMS IN THE ENVIRONMENT, P277; OLSON BH, 1984, ADV APPL MICROBIOL, V30, P73, DOI 10.1016/S0065-2164(08)70053-4; Pisciotta JM, 2002, APPL ENVIRON MICROB, V68, P539, DOI 10.1128/AEM.68.2.539-544.2002; Sargaonkar A, 2006, ENVIRON MONIT ASSESS, V117, P491, DOI 10.1007/s10661-006-0769-2; Sartory DP, 2004, INT J FOOD MICROBIOL, V92, P297, DOI 10.1016/j.ijfoodmicro.2003.08.006; Savichtcheva O, 2006, WATER RES, V40, P2463, DOI 10.1016/j.watres.2006.04.040; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwarzenbach RP, 2010, ANNU REV ENV RESOUR, V35, P109, DOI 10.1146/annurev-environ-100809-125342; Simek K, 2005, APPL ENVIRON MICROB, V71, P2381, DOI 10.1128/AEM.71.5.2381-2390.2005; Szewzyk U, 2000, ANNU REV MICROBIOL, V54, P81, DOI 10.1146/annurev.micro.54.1.81; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; Tseng CH, 2013, ISME J, V7, P2374, DOI 10.1038/ismej.2013.118; Turkum A, 2008, ATMOS RES, V89, P315, DOI 10.1016/j.atmosres.2008.03.010; USEPA, 2002, EPA821R02022 OFF WAT; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vergin KL, 2001, BIOTECHNIQUES, V30, P938, DOI 10.2144/01305bm03; WARD NR, 1986, ADV APPL MICROBIOL, V31, P293, DOI 10.1016/S0065-2164(08)70446-5; Warnecke F, 2004, ENVIRON MICROBIOL, V6, P242, DOI 10.1111/j.1462-2920.2004.00561.x; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; WHO, 2006, GUID DRINK WAT QUAL; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Womack AM, 2010, PHILOS T R SOC B, V365, P3645, DOI 10.1098/rstb.2010.0283; Wu X, 2007, FEMS MICROBIOL ECOL, V61, P85, DOI 10.1111/j.1574-6941.2007.00326.x; Zehr JP, 2002, APPL ENVIRON MICROB, V68, P1015, DOI 10.1128/AEM.68.3.1015-1024.2002; Zhou JZ, 2008, P NATL ACAD SCI USA, V105, P7768, DOI 10.1073/pnas.0709016105; Zwart G, 1998, SYST APPL MICROBIOL, V21, P546, DOI 10.1016/S0723-2020(98)80067-2	71	29	29	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100737	10.1371/journal.pone.0100737	http://dx.doi.org/10.1371/journal.pone.0100737			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979573	Green Published, gold			2022-12-27	WOS:000338506400038
J	Lu, M; Wang, XX; Sun, GW; Qin, B; Xiao, JZ; Yan, SL; Pan, YJ; Wang, YJ				Lu, Man; Wang, Xingxing; Sun, Guowei; Qin, Bing; Xiao, Jinzhou; Yan, Shuling; Pan, Yingjie; Wang, Yongjie			Fine Structure of Tibetan Kefir Grains and Their Yeast Distribution, Diversity, and Shift	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; SACCHAROMYCES-CEREVISIAE; MICROBIAL DIVERSITY; RIBOSOMAL-RNA; IDENTIFICATION; CULTURE; PCR; GENES	Tibetan kefir grains (TKGs), a kind of natural starter for fermented milk in Tibet, China, host various microorganisms of lactic acid bacteria, yeasts, and occasionally acetic acid bacteria in a polysaccharide/protein matrix. In the present study, the fine structure of TKGs was studied to shed light on this unusual symbiosis with stereomicroscopy and thin sections. The results reveal that TKGs consist of numerous small grain units, which are characterized by a hollow globular structure with a diameter between 2.0 and 9.0 mm and a wall thickness of approximately 200 mm. A polyhedron-like net structure, formed mainly by the bacteria, was observed in the wall of the grain units, which has not been reported previously to our knowledge. Towards the inside of the grain unit, the polyhedron-like net structures became gradually larger in diameter and fewer in number. Such fine structures may play a crucial role in the stability of the grains. Subsequently, the distribution, diversity, and shift of yeasts in TKGs were investigated based on thin section, scanning electron microscopy, cloning and sequencing of D1/D2 of the 26S rRNA gene, real-time quantitative PCR, and in situ hybridization with specific fluorescence-labeled oligonucleotide probes. These show that (i) yeasts appear to localize on the outer surface of the grains and grow normally together to form colonies embedded in the bacterial community; (ii) the diversity of yeasts is relatively low on genus level with three dominant species - Saccharomyces cerevisiae, Kluyveromyces marxianus, and Yarrowia lipolytica; (iii) S. cerevisiae is the stable predominant yeast species, while the composition of Kluyveromyces and Yarrowia are subject to change over time. Our results indicate that TKGs are relatively stable in structure, and culture conditions to some extent shape the microbial community and interaction in kefir grains. These findings pave the way for further study of the specific symbiotic associations between S. cerevisiae and Lactobacillus bacteria in TKGs.	[Lu, Man; Wang, Xingxing; Sun, Guowei; Qin, Bing; Xiao, Jinzhou; Pan, Yingjie; Wang, Yongjie] Minist Agr, Lab Qual & Safety Risk Assessment Aquat Prod Stor, Shanghai, Peoples R China; [Lu, Man; Wang, Xingxing; Sun, Guowei; Qin, Bing; Xiao, Jinzhou; Pan, Yingjie; Wang, Yongjie] Shanghai Ocean Univ, Coll Food Sci & Technol, Shanghai, Peoples R China; [Yan, Shuling] Univ Goettingen, Inst Biochem & Mol Cell Biol, Gottingen, Germany	Ministry of Agriculture & Rural Affairs; Shanghai Ocean University; University of Gottingen	Wang, YJ (corresponding author), Minist Agr, Lab Qual & Safety Risk Assessment Aquat Prod Stor, Shanghai, Peoples R China.	yjwang@shou.edu.cn		Wang, Yongjie/0000-0002-7209-585X	National Natural Science Foundation of China [41376135]; Program for Professor of Special Appointment from Shanghai Municipal Education Commission [20101222]; Shanghai Talent Development Fund from Shanghai Municipal Human Resources and Social Security Bureau, China [2011010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Professor of Special Appointment from Shanghai Municipal Education Commission; Shanghai Talent Development Fund from Shanghai Municipal Human Resources and Social Security Bureau, China	This work was supported by the National Natural Science Foundation of China (Grant No. 41376135), the Program for Professor of Special Appointment (Eastern Scholar, 20101222) from Shanghai Municipal Education Commission and Shanghai Talent Development Fund (2011010) from Shanghai Municipal Human Resources and Social Security Bureau, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2013, CRIT REV FOOD SCI, V53, P422, DOI 10.1080/10408398.2010.540360; Breunig KD, 2000, ENZYME MICROB TECH, V26, P771, DOI 10.1016/S0141-0229(00)00170-8; Brialy C, 1995, FOLIA MICROBIOL, V40, P198, DOI 10.1007/BF02815423; Chen HC, 2008, FOOD MICROBIOL, V25, P492, DOI 10.1016/j.fm.2008.01.003; Diniz RO, 2003, PHARMACOL RES, V47, P49, DOI 10.1016/S1043-6618(02)00240-2; Farnworth E. R., 2005, Food Science and Technology Bulletin:  Functional Foods, V2, P1, DOI 10.1616/1476-2137.13938; Ferreira IMPLVO, 2010, J DAIRY SCI, V93, P27, DOI 10.3168/jds.2009-2501; Foster HA, 2010, METHODS MOL BIOL, V659, P427, DOI 10.1007/978-1-60761-789-1_33; Gao J, 2013, EUR FOOD RES TECHNOL, V236, P549, DOI 10.1007/s00217-013-1912-2; Gao J, 2012, J FOOD SCI, V77, pM425, DOI 10.1111/j.1750-3841.2012.02805.x; Garner CD, 2010, J CLIN MICROBIOL, V48, P2140, DOI 10.1128/JCM.02306-09; Garrote GL, 2001, J DAIRY RES, V68, P639, DOI 10.1017/S0022029901005210; Ho JN, 2013, J SCI FOOD AGR, V93, P485, DOI 10.1002/jsfa.5792; Inacio J, 2003, APPL ENVIRON MICROB, V69, P2899, DOI 10.1128/AEM.69.5.2899-2905.2003; Kesmen Z, 2011, J FOOD SCI, V76, pM276, DOI 10.1111/j.1750-3841.2011.02191.x; Kowalczyk M, 2012, J DAIRY RES, V79, P26, DOI 10.1017/S0022029911000677; Kurtzman CP, 2014, INT J SYST EVOL MICR, V64, P325, DOI 10.1099/ijs.0.054197-0; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Leite AMO, 2012, FOOD MICROBIOL, V31, P215, DOI 10.1016/j.fm.2012.03.011; LIBUDZISZ Z, 1990, DAIRY IND INT, V55, P31; Lin CW, 1999, AUST J DAIRY TECHNOL, V54, P14; Magalhaes KT, 2010, WORLD J MICROB BIOT, V26, P1241, DOI 10.1007/s11274-009-0294-x; Marsh AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069371; MARSHALL VM, 1985, J DAIRY RES, V52, P451, DOI 10.1017/S0022029900024353; Mendes F, 2013, APPL ENVIRON MICROB, V79, P5949, DOI 10.1128/AEM.01115-13; Mounier J, 2009, INT J FOOD MICROBIOL, V133, P31, DOI 10.1016/j.ijfoodmicro.2009.04.020; Nicaud JM, 2012, YEAST, V29, P409, DOI 10.1002/yea.2921; Park EJ, 2009, J MICROBIOL, V47, P682, DOI 10.1007/s12275-009-0297-1; Pei Y, 2011, ACS NANO, V5, P1441, DOI 10.1021/nn103217z; Plessas S, 2011, FOOD CHEM, V124, P627, DOI 10.1016/j.foodchem.2010.06.086; Ritalahti KM, 2006, APPL ENVIRON MICROB, V72, P2765, DOI 10.1128/AEM.72.4.2765-2774.2006; Rodrigues KL, 2005, INT J ANTIMICROB AG, V25, P404, DOI 10.1016/j.ijantimicag.2004.09.020; Rossmann MG, 2013, Q REV BIOPHYS, V46, P133, DOI 10.1017/S0033583513000012; Simova E, 2002, J IND MICROBIOL BIOT, V28, P1, DOI [10.1038/sj/jim/7000186, 10.1038/sj.jim.7000186]; Stadie J, 2013, FOOD MICROBIOL, V35, P92, DOI 10.1016/j.fm.2013.03.009; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Urdaneta E, 2007, NUTR RES, V27, P653, DOI 10.1016/j.nutres.2007.08.002; VIEGAS CA, 1989, APPL ENVIRON MICROB, V55, P21, DOI 10.1128/AEM.55.1.21-28.1989; Vinderola CG, 2005, J DAIRY RES, V72, P195, DOI 10.1017/S0022029905000828; Wang SY, 2008, J DAIRY SCI, V91, P3798, DOI 10.3168/jds.2007-0468; Zhou JZ, 2009, FOOD MICROBIOL, V26, P770, DOI 10.1016/j.fm.2009.04.009	41	9	12	5	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101387	10.1371/journal.pone.0101387	http://dx.doi.org/10.1371/journal.pone.0101387			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977409	Green Published, gold, Green Submitted			2022-12-27	WOS:000338506400125
J	Mohapatra, S; Chakraborty, T; Prusty, AK; PaniPrasad, K; Mohanta, KN				Mohapatra, Sipra; Chakraborty, Tapas; Prusty, Ashisa K.; PaniPrasad, Kurchetti; Mohanta, Kedar N.			Beneficial Effects of Dietary Probiotics Mixture on Hemato-Immunology and Cell Apoptosis of Labeo rohita Fingerlings Reared at Higher Water Temperatures	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; INDIAN MAJOR CARP; GROWTH-PERFORMANCE; GILTHEAD SEABREAM; VITAMIN-C; FISH; METABOLISM; EXPRESSION; TOLERANCE; BACTERIA	Probiotics play an important role in growth increment, immune enhancement and stress mitigation in fish. Increasing temperature is a major concern in present aquaculture practices as it markedly deteriorates the health condition and reduces the growth in fish. In order to explore the possibilities of using probiotics as a counter measure for temperature associated problems, a 30 days feeding trial was conducted to study the hemato-immunological and apoptosis response of Labeo rohita (8.3 +/- 0.4 g) reared at different water temperatures, fed with or without dietary supplementation of a probiotic mixture (PM) consisting of Bacillus subtilis, Lactococcus lactis and Saccharomyces cerevisiae) (10(11) cfu kg(-1)). Three hundred and sixty fish were randomly distributed into eight treatment groups in triplicates, namely, T1(28 degrees C+BF(Basal feed)+PM), T2(31 degrees C+BF+PM), T3(34 degrees C+BF+PM), T4(37 degrees C+BF+PM), T5(28 degrees C+BF), T6(31 degrees C+BF), T7(34 degrees C+BF) and T8(37 degrees C+BF). A significant increase (P<0.01) in weight gain percentage was observed in the probiotic fed fish even when reared at higher water temperature (34-37 degrees C). Respiratory burst assay, blood glucose, erythrocyte count, total serum protein, albumin, alkaline phosphatase and acid phosphatase were significantly higher (P<0.01) in the probiotic fed groups compared to the non-probiotic fed groups. A significant (P<0.01) effect of rearing temperature and dietary probiotic mixture on serum myeloperoxidase activity, HSP70 level and immunoglobulin production was observed. Degree of apoptosis in different tissues was also significantly reduced in probiotic-supplemented groups. Hence, the present results show that a dietary PM could be beneficial in enhancing the immune status of the fish and also help in combating the stress caused to the organism by higher rearing water temperature.	[Mohapatra, Sipra] NIBB, Lab Bioresource, Okazaki, Aichi, Japan; [Chakraborty, Tapas] NIBB, Div Mol Environm Endocrinol, Okazaki, Aichi, Japan; [Mohapatra, Sipra; Chakraborty, Tapas] Ehime Univ, South Ehime Fisheries Res Ctr, Ainan, Japan; [Prusty, Ashisa K.] Project Directorate Farming Syst Res, Meerut, Uttar Pradesh, India; [Mohapatra, Sipra; PaniPrasad, Kurchetti] Cent Inst Fisheries Educ, Bombay, Maharashtra, India; [Mohanta, Kedar N.] Cent Inst Freshwater Aquaculture, Bhubaneswar, Orissa, India	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Ehime University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Farming Systems Research; Indian Council of Agricultural Research (ICAR); ICAR - Central Institute of Fisheries Education; Indian Council of Agricultural Research (ICAR); ICAR - Central Institute of Freshwater Aquaculture	Mohapatra, S (corresponding author), NIBB, Lab Bioresource, Okazaki, Aichi, Japan.	sipra@nibb.ac.jp; tapas_c@nibb.ac.jp	Mohanta, Dr Kedar Nath/AAZ-1086-2021; Chakraborty, Tapas/M-5865-2018	Mohapatra, Sipra/0000-0002-0891-6713; Chakraborty, Tapas/0000-0003-1984-234X; Prusty, Ashisa Kumar/0000-0003-3402-9744	Indian Council of Agricultural Research (ICAR), New Delhi, India; MEXT, Japan	Indian Council of Agricultural Research (ICAR), New Delhi, India(Indian Council of Agricultural Research (ICAR)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding was provided by Indian Council of Agricultural Research (ICAR), New Delhi, India and MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar MS, 2011, J ANIMAL PHYSL ANIMA, V96, P581; Al-Dohail MA, 2009, AQUAC RES, V40, P1642, DOI 10.1111/j.1365-2109.2009.02265.x; Bly J.E., 1992, Fish & Shellfish Immunology, V2, P159, DOI 10.1016/S1050-4648(05)80056-7; Bozorgnia A., 2011, INT C ENV SCI TECHN, V6; Burel C, 1996, J FISH BIOL, V49, P678, DOI 10.1111/j.1095-8649.1996.tb00064.x; Das T, 2006, ASIAN AUSTRAL J ANIM, V19, P1033, DOI 10.5713/ajas.2006.1033; Das T, 2005, J THERM BIOL, V30, P378, DOI 10.1016/j.jtherbio.2005.03.001; Dash G, 2011, CHRON YOUNG SCI, V2, P29, DOI DOI 10.4103/2229-5186.79347; DYER SD, 1991, CAN J ZOOL, V69, P2021, DOI 10.1139/z91-282; Eaton A.D., 1998, STANDARD METHODS EXA, V20th; Ekert PG, 1997, BRIT MED BULL, V53, P591; Ficke AD, 2007, REV FISH BIOL FISHER, V17, P581, DOI 10.1007/s11160-007-9059-5; FOSTER GD, 1986, FISH PHYSIOL BIOCHEM, V1, P113, DOI 10.1007/BF02290211; Gomes LC, 2009, AQUAC RES, V40, P157, DOI 10.1111/j.1365-2109.2008.02077.x; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Jhingran V.G., 1975, FISH FISHERIES INDIA; Kausar R., 2006, Pakistan Veterinary Journal, V26, P105; Koninkx JFJG, 2008, FOLIA MICROBIOL, V53, P189, DOI 10.1007/s12223-008-0023-0; Kumar R, 2006, AQUAC RES, V37, P1215, DOI 10.1111/j.1365-2109.2006.01551.x; Li SQ, 2012, J PHYSIOL SCI, V62, P29, DOI 10.1007/s12576-011-0183-6; Luzio A, 2013, AQUAT TOXICOL, V128, P183, DOI 10.1016/j.aquatox.2012.12.018; Marzouk M. S., 2008, From the pharaohs to the future. Eighth International Symposium on Tilapia in Aquaculture. Proceedings. Cairo, Egypt, 12-14 October, 2008, P1043; Matsumoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023652; Mohanty S. N., 1996, Journal of Aquaculture in the Tropics, V11, P253; Mohapatra S, 2013, J ANIM PHYSIOL AN N, V97, P405, DOI 10.1111/j.1439-0396.2012.01301.x; Mohapatra S, 2012, AQUACULT NUTR, V18, P1, DOI 10.1111/j.1365-2095.2011.00866.x; Mohapatra S, 2011, FISH PHYSIOL BIOCHEM, V37, P177, DOI 10.1007/s10695-010-9428-1; Mohapatra S, 2012, PESTIC BIOCHEM PHYS, V104, P28, DOI 10.1016/j.pestbp.2012.06.006; Nayak SK, 2010, FISH SHELLFISH IMMUN, V29, P2, DOI 10.1016/j.fsi.2010.02.017; Nelson JW, 1945, HAWKS PHYSIOLOGICAL; OCONOR GT, 1986, CELL TISSUE KINET, V19, P539, DOI 10.1111/j.1365-2184.1986.tb00754.x; Ortuno J, 2003, FISH SHELLFISH IMMUN, V14, P145, DOI 10.1006/fsim.2002.0428; Oser B.L., 1965, HAWKS PHYSIOLOGICAL; Panigrahi A, 2007, FISH PHYSIOL BIOCHEM, V33, P429, DOI 10.1007/s10695-007-9160-7; Picchietti S, 2007, FISH SHELLFISH IMMUN, V22, P57, DOI 10.1016/j.fsi.2006.03.009; Picchietti S, 2009, FISH SHELLFISH IMMUN, V26, P368, DOI 10.1016/j.fsi.2008.10.008; Quade MJ, 1997, VET IMMUNOL IMMUNOP, V58, P239, DOI 10.1016/S0165-2427(97)00048-2; RENUKARADHYA KM, 1986, P INDIAN AS-ANIM SCI, V95, P103, DOI 10.1007/BF03179363; Sakai M, 1999, AQUACULTURE, V172, P63, DOI 10.1016/S0044-8486(98)00436-0; Salinas I, 2008, FISH SHELLFISH IMMUN, V25, P114, DOI 10.1016/j.fsi.2008.03.011; Salminen S, 1999, TRENDS FOOD SCI TECH, V10, P107, DOI 10.1016/S0924-2244(99)00027-8; Sarma K, 2009, SCI TOTAL ENVIRON, V407, P3668, DOI 10.1016/j.scitotenv.2009.02.031; Sharp G. J. E., 1993, Fish & Shellfish Immunology, V3, P119, DOI 10.1006/fsim.1993.1013; SMITH LS, 1989, FISH NUTR, P331; Stasiak SA, 1996, FISH SHELLFISH IMMUN, V6, P537, DOI 10.1006/fsim.1996.0050; Stenslokken KO, 2010, AM J PHYSIOL-REG I, V298, pR1499, DOI 10.1152/ajpregu.00675.2009; Swain P, 2007, VET IMMUNOL IMMUNOP, V117, P137, DOI 10.1016/j.vetimm.2007.02.010; Taoka Y, 2006, FISHERIES SCI, V72, P310, DOI 10.1111/j.1444-2906.2006.01152.x; Tejpal Dahiya, 2012, Journal of Fisheries and Aquatic Science, V7, P279, DOI 10.3923/jfas.2012.279.290; Vasudevan DM, 1998, TXB BIOCH MED STUDEN; Wang YB, 2007, AQUACULTURE, V269, P259, DOI 10.1016/j.aquaculture.2007.05.035; Weber LP, 2001, AQUAT TOXICOL, V54, P39, DOI 10.1016/S0166-445X(00)00179-X; Yamashita Michiaki, 2010, Aqua-Bioscience Monographs, V3, P111, DOI 10.5047/absm.2010.00304.0111; Yun SI, 2009, J APPL MICROBIOL, V107, P1681, DOI 10.1111/j.1365-2672.2009.04350.x; Zhou XX, 2010, FISH PHYSIOL BIOCHEM, V36, P501, DOI 10.1007/s10695-009-9320-z	55	46	51	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100929	10.1371/journal.pone.0100929	http://dx.doi.org/10.1371/journal.pone.0100929			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979660	gold, Green Published, Green Submitted			2022-12-27	WOS:000338506400050
J	Reznik, B; Clement, SL; Lykke-Andersen, J				Reznik, Boris; Clement, Sandra L.; Lykke-Andersen, Jens			hnRNP F Complexes with Tristetraprolin and Stimulates ARE-mRNA Decay	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; AU-RICH ELEMENTS; BINDING PROPERTIES; NANOS TRANSLATION; GENE-EXPRESSION; MEDIATED DECAY; TTP; TURNOVER; REGULATOR; FAMILY	The tristetraprolin (TTP) family of zinc-finger proteins, TTP, BRF1 and BRF2, regulate the stability of a subset of mRNAs containing 3'UTR AU-rich elements (AREs), including mRNAs coding for cytokines, transcription factors, and proto-oncogenes. To better understand the mechanism by which TTP-family proteins control mRNA stability in mammalian cells, we aimed to identify TTP- and BRF1-interacting proteins as potential TTP-family co-factors. This revealed hnRNP F as a prominent interactor of TTP and BRF1. While TTP, BRF1 and hnRNP F are all RNA binding proteins (RBPs), the interaction of hnRNP F with TTP and BRF1 is independent of RNA. Depletion of hnRNP F impairs the decay of a subset of TTP-substrate ARE-mRNAs by a mechanism independent of the extent of hnRNP F binding to the mRNA. Taken together, these findings implicate hnRNP F as a co-factor in a subset of TTP/BRF-mediated mRNA decay and highlight the importance of RBP cooperativity in mRNA regulation.	[Reznik, Boris; Clement, Sandra L.; Lykke-Andersen, Jens] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Lykke-Andersen, J (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	jlykkeandersen@ucsd.edu		Lykke-Andersen, Jens/0000-0003-1821-0754	National Institutes of Health [R01 GM077243]; National Institutes of Health NRSA Institutional Training Grant from the National Institute of General Medical Sciences [GM007240]; American Cancer Society [PF-06-156-01-GMC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health NRSA Institutional Training Grant from the National Institute of General Medical Sciences; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grant R01 GM077243 to J.L.-A. from the National Institutes of Health. B. R. was supported by National Institutes of Health NRSA Institutional Training Grant GM007240 from the National Institute of General Medical Sciences. S. L. C. was supported by a postdoctoral fellowship (PF-06-156-01-GMC) from the American Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan SA, 2006, BIOCHEM J, V393, P361, DOI 10.1042/BJ20050538; Andrews S, 2011, RNA, V17, P967, DOI 10.1261/rna.2478611; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bell SE, 2006, DEV DYNAM, V235, P3144, DOI 10.1002/dvdy.20949; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carrick DM, 2004, ARTHRITIS RES THER, V6, P248, DOI 10.1186/ar1441; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Ciais D, 2004, ONCOGENE, V23, P8673, DOI 10.1038/sj.onc.1207939; Desroches-Castan A, 2011, MOL BIOL CELL, V22, P3625, DOI 10.1091/mbc.E11-02-0149; Durand S, 2013, NAT STRUCT MOL BIOL, V20, P702, DOI 10.1038/nsmb.2575; Emmons J, 2008, RNA, V14, P888, DOI 10.1261/rna.748408; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Gingerich Timothy J., 2004, Animal Health Research Reviews, V5, P49, DOI [10.1079/AHR200460, 10.1079/AHRR200460]; Hau HH, 2007, J CELL BIOCHEM, V100, P1477, DOI 10.1002/jcb.21130; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Hodson DJ, 2010, NAT IMMUNOL, V11, P717, DOI 10.1038/ni.1901; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Johnson BA, 2002, J BIOL CHEM, V277, P18029, DOI 10.1074/jbc.M110465200; Kalifa Y, 2006, DEV CELL, V10, P291, DOI 10.1016/j.devcel.2006.01.001; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Lai WS, 2005, J BIOL CHEM, V280, P34365, DOI 10.1074/jbc.M506757200; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jbc.M110395200; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; MATUNIS MJ, 1994, NUCLEIC ACIDS RES, V22, P1059, DOI 10.1093/nar/22.6.1059; Michel SLJ, 2003, BIOCHEMISTRY-US, V42, P4626, DOI 10.1021/bi034073h; MIN HS, 1995, GENE DEV, V9, P2659, DOI 10.1101/gad.9.21.2659; Ming XF, 2001, MOL CELL BIOL, V21, P5778, DOI 10.1128/MCB.21.17.5778-5789.2001; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Mukherjee N, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r12; Murata T, 2002, BIOCHEM BIOPH RES CO, V293, P1242, DOI 10.1016/S0006-291X(02)00363-7; Phillips RS, 2002, J BIOL CHEM, V277, P11606, DOI 10.1074/jbc.M111457200; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; Sandler H, 2011, NUCLEIC ACIDS RES, V39, P4373, DOI 10.1093/nar/gkr011; Schaub MC, 2007, J BIOL CHEM, V282, P13617, DOI 10.1074/jbc.M700774200; Stoecklin G, 2002, EMBO J, V21, P4709, DOI 10.1093/emboj/cdf444; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; Stumpo DJ, 2009, BLOOD, V114, P2401, DOI 10.1182/blood-2009-04-214619; Stumpo DJ, 2004, MOL CELL BIOL, V24, P6445, DOI 10.1128/MCB.24.14.6445-6455.2004; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; VARNUM BC, 1991, MOL CELL BIOL, V11, P1754, DOI 10.1128/MCB.11.3.1754; Veraldi KL, 2001, MOL CELL BIOL, V21, P1228, DOI 10.1128/MCB.21.4.1228-1238.2001; Wang J, 2013, INT J MOL SCI, V14, P10015, DOI 10.3390/ijms140510015; White R, 2012, J BIOL CHEM, V287, P1742, DOI 10.1074/jbc.M111.235010; Worthington MT, 2002, J BIOL CHEM, V277, P48558, DOI 10.1074/jbc.M206505200	51	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100992	10.1371/journal.pone.0100992	http://dx.doi.org/10.1371/journal.pone.0100992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978456	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400057
J	Ferraro, CF; Trotter, CL; Nascimento, MC; Jusot, JF; Omotara, BA; Hodgson, A; Ali, O; Alavo, S; Sow, S; Daugla, DM; Stuart, JM				Ferraro, Claire F.; Trotter, Caroline L.; Nascimento, Maria C.; Jusot, Jean-Francois; Omotara, Babatunji A.; Hodgson, Abraham; Ali, Oumer; Alavo, Serge; Sow, Samba; Daugla, Doumagoum Moto; Stuart, James M.			Household Crowding, Social Mixing Patterns and Respiratory Symptoms in Seven Countries of the African Meningitis Belt	PLOS ONE			English	Article							MENINGOCOCCAL CARRIAGE; RISK-FACTORS; DISEASE TRANSMISSION; TUBERCULOSIS; INFECTION; EPIDEMIC; COMMUNITY; CONTACTS; CHILDREN; SPREAD	Objectives: To describe the variation in household crowding and social mixing patterns in the African meningitis belt and to assess any association with self-reported recent respiratory symptoms. Methods: In 2010, the African Meningococcal Carriage Consortium (MenAfriCar) conducted cross-sectional surveys in urban and rural areas of seven countries. The number of household members, rooms per household, attendance at social gatherings and meeting places were recorded. Associations with self-reported recent respiratory symptoms were analysed by univariate and multivariate regression models. Results: The geometric mean people per room ranged from 1.9 to 2.8 between Ghana and Ethiopia respectively. Attendance at different types of social gatherings was variable by country, ranging from 0.5 to 1.5 per week. Those who attended 3 or more different types of social gatherings a week (frequent mixers) were more likely to be older, male (OR 1.27, p<0.001) and live in urban areas (OR 1.45, p<0.001). Frequent mixing and young age, but not increased household crowding, were associated with higher odds of self-reported respiratory symptoms (aOR 2.2, p<0.001 and OR 2.8, p<0.001 respectively). A limitation is that we did not measure school and workplace attendance. Conclusion: There are substantial variations in household crowding and social mixing patterns across the African meningitis belt. This study finds a clear association between age, increased social mixing and respiratory symptoms. It lays the foundation for designing and implementing more detailed studies of social contact patterns in this region.	[Ferraro, Claire F.; Nascimento, Maria C.; Stuart, James M.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Trotter, Caroline L.] Univ Cambridge, Dept Vet Med, Dis Dynam Unit, Cambridge, England; [Jusot, Jean-Francois] Ctr Rech Med & Sanit CERMES, Epidemiol Unit, Niamey, Niger; [Omotara, Babatunji A.] Univ Maiduguri, Dept Community Med, Maiduguri, Nigeria; [Hodgson, Abraham] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Hodgson, Abraham] Ghana Hlth Serv, Div Res & Dev, Accra, Ghana; [Ali, Oumer] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Alavo, Serge] Inst Rech Dev, Dakar, Senegal; [Sow, Samba] Ctr Vaccine Dev Mali CVD MALI, Bamako, Mali; [Daugla, Doumagoum Moto] CSSI, Ndjamena, Chad	University of London; London School of Hygiene & Tropical Medicine; University of Cambridge; Navrongo Health Research Center; Ghana Health Service; Institut de Recherche pour le Developpement (IRD)	Trotter, CL (corresponding author), Univ Cambridge, Dept Vet Med, Dis Dynam Unit, Cambridge, England.	clt56@cam.ac.uk	Trotter, Caroline L/H-5077-2013	Trotter, Caroline/0000-0003-4000-2708	Bill and Melinda Gates Foundation; Wellcome Trust	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust(Wellcome TrustEuropean Commission)	The MenAfriCar Consortium was funded through grants from the Bill and Melinda Gates Foundation and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abubakar I, 2012, LANCET INFECT DIS, V12, P66, DOI 10.1016/S1473-3099(11)70246-8; Ali O, 2013, TROP MED INT HEALTH, V18, P968, DOI 10.1111/tmi.12125; Baker M, 2000, PEDIATR INFECT DIS J, V19, P983, DOI 10.1097/00006454-200010000-00009; Baker M, 2008, J EPIDEMIOL COMMUN H, V62, P715, DOI 10.1136/jech.2007.063610; Beaman L, 2010, DO HOUSEHOLD DEFINIT; BECKER NG, 1995, MATH BIOSCI, V127, P207, DOI 10.1016/0025-5564(94)00055-5; Bediako G, 2008, GHANA LIVING STANDAR; Bharti N, 2010, EPIDEMIOL INFECT, V138, P1308, DOI 10.1017/S0950268809991385; Boadi KO, 2006, J BIOSOC SCI, V38, P403, DOI 10.1017/S0021932005026635; BONGAARTS J, 2001, HOUSEHOLD SIZE COMPO; CARTWRIGHT KAV, 1991, LANCET, V338, P554, DOI 10.1016/0140-6736(91)91112-8; Classen CN, 1999, THORAX, V54, P136, DOI 10.1136/thx.54.2.136; Cross PC, 2007, J R SOC INTERFACE, V4, P315, DOI 10.1098/rsif.2006.0185; Deutch S, 2004, SCAND J INFECT DIS, V36, P20, DOI 10.1080/00365540310017500; Edmunds WJ, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-10; Fullerton DG, 2008, T ROY SOC TROP MED H, V102, P843, DOI 10.1016/j.trstmh.2008.05.028; Fumanelli L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002673; HASSANKING M, 1979, T ROY SOC TROP MED H, V73, P567, DOI 10.1016/0035-9203(79)90054-3; Hill PC, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-156; Horby P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016965; Iozzi F, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001021; Jaine R, 2008, J PAEDIATR CHILD H, V44, P564, DOI 10.1111/j.1440-1754.2008.01384.x; Johnstone-Robertson SP, 2011, AM J EPIDEMIOL, V174, P1246, DOI 10.1093/aje/kwr251; Jusot JF, 2012, INFLUENZA OTHER RESP, V6, P87, DOI 10.1111/j.1750-2659.2011.00286.x; Klovdahl AS, 2001, SOC SCI MED, V52, P681, DOI 10.1016/S0277-9536(00)00170-2; Kristiansen PA, 2011, CLIN VACCINE IMMUNOL, V18, P435, DOI 10.1128/CVI.00479-10; LaForce FM, 2011, HEALTH AFFAIR, V30, P1049, DOI 10.1377/hlthaff.2011.0328; MacLennan J, 2006, EMERG INFECT DIS, V12, P950; McCall BJ, 2004, INTERN MED J, V34, P464, DOI 10.1111/j.1445-5994.2004.00564.x; Mccaw JM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-166; Molesworth AM, 2002, T ROY SOC TROP MED H, V96, P242, DOI 10.1016/S0035-9203(02)90089-1; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Mueller JE, 2008, TROP MED INT HEALTH, V13, P1543, DOI 10.1111/j.1365-3156.2008.02165.x; Ogunjimi B, 2009, MATH BIOSCI, V218, P80, DOI 10.1016/j.mbs.2008.12.009; Okiro EA, 2008, TROP MED INT HEALTH, V13, P914, DOI 10.1111/j.1365-3156.2008.02092.x; Randall S, 2011, POP STUD-J DEMOG, V65, P217, DOI 10.1080/00324728.2011.576768; Simoes EAF, 2011, PEDIATR INFECT DIS J, V30, P778, DOI 10.1097/INF.0b013e318218ab9e; Smieszek T, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-25; Smieszek T, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-11; Trotter CL, 2007, LANCET INFECT DIS, V7, P797, DOI 10.1016/S1473-3099(07)70288-8; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Weber MW, 1999, INT J EPIDEMIOL, V28, P157, DOI 10.1093/ije/28.1.157; Xia S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065271; YOUNG LS, 1972, NEW ENGL J MED, V287, P5, DOI 10.1056/NEJM197207062870102	44	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101129	10.1371/journal.pone.0101129	http://dx.doi.org/10.1371/journal.pone.0101129			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BA	24988195	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000341354100063
J	Marshall, MM; Ruzicka, JA; Taylor, EW; Hall, AR				Marshall, Michael M.; Ruzicka, Jan A.; Taylor, Ethan W.; Hall, Adam R.			Detecting DNA Depurination with Solid-State Nanopores	PLOS ONE			English	Article							DEOXYRIBONUCLEIC ACID; ABASIC SITES; SINGLE; TRANSLOCATION; MOLECULES; GENE; ELECTROPHORESIS; SEQUENCES; PROTEINS	Among the different types of DNA damage that occur endogenously in the cell, depurination is especially prevalent. These lesions can initiate mutagenesis and have been implicated in a variety of diseases, including cancer. Here, we demonstrate a new approach for the detection of depurination at the single-molecule scale using solid-state nanopores. We induce depurination in short duplex DNA using acidic conditions and observe that the presence of apurinic sites results in significantly slower dynamics during electrokinetic translocation. This procedure may be valuable as a diagnostic for in situ quantification of DNA depurination.	[Marshall, Michael M.; Ruzicka, Jan A.; Taylor, Ethan W.; Hall, Adam R.] Univ N Carolina, Joint Sch Nanosci & Nanoengn, Greensboro, NC 27412 USA; [Hall, Adam R.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biomed Engn, Winston Salem, NC USA; [Hall, Adam R.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Comprehens Canc, Winston Salem, NC USA	University of North Carolina; University of North Carolina Greensboro; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Hall, AR (corresponding author), Univ N Carolina, Joint Sch Nanosci & Nanoengn, Greensboro, NC 27412 USA.	arhall@wakehealth.edu			Wake Forest University School of Medicine; Dr. Arthur and Bonnie Ennis Foundation, Decatur, IL	Wake Forest University School of Medicine; Dr. Arthur and Bonnie Ennis Foundation, Decatur, IL	ARH acknowledges start-up funding from the Wake Forest University School of Medicine. JR and EWT acknowledge funding from the Dr. Arthur and Bonnie Ennis Foundation, Decatur, IL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullin TI, 2008, J ANAL CHEM+, V63, P690, DOI 10.1134/S1061934808070150; Alvarez-Dominguez JR, 2013, J BIOL CHEM, V288, P11581, DOI 10.1074/jbc.M113.454744; Amosova O, 2006, P NATL ACAD SCI USA, V103, P4392, DOI 10.1073/pnas.0508499103; An N, 2012, P NATL ACAD SCI USA, V109, P11504, DOI 10.1073/pnas.1201669109; Anderson BN, 2013, ACS NANO, V7, P1408, DOI 10.1021/nn3051677; Boiteux S, 2004, DNA REPAIR, V3, P1, DOI 10.1016/j.dnarep.2003.10.002; Cavalieri E, 2012, IUBMB LIFE, V64, P169, DOI 10.1002/iub.586; Dekker C, 2007, NAT NANOTECHNOL, V2, P209, DOI 10.1038/nnano.2007.27; Evers DL, 2007, ANAL BIOCHEM, V370, P255, DOI 10.1016/j.ab.2007.06.002; Firnkes M, 2010, NANO LETT, V10, P2162, DOI 10.1021/nl100861c; FREESE EB, 1961, P NATL ACAD SCI USA, V47, P540, DOI 10.1073/pnas.47.4.540; Healy K, 2007, NANOMEDICINE-UK, V2, P459, DOI 10.2217/17435889.2.4.459; IOCONO JA, 1990, TETRAHEDRON LETT, V31, P175, DOI 10.1016/S0040-4039(00)94363-6; Kowalczyk SW, 2010, NANO LETT, V10, P324, DOI 10.1021/nl903631m; Li JL, 2003, NAT MATER, V2, P611, DOI 10.1038/nmat965; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3618, DOI 10.1021/bi00769a019; MANNING GS, 1978, Q REV BIOPHYS, V11, P179, DOI 10.1017/S0033583500002031; Nakamura J, 1998, CANCER RES, V58, P222; Plesa C, 2013, NANO LETT, V13, P658, DOI 10.1021/nl3042678; Shim J, 2013, SCI REP-UK, V3, DOI [10.1038/srep01389, 10.1038/srep02325]; Singer A, 2012, NANO LETT, V12, P1722, DOI 10.1021/nl300372a; Skinner GM, 2009, NANO LETT, V9, P2953, DOI 10.1021/nl901370w; Smeets RMM, 2009, NANO LETT, V9, P3089, DOI 10.1021/nl803189k; Smeets RMM, 2006, NANO LETT, V6, P89, DOI 10.1021/nl052107w; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Storm AJ, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.051903; TAMM C, 1952, J BIOL CHEM, V195, P49; Wanunu M, 2012, PHYS LIFE REV, V9, P125, DOI 10.1016/j.plrev.2012.05.010; Wanunu M, 2011, J AM CHEM SOC, V133, P486, DOI 10.1021/ja107836t; Wanunu M, 2009, NANO LETT, V9, P3498, DOI 10.1021/nl901691v; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Yang JJ, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/28/285310	34	13	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101632	10.1371/journal.pone.0101632	http://dx.doi.org/10.1371/journal.pone.0101632			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988437	Green Published, Green Submitted, gold			2022-12-27	WOS:000341354100122
J	Taina, M; Korhonen, M; Haataja, M; Muuronen, A; Arponen, O; Hedman, M; Jakala, P; Sipola, P; Mustonen, P; Vanninen, R				Taina, Mikko; Korhonen, Miika; Haataja, Mika; Muuronen, Antti; Arponen, Otso; Hedman, Marja; Jakala, Pekka; Sipola, Petri; Mustonen, Pirjo; Vanninen, Ritva			Morphological and Volumetric Analysis of Left Atrial Appendage and Left Atrium: Cardiac Computed Tomography-Based Reproducibility Assessment	PLOS ONE			English	Article							STROKE; ECHOCARDIOGRAPHY; RISK; ANGIOGRAPHY; PREDICTOR; CLOSURE; FLOW	Objectives: Left atrial appendage (LAA) dilatation and morphology may influence an individual's risk for intracardiac thrombi and ischemic stroke. LAA size and morphology can be evaluated using cardiac computed tomography (cCT). The present study evaluated the reproducibility of LAA volume and morphology assessments. Methods: A total of 149 patients (47 females; mean age 60.9 +/- 10.6 years) with suspected cardioembolic stroke/transient ischemic attack underwent cCT. Image quality was rated based on four categories. Ten patients were selected from each image quality category (N = 40) for volumetric reproducibility analysis by two individual readers. LAA and left atrium (LA) volume were measured in both two-chamber (2CV) and transversal view (TV) orientation. Intertechnique reproducibility was assessed between 2CV and TV (200 measurement pairs). LAA morphology (A = Cactus, B = ChickenWing, C = WindSock, D = CauliFlower), LAA opening height, number of LAA lobes, trabeculation, and orientation of the LAA tip was analysed in all study subjects by three individual readers (447 interobserver measurement pairs). The reproducibility of volume measurements was assessed by intra-class correlation (ICC) and the reproducibility of LAA morphology assessments by Cohen's kappa. Results: The intra-observer and interobserver reproducibility of LAA and LA volume measurements was excellent (ICCs>0.9). The LAA (ICC = 0.954) and LA (ICC = 0.945) volume measurements were comparable between 2CV and TV. Morphological classification (kappa = 0.24) and assessments of LAA opening height (kappa = 0.1), number of LAA lobes (kappa = 0.16), trabeculation (kappa = 0.15), and orientation of the LAA tip (kappa = 0.37) was only slightly to fairly reproducible. Conclusions: LA and LAA volume measurements on cCT provide excellent reproducibility, whereas visual assessment of LAA morphological features is challenging and results in unsatisfactory agreement between readers.	[Taina, Mikko; Korhonen, Miika; Haataja, Mika; Muuronen, Antti; Arponen, Otso; Hedman, Marja; Sipola, Petri; Vanninen, Ritva] Kuopio Univ Hosp, Dept Clin Radiol, SF-70210 Kuopio, Finland; [Taina, Mikko; Korhonen, Miika; Haataja, Mika; Muuronen, Antti; Arponen, Otso; Sipola, Petri; Vanninen, Ritva] Univ Eastern Finland, Inst Clin Med, Radiol Unit, Kuopio, Finland; [Hedman, Marja] Kuopio Univ Hosp, Ctr Heart, SF-70210 Kuopio, Finland; [Jakala, Pekka] Kuopio Univ Hosp, NeuroCtr, SF-70210 Kuopio, Finland; [Jakala, Pekka] Univ Eastern Finland, Inst Clin Med, Neurol Unit, Kuopio, Finland; [Mustonen, Pirjo] Keski Suomi Cent Hosp, Dept Cardiol, Jyvaskyla, Finland	Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Central Finland Central Hospital	Taina, M (corresponding author), Kuopio Univ Hosp, Dept Clin Radiol, SF-70210 Kuopio, Finland.	Mikko.Taina@kuh.fi			Kuopio University Hospital [5063519]	Kuopio University Hospital	This study was supported by the Kuopio University Hospital (grant number 5063519). Kuopio University Hospital web site: www.psshp.fi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saady NM, 1999, HEART, V82, P547, DOI 10.1136/hrt.82.5.547; Amarenco P, 2009, CEREBROVASC DIS, V27, P97, DOI 10.1159/000200446; Anwar AM, 2010, INT J CARDIOVAS IMAG, V26, P519, DOI 10.1007/s10554-010-9593-4; Artang R, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-16; Bang OY, 2003, ANN NEUROL, V54, P227, DOI 10.1002/ana.10644; Bauer M, 2001, Z KARDIOL, V90, P535, DOI 10.1007/s003920170121; Beinart R, 2011, J CARDIOVASC ELECTR, V22, P10, DOI 10.1111/j.1540-8167.2010.01854.x; Bouzas-Mosquera A, 2011, CAN MED ASSOC J, V183, pE657, DOI 10.1503/cmaj.091688; Burrell LD, 2013, AM J CARDIOL, V112, P1148, DOI 10.1016/j.amjcard.2013.05.062; Chen OD, 2012, CHINESE MED J-PEKING, V125, P3416, DOI 10.3760/cma.j.issn.0366-6999.2012.19.010; Di Biase L, 2012, J AM COLL CARDIOL, V60, P531, DOI 10.1016/j.jacc.2012.04.032; Erol B, 2011, EUR J RADIOL, V80, pE346, DOI 10.1016/j.ejrad.2010.11.008; Fagan SM, 2000, ECHOCARDIOGR-J CARD, V17, P365, DOI 10.1111/j.1540-8175.2000.tb01152.x; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Handke M, 2005, J AM SOC ECHOCARDIOG, V18, P1366, DOI 10.1016/j.echo.2005.05.006; Ho ICK, 2007, HEART RHYTHM, V4, P567, DOI 10.1016/j.hrthm.2007.01.014; Hur J, 2009, RADIOLOGY, V251, P683, DOI 10.1148/radiol.2513090794; Kamp O, 1999, EUR HEART J, V20, P979, DOI 10.1053/euhj.1998.1453; Kataoka A, 2011, INT J CARDIOL, V153, P47, DOI 10.1016/j.ijcard.2010.08.036; Kaur H, 2013, J NEMATOL, V45, P122; Khurram IM, 2013, HEART RHYTHM, V10, P1843, DOI 10.1016/j.hrthm.2013.09.065; Kimura T, 2013, HEART RHYTHM, V10, P921, DOI 10.1016/j.hrthm.2013.01.036; Kondratyev E, 2013, EUR J RADIOL, V82, P2233, DOI 10.1016/j.ejrad.2013.08.053; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Landmesser U, 2012, EUR HEART J, V33, P698, DOI 10.1093/eurheartj/ehr393; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Mahabadi Amir A, 2009, J Cardiovasc Comput Tomogr, V3, P80, DOI 10.1016/j.jcct.2009.02.002; Michael KA, 2009, J CARDIOVASC ELECTR, V20, P1217, DOI 10.1111/j.1540-8167.2009.01537.x; Nakajima H, 2010, AM J CARDIOL, V106, P885, DOI 10.1016/j.amjcard.2010.05.014; Nedios S, 2011, J INTERV CARD ELECTR, V32, P87, DOI 10.1007/s10840-011-9591-z; Nucifora G, 2011, CIRC-CARDIOVASC IMAG, V4, P514, DOI 10.1161/CIRCIMAGING.111.963892; Palios John, 2014, Thrombosis, V2014, P832752, DOI 10.1155/2014/832752; Park HC, 2013, INT J CARDIOVAS IMAG, V29, P935, DOI 10.1007/s10554-012-0161-y; Sipola P, 2013, CEREBROVASC DIS, V35, P521, DOI 10.1159/000350734; Stojanovska J, 2011, AM J ROENTGENOL, V197, P631, DOI 10.2214/AJR.10.5955; Taina M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079519; Wang Y, 2010, J CARDIOVASC ELECTR, V21, P973, DOI 10.1111/j.1540-8167.2010.01814.x	37	14	16	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101580	10.1371/journal.pone.0101580	http://dx.doi.org/10.1371/journal.pone.0101580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988467	Green Published, gold, Green Submitted			2022-12-27	WOS:000341354100115
J	Jonker, I; Klein, HC; Duivis, HE; Yolken, RH; Rosmalen, JGM; Schoevers, RA				Jonker, Iris; Klein, Hans C.; Duivis, Hester E.; Yolken, Robert H.; Rosmalen, Judith G. M.; Schoevers, Robert A.			Association between Exposure to HSV1 and Cognitive Functioning in a General Population of Adolescents. The TRAILS Study	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; C-REACTIVE PROTEIN; BIPOLAR DISORDER; SOCIOECONOMIC POSITION; PSYCHIATRIC-DISORDER; INFLAMMATORY MARKERS; INFECTIOUS AGENTS; EUTHYMIC PATIENTS; UNITED-STATES; RISK-FACTORS	Background: Infections with different herpes viruses have been associated with cognitive functioning in psychiatric patients and healthy adults. The aim of this study was to find out whether antibodies to different herpes viruses are prospectively associated with cognitive functioning in a general adolescent population. Methods: This study was performed in TRAILS, a large prospective general population cohort (N = 1084, 54% female, mean age 16.2 years (SD 0.6)). At age 16, immunoglobulin G antibodies against HSV1, HSV2, CMV and EBV were measured next to high sensitive C-Reactive Protein (hsCRP). Two years later, immediate memory and executive functioning were assessed using the 15 words task and the self ordered pointing task. Multiple linear regression analysis with bootstrapping was performed to study the association between viral infections and cognitive function, adjusting for gender, socioeconomic status, ethnicity, and cannabis use. Results: Presence of HSV1 antibodies was associated with memory function ((B = -0.272, 95% CI = -0.556 to -0.016, p = 0.047)), while the association with executive functioning did not reach statistical significance (B = 0.560, 95% CI is -0.053 to 1.184, p = 0.075). The level of HSV1 antibodies was associated with both memory function (B = -0.160, 95% CI = -0.280 to -0.039, p = 0.014) and executive functioning (B = 0.296, 95% CI = 0.011 to 0.578, p = 0.046). Other herpes viruses and hsCRP were not associated with cognitive functioning. Conclusions: Both presence and level of HSV1 antibodies are prospectively associated with reduced cognitive performance in a large cohort of adolescents.	[Jonker, Iris; Klein, Hans C.; Rosmalen, Judith G. M.; Schoevers, Robert A.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [Duivis, Hester E.] Tilburg Univ, Dept Med & Neuropsychol, Ctr Res Psychol Somat Dis, NL-5000 LE Tilburg, Netherlands; [Rosmalen, Judith G. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands; [Yolken, Robert H.] Johns Hopkins Med Sch, Baltimore, MD USA	University of Groningen; Tilburg University; University of Groningen; Johns Hopkins University; Johns Hopkins Medicine	Jonker, I (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands.	i.jonker01@umcg.nl	yolken, robert/AAW-2556-2021; Rosmalen, Judith G.M./F-5375-2011	Rosmalen, Judith G.M./0000-0002-6393-0032; Jonker, Iris/0000-0003-2186-6834; Schoevers, Robert A/0000-0003-0760-9866	Netherlands Organization for Scientific Research NWO (Medical Research Council program grant) [GB-MW 940-38-011]; Netherlands Organization for Scientific Research NWO (ZonMW Brainpower grant) [100-001-004]; Netherlands Organization for Scientific Research NWO (ZonMw Risk Behavior and Dependence grants) [60-60600-97-118]; Netherlands Organization for Scientific Research NWO (ZonMw Culture and Health grant) [261-98-710]; Netherlands Organization for Scientific Research NWO (Social Sciences Council medium-sized investment grants) [GB-MaGW 480-01-006, GB-MaGW 480-07-001]; Netherlands Organization for Scientific Research NWO (Social Sciences Council project grants) [GB-MaGW 452-04-314, GB-MaGW 452-06-004]; Netherlands Organization for Scientific Research NWO (NWO large-sized investment grant) [175.010.2003.005]; Netherlands Organization for Scientific Research NWO (NWO Longitudinal Survey and Panel Funding) [481-08-013]; Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS project) [FP-006]; Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL [CP 32]; Accare Center for Child and Adolescent Psychiatry	Netherlands Organization for Scientific Research NWO (Medical Research Council program grant); Netherlands Organization for Scientific Research NWO (ZonMW Brainpower grant); Netherlands Organization for Scientific Research NWO (ZonMw Risk Behavior and Dependence grants); Netherlands Organization for Scientific Research NWO (ZonMw Culture and Health grant); Netherlands Organization for Scientific Research NWO (Social Sciences Council medium-sized investment grants); Netherlands Organization for Scientific Research NWO (Social Sciences Council project grants); Netherlands Organization for Scientific Research NWO (NWO large-sized investment grant); Netherlands Organization for Scientific Research NWO (NWO Longitudinal Survey and Panel Funding); Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS project); Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL; Accare Center for Child and Adolescent Psychiatry	This research is part of the TRacking Adolescents' Individual Lives Survey (TRAILS). Participating centers of TRAILS include various departments of the University Medical Center and University of Groningen, the Erasmus University Medical Center Rotterdam, the University of Utrecht, the Radboud Medical Center Nijmegen, and the Parnassia Bavo group, all in the Netherlands. TRAILS has been financially supported by various grants from the Netherlands Organization for Scientific Research NWO (Medical Research Council program grant GB-MW 940-38-011; ZonMW Brainpower grant 100-001-004; ZonMw Risk Behavior and Dependence grants 60-60600-97-118; ZonMw Culture and Health grant 261-98-710; Social Sciences Council medium-sized investment grants GB-MaGW 480-01-006 and GB-MaGW 480-07-001; Social Sciences Council project grants GB-MaGW 452-04-314 and GB-MaGW 452-06-004; NWO large-sized investment grant 175.010.2003.005; NWO Longitudinal Survey and Panel Funding 481-08-013), the Dutch Ministry of Justice (WODC), the European Science Foundation (EuroSTRESS project FP-006), Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL (CP 32), the participating universities, and Accare Center for Child and Adolescent Psychiatry. The authors are grateful to all adolescents, their parents and teachers who participated in this research and to everyone who worked on this project and made it possible. The funders had no role in the study design, data collections and analysis, decision to publish or preparation of the manuscript.	Amone-P'Olak K, 2009, SOC PSYCH PSYCH EPID, V44, P231, DOI 10.1007/s00127-008-0424-z; Andrie Rene P, 2010, Cardiovasc Pathol, V19, pe205, DOI 10.1016/j.carpath.2009.09.009; Archer T, 2008, NEUROTOX RES, V14, P205, DOI 10.1007/BF03033811; Ardila A, 2011, DEV PSYCHOL, V47, P984, DOI 10.1037/a0023819; Balfour HH, 2013, J INFECT DIS, V208, P1286, DOI 10.1093/infdis/jit321; Brummett BH, 2013, PSYCHOSOM MED; Cabral GA, 1998, J NEUROIMMUNOL, V83, P116, DOI 10.1016/S0165-5728(97)00227-0; Dickerson F, 2008, BRAIN BEHAV IMMUN, V22, P1103, DOI 10.1016/j.bbi.2008.04.156; Dickerson F, 2007, SCHIZOPHR RES, V93, P261, DOI 10.1016/j.schres.2007.03.022; Dickerson F, 2012, SCHIZOPHR RES, V134, P83, DOI 10.1016/j.schres.2011.10.003; Dickerson FB, 2006, BIPOLAR DISORD, V8, P124, DOI 10.1111/j.1399-5618.2006.00288.x; Dickerson FB, 2004, BIOL PSYCHIAT, V55, P588, DOI 10.1016/j.biopsych.2003.10.008; Dickerson FB, 2003, ARCH GEN PSYCHIAT, V60, P466, DOI 10.1001/archpsyc.60.5.466; Doorduin J, 2009, J NUCL MED, V50, P1801, DOI 10.2967/jnumed.109.066647; Enders G, 2012, MED MICROBIOL IMMUN, V201, P303, DOI 10.1007/s00430-012-0232-7; Ferrier IN, 1999, BRIT J PSYCHIAT, V175, P246, DOI 10.1192/bjp.175.3.246; Ganzeboom HBG, 1996, SOC SCI RES, V25, P201, DOI 10.1006/ssre.1996.0010; Gerber SI, 2012, PROG NEURO-PSYCHOPH, V36, P110, DOI 10.1016/j.pnpbp.2011.09.003; Gimeno D, 2008, PSYCHONEUROENDOCRINO, V33, P1322, DOI 10.1016/j.psyneuen.2008.07.006; Hasselbalch BJ, 2011, J AFFECT DISORDERS, V134, P20, DOI 10.1016/j.jad.2010.11.011; Ho TC, 2013, J AM ACAD CHILD PSY, V52, P1076, DOI 10.1016/j.jaac.2013.07.008; Huisman M, 2008, INT J EPIDEMIOL, V37, P1227, DOI 10.1093/ije/dym273; Janssens KAM, 2010, J CHILD PSYCHOL PSYC, V51, P304, DOI 10.1111/j.1469-7610.2009.02174.x; Kaplan GA, 2001, INT J EPIDEMIOL, V30, P256, DOI 10.1093/ije/30.2.256; Keefe RSE, 2007, J CLIN PSYCHIAT, V68, P8; Kramer M A, 2008, Euro Surveill, V13; Krause D, 2010, WORLD J BIOL PSYCHIA, V11, P739, DOI 10.3109/15622971003653246; Krogh J, 2013, BRAIN BEHAV IMMUN; Kuo HK, 2005, LANCET NEUROL, V4, P371, DOI 10.1016/S1474-4422(05)70099-5; Llorente AM, 2012, APPL NEUROPSYCH-CHIL, V1, P63, DOI 10.1080/21622965.2012.677605; Nijenhuis JT, 2001, J BIOSOC SCI, V33, P469, DOI 10.1017/S0021932001004692; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; Prasad KM, 2012, SCHIZOPHRENIA BULL, V38, P1137, DOI 10.1093/schbul/sbs046; Quinn JP, 2000, PROG NEUROBIOL, V60, P167, DOI 10.1016/S0301-0082(99)00024-6; Rifai N, 2001, CLIN CHEM, V47, P403; Rosenthal SL, 1997, CLIN INFECT DIS, V24, P135, DOI 10.1093/clinids/24.2.135; Ross TP, 2007, ARCH CLIN NEUROPSYCH, V22, P449, DOI 10.1016/j.acn.2007.01.023; Sauerbrei Andreas, 2004, Clin Lab, V50, P425; Shirts BH, 2008, SCHIZOPHR RES, V106, P268, DOI 10.1016/j.schres.2008.07.017; SHOJI H, 1979, J NEUROL, V221, P163, DOI 10.1007/BF00313047; Simanek AM, 2009, INT J EPIDEMIOL, V38, P775, DOI 10.1093/ije/dyn273; Solowij N, 2011, PSYCHOPHARMACOLOGY, V216, P131, DOI 10.1007/s00213-011-2203-x; Thomas P, 2013, J PSYCHIATR RES, V47, P1680, DOI 10.1016/j.jpsychires.2013.07.010; Van der Elst W, 2005, J INT NEUROPSYCH SOC, V11, P290, DOI 10.1017/S1355617705050344; van der Werf-Eldering MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013032; Wang H, 2011, SCHIZOPHR RES, V129, P47, DOI 10.1016/j.schres.2011.03.013; Watson AMM, 2013, PSYCHOL MED, V43, P1023, DOI 10.1017/S003329171200195X; Wright D.B., 2011, J EXPER PSYCHOPATHOL, V2, P252, DOI [10.5127/jep.013611, DOI 10.5127/JEP.013611]; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964; Yaffe K, 2003, NEUROLOGY, V61, P76, DOI 10.1212/01.WNL.0000073620.42047.D7; Yolken RH, 2011, SCHIZOPHR RES, V128, P61, DOI 10.1016/j.schres.2011.01.020; Yun RJ, 2010, BRAIN IMAGING BEHAV, V4, P96, DOI 10.1007/s11682-010-9089-9; Zorrilla EP, 1996, AM J PSYCHIAT, V153, P626	53	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101549	10.1371/journal.pone.0101549	http://dx.doi.org/10.1371/journal.pone.0101549			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983885	gold, Green Submitted, Green Published			2022-12-27	WOS:000339635000118
J	Persichetti, E; Chiasserini, D; Parnetti, L; Eusebi, P; Paciotti, S; De Carlo, C; Codini, M; Tambasco, N; Rossi, A; El Agnaf, OM; Calabresi, P; Beccari, T				Persichetti, Emanuele; Chiasserini, Davide; Parnetti, Lucilla; Eusebi, Paolo; Paciotti, Silvia; De Carlo, Claudia; Codini, Michela; Tambasco, Nicola; Rossi, Aroldo; El Agnaf, Omar M.; Calabresi, Paolo; Beccari, Tommaso			Factors Influencing the Measurement of Lysosomal Enzymes Activity in Human Cerebrospinal Fluid	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; GLUCOCEREBROSIDASE MUTATIONS; PARKINSONS-DISEASE; HYDROLASES; ORIGIN; DYSFUNCTION; BIOMARKERS; AUTOPHAGY; PLASMA; CSF	Measurements of the activities of lysosomal enzymes in cerebrospinal fluid have recently been proposed as putative biomarkers for Parkinson's disease and other synucleinopathies. To define the operating procedures useful for ensuring the reliability of these measurements, we analyzed several pre-analytical factors that may influence the activity of beta-glucocerebrosidase, alpha-mannosidase, beta-mannosidase, beta-galactosidase, alpha-fucosidase, beta-hexosaminidase, cathepsin D and cathepsin E in cerebrospinal fluid. Lysosomal enzyme activities were measured by well-established fluorimetric assays in a consecutive series of patients (n = 28) with different neurological conditions, including Parkinson's disease. The precision, pre-storage and storage conditions, and freeze/thaw cycles were evaluated. All of the assays showed within-and between-run variabilities below 10%. At -20 degrees C, only cathepsin D was stable up to 40 weeks. At 280 degrees C, the cathepsin D, cathepsin E, and beta-mannosidase activities did not change significantly up to 40 weeks, while beta-glucocerebrosidase activity was stable up to 32 weeks. The beta-galactosidase and alpha-fucosidase activities significantly increased (+54.9 +/- 38.08% after 4 weeks and + 88.94 +/- 36.19% after 16 weeks, respectively). Up to four freeze/thaw cycles did not significantly affect the activities of cathepsins D and E. The beta-glucocerebrosidase activity showed a slight decrease (-14.6%) after two freeze/thaw cycles. The measurement of lysosomal enzyme activities in cerebrospinal fluid is reliable and reproducible if pre-analytical factors are accurately taken into consideration. Therefore, the analytical recommendations that ensue from this study may contribute to the establishment of actual values for the activities of cerebrospinal fluid lysosomal enzymes as putative biomarkers for Parkinson's disease and other neurodegenerative disorders.	[Persichetti, Emanuele; Paciotti, Silvia; Codini, Michela; Beccari, Tommaso] Univ Perugia, Dept Pharmaceut Sci, I-06100 Perugia, Italy; [Chiasserini, Davide; Parnetti, Lucilla; De Carlo, Claudia; Tambasco, Nicola; Rossi, Aroldo; Calabresi, Paolo] Univ Perugia, Neurol Sect, Dept Med, I-06100 Perugia, Italy; [Eusebi, Paolo] Reg Hlth Author Umbria, Dept Epidemiol, Perugia, Italy; [El Agnaf, Omar M.] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Biochem, Al Ain, U Arab Emirates; [El Agnaf, Omar M.] King Abdulaziz Univ, Fac Med, Jeddah 21413, Saudi Arabia; [Calabresi, Paolo] Fdn S Lucia, IRCCS, Rome, Italy	University of Perugia; University of Perugia; United Arab Emirates University; King Abdulaziz University; IRCCS Santa Lucia	Beccari, T (corresponding author), Univ Perugia, Dept Pharmaceut Sci, I-06100 Perugia, Italy.	tommaso.beccari@unipg.it	Tambasco, Nicola/AAS-8795-2020; Tambasco, Nicola/K-4788-2018; Calabresi, Paolo/G-8496-2011; Parnetti, Lucilla/K-8258-2016; paciotti, silvia/O-6070-2019; Eusebi, Paolo/O-2721-2013; Chiasserini, Davide/K-7074-2016	Tambasco, Nicola/0000-0003-1497-4482; Tambasco, Nicola/0000-0003-1497-4482; Calabresi, Paolo/0000-0003-0326-5509; Parnetti, Lucilla/0000-0001-5722-3967; paciotti, silvia/0000-0003-1467-0155; Eusebi, Paolo/0000-0002-0715-6396; Chiasserini, Davide/0000-0002-1169-3258	Michael J. Fox Foundation for Parkinson's Research; Fondazione Cassa di Risparmio di Perugia [2013-0274.021]	Michael J. Fox Foundation for Parkinson's Research; Fondazione Cassa di Risparmio di Perugia(Fondazione Cassa Risparmio Perugia)	Michael J. Fox Foundation for Parkinson's Research (www.michaeljfox.org) - Rapid response innovation awards: CSF Lysosomal Hydrolases' Activity as Possible Marker of Parkinson's Disease, 2010-2011 and Validation of Lysosomal Enzymes Assay in CSF, 2011-2012. EP, PE received the funding. Fondazione Cassa di Risparmio di Perugia (www.fondazionecrpg.com) grant n. 2013-0274.021. TB research group received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon-Peretz J, 2004, NEW ENGL J MED, V351, P1972, DOI 10.1056/NEJMoa033277; Armstrong A, 2014, NEUROMOL MED, V16, P150, DOI 10.1007/s12017-013-8269-3; Balducci C, 2007, MOVEMENT DISORD, V22, P1481, DOI 10.1002/mds.21399; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bellettato CM, 2010, J INHERIT METAB DIS, V33, P347, DOI 10.1007/s10545-010-9075-9; Beratis NG, 1997, PEDIATR RES, V41, P235, DOI 10.1203/00006450-199702000-00014; Cleeter MWJ, 2013, NEUROCHEM INT, V62, P1, DOI 10.1016/j.neuint.2012.10.010; Crabtree D, 2013, J NEUROCHEM IN PRESS; Gegg ME, 2012, ANN NEUROL, V72, P455, DOI 10.1002/ana.23614; GOI G, 1987, CLIN CHIM ACTA, V163, P215, DOI 10.1016/0009-8981(87)90025-8; GOI G, 1993, EUR NEUROL, V33, P1, DOI 10.1159/000116888; Haque A, 2008, CNS NEUROL DISORD-DR, V7, P270, DOI 10.2174/187152708784936653; Hartonen M, 2013, J CHROMATOGR A, V1293, P142, DOI 10.1016/j.chroma.2013.04.005; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; HULTBERG B, 1978, ACTA NEUROL SCAND, V57, P201, DOI 10.1111/j.1600-0404.1978.tb05867.x; Khurana V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001026; Lampe C, 2013, RHEUM DIS CLIN N AM, V39, P431, DOI 10.1016/j.rdc.2013.03.004; Lee S, 2011, AUTOPHAGY, V7, P1562, DOI 10.4161/auto.7.12.17956; LOMBARDO A, 1980, CLIN CHIM ACTA, V108, P337, DOI 10.1016/0009-8981(80)90339-3; Lwin A, 2004, MOL GENET METAB, V81, P70, DOI 10.1016/j.ymgme.2003.11.004; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Murphy KE, 2014, BRAIN, V137, P834, DOI 10.1093/brain/awt367; Osellame LD, 2013, CELL METAB, V17, P941, DOI 10.1016/j.cmet.2013.04.014; Pan TH, 2008, BRAIN, V131, P1969, DOI 10.1093/brain/awm318; Parnetti L, 2009, NEUROBIOL DIS, V34, P484, DOI 10.1016/j.nbd.2009.03.002; Parnetti L, 2014, MOVEMENT DI IN PRESS; Parnetti L, 2013, NAT REV NEUROL, V9, P131, DOI 10.1038/nrneurol.2013.10; Pshezhetsky AV, 2001, PROG NUCLEIC ACID RE, V69, P81, DOI 10.1016/S0079-6603(01)69045-7; R Core Team, 2021, R LANGUAGE ENV STAT; RAGHAVAN SS, 1980, AM J HUM GENET, V32, P158; SCHWAGERL AL, 1995, J NEUROCHEM, V64, P443; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; van Dijk KD, 2013, MOVEMENT DISORD, V28, P747, DOI 10.1002/mds.25495; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Wayne P, 2004, EP05A2 CLIN LAB STAN; Yap TL, 2013, MOL GENET METAB, V108, P56, DOI 10.1016/j.ymgme.2012.11.010; Ziegler SG, 2007, MOL GENET METAB, V91, P195, DOI 10.1016/j.ymgme.2007.03.004; ZIMRAN A, 1989, LANCET, V2, P349	38	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101453	10.1371/journal.pone.0101453	http://dx.doi.org/10.1371/journal.pone.0101453			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983953	Green Published, Green Submitted, gold			2022-12-27	WOS:000339635000109
J	Akiyama, K; Takeuchi, F; Isono, M; Chakrawarthy, S; Nguyen, QN; Wen, WQ; Yamamoto, K; Katsuya, T; Kasturiratne, A; Pham, ST; Zheng, W; Matsushita, Y; Kishimoto, M; Do, LD; Shu, XO; Wickremasinghe, AR; Kajio, H; Kato, N				Akiyama, Koichi; Takeuchi, Fumihiko; Isono, Masato; Chakrawarthy, Sureka; Quang Ngoc Nguyen; Wen, Wanqing; Yamamoto, Ken; Katsuya, Tomohiro; Kasturiratne, Anuradhani; Son Thai Pham; Zheng, Wei; Matsushita, Yumi; Kishimoto, Miyako; Loi Doan Do; Shu, Xiao-Ou; Wickremasinghe, Ananda R.; Kajio, Hiroshi; Kato, Norihiro			Systematic Fine-Mapping of Association with BMI and Type 2 Diabetes at the FTO Locus by Integrating Results from Multiple Ethnic Groups	PLOS ONE			English	Article							BODY-MASS INDEX; GENOME-WIDE ASSOCIATION; CAUSAL VARIANTS; POPULATION; OBESITY; METAANALYSIS; GENE	Background/Objective: The 16q12.2 locus in the first intron of FTO has been robustly associated with body mass index (BMI) and type 2 diabetes in genome-wide association studies (GWAS). To improve the resolution of fine-scale mapping at FTO, we performed a systematic approach consisting of two parts. Methods: The first part is to partition the associated variants into linkage disequilibrium (LD) clusters, followed by conditional and haplotype analyses. The second part is to filter the list of potential causal variants through trans-ethnic comparison. Results: We first examined the LD relationship between FTO SNPs showing significant association with type 2 diabetes in Japanese GWAS and between those previously reported in European GWAS. We could partition all the assayed or imputed SNPs showing significant association in the target FTO region into 7 LD clusters. Assaying 9 selected SNPs in 4 Asian-descent populations-Japanese, Vietnamese, Sri Lankan and Chinese (n <= 26,109 for BMI association and n <= 24,079 for type 2 diabetes association), we identified a responsible haplotype tagged by a cluster of SNPs and successfully narrowed the list of potential causal variants to 25 SNPs, which are the smallest in number among the studies conducted to date for FTO. Conclusions: Our data support that the power to resolve the causal variants from those in strong LD increases consistently when three distant populations-Europeans, Asians and Africans-are included in the follow-up study. It has to be noted that this fine-mapping approach has the advantage of applicability to the existing GWAS data set in combination with direct genotyping of selected variants.	[Akiyama, Koichi; Takeuchi, Fumihiko; Isono, Masato; Kato, Norihiro] Natl Ctr Global Hlth & Med, Dept Gene Diagnost & Therapeut, Res Inst, Tokyo, Japan; [Chakrawarthy, Sureka; Kasturiratne, Anuradhani; Wickremasinghe, Ananda R.] Univ Kelaniya, Dept Publ Hlth, Fac Med, Ragama, Sri Lanka; [Quang Ngoc Nguyen; Son Thai Pham; Loi Doan Do] Bach Mai Hosp, Hanoi, Vietnam; [Wen, Wanqing; Zheng, Wei; Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Div Epidemiol, Dept Med,Vanderbilt Epidemiol Ctr,Vanderbilt Ingr, Nashville, TN 37212 USA; [Yamamoto, Ken] Kyushu Univ, Med Inst Bioregulat, Div Genom, Fukuoka 812, Japan; [Katsuya, Tomohiro] Osaka Univ, Dept Clin Gene Therapy, Grad Sch Med, Suita, Osaka, Japan; [Katsuya, Tomohiro] Osaka Univ, Dept Geriatr Med & Nephrol, Grad Sch Med, Suita, Osaka, Japan; [Matsushita, Yumi] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Tokyo, Japan; [Kishimoto, Miyako; Kajio, Hiroshi] Natl Ctr Global Hlth & Med, Ctr Hosp, Tokyo, Japan	National Center for Global Health & Medicine - Japan; University Kelaniya; Vanderbilt University; Kyushu University; Osaka University; Osaka University; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Kato, N (corresponding author), Natl Ctr Global Hlth & Med, Dept Gene Diagnost & Therapeut, Res Inst, Tokyo, Japan.	nokato@ri.ncgm.go.jp	Zheng, Wei/O-3351-2013; zhang, weihua/GXV-1334-2022	Zheng, Wei/0000-0003-1226-070X; Kasturiratne, Anuradhani/0000-0001-5260-2394	National Center for Global Health and Medicine (NCGM) [22S-10, 23S-302, 25S-1]; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation Organization; JSPS KAKENHI [23710228]; Japan Ministry of Education, Culture, Sports, Science and Technology; JSPS; Ministry of Health, Labour and Welfare [17C-1, 20S-6]; Manpei Suzuki Diabetes Foundation; NATIONAL CANCER INSTITUTE [UM1CA173640, UM1CA182910] Funding Source: NIH RePORTER	National Center for Global Health and Medicine (NCGM); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation Organization; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Manpei Suzuki Diabetes Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Center for Global Health and Medicine (NCGM) (22S-10, 23S-302 and 25S-1); a grant from the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation Organization; JSPS KAKENHI (Grant Number 23710228); Grants-in-Aid for the 21st Century Center of Excellence Program (Kyushu University) from the Japan Ministry of Education, Culture, Sports, Science and Technology and for Scientific Research (A) from JSPS; International Health Research (17C-1 and 20S-6) from the Ministry of Health, Labour and Welfare; and Manpei Suzuki Diabetes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Dunning AM, 2000, AM J HUM GENET, V67, P1544, DOI 10.1086/316906; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gorkin DU, 2014, NATURE, V507, P309, DOI 10.1038/nature13212; Hassanein MT, 2010, HUM MOL GENET, V19, P2907, DOI 10.1093/hmg/ddq178; Meyer KB, 2013, AM J HUM GENET, V93, P1046, DOI 10.1016/j.ajhg.2013.10.026; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; Nanri A, 2008, AM J CLIN NUTR, V87, P1488, DOI 10.1093/ajcn/87.5.1488; Peters U, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003171; Pinidiyapathirage M Janani, 2011, BMC Res Notes, V4, P513, DOI 10.1186/1756-0500-4-513; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shu XO, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001127; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Takeuchi F, 2010, DIABETOLOGIA, V53, P299, DOI 10.1007/s00125-009-1595-1; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Teo YY, 2010, GENET EPIDEMIOL, V34, P653, DOI 10.1002/gepi.20522; Tsuchihashi-Makaya M, 2009, HYPERTENS RES, V32, P207, DOI 10.1038/hr.2009.3; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Zaitlen N, 2010, AM J HUM GENET, V86, P23, DOI 10.1016/j.ajhg.2009.11.016; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	25	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101329	10.1371/journal.pone.0101329	http://dx.doi.org/10.1371/journal.pone.0101329			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978468	gold, Green Submitted, Green Published			2022-12-27	WOS:000338506400117
J	Brittain, A; Stroebele, E; Erives, A				Brittain, Andrew; Stroebele, Elizabeth; Erives, Albert			Microsatellite Repeat Instability Fuels Evolution of Embryonic Enhancers in Hawaiian Drosophila	PLOS ONE			English	Article							NATURAL-POPULATIONS; PIGMENT PATTERNS; SHADOW ENHANCERS; GENE MASTERMIND; MELANOGASTER; GRADIENT; GENOME; MIMICA; NEUROECTODERM; VARIABILITY	For,30 million years, the eggs of Hawaiian Drosophila were laid in ever-changing environments caused by high rates of island formation. The associated diversification of the size and developmental rate of the syncytial fly embryo would have altered morphogenic gradients, thus necessitating frequent evolutionary compensation of transcriptional responses. We investigate the consequences these radiations had on transcriptional enhancers patterning the embryo to see whether their pattern of molecular evolution is different from non-Hawaiian species. We identify and functionally assay in transgenic D. melanogaster the Neurogenic Ectoderm Enhancers from two different Hawaiian Drosophila groups: (i) the picture wing group, and (ii) the modified mouthparts group. We find that the binding sites in this set of well-characterized enhancers are footprinted by diverse microsatellite repeat (MSR) sequences. We further show that Hawaiian embryonic enhancers in general are enriched in MSR relative to both Hawaiian non-embryonic enhancers and non-Hawaiian embryonic enhancers. We propose embryonic enhancers are sensitive to Activator spacing because they often serve as assembly scaffolds for the aggregation of transcription factor activator complexes. Furthermore, as most indels are produced by microsatellite repeat slippage, enhancers from Hawaiian Drosophila lineages, which experience dynamic evolutionary pressures, would become grossly enriched in MSR content.	[Brittain, Andrew; Stroebele, Elizabeth; Erives, Albert] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	University of Iowa	Erives, A (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	albert-erives@uiowa.edu			National Science Foundation [1239673]; National Institutes of Health [T32GM082729]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM082729] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [1239673] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	AE: National Science Foundation, Award: 1239673. ES: National Institutes of Health, Training Grant: T32GM082729. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananda G, 2013, GENOME BIOL EVOL, V5, P606, DOI 10.1093/gbe/evs116; Arthur BJ, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-11; Ashley CT, 1995, ANNU REV GENET, V29, P703, DOI 10.1146/annurev.ge.29.120195.003415; Ayala FJ, 1996, MOL BIOL EVOL, V13, P1363, DOI 10.1093/oxfordjournals.molbev.a025582; Bachtrog D, 2000, MOL BIOL EVOL, V17, P1277, DOI 10.1093/oxfordjournals.molbev.a026411; Bachtrog D, 1999, MOL BIOL EVOL, V16, P602, DOI 10.1093/oxfordjournals.molbev.a026142; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barolo S, 2012, BIOESSAYS, V34, P135, DOI 10.1002/bies.201100121; Bhat KM, 1996, DEVELOPMENT, V122, P1113; Bhutkar A, 2008, GENETICS, V179, P1657, DOI 10.1534/genetics.107.086108; Cande J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043888; Carson HL, 2002, GENETICA, V116, P383, DOI 10.1023/A:1021280325474; Carson HL, 1997, J HERED, V88, P343, DOI 10.1093/oxfordjournals.jhered.a023115; CARSON HL, 1973, NATURE, V241, P200, DOI 10.1038/241200a0; CARSON HL, 1967, P NATL ACAD SCI USA, V57, P1280, DOI 10.1073/pnas.57.5.1280; CARSON HL, 1982, HEREDITY, V48, P3, DOI 10.1038/hdy.1982.2; CARSON HL, 1983, GENETICS, V103, P465; Chen HT, 2012, CELL, V149, P618, DOI 10.1016/j.cell.2012.03.018; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cooley AM, 2012, EVOL DEV, V14, P317, DOI 10.1111/j.1525-142X.2012.00550.x; Crocker J, 2013, DEV BIOL, V378, P64, DOI 10.1016/j.ydbio.2013.03.002; Crocker J, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1102; Crocker J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000276; Crocker J, 2008, PLOS BIOL, V6, P2576, DOI 10.1371/journal.pbio.0060263; Dieringer D, 2003, GENOME RES, V13, P2242, DOI 10.1101/gr.1416703; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; Edwards KA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000487; Erives A, 1998, DEV BIOL, V194, P213, DOI 10.1006/dbio.1997.8810; Erives A, 2004, P NATL ACAD SCI USA, V101, P3851, DOI 10.1073/pnas.0400611101; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Harr B, 1998, MOL BIOL EVOL, V15, P176, DOI 10.1093/oxfordjournals.molbev.a025913; Harrison MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002266; Harrison MM, 2010, DEV BIOL, V345, P248, DOI 10.1016/j.ydbio.2010.06.026; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; Huntley MA, 2007, MOL BIOL EVOL, V24, P2598, DOI 10.1093/molbev/msm129; IP YT, 1992, GENE DEV, V6, P1728, DOI 10.1101/gad.6.9.1728; Jung J, 2011, GENETICS, V187, P61, DOI 10.1534/genetics.110.121418; KAMBYSELLIS MP, 1971, AM NAT, V105, P31, DOI 10.1086/282700; KAMBYSELLIS MP, 1980, AM NAT, V115, P67, DOI 10.1086/283546; Kanodia JS, 2009, P NATL ACAD SCI USA, V106, P21707, DOI 10.1073/pnas.0912395106; Kofler R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-612; Li L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r101; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; NEWFELD SJ, 1994, J MOL EVOL, V38, P637; NEWFELD SJ, 1993, J MOL EVOL, V37, P483, DOI 10.1007/BF00160429; Nien CY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002339; O'Grady PM, 2003, ANN ENTOMOL SOC AM, V96, P12, DOI 10.1603/0013-8746(2003)096[0012:ROTDMS]2.0.CO;2; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Powell J. R., 1997, PROGR PROSPECTS EVOL; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Shirangi TR, 2013, CELL REP, V5, P678, DOI 10.1016/j.celrep.2013.09.039; Stathopoulos A, 2004, CURR OPIN GENET DEV, V14, P477, DOI 10.1016/j.gde.2004.07.004; Sullivan W, 2000, DROSOPHILA PROTOCOLS, Vxiv; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; Wittkopp PJ, 2003, P NATL ACAD SCI USA, V100, P1808, DOI 10.1073/pnas.0336368100; Yanez-Cuna JO, 2014, GENOME RES	57	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101177	10.1371/journal.pone.0101177	http://dx.doi.org/10.1371/journal.pone.0101177			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978198	Green Submitted, Green Published, gold			2022-12-27	WOS:000338506400092
J	Barrado, MJG; Blanco, EJ; Hernandez, MC; Osma, MCI; Carretero, M; Herrero, JJ; Burks, DJ; Carretero, J				Garcia Barrado, Maria Jose; Blanco, Enrique J.; Carretero Hernandez, Marta; Iglesias Osma, Maria Carmen; Carretero, Manuel; Herrero, Julio J.; Jane Burks, Deborah; Carretero, Jose			Local Transformations of Androgens into Estradiol by Aromatase P450 Is Involved in the Regulation of Prolactin and the Proliferation of Pituitary Prolactin-Positive Cells	PLOS ONE			English	Article							MESSENGER-RIBONUCLEIC-ACID; RAT PITUITARY; GROWTH-HORMONE; SEX STEROIDS; IN-VIVO; RNA-EXPRESSION; ADULT MALE; ESTROGEN; SECRETION; RELEASE	In previous studies we demonstrated the immunohistochemical expression of aromatase in pituitary cells. In order to determine whether pituitary aromatase is involved in the paracrine regulation of prolactin-producing pituitary cells and the physiological relevance of pituitary aromatase in the control of these cells, an in vivo and in vitro immunocytochemical and morphometric study of prolactin-positive pituitary cells was carried out on the pituitary glands of adult male rats treated with the aromatase antagonist fadrozole. Moreover, we analyzed the expression of mRNA for the enzyme in pituitary cells of male adult rats by in situ hybridization. The aromatase-mRNA was seen to be located in the cytoplasm of 41% of pituitary cells and was well correlated with the immunocytochemical staining. After in vivo treatment with fadrozole, the size (cellular and nuclear areas) of prolactin cells, as well as the percentage of prolactin-positive cells and the percentage of proliferating-prolactin cells, was significantly decreased. Moreover, fadrozole decreased serum prolactin levels. In vitro, treatment with fadrozole plus testosterone induced similar effects on prolactin-positive cells, inhibiting their cellular proliferation. Our results suggest that under physiological conditions aromatase P450 exerts a relevant control over male pituitary prolactin-cells, probably transforming testosterone to estradiol in the pituitary gland.	[Blanco, Enrique J.; Carretero Hernandez, Marta; Carretero, Jose] Univ Salamanca, Fac Med, Dept Human Anat & Histol, E-37008 Salamanca, Spain; [Garcia Barrado, Maria Jose; Blanco, Enrique J.; Iglesias Osma, Maria Carmen; Carretero, Jose] Univ Salamanca, Inst Neurosci Castilla & Leon, Neuroendocrinol Lab, E-37008 Salamanca, Spain; [Garcia Barrado, Maria Jose; Blanco, Enrique J.; Iglesias Osma, Maria Carmen; Carretero, Jose] Univ Salamanca, Lab Endocrine Metab Dis IBSAL, E-37008 Salamanca, Spain; [Garcia Barrado, Maria Jose; Iglesias Osma, Maria Carmen] Univ Salamanca, Fac Med, Dept Physiol & Pharmacol, E-37008 Salamanca, Spain; [Carretero, Manuel] Univ Salamanca, Fac Human & Social Sci, E-37008 Salamanca, Spain; [Herrero, Julio J.] Univ Salamanca, Fac Med, Dept Surg, E-37008 Salamanca, Spain; [Jane Burks, Deborah] CIPF, Neuroendocrinol Lab, Valencia, Spain	University of Salamanca; University of Salamanca; University of Salamanca; University of Salamanca; University of Salamanca; University of Salamanca; Prince Felipe Research Center	Barrado, MJG (corresponding author), Univ Salamanca, Inst Neurosci Castilla & Leon, Neuroendocrinol Lab, E-37008 Salamanca, Spain.	barrado@usal.es	Carretero, José J/L-6930-2014; Carretero, Manuel/N-1717-2016; Barrado, Maria Jose Garcia/L-4852-2014; Blanco, Enrique J/B-2243-2017; Iglesias-Osma, Maria Carmen/B-1641-2013	Carretero, José J/0000-0003-3143-6512; Carretero, Manuel/0000-0002-3026-5304; Barrado, Maria Jose Garcia/0000-0003-2552-5973; Blanco, Enrique J/0000-0002-5332-4282; Iglesias-Osma, Maria Carmen/0000-0002-2206-9119	FIS Spanish program [PI0-21803]	FIS Spanish program	This work was financially supported by the FIS Spanish program No. PI0-21803. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinci H, 2013, PITUITARY, V16, P386, DOI 10.1007/s11102-012-0436-2; AMARA JF, 1987, ENDOCRINOLOGY, V120, P264, DOI 10.1210/endo-120-1-264; BARRACLOUGH CA, 1986, NEUROENDOCRINOLOGY, V42, P6, DOI 10.1159/000124241; BONSALL RW, 1992, HORM BEHAV, V26, P240, DOI 10.1016/0018-506X(92)90045-W; BURDMAN JA, 1984, J ENDOCRINOL, V101, P197, DOI 10.1677/joe.0.1010197; CARR LA, 1977, BRAIN RES, V133, P305, DOI 10.1016/0006-8993(77)90766-1; Carretero J, 1999, CELL TISSUE RES, V295, P419, DOI 10.1007/s004410051248; CARRETERO J, 1995, NEUROENDOCRINOLOGY, V62, P277, DOI 10.1159/000127014; Carretero Jose, 2002, Pituitary, V5, P5, DOI 10.1023/A:1022176631922; Carretero J, 2013, ANN ANAT, V195, P253, DOI 10.1016/j.aanat.2013.01.009; CARRILLO AJ, 1987, ENDOCRINOLOGY, V121, P1993, DOI 10.1210/endo-121-6-1993; CHANG RJ, 1982, AM J OBSTET GYNECOL, V144, P402, DOI 10.1016/0002-9378(82)90244-7; Chowen JA, 1998, J NEUROENDOCRINOL, V10, P493, DOI 10.1046/j.1365-2826.1998.00228.x; DADA MO, 1984, J ENDOCRINOL, V101, P87, DOI 10.1677/joe.0.1010087; DEYO SN, 1982, LIFE SCI, V31, P2171, DOI 10.1016/0024-3205(82)90111-4; Galmiche G, 2006, ANN NY ACAD SCI, V1070, P286, DOI 10.1196/annals.1317.028; Galmiche G, 2006, ENDOCRINOLOGY, V147, P4234, DOI 10.1210/en.2005-1650; GIGUERE V, 1982, ENDOCRINOLOGY, V111, P857, DOI 10.1210/endo-111-3-857; GOLUBOFF LG, 1969, J CLIN ENDOCR METAB, V29, P1533, DOI 10.1210/jcem-29-12-1533; Goto-Kazeto R, 2004, GEN COMP ENDOCR, V139, P72, DOI 10.1016/j.ygcen.2004.07.003; GUNSON DE, 1995, BRIT J CANCER, V72, P72, DOI 10.1038/bjc.1995.279; HAUG E, 1976, ENDOCRINOLOGY, V99, P1482, DOI 10.1210/endo-99-6-1482; Heidari Z, 2010, ENDOCR PRACT, V16, P669, DOI 10.4158/EP10026.CR; HICKEY GJ, 1990, MOL ENDOCRINOL, V4, P3, DOI 10.1210/mend-4-1-3; HYMER WC, 1961, ENDOCRINOLOGY, V69, P81, DOI 10.1210/endo-69-1-81; Kadioglu P, 2008, PITUITARY, V11, P29, DOI 10.1007/s11102-007-0065-3; KUBOTA T, 1989, NEUROENDOCRINOLOGY, V50, P400, DOI 10.1159/000125255; LANNIGAN DA, 1990, PROG CLIN BIOL RES, V322, P187; LIEBERMAN ME, 1978, P NATL ACAD SCI USA, V75, P5946, DOI 10.1073/pnas.75.12.5946; LLOYD HM, 1975, NATURE, V255, P497, DOI 10.1038/255497a0; LLOYD RV, 1988, AM J PATHOL, V133, P397; MACLEOD RM, 1969, ENDOCRINOLOGY, V84, P1475, DOI 10.1210/endo-84-6-1475; MAURER RA, 1982, J BIOL CHEM, V257, P2133; MAURER RA, 1977, ENDOCRINOLOGY, V101, P76, DOI 10.1210/endo-101-1-76; Menuet A, 2003, J COMP NEUROL, V462, P180, DOI 10.1002/cne.10726; Nocillado JN, 2007, MOL CELL ENDOCRINOL, V263, P65, DOI 10.1016/j.mce.2006.08.013; Nolan LA, 2006, J ENDOCRINOL, V188, P387, DOI 10.1677/joe.1.06508; PANTIC V, 1969, Z ZELLFORSCH MIK ANA, V95, P280, DOI 10.1007/BF00968458; PEREZ RL, 1986, J ENDOCRINOL, V108, P399, DOI 10.1677/joe.0.1080399; POOLE MC, 1980, AM J ANAT, V158, P3, DOI 10.1002/aja.1001580103; SAKUMA S, 1984, J ENDOCRINOL, V100, P323, DOI 10.1677/joe.0.1000323; SAUNDERS SL, 1983, CELL TISSUE RES, V232, P21; Schaufele F, 1999, MOL ENDOCRINOL, V13, P935, DOI 10.1210/me.13.6.935; SHULL JD, 1985, ENDOCRINOLOGY, V116, P2456, DOI 10.1210/endo-116-6-2456; SHULL JD, 1984, ENDOCRINOLOGY, V114, P1550, DOI 10.1210/endo-114-5-1550; SHULL JD, 1986, VITAM HORM, V43, P197; SHUPNIK MA, 1979, ENDOCRINOLOGY, V104, P729, DOI 10.1210/endo-104-3-729; Simpson ER, 2001, ENDOCRINOLOGY, V142, P4589, DOI 10.1210/endo.142.11.8547; SMITH RE, 1966, J CELL BIOL, V31, P319, DOI 10.1083/jcb.31.2.319; SOMASEKHAR MB, 1988, GENE, V69, P13, DOI 10.1016/0378-1119(88)90373-3; STEELE R E, 1987, Steroids, V50, P147, DOI 10.1016/0039-128X(83)90068-5; TORRES AI, 1987, J ENDOCRINOL, V114, P213, DOI 10.1677/joe.0.1140213; Trubiroha A, 2012, GEN COMP ENDOCR, V178, P529, DOI 10.1016/j.ygcen.2012.07.002; TSAI PS, 1994, BIOL REPROD, V50, P144, DOI 10.1095/biolreprod50.1.144; VELDHUIS JD, 1989, AM J OBSTET GYNECOL, V161, P1149, DOI 10.1016/0002-9378(89)90654-6; VICIAN L, 1979, ENDOCRINOLOGY, V104, P736, DOI 10.1210/endo-104-3-736; Vona-Davis L, 2013, J MAMMARY GLAND BIOL, V18, P291, DOI 10.1007/s10911-013-9299-z; WATERMAN ML, 1988, MOL ENDOCRINOL, V2, P14, DOI 10.1210/mend-2-1-14; YAMAMOTO N, 1986, NEUROENDOCRINOLOGY, V42, P494, DOI 10.1159/000124493	59	12	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101403	10.1371/journal.pone.0101403	http://dx.doi.org/10.1371/journal.pone.0101403			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978194	Green Submitted, Green Published, gold			2022-12-27	WOS:000338506400128
J	ManickamAchari, V; Bryce, RA; Hashim, R				ManickamAchari, Vijayan; Bryce, Richard A.; Hashim, Rauzah			Conformational Dynamics of Dry Lamellar Crystals of Sugar Based Lipids: An Atomistic Simulation Study	PLOS ONE			English	Article							THERMOTROPIC PHASE-BEHAVIOR; BRANCHED-CHAIN GLYCOSIDES; PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; LYOTROPIC PHASES; BILAYER; GLYCOLIPIDS; SYSTEM; MODEL; UNSATURATION	The rational design of a glycolipid application (e. g. drug delivery) with a tailored property depends on the detailed understanding of its structure and dynamics. Because of the complexity of sugar stereochemistry, we have undertaken a simulation study on the conformational dynamics of a set of synthetic glycosides with different sugar groups and chain design, namely dodecyl beta-maltoside, dodecyl beta-cellobioside, dodecyl beta-isomaltoside and a C12C10 branched beta-maltoside under anhydrous conditions. We examined the chain structure in detail, including the chain packing, gauche/trans conformations and chain tilting. In addition, we also investigated the rotational dynamics of the headgroup and alkyl chains. Monoalkylated glycosides possess a small amount of gauche conformers (similar to 20%) in the hydrophobic region of the lamellar crystal (L-C) phase. In contrast, the branched chain glycolipid in the fluid L-alpha phase has a high gauche population of up to similar to 40%. Rotational diffusion analysis reveals that the carbons closest to the headgroup have the highest correlation times. Furthermore, its value depends on sugar type, where the rotational dynamics of an isomaltose was found to be 11-15% and more restrained near the sugar, possibly due to the chain disorder and partial inter-digitation compared to the other monoalkylated lipids. Intriguingly, the present simulation demonstrates the chain from the branched glycolipid bilayer has the ability to enter into the hydrophilic region. This interesting feature of the anhydrous glycolipid bilayer simulation appears to arise from a combination of lipid crowding and the amphoteric nature of the sugar headgroups.	[ManickamAchari, Vijayan; Hashim, Rauzah] Univ Malaya, Dept Chem, Kuala Lumpur 59100, Malaysia; [Bryce, Richard A.] Univ Manchester, Manchester Pharm Sch, Manchester, Lancs, England; [ManickamAchari, Vijayan; Hashim, Rauzah] Chinese Acad Sci, Kavli Inst Theoret Phys China, Beijing, Peoples R China	Universiti Malaya; University of Manchester; Chinese Academy of Sciences	Hashim, R (corresponding author), Univ Malaya, Dept Chem, Kuala Lumpur 59100, Malaysia.	rauzah@um.edu.my	Manickam Achari, Vijayan/S-7858-2016; Hashim, Rauzah/B-9566-2010; Bryce, Richard/F-9955-2015	Manickam Achari, Vijayan/0000-0002-0540-3728; Hashim, Rauzah/0000-0002-4074-9783; Bryce, Richard/0000-0002-8145-2345	High Impact Grant (HIR) from the Ministry of Higher Education (Malaysia); University of Malaya [UM.C/625/1/HIR/MOHE/05]; European Union [233533]	High Impact Grant (HIR) from the Ministry of Higher Education (Malaysia); University of Malaya(Universiti Malaya); European Union(European Commission)	The High Impact Grant (HIR) from the Ministry of Higher Education (Malaysia) and University of Malaya UM.C/625/1/HIR/MOHE/05 supports this project. The European Union's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement No. 233533 (INFORM) also partially provides travel grant to RH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 1998, J CHEM SOC PERK T 2, P177, DOI 10.1039/a702415k; Abe Y, 2000, J CHEM SOC PERK T 2, P341, DOI 10.1039/a905624f; Abeygunaratne S, 2007, LIQ CRYST, V34, P441, DOI 10.1080/02678290701223939; Achari VM, 2012, J PHYS CHEM B, V116, P11626, DOI 10.1021/jp302292s; Ahmad N, 2012, LANGMUIR, V28, P2395, DOI 10.1021/la203736b; ANDREA TA, 1983, J CHEM PHYS, V79, P4576, DOI 10.1063/1.446373; Anezo C, 2003, J PHYS CHEM B, V107, P9424, DOI 10.1021/jp0348981; Auvray X, 2001, EUR PHYS J E, V4, P489, DOI 10.1007/s101890170104; BALASUBRAMANIAN D, 1993, J AM CHEM SOC, V115, P74, DOI 10.1021/ja00054a010; BRUNDISH DE, 1966, BIOCHEM J, V99, P546; CARRIER D, 1989, BIOCHIM BIOPHYS ACTA, V983, P100, DOI 10.1016/0005-2736(89)90385-4; Case D, 2006, AMBER 9; CHEN CH, 1981, BIOPHYS J, V36, P359, DOI 10.1016/S0006-3495(81)84737-6; CULLIS PR, 1979, BIOCHIM BIOPHYS ACTA, V559, P399, DOI 10.1016/0304-4157(79)90012-1; DAMODARAN KV, 1992, BIOCHEMISTRY-US, V31, P7656, DOI 10.1021/bi00148a029; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Domanov YA, 2006, BIOPHYS J, V91, P4427, DOI 10.1529/biophysj.106.091702; Dormann P., 2010, ROLE GLYCOLIPIDS PHO, P265; Doxastakis M, 2007, BIOPHYS J, V92, P147, DOI 10.1529/biophysj.106.089631; Ericsson CA, 2005, PHYS CHEM CHEM PHYS, V7, P2970, DOI 10.1039/b502922h; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Essmann U, 1999, BIOPHYS J, V76, P2081, DOI 10.1016/S0006-3495(99)77364-9; GARELLICALVET R, 1993, SYNTHETIC COMMUN, V23, P35, DOI 10.1080/00397919308020398; Gawrisch K., 2005, STRUCTURE BIOL MEMBR, P147; Gentilcore A, 2009, MULTISCALE COMPUTATI; Goodby JW, 2007, CHEM SOC REV, V36, P1971, DOI 10.1039/b708458g; Gurtovenko AA, 2007, J PHYS CHEM B, V111, P13554, DOI 10.1021/jp077094k; HAM JT, 1970, ACTA CRYSTALL B-STRU, VB 26, P1373, DOI 10.1107/S0567740870004132; Hamid Hairul A. A., 2014, Advanced Materials Research, V895, P111, DOI 10.4028/www.scientific.net/AMR.895.111; Hashim R, 2006, THIN SOLID FILMS, V509, P27, DOI 10.1016/j.tsf.2005.09.009; Hashim R, 2012, LIQ CRYST, V39, P1, DOI 10.1080/02678292.2011.614017; Hogberg CJ, 2007, BIOPHYS CHEM, V125, P416, DOI 10.1016/j.bpc.2006.10.005; Huang CH, 1999, BBA-REV BIOMEMBRANES, V1422, P273, DOI 10.1016/S0005-2736(99)00099-1; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jayaraman N, 2007, J MATER CHEM, V17, P2228, DOI 10.1039/b618753f; JEFFREY GA, 1992, LIQ CRYST, V12, P179, DOI 10.1080/02678299208030392; JEFFREY GA, 1991, CARBOHYD RES, V222, P47, DOI 10.1016/0008-6215(91)89005-Z; JIMENEZBARBERO J, 1995, J AM CHEM SOC, V117, P11198, DOI 10.1021/ja00150a016; Kasson PM, 2004, BIOPHYS J, V86, P3744, DOI 10.1529/biophysj.103.029652; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; KIWADA H, 1985, CHEM PHARM BULL, V33, P753; Kocherbitov V, 2004, LANGMUIR, V20, P3056, DOI 10.1021/la035553c; Kulkarni CV, 2012, NANOSCALE, V4, P5779, DOI 10.1039/c2nr31465g; LEMIEUX RU, 1989, CHEM SOC REV, V18, P347, DOI 10.1039/cs9891800347; Lewis R. N. A. H., 1992, STRUCTURE BIOL MEMBR, P73; Lipowsky R, 2013, FARADAY DISCUSS, V161, P305, DOI 10.1039/c2fd20105d; McNaught AD, 1996, PURE APPL CHEM, V68, P1919, DOI 10.1351/pac199668101919; Misran O, 2013, J PHYS CHEM B, V117, P7335, DOI 10.1021/jp401787b; Mitchell FL, 2010, BIOPHYS J, V98, pL38, DOI 10.1016/j.bpj.2010.01.006; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mizushima S-I, 1936, NATURE, V137, P945; Moore PB, 2001, BIOPHYS J, V81, P2484, DOI 10.1016/S0006-3495(01)75894-8; Nagle JF, 2001, BIOL PHYS SER, P1; Naidoo KJ, 2001, J COMPUT CHEM, V22, P445, DOI 10.1002/1096-987X(200103)22:4<445::AID-JCC1015>3.0.CO;2-P; Niemela P, 2004, BIOPHYS J, V87, P2976, DOI 10.1529/biophysj.104.048702; Niemela PS, 2006, BIOPHYS J, V90, P851, DOI 10.1529/biophysj.105.067371; Ott KH, 1996, CARBOHYD RES, V281, P11, DOI 10.1016/0008-6215(95)00320-7; Rog T, 2004, J LIPID RES, V45, P326, DOI 10.1194/jlr.M300187-JLR200; Rog T, 2007, J PHYS CHEM B, V111, P10146, DOI 10.1021/jp0730895; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sakya P, 1997, LIQ CRYST, V23, P409, DOI 10.1080/026782997208334; Shinoda W, 2003, J PHYS CHEM B, V107, P14030, DOI 10.1021/jp035493j; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; SMALL DM, 1984, J LIPID RES, V25, P1490; TARDIEU A, 1973, J MOL BIOL, V75, P711, DOI 10.1016/0022-2836(73)90303-3; Vandenbussche S, 2008, CHEM-EUR J, V14, P7570, DOI 10.1002/chem.200800247; Vill V, 2002, CURR OPIN COLLOID IN, V7, P395, DOI 10.1016/S1359-0294(02)00091-2; Yamashita I, 2004, COLLOID SURFACE A, V250, P485, DOI 10.1016/j.colsurfa.2004.04.093	68	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101110	10.1371/journal.pone.0101110	http://dx.doi.org/10.1371/journal.pone.0101110			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978205	Green Submitted, Green Published, gold			2022-12-27	WOS:000338506400080
J	Okudela, K; Tateishi, Y; Umeda, S; Mitsui, H; Suzuki, T; Saito, Y; Woo, T; Tajiri, M; Masuda, M; Miyagi, Y; Ohashi, K				Okudela, Koji; Tateishi, Yoko; Umeda, Shigeaki; Mitsui, Hideaki; Suzuki, Takeshisa; Saito, Yuichi; Woo, Tetsukan; Tajiri, Michihiko; Masuda, Munetaka; Miyagi, Yohei; Ohashi, Kenichi			Allelic Imbalance in the miR-31 Host Gene Locus in Lung Cancer - Its Potential Role in Carcinogenesis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; DOWN-REGULATION; C/EBP-ALPHA; MICRORNA MARKERS; BREAST-CANCER; EXPRESSION; MUTATIONS; ADENOCARCINOMA; METASTASIS; REGULATOR	Small non-protein coding RNA, microRNA (miR), which regulate messenger RNA levels, have recently been identified, and may play important roles in the pathogenesis of various diseases. The present study focused on miR-31 and investigated its potential involvement in lung carcinogenesis. The expression of miR-31 was altered in lung cancer cells through either the amplification or loss of the host gene locus. The strong expression of miR-31 in large cell carcinomas was attributed to the gene amplification. Meanwhile, the loss of miR-31 expression was more frequently observed in aggressive adenocarcinomas. Thus, miR-31 may play a pleiotropic role in the development of lung cancers among different histological types. To the best of our knowledge, this is the first study to show the potential causative mechanism of the altered expression of miR-31 and suggest its potentially diverse significance in the different histological types of lung cancers.	[Okudela, Koji; Tateishi, Yoko; Umeda, Shigeaki; Mitsui, Hideaki; Suzuki, Takeshisa; Saito, Yuichi; Ohashi, Kenichi] Yokohama City Univ, Grad Sch Med, Dept Pathol, Yokohama, Kanagawa 232, Japan; [Woo, Tetsukan; Masuda, Munetaka] Yokohama City Univ, Grad Sch Med, Dept Surg, Yokohama, Kanagawa 232, Japan; [Tajiri, Michihiko] Kanagawa Cardiovasc & Resp Dis Ctr Hosp, Div Gen Thorac Surg, Yokohama, Kanagawa, Japan; [Miyagi, Yohei] Kanagawa Prefectural Canc Ctr Hosp, Clin Res Inst, Yokohama, Kanagawa, Japan	Yokohama City University; Yokohama City University; Kanagawa Cardiovascular & Respiratory Center; Kanagawa Prefectural Cancer Center	Okudela, K (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Pathol, Yokohama, Kanagawa 232, Japan.	kojixok@med.yokohama-cu.ac.jp			Japanese Ministry of Education, Culture, Sports, and Science (Tokyo Japan); Yokohama Medical Facility (Yokohama, Japan)	Japanese Ministry of Education, Culture, Sports, and Science (Tokyo Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yokohama Medical Facility (Yokohama, Japan)	This work was supported by the Japanese Ministry of Education, Culture, Sports, and Science (Tokyo Japan), and by a grant from the Yokohama Medical Facility (Yokohama, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augoff K, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-5; Augoff K, 2011, MOL CANCER RES, V9, P1500, DOI 10.1158/1541-7786.MCR-11-0311; Bennett KL, 2007, CANCER RES, V67, P4657, DOI 10.1158/0008-5472.CAN-06-4793; Costa DB, 2007, LUNG CANCER, V56, P97, DOI 10.1016/j.lungcan.2006.11.023; Costa DB, 2006, LUNG CANCER, V53, P253, DOI 10.1016/j.lungcan.2006.04.011; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Gao W, 2010, BIOMED PHARMACOTHER, V64, P399, DOI 10.1016/j.biopha.2010.01.018; Guan P, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-54; Halmos B, 2002, CANCER RES, V62, P528; Hoffman PC, 2002, LUNG CANCER-J IASLC, V38, P65, DOI 10.1016/S0169-5002(02)00144-7; Jang JS, 2012, CLIN CANCER RES, V18, P3658, DOI 10.1158/1078-0432.CCR-11-2857; Masuda A, 1997, CANCER RES, V57, P4898; Meng W, 2013, CLIN CANC RES; Okudela K, 2007, PATHOL INT, V57, P664, DOI 10.1111/j.1440-1827.2007.02155.x; Okudela K, 2010, PATHOL INT, V60, P651, DOI 10.1111/j.1440-1827.2010.02580.x; Okudela K, 2009, AM J PATHOL, V175, P2646, DOI 10.2353/ajpath.2009.080571; Okudela K, 2009, AM J PATHOL, V175, P867, DOI 10.2353/ajpath.2009.080489; Pedrioli DML, 2010, MOL CELL BIOL, V30, P3620, DOI 10.1128/MCB.00185-10; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Spira A, 2004, NEW ENGL J MED, V350, P379, DOI 10.1056/NEJMra035536; Tan XG, 2011, CLIN CANCER RES, V17, P6802, DOI 10.1158/1078-0432.CCR-11-0419; Valastyan S, 2010, CANCER RES, V70, P5147, DOI 10.1158/0008-5472.CAN-10-0410; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Vosa U, 2011, GENE CHROMOSOME CANC, V50, P812, DOI 10.1002/gcc.20902; Watanabe K, 2012, INT J CANCER, V130, P2580, DOI 10.1002/ijc.26254; Woo T, 2009, LUNG CANCER, V65, P355, DOI 10.1016/j.lungcan.2008.11.020; World Medical Association, 2009, J INDIAN MED ASSOC, V107, P403; Xi SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013764; Xing LX, 2010, MODERN PATHOL, V23, P1157, DOI 10.1038/modpathol.2010.111; Yamagishi M, 2012, CANCER CELL, V21, P121, DOI 10.1016/j.ccr.2011.12.015; Yazawa T, 1999, J PATHOL, V187, P191, DOI 10.1002/(SICI)1096-9896(199901)187:2<191::AID-PATH206>3.0.CO;2-3; Yu L, 2010, INT J CANCER, V127, P2870, DOI 10.1002/ijc.25289; Zhang YY, 2010, MED ONCOL, V27, P685, DOI 10.1007/s12032-009-9269-x	34	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100581	10.1371/journal.pone.0100581	http://dx.doi.org/10.1371/journal.pone.0100581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978700	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400034
J	Pape-Zambito, D; Jiang, ZY; Wu, H; Devarajan, K; Slater, CM; Cai, KQ; Patchefsky, A; Daly, MB; Chen, XW				Pape-Zambito, Dana; Jiang, Zhengyu; Wu, Hong; Devarajan, Karthik; Slater, Carolyn M.; Cai, Kathy Q.; Patchefsky, Arthur; Daly, Mary B.; Chen, Xiaowei			Identifying a Highly-Aggressive DCIS Subgroup by Studying Intra-Individual DCIS Heterogeneity among Invasive Breast Cancer Patients	PLOS ONE			English	Article							CARCINOMA IN-SITU; DUCTAL CARCINOMA; PROGNOSTIC-SIGNIFICANCE; BIOMARKER EXPRESSION; BIOLOGICAL MARKERS; ER-ALPHA; SUBTYPES; BIOPSY; RECURRENCE; HER-2/NEU	The heterogeneity among multiple ductal carcinoma in situ (DCIS) lesions within the same patient also diagnosed with invasive ductal carcinoma (IDC) has not been well evaluated, leaving research implications of intra-individual DCIS heterogeneity yet to be explored. In this study formalin-fixed paraffin embedded sections from 36 patients concurrently diagnosed with DCIS and IDC were evaluated by immunohistochemistry. Ten DCIS lesions from each patient were then randomly selected and scored. Our results showed that expression of PR, HER2, Ki-67, and p16 varied significantly within DCIS lesions from a single patient (P<0.05 for PR; P<1x10(-8) for HER2, Ki-67 and p16). In addition, seventy-two percent of the individuals had heterogeneous expression of at least 2/6 markers. Importantly, by evaluating the expression of promising DCIS risk biomarkers (Ki-67, p53 and p16) among different DCIS subgroups classified by comparing DCIS molecular subtypes with those of adjacent normal terminal duct lobular units (TDLU) and IDC, our results suggest the existence of a highly-aggressive DCIS subgroup, which had the same molecular subtype as the adjacent IDC but not the same subtype as the adjacent normal TDLU. By using a systematic approach, our results clearly demonstrate that intra-individual heterogeneity in DCIS is very common in patients concurrently diagnosed with IDC. Our novel findings of a DCIS subpopulation with aggressive characteristics will provide a new paradigm for mechanistic studies of breast tumor progression and also have broad implications for prevention research as heterogeneous pre-invasive lesions are present in many other cancer types.	[Pape-Zambito, Dana; Jiang, Zhengyu; Slater, Carolyn M.; Cai, Kathy Q.; Chen, Xiaowei] Fox Chase Canc Ctr, Canc Epigenet Program, Philadelphia, PA 19111 USA; [Wu, Hong; Patchefsky, Arthur] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA; [Devarajan, Karthik] Fox Chase Canc Ctr, Dept Biostat & Bioinformat, Philadelphia, PA 19111 USA; [Daly, Mary B.] Fox Chase Canc Ctr, Dept Clin Genet, Philadelphia, PA 19111 USA	Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center	Chen, XW (corresponding author), Fox Chase Canc Ctr, Canc Epigenet Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Xiaowei.Chen@fccc.edu			Susan G. Komen for the Cure [KG100274]; National Institutes of Health [R01 CA138819, P30 CA006927]; Eileen Stein Jacoby Fund; Hedda L. Komins Fund; Personalized Risk and Prevention Keystone Program at Fox Chase Cancer Center; NATIONAL CANCER INSTITUTE [P30CA006927, R21CA186853, R01CA138819] Funding Source: NIH RePORTER	Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eileen Stein Jacoby Fund; Hedda L. Komins Fund; Personalized Risk and Prevention Keystone Program at Fox Chase Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was kindly supported by the Susan G. Komen for the Cure to XC (KG100274), National Institutes of Health to MD (R01 CA138819) and to the Fox Chase Cancer Center (P30 CA006927), the Eileen Stein Jacoby Fund to XC, the Hedda L. Komins Fund (to XC), as well as the Personalized Risk and Prevention Keystone Program at Fox Chase Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred DC, 2008, CLIN CANCER RES, V14, P370, DOI 10.1158/1078-0432.CCR-07-1127; BELLAMY COC, 1993, HUM PATHOL, V24, P16, DOI 10.1016/0046-8177(93)90057-N; Boughey JC, 2007, ONCOLOGIST, V12, P1276, DOI 10.1634/theoncologist.12-11-1276; Cai KQ, 2009, GYNECOL ONCOL, V114, P18, DOI 10.1016/j.ygyno.2009.03.023; Clark SE, 2011, BRIT J CANCER, V104, P120, DOI 10.1038/sj.bjc.6606021; Collins LC, 2005, CANCER-AM CANCER SOC, V103, P1778, DOI 10.1002/cncr.20979; Cornfield DB, 2004, CANCER, V100, P2317, DOI 10.1002/cncr.20260; Dumay A, 2012, INT J CANC; Edgerton ME, 2011, ANAL CELL PATHOL, V34, P247, DOI [10.1155/2011/803816, 10.3233/ACP-2011-0019]; Engels CC, 2013, BREAST CANCER RES TR, V142, P323, DOI 10.1007/s10549-013-2748-y; Erbas B, 2006, BREAST CANCER RES TR, V97, P135, DOI 10.1007/s10549-005-9101-z; Ernster VL, 2002, J NATL CANCER I, V94, P1546; FISHER ER, 1995, CANCER-AM CANCER SOC, V75, P1310, DOI 10.1002/1097-0142(19950315)75:6<1310::AID-CNCR2820750613>3.0.CO;2-G; Gasco M, 2002, BREAST CANCER RES, V4, P70, DOI 10.1186/bcr426; Hodi Z, 2007, J CLIN PATHOL, V60, P299, DOI 10.1136/jcp.2006.036665; JENSEN HM, 1976, SCIENCE, V191, P295, DOI 10.1126/science.1246614; Kerlikowske K, 2010, JNCI-J NATL CANCER I, V102, P627, DOI 10.1093/jnci/djq101; Kuerer HM, 2011, CANCER-AM CANCER SOC, V117, P39, DOI 10.1002/cncr.25399; Kuerer HM, 2009, J CLIN ONCOL, V27, P279, DOI 10.1200/JCO.2008.18.3103; Lari SA, 2011, J CANCER, V2, P232, DOI 10.7150/jca.2.232; LENNINGTON WJ, 1994, CANCER, V73, P118, DOI 10.1002/1097-0142(19940101)73:1<118::AID-CNCR2820730121>3.0.CO;2-R; Liedtke C, 2009, ANN ONCOL, V20, P1953, DOI 10.1093/annonc/mdp263; Macklin P, 2012, J THEOR BIOL, V301, P122, DOI 10.1016/j.jtbi.2012.02.002; Morrison DH, 2012, BRIT J CANCER, V107, P382, DOI 10.1038/bjc.2012.219; National Institutes of Health, 2009, STAT OF THE SCI C DI; Parton M, 2002, CLIN CANCER RES, V8, P2100; PAVELIC ZP, 1992, CANCER RES, V52, P2597; Peurala E, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3376; Provenzano E, 2003, EUR J CANCER, V39, P622, DOI 10.1016/S0959-8049(02)00666-4; Quinn CM, 1997, J CLIN PATHOL, V50, P596, DOI 10.1136/jcp.50.7.596; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Steinman S, 2007, ANN CLIN LAB SCI, V37, P127; Tang P, 2006, ANN CLIN LAB SCI, V36, P137; Vincent-Salomon A, 2008, CLIN CANCER RES, V14, P1956, DOI 10.1158/1078-0432.CCR-07-1465; WELLINGS SR, 1975, J NATL CANCER I, V55, P231; Yen TWF, 2005, J AM COLL SURGEONS, V200, P516, DOI 10.1016/j.jamcollsurg.2004.11.012	38	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100488	10.1371/journal.pone.0100488	http://dx.doi.org/10.1371/journal.pone.0100488			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978026	Green Submitted, Green Published, gold			2022-12-27	WOS:000338506400031
J	Akers, KG; Hamilton, DA				Akers, Katherine G.; Hamilton, Derek A.			Effect of High-Frequency Stimulation of the Perforant Path on Previously Acquired Spatial Memory in Rats: Influence of Memory Strength and Reactivation	PLOS ONE			English	Article							HIPPOCAMPAL SYNAPTIC-TRANSMISSION; EXTINCTION; RECOVERY	If memory depends on changes in synaptic strength, then manipulation of synaptic strength after learning should alter memory for what was learned. Here, we examined whether high frequency stimulation of the perforant path in vivo disrupts memory for a previously-learned hidden platform location in the Morris water task as well as whether this effect is modulated by memory strength or memory reactivation. We found that high frequency stimulation affected probe test performance regardless of memory strength or state of memory activation, although the precise nature of this effect differed depending on whether rats received minimal or extensive training prior to high frequency stimulation. These findings suggest that artificial manipulation of synaptic strength between the entorhinal cortex and hippocampus may destabilize memory for a previously-learned spatial location.	[Akers, Katherine G.; Hamilton, Derek A.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Hamilton, Derek A.] Univ New Mexico, Dept Neurosci, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico	Akers, KG (corresponding author), Wayne State Univ, Shiffman Med Lib, Detroit, MI 48202 USA.	katherine.akers@wayne.edu	Akers, Katherine G./A-4537-2013; Hamilton, Derek A/H-4447-2013	Akers, Katherine G./0000-0002-4578-6575; Hamilton, Derek A/0000-0001-7021-3288	Quad-L Foundation; Student Resource Allocations Committee; Graduate Studies at the University of New Mexico; National Institutes of Health [AA015356, AA019462]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015356, R01AA019462] Funding Source: NIH RePORTER	Quad-L Foundation; Student Resource Allocations Committee; Graduate Studies at the University of New Mexico; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was funded by grants from the Quad-L Foundation, Student Resource Allocations Committee, and Graduate Studies at the University of New Mexico to KGA and grants from the National Institutes of Health (AA015356 and AA019462) to DAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGER TW, 1984, SCIENCE, V224, P627, DOI 10.1126/science.6324350; Brun VH, 2001, J NEUROSCI, V21, P356, DOI 10.1523/JNEUROSCI.21-01-00356.2001; Clark RE, 2005, HIPPOCAMPUS, V15, P340, DOI 10.1002/hipo.20076; Clark RE, 2007, J NEUROSCI, V27, P6647, DOI 10.1523/JNEUROSCI.0913-07.2007; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Fyhn M, 2002, NEURON, V35, P555, DOI 10.1016/S0896-6273(02)00784-5; Kesner RP, 2007, LEARN MEMORY, V14, P771, DOI 10.1101/lm.688207; Lattal KM, 2003, BEHAV NEUROSCI, V117, P1017, DOI 10.1037/0735-7044.117.5.1017; Leutgeb S, 2007, LEARN MEMORY, V14, P745, DOI 10.1101/lm.703907; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MCNAUGHTON BL, 1986, J NEUROSCI, V6, P563; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Prados J, 2003, LEARN BEHAV, V31, P299; Prados J, 2008, LEARN BEHAV, V36, P311, DOI 10.3758/LB.36.4.311; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73	17	0	0	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100766	10.1371/journal.pone.0100766	http://dx.doi.org/10.1371/journal.pone.0100766			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971994	Green Published, gold, Green Submitted			2022-12-27	WOS:000338512200059
J	Hill-Cawthorne, GA; Hudson, LO; El Ghany, MFA; Piepenburg, O; Nair, M; Dodgson, A; Forrest, MS; Clark, TG; Pain, A				Hill-Cawthorne, Grant A.; Hudson, Lyndsey O.; El Ghany, Moataz Fouad Abd; Piepenburg, Olaf; Nair, Mridul; Dodgson, Andrew; Forrest, Matthew S.; Clark, Taane G.; Pain, Arnab			Recombinations in Staphylococcal Cassette Chromosome mec Elements Compromise the Molecular Detection of Methicillin Resistance in Staphylococcus aureus	PLOS ONE			English	Article							CATABOLIC MOBILE ELEMENT; RAPID DETECTION; COMMUNITY; VIRULENCE; STRAINS; MRSA; EVOLUTION; ASSAY; PCR; UK	Clinical laboratories are increasingly using molecular tests for methicillin-resistant Staphylococcus aureus (MRSA) screening. However, primers have to be targeted to a variable chromosomal region, the staphylococcal cassette chromosome mec (SCCmec). We initially screened 726 MRSA isolates from a single UK hospital trust by recombinase polymerase amplification (RPA), a novel, isothermal alternative to PCR. Undetected isolates were further characterised using multilocus sequence, spa typing and whole genome sequencing. 96% of our tested phenotypically MRSA isolates contained one of the six orfX-SCCmec junctions our RPA test and commercially available molecular tests target. However 30 isolates could not be detected. Sequencing of 24 of these isolates demonstrated recombinations within the SCCmec element with novel insertions that interfered with the RPA, preventing identification as MRSA. This result suggests that clinical laboratories cannot rely solely upon molecular assays to reliably detect all methicillin-resistance. The presence of significant recombinations in the SCCmec element, where the majority of assays target their primers, suggests that there will continue to be isolates that escape identification. We caution that dependence on amplification-based molecular assays will continue to result in failure to diagnose a small proportion (similar to 4%) of MRSA isolates, unless the true level of SCCmec natural diversity is determined by whole genome sequencing of a large collection of MRSA isolates.	[Hill-Cawthorne, Grant A.; El Ghany, Moataz Fouad Abd; Nair, Mridul; Pain, Arnab] King Abdullah Univ Sci & Technol KAUST, Pathogen Genom Lab, Thuwal, Saudi Arabia; [Hill-Cawthorne, Grant A.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia; [Hill-Cawthorne, Grant A.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Hudson, Lyndsey O.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Piepenburg, Olaf; Forrest, Matthew S.] TwistDx Ltd, Babraham, England; [Dodgson, Andrew] Cent Manchester Univ Hosp NHS Fdn Trust, Dept Microbiol, Manchester, Lancs, England; [Clark, Taane G.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England	King Abdullah University of Science & Technology; University of Sydney; University of Sydney; Imperial College London; University of Manchester; University of London; London School of Hygiene & Tropical Medicine	Pain, A (corresponding author), King Abdullah Univ Sci & Technol KAUST, Pathogen Genom Lab, Thuwal, Saudi Arabia.	arnab.pain@kaust.edu.sa	Hill-Cawthorne, Grant A/B-8039-2009; Clark, Taane G./AAM-2570-2020; Pain, Arnab/L-5766-2015	Hill-Cawthorne, Grant A/0000-0002-3828-5473; Clark, Taane G./0000-0001-8985-9265; Forrest, Matthew/0000-0002-2141-0303; Pain, Arnab/0000-0002-1755-2819; Abd El Ghany, Moataz/0000-0002-0020-261X	Smart Solutions for HCAI; North West Innovation service; King Abdullah University of Science and Technology; Biotechnology and Biological Sciences Research Council [BB/D52637X/1]; Wellcome Trust [096249/Z/11/B]	Smart Solutions for HCAI; North West Innovation service; King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by TwistDx. The funder provided support in the form of salaries for authors OP and MSF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section. This study was also supported by Smart Solutions for HCAI, run by TRUSTECH, The North West Innovation service, http://www.trustech.org.uk/[AD & MSF]; baseline faculty funding from the King Abdullah University of Science and Technology, www.kaust.edu.sa [GAH-C, MFM, MN & AP]; the Biotechnology and Biological Sciences Research Council, www.bbsrc.ac.uk [grant number BB/D52637X/1 to LOH, OP & MSF] and the Wellcome Trust, www.wellcome.ac.uk [grant number 096249/Z/11/B to TGC]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J MED MICROBIOL; Barbier F, 2010, J INFECT DIS, V202, P270, DOI 10.1086/653483; Bartels MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016193; Bartels MD, 2009, J CLIN MICROBIOL, V47, P1524, DOI 10.1128/JCM.02153-08; BD Diagnostics, MRSA PREV CONTR; Bischof LJ, 2009, J CLIN MICROBIOL, V47, P2281, DOI 10.1128/JCM.02256-08; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cepheid, XPERT MRSA TEST METH; Cuny C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024360; D'Souza N, 2010, J CLIN MICROBIOL, V48, P1806, DOI 10.1128/JCM.01867-09; Darzentas N, 2010, BIOINFORMATICS, V26, P2620, DOI 10.1093/bioinformatics/btq484; Diep BA, 2006, J INFECT DIS, V193, P1495, DOI 10.1086/503777; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Ellington MJ, 2010, J ANTIMICROB CHEMOTH, V65, P446, DOI 10.1093/jac/dkp448; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Francois P, 2008, EMERG INFECT DIS, V14, P304, DOI 10.3201/eid1402.070229; Francois P, 2007, J CLIN MICROBIOL, V45, P2011, DOI 10.1128/JCM.00232-07; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Green SM, 2010, J MED MICROBIOL, V59, P1084, DOI 10.1099/jmm.0.018986-0; Harris SR, 2013, LANCET INFECT DIS, V13, P130, DOI 10.1016/S1473-3099(12)70268-2; Heusser R, 2007, ANTIMICROB AGENTS CH, V51, P390, DOI 10.1128/AAC.00921-06; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Hudson LO, 2012, METHICILLIN RESISTAN; Huletsky A, 2004, J CLIN MICROBIOL, V42, P1875, DOI 10.1128/JCM.42.5.1875-1884.2004; Huletsky A, 2011, SEQUENCES DETECTION; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Joshi GS, 2011, MOL MICROBIOL, V82, P9, DOI 10.1111/j.1365-2958.2011.07809.x; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r116; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Laurent C, 2010, EUR J CLIN MICROBIOL, V29, P995, DOI 10.1007/s10096-010-0958-3; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Malhotra-Kumar S, 2008, J CLIN MICROBIOL, V46, P1577, DOI 10.1128/JCM.00326-08; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2007, CLIN MICROBIOL INFEC, V13, P236, DOI 10.1111/j.1469-0691.2006.01635.x; Montgomery CP, 2009, INFECT IMMUN, V77, P2650, DOI 10.1128/IAI.00256-09; Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204; Polisena J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-336; Ridom bioinformatics, 2004, DNA SEQ SP GEN RID; Roche, LIGHTCYCLER MRSA ADV; Rossney AS, 2007, EUR J CLIN MICROBIOL, V26, P459, DOI 10.1007/s10096-007-0303-7; Scicluna EA, 2010, EUR J CLIN MICROBIOL, V29, P163, DOI 10.1007/s10096-009-0834-1; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P3765, DOI 10.1128/AAC.00187-11; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P1896, DOI 10.1128/AAC.01756-10; Simons M, 2011, NUCLEIC ACIDS RES, V39, P7656, DOI 10.1093/nar/gkr479; Sissonen S, 2009, EUR J CLIN MICROBIOL, V28, P1271, DOI 10.1007/s10096-009-0771-z; Snyder JW, 2009, J CLIN MICROBIOL, V47, P3747, DOI 10.1128/JCM.01391-09; Swain MT, 2012, NAT PROTOC, V7, P1260, DOI 10.1038/nprot.2012.068; Tsubakishita S, 2010, ANTIMICROB AGENTS CH, V54, P4352, DOI 10.1128/AAC.00356-10; UK Health Protection Agency (HPA), 2008, INV SPEC SCREEN MRSA; Wolk DM, 2009, J CLIN MICROBIOL, V47, P758, DOI 10.1128/JCM.01714-08; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	52	48	50	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101419	10.1371/journal.pone.0101419	http://dx.doi.org/10.1371/journal.pone.0101419			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972080	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000338512200117
J	Jump, RLP; Polinkovsky, A; Hurless, K; Sitzlar, B; Eckart, K; Tomas, M; Deshpande, A; Nerandzic, MM; Donskey, CJ				Jump, Robin L. P.; Polinkovsky, Alex; Hurless, Kelly; Sitzlar, Brett; Eckart, Kevin; Tomas, Myreen; Deshpande, Abhishek; Nerandzic, Michelle M.; Donskey, Curtis J.			Metabolomics Analysis Identifies Intestinal Microbiota-Derived Biomarkers of Colonization Resistance in Clindamycin-Treated Mice	PLOS ONE			English	Article							CLOSTRIDIUM-DIFFICILE INFECTION; GERM-FREE-MICE; REAL-TIME PCR; ANTIBIOTIC-TREATMENT; BACTERIA; PRIMERS; QUANTIFICATION; SUSCEPTIBILITY; ASSOCIATION; METABOLISM	Background: The intestinal microbiota protect the host against enteric pathogens through a defense mechanism termed colonization resistance. Antibiotics excreted into the intestinal tract may disrupt colonization resistance and alter normal metabolic functions of the microbiota. We used a mouse model to test the hypothesis that alterations in levels of bacterial metabolites in fecal specimens could provide useful biomarkers indicating disrupted or intact colonization resistance after antibiotic treatment. Methods: To assess in vivo colonization resistance, mice were challenged with oral vancomycin-resistant Enterococcus or Clostridium difficile spores at varying time points after treatment with the lincosamide antibiotic clindamycin. For concurrent groups of antibiotic-treated mice, stool samples were analyzed using quantitative real-time polymerase chain reaction to assess changes in the microbiota and using non-targeted metabolic profiling. To assess whether the findings were applicable to another antibiotic class that suppresses intestinal anaerobes, similar experiments were conducted with piperacillin/tazobactam. Results: Colonization resistance began to recover within 5 days and was intact by 12 days after clindamycin treatment, coinciding with the recovery bacteria from the families Lachnospiraceae and Ruminococcaceae, both part of the phylum Firmicutes. Clindamycin treatment caused marked changes in metabolites present in fecal specimens. Of 484 compounds analyzed, 146 (30%) exhibited a significant increase or decrease in concentration during clindamycin treatment followed by recovery to baseline that coincided with restoration of in vivo colonization resistance. Identified as potential biomarkers of colonization resistance, these compounds included intermediates in carbohydrate or protein metabolism that increased (pentitols, gamma-glutamyl amino acids and inositol metabolites) or decreased (pentoses, dipeptides) with clindamycin treatment. Piperacillin/tazobactam treatment caused similar alterations in the intestinal microbiota and fecal metabolites. Conclusions: Recovery of colonization resistance after antibiotic treatment coincided with restoration of several fecal bacterial metabolites. These metabolites could provide useful biomarkers indicating intact or disrupted colonization resistance during and after antibiotic treatment.	[Jump, Robin L. P.; Donskey, Curtis J.] Cleveland Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Cleveland, OH 44106 USA; [Jump, Robin L. P.; Tomas, Myreen; Donskey, Curtis J.] Case Western Reserve Univ, Dept Med, Div Infect Dis & HIV Med, Cleveland, OH 44106 USA; [Polinkovsky, Alex; Hurless, Kelly; Sitzlar, Brett; Eckart, Kevin; Deshpande, Abhishek; Nerandzic, Michelle M.; Donskey, Curtis J.] Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH USA	Geriatric Research Education & Clinical Center; Case Western Reserve University	Jump, RLP (corresponding author), Cleveland Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Cleveland, OH 44106 USA.	robinjump@gmail.com	Jump, Robin/AAD-8364-2019		Atlantic Philanthropies, Inc.; John A. Hartford Foundation; Association of Specialty Professors; Infectious Diseases Society of America; National Foundation for Infectious Diseases; National Institutes of Health [R03-AG040722]; Veterans Affairs Merit Review Program; STERIS Corporation for Infectious Diseases; Veterans Integrated Service Network 10 Geriatric Research Education and Clinical Center (VISN 10 GRECC); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG040722] Funding Source: NIH RePORTER	Atlantic Philanthropies, Inc.; John A. Hartford Foundation; Association of Specialty Professors; Infectious Diseases Society of America; National Foundation for Infectious Diseases; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review Program(US Department of Veterans Affairs); STERIS Corporation for Infectious Diseases; Veterans Integrated Service Network 10 Geriatric Research Education and Clinical Center (VISN 10 GRECC); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	RLPJ gratefully acknowledges the T. Franklin Williams Scholarship with funding provided by Atlantic Philanthropies, Inc.; the John A. Hartford Foundation, the Association of Specialty Professors, the Infectious Diseases Society of America and the National Foundation for Infectious Diseases. This work was supported by the National Institutes of Health (R03-AG040722 to RLPJ), by the Veterans Affairs Merit Review Program (CJD), by an unrestricted grant from the STERIS Corporation for Infectious Diseases Research Support for Investigators (RLPJ) and the Veterans Integrated Service Network 10 Geriatric Research Education and Clinical Center (VISN 10 GRECC; RLPJ, BS, CJD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abujamel T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076269; Antharam VC, 2013, J CLIN MICROBIOL, V51, P2884, DOI 10.1128/JCM.00845-13; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; Bernhard AE, 2000, APPL ENVIRON MICROB, V66, P4571, DOI 10.1128/AEM.66.10.4571-4574.2000; Blaut M, 2007, J NUTR, V137, p751S, DOI 10.1093/jn/137.3.751S; Buffie CG, 2012, INFECT IMMUN, V80, P62, DOI 10.1128/IAI.05496-11; CHUNG KT, 1975, J BACTERIOL, V124, P573, DOI 10.1128/JB.124.1.573-575.1975; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Donskey CJ, 2000, NEW ENGL J MED, V343, P1925, DOI 10.1056/NEJM200012283432604; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Evans M., 2012, J POSTGENOMICS DRUG, P02; Holmes E, 2011, TRENDS MICROBIOL, V19, P349, DOI 10.1016/j.tim.2011.05.006; Jump RLP, 2007, ANTIMICROB AGENTS CH, V51, P2883, DOI 10.1128/AAC.01443-06; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Lawley TD, 2013, IMMUNOLOGY, V138, P1, DOI 10.1111/j.1365-2567.2012.03616.x; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Lerner A, 2013, ANTIMICROB AGENTS CH, V57, P1474, DOI 10.1128/AAC.01275-12; Louie TJ, 2012, CLIN INFECT DIS, V55, pS132, DOI 10.1093/cid/cis338; Loy A, 2003, NUCLEIC ACIDS RES, V31, P514, DOI 10.1093/nar/gkg016; Macfarlane GT, 2012, J AOAC INT, V95, P50, DOI 10.5740/jaoacint.SGE_Macfarlane; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nerandzic MM, 2009, J CLIN MICROBIOL, V47, P397, DOI 10.1128/JCM.01591-08; Ng KM, 2013, NATURE, V502, P96, DOI 10.1038/nature12503; Pultz NJ, 2005, ANTIMICROB AGENTS CH, V49, P3529, DOI 10.1128/AAC.49.8.3529-3532.2005; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Development Core Team, 2012, R LANG ENV STAT COMP; Reeves AE, 2012, INFECT IMMUN, V80, P3786, DOI 10.1128/IAI.00647-12; Reeves AE, 2011, GUT MICROBES, V2, P145, DOI 10.4161/gmic.2.3.16333; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; ROLFE RD, 1983, J INFECT DIS, V147, P227, DOI 10.1093/infdis/147.2.227; ROLFE RD, 1984, INFECT IMMUN, V45, P185, DOI 10.1128/IAI.45.1.185-191.1984; Romick-Rosendale LE, 2009, MAGN RESON CHEM, V47, pS36, DOI 10.1002/mrc.2511; Rowland IR, 2000, NUTR CANCER, V36, P27, DOI 10.1207/S15327914NC3601_5; SEGAL S, 1958, J CLIN INVEST, V37, P719, DOI 10.1172/JCI103658; Stiefel U, 2004, INFECT CONT HOSP EP, V25, P373, DOI 10.1086/502408; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Swann JR, 2011, J PROTEOME RES, V10, P3590, DOI 10.1021/pr200243t; Theriot CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4114; TRONICK SR, 1973, J BACTERIOL, V115, P858, DOI 10.1128/JB.115.3.858-868.1973; VANDERWAAIJ D, 1971, J HYG-CAMB, V69, P405, DOI 10.1017/S0022172400021653; Vincent C, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-18; WELLING GW, 1980, J GEN MICROBIOL, V117, P57; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Yap IKS, 2008, J PROTEOME RES, V7, P3718, DOI 10.1021/pr700864x	49	51	53	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101267	10.1371/journal.pone.0101267	http://dx.doi.org/10.1371/journal.pone.0101267			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988418	Green Published, gold			2022-12-27	WOS:000341354100073
J	Kim, YS; Lee, IS; Jung, GU; Kim, MJ; Oh, CS; Yoo, DS; Lee, WJ; Lee, E; Cha, SC; Shin, DH				Kim, Yi-Suk; Lee, In Sun; Jung, Go-Un; Kim, Myeung Ju; Oh, Chang Seok; Yoo, Dong Su; Lee, Won-Joon; Lee, Eunju; Cha, Soon Chul; Shin, Dong Hoon			Radiological Diagnosis of Congenital Diaphragmatic Hernia in 17th Century Korean Mummy	PLOS ONE			English	Article							MEDIEVAL CHILD MUMMY; BOCHDALEK HERNIA; JOSEON DYNASTY; FEMALE MUMMY; ADULT; YANGJU; EGGS; 16TH-CENTURY; TOMOGRAPHY; MANAGEMENT	Congenital diaphragmatic hernia (CDH) is a birth defect of the diaphragm resulting in pulmonary sequelae that threaten the lives of infants. In computed tomography (CT) images of a 17th century middle-aged male mummy (the Andong mummy), we observed that the abdominal contents had protruded into the right thoracic cavity through the diaphragmatic defect, accompanied by a mediastinal shift to the left. On autopsy, the defect in the right posterolateral aspect of the diaphragm was reconfirmed, as was the herniation of the abdominal organs. The herniated contents included the right lobe of the liver, the pyloric part of the stomach, a part of the greater omentum, and the right colic flexure connecting the superior part of the ascending colon and the right part of the transverse colon. Taking our CT and autopsy results together, this case was diagnosed as the Bochdalek-type CDH. Herein we make the first ever report of a CT-assisted diagnosis of a pre-modern historical case of CDH. Our results show the promising utility of this modality in investigations of mummified human remains archaeologically obtained.	[Kim, Yi-Suk; Jung, Go-Un] Ewha Womans Univ, Sch Med, Dept Anat, Seoul, South Korea; [Lee, In Sun] Seoul Natl Univ Hosp, Dept Radiol, Bundang, South Korea; [Kim, Myeung Ju] Dankook Univ, Coll Med, Dept Anat, Cheonan, South Korea; [Oh, Chang Seok; Lee, Won-Joon; Shin, Dong Hoon] Seoul Natl Univ, Coll Med, Dept Anat, Seoul, South Korea; [Oh, Chang Seok; Lee, Won-Joon; Shin, Dong Hoon] Seoul Natl Univ, Coll Med, Inst Forens Sci, Seoul, South Korea; [Yoo, Dong Su] Dankook Univ, Coll Med, Dept Diagnost Radiol, Cheonan, South Korea; [Lee, Eunju] Asan Med Ctr, Dept Internal Med, Seoul, South Korea; [Cha, Soon Chul] Dongguk Inst Cultural Properties, Taegu, South Korea	Ewha Womans University; Seoul National University (SNU); Seoul National University Hospital; Dankook University; Seoul National University (SNU); Seoul National University (SNU); Dankook University; University of Ulsan; Asan Medical Center	Shin, DH (corresponding author), Seoul Natl Univ, Coll Med, Dept Anat, Seoul, South Korea.	cuteminjae@gmail.com		Lee, Eunju/0000-0003-4612-0625	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2013R1A1A2009688]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A1A2009688). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELMAN S, 1976, J PEDIATR SURG, V11, P569, DOI 10.1016/S0022-3468(76)80015-2; Alam A, 2005, Med J Armed Forces India, V61, P284, DOI 10.1016/S0377-1237(05)80177-7; Bar-Gal GK, 2012, HEPATOLOGY, V56, P1671, DOI 10.1002/hep.25852; BERMAN L, 1988, J PEDIATR SURG, V23, P735, DOI 10.1016/S0022-3468(88)80414-7; Bianchi Enrica, 2013, J Med Case Rep, V7, P125, DOI 10.1186/1752-1947-7-125; BOCKUS HL, 1963, GASTROENTEROLOGY; Buikstra JE, 1994, ALKANSAS ARCHEOLOGIC, V44; Chang BS, 2008, INT J OSTEOARCHAEOL, V18, P624, DOI 10.1002/oa.963; Chang SW, 2010, PEDIATR NEONATOL, V51, P26, DOI 10.1016/S1875-9572(10)60006-X; Chui P. P. S., 1993, Annals Academy of Medicine Singapore, V22, P57; Colvin J, 2005, PEDIATRICS, V116, pE356, DOI 10.1542/peds.2004-2845; FINE R, 1987, NEW YORK STATE J MED, V87, P516; Friedenwald J, 1925, AM J MED SCI, V170, P263; Gaxiola A, 2009, ACTA PAEDIATR, V98, P621, DOI 10.1111/j.1651-2227.2008.01212.x; GERSZTEN E, 1976, B NEW YORK ACAD MED, V52, P601; HAINES JO, 1970, RADIOLOGY, V95, P277, DOI 10.1148/95.2.277; Haller J A Jr, 1986, Prog Pediatr Surg, V20, P252; Kadian Yogender Singh, 2009, J Indian Assoc Pediatr Surg, V14, P31, DOI 10.4103/0971-9261.44775; Kim SB, 2006, J ANAT, V209, P681, DOI 10.1111/j.1469-7580.2006.00637.x; Kumar Ameet, 2009, World J Emerg Surg, V4, P16, DOI 10.1186/1749-7922-4-16; LAMENDIN H, 1992, J FORENSIC SCI, V37, P1373; Lee IS, 2007, ANN ANAT, V189, P558, DOI 10.1016/j.aanat.2007.03.005; Lee IS, 2009, ANN ANAT, V191, P309, DOI 10.1016/j.aanat.2009.02.006; Lim DS, 2008, J ANAT, V213, P482, DOI 10.1111/j.1469-7580.2008.00955.x; Lim DS, 2010, J ANAT, V217, P67, DOI 10.1111/j.1469-7580.2010.01240.x; MUNIZAGA J, 1978, AM J PHYS ANTHROPOL, V48, P17, DOI 10.1002/ajpa.1330480104; MURDOCK AI, 1971, BIOL NEONATE, V17, P161; Murfitt J, 2003, TXB RADIOLOGY IMAGIN; Oh CS, 2011, ANN ANAT, V193, P544, DOI 10.1016/j.aanat.2011.02.005; Rout S, 2007, Hernia, V11, P359; SALACIN S, 1994, J FORENSIC SCI, V39, P1112; Seo M, 2008, J PARASITOL, V94, P467, DOI 10.1645/GE-1365.1; Seo M, 2007, J PARASITOL, V93, P589, DOI 10.1645/GE-905R3.1; Shin DH, 2003, ANN ANAT, V185, P377, DOI 10.1016/S0940-9602(03)80065-1; Shin DH, 2003, FORENSIC SCI INT, V137, P172, DOI 10.1016/S0379-0738(03)00335-9; Shin DH, 2012, J PARASITOL, V98, P1283, DOI 10.1645/GE-2920.1; Shin DH, 2013, J ARCHAEOL SCI, V40, P211, DOI 10.1016/j.jas.2012.08.009; Shin DH, 2012, J ARCHAEOL SCI, V39, P1103, DOI 10.1016/j.jas.2011.12.011; Shin DH, 2011, KOREAN J PARASITOL, V49, P323, DOI 10.3347/kjp.2011.49.3.323; Shin DH, 2010, J ANAT, V216, P329, DOI 10.1111/j.1469-7580.2009.01185.x; Shin DH, 2009, J PARASITOL, V95, P137, DOI 10.1645/GE-1588.1; Swain J M, 2001, Semin Laparosc Surg, V8, P246, DOI 10.1053/slas.2001.30408; THOMAS S, 1991, JPN J SURG, V21, P114, DOI 10.1007/BF02470876; Vagefi PA, 2009, J AM COLL SURGEONS, V209, P540, DOI 10.1016/j.jamcollsurg.2009.01.052; Venkatesh SP, 2011, INDIAN J SURG, V73, P382, DOI 10.1007/s12262-011-0332-4; Wade AD, 2012, RADIOGRAPHICS, V32, P1235, DOI 10.1148/rg.324125704; Wynn J, 2013, J PEDIATR SURG, V48, P1995, DOI 10.1016/j.jpedsurg.2013.02.041; Zhou YB, 2014, J CARDIOTHORAC SURG, V9, DOI 10.1186/1749-8090-9-31	48	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e99779	10.1371/journal.pone.0099779	http://dx.doi.org/10.1371/journal.pone.0099779			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988465	Green Published, Green Submitted, gold			2022-12-27	WOS:000341354100018
J	Sohaila, A; Tikmani, SS; Khan, IA; Atiq, H; Akhtar, ASM; Kumar, P; Kumar, K				Sohaila, Arjumand; Tikmani, Shiyam Sunder; Khan, Iqtidar Ahmed; Atiq, Huba; Akhtar, Ali Syed Muhammad; Kumar, Prem; Kumar, Kishwer			Frequency of Retinopathy of Prematurity in Premature Neonates with a Birth Weight below 1500 Grams and a Gestational Age Less than 32 Weeks: A Study from a Tertiary Care Hospital in a Lower-Middle Income Country...	PLOS ONE			English	Article							VISUAL IMPAIRMENT; RISK-FACTORS; POPULATION; INFANTS	Introduction: Retinopathy of prematurity (ROP) is a treatable cause of blindness in neonates. In Pakistan, ROP is often not recognized early because screening and treatment programs are not yet in place in most neonatal units, even in tertiary care hospitals. It is hoped that this report will help inform medical professionals of the magnitude of the problem and help to design appropriate management strategies. Objectives: The aim was to determine the frequency of ROP in premature and very low birth weight (BW) neonates (BW<1500 g and gestational age (GA) <32 weeks). Study Design: Cross-sectional study. Study Setting: Neonatal intensive care unit (NICU) of a tertiary care hospital in Karachi, Pakistan. Study Duration: From June 2009 to May 2010. Subjects and Methods: Neonates with a Birth weight (BW) <1500 g and Gestational Age (GA) <32 weeks who were admitted to the NICU and received an eye examination, or were referred for a ROP eye examination as an outpatient, were included in the study. GA was estimated from intrauterine ultrasound findings. Neonates with major congenital malformations, syndromes or congenital cataracts or tumors of the eyes, and those that died before the eye examination or did not attend the out patients department for an eye examination, were excluded. The neonatal eye examination was performed by a trained ophthalmologist at 4 or 6 weeks of age. Results: Out of 86 neonates, ROP was identified in nine neonates (10.5%) at the first eye examination. ROP was significantly associated with BW (P = 0.037), GA (P = 0.033), and chronological age (P<0.001). Conclusions: we identified ROP in 10.5% of neonates at first eye examination. Significant associations between ROP and a GA<32 weeks and a BW<1500 g were also observed. we also stress that serial follow-up of neonates at risk for ROP is important when making a final diagnosis.	[Sohaila, Arjumand; Tikmani, Shiyam Sunder; Khan, Iqtidar Ahmed; Akhtar, Ali Syed Muhammad; Kumar, Prem; Kumar, Kishwer] Aga Khan Univ Hosp, Dept Paediat & Child Hlth, Karachi, Pakistan; [Atiq, Huba] Aga Khan Univ Hosp, Dept Accid & Emergency, Karachi, Pakistan	Aga Khan University; Aga Khan University	Sohaila, A (corresponding author), Aga Khan Univ Hosp, Dept Paediat & Child Hlth, Karachi, Pakistan.	arjumand.sohaila@aku.edu	Sunder, Shiyam/N-6284-2019; Tikmani, Shiyam Sunder/AAQ-9562-2021					Aucott Susan W, 2004, J Perinatol, V24, P435; Blencowe H, 2013, PEDIATR RES, V74, P35, DOI 10.1038/pr.2013.205; Dutta Sourabh, 2004, Indian Pediatr, V41, P665; Gilbert C, 2005, PEDIATRICS, V115, pE518, DOI 10.1542/peds.2004-1180; Gilbert C, 1997, LANCET, V350, P12, DOI 10.1016/S0140-6736(97)01107-0; Gilbert C, 2008, EARLY HUM DEV, V84, P77, DOI 10.1016/j.earlhumdev.2007.11.009; Good WV, 2005, PEDIATRICS, V116, P15, DOI 10.1542/peds.2004-1413; Kim T, 2004, PAEDIATR PERINAT EP, V18, P130, DOI 10.1111/j.1365-3016.2003.00545.x; Maheshwari R, 1996, NATL MED J INDIA, V9, P211; Rahi JS, 2003, LANCET, V362, P1359, DOI 10.1016/S0140-6736(03)14631-4; Regev RH, 2003, J PEDIATR-US, V143, P186, DOI 10.1067/S0022-3476(03)00181-1; Taqui AM, 2008, J PAK MED ASS, V58; Wilkinson AR, 1996, EARLY HUM DEV, V46, P239; World Health Organization, 2000, WHO IAPB SCI M GEN; Zaw W, 2003, PEDIATRICS, V111, P1273, DOI 10.1542/peds.111.6.1273	15	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100785	10.1371/journal.pone.0100785	http://dx.doi.org/10.1371/journal.pone.0100785			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987962	Green Published, gold, Green Submitted			2022-12-27	WOS:000341354100045
J	Ycart, B; Veziris, N				Ycart, Bernard; Veziris, Nicolas			Unbiased Estimation of Mutation Rates under Fluctuating Final Counts	PLOS ONE			English	Article							LURIA-DELBRUCK DISTRIBUTION; INDIVIDUAL BACTERIAL-CELLS; MYCOBACTERIUM-TUBERCULOSIS; PROBABILITY-DISTRIBUTION; GROWTH-RATE; MUTANTS; NUMBER; POPULATIONS; RESISTANCE	Estimation methods for mutation rates (or probabilities) in Luria-Delbruck fluctuation analysis usually assume that the final number of cells remains constant from one culture to another. We show that this leads to systematically underestimate the mutation rate. Two levels of information on final numbers are considered: either the coefficient of variation has been independently estimated, or the final number of cells in each culture is known. In both cases, unbiased estimation methods are proposed. Their statistical properties are assessed both theoretically and through Monte-Carlo simulation. As an application, the data from two well known fluctuation analysis studies on Mycobacterium tuberculosis are reexamined.	[Ycart, Bernard] Univ Grenoble Alpes, Lab Jean Kuntzmann, Grenoble, France; [Ycart, Bernard] Lab Excellence TOUCAN Toulouse Canc, Toulouse, France; [Veziris, Nicolas] Univ Paris 06, Sorbonne Univ, Ctr Immunol & Malad Infect, CIMI,Team Bacteriol E13,CR7, Paris, France; [Veziris, Nicolas] INSERM, Ctr Immunol & Malad Infect, CIMI, U1135,Team Bacteriol E13, Paris, France; [Veziris, Nicolas] Hop La Pitie Salpetriere, AP HP, Lab Bacteriol Hyg, Ctr Natl Reference Mycobacteries & Resistance Myc, Paris, France; [Veziris, Nicolas] Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Inria; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Colorado State University	Ycart, B (corresponding author), Univ Grenoble Alpes, Lab Jean Kuntzmann, Grenoble, France.	Bernard.Ycart@imag.fr	veziris, nicolas/O-9783-2017	veziris, nicolas/0000-0001-5660-6544	Laboratoire d'Excellence TOUCAN (Toulouse Cancer); Fondation du Souffle; Fonds de Dotation Recherche en Sante Respiratoire	Laboratoire d'Excellence TOUCAN (Toulouse Cancer); Fondation du Souffle; Fonds de Dotation Recherche en Sante Respiratoire	Research supported by Laboratoire d'Excellence TOUCAN (Toulouse Cancer), by Fondation du Souffle and Fonds de Dotation Recherche en Sante Respiratoire. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angerer WP, 2001, J MATH BIOL, V42, P145, DOI 10.1007/s002850000053; DAVID HL, 1970, APPL MICROBIOL, V20, P810, DOI 10.1128/AEM.20.5.810-814.1970; de la Iglesia F, 2012, J VIROL, V86, P3386, DOI 10.1128/JVI.06909-11; Dewanji A, 2005, MATH BIOSCI, V197, P140, DOI 10.1016/j.mbs.2005.07.003; Dyke P, 2001, INTRO LAPLACE TRANSF; Ford CB, 2013, NAT GENET, V45, P784, DOI 10.1038/ng.2656; Foster PL, 2006, METHOD ENZYMOL, V409, P195, DOI 10.1016/S0076-6879(05)09012-9; FU JL, 1982, MUTAT RES, V105, P363, DOI 10.1016/0165-7992(82)90108-7; Gerrish P, 2008, GENETICS, V180, P1773, DOI 10.1534/genetics.108.091777; GUPTA NK, 1974, IEEE T AUTOMAT CONTR, VAC19, P774, DOI 10.1109/TAC.1974.1100714; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Hamon A, 2012, ELECTRON J STAT, V6, P1251, DOI 10.1214/12-EJS711; JAEGER G, 1995, GENETICA, V96, P217, DOI 10.1007/BF01439575; Jin JL, 2012, SCI CHINA LIFE SCI, V55, P1007, DOI 10.1007/s11427-012-4395-7; JONES ME, 1993, COMPUT BIOL MED, V23, P525, DOI 10.1016/0010-4825(93)90099-M; JONES ME, 1994, J THEOR BIOL, V166, P355, DOI 10.1006/jtbi.1994.1032; Kelly CD, 1932, J BACTERIOL, V23, P147, DOI 10.1128/JB.23.2.147-153.1932; KENDAL WS, 1988, CANCER RES, V48, P1060; Kornarova NL, 2007, MATH BIOSCI, V210, P253, DOI 10.1016/j.mbs.2007.04.007; Koutsoumanis KP, 2013, APPL ENVIRON MICROB, V79, P2294, DOI 10.1128/AEM.03629-12; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Luria SE, 1943, GENETICS, V28, P491; MA WT, 1992, J APPL PROBAB, V29, P255, DOI 10.2307/3214564; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Pope CF, 2008, ANTIMICROB AGENTS CH, V52, P1209, DOI 10.1128/AAC.01152-07; R Core Team, 2018, R LANG ENV STAT COMP; SARKAR S, 1992, GENETICA, V85, P173, DOI 10.1007/BF00120324; SARKAR S, 1991, GENETICS, V127, P257; STEWART FM, 1994, GENETICS, V137, P1139; STEWART FM, 1990, GENETICS, V124, P175; TAN WY, 1982, SIAM J APPL MATH, V42, P719, DOI 10.1137/0142050; Wasserman L., 2004, ALL STAT CONCISE COU, V26; Werngren J, 2003, J CLIN MICROBIOL, V41, P1520, DOI 10.1128/JCM.41.4.1520-1524.2003; Ycart B, 2014, J APPL PROBAB STAT, V9, P12; Ycart B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080958; Zheng Q, 2005, MATH BIOSCI, V196, P198, DOI 10.1016/j.mbs.2005.03.011; Zheng Q, 2002, MATH BIOSCI, V176, P237, DOI 10.1016/S0025-5564(02)00087-1; Zheng Q, 2007, MATH BIOSCI, V209, P500, DOI 10.1016/j.mbs.2007.03.003	38	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101434	10.1371/journal.pone.0101434	http://dx.doi.org/10.1371/journal.pone.0101434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988217	Green Published, gold			2022-12-27	WOS:000341354100087
J	Edger, PP; Tang, M; Bird, KA; Mayfield, DR; Conant, G; Mummenhoff, K; Koch, MA; Pires, JC				Edger, Patrick P.; Tang, Michelle; Bird, Kevin A.; Mayfield, Dustin R.; Conant, Gavin; Mummenhoff, Klaus; Koch, Marcus A.; Pires, J. Chris			Secondary Structure Analyses of the Nuclear rRNA Internal Transcribed Spacers and Assessment of Its Phylogenetic Utility across the Brassicaceae (Mustards)	PLOS ONE			English	Article							CONCERTED EVOLUTION; MOLECULAR SYSTEMATICS; WHOLE GENOME; DNA; ARABIDOPSIS; SEQUENCE; DIVERSIFICATION; IDENTIFICATION; DUPLICATIONS; POLYPLOIDY	The internal transcribed spacers of the nuclear ribosomal RNA gene cluster, termed ITS1 and ITS2, are the most frequently used nuclear markers for phylogenetic analyses across many eukaryotic groups including most plant families. The reasons for the popularity of these markers include: 1.) Ease of amplification due to high copy number of the gene clusters, 2.) Available cost-effective methods and highly conserved primers, 3.) Rapidly evolving markers (i.e. variable between closely related species), and 4.) The assumption (and/or treatment) that these sequences are non-functional, neutrally evolving phylogenetic markers. Here, our analyses of ITS1 and ITS2 for 50 species suggest that both sequences are instead under selective constraints to preserve proper secondary structure, likely to maintain complete self-splicing functions, and thus are not neutrally-evolving phylogenetic markers. Our results indicate the majority of sequence sites are co-evolving with other positions to form proper secondary structure, which has implications for phylogenetic inference. We also found that the lowest energy state and total number of possible alternate secondary structures are highly significantly different between ITS regions and random sequences with an identical overall length and Guanine-Cytosine (GC) content. Lastly, we review recent evidence highlighting some additional problematic issues with using these regions as the sole markers for phylogenetic studies, and thus strongly recommend additional markers and cost-effective approaches for future studies to estimate phylogenetic relationships.	[Edger, Patrick P.; Tang, Michelle; Bird, Kevin A.; Mayfield, Dustin R.; Pires, J. Chris] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Edger, Patrick P.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Conant, Gavin; Pires, J. Chris] Univ Missouri, Inst Informat, Columbia, MO USA; [Conant, Gavin] Univ Missouri, Div Anim Sci, Columbia, MO USA; [Mummenhoff, Klaus] Univ Osnabruck, Dept Biol, Osnabruck, Germany; [Koch, Marcus A.] Heidelberg Univ, Dept Biodivers & Plant Systemat, Heidelberg, Germany	University of Missouri System; University of Missouri Columbia; University of California System; University of California Berkeley; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University Osnabruck; Ruprecht Karls University Heidelberg	Pires, JC (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	piresjc@missouri.edu	Koch, Marcus A/A-4924-2011; Pires, J. Chris/O-5122-2014; Conant, Gavin/R-7022-2019; Edger, Patrick/AAP-3846-2021; Edger, Patrick/ABE-6442-2020	Koch, Marcus A/0000-0002-1693-6829; Pires, J. Chris/0000-0001-9682-2639; Conant, Gavin/0000-0002-8677-4933; Tang, Michelle/0000-0002-8779-8697; Mummenhoff, Klaus/0000-0002-8449-1593; Bird, Kevin/0000-0002-3174-3646	USA National Science Foundation [DEB 1146603, DBI 1110443, NPGI 1202793]; German Research Foundation (DFG) [KO2302-11/1]	USA National Science Foundation(National Science Foundation (NSF)); German Research Foundation (DFG)(German Research Foundation (DFG))	PPE and JCP acknowledge support from the USA National Science Foundation (DEB 1146603, DBI 1110443, and NPGI 1202793). M.A.K. acknowledged funding from the German Research Foundation (DFG) under the code KO2302-11/1. 1. http://www.nsf.gov/; 2. http://www.dfg.de/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shehbaz IA, 2012, TAXON, V61, P931, DOI 10.1002/tax.615002; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Bailey CD, 2006, MOL BIOL EVOL, V23, P2142, DOI 10.1093/molbev/msl087; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; Beilstein MA, 2006, AM J BOT, V93, P607, DOI 10.3732/ajb.93.4.607; Beilstein MA, 2010, P NATL ACAD SCI USA, V107, P18724, DOI 10.1073/pnas.0909766107; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Couvreur TLP, 2010, MOL BIOL EVOL, V27, P55, DOI 10.1093/molbev/msp202; DRON M, 1982, NUCLEIC ACIDS RES, V10, P7609, DOI 10.1093/nar/10.23.7609; Duarte JM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-61; Edwards SV, 2009, P NATL ACAD SCI USA, V106, P8799, DOI 10.1073/pnas.0904103106; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Feodorova TA, 2010, SYST BOT, V35, P811, DOI 10.1600/036364410X539880; Franzke A, 1999, THEOR APPL GENET, V98, P831, DOI 10.1007/s001220051140; Franzke A, 2011, TRENDS PLANT SCI, V16, P108, DOI 10.1016/j.tplants.2010.11.005; German DA, 2011, PLANT SYST EVOL, V294, P65, DOI 10.1007/s00606-011-0452-0; German DA, 2009, PLANT SYST EVOL, V283, P33, DOI 10.1007/s00606-009-0213-5; Goertzen LR, 2003, MOL PHYLOGENET EVOL, V29, P216, DOI 10.1016/S1055-7903(03)00094-0; Gottschling M, 2001, PLANT BIOLOGY, V3, P629, DOI 10.1055/s-2001-19371; Heenan PB, 2012, TAXON, V61, P970, DOI 10.1002/tax.615004; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; HILLIS DM, 1995, SYST BIOL, V44, P3, DOI 10.2307/2413480; Hofberger JA, 2013, GENOME BIOL EVOL, V5, P2155, DOI 10.1093/gbe/evt162; Johnson MTJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050226; Jordon-Thaden I, 2010, MOL PHYLOGENET EVOL, V55, P524, DOI 10.1016/j.ympev.2010.02.012; Kiefer M, 2014, PLANT CELL PHYSIOL, V55, DOI 10.1093/pcp/pct158; Koch M, 2001, AM J BOT, V88, P534, DOI 10.2307/2657117; Koch MA, 2003, MOL BIOL EVOL, V20, P338, DOI 10.1093/molbev/msg046; Koch MA., 2009, BIOL BREEDING CRUCIF, P1; Koch MA, 2007, MOL BIOL EVOL, V24, P63, DOI 10.1093/molbev/msl130; Koch MA, 2012, TAXON, V61, P1001, DOI 10.1002/tax.615007; Koetschan C, 2012, MOL PHYLOGENET EVOL, V63, P585, DOI 10.1016/j.ympev.2012.01.026; Kovarik A, 2005, GENETICS, V169, P931, DOI 10.1534/genetics.104.032839; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Lysak MA, 2011, PLANT GENET GENOMICS, V9, P1, DOI 10.1007/978-1-4419-7118-0_1; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Mai JC, 1997, J MOL EVOL, V44, P258, DOI 10.1007/PL00006143; Mayfield-Jones D, 2013, SEMIN CELL DEV BIOL, V24, P320, DOI 10.1016/j.semcdb.2013.02.002; Morgan JAT, 1998, J MOL EVOL, V47, P406, DOI 10.1007/PL00006398; Poczai P, 2010, MOL BIOL REP, V37, P1897, DOI 10.1007/s11033-009-9630-3; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Schranz ME, 2012, CURR OPIN PLANT BIOL, V15, P147, DOI 10.1016/j.pbi.2012.03.011; Simillion C, 2002, P NATL ACAD SCI USA, V99, P13627, DOI 10.1073/pnas.212522399; Team RDC, 2019, R LANG ENV STAT COMP; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Warwick SI, 2010, PLANT SYST EVOL, V285, P209, DOI 10.1007/s00606-010-0271-8; WENDEL JF, 1995, MOL PHYLOGENET EVOL, V4, P298, DOI 10.1006/mpev.1995.1027; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280; Wendel JF, 1998, MOL SYSTEMATICS PLAN; WHEELER WC, 1988, MOL BIOL EVOL, V5, P90	50	20	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101341	10.1371/journal.pone.0101341	http://dx.doi.org/10.1371/journal.pone.0101341			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984034	Green Published, Green Submitted, gold			2022-12-27	WOS:000339635000091
J	Mantile, F; Trovato, M; Santoni, A; Barba, P; Ottonello, S; De Berardinis, P; Prisco, A				Mantile, Francesca; Trovato, Maria; Santoni, Andrea; Barba, Pasquale; Ottonello, Simone; De Berardinis, Piergiuseppe; Prisco, Antonella			Alum and Squalene-Oil-in-Water Emulsion Enhance the Titer and Avidity of Anti-A beta Antibodies Induced by Multimeric Protein Antigen (1-11)E2, Preserving the Igg1-Skewed Isotype Distribution	PLOS ONE			English	Article							AMYLOID-BETA; ALZHEIMERS-DISEASE; MOUSE MODEL; FOLLOW-UP; IMMUNOTHERAPY; IMMUNIZATION; PATHOLOGY; PEPTIDE; DECLINE; BURDEN	The development of active immunotherapy for Alzheimer's disease (AD) requires the identification of immunogens that can ensure a high titer antibody response toward A beta, while minimizing the risks of adverse reactions. Multimeric protein (1-11)E2 induces a robust and persistent antibody response to A beta in mice, when formulated in Freund's adjuvant. The goal of this translational study was to evaluate the immunogenicity of (1-11)E2 formulated in alum (Alhydrogel 2%), or in a squalene oil-in-water emulsion (AddaVax), or without adjuvant. A IgG1-skewed isotype distribution was observed for the anti-A beta antibodies generated in mice immunized with either the non-adjuvanted or the adjuvanted vaccine, indicating that (1-11)E2 induces a Th2-like response in all tested conditions. Both Alhydrogel 2% and AddaVax enhanced the titer and avidity of the anti-A beta response elicited by (1-11)E2. We conclude that (1-11)E2 is a promising candidate for anti-A beta immunization protocols that include alum or squalene-oil-in-water emulsion, or no adjuvant.	[Mantile, Francesca; Barba, Pasquale; Prisco, Antonella] CNR, Inst Genet & Biophys, I-80125 Naples, Italy; [Trovato, Maria; De Berardinis, Piergiuseppe] CNR, Inst Prot Biochem, I-80125 Naples, Italy; [Santoni, Andrea; Ottonello, Simone] Univ Parma, Dept Life Sci, I-43100 Parma, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); University of Parma	De Berardinis, P (corresponding author), CNR, Inst Prot Biochem, I-80125 Naples, Italy.	p.deberardinis@ibp.cnr.it; prisco@igb.cnr.it	Prisco, Antonella/X-5749-2019; De Berardinis, Piergiuseppe/AAX-1049-2020; De Berardinis, Piergiuseppe/HCI-0893-2022	De Berardinis, Piergiuseppe/0000-0001-6579-1729; Trovato, Maria/0000-0002-3831-6073; Mantile, Francesca/0000-0003-2130-3388; Prisco, Antonella/0000-0001-8061-0068; Santoni, Andrea/0000-0001-7404-8099	FIRB-Merit [RBNE08LN4P_002]; CNR-MIUR Epigenetics Flagship Project [v.n.3120]; Progetto invecchiamento CNR; National Institutes of Health [R01 AI074379]; MIUR-PON [01_00117]	FIRB-Merit(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); CNR-MIUR Epigenetics Flagship Project; Progetto invecchiamento CNR; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIUR-PON(Ministry of Education, Universities and Research (MIUR))	AP acknowledges support from FIRB-Merit RBNE08LN4P_002 and CNR-MIUR Epigenetics Flagship Project v.n.3120. AP and PDB acknowledge support from Progetto invecchiamento CNR. PDB and MT acknowledge support from grant National Institutes of Health R01 AI074379 and MIUR-PON 01_00117. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Basi GS, 2010, J BIOL CHEM, V285, P3417, DOI 10.1074/jbc.M109.045187; Beeg M, 2011, ANAL BIOCHEM, V411, P297, DOI 10.1016/j.ab.2010.12.032; Benilova I, NAT NEUROSCI, V15, P349; Brody DL, 2008, ANNU REV NEUROSCI, V31, P175, DOI 10.1146/annurev.neuro.31.060407.125529; Castiglione F, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/842329; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; Esposito M, 2008, MOL IMMUNOL, V45, P1056, DOI 10.1016/j.molimm.2007.07.023; Golde TE, EXP NEUROL, V223, P252; Golde TE, 2009, CNS NEUROL DISORD-DR, V8, P31, DOI 10.2174/187152709787601830; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Jones LS, 2005, J BIOL CHEM, V280, P13406, DOI 10.1074/jbc.M500687200; Lemere CA, 2010, NAT REV NEUROL, V6, P108, DOI 10.1038/nrneurol.2009.219; Levites Y, 2006, J CLIN INVEST, V116, P193, DOI 10.1172/JCI25410; Mantile F, 2011, IMMUNOL CELL BIOL, V89, P604, DOI 10.1038/icb.2010.134; Matheus S, 2005, J CLIN MICROBIOL, V43, P2793, DOI 10.1128/JCM.43.6.2793-2797.2005; Moretto N, 2007, J BIOL CHEM, V282, P11436, DOI 10.1074/jbc.M609690200; Pride M, 2008, NEURODEGENER DIS, V5, P194, DOI 10.1159/000113700; Prisco Antonella, 2012, Biomol Concepts, V3, P479, DOI 10.1515/bmc-2012-0010; Prisco A, 2012, INT J MOL SCI, V13, P5179, DOI 10.3390/ijms13045179; Serrano-Pozo A, 2010, BRAIN, V133, P1312, DOI 10.1093/brain/awq056; STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0; Vellas B, 2009, CURR ALZHEIMER RES, V6, P144, DOI 10.2174/156720509787602852; Weiner HL, 2006, NAT REV IMMUNOL, V6, P404, DOI 10.1038/nri1843	28	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101474	10.1371/journal.pone.0101474	http://dx.doi.org/10.1371/journal.pone.0101474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983378	Green Submitted, gold, Green Published			2022-12-27	WOS:000339635000114
J	Tian, JW; Lei, ZC; Qiu, P; Wang, L; Tian, YQ				Tian Jiewei; Lei Zuchao; Qiu Peng; Wang Lei; Tian Yongqiang			Purification and Characterization of a Cold-Adapted Lipase from Oceanobacillus Strain PT-11	PLOS ONE			English	Article							SP-NOV; EXTREMOPHILES; ENZYMES	We isolated a moderately halophilic lipase-producing bacterium from the saline soil. Based on the morphological, physiological, chemotaxonomic and phylogenetic analysis, the isolate PT-11 was postulated to be a novel species identified as Oceanobacillus rekensis PT-11. The lipase was purified 2.50-fold by Q-Sepharose FF and SP-Sepharose FF chromatography and its molecular mass was estimated to be 23.5 kDa by SDS-PAGE. It was highly active over the broad temperature ranging from 10 to 35 degrees C and showed up to 80% of the maximum activity at 10 degrees C indicating the lipase to be a typical cold-adapted enzyme. The enzyme activity was slightly enhanced by Na+, Li+ and K+. Incubation with detergents, such as Tween-20 and Tween-80, slightly inhibited the enzyme activity; while Triton X-100decreased the enzyme activity. The enzyme was fairly stable in the presence of long-chain alcohols but was highly denatured in hydrophilic solvents such as acetone or short-chain alcohols (C1-C3).	[Tian Jiewei; Tian Yongqiang] Sichuan Univ, Coll Light Ind Text & Food Engn, Key Lab Leather Chem & Engn, Chengdu 610064, Peoples R China; [Tian Jiewei; Lei Zuchao; Qiu Peng; Wang Lei] Sichuan Univ, Coll Chem Engn, Dept Pharmaceut & Biol Engn, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University	Tian, YQ (corresponding author), Sichuan Univ, Coll Light Ind Text & Food Engn, Key Lab Leather Chem & Engn, Chengdu 610064, Peoples R China.	yqtian@scu.edu.cn			Fundermental Research Funds for the Central University	Fundermental Research Funds for the Central University	This work was supported by "the Fundermental Research Funds for the Central University". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cui XL, 2001, INT J SYST EVOL MICR, V51, P357, DOI 10.1099/00207713-51-2-357; de Champdore M, 2007, J R SOC INTERFACE, V4, P183, DOI 10.1098/rsif.2006.0174; Demirjian DC, 2001, CURR OPIN CHEM BIOL, V5, P144, DOI 10.1016/S1367-5931(00)00183-6; EZAKI T, 1989, INT J SYST BACTERIOL, V39, P224, DOI 10.1099/00207713-39-3-224; Florczak T, 2013, ENZYME MICROB TECH, V53, P18, DOI 10.1016/j.enzmictec.2013.03.021; Gerday C, 1997, BBA-PROTEIN STRUCT M, V1342, P119, DOI 10.1016/S0167-4838(97)00093-9; Hasan F, 2006, ENZYME MICROB TECH, V39, P235, DOI 10.1016/j.enzmictec.2005.10.016; Joseph B, 2007, BIOTECHNOL MOL BIOL, V2, P039; Kapoor M, 2012, PROCESS BIOCHEM, V47, P555, DOI 10.1016/j.procbio.2012.01.011; Kim YO, 2012, J BIOSCI BIOENG, V114, P589, DOI 10.1016/j.jbiosc.2012.06.013; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lentzen G, 2006, APPL MICROBIOL BIOT, V72, P623, DOI 10.1007/s00253-006-0553-9; Lokendra Kumar, 2011, Biotechnology, V10, P121; Patel RN, 2002, ENZYME MICROB TECH, V31, P804, DOI 10.1016/S0141-0229(02)00186-2; Pikuta EV, 2007, CRIT REV MICROBIOL, V33, P183, DOI 10.1080/10408410701451948; Podar M, 2006, CURR OPIN BIOTECH, V17, P250, DOI 10.1016/j.copbio.2006.05.002; Romero CM, 2012, BIOCATAL AGRIC BIOTE, V1, P25, DOI 10.1016/j.bcab.2011.08.013; Ryu HS, 2006, APPL MICROBIOL BIOT, V70, P321, DOI 10.1007/s00253-005-0058-y; Saxena RK, 2003, J MICROBIOL METH, V52, P1, DOI 10.1016/S0167-7012(02)00161-6; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tesch C, 1996, J BACTERIOL, V178, P1858, DOI 10.1128/jb.178.7.1858-1865.1996; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; WINKLER UK, 1979, J BACTERIOL, V138, P663, DOI 10.1128/JB.138.3.663-670.1979; Yang JY, 2010, INT J SYST EVOL MICR, V60, P2409, DOI 10.1099/ijs.0.016295-0	27	10	13	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101343	10.1371/journal.pone.0101343	http://dx.doi.org/10.1371/journal.pone.0101343			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984141	Green Published, Green Submitted, gold			2022-12-27	WOS:000339635000092
J	Epel, ES; Tomiyama, AJ; Mason, AE; Laraia, BA; Hartman, W; Ready, K; Acree, M; Adam, TC; St Jeor, S; Kessler, D				Epel, Elissa S.; Tomiyama, A. Janet; Mason, Ashley E.; Laraia, Barbara A.; Hartman, William; Ready, Karen; Acree, Michael; Adam, Tanja C.; St Jeor, Sachiko; Kessler, David			The Reward-Based Eating Drive Scale: A Self-Report Index of Reward-Based Eating	PLOS ONE			English	Article							FOOD ADDICTION; GRAY-MATTER; BODY-WEIGHT; PSYCHOLOGICAL STRESS; PHYSICAL-ACTIVITY; OBESITY; QUESTIONNAIRE; MORTALITY; CRITERIA; VOLUMES	Why are some individuals more vulnerable to persistent weight gain and obesity than are others? Some obese individuals report factors that drive overeating, including lack of control, lack of satiation, and preoccupation with food, which may stem from reward-related neural circuitry. These are normative and common symptoms and not the sole focus of any existing measures. Many eating scales capture these common behaviors, but are confounded with aspects of dysregulated eating such as binge eating or emotional overeating. Across five studies, we developed items that capture this reward-based eating drive (RED). Study 1 developed the items in lean to obese individuals (n = 327) and examined changes in weight over eight years. In Study 2, the scale was further developed and expert raters evaluated the set of items. Study 3 tested psychometric properties of the final 9 items in 400 participants. Study 4 examined psychometric properties and race invariance (n = 80 women). Study 5 examined psychometric properties and age/gender invariance (n = 381). Results showed that RED scores correlated with BMI and predicted earlier onset of obesity, greater weight fluctuations, and greater overall weight gain over eight years. Expert ratings of RED scale items indicated that the items reflected characteristics of reward-based eating. The RED scale evidenced high internal consistency and invariance across demographic factors. The RED scale, designed to tap vulnerability to reward-based eating behavior, appears to be a useful brief tool for identifying those at higher risk of weight gain over time. Given the heterogeneity of obesity, unique brief profiling of the reward-based aspect of obesity using a self-report instrument such as the RED scale may be critical for customizing effective treatments in the general population.	[Epel, Elissa S.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94117 USA; [Epel, Elissa S.; Tomiyama, A. Janet; Laraia, Barbara A.] UCSF Ctr Obes Assessment Study & Treatment, San Francisco, CA USA; [Tomiyama, A. Janet] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Mason, Ashley E.; Acree, Michael] UCSF Osher Ctr Integrat Med, San Francisco, CA USA; [Laraia, Barbara A.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Hartman, William; Ready, Karen] MD Weight Management Program, San Francisco, CA USA; [Adam, Tanja C.] Maastricht Univ, Dept Human Biol, Maastricht, Netherlands; [St Jeor, Sachiko] Univ Nevada, Sch Med, Div Endocrinol Nutr & Metab, Reno, NV 89557 USA; [Kessler, David] UCSF Sch Med, Dept Pediat, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California System; University of California Berkeley; Maastricht University; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of California System; University of California San Francisco	Epel, ES (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94117 USA.	eepel@lppi.ucsf.edu; tomiyama@psych.ucla.edu	Laraia, Barbara/GXG-1829-2022		UC Berkeley Population Center; University of the California Office of the President, Multi-campus Research Programs and Initiatives [142691]; National Center for Complementary & Integrative Health [T32AT003997] Funding Source: NIH RePORTER	UC Berkeley Population Center; University of the California Office of the President, Multi-campus Research Programs and Initiatives(University of California System); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was funded by the UC Berkeley Population Center. Funding for this project was provided by the University of the California Office of the President, Multi-campus Research Programs and Initiatives Grant 142691 to the Stress, Environment and Weight Center at UCSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S. H., 2013, NEUROSCIENCE 21 CENT, P2833; [Anonymous], CONFIRMATORY FACTOR; Blair SN, 2009, BRIT J SPORT MED, V43, P1; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Brown I, 2006, J ADV NURS, V53, P221, DOI 10.1111/j.1365-2648.2006.03718.x; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cappelleri JC, 2009, INT J OBESITY, V33, P913, DOI 10.1038/ijo.2009.107; Cappelleri JC, 2003, EXPLORATORY FACTOR A, P343; Carr Katelyn A, 2011, Curr Drug Abuse Rev, V4, P190; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Church TS, 2004, DIABETES CARE, V27, P83, DOI 10.2337/diacare.27.1.83; Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685; Corsica JA, 2010, CURR OPIN GASTROEN, V26, P165, DOI 10.1097/MOG.0b013e328336528d; Corsica Joyce A, 2008, Eat Behav, V9, P447, DOI 10.1016/j.eatbeh.2008.07.004; Curioni C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006062.pub2; Czernichow S, 2011, OBES REV, V12, P680, DOI 10.1111/j.1467-789X.2011.00879.x; Daubenmier J, 2014, APPETITE, V74, P92, DOI 10.1016/j.appet.2013.11.014; Davis C, 2011, APPETITE, V57, P711, DOI 10.1016/j.appet.2011.08.017; Dimsdale JE, 2008, J AM COLL CARDIOL, V51, P1237, DOI 10.1016/j.jacc.2007.12.024; Drewnowski A, 2005, AM J CLIN NUTR, V82, p265S, DOI 10.1093/ajcn/82.1.265S; Ebrahim S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001561.pub3; Ender P, 2006, FAPARA COMMAND COMPU; Field AE, 1999, AM J EPIDEMIOL, V150, P573, DOI 10.1093/oxfordjournals.aje.a010055; Flint AJ, 2014, AM J CLIN NUTR AJCN; Fogelholm M, 2010, OBES REV, V11, P202, DOI 10.1111/j.1467-789X.2009.00653.x; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Fontaine KR, 1998, ARCH FAM MED, V7, P381, DOI 10.1001/archfami.7.4.381; Fontaine KR, 2001, J WOMEN HEALTH GEN-B, V10, P463, DOI 10.1089/152460901300233939; Franklin TR, 2002, BIOL PSYCHIAT, V51, P134, DOI 10.1016/S0006-3223(01)01269-0; Gaser C, 2003, J NEUROSCI, V23, P9240; Gearhardt A, 2013, PRELIMINARY VALIDATI; Gearhardt AN, 2011, ARCH GEN PSYCHIAT, V68, P808, DOI 10.1001/archgenpsychiatry.2011.32; Gearhardt AN, 2009, J ADDICT MED, V3, P1, DOI 10.1097/ADM.0b013e318193c993; GORMALLY J, 1982, ADDICT BEHAV, V7, P47, DOI 10.1016/0306-4603(82)90024-7; Gregorich SE, 2006, MED CARE, V44, pS78, DOI 10.1097/01.mlr.0000245454.12228.8f; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kessler D.A., 2010, END OVEREATING TAKIN; Kittur A., 2008, CROWDSOURCING USER S; Lowe MR, 2009, APPETITE, V53, P114, DOI 10.1016/j.appet.2009.05.016; Luders E, 2009, NEUROIMAGE, V45, P672, DOI 10.1016/j.neuroimage.2008.12.061; Maguire EA, 2006, HIPPOCAMPUS, V16, P1091, DOI 10.1002/hipo.20233; Mann T, 2007, AM PSYCHOL, V62, P220, DOI 10.1037/0003-066X.62.3.220; MORRISON JA, 1992, AM J PUBLIC HEALTH, V82, P1613; Moss M., 2013, SALT SUGAR FAT FOOD; Nijs IMT, 2007, APPETITE, V49, P38, DOI 10.1016/j.appet.2006.11.001; Pelchat ML, 2009, J NUTR, V139, P620, DOI 10.3945/jn.108.097816; PFEFFERBAUM A, 1992, ALCOHOL CLIN EXP RES, V16, P1078, DOI 10.1111/j.1530-0277.1992.tb00702.x; Pfefferbaum A, 1998, ARCH GEN PSYCHIAT, V55, P905, DOI 10.1001/archpsyc.55.10.905; Sim ME, 2007, NEUROPSYCHOPHARMACOL, V32, P2229, DOI 10.1038/sj.npp.1301346; Stice E, 2010, J NEUROSCI, V30, P13105, DOI 10.1523/JNEUROSCI.2105-10.2010; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; van Dillen SME, 2013, PATIENT EDUC COUNS, V90, P155, DOI 10.1016/j.pec.2012.10.022; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T; Velicer W.F., 2000, PROBLEMS SOLUTIONS H, P41, DOI [10.1007/978-1-4615-4397-8_3, DOI 10.1007/978-1-4615-4397-8_3]; Volkow ND, 2013, OBES REV, V14, P2, DOI 10.1111/j.1467-789X.2012.01031.x; Volkow N D, 2012, Curr Top Behav Neurosci, V11, P1, DOI 10.1007/7854_2011_169; Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001; Wadden TA, 2002, J CONSULT CLIN PSYCH, V70, P510, DOI 10.1037//0022-006X.70.3.510; Yokum S, 2012, INT J OBESITY, V36, P656, DOI 10.1038/ijo.2011.175; ZIPURSKY RB, 1992, ARCH GEN PSYCHIAT, V49, P195	60	47	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101350	10.1371/journal.pone.0101350	http://dx.doi.org/10.1371/journal.pone.0101350			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK5ZO	24979216	Green Published, gold			2022-12-27	WOS:000338506400120
J	Iversen, M; Fauchald, P; Langeland, K; Ims, RA; Yoccoz, NG; Brathen, KA				Iversen, Marianne; Fauchald, Per; Langeland, Knut; Ims, Rolf A.; Yoccoz, Nigel G.; Brathen, Kari Anne			Phenology and Cover of Plant Growth Forms Predict Herbivore Habitat Selection in a High Latitude Ecosystem	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; 1ST-PASSAGE TIME; DIET SELECTION; FORAGE QUALITY; REINDEER; SCALE; VEGETATION; FEEDBACKS; DYNAMICS; CARIBOU	The spatial and temporal distribution of forage quality is among the most central factors affecting herbivore habitat selection. Yet, for high latitude areas, forage quantity has been found to be more important than quality. Studies on large ungulate foraging patterns are faced with methodological challenges in both assessing animal movements at the scale of forage distribution, and in assessing forage quality with relevant metrics. Here we use first-passage time analyses to assess how reindeer movements relate to forage quality and quantity measured as the phenology and cover of growth forms along reindeer tracks. The study was conducted in a high latitude ecosystem dominated by low-palatable growth forms. We found that the scale of reindeer movement was season dependent, with more extensive area use as the summer season advanced. Small-scale movement in the early season was related to selection for younger stages of phenology and for higher abundances of generally phenologically advanced palatable growth forms (grasses and deciduous shrubs). Also there was a clear selection for later phenological stages of the most dominant, yet generally phenologically slow and low-palatable growth form (evergreen shrubs). As the summer season advanced only quantity was important, with selection for higher quantities of one palatable growth form and avoidance of a low palatable growth form. We conclude that both forage quality and quantity are significant predictors to habitat selection by a large herbivore at high latitude. The early season selectivity reflected that among dominating low palatability growth forms there were palatable phenological stages and palatable growth forms available, causing herbivores to be selective in their habitat use. The diminishing selectivity and the increasing scale of movement as the season developed suggest a response by reindeer to homogenized forage availability of low quality.	[Iversen, Marianne; Ims, Rolf A.; Yoccoz, Nigel G.; Brathen, Kari Anne] UiT Arctic Univ Norway, Dept Arct & Marine Biol, Tromso, Norway; [Fauchald, Per; Langeland, Knut] Norwegian Inst Nat Res NINA, Dept Arct Ecol, Fram Ctr, Tromso, Norway	UiT The Arctic University of Tromso; Norwegian Institute Nature Research	Brathen, KA (corresponding author), UiT Arctic Univ Norway, Dept Arct & Marine Biol, Tromso, Norway.	kari.brathen@uit.no	Bråthen, Kari Anne/AAN-4666-2020; Fauchald, Per/AAV-4242-2021; Yoccoz, Nigel/C-8561-2014	Bråthen, Kari Anne/0000-0003-0942-1074; Yoccoz, Nigel/0000-0003-2192-1039	Sami University College; Norwegian Research Council	Sami University College; Norwegian Research Council(Research Council of NorwayEuropean Commission)	This study was supported by a grant to Marianne Iversen from the Sami University College and is a contribution from the "Ecosystem Finnmark" project, financed by Norwegian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBON SD, 1992, OIKOS, V65, P502, DOI 10.2307/3545568; Ballesteros M, 2012, J ZOOL, V287, P34, DOI 10.1111/j.1469-7998.2011.00883.x; Bardsen BJ, 2008, ECOLOGY, V89, P829, DOI 10.1890/07-0414.1; Brathen KA, 2004, OIKOS, V105, P461, DOI 10.1111/j.0030-1299.2004.12926.x; Brathen KA, 2007, ECOSYSTEMS, V10, P773, DOI 10.1007/s10021-007-9058-3; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Chapin FS, 1996, J VEG SCI, V7, P347, DOI 10.2307/3236278; Cornelissen JHC, 2004, FUNCT ECOL, V18, P779, DOI 10.1111/j.0269-8463.2004.00900.x; DEMMENT MW, 1985, AM NAT, V125, P641, DOI 10.1086/284369; Dorrepaal E, 2007, J ECOL, V95, P1167, DOI 10.1111/j.1365-2745.2007.01294.x; Dorrepaal E, 2007, OECOLOGIA, V151, P251, DOI 10.1007/s00442-006-0580-3; Farbrot H, 2008, P 9 INT C PERM U AL, P427; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Fauchald P, 2006, OECOLOGIA, V149, P383, DOI 10.1007/s00442-006-0463-7; FRYXELL JM, 1991, AM NAT, V138, P478, DOI 10.1086/285227; Gaillard JM, 2010, PHILOS T R SOC B, V365, P2255, DOI 10.1098/rstb.2010.0085; Grime J. P., 2001, PLANT STRATEGIES VEG; Hagemoen RIM, 2002, J ANIM ECOL, V71, P883, DOI 10.1046/j.1365-2656.2002.00654.x; Hamer KC, 2009, J ANIM ECOL, V78, P880, DOI 10.1111/j.1365-2656.2009.01549.x; Hanley TA, 1997, OIKOS, V79, P209, DOI 10.2307/3546006; Hansen BB, 2009, POLAR BIOL, V32, P971, DOI 10.1007/s00300-009-0597-2; Hansen BB, 2009, OIKOS, V118, P859, DOI 10.1111/j.1600-0706.2009.17098.x; Inga Berit, 2007, Rangifer, V27, P93; Inga Berit, 2012, Rangifer, V32, P1; Iversen M, 2009, J VEG SCI, V20, P903, DOI 10.1111/j.1654-1103.2009.01088.x; JEFFERIES RL, 1994, OIKOS, V71, P193, DOI 10.2307/3546267; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; KIRKERUD K, 1989, OBJECT ORIENTED PROG; KLEIN D R, 1990, Rangifer, P123; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; KUDO G, 1991, ARCTIC ALPINE RES, V23, P436, DOI 10.2307/1551685; Lavorel S, 2012, J ECOL, V100, P128, DOI 10.1111/j.1365-2745.2011.01914.x; Manly B.F.J., 2002, RESOURCE SELECTION A; Marell A, 2006, BASIC APPL ECOL, V7, P13, DOI 10.1016/j.baae.2005.04.005; Marell A, 2002, CAN J ZOOL, V80, P854, DOI 10.1139/Z02-061; MCARTHUR C, 1993, CAN J ZOOL, V71, P2236, DOI 10.1139/z93-314; Meir P, 2006, TRENDS ECOL EVOL, V21, P254, DOI 10.1016/j.tree.2006.03.005; Miller-Rushing AJ, 2008, ECOLOGY, V89, P332, DOI 10.1890/07-0068.1; Moen A., 1998, NATL ATLAS NORWAY VE; Mysterud A, 2000, J ANIM ECOL, V69, P959, DOI 10.1046/j.1365-2656.2000.00454.x; Mysterud A, 2001, J ANIM ECOL, V70, P915, DOI 10.1046/j.0021-8790.2001.00559.x; Nilsson MC, 1998, OIKOS, V81, P6, DOI 10.2307/3546462; Noble IR, 1996, J VEG SCI, V7, P329, DOI 10.2307/3236276; Palmer SCF, 2003, ECOLOGY, V84, P2877, DOI 10.1890/02-0245; Pettorelli N, 2003, OECOLOGIA, V137, P363, DOI 10.1007/s00442-003-1364-7; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; Pinaud D, 2008, J APPL ECOL, V45, P91, DOI 10.1111/j.1365-2664.2007.01370.x; Pinheiro JC, 2000, LINEAR MIXED EFFECTS; Post E, 1999, ECOLOGY, V80, P1322, DOI 10.1890/0012-9658(1999)080[1322:CVPPAN]2.0.CO;2; Post E, 2003, CAN J ZOOL, V81, P1709, DOI 10.1139/Z03-172; Rettie WJ, 2000, ECOGRAPHY, V23, P466, DOI 10.1034/j.1600-0587.2000.230409.x; SENFT RL, 1987, BIOSCIENCE, V37, P789, DOI 10.2307/1310545; Shevtsova A, 1997, OIKOS, V78, P440, DOI 10.2307/3545606; Skarin A, 2014, POLAR BIOL; Skjenneberg S., 1968, REINDRIFTEN DENS NAT; SKOGLAND T, 1989, OIKOS, V55, P101, DOI 10.2307/3565879; SKOGLAND T, 1980, J ANIM ECOL, V49, P81, DOI 10.2307/4278; SKOGLAND T, 1984, HOLARCTIC ECOL, V7, P345; TRUDELL J, 1981, J APPL ECOL, V18, P63, DOI 10.2307/2402479; Van der Wal R, 2000, OECOLOGIA, V123, P108, DOI 10.1007/s004420050995; Van Soest PJ, 1994, NUTR ECOLOGY RUMINAN, P7; Warenberg K., 1997, FLORA REINBEITELAND; WHITE RG, 1983, OIKOS, V40, P377, DOI 10.2307/3544310; WHITE RG, 1980, ARCTIC ALPINE RES, V12, P511, DOI 10.2307/1550498; Wielgolaski F, 1975, PLANTS MICROORGANISM, P94; WIENS JA, 1993, OIKOS, V66, P369, DOI 10.2307/3544931; Wintle BC, 2013, METHODS ECOL EVOL, V4, P53, DOI 10.1111/j.2041-210x.2012.00254.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wookey PA, 2009, GLOBAL CHANGE BIOL, V15, P1153, DOI 10.1111/j.1365-2486.2008.01801.x; Zweifel-Schielly B, 2009, ECOGRAPHY, V32, P103, DOI 10.1111/j.1600-0587.2008.05178.x	70	23	24	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100780	10.1371/journal.pone.0100780	http://dx.doi.org/10.1371/journal.pone.0100780			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972188	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000338512200061
J	Trivodaliev, K; Bogojeska, A; Kocarev, L				Trivodaliev, Kire; Bogojeska, Aleksandra; Kocarev, Ljupco			Exploring Function Prediction in Protein Interaction Networks via Clustering Methods	PLOS ONE			English	Article							MODULAR ORGANIZATION; RANDOM-WALKS; COMPLEXES; YEAST; ALGORITHM; TOPOLOGY; DATABASE	Complex networks have recently become the focus of research in many fields. Their structure reveals crucial information for the nodes, how they connect and share information. In our work we analyze protein interaction networks as complex networks for their functional modular structure and later use that information in the functional annotation of proteins within the network. We propose several graph representations for the protein interaction network, each having different level of complexity and inclusion of the annotation information within the graph. We aim to explore what the benefits and the drawbacks of these proposed graphs are, when they are used in the function prediction process via clustering methods. For making this cluster based prediction, we adopt well established approaches for cluster detection in complex networks using most recent representative algorithms that have been proven as efficient in the task at hand. The experiments are performed using a purified and reliable Saccharomyces cerevisiae protein interaction network, which is then used to generate the different graph representations. Each of the graph representations is later analysed in combination with each of the clustering algorithms, which have been possibly modified and implemented to fit the specific graph. We evaluate results in regards of biological validity and function prediction performance. Our results indicate that the novel ways of presenting the complex graph improve the prediction process, although the computational complexity should be taken into account when deciding on a particular approach.	[Trivodaliev, Kire; Bogojeska, Aleksandra; Kocarev, Ljupco] Fac Comp Sci & Engn, Dept Intelligent Syst, Skopje, North Macedonia; [Kocarev, Ljupco] Macedonian Acad Sci & Arts, Skopje, North Macedonia		Kocarev, L (corresponding author), Fac Comp Sci & Engn, Dept Intelligent Syst, Skopje, North Macedonia.	lkocarev@manu.edu.mk	Bogojeska, Aleksandra/K-1787-2014; Kocarev, Ljupco/AAS-3002-2020	Bogojeska, Aleksandra/0000-0002-6668-1000; 				Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; [Anonymous], [No title captured]; Arnau V, 2005, BIOINFORMATICS, V21, P364, DOI 10.1093/bioinformatics/bti021; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asur S, 2007, BIOINFORMATICS, V23, pI29, DOI 10.1093/bioinformatics/btm212; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bader GD, 2000, BIOINFORMATICS, V16, P465, DOI 10.1093/bioinformatics/16.5.465; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Blatt M, 1996, PHYS REV LETT, V76, P3251, DOI 10.1103/PhysRevLett.76.3251; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r23; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chen JC, 2006, BIOINFORMATICS, V22, P2283, DOI 10.1093/bioinformatics/btl370; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Dong D, 2007, CHINESE SCI BULL, V52, P2938, DOI 10.1007/s11434-007-0454-z; Dunn R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-39; Dwight SS, 2002, NUCLEIC ACIDS RES, V30, P69, DOI 10.1093/nar/30.1.69; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Evans TS, 2010, EUR PHYS J B, V77, P265, DOI 10.1140/epjb/e2010-00261-8; Evans TS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016105; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Friedel CC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-519; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD436, DOI 10.1093/nar/gkj003; Hakes L, 2007, P NATL ACAD SCI USA, V104, P7999, DOI 10.1073/pnas.0609962104; Hart GT, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-120; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; King AD, 2004, BIOINFORMATICS, V20, P3013, DOI 10.1093/bioinformatics/bth351; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lambiotte Renaud, 2010, 2010 8th International Symposium on Modeling and Optimization in Mobile, Ad Hoc and Wireless Networks (WiOpt), P546; Lambiotte R, 2014, IEEE T NETW SCI ENG, V1, P76, DOI 10.1109/TNSE.2015.2391998; LANCICHINETTI A, 2009, PHYS REV E 2, V80, DOI DOI 10.1103/PHYSREVE.80.056117; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Letovsky S, 2003, BIOINFORMATICS, V19, pi197, DOI 10.1093/bioinformatics/btg1026; Luo F, 2007, BIOINFORMATICS, V23, P207, DOI 10.1093/bioinformatics/btl562; Mukhopadhyay A, 2012, MOL BIOSYST, V8, P3036, DOI 10.1039/c2mb25302j; Newman M.E.J., 2004, PHYS REV E, V70; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Przulj N, 2004, BIOINFORMATICS, V20, P340, DOI 10.1093/bioinformatics/btg415; Punta M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000160; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Sen TZ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-355; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Yu GX, 2005, PROTEINS, V61, P907, DOI 10.1002/prot.20652; Zhang YJ, 2013, IEEE ACM T COMPUT BI, V10, P729, DOI 10.1109/TCBB.2013.86	58	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e99755	10.1371/journal.pone.0099755	http://dx.doi.org/10.1371/journal.pone.0099755			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972109	Green Submitted, Green Published, gold			2022-12-27	WOS:000338512200013
J	Yang, Y; Matsuzaki, M; Takahashi, F; Qu, L; Nozaki, H				Yang, Yi; Matsuzaki, Motomichi; Takahashi, Fumio; Qu, Lei; Nozaki, Hisayoshi			Phylogenomic Analysis of "Red" Genes from Two Divergent Species of the "Green" Secondary Phototrophs, the Chlorarachniophytes, Suggests Multiple Horizontal Gene Transfers from the Red Lineage before the Divergence of Extant Chlorarachniophytes	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; DIVISION; ORIGIN; ARABIDOPSIS; CHLOROPLAST; PLASTIDS; PROTEIN; ALGAE; RNA; CLASSIFICATION	The plastids of chlorarachniophytes were derived from an ancestral green alga via secondary endosymbiosis. Thus, genes from the "green" lineage via secondary endosymbiotic gene transfer (EGT) are expected in the nuclear genomes of the Chlorarachniophyta. However, several recent studies have revealed the presence of "red" genes in their nuclear genomes. To elucidate the origin of such "red" genes in chlorarachniophyte nuclear genomes, we carried out exhaustive single-gene phylogenetic analyses, including two operational taxonomic units (OTUs) that represent two divergent sister lineages of the Chlorarachniophyta, Amorphochlora amoeboformis (=Lotharella amoeboformis; based on RNA sequences newly determined here) and Bigelowiella natans (based on the published genome sequence). We identified 10 genes of cyanobacterial origin, phylogenetic analysis of which showed the chlorarachniophytes to branch with the red lineage (red algae and/or red algal secondary or tertiary plastid-containing eukaryotes). Of the 10 genes, 7 demonstrated robust monophyly of the two chlorarachniophyte OTUs. Thus, the common ancestor of the extant chlorarachniophytes likely experienced multiple horizontal gene transfers from the red lineage. Because 4 of the 10 genes are obviously photosynthesis-and/or plastid-related, and almost all of the eukaryotic OTUs in the 10 trees possess plastids, such red genes most likely originated directly from photosynthetic eukaryotes. This situation could be explained by a possible cryptic endosymbiosis of a red algal plastid before the secondary endosymbiosis of the green algal plastid, or a long-term feeding on a single (or multiple closely related) red algal plastid-containing eukaryote(s) after the green secondary endosymbiosis.	[Yang, Yi; Nozaki, Hisayoshi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan; [Matsuzaki, Motomichi] Univ Tokyo, Grad Sch Sci, Dept Biomed Chem, Bunkyo Ku, Tokyo 113, Japan; [Takahashi, Fumio] Ritsumeikan Univ, Coll Life Sci, Kusatsu, Shiga, Japan; [Takahashi, Fumio] JST, PRESTO, Kawaguchi, Saitama, Japan; [Qu, Lei] Fudan Univ, Sch Comp Sci, Shanghai 200433, Peoples R China	University of Tokyo; University of Tokyo; Ritsumeikan University; Japan Science & Technology Agency (JST); Fudan University	Nozaki, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan.	nozaki@bs.s.u-tokyo.ac.jp	Matsuzaki, Motomichi/D-4043-2016	Matsuzaki, Motomichi/0000-0001-5811-798X; Nozaki, Hisayoshi/0000-0002-9308-4498	MEXT/JSPS KAKENHI [24657045, 24247042]; Grants-in-Aid for Scientific Research [24657045] Funding Source: KAKEN	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Challenging Exploratory Research (number 24657045 to HN) and Scientific Research (A) (number 24247042 to HN) from MEXT/JSPS KAKENHI (http://www.jsps.go.jp/english/e-grants/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Archibald JM, 2012, ADV BOT RES, V64, P87, DOI 10.1016/B978-0-12-391499-6.00003-7; Arichbald JM, 2003, PNAS, V100, P7678; Baurain D, 2010, MOL BIOL EVOL, V27, P1698, DOI 10.1093/molbev/msq059; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Blake C, 1997, NATURE, V385, P204, DOI 10.1038/385204a0; Burki F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000790; Burki F, 2012, P ROY SOC B-BIOL SCI, V279, P2246, DOI 10.1098/rspb.2011.2301; Curtis BA, 2012, NATURE, V492, P59, DOI 10.1038/nature11681; Deschamps P, 2012, GENOME BIOL EVOL, V4, P795, DOI 10.1093/gbe/evs053; Dhar A, 2010, P NATL ACAD SCI USA, V107, P17586, DOI 10.1073/pnas.1006760107; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsner G, 2011, GENOME BIOL EVOL, V3, P140, DOI 10.1093/gbe/evq074; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hallegraeff GM, 2003, MANUAL HARMFUL MARIN; Hampl V, 2009, P NATL ACAD SCI USA, V106, P3859, DOI 10.1073/pnas.0807880106; HIBBERD DJ, 1984, J PHYCOL, V20, P310, DOI 10.1111/j.0022-3646.1984.00310.x; Ishida K, 1997, J MOL EVOL, V45, P682, DOI 10.1007/PL00006272; Lartillot N, 2006, SYST BIOL, V55, P195, DOI 10.1080/10635150500433722; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; LUDWIG M, 1989, J PHYCOL, V25, P385, DOI 10.1111/j.1529-8817.1989.tb00135.x; Mackiewicz P, 2012, SYMBIOSIS, V58, P99, DOI 10.1007/s13199-012-0202-2; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Maruyama S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-105; MCFADDEN GI, 1994, P NATL ACAD SCI USA, V91, P3690, DOI 10.1073/pnas.91.9.3690; McFadden GI, 1997, PLANT SYST EVOL, P175; Meurer J, 1998, EMBO J, V17, P5286, DOI 10.1093/emboj/17.18.5286; Moustafa A, 2009, SCIENCE, V324, P1724, DOI 10.1126/science.1172983; Nozaki H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050827; Nozaki H, 2009, MOL PHYLOGENET EVOL, V53, P872, DOI 10.1016/j.ympev.2009.08.015; Ota S, 2012, PROTIST, V163, P91, DOI 10.1016/j.protis.2011.02.004; Parfrey LW, 2010, SYST BIOL, V59, P518, DOI 10.1093/sysbio/syq037; Peltier JB, 2002, PLANT CELL, V14, P211, DOI 10.1105/tpc.010304; Petersen J, 2006, J MOL EVOL, V62, P143, DOI 10.1007/s00239-004-0305-3; Pielak GJ, 2010, P NATL ACAD SCI USA, V107, P17457, DOI 10.1073/pnas.1013095107; Reyes-Prieto A, 2007, ANNU REV GENET, V41, P147, DOI 10.1146/annurev.genet.41.110306.130134; Rogers MB, 2007, MOL BIOL EVOL, V24, P54, DOI 10.1093/molbev/msl129; SASA T, 1992, PLANT CELL PHYSIOL, V33, P921; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strepp R, 1998, P NATL ACAD SCI USA, V95, P4368, DOI 10.1073/pnas.95.8.4368; Takahashi F, 2007, J PHYCOL, V43, P1302, DOI 10.1111/j.1529-8817.2007.00411.x; Tanaka R, 1999, PLANT PHYSIOL, V120, P695, DOI 10.1104/pp.120.3.695; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; VanDePeer Y, 1996, P NATL ACAD SCI USA, V93, P7732, DOI 10.1073/pnas.93.15.7732; Yamaguchi A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-29; Yang Yi, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-330; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075	55	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101158	10.1371/journal.pone.0101158	http://dx.doi.org/10.1371/journal.pone.0101158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972019	Green Published, gold, Green Submitted			2022-12-27	WOS:000338512200100
J	Edgar, R; Drolet, D; Ehrman, JM; Kaczmarska, I				Edgar, Robyn; Drolet, David; Ehrman, James M.; Kaczmarska, Irena			Motile Male Gametes of the Araphid Diatom Tabularia fasciculata Search Randomly for Mates	PLOS ONE			English	Article							SEXUAL REPRODUCTION; SWIMMING BEHAVIOR; LEVY WALKS; PATTERNS; BACILLARIOPHYTA; MOVEMENT; MODELS	Sexuality in the marine araphid diatom Tabularia involves an unusual type of gamete, not only among diatoms but possibly in all of nature. The non-flagellated male gamete is free and vigorously motile, propelled by pseudopodia. However, the cues (if any) in their search for compatible female gametes and the general search patterns to locate them are unknown. We tracked and compared male gamete movements in the presence and absence of receptive female gametes. Path linearity of male movement was not affected by presence of female gametes. Male gametes did not move towards female gametes regardless of their proximity to each other, suggesting that the detection range for a compatible mate is very small compared to known algal examples (mostly spermatozoids) and that mate recognition requires (near) contact with a female gamete. We therefore investigated how male gametes move to bring insight into their search strategy and found that it was consistent with the predictions of a random-walk model with changes in direction coming from an even distribution. We further investigated the type of random walk by determining the best-fit distribution on the tail of the move length distribution and found it to be consistent with a truncated power law distribution with an exponent of 2.34. Although consistent with a Levy walk search pattern, the range of move lengths in the tail was too narrow for Levy properties to emerge and so would be best described as Brownian motion. This is somewhat surprising because female gametes were often outnumbered by male gametes, thus contrary to the assumption that a Brownian search mode may be most optimal with an abundant target resource. This is also the first mathematically analysed search pattern of a non-flagellated protistan gamete, supporting the notion that principles of Brownian motion have wide application in biology.	[Edgar, Robyn] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Drolet, David] Univ Prince Edward Isl, Atlant Vet Coll, Dept Hlth Management, Charlottetown, PE C1A 4P3, Canada; [Ehrman, James M.] Mt Allison Univ, Digital Microscopy Facil, Sackville, NB E0A 3C0, Canada; [Edgar, Robyn; Drolet, David; Kaczmarska, Irena] Mt Allison Univ, Dept Biol, Sackville, NB E0A 3C0, Canada	Laval University; University of Prince Edward Island; Mount Allison University; Mount Allison University	Kaczmarska, I (corresponding author), Mt Allison Univ, Dept Biol, Sackville, NB E0A 3C0, Canada.	iehrman@mta.ca			NSERC Discovery Grant	NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by an NSERC Discovery Grant to IK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsler C.D., 2008, ALGAL CHEM ECOLOGY; Ashworth MP, 2012, PHYCOLOGIA, V51, P684, DOI 10.2216/12-004.1; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Benichou O, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.198101; Berg H. C., 1983, RANDOM WALKS BIOL; Boakes DE, 2011, J PLANKTON RES, V33, P641, DOI 10.1093/plankt/fbq136; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; COOKSEY B, 1988, J CELL SCI, V91, P523; Davidovich N. A., 2001, P 16 INT DIAT S, P191; Davidovich NA, 2012, PROTIST, V163, P480, DOI 10.1016/j.protis.2011.09.002; Davidovich NA, 2010, FOTTEA, V10, P251, DOI 10.5507/fot.2010.016; de Jager M, 2011, SCIENCE, V332, P1551, DOI 10.1126/science.1201187; Drebes G., 1977, BOTANICAL MONOGRAPHS, P250; Edwards AM, 2012, PLOS ONE, V7; Edwards AM, 2008, J ANIM ECOL, V77, P1212, DOI 10.1111/j.1365-2656.2008.01428.x; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Fenchel T, 2004, EUR J PROTISTOL, V40, P49, DOI 10.1016/j.ejop.2003.09.001; Garcia M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.035301; Gillard J., 2012, ANGEW CHEM INT EDIT, V51, P1; Govorunova EG, 2005, BIOCHEMISTRY-MOSCOW+, V70, P717, DOI 10.1007/s10541-005-0176-2; Hiltz M, 2000, PHYCOLOGIA, V39, P59, DOI 10.2216/i0031-8884-39-1-59.1; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; James A, 2011, J R SOC INTERFACE, V8, P1233, DOI 10.1098/rsif.2011.0200; Kaczmarska I, 1997, MAR BIOL, V128, P695, DOI 10.1007/s002270050137; Kaczmarska I, 2013, DIATOM RES, V28, P263, DOI 10.1080/0269249X.2013.791344; Kaczmarska I, 2009, PHYCOLOGIA, V48, P391, DOI 10.2216/08-74.1; Levandowsky M, 1997, ACTA PROTOZOOL, V36, P237; LEVANDOWSKY M, 1988, B MAR SCI, V43, P758; LEVITAN DR, 1995, TRENDS ECOL EVOL, V10, P228, DOI 10.1016/S0169-5347(00)89071-0; MacGillivary ML, 2011, THESIS MOUNT ALLISON; MAIER I, 1986, BIOL BULL, V170, P145, DOI 10.2307/1541801; Mather LA, 2013, THESIS MOUNT ALLISON; MCCUTCHEON M, 1946, PHYSIOL REV, V26, P319, DOI 10.1152/physrev.1946.26.3.319; Medlin LK, 2008, J PHYCOL, V44, P1340, DOI 10.1111/j.1529-8817.2008.00560.x; PODUNAY Y.A., 2014, ALGOLOGIA, V24, P3, DOI DOI 10.15407/ALG24.01.003; Reynold CS, 1984, ECOLOGY FRESHWATER P; Round F. E., 1990, DIATOMS BIOL MORPHOL; Sato S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026923; Turchin Peter, 1998; Vandromme P, 2010, ZOOL STUD, V49, P289; Yund PO, 2003, LIMNOL OCEANOGR, V48, P795, DOI 10.4319/lo.2003.48.2.0795; Zar JH., 2010, BIOSTAT ANAL, V5th	43	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101767	10.1371/journal.pone.0101767	http://dx.doi.org/10.1371/journal.pone.0101767			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991803	gold, Green Published			2022-12-27	WOS:000341253400113
J	Kronen, MR; Schoenfelder, KP; Klein, AM; Nystul, TG				Kronen, Maria R.; Schoenfelder, Kevin P.; Klein, Allon M.; Nystul, Todd G.			Basolateral Junction Proteins Regulate Competition for the Follicle Stem Cell Niche in the Drosophila Ovary	PLOS ONE			English	Article							SELF-RENEWAL; ADULT TISSUES; PROLIFERATION; OOGENESIS; INVASION; REPLACEMENT; INHIBITION; EFFICIENT; POLARITY; MODELS	Epithelial stem cells are routinely lost or damaged during adult life and must therefore be replaced to maintain homeostasis. Recent studies indicate that stem cell replacement occurs through neutral competition in many types of epithelial tissues, but little is known about the factors that determine competitive outcome. The epithelial follicle stem cells (FSCs) in the Drosophila ovary are regularly lost and replaced during normal homeostasis, and we show that FSC replacement conforms to a model of neutral competition. In addition, we found that FSCs mutant for the basolateral junction genes, lethal giant larvae (lgl) or discs large (dlg), undergo a biased competition for niche occupancy characterized by increased invasion of neighboring FSCs and reduced loss. Interestingly, FSCs mutant for a third basolateral junction gene, scribble (scrib), do not exhibit biased competition, suggesting that Lgl and Dlg regulate niche competition through a Scrib-independent process. Lastly, we found that FSCs have a unique cell polarity characterized by broadly distributed adherens junctions and the lack of a mature apical domain. Collectively, these observations indicate that Lgl and Dlg promote the differentiation of FSC progeny to a state in which they are less prone to invade the neighboring niche. In addition, we demonstrate that the neutral drift model can be adapted to quantify non-neutral behavior of mutant clones.	[Kronen, Maria R.; Schoenfelder, Kevin P.; Nystul, Todd G.] Univ Calif San Francisco, Ctr Reprod Sci, Dept Anat, San Francisco, CA 94143 USA; [Kronen, Maria R.; Schoenfelder, Kevin P.; Nystul, Todd G.] Univ Calif San Francisco, Ctr Reprod Sci, Dept OB GYN RS, San Francisco, CA 94143 USA; [Klein, Allon M.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02163 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard Medical School	Klein, AM (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02163 USA.	allon_klein@hms.harvard.edu; todd.nystul@ucsf.edu	Nystul, Todd/AAA-7344-2022	Nystul, Todd/0000-0002-6250-2394	National Institute of General Medical Sciences [R01GM097158]; Program for Breakthrough Biomedical Research; Sandler Foundation; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097158] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Program for Breakthrough Biomedical Research; Sandler Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institute of General Medical Sciences, Award Number R01GM097158, and the Program for Breakthrough Biomedical Research, which is partially funded by the Sandler Foundation. A.M.K. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Chang YC, 2013, P NATL ACAD SCI USA, V110, pE1734, DOI 10.1073/pnas.1300725110; Chen J, 2005, PLOS BIOL, V3, P207, DOI 10.1371/journal.pbio.0030059; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; de Cuevas M, 2011, DEVELOPMENT, V138, P2861, DOI 10.1242/dev.056242; de Navascues J, 2012, EMBO J, V31, P2473, DOI 10.1038/emboj.2012.106; Ewens W.J., 2004, MATH POPULATION GENE, DOI [DOI 10.1007/978-0-387-21822-9, 10.1007/978-0-387-21822-9]; Ferraro F, 2010, ADV EXP MED BIOL, V695, P155, DOI 10.1007/978-1-4419-7037-4_11; Franz A, 2010, DEV BIOL, V338, P136, DOI 10.1016/j.ydbio.2009.11.027; Goode S, 1997, GENE DEV, V11, P2532, DOI 10.1101/gad.11.19.2532; HARRISON DA, 1993, CURR BIOL, V3, P424, DOI 10.1016/0960-9822(93)90349-S; Hartman TR, 2010, J CELL BIOL, V191, P943, DOI 10.1083/jcb.201007142; Huang J, 2009, P NATL ACAD SCI USA, V106, P8284, DOI 10.1073/pnas.0900641106; Issigonis M, 2009, SCIENCE, V326, P153, DOI 10.1126/science.1176817; Jin ZG, 2008, CELL STEM CELL, V2, P39, DOI 10.1016/j.stem.2007.10.021; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Liu YI, 2008, DEV BIOL, V323, P41, DOI 10.1016/j.ydbio.2008.08.011; Losick VP, 2011, DEV CELL, V21, P159, DOI 10.1016/j.devcel.2011.06.018; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; Nystul T, 2007, CELL STEM CELL, V1, P277, DOI 10.1016/j.stem.2007.07.009; Nystul T, 2010, GENETICS, V184, P503, DOI 10.1534/genetics.109.109538; Rhiner C, 2009, DEVELOPMENT, V136, P995, DOI 10.1242/dev.033340; Roegiers F, 2009, GENETICS, V182, P407, DOI 10.1534/genetics.109.101808; Sahai-Hernandez P, 2013, DEVELOPMENT, V140, P4490, DOI 10.1242/dev.098558; Sahai-Hernandez P, 2012, WIRES DEV BIOL, V1, P447, DOI 10.1002/wdev.36; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Snippert HJ, 2014, EMBO REP, V15, P62, DOI 10.1002/embr.201337799; Szafranski P, 2007, DEV DYNAM, V236, P364, DOI 10.1002/dvdy.21020; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Vermeulen L, 2013, SCIENCE, V342, P995, DOI 10.1126/science.1243148; Wang ZA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1765; Wasserman L., 2004, ALL STAT CONCISE COU, V26; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 2008, COLD SH Q B, V73, P39, DOI 10.1101/sqb.2008.73.014; Xie T, 2013, WIRES DEV BIOL, V2, P261, DOI 10.1002/wdev.60; XU T, 1993, DEVELOPMENT, V117, P1223; Zeitler J, 2004, J CELL BIOL, V167, P1137, DOI 10.1083/jcb.200407158; Zhao M, 2008, GENETICS, V178, P1947, DOI 10.1534/genetics.108.086983	40	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101085	10.1371/journal.pone.0101085	http://dx.doi.org/10.1371/journal.pone.0101085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991805	Green Submitted, Green Published, gold			2022-12-27	WOS:000341253400041
J	Xu, Y; Xie, JH; Cao, Y; Zhou, HG; Ping, Y; Chen, LK; Gu, LH; Hu, W; Bi, G; Ge, JY; Chen, X; Zhao, ZQ				Xu, Yan; Xie, Jianhui; Cao, Yu; Zhou, Huaigu; Ping, Yuan; Chen, Liankang; Gu, Lihua; Hu, Wei; Bi, Gang; Ge, Jianye; Chen, Xin; Zhao, Ziqin			Development of Highly Sensitive and Specific mRNA Multiplex System (XCYR1) for Forensic Human Body Fluids and Tissues Identification	PLOS ONE			English	Article							COLLABORATIVE EDNAP EXERCISE; RNA/DNA CO-ANALYSIS; PROSTATE-SPECIFIC ANTIGEN; TAMM-HORSFALL PROTEIN; QUANTITATIVE RT-PCR; MATRIX-METALLOPROTEINASES; MENSTRUAL BLOOD; VAGINAL SECRETIONS; SWEAT GLANDS; HUMAN SALIVA	The identification of human body fluids or tissues through mRNA-based profiling is very useful for forensic investigations. Previous studies have shown mRNA biomarkers are effective to identify the origin of biological samples. In this study, we selected 16 tissue specific biomarkers to evaluate their specificities and sensitivities for human body fluids and tissues identification, including porphobilinogen deaminase (PBGD), hemoglobin beta (HBB) and Glycophorin A (GLY) for circulatory blood, protamine 2 (PRM2) and transglutaminase 4 (TGM4) for semen, mucin 4 (MUC4) and human beta defensin 1(HBD1) for vaginal secretion, matrix metalloproteinases 7 and 11 (MMP7 and MMP11) for menstrual blood, keratin 4(KRT4) for oral mucosa, loricrin (LOR) and cystatin 6 (CST6) for skin, histatin 3(HTN3) for saliva, statherin (STATH) for nasal secretion, dermcidin (DCD) for sweat and uromodulin (UMOD) for urine. The above mentioned ten common forensic body fluids or tissues were used in the evaluation. Based on the evaluation, a reverse transcription (RT) PCR multiplex assay, XCYR1, which includes 12 biomarkers (i.e., HBB, GLY, HTN3, PRM2, KRT4, MMP11, MUC4, DCD, UMOD, MMP7, TGM4, and STATH) and 2 housekeeping genes [i.e., glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and 18SrRNA], was developed. This assay was further validated with real casework samples and mock samples (with both single source and mixture) and it was approved that XCYR1 is effective to identify common body fluids or tissues (i.e., circulatory blood, saliva, semen, vaginal secretion, menstrual blood, oral mucosa, nasal secretion, sweat and urine) in forensic casework samples.	[Xu, Yan; Xie, Jianhui; Zhao, Ziqin] Fudan Univ, Shanghai Med Coll, Dept Forens Med, Shanghai 200433, Peoples R China; [Xu, Yan; Cao, Yu; Zhou, Huaigu; Ping, Yuan; Chen, Liankang; Gu, Lihua; Hu, Wei; Bi, Gang; Chen, Xin] Shanghai Publ Secur Bur, Inst Forens Sci, Key Lab Forens Evidence & Sci Technol, Shanghai Key Lab Crime Sci Evidence,Minist Publ S, Shanghai, Peoples R China; [Ge, Jianye] Life Technol, Human Identificat Div, South San Francisco, CA USA	Fudan University; Institute of Forensic Science Ministry of Justice PRC; Thermo Fisher Scientific	Chen, X (corresponding author), Shanghai Publ Secur Bur, Inst Forens Sci, Key Lab Forens Evidence & Sci Technol, Shanghai Key Lab Crime Sci Evidence,Minist Publ S, Shanghai, Peoples R China.	cxourose@gmail.com; zqzhao@shmu.edu.cn			P.R.C Ministry of Public Security for Scientific Research within the framework of the Forensic Genomics [2012GABJC005]	P.R.C Ministry of Public Security for Scientific Research within the framework of the Forensic Genomics	This study was supported by a grant from the P.R.C Ministry of Public Security for Scientific Research within the framework of the Forensic Genomics (No. 2012GABJC005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiko Yoshihiro, 2003, Medical Electron Microscopy, V36, P247, DOI 10.1007/s00795-003-0225-0; Akutsu T, 2010, J FORENSIC SCI, V55, P742, DOI 10.1111/j.1556-4029.2010.01325.x; Alvarez M, 2004, ANAL BIOCHEM, V335, P289, DOI 10.1016/j.ab.2004.09.002; Bauer M, 2007, FORENSIC SCI INT-GEN, V1, P69, DOI 10.1016/j.fsigen.2006.11.002; Bauer M, 2002, J FORENSIC SCI, V47, P1278; CANDI E, 1995, J BIOL CHEM, V270, P26382, DOI 10.1074/jbc.270.44.26382; Cossu C, 2009, FORENS SCI INT-GEN S, V2, P536, DOI 10.1016/j.fsigss.2009.08.063; Fleming RI, 2010, FORENSIC SCI INT-GEN, V4, P244, DOI 10.1016/j.fsigen.2009.10.006; Goffin F, 2003, BIOL REPROD, V69, P976, DOI 10.1095/biolreprod.103.015933; Haas C, 2014, FORENSIC SCI INT-GEN, V8, P203, DOI 10.1016/j.fsigen.2013.09.009; Haas C, 2013, FORENSIC SCI INT-GEN, V7, P230, DOI 10.1016/j.fsigen.2012.10.011; Haas C, 2012, FORENSIC SCI INT-GEN, V6, P70, DOI 10.1016/j.fsigen.2011.02.004; Haas C, 2011, FORENSIC SCI INT-GEN, V5, P449, DOI 10.1016/j.fsigen.2010.09.006; Haas C, 2009, FORENSIC SCI INT-GEN, V3, P80, DOI 10.1016/j.fsigen.2008.11.003; Hanson E, 2012, FORENSIC SCI INT-GEN, V6, P548, DOI 10.1016/j.fsigen.2012.01.004; Hanson EK, 2013, SCI JUSTICE, V53, P14, DOI 10.1016/j.scijus.2012.03.007; Harteveld J, 2013, SCI JUSTICE, V53, P261, DOI 10.1016/j.scijus.2013.02.001; Hochmeister MN, 1999, J FORENSIC SCI, V44, P1057; HOYER JR, 1979, KIDNEY INT, V16, P279, DOI 10.1038/ki.1979.130; Ishizuya-Oka A, 2000, J CELL BIOL, V150, P1177, DOI 10.1083/jcb.150.5.1177; Jakubowska J, 2013, FORENSIC SCI INT-GEN, V7, P272, DOI 10.1016/j.fsigen.2012.11.005; Juusola J, 2005, FORENSIC SCI INT, V152, P1, DOI 10.1016/j.forsciint.2005.02.020; Juusola J, 2003, FORENSIC SCI INT, V135, P85, DOI 10.1016/S0379-0738(03)00197-X; Juusola J, 2007, J FORENSIC SCI, V52, P1252, DOI 10.1111/j.1556-4029.2007.00550.x; Kohlmeier F, 2012, FORENSIC SCI INT-GEN, V6, P274, DOI 10.1016/j.fsigen.2011.04.007; Lindenbergh A, 2013, INT J LEGAL MED, V127, P891, DOI 10.1007/s00414-013-0895-7; Lindenbergh A, 2012, FORENSIC SCI INT-GEN, V6, P565, DOI 10.1016/j.fsigen.2012.01.009; Liu B, 2002, J HISTOCHEM CYTOCHEM, V50, P811, DOI 10.1177/002215540205000607; Mannello F, 2005, APOPTOSIS, V10, P19, DOI 10.1007/s10495-005-6058-7; Park SM, 2013, FORENSIC SCI INT-GEN, V7, P143, DOI 10.1016/j.fsigen.2012.09.001; Powell WC, 1999, CURR BIOL, V9, P1441, DOI 10.1016/S0960-9822(00)80113-X; Richard MLL, 2012, FORENSIC SCI INT-GEN, V6, P452, DOI 10.1016/j.fsigen.2011.09.007; Rieg S, 2004, BRIT J DERMATOL, V151, P534, DOI 10.1111/j.1365-2133.2004.06081.x; Sakurada K, 2012, LEGAL MED-TOKYO, V14, P201, DOI 10.1016/j.legalmed.2012.01.014; Sakurada K, 2011, LEGAL MED-TOKYO, V13, P309, DOI 10.1016/j.legalmed.2011.07.002; Sakurada K, 2010, FORENSIC SCI INT, V194, P80, DOI 10.1016/j.forsciint.2009.10.015; Sakurada Koichi, 2009, Legal Medicine, V11, P125, DOI 10.1016/j.legalmed.2008.10.002; Sato I, 2002, FORENSIC SCI INT, V127, P71, DOI 10.1016/S0379-0738(02)00111-1; SCHENKELS LCPM, 1995, CRIT REV ORAL BIOL M, V6, P161, DOI 10.1177/10454411950060020501; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Setzer M, 2008, J FORENSIC SCI, V53, P296, DOI 10.1111/j.1556-4029.2007.00652.x; TAYLOR MC, 1983, J FORENSIC SCI SOC, V23, P67, DOI 10.1016/S0015-7368(83)71546-X; TSUTSUMI H, 1988, J FORENSIC SCI, V33, P237; Verma RP, 2007, BIOORGAN MED CHEM, V15, P2223, DOI 10.1016/j.bmc.2007.01.011; Virkler K, 2009, FORENSIC SCI INT, V188, P1, DOI 10.1016/j.forsciint.2009.02.013; Visser M, 2011, INT J LEGAL MED, V125, P253, DOI 10.1007/s00414-010-0545-2; Wobst J, 2011, FORENS SCI INT-GEN S, V3, pE421, DOI 10.1016/j.fsigss.2011.09.072	47	35	38	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100123	10.1371/journal.pone.0100123	http://dx.doi.org/10.1371/journal.pone.0100123			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991806	Green Submitted, Green Published, gold			2022-12-27	WOS:000341253400017
J	Dong, CT; Huang, ZJ; Martin, MC; Huang, J; Liu, HL; Deng, B; Lai, WH; Liu, L; Yang, YH; Hu, Y; Qin, GM; Zhang, LL; Song, ZB; Wei, DY; Nan, L; Wang, QX; Deng, HX; Zhang, JX; Wong, FY; Yang, W				Dong, Caiting; Huang, Z. Jennifer; Martin, Maria C.; Huang, Jun; Liu, Honglu; Deng, Bin; Lai, Wenhong; Liu, Li; Yang, Yihui; Hu, Ying; Qin, Guangming; Zhang, Linglin; Song, Zhibin; Wei, Daying; Nan, Lei; Wang, Qixing; Deng, Hongxia; Zhang, Jianxun; Wong, Frank Y.; Yang, Wen			The Impact of Social Factors on Human Immunodeficiency Virus and Hepatitis C Virus Co-Infection in a Minority Region of Si-Chuan, the People's Republic of China: A Population-Based Survey and Testing Study	PLOS ONE			English	Article							INJECTION-DRUG USERS; SICHUAN PROVINCE; SOUTHERN CHINA; HIV; HCV; PREVALENCE; EPIDEMIOLOGY; TRANSMISSION	Background: While many human immunodeficiency virus (HIV) studies have been performed in Liangshan, most were focused only on HIV infection and based on a sampling survey. In order to fully understand HIV and hepatitis C virus (HCV) prevalence and related risk factors in this region, this study implemented in 2009, included a survey, physical examination, HIV and HCV test in two towns. Methods: All residents in two towns of the Butuo county were provided a physical examination and blood tests for HIV and HCV, and then followed by an interview for questionnaire. Results: In total, 10,104 residents (92.4%) were enrolled and 9,179 blood samples were collected for HIV and HCV testing, 6,072 were from individuals >14 years old. The rates of HIV, HCV, and HIV/HCV co-infection were 11.4%, 14.0%, and 7.7%, respectively for >14-year-old residents. The 25-34 yr age group had the highest prevalence of HIV, HCV, and HIV/HCV co-infections, reaching 24.4%, 26.2% and 16.0%, respectively. Overall, males had a much higher prevalence of all infections than females (HIV: 16.3% vs. 6.8%, HCV: 24.6% vs. 3.9%, HIV/HCV co-infected: 14.7% vs. 1.1%, respectively; P = 0.000). Approximately half of intravenous drug users tested positive for HIV (48.7%) and 68.4% tested positive for HCV. Logistic regression analysis showed that five factors were significantly associated with HIV and HCV infection: gender (odds ratio [OR] = 5.8), education (OR = 2.29); occupation (student as reference; farmer: OR = 5.02, migrant worker: OR = 6.12); drug abuse (OR = 18.0); and multiple sexual partners (OR = 2.92). Knowledge of HIV was not associated with infection. Conclusion: HIV and HCV prevalence in the Liangshan region is very serious and drug use, multiple sexual partners, and low education levels were the three main risk factors. The government should focus on improving education and personal health awareness while enhancing drug control programs.	[Dong, Caiting; Huang, Jun; Liu, Honglu; Deng, Bin; Lai, Wenhong; Liu, Li; Yang, Yihui; Hu, Ying; Qin, Guangming; Zhang, Linglin; Yang, Wen] Si Chuan Ctr Dis Control & Prevent, Dept HIV Control & Prevent, Chengdu, Peoples R China; [Huang, Z. Jennifer] Georgetown Univ, Dept Int Hlth, Washington, DC USA; [Martin, Maria C.] Univ Calif San Francisco, Dept Pediat Adolescent & Young Adult Med, San Francisco, CA 94143 USA; [Song, Zhibin] Liangshan Prefecture Hlth Bur, Dept HIV Control & Prevent, Xichang, Si Chuan, Peoples R China; [Wei, Daying; Nan, Lei; Wang, Qixing] Lianshan Ctr Dis Control & Prevent, Dept HIV Control & Prevent, Xichang, Si Chuan, Peoples R China; [Deng, Hongxia; Zhang, Jianxun] Butuo Hlth Bur, Dept HIV Control & Prevent, Butuo, Si Chuan, Peoples R China; [Wong, Frank Y.] Emory Univ, Dept Behav Sci & Hlth Educ, Atlanta, GA 30322 USA	Georgetown University; University of California System; University of California San Francisco; Emory University	Yang, W (corresponding author), Si Chuan Ctr Dis Control & Prevent, Dept HIV Control & Prevent, Chengdu, Peoples R China.	yangwenn@yeah.net		Wong, Frank Y./0000-0001-5835-9938	Mega-Project for National Science and Technology Development under the "11th and 12th, Five-Year Plan of China" [2009ZX10004-905, 2011ZX10001-002]	Mega-Project for National Science and Technology Development under the "11th and 12th, Five-Year Plan of China"	This study was supported by grants from the Mega-Project for National Science and Technology Development under the "11th and 12th, Five-Year Plan of China" (2009ZX10004-905, 2011ZX10001-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balagopal A, 2008, GASTROENTEROLOGY, V135, P226, DOI 10.1053/j.gastro.2008.03.022; Bao YP, 2012, JAIDS-J ACQ IMM DEF, V60, P438, DOI 10.1097/QAI.0b013e31825694f2; Bonnard P, 2007, J VIRAL HEPATITIS, V14, P806, DOI 10.1111/j.1365-2893.2007.00874.x; Dai SY, 2012, J MED VIROL, V84, P1, DOI 10.1002/jmv.22214; Garten RJ, 2004, INT J EPIDEMIOL, V33, P182, DOI 10.1093/ije/dyh019; Infectious Disease Experts Call for More Focus on Hepatitis C, 2011, INFECT DIS EXPERTS C; Liangshan Center for Disease Control and Prevention, 2008, SURV REP HIV AIDS LI; Liu Jian-Bo, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P656; Liu S.-h., 2011, PASSAGE MANHOOD YOUT; Liu SH, 2011, MED ANTHROPOL Q, V25, P395, DOI 10.1111/j.1548-1387.2011.01168.x; Lu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008467; Maimaiti Rena, 2013, J Int Assoc Provid AIDS Care, V12, P58, DOI 10.1177/1545109712446176; Ministry of Health People's Republic of China Joint United Nations Programmme on HIV/ AIDS WHO, 2013, 2011 EST HIV AIDS EP; Quan VM, 2009, AIDS CARE, V21, P7, DOI 10.1080/09540120802017610; Ruan YH, 2005, JAIDS-J ACQ IMM DEF, V39, P459, DOI 10.1097/01.qai.0000152398.47025.0f; Ruan YH, 2004, SEX TRANSM DIS, V31, P623; Sichuan Center for Disease Control and Prevention, 2012, EP AN REP HIV AIDS S; Solomon SS, 2008, JAIDS-J ACQ IMM DEF, V49, P327, DOI 10.1097/QAI.0b013e3181831e85; SUN X, 2010, INT J EPIDEMIOL S2, V39, P4, DOI DOI 10.1093/IJE/DYQ217; Tan Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003608; Verucchi G, 2004, INFECTION, V32, P33, DOI 10.1007/s15010-004-3063-7; Zhuang X, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-130	22	9	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101241	10.1371/journal.pone.0101241	http://dx.doi.org/10.1371/journal.pone.0101241			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988219	Green Submitted, Green Published, gold			2022-12-27	WOS:000341354100071
J	Floyd, CN; Mustafa, A; Ferro, A				Floyd, Christopher N.; Mustafa, Agnesa; Ferro, Albert			The PlA1/A2 Polymorphism of Glycoprotein IIIa as a Risk Factor for Myocardial Infarction: A Meta-Analysis	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; ANGIOTENSIN-CONVERTING ENZYME; PROTHROMBOTIC GENE POLYMORPHISMS; PLATELET FIBRINOGEN RECEPTOR; GPIIIA PIA2 POLYMORPHISM; ISCHEMIC-HEART-DISEASE; NITRIC-OXIDE SYNTHASE; PL(A) POLYMORPHISM; CARDIOVASCULAR-DISEASE; YOUNG MEN	Background: The PlA2 polymorphism of glycoprotein IIIa (GPIIIa) has been previously identified as being associated with myocardial infarction (MI), but whether this represents a true association is entirely unclear due to differences in findings from different studies. We performed a meta-analysis to evaluate whether this polymorphism is a risk factor for MI. Methods: Electronic databases (MEDLINE and EMBASE) were searched for all articles evaluating genetic polymorphisms of GPIIIa. For studies where acute coronary events were recorded in association with genetic analysis, pooled odds ratios (ORs) were calculated using fixed-effects and random-effects models. The primary outcome measure was MI, and a secondary analysis was also performed for acute coronary syndromes (ACS) more generally. Findings: 57 studies were eligible for statistical analysis and included 17,911 cases and 24,584 controls. Carriage of the PlA2 allele was significantly associated with MI (n = 40,692; OR 1.077, 95% CI 1.024-1.132; p = 0.004) but with significant publication bias (p = 0.040). The degree of association with MI increased with decreasing age of subjects (<= 45 years old: n = 9,547; OR 1.205, 95% CI 1.067-1.360; p = 0.003) and with adjustment of data for conventional cardiovascular risk factors (n = 12,001; OR 1.240, 95% CI 1.117-1.376; p<0.001). There was a low probability of publication bias for these subgroup analyses (all p<0.05). Conclusions: The presence of significant publication bias makes it unclear whether the association between carriage of the PlA2 allele and MI is true for the total population studied. However for younger subjects, the relative absence of conventional cardiovascular risk factors results in a significant association between carriage of the PlA2 allele and MI.	[Floyd, Christopher N.; Mustafa, Agnesa; Ferro, Albert] Kings Coll London, Dept Clin Pharmacol, British Heart Fdn, Cardiovasc Div,Ctr Res Excellence, London, England	University of London; King's College London; University College London	Ferro, A (corresponding author), Kings Coll London, Dept Clin Pharmacol, British Heart Fdn, Cardiovasc Div,Ctr Res Excellence, London, England.	albert.ferro@kcl.ac.uk	Floyd, christopher/AAF-2979-2020	Ferro, Albert/0000-0002-5486-9145	Guy's & St Thomas' Charity	Guy's & St Thomas' Charity	This work was funded by Guy's & St Thomas' Charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud N, 2010, CARDIOVASC PATHOL, V19, P302, DOI 10.1016/j.carpath.2009.04.003; Abboud N, 2010, J THROMB THROMBOLYS, V29, P409, DOI 10.1007/s11239-009-0368-5; Abu-Amero KK, 2004, BLOOD COAGUL FIBRIN, V15, P77, DOI 10.1097/00001721-200401000-00012; Addad F, 2010, BLOOD COAGUL FIBRIN, V21, P674, DOI 10.1097/MBC.0b013e32833e47c1; Aleksic N, 2000, CIRCULATION, V102, P1901, DOI 10.1161/01.CIR.102.16.1901; Anderson JL, 1999, J AM COLL CARDIOL, V33, P727, DOI 10.1016/S0735-1097(98)00603-2; Araujo F, 1999, HAEMOSTASIS, V29, P212; Ardissino D, 1999, BLOOD, V94, P46; Ashavaid TF, 2011, PLATELETS, V22, P85, DOI 10.3109/09537104.2010.522275; Auguadro Carla, 2002, Acta Cardiol, V57, P32; Aydinalp A, 2010, ACTA CARDIOL, V65, P225, DOI 10.2143/AC.65.2.2047058; Barakat K, 2001, J AM COLL CARDIOL, V38, P1639, DOI 10.1016/S0735-1097(01)01610-2; Benze G, 2002, EUR HEART J, V23, P325, DOI 10.1053/euhj.2001.2776; Boekholdt SM, 2004, AM HEART J, V147, P181, DOI 10.1016/j.ahj.2003.07.008; Bojesen SE, 2003, J AM COLL CARDIOL, V42, P661, DOI 10.1016/S0735-1097(03)00781-2; Borenstein M., 2009, INTRO METAANALYSIS; Bottiger C, 2000, THROMB HAEMOSTASIS, V83, P559; Bray PF, 2001, AM J CARDIOL, V88, P347, DOI 10.1016/S0002-9149(01)01677-0; Brscic E, 2000, AM HEART J, V139, P979, DOI 10.1067/mhj.2000.106165; Carter AM, 1996, LANCET, V348, P485, DOI 10.1016/S0140-6736(05)64592-8; Carter AM, 1996, NEW ENGL J MED, V335, P1072; Carter AM, 1998, DIABETIC MED, V15, P315, DOI 10.1002/(SICI)1096-9136(199804)15:4<315::AID-DIA590>3.0.CO;2-A; Carter AM, 1997, CIRCULATION, V96, P1424, DOI 10.1161/01.CIR.96.5.1424; Cayla G, 2011, CIRCULATION, V1; Cayla G, 2011, JAMA-J AM MED ASSOC, V306, P1765, DOI 10.1001/jama.2011.1529; Cenarro A, 1999, ATHEROSCLEROSIS, V143, P99, DOI 10.1016/S0021-9150(98)00283-4; Chiznski K, 2002, POLSKI PRZEGLAD KARD, V4, P35; Corral J, 1997, BLOOD COAGUL FIBRIN, V8, P284, DOI 10.1097/00001721-199707000-00004; Cymbron T, 2011, ANN HUM BIOL, V38, P354, DOI 10.3109/03014460.2011.553203; Dankovtseva EN, 2005, KARDIOLOGIYA, V45, P17; Dayakar S, 2011, THROMB RES, V128, P595, DOI 10.1016/j.thromres.2011.07.010; De Rosa R, 2010, CARDIOVASC RES, V87, pS74; Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Di Castelnuovo A, 2001, THROMB HAEMOSTASIS, V85, P626; Dogra RK, 2012, J THROMB THROMBOLYS, V34, P276, DOI 10.1007/s11239-012-0734-6; Dudas K, 2011, CIRCULATION, V123, P46, DOI 10.1161/CIRCULATIONAHA.110.964999; Durante-Mangoni E, 1998, THROMB HAEMOSTASIS, V80, P218, DOI 10.1055/s-0037-1615175; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Falchi A, 2005, EXP MOL PATHOL, V79, P210, DOI 10.1016/j.yexmp.2005.09.005; Faraday N, 2004, ANESTHESIOLOGY, V101, P1291; Floyd CN, 2012, JRSM CARDIOVASC DIS, V1, DOI 10.1258/cvd.2012.012007; Floyd CN, 2014, BRIT J CLIN PHARMACO, V77, P446, DOI 10.1111/bcp.12204; French JK, 2003, AM HEART J, V145, P118, DOI 10.1067/mhj.2003.29; Galasso G, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-41; Garcia-Ribes M, 1998, THROMB HAEMOSTASIS, V79, P1126; Gardemann A, 1998, THROMB HAEMOSTASIS, V80, P214; Garg UC, 1998, THROMB RES, V89, P85, DOI 10.1016/S0049-3848(97)00295-8; Goldschmidt-Clermont PJ, 1999, ARCH PATHOL LAB MED, V123, P1223; Goodall AH, 1999, EUR HEART J, V20, P742, DOI 10.1053/euhj.1998.1203; Grove EL, 2004, J INTERN MED, V255, P637, DOI 10.1111/j.1365-2796.2004.01327.x; Gruchala M, 2003, INT J CARDIOL, V88, P229, DOI 10.1016/S0167-5273(02)00412-6; Gul I, 2012, POSTEP KARDIOL INTER, V8, P25, DOI 10.5114/pwki.2012.27922; Herrmann SM, 1997, THROMB HAEMOSTASIS, V77, P1179; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hooper WC, 1999, CHEST, V116, P880, DOI 10.1378/chest.116.4.880; Jansen ACM, 2005, ARTERIOSCL THROM VAS, V25, P1475, DOI 10.1161/01.ATV.0000168909.44877.a7; Joven J, 1998, ATHEROSCLEROSIS, V140, P155, DOI 10.1016/S0021-9150(98)00076-8; Kastrati A, 1999, CIRCULATION, V99, P1005, DOI 10.1161/01.CIR.99.8.1005; Kastrati A, 2000, J AM COLL CARDIOL, V36, P84, DOI 10.1016/S0735-1097(00)00709-9; Kekomaki S, 1999, J CARDIOVASC RISK, V6, P13; Knowles JW, 2007, AM HEART J, V154, P1052, DOI 10.1016/j.ahj.2007.05.021; Kolodgie FD, 2001, CURR OPIN CARDIOL, V16, P285, DOI 10.1097/00001573-200109000-00006; Komarova A G, 2010, Klin Med (Mosk), V88, P22; Kozieradzka A, 2007, ACTA DIABETOL, V44, P30, DOI 10.1007/s00592-007-0238-6; Kozieradzka Anna, 2006, Kardiol Pol, V64, P1350; Kucharska-Newton AM, 2011, ATHEROSCLEROSIS, V216, P151, DOI 10.1016/j.atherosclerosis.2011.01.038; Lagercrantz J, 2003, BLOOD COAGUL FIBRIN, V14, P749, DOI 10.1097/00001721-200312000-00010; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Larsen GK, 2013, JAMA INTERN MED, V173, P1261, DOI 10.1001/jamainternmed.2013.6075; Laule M, 1999, LANCET, V353, P708, DOI 10.1016/S0140-6736(98)07257-2; Le Hello Claire, 2007, Thromb J, V5, P19, DOI 10.1186/1477-9560-5-19; Lim J, 2003, INT J CARDIOL, V90, P269, DOI 10.1016/S0167-5273(02)00567-3; Lopes NHM, 2004, AM J CARDIOL, V93, P1469, DOI 10.1016/j.amjcard.2004.03.005; Lu L, 1999, CHINESE J CARDIOLOGY, V27, P111; Maksimenko LV, 2000, B EXP BIOL MED+, V129, P578, DOI 10.1007/BF02434882; Mamotte CDS, 1998, AM J CARDIOL, V82, P13, DOI 10.1016/S0002-9149(98)00235-5; Mannucci PM, 2003, CIRCULATION, V107, P1117, DOI 10.1161/01.CIR.0000051465.94572.D0; MANTEL N, 1959, J NATL CANCER I, V22, P719; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Marian AJ, 1996, NEW ENGL J MED, V335, P1071; Martini CH, 2005, J THROMB HAEMOST, V3, P177, DOI 10.1111/j.1538-7836.2004.01080.x; Marz W, 2004, DIABETOLOGIA, V47, P1969, DOI 10.1007/s00125-004-1557-6; McCarthy JJ, 2003, HUM GENET, V114, P87, DOI 10.1007/s00439-003-1026-1; Melus V, 1999, Bratisl Lek Listy, V100, P593; Meshkov AN, 2005, KARDIOLOGIYA, V45, P10; Mikkelsson J, 2000, J AM COLL CARDIOL, V36, P1317, DOI 10.1016/S0735-1097(00)00871-8; Morgan TM, 2007, JAMA-J AM MED ASSOC, V297, P1551, DOI 10.1001/jama.297.14.1551; Moshfegh K, 1999, THROMB HAEMOSTASIS, P361; Motovska Z, 2010, ATHEROSCLEROSIS, V212, P548, DOI 10.1016/j.atherosclerosis.2010.07.006; Musino Lorena, 2010, Front Biosci (Elite Ed), V2, P559, DOI 10.2741/e114; Nassar BA, 1999, CLIN BIOCHEM, V32, P275, DOI 10.1016/S0009-9120(99)00017-X; NEWMAN PJ, 1995, THROMB HAEMOSTASIS, V74, P234; Ni YB, 2004, CLIN CARDIOL, V27, P455, DOI 10.1002/clc.4960270807; Nikolajevic-Starcevic J, 2012, MOL BIOL REP; NORA JJ, 1980, CIRCULATION, V61, P503, DOI 10.1161/01.CIR.61.3.503; Odeberg J, 2006, J THROMB HAEMOST, V4, P909, DOI 10.1111/j.1538-7836.2006.01835.x; Osborn SV, 1996, LANCET, V348, P1309, DOI 10.1016/S0140-6736(05)65785-6; Pamukcu B, 2005, AM HEART J, V149, P675, DOI 10.1016/j.ahj.2004.10.007; Park S, 2004, YONSEI MED J, V45, P428, DOI 10.3349/ymj.2004.45.3.428; Pastinen T, 1998, HUM MOL GENET, V7, P1453, DOI 10.1093/hmg/7.9.1453; Pavlova TV, 2009, KARDIOLOGIYA, V49, P9; Pchelina SN, 2007, KARDIOLOGIYA, V47, P29; Pegoraro R J, 2005, Cardiovasc J S Afr, V16, P266; Pellitero S, 2010, THROMB HAEMOSTASIS, V103, P630, DOI 10.1160/TH09-07-0453; Ridker PM, 1997, LANCET, V349, P385, DOI 10.1016/S0140-6736(97)80010-4; Rinder CS, 2002, ANESTHESIOLOGY, V97, P1118, DOI 10.1097/00000542-200211000-00013; Rosenberg N, 2002, ISR MED ASSOC J, V4, P411; Samani NJ, 1997, CARDIOVASC RES, V33, P693, DOI 10.1016/S0008-6363(96)00222-2; Santiago-German D, 2012, J THROMB THROMBOLYS, V33, P389, DOI 10.1007/s11239-012-0714-x; Scaglione L, 1998, EUR J CLIN INVEST, V28, P385; Schwartz E, 2003, MOL GENET METAB, V79, P229, DOI 10.1016/S1096-7192(03)00090-8; Senti M, 1998, CLIN BIOCHEM, V31, P647, DOI 10.1016/S0009-9120(98)00077-0; Senti M, 1998, METABOLISM, V47, P1040, DOI 10.1016/S0026-0495(98)90274-8; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; SIMSEK S, 1993, BLOOD, V81, P835; Smith FB, 2003, THROMB RES, V112, P209, DOI 10.1016/j.thromres.2003.11.010; Sperr WR, 1998, THROMB RES, V90, P117, DOI 10.1016/S0049-3848(98)00042-5; Syros George, 2009, Acute Card Care, V11, P88, DOI 10.1080/17482940902785474; Tchoudakova D. A., 2004, Genetika, V40, P1402; Tereschenko SN, 1999, TERAPEVT ARKH, V71, P66; Tobin MD, 2004, EUR HEART J, V25, P459, DOI 10.1016/j.ehj.2003.11.014; Todur SP, 2010, ARTERIOSCLER THROMB, V29, pe87; Undas A, 2001, CIRCULATION, V104, P2666, DOI 10.1161/hc4701.099787; Var A, 2009, MOL BIOL REP, V36, P2235, DOI 10.1007/s11033-008-9439-5; Verschuren JJW, 2012, EUR HEART J, V33, P516; Volzke H, 2005, INT J CARDIOL, V98, P133, DOI 10.1016/j.ijcard.2004.03.058; Volzke H, 2004, CLIN SCI, V106, P35; Wagner CL, 1996, BLOOD, V88, P907; Walter DH, 1997, LANCET, V350, P1217, DOI 10.1016/S0140-6736(97)05399-3; Walter DH, 2001, EUR HEART J, V22, P587, DOI 10.1053/euhj.2000.2313; Weiss EJ, 1996, NEW ENGL J MED, V334, P1090, DOI 10.1056/NEJM199604253341703; Yang SL, 2002, CHINESE J CLIN REHAB, V6, P3294; Ye Z, 2006, LANCET, V367, P651, DOI 10.1016/S0140-6736(06)68263-9; Yucel O, 2012, MOL BIOL REP, V39, P6141, DOI 10.1007/s11033-011-1430-x; Zotz RB, 2005, J THROMB HAEMOST, V3, P1522, DOI 10.1111/j.1538-7836.2005.01432.x; Zotz RB, 1998, THROMB HAEMOSTASIS, V79, P731, DOI 10.1055/s-0037-1615054; Zotz RB, 2000, THROMB HAEMOSTASIS, V83, P404	138	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101518	10.1371/journal.pone.0101518	http://dx.doi.org/10.1371/journal.pone.0101518			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988220	Green Published, gold, Green Submitted			2022-12-27	WOS:000341354100103
J	Hallgren, W; Gunturu, UB; Schlosser, A				Hallgren, Willow; Gunturu, Udaya Bhaskar; Schlosser, Adam			The Potential Wind Power Resource in Australia: A New Perspective	PLOS ONE			English	Article							GENERATED ELECTRICITY; UNITED-STATES; REGION	Australia's wind resource is considered to be very good, and the utilization of this renewable energy resource is increasing rapidly: wind power installed capacity increased by 35% from 2006 to 2011 and is predicted to account for over 12% of Australia's electricity generation in 2030. Due to this growth in the utilization of the wind resource and the increasing importance of wind power in Australia's energy mix, this study sets out to analyze and interpret the nature of Australia's wind resources using robust metrics of the abundance, variability and intermittency of wind power density, and analyzes the variation of these characteristics with current and potential wind turbine hub heights. We also assess the extent to which wind intermittency, on hourly or greater timescales, can potentially be mitigated by the aggregation of geographically dispersed wind farms, and in so doing, lessen the severe impact on wind power economic viability of long lulls in wind and power generated. Our results suggest that over much of Australia, areas that have high wind intermittency coincide with large expanses in which the aggregation of turbine output does not mitigate variability. These areas are also geographically remote, some are disconnected from the east coast's electricity grid and large population centers, which are factors that could decrease the potential economic viability of wind farms in these locations. However, on the eastern seaboard, even though the wind resource is weaker, it is less variable, much closer to large population centers, and there exists more potential to mitigate it's intermittency through aggregation. This study forms a necessary precursor to the analysis of the impact of large-scale circulations and oscillations on the wind resource at the mesoscale.	[Hallgren, Willow; Gunturu, Udaya Bhaskar; Schlosser, Adam] MIT, MIT Joint Program Sci & Policy Global Change, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Hallgren, W (corresponding author), MIT, MIT Joint Program Sci & Policy Global Change, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	hallgren@mit.edu			MIT Joint Program on the Science and Policy of Global Change	MIT Joint Program on the Science and Policy of Global Change	The authors gratefully acknowledge the financial support for this work provided by the MIT Joint Program on the Science and Policy of Global Change through a number of federal agencies and industrial sponsors (for the complete list, see http://globalchange.mit.edu/sponsors/current.html). The funders of the Joint Program had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer CL, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005462; Archer CL, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002076; Archer CL, 2007, J APPL METEOROL CLIM, V46, P1701, DOI 10.1175/2007JAMC1538.1; Blakers A, 1991, R9317 AUSTR GOV DASE; Calif R, 2014, NONLINEAR PROC GEOPH, V21, P379, DOI 10.5194/npg-21-379-2014; Calif R, 2013, PHYSICA A, V392, P4106, DOI 10.1016/j.physa.2013.04.038; CEC, 2021, CLEAN EN AUSTR REP; Chadee XT, 2014, RENEW SUST ENERG REV, V30, P45, DOI 10.1016/j.rser.2013.09.018; Clarke D, 2013, WIND FARMS S AUSTR; Clarke D, 2013, WIND FARMS NEW S WAL; Coppin P.A., 2003, WIND RESOURCE ASSESS; Davy R., 2003, S E AUSTR WIND POWER; Dear SJ, 1990, W AUSTR WIND ATLAS; Dear SJ, 1991, VICTORIAN COASTAL WI; Electricity Trust of South Australia, 1989, TECHNICAL REPORT; Elliott D., 1987, 87 NASA STI, P24819; Elliott DL, 1991, TECHNICAL REPORT, P7306; Farkas Z., 2011, ARXIV11032198; Gentilli J, 1971, WORLD SURVEY CLIMATO; Geoscience Australia ABARE, 2010, CANB AUSTR EN RES AS; Gunturu UB, 2012, ATMOS CHEM PHYS, V12, P9687, DOI 10.5194/acp-12-9687-2012; Gunturu UB, 2011, 20965 MIT; HENNESSEY JP, 1977, J APPL METEOROL, V16, P119, DOI 10.1175/1520-0450(1977)016<0119:SAOWPS>2.0.CO;2; Hurley PJ, 2001, ATMOS ENVIRON, V35, P1871, DOI 10.1016/S1352-2310(00)00486-6; International Renewable Energy Agency, 2012, IRENA CAS STUD 2013; KAHN E, 1979, ELECTR POW SYST RES, V2, P1, DOI 10.1016/0378-7796(79)90021-X; Lu X, 2009, P NATL ACAD SCI USA, V106, P10933, DOI 10.1073/pnas.0904101106; Mason, 2010, TELEGRAPH; McElroy MB, 2009, SCIENCE, V325, P1378, DOI 10.1126/science.1175706; Merz Sinclair Knight, 2010, EN RES 2; Mills D, 2001, THESIS U QUEENSLAND; Oswald J, 2008, ENERG POLICY, V36, P3212, DOI 10.1016/j.enpol.2008.04.033; Panofsky H. A., 1984, ATMOSPHERIC TURBULEN; PARKINSON G, 1986, ATLAS AUSTR RESOURCE, V4; Pryor SC, 2011, P NATL ACAD SCI USA, V108, P8167, DOI 10.1073/pnas.1019388108; Pryor SC, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026000; Rienecker MM, 2011, J CLIMATE, V24, P3624, DOI 10.1175/JCLI-D-11-00015.1; Schwartz M, 1999, 11 APPL CLIM C AM ME; Steggle N, 2002, PAR P GLOB WIND POW	39	27	28	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e99608	10.1371/journal.pone.0099608	http://dx.doi.org/10.1371/journal.pone.0099608			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988222	Green Published, gold, Green Submitted			2022-12-27	WOS:000341354100015
J	Hayashi, T; Doyama, H; Shirota, Y; Tsuji, H; Marukawa, Y; Ohta, H; Miwa, K; Masunaga, T; Terasaki, S; Matano, Y; Tsuji, K; Kaneko, Y; Okada, T; Kurumaya, H; Kaneko, S				Hayashi, Tomoyuki; Doyama, Hisashi; Shirota, Yukihiro; Tsuji, Hirokazu; Marukawa, Youhei; Ohta, Hajime; Miwa, Kazuhiro; Masunaga, Takaharu; Terasaki, Shuichi; Matano, Yutaka; Tsuji, Kunihiro; Kaneko, Yoshibumi; Okada, Toshihide; Kurumaya, Hiroshi; Kaneko, Shuichi			Assessment of Still and Moving Images in the Diagnosis of Gastric Lesions Using Magnifying Narrow-Band Imaging in a Prospective Multicenter Trial	PLOS ONE			English	Article							ENDOSCOPIC FINDINGS; CANCER; CLASSIFICATION; DOCUMENTATION; TISSUE	Objectives: Magnifying narrow-band imaging (M-NBI) is more accurate than white-light imaging for diagnosing small gastric cancers. However, it is uncertain whether moving M-NBI images have additional effects in the diagnosis of gastric cancers compared with still images. Design: A prospective multicenter cohort study. Methods: To identify the additional benefits of moving M-NBI images by comparing the diagnostic accuracy of still images only with that of both still and moving images. Still and moving M-NBI images of 40 gastric lesions were obtained by an expert endoscopist prior to this prospective multicenter cohort study. Thirty-four endoscopists from ten different Japanese institutions participated in the prospective multicenter cohort study. Each study participant was first tested using only still M-NBI images (still image test), then tested 1 month later using both still and moving M-NBI images (moving image test). The main outcome was a difference in the diagnostic accuracy of cancerous versus noncancerous lesions between the still image test and the moving image test. Results: Thirty-four endoscopists were analysed. There were no significant difference of cancerous versus noncancerous lesions between still and moving image tests in the diagnostic accuracy (59.9% versus 61.5%), sensitivity (53.4% versus 55.9%), and specificity (67.0% versus 67.6%). And there were no significant difference in the diagnostic accuracy between still and moving image tests of demarcation line (65.4% versus 65.5%), microvascular pattern (56.7% versus 56.9%), and microsurface pattern (48.1% versus 50.9%). Diagnostic accuracy showed no significant difference between the still and moving image tests in the subgroups of endoscopic findings of the lesions. Conclusions: The addition of moving M-NBI images to still M-NBI images does not improve the diagnostic accuracy for gastric lesions. It is reasonable to concentrate on taking sharp still M-NBI images during endoscopic observation and use them for diagnosis.	[Hayashi, Tomoyuki; Doyama, Hisashi; Okada, Toshihide] Ishikawa Prefectural Cent Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan; [Shirota, Yukihiro] Saiseikai Kanazawa Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan; [Tsuji, Hirokazu] Kanazawa Municipal Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan; [Marukawa, Youhei; Ohta, Hajime] Kanazawa Med Ctr, Dept Gastroenterol, Kanazawa, Ishikawa, Japan; [Miwa, Kazuhiro] Kanazawa Social Insurance Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan; [Masunaga, Takaharu] Hokuriku Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan; [Terasaki, Shuichi] Kanazawa Red Cross Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan; [Matano, Yutaka] Komatsu Municipal Hosp, Dept Gastroenterol, Komatsu, Ishikawa, Japan; [Tsuji, Kunihiro] Suzu Gen Hosp, Dept Internal Med, Suzu, Ishikawa, Japan; [Kaneko, Yoshibumi] Sangane Clin, Dept Internal Med, Kouta, Aichi, Japan; [Kurumaya, Hiroshi] Ishikawa Prefectural Cent Hosp, Dept Diagnost Pathol, Kanazawa, Ishikawa, Japan; [Kaneko, Shuichi] Kanazawa Univ Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan	Ishikawa Prefectural Central Hospital; Ishikawa Prefectural Central Hospital; Kanazawa University	Doyama, H (corresponding author), Ishikawa Prefectural Cent Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan.	doyama.134@ipch.jp		Shirota, Yukihiro/0000-0001-6561-4626				de Lange T, 2006, GASTROINTEST ENDOSC, V63, P445, DOI 10.1016/j.gie.2005.11.053; de Lange T, 2005, GASTROINTEST ENDOSC, V61, P715, DOI 10.1016/S0016-5107(05)00337-8; Dias-Silva D, 2014, GASTROINTEST ENDOSC, V79, P910, DOI 10.1016/j.gie.2013.10.020; Dinis-Ribeiro MJ, 2008, WORLD J GASTROENTERO, V14, P7086, DOI 10.3748/wjg.14.7086; Ezoe Y, 2011, GASTROENTEROLOGY, V141, P2017, DOI 10.1053/j.gastro.2011.08.007; Ezoe Y, 2010, GASTROINTEST ENDOSC, V71, P477, DOI 10.1016/j.gie.2009.10.036; Gono K, 2004, J BIOMED OPT, V9, P568, DOI 10.1117/1.1695563; Gono K, 2003, OPT REV, V10, P211, DOI 10.1007/s10043-003-0211-8; Guo T, 2014, GASTRIC CANCER, V17, P122, DOI 10.1007/s10120-013-0250-1; Ito R, 2013, ENDOSCOPIC FORUM DIG, V29, P89; Iwashita, 2002, DIGEST ENDOSC, V14, pS83, DOI DOI 10.1046/J.1443-1661.14.S1.16.X; Kato M, 2010, GASTROINTEST ENDOSC, V72, P523, DOI 10.1016/j.gie.2010.04.041; Kiyotoki S, 2010, J GASTROEN HEPATOL, V25, P1636, DOI 10.1111/j.1440-1746.2010.06379.x; Mabe K, 2014, ANN GASTROENTEROL, V27, P149; Miwa K, 2012, GASTRIC CANCER, V15, P170, DOI 10.1007/s10120-011-0093-6; Nagahama T, 2011, GASTROINTEST ENDOSC, V74, P1259, DOI 10.1016/j.gie.2011.09.005; Schlemper RJ, 2000, GUT, V47, P251, DOI 10.1136/gut.47.2.251; Schlemper RJ, 2000, J GASTROEN HEPATOL, V15, pC52; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Wurnig PN, 2003, SURG ENDOSC, V17, P232, DOI 10.1007/s00464-002-9022-4; Yamada S, 2014, GASTROINTEST ENDOSC, V79, P55, DOI 10.1016/j.gie.2013.07.008; Yao K, 2002, GASTROINTEST ENDOSC, V56, P279, DOI 10.1067/mge.2002.126061; Yao K, 2009, ENDOSCOPY, V41, P462, DOI 10.1055/s-0029-1214594; Yao K, 2007, CLIN GASTROENTEROL H, V5, P869, DOI 10.1016/j.cgh.2007.02.034; Yao K, 2014, GASTRIC CANCER, V17, P669, DOI 10.1007/s10120-013-0332-0; Yoo CH, 2014, CLIN ENDOSC, V47, P74, DOI 10.5946/ce.2014.47.1.74; Zhang J, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-135	27	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100857	10.1371/journal.pone.0100857	http://dx.doi.org/10.1371/journal.pone.0100857			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988209	gold, Green Published, Green Submitted			2022-12-27	WOS:000341354100047
J	Narayanaswamy, PB; Hodjat, M; Haller, H; Dumler, I; Kiyan, Y				Narayanaswamy, Pavan B.; Hodjat, Mahshid; Haller, Hermann; Dumler, Inna; Kiyan, Yulia			Loss of Urokinase Receptor Sensitizes Cells to DNA Damage and Delays DNA Repair	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; 26S PROTEASOME; CANCER-THERAPY; UPAR; DEGRADATION; RESISTANCE; DISEASE; SYSTEM; TARGET	DNA damage induced by numerous exogenous or endogenous factors may have irreversible consequences on the cell leading to cell cycle arrest, senescence and cell death. The DNA damage response (DDR) is powerful signaling machinery triggered in response to DNA damage, to provide DNA damage recognition, signaling and repair. Most anticancer drugs induce DNA damage, and DNA repair in turn attenuates therapeutic efficiency of those drugs. Approaches delaying DNA repair are often used to increase efficiency of treatment. Recent data show that ubiquitin-proteasome system is essential for signaling and repair of DNA damage. However, mechanisms providing regulation of proteasome intracellular localization, activity, and recruitment to DNA damage sites are elusive. Even less investigated are the roles of extranuclear signaling proteins in these processes. In this study, we report the involvement of the serine protease urokinase-type plasminogen activator receptor (uPAR) in DDR-associated regulation of proteasome. We show that in vascular smooth muscle cells (VSMC) uPAR activates DNA single strand break repair signaling pathway. We provide evidence that uPAR is essential for functional assembly of the 26S proteasome. We further demonstrate that uPAR mediates DNA damage-induced phosphorylation, nuclear import, and recruitment of the regulatory subunit PSMD6 to proteasome. We found that deficiency of uPAR and PSMD6 delays DNA repair and leads to decreased cell survival. These data may offer new therapeutic approaches for diseases such as cancer, cardiovascular and neurodegenerative disorders.	[Narayanaswamy, Pavan B.; Hodjat, Mahshid; Haller, Hermann; Dumler, Inna; Kiyan, Yulia] Hannover Med Sch, Dept Nephrol, Hannover, Germany	Hannover Medical School	Kiyan, Y (corresponding author), Hannover Med Sch, Dept Nephrol, Hannover, Germany.	kiian.ioulia@mh-hannover.de	Kiyan, Yulia/D-7284-2011	Hodjat, Mahshid/0000-0001-8335-3546; Kiyan, Yulia/0000-0002-2063-6327; Narayanaswamy, Pavan/0000-0001-5135-0527	Deutsche Forschungsgemeinschaft [KI 1376/2-1, KI 1376/2-2]; Deutsche Akademischer Austausch Dienst [A/08/98019]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/), grant numbers: KI 1376/2-1, KI 1376/2-2 and by Deutsche Akademischer Austausch Dienst (https://www.daad.de/en/), fellowship number A/08/98019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asuthkar S, 2012, J BIOL CHEM, V287, P20576, DOI 10.1074/jbc.M112.348888; Bai J, 2012, ASIAN PAC J CANCER P, V13, P4879, DOI 10.7314/APJCP.2012.13.10.4879; Barakat K, 2012, CURR TOP MED CHEM, V12, P1376, DOI 10.2174/156802612801319070; Binder BR, 2007, THROMB HAEMOSTASIS, V97, P336, DOI 10.1160/TH06-11-0669; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Cho-Park PF, 2013, CELL, V153, P614, DOI 10.1016/j.cell.2013.03.040; Dhawan A, 2001, MUTAT RES-FUND MOL M, V474, P121, DOI 10.1016/S0027-5107(00)00171-8; Espinosa E, 2003, CANCER TREAT REV, V29, P515, DOI 10.1016/S0305-7372(03)00116-6; FALLIERBECKER P, 1990, CELL CULTURE TECHNIQ, P247; Frankland-Searby S, 2012, BBA-REV CANCER, V1825, P64, DOI 10.1016/j.bbcan.2011.10.003; Gillette TG, 2006, EMBO J, V25, P2529, DOI 10.1038/sj.emboj.7601120; Gray K, 2011, BIOCHEM PHARMACOL, V82, P693, DOI 10.1016/j.bcp.2011.06.025; Hayward R, 2013, J PHYSIOL BIOCHEM, V69, P177, DOI 10.1007/s13105-012-0200-0; Hodjat M, 2013, J VASC RES, V50, P109, DOI 10.1159/000343000; Imai J, 2003, EMBO J, V22, P3557, DOI 10.1093/emboj/cdg349; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Karpov DS, 2013, FEBS LETT, V587, P3108, DOI 10.1016/j.febslet.2013.08.007; Kikuchi J, 2010, PROTEOMICS, V10, P2769, DOI 10.1002/pmic.200900283; Kiyan Y, 2012, ARTERIOSCL THROM VAS, V32, P110, DOI 10.1161/ATVBAHA.111.234369; Lebwohl M, 2005, ANN RHEUM DIS, V64, P83, DOI 10.1136/ard.2004.030791; Lee MY, 2007, BIOCHEM BIOPH RES CO, V360, P483, DOI 10.1016/j.bbrc.2007.06.084; Malla RR, 2012, NEURO-ONCOLOGY, V14, P745, DOI 10.1093/neuonc/nos088; Moiseeva TN, 2013, ONCOTARGET, V4, P1338, DOI 10.18632/oncotarget.1060; Pillay V, 2007, TRENDS BIOTECHNOL, V25, P33, DOI 10.1016/j.tibtech.2006.10.011; Ponnala S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026191; Ramadan K, 2011, FEBS LETT, V585, P2868, DOI 10.1016/j.febslet.2011.04.046; Ranek MJ, 2009, CURR HYPERTENS REP, V11, P389, DOI 10.1007/s11906-009-0068-8; Rowe LA, 2008, FREE RADICAL BIO MED, V45, P1167, DOI 10.1016/j.freeradbiomed.2008.07.018; Shushakova N, 2005, J CELL SCI, V118, P2743, DOI 10.1242/jcs.02409; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Tsolou A, 2012, IUBMB LIFE, V64, P432, DOI 10.1002/iub.1018; Ullrich O, 1999, P NATL ACAD SCI USA, V96, P6223, DOI 10.1073/pnas.96.11.6223; Vallabhaneni KC, 2011, CARDIOVASC RES, V90, P113, DOI 10.1093/cvr/cvq362; Zhang FG, 2005, RAPID COMMUN MASS SP, V19, P438, DOI 10.1002/rcm.1806	35	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101529	10.1371/journal.pone.0101529	http://dx.doi.org/10.1371/journal.pone.0101529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987841	Green Submitted, gold, Green Published			2022-12-27	WOS:000341354100108
J	Olivieri, C; Marota, I; Rizzi, E; Ermini, L; Fusco, L; Pietrelli, A; De Bellis, G; Rollo, F; Luciani, S				Olivieri, Cristina; Marota, Isolina; Rizzi, Ermanno; Ermini, Luca; Fusco, Letizia; Pietrelli, Alessandro; De Bellis, Gianluca; Rollo, Franco; Luciani, Stefania			Positioning the Red Deer (Cervus elaphus) Hunted by the Tyrolean Iceman into a Mitochondrial DNA Phylogeny	PLOS ONE			English	Article							PHYLOGEOGRAPHY; COLONIZATION; POPULATIONS	In the last years several phylogeographic studies of both extant and extinct red deer populations have been conducted. Three distinct mitochondrial lineages (western, eastern and North-African/Sardinian) have been identified reflecting different glacial refugia and postglacial recolonisation processes. However, little is known about the genetics of the Alpine populations and no mitochondrial DNA sequences from Alpine archaeological specimens are available. Here we provide the first mitochondrial sequences of an Alpine Copper Age Cervus elaphus. DNA was extracted from hair shafts which were part of the remains of the clothes of the glacier mummy known as the Tyrolean Iceman or Otzi (5,350-5,100 years before present). A 2,297 base pairs long fragment was sequenced using a mixed sequencing procedure based on PCR amplifications and 454 sequencing of pooled amplification products. We analyzed the phylogenetic relationships of the Alpine Copper Age red deer's haplotype with haplotypes of modern and ancient European red deer. The phylogenetic analyses showed that the haplotype of the Alpine Copper Age red deer falls within the western European mitochondrial lineage in contrast with the current populations from the Italian Alps belonging to the eastern lineage. We also discussed the phylogenetic relationships of the Alpine Copper Age red deer with the populations from Mesola Wood (northern Italy) and Sardinia.	[Olivieri, Cristina; Marota, Isolina; Fusco, Letizia; Rollo, Franco; Luciani, Stefania] Univ Camerino, Sch Biosci & Vet Med, Lab Mol Archaeoanthropol Ancient DNA, I-62032 Camerino, Italy; [Rizzi, Ermanno; Pietrelli, Alessandro; De Bellis, Gianluca] CNR, Inst Biomed Technol, Segrate, Italy; [Ermini, Luca] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark	University of Camerino; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Copenhagen	Luciani, S (corresponding author), Univ Camerino, Sch Biosci & Vet Med, Lab Mol Archaeoanthropol Ancient DNA, I-62032 Camerino, Italy.	stefania.luciani@unicam.it	Ermini, Luca/O-4813-2016; rizzi, ermanno/Q-3399-2016; Pietrelli, Alessandro/J-4389-2016; De Bellis, Gianluca/H-9725-2013	Ermini, Luca/0000-0001-8109-6021; rizzi, ermanno/0000-0002-9898-2326; Pietrelli, Alessandro/0000-0003-0241-8542; Olivieri, Cristina/0000-0002-2957-5452; De Bellis, Gianluca/0000-0002-1622-4477	University of Camerino (Fondo di Ricerca di Ateneo); Italian Research Ministry grants "Futuro in ricerca" [RBFR08U07M_003, RBFR126B8I_003]	University of Camerino (Fondo di Ricerca di Ateneo); Italian Research Ministry grants "Futuro in ricerca"	This study was supported by the University of Camerino (Fondo di Ricerca di Ateneo). ER was supported by Italian Research Ministry grants "Futuro in ricerca" RBFR08U07M_003 and RBFR126B8I_003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZZI CM, 1974, RADIOCARBON, V16, P10, DOI 10.1017/S0033822200001405; Bagolini B, 1995, MANN EIS NEUE FUNDE, P3; Barker G., 1985, PREHISTORIC FARMING; BIETTI A, 1994, QUATERNARIA NOVA, V4, P9; Carden RF, 2012, QUATERNARY SCI REV, V42, P74, DOI 10.1016/j.quascirev.2012.02.012; Cassoli P.F., 1995, Quaternaria Nova, V4, P101; Gilbert MTP, 2003, AM J HUM GENET, V72, P48, DOI 10.1086/345379; Groenman-van Waatering W., 1992, JB ROMISCH GERMANISC, V39, P114; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HARTL GB, 1995, Z SAUGETIERKD, V60, P41; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hollemeyer K, 2012, RAPID COMMUN MASS SP, V26, P1735, DOI 10.1002/rcm.6277; Lange J, 1992, MANN EIS, V187, P419; Lorenzini R, 2005, MAMM BIOL, V70, P187, DOI 10.1016/j.mambio.2004.11.018; Ludt CJ, 2004, MOL PHYLOGENET EVOL, V31, P1064, DOI 10.1016/j.ympev.2003.10.003; MATTIOLI S, 2001, HYSTRIX, V12, P27; Meiri M, 2013, MOL ECOL, V22, P4711, DOI 10.1111/mec.12420; Mussi M, 2001, EARLIEST ITALY OVERV, P317; Olivieri C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033792; Rollo F, 2002, P NATL ACAD SCI USA, V99, P12594, DOI 10.1073/pnas.192184599; Rollo F, 1994, ANCIENT DNA NEWSLETT, V2, P21; Rollo F, 1995, MANN EIS, P91; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Skog A, 2009, J BIOGEOGR, V36, P66, DOI 10.1111/j.1365-2699.2008.01986.x; Sommer RS, 2008, QUATERNARY SCI REV, V27, P714, DOI 10.1016/j.quascirev.2007.11.016; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Zachos FE, 2009, WILDLIFE BIOL, V15, P175, DOI 10.2981/07-075	29	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100136	10.1371/journal.pone.0100136	http://dx.doi.org/10.1371/journal.pone.0100136			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988290	Green Published, Green Submitted, gold			2022-12-27	WOS:000341354100024
J	Tarrega, S; Fagundo, AB; Jimenez-Murcia, S; Granero, R; Giner-Bartolome, C; Forcano, L; Sanchez, I; Santamaria, JJ; Ben-Moussa, M; Magnenat-Thalmann, N; Konstantas, D; Lucas, M; Nielsen, J; Bults, RGA; Lam, T; Kostoulas, T; Fakotakis, N; Riesco, N; Wolz, I; Comin-Colet, J; Cardi, V; Treasure, J; Fernandez-Formoso, JA; Menchon, JM; Fernandez-Aranda, F				Tarrega, Salome; Fagundo, Ana B.; Jimenez-Murcia, Susana; Granero, Roser; Giner-Bartolome, Cristina; Forcano, Laura; Sanchez, Isabel; Jose Santamaria, Juan; Ben-Moussa, Maher; Magnenat-Thalmann, Nadia; Konstantas, Dimitri; Lucas, Mikkel; Nielsen, Jeppe; Bults, Richard G. A.; Lam, Tony; Kostoulas, Theodoros; Fakotakis, Nikos; Riesco, Nadine; Wolz, Ines; Comin-Colet, Josep; Cardi, Valentina; Treasure, Janet; Antonio Fernandez-Formoso, Jose; Manuel Menchon, Jose; Fernandez-Aranda, Fernando			Explicit and Implicit Emotional Expression in Bulimia Nervosa in the Acute State and after Recovery	PLOS ONE			English	Article							EATING-DISORDERS; INDIVIDUAL-DIFFERENCES; SUPPRESSION; SLEEP; ANGER; PSYCHOPATHOLOGY; REAPPRAISAL; PERSONALITY; PREVALENCE; THERAPY	Expression of emotional state is considered to be a core facet of an individual's emotional competence. Emotional processing in BN has not been often studied and has not been considered from a broad perspective. This study aimed at examining the implicit and explicit emotional expression in BN patients, in the acute state and after recovery. Sixty-three female participants were included: 22 BN, 22 recovered BN (R-BN), and 19 healthy controls (HC). The clinical cases were drawn from consecutive admissions and diagnosed according to DSM-IV-TR diagnostic criteria. Self reported (explicit) emotional expression was measured with State-Trait Anger Expression Inventory-2, State-Trait Anxiety Inventory, and Symptom Check List-90 items-Revised. Emotional facial expression (implicit) was recorded by means of an integrated camera (by detecting Facial Feature Tracking), during a 20 minutes therapeutic video game. In the acute illness explicit emotional expression [anxiety (p<0.001) and anger (p<0.05)] was increased. In the recovered group this was decreased to an intermediate level between the acute illness and healthy controls [anxiety (p<0.001) and anger (p<0.05)]. In the implicit measurement of emotional expression patients with acute BN expressed more joy (p<0.001) and less anger (p<0.001) than both healthy controls and those in the recovered group. These findings suggest that there are differences in the implicit and explicit emotional processing in BN, which is significantly reduced after recovery, suggesting an improvement in emotional regulation.	[Tarrega, Salome; Granero, Roser] Univ Autonoma Barcelona, Dept Psicobiol & Metodol Ciencies Salut, E-08193 Barcelona, Spain; [Fagundo, Ana B.; Jimenez-Murcia, Susana; Granero, Roser; Forcano, Laura; Jose Santamaria, Juan; Fernandez-Aranda, Fernando] Inst Salud Carlos III, Ciber Fisiopatol & Obesidad Nutr CIBERObn, Madrid, Spain; [Fagundo, Ana B.; Jimenez-Murcia, Susana; Giner-Bartolome, Cristina; Forcano, Laura; Sanchez, Isabel; Jose Santamaria, Juan; Riesco, Nadine; Wolz, Ines; Manuel Menchon, Jose; Fernandez-Aranda, Fernando] Bellvitge Univ Hosp IDIBELL, Dept Psychiat, Barcelona, Spain; [Jimenez-Murcia, Susana; Manuel Menchon, Jose; Fernandez-Aranda, Fernando] Univ Barcelona, Sch Med, Dept Clin Sci, Barcelona, Spain; [Ben-Moussa, Maher; Magnenat-Thalmann, Nadia; Konstantas, Dimitri] Univ Geneva, Fac Social Sci & Econ, Geneva, Switzerland; [Lucas, Mikkel; Nielsen, Jeppe] Serious Game Interact SGI, Copenhagen, Denmark; [Bults, Richard G. A.] MobiHealth BV, Enschede, Netherlands; [Lam, Tony] NetUnion, Lausanne, Switzerland; [Kostoulas, Theodoros; Fakotakis, Nikos] Univ Patras, Wire Commun Lab, Patras, Greece; [Comin-Colet, Josep] Inst Hosp del Mar Invest Med, Dept Cardiol, Barcelona, Spain; [Cardi, Valentina; Treasure, Janet] Kings Coll London, Inst Psychiat, Eating Disorders Unit, London WC2R 2LS, England; [Antonio Fernandez-Formoso, Jose] Inst Salud Carlos III, CIBER, Madrid, Spain; [Manuel Menchon, Jose] Inst Salud Carlos III, CIBER Salud Mental CIBERSAM, Barcelona, Spain	Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Barcelona; University of Geneva; University of Patras; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of London; King's College London; CIBER - Centro de Investigacion Biomedica en Red; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III	Fernandez-Aranda, F (corresponding author), Inst Salud Carlos III, Ciber Fisiopatol & Obesidad Nutr CIBERObn, Madrid, Spain.	ffernandez@bellvitgehospital.cat	Larrea, Salomé Tárrega/AAE-2684-2020; Tárrega, Salomé/D-8876-2011; Díaz, Isabel M Sánchez/G-7277-2017; FERNANDEZ-ARANDA, FERNANDO/AGY-1597-2022; Lorenzo, Juan Jose Santamaria/G-6309-2019; Granero, Roser/F-9492-2016; Fernandez-Aranda, Fernando/L-9762-2014; FORCANO, LAURA/AAP-1933-2020; Comin-Colet, Josep/AAM-3000-2021; Gamazo, Laura Forcano/B-1154-2017; Thalmann, Nadia/AAK-5195-2021; Granero, Roser/S-3529-2019; JIMENEZ-MURCIA, SUSANA/L-9786-2014; Riesco, Nadine/L-1114-2014; Menchon, Jose/A-5242-2009	Larrea, Salomé Tárrega/0000-0002-5820-6795; Tárrega, Salomé/0000-0002-5820-6795; Díaz, Isabel M Sánchez/0000-0001-5874-8204; FERNANDEZ-ARANDA, FERNANDO/0000-0002-2968-9898; Lorenzo, Juan Jose Santamaria/0000-0001-9957-9363; Granero, Roser/0000-0001-6308-3198; Fernandez-Aranda, Fernando/0000-0002-2968-9898; FORCANO, LAURA/0000-0002-8478-1451; Comin-Colet, Josep/0000-0001-8780-720X; Gamazo, Laura Forcano/0000-0002-8478-1451; Thalmann, Nadia/0000-0002-1459-5960; JIMENEZ-MURCIA, SUSANA/0000-0002-3596-8033; Riesco, Nadine/0000-0002-6336-4907; Cardi, Valentina/0000-0002-7763-7099; Wolz, Ines/0000-0001-8338-3948; Menchon, Jose/0000-0002-6231-6524; Konstantas, Dimitri/0000-0002-2664-9348; Fagundo, Ana Beatriz/0000-0003-1703-9457; Kostoulas, Theodoros/0000-0003-2201-6938; FERNANDEZ FORMOSO, JOSE ANTONIO/0000-0001-5310-1655; Treasure, Janet/0000-0003-0871-4596	European Union [OCK1-1999-916]; AGAUR [2009SGR1554]; Fondo de Investigacion Sanitaria -FIS [FI12/00470, PI081573, PI11/210]; Ministerio de Ciencia e Innovacion-MICINN Subprograma Juan de la Cierva [JCI-2011-09248]	European Union(European Commission); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Fondo de Investigacion Sanitaria -FIS(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion-MICINN Subprograma Juan de la Cierva	Financial support was received from the European Union (Framework-V Multicenter Research Grant, OCK1-1999-916), AGAUR (2009SGR1554) and Fondo de Investigacion Sanitaria -FIS (FI12/00470, PI081573 and PI11/210). BF was supported by Ministerio de Ciencia e Innovacion-MICINN Subprograma Juan de la Cierva (JCI-2011-09248). CIBERobn and CIBERSAM were both initiatives of Instituto de Salud Carlos III (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JL, 2005, ARCH GEN PSYCHIAT, V62, P668, DOI 10.1001/archpsyc.62.6.668; Allen KL, 2013, J ABNORM PSYCHOL, V122, P720, DOI 10.1037/a0034004; APA, 2000, DSM 4 TR DIAGN STAT; Arcelus J, 2013, CLIN PSYCHOL REV, V33, P156, DOI 10.1016/j.cpr.2012.10.009; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; Berg KC, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0407-y; Butler EA, 2014, BIOL PSYCHOL, V98, P6, DOI 10.1016/j.biopsycho.2013.09.003; Cagar-Nazai HP, 2014, NEUROSCI BIOBEHAV R, V42, P55, DOI 10.1016/j.neubiorev.2013.12.002; Cardi V, 2013, WORLD J BIOL PSYCHIA, V14, P622, DOI 10.3109/15622975.2012.665479; Carver CS, 2009, PSYCHOL BULL, V135, P183, DOI 10.1037/a0013965; Claes L, 2012, EUR EAT DISORD REV, V20, P484, DOI 10.1002/erv.2212; Corstorphine E, 2006, EUR EAT DISORD REV, V14, P448, DOI 10.1002/erv.747; Davies H, 2012, EUR EAT DISORD REV, V20, P476, DOI 10.1002/erv.1157; Davies H, 2011, INT J EAT DISORDER, V44, P531, DOI 10.1002/eat.20852; Deliens G, 2014, EXP BRAIN RES, V232, P1403, DOI 10.1007/s00221-014-3832-1; Derogatis, 1994, SCL 90 R CUESTIONARI; English T, 2013, EMOTION, V13, P314, DOI 10.1037/a0029847; Fagundo AB, 2013, EUR EAT DISORD REV, V21, P493, DOI 10.1002/erv.2259; Fairburn CG, 2003, LANCET, V361, P407, DOI 10.1016/S0140-6736(03)12378-1; Fassino S, 2001, J PSYCHOSOM RES, V51, P757, DOI 10.1016/S0022-3999(01)00280-X; Fernandez-Aranda F, 2012, J MENT HEALTH, V21, P364, DOI 10.3109/09638237.2012.664302; First M. D., 1996, USERS GUIDE STRUCTUR; Fox JRE, 2009, CLIN PSYCHOL PSYCHOT, V16, P240, DOI 10.1002/cpp.626; Giuliani NR, 2011, NEUROIMAGE, V58, P10, DOI 10.1016/j.neuroimage.2011.06.028; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Gonzalez de Rivera JL, 2002, CUESTIONARIO 90 SINT; Gosselin P, 2002, J GENET PSYCHOL, V163, P479, DOI 10.1080/00221320209598697; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Guillen-Riquelme A, 2011, PSICOTHEMA, V23, P510; Gyurak A, 2011, COGNITION EMOTION, V25, P400, DOI 10.1080/02699931.2010.544160; Hagemann T, 2006, PSYCHOPHYSIOLOGY, V43, P104, DOI 10.1111/j.1469-8986.2006.00382.x; Hermann A, 2009, SOC COGN AFFECT NEUR, V4, P257, DOI 10.1093/scan/nsp013; Ioannou K, 2009, CLIN PSYCHOL PSYCHOT, V16, P336, DOI 10.1002/cpp.632; Kim KR, 2010, PSYCHIAT RES, V176, P88, DOI 10.1016/j.psychres.2009.03.021; Kompus K, 2009, NEUROSCI LETT, V467, P76, DOI 10.1016/j.neulet.2009.10.005; Krug I, 2008, PSYCHIAT RES, V161, P195, DOI 10.1016/j.psychres.2007.10.003; Lane RD, 2009, NEUROIMAGE, V44, P213, DOI 10.1016/j.neuroimage.2008.07.056; Lauer CJ, 2004, SLEEP MED REV, V8, P109, DOI 10.1016/S1087-0792(02)00122-3; Levesque J, 2003, BIOL PSYCHIAT, V53, P502, DOI 10.1016/S0006-3223(02)01817-6; Martinez-Azumendi O, 2001, ACTAS ESP PSIQUIATRI, V29, P95; Meyer C, 2010, INT J EAT DISORDER, V43, P187, DOI 10.1002/eat.20659; Miguel-Tobal J.J., 2001, INVENTARIO EXPRESSIO; Oldershaw A, 2011, NEUROSCI BIOBEHAV R, V35, P970, DOI 10.1016/j.neubiorev.2010.11.001; Spielberger C.D., 1999, STAXI 2 STATE TRAIT; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Spielberger CD., 1982, STAI CUESTIONARIO AN; Vanderhasselt MA, 2013, BIOL PSYCHOL, V92, P433, DOI 10.1016/j.biopsycho.2012.03.005; Zeidan F, 2014, SOC COGN AFFECT NEUR, V9, P751, DOI 10.1093/scan/nst041	48	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101639	10.1371/journal.pone.0101639	http://dx.doi.org/10.1371/journal.pone.0101639			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BA	24987853	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000341354100124
J	Walvekar, AS; Choudhury, R; Punekar, NS				Walvekar, Adhish S.; Choudhury, Rajarshi; Punekar, Narayan S.			Mixed Disulfide Formation at Cys141 Leads to Apparent Unidirectional Attenuation of Aspergillus niger NADP-Glutamate Dehydrogenase Activity	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; CYSTEINE RESIDUE; AMINO-ACID; SUBSTRATE-SPECIFICITY; REACTIVE CYSTEINE; INHIBITION; IDENTIFICATION; ENZYME; 2-MERCAPTOETHANOL; DEAMIDATION	NADP-Glutamate dehydrogenase from Aspergillus niger (AnGDH) exhibits sigmoid 2-oxoglutarate saturation. Incubation with 2-hydroxyethyl disulfide (2-HED, the disulfide of 2-mercaptoethanol) resulted in preferential attenuation of AnGDH reductive amination (forward) activity but with a negligible effect on oxidative deamination (reverse) activity, when monitored in the described standard assay. Such a disulfide modified AnGDH displaying less than 1.0% forward reaction rate could be isolated after 2-HED treatment. This unique forward inhibited GDH form (FIGDH), resembling a hypothetical 'one-way' active enzyme, was characterized. Kinetics of 2-HED mediated inhibition and protein thiol titrations suggested that a single thiol group is modified in FIGDH. Two site-directed cysteine mutants, C141S and C415S, were constructed to identify the relevant thiol in FIGDH. The forward activity of C141S alone was insensitive to 2-HED, implicating Cys141 in FIGDH formation. It was observed that FIGDH displayed maximal reaction rate only after a pre-incubation with 2-oxoglutarate and NADPH. In addition, compared to the native enzyme, FIGDH showed a four fold increase in K-0.5 for 2-oxoglutarate and a two fold increase in the Michaelis constants for ammonium and NADPH. With no change in the GDH reaction equilibrium constant, the FIGDH catalyzed rate of approach to equilibrium from reductive amination side was sluggish. Altered kinetic properties of FIGDH at least partly account for the observed apparent loss of forward activity when monitored under defined assay conditions. In sum, although Cys141 is catalytically not essential, its covalent modification provides a striking example of converting the biosynthetic AnGDH into a catabolic enzyme.	[Walvekar, Adhish S.; Choudhury, Rajarshi; Punekar, Narayan S.] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Punekar, NS (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	nsp@iitb.ac.in	Walvekar, Adhish/AAO-1577-2021	Walvekar, Adhish/0000-0001-7344-7653	Council of Scientific and Industrial Research, India	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported under a project and also research fellowships (to ASW and RC) from Council of Scientific and Industrial Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES LD, 1972, BIOCHEMISTRY-US, V11, P4322, DOI 10.1021/bi00773a019; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROTHERTON JE, 1980, PHYSIOL CHEM PHYS M, V12, P483; Budavari S., 1997, MERCK INDEX, Vthirteenth; Cho SW, 1999, MOL CELLS, V9, P91; Choudhury R, 2009, MYCOL RES, V113, P1121, DOI 10.1016/j.mycres.2009.07.009; Cornish-Bowden A., 2012, FUNDAMENTALS ENZYME; COSSON MP, 1976, BIOCHEM BIOPH RES CO, V72, P1304, DOI 10.1016/S0006-291X(76)80157-X; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; DeLuna A, 2005, BIOCHEM BIOPH RES CO, V328, P1083, DOI 10.1016/j.bbrc.2005.01.057; DONASCIMENTO KH, 1975, BIOCHEM J, V149, P349, DOI 10.1042/bj1490349; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENGEL PC, 1967, BIOCHEM J, V105, P691, DOI 10.1042/bj1050691; Fincham JRS, 2000, GENET RES, V76, P1, DOI 10.1017/S0016672300004602; FRIEDEN C, 1964, J BIOL CHEM, V239, P3522; GAN ZR, 1987, ANAL BIOCHEM, V162, P265, DOI 10.1016/0003-2697(87)90036-4; HAEFFNERGORMLEY L, 1992, ARCH BIOCHEM BIOPHYS, V292, P179, DOI 10.1016/0003-9861(92)90066-6; HUDSON RC, 1993, COMP BIOCHEM PHYS B, V106, P767, DOI 10.1016/0305-0491(93)90031-Y; JONES KM, 1993, MOL GEN GENET, V240, P286, DOI 10.1007/BF00277068; Karaca M, 2011, NEUROCHEM INT, V59, P510, DOI 10.1016/j.neuint.2011.03.024; Khan MIH, 2005, BIOSCI BIOTECH BIOCH, V69, P1802, DOI 10.1271/bbb.69.1802; KLEMME JH, 1976, ARCH MICROBIOL, V107, P189, DOI 10.1007/BF00446838; KOUNDAL KR, 1983, PHYTOCHEMISTRY, V22, P2183, DOI 10.1016/S0031-9422(00)80142-9; KREBS HA, 1977, ADV ENZYME REGUL, V15, P375, DOI 10.1016/0065-2571(77)90026-7; KURAMITS.HK, 1966, BIOCHEM BIOPH RES CO, V23, P329, DOI 10.1016/0006-291X(66)90550-X; LAL M, 1985, CAN J CHEM, V63, P30, DOI 10.1139/v85-005; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAURENT TC, 1964, J CHROMATOGR, V14, P317, DOI 10.1016/S0021-9673(00)86637-6; LEJOHN HB, 1968, J BIOL CHEM, V243, P5126; LEUNG PSK, 1985, J PHYS CHEM-US, V89, P5267, DOI 10.1021/j100270a029; Li Q, 2008, MYCOL RES, V112, P1049, DOI 10.1016/j.mycres.2008.03.004; LILLEY KS, 1992, EUR J BIOCHEM, V207, P533, DOI 10.1111/j.1432-1033.1992.tb17079.x; Lundblad R.L., 1994, TECHNIQUES PROTEIN M; MCPHERSON MJ, 1988, PROTEIN ENG, V2, P147, DOI 10.1093/protein/2.2.147; MICHEL F, 1978, EUR J BIOCHEM, V84, P267, DOI 10.1111/j.1432-1033.1978.tb12165.x; Montero-Moran GM, 2001, BIOCHEMISTRY-US, V40, P10187, DOI 10.1021/bi0105835; Montrichard F, 2009, J PROTEOMICS, V72, P452, DOI 10.1016/j.jprot.2008.12.002; MUDD SH, 1963, J BIOL CHEM, V238, P2164; NAKAJIMA Y, 1991, J BIOCHEM, V109, P251; Noor S, 2005, MICROBIOL-SGM, V151, P1409, DOI 10.1099/mic.0.27751-0; OLSON JA, 1953, J BIOL CHEM, V202, P841; OZTURK DH, 1991, BIOCHEMISTRY-US, V30, P7126, DOI 10.1021/bi00243a013; Paradisi F, 2005, BIOCHEMISTRY-US, V44, P3636, DOI 10.1021/bi047679u; PONTIS HG, 1981, P NATL ACAD SCI-BIOL, V78, P6667, DOI 10.1073/pnas.78.11.6667; PONTREMOLI S, 1967, P NATL ACAD SCI USA, V58, P286, DOI 10.1073/pnas.58.1.286; RASCHED I, 1982, BIOCHIM BIOPHYS ACTA, V707, P267, DOI 10.1016/0167-4838(82)90360-0; ROBINSON GW, 1967, J BIOL CHEM, V242, P2709; Sharkey MA, 2008, FEMS MICROBIOL LETT, V281, P132, DOI 10.1111/j.1574-6968.2008.01086.x; STOREY KB, 1975, COMP BIOCHEM PHYS B, V52, P169, DOI 10.1016/0305-0491(75)90135-2; WANG XG, 1994, PROTEIN ENG, V7, P1013, DOI 10.1093/protein/7.8.1013; WANG XG, 1995, PROTEIN ENG, V8, P147, DOI 10.1093/protein/8.2.147; Wang XG, 2001, EUR J BIOCHEM, V268, P5791, DOI 10.1046/j.0014-2956.2001.02523.x; Yang SJ, 2005, MOL CELLS, V19, P97; Yoon HY, 2004, BIOCHIMIE, V86, P261, DOI 10.1016/j.biochi.2004.04.005	55	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101662	10.1371/journal.pone.0101662	http://dx.doi.org/10.1371/journal.pone.0101662			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987966	gold, Green Published, Green Submitted			2022-12-27	WOS:000341354100125
J	Asok, A; Bernard, K; Rosen, JB; Dozier, M; Roth, TL				Asok, Arun; Bernard, Kristin; Rosen, Jeffrey B.; Dozier, Mary; Roth, Tania L.			Infant-Caregiver Experiences Alter Telomere Length in the Brain	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; EARLY-LIFE STRESS; CELL-PROLIFERATION; OXIDATIVE STRESS; RAT MODEL; AMYGDALA; MALTREATMENT; ADOLESCENT; BEHAVIOR; ANXIETY	Following adverse childhood experiences, high quality maternal care can protect against accelerated telomere shortening in peripheral cells. It is less clear, however, how telomere length in the brain is influenced by early caregiving experiences. Using rats, we investigated if quality of care (i.e., aversive or nurturing care outside of the homecage) during the first seven days of postnatal (PN) life affected telomere length in the adult brain (PN90) of male and female rats. At PN90, we found that nurturing care outside of the homecage was associated with longer telomeres in the medial prefrontal cortex relative to nurturing care inside the homecage (i.e., normal maternal care) and aversive care outside of the homecage. Further, pups exposed to aversive care outside of the homecage demonstrated longer telomeres in the amygdala relative to pups exposed to nurturing care inside the homecage. These effects were specific to females. No differences in telomere length between caregiving conditions were observed in the ventral hippocampus. Thus, positive and negative early-life experiences result in long-term, sex-specific changes of telomeres in the brain.	[Asok, Arun; Rosen, Jeffrey B.; Dozier, Mary; Roth, Tania L.] Univ Delaware, Dept Psychol & Brain Sci, Newark, DE 19716 USA; [Bernard, Kristin] SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA	University of Delaware; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Roth, TL (corresponding author), Univ Delaware, Dept Psychol & Brain Sci, Newark, DE 19716 USA.	troth@psych.udel.edu	Dozier, Mary/AAN-9486-2020	Asok, Arun/0000-0001-9056-8799	University of Delaware Research Foundation; NIGMS [1P20GM103653]; Brain & Behavior Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103653] Funding Source: NIH RePORTER	University of Delaware Research Foundation; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Brain & Behavior Research Foundation(NARSAD); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this research was provided by University of Delaware Research Foundation, NIGMS (1P20GM103653), and The Brain & Behavior Research Foundation to T.L.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asok A, 2013, DEV PSYCHOPATHOL, V25, P577, DOI 10.1017/S0954579413000011; Beery AK, 2012, BIOL LETTERS, V8, P1063, DOI 10.1098/rsbl.2012.0747; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Blaze J, 2013, INT J DEV NEUROSCI, V31, P804, DOI 10.1016/j.ijdevneu.2013.10.001; Blaze J, 2013, DEV NEUROSCI-BASEL, V35, P306, DOI 10.1159/000350716; Bock J, 2005, CEREB CORTEX, V15, P802, DOI 10.1093/cercor/bhh181; Botha Martmari, 2012, BMC Res Notes, V5, P697, DOI 10.1186/1756-0500-5-697; Branchi I, 2013, PSYCHONEUROENDOCRINO, V38, P522, DOI 10.1016/j.psyneuen.2012.07.010; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; Champagne FA, 2013, BEHAV NEUROSCI, V127, P628, DOI 10.1037/a0034186; Cherif H, 2003, NUCLEIC ACIDS RES, V31, P1576, DOI 10.1093/nar/gkg208; Cicchetti D, 2005, ANNU REV CLIN PSYCHO, V1, P409, DOI 10.1146/annurev.clinpsy.1.102803.144029; CovielloMcLaughlin GM, 1997, NUCLEIC ACIDS RES, V25, P3051, DOI 10.1093/nar/25.15.3051; D'Andrea I, 2010, BEHAV BRAIN RES, V215, P71, DOI 10.1016/j.bbr.2010.06.030; Dabouras V, 2004, NEUROSCI LETT, V368, P68, DOI 10.1016/j.neulet.2004.06.066; Drury SS, 2012, MOL PSYCHIATR, V17, P719, DOI 10.1038/mp.2011.53; Eitan E, 2014, TRENDS NEUR IN PRESS; Elvsashagen T, 2011, J AFFECT DISORDERS, V135, P43, DOI 10.1016/j.jad.2011.08.006; Epel ES, 2013, CLIN PSYCHOL SCI, V1, P75, DOI 10.1177/2167702612460234; Epel ES, 2009, HORM-INT J ENDOCRINO, V8, P7, DOI 10.14310/horm.2002.1217; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Flanary B, 2005, REJUV RES, V8, P82, DOI 10.1089/rej.2005.8.82; Flanary BE, 2003, J ANTI-AGING MED, V6, P299, DOI 10.1089/109454503323028894; Ganzel BL, 2013, DEV PSYCHOPATHOL, V25, P879, DOI 10.1017/S0954579413000242; Gee DG, 2013, P NATL ACAD SCI USA, V110, P15638, DOI 10.1073/pnas.1307893110; Gilles EE, 1996, PEDIATR NEUROL, V15, P114, DOI 10.1016/0887-8994(96)00153-1; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Gunnar M, 2007, ANNU REV PSYCHOL, V58, P145, DOI 10.1146/annurev.psych.58.110405.085605; Hanson JL, 2013, CHILD DEV, V84, P1566, DOI 10.1111/cdev.12069; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Houben JMJ, 2008, FREE RADICAL BIO MED, V44, P235, DOI 10.1016/j.freeradbiomed.2007.10.001; Ivy AS, 2008, NEUROSCIENCE, V154, P1132, DOI 10.1016/j.neuroscience.2008.04.019; Kawamura T, 2006, NEUROREPORT, V17, P1515, DOI 10.1097/01.wnr.0000236849.53682.6d; Koss WA, 2014, SYNAPSE, V68, P61, DOI 10.1002/syn.21716; Kosten TA, 2006, BRAIN RES, V1087, P142, DOI 10.1016/j.brainres.2006.03.009; Kosten TA, 2012, NEUROSCI BIOBEHAV R, V36, P1985, DOI 10.1016/j.neubiorev.2012.07.003; Kroenke CH, 2011, PSYCHOSOM MED, V73, P533, DOI 10.1097/PSY.0b013e318229acfc; Landers MS, 2012, DEV NEUROSCI-BASEL, V34, P101, DOI 10.1159/000336732; Leuner B, 2013, NEUROSCIENCE, V251, P108, DOI 10.1016/j.neuroscience.2012.04.021; Leventopoulos M, 2007, BRAIN RES, V1142, P119, DOI 10.1016/j.brainres.2007.01.039; Maheu FS, 2010, COGN AFFECT BEHAV NE, V10, P34, DOI 10.3758/CABN.10.1.34; McEwen BS, 2008, METABOLISM, V57, pS11, DOI 10.1016/j.metabol.2008.07.006; Muhammad A, 2012, NEUROSCIENCE, V216, P103, DOI 10.1016/j.neuroscience.2012.04.041; O'Callaghan NJ, 2011, BIOL PROCED ONLINE, V13, DOI 10.1186/1480-9222-13-3; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Puterman E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010837; Radley JJ, 2005, AGEING RES REV, V4, P271, DOI 10.1016/j.arr.2005.03.004; Raineki C, 2010, BIOL PSYCHIAT, V67, P1137, DOI 10.1016/j.biopsych.2009.12.019; Roth TL, 2011, J CHILD PSYCHOL PSYC, V52, P398, DOI 10.1111/j.1469-7610.2010.02282.x; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Roth TL, 2005, BIOL PSYCHIAT, V57, P823, DOI 10.1016/j.biopsych.2005.01.032; Roth TL, 2014, DEV PSYCHOB IN PRESS; Sachs BD, 2013, INT J NEUROPSYCHOPH, V16, P2081, DOI 10.1017/S1461145713000321; Saul ML, 2014, DEV PSYCHOBIOL, V56, P517, DOI 10.1002/dev.21115; Shalev I, 2013, MOL PSYCHIATR, V18, P576, DOI 10.1038/mp.2012.32; Shalev I, 2014, MOL PSYCHIA IN PRESS; Thomas P, 2008, MECH AGEING DEV, V129, P183, DOI 10.1016/j.mad.2007.12.004; Tottenham N, 2010, DEVELOPMENTAL SCI, V13, P46, DOI 10.1111/j.1467-7687.2009.00852.x; Tyrka AR, 2010, BIOL PSYCHIAT, V67, P531, DOI 10.1016/j.biopsych.2009.08.014; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Wikgren M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034292; Zeichner SL, 1999, BLOOD, V93, P2824; Zhang P, 2007, NEUROSCIENCE, V145, P1439, DOI 10.1016/j.neuroscience.2006.11.052; Zhou JZ, 2014, BMB REP, V47, P8, DOI 10.5483/BMBRep.2014.47.1.284; Zhou QG, 2011, J NEUROSCI, V31, P12258, DOI 10.1523/JNEUROSCI.0805-11.2011	66	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101437	10.1371/journal.pone.0101437	http://dx.doi.org/10.1371/journal.pone.0101437			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1UX	24983884	gold, Green Published			2022-12-27	WOS:000339635000108
J	Bennet, M; McCarthy, A; Fix, D; Edwards, MR; Repp, F; Vach, P; Dunlop, JWC; Sitti, M; Buller, GS; Klumpp, S; Faivre, D				Bennet, Mathieu; McCarthy, Aongus; Fix, Dmitri; Edwards, Matthew R.; Repp, Felix; Vach, Peter; Dunlop, John W. C.; Sitti, Metin; Buller, Gerald S.; Klumpp, Stefan; Faivre, Damien			Influence of Magnetic Fields on Magneto-Aerotaxis	PLOS ONE			English	Article							BAND FORMATION; BACTERIA; OXYGEN; CHEMOTAXIS; RESPONSES	The response of cells to changes in their physico-chemical micro-environment is essential to their survival. For example, bacterial magnetotaxis uses the Earth's magnetic field together with chemical sensing to help microorganisms move towards favoured habitats. The studies of such complex responses are lacking a method that permits the simultaneous mapping of the chemical environment and the response of the organisms, and the ability to generate a controlled physiological magnetic field. We have thus developed a multi-modal microscopy platform that fulfils these requirements. Using simultaneous fluorescence and high-speed imaging in conjunction with diffusion and aerotactic models, we characterized the magneto-aerotaxis of Magnetospirillum gryph is waldense. We assessed the influence of the magnetic field (orientation; strength) on the formation and the dynamic of a micro-aerotactic band (size, dynamic, position). As previously described by models of magnetotaxis, the application of a magnetic field pointing towards the anoxic zone of an oxygen gradient results in an enhanced aerotaxis even down to Earth's magnetic field strength. We found that neither a ten-fold increase of the field strength nor a tilt of 45 degrees resulted in a significant change of the aerotactic efficiency. However, when the field strength is zeroed or when the field angle is tilted to 90 degrees, the magneto-aerotaxis efficiency is drastically reduced. The classical model of magneto-aerotaxis assumes a response proportional to the cosine of the angle difference between the directions of the oxygen gradient and that of the magnetic field. Our experimental evidence however shows that this behaviour is more complex than assumed in this model, thus opening up new avenues for research.	[Bennet, Mathieu; Fix, Dmitri; Repp, Felix; Vach, Peter; Dunlop, John W. C.; Faivre, Damien] Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany; [McCarthy, Aongus; Buller, Gerald S.] Heriot Watt Univ, Sch Engn & Phys Sci, Inst Photon & Quantum Sci, Edinburgh, Midlothian, Scotland; [McCarthy, Aongus; Buller, Gerald S.] Heriot Watt Univ, Sch Engn & Phys Sci, SUPA, Edinburgh, Midlothian, Scotland; [Edwards, Matthew R.; Sitti, Metin] Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA; [Klumpp, Stefan] Max Planck Inst Colloids & Interfaces, Dept Theory & Biosyst, Potsdam, Germany	Max Planck Society; Heriot Watt University; Heriot Watt University; University of Edinburgh; Carnegie Mellon University; Max Planck Society	Faivre, D (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Biomat, Sci Pk Golm, Potsdam, Germany.	Damien.Faivre@mpikg.mpg.de	Klumpp, Stefan/AAC-3936-2019; Sitti, Metin/AGP-6288-2022; McCarthy, Aongus/B-4965-2013; Dunlop, John W C/A-1997-2012; faivre, damien/D-3713-2009; Klumpp, Stefan/C-2966-2008	Klumpp, Stefan/0000-0003-0584-2146; McCarthy, Aongus/0000-0002-0124-0060; Dunlop, John W C/0000-0003-2741-6383; faivre, damien/0000-0001-6191-3389; Klumpp, Stefan/0000-0003-0584-2146; bennet, mathieu/0000-0002-1292-7984; Buller, Gerald/0000-0003-0441-2830; Edwards, Matthew/0000-0002-9701-0736	Max Planck Society; ERC through a Starting Grant [256915-MB2]; UK Engineering and Physical Sciences Research Council; National Science Foundation under a CPS Medium Project [CNS-1135850]; National Science Foundation Graduate Research Fellowship Program [0946825I]; EPSRC [EP/K015338/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K015338/1] Funding Source: researchfish	Max Planck Society(Max Planck SocietyFoundation CELLEX); ERC through a Starting Grant; UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Science Foundation under a CPS Medium Project; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The research was supported by the Max Planck Society and the ERC through a Starting Grant to DaF (256915-MB2). AMcC and GSB acknowledge the support of the UK Engineering and Physical Sciences Research Council. MRE and MS acknowledge the support of the National Science Foundation under a CPS Medium Project (CNS-1135850) and of the National Science Foundation Graduate Research Fellowship Program under Grant No. 0946825I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER J, 1966, SCIENCE, V153, P708, DOI 10.1126/science.153.3737.708; Alexandre G, 1999, J BACTERIOL, V181, P6730, DOI 10.1128/JB.181.21.6730-6738.1999; ARMITAGE JP, 1992, ANNU REV PHYSIOL, V54, P683, DOI 10.1146/annurev.ph.54.030192.003343; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; Bennet MA, 2011, LAB CHIP, V11, P3821, DOI 10.1039/c1lc20391f; Berg HC, 1972, NATURE, V239; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Cussler EL, 1985, AICHE J, V31, P523, DOI [10.1002/aic.690310333, DOI 10.1002/AIC.690310333]; de Gennes PG, 2004, EUR BIOPHYS J BIOPHY, V33, P691, DOI 10.1007/s00249-004-0426-z; Dreyfus R, 2005, NATURE, V437, P862, DOI 10.1038/nature04090; Eder SHK, 2012, P NATL ACAD SCI USA, V109, P12022, DOI 10.1073/pnas.1205653109; Engelmann TW, 1881, PFLUGERS ARCH GESAMM, P285, DOI [10.1007/BF01661982, DOI 10.1007/BF01661982]; Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w; Fischer JP, 2006, FEMS MICROBIOL ECOL, V55, P186, DOI 10.1111/j.1574-695X.2005.00024.x; Frankel RB, 1997, BIOPHYS J, V73, P994, DOI 10.1016/S0006-3495(97)78132-3; Heyen U, 2003, APPL MICROBIOL BIOT, V61, P536, DOI 10.1007/s00253-002-1219-x; Lefevre CT, 2009, APPL ENVIRON MICROB, V75, P3835, DOI 10.1128/AEM.00165-09; Mazzag BC, 2003, BIOPHYS J, V85, P3558, DOI 10.1016/S0006-3495(03)74775-4; Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112; Murray JD, INTERDISCIPLINARY AP, V17, P1; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Romagnoli S, 2002, J BACTERIOL, V184, P5590, DOI 10.1128/JB.184.20.5590-5598.2002; SCHLEIFER KH, 1991, SYST APPL MICROBIOL, V14, P379, DOI 10.1016/S0723-2020(11)80313-9; Smith MJ, 2006, BIOPHYS J, V91, P1098, DOI 10.1529/biophysj.106.085167; Thar R, 2005, APPL ENVIRON MICROB, V71, P3682, DOI 10.1128/AEM.71.7.3682-3691.2005; Vach PJ, 2013, NANO LETT, V13, P5373, DOI 10.1021/nl402897x; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Zhulin IB, 1996, J BACTERIOL, V178, P5199, DOI 10.1128/jb.178.17.5199-5204.1996	30	39	39	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101150	10.1371/journal.pone.0101150	http://dx.doi.org/10.1371/journal.pone.0101150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983865	gold, Green Published, Green Submitted			2022-12-27	WOS:000339635000058
J	Frederix, M; Hutter, K; Leu, J; Batth, TS; Turner, WJ; Ruegg, TL; Blanch, HW; Simmons, BA; Adams, PD; Keasling, JD; Thelen, MP; Dunlop, MJ; Petzold, CJ; Mukhopadhyay, A				Frederix, Marijke; Huetter, Kimmo; Leu, Jessica; Batth, Tanveer S.; Turner, William J.; Rueegg, Thomas L.; Blanch, Harvey W.; Simmons, Blake A.; Adams, Paul D.; Keasling, Jay D.; Thelen, Michael P.; Dunlop, Mary J.; Petzold, Christopher J.; Mukhopadhyay, Aindrila			Development of a Native Escherichia coli Induction System for Ionic Liquid Tolerance	PLOS ONE			English	Article							PROTEIN OVEREXPRESSION; MARR FAMILY; FERMENTATION; PRETREATMENT; EXPRESSION; BIOMASS; INHIBITORS; MECHANISM; TOXICITY; GROWTH	The ability to solubilize lignocellulose makes certain ionic liquids (ILs) very effective reagents pretreating biomass prior to saccharification for biofuel fermentation. However, residual IL in the aqueous sugar solution can inhibit he growth and unction of biofuel-producing microorganism In E. coli this toxicity can be partially overcome by the heterologous expression of an IL efflux pump encoded by eilA from Enterobacter lignolyticus. In the present work, we used microarray analysis to identify native E. coli IL-inducible promoters and develop control systems for regulating eilA gene expression. Three candidate promoters, PmarR' PydfO', and PydfA', were selected and compared to the IPTG-inducible PiacUV5 system for controlling expression of eilA. The PydfA' and PmarR' based systems are as effective as PlacUV5 in their ability to rescue E. oil from typically toxic levels of IL, thereby eliminating the need to use an IPTG-based system for such tolerance engineering. We Present a mechanistic model indicating that inducible control systems reduce target gene expression hen IL levels are low. Selected-reaction monitoring mass spectrometry analysis revealed that at high IL concentrations EilA protein levels were significantly elevated under the control of PydfA' and PmaR' in comparison to the other promoters Further, in a pooled culture competition designed to determine fitness, the strain containing pPmarR'-eilA outcompetecl rains with other promoter constructs, most significantly at IL concentrations above 150 mM. These results indicate that native promoters such as PmarR' can provide effective systems for regulating the expression of heterologous genes in host engineering and simplify the development of industrially useful strains.	[Frederix, Marijke; Huetter, Kimmo; Leu, Jessica; Batth, Tanveer S.; Rueegg, Thomas L.; Blanch, Harvey W.; Simmons, Blake A.; Adams, Paul D.; Keasling, Jay D.; Thelen, Michael P.; Petzold, Christopher J.; Mukhopadhyay, Aindrila] Joint BioEnergy Inst, Emeryville, CA 94608 USA; [Frederix, Marijke; Huetter, Kimmo; Leu, Jessica; Batth, Tanveer S.; Blanch, Harvey W.; Adams, Paul D.; Keasling, Jay D.; Petzold, Christopher J.; Mukhopadhyay, Aindrila] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Turner, William J.; Dunlop, Mary J.] Univ Vermont, Sch Engn, Burlington, VT USA; [Rueegg, Thomas L.] Univ Basel, Inst Bot, CH-4056 Basel, Switzerland; [Rueegg, Thomas L.; Thelen, Michael P.] Lawrence Livermore Natl Lab, Biol & Biotechnol Div, Phys & Life Sci Directorate, Livermore, CA USA; [Blanch, Harvey W.; Keasling, Jay D.] Univ Calif Berkeley, Dept Chem, Coll Chem, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Coll Chem, Berkeley, CA 94720 USA; [Simmons, Blake A.] Sandia Natl Labs, Biol & Mat Sci Ctr, Livermore, CA USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Vermont; University of Basel; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Sandia National Laboratories	Mukhopadhyay, A (corresponding author), Joint BioEnergy Inst, Emeryville, CA 94608 USA.	amukhopadhyay@lbl.gov	Simmons, Blake/N-6022-2016; Keasling, Jay D/J-9162-2012; Thelen, Michael P/G-2032-2014; Mukhopadhyay, Aindrila/AAW-7257-2021; Adams, Paul David/A-1977-2013	Simmons, Blake/0000-0002-1332-1810; Keasling, Jay D/0000-0003-4170-6088; Thelen, Michael P/0000-0002-2479-5480; Adams, Paul David/0000-0001-9333-8219; Petzold, Christopher/0000-0002-8270-5228; Batth, Tanveer Singh/0000-0001-5346-4544	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; Mannheim University of Applied Sciences; Office of Science (BER) at the U.S. Department of Energy; NASA Vermont Space Grant Consortium	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Mannheim University of Applied Sciences; Office of Science (BER) at the U.S. Department of Energy(United States Department of Energy (DOE)); NASA Vermont Space Grant Consortium(National Aeronautics & Space Administration (NASA))	This work was part of the DOE Joint BioEnergy Institute (http://www.jbei.org) supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy. Kimmo Hutter was supported by his Master program at the Mannheim University of Applied Sciences and Prof. Matthias Mack. William Turner and Mary Dunlop were supported by the Office of Science (BER) at the U.S. Department of Energy and the NASA Vermont Space Grant Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa TM, 2000, J BACTERIOL, V182, P3467, DOI 10.1128/JB.182.12.3467-3474.2000; BRISSETTE JL, 1991, J MOL BIOL, V220, P35, DOI 10.1016/0022-2836(91)90379-K; Chubiz LM, 2010, J BACTERIOL, V192, P4786, DOI 10.1128/JB.00371-10; Dahl RH, 2013, NAT BIOTECHNOL, V31, P1039, DOI 10.1038/nbt.2689; Dunlop MJ, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.21; Dunlop Mary J, 2010, Syst Synth Biol, V4, P95, DOI 10.1007/s11693-010-9052-5; Grkovic S, 2001, SEMIN CELL DEV BIOL, V12, P225, DOI 10.1006/scdb.2000.0248; Harrison ME, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00360; Holtz WJ, 2010, CELL, V140, P19, DOI 10.1016/j.cell.2009.12.029; HOLTZAPPLE MT, 1991, APPL BIOCHEM BIOTECH, V28-9, P59, DOI 10.1007/BF02922589; HOPKIN KA, 1992, J BIOL CHEM, V267, P24253; Khudyakov JI, 2012, P NATL ACAD SCI US; Klein-Marcuschamer D, 2011, BIOFUEL BIOPROD BIOR, V5, P562, DOI 10.1002/bbb.303; Lau MW, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-30; Li Q, 2010, APPL MICROBIOL BIOT, V87, P117, DOI 10.1007/s00253-010-2484-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Martin RG, 2002, MOL MICROBIOL, V44, P1611, DOI 10.1046/j.1365-2958.2002.02985.x; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Mora-Pale M, 2011, BIOTECHNOL BIOENG, V108, P1229, DOI 10.1002/bit.23108; Nichols NN, 2008, ENZYME MICROB TECH, V42, P624, DOI 10.1016/j.enzmictec.2008.02.008; Ouellet M, 2011, GREEN CHEM, V13, P2743, DOI 10.1039/c1gc15327g; Ouellet M, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-97; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P25, DOI 10.1016/S0960-8524(99)00161-3; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P17, DOI 10.1016/S0960-8524(99)00160-1; Pienkos PT, 2009, CELLULOSE, V16, P743, DOI 10.1007/s10570-009-9309-x; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Quan S, 2011, NAT STRUCT MOL BIOL, V18, P262, DOI 10.1038/nsmb.2016; Quijano G, 2010, BIORESOURCE TECHNOL, V101, P8923, DOI 10.1016/j.biortech.2010.06.161; Redding-Johanson AM, 2011, METAB ENG, V13, P194, DOI 10.1016/j.ymben.2010.12.005; Romero A, 2008, J HAZARD MATER, V151, P268, DOI 10.1016/j.jhazmat.2007.10.079; Ruegg TL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4490; Saridakis V, 2008, J MOL BIOL, V377, P655, DOI 10.1016/j.jmb.2008.01.001; Singh S, 2009, BIOTECHNOL BIOENG, V104, P68, DOI 10.1002/bit.22386; Skorko-Glonek J, 1999, MOL GEN GENET, V262, P342, DOI 10.1007/s004380051092; Suryawati L, 2009, PROCESS BIOCHEM, V44, P540, DOI 10.1016/j.procbio.2009.01.011; Thi PTP, 2010, WATER RES, V44, P352, DOI 10.1016/j.watres.2009.09.030; TOUATI D, 1995, J BACTERIOL, V177, P2305, DOI 10.1128/jb.177.9.2305-2314.1995; Wagner S, 2007, MOL CELL PROTEOMICS, V6, P1527, DOI 10.1074/mcp.M600431-MCP200; Wang XX, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1146; White DG, 1997, J BACTERIOL, V179, P6122, DOI 10.1128/jb.179.19.6122-6126.1997; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Wyman CE, 2005, BIORESOURCE TECHNOL, V96, P2026, DOI 10.1016/j.biortech.2005.01.018; Yoon LW, 2011, J CHEM TECHNOL BIOT, V86, P1342, DOI 10.1002/jctb.2651; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895; Zhou K, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-18	46	28	29	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101115	10.1371/journal.pone.0101115	http://dx.doi.org/10.1371/journal.pone.0101115			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983352	Green Published, Green Submitted, gold			2022-12-27	WOS:000339635000054
J	Fujiwara, T; Kawachi, I				Fujiwara, Takeo; Kawachi, Ichiro			Are Maternal Social Networks and Perceptions of Trust Associated with Suspected Autism Spectrum Disorder in Offspring? A Population-Based Study in Japan	PLOS ONE			English	Article							PERVASIVE DEVELOPMENTAL DISORDERS; QUALITY-OF-LIFE; ZINC-DEFICIENCY; PARENTAL AGE; CHILDREN; RISK; HEALTH; COPPER; LEVEL	Objective: To investigate the associations of maternal social networks and perceptions of trust with the prevalence of suspected autism spectrum disorders in 18-month-old offspring in Japan. Methods: Questionnaires included measurements of maternal social networks (number of relatives or friends they could call upon for assistance), maternal perceptions of trust, mutual assistance (i.e. individual measures of "cognitive social capital"), and social participation (i.e. individual measures of "structural social capital") as well as the Modified Checklist for Autism in Toddlers to detect suspected autism spectrum disorder (ASD). These tools were mailed to all families with 18-month-old toddlers in Chiba, a city near Tokyo (N = 6061; response rate: 64%). The association between social capital or social network indicators and suspected ASD were analyzed, adjusted for covariates by logistic regression analysis. Results: Low maternal social trust was found to be significantly positively associated with suspected ASD in toddlers compared with high maternal social trust (adjusted odds ratio [OR]: 1.82, 95% confidence interval [CI]: 1.38 to 2.40); mutual aid was also significantly positively related (low vs. high: OR, 1.82, 95% CI: 1.38 to 2.40). However, maternal community participation showed U-shape association with suspected ASD of offspring. Maternal social network showed consistent inverse associations with suspected ASD of offspring, regardless of the type of social connection (e. g., relatives, neighbors, or friends living outside of their neighborhood). Conclusions: Mothers' cognitive social capital and social networks, but not structural social capital, might be associated with suspected ASD in offspring.	[Fujiwara, Takeo] Natl Res Inst Child Hlth & Dev, Dept Social Med, Setagaya Ku, Tokyo, Japan; [Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Soc & Behav Sci, Boston, MA 02115 USA	National Center for Child Health & Development - Japan; Harvard University; Harvard T.H. Chan School of Public Health	Fujiwara, T (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Social Med, Setagaya Ku, Tokyo, Japan.	fujiwara-tk@ncchd.go.jp			Ministry of Education, Culture, Sports, Science and Technology KAKENHI [21119003]	Ministry of Education, Culture, Sports, Science and Technology KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from a Grant-in-aid for Scientific Research on Innovative Areas, Ministry of Education, Culture, Sports, Science and Technology KAKENHI (21119003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2010, ARCH NEUROL-CHICAGO, V67, P395, DOI 10.1001/archneurol.2010.47; Aoyama M, 2013, ENVIRON HEALTH PREV, V18, P57, DOI 10.1007/s12199-012-0303-9; Brugha TS, 2011, ARCH GEN PSYCHIAT, V68, P459, DOI 10.1001/archgenpsychiatry.2011.38; Faber S, 2009, BIOMARKERS, V14, P171, DOI 10.1080/13547500902783747; Fujiwara T, 2008, J EPIDEMIOL COMMUN H, V62, P627, DOI 10.1136/jech.2007.064261; Fujiwara T, 2008, AM J PREV MED, V35, P139, DOI 10.1016/j.amepre.2008.04.015; Fujiwara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052018; Fujiwara T, 2012, ACTA MED OKAYAMA, V66, P343; Gardener H, 2009, BRIT J PSYCHIAT, V195, P7, DOI 10.1192/bjp.bp.108.051672; GOLUB MS, 1995, J NUTR, V125, pS2263, DOI 10.1093/jn/125.suppl_8.2263S; Grabrucker Andreas M, 2012, Front Psychiatry, V3, P118, DOI 10.3389/fpsyt.2012.00118; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Honda H, 2009, J CHILD PSYCHOL PSYC, V50, P972, DOI 10.1111/j.1469-7610.2009.02055.x; Inada N, 2011, RES AUTISM SPECT DIS, V5, P330, DOI 10.1016/j.rasd.2010.04.016; Karr CJ, 2007, PEDIATR CLIN N AM, V54, P63, DOI 10.1016/j.pcl.2006.11.005; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Krakowiak P, 2012, PEDIATRICS, V129, pE1121, DOI 10.1542/peds.2011-2583; Lampi KM, 2013, J AUTISM DEV DISORD, V43, P2526, DOI 10.1007/s10803-013-1801-3; Libbey JE, 2005, J NEUROVIROL, V11, P1, DOI 10.1080/13550280590900553; Lipman EL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-4; Ministry of Health Labor and Welfare, 2012, INC DISTR; Modahl C, 1998, BIOL PSYCHIAT, V43, P270, DOI 10.1016/S0006-3223(97)00439-3; Moore SJ, 2000, J MED GENET, V37, P489, DOI 10.1136/jmg.37.7.489; Mugno D, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-22; Murayama H, 2012, J EPIDEMIOL, V22, P179, DOI 10.2188/jea.JE20110128; Pardo CA, 2006, INT REV PSYCHIATR, V17, P485, DOI 10.1080/02646830500381930; Parner ET, 2012, ANN EPIDEMIOL, V22, P143, DOI 10.1016/j.annepidem.2011.12.006; Priya MDL, 2011, BIOL TRACE ELEM RES, V142, P148, DOI 10.1007/s12011-010-8766-2; Rai D, 2012, J AM ACAD CHILD PSY, V51, P467, DOI 10.1016/j.jaac.2012.02.012; Roberts EM, 2007, ENVIRON HEALTH PERSP, V115, P1482, DOI 10.1289/ehp.10168; Robins DL, 2001, J AUTISM DEV DISORD, V31, P131, DOI 10.1023/A:1010738829569; STROMLAND K, 1994, DEV MED CHILD NEUROL, V36, P351; Sullivan A, 2012, J APPL RES INTELLECT, V25, P484, DOI 10.1111/j.1468-3148.2012.00695.x; Ueshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012135; Wan MW, 2013, J CHILD PSYCHOL PSYC, V54, P763, DOI 10.1111/jcpp.12032; Windham GC, 2009, AUTISM RES, V2, P183, DOI 10.1002/aur.84; Yamada A, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-119; Yasuda H, 2011, SCI REP-UK, V1, DOI 10.1038/srep00129	39	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101359	10.1371/journal.pone.0101359	http://dx.doi.org/10.1371/journal.pone.0101359			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1UX	24983630	Green Submitted, Green Published, gold			2022-12-27	WOS:000339635000096
J	Grynberg, D; Maurage, P				Grynberg, Delphine; Maurage, Pierre			Pain and Empathy: The Effect of Self-Oriented Feelings on the Detection of Painful Facial Expressions	PLOS ONE			English	Article							EMOTIONAL RESPONSES	Background: Painful facial expressions have been shown to trigger affective responses among observers. However, there is so far no clear indication about the self-or other-oriented nature of these feelings. The purpose of this study was to assess whether facial expressions of pain are unconsciously associated with other-oriented feelings (empathic concern) or with self-oriented feelings (personal distress). Method: 70 participants took part in a priming paradigm in which ambiguous facial expressions of pain were primed by words related to empathic concern, distress, negative or by neutral words. It was hypothesized that empathic concern or distress-related words might facilitate the detection of pain in ambiguous facial expressions of pain, independently of a mere effect of prime (i.e., neutral words) or an effect of valence congruency (negative primes). Results: The results showed an effect of prime on the detection and on the reaction time to answer "pain" when confronted to ambiguous facial expressions of pain. More specifically, the detection of pain was higher and faster when preceded by distress primes relative to either neutral or negative primes. Conclusion: The present study suggests that painful expressions are unconsciously related to self-oriented feelings of distress and that their threat value might account for this effect. These findings thus shed new light on the automatic relationship between painful expressions and the affective components of empathy.	[Grynberg, Delphine; Maurage, Pierre] Catholic Univ Louvain, Psychol Sci Res Inst, Louvain La Neuve, Belgium; [Maurage, Pierre] Catholic Univ Louvain, Psychol Sci Res Inst, Lab Expt Psychopathol, Louvain La Neuve, Belgium	Universite Catholique Louvain; Universite Catholique Louvain	Grynberg, D (corresponding author), Catholic Univ Louvain, Psychol Sci Res Inst, Louvain La Neuve, Belgium.	Delphine.Grynberg@uclouvain.be	Grynberg, Delphine/K-6853-2019	Grynberg, Delphine/0000-0002-4588-4116; Maurage, Pierre/0000-0003-0197-0810	Belgian National Fund for Scientific Research (FNRS-FRS) [1.1233.09]	Belgian National Fund for Scientific Research (FNRS-FRS)(Fonds de la Recherche Scientifique - FNRS)	study was also supported by grant 1.1233.09 from the Belgian National Fund for Scientific Research (FNRS-FRS) to Delphine Grynberg (Research Fellow). Pierre Maurage is a FNRS Research Associate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	BATSON CD, 1987, J PERS, V55, P19, DOI 10.1111/j.1467-6494.1987.tb00426.x; BATSON CD, 1981, J PERS SOC PSYCHOL, V40, P290, DOI 10.1037/0022-3514.40.2.290; Danziger N, 2009, NEURON, V61, P203, DOI 10.1016/j.neuron.2008.11.023; Eippert F, 2007, HUM BRAIN MAPP, V28, P409, DOI 10.1002/hbm.20291; Goubert L, 2008, J PAIN, V9, P272, DOI 10.1016/j.jpain.2007.11.006; Goubert L, 2009, PAIN, V143, P5, DOI 10.1016/j.pain.2009.02.023; Grynberg D, 2013, NORMS FRENC IN PRESS; Grynberg D, 2014, INT J PSYCHOL, V49, P371, DOI 10.1002/ijop.12006; Grynberg D, 2010, PERS INDIV DIFFER, V49, P845, DOI 10.1016/j.paid.2010.07.013; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Pfaller M, 2012, PAIN, V153, P1976, DOI 10.1016/j.pain.2012.05.031; Saarela MV, 2007, CEREB CORTEX, V17, P230, DOI 10.1093/cercor/bhj141; Simon D, 2008, PAIN, V135, P55, DOI 10.1016/j.pain.2007.05.008; Yamada M, 2009, PAIN, V143, P71, DOI 10.1016/j.pain.2009.01.028	15	7	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100434	10.1371/journal.pone.0100434	http://dx.doi.org/10.1371/journal.pone.0100434			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1UX	24983356	gold, Green Published, Green Submitted			2022-12-27	WOS:000339635000024
J	Huang, YN; Lai, CC; Chiu, CT; Lin, JJ; Wang, JY				Huang, Ya-Ni; Lai, Chien-Cheng; Chiu, Chien-Tsai; Lin, Jhen-Jhe; Wang, Jia-Yi			L-Ascorbate Attenuates the Endotoxin-Induced Production of Inflammatory Mediators by Inhibiting MAPK Activation and NF-kappa B Translocation in Cortical Neurons/Glia Cocultures	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; VITAMIN-C; OXIDATIVE STRESS; PROINFLAMMATORY CYTOKINES; DEHYDROASCORBIC ACID; CEREBROSPINAL-FLUID; NEUROINFLAMMATION; INDUCTION; DIFFERENTIATION	In response to acute insults to the central nervous system, such as pathogen invasion or neuronal injuries, glial cells become activated and secrete inflammatory mediators such as nitric oxide (NO), cytokines, and chemokines. This neuroinflammation plays a crucial role in the pathophysiology of chronic neurodegenerative diseases. Endogenous ascorbate levels are significantly decreased among patients with septic encephalopathy. Using the bacterial endotoxin lipopolysaccharide (LPS) to induce neuroinflammation in primary neuron/glia cocultures, we investigated how L-ascorbate (vitamin C; Vit. C) affected neuroinflammation. LPS (100 ng/ml) induced the expression of inducible NO synthase (iNOS) and the production of NO, interleukin (IL)-6, and macrophage inflammatory protein-2 (MIP-2/CXCL2) in a time-dependent manner; however, cotreatment with Vit. C (5 or 10 mM) attenuated the LPS-induced iNOS expression and production of NO, IL-6, and MIP-2 production. The morphological features revealed after immunocytochemical staining confirmed that Vit. C suppressed LPS-induced astrocytic and microglial activation. Because Vit. C can be transported into neurons and glia via the sodium-dependent Vit. C transporter-2, we examined how Vit. C affected LPS-activated intracellular signaling in neuron/glia cocultures. The results indicated the increased activation (caused by phosphorylation) of mitogen-activated protein kinases (MAPKs), such as p38 at 30 min and extracellular signal-regulated kinases (ERKs) at 180 min after LPS treatment. The inhibition of p38 and ERK MAPK suppressed the LPS-induced production of inflammatory mediators. Vit. C also inhibited the LPS-induced activation of p38 and ERK. Combined treatments of Vit. C and the inhibitors of p38 and ERK yielded no additional inhibition compared with using the inhibitors alone, suggesting that Vit. C functions through the same signaling pathway (i.e., MAPK) as these inhibitors. Vit. C also reduced LPS-induced I kappa B-alpha degradation and NF-kappa B translocation. Thus, Vit. C suppressed the LPS-stimulated production of inflammatory mediators in neuron/glia cocultures by inhibiting the MAPK and NF-kappa B signaling pathways.	[Huang, Ya-Ni] Hsin Sheng Jr Coll Med Care & Management, Dept Nursing, Taoyuan, Taiwan; [Lai, Chien-Cheng] Far Eastern Mem Hosp, Dept Surg, Div Orthoped, New Taipei City, Taiwan; [Chiu, Chien-Tsai] En Chu Kong Hosp, Dept Neurosurg, New Taipei City, Taiwan; [Lin, Jhen-Jhe; Wang, Jia-Yi] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan; [Lin, Jhen-Jhe; Wang, Jia-Yi] Taipei Med Univ, Coll Med, Dept Physiol, Taipei, Taiwan	Far Eastern Memorial Hospital; En Chu Kong Hospital; Taipei Medical University; Taipei Medical University	Wang, JY (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan.	jywang2010@tmu.edu.tw		Wang, Jia-Yi/0000-0002-9106-3351	Hsin Sheng College of Medical Care and Management, Taiwan [HSC-102-005]; National Science Council, Taiwan [NSC99-2320-B-038-006-MY3, NSC 101-2321-B-038-003]	Hsin Sheng College of Medical Care and Management, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported in part by a grant (HSC-102-005) to YNH from the Hsin Sheng College of Medical Care and Management, Taiwan; and grants (NSC99-2320-B-038-006-MY3 and NSC 101-2321-B-038-003 to JYW) from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Becker JC, 2003, BIOCHEM BIOPH RES CO, V312, P507, DOI 10.1016/j.bbrc.2003.10.146; Bigler ED, 2013, BRAIN, V136, P9, DOI 10.1093/brain/aws342; Bowie AG, 2000, J IMMUNOL, V165, P7180, DOI 10.4049/jimmunol.165.12.7180; Carcamo JM, 2002, BLOOD, V99, P3205, DOI 10.1182/blood.V99.9.3205; Chiu CT, 2011, J INFECT DIS, V204, P1563, DOI 10.1093/infdis/jir608; Christen S, 2001, FREE RADICAL BIO MED, V31, P754, DOI 10.1016/S0891-5849(01)00642-6; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; Harrison FE, 2009, FREE RADICAL BIO MED, V46, P719, DOI 10.1016/j.freeradbiomed.2008.12.018; Hediger MA, 2002, NAT MED, V8, P445, DOI 10.1038/nm0502-445; HORNIG D, 1975, ANN NY ACAD SCI, V258, P103, DOI 10.1111/j.1749-6632.1975.tb29271.x; Huang J, 2001, P NATL ACAD SCI USA, V98, P11720, DOI 10.1073/pnas.171325998; Huang YN, 2012, TOXICOL APPL PHARM, V265, P241, DOI 10.1016/j.taap.2012.08.036; Huang YN, 2009, TOXICOL APPL PHARM, V240, P315, DOI 10.1016/j.taap.2009.06.021; Kim BW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055792; Kim WI, 2012, NEUROL RES; KINUTA Y, 1989, J NEUROSURG, V71, P421, DOI 10.3171/jns.1989.71.3.0421; Korcok J, 2002, J NEUROCHEM, V81, P185, DOI 10.1046/j.1471-4159.2002.00814.x; Lee JY, 2003, J NEUROSCI RES, V73, P156, DOI 10.1002/jnr.10647; Leow-Dyke S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-230; Lin CH, 2006, J NEUROSCI RES, V84, P1485, DOI 10.1002/jnr.21047; Lu XF, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-46; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; O'Callaghan JP, 2008, ANN NY ACAD SCI, V1139, P318, DOI 10.1196/annals.1432.032; PADH H, 1990, BIOCHEM CELL BIOL, V68, P1166, DOI 10.1139/o90-173; Raza SS, 2013, NEUROSCIENCE, V230, P157, DOI 10.1016/j.neuroscience.2012.10.041; REBEC GV, 1994, PROG NEUROBIOL, V43, P537, DOI 10.1016/0301-0082(94)90052-3; Rice ME, 2000, TRENDS NEUROSCI, V23, P209, DOI 10.1016/S0166-2236(99)01543-X; Rosales-Corral S, 2003, J PINEAL RES, V35, P80, DOI 10.1034/j.1600-079X.2003.00057.x; Ryu JR, 2002, EXP BRAIN RES, V143, P257, DOI 10.1007/s00221-001-0991-7; Semmler A, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-38; Shin DM, 2004, NEUROREPORT, V15, P1959, DOI 10.1097/00001756-200408260-00025; Sochocka M, 2013, CNS NEUROL DISORD DR; Son EW, 2004, ARCH PHARM RES, V27, P1073, DOI 10.1007/BF02975434; Tan PH, 2005, J IMMUNOL, V174, P7633, DOI 10.4049/jimmunol.174.12.7633; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Voigt K, 2002, FREE RADICAL RES, V36, P735, DOI 10.1080/10715760290032557; Wang JY, 1998, LIFE SCI, V63, P1571, DOI 10.1016/S0024-3205(98)00424-X; Wang YP, 2011, J IMMUNOL, V173, P5196; Wen LL, 2007, EXP NEUROL, V205, P270, DOI 10.1016/j.expneurol.2007.02.011; Wilson JX, 2009, BIOFACTORS, V35, P5, DOI 10.1002/biof.7; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xie Z, 2004, GLIA, V45, P170, DOI 10.1002/glia.10314; Zhang F, 2010, EUR J PHARMACOL, V636, P1, DOI 10.1016/j.ejphar.2010.03.043; Zhao SQ, 2011, INT IMMUNOPHARMACOL, V11, P468, DOI 10.1016/j.intimp.2010.12.017; Zhu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035125	47	14	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e97276	10.1371/journal.pone.0097276	http://dx.doi.org/10.1371/journal.pone.0097276			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983461	Green Submitted, Green Published, gold			2022-12-27	WOS:000339635000005
J	Zhou, Y; Sun, JJ; Li, CJ; Wang, YH; Li, L; Cai, HF; Lan, XY; Lei, CZ; Zhao, X; Chen, H				Zhou, Yang; Sun, Jiajie; Li, Congjun; Wang, Yanhong; Li, Lan; Cai, Hanfang; Lan, Xianyong; Lei, Chuzhao; Zhao, Xin; Chen, Hong			Characterization of Transcriptional Complexity during Adipose Tissue Development in Bovines of Different Ages and Sexes	PLOS ONE			English	Article							NONCODING RNA; ADIPOCYTE DIFFERENTIATION; ENDOCRINE ORGAN; GENE-EXPRESSION; CANCER; OBESITY; INFLAMMATION; OVERWEIGHT; ANDROGENS; STEROIDS	Background: Adipose tissue has long been recognized to play an extremely important role in development. In bovines, it not only serves a fundamental function but also plays a key role in the quality of beef and, consequently, has drawn much public attention. Age and sex are two key factors that affect the development of adipose tissue, and there has not yet been a global study detailing the effects of these two factors on expressional differences of adipose tissues. Results: In this study, total RNA from the back fat of fetal bovines, adult bulls, adult heifers and adult steers were used to construct libraries for Illumina next-generation sequencing. We detected the expression levels of 12,233 genes, with over 3,000 differently expressed genes when comparing fetal and adult patterns and an average of 1000 differently expressed genes when comparing adult patterns. Multiple Gene Ontology terms and pathways were found to be significantly enriched for these differentially expressed genes. Of the 12,233 detected genes, a total of 4,753 genes (38.85%) underwent alternative splicing events, and over 50% were specifically expressed in each library. Over 4,000 novel transcript units were discovered for one library, whereas only approximately 30% were considered to have coding ability, which supplied a large amount of information for the lncRNA study. Additionally, we detected 56,564 (fetal bovine), 65,154 (adult bull), 78,061 (adult heifer) and 86,965 (adult steer) putative single nucleotide polymorphisms located in coding regions of the four pooled libraries. Conclusion: Here, we present, for the first time, a complete dataset involving the spatial and temporal transcriptome of bovine adipose tissue using RNA-seq. These data will facilitate the understanding of the effects of age and sex on the development of adipose tissue and supply essential information towards further studies on the genomes of beef cattle and other related mammals.	[Zhou, Yang; Sun, Jiajie; Li, Lan; Cai, Hanfang; Lan, Xianyong; Lei, Chuzhao; Zhao, Xin; Chen, Hong] Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Agr Mol Biol, Yangling, Shaanxi, Peoples R China; [Li, Congjun] ARS, USDA, Bovine Funct Genom Lab, Beltsville, MD USA; [Wang, Yanhong] Jiangsu Normal Univ, Inst Cellular & Mol Biol, Xuzhou, Jiangsu, Peoples R China	Northwest A&F University - China; United States Department of Agriculture (USDA); Jiangsu Normal University	Chen, H (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Agr Mol Biol, Yangling, Shaanxi, Peoples R China.	chenhong1212@263.net	Wang, Yanbo/HFZ-8018-2022; Zhao, Xin/M-4312-2015; wang, yan/GSE-6489-2022; wang, yi/GVT-8516-2022; Li, Cong-jun/J-8572-2014	Zhao, Xin/0000-0002-1078-7332; Li, Cong-jun/0000-0003-1389-9820	National Natural Science Foundation of China [31272408]; National 863 Program of China [2013AA102505]; Agricultural Science and Technology Innovation Projects of Shaanxi Province [2012NKC01-13]; Program of National Beef Cattle Industrial Technology System [CARS-38]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 Program of China(National High Technology Research and Development Program of China); Agricultural Science and Technology Innovation Projects of Shaanxi Province; Program of National Beef Cattle Industrial Technology System	This study was supported by the National Natural Science Foundation of China (Grant No. 31272408), National 863 Program of China (Grant No. 2013AA102505), Agricultural Science and Technology Innovation Projects of Shaanxi Province (No. 2012NKC01-13), and Program of National Beef Cattle Industrial Technology System (CARS-38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Benjamini Y, 2001, ANN STAT, V29, P1165; BERG RT, 1979, CAN J ANIM SCI, V59, P359, DOI 10.4141/cjas79-044; Blouin K, 2008, J STEROID BIOCHEM, V108, P272, DOI 10.1016/j.jsbmb.2007.09.001; Blouin K, 2010, CLIN ENDOCRINOL, V72, P176, DOI 10.1111/j.1365-2265.2009.03645.x; Broadbent KM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r56; Bruno VM, 2010, GENOME RES, V20, P1451, DOI 10.1101/gr.109553.110; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Canovas A, 2010, MAMM GENOME, V21, P592, DOI 10.1007/s00335-010-9297-z; Choi B, 2010, LIVEST SCI, V131, P218, DOI 10.1016/j.livsci.2010.04.004; De Maddalena C, 2012, J CELL PHYSIOL, V227, P3744, DOI 10.1002/jcp.24096; Dieudonne MN, 1998, AM J PHYSIOL-CELL PH, V274, pC1645, DOI 10.1152/ajpcell.1998.274.6.C1645; Evans NA, 2004, AM J SPORT MED, V32, P534, DOI 10.1177/0363546503262202; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fonseca-Alaniz MH, 2007, J PEDIAT-BRAZIL, V83, pS192, DOI [10.1590/S0021-75572007000700011, 10.2223/JPED.1709]; Fritsche S, 1998, J ANIM SCI, V76, P1621; Gaucher EA, 2003, GENETICS, V163, P1549; Gentile MA, 2010, J MOL ENDOCRINOL, V44, P55, DOI 10.1677/JME-09-0048; GREENWOOD MR, 1974, J LIPID RES, V15, P474; Grimaldi PA, 2001, PROG LIPID RES, V40, P269, DOI 10.1016/S0163-7827(01)00005-4; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; He H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064356; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kiess W, 2008, BEST PRACT RES CL EN, V22, P135, DOI 10.1016/j.beem.2007.10.002; Kurth T, 2002, ARCH INTERN MED, V162, P2557, DOI 10.1001/archinte.162.22.2557; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Maachi M, 2004, INT J OBESITY, V28, P993, DOI 10.1038/sj.ijo.0802718; Masek T, 2010, ITALIAN J ANIMAL SCI, V9; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Medrano J, 2010, COMP ANAL BOVINE MIL; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Nie L, 2012, AM J TRANSL RES, V4, P127; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ronti T, 2006, CLIN ENDOCRINOL, V64, P355, DOI 10.1111/j.1365-2265.2006.02474.x; Rubin GL, 2000, CANCER RES, V60, P1604; Schutte AE, 2006, J HUM HYPERTENS, V20, P850, DOI 10.1038/sj.jhh.1002065; Scollan N, 2006, MEAT SCI, V74, P17, DOI 10.1016/j.meatsci.2006.05.002; Sethi JK, 2007, J LIPID RES, V48, P1253, DOI 10.1194/jlr.R700005-JLR200; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; Wickramasinghe S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-45; Wozniak SE, 2009, DIGEST DIS SCI, V54, P1847, DOI 10.1007/s10620-008-0585-3; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109	54	24	27	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101261	10.1371/journal.pone.0101261	http://dx.doi.org/10.1371/journal.pone.0101261			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983926	Green Submitted, Green Published, gold			2022-12-27	WOS:000339635000079
J	Esghaei, M; Daliri, MR				Esghaei, Moein; Daliri, Mohammad Reza			Decoding of Visual Attention from LFP Signals of Macaque MT	PLOS ONE			English	Article							RHYTHMIC NEURONAL SYNCHRONIZATION; BRAIN-COMPUTER INTERFACES; LOCAL-FIELD POTENTIALS; AREA MT; CORTEX; OSCILLATIONS; MODULATION; MONKEY; EEG; NETWORKS	The local field potential (LFP) has recently been widely used in brain computer interfaces (BCI). Here we used power of LFP recorded from area MT of a macaque monkey to decode where the animal covertly attended. Support vector machines (SVM) were used to learn the pattern of power at different frequencies for attention to two possible positions. We found that LFP power at both low (<9 Hz) and high (31-120 Hz) frequencies contains sufficient information to decode the focus of attention. Highest decoding performance was found for gamma frequencies (31-120 Hz) and reached 82%. In contrast low frequencies (<9 Hz) could help the classifier reach a higher decoding performance with a smaller amount of training data. Consequently, we suggest that low frequency LFP can provide fast but coarse information regarding the focus of attention, while higher frequencies of the LFP deliver more accurate but less timely information about the focus of attention.	[Esghaei, Moein; Daliri, Mohammad Reza] Inst Res Fundamental Sci IPM, Sch Cognit Sci, Tehran, Iran; [Daliri, Mohammad Reza] Iran Univ Sci & Technol, Fac Elect Engn, Dept Biomed Engn, Tehran, Iran; [Esghaei, Moein; Daliri, Mohammad Reza] German Primate Ctr DPZ, Cognit Neurosci Lab, Gottingen, Germany	Iran University Science & Technology; Deutsches Primatenzentrum (DPZ)	Esghaei, M (corresponding author), Inst Res Fundamental Sci IPM, Sch Cognit Sci, Tehran, Iran.	esghaei@ipm.ir; daliri@iust.ac.ir	Daliri, Mohammad Reza/AAF-4609-2021; Daliri, Mohammad Reza/S-9308-2018	Daliri, Mohammad Reza/0000-0001-9241-8751	Institute for Research in Fundamental Sciences (IPM), School of Cognitive Sciences	Institute for Research in Fundamental Sciences (IPM), School of Cognitive Sciences	This work was funded by the Institute for Research in Fundamental Sciences (IPM), School of Cognitive Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baluchi F, 2011, TRENDS NEUROSCI, V34, P210, DOI 10.1016/j.tins.2011.02.003; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Chalk M, 2010, NEURON, V66, P114, DOI 10.1016/j.neuron.2010.03.013; Chrobak JJ, 1998, J NEUROSCI, V18, P388; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Fazel-Rezai Reza, 2012, Front Neuroeng, V5, P14, DOI 10.3389/fneng.2012.00014; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2008, J NEUROSCI, V28, P4823, DOI 10.1523/JNEUROSCI.4499-07.2008; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Ince NF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014384; Kaliukhovich DAE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074665; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Khayat PS, 2010, J NEUROSCI, V30, P7037, DOI 10.1523/JNEUROSCI.0404-10.2010; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; Lisman JE, 2013, NEURON, V77, P1002, DOI 10.1016/j.neuron.2013.03.007; Liu J, 2006, J NEUROSCI, V26, P7779, DOI 10.1523/JNEUROSCI.5052-05.2006; Manyakov NV, 2010, IEEE T NEURAL NETWOR, V21, P1892, DOI 10.1109/TNN.2010.2078834; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; McFarland DJ, 2011, COMMUN ACM, V54, P60, DOI 10.1145/1941487.1941506; Mehring C, 2003, NAT NEUROSCI, V6, P1253, DOI 10.1038/nn1158; Mo J, 2011, J NEUROSCI, V31, P878, DOI 10.1523/JNEUROSCI.5295-10.2011; Moran D, 2010, CURR OPIN NEUROBIOL, V20, P741, DOI 10.1016/j.conb.2010.09.010; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Nelson MJ, 2008, J NEUROSCI METH, V169, P141, DOI 10.1016/j.jneumeth.2007.12.010; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Rotermund D, 2013, J NEUROSCI, V33, P6001, DOI 10.1523/JNEUROSCI.4225-12.2013; Rotermund D, 2009, J NEUROSCI, V29, P10120, DOI 10.1523/JNEUROSCI.5508-08.2009; Slutzky MW, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036013; Smith E, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/1/016010; Treue S, 2001, TRENDS NEUROSCI, V24, P295, DOI 10.1016/S0166-2236(00)01814-2; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Whittingstall K, 2009, NEURON, V64, P281, DOI 10.1016/j.neuron.2009.08.016; Womelsdorf T, 2011, RES PER NEUROSCI, P109, DOI 10.1007/978-3-642-18015-6_7; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P8850, DOI 10.1073/pnas.1100999108	43	21	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100381	10.1371/journal.pone.0100381	http://dx.doi.org/10.1371/journal.pone.0100381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979704	gold, Green Published, Green Submitted			2022-12-27	WOS:000338506400027
J	Ieda, S; Moriyama, M; Takashita, T; Maehara, T; Imabayashi, Y; Shinozaki, S; Tanaka, A; Hayashida, JN; Furukawa, S; Ohta, M; Yamashita, Y; Nakamura, S				Ieda, Shinsuke; Moriyama, Masafumi; Takashita, Toru; Maehara, Takashi; Imabayashi, Yumi; Shinozaki, Shoichi; Tanaka, Akihiko; Hayashida, Jun-Nosuke; Furukawa, Sachiko; Ohta, Miho; Yamashita, Yoshihisa; Nakamura, Seiji			Molecular Analysis of Fungal Populations in Patients with Oral Candidiasis Using Internal Transcribed Spacer Region	PLOS ONE			English	Article							IDENTIFICATION; DUBLINIENSIS; XEROSTOMIA; INFECTION; ALBICANS; RISK	Oral candidiasis is closely associated with changes in the oral fungal flora and is caused primarily by Candida albicans. Conventional methods of fungal culture are time-consuming and not always conclusive. However, molecular genetic analysis of internal transcribed spacer (ITS) regions of fungal rRNA is rapid, reproducible and simple to perform. In this study we examined the fungal flora in patients with oral candidiasis and investigated changes in the flora after antifungal treatment using length heterogeneity-polymerization chain reaction (LH-PCR) analysis of ITS regions. Fifty-two patients with pseudomembranous oral candidiasis (POC) and 30 healthy controls were included in the study. Fungal DNA from oral rinse was examined for fungal species diversity by LH-PCR. Fungal populations were quantified by real-time PCR and previously-unidentified signals were confirmed by nucleotide sequencing. Relationships between the oral fungal flora and treatment-resistant factors were also examined. POC patients showed significantly more fungal species and a greater density of fungi than control individuals. Sixteen fungi were newly identified. The fungal populations from both groups were composed predominantly of C. albicans, though the ratio of C. dubliniensis was significantly higher in POC patients than in controls. The diversity and density of fungi were significantly reduced after treatment. Furthermore, fungal diversity and the proportion of C. dubliniensis were positively correlated with treatment duration. These results suggest that C. dubliniensis and high fungal flora diversity might be involved in the pathogenesis of oral candidiasis. We therefore conclude that LH-PCR is a useful technique for diagnosing and assessing the severity of oral candidal infection.	[Ieda, Shinsuke; Moriyama, Masafumi; Maehara, Takashi; Imabayashi, Yumi; Shinozaki, Shoichi; Tanaka, Akihiko; Hayashida, Jun-Nosuke; Furukawa, Sachiko; Ohta, Miho; Nakamura, Seiji] Kyushu Univ, Fac Dent Sci, Sect Oral & Maxillofacial Oncol, Div Maxillofacial Diagnost & Surg Sci, Fukuoka 812, Japan; [Takashita, Toru; Yamashita, Yoshihisa] Kyushu Univ, Fac Dent Sci, Sect Prevent & Publ Hlth Dent, Div Oral Hlth Growth & Dev, Fukuoka 812, Japan	Kyushu University; Kyushu University	Moriyama, M (corresponding author), Kyushu Univ, Fac Dent Sci, Sect Oral & Maxillofacial Oncol, Div Maxillofacial Diagnost & Surg Sci, Fukuoka 812, Japan.	moriyama@dent.kyushu-u.ac.jp	Takeshita, Toru/AAT-2321-2021		Ministry of Education, Culture, Sports, Science, and Technology of Japan [20452774]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (http://kaken.nii.ac.jp/d/p/26670868.en.html), grant number: 20452774. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendrup MC, 2013, DAN MED J, V60; Bossola M, 2012, NAT REV NEPHROL, V8, P176, DOI 10.1038/nrneph.2011.218; Eraso E, 2006, J CLIN MICROBIOL, V44, P3340, DOI 10.1128/JCM.00213-06; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Ihalin R, 2006, ARCH BIOCHEM BIOPHYS, V445, P261, DOI 10.1016/j.abb.2005.07.004; Jabra-Rizk Mary Ann, 2007, J Clin Pediatr Dent, V31, P260; Klentrou P, 2002, EUR J APPL PHYSIOL, V87, P153, DOI 10.1007/s00421-002-0609-1; KOHLER PF, 1985, ARTHRITIS RHEUM-US, V28, P1128, DOI 10.1002/art.1780281008; Krcmery V, 2002, J HOSP INFECT, V50, P243, DOI 10.1053/jhin.2001.1151; Le J, 2013, ANTIMICROB AGENTS CH, V57, P2550, DOI 10.1128/AAC.02088-12; Li H, 2012, ORAL DIS, V18, P771, DOI 10.1111/j.1601-0825.2012.01944.x; Lin HL, 2013, AM J INFECT CONTROL, V41, P850, DOI 10.1016/j.ajic.2013.04.021; Liu ZJ, 1996, NUCLEIC ACIDS RES, V24, P2458, DOI 10.1093/nar/24.12.2458; Moran GP, 1997, ANTIMICROB AGENTS CH, V41, P617, DOI 10.1128/AAC.41.3.617; Ostrosky-Zeichner L, 2012, AM J MED, V125, pS14, DOI 10.1016/j.amjmed.2011.10.008; Pasqualotto AC, 2009, PAEDIATR RESPIR REV, V10, P186, DOI 10.1016/j.prrv.2009.09.001; Richardson MD, 2005, J ANTIMICROB CHEMOTH, V56, P5, DOI 10.1093/jac/dki218; Sharifzadeh A, 2013, J MYCOL MED, V23, P105, DOI 10.1016/j.mycmed.2013.02.001; Shinozaki S, 2012, ORAL DIS, V18, P667, DOI 10.1111/j.1601-0825.2012.01923.x; Sullivan DJ, 2005, FEMS MICROBIOL LETT, V253, P9, DOI 10.1016/j.femsle.2005.09.015; SULLIVAN DJ, 1995, MICROBIOL-UK, V141, P1507, DOI 10.1099/13500872-141-7-1507; Takeshita T, 2007, ORAL MICROBIOL IMMUN, V22, P419, DOI 10.1111/j.1399-302X.2007.00384.x; Teramoto S, 2008, J AM GERIATR SOC, V56, P577, DOI 10.1111/j.1532-5415.2008.01597.x; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Williams EJ, 2013, ACTA PAEDIATR, V102, P999, DOI 10.1111/apa.12341; Yurayart C, 2011, VET MICROBIOL, V148, P356, DOI 10.1016/j.vetmic.2010.09.020	28	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101156	10.1371/journal.pone.0101156	http://dx.doi.org/10.1371/journal.pone.0101156			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979710	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400087
J	Insenser, M; Montes-Nieto, R; Martinez-Garcia, MA; Duran, EF; Santiuste, C; Gomez, V; Kline, JA; Escobar-Morreale, HF; Jimenez, D				Insenser, Maria; Montes-Nieto, Rafael; Angeles Martinez-Garcia, M.; Fernandez Duran, Elena; Santiuste, Carmen; Gomez, Vicente; Kline, Jeffrey A.; Escobar-Morreale, Hector F.; Jimenez, David			Identification of Reduced Circulating Haptoglobin Concentration as a Biomarker of the Severity of Pulmonary Embolism: A Nontargeted Proteomic Study	PLOS ONE			English	Article							SELECTING PATIENTS; PROGNOSTIC MODELS; HEMOPEXIN; PLASMA; THROMBOEMBOLISM; POLYMORPHISM; DIAGNOSIS; PROTEINS; CT	Risk stratification of patients with pulmonary embolism (PE) may identify patients at high risk of early death who may benefit from more intensive surveillance or aggressive therapy. Nontargeted proteomics may identify biomarkers useful for the risk stratification of patients with acute symptomatic pulmonary embolism (PE). We studied 6 patients presenting with low-risk PE and 6 patients presenting with intermediate (n = 3) or high-risk (n = 3) PE. Two-dimensional difference gel electrophoresis was used to compare their plasma protein abundances. Candidate protein markers were identified by matrix assisted laser desorption ionization time-of-flight mass spectrometry. A panel of four biomarkers (haptoglobin, hemopexin, alpha(2)-macroglobulin, and Ig alpha(1)-chain C region) showed differences in plasma abundance among patients with acute symptomatic PE of different severity. Haptoglobin and hemopexin were decreased, whereas alpha(2)-macroglobulin and Ig alpha(1)-chain C region were increased, in patients with high or intermediate-risk PE compared with low-risk PE patient. In a separate clinical population consisting of 104 adults with acute PE, serum haptoglobin concentrations had an 85% chance of correctly identifying patients with high-risk PE according to receiving operating characteristics curve analysis. Moreover, serum haptoglobin concentrations <= 1 g/l showed an 80% sensitivity and a 96% specificity for the diagnosis of high-risk PE. Nontargeted proteomics identified protein biomarkers for the severity of PE that are involved in iron metabolism pathways and acute-phase response. Among them, reduced serum haptoglobin concentrations show a high accuracy for the biochemical detection of high-risk PE.	[Insenser, Maria; Montes-Nieto, Rafael; Angeles Martinez-Garcia, M.; Fernandez Duran, Elena; Escobar-Morreale, Hector F.] Hosp Univ Ramon & Cajal, Dept Endocrinol & Nutr, Diabet Obes & Human Reprod Res Grp, Madrid, Spain; [Insenser, Maria; Montes-Nieto, Rafael; Angeles Martinez-Garcia, M.; Fernandez Duran, Elena; Escobar-Morreale, Hector F.; Jimenez, David] Univ Alcala, Madrid, Spain; [Insenser, Maria; Montes-Nieto, Rafael; Angeles Martinez-Garcia, M.; Fernandez Duran, Elena; Escobar-Morreale, Hector F.; Jimenez, David] Inst Ramon &Cajal Invest Sanitaria IRYCIS, Madrid, Spain; [Insenser, Maria; Montes-Nieto, Rafael; Angeles Martinez-Garcia, M.; Fernandez Duran, Elena; Escobar-Morreale, Hector F.] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain; [Santiuste, Carmen] Hosp Univ Ramon & Cajal, Dept Clin Biochem, Madrid, Spain; [Gomez, Vicente] Hosp Univ Ramon & Cajal, Dept Internal Med, Madrid, Spain; [Kline, Jeffrey A.] Indiana Univ Sch Med, Dept Emergency Med, Indianapolis, IN 46202 USA; [Jimenez, David] Hosp Univ Ramon & Cajal, Resp Dept, Pulm Embolism Res Grp, Madrid, Spain	Hospital Universitario Ramon y Cajal; Universidad de Alcala; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Hospital Universitario Ramon y Cajal; Hospital Universitario Ramon y Cajal; Indiana University System; Indiana University Bloomington; Hospital Universitario Ramon y Cajal	Insenser, M (corresponding author), Hosp Univ Ramon & Cajal, Dept Endocrinol & Nutr, Diabet Obes & Human Reprod Res Grp, Madrid, Spain.	mariarosa.insenser@salud.madrid.org	Insenser, María/B-9674-2014; Escobar-Morreale, Héctor F/G-5468-2010; García, María Ángeles Martínez/B-9712-2014	Insenser, María/0000-0003-3168-7856; Escobar-Morreale, Héctor F/0000-0002-6890-1644; García, María Ángeles Martínez/0000-0002-8354-7284	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness [PI080944, PI08200, PI110246, PI110357]	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness	This study was supported by grants PI080944, PI08200, PI110246 and PI110357 from Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness. The sponsors had no role in the study design, in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.	BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Buller HR, 2003, NEW ENGL J MED, V349, P1695; CID MC, 1993, J CLIN INVEST, V91, P977, DOI 10.1172/JCI116319; Cohen AT, 2007, THROMB HAEMOSTASIS, V98, P756, DOI 10.1160/TH07-03-0212; Conget F, 2008, THROMB HAEMOSTASIS, V100, P937, DOI 10.1160/TH08-02-0065; Coombes KR, 2005, NAT BIOTECHNOL, V23, P291, DOI 10.1038/nbt0305-291; Dati F, 1996, EUR J CLIN CHEM CLIN, V34, P517; de Kleijn DPV, 2002, FASEB J, V16, P1123, DOI 10.1096/fj.02-0019fje; Delanghe JR, 2001, CLIN CHIM ACTA, V312, P13, DOI 10.1016/S0009-8981(01)00586-1; Douketis JD, 1998, JAMA-J AM MED ASSOC, V279, P458, DOI 10.1001/jama.279.6.458; Fink MP, 2009, J LEUKOCYTE BIOL, V86, P203, DOI 10.1189/jlb.0309137; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Insenser M, 2012, MOL CELL ENDOCRINOL, V363, P10, DOI 10.1016/j.mce.2012.07.001; Insenser M, 2010, PROTEOM CLIN APPL, V4, P739, DOI 10.1002/prca.201000007; Insenser M, 2010, J CLIN ENDOCR METAB, V95, P3863, DOI 10.1210/jc.2010-0220; Issaq HJ, 2002, BIOCHEM BIOPH RES CO, V292, P587, DOI 10.1006/bbrc.2002.6678; Jimenez D, 2008, CURR OPIN PULM MED, V14, P414, DOI 10.1097/MCP.0b013e3283043e44; Jimenez D, 2007, CHEST, V132, P24, DOI 10.1378/chest.06-2921; Jimenez D, 2014, THORAX, V69, P109, DOI 10.1136/thoraxjnl-2012-202900; Kearon C, 1998, ANN INTERN MED, V129, P1044, DOI 10.7326/0003-4819-129-12-199812150-00009; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Kline JA, 2009, J THROMB HAEMOST, V7, P1597, DOI 10.1111/j.1538-7836.2009.03535.x; Koch W, 2002, CLIN CHEM, V48, P1377; Langlois MR, 1996, CLIN CHEM, V42, P1589; Liang XY, 2009, J LEUKOCYTE BIOL, V86, P229, DOI 10.1189/jlb.1208742; Lin TA, 2010, J INFECT DIS, V202, P624, DOI 10.1086/654929; Nielsen MJ, 2009, BLOOD, V114, P764, DOI 10.1182/blood-2009-01-198309; REMYJARDIN M, 1992, RADIOLOGY, V185, P381, DOI 10.1148/radiology.185.2.1410342; Tapson VF, 2008, NEW ENGL J MED, V358, P1037, DOI 10.1056/NEJMra072753; tenCate JW, 1997, NEW ENGL J MED, V337, P657; Verrills Nicole M, 2006, Clin Biochem Rev, V27, P99; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; Watts JA, 2012, THROMB RES, V130, P122, DOI 10.1016/j.thromres.2011.09.016; Zagorski J, 2010, J THROMB HAEMOST, V8, P389, DOI 10.1111/j.1538-7836.2009.03704.x	34	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100902	10.1371/journal.pone.0100902	http://dx.doi.org/10.1371/journal.pone.0100902			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979072	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400047
J	Mazoyer, B; Zago, L; Jobard, G; Crivello, F; Joliot, M; Perchey, G; Mellet, E; Petit, L; Tzourio-Mazoyer, N				Mazoyer, Bernard; Zago, Laure; Jobard, Gael; Crivello, Fabrice; Joliot, Marc; Perchey, Guy; Mellet, Emmanuel; Petit, Laurent; Tzourio-Mazoyer, Nathalie			Gaussian Mixture Modeling of Hemispheric Lateralization for Language in a Large Sample of Healthy Individuals Balanced for Handedness	PLOS ONE			English	Article							FUNCTIONAL TRANSCRANIAL DOPPLER; WADA TEST; DOMINANCE; FMRI; MRI; BRAIN; COMPLEMENTARY; ATTENTION; PEOPLE; TASK	Hemispheric lateralization for language production and its relationships with manual preference and manual preference strength were studied in a sample of 297 subjects, including 153 left-handers (LH). A hemispheric functional lateralization index (HFLI) for language was derived from fMRI acquired during a covert sentence generation task as compared with a covert word list recitation. The multimodal HFLI distribution was optimally modeled using a mixture of 3 and 4 Gaussian functions in right-handers (RH) and LH, respectively. Gaussian function parameters helped to define 3 types of language hemispheric lateralization, namely "Typical'' (left hemisphere dominance with clear positive HFLI values, 88% of RH, 78% of LH), "Ambilateral'' (no dominant hemisphere with HFLI values close to 0, 12% of RH, 15% of LH) and "Strongly-atypical'' (right-hemisphere dominance with clear negative HFLI values, 7% of LH). Concordance between dominant hemispheres for hand and for language did not exceed chance level, and most of the association between handedness and language lateralization was explained by the fact that all Strongly-atypical individuals were left-handed. Similarly, most of the relationship between language lateralization and manual preference strength was explained by the fact that Strongly-atypical individuals exhibited a strong preference for their left hand. These results indicate that concordance of hemispheric dominance for hand and for language occurs barely above the chance level, except in a group of rare individuals (less than 1% in the general population) who exhibit strong right hemisphere dominance for both language and their preferred hand. They call for a revisit of models hypothesizing common determinants for handedness and for language dominance.	[Mazoyer, Bernard] CEA, CNRS, Grp Imagerie Neurofonct, Bordeaux, France; Univ Bordeaux, Bordeaux, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Mazoyer, B (corresponding author), CEA, CNRS, Grp Imagerie Neurofonct, Bordeaux, France.	bernard.mazoyer@univ-bordeaux.fr	Petit, Laurent/M-3888-2019; Crivello, Fabrice/ABB-4531-2021; Jobard, Gaël/C-3166-2014; Jobard, Gaël/M-2970-2019; Tzourio-Mazoyer, Nathalie/B-5598-2008; Mazoyer, Bernard M/B-6303-2012; Mellet, Emmanuel/B-7125-2008; mazoyer, bernard m/A-5369-2009; Zago, Laure/B-7124-2008; Petit, Laurent/D-6583-2011	Petit, Laurent/0000-0003-2499-5367; Jobard, Gaël/0000-0003-4536-0643; Jobard, Gaël/0000-0003-4536-0643; Tzourio-Mazoyer, Nathalie/0000-0002-6236-4390; Mazoyer, Bernard M/0000-0003-0970-2837; Mellet, Emmanuel/0000-0002-2676-9112; mazoyer, bernard m/0000-0003-0970-2837; Petit, Laurent/0000-0003-2499-5367; Crivello, Fabrice/0000-0001-6950-984X; Zago, Laure/0000-0001-8235-2154; joliot, marc/0000-0001-7792-308X	Centre National de la Recherche Scientifique	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	Financial support for this study was internal to the authors' Institution, i.e. the Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Armour JAL, 2014, HEREDITY, V112, P221, DOI 10.1038/hdy.2013.93; Badzakova-Trajkov G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009682; Berl MM, 2014, ANN NEUROL, V75, P33, DOI 10.1002/ana.24015; Bethmann A, 2007, BRAIN RES, V1133, P145, DOI 10.1016/j.brainres.2006.11.057; Binder JR, 2011, EPILEPSY BEHAV, V20, P214, DOI 10.1016/j.yebeh.2010.08.004; Bishop DVM, 2013, SCIENCE, V340, DOI 10.1126/science.1230531; Cai Q, 2013, P NATL ACAD SCI USA, V110, pE322, DOI 10.1073/pnas.1212956110; Corballis MC, 2012, PROG BRAIN RES, V195, P103, DOI 10.1016/B978-0-444-53860-4.00006-4; Drane DL, 2012, EPILEPSIA, V53, P1790, DOI 10.1111/j.1528-1167.2012.03573.x; Dym RJ, 2011, RADIOLOGY, V261, P446, DOI 10.1148/radiol.11101344; FLEISS JL, 1969, PSYCHOL BULL, V72, P323, DOI 10.1037/h0028106; Groen MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064876; Gutbrod K, 2012, J NEUROIMAGING, V22, P266, DOI 10.1111/j.1552-6569.2011.00646.x; Hecaen H, 1971, Cortex, V7, P19; Hund-Georgiadis M, 2002, EXP BRAIN RES, V145, P166, DOI 10.1007/s00221-002-1090-0; Isaacs KL, 2006, NEUROLOGY, V66, P1855, DOI 10.1212/01.wnl.0000219623.28769.74; Knecht S, 2000, BRAIN, V123, P74, DOI 10.1093/brain/123.1.74; Knecht S, 2000, BRAIN, V123, P2512, DOI 10.1093/brain/123.12.2512; Mateer CA, 1982, HUM NEUROBIOL, V2, P135; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Petit L., 2012, 18 ANN M ORG HUM BRA; Pujol J, 1999, NEUROLOGY, V52, P1038, DOI 10.1212/WNL.52.5.1038; Rosch RE, 2012, NEUROPSYCHOLOGIA, V50, P810, DOI 10.1016/j.neuropsychologia.2012.01.015; Seghier ML, 2011, HUM BRAIN MAPP, V32, P1602, DOI 10.1002/hbm.21130; Springer JA, 1999, BRAIN, V122, P2033, DOI 10.1093/brain/122.11.2033; Stroobant N, 2009, BEHAV BRAIN RES, V199, P190, DOI 10.1016/j.bbr.2008.11.040; Szaflarski JP, 2002, NEUROLOGY, V59, P238, DOI 10.1212/WNL.59.2.238; Van der Haegen L, 2011, NEUROPSYCHOLOGIA, V49, P2879, DOI 10.1016/j.neuropsychologia.2011.06.014; WADA J, 1960, J NEUROSURG, V17, P266, DOI 10.3171/jns.1960.17.2.0266; Whitehouse AJO, 2009, NEUROPSYCHOLOGIA, V47, P1938, DOI 10.1016/j.neuropsychologia.2009.03.005; Wilke M, 2007, J NEUROSCI METH, V163, P128, DOI 10.1016/j.jneumeth.2007.01.026; Zaca D, 2012, NEURORADIOLOGY, V54, P1015, DOI 10.1007/s00234-012-1056-2	33	182	183	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101165	10.1371/journal.pone.0101165	http://dx.doi.org/10.1371/journal.pone.0101165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977417	Green Published, gold, Green Submitted			2022-12-27	WOS:000338506400089
J	Loss, SR; Will, T; Marra, PP				Loss, Scott R.; Will, Tom; Marra, Peter P.			Refining Estimates of Bird Collision and Electrocution Mortality at Power Lines in the United States	PLOS ONE			English	Article							EAGLE HIERAAETUS-FASCIATUS; RAPTOR ELECTROCUTION; TRANSMISSION-LINES; UTILITY STRUCTURES; AVIAN MORTALITY; RISK; POPULATION; CRANE; MITIGATION; MARKING	Collisions and electrocutions at power lines are thought to kill large numbers of birds in the United States annually. However, existing estimates of mortality are either speculative (for electrocution) or based on extrapolation of results from one study to all U.S. power lines (for collision). Because national-scale estimates of mortality and comparisons among threats are likely to be used for prioritizing policy and management strategies and for identifying major research needs, these estimates should be based on systematic and transparent assessment of rigorously collected data. We conducted a quantitative review that incorporated data from 14 studies meeting our inclusion criteria to estimate that between 12 and 64 million birds are killed each year at U.S. power lines, with between 8 and 57 million birds killed by collision and between 0.9 and 11.6 million birds killed by electrocution. Sensitivity analyses indicate that the majority of uncertainty in our estimates arises from variation in mortality rates across studies; this variation is due in part to the small sample of rigorously conducted studies that can be used to estimate mortality. Little information is available to quantify species-specific vulnerability to mortality at power lines; the available literature over-represents particular bird groups and habitats, and most studies only sample and present data for one or a few species. Furthermore, additional research is needed to clarify whether, to what degree, and in what regions populations of different bird species are affected by power line-related mortality. Nonetheless, our data-driven analysis suggests that the amount of bird mortality at U.S. power lines is substantial and that conservation management and policy is necessary to reduce this mortality.	[Loss, Scott R.; Marra, Peter P.] Migratory Bird Ctr, Smithsonian Conservat Biol Inst, Washington, DC USA; [Will, Tom] US Fish & Wildlife Serv, Div Migratory Birds, Midwest Reg Off, Bloomington, MA USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; United States Department of the Interior; US Fish & Wildlife Service	Loss, SR (corresponding author), Oklahoma State Univ, Dept Nat Resource Ecol & Management, Stillwater, OK 74078 USA.	scott.loss@okstate.edu		Loss, Scott/0000-0002-8753-2995; Marra, Peter/0000-0002-0508-7577	U.S. Fish and Wildlife Service	U.S. Fish and Wildlife Service(US Fish & Wildlife Service)	S.R.L. was supported by a postdoctoral fellowship funded by the U. S. Fish and Wildlife Service through the Smithsonian Institution's Postdoctoral Fellowship program. T.W. participated as a collaborator and co-author throughout the project; however, the U.S. Fish and Wildlife as a larger entity had no role in study design; collection, analysis, and interpretation of data; in writing the report; and in the decision to submit the paper for publication.	AISI (American Iron and Steel Institute), 2013, STEELW ONL RES STEEL; ALONSO JC, 1994, BIOL CONSERV, V67, P129, DOI 10.1016/0006-3207(94)90358-1; APLIC, 2012, RED AV COLL POW LIN; Arnold TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024708; Avian Powerline Interaction Committee [APLIC], 2006, SUGG PRACT AV PROT P; Barrientos R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032569; Barrientos R, 2011, CONSERV BIOL, V25, P893, DOI 10.1111/j.1523-1739.2011.01699.x; Bevanger K, 1995, J APPL ECOL, V32, P745, DOI 10.2307/2404814; BEVANGER K, 1994, IBIS, V136, P412, DOI 10.1111/j.1474-919X.1994.tb01116.x; Bevanger K, 2001, BIOL CONSERV, V99, P341, DOI 10.1016/S0006-3207(00)00217-2; Bevanger K, 1999, BIRDS POWER LINES CO, P29; Blancher P, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00557-080203; Brown W.M., 1987, P 1985 CRAN WORKSH G; BROWN WM, 1995, WILDLIFE SOC B, V23, P217; Calvert AM, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00581-080211; CRIVELLI AJ, 1988, COLON WATERBIRD, V11, P301, DOI 10.2307/1521012; Crowder MR, 2002, SEVENTH INTERNATIONAL SYMPOSIUM ON ENVIRONMENTAL CONCERNS IN RIGHTS-OF-WAY-MANAGEMENT, P403; Dwyer JF, 2014, CONSERV BIOL, V28, P159, DOI 10.1111/cobi.12145; Dwyer JF, 2007, J RAPTOR RES, V41, P259, DOI 10.3356/0892-1016(2007)41[259:PREIAU]2.0.CO;2; Erickson Wallace P., 2005, U S Forest Service General Technical Report PSW, V191, P1029; Faanes C.A., 1987, 7 US FISH WILDL SERV; Garrido JR, 2003, ARDEOLA, V50, P191; Guil F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028212; Harness RE, 2001, WILDLIFE SOC B, V29, P612; Harness RE, 2001, P WORKSH HELD CHARL, P29; Henderson IG, 1996, BIOL CONSERV, V77, P185, DOI 10.1016/0006-3207(95)00144-1; Hunting K, 2002, P50002071F CAL EN CO; Huso MMP, 2011, ENVIRONMETRICS, V22, P318, DOI 10.1002/env.1052; Janss GFE, 1999, WILDLIFE SOC B, V27, P263; Janss GFE, 1998, J FIELD ORNITHOL, V69, P8; Jenkins AR, 2010, BIRD CONSERV INT, V20, P263, DOI 10.1017/S0959270910000122; Lehman RN, 2001, WILDLIFE SOC B, V29, P804; Lehman RN, 2007, BIOL CONSERV, V136, P159, DOI 10.1016/j.biocon.2006.09.015; Lehman RN, 2010, J WILDLIFE MANAGE, V74, P459, DOI 10.2193/2008-332; Longcore T, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00606-080201; Longcore T, 2013, BIOL CONSERV, V158, P410, DOI 10.1016/j.biocon.2012.09.019; Longcore T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034025; Loss SR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2380; Loss SR, 2014, J WILDLIFE MANAGE, V78, P763, DOI 10.1002/jwmg.721; Loss SR, 2014, CONDOR, V116, P8, DOI 10.1650/CONDOR-13-090.1; Loss SR, 2013, BIOL CONSERV, V168, P201, DOI 10.1016/j.biocon.2013.10.007; Loss SR, 2012, FRONT ECOL ENVIRON, V10, P357, DOI 10.1890/110251; Machtans CS, 2014, CONDOR, V116, P3, DOI 10.1650/CONDOR-13-134.1; Machtans CS, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00568-080206; MALCOLM J M, 1982, Wildlife Society Bulletin, V10, P297; Manville AMII., 2013, INVITED WHITE PAPER, P16; Manville II A.M., 2005, USDAFOREST SERVICE G, P1051; McIntyre CL, 2012, J RAPTOR RES, V46, P129, DOI 10.3356/JRR-10-96.1; ML Yee, 2008, CEC500200722 PIER EN; MORKILL AE, 1991, WILDLIFE SOC B, V19, P442; Olendorff RR, 1981, 4 RAPT RES FDN; Pearson DC, 2002, AVIAN INTERACTIONS U, P105; Ponce C, 2010, ANIM CONSERV, V13, P603, DOI 10.1111/j.1469-1795.2010.00387.x; Real J, 2001, BIRD STUDY, V48, P221, DOI 10.1080/00063650109461221; Rioux S, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00614-080207; Rollan A, 2010, BIRD CONSERV INT, V20, P279, DOI 10.1017/S0959270910000250; RUSZ PJ, 1986, WILDLIFE SOC B, V14, P441; Savereno AJ, 1996, WILDLIFE SOC B, V24, P636; Schaub M., 2004, Animal Biodiversity and Conservation, V27, P73; Schaub M, 2004, ECOLOGY, V85, P930, DOI 10.1890/03-0012; Sergio F, 2004, J APPL ECOL, V41, P836, DOI 10.1111/j.0021-8901.2004.00946.x; Shaw JM, 2010, IBIS, V152, P590, DOI 10.1111/j.1474-919X.2010.01039.x; Smallwood KS, 2013, WILDLIFE SOC B, V37, P19, DOI 10.1002/wsb.260; Sundar KSG, 2005, ENVIRON CONSERV, V32, P260, DOI 10.1017/S0376892905002341; Thompson C., 2009, TUNDRA TROPICS CONNE, P262; Tinto A, 2010, J WILDLIFE MANAGE, V74, P1852, DOI 10.2193/2009-521; Ward J. P., 1992, P 1988 N AM CRANE WO, P189; Winning G., 1997, WETLANDS, V17, P29	68	84	90	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101565	10.1371/journal.pone.0101565	http://dx.doi.org/10.1371/journal.pone.0101565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991997	gold, Green Published, Green Submitted			2022-12-27	WOS:000341253400091
J	Nowak, A; Friedrich, B; Artunc, F; Serra, AL; Breidthardt, T; Twerenbold, R; Peter, M; Mueller, C				Nowak, Albina; Friedrich, Bjoern; Artunc, Ferruh; Serra, Andreas L.; Breidthardt, Tobias; Twerenbold, Raphael; Peter, Myriam; Mueller, Christian			Prognostic Value and Link to Atrial Fibrillation of Soluble Klotho and FGF23 in Hemodialysis Patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GROWTH-FACTOR 23; STAGE RENAL-DISEASE; SECRETED KLOTHO; MYOCARDIAL-INFARCTION; ARTERY CALCIFICATION; MEDIA CALCIFICATION; RISK-FACTORS; MORTALITY; DIALYSIS	Deranged calcium-phosphate metabolism contributes to the burden of morbidity and mortality in dialysis patients. This study aimed to assess the association of the phosphaturic hormone fibroblast growth factor 23 (FGF23) and soluble Klotho with all-cause mortality. We measured soluble Klotho and FGF23 levels at enrolment and two weeks later in 239 prevalent hemodialysis patients. The primary hypothesis was that low Klotho and high FGF23 are associated with increased mortality. The association between Klotho and atrial fibrillation (AF) at baseline was explored as secondary outcome. AF was defined as presence of paroxysmal, persistent or permanent AF. During a median follow-up of 924 days, 59 (25%) patients died from any cause. Lower Klotho levels were not associated with mortality in a multivariable adjusted analysis when examined either on a continuous scale (HR 1.25 per SD increase, 95% CI 0.84-1.86) or in tertiles, with tertile 1 as the reference category (HR for tertile two 0.65, 95% CI 0.26-1.64; HR for tertile three 2.18, 95% CI 0.91-2.23). Higher Klotho levels were associated with the absence of AF in a multivariable logistic regression analysis (OR 0.66 per SD increase, 95% CI 0.41-1.00). Higher FGF23 levels were associated with mortality risk in a multivariable adjusted analysis when examined either on a continuous scale (HR 1.45 per SD increase, 95% CI 1.05-1.99) or in tertiles, with the tertile 1 as the reference category (HR for tertile two 1.63, 95% CI 0.64-4.14; HR for tertile three 3.91, 95% CI 1.28-12.20). FGF23 but not Klotho levels are associated with mortality in hemodialysis patients. Klotho may be protective against AF.	[Nowak, Albina] Univ Zurich Hosp, Div Internal Med, CH-8091 Zurich, Switzerland; [Friedrich, Bjoern; Artunc, Ferruh] Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Vasc Dis Nephrol & Clin C, Tubingen, Germany; [Friedrich, Bjoern] Dialysis Ctr Leonberg, Leonberg, Germany; [Serra, Andreas L.] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Breidthardt, Tobias] Univ Basel Hosp, Div Nephrol, CH-4031 Basel, Switzerland; [Twerenbold, Raphael; Peter, Myriam; Mueller, Christian] Univ Basel Hosp, Div Cardiol, CH-4031 Basel, Switzerland	University of Zurich; University Zurich Hospital; Eberhard Karls University of Tubingen; University of Zurich; University Zurich Hospital; University of Basel; University of Basel	Nowak, A (corresponding author), Univ Zurich Hosp, Div Internal Med, CH-8091 Zurich, Switzerland.	albina.nowak@usz.ch	Twerenbold, Raphael/H-3533-2018; Müller, Christian/AAB-4783-2022	Müller, Christian/0000-0002-1120-6405; Twerenbold, Raphael/0000-0003-3814-6542; Breidthardt, Tobias/0000-0003-2671-6456				Akimoto T, 2012, CLIN EXP NEPHROL, V16, P442, DOI 10.1007/s10157-011-0582-2; Alexander RT, 2009, J AM SOC NEPHROL, V20, P2371, DOI 10.1681/ASN.2008121273; Anour R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031376; Artunc F, 2012, KIDNEY BLOOD PRESS R, V36, P172, DOI 10.1159/000343406; Artunc F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047610; Drueke TB, 2010, KIDNEY INT, V78, P1057, DOI 10.1038/ki.2010.339; Etter C, 2010, EUR HEART J, V31, P354, DOI 10.1093/eurheartj/ehp429; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Gutierrez OM, 2011, CLIN J AM SOC NEPHRO, V6, P2871, DOI 10.2215/CJN.02740311; Heijboer AC, 2013, NEPHROL DIAL TRANSPL; Huang CL, 2010, KIDNEY INT, V77, P855, DOI 10.1038/ki.2010.73; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Kendrick J, 2011, J AM SOC NEPHROL, V22, P1913, DOI 10.1681/ASN.2010121224; Kitagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056695; Komaba H, 2012, NEPHROL DIAL TRANSPL, V27, P1967, DOI 10.1093/ndt/gfr645; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Lim K, 2012, CIRCULATION, V125, P2243, DOI 10.1161/CIRCULATIONAHA.111.053405; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Maekawa Y, 2009, ENDOCRINE, V35, P341, DOI 10.1007/s12020-009-9181-3; Moe SM, 2011, J BONE MINER RES, V26, P2672, DOI 10.1002/jbmr.485; Pavik I, 2012, NEPHROL DIAL TRANSPL; Pavik I, 2013, NEPHROL DIAL TRANSPL, V28, P352, DOI 10.1093/ndt/gfs460; Quarles LD, 2008, J CLIN INVEST, V118, P3820, DOI 10.1172/JCI36479; Seiler C, 2011, EUR HEART J, V32, P261, DOI [10.1093/eurheartj/ehq314, 10.1093/eurheartj/ehr215]; Seiler S, 2013, KIDNEY INT, V83, P121, DOI 10.1038/ki.2012.288; Shroff GR, 2012, AM HEART J, V163, P399, DOI 10.1016/j.ahj.2011.12.002; Six I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093423; Smith ER, 2013, CLIN CHEM LAB MED, V51, P1971, DOI 10.1515/cclm-2013-0208; Takeshita K, 2004, CIRCULATION, V109, P1776, DOI 10.1161/01.CIR.0000124224.48962.32; Tandon T, 2013, NEPHROL DIAL TRANSPL, V28, P1562, DOI 10.1093/ndt/gfs597; Tangri N, 2011, NEPHROL DIAL TRANSPL, V26, P3998, DOI 10.1093/ndt/gfr188; Tong LL, 2008, HEMODIAL INT, V12, P16, DOI 10.1111/j.1542-4758.2008.00234.x; Trivedi H, 2009, NEPHROL DIAL TRANSPL, V24, P258, DOI 10.1093/ndt/gfn426; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Xie J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2240; Yamazaki Y, 2010, BIOCHEM BIOPH RES CO, V398, P513, DOI 10.1016/j.bbrc.2010.06.110; Yoshida H, 2011, CLIN NEPHROL, V75, P1, DOI 10.2379/CN106401; Zaritsky J, 2013, NEPHROL DIAL TRANSPL	41	49	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100688	10.1371/journal.pone.0100688	http://dx.doi.org/10.1371/journal.pone.0100688			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991914	Green Submitted, gold, Green Published			2022-12-27	WOS:000341253400026
J	Bartz, RR; Fu, P; Suliman, HB; Crowley, SD; MacGarvey, NC; Welty-Wolf, K; Piantadosi, CA				Bartz, Raquel R.; Fu, Ping; Suliman, Hagir B.; Crowley, Stephen D.; MacGarvey, Nancy Chou; Welty-Wolf, Karen; Piantadosi, Claude A.			Staphylococcus aureus Sepsis Induces Early Renal Mitochondrial DNA Repair and Mitochondrial Biogenesis in Mice	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; CRITICALLY-ILL PATIENTS; OXIDATIVE STRESS; HEME OXYGENASE; BLOOD-FLOW; DAMAGE; 8-OXOGUANINE; DYSFUNCTION; METABOLISM; MODEL	Acute kidney injury (AKI) contributes to the high morbidity and mortality of multi-system organ failure in sepsis. However, recovery of renal function after sepsis-induced AKI suggests active repair of energy-producing pathways. Here, we tested the hypothesis in mice that Staphyloccocus aureus sepsis damages mitochondrial DNA (mtDNA) in the kidney and activates mtDNA repair and mitochondrial biogenesis. Sepsis was induced in wild-type C57Bl/6J and Cox-8 Gfp-tagged mitochondrial-reporter mice via intraperitoneal fibrin clots embedded with S. aureus. Kidneys from surviving mice were harvested at time zero (control), 24, or 48 hours after infection and evaluated for renal inflammation, oxidative stress markers, mtDNA content, and mitochondrial biogenesis markers, and OGG1 and UDG mitochondrial DNA repair enzymes. We examined the kidneys of the mitochondrial reporter mice for changes in staining density and distribution. S. aureus sepsis induced sharp amplification of renal Tnf, Il-10, and Ngal mRNAs with decreased renal mtDNA content and increased tubular and glomerular cell death and accumulation of protein carbonyls and 8-OHdG. Subsequently, mtDNA repair and mitochondrial biogenesis was evidenced by elevated OGG1 levels and significant increases in NRF-1, NRF-2, and mtTFA expression. Overall, renal mitochondrial mass, tracked by citrate synthase mRNA and protein, increased in parallel with changes in mitochondrial GFP-fluorescence especially in proximal tubules in the renal cortex and medulla. Sub-lethal S. aureus sepsis thus induces widespread renal mitochondrial damage that triggers the induction of the renal mtDNA repair protein, OGG1, and mitochondrial biogenesis as a conspicuous resolution mechanism after systemic bacterial infection.	[Bartz, Raquel R.; Fu, Ping; Suliman, Hagir B.; Piantadosi, Claude A.] Duke Univ, Sch Med, Dept Anesthesiol, Durham, NC 27708 USA; [Crowley, Stephen D.] Duke Univ, Sch Med, Dept Med, Div Nephrol, Durham, NC 27706 USA; [MacGarvey, Nancy Chou] Drexel Coll Med, Dept Med, Philadelphia, PA USA; [Bartz, Raquel R.; Welty-Wolf, Karen; Piantadosi, Claude A.] Durham Vet Affairs Med Ctr, Durham, NC USA; [Welty-Wolf, Karen; Piantadosi, Claude A.] Duke Univ, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Durham, NC 27706 USA	Duke University; Duke University; Drexel University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University	Bartz, RR (corresponding author), Duke Univ, Sch Med, Dept Anesthesiol, Durham, NC 27708 USA.	Raquel.bartz@dm.duke.edu			National Institutes of Health [K08GM087429, NIHRO1GM084116]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL108801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084116, K08GM087429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health K08GM087429 (RRB) and NIHRO1GM084116 (CAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL A, 1995, KIDNEY INT, V48, P1298, DOI 10.1038/ki.1995.414; Arai T, 2002, CARCINOGENESIS, V23, P2005, DOI 10.1093/carcin/23.12.2005; Bagshaw SM, 2007, CRIT CARE MED, V35, P1592, DOI 10.1097/01.CCM.0000266684.17500.2F; Bagshaw SM, 2007, CLIN J AM SOC NEPHRO, V2, P431, DOI 10.2215/CJN.03681106; Bartz RR, 2011, AM J RESP CRIT CARE, V183, P226, DOI 10.1164/rccm.200911-1709OC; Bolisetty S, 2013, AM J PHYSL RENAL PHY; Carchman EH, 2013, FASEB J, V27, P4703, DOI 10.1096/fj.13-229476; Carre JE, 2010, AM J RESP CRIT CARE, V182, P745, DOI 10.1164/rccm.201003-0326OC; Chertow GM, 2006, KIDNEY INT, V70, P1120, DOI 10.1038/sj.ki.5001579; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Chouteau JM, 2011, AM J PHYSIOL-LUNG C, V301, pL892, DOI 10.1152/ajplung.00210.2011; CLARK JB, 1974, BIOCHEM J, V140, P25, DOI 10.1042/bj1400025; CLARK JB, 1970, J BIOL CHEM, V245, P4724; de Souza-Pinto NC, 2001, CANCER RES, V61, P5378; Funk JA, 2010, J PHARMACOL EXP THER, V333, P593, DOI 10.1124/jpet.109.161992; Haden DW, 2007, AM J RESP CRIT CARE, V176, P768, DOI 10.1164/rccm.200701-161OC; HARRIS SI, 1982, J BIOL CHEM, V257, P6996; Holthoff JH, 2012, KIDNEY INT, V81, P370, DOI 10.1038/ki.2011.347; Jaloszynski P, 2007, BIOCHEM BIOPH RES CO, V364, P966, DOI 10.1016/j.bbrc.2007.10.123; JONES DP, 1986, ANNU REV PHYSIOL, V48, P33; Kalakeche R, 2011, J AM SOC NEPHROL, V22, P1505, DOI 10.1681/ASN.2011020203; Kaliman PA, 2003, B EXP BIOL MED+, V135, P37, DOI 10.1023/A:1023485626795; Kitada M, 2011, DIABETES, V60, P634, DOI 10.2337/db10-0386; Koopman Werner J H, 2010, Antioxid Redox Signal, V12, P1431, DOI 10.1089/ars.2009.2743; Langenberg C, 2006, KIDNEY INT, V69, P1996, DOI 10.1038/sj.ki.5000440; Langenberg C, 2005, CRIT CARE, V9, pR363, DOI 10.1186/cc3540; Leach M, 1998, BRIT J PHARMACOL, V125, P817, DOI 10.1038/sj.bjp.0702123; Lee SY, 2012, CRIT CARE MED, V40, P2997, DOI 10.1097/CCM.0b013e31825b912d; Lefort N, 2010, DIABETES, V59, P2444, DOI 10.2337/db10-0174; MacGarvey NC, 2012, AM J RESP CRIT CARE, V185, P851, DOI 10.1164/rccm.201106-1152OC; Messner UK, 1999, KIDNEY INT, V55, P2322, DOI 10.1046/j.1523-1755.1999.00473.x; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Murugan R, 2010, KIDNEY INT, V77, P527, DOI 10.1038/ki.2009.502; Nishimura S, 2002, FREE RADICAL BIO MED, V32, P813, DOI 10.1016/S0891-5849(02)00778-5; Nowak G, 1998, AM J PHYSIOL-RENAL, V274, pF509, DOI 10.1152/ajprenal.1998.274.3.F509; Palsamy P, 2011, BIOCH BIOPHYS ACTA; Rasbach KA, 2007, J BIOL CHEM, V282, P2355, DOI 10.1074/jbc.M608009200; Ruchko MV, 2011, FREE RADICAL BIO MED, V50, P1107, DOI 10.1016/j.freeradbiomed.2010.10.692; Suliman HB, 2003, AM J RESP CRIT CARE, V167, P570, DOI 10.1164/rccm.200206-518OC; Takasu O, 2013, AM J RESP CRIT CARE, V187, P509, DOI 10.1164/rccm.201211-1983OC; TAYLOR DE, 1995, ARCH BIOCHEM BIOPHYS, V316, P70, DOI 10.1006/abbi.1995.1011; Tran M, 2011, J CLIN INVEST, V121, P4003, DOI 10.1172/JCI58662; Tsuruya K, 2003, DNA REPAIR, V2, P211, DOI 10.1016/S1568-7864(02)00214-8; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Zhang Y, 2011, ANTIOXID REDOX SIGNA	45	31	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100912	10.1371/journal.pone.0100912	http://dx.doi.org/10.1371/journal.pone.0100912			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988481	Green Published, Green Submitted, gold			2022-12-27	WOS:000341354100051
J	Chen, Z; Chen, M; Xu, ZS; Li, LC; Chen, XP; Ma, YZ				Chen Zhu; Chen Ming; Xu Zhao-shi; Li Lian-cheng; Chen Xue-ping; Ma You-zhi			Characteristics and Expression Patterns of the Aldehyde Dehydrogenase (ALDH) Gene Superfamily of Foxtail Millet (Setaria italica L.)	PLOS ONE			English	Article							PLANT CRATEROSTIGMA-PLANTAGINEUM; GENOME-WIDE ANALYSIS; ARABIDOPSIS-THALIANA; EVOLUTIONARY FATE; STRESS TOLERANCE; TOBACCO PLANTS; SALT TOLERANCE; PROTEIN; RICE; SEQUENCE	Recent genomic sequencing of the foxtail millet, an abiotic, stress-tolerant crop, has provided a great opportunity for novel gene discovery and functional analysis of this popularly-grown grass. However, few stress-mediated gene families have been studied. Aldehyde dehydrogenases (ALDHs) comprise a gene superfamily encoding NAD (P)(+)-dependent enzymes that play the role of "aldehyde scavengers'', which indirectly detoxify cellular ROS and reduce the effect of lipid peroxidation meditated cellular toxicity under various environmental stresses. In the current paper, we identified a total of 20 ALDH genes in the foxtail millet genome using a homology search and a phylogenetic analysis and grouped them into ten distinct families based on their amino acid sequence identity. Furthermore, evolutionary analysis of foxtail millet reveals that both tandem and segmental duplication contributed significantly to the expansion of its ALDH genes. The exon-intron structures of members of the same family in foxtail millet or the orthologous genes in rice display highly diverse distributions of their exonic and intronic regions. Also, synteny analysis shows that the majority of foxtail millet and rice ALDH gene homologs exist in the syntenic blocks between the two, implying that these ALDH genes arose before the divergence of cereals. Semiquantitative and real-time quantitative PCR data reveals that a few SiALDH genes are expressed in an organ-specific manner and that the expression of a number of foxtail millet ALDH genes, such as, SiALDH7B1, SiALDH12A1 and SiALDH18B2 are upregulated by osmotic stress, cold, H2O2, and phytohormone abscisic acid (ABA). Furthermore, the transformation of SiALDH2B2, SiALDH10A2, SiALDH5F1, SiALDH22A1, and SiALDH3E2 into Escherichia coli (E. coli) was able to improve their salt tolerance. Taken together, our results show that genome-wide identification characteristics and expression analyses provide unique opportunities for assessing the functional roles of foxtail millet ALDH genes in stress responses.	[Chen Zhu; Chen Xue-ping] Univ Sci & Technol China, Dept Chem, Hefei 230026, Anhui, Peoples R China; [Chen Zhu; Chen Ming; Xu Zhao-shi; Li Lian-cheng; Ma You-zhi] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Triticeae Crops, Natl Key Facil Crop Gene Resources & Genet Improv, Minist Agr,Inst Crop Sci, Beijing 100193, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs	Chen, XP (corresponding author), Univ Sci & Technol China, Dept Chem, Hefei 230026, Anhui, Peoples R China.	chenxp08@ustc.edu.cn; mayouzhi@caas.cn	Chen, Zhu/W-6748-2018	chen, zhu/0000-0002-9974-0716	National Key Project for Research on Transgenic Biology [2013ZX08002-002]; National 863 High-tech Project [2012AA10A309]	National Key Project for Research on Transgenic Biology; National 863 High-tech Project(National High Technology Research and Development Program of China)	This work was supported by the National Key Project for Research on Transgenic Biology (2013ZX08002-002) and the National 863 High-tech Project (2012AA10A309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achary VMM, 2008, ECOTOX ENVIRON SAFE, V70, P300, DOI 10.1016/j.ecoenv.2007.10.022; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bartels D, 2001, PLANT PHYSIOL, V127, P1346, DOI 10.1104/pp.010765; Bartels D, 2001, TRENDS PLANT SCI, V6, P284, DOI 10.1016/S1360-1385(01)01983-5; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Bouche N, 2003, P NATL ACAD SCI USA, V100, P6843, DOI 10.1073/pnas.1037532100; Briesemeister S, 2010, NUCLEIC ACIDS RES, V38, pW497, DOI 10.1093/nar/gkq477; Briesemeister S, 2010, BIOINFORMATICS, V26, P1232, DOI 10.1093/bioinformatics/btq115; Brocker C, 2013, PLANTA, V237, P189, DOI 10.1007/s00425-012-1749-0; Cui XQ, 1996, SCIENCE, V272, P1334, DOI 10.1126/science.272.5266.1334; Fitzgerald TL, 2009, PLANT BIOLOGY, V11, P119, DOI 10.1111/j.1438-8677.2008.00161.x; Fredslund J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-369; Gallardo K, 2001, PLANT PHYSIOL, V126, P835, DOI 10.1104/pp.126.2.835; Gao CX, 2009, GENE, V431, P86, DOI 10.1016/j.gene.2008.11.010; GarciaRios M, 1997, P NATL ACAD SCI USA, V94, P8249, DOI 10.1073/pnas.94.15.8249; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Grabber JH, 2000, J AGR FOOD CHEM, V48, P6106, DOI 10.1021/jf0006978; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Huang WZ, 2008, PLANT MOL BIOL, V68, P451, DOI 10.1007/s11103-008-9382-9; Igarashi Y, 1997, PLANT MOL BIOL, V33, P857, DOI 10.1023/A:1005702408601; Jain M, 2008, FUNCT INTEGR GENOMIC, V8, P69, DOI 10.1007/s10142-007-0052-9; Jimenez-Lopez JC, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-43; Juretic N, 2005, GENOME RES, V15, P1292, DOI 10.1101/gr.4064205; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Kirch HH, 2005, PLANT MOL BIOL, V57, P315, DOI 10.1007/s11103-004-7796-6; Kirch HH, 2004, TRENDS PLANT SCI, V9, P371, DOI 10.1016/j.tplants.2004.06.004; Kirch HH, 2001, PLANT J, V28, P555, DOI 10.1046/j.1365-313X.2001.01176.x; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; Kotchoni SO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011516; Kotchoni SO, 2012, GENE, V495, P128, DOI 10.1016/j.gene.2011.12.035; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lecharny Alain, 2003, Journal of Structural and Functional Genomics, V3, P111, DOI 10.1023/A:1022614001371; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Liu F, 2001, PLANT CELL, V13, P1063, DOI 10.1105/tpc.13.5.1063; Liu Y, 2005, BIOCHEM BIOPH RES CO, V331, P325, DOI 10.1016/j.bbrc.2005.03.165; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Miller G, 2009, J BIOL CHEM, V284, P26482, DOI 10.1074/jbc.M109.009340; Mishra AM, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095280, 10.1371/journal.pone.0086852]; Nair RB, 2004, PLANT CELL, V16, P544, DOI 10.1105/tpc.017509; Nakamura T, 1997, PLANT J, V11, P1115, DOI 10.1046/j.1365-313X.1997.11051115.x; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Paterson AH, 2012, PLANT GEN DIVER, V1, P195, DOI DOI 10.1007/978-3-7091-1130-7_13; Puranik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064594; Rambaldi D, 2009, BIOINFORMATICS, V25, P2281, DOI 10.1093/bioinformatics/btp381; Rathinasabapathi B, 1997, P NATL ACAD SCI USA, V94, P3454, DOI 10.1073/pnas.94.7.3454; Razavizadeh R, 2009, EFFECTS SALT STRESS; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rodrigues SM, 2006, J EXP BOT, V57, P1909, DOI 10.1093/jxb/erj132; Shin JH, 2009, PLANT PHYSIOL, V149, P905, DOI 10.1104/pp.108.130716; Singh S, 2013, FREE RADICAL BIO MED, V56, P89, DOI 10.1016/j.freeradbiomed.2012.11.010; Stiti N, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00065; Sunkar R, 2003, PLANT J, V35, P452, DOI 10.1046/j.1365-313X.2003.01819.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Valverde F, 1999, FEBS LETT, V449, P153, DOI 10.1016/S0014-5793(99)00430-5; Vasiliou V, 1999, PHARMACOGENETICS, V9, P421, DOI 10.1097/00008571-199910000-00004; Wang XY, 2011, PLANT CELL, V23, P27, DOI 10.1105/tpc.110.080622; Wen YQ, 2012, PLANTA, V236, P525, DOI 10.1007/s00425-012-1624-z; Xu GX, 2012, P NATL ACAD SCI USA, V109, P1187, DOI 10.1073/pnas.1109047109; Yamada A, 2002, PLANT CELL PHYSIOL, V43, P1043, DOI 10.1093/pcp/pcf120; Yang ZF, 2008, J MOL EVOL, V67, P266, DOI 10.1007/s00239-008-9143-z; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yoshiba Y, 1997, PLANT CELL PHYSIOL, V38, P1095, DOI 10.1093/oxfordjournals.pcp.a029093; Yoshida A, 1998, EUR J BIOCHEM, V251, P549, DOI 10.1046/j.1432-1327.1998.2510549.x; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhang YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033514	69	27	29	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101136	10.1371/journal.pone.0101136	http://dx.doi.org/10.1371/journal.pone.0101136			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988301	Green Published, gold			2022-12-27	WOS:000341354100064
J	Heenan, A; Troje, NF				Heenan, Adam; Troje, Nikolaus F.			Both Physical Exercise and Progressive Muscle Relaxation Reduce the Facing-the-Viewer Bias in Biological Motion Perception	PLOS ONE			English	Article							ATTENTIONAL BIAS; SOCIAL PHOBIA; ANXIETY; THREAT; POINT; METAANALYSIS; ORIENTATION; STRESS; GENDER	Biological motion stimuli, such as orthographically projected stick figure walkers, are ambiguous about their orientation in depth. The projection of a stick figure walker oriented towards the viewer, therefore, is the same as its projection when oriented away. Even though such figures are depth-ambiguous, however, observers tend to interpret them as facing towards them more often than facing away. Some have speculated that this facing-the-viewer bias may exist for sociobiological reasons: Mistaking another human as retreating when they are actually approaching could have more severe consequences than the opposite error. Implied in this hypothesis is that the facing-towards percept of biological motion stimuli is potentially more threatening. Measures of anxiety and the facing-the-viewer bias should therefore be related, as researchers have consistently found that anxious individuals display an attentional bias towards more threatening stimuli. The goal of this study was to assess whether physical exercise (Experiment 1) or an anxiety induction/reduction task (Experiment 2) would significantly affect facing-the-viewer biases. We hypothesized that both physical exercise and progressive muscle relaxation would decrease facing-the-viewer biases for full stick figure walkers, but not for bottom-or top-half-only human stimuli, as these carry less sociobiological relevance. On the other hand, we expected that the anxiety induction task (Experiment 2) would increase facing-the-viewer biases for full stick figure walkers only. In both experiments, participants completed anxiety questionnaires, exercised on a treadmill (Experiment 1) or performed an anxiety induction/reduction task (Experiment 2), and then immediately completed a perceptual task that allowed us to assess their facing-theviewer bias. As hypothesized, we found that physical exercise and progressive muscle relaxation reduced facing-the-viewer biases for full stick figure walkers only. Our results provide further support that the facing-the-viewer bias for biological motion stimuli is related to the sociobiological relevance of such stimuli.	[Heenan, Adam; Troje, Nikolaus F.] Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada; [Troje, Nikolaus F.] Queens Univ, Sch Comp, Kingston, ON, Canada; [Troje, Nikolaus F.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Troje, Nikolaus F.] Canadian Inst Adv Res, Toronto, ON, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada; Canadian Institute for Advanced Research (CIFAR)	Heenan, A (corresponding author), Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada.	adam.heenan@queensu.ca		Troje, Niko/0000-0002-1533-2847	Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institute for Advanced Research (CIfAR); Canadian Action and Perception Network (CAPnet)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute for Advanced Research (CIfAR)(Canadian Institute for Advanced Research (CIFAR)); Canadian Action and Perception Network (CAPnet)	This research was supported by funding from the Natural Sciences and Engineering Research Council of Canada (NSERC), the Canadian Institute for Advanced Research (CIfAR), and the Canadian Action and Perception Network (CAPnet). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHRKE MS, 1978, COGNITIVE THER RES, V2, P323, DOI 10.1007/BF01172650; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Beard C, 2008, BEHAV RES THER, V46, P1135, DOI 10.1016/j.brat.2008.05.012; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson H., 1975, RELAXATION RESPONSE; Bourne, 2011, ANXIETY PHOBIA WORKB; Brooks A, 2008, CURR BIOL, V18, pR728, DOI 10.1016/j.cub.2008.06.054; CICONE MV, 1978, J SOC ISSUES, V34, P5, DOI 10.1111/j.1540-4560.1978.tb02537.x; Clark D. M., 1995, SOCIALPHOBIA DIAGNOS, P69, DOI DOI 10.1017/S1352465808004487; CLARK DM, 1986, BEHAV RES THER, V24, P461, DOI 10.1016/0005-7967(86)90011-2; DRISCOLL R, 1976, PSYCHOL REC, V26, P87, DOI 10.1007/BF03394364; Fox E, 2002, COGNITION EMOTION, V16, P355, DOI 10.1080/02699930143000527; Gray KLH, 2009, COGNITION, V113, P105, DOI 10.1016/j.cognition.2009.06.009; Heenan A, 2012, CAN J EXP PSYCHOL, V66, P302; Heeren A, 2012, COGNITIVE THER RES, V36, P512, DOI 10.1007/s10608-011-9394-7; HOLLAND JC, 1991, J CLIN ONCOL, V9, P1004, DOI 10.1200/JCO.1991.9.6.1004; Jackson S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003982; Kilts CD, 2006, NEUROPSYCHOPHARMACOL, V31, P2243, DOI 10.1038/sj.npp.1301053; Kimbrell TA, 1999, BIOL PSYCHIAT, V46, P454, DOI 10.1016/S0006-3223(99)00103-1; Langer MS, 2001, PERCEPTION, V30, P403, DOI 10.1068/p3178; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; Manera V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037514; MATHEWS A, 1985, BEHAV RES THER, V23, P563, DOI 10.1016/0005-7967(85)90104-4; Mattick RP, 1998, BEHAV RES THER, V36, P455, DOI 10.1016/S0005-7967(97)10031-6; Musa CZ, 2000, EUR PSYCHIAT, V15, P59, DOI 10.1016/S0924-9338(00)00210-8; OST LG, 1988, BEHAV RES THER, V26, P13, DOI 10.1016/0005-7967(88)90029-0; Pavlova M, 2000, PERCEPT PSYCHOPHYS, V62, P889, DOI 10.3758/BF03212075; PETRUZZELLO SJ, 1991, SPORTS MED, V11, P143, DOI 10.2165/00007256-199111030-00002; Rapee RM, 1997, BEHAV RES THER, V35, P741, DOI 10.1016/S0005-7967(97)00022-3; Salmon P, 2001, CLIN PSYCHOL REV, V21, P33, DOI 10.1016/S0272-7358(99)00032-X; Schouten B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056978; Schouten B, 2011, ATTEN PERCEPT PSYCHO, V73, P130, DOI 10.3758/s13414-010-0018-1; Schouten B, 2010, ATTEN PERCEPT PSYCHO, V72, P1256, DOI 10.3758/APP.72.5.1256; Schouten B, 2010, BEHAV RES METHODS, V42, P161, DOI 10.3758/BRM.42.1.161; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Singer N, 2012, EMOTION, V12, P960, DOI 10.1037/a0027070; Sinha R, 1999, PSYCHOPHARMACOLOGY, V142, P343, DOI 10.1007/s002130050898; Spielberger C. D., 1973, MANUAL STATE TRAIT I; STEPHENS T, 1988, PREV MED, V17, P35, DOI 10.1016/0091-7435(88)90070-9; SUMI S, 1984, PERCEPTION, V13, P283, DOI 10.1068/p130283; Troje N., 2008, UNDERSTANDING EVENTS, P308, DOI [10.1093/acprof:oso/9780195188370.003.0014, DOI 10.1093/ACPR0T0S0/9780195188370.003.0014]; Troje NF, 2006, CURR BIOL, V16, P821, DOI 10.1016/j.cub.2006.03.022; Troje NF, 2002, J VISION, V2, P371, DOI 10.1167/2.5.2; Van de Cruys S, 2013, ACTA PSYCHOL, V144, P548, DOI 10.1016/j.actpsy.2013.09.010; Vanrie J, 2004, PERCEPTION, V33, P547, DOI 10.1068/p5004; Vanrie J, 2006, PERCEPT PSYCHOPHYS, V68, P601, DOI 10.3758/BF03208762; Wipfli BM, 2008, J SPORT EXERCISE PSY, V30, P392, DOI 10.1123/jsep.30.4.392	47	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e99902	10.1371/journal.pone.0099902	http://dx.doi.org/10.1371/journal.pone.0099902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BA	24987956	Green Submitted, Green Published, gold			2022-12-27	WOS:000341354100021
J	Takeda, D; Hasegawa, T; Ueha, T; Imai, Y; Sakakibara, A; Minoda, M; Kawamoto, T; Minamikawa, T; Shibuya, Y; Akisue, T; Sakai, Y; Kurosaka, M; Komori, T				Takeda, Daisuke; Hasegawa, Takumi; Ueha, Takeshi; Imai, Yusuke; Sakakibara, Akiko; Minoda, Masaya; Kawamoto, Teruya; Minamikawa, Tsutomu; Shibuya, Yasuyuki; Akisue, Toshihiro; Sakai, Yoshitada; Kurosaka, Masahiro; Komori, Takahide			Transcutaneous Carbon Dioxide Induces Mitochondrial Apoptosis and Suppresses Metastasis of Oral Squamous Cell Carcinoma In Vivo	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTORS; LYMPH-NODE METASTASIS; MATRIX METALLOPROTEINASE-2; CLINICAL-SIGNIFICANCE; EXPRESSION; TRANSPLANTATION; TONGUE; CANCER; VEGF; MATRIX-METALLOPROTEINASE-9	Squamous cell carcinoma (SCC) is the main histological type of oral cancer. Its growth rate and incidence of metastasis to regional lymph nodes is influenced by various factors, including hypoxic conditions. We have previously reported that transcutaneous CO2 induces mitochondrial apoptosis and decreases lung metastasis by reoxygenating sarcoma cells. However, previous studies have not determined the sequential mechanism by which transcutaneous CO2 suppresses growth of epithelial tumors, including SCCs. Moreover, there is no report that transcutaneous CO2 suppresses lymphogenous metastasis using human cell lines xenografts. In this study, we examined the effects of transcutaneous CO2 on cancer apoptosis and lymphogenous metastasis using human SCC xenografts. Our results showed that transcutaneous CO2 affects expressions of PGC-1 alpha and TFAM and protein levels of cleavage products of caspase-3, caspase-9 and PARP, which relatives mitochondrial apoptosis. They also showed that transcutaneous CO2 significantly inhibits SCC tumor growth and affects expressions of HIF-1 alpha, VEGF, MMP-2 and MMP-9, which play essential roles in tumor angiogenesis, invasion and metastasis. In conclusion, transcutaneous CO2 suppressed tumor growth, increased mitochondrial apoptosis and decreased the number of lymph node metastasis in human SCC by decreasing intra-tumoral hypoxia and suppressing metastatic potential with no observable effect in vivo. Our findings indicate that transcutaneous CO2 could be a novel therapeutic tool for treating human SCC.	[Takeda, Daisuke; Hasegawa, Takumi; Imai, Yusuke; Sakakibara, Akiko; Minamikawa, Tsutomu; Shibuya, Yasuyuki; Komori, Takahide] Kobe Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kobe, Hyogo 657, Japan; [Ueha, Takeshi] NeoChemir, Kobe, Hyogo, Japan; [Minoda, Masaya; Kawamoto, Teruya; Akisue, Toshihiro; Kurosaka, Masahiro] Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Kobe, Hyogo 657, Japan; [Sakai, Yoshitada] Kobe Univ, Grad Sch Med, Div Rehabil Med, Kobe, Hyogo 657, Japan	Kobe University; Kobe University; Kobe University	Hasegawa, T (corresponding author), Kobe Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kobe, Hyogo 657, Japan.	hasetaku@med.kobe-u.ac.jp	Akisue, Toshihiro/V-6187-2019	Akisue, Toshihiro/0000-0003-3708-4095; Kawamoto, Teruya/0000-0003-1845-7482	Japan Society for the Promotion of Science [24792209]; Grants-in-Aid for Scientific Research [24593028] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by a Grant-in-Aid for Young Scientists (B) Number 24792209 from Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beasley NJP, 2002, CANCER RES, V62, P2493; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Comerford KM, 2002, CANCER RES, V62, P3387; de Vicente JC, 2005, ORAL ONCOL, V41, P283, DOI 10.1016/j.oraloncology.2004.08.013; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Harada R, 2013, EXP CELL RES, V319, P1988, DOI 10.1016/j.yexcr.2013.05.019; Hartmann BR, 1997, ANGIOLOGY, V48, P337, DOI 10.1177/000331979704800406; Kang FW, 2013, EXP THER MED, V5, P112, DOI 10.3892/etm.2012.779; Komatsubara Hideki, 2002, Kobe Journal of Medical Sciences, V48, P145; Komatsubara Hideki, 2005, Kobe Journal of Medical Sciences, V51, P67; Liang XH, 2008, ANTICANCER RES, V28, P1659; Ling W, 2013, J ORAL MAXIL SURG, V71, P775, DOI 10.1016/j.joms.2012.09.026; Matsui T, 1998, ORAL ONCOL, V34, P253; Mayland MK, 2005, LARYNGOSCOPE, V115, P629, DOI 10.1097/01.mlg.0000161338.54515.b1; Miyazaki Y, 2008, INT J ONCOL, V32, P145; Oe K, 2011, BIOCHEM BIOPH RES CO, V407, P148, DOI 10.1016/j.bbrc.2011.02.128; Oguni A, 2010, INT J ORAL MAX SURG, V39, P42, DOI 10.1016/j.ijom.2009.10.006; Okada Y, 2010, ODONTOLOGY, V98, P52, DOI 10.1007/s10266-009-0117-4; Onishi Y, 2012, J CANC SCI THERAPY, V4, P7, DOI 10.4172/1948-5956.1000136; Onishi Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep03916; Onishi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049189; Patel BP, 2007, HEAD NECK-J SCI SPEC, V29, P564, DOI 10.1002/hed.20561; Perez-Sayans M, 2011, CANCER LETT, V313, P1, DOI 10.1016/j.canlet.2011.08.017; Qiao B, 2010, INT J ONCOL, V37, P663, DOI 10.3892/ijo_00000715; Resch K L, 1994, Wien Med Wochenschr, V144, P45; SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3; Sakai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024137; Sasabe E, 2005, CANCER SCI, V96, P394, DOI 10.1111/j.1349-7006.2005.00065.x; Shemirani B, 2002, ORAL ONCOL, V38, P251, DOI 10.1016/S1368-8375(01)00052-5; Shigeta T, 2008, ORAL SURG ORAL MED O, V105, P486, DOI 10.1016/j.tripleo.2007.06.016; Smith BD, 2000, J CLIN ONCOL, V18, P2046, DOI 10.1200/JCO.2000.18.10.2046; Sugiura T, 2009, INT J ONCOL, V34, P673, DOI 10.3892/ijo_00000193; Sun R, 2008, CHINESE MED J-PEKING, V121, P1891, DOI 10.1097/00029330-200810010-00007; Tamamura R, 2013, ACTA HISTOCHEM, V115, P113, DOI 10.1016/j.acthis.2012.05.001; Teppo S, 2013, EXP CELL RES, V319, P376, DOI 10.1016/j.yexcr.2012.12.010; Uehara M, 2009, ORAL ONCOL, V45, P241, DOI 10.1016/j.oraloncology.2008.05.007; Umeda M, 2001, BRIT J ORAL MAX SURG, V39, P376, DOI 10.1054/bjom.2000.0590; Yang An-Kui, 2008, Ai Zheng, V27, P1315; Yang MH, 2008, CELL CYCLE, V7, P2090, DOI 10.4161/cc.7.14.6324; Yasuda A, 2011, ORAL ONCOL, V47, P334, DOI 10.1016/j.oraloncology.2011.03.001; Yu M, 2010, CLIN CHIM ACTA, V411, P679, DOI 10.1016/j.cca.2010.01.035; Zhou CX, 2010, AUST DENT J, V55, P385, DOI 10.1111/j.1834-7819.2010.01258.x	45	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100530	10.1371/journal.pone.0100530	http://dx.doi.org/10.1371/journal.pone.0100530			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988190	Green Submitted, gold, Green Published			2022-12-27	WOS:000341354100031
J	Su, QJ; Yao, DP; Jiang, ML; Liu, F; Jiang, JJ; Xu, CX; Dai, Y; Yu, MY; Long, LL; Li, HZ; Liu, JR; Zhang, ZK; Zhang, J; Xiao, CQ; Guo, WB				Su, Qinji; Yao, Dapeng; Jiang, Muliang; Liu, Feng; Jiang, Jiajing; Xu, Chunxing; Dai, Yi; Yu, Miaoyu; Long, Liling; Li, Hongzheng; Liu, Jianrong; Zhang, Zhikun; Zhang, Jian; Xiao, Changqing; Guo, Wenbin			Dissociation of Regional Activity in Default Mode Network in Medication-Naive, First-Episode Somatization Disorder	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; LOW-FREQUENCY OSCILLATIONS; POSTERIOR PARIETAL CORTEX; STATE BRAIN ACTIVITY; FUNCTIONAL CONNECTIVITY; PRIMARY-CARE; AMPLITUDE; PAIN; SCHIZOPHRENIA; RESONANCE	Background: Patients with somatization disorder (SD) have altered neural activity in the brain regions of the default mode network (DMN). However, the regional alteration of the DMN in SD remains unknown. The present study was designed to investigate the regional alterations of the DMN in patients with SD at rest. Methods: Twenty-five first-episode, medication-naive patients with SD and 28 age-, sex-, education-matched healthy controls underwent a resting-state functional magnetic resonance imaging (fMRI) scan. The fractional amplitude of low-frequency fluctuations (fALFF) was applied to analyze the data. Results: Patients with SD showed a dissociation pattern of resting-state fALFF in the DMN, with increased fALFF in the bilateral superior medial prefrontal cortex (MPFC, BA8, 9) and decreased fALFF in the left precuneus (PCu, BA7). Furthermore, significantly positive correlation was observed between the z values of the voxels within the bilateral superior MPFC and somatization subscale scores of the Symptom Check List (SCL-90) in patients with SD. Conclusions: Our findings indicate that there is a dissociation pattern of the anterior and posterior DMN in first-episode, treatment-naive patients with SD. The results provide new insight for the importance of the DMN in the pathophysiology of SD.	[Su, Qinji; Yao, Dapeng; Jiang, Jiajing; Yu, Miaoyu; Liu, Jianrong; Zhang, Zhikun; Zhang, Jian; Xiao, Changqing; Guo, Wenbin] Guangxi Med Univ, Affiliated Hosp 1, Mental Hlth Ctr, Nanning, Guangxi, Peoples R China; [Jiang, Muliang; Dai, Yi; Long, Liling] Guangxi Med Univ, Dept Radiol, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China; [Liu, Feng] Univ Elect Sci & Technol China, Key Lab NeuroInformat, Minist Educ, Sch Life Sci & Technol, Chengdu 610054, Sichuan, Peoples R China; [Xu, Chunxing; Li, Hongzheng] Chinese Peoples Liberat Army, Hosp 303, Mental Hlth Inst, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University; University of Electronic Science & Technology of China	Guo, WB (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Mental Hlth Ctr, Nanning, Guangxi, Peoples R China.	guowenbin76@163.com	Liu, Feng/W-7572-2019	Liu, Feng/0000-0002-3570-4222; Long, Liling/0000-0003-3369-8532; Su, Qinji/0000-0002-8191-583X	National Natural Science Foundation of China [81260210, 30900483]; Natural Science Foundation of Guangxi [2013GXNSFAA019107]; Ministry of Health of the Peoples' Republic of China [201002003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangxi(National Natural Science Foundation of Guangxi Province); Ministry of Health of the Peoples' Republic of China	The study was supported by Grants from the National Natural Science Foundation of China (Grant nos. 81260210, and 30900483), the Natural Science Foundation of Guangxi (Grant no. 2013GXNSFAA019107), and the special funding by the Ministry of Health of the Peoples' Republic of China (Grant no. 201002003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alalade E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020035; Amft M, 2015, BRAIN STRUCT FUNCT, V220, P1031, DOI 10.1007/s00429-013-0698-0; Argyelan M, 2008, J NEUROSCI, V28, P10687, DOI 10.1523/JNEUROSCI.2933-08.2008; Atmaca M, 2011, PROG NEURO-PSYCHOPH, V35, P1699, DOI 10.1016/j.pnpbp.2011.05.016; BARBAS H, 1993, NEUROSCIENCE, V56, P841, DOI 10.1016/0306-4522(93)90132-Y; Barsky AJ, 2005, ARCH GEN PSYCHIAT, V62, P903, DOI 10.1001/archpsyc.62.8.903; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Brody AL, 2001, BIOL PSYCHIAT, V50, P171, DOI 10.1016/S0006-3223(01)01117-9; BROWN FW, 1990, PSYCHOSOM MED, V52, P445, DOI 10.1097/00006842-199007000-00006; Browning M, 2011, PSYCHOSOM MED, V73, P173, DOI 10.1097/PSY.0b013e31820824f6; Carmichael ST, 1995, J COMP NEUROL, V363, P642, DOI 10.1002/cne.903630409; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Damasio Antonio, 2008, DESCARTES ERROR EMOT; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; DEROGATIS LR, 1976, BRIT J PSYCHIAT, V128, P280, DOI 10.1192/bjp.128.3.280; Dimsdale JE, 2013, AM J PSYCHIAT, V170, P1393, DOI 10.1176/appi.ajp.2013.13050589; Fayed N, 2012, ACTA PSYCHIAT SCAND, V126, P115, DOI 10.1111/j.1600-0447.2011.01820.x; First M. B., 1997, STRUCTURED CLIN INTE; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; Gracely RH, 2004, BRAIN, V127, P835, DOI 10.1093/brain/awh098; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gundel H, 2008, PAIN, V137, P413, DOI 10.1016/j.pain.2007.10.003; Guo WB, 2014, EUR NEUROPSYCHOPHARM, V24, P545, DOI 10.1016/j.euroneuro.2014.01.004; Guo WB, 2014, PROG NEURO-PSYCHOPH, V49, P16, DOI 10.1016/j.pnpbp.2013.10.021; Guo WB, 2013, J AFFECT DISORDERS, V151, P1097, DOI 10.1016/j.jad.2013.09.003; Guo WB, 2013, PROG NEURO-PSYCHOPH, V46, P13, DOI 10.1016/j.pnpbp.2013.06.009; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hamilton M, 1959, BR J MED PSYCHOL; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; KATON W, 1991, AM J PSYCHIAT, V148, P34; Knauff M, 2003, J COGNITIVE NEUROSCI, V15, P559, DOI 10.1162/089892903321662949; Koch H, 2007, QUAL LIFE RES, V16, P1483, DOI 10.1007/s11136-007-9252-y; Konnopka A, 2012, PSYCHOTHER PSYCHOSOM, V81, P265, DOI 10.1159/000337349; Kroenke K, 1997, ARCH GEN PSYCHIAT, V54, P352; Kunisato Y, 2011, NEUROSCI LETT, V492, P109, DOI 10.1016/j.neulet.2011.01.067; Kunisato Y, 2011, NEUROSCI RES, V69, P129, DOI 10.1016/j.neures.2010.11.005; Lai CH, 2012, J AFFECT DISORDERS, V142, P180, DOI 10.1016/j.jad.2012.04.021; Leichnetz GR, 2001, ANAT RECORD, V263, P215, DOI 10.1002/ar.1082; Lemche E, 2013, SCI REP-UK, V3, DOI 10.1038/srep01032; Li BJ, 2013, BIOL PSYCHIAT, V74, P48, DOI 10.1016/j.biopsych.2012.11.007; LIPOWSKI ZJ, 1988, AM J PSYCHIAT, V145, P1358; Liu CH, 2013, J AFFECT DISORDERS, V149, P299, DOI 10.1016/j.jad.2013.02.002; Liu F, 2013, J AFFECT DISORDERS, V146, P401, DOI 10.1016/j.jad.2012.10.001; Lowe B, 2008, GEN HOSP PSYCHIAT, V30, P191, DOI 10.1016/j.genhosppsych.2008.01.001; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Ogiso T, 2000, NEUROREPORT, V11, P1345, DOI 10.1097/00001756-200004270-00039; Otti A, 2010, NEUROSCIENCE, V169, P143, DOI 10.1016/j.neuroscience.2010.04.072; Otti A, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-84; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Raichle ME, 2005, J COMP NEUROL, V493, P167, DOI 10.1002/cne.20752; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rief W, 2001, PSYCHOSOM MED, V63, P595, DOI 10.1097/00006842-200107000-00012; ROLLS ET, 1994, J NEUROSCI, V14, P5437; Sadock BJ, 2007, KAPLAN SADOCKS SYNOP, P634; Simon GE, 1999, NEW ENGL J MED, V341, P1329, DOI 10.1056/NEJM199910283411801; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Teasdale JD, 1999, AM J PSYCHIAT, V156, P209; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	67	29	30	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e99273	10.1371/journal.pone.0099273	http://dx.doi.org/10.1371/journal.pone.0099273			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983962	Green Published, gold, Green Submitted			2022-12-27	WOS:000339635000010
J	Wang, MC; Wang, YP; Chu, CH; Tu, TY; Shiao, AS; Chou, P				Wang, Mao-Che; Wang, Ying-Piao; Chu, Chia-Huei; Tu, Tzong-Yang; Shiao, An-Suey; Chou, Pesus			The Protective Effect of Adenoidectomy on Pediatric Tympanostomy Tube Re-Insertions: A Population-Based Birth Cohort Study	PLOS ONE			English	Article							CHRONIC OTITIS-MEDIA; PNEUMOCOCCAL CONJUGATE VACCINE; CLINICAL-PRACTICE GUIDELINE; NATURAL-HISTORY; RISK-FACTORS; CLEFT-LIP; CHILDREN; EFFUSION; PLACEMENT; EAR	Objectives: Adenoidectomy in conjunction with tympanostomy tube insertion for treating pediatric otitis media with effusion and recurrent acute otitis media has been debated for decades. Practice differed surgeon from surgeon. This study used population-based data to determine the protective effect of adenoidectomy in preventing tympanostomy tube reinsertion and tried to provide more evidence based information for surgeons when they do decision making. Study Design: Retrospective birth cohort study. Methods: This study used the National Health Insurance Research Database for the period 2000-2009 in Taiwan. The tube reinsertion rate and time to tube re-insertion among children who received tympanostomy tubes with or without adenoidectomy were compared. Age stratification analysis was also done to explore the effects of age. Results: Adenoidectomy showed protective effects on preventing tube re-insertion compared to tympanostomy tubes alone in children who needed tubes for the first time (tube re-insertion rate 9% versus 5.1%, p =0.002 and longer time to reinsertions, p = 0.01), especially those aged over 4 years when they had their first tube surgery. After controlling the effect of age, adenoidectomy reduced the rate of re-insertion by 40% compared to tympanostomy tubes alone (aHR: 0.60; 95% CI: 0.41-0.89). However, the protective effect of conjunction adenoidectomy was not obvious among children with a second tympanostomy tube insertion. Children who needed their first tube surgery at the age 2-4 years were most prone to have tube re-insertions, followed by the age group of 4-6 years. Conclusions: Adenoidectomy has protective effect in preventing tympanostomy tube re-insertions compared to tympanostomy tubes alone, especially for children older than 4 years old and who needed tubes for the first time. Nonetheless, clinicians should still weigh the pros and cons of the procedure for their pediatric patients.	[Wang, Mao-Che; Chu, Chia-Huei; Tu, Tzong-Yang; Shiao, An-Suey] Taipei Vet Gen Hosp, Dept Otolaryngol Head Neck Surg, Taipei, Taiwan; [Wang, Mao-Che; Chu, Chia-Huei; Tu, Tzong-Yang; Shiao, An-Suey] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Wang, Mao-Che; Wang, Ying-Piao; Chou, Pesus] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Wang, Mao-Che; Wang, Ying-Piao; Chou, Pesus] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Wang, Ying-Piao] Mackay Mem Hosp, Dept Otolaryngol Head Neck Surg, Taipei, Taiwan; [Wang, Ying-Piao] Mackay Med Coll, Dept Audiol & Speech Language Pathol, New Taipei City, Taiwan; [Wang, Ying-Piao] Mackay Med Coll, Sch Med, New Taipei City, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Mackay Medical College; Mackay Medical College	Chou, P (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan.	pschou@ym.edu.tw			Taipei Veterans General Hospital [V102B-050]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This study was supported by the research grant of Taipei Veterans General Hospital (V102B-050). Website of Taipei Veterans General Hospital: www.vghtpe.gov.tw. The first author WANG MC received the funding. Taipei Veterans General hospital is a government owned hospital in Taiwan. WANG MC, CHU CH, TU TY, SHIAO AS are employees of Taipei Veterans General Hospital. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah B, 2006, J LARYNGOL OTOL, V120, P556, DOI 10.1017/S0022215106000818; [Anonymous], TAIW NAT STAT REP; BLACK NA, 1990, BRIT MED J, V300, P1551, DOI 10.1136/bmj.300.6739.1551; Boston M, 2003, ARCH OTOLARYNGOL, V129, P293, DOI 10.1001/archotol.129.3.293; Casselbrant ML, 2009, INT J PEDIATR OTORHI, V73, P1718, DOI 10.1016/j.ijporl.2009.09.007; Cengel S, 2006, INT J PEDIATR OTORHI, V70, P639, DOI 10.1016/j.ijporl.2005.08.013; Coyte PC, 2001, NEW ENGL J MED, V344, P1188, DOI 10.1056/NEJM200104193441602; DEMPSTER JH, 1993, J LARYNGOL OTOL, V107, P284, DOI 10.1017/S0022215100122844; Fireman B, 2003, PEDIATR INFECT DIS J, V22, P10, DOI 10.1097/00006454-200301000-00006; GATES GA, 1987, NEW ENGL J MED, V317, P1444, DOI 10.1056/NEJM198712033172305; Gleinser DM, 2011, INT J PEDIATR OTORHI, V75, P1247, DOI 10.1016/j.ijporl.2011.06.023; Haggard MP, 2012, CLIN OTOLARYNGOL, V37, P107, DOI 10.1111/j.1749-4486.2012.02469.x; Hammaren-Malmi S, 2005, PEDIATRICS, V116, P185, DOI 10.1542/peds.2004-2253; Kadhim AL, 2007, LARYNGOSCOPE, V117, P427, DOI 10.1097/MLG.0b013e31802c938b; KAUFMAN FL, 1991, PEDIATR CLIN N AM, V38, P1127; Keyhani S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1607; Keyhani S, 2008, PEDIATRICS, V121, pE24, DOI 10.1542/peds.2007-0623; Kobayashi H, 2012, INT J PEDIATR OTORHI, V76, P718, DOI 10.1016/j.ijporl.2012.02.027; Kogan MD, 2000, AM J PUBLIC HEALTH, V90, P245, DOI 10.2105/AJPH.90.2.245; Kujala T, 2012, PEDIATR INFECT DIS J, V31, P565, DOI 10.1097/INF.0b013e318255ddde; Kvaerner KJ, 2002, ANN OTO RHINOL LARYN, V111, P1034, DOI 10.1177/000348940211101115; MANDEL EM, 1992, PEDIATR INFECT DIS J, V11, P270, DOI 10.1097/00006454-199204000-00003; MANDEL EM, 1989, ARCH OTOLARYNGOL, V115, P1217; Marchica CL, 2013, INT J PEDIATR OTORHI, V77, P252, DOI 10.1016/j.ijporl.2012.11.010; MAW AR, 1983, BRIT MED J, V287, P1586, DOI 10.1136/bmj.287.6405.1586; MAW AR, 1985, J ROY SOC MED, V78, P1014, DOI 10.1177/014107688507801207; Maw AR, 1993, BMJ-BRIT MED J, V306, P756; Mikals SJ, 2014, JAMA OTOLARYNGOL, V140, P95, DOI 10.1001/jamaoto.2013.5842; Musher DM, 2006, NEW ENGL J MED, V354, P1522, DOI 10.1056/NEJMe068038; Nguyen LHP, 2004, LARYNGOSCOPE, V114, P863, DOI 10.1097/00005537-200405000-00014; Palmu AAI, 2004, PEDIATR INFECT DIS J, V23, P732, DOI 10.1097/01.inf.0000133049.30299.5d; Paradise JL, 1997, PEDIATRICS, V99, P318, DOI 10.1542/peds.99.3.318; Paradise JL, 1999, JAMA-J AM MED ASSOC, V282, P945, DOI 10.1001/jama.282.10.945; PARADISE JL, 1990, JAMA-J AM MED ASSOC, V263, P2066, DOI 10.1001/jama.263.15.2066; Poehling KA, 2007, PEDIATRICS, V119, P707, DOI 10.1542/peds.2006-2138; Randall DA, 1998, OTOLARYNG HEAD NECK, V118, P61, DOI 10.1016/S0194-5998(98)70376-6; Rosenfeld RM, 2013, OTOLARYNG HEAD NECK, V149, pS1, DOI 10.1177/0194599813487302; Rosenfeld RM, 2004, OTOLARYNG HEAD NECK, V130, pS95, DOI 10.1016/j.otohns.2004.02.002; Sheahan P, 2003, INT J PEDIATR OTORHI, V67, P785, DOI 10.1016/S0165-5876(03)00098-3; Shiao AS, 2005, INT J PEDIATR OTORHI, V69, P1497, DOI 10.1016/j.ijporl.2005.03.041; Spielmann PM, 2008, J LARYNGOL OTOL, V122, P580, DOI 10.1017/S0022215107001168; Stool SE, 1994, AHCPR PUBL; Thomas K, 2013, INT J PEDIATR OTORHI, V77, P1716, DOI 10.1016/j.ijporl.2013.07.032; TOS M, 1984, AM J OTOL, V5, P459; van der Griend BF, 2011, ANESTH ANALG, V112, P1440, DOI 10.1213/ANE.0b013e318213be52; Wang MC, 2012, J EVAL CLIN PRACT, V18, P919, DOI 10.1111/j.1365-2753.2011.01754.x; WILLIAMSON IG, 1994, J LARYNGOL OTOL, V108, P930, DOI 10.1017/S0022215100128567; Wright ED, 1998, INT J PEDIATR OTORHI, V45, P207, DOI 10.1016/S0165-5876(98)00113-X; Yasan H, 2003, INT J PEDIATR OTORHI, V67, P1179, DOI 10.1016/S0165-5876(03)00222-2	49	19	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101175	10.1371/journal.pone.0101175	http://dx.doi.org/10.1371/journal.pone.0101175			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983459	Green Published, gold, Green Submitted			2022-12-27	WOS:000339635000065
J	Liu, XH; Matsushima, A; Shimohigashi, M; Shimohigashi, Y				Liu, Xiaohui; Matsushima, Ayami; Shimohigashi, Miki; Shimohigashi, Yasuyuki			A Characteristic Back Support Structure in the Bisphenol A-Binding Pocket in the Human Nuclear Receptor ERR gamma	PLOS ONE			English	Article							ESTROGEN; EXPRESSION; EXPOSURE; ALTERS; DOMAIN; ASSAY	The endocrine disruptor bisphenol A (BPA) affects various genes and hormones even at merely physiological levels. We recently demonstrated that BPA binds strongly to human nuclear receptor estrogen-related receptor (ERR) gamma and that the phenol-A group of BPA is in a receptacle pocket with essential amino acid residues to provide structural support at the backside. This led BPA to bind to ERR gamma in an induced-fit-type binding mode, for example, with a rotated motion of Val313 to support the Tyr326-binding site. A similar binding mechanism appears to occur at the binding site of the BPA phenol-B ring. X-ray crystal analysis of the ERR gamma-ligand-binding domain/BPA complex suggested that the ERR gamma receptor residues Leu342, Leu345, Asn346, and Ile349 function as intrinsic binding sites of the BPA phenol-B, whereas Leu265, Leu268, Ile310, Val313, Leu324, Tyr330, Lys430, Ala431, and His434 work as structural elements to assist these binding sites. In the present study, by evaluating the mutant receptors replaced by a series of amino acids, we demonstrated that a finely assembled structural network indeed exists around the two adjacent Leu(342)-Asn(346) and Leu(345)-Ile(349) ridges on the same alpha-helix 7 (H7), constructing a part of the binding pocket structure with back support residues for the BPA phenol-B ring. The results reveal that the double-layer binding sites, namely, the ordinary ligand binding sites and their back support residues, substantiate the strong binding of BPA to ERR gamma. When ERR gamma-Asn346 was replaced by the corresponding Gly and Tyr in ERR alpha and ERR beta, respectively, the binding affinity of BPA and even 4-hydroxytamxifen (4-OHT) is much reduced. Asn346 was found to be one of the residues that make ERRc to be exclusive to BPA.	[Liu, Xiaohui; Matsushima, Ayami; Shimohigashi, Yasuyuki] Kyushu Univ, Fac Sci, Dept Chem, Lab Struct Funct Biochem, Fukuoka 812, Japan; [Liu, Xiaohui; Matsushima, Ayami; Shimohigashi, Yasuyuki] Kyushu Univ, Risk Sci Res Ctr, Fukuoka 812, Japan; [Shimohigashi, Miki] Fukuoka Univ, Div Biol, Fac Sci, Fukuoka 81401, Japan	Kyushu University; Kyushu University; Fukuoka University	Shimohigashi, Y (corresponding author), Kyushu Univ, Fac Sci, Dept Chem, Lab Struct Funct Biochem, Fukuoka 812, Japan.	shimo@kyudai.jp			Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Science, Sports, and Culture in Japan [19291912, 22221005, 20710053, 25701008, 23710080, 25740024]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Sports, and Culture in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Health and Labour Sciences Research Grants for Research on the Risk of Chemical Substances from the Ministry of Health, Labor and Welfare of Japan to Y.S. Grants-in-aid from the Ministry of Education, Science, Sports, and Culture in Japan to Y.S. (19291912 and 22221005), to A.M. (20710053 and 25701008), and to X.L. (23710080 and 25740024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; Birnbaum LS, 2018, TESTIMONY FEDERAL RO; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao JY, 2013, TOXICOL SCI, V133, P157, DOI 10.1093/toxsci/kft035; Coward P, 2001, P NATL ACAD SCI USA, V98, P8880, DOI 10.1073/pnas.151244398; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; DIRR H, 1994, J MOL BIOL, V243, P72, DOI 10.1006/jmbi.1994.1631; Giguere V, 2002, TRENDS ENDOCRIN MET, V13, P220, DOI 10.1016/S1043-2760(02)00592-1; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Greschik H, 2002, MOL CELL, V9, P303, DOI 10.1016/S1097-2765(02)00444-6; Horard B, 2003, J MOL ENDOCRINOL, V31, P349, DOI 10.1677/jme.0.0310349; Kamrin MA, 2007, INT J TOXICOL, V26, P13, DOI 10.1080/10915810601117968; Kojo H, 2006, J STEROID BIOCHEM, V98, P181, DOI 10.1016/j.jsbmb.2005.10.004; Kubo K, 2003, NEUROSCI RES, V45, P345, DOI 10.1016/S0168-0102(02)00251-1; Kundakovic M, 2013, P NATL ACAD SCI USA, V110, P9956, DOI 10.1073/pnas.1214056110; Kunz N, 2011, INT J DEV NEUROSCI, V29, P37, DOI 10.1016/j.ijdevneu.2010.09.009; Liu X, 2007, FEBS J, V274, P6340, DOI 10.1111/j.1742-4658.2007.06152.x; Liu XH, 2012, J BIOCHEM, V151, P403, DOI 10.1093/jb/mvs008; Lui K, 2006, PROSTATE, V66, P1600, DOI 10.1002/pros.20429; Matsushima A, 2008, BIOCHEM BIOPH RES CO, V373, P408, DOI 10.1016/j.bbrc.2008.06.050; Matsushima A, 2007, J BIOCHEM, V142, P517, DOI 10.1093/jb/mvm158; Nakai M, 1999, BIOCHEM BIOPH RES CO, V254, P311, DOI 10.1006/bbrc.1998.9928; Okada H, 2008, ENVIRON HEALTH PERSP, V116, P32, DOI 10.1289/ehp.10587; PICHON MF, 1973, STEROIDS, V21, P335; Poidatz D, 2012, PLACENTA, V33, P688, DOI 10.1016/j.placenta.2012.06.002; Sambrook J., 2001, MOL CLONING LAB MANU; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Takayanagi S, 2006, TOXICOL LETT, V167, P95, DOI 10.1016/j.toxlet.2006.08.012; Takeda Y, 2009, J BIOCHEM, V146, P113, DOI 10.1093/jb/mvp049; Viberg H, 2012, NEUROTOXICOLOGY, V33, P1390, DOI 10.1016/j.neuro.2012.09.002; Vom Saal FS, 1998, TOXICOL IND HEALTH, V14, P239, DOI 10.1177/074823379801400115; vom Saal FS, 2005, ENVIRON HEALTH PERSP, V113, P926, DOI 10.1289/ehp.7713; Wang L, 2006, J BIOL CHEM, V281, P37773, DOI 10.1074/jbc.M608410200; Yan SJ, 2013, FOOD CHEM TOXICOL, V56, P75, DOI 10.1016/j.fct.2013.02.011	34	13	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101252	10.1371/journal.pone.0101252	http://dx.doi.org/10.1371/journal.pone.0101252			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978476	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400105
J	Clements, HS; Tambling, CJ; Hayward, MW; Kerley, GIH				Clements, Hayley S.; Tambling, Craig J.; Hayward, Matt W.; Kerley, Graham I. H.			An Objective Approach to Determining the Weight Ranges of Prey Preferred by and Accessible to the Five Large African Carnivores	PLOS ONE			English	Article							HYENA CROCUTA-CROCUTA; KRUGER-NATIONAL-PARK; LION PANTHERA-LEO; SPOTTED HYENA; CARRYING-CAPACITY; LYCAON-PICTUS; SOUTH-AFRICA; PREFERENCES; CONSERVATION; SELECTION	Broad-scale models describing predator prey preferences serve as useful departure points for understanding predator-prey interactions at finer scales. Previous analyses used a subjective approach to identify prey weight preferences of the five large African carnivores, hence their accuracy is questionable. This study uses a segmented model of prey weight versus prey preference to objectively quantify the prey weight preferences of the five large African carnivores. Based on simulations of known predator prey preference, for prey species sample sizes above 32 the segmented model approach detects up to four known changes in prey weight preference (represented by model break-points) with high rates of detection (75% to 100% of simulations, depending on number of break-points) and accuracy (within 1.3 +/- 4.0 to 2.7 +/- 4.4 of known break-point). When applied to the five large African carnivores, using carnivore diet information from across Africa, the model detected weight ranges of prey that are preferred, killed relative to their abundance, and avoided by each carnivore. Prey in the weight ranges preferred and killed relative to their abundance are together termed "accessible prey''. Accessible prey weight ranges were found to be 14-135 kg for cheetah Acinonyx jubatus, 1-45 kg for leopard Panthera pardus, 32-632 kg for lion Panthera leo, 15-1600 kg for spotted hyaena Crocuta crocuta and 10-289 kg for wild dog Lycaon pictus. An assessment of carnivore diets throughout Africa found these accessible prey weight ranges include 88 +/- 2% (cheetah), 82 +/- 3% (leopard), 81 +/- 2% (lion), 97 +/- 2% (spotted hyaena) and 96 +/- 2% (wild dog) of kills. These descriptions of prey weight preferences therefore contribute to our understanding of the diet spectrum of the five large African carnivores. Where datasets meet the minimum sample size requirements, the segmented model approach provides a means of determining, and comparing, the prey weight range preferences of any carnivore species.	[Clements, Hayley S.; Tambling, Craig J.; Hayward, Matt W.; Kerley, Graham I. H.] Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales; [Hayward, Matt W.] Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales; [Hayward, Matt W.] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales	Bangor University; Bangor University; Bangor University	Clements, HS (corresponding author), Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales.	clementshayley@gmail.com	Clements, Hayley/H-8549-2019; Hayward, Matt W./F-3569-2010; Tambling, Craig/H-3554-2019	Clements, Hayley/0000-0002-7015-6532; Hayward, Matt W./0000-0002-5574-1653; Tambling, Craig/0000-0001-9830-5985	National Research Foundation; Nelson Mandela Metropolitan University; Claude Leon Postdoctoral Fellowship	National Research Foundation; Nelson Mandela Metropolitan University; Claude Leon Postdoctoral Fellowship	HS Clements was funded by the National Research Foundation and Nelson Mandela Metropolitan University. CJ Tambling was funded by the National Research Foundation and a Claude Leon Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bertram B. C. B., 1979, SERENGETI DYNAMICS E, P221; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Caro T, 1994, CHEETAH SERENGETI PL; Cooper SM, 1999, AFR J ECOL, V37, P149, DOI 10.1046/j.1365-2028.1999.00161.x; Dalerum F, 2008, BIODIVERS CONSERV, V17, P2939, DOI 10.1007/s10531-008-9406-4; Di Silvestre I, 2000, AFR J ECOL, V38, P102; Fischhoff IR, 2007, BEHAV ECOL, V18, P725, DOI 10.1093/beheco/arm036; Funston PJ, 1998, ANIM BEHAV, V56, P1333, DOI 10.1006/anbe.1998.0884; Funston PJ, 2001, J ZOOL, V253, P419, DOI 10.1017/S0952836901000395; Garrott RA, 2007, ECOL APPL, V17, P1588, DOI 10.1890/06-1439.1; Ginsberg JR, 2001, CONSERV BIOL SER, V5, P498; Harrington R, 1999, BIOL CONSERV, V90, P69, DOI 10.1016/S0006-3207(98)00120-7; Hayward MW, 2006, J ZOOL, V270, P615, DOI 10.1111/j.1469-7998.2006.00184.x; Hayward MW, 2006, J ZOOL, V270, P606, DOI 10.1111/j.1469-7998.2006.00183.x; Hayward MW, 2006, J ZOOL, V270, P298, DOI 10.1111/j.1469-7998.2006.00139.x; Hayward MW, 2012, J ZOOL, V286, P221, DOI 10.1111/j.1469-7998.2011.00871.x; Hayward MW, 2006, J MAMMAL, V87, P1122, DOI 10.1644/05-MAMM-A-304R2.1; Hayward MW, 2007, J WILDLIFE MANAGE, V71, P1567, DOI 10.2193/2006-264; Hayward MW, 2007, BIOL CONSERV, V139, P219, DOI 10.1016/j.biocon.2007.06.018; Hayward MW, 2011, ACTA OECOL, V37, P314, DOI 10.1016/j.actao.2011.03.003; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; Hrabar H, 2013, ORYX, V47, P403, DOI 10.1017/S0030605311002018; HUDSON DJ, 1966, J AM STAT ASSOC, V61, P1097, DOI 10.2307/2283203; Ivlev V.S., 1961, EXPT ECOLOGY FEEDING; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Jooste E, 2013, EUR J WILDLIFE RES, V59, P487, DOI 10.1007/s10344-013-0696-9; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Kruuk H., 1972, SPOTTED HYAENA STUDY; Kruuk H., 1970, ANIMAL POPULATIONS R, P359; Louw J, 2012, S AFR J WILDL RES, V42, P73, DOI 10.3957/056.042.0211; Lyngdoh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088349; Meena V, 2011, J ZOOL, V284, P60, DOI 10.1111/j.1469-7998.2010.00780.x; Muggeo V.M., 2008, R NEWS, V8, P20; Owen-Smith N, 2008, J ANIM ECOL, V77, P173, DOI 10.1111/j.1365-2656.2007.01314.x; Radloff FGT, 2004, J ANIM ECOL, V73, P410, DOI 10.1111/j.0021-8790.2004.00817.x; Reich A., 1981, BEHAV ECOLOGY AFRICA; Schaller G. B., 1972, SERENGETI LION STUDY; Skinner J.D., 2005, MAMMALS SO AFRICAN S, DOI DOI 10.1017/CBO9781107340992; Stuart C, 2000, FIELD GUIDE LARGER M; Svengren H, 2010, S AFR J WILDL RES, V40, P121, DOI 10.3957/056.040.0203; Wentworth JC, 2011, ACTA THERIOL, V56, P389, DOI 10.1007/s13364-011-0033-1; Woodroffe R, 2007, J MAMMAL, V88, P181, DOI 10.1644/05-MAMM-A-405R1.1; Zar J. H., 1996, BIOSTATISTICAL ANAL	45	67	67	2	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101054	10.1371/journal.pone.0101054	http://dx.doi.org/10.1371/journal.pone.0101054			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988433	Green Submitted, gold, Green Published			2022-12-27	WOS:000341354100057
J	Dhimolea, E; Wadia, PR; Murray, TJ; Settles, ML; Treitman, JD; Sonnenschein, C; Shioda, T; Soto, AM				Dhimolea, Eugen; Wadia, Perinaaz R.; Murray, Tessa J.; Settles, Matthew L.; Treitman, Jo D.; Sonnenschein, Carlos; Shioda, Toshi; Soto, Ana M.			Prenatal Exposure to BPA Alters the Epigenome of the Rat Mammary Gland and Increases the Propensity to Neoplastic Development	PLOS ONE			English	Article							IN-UTERO EXPOSURE; BISPHENOL-A ALTERS; PERINATAL EXPOSURE; BREAST-CANCER; CARCINOGENESIS; DIETHYLSTILBESTROL; SUSCEPTIBILITY; HYPERPLASIAS; DISORDERS; RISK	Exposure to environmental estrogens (xenoestrogens) may play a causal role in the increased breast cancer incidence which has been observed in Europe and the US over the last 50 years. The xenoestrogen bisphenol A (BPA) leaches from plastic food/beverage containers and dental materials. Fetal exposure to BPA induces preneoplastic and neoplastic lesions in the adult rat mammary gland. Previous results suggest that BPA acts through the estrogen receptors which are detected exclusively in the mesenchyme during the exposure period by directly altering gene expression, leading to alterations of the reciprocal interactions between mesenchyme and epithelium. This initiates a long sequence of altered morphogenetic events leading to neoplastic transformation. Additionally, BPA induces epigenetic changes in some tissues. To explore this mechanism in the mammary gland, Wistar-Furth rats were exposed subcutaneously via osmotic pumps to vehicle or 250 mu g BPA/kg BW/day, a dose that induced ductal carcinomas in situ. Females exposed from gestational day 9 to postnatal day (PND) 1 were sacrificed at PND4, PND21 and at first estrus after PND50. Genomic DNA (gDNA) was isolated from the mammary tissue and immuno-precipitated using anti-5-methylcytosine antibodies. Detection and quantification of gDNA methylation status using the Nimblegen ChIP array revealed 7412 differentially methylated gDNA segments (out of 58207 segments), with the majority of changes occurring at PND21. Transcriptomal analysis revealed that the majority of gene expression differences between BPA- and vehicle-treated animals were observed later (PND50). BPA exposure resulted in higher levels of pro-activation histone H3K4 trimethylation at the transcriptional initiation site of the alpha-lactalbumin gene at PND4, concomitantly enhancing mRNA expression of this gene. These results show that fetal BPA exposure triggers changes in the postnatal and adult mammary gland epigenome and alters gene expression patterns. These events may contribute to the development of pre-neoplastic and neoplastic lesions that manifest during adulthood.	[Dhimolea, Eugen; Wadia, Perinaaz R.; Murray, Tessa J.; Treitman, Jo D.; Sonnenschein, Carlos; Soto, Ana M.] Tufts Univ, Sch Med, Dept Anat & Cellular Biol, Boston, MA 02111 USA; [Settles, Matthew L.] Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA; [Shioda, Toshi] Massachusetts Gen Hosp, MGH Ctr Canc Res, Charlestown, MA USA	Tufts University; Idaho; University of Idaho; Harvard University; Massachusetts General Hospital	Soto, AM (corresponding author), Tufts Univ, Sch Med, Dept Anat & Cellular Biol, Boston, MA 02111 USA.	ana.soto@tufts.edu	Settles, Matthew L/F-2031-2011	Settles, Matthew L/0000-0002-3424-1086	NIH National Institute of Environmental Health Sciences [ES015182, ES018822, ES08314]; Susan G. Komen for Cure [FAS0703860, KG090515]; ArtBeCause Breast Cancer Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [RC2ES018822, R01ES008314, R21ES015182] Funding Source: NIH RePORTER	NIH National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Susan G. Komen for Cure(Susan G. Komen Breast Cancer Foundation); ArtBeCause Breast Cancer Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by NIH National Institute of Environmental Health Sciences award numbers ES015182, ES018822, ES08314, (AS), Susan G. Komen for Cure (FAS0703860 and KG090515) (TS) and the ArtBeCause Breast Cancer Foundation (PW). The content is solely the responsibility of the authors and does not necessarily represent the official position of the Centers for Disease Control and Prevention, the National Institute of Environmental Health Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo N, 2013, ENVIRON HEALTH PERSP, V121, P1040, DOI 10.1289/ehp.1306734; Ayyanan A, 2011, MOL ENDOCRINOL, V25, P1915, DOI 10.1210/me.2011-1129; Barker DJP, 2004, ACTA PAEDIATR, V93, P1559, DOI 10.1080/08035250410024772; Betancourt AM, 2010, ENVIRON HEALTH PERSP, V118, P1614, DOI 10.1289/ehp.1002148; Biles JE, 1997, J AGR FOOD CHEM, V45, P3541, DOI 10.1021/jf970072i; BOYLAN ES, 1983, CANCER RES, V43, P4872; BRAUN MM, 1995, CANCER CAUSE CONTROL, V6, P519, DOI 10.1007/BF00054160; Bromer JG, 2010, FASEB J, V24, P2273, DOI 10.1096/fj.09-140533; BROTONS JA, 1994, ENV HLTH PERSPECT, V103, P608, DOI DOI 10.1289/EHP.95103608; Cabaton NJ, 2011, ENVIRON HEALTH PERSP, V119, P547, DOI 10.1289/ehp.1002559; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Delfosse V, 2012, P NATL ACAD SCI USA, V109, P14930, DOI 10.1073/pnas.1203574109; Durando M, 2007, ENVIRON HEALTH PERSP, V115, P80, DOI 10.1289/ehp.9282; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; GRUBBS CJ, 1983, J NATL CANCER I, V70, P209; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516; Honma S, 2002, REPROD TOXICOL, V16, P117, DOI 10.1016/S0890-6238(02)00006-0; Howdeshell KL, 1999, NATURE, V401, P763, DOI 10.1038/44517; Iacobuzio-Donahue CA, 2009, ANNU REV PATHOL-MECH, V4, P229, DOI 10.1146/annurev.pathol.3.121806.151442; Ikezuki Y, 2002, HUM REPROD, V17, P2839, DOI 10.1093/humrep/17.11.2839; Jenkins S, 2009, ENVIRON HEALTH PERSP, V117, P910, DOI 10.1289/ehp.11751; Land CE, 2003, RADIAT RES, V160, P707, DOI 10.1667/RR3082; Lozada KW, 2011, BIOL REPROD, V85, P490, DOI 10.1095/biolreprod.110.090431; Markey CM, 2002, J STEROID BIOCHEM, V83, P235, DOI 10.1016/S0960-0760(02)00272-8; MARKEY CM, 2003, EVOL DEV, V5, P1, DOI DOI 10.1016/S0960-0760(02)00272-8; Munoz-de-Toro M, 2005, ENDOCRINOLOGY, V146, P4138, DOI 10.1210/en.2005-0340; Murray TJ, 2007, REPROD TOXICOL, V23, P383, DOI 10.1016/j.reprotox.2006.10.002; Olea N, 1996, ENVIRON HEALTH PERSP, V104, P298, DOI 10.2307/3432888; Rijnkels M, 2010, J MAMMARY GLAND BIOL, V15, P85, DOI 10.1007/s10911-010-9170-4; Rubin BS, 2001, ENVIRON HEALTH PERSP, V109, P675, DOI 10.2307/3454783; Russo IH, 1996, ENVIRON HEALTH PERSP, V104, P938, DOI 10.2307/3433143; Sallout B, 2003, J Obstet Gynaecol, V23, P555; Schonfelder G, 2002, ENVIRON HEALTH PERSP, V110, pA703, DOI 10.1289/ehp.021100703; SHARPE RM, 1993, LANCET, V341, P1392, DOI 10.1016/0140-6736(93)90953-E; Singh M, 2000, LAB INVEST, V80, P221, DOI 10.1038/labinvest.3780025; Skakkebaek NE, 1998, APMIS, V106, P3, DOI 10.1111/j.1699-0463.1998.tb01314.x; Sonnenschein C, 2011, J DEV ORIG HLTH DIS, V2, P9, DOI 10.1017/S2040174411000043; Sonnenschein C., 1999, SOC CELLS CANC CONTR; Sonnenschein C, 2011, CANCER RES, V71, P4334, DOI 10.1158/0008-5472.CAN-11-0639; Soto AM, 2013, J MAMMARY GLAND BIOL, V18, P199, DOI 10.1007/s10911-013-9293-5; Soto AM, 2011, BIOESSAYS, V33, P332, DOI 10.1002/bies.201100025; Soto AM, 2010, NAT REV ENDOCRINOL, V6, P364, DOI 10.1038/nrendo.2010.87; Susiarjo M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003401; Tharp AP, 2012, P NATL ACAD SCI USA, V109, P8190, DOI 10.1073/pnas.1120488109; Trichopoulos D, 1990, Epidemiology, V1, P95; Vandenberg LN, 2007, ENDOCRINOLOGY, V148, P116, DOI 10.1210/en.2006-0561; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Vandenberg LN, 2008, REPROD TOXICOL, V26, P210, DOI 10.1016/j.reprotox.2008.09.015; Wadia PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063902; Weinberg RA, 2006, BIOL CANC; Woodruff TJ, 2011, ENVIRON HEALTH PERSP, V119, P878, DOI 10.1289/ehp.1002727; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yahata T, 2001, GENE DEV, V15, P2598, DOI 10.1101/gad.906301; Yaoi T, 2008, BIOCHEM BIOPH RES CO, V376, P563, DOI 10.1016/j.bbrc.2008.09.028; Ye X, 2008, TALANTA, V76, P865, DOI 10.1016/j.talanta.2008.04.034	57	69	71	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e99800	10.1371/journal.pone.0099800	http://dx.doi.org/10.1371/journal.pone.0099800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988533	Green Published, gold, Green Submitted			2022-12-27	WOS:000341354100019
J	Jones-Lopez, EC; Kim, S; Fregona, G; Marques-Rodrigues, P; Hadad, DJ; Molina, LPD; Vinhas, S; Reilly, N; Moine, S; Chakravorty, S; Gaeddert, M; Ribeiro-Rodrigues, R; Salgame, P; Palaci, M; Alland, D; Ellner, JJ; Dietze, R				Jones-Lopez, Edward C.; Kim, Soyeon; Fregona, Geisa; Marques-Rodrigues, Patricia; Hadad, David Jamil; Dutra Molina, Lucilia Pereira; Vinhas, Solange; Reilly, Nancy; Moine, Stephanie; Chakravorty, Soumitesh; Gaeddert, Mary; Ribeiro-Rodrigues, Rodrigo; Salgame, Padmini; Palaci, Moises; Alland, David; Ellner, Jerrold J.; Dietze, Reynaldo			Importance of Cough and M. tuberculosis Strain Type as Risks for Increased Transmission within Households	PLOS ONE			English	Article							LARGE SEQUENCE POLYMORPHISMS; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; IMMUNE-RESPONSE; GROWTH-RATES; INFECTION; MODEL; PATHOGENESIS; VARIABILITY; SUBLINEAGE	Rationale: The degree to which tuberculosis (TB) is transmitted between persons is variable. Identifying the factors that contribute to transmission could provide new opportunities for TB control. Transmission is influenced by host, bacterial and environmental factors. However, distinguishing their individual effects is problematic because measures of disease severity are tightly correlated, and assessing the virulence of Mycobacterium tuberculosis isolates is complicated by epidemiological and clinical confounders. Objectives: To overcome these problems, we investigated factors potentially associated with TB transmission within households. Methods: We evaluated patients with smear-positive (>= 2+), pulmonary TB and classified M. tuberculosis strains into single nucleotide polymorphism genetic cluster groups (SCG). We recorded index case, household contact, and environmental characteristics and tested contacts with tuberculin skin test (TST) and interferon-gamma release assay. Households were classified as high (>= 70% of contacts with TST >= 10 mm) and low (<= 40%) transmission. We used logistic regression to determine independent predictors. Result: From March 2008 to June 2012, we screened 293 TB patients to enroll 124 index cases and their 731 contacts. There were 23 low and 73 high transmission households. Index case factors associated with high transmission were severity of cough as measured by a visual analog cough scale (VACS) and the Leicester Cough Questionnaire (LCQ), and cavitation on chest radiograph. SCG 3b strains tended to be more prevalent in low (27.3%) than in high (12.5%) transmission households (p = 0.11). In adjusted models, only VACS (p<0.001) remained significant. SCG was associated with bilateral disease on chest radiograph (p = 0.002) and marginally associated with LCQ sores (p = 0.058), with group 3b patients having weaker cough. Conclusions: We found differential transmission among otherwise clinically similar patients with advanced TB disease. We propose that distinct strains may cause differing patterns of cough strength and cavitation in the host leading to diverging infectiousness. Larger studies are needed to verify this hypothesis.	[Jones-Lopez, Edward C.; Moine, Stephanie; Gaeddert, Mary; Ellner, Jerrold J.] Boston Med Ctr, Dept Med, Infect Dis Sect, Boston, MA 02118 USA; [Jones-Lopez, Edward C.; Moine, Stephanie; Gaeddert, Mary; Ellner, Jerrold J.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Kim, Soyeon] Rutgers State Univ, New Jersey Med Sch, Dept Prevent Med & Community Hlth, Newark, NJ 07102 USA; [Fregona, Geisa; Marques-Rodrigues, Patricia; Hadad, David Jamil; Dutra Molina, Lucilia Pereira; Dietze, Reynaldo] Univ Fed Espirito Santo, NDI, Vitoria, Brazil; [Vinhas, Solange; Palaci, Moises] Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Mycobacteriol Lab, Vitoria, Brazil; [Reilly, Nancy; Chakravorty, Soumitesh; Salgame, Padmini; Alland, David] Rutgers State Univ, Dept Med, New Jersey Med Sch, Div Infect Dis, Newark, NJ 07102 USA; [Ribeiro-Rodrigues, Rodrigo] Univ Fed Espirito Santo, Cellular & Mol Immunol Lab, Nucleo Doencas Infecciosas, Vitoria, Brazil	Boston Medical Center; Boston University; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Universidade Federal do Espirito Santo	Jones-Lopez, EC (corresponding author), Boston Med Ctr, Dept Med, Infect Dis Sect, Boston, MA 02118 USA.	edward.jones@bmc.org	Ribeiro-Rodrigues, Rodrigo/AAY-7820-2020	Ribeiro-Rodrigues, Rodrigo/0000-0002-0675-110X; Fregona, Geisa/0000-0001-5835-8222; Dietze, Reynaldo/0000-0002-6995-8001; Jones Lopez, Edward/0000-0001-6323-286X	NIH-NIAID [U01 AI065663-01]; Section of Infectious Diseases at Boston Medical Center; Nucleo de Doencas Infecciosas, Universidade Federal do Espirito Santo; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI065663] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Section of Infectious Diseases at Boston Medical Center; Nucleo de Doencas Infecciosas, Universidade Federal do Espirito Santo; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by NIH-NIAID award U01 AI065663-01 (International Collaboration in Infectious Diseases Research) and funds from the Section of Infectious Diseases at Boston Medical Center and Nucleo de Doencas Infecciosas, Universidade Federal do Espirito Santo. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanna AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025075; Alland D, 2007, J CLIN MICROBIOL, V45, P39, DOI 10.1128/JCM.02483-05; Almeida AS, 2009, J IMMUNOL, V183, P718, DOI 10.4049/jimmunol.0801212; Birring SS, 2003, THORAX, V58, P339, DOI 10.1136/thorax.58.4.339; Borgdorff MW, 2001, AM J EPIDEMIOL, V154, P934, DOI 10.1093/aje/154.10.934; BROOKS SM, 1973, AM REV RESPIR DIS, V108, P799; Canetti G., 1955, TUBERCLE BACILLUS PU; Conde MB, 2009, J BRAS PNEUMOL, V35, P1018, DOI 10.1590/S1806-37132009001000011; do Prado TN, 2011, J BRAS PNEUMOL, V37, P93, DOI 10.1590/S1806-37132011000100014; Dormans J, 2004, CLIN EXP IMMUNOL, V137, P460, DOI 10.1111/j.1365-2249.2004.02551.x; Escombe AR, 2008, PLOS MED, V5, P1387, DOI 10.1371/journal.pmed.0050188; Falk A OCJ, 1969, DIAGNOSTIC STANDARDS; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Guwatudde D, 2003, AM J EPIDEMIOL, V158, P887, DOI 10.1093/aje/kwg227; HAMBURG MA, 1994, NEW ENGL J MED, V330, P1750, DOI 10.1056/NEJM199406163302410; Hanekom M, 2007, J CLIN MICROBIOL, V45, P1483, DOI 10.1128/JCM.02191-06; Hanekom M, 2011, TUBERCULOSIS, V91, P510, DOI 10.1016/j.tube.2011.07.005; HERTZBERG GERH, 1957, AN EPIDEMIOLOGICAL INVESTIGATION ACTA TUBERC SCAND SUPPL, V38, P1; HIRJI KF, 1987, J AM STAT ASSOC, V82, P1110, DOI 10.2307/2289388; Jones-Lopez EC, 2013, AM J RESP CRIT CARE, V187, P1007, DOI 10.1164/rccm.201208-1422OC; Kato-Maeda M, 2011, INT J TUBERC LUNG D, V15, P131; Krishnan N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023870; Leconte S, 2011, RESPIRATION, V81, P161, DOI 10.1159/000321231; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; LOUDON RG, 1969, AM REV RESPIR DIS, V99, P109; Manca C, 2004, INFECT IMMUN, V72, P5511, DOI 10.1128/IAI.72.9.5511-5514.2004; Mathema B, 2012, J INFECT DIS, V205, P964, DOI 10.1093/infdis/jir876; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Palanisamy GS, 2009, TUBERCULOSIS, V89, P203, DOI 10.1016/j.tube.2009.01.005; Perrin FMR, 2010, INT J TUBERC LUNG D, V14, P1596; Portevin D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001307; Raj AA, 2007, PULM PHARMACOL THER, V20, P334, DOI 10.1016/j.pupt.2006.10.002; Rich A, 1951, PATHOGENESIS TUBERCU, P622; Rich A., 1951, PATHOGENESIS TUBERCU, V2nd; Riley R, 1961, AIRBORNE INFECT; RILEY RL, 1962, AM REV RESPIR DIS, V85, P511; Roy CJ, 2004, NEW ENGL J MED, V350, P1710, DOI 10.1056/NEJMp048051; Saude MD, 2002, CONTROLE TUBERCULOSE; SULTAN L, 1960, AM REV RESPIR DIS, V82, P358; Sutinen S, 1968, Scand J Respir Dis Suppl, V67, P5; Theus SA, 2005, J INFECT DIS, V191, P453, DOI 10.1086/425936; Theus SA, 2004, INFECT IMMUN, V72, P1169, DOI 10.1128/IAI.72.2.1169-1173.2004; Tsenova L, 2005, J INFECT DIS, V192, P98, DOI 10.1086/430614; van Geuns H A, 1975, Bull Int Union Tuberc, V50, P107; van Zyl-Smit RN, 2009, AM J RESP CRIT CARE, V180, P49, DOI 10.1164/rccm.200811-1704OC; Verhagen LM, 2011, J INFECT DIS, V203, P1249, DOI 10.1093/infdis/jir013; Victor TC, 2007, INT J TUBERC LUNG D, V11, P195; Weisenberg SA, 2012, INFECT GENET EVOL, V12, P664, DOI 10.1016/j.meegid.2011.07.018; Whalen CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016137; WOODRING JH, 1986, AM J ROENTGENOL, V146, P497, DOI 10.2214/ajr.146.3.497; World Health Organization (WHO), 1998, LAB SERVICES TUBERCU; Yoder MA, 2004, CURR SCI INDIA, V86, P74	53	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100984	10.1371/journal.pone.0100984	http://dx.doi.org/10.1371/journal.pone.0100984			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988000	gold, Green Submitted, Green Published			2022-12-27	WOS:000341354100053
J	Barrilleaux, BL; Burow, D; Lockwood, SH; Yu, A; Segal, DJ; Knoepfler, PS				Barrilleaux, Bonnie L.; Burow, Dana; Lockwood, Sarah H.; Yu, Abigail; Segal, David J.; Knoepfler, Paul S.			Miz-1 Activates Gene Expression via a Novel Consensus DNA Binding Motif	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; C/EBP-DELTA; MYC; PROTEIN; REPRESSION; FINGERS; DOMAIN; DIFFERENTIATION; NEUROBLASTOMA; SUPPRESSION	The transcription factor Miz-1 can either activate or repress gene expression in concert with binding partners including the Myc oncoprotein. The genomic binding of Miz-1 includes both core promoters and more distal sites, but the preferred DNA binding motif of Miz-1 has been unclear. We used a high-throughput in vitro technique, Bind-n-Seq, to identify two Miz-1 consensus DNA binding motif sequences-ATCGGTAATC and ATCGAT (Mizm1 and Mizm2)-bound by full-length Miz-1 and its zinc finger domain, respectively. We validated these sequences directly as high affinity Miz-1 binding motifs. Competition assays using mutant probes indicated that the binding affinity of Miz-1 for Mizm1 and Mizm2 is highly sequence-specific. Miz-1 strongly activates gene expression through the motifs in a Myc-independent manner. MEME-ChIP analysis of Miz-1 ChIP-seq data in two different cell types reveals a long motif with a central core sequence highly similar to the Mizm1 motif identified by Bind-n-Seq, validating the in vivo relevance of the findings. Miz-1 ChIP-seq peaks containing the long motif are predominantly located outside of proximal promoter regions, in contrast to peaks without the motif, which are highly concentrated within 1.5 kb of the nearest transcription start site. Overall, our results indicate that Miz-1 may be directed in vivo to the novel motif sequences we have identified, where it can recruit its specific binding partners to control gene expression and ultimately regulate cell fate.	[Barrilleaux, Bonnie L.; Burow, Dana; Knoepfler, Paul S.] Univ Calif Davis Sch Med, Dept Cell Biol & Human Anat, Davis, CA 95616 USA; [Barrilleaux, Bonnie L.; Burow, Dana; Lockwood, Sarah H.; Yu, Abigail; Segal, David J.; Knoepfler, Paul S.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Barrilleaux, Bonnie L.; Burow, Dana; Knoepfler, Paul S.] Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA 95817 USA; [Lockwood, Sarah H.; Yu, Abigail; Segal, David J.] Univ Calif Davis, Dept Biochem, Davis, CA 95616 USA; [Barrilleaux, Bonnie L.; Burow, Dana; Knoepfler, Paul S.] Shriners Hosp Children Northern Calif, Inst Pediat Regenerat Med, Sacramento, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Knoepfler, PS (corresponding author), Univ Calif Davis Sch Med, Dept Cell Biol & Human Anat, Davis, CA 95616 USA.	knoepfler@ucdavis.edu		Knoepfler, Paul/0000-0001-5444-334X	National Institutes of Health [1R01GM100782, R01 GM097073]; California Institute for Regenerative Medicine [RN2-00922-1]; California Institute for Regenerative Medicine Bridges Training Grant Award [TB1-01184]; National Institutes of Health T32 Training Grant [CA108459-07]; NATIONAL CANCER INSTITUTE [T32CA108459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100782, R01GM097073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); California Institute for Regenerative Medicine Bridges Training Grant Award; National Institutes of Health T32 Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health [grant number 1R01GM100782] and California Institute for Regenerative Medicine [grant number RN2-00922-1] to PK, a National Institutes of Health [grant number R01 GM097073] to DS, a National Institutes of Health T32 Training Grant award [grant number CA108459-07] to BB, and California Institute for Regenerative Medicine Bridges Training Grant Award [grant number TB1-01184] to DB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary S, 2003, MOL CELL BIOL, V23, P7648, DOI 10.1128/MCB.23.21.7648-7657.2003; Akter J, 2011, CLIN CANCER RES, V17, P6681, DOI 10.1158/1078-0432.CCR-11-0313; Bedard M, 2012, J BIOMOL NMR, V54, P317, DOI 10.1007/s10858-012-9670-1; Bernard D, 2013, J BIOMOL NMR, V57, P103, DOI 10.1007/s10858-013-9770-6; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Do-Umehara HC, 2013, NAT IMMUNOL, V14, P461, DOI 10.1038/ni.2566; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Gebhardt A, 2007, J CELL SCI, V120, P2586, DOI 10.1242/jcs.007104; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Ikegaki N, 2007, CLIN CANCER RES, V13, P6001, DOI 10.1158/1078-0432.CCR-07-0071; Iraci N, 2011, CANCER RES, V71, P404, DOI 10.1158/0008-5472.CAN-10-2627; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kime L, 2003, BIOCHEM J, V370, P291, DOI 10.1042/BJ20021679; Kosan C, 2010, IMMUNITY, V33, P917, DOI 10.1016/j.immuni.2010.11.028; Moon NS, 2001, MOL CELL BIOL, V21, P6332, DOI 10.1128/MCB.21.18.6332-6345.2001; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Si JL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-92; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Stead MA, 2007, J MOL BIOL, V373, P820, DOI 10.1016/j.jmb.2007.08.026; Stogios PJ, 2010, J MOL BIOL, V400, P983, DOI 10.1016/j.jmb.2010.05.028; Truscott M, 2004, J BIOL CHEM, V279, P49787, DOI 10.1074/jbc.M409484200; Truscott M, 2008, MOL CELL BIOL, V28, P3127, DOI 10.1128/MCB.02089-07; Varlakhanova N, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-20; Wanzel M, 2003, TRENDS CELL BIOL, V13, P146, DOI 10.1016/S0962-8924(03)00003-5; Wanzel M, 2008, NAT CELL BIOL, V10, P1051, DOI 10.1038/ncb1764; Wolf E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3535; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Zykovich A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp802	31	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101151	10.1371/journal.pone.0101151	http://dx.doi.org/10.1371/journal.pone.0101151			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983942	Green Published, Green Submitted, gold			2022-12-27	WOS:000339635000059
J	Kanungo, S; Sen, B; Ramamurthy, T; Sur, D; Manna, B; Pazhani, GP; Chowdhury, G; Jhunjhunwala, P; Nandy, RK; Koley, H; Bhattacharya, MK; Gupta, S; Goel, G; Dey, B; Thungapathra, M; Nair, GB; Ghosh, A; Mahalanabis, D				Kanungo, Suman; Sen, Bandana; Ramamurthy, Thandavarayan; Sur, Dipika; Manna, Byomkesh; Pazhani, Gururaja P.; Chowdhury, Goutam; Jhunjhunwala, Puja; Nandy, Ranjan K.; Koley, Hemanta; Bhattacharya, Mihir Kumar; Gupta, Sanjay; Goel, Gaurav; Dey, Bindu; Thungapathra, M.; Nair, G. Balakrish; Ghosh, Amit; Mahalanabis, Dilip			Safety and Immunogenicity of a Live Oral Recombinant Cholera Vaccine VA1.4: A Randomized, Placebo Controlled Trial in Healthy Adults in a Cholera Endemic Area in Kolkata, India	PLOS ONE			English	Article							VIBRIOCIDAL ANTIBODY TITER; ANTITOXIC IMMUNITY; FIELD-TRIAL; EL-TOR; SERUM; PROTECTION; BANGLADESH; RESPONSES; CHILDREN; O1	Background: A live oral cholera vaccine VA 1.4 developed from a non-toxigenic Vibrio cholerae O1 El Tor strain using ctxB gene insertion was further developed into a clinical product following cGMP and was evaluated in a double-blind randomized placebo controlled parallel group two arm trial with allocation ratio of 1: 1 for safety and immunogenicity in men and women aged 18-60 years from Kolkata, India. Method: A lyophilized dose of 1.9x10(9) CFU (n = 44) or a placebo (n = 43) reconstituted with a diluent was administered within 5 minutes of drinking 100 ml of a buffer solution made of sodium bicarbonate and ascorbic acid and a second dose on day 14. Result: The vaccine did not elicit any diarrhea related adverse events. Other adverse events were rare, mild and similar in two groups. One subject in the vaccine group excreted the vaccine strain on the second day after first dose. The proportion of participants who seroconverted (i.e. had 4-folds or higher rise in reciprocal titre) in the vaccine group were 65.9% (95% CI: 50.1%-79.5%) at both 7 days (i.e. after 1 st dose) and 21 days (i.e. after 2 nd dose). None of the placebo recipients seroconverted. Anti-cholera toxin antibody was detected in very few recipients of the vaccine. Conclusion: This study demonstrates that VA 1.4 at a single dose of 1.9x10(9) is safe and immunogenic in adults from a cholera endemic region. No additional benefit after two doses was seen.	[Sen, Bandana; Mahalanabis, Dilip] Soc Appl Studies, Kolkata, W Bengal, India; [Kanungo, Suman; Sur, Dipika; Manna, Byomkesh; Bhattacharya, Mihir Kumar] Natl Inst Cholera & Enter Dis, Dept Epidemiol, Kolkata, W Bengal, India; [Ramamurthy, Thandavarayan; Pazhani, Gururaja P.; Chowdhury, Goutam; Jhunjhunwala, Puja; Nandy, Ranjan K.; Koley, Hemanta; Ghosh, Amit] Natl Inst Cholera & Enter Dis, Dept Microbiol, Kolkata, W Bengal, India; [Gupta, Sanjay; Goel, Gaurav] Catalyst Clin Serv Pvt Ltd, Delhi, India; [Dey, Bindu] Minist Sci & Technol, Dept Biotechnol, New Delhi, India; [Thungapathra, M.] Inst Post Grad Med & Res, Chandigarh, India; [Nair, G. Balakrish] Translat Hlth Sci & Technol Inst, Gurgaon, Haryana, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI)	Mahalanabis, D (corresponding author), Soc Appl Studies, Kolkata, W Bengal, India.	sas_kolkata@vsnl.net	Kanungo, Sloka/HHM-7508-2022; Ghosh, Amit/AAB-3140-2019	CHOWDHURY, GOUTAM/0000-0003-1830-1920; Nandy, Ranjan Kumar/0000-0002-0012-9803; Pazhani, Gururaja Perumal/0000-0001-9500-006X; Kanungo, Suman/0000-0003-4441-4443	Department of Biotechnology of the Ministry of Science and Technology (DBT), Government of India; DBT, Ministry of Science and Technology, Government of India; DBT; SAS	Department of Biotechnology of the Ministry of Science and Technology (DBT), Government of India; DBT, Ministry of Science and Technology, Government of India; DBT(Department of Biotechnology (DBT) India); SAS	This vaccine was developed in three research laboratories of the Government of India and was not driven by the industry. The Department of Biotechnology of the Ministry of Science and Technology (DBT), Government of India was the lead agency that funded the project. (DBT) contracted Shantha Biotechnics Private Limited, Hyderabad, India to develop the vaccine into a clinical product (IP) for the present study. DBT, Ministry of Science and Technology, Government of India supported this project through a research grant to Society for Applied Studies, Kolkata. Sanjay Gupta and Gaurav Goel from the Catalyst Clinical Services Pvt. Ltd were contracted by DBT and used part of their salary to fund this study. The lead organization, Society for Applied studies (SAS), received a research grant from DBT and Bandana Sen a Research Fellow of SAS was financially supported from this grant. The funders and their contractors had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2010, Wkly Epidemiol Rec, V85, P117; [Anonymous], 2013, WEEKLY EPIDEMIOLOGIC, V88, P321; BENENSON AS, 1968, B WORLD HEALTH ORGAN, V38, P277; Chowdhury F, 2008, PEDIATR INFECT DIS J, V27, P986, DOI 10.1097/INF.0b013e3181783adf; CLEMENS JD, 1991, J INFECT DIS, V163, P1235, DOI 10.1093/infdis/163.6.1235; FUJITA K, 1972, J INFECT DIS, V125, P647, DOI 10.1093/infdis/125.6.647; GLASS RI, 1985, J INFECT DIS, V151, P236, DOI 10.1093/infdis/151.2.236; HOLMGREN J, 1975, INFECT IMMUN, V12, P1331, DOI 10.1128/IAI.12.6.1331-1340.1975; LEVINE MM, 1993, VACCINE, V11, P207, DOI 10.1016/0264-410X(93)90019-T; Levine Myron M., 1992, P285; Mahalanabis D, 2009, VACCINE, V27, P4850, DOI 10.1016/j.vaccine.2009.05.065; Mahalanabis D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002323; MOSLEY WH, 1969, J BACTERIOL, V100, P547, DOI 10.1128/JB.100.1.547-549.1969; MOSLEY WH, 1968, B WORLD HEALTH ORGAN, V38, P777; MOSLEY WH, 1968, B WORLD HEALTH ORGAN, V38, P327; Nandy RK, 1996, VACCINE, V14, P1137, DOI 10.1016/0264-410X(96)00035-7; Noriki H, 1976, P 12 JOINT C CHOL US, P302; PETERSON JW, 1979, INFECT IMMUN, V26, P594, DOI 10.1128/IAI.26.2.594-598.1979; PIERCE NF, 1977, J INFECT DIS, V135, P888, DOI 10.1093/infdis/135.6.888; PIERCE NF, 1974, J IMMUNOL, V113, P1017; Qadri F, 2005, J INFECT DIS, V192, P573, DOI 10.1086/432074; Raychoudhuri A, 2007, J INFECTION, V55, P431, DOI 10.1016/j.jinf.2007.07.020; Saha D, 2004, J INFECT DIS, V189, P2318, DOI 10.1086/421275; Thungapathra M, 1999, IMMUNOL LETT, V68, P219, DOI 10.1016/S0165-2478(99)00076-0; VARELA P, 1993, FEBS LETT, V315, P74, DOI 10.1016/0014-5793(93)81136-N	25	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e99381	10.1371/journal.pone.0099381	http://dx.doi.org/10.1371/journal.pone.0099381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983989	gold, Green Published, Green Submitted			2022-12-27	WOS:000339635000011
J	Kelly, JN; Barr, SD				Kelly, Jenna N.; Barr, Stephen D.			In Silico Analysis of Functional Single Nucleotide Polymorphisms in the Human TRIM22 Gene	PLOS ONE			English	Article							HUMAN TRIM5-ALPHA; RETROVIRAL RESTRICTION; HIV-1 INFECTION; AMINO-ACID; POSTTRANSLATIONAL MODIFICATION; PHOSPHORYLATION SITES; B30.2(SPRY) DOMAIN; MISSENSE MUTATIONS; VIRUS RESTRICTION; B30.2/SPRY DOMAIN	Tripartite motif protein 22 (TRIM22) is an evolutionarily ancient protein that plays an integral role in the host innate immune response to viruses. The antiviral TRIM22 protein has been shown to inhibit the replication of a number of viruses, including HIV-1, hepatitis B, and influenza A. TRIM22 expression has also been associated with multiple sclerosis, cancer, and autoimmune disease. In this study, multiple in silico computational methods were used to identify non-synonymous or amino acid-changing SNPs (nsSNP) that are deleterious to TRIM22 structure and/or function. A sequence homology-based approach was adopted for screening nsSNPs in TRIM22, including six different in silico prediction algorithms and evolutionary conservation data from the ConSurf web server. In total, 14 high-risk nsSNPs were identified in TRIM22, most of which are located in a protein interaction module called the B30.2 domain. Additionally, 9 of the top high-risk nsSNPs altered the putative structure of TRIM22's B30.2 domain, particularly in the surface-exposed v2 and v3 regions. These same regions are critical for retroviral restriction by the closely-related TRIM5 alpha protein. A number of putative structural and functional residues, including several sites that undergo post-translational modification, were also identified in TRIM22. This study is the first extensive in silico analysis of the highly polymorphic TRIM22 gene and will be a valuable resource for future targeted mechanistic and population-based studies.	[Kelly, Jenna N.; Barr, Stephen D.] Univ Western Ontario, Dept Microbiol & Immunol, Schulich Sch Med & Dent, Ctr Human Immunol, London, ON, Canada	Western University (University of Western Ontario)	Barr, SD (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, Schulich Sch Med & Dent, Ctr Human Immunol, Dent Sci Bldg, London, ON, Canada.	stephen.barr@uwo.ca		Kelly, Jenna/0000-0001-7265-2233; Barr, Stephen/0000-0002-0028-7430	Ontario Graduate Scholarship and Queen Elizabeth II Graduate Scholarship in Science and Technology; Ontario HIV Treatment Network salary award; CIHR [HBF107546, HBF134179]	Ontario Graduate Scholarship and Queen Elizabeth II Graduate Scholarship in Science and Technology; Ontario HIV Treatment Network salary award; CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported in part by: an Ontario Graduate Scholarship and Queen Elizabeth II Graduate Scholarship in Science and Technology to JNK; an Ontario HIV Treatment Network salary award to SDB; and CIHR grants HBF107546 and HBF134179 to SDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Arriagada G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002019; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Azad AK, 2012, INFECT IMMUN, V80, P3343, DOI 10.1128/IAI.00443-12; Bao L, 2005, NUCLEIC ACIDS RES, V33, pW480, DOI 10.1093/nar/gki372; Barr SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000007; Bates PA, 2001, PROTEINS, P39; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Biris N, 2012, P NATL ACAD SCI USA, V109, P13278, DOI 10.1073/pnas.1203536109; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Borden KLB, 1998, BIOCHEM CELL BIOL, V76, P351, DOI 10.1139/bcb-76-2-3-351; Bouazzaoui A, 2006, VIROLOGY, V356, P79, DOI 10.1016/j.virol.2006.07.025; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Carthagena L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004894; Carugo O, 2001, PROTEIN SCI, V10, P1470, DOI 10.1110/ps.690101; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Daley D, 2012, J ALLERGY CLIN IMMUN, V130, P1284, DOI 10.1016/j.jaci.2012.07.051; Doniger SW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000183; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Duan ZJ, 2008, BIOCHEM BIOPH RES CO, V374, P502, DOI 10.1016/j.bbrc.2008.07.070; Ferrer-Costa C, 2002, J MOL BIOL, V315, P771, DOI 10.1006/jmbi.2001.5255; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Gill G, 2003, CURR OPIN GENET DEV, V13, P108, DOI 10.1016/S0959-437X(03)00021-2; Goldschmidt V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-54; Gresko E, 2009, ONCOGENE, V28, P698, DOI 10.1038/onc.2008.420; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hattlmann Clayton J, 2012, Mol Biol Int, V2012, P153415, DOI 10.1155/2012/153415; Hayakawa F, 2004, CANCER CELL, V5, P389, DOI 10.1016/S1535-6108(04)00082-0; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Heim MH, 2013, J HEPATOL, V58, P564, DOI 10.1016/j.jhep.2012.10.005; Jefferies C, 2011, NAT REV IMMUNOL, V11, P617, DOI 10.1038/nri3043; Kajaste-Rudnitski A, 2011, J VIROL, V85, P5183, DOI 10.1128/JVI.02302-10; Kawai T, 2011, EMBO MOL MED, V3, P513, DOI 10.1002/emmm.201100160; Kono K, 2009, VIROLOGY, V388, P160, DOI 10.1016/j.virol.2009.03.004; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li Y, 2006, J VIROL, V80, P6738, DOI 10.1128/JVI.00270-06; Lukic Z, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-10; Marin I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050030; Mavroconstanti T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071445; Mayer S, 2007, J MOL BIOL, V372, P268, DOI 10.1016/j.jmb.2007.06.044; Mcnab FW, 2011, CURR OPIN IMMUNOL, V23, P46, DOI 10.1016/j.coi.2010.10.021; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; Nakajima T, 2009, AIDS, V23, P2091, DOI 10.1097/QAD.0b013e328331567a; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Ohkura S, 2006, J VIROL, V80, P8554, DOI 10.1128/JVI.00688-06; Ohmine S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016121; Perron MJ, 2006, J VIROL, V80, P5631, DOI 10.1128/JVI.00219-06; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; PRIOR TW, 1993, NAT GENET, V4, P357, DOI 10.1038/ng0893-357; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Rajsbaum R, 2008, EUR J IMMUNOL, V38, P619, DOI 10.1002/eji.200737916; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Roberts JD, 2007, AM J PHYSIOL-LUNG C, V293, pL903, DOI 10.1152/ajplung.00157.2007; Santana-de Anda K, 2011, AUTOIMMUN REV, V11, P98, DOI 10.1016/j.autrev.2011.08.006; Sawyer SL, 2007, PLOS PATHOG, V3, P1918, DOI 10.1371/journal.ppat.0030197; Sawyer SL, 2006, CURR BIOL, V16, P95, DOI 10.1016/j.cub.2005.11.045; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Singh R, 2011, J VIROL, V85, P208, DOI 10.1128/JVI.01810-10; Singh RP, 2014, BRIT J OPHTHALMOL, V98, P1, DOI 10.1136/bjophthalmol-2014-305502; Singh SM, 2010, P NATL ACAD SCI USA, V107, P15069, DOI 10.1073/pnas.1008818107; Sivaramakrishnan G, 2009, FEBS LETT, V583, P2093, DOI 10.1016/j.febslet.2009.05.036; Sobieszczyk ME, 2011, CURR OPIN HIV AIDS, V6, P427, DOI 10.1097/COH.0b013e3283497155; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Stacey KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034041; Stremlau M, 2005, J VIROL, V79, P3139, DOI 10.1128/JVI.79.5.3139-3145.2005; Stremlau M, 2004, CYTOPLASMIC BODY COM, P427; TISSOT C, 1995, J BIOL CHEM, V270, P14891, DOI 10.1074/jbc.270.25.14891; Uchil PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040016; Valiyeva F, 2011, MOL CANCER THER, V10, P1229, DOI 10.1158/1535-7163.MCT-11-0077; Van Manen D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040018; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; Yap MW, 2005, CURR BIOL, V15, P73, DOI 10.1016/j.cub.2004.12.042; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	84	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101436	10.1371/journal.pone.0101436	http://dx.doi.org/10.1371/journal.pone.0101436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983760	Green Published, gold, Green Submitted			2022-12-27	WOS:000339635000107
J	Li, X; Hu, JT; Zhang, J; Jin, Q; Wang, DM; Yu, J; Zhang, QG; Zhang, YB				Li, Xin; Hu, Jintian; Zhang, Jiao; Jin, Qian; Wang, Duen-Mei; Yu, Jun; Zhang, Qingguo; Zhang, Yong-Biao			Genome-Wide Linkage Study Suggests a Susceptibility Locus for Isolated Bilateral Microtia on 4p15.32-4p16.2	PLOS ONE			English	Article							VAN-CREVELD-SYNDROME; CONGENITAL MICROTIA; HOMEOBOX GENE; MUTATIONS; BAPX1; EAR; IDENTIFICATION; EPIDEMIOLOGY; ASSOCIATION; REGION	Microtia is a congenital deformity where the external ear is underdeveloped. Genetic investigations have identified many susceptibility genes of microtia-related syndromes. However, no causal genes were reported for isolated microtia, the main form of microtia. We conducted a genome-wide linkage analysis on a 5-generation Chinese pedigree with isolated bilateral microtia. We identified a suggestive linkage locus on 4p15.32-4p16.2 with parametric LOD score of 2.70 and nonparametric linkage score (Zmean) of 12.28 (simulated occurrence per genome scan equal to 0.46 and 0.47, respectively). Haplotype reconstruction analysis of the 4p15.32-4p16.2 region further confined the linkage signal to a 10-Mb segment located between rs12505562 and rs12649803 (9.65-30.24 cM; 5.54-15.58 Mb). Various human organ developmental genes reside in this 10-Mb susceptibility region, such as EVC, EVC2, SLC2A9, NKX3-2, and HMX1. The coding regions of three genes, EVC known for cartilage development and NKX3-2, HMX1 involved in microtia, were selected for sequencing with 5 individuals from the pedigree. Of the 38 identified sequence variants, none segregates along with the disease phenotype. Other genes or DNA sequences of the 10-Mb region warrant for further investigation. In conclusion, we report a susceptibility locus of isolated microtia, and this finding will encourage future studies on the genetic basis of ear deformity.	[Li, Xin; Wang, Duen-Mei; Yu, Jun; Zhang, Yong-Biao] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Li, Xin; Wang, Duen-Mei; Yu, Jun; Zhang, Yong-Biao] Chinese Acad Sci, Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Li, Xin] Capital Univ Med Sci, Beijing Anzhen Hosp, Dept Cardiol, Beijing, Peoples R China; [Hu, Jintian; Zhang, Jiao; Jin, Qian; Zhang, Qingguo] Chinese Acad Med Sci, Plast Surg Hosp, Dept Ear Reconstruct, Beijing 100730, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Plastic Surgery Hospital - CAMS	Zhang, QG (corresponding author), Chinese Acad Med Sci, Plast Surg Hosp, Dept Ear Reconstruct, Beijing 100730, Peoples R China.	plastic135@126.com; zhangyongbiao@gmail.com	Hu, Jintian/HGB-2102-2022	Hu, Jintian/0000-0003-2036-2343	National Natural Science Foundation of China [31201006, 31371347, 81372085, 81300863]; PUMC Youth Fund; Fundamental Research Funds for the Central Universities [3332013091]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); PUMC Youth Fund; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by grants from the National Natural Science Foundation of China (31201006, 31371347 to Y-B.Z., 81372085 to Q.Z. 81300863 to J.H.) and PUMC Youth Fund and the Fundamental Research Funds for the Central Universities (3332013091 to J.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhak S, 1997, HUM MOL GENET, V6, P2247, DOI 10.1093/hmg/6.13.2247; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Alasti F, 2008, AM J HUM GENET, V82, P982, DOI 10.1016/j.ajhg.2008.02.015; Arnold JS, 2006, HUM MOL GENET, V15, P1629, DOI 10.1093/hmg/ddl084; Bader V, 2012, HUM MOL GENET, V21, P4406, DOI 10.1093/hmg/dds273; Balikova I, 2008, AM J HUM GENET, V82, P181, DOI 10.1016/j.ajhg.2007.08.001; Blair HJ, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-14; Brown KK, 2013, HUM MUTAT, V34, P1347, DOI 10.1002/humu.22367; Carey JC, 2006, HUMAN MALFORMATIONS, P329; Correa A, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.028; Davies AF, 1998, J MED GENET, V35, P857, DOI 10.1136/jmg.35.10.857; Fischer S, 2006, HUM MOL GENET, V15, P581, DOI 10.1093/hmg/ddi474; Gavalas A, 1998, DEVELOPMENT, V125, P1123; Giannatou E, 2009, GENET COUNSEL, V20, P181; Griffith CB, 2009, AM J MED GENET A, V149A, P1346, DOI 10.1002/ajmg.a.32883; Harris J, 1996, J MED GENET, V33, P809, DOI 10.1136/jmg.33.10.809; Hellemans J, 2009, AM J HUM GENET, V85, P916, DOI 10.1016/j.ajhg.2009.11.005; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Jockel JA, 2012, KNEE, V19, P218, DOI 10.1016/j.knee.2011.03.003; Kawakami K, 2000, BIOESSAYS, V22, P616, DOI 10.1002/1521-1878(200007)22:7<616::AID-BIES4>3.3.CO;2-I; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Luquetti DV, 2011, AM J MED GENET A; Ma C, 2010, AM J MED GENET A, V152A, P2756, DOI 10.1002/ajmg.a.33694; Marneros AG, 2013, AM J HUM GENET, V92, P621, DOI 10.1016/j.ajhg.2013.03.002; MASTROIACOVO P, 1995, J MED GENET, V32, P453, DOI 10.1136/jmg.32.6.453; Mobasheri A, 2002, CELL BIOL INT, V26, P297, DOI 10.1006/cbir.2001.0850; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Ott J, 2011, NAT REV GENET, V12, P465, DOI 10.1038/nrg2989; Placzek MR, 2001, J NEUROL NEUROSUR PS, V71, P262, DOI 10.1136/jnnp.71.2.262; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ruiz-Perez VL, 2000, NAT GENET, V24, P283, DOI 10.1038/73508; Schorderet DF, 2008, AM J HUM GENET, V82, P1178, DOI 10.1016/j.ajhg.2008.03.007; Singh H, 2010, PLACENTA, V31, P1085, DOI 10.1016/j.placenta.2010.10.003; Tallila J, 2008, AM J HUM GENET, V82, P1361, DOI 10.1016/j.ajhg.2008.05.004; Tasse C, 2005, EUR J MED GENET, V48, P397, DOI 10.1016/j.ejmg.2005.04.015; Tribioli C, 1997, MECH DEVELOP, V65, P145, DOI 10.1016/S0925-4773(97)00067-1; Tucker AS, 2004, DEVELOPMENT, V131, P1235, DOI 10.1242/dev.01017; Zhang QG, 2009, PLAST RECONSTR SURG, V124, P1157, DOI 10.1097/PRS.0b013e3181b454d8; Zhang QG, 2010, PLAST RECONSTR SURG, V125, P979, DOI 10.1097/PRS.0b013e3181ccdbba; Zhang YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041768	41	22	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101152	10.1371/journal.pone.0101152	http://dx.doi.org/10.1371/journal.pone.0101152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983964	gold, Green Published, Green Submitted			2022-12-27	WOS:000339635000060
J	Sorberg, A; Gunnell, D; Falkstedt, D; Allebeck, P; Aberg, M; Hemmingsson, T				Sorberg, Alma; Gunnell, David; Falkstedt, Daniel; Allebeck, Peter; Aberg, Maria; Hemmingsson, Tomas			Body Mass Index in Young Adulthood and Suicidal Behavior up to Age 59 in a Cohort of Swedish Men	PLOS ONE			English	Article							RISK-FACTORS; US ADULTS; ASSOCIATION; OBESITY; DEPRESSION; MORTALITY; HEALTH; POPULATION; OVERWEIGHT; SCHIZOPHRENIA	An association of higher body mass index (BMI) with lower risk of attempted and completed suicide has been reported. In contrast, increasing BMI has been found to be associated with depression and other risk factors for suicidal behavior. We aimed to investigate this possible paradox in a cohort comprising 49 000 Swedish men. BMI, mental health, lifestyle and socioeconomic measures were recorded at conscription in 1969-70, at ages 18-20. Information on attempted suicide 1973-2008 and completed suicide 1971-2008 was obtained from national records. Hazard ratios (HR) were estimated by Cox proportional hazard models. We found that each standard deviation (SD) increase in BMI was associated with a 12% lower risk of later suicide attempt (HR 0.88, 95% CI 0.83-0.94). Associations were somewhat weaker for completed suicide and did not reach conventional levels of statistical significance (HR 0.93, 95% CI 0.85-1.01). Adjustment for a wide range of possible confounding factors had little effect on the associations. Lower BMI at conscription was also associated with higher prevalence of psychiatric diagnoses, low emotional control and depressed mood. Our results confirm previous findings regarding the association of higher BMI with a reduced risk of suicide, extending them to show similar findings in relation to suicide attempts. The associations were little affected by adjustment for a range of possible confounding factors. However, we found no evidence that high BMI was associated with an increased risk of depression cross-sectionally or longitudinally.	[Sorberg, Alma; Hemmingsson, Tomas] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Gunnell, David] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Falkstedt, Daniel; Allebeck, Peter] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Falkstedt, Daniel] Karolinska Inst, Div Psychol, Dept Clin Neurosci, Stockholm, Sweden; [Aberg, Maria] Univ Gothenburg, Inst Neurosci & Physiol, Ctr Brain Repair & Rehabil, Gothenburg, Sweden; [Aberg, Maria] Univ Gothenburg, Inst Med, Dept Primary Hlth Care, Gothenburg, Sweden; [Hemmingsson, Tomas] Stockholm Univ, Ctr Social Res Alcohol & Drugs, S-10691 Stockholm, Sweden	Karolinska Institutet; University of Bristol; Karolinska Institutet; Karolinska Institutet; University of Gothenburg; University of Gothenburg; Stockholm University	Sorberg, A (corresponding author), Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden.	alma.sorberg@ki.se	Aberg, Maria/R-4001-2016; Gunnell, David/ABE-6653-2020	Gunnell, David/0000-0002-0829-6470; Hemmingsson, Tomas/0000-0001-6156-3964; Sorberg Wallin, Alma/0000-0002-8804-095X; Aberg, Maria/0000-0002-0323-1061; Falkstedt, Daniel/0000-0003-4441-7003	Swedish Council for Health, Working Life and Welfare [2008-0907]; National Institute for Health Research [NF-SI-0512-10068] Funding Source: researchfish	Swedish Council for Health, Working Life and Welfare; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by research grants from the Swedish Council for Health, Working Life and Welfare (Project No. 2008-0907; http://www.forte.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEBECK P, 1991, SCAND J SOC MED, V19, P242, DOI 10.1177/140349489101900405; ALLEBECK P, 1988, BRIT MED J, V297, P176, DOI 10.1136/bmj.297.6642.176; ALLEBECK P, 1990, BRIT J PSYCHIAT, V157, P339, DOI 10.1192/bjp.157.3.339; Batty GD, 2010, AM J EPIDEMIOL, V172, P890, DOI 10.1093/aje/kwq274; Bjerkeset O, 2008, AM J EPIDEMIOL, V167, P193, DOI 10.1093/aje/kwm280; Brezo J, 2006, ACTA PSYCHIAT SCAND, V113, P180, DOI 10.1111/j.1600-0447.2005.00702.x; Chang SS, 2012, AM J EPIDEMIOL, V175, P804, DOI 10.1093/aje/kwr386; Elovainio M, 2009, J AFFECT DISORDERS, V116, P218, DOI 10.1016/j.jad.2008.12.002; Gao S, 2013, OBESITY, V21, pE334, DOI 10.1002/oby.20143; Gariepy G, 2010, OBESITY, V18, P1033, DOI 10.1038/oby.2009.333; Goldney RD, 2009, AUST NZ J PSYCHIAT, V43, P652, DOI 10.1080/00048670902970825; GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406; Gunnell D, 2011, INTERNATIONAL HANDBOOK OF SUICIDE PREVENTION: RESEARCH, POLICY AND PRACTICE, P275; Jee SH, 2011, EUR HEART J, V32, P2773, DOI 10.1093/eurheartj/ehr229; Jiang GX, 1999, ACTA PSYCHIAT SCAND, V100, P433, DOI 10.1111/j.1600-0447.1999.tb10893.x; Kaplan MS, 2007, J NERV MENT DIS, V195, P948, DOI 10.1097/NMD.0b013e3181594833; Karlsson H, 2010, BRAIN BEHAV IMMUN, V24, P868, DOI 10.1016/j.bbi.2010.02.009; Larsson D, 2002, SCAND J PUBLIC HEALT, V30, P259, DOI 10.1080/14034940210133997; Lawlor DA, 2007, PSYCHOL MED, V37, P1151, DOI 10.1017/S0033291707000384; Lewis G, 2000, BRIT J PSYCHIAT, V177, P416, DOI 10.1192/bjp.177.5.416; Lilieblad B, 1977, RELIABILITET HOS PSY; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Magnusson PKE, 2006, AM J EPIDEMIOL, V163, P1, DOI 10.1093/aje/kwj002; Mansson NO, 1996, INT J EPIDEMIOL, V25, P80, DOI 10.1093/ije/25.1.80; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Mukamal KJ, 2007, ARCH INTERN MED, V167, P468, DOI 10.1001/archinte.167.5.468; Mukamal KJ, 2010, EPIDEMIOLOGY, V21, P82, DOI 10.1097/EDE.0b013e3181c1fa2d; Mukamal KJ, 2009, OBESITY, V17, P532, DOI 10.1038/oby.2008.538; Ohberg A, 1998, ACTA PSYCHIAT SCAND, V98, P214, DOI 10.1111/j.1600-0447.1998.tb10069.x; Osler M, 2008, J EPIDEMIOL COMMUN H, V62, P23, DOI 10.1136/jech.2006.053330; Rasmussen F, 1999, ACTA PAEDIATR, V88, P431, DOI 10.1080/08035259950169837; Rebholz CM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-56; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Sorberg A, 2013, PSYCHOL MED, V43, P49, DOI 10.1017/S0033291712001043; Terracciano A, 2009, PSYCHOSOM MED, V71, P682, DOI 10.1097/PSY.0b013e3181a2925b; Wahlbeck K, 2001, ARCH GEN PSYCHIAT, V58, P48, DOI 10.1001/archpsyc.58.1.48; Zammit S, 2007, ACTA PSYCHIAT SCAND, V116, P378, DOI 10.1111/j.1600-0447.2007.01063.x; Zhang J, 2012, J AFFECT DISORD; Zhao G, 2009, INT J OBESITY, V33, P257, DOI 10.1038/ijo.2008.268	39	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101213	10.1371/journal.pone.0101213	http://dx.doi.org/10.1371/journal.pone.0101213			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1UX	24983947	Green Published, gold			2022-12-27	WOS:000339635000069
J	Guo, LJ; Yang, YH; Liu, J; Wang, L; Li, JF; Wang, Y; Liu, Y; Gu, S; Gan, HL; Cai, J; Yuan, JXJ; Wang, J; Wang, C				Guo, Lijuan; Yang, Yuanhua; Liu, Jie; Wang, Lei; Li, Jifeng; Wang, Ying; Liu, Yan; Gu, Song; Gan, Huili; Cai, Jun; Yuan, Jason X. -J.; Wang, Jun; Wang, Chen			Differentially Expressed Plasma MicroRNAs and the Potential Regulatory Function of Let-7b in Chronic Thromboembolic Pulmonary Hypertension	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CELLS; ARTERIAL-HYPERTENSION; CA2+ ENTRY; TGF-BETA; PROLIFERATION; GROWTH; SIGNATURE; DIAGNOSIS; BIOMARKER; PROTEIN	Chronic thromboembolic pulmonary hypertension (CTEPH) is a progressive disease characterized by misguided thrombolysis and remodeling of pulmonary arteries. MicroRNAs are small non-coding RNAs involved in multiple cell processes and functions. During CTEPH, circulating microRNA profile endued with characteristics of diseased cells could be identified as a biomarker, and might help in recognition of pathogenesis. Thus, in this study, we compared the differentially expressed microRNAs in plasma of CTEPH patients and healthy controls and investigated their potential functions. Microarray was used to identify microRNA expression profile and qRT-PCR for validation. The targets of differentially expressed microRNAs were identified in silico, and the Gene Ontology database and Kyoto Encyclopedia of Genes and Genomes pathway database were used for functional investigation of target gene profile. Targets of let-7b were validated by fluorescence reporter assay. Protein expression of target genes was determined by ELISA or western blotting. Cell migration was evaluated by wound healing assay. The results showed that 1) thirty five microRNAs were differentially expressed in CTEPH patients, among which, a signature of 17 microRNAs, which was shown to be related to the disease pathogenesis by in silico analysis, gave diagnostic efficacy of both sensitivity and specificity >0.9. 2) Let-7b, one of the down-regulated anti-oncogenic microRNAs in the signature, was validated to decrease to about 0.25 fold in CTEPH patients. 3) ET-1 and TGFBR1 were direct targets of let-7b. Altering let-7b level influenced ET-1 and TGFBR1 expression in pulmonary arterial endothelial cells (PAECs) as well as the migration of PAECs and pulmonary arterial smooth muscle cells (PASMCs). These results suggested that CTEPH patients had aberrant microRNA signature which might provide some clue for pathogenesis study and biomarker screening. Reduced let-7b might be involved in the pathogenesis of CTEPH by affecting ET-1 expression and the function of PAECs and PASMCs.	[Guo, Lijuan; Wang, Lei; Li, Jifeng; Wang, Ying; Wang, Jun; Wang, Chen] Capital Med Univ, Beijing Chao Yang Hosp, Beijing Key Lab Resp & Pulm Circulat Disorders, Beijing, Peoples R China; [Guo, Lijuan; Yang, Yuanhua; Wang, Lei; Li, Jifeng; Wang, Chen] Capital Med Univ, Beijing Inst Resp Med, Beijing, Peoples R China; [Liu, Jie; Wang, Jun] Capital Med Univ, Dept Physiol, Beijing, Peoples R China; [Liu, Yan; Gu, Song; Cai, Jun] Capital Med Univ, Beijing Chao Yang Hosp, Dept Cardiol, Beijing, Peoples R China; [Gan, Huili] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China; [Gan, Huili] Capital Med Univ, Beijing Inst Heart Lung & Vessel Dis, Beijing, Peoples R China; [Yuan, Jason X. -J.] Univ Illinois, Dept Med, Chicago, IL USA; [Wang, Chen] Minist Hlth, Dept Beijing Hosp, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Wang, J (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Beijing Key Lab Resp & Pulm Circulat Disorders, Beijing, Peoples R China.	wang_jun@ccmu.edu.cn; cyh-birm@263.net	wang, chen/GWM-9481-2022		Fund of National Natural Science Foundation of China [81070041, 81070042, 81111130212, 81228001, 81370152]	Fund of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fund of National Natural Science Foundation of China (81070041, 81070042, 81111130212, 81228001, 81370152, 81228001). URL: http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldea M, 2011, CANCER LETT, V311, P210, DOI 10.1016/j.canlet.2011.07.022; Arunthari Vichaya, 2009, Open Respir Med J, V3, P85, DOI 10.2174/1874306400903010085; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barst RJ, 2004, J AM COLL CARDIOL, V43, p40S, DOI 10.1016/j.jacc.2004.02.032; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonderman D, 2009, EUR RESPIR J, V33, P325, DOI 10.1183/09031936.00087608; Caruso P, 2010, ARTERIOSCL THROM VAS, V30, P716, DOI 10.1161/ATVBAHA.109.202028; Castanares C, 2007, J CELL SCI, V120, P1256, DOI 10.1242/jcs.03419; Castanares C, 2006, EXP BIOL MED, V231, P700; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen ZY, 2010, HUM GENET, V128, P443, DOI 10.1007/s00439-010-0866-8; Condliffe R, 2008, AM J RESP CRIT CARE, V177, P1122, DOI 10.1164/rccm.200712-1841OC; Confalonieri Marco, 2009, Expert Rev Cardiovasc Ther, V7, P1503, DOI 10.1586/erc.09.148; Dentali F, 2009, THROMB RES, V124, P256, DOI 10.1016/j.thromres.2009.01.003; Dupuis J, 2008, EUR RESPIR J, V31, P407, DOI 10.1183/09031936.00078207; Fedullo PF, 2001, NEW ENGL J MED, V345, P1465, DOI 10.1056/NEJMra010902; Jachec W, 2008, INT J MOL MED, V21, P99; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kittleson MM, 2005, TRENDS CARDIOVAS MED, V15, P130, DOI 10.1016/j.tcm.2005.05.007; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; KURIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P1435, DOI 10.1016/0006-291X(89)92270-5; Lang I, 2010, BRIT J HAEMATOL, V149, P478, DOI 10.1111/j.1365-2141.2010.08142.x; Langer F, 2005, J THORAC CARDIOV SUR, V130, P1342, DOI 10.1016/j.jtcvs.2005.06.044; Lankeit M, 2008, EUR RESPIR J, V31, P1024, DOI 10.1183/09031936.00100407; Lauder H, 1998, Angiogenesis, V2, P67, DOI 10.1023/A:1009006527462; Liu N, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70102-X; Long L, 2009, CIRCULATION, V119, P566, DOI 10.1161/CIRCULATIONAHA.108.821504; Man TK, 2005, CANCER RES, V65, P8142, DOI 10.1158/0008-5472.CAN-05-0985; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ogawa A, 2009, AM J PHYSIOL-LUNG C, V297, pL666, DOI 10.1152/ajplung.90548.2008; Ohshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013247; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Peacock Andrew, 2006, Proc Am Thorac Soc, V3, P608, DOI 10.1513/pats.200605-114LR; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Reesink HJ, 2007, ANN THORAC SURG, V84, P537, DOI 10.1016/j.athoracsur.2007.04.006; Reesink HJ, 2006, CIRC J, V70, P1058, DOI 10.1253/circj.70.1058; RIEDEL M, 1982, CHEST, V81, P151, DOI 10.1378/chest.81.2.151; Rodriguez-Pascual F, 2011, PHARMACOL RES, V63, P463, DOI 10.1016/j.phrs.2011.01.014; Sacks RS, 2006, SEMIN THORAC CARDIOV, V18, P265, DOI 10.1053/j.semtcvs.2006.09.004; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Shi XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093995; Skoro-Sajer N, 2007, AM J RESP CRIT CARE, V176, P1154, DOI 10.1164/rccm.200702-278OC; Surie S, 2010, THROMB RES, V125, pE202, DOI 10.1016/j.thromres.2009.12.016; Thomas M, 2009, AM J PATHOL, V174, P380, DOI 10.2353/ajpath.2009.080565; Tsai S, 2009, AM J PHYSIOL-HEART C, V297, pH540, DOI 10.1152/ajpheart.91478.2007; Wang C, 2008, J PHARMACOL SCI, V108, P71, DOI 10.1254/jphs.08069FP; Wang L, 2013, PULM CIRC, V3, P654, DOI 10.1086/674310; Xiao JJ, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-159; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yang SZ, 2012, AM J PHYSIOL-LUNG C, V302, pL521, DOI 10.1152/ajplung.00316.2011; Youssef YM, 2011, EUR UROL, V59, P721, DOI 10.1016/j.eururo.2011.01.004	52	41	44	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101055	10.1371/journal.pone.0101055	http://dx.doi.org/10.1371/journal.pone.0101055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978044	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400067
J	Singh, SK; Shukla, AK; Dhawan, OP; Shasany, AK				Singh, Sharad K.; Shukla, Ashutosh K.; Dhawan, Om P.; Shasany, Ajit K.			Recessive Loci Pps-1 and OM Differentially Regulate PISTILLATA-1 and APETALA3-1 Expression for Sepal and Petal Development in Papaver somniferum	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; HOMEOTIC GENE; MADS-BOX; MOLECULAR EVOLUTION; PLANT DEVELOPMENT; DNA-BINDING; CONSERVATION; PROTEINS; FLOWER; L.	The involvement of PISTILLATA (PI) and APETALA (AP) transcription factors in the development of floral organs has previously been elucidated but little is known about their upstream regulation. In this investigation, two novel mutants generated in Papaver somniferum were analyzed - one with partially petaloid sepals and another having sepaloid petals. Progeny from reciprocal crosses of respective mutant parent genotypes showed a good fit to the monogenic Mendelian inheritance model, indicating that the mutant traits are likely controlled by the single, recessive nuclear genes named "Pps1" and "OM" in the partially petaloid sepal and sepaloid petal phenotypes, respectively. Both paralogs of PISTILLATA (PapsPI-1 and PapsPI-3) were obtained from the sepals and petals of P. somniferum. Ectopic expression of PapsPI-1 in tobacco resulted in a partially petaloid sepal phenotype at a low frequency. Upregulation of PapsPI-1 and PapsAP3-1 in the petal and the petal part of partially petaloid sepal mutant and down-regulation of the same in sepaloid petal mutant indicates a differential pattern of regulation for flowering-related genes in various whorls. Similarly, it was found that the recessive mutation OM in sepaloid petal mutant downregulates PapsPI-1 and PapsAP3-1 transcripts. The recessive nature of the mutations was confirmed by the segregation ratios obtained in this analysis.	[Singh, Sharad K.; Dhawan, Om P.] CSIR Cent Inst Med & Aromat Plants, Genet & Plant Breeding Div, Lucknow, Uttar Pradesh, India; [Singh, Sharad K.; Shukla, Ashutosh K.; Shasany, Ajit K.] CSIR Cent Inst Med & Aromat Plants, Div Biotechnol, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP)	Dhawan, OP (corresponding author), CSIR Cent Inst Med & Aromat Plants, Genet & Plant Breeding Div, Lucknow, Uttar Pradesh, India.	op.dhawan@cimap.res.in; akshasany@yahoo.com			Council of Scientific and Industrial Research (CSIR) [BSC0203]	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	This work was funded by the Council of Scientific and Industrial Research (CSIR) through the Twelfth Five Year Plan project (BSC0203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose BA, 2000, MOL CELL, V5, P569, DOI 10.1016/S1097-2765(00)80450-5; Berbel A, 2005, PLANT PHYSIOL, V139, P174, DOI 10.1104/pp.104.057687; Birchler JA, 2007, PLANT CELL, V19, P395, DOI 10.1105/tpc.106.049338; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Brunner AM, 2004, NEW PHYTOL, V164, P43, DOI 10.1111/j.1469-8137.2004.01165.x; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Davies B, 1996, PLANT J, V10, P663, DOI 10.1046/j.1365-313X.1996.10040663.x; Dhawan OP, 2007, J HERED, V98, P373, DOI 10.1093/jhered/esm037; Drea S, 2007, DEVELOPMENT, V134, P4157, DOI 10.1242/dev.013136; Dubey MK, 2009, J HERED, V100, P76, DOI 10.1093/jhered/esn071; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evangelisti AM, 2004, J EXP ZOOL PART B, V302B, P392, DOI 10.1002/jez.b.20027; GOTO K, 1994, GENE DEV, V8, P1548, DOI 10.1101/gad.8.13.1548; HALFTER U, 1994, EMBO J, V13, P1443, DOI 10.1002/j.1460-2075.1994.tb06398.x; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; Honma T, 2000, DEVELOPMENT, V127, P2021; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; JACK T, 1992, CELL, V68, P683, DOI 10.1016/0092-8674(92)90144-2; Jack T, 2001, PLANT MOL BIOL, V46, P515, DOI 10.1023/A:1010689126632; Jack T, 2004, PLANT CELL, V16, pS1, DOI 10.1105/tpc.017038; Kramer EM, 1998, GENETICS, V149, P765; Lamb RS, 2003, P NATL ACAD SCI USA, V100, P6558, DOI 10.1073/pnas.0631708100; Li JH, 2010, P NATL ACAD SCI USA, V107, P5664, DOI 10.1073/pnas.0910955107; Luo HR, 2006, AFR J BIOTECHNOL, V5, P1851; Maeda H, 2003, FEMS IMMUNOL MED MIC, V39, P81, DOI 10.1016/S0928-8244(03)00224-4; Misra A, 2012, GENE, V510, P193, DOI 10.1016/j.gene.2012.09.015; Misra P, 2010, PLANT PHYSIOL, V152, P2258, DOI 10.1104/pp.109.150979; Ng M, 2001, NAT REV GENET, V2, P186, DOI 10.1038/35056041; Pelaz S, 2001, CURR BIOL, V11, P182, DOI 10.1016/S0960-9822(01)00024-0; Poupin MJ, 2007, GENE, V404, P10, DOI 10.1016/j.gene.2007.08.005; Riechmann JL, 1996, NUCLEIC ACIDS RES, V24, P3134, DOI 10.1093/nar/24.16.3134; Riechmann JL, 1997, BIOL CHEM, V378, P1079; SCHWARZSOMMER Z, 1992, EMBO J, V11, P251, DOI 10.1002/j.1460-2075.1992.tb05048.x; TROBNER W, 1992, EMBO J, V11, P4693, DOI 10.1002/j.1460-2075.1992.tb05574.x; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; Whipple CJ, 2004, DEVELOPMENT, V131, P6083, DOI 10.1242/dev.01523; Whipple CJ, 2007, P NATL ACAD SCI USA, V104, P1081, DOI 10.1073/pnas.0606434104; Wilkinson M, 2000, DEVELOPMENT, V127, P3725; Winefield C, 2006, MOLECULAR BIOLOGY AND BIOTECHNOLOGY OF FLOWERING, 2ND EDITION, P237, DOI 10.1079/9781845930424.0237; Zhang XN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003563	42	7	9	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101272	10.1371/journal.pone.0101272	http://dx.doi.org/10.1371/journal.pone.0101272			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979593	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400110
J	Van Hecke, T; Vossen, E; Bussche, JV; Raes, K; Vanhaecke, L; De Smet, S				Van Hecke, Thomas; Vossen, Els; Bussche, Julie Vanden; Raes, Katleen; Vanhaecke, Lynn; De Smet, Stefaan			Fat Content and Nitrite-Curing Influence the Formation of Oxidation Products and NOC-Specific DNA Adducts during In Vitro Digestion of Meat	PLOS ONE			English	Article							MUCIN-DEPLETED FOCI; RED MEAT; COLORECTAL-CANCER; COLON-CANCER; LIPID-PEROXIDATION; PROTEIN OXIDATION; RAT COLON; DAMAGE; HEME; CARCINOGENESIS	The effects of fat content and nitrite-curing of pork were investigated on the formation of cytotoxic and genotoxic lipid oxidation products (malondialdehyde, 4-hydroxy-2-nonenal, volatile simple aldehydes), protein oxidation products (protein carbonyl compounds) and NOC-specific DNA adducts (O-6-carboxy-methylguanine) during in vitro digestion. The formation of these products during digestion is suggested to be responsible for the association between red meat and processed meat consumption and colorectal cancer risk. Digestion of uncured pork to which fat was added (total fat content 5 or 20%), resulted in significantly higher lipid and protein oxidation in the mimicked duodenal and colonic fluids, compared to digestion of pork without added fat (1% fat). A higher fat content also significantly favored the formation of O-6-carboxy-methylguanine in the colon. Nitrite-curing of meat resulted in significantly lower lipid and protein oxidation before and after digestion, while an inconsistent effect on the formation of O-6-carboxy-methylguanine was observed. The presented results demonstrate that haem-Fe is not solely responsible for oxidation and nitrosation reactions throughout an in vitro digestion approach but its effect is promoted by a higher fat content in meat.	[Van Hecke, Thomas; Vossen, Els; De Smet, Stefaan] Univ Ghent, Fac Biosci Engn, Dept Anim Prod, Lab Anim Nutr & Anim Prod Qual, Melle, Belgium; [Bussche, Julie Vanden; Vanhaecke, Lynn] Univ Ghent, Dept Vet Publ Hlth & Food Safety, Chem Anal Lab, Fac Vet Med, Merelbeke, Belgium; [Raes, Katleen] Univ Ghent, Fac Biosci Engn, Dept Ind Biol Sci, Lab Food Microbiol & Biotechnol, Kortrijk, Belgium	Ghent University; Ghent University; Ghent University	De Smet, S (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Anim Prod, Lab Anim Nutr & Anim Prod Qual, Melle, Belgium.	stefaan.desmet@ugent.be	DeSmet, Stefaan/N-7576-2017; Vanden Bussche, Julie/K-5134-2014; Vanhaecke, Lynn/N-1061-2017	DeSmet, Stefaan/0000-0003-1422-805X; Vanden Bussche, Julie/0000-0002-3831-6663; Vanhaecke, Lynn/0000-0003-0400-2188; Raes, Katleen/0000-0003-2382-120X	Federal Public Service of Health, Food Chain Safety and Environment, Belgium [RF-11/625 MEATNOX]; Research Foundation - Flanders (FWO)	Federal Public Service of Health, Food Chain Safety and Environment, Belgium; Research Foundation - Flanders (FWO)(FWO)	This study was financed by the Federal Public Service of Health, Food Chain Safety and Environment, Belgium (grant RF-11/625 MEATNOX) (http://www.health.belgium.be/eportal). L. Vanhaecke is supported by a postdoctoral fellowship from the Research Foundation - Flanders (FWO) (http://www.fwo.be/Postdoctorale-mandaten.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J CHROMATOGR A, V1257, P25; Bajka BH, 2008, CARCINOGENESIS, V29, P2169, DOI 10.1093/carcin/bgn173; Chan DSM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020456, 10.1371/journal.pone.0027218]; CHANEY AL, 1962, CLIN CHEM, V8, P130; Chenni FZ, 2013, NUTR CANCER, V65, P227, DOI 10.1080/01635581.2013.749291; CORPET DE, 1995, NUTR CANCER, V23, P271, DOI 10.1080/01635589509514381; Corpet DE, 2011, MEAT SCI, V89, P310, DOI 10.1016/j.meatsci.2011.04.009; Cross AJ, 2003, CANCER RES, V63, P2358; Dabrowska-Ufniarz Elzbieta, 2002, Med Sci Monit, V8, pCR96; DARLEYUSMAR V, 1995, FEBS LETT, V369, P131, DOI 10.1016/0014-5793(95)00764-Z; Dean RT, 1997, BIOCHEM J, V324, P1; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ganhao R, 2010, MEAT SCI, V85, P402, DOI 10.1016/j.meatsci.2010.02.008; Gorelik S, 2008, FASEB J, V22, P41, DOI 10.1096/fj.07-9041com; Grotto D, 2007, J PHARMACEUT BIOMED, V43, P619, DOI 10.1016/j.jpba.2006.07.030; Guven Y, 1996, J CLIN PERIODONTOL, V23, P879, DOI 10.1111/j.1600-051X.1996.tb00627.x; HOLLEY AE, 1993, FREE RADICAL BIO MED, V15, P281, DOI 10.1016/0891-5849(93)90075-6; Honikel KO, 2008, MEAT SCI, V78, P68, DOI 10.1016/j.meatsci.2007.05.030; Hornsey H.C., 1956, J SCI FOOD AGR, V7, P534, DOI [10.1002/jsfa.2740070804, DOI 10.1002/JSFA.2740070804]; Hur SJ, 2009, J FOOD SCI, V74, pC653, DOI 10.1111/j.1750-3841.2009.01344.x; Ismail HA, 2009, J FOOD SCI, V74, pC432, DOI 10.1111/j.1750-3841.2009.01207.x; Joosen AMCP, 2009, CARCINOGENESIS, V30, P1402, DOI 10.1093/carcin/bgp130; Lai C, 1997, CANCER LETT, V112, P87, DOI 10.1016/S0304-3835(96)04549-1; Larsson SC, 2006, INT J CANCER, V119, P2657, DOI 10.1002/ijc.22170; Lewin MH, 2006, CANCER RES, V66, P1859, DOI 10.1158/0008-5472.CAN-05-2237; Liu XP, 1998, P NATL ACAD SCI USA, V95, P2175, DOI 10.1073/pnas.95.5.2175; Mirvish SS, 2002, J NUTR, V132, p3526S, DOI 10.1093/jn/132.11.3526S; MOLLY K, 1994, MICROB ECOL HEALTH D, V7, P191, DOI 10.3109/08910609409141354; Moore SA, 2010, ANAL BIOCHEM, V403, P67, DOI 10.1016/j.ab.2010.04.015; Nair U, 2007, FREE RADICAL BIO MED, V43, P1109, DOI 10.1016/j.freeradbiomed.2007.07.012; NALINI S, 1992, J GASTROEN HEPATOL, V7, P497, DOI 10.1111/j.1440-1746.1992.tb01027.x; Pierre FHF, 2010, NUTR CANCER, V62, P567, DOI 10.1080/01635580903532408; Raes K, 2001, ANIM SCI, V73, P253, DOI 10.1017/S1357729800058227; Rosignoli P, 2001, CARCINOGENESIS, V22, P1675, DOI 10.1093/carcin/22.10.1675; Santarelli RL, 2010, CANCER PREV RES, V3, P852, DOI 10.1158/1940-6207.CAPR-09-0160; Sante-Lhoijtellier V, 2008, J AGR FOOD CHEM, V56, P1488, DOI 10.1021/jf072999g; Sesink ALA, 2000, CARCINOGENESIS, V21, P1909, DOI 10.1093/carcin/21.10.1909; Skrzydlewska E, 2005, WORLD J GASTROENTERO, V11, P403, DOI 10.3748/wjg.v11.i3.403; Takahama U, 2003, J AGR FOOD CHEM, V51, P6014, DOI 10.1021/jf021253+; Trostchansky A, 2008, FREE RADICAL BIO MED, V44, P1887, DOI 10.1016/j.freeradbiomed.2008.03.006; Van de Wiele T, 2005, ENVIRON HEALTH PERSP, V113, P6, DOI 10.1289/ehp.7259; Versantvoort CHM, 2005, FOOD CHEM TOXICOL, V43, P31, DOI 10.1016/j.fct.2004.08.007; Yeh CC, 2010, CARCINOGENESIS, V31, P228, DOI 10.1093/carcin/bgp286	43	31	31	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101122	10.1371/journal.pone.0101122	http://dx.doi.org/10.1371/journal.pone.0101122			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978825	Green Published, gold, Green Submitted			2022-12-27	WOS:000338506400082
J	Ezpeleta, L; Granero, R; de la Osa, N; Navarro, JB; Penelo, E; Domenech, JM				Ezpeleta, Lourdes; Granero, Roser; de la Osa, Nuria; Blas Navarro, Jose; Penelo, Eva; Domenech, Josep M.			Tracing Developmental Trajectories of Oppositional Defiant Behaviors in Preschool Children	PLOS ONE			English	Article							DSM-IV DISORDERS; PSYCHOMETRIC PROPERTIES; RISK-FACTORS; MISSING DATA; HYPERACTIVITY; COMORBIDITY; PREDICTORS; CHILDHOOD; NUMBER	Objective: Previous studies on developmental trajectories have used ad hoc definitions of oppositional defiant behaviors (ODB), which makes it difficult to compare results. This article defines developmental trajectories of ODB from ages 3-5 based on five different standard measurements derived from three separate instruments. Method: A sample of 622 three-year-old preschoolers, followed up at ages 4, 5, and 6, was assessed with the five measures of oppositionality answered by parents and teachers. Growth-Mixture-Modeling (GMM) estimated separate developmental trajectories for each ODB measure for ages 3 to 5. Results: The number of classes-trajectories obtained in each GMM depended on the ODB measure, but two clear patterns emerged: four trajectories (persistent low, decreasers, increasers/high increasers, persistent moderate/persistent high) or three trajectories (persistent low, decreasers, increasers/high increasers). Persistent high trajectories accounted for 4.4%-9.5% of the children. The trajectories emerging from the different ODB measures at ages 3 to 5 discriminated disruptive disorders, comorbidity, use of services, and impairment at age 6, and globally showed a similar pattern, summarizing longitudinal information on oppositionality in preschool children in a similar way. Conclusions: Trajectories resulting from standard scales of the questionnaires have predictive validity for identifying relevant clinical outcomes, but are measure-specific. The results contribute to knowledge about the development of ODB in preschool children.	[Ezpeleta, Lourdes; Granero, Roser; de la Osa, Nuria; Domenech, Josep M.] Univ Autonoma Barcelona, Dept Psicol Clin & Salut, Unitat Epidemiol & Diagnost Psicopatol Desenvolup, E-08193 Barcelona, Spain; [Blas Navarro, Jose; Penelo, Eva] Univ Autonoma Barcelona, Dept Psicobiol & Metodol Ciencies Salut, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona	Ezpeleta, L (corresponding author), Univ Autonoma Barcelona, Dept Psicol Clin & Salut, Unitat Epidemiol & Diagnost Psicopatol Desenvolup, E-08193 Barcelona, Spain.	lourdes.ezpeleta@uab.cat	Granero, Roser/S-3529-2019; Navarro, Jose Blas/GWZ-2684-2022; Granero, Roser/F-9492-2016	Granero, Roser/0000-0001-6308-3198; Navarro Pastor, Jose Blas/0000-0001-5929-4224; Ezpeleta, Lourdes/0000-0002-8957-083X; Penelo, Eva/0000-0001-6796-7660	Spanish Ministry of Economy and Competitiveness [PSI2012-32695]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	Funding was from Spanish Ministry of Economy and Competitiveness grant PSI2012-32695. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T. M., 2000, MANUAL ASEBA PRESCHO; Achenbach T. M., 1992, MANUAL CHILD BEHAV C; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, DOI [10.1176/appi.books.9780890423349., DOI 10.1176/APPI.BOOKS.9780890423349]; [Anonymous], 1991, MANUAL CHILD BEHAV C; Bufferd SJ, 2011, COMPR PSYCHIAT, V52, P359, DOI 10.1016/j.comppsych.2010.08.006; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Copeland WE, 2009, ARCH GEN PSYCHIAT, V66, P764, DOI 10.1001/archgenpsychiatry.2009.85; De Los Reyes A, 2005, PSYCHOL BULL, V131, P483, DOI 10.1037/0033-2909.131.4.483; Dirks MA, 2012, J CHILD PSYCHOL PSYC, V53, P558, DOI 10.1111/j.1469-7610.2012.02537.x; Drabick DAG, 2007, J AM ACAD CHILD PSY, V46, P92, DOI 10.1097/01.chi.0000242245.00174.90; Enders CK, 2001, STRUCT EQU MODELING, V8, P128, DOI 10.1207/S15328007SEM0801_7; Ezpeleta L, 2001, J CHILD PSYCHOL PSYC, V42, P901, DOI 10.1111/1469-7610.00786; Ezpeleta L, 2014, SOC PSYCH PSYCH EPID, V49, P145, DOI 10.1007/s00127-013-0683-1; Ezpeleta L, 2011, PSYCHIAT RES, V190, P137, DOI 10.1016/j.psychres.2011.04.034; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Keiley MK, 2000, J ABNORM CHILD PSYCH, V28, P161, DOI 10.1023/A:1005122814723; Lo YT, 2001, BIOMETRIKA, V88, P767, DOI 10.1093/biomet/88.3.767; Luby JL, 2006, J CHILD PSYCHOL PSYC, V47, P1292, DOI 10.1111/j.1469-7610.2006.01672.x; Maughan B, 2004, J CHILD PSYCHOL PSYC, V45, P609, DOI 10.1111/j.1469-7610.2004.00250.x; Miner JL, 2008, DEV PSYCHOL, V44, P771, DOI 10.1037/0012-1649.44.3.771; Nagin D, 1999, CHILD DEV, V70, P1181, DOI 10.1111/1467-8624.00086; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Petitclerc A, 2009, J CHILD PSYCHOL PSYC, V50, P1477, DOI 10.1111/j.1469-7610.2009.02118.x; Reef J, 2011, SOC PSYCH PSYCH EPID, V46, P1233, DOI 10.1007/s00127-010-0297-9; Reef J, 2010, J AM ACAD CHILD PSY, V49, P1117, DOI 10.1016/j.jaac.2010.08.002; Rowe R, 2010, J ABNORM PSYCHOL, V119, P726, DOI 10.1037/a0020798; SHAFFER D, 1983, ARCH GEN PSYCHIAT, V40, P1228; Shaw DS, 2005, J CHILD PSYCHOL PSYC, V46, P931, DOI 10.1111/j.1469-7610.2004.00390.x; Stringaris A, 2009, J AM ACAD CHILD PSY, V48, P404, DOI 10.1097/CHI.0b013e3181984f30; Tremblay RE, 2010, J CHILD PSYCHOL PSYC, V51, P341, DOI 10.1111/j.1469-7610.2010.02211.x	31	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101089	10.1371/journal.pone.0101089	http://dx.doi.org/10.1371/journal.pone.0101089			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK6BK	24972147	Green Submitted, Green Published, gold			2022-12-27	WOS:000338512200093
J	Maskey, M; Lowry, J; Rodgers, J; McConachie, H; Parr, JR				Maskey, Morag; Lowry, Jessica; Rodgers, Jacqui; McConachie, Helen; Parr, Jeremy R.			Reducing Specific Phobia/Fear in Young People with Autism Spectrum Disorders (ASDs) through a Virtual Reality Environment Intervention	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; COMORBID PSYCHIATRIC-DISORDERS; ANXIETY DISORDERS; CHILDREN; ADOLESCENTS; SYMPTOMS; YOUTH; RESPONSES; EMOTIONS; SKILLS	Anxiety is common in children with autism spectrum disorders (ASD), with specific fears and phobias one of the most frequent subtypes. Specific fears and phobias can have a serious impact on young people with ASD and their families. In this study we developed and evaluated a unique treatment combining cognitive behaviour therapy (CBT) with graduated exposure in a virtual reality environment (VRE). Nine verbally fluent boys with an ASD diagnosis and no reported learning disability, aged 7 to 13 years old, were recruited. Each had anxiety around a specific situation (e. g. crowded buses) or stimulus (e. g. pigeons). An individualised scene was recreated in our 'wrap-around' VRE. In the VRE participants were coached by a psychologist in cognitive and behavioural techniques (e.g. relaxation and breathing exercises) while the exposure to the phobia/fear stimulus was gradually increased as the child felt ready. Each child received four 20-30 minute sessions. After participating in the study, eight of the nine children were able to tackle their phobia situation. Four of the participants completely overcame their phobia. Treatment effects were maintained at 12 months. These results provide evidence that CBT with VRE can be a highly effective treatment for specific phobia/fear for some young people with ASD.	[Maskey, Morag; Rodgers, Jacqui; Parr, Jeremy R.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Lowry, Jessica; McConachie, Helen] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Maskey, M (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	morag.maskey@ncl.ac.uk; Jeremy.parr@ncl.ac.uk		Rodgers, Jacqui/0000-0002-1759-316X	Newcastle University	Newcastle University	Dr Morag Maskey has a Daphne Jackson Fellowship sponsored by Newcastle University (http://www.daphnejackson.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinis A., 2008, LEEDS RELIABLE CHANG; [Anonymous], 2005, EMOTIONAL DEV RECENT; Arnold LE, 2003, J AM ACAD CHILD PSY, V42, P1443, DOI 10.1097/00004583-200312000-00011; Ashburner J, 2010, RES AUTISM SPECT DIS, V4, P18, DOI 10.1016/j.rasd.2009.07.002; Berument SK, 1999, BRIT J PSYCHIAT, V175, P444, DOI 10.1192/bjp.175.5.444; Chalfant AM, 2007, J AUTISM DEV DISORD, V37, P1842, DOI 10.1007/s10803-006-0318-4; de Bruin EI, 2007, J AUTISM DEV DISORD, V37, P877, DOI 10.1007/s10803-006-0215-x; Drahota A, 2011, J AUTISM DEV DISORD, V41, P257, DOI 10.1007/s10803-010-1037-4; Eaves LC, 2006, AUTISM, V10, P229, DOI 10.1177/1362361306063288; Fabri M, 2007, LECT NOTES COMPUT SC, V4552, P275; Gjevik E, 2011, J AUTISM DEV DISORD, V41, P761, DOI 10.1007/s10803-010-1095-7; Hill E, 2004, J AUTISM DEV DISORD, V34, P229, DOI 10.1023/B:JADD.0000022613.41399.14; Hirstein W, 2001, P ROY SOC B-BIOL SCI, V268, P1883, DOI 10.1098/rspb.2001.1724; IALONGO N, 1995, J CHILD PSYCHOL PSYC, V36, P427, DOI 10.1111/j.1469-7610.1995.tb01300.x; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Joshi G, 2010, J AUTISM DEV DISORD, V40, P1361, DOI 10.1007/s10803-010-0996-9; Josman N, 2008, INT J DISABIL HUM DE, V7, P49; Leyfer OT, 2006, J AUTISM DEV DISORD, V36, P849, DOI 10.1007/s10803-006-0123-0; Lind SE, 2014, NEUROPSYCHOLOGY, V28, P55, DOI 10.1037/neu0000005; Low J, 2009, BRIT J DEV PSYCHOL, V27, P425, DOI 10.1348/026151008X334728; Maskey M, 2013, J AUTISM DEV DISORD, V43, P851, DOI 10.1007/s10803-012-1622-9; Mattila ML, 2010, J AUTISM DEV DISORD, V40, P1080, DOI 10.1007/s10803-010-0958-2; Mayes SD, 2013, RES AUTISM SPECT DIS, V7, P151, DOI 10.1016/j.rasd.2012.08.002; McConachie H, 2009, ARCH DIS CHILD, V94, P38, DOI 10.1136/adc.2007.126326; McConachie H, 2013, AUTISM; McPheeters ML, 2011, J AUTISM DEV DISORD, V41, P646, DOI 10.1007/s10803-010-1085-9; Mitchell P, 2007, J AUTISM DEV DISORD, V37, P589, DOI 10.1007/s10803-006-0189-8; Moore M, 2000, J AUTISM DEV DISORD, V30, P359, DOI 10.1023/A:1005535602064; Moree BN, 2010, RES AUTISM SPECT DIS, V4, P346, DOI 10.1016/j.rasd.2009.10.015; National Institute for Health and Care Excellence (NICE), 2011, REC REF DIAGN CHILDR, V128; Nauta MH, 2004, BEHAV RES THER, V42, P813, DOI 10.1016/S0005-7967(03)00200-6; O'Riordan MA, 2001, J EXP PSYCHOL HUMAN, V27, P719, DOI 10.1037//0096-1523.27.3.719; Ollendick TH, 2006, HDB INTERVENTIONS WO, P3; Ozsivadjian Ann, 2011, Clin Child Psychol Psychiatry, V16, P203, DOI 10.1177/1359104511404749; Pine DS, 1998, ARCH GEN PSYCHIAT, V55, P56, DOI 10.1001/archpsyc.55.1.56; Puleo CM, 2011, J AUTISM DEV DISORD, V41, P275, DOI 10.1007/s10803-010-1047-2; Rieffe C, 2007, J AUTISM DEV DISORD, V37, P455, DOI 10.1007/s10803-006-0171-5; Rothbaum BO, 1999, BEHAV MODIF, V23, P507, DOI 10.1177/0145445599234001; Samson AC, 2012, EMOTION, V12, P659, DOI 10.1037/a0027975; Silverman WK, 1996, ANXIETY DISORDERS IN; Simonoff E, 2008, J AM ACAD CHILD PSY, V47, P921, DOI 10.1097/CHI.0b013e318179964f; Slater M, 2006, CYBERPSYCHOL BEHAV, V9, P627, DOI 10.1089/cpb.2006.9.627; Sofronoff K, 2005, J CHILD PSYCHOL PSYC, V46, P1152, DOI 10.1111/j.1469-7610.2005.00411.x; Spence SH, 1998, BEHAV RES THER, V36, P545, DOI 10.1016/S0005-7967(98)00034-5; Strickland DC, 2007, TOP LANG DISORD, V27, P226, DOI 10.1097/01.TLD.0000285357.95426.72; van Steensel FJA, 2013, J AUTISM DEV DISORD, P1; Wallace S, 2010, AUTISM, V14, P199, DOI 10.1177/1362361310363283; Witwer AN, 2010, J DEV PHYS DISABIL, V22, P367, DOI 10.1007/s10882-010-9194-0; Wood JJ, 2010, CLIN PSYCHOL-SCI PR, V17, P281, DOI 10.1111/j.1468-2850.2010.01220.x	49	84	89	2	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100374	10.1371/journal.pone.0100374	http://dx.doi.org/10.1371/journal.pone.0100374			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BA	24987957	Green Submitted, Green Published, gold			2022-12-27	WOS:000341354100029
J	McCreesh, N; Booth, M				McCreesh, Nicky; Booth, Mark			The Effect of Increasing Water Temperatures on Schistosoma mansoni Transmission and Biomphalaria pfeifferi Population Dynamics: An Agent-Based Modelling Study	PLOS ONE			English	Article							CLIMATE-CHANGE; MALARIA RESURGENCE; LONG-TERM; IMPACT; EPIDEMIOLOGY; PLANORBIDAE; GASTROPODA; UGANDA; AIR	Introduction: There is increasing interest in the control and elimination of schistosomiasis. Little is known, however, about the likely effects of increasing water-body temperatures on transmission. Methods: We have developed an agent-based model of the temperature-sensitive stages of the Schistosoma and intermediate host snail life-cycles, parameterised using data from S. mansoni and Biomphalaria pfeifferi laboratory and field-based observations. Infection risk is calculated as the number of cercariae in the model, adjusted for their probability of causing infection. Results: The number of snails in the model is approximately constant between 15-31 degrees C. Outside this range, snail numbers drop sharply, and the snail population cannot survive outside the range 14-32 degrees C. Mean snail generation time decreases with increasing temperature from 176 days at 14 degrees C to 46 days at 26 degrees C. Human infection risk is highest between 16-18 degrees C and 1 pm and 6-10 pm in calm water, and 20-25 degrees C and 12-4 pm in flowing water. Infection risk increases sharply when temperatures increase above the minimum necessary for sustained transmission. Conclusions: The model suggests that, in areas where S. mansoni is already endemic, warming of the water at transmission sites will have differential effects on both snails and parasites depending on abiotic properties of the water-body. Snail generation times will decrease in most areas, meaning that snail populations will recover faster from natural population reductions and from snail-control efforts. We suggest a link between the ecological properties of transmission sites and infection risk which could significantly affect the outcomes of interventions designed to alter water contact behaviour proposing that such interventions are more likely to reduce infection levels at river locations than lakes, where infection risk remains high for longer. In cooler areas where snails are currently found, increasing temperatures may significantly increase infection risk, potentially leading to new, high-intensity foci of infection.	[McCreesh, Nicky; Booth, Mark] Univ Durham, Sch Med Pharm & Hlth, Durham, England	Durham University	McCreesh, N (corresponding author), Univ Durham, Sch Med Pharm & Hlth, Durham, England.	Nicky.mccreesh@durham.ac.uk	Booth, Mark/D-2266-2011	Booth, Mark/0000-0002-5507-888X; McCreesh, Nicky/0000-0003-1409-8531	European Union [266327]	European Union(European Commission)	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 266327. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLETON CC, 1984, T ROY SOC TROP MED H, V78, P49, DOI 10.1016/0035-9203(84)90171-8; Brown DS, 1994, FRESHWATER SNAILS AF, DOI 10.1201/9781482295184; Chaves LF, 2010, Q REV BIOL, V85, P27, DOI 10.1086/650284; CHU KY, 1970, B WORLD HEALTH ORGAN, V42, P575; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; de Moira AP, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000820; GHANDOUR A M, 1973, International Journal for Parasitology, V3, P789, DOI 10.1016/0020-7519(73)90070-2; Hay SI, 2002, TRENDS PARASITOL, V18, P530, DOI 10.1016/S1471-4922(02)02374-7; Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a; IPCC, 1990, CLIM CHANG IPCC IMPL; John R, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-110; Kabatereine NB, 2004, TROP MED INT HEALTH, V9, P372, DOI 10.1046/j.1365-3156.2003.01176.x; Kariuki HC, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-107; Kazibwe F, 2006, HYDROBIOLOGIA, V568, P433, DOI 10.1007/s10750-006-0224-y; KLOOS H, 1988, SOC SCI MED, V26, P803, DOI 10.1016/0277-9536(88)90174-8; LOREAU M, 1987, J MOLLUS STUD, V53, P249, DOI 10.1093/mollus/53.3.249; LOREAU M, 1987, J MOLLUS STUD, V53, P171, DOI 10.1093/mollus/53.2.171; Mangal TD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001438; Martens WJM, 1997, CLIMATIC CHANGE, V35, P145, DOI 10.1023/A:1005365413932; MARTENS WJM, 1995, GLOBAL ENVIRON CHANG, V5, P195, DOI 10.1016/0959-3780(95)00051-O; McCreesh Nicky, 2014, PLoS One, V9, pe87892, DOI 10.1371/journal.pone.0087892; McCreesh N, 2013, TRENDS PARASITOL, V29, P548, DOI 10.1016/j.pt.2013.08.007; Mouchet J, 1998, J AM MOSQUITO CONTR, V14, P121; Parry M. L., 2007, CONTRIBUTION WORKING, P976; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Patz JA, 2002, NATURE, V420, P627, DOI 10.1038/420627a; Portner H.-O., 2022, SUMMARY POLICYMAKERS; SHIFF CJ, 1975, INT J PARASITOL, V5, P119, DOI 10.1016/0020-7519(75)90109-5; Stensgaard AS, 2013, ACTA TROP, V128, P378, DOI 10.1016/j.actatropica.2011.11.010; UPATHAM ES, 1972, J HELMINTHOL, V46, P271, DOI 10.1017/S0022149X0002441X; WHO WMO UNEP, 2003, CLIMATE CHANGE HLTH; Zhou XN, 2008, AM J TROP MED HYG, V78, P188, DOI 10.4269/ajtmh.2008.78.188	32	27	27	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101462	10.1371/journal.pone.0101462	http://dx.doi.org/10.1371/journal.pone.0101462			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987963	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000341354100093
J	Meffert, SM; Henn-Haase, C; Metzler, TJ; Qian, M; Best, S; Hirschfeld, A; McCaslin, S; Inslicht, S; Neylan, TC; Marmar, CR				Meffert, Susan M.; Henn-Haase, Clare; Metzler, Thomas J.; Qian, Meng; Best, Suzanne; Hirschfeld, Ayelet; McCaslin, Shannon; Inslicht, Sabra; Neylan, Thomas C.; Marmar, Charles R.			Prospective Study of Police Officer Spouse/Partners: A New Pathway to Secondary Trauma and Relationship Violence?	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; EMERGENCY SERVICES PERSONNEL; MALE VIETNAM VETERANS; COMBAT VETERANS; WAR VETERANS; PSYCHOLOGICAL DISTRESS; PARTNERS PERCEPTIONS; MISSISSIPPI SCALE; MENTAL-HEALTH; PTSD	Introduction: It has been reported that posttraumatic stress disorder (PTSD) is associated with secondary spouse/partner (S/P) emotional distress and relationship violence. Objective: To investigate the relationships between PTSD, S/P emotional distress and relationship violence among police recruits using a prospective design. Methods: Two hypotheses were tested in 71 S/Ps: (1) Police officer reports of greater PTSD symptoms after 12 months of police service will be associated with greater secondary trauma symptoms among S/Ps; (2) Greater secondary trauma symptoms among S/Ps at 12 months will be associated with S/P reports of greater relationship violence. Methods: 71 police recruits and their S/Ps were assessed at baseline and 12 months after the start of police officer duty. Using linear and logistic regression, we analyzed explanatory variables for 12 month S/P secondary traumatic stress symptoms and couple violence, including baseline S/P variables and couple violence, as well as exposure and PTSD reports from both S/P and officer. Results: S/P perception of officer PTSD symptoms predicted S/P secondary traumatic stress. OS/P secondary trauma was significantly associated with both total couple violence (.34, p = .004) and S/P to officer violence (.35, p = .003). Conclusions: Although results from this relatively small study of young police officers and their S/Ps must be confirmed by larger studies in general populations, findings suggest that S/P perception of PTSD symptoms may play a key role in the spread of traumatic stress symptoms across intimate partner relationships and intimate partner violence in the context of PTSD.	[Meffert, Susan M.; Inslicht, Sabra; Neylan, Thomas C.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Metzler, Thomas J.; Hirschfeld, Ayelet; Inslicht, Sabra; Neylan, Thomas C.] San Francisco Vet Adm Med Ctr, Mental Hlth Serv, San Francisco, CA USA; [Henn-Haase, Clare; Qian, Meng; Marmar, Charles R.] NYU, Dept Psychiat, New York, NY 10016 USA; [Best, Suzanne] Lewis & Clark Coll, Grad Sch Educ & Counseling, Portland, OR 97219 USA; [McCaslin, Shannon] Natl Ctr PTSD, Disseminat & Training Div, Palo Alto, CA USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; New York University	Meffert, SM (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	susan.meffert@ucsf.edu	Marmar, Charles R./O-1902-2017; Inslicht, Sabra S/O-3697-2017	Marmar, Charles R./0000-0001-8427-5607; Inslicht, Sabra S/0000-0002-2456-1625; Henn-Haase, Clare/0000-0003-0429-781X; meffert, susan/0000-0002-5882-7102	National Institute of Mental Health [R01 - MH056350-06]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056350] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by National Institute of Mental Health Grant (R01 - MH056350-06) to CRM. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of this manuscript.	Adams RE, 2006, AM J ORTHOPSYCHIAT, V76, P103, DOI 10.1037/0002-9432.76.1.103; Al-Turkait FA, 2008, J ANXIETY DISORD, V22, P18, DOI 10.1016/j.janxdis.2007.01.011; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Ben Arzi N, 2000, BRAIN INJURY, V14, P725; Chartier-Otis M, 2009, J NERV MENT DIS, V197, P543, DOI 10.1097/NMD.0b013e3181aac807; Dekel R, 2006, SOC PSYCH PSYCH EPID, V41, P27, DOI 10.1007/s00127-005-0002-6; DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13; Devilly GJ, 2009, AUST NZ J PSYCHIAT, V43, P373, DOI 10.1080/00048670902721079; Franciskovic T, 2007, CROAT MED J, V48, P177; Hirshfeld A, 2005, SECONDARY EFFECTS TR; Jakupcak M, 2007, J TRAUMA STRESS, V20, P945, DOI 10.1002/jts.20258; Jakupcak Matthew, 2005, Violence Vict, V20, P589, DOI 10.1891/088667005780927494; JORDAN BK, 1992, J CONSULT CLIN PSYCH, V60, P916, DOI 10.1037/0022-006X.60.6.916; KEANE TM, 1988, J CONSULT CLIN PSYCH, V56, P85, DOI 10.1037/0022-006X.56.1.85; Lambert JE, 2012, J FAM PSYCHOL, V26, P729, DOI 10.1037/a0029341; Lane Eric J, 2010, Int J Emerg Ment Health, V12, P257; Lauterbach D, 1997, J TRAUMA STRESS, V10, P499, DOI 10.1002/jts.2490100313; Little R.J.A., 2002, STAT ANAL MISSING DA; MacDonald C, 1999, J TRAUMA STRESS, V12, P701, DOI 10.1023/A:1024729520686; Marmar CR, 1996, AM J PSYCHIAT, V153, P94; Motta R, 2004, BEHAV THERAPIST, V27, P54; Motta R. W., 2001, J PSYCHOTHERAPY INDE, V24, P17, DOI [10.1300/J288v02n04_02, DOI 10.1300/J288V02N04_02]; Motta Robert W, 2004, Int J Emerg Ment Health, V6, P67; Motta Robert W, 2008, Int J Emerg Ment Health, V10, P291; Motta RW, 1999, PSYCHOL REP, V85, P997, DOI 10.2466/PR0.85.7.997-1002; Norris FH, 1996, J TRAUMA STRESS, V9, P285, DOI 10.1007/BF02110661; Payne R., 1985, 9 MENTAL MEASUREMENT; Renshaw KD, 2012, BEHAV THER, V43, P416, DOI 10.1016/j.beth.2011.09.002; Renshaw KD, 2011, J FAM PSYCHOL, V25, P953, DOI 10.1037/a0025871; Renshaw KD, 2010, J ANXIETY DISORD, V24, P743, DOI 10.1016/j.janxdis.2010.05.007; Riggs DS, 1998, J TRAUMA STRESS, V11, P87, DOI 10.1023/A:1024409200155; Royston P., 2011, J STAT SOFTWARE, V45; Rubin DB, 2004, MULTIPLE IMPUTATION; Sabin-Farrell R, 2003, CLIN PSYCHOL REV, V23, P449, DOI 10.1016/S0272-7358(03)00030-8; Salston M, 2003, J TRAUMA STRESS, V16, P167, DOI 10.1023/A:1022899207206; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Swan Suzanne C, 2005, Violence Vict, V20, P267, DOI 10.1891/088667005780997929; Taft CT, 2007, J FAM PSYCHOL, V21, P270, DOI 10.1037/0893-3200.21.2.270; Taft CT, 2009, VIOLENCE VICTIMS, V24, P639, DOI 10.1891/0886-6708.24.5.639; Teten AL, 2010, J INTERPERS VIOLENCE; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Wang Z, 2010, PSYCHIAT RES, V175, P211, DOI 10.1016/j.psychres.2008.11.010; Weiss DS, 2010, J TRAUMA STRESS, V23, P734, DOI 10.1002/jts.20576; WEISS DS, 1995, J CONSULT CLIN PSYCH, V63, P361, DOI 10.1037/0022-006X.63.3.361	44	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100663	10.1371/journal.pone.0100663	http://dx.doi.org/10.1371/journal.pone.0100663			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BA	24987848	Green Published, gold			2022-12-27	WOS:000341354100036
J	Mun, S; Lee, J; Kim, YJ; Kim, HS; Han, K				Mun, Seyoung; Lee, Jungnam; Kim, Yun-Ji; Kim, Heui-Soo; Han, Kyudong			Chimpanzee-Specific Endogenous Retrovirus Generates Genomic Variations in the Chimpanzee Genome	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; MEDIATED DELETION; DNA-SEQUENCE; INSERTIONS; L1; IDENTIFICATION; SUBFAMILIES; CHROMOSOME; EVOLUTION; FAMILY	Endogenous retroviruses (ERVs), eukaryotic transposable elements, exist as proviruses in vertebrates including primates and contribute to genomic changes during the evolution of their host genomes. Many studies about ERVs have focused on the elements residing in the human genome but only a few studies have focused on the elements which exist in non-human primate genomes. In this study, we identified 256 chimpanzee-specific endogenous retrovirus copies (PtERVs: Pan troglodyte endogenous retroviruses) from the chimpanzee reference genome sequence through comparative genomics. Among the chimpanzee-specific ERV copies, 121 were full-length chimpanzee-specific ERV elements while 110 were chimpanzee-specific solitary LTR copies. In addition, we found eight potential retrotransposition-competent full-length chimpanzee-specific ERV copies containing an intact env gene, and two of them were polymorphic in chimpanzee individuals. Through computational analysis and manual inspection, we found that some of the chimpanzee-specific ERVs have propagated via non-classical PtERV insertion (NCPI), and at least one of the PtERVs may have played a role in creating an alternative transcript of a chimpanzee gene. Based on our findings in this study, we state that the chimpanzee-specific ERV element is one of the sources of chimpanzee genomic variations, some of which might be related to the alternative transcripts in the chimpanzee population.	[Mun, Seyoung; Lee, Jungnam; Kim, Yun-Ji; Han, Kyudong] Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea; [Mun, Seyoung; Kim, Yun-Ji; Han, Kyudong] Dankook Univ, PLUS NBM Global Res Ctr Regenerat Med BK21, Cheonan, South Korea; [Mun, Seyoung; Kim, Yun-Ji; Han, Kyudong] DKU Theragen Inst NGS Anal DTiNa, Cheonan, South Korea; [Lee, Jungnam] Univ Florida, Coll Dent, Dept Periodontol, Gainesville, FL USA; [Lee, Jungnam] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA; [Kim, Heui-Soo] Pusan Natl Univ, Coll Nat Sci, Dept Biol Sci, Pusan, South Korea	Dankook University; Dankook University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Pusan National University	Han, K (corresponding author), Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea.	jim97@dankook.ac.kr	Kim, Heui-Soo/ABF-3773-2021; Han, Kyudong/AAF-1788-2019	Kim, Heui-Soo/0000-0002-5226-6594; Han, Kyudong/0000-0001-6791-2408; Mun, Seyoung/0000-0002-9669-4494	National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2011-0009080]	National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This research was supported by the Basic Science Research (2011-0009080) program, through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science, and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A.F.A. Smit RHPG, 2014, REPEATMASKER OP 4 0; Anderssen S, 1997, VIROLOGY, V234, P14, DOI 10.1006/viro.1997.8590; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Buzdin A, 2003, GENOMICS, V81, P149, DOI 10.1016/S0888-7543(02)00027-7; Callinan PA, 2005, J MOL BIOL, V348, P791, DOI 10.1016/j.jmb.2005.02.043; Chu G, 1997, J BIOL CHEM, V272, P24097, DOI 10.1074/jbc.272.39.24097; COPELAND NG, 1983, CELL, V33, P379, DOI 10.1016/0092-8674(83)90419-1; Griffiths DJ, 2001, GENOME BIOL, V2; Hall T., 2013, IBIS BIOSCIENCES; Han KD, 2005, NUCLEIC ACIDS RES, V33, P4040, DOI 10.1093/nar/gki718; Han KD, 2005, GENOME RES, V15, P655, DOI 10.1101/gr.3492605; Han K, 2007, PLOS GENET, V3, P1939, DOI 10.1371/journal.pgen.0030184; Han KD, 2008, P NATL ACAD SCI USA, V105, P19366, DOI 10.1073/pnas.0807866105; Jern P, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-50; Jern P, 2008, ANNU REV GENET, V42, P709, DOI 10.1146/annurev.genet.42.110807.091501; KAPLAN N, 1985, GENETICS, V109, P459; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Katzourakis A, 2005, TRENDS MICROBIOL, V13, P463, DOI 10.1016/j.tim.2005.08.004; Khodosevich K, 2002, COMP FUNCT GENOM, V3, P494, DOI 10.1002/cfg.216; Kim DS, 2011, BIOINFORMATICS, V27, P14, DOI 10.1093/bioinformatics/btq612; Kim RN, 2011, FUNCT INTEGR GENOMIC, V11, P507, DOI 10.1007/s10142-011-0220-9; Kim Yun-Ji, 2012, Genomics & Informatics, V10, P226, DOI 10.5808/GI.2012.10.4.226; KJELLMAN C, 1995, GENE, V161, P163, DOI 10.1016/0378-1119(95)00248-5; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kuroki Y, 2006, NAT GENET, V38, P158, DOI 10.1038/ng1729; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lavrentieva I, 1998, HUM GENET, V102, P107, DOI 10.1007/s004390050662; LEIBMOSCH C, 1993, GENOMICS, V18, P261, DOI 10.1006/geno.1993.1464; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Mullaney JM, 2010, HUM MOL GENET, V19, pR131, DOI 10.1093/hmg/ddq400; Nakagawa K, 1996, IMMUNOL REV, V152, P193, DOI 10.1111/j.1600-065X.1996.tb00917.x; PASCALE E, 1993, J MOL EVOL, V36, P9, DOI 10.1007/BF02407302; Polavarapu N, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r51; Rassool FV, 2003, CANCER LETT, V193, P1, DOI 10.1016/S0304-3835(02)00692-4; Sayers EW, 2010, NUCLEIC ACIDS RES, V40, pD13; Shaw D, 2013, DOUGS RANDOM SAMPLIN; Shin W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060605; Shirasu K, 2000, GENOME RES, V10, P908, DOI 10.1101/gr.10.7.908; Spencer TE, 2012, SOC REPROD FERTIL S, V67, P95; Sperber G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S4; Stoye JP, 2001, CURR BIOL, V11, pR914, DOI 10.1016/S0960-9822(01)00553-X; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Udaka T, 2007, AM J MED GENET A, V143A, P721, DOI 10.1002/ajmg.a.31441; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Varki A, 2005, GENOME RES, V15, P1746, DOI 10.1101/gr.3737405; VOLIVA CF, 1984, J MOL BIOL, V178, P795, DOI 10.1016/0022-2836(84)90312-7; Watanabe H, 2004, NATURE, V429, P382, DOI 10.1038/nature02564; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Yohn CT, 2005, PLOS BIOL, V3, P577, DOI 10.1371/journal.pbio.0030110	49	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101195	10.1371/journal.pone.0101195	http://dx.doi.org/10.1371/journal.pone.0101195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987855	Green Published, Green Submitted, gold			2022-12-27	WOS:000341354100068
J	Nikolaisen, J; Nilsson, LIH; Pettersen, IKN; Willems, PHGM; Lorens, JB; Koopman, WJH; Tronstad, KJ				Nikolaisen, Julie; Nilsson, Linn I. H.; Pettersen, Ina K. N.; Willems, Peter H. G. M.; Lorens, James B.; Koopman, Werner J. H.; Tronstad, Karl J.			Automated Quantification and Integrative Analysis of 2D and 3D Mitochondrial Shape and Network Properties	PLOS ONE			English	Article							HELA-CELLS; COMPLEX-I; MORPHOLOGY; DYNAMICS; PHOSPHORYLATION; MOTILITY; ELECTRON; CHAIN	Mitochondrial morphology and function are coupled in healthy cells, during pathological conditions and (adaptation to) endogenous and exogenous stress. In this sense mitochondrial shape can range from small globular compartments to complex filamentous networks, even within the same cell. Understanding how mitochondrial morphological changes (i.e. "mitochondrial dynamics'') are linked to cellular (patho) physiology is currently the subject of intense study and requires detailed quantitative information. During the last decade, various computational approaches have been developed for automated 2-dimensional (2D) analysis of mitochondrial morphology and number in microscopy images. Although these strategies are well suited for analysis of adhering cells with a flat morphology they are not applicable for thicker cells, which require a three-dimensional (3D) image acquisition and analysis procedure. Here we developed and validated an automated image analysis algorithm allowing simultaneous 3D quantification of mitochondrial morphology and network properties in human endothelial cells (HUVECs). Cells expressing a mitochondria-targeted green fluorescence protein (mitoGFP) were visualized by 3D confocal microscopy and mitochondrial morphology was quantified using both the established 2D method and the new 3D strategy. We demonstrate that both analyses can be used to characterize and discriminate between various mitochondrial morphologies and network properties. However, the results from 2D and 3D analysis were not equivalent when filamentous mitochondria in normal HUVECs were compared with circular/spherical mitochondria in metabolically stressed HUVECs treated with rotenone (ROT). 2D quantification suggested that metabolic stress induced mitochondrial fragmentation and loss of biomass. In contrast, 3D analysis revealed that the mitochondrial network structure was dissolved without affecting the amount and size of the organelles. Thus, our results demonstrate that 3D imaging and quantification are crucial for proper understanding of mitochondrial shape and topology in non-flat cells. In summary, we here present an integrative method for unbiased 3D quantification of mitochondrial shape and network properties in mammalian cells.	[Nikolaisen, Julie; Nilsson, Linn I. H.; Pettersen, Ina K. N.; Lorens, James B.; Tronstad, Karl J.] Univ Bergen, Dept Biomed, Bergen, Norway; [Willems, Peter H. G. M.; Koopman, Werner J. H.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem 286, NL-6525 ED Nijmegen, Netherlands	University of Bergen; Radboud University Nijmegen	Tronstad, KJ (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	karl.tronstad@biomed.uib.no	Koopman, Werner J.H./AAC-9668-2020; Koopman, Werner J.H./D-3592-2009; Willems, P.H.G.M./L-4759-2015; Lorens, James/B-9737-2017	Koopman, Werner J.H./0000-0002-5340-6747; Koopman, Werner J.H./0000-0002-5340-6747; Willems, P.H.G.M./0000-0002-0915-1599; Lorens, James/0000-0002-6782-3349; Tronstad, Karl Johan/0000-0003-3496-3123	Norwegian Research Council [214187/F20]; Norwegian Health Association; Bergen Medical Research Foundation; Department of Biomedicine; "Tjomsland legacy" (University of Bergen); Centres for Systems Biology Research initiative from NWO (Netherlands Organization for Scientific Research) [CSBR09/013V]	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Health Association; Bergen Medical Research Foundation; Department of Biomedicine; "Tjomsland legacy" (University of Bergen); Centres for Systems Biology Research initiative from NWO (Netherlands Organization for Scientific Research)(Netherlands Organization for Scientific Research (NWO))	The work was funded by grants from the Norwegian Research Council (214187/F20), Norwegian Health Association, Bergen Medical Research Foundation, the Department of Biomedicine and "Tjomsland legacy" (University of Bergen). The research of PHGMW and WJHK was supported by the Centres for Systems Biology Research initiative (CSBR09/013V) from NWO (Netherlands Organization for Scientific Research). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Biggs DS, 2010, CURR PROTOC CYTOM, V19, P11; BINDOFF LA, 1991, J NEUROL SCI, V102, P17, DOI 10.1016/0022-510X(91)90088-O; Campanella M, 2009, BBA-BIOENERGETICS, V1787, P393, DOI 10.1016/j.bbabio.2009.02.023; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Cereghetti GM, 2006, ONCOGENE, V25, P4717, DOI 10.1038/sj.onc.1209605; Chevrollier A, 2012, INT J BIOCHEM CELL B, V44, P980, DOI 10.1016/j.biocel.2012.03.006; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616; Distelmaier F, 2008, CYTOM PART A, V73A, P129, DOI 10.1002/cyto.a.20503; Distelmaier F, 2012, ANTIOXID REDOX SIGN, V17, P1657, DOI 10.1089/ars.2011.4294; Duchen MR, 2003, METHOD ENZYMOL, V361, P353; Egner A, 2002, P NATL ACAD SCI USA, V99, P3370, DOI 10.1073/pnas.052545099; Eisenberg I, 2008, HUM MOL GENET, V17, P3663, DOI 10.1093/hmg/ddn261; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Frazier AE, 2006, BIOL CHEM, V387, P1551, DOI 10.1515/BC.2006.193; Frederick RL, 2007, TRAFFIC, V8, P1668, DOI 10.1111/j.1600-0854.2007.00644.x; Giedt RJ, 2012, ANN BIOMED ENG, V40, P1903, DOI 10.1007/s10439-012-0568-6; Hagland H, 2007, EXPERT OPIN THER TAR, V11, P1055, DOI 10.1517/14728222.11.8.1055; Heeman B, 2011, J CELL SCI, V124, P1115, DOI 10.1242/jcs.078303; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Koopman WJH, 2007, AM J PHYSIOL-CELL PH, V293, pC22, DOI 10.1152/ajpcell.00194.2006; Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478; Koopman WJH, 2008, METHODS, V46, P304, DOI 10.1016/j.ymeth.2008.09.018; Koopman WJH, 2006, CYTOM PART A, V69A, P1, DOI 10.1002/cyto.a.20198; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V289, pC881, DOI 10.1152/ajpcell.00104.2005; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V288, pC1440, DOI 10.1152/ajpcell.00607.2004; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Lee Ji-Sook, 2014, J Biomol Tech, V25, P31, DOI 10.7171/jbt.14-2501-002; Liesa M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003613; Lihavainen E, 2012, BIOINFORMATICS, V28, P1050, DOI 10.1093/bioinformatics/bts073; Lorens JB, 2000, MOL THER, V1, P438, DOI 10.1006/mthe.2000.0063; Matthews GD, 2010, J CELL SCI, V123, P351, DOI 10.1242/jcs.060749; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Mitra K, 2010, CURR PROTOC CELL BIO, V25, P21; Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Pucci B, 2008, J CELL PHYSIOL, V217, P442, DOI 10.1002/jcp.21513; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Shirure VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044529; Song W, 2008, METHODS, V46, P295, DOI 10.1016/j.ymeth.2008.10.003; Supale S, 2012, TRENDS ENDOCRIN MET, V23, P477, DOI 10.1016/j.tem.2012.06.002; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Tronstad KJ, 2014, CURR PHARM DES; Willems P, 2013, ANTIOXID REDOX SIGN, V18, P129, DOI 10.1089/ars.2011.4253; Willems PHGM, 2009, INT J BIOCHEM CELL B, V41, P1773, DOI 10.1016/j.biocel.2009.01.012; Zhu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036377	47	40	42	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101365	10.1371/journal.pone.0101365	http://dx.doi.org/10.1371/journal.pone.0101365			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988307	Green Published, gold			2022-12-27	WOS:000341354100080
J	Williams, GR; Shutler, D; Burgher-MacLellan, KL; Rogers, REL				Williams, Geoffrey R.; Shutler, Dave; Burgher-MacLellan, Karen L.; Rogers, Richard E. L.			Infra-Population and -Community Dynamics of the Parasites Nosema apis and Nosema ceranae, and Consequences for Honey Bee (Apis mellifera) Hosts	PLOS ONE			English	Article							MICROSPORIDIAN PARASITE; WIDESPREAD DISPERSAL; BOMBUS SPP.; INFECTION; HYMENOPTERA; VIRULENCE; PATHOGEN; ORIGIN; PCR	Nosema spp. fungal gut parasites are among myriad possible explanations for contemporary increased mortality of western honey bees (Apis mellifera, hereafter honey bee) in many regions of the world. Invasive Nosema ceranae is particularly worrisome because some evidence suggests it has greater virulence than its congener N. apis. N. ceranae appears to have recently switched hosts from Asian honey bees (Apis cerana) and now has a nearly global distribution in honey bees, apparently displacing N. apis. We examined parasite reproduction and effects of N. apis, N. ceranae, and mixed Nosema infections on honey bee hosts in laboratory experiments. Both infection intensity and honey bee mortality were significantly greater for N. ceranae than for N. apis or mixed infections; mixed infection resulted in mortality similar to N. apis parasitism and reduced spore intensity, possibly due to inter-specific competition. This is the first long-term laboratory study to demonstrate lethal consequences of N. apis and N. ceranae and mixed Nosema parasitism in honey bees, and suggests that differences in reproduction and intra-host competition may explain apparent heterogeneous exclusion of the historic parasite by the invasive species.	[Williams, Geoffrey R.; Shutler, Dave] Acadia Univ, Dept Biol, Wolfville, NS B0P 1X0, Canada; [Williams, Geoffrey R.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Williams, Geoffrey R.] Univ Bern, Vetsuisse Fac, Inst Bee Hlth, Bern, Switzerland; [Williams, Geoffrey R.] Agroscope, Swiss Bee Res Ctr, Bern, Switzerland; [Burgher-MacLellan, Karen L.] Agr & Agri Food Canada, Atlantic Food & Hort Res Ctr, Kentville, NS, Canada; [Rogers, Richard E. L.] Wildwood Labs, Kentville, NS, Canada	Acadia University; Dalhousie University; University of Bern; Swiss Federal Research Station Agroscope; Agriculture & Agri Food Canada	Williams, GR (corresponding author), Acadia Univ, Dept Biol, Wolfville, NS B0P 1X0, Canada.	geoffrey.r.williams@gmail.com	Williams, Geoffrey/C-9637-2015	Williams, Geoffrey/0000-0002-0093-1126	Natural Sciences and Engineering Research Council of Canada (NSERC) postgraduate scholarship; NSERC Discovery Grant; Bayer CropScience	Natural Sciences and Engineering Research Council of Canada (NSERC) postgraduate scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Bayer CropScience(Bayer AG)	This research was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) postgraduate scholarship to G.R.W. and a NSERC Discovery Grant to D.S. Additional financial assistance was provided by Bayer CropScience for consumable expenses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Aufauvre J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00326; BAILEY L, 1983, ANN APPL BIOL, V103, P13, DOI 10.1111/j.1744-7348.1983.tb02735.x; Botias C, 2012, J INVERTEBR PATHOL, V110, P108, DOI 10.1016/j.jip.2012.02.014; Bromenshenk JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013181; Burgher-MacLellan KL, 2010, CAN ENTOMOL, V142, P271, DOI 10.4039/n10-010; CANTWELL G E, 1970, American Bee Journal, V110, P222; Chaimanee V, 2012, J INSECT PHYSIOL, V58, P1090, DOI 10.1016/j.jinsphys.2012.04.016; Chaimanee V, 2010, J INVERTEBR PATHOL, V105, P207, DOI 10.1016/j.jip.2010.06.005; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Chen YP, 2009, J INVERTEBR PATHOL, V101, P204, DOI 10.1016/j.jip.2009.05.012; Chen YP, 2009, J EUKARYOT MICROBIOL, V56, P142, DOI 10.1111/j.1550-7408.2008.00374.x; Chen YW, 2012, J INVERTEBR PATHOL, V111, P264, DOI 10.1016/j.jip.2012.08.014; Copley TR, 2012, APIDOLOGIE, V43, P753, DOI 10.1007/s13592-012-0147-8; Costa C, 2011, J INVERTEBR PATHOL, V108, P224, DOI 10.1016/j.jip.2011.08.012; Crawley MJ, 2009, STAT INTRO USING R A; Dussaubat C, 2013, VET MICROBIOL, V162, P670, DOI 10.1016/j.vetmic.2012.09.012; Dussaubat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037017; Forsgren E, 2010, VET PARASITOL, V170, P212, DOI 10.1016/j.vetpar.2010.02.010; Fries I, 2006, J APICULT RES, V45, P230; FRIES I, 1993, BEE WORLD, V74, P5, DOI 10.1080/0005772X.1993.11099149; Fries I, 1996, EUR J PROTISTOL, V32, P356, DOI 10.1016/S0932-4739(96)80059-9; FRIES I, 1988, APIDOLOGIE, V19, P319, DOI 10.1051/apido:19880310; Fries I, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.14; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Gisder S, 2010, APPL ENVIRON MICROB, V76, P3032, DOI 10.1128/AEM.03097-09; Guzman-Novoa E, 2010, APIDOLOGIE, V41, P443, DOI 10.1051/apido/2009076; Higes M, 2006, J INVERTEBR PATHOL, V92, P93, DOI 10.1016/j.jip.2006.02.005; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2008, J INVERTEBR PATHOL, V97, P76, DOI 10.1016/j.jip.2007.06.002; Higes M, 2007, J INVERTEBR PATHOL, V94, P211, DOI 10.1016/j.jip.2006.11.001; Higes M, 2009, J APICULT RES, V48, P217, DOI 10.3896/IBRA.1.48.3.12; Huang WF, 2007, APIDOLOGIE, V38, P30, DOI 10.1051/apido:2006054; Huang WF, 2013, J INVERTEBR PATHOL, V113, P35, DOI 10.1016/j.jip.2013.01.001; Invernizzi C, 2009, J INVERTEBR PATHOL, V101, P150, DOI 10.1016/j.jip.2009.03.006; Medici SK, 2012, PARASITOL RES, V110, P859, DOI 10.1007/s00436-011-2566-2; Klee J, 2006, J INVERTEBR PATHOL, V91, P98, DOI 10.1016/j.jip.2005.10.012; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kraus B, 1997, NATURWISSENSCHAFTEN, V84, P217, DOI 10.1007/s001140050382; Kyriazakis I, 1998, ANIM BEHAV, V56, P265, DOI 10.1006/anbe.1998.0761; Martin-Hernandez R, 2007, APPL ENVIRON MICROB, V73, P6331, DOI 10.1128/AEM.00270-07; Martin-Hernandez R, 2012, ENVIRON MICROBIOL, V14, P2127, DOI 10.1111/j.1462-2920.2011.02645.x; Martin-Hernandez R, 2011, PARASITOL RES, V109, P605, DOI 10.1007/s00436-011-2292-9; Mayack C, 2010, J INSECT PHYSIOL, V56, P1572, DOI 10.1016/j.jinsphys.2010.05.016; Mayack C, 2009, J INVERTEBR PATHOL, V100, P185, DOI 10.1016/j.jip.2008.12.001; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Paxton RJ, 2007, APIDOLOGIE, V38, P558, DOI 10.1051/apido:2007037; Pettis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070182; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Poulin R., 2006, EVOLUTIONARY ECOLOGY; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Solter LF, 2002, J INVERTEBR PATHOL, V81, P103, DOI 10.1016/S0022-2011(02)00155-6; Tay WT, 2005, J EUKARYOT MICROBIOL, V52, P505, DOI 10.1111/j.1550-7408.2005.00057.x; Traver BE, 2011, J INVERTEBR PATHOL, V107, P43, DOI 10.1016/j.jip.2011.02.003; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Villa JD, 2013, APIDOLOGIE, V44, P511, DOI 10.1007/s13592-013-0201-1; Williams GR, 2008, J INVERTEBR PATHOL, V99, P342, DOI 10.1016/j.jip.2008.04.005; Williams GR, 2008, J INVERTEBR PATHOL, V97, P189, DOI 10.1016/j.jip.2007.08.005; Williams GR, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.04; Williams GR, 2011, APIDOLOGIE, V42, P15, DOI 10.1051/apido/2010030; Williams GR, 2010, CAN ENTOMOL, V142, P584, DOI 10.4039/n10-029; Williams GR, 2010, BIOESSAYS, V32, P845, DOI 10.1002/bies.201000075; Williams GR, 2010, J INVERTEBR PATHOL, V104, P4, DOI 10.1016/j.jip.2010.01.009; Winston M., 1987, The biology of the honey bee.	67	52	53	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e99465	10.1371/journal.pone.0099465	http://dx.doi.org/10.1371/journal.pone.0099465			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987989	Green Submitted, Green Published, gold			2022-12-27	WOS:000341354100013
J	Zhang, YQ; Wang, XM; Wu, AL; Ren, Y				Zhang, Yu-Qu; Wang, Xu-Mei; Wu, A-Li; Ren, Yi			Merging Fargesia dracocephala into Fargesia decurvata (Bambusoideae, Poaceae): Implications from Morphological and ITS Sequence Analyses	PLOS ONE			English	Article							THAMNOCALAMUS GROUP; ALLIES GRAMINEAE; EVOLUTION; GENE	Aims: Fargesia decurvata is closely allied with F. dracocephala and differs in 5 major characters (i.e. the culm sheath blade base shape, the width of the culm sheath blade base, the auricle shape, and the lower surface of leaf blade) in Fargesia. It is difficult to distinguish these two species because of existing of transitional statements of characters. The aims of this paper are to (i) investigate whether the variation of the characters is continuous or not; (ii) reveal whether the publishment of F. dracocephala was the result of discontinuous sampling of F. decurvata or not. Methods: Ten populations of F. decurvata and F. dracocephala were investigated in their entire distribution (including type localities). The statements of 5 major characters were measured from 693 annual and 693 perennial culms of 231 individuals in 10 populations, and analyzed at population, individual and culm levels. UPGMA cluster analysis was carried out based on 29 characters from 10 populations of F. decurvata and F. dracocephala and 2 populations of F. qinlingensis as outgroup. The ITS sequences were also sequenced and analyzed. Important Findings: Five major characters exhibited great variation not only at population level, but at individual level within a population, even the culm level within an individual and in different parts of the same culm. Cluster analyses showed that 10 populations of F. decurvata and F. dracocephala were not divided into two species, but they were well separated with outgroup. There was no difference in floral organ between F. decurvata and F. dracocephala. MP and NJ trees based on ITS sequences showed the same results with the cluster analysis on morphological characters. All the facts indicated that the publishment of F. dracocephala was the result of discontinuous sampling of F. decurvata, and F. dracocephala should be treated as the synonym of F. decurvata.	[Zhang, Yu-Qu; Ren, Yi] Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China; [Wang, Xu-Mei] Xi An Jiao Tong Univ, Sch Pharm, Xian 710049, Peoples R China; [Wu, A-Li] Shaanxi Changqing Natl Nat Reserve, Huayang, Peoples R China	Shaanxi Normal University; Xi'an Jiaotong University	Ren, Y (corresponding author), Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China.	renyi@snnu.edu.cn		zhang, Yuqu/0000-0003-1517-9229	Giant Panda International Cooperation Project of the State Forestry Administration of China [WH0630]	Giant Panda International Cooperation Project of the State Forestry Administration of China	Funding came from the Giant Panda International Cooperation Project of the State Forestry Administration of China (WH0630). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; BARBER HN, 1955, EVOLUTION, V9, P1, DOI 10.2307/2405353; Chen JK, 1986, J WUHAN BOT RES, V4, P377; Davis PH, 1963, PRINCIPLES ANGIOSPER; Doyle J. J., 1987, PHYTOCHEM B, P11; Gallego MT, 2005, NOVA HEDWIGIA, V80, P301, DOI 10.1127/0029-5035/2005/0080-0301; Grang V, 1985, EVOLUTIONARY PROCESS; Guo ZH, 2002, MOL PHYLOGENET EVOL, V22, P20, DOI 10.1006/mpev.2001.1039; Guo ZH, 2004, MOL PHYLOGENET EVOL, V30, P1, DOI 10.1016/S1055-7903(03)00161-1; Guo ZH, 2001, J PLANT RES, V114, P315, DOI 10.1007/PL00013993; Harper JL, 1982, PLANT COMMUNITY WORK, P11; HEYWOOD V. H., 1959, SYST ASS PUBLICATION, V3, P87; Hinchliff CE, 2009, AM J BOT, V96, P1487, DOI 10.3732/ajb.0800252; Hodkinson TR, 2000, J PLANT RES, V113, P259, DOI 10.1007/PL00013936; Hsu PS, 1986, GUANGXI FLORA, V6, P201; Hsu PS, 1987, B BOT RES, V7, P81; Keng PC, 1989, J BAMB RES, V8, P17; Keng PC, 1982, J BAMBOO RES, V1, P1; Kosnar J, 2010, AM J BOT, V97, P1229, DOI 10.3732/ajb.1000029; Kumar M, 2011, AFR J BIOTECHNOL, V10, P4532; Lai GH, 1999, J WUHAN BOT RES, V17, P319; Lai GH, 2001, B BOT RES, V21, P182; Li DZ, 2006, FLORA CHINA, V22, P74; Lu JL, 1981, J HENAN COLL AGR, V74, P70; MAYR E., 1942, Systematics and the origin of species from the viewpoint of a zoologist.; Mayr E., 1982, GROWTH BIOL THOUGHT; Munro W., 1868, T LINNEAN SOC LONDON, V26, P1, DOI DOI 10.1111/J.1096-3642.1968.TB00502.X; NOOTEBOOM HP, 1992, TAXON, V41, P318, DOI 10.2307/1222338; Renvoize SA, 1997, LINNEAN SOC, P95; Roalson EH, 2000, SYST BOT, V25, P323, DOI 10.2307/2666645; Ruiz-Sanchez E, 2011, TAXON, V60, P89, DOI 10.1002/tax.601008; Stapleton CMA, 1997, LINNEAN SOC, P251; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang YC, 1989, ACTA PHYTOTAXONOMICA, V27, P81; Tarciso VP, 2011, BRITT, V63, P102; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Xiang QY, 1989, B BOT RES, V9, P125; Yang ZY, 2007, PHYTOMEDICINE, V14, P416, DOI 10.1016/j.phymed.2007.04.009; Yano O, 2004, J PLANT RES, V117, P409, DOI 10.1007/s10265-004-0173-3; Yi T. P., 1985, Journal of Bamboo Research, V4, P20; Yi TP, 1990, J BAMB RES, V9, P27; Yi TP, 1996, FLORA REIPUBLICAE PO, V9, P387; Yi TP, 1985, B BOT RES, V5, P121	44	3	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101362	10.1371/journal.pone.0101362	http://dx.doi.org/10.1371/journal.pone.0101362			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988081	gold, Green Published, Green Submitted			2022-12-27	WOS:000341354100078
J	Bublitz, DC; Wright, PC; Bodager, JR; Rasambainarivo, FT; Bliska, JB; Gillespie, TR				Bublitz, DeAnna C.; Wright, Patricia C.; Bodager, Jonathan R.; Rasambainarivo, Fidisoa T.; Bliska, James B.; Gillespie, Thomas R.			Epidemiology of Pathogenic Enterobacteria in Humans, Livestock, and Peridomestic Rodents in Rural Madagascar	PLOS ONE			English	Article							ENTEROTOXIGENIC ESCHERICHIA-COLI; POLYMERASE-CHAIN-REACTION; DEVELOPING-COUNTRIES; YERSINIA-PSEUDOTUBERCULOSIS; ANTIMICROBIAL RESISTANCE; BORNE TRANSMISSION; ENTERIC PATHOGENS; DIARRHEAL DISEASE; PCR DETECTION; HUMAN HEALTH	Background: Among the families of enteric bacteria are globally important diarrheal agents. Despite their potential for zoonotic and environmental transmission, few studies have examined the epidemiology of these pathogens in rural systems characterized by extensive overlap among humans, domesticated and peridomestic animals. We investigated patterns of infection with Enterotoxigenic Escherichia coli, Shigella spp., Salmonella enterica, Vibrio cholerae, and Yersinia spp. (enterocolitica, and pseudotuberculosis) in Southeastern Madagascar where the potential for the aforementioned interactions is high. In this pilot project we conducted surveys to examine behaviors potentially associated with risk of infection and if infection with specific enterobacteria species was associated with diarrheal disease. Methodology/Principal Findings: PCR was conducted on DNA from human, livestock, and rodent fecal samples from three villages. Overall, human prevalence was highest (77%), followed by rodents (51%) and livestock (18%). Rodents were similar to 2.8 times more likely than livestock to carry one of the bacteria. The incidence of individual species varied between villages, with the observation that, E. coli and Shigella spp. were consistently associated with co-infections. As an aggregate, there was a significant risk of infection linked to a water source in one village. Individually, different pathogens were associated with certain behaviors, including: those who had used medication, experienced diarrhea in the past four weeks, or do not use toilets. Conclusions/Significance: Different bacteria were associated with an elevated risk of infection for various human activities or characteristics. Certain bacteria may also predispose people to co-infections. These data suggest that a high potential for transmission among these groups, either directly or via contaminated water sources. As these bacteria were most prevalent in humans, it is possible that they are maintained in humans and that transmission to other species is infrequent. Further studies are needed to understand bacterial persistence, transmission dynamics, and associated consequences in this and similar systems.	[Bublitz, DeAnna C.; Wright, Patricia C.; Rasambainarivo, Fidisoa T.; Bliska, James B.; Gillespie, Thomas R.] Ctr ValBio, Ranomafana, Madagascar; [Bublitz, DeAnna C.; Bliska, James B.] SUNY Stony Brook, Ctr Infect Dis, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Wright, Patricia C.] SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA; [Bodager, Jonathan R.; Gillespie, Thomas R.] Emory Univ, Dept Environm Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Gillespie, Thomas R.] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA; [Gillespie, Thomas R.] Emory Univ, Program Populat Biol Ecol & Evolut, Atlanta, GA 30322 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Emory University; Rollins School Public Health; Emory University; Emory University	Gillespie, TR (corresponding author), Ctr ValBio, Ranomafana, Madagascar.	thomas.gillespie@emory.edu	Rasambainarivo, Fidisoa/AAJ-5285-2021; Gillespie, Thomas R/A-5132-2010	Gillespie, Thomas R/0000-0002-7901-7248; Bublitz, DeAnna/0000-0003-3419-2103; Rasambainarivo, Fidisoa/0000-0002-7744-9477	Jim and Robin Herrnstein Foundation; Stony Brook University; Emory University Global Health Institute; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [T32AI007539]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007539] Funding Source: NIH RePORTER	Jim and Robin Herrnstein Foundation; Stony Brook University; Emory University Global Health Institute; National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Jim and Robin Herrnstein Foundation, Stony Brook University, and the Emory University Global Health Institute. Research reported in this publication that was performed by DeAnna Bublitz was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number T32AI007539 (awarded to James Bliska). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bronze MS, 2005, BIODEFENSE PRINCIPLE; Brunkard JM, 2014, CDC HLTH INFORM INT, P158; Calderon G, 1999, EMERG INFECT DIS, V5, P792, DOI 10.3201/eid0506.990608; Centers for Disease Control and Prevention, 1982, MMWR-MORBID MORTAL W, P562; Chanteau S, 2000, MICROBES INFECT, V2, P25, DOI 10.1016/S1286-4579(00)00289-6; Chapman PA, 1996, J MED MICROBIOL, V44, P267, DOI 10.1099/00222615-44-4-267; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Chouikha I, 2012, CURR OPIN MICROBIOL, V15, P239, DOI 10.1016/j.mib.2012.02.003; COHEN D, 1989, J CLIN MICROBIOL, V27, P162, DOI 10.1128/JCM.27.1.162-167.1989; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Daszak P, 2013, P NATL ACAD SCI USA, V110, P3681, DOI 10.1073/pnas.1201243109; Dearing MD, 2010, ANN NY ACAD SCI, V1195, P99, DOI 10.1111/j.1749-6632.2010.05452.x; Family and Community Health Unit Water Sanitation and Health Unit and WHO, 2013, WAT REL DIS; Ganzhorn JU, 2001, ORYX, V35, P346, DOI 10.1046/j.1365-3008.2001.00201.x; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gaudio PA, 1997, J INFECT DIS, V176, P1013, DOI 10.1086/516531; Gillespie TR, 2005, J APPL ECOL, V42, P699, DOI 10.1111/j.1365-2664.2005.01049.x; Gillespie TR, 2005, J PARASITOL, V91, P569, DOI 10.1645/GE-434R; GOMES TAT, 1991, J INFECT DIS, V164, P331, DOI 10.1093/infdis/164.2.331; GOODMAN SM, 1995, CONSERV BIOL, V9, P450, DOI 10.1046/j.1523-1739.1995.9020450.x; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Hale CR, 2012, CLIN INFECT DIS, V54, pS472, DOI 10.1093/cid/cis051; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Harris JB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000221; Hart CA, 1998, BRIT MED J, V317, P647, DOI 10.1136/bmj.317.7159.647; Hinnebusch BJ, 2005, CURR ISSUES MOL BIOL, V7, P197, DOI 10.21775/cimb.007.197; Johansson E, 2009, DIARRHOEA WHY CHILDR; Johnston AR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000683; Junge RE, 2011, AM J PRIMATOL, V73, P632, DOI 10.1002/ajp.20938; Katakweba AAS, 2012, AFR ZOOL, V47, P119, DOI 10.3377/004.047.0112; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Laudisoit A, 2007, EMERG INFECT DIS, V13, P687, DOI 10.3201/eid1305.061084; Lindsay B, 2011, EMERG INFECT DIS, V17, P606, DOI 10.3201/eid1704.100939; Lohmus M, 2013, J WILDLIFE DIS, V49, P747, DOI 10.7589/2013-02-028; Meerburg BG, 2009, CRIT REV MICROBIOL, V35, P221, DOI 10.1080/10408410902989837; Mills J. N., 1995, METHODS TRAPPING SAM; Mills James N., 2006, BIODIVERSITY-OTTAWA, V7, P9; Nair GB, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-4; Nuorti JP, 2004, J INFECT DIS, V189, P766, DOI 10.1086/381766; Okeke IN, 2007, EMERG INFECT DIS, V13, P1640, DOI 10.3201/eid1311.070674; Perron GG, 2007, INFECT GENET EVOL, V7, P223, DOI 10.1016/j.meegid.2006.09.003; Pruss-Ustun A., 2008, SAFER WATER BETTER H; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Qadri F, 2007, INFECT IMMUN, V75, P3961, DOI 10.1128/IAI.00459-07; Rabinowitz P, 2013, ANNU REV PUBL HEALTH, V34, P189, DOI 10.1146/annurev-publhealth-031912-114426; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; RAHN K, 1992, MOL CELL PROBE, V6, P271, DOI 10.1016/0890-8508(92)90002-F; Randremanana R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044533; Thoerner P, 2003, APPL ENVIRON MICROB, V69, P1810, DOI 10.1128/AEM.69.3.1810-1816.2003; van den Beld MJC, 2012, EUR J CLIN MICROBIOL, V31, P899, DOI 10.1007/s10096-011-1395-7; Wang RF, 1997, J APPL MICROBIOL, V83, P727, DOI 10.1046/j.1365-2672.1997.00300.x; WHO/DFID-AHP, 2013, MAD HLTH PROF; WHO/DFID-AHP, 2006, CONTR NEGL ZOON DIS; WHO/ UNICEF, 2000, GLOB WAT SUPPL SAN A; With KA, 2004, RISK ANAL, V24, P803, DOI 10.1111/j.0272-4332.2004.00480.x; World Health Organization DoMaHI, 2011, GLOB BURD DIS DEATH; Wright Patricia C., 1997, P381; Wright Patricia C., 1992, Evolutionary Anthropology, V1, P25, DOI 10.1002/evan.1360010108	58	16	17	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101456	10.1371/journal.pone.0101456	http://dx.doi.org/10.1371/journal.pone.0101456			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983990	gold, Green Submitted, Green Published			2022-12-27	WOS:000339635000110
J	Gomez-Ramos, A; Sanchez-Sanchez, R; Muhaisen, A; Rabano, A; Soriano, E; Avila, J				Gomez-Ramos, Alberto; Sanchez-Sanchez, Rafael; Muhaisen, Ashraf; Rabano, Alberto; Soriano, Eduardo; Avila, Jesus			Similarities and Differences between Exome Sequences Found in a Variety of Tissues from the Same Individual	PLOS ONE			English	Article							DETECTABLE CLONAL MOSAICISM; GENETIC-VARIATION; GENOME; DNA; MUTATIONS; CANCER; FRAMEWORK; DATABASE	DNA is the most stable nucleic acid and most important store of genetic information. DNA sequences are conserved in virtually all the cells of a multicellular organism. To analyze the sequences of various individuals with distinct pathological disorders, DNA is routinely isolated from blood, independently of the tissue that is the target of the disease. This approach has proven useful for the identification of familial diseases where mutations are present in parental germinal cells. With the capacity to compare DNA sequences from distinct tissues or cells, present technology can be used to study whether DNA sequences in tissues are invariant. Here we explored the presence of specific SNVs (Single Nucleotide Variations) in various tissues of the same individual. We tested for the presence of tissue-specific exonic SNVs, taking blood exome as a control. We analyzed the chromosomal location of these SNVs. The number of SNVs per chromosome was found not to depend on chromosome length, but mainly on the number of protein-coding genes per chromosome. Although similar but not identical patterns of chromosomal distribution of tissue-specific SNVs were found, clear differences were detected. This observation supports the notion that each tissue has a specific SNV exome signature.	[Gomez-Ramos, Alberto; Avila, Jesus] Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain; [Sanchez-Sanchez, Rafael] Hosp Univ Reina Sofia, IMIBIC, Cordoba, Spain; [Rabano, Alberto] Fdn CIEN, Vallecas, Spain; [Muhaisen, Ashraf; Soriano, Eduardo] Univ Barcelona, Dept Cell Biol, Barcelona, Spain; [Muhaisen, Ashraf; Soriano, Eduardo; Avila, Jesus] Inst Recerca Hosp Univ Vall dHebron VHIR, Barcelona, Spain; [Gomez-Ramos, Alberto; Muhaisen, Ashraf; Soriano, Eduardo; Avila, Jesus] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Hospital Universitario Reina Sofia - Cordoba; University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBERNED	Avila, J (corresponding author), Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain.	jesus.avila@cbm.csic.es	Soriano, Eduardo/AAB-3216-2019; Avila, Jesus/I-2610-2015; Gomez-Ramos, Alberto/K-3907-2014	Soriano, Eduardo/0000-0002-3204-9285; Avila, Jesus/0000-0002-6288-0571; Gomez-Ramos, Alberto/0000-0001-9502-9241; Sanchez-Sanchez, Rafael/0000-0002-9821-0211	BBVA Foundation; MICINN-MINECO; MICINNN-MINECO [BFU2008-3980, SAF2011-24841]	BBVA Foundation(BBVA Foundation); MICINN-MINECO; MICINNN-MINECO	This study was supported by the grants of BBVA Foundation and MICINN-MINECO. The authors would also like to acknowledge the help of Reina Sofia Foundation, the CIEN Foundation, CIBERNED (ISCIII), and grants BFU2008-3980 (ES) and SAF2011-24841 (JA) from MICINNN-MINECO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cech TR, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006742; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Eberwine J, 2014, NAT METHODS, V11, P25, DOI 10.1038/nmeth.2769; Frank SA, 2010, P NATL ACAD SCI USA, V107, P1725, DOI 10.1073/pnas.0909343106; Frumkin D, 2005, PLOS COMPUT BIOL, V1, P382, DOI 10.1371/journal.pcbi.0010050; Gottipati S, 2011, NAT GENET, V43, P741, DOI 10.1038/ng.877; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Linnarsson S, 2012, NAT METHODS, V9, P339, DOI 10.1038/nmeth.1934; Lupski JR, 2013, SCIENCE, V341, P358, DOI 10.1126/science.1239503; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Pagnamenta AT, 2012, J HUM GENET, V57, P70, DOI 10.1038/jhg.2011.128; Pelak K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001111; Pennisi E, 2012, SCIENCE, V336, P534, DOI 10.1126/science.336.6081.534; Podlesniy P, 2013, ANN NEUROL, V74, P655, DOI 10.1002/ana.23955; Sakharkar Meena Kishore, 2004, In Silico Biology, V4, P387; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shi YW, 2012, GENES BRAIN BEHAV, V11, P170, DOI 10.1111/j.1601-183X.2011.00756.x; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402	25	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101412	10.1371/journal.pone.0101412	http://dx.doi.org/10.1371/journal.pone.0101412			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984015	gold, Green Published			2022-12-27	WOS:000339635000101
J	Jia, ZJ; Sun, Y; Liu, SS; Liu, Y; Yang, TX				Jia, Zhanjun; Sun, Ying; Liu, Shanshan; Liu, Ying; Yang, Tianxin			COX-2 but Not mPGES-1 Contributes to Renal PGE2 Induction and Diabetic Proteinuria in Mice with Type-1 Diabetes	PLOS ONE			English	Article							PROSTAGLANDIN E-2 BIOSYNTHESIS; E SYNTHASE-1; OXIDATIVE STRESS; MESANGIAL CELLS; INHIBITION; RATS; STREPTOZOTOCIN; EXPRESSION; KIDNEY; NEPHROPATHY	Prostaglandin E2 (PGE2) has been implicated to play a pathogenic role in diabetic nephropathy (DN) but its source remains unlcear. To elucidate whether mPGES-1, the best characterized PGE2 synthase, was involved in the development of DN, we examined the renal phenotype of mPGES-1 KO mice subjected to STZ-induced type-1 diabetes. After STZ treatment, mPGES1 WT and KO mice presented the similar onset of diabetes as shown by similar elevation of blood glucose. Meanwhile, both genotypes of mice exhibited similar increases of urinary and renal PGE2 production. In parallel with this comparable diabetic status, the kidney injury indices including the urinary albumin excretion, kidney weight and the kidney histology (PAS staining) did not show any difference between the two genotypes. By Western-blotting and quantitative qRT-PCR, mPGES-1, mPGES-2, cPGES and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) remain unaltered following six weeks of diabetes. Finally, a selective COX-2 inhibitor celecoxib (50 mg/kg/day) was applied to the STZ-treated KO mice, which resulted in significant reduction of urinary albumin excretion (KO/STZ: 141.5+/-38.4 vs. KO/STZ + Celebrex: 48.7+/-20.8 ug/24 h, p<0.05) and the blockade of renal PGE2 induction (kidney: KO/STZ: 588.7+/-89.2 vs. KO/STZ + Celebrex: 340.8+/-58.7 ug/24 h, p<0.05; urine: KO/STZ 1667.6+/-421.4 vs. KO/STZ + Celebrex 813.6+/-199.9 pg/24 h, p<0.05), without affecting the blood glucose levels and urine volume. Taken together, our data suggests that an as yet unidentified prostaglanind E synthase but not mPGES-1 may couple with COX-2 to mediate increased renal PGE2 sythsesis in DN.	[Jia, Zhanjun; Sun, Ying; Liu, Shanshan; Liu, Ying; Yang, Tianxin] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; [Jia, Zhanjun; Sun, Ying; Liu, Shanshan; Liu, Ying; Yang, Tianxin] Vet Affairs Med Ctr, Salt Lake City, UT 84148 USA; [Yang, Tianxin] Sun Yat Sen Univ, Sch Med, Inst Hypertens, Guangzhou 510275, Guangdong, Peoples R China	Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA); Sun Yat Sen University	Yang, TX (corresponding author), Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA.	Tianxin.Yang@hsc.utah.edu		Sun, Ying/0000-0002-1720-8540	VA Merit Review; National Institutes of Health [DK079162]; National Natural Science Foundation of China [31330037]; American Heart Association [11SDG7480006]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079162] Funding Source: NIH RePORTER	VA Merit Review(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by VA Merit Review (T. Yang), National Institutes of Health Grant DK079162 (T. Yang), and National Natural Science Foundation of China Grant No. 31330037 (T. Yang), and an American Heart Association Scientist Develop Grant (11SDG7480006) to Z. Jia. T. Yang is an Established Investigator from American Heart Association and Research Career Scientist in Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breyer MD, 1996, J AM SOC NEPHROL, V7, P8; Chiasson JF, 2011, BIOORG MED CHEM LETT, V21, P1488, DOI 10.1016/j.bmcl.2011.01.006; CRAVEN PA, 1989, J LAB CLIN MED, V113, P674; DERUBERTIS FR, 1993, AM J KIDNEY DIS, V22, P727, DOI 10.1016/S0272-6386(12)80439-2; ENSOR CM, 1995, J LIPID MEDIAT CELL, V12, P313, DOI 10.1016/0929-7855(95)00040-W; Francois H, 2005, CELL METAB, V2, P201, DOI 10.1016/j.cmet.2005.08.005; GERRARD JM, 1980, J LAB CLIN MED, V95, P950; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; HOMMEL E, 1987, DIABETOLOGIA, V30, P78; Ishibashi R, 1999, KIDNEY INT, V56, P589, DOI 10.1046/j.1523-1755.1999.00566.x; Jania LA, 2009, PROSTAG OTH LIPID M, V88, P73, DOI 10.1016/j.prostaglandins.2008.10.003; Jia ZJ, 2008, HYPERTENSION, V52, P952, DOI 10.1161/HYPERTENSIONAHA.108.111229; Jia ZJ, 2006, CIRC RES, V99, P1243, DOI 10.1161/01.RES.0000251306.40546.08; Jia ZJ, 2011, KIDNEY INT, V79, P77, DOI 10.1038/ki.2010.331; Jia ZJ, 2010, AM J PHYSIOL-RENAL, V299, pF155, DOI 10.1152/ajprenal.90702.2008; Jia ZJ, 2010, HYPERTENSION, V55, P539, DOI 10.1161/HYPERTENSIONAHA.109.144840; Jia ZJ, 2009, AM J PHYSIOL-RENAL, V297, pF1689, DOI 10.1152/ajprenal.00117.2009; Komers R, 2007, CLIN EXP PHARMACOL P, V34, P36, DOI 10.1111/j.1440-1681.2007.04534.x; Korners R, 2001, J CLIN INVEST, V107, P889, DOI 10.1172/JCI10228; Kudo I, 2005, J BIOCHEM MOL BIOL, V38, P633; Lovgren AK, 2007, MOL CELL BIOL, V27, P4416, DOI 10.1128/MCB.02314-06; Makino H, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000019782.37851.BF; Mancini JA, 2001, J BIOL CHEM, V276, P4469, DOI 10.1074/jbc.M006865200; Mohamed R, 2013, LAB INVEST, V93, P933, DOI 10.1038/labinvest.2013.85; Moore AH, 2004, J NEUROIMMUNOL, V148, P32, DOI 10.1016/j.jneuroim.2003.11.001; Murakami M, 2003, J BIOL CHEM, V278, P37937, DOI 10.1074/jbc.M305108200; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Nakatani Y, 2007, BIOCHEM BIOPH RES CO, V362, P387, DOI 10.1016/j.bbrc.2007.07.180; Nasrallah R, 2007, AM J PHYSIOL-RENAL, V292, pF278, DOI 10.1152/ajprenal.00089.2006; Nasrallah R, 2009, AM J NEPHROL, V30, P346, DOI 10.1159/000229304; Paliege A, 2004, AM J PHYSIOL-RENAL, V287, pF152, DOI 10.1152/ajprenal.00287.2003; Parazzoli S, 2012, J BIOL CHEM, V287, P32246, DOI 10.1074/jbc.M112.364612; Quilley J, 2011, AM J PHYSIOL-HEART C, V300, pH2316, DOI 10.1152/ajpheart.01259.2010; SCHAMBELAN M, 1985, J CLIN INVEST, V75, P404, DOI 10.1172/JCI111714; Schneider A, 2004, KIDNEY INT, V65, P1205, DOI 10.1111/j.1523-1755.2004.00493.x; Soodvilai S, 2009, AM J PHYSIOL-RENAL, V296, pF1129, DOI 10.1152/ajprenal.90478.2008; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; Wang J, 2010, BIOORG MED CHEM LETT, V20, P1604, DOI 10.1016/j.bmcl.2010.01.060; WILLIAMS B, 1993, J CLIN INVEST, V92, P2889, DOI 10.1172/JCI116911; Xu DG, 2008, J PHARMACOL EXP THER, V326, P754, DOI 10.1124/jpet.108.138776	41	25	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e93182	10.1371/journal.pone.0093182	http://dx.doi.org/10.1371/journal.pone.0093182			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984018	Green Published, gold, Green Submitted			2022-12-27	WOS:000339635000001
J	Wells, C; Kolt, GS; Marshall, P; Hill, B; Bialocerkowski, A				Wells, Cherie; Kolt, Gregory S.; Marshall, Paul; Hill, Bridget; Bialocerkowski, Andrea			The Effectiveness of Pilates Exercise in People with Chronic Low Back Pain: A Systematic Review	PLOS ONE			English	Review							FUNCTIONAL DISABILITY; GENERAL EXERCISE; DELPHI SURVEY; PERSISTENT; OUTCOMES; THERAPY; TRIALS; MANAGEMENT; BURDEN	Objective: To evaluate the effectiveness of Pilates exercise in people with chronic low back pain (CLBP) through a systematic review of randomised controlled trials (RCTs). Data Sources: A search for RCTs was undertaken using Medical Search Terms and synonyms for "Pilates" and "low back pain" within the maximal date range of 10 databases. Databases included the Cumulative Index to Nursing and Allied Health Literature; Cochrane Library; Medline; Physiotherapy Evidence Database; ProQuest: Health and Medical Complete, Nursing and Allied Health Source, Dissertation and Theses; Scopus; Sport Discus; Web of Science. Study Selection: Two independent reviewers were involved in the selection of evidence. To be included, relevant RCTs needed to be published in the English language. From 152 studies, 14 RCTs were included. Data Extraction: Two independent reviewers appraised the methodological quality of RCTs using the McMaster Critical Review Form for Quantitative Studies. The author(s), year of publication, and details regarding participants, Pilates exercise, comparison treatments, and outcome measures, and findings, were then extracted. Data Synthesis: The methodological quality of RCTs ranged from "poor" to "excellent". A meta-analysis of RCTs was not undertaken due to the heterogeneity of RCTs. Pilates exercise provided statistically significant improvements in pain and functional ability compared to usual care and physical activity between 4 and 15 weeks, but not at 24 weeks. There were no consistent statistically significant differences in improvements in pain and functional ability with Pilates exercise, massage therapy, or other forms of exercise at any time period. Conclusions: Pilates exercise offers greater improvements in pain and functional ability compared to usual care and physical activity in the short term. Pilates exercise offers equivalent improvements to massage therapy and other forms of exercise. Future research should explore optimal Pilates exercise designs, and whether some people with CLBP may benefit from Pilates exercise more than others.	[Wells, Cherie] Univ Canberra, Fac Hlth, Bruce, ACT, Australia; [Wells, Cherie; Kolt, Gregory S.; Marshall, Paul] Univ Western Sydney, Sch Sci & Hlth, Campbelltown, NSW, Australia; [Hill, Bridget] Epworth HealthCare, Richmond, Vic, Australia; [Bialocerkowski, Andrea] Griffith Univ, Griffith Hlth Inst, Gold Coast, Qld, Australia	University of Canberra; Western Sydney University; Griffith University; Menzies Health Institute Queensland	Wells, C (corresponding author), Univ Canberra, Fac Hlth, Bruce, ACT, Australia.	Cherie.Wells@canberra.edu.au	Kolt, Gregory/W-1342-2019	Kolt, Gregory/0000-0002-9223-3324; Hill, Bridget/0000-0002-8632-094X; Wells, Cherie/0000-0002-4424-1207				Aladro-Gonzalvo AR, 2013, J BODYW MOV THER, V17, P125, DOI 10.1016/j.jbmt.2012.08.003; Anderson B, 2005, THESIS U MIAMI MIAMI; Australian Government: National Health Medical Research Council (NHMRC), 2009, NHMRC ADD LEV EV GRA; Borges J, 2014, J BODYW MOV THER, V18, P68, DOI 10.1016/j.jbmt.2013.05.010; Brennan S, 2008, PHYS THER REV, V13, P212; Brooks C, 2012, SPINE, V37, pE1543, DOI 10.1097/BRS.0b013e31826feac0; Chapman JR, 2011, SPINE, V36, pS54, DOI 10.1097/BRS.0b013e31822ef74d; Colle F, 2002, ARCH PHYS MED REHAB, V83, P1745, DOI 10.1053/apmr.2002.35657; Collins J, HUM REPROD UPDATE, V11, P103; Cook DJ, 1997, ANN INTERN MED, V126, P376, DOI 10.7326/0003-4819-126-5-199703010-00006; Costa LOP, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD010265, DOI 10.1002/14651858.CD010265]; da Fonseca JL, 2009, J SPORT REHABIL, V18, P269, DOI 10.1123/jsr.18.2.269; Da Luz MA, 2014, PHYS THER, V94, P623, DOI 10.2522/ptj.20130277; Dagenais S, 2008, SPINE J, V8, P8, DOI 10.1016/j.spinee.2007.10.005; Daly AE, 2009, EUR J PAIN, V13, P339, DOI 10.1016/j.ejpain.2008.05.003; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Edmond-Charlton, 2005, CHAPTER 12 SEX GENDE; Fletcher J, 2007, BMJ-BRIT MED J, V334, P94, DOI 10.1136/bmj.39057.406644.68; Gagnon LH, 2005, EFFICACY PILATES EXE; Gladwell V, 2006, J SPORT REHABIL, V15, P338, DOI 10.1123/jsr.15.4.338; Hayden JA, 2005, ANN INTERN MED, V142, P776, DOI 10.7326/0003-4819-142-9-200505030-00014; Herbert R., 2013, CONFIDENCE INTERVAL; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hopewell S, 2008, LANCET, V371, P281, DOI 10.1016/S0140-6736(07)61835-2; Hoy D, 2010, BEST PRACT RES CL RH, V24, P155, DOI 10.1016/j.berh.2009.11.002; Kamper SJ, 2014, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000335.PUB2; Katrak Persis, 2004, BMC Med Res Methodol, V4, P22, DOI 10.1186/1471-2288-4-22; Kawanishi CY, 2011, REV TERAPIA MANUAL, V9, P410; Kunz R, 2007, COCHRANE DB SYST REV, V2; La Touche R, 2008, J BODYW MOV THER, V12, P364, DOI 10.1016/j.jbmt.2007.11.004; Latey P, 2001, J BODYWMOV THER, V5, P275, DOI DOI 10.1054/JBMT.2001.0237; Law M, 1998, EVIDENCE BASED REHAB; Lekkas P, 2007, AUST J PHYSIOTHER, V53, P19, DOI 10.1016/S0004-9514(07)70058-2; Lim ECW, 2011, J ORTHOP SPORT PHYS, V41, P70, DOI 10.2519/jospt.2011.3393; Macedo LG, 2009, PHYS THER, V89, P9, DOI 10.2522/ptj.20080103; MacIntyre L, 2006, THESIS U WITWATERSRA; Marshall PWM, 2013, SPINE, V38, pE952, DOI 10.1097/BRS.0b013e318297c1e5; Miyamoto GC, 2013, BRAZ J PHYS THER, V17, P517, DOI 10.1590/S1413-35552012005000127; Miyamoto GC, 2013, PHYS THER, V93, P310, DOI 10.2522/ptj.20120190; Montero-Camara J., 2013, FISIOTERAPIA, V35, P206, DOI [10.1016/j.ft.2012.10.004, DOI 10.1016/J.FT.2012.10.004]; Noordzij M, 2010, NEPHROL DIAL TRANSPL, V25, P1388, DOI 10.1093/ndt/gfp732; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Ostelo RWJG, 2005, BEST PRACT RES CL RH, V19, P593, DOI 10.1016/j.berh.2005.03.003; Pereira LM, 2012, CLIN REHABIL, V26, P10, DOI 10.1177/0269215511411113; Pillastrini P, 2012, JOINT BONE SPINE, V79, P176, DOI 10.1016/j.jbspin.2011.03.019; Posadzki Paul, 2011, Complement Ther Clin Pract, V17, P85, DOI 10.1016/j.ctcp.2010.09.005; Quinn J, 2005, THESIS FLORIDA ATLAN; Quinn K, 2011, PHYSIOTHERAPY IRELAN, V32, P5; Rajpal N, 2008, PHYSIOTHERAPY OCCUPA, V1, P33; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Rydeard RA, 2001, THESIS QUEENS U KING; Rydeard R, 2006, J ORTHOP SPORT PHYS, V36, P472, DOI 10.2519/jospt.2006.2144; Schabrun SM, 2009, CLIN REHABIL, V23, P27, DOI 10.1177/0269215508098897; Stolze LR, 2012, J ORTHOP SPORT PHYS, V42, P425, DOI 10.2519/jospt.2012.3826; The Cochrane Collaboration, 2012, REV MAN REVMAN VERS; van Tulder M, 2007, SPINE, V32, P1785, DOI 10.1097/BRS.0b013e3180b9ef49; Viera AJ, 2005, FAM MED, V37, P360; Wajswelner H, 2012, MED SCI SPORT EXER, V44, P1197, DOI 10.1249/MSS.0b013e318248f665; Wells C, 2014, PHYS THER, V94, P806, DOI 10.2522/ptj.20130568; Wells C, 2014, PHYS THER, V94, P792, DOI 10.2522/ptj.20130030; Wells C, 2012, COMPLEMENT THER MED, V20, P253, DOI 10.1016/j.ctim.2012.02.005; Welss C, 2013, BMC MED RES METHODOL, V19, P13, DOI DOI 10.1186/1471-2288-13-7; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; Zeada MA, 2011, OVIDIUS U ANN SERIES, V12, P41	64	65	67	2	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100402	10.1371/journal.pone.0100402	http://dx.doi.org/10.1371/journal.pone.0100402			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984069	Green Published, gold			2022-12-27	WOS:000339635000022
J	Badding, MA; Fix, NR; Antonini, JM; Leonard, SS				Badding, Melissa A.; Fix, Natalie R.; Antonini, James M.; Leonard, Stephen S.			A Comparison of Cytotoxicity and Oxidative Stress from Welding Fumes Generated with a New Nickel-, Copper-Based Consumable versus Mild and Stainless Steel-Based Welding in RAW 264.7 Mouse Macrophages	PLOS ONE			English	Article							DIESEL EXHAUST PARTICLES; ELECTRON-SPIN-RESONANCE; TUMOR SUSCEPTIBLE A/J; SHORT-TERM INHALATION; DNA-DAMAGE; IN-VITRO; ALVEOLAR MACROPHAGES; PARTICULATE MATTER; LUNG INFLAMMATION; DEFENSE RESPONSES	Welding processes that generate fumes containing toxic metals, such as hexavalent chromium (Cr(VI)), manganese (Mn), and nickel (Ni), have been implicated in lung injury, inflammation, and lung tumor promotion in animal models. While federal regulations have reduced permissible worker exposure limits to Cr(VI), this is not always practical considering that welders may work in confined spaces and exhaust ventilation may be ineffective. Thus, there has been a recent initiative to minimize the potentially hazardous components in welding materials by developing new consumables containing much less Cr(VI) and Mn. A new nickel (Ni) and copper (Cu)-based material (Ni-Cu WF) is being suggested as a safer alternative to stainless steel consumables; however, its adverse cellular effects have not been studied. This study compared the cytotoxic effects of the newly developed Ni-Cu WF with two well-characterized welding fumes, collected from gas metal arc welding using mild steel (GMA-MS) or stainless steel (GMA-SS) electrodes. RAW 264.7 mouse macrophages were exposed to the three welding fumes at two doses (50 mg/ml and 250 mg/ml) for up to 24 hours. Cell viability, reactive oxygen species (ROS) production, phagocytic function, and cytokine production were examined. The GMA-MS and GMA-SS samples were found to be more reactive in terms of ROS production compared to the Ni-Cu WF. However, the fumes from this new material were more cytotoxic, inducing cell death and mitochondrial dysfunction at a lower dose. Additionally, pre-treatment with Ni-Cu WF particles impaired the ability of cells to phagocytize E. coli, suggesting macrophage dysfunction. Thus, the toxic cellular responses to welding fumes are largely due to the metal composition. The results also suggest that reducing Cr(VI) and Mn in the generated fume by increasing the concentration of other metals (e. g., Ni, Cu) may not necessarily improve welder safety.	[Badding, Melissa A.; Fix, Natalie R.; Antonini, James M.; Leonard, Stephen S.] NIOSH, Hlth Effects Lab Div, Morgantown, WV 26505 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Badding, MA (corresponding author), NIOSH, Hlth Effects Lab Div, Morgantown, WV 26505 USA.	wid5@cdc.gov		Badding, Melissa/0000-0001-8901-7105	NIOSH intramural National Occupational Research Agenda (NORA)	NIOSH intramural National Occupational Research Agenda (NORA)	This work was supported by a NIOSH intramural National Occupational Research Agenda (NORA) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed M, 2010, BIOCHEM BIOPH RES CO, V396, P578, DOI 10.1016/j.bbrc.2010.04.156; Antonini JM, 2007, J IMMUNOTOXICOL, V4, P117, DOI 10.1080/15476910701336953; Antonini JM, 2007, TOXICOL APPL PHARM, V223, P234, DOI 10.1016/j.taap.2007.06.020; Antonini JM, 2006, NEUROTOXICOLOGY, V27, P304, DOI 10.1016/j.neuro.2005.09.001; Antonini JM, 2013, ANN OCCUP HYG, V57, P1167, DOI 10.1093/annhyg/met032; Antonini JM, 2012, J IMMUNOTOXICOL, V9, P184, DOI 10.3109/1547691X.2011.650733; Antonini JM, 2011, ARCH TOXICOL, V85, P487, DOI 10.1007/s00204-010-0601-1; Antonini JM, 2009, INHAL TOXICOL, V21, P182, DOI 10.1080/08958370802360661 ; Antonini JM, 2005, MOL CELL BIOCHEM, V279, P17, DOI 10.1007/s11010-005-8211-6; Antonini JM, 2004, J TOXICOL ENV HEAL A, V67, P233, DOI 10.1080/15287390490266909; Antonini JM, 2003, AM J IND MED, V43, P350, DOI 10.1002/ajim.10194; Antonini JM, 1997, EXP LUNG RES, V23, P205, DOI 10.3109/01902149709087368; Antonini JM, 1998, TOXICOL LETT, V98, P77, DOI 10.1016/S0378-4274(98)00103-9; Antonini JM, 1996, TOXICOL APPL PHARM, V140, P188, DOI 10.1006/taap.1996.0212; Antonini JM, 1999, J TOXICOL ENV HEAL A, V58, P343, DOI 10.1080/009841099157205; Becker N, 1999, J OCCUP ENVIRON MED, V41, P294, DOI 10.1097/00043764-199904000-00012; Capasso L, 2014, TOXICOL LETT; Contreras GR, 1997, OCCUP ENVIRON MED, V54, P836, DOI 10.1136/oem.54.11.836; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Dreher KL, 1997, J TOXICOL ENV HEALTH, V50, P285, DOI 10.1080/009841097160492; Erdely A, 2011, TOXICOLOGY, V287, P153, DOI 10.1016/j.tox.2011.06.008; Erdely A, 2011, TOXICOL LETT, V204, P12, DOI 10.1016/j.toxlet.2011.03.030; Fahmy B, 2009, TOXICOL IN VITRO, V23, P1365, DOI 10.1016/j.tiv.2009.08.005; FAIRBAIRN DW, 1995, MUTAT RES-REV GENET, V339, P37, DOI 10.1016/0165-1110(94)00013-3; Gurr JR, 2005, TOXICOLOGY, V213, P66, DOI 10.1016/j.tox.2005.05.007; Halatek Tadeusz, 2005, International Journal of Occupational Medicine and Environmental Health, V18, P265; Halliwell B., 2007, FREE RADICALS BIOL M; Han JY, 2001, FREE RADICAL BIO MED, V30, P516, DOI 10.1016/S0891-5849(00)00501-3; Hannu T, 2005, EUR RESPIR J, V26, P736, DOI 10.1183/09031936.05.00130504; HANSEN K, 1983, ENVIRON HEALTH PERSP, V51, P223, DOI 10.2307/3429753; HANSEN K, 1984, IARC SCI PUBL, P193; Henderson L, 1998, MUTAGENESIS, V13, P89, DOI 10.1093/mutage/13.1.89; HOOFTMAN RN, 1988, ANN OCCUP HYG, V32, P95, DOI 10.1093/annhyg/32.1.95; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; KASPRZAK KS, 1989, CANCER RES, V49, P5964; Kawanishi S, 2001, FREE RADICAL BIO MED, V31, P108, DOI 10.1016/S0891-5849(01)00558-5; Leonard SS, 2004, FREE RADICAL BIO MED, V37, P1921, DOI 10.1016/j.freeradbiomed.2004.09.010; Leonard SS, 2003, BIOCHEM BIOPH RES CO, V309, P1017, DOI 10.1016/j.bbrc.2003.08.105; Leonard SS, 2004, MOL CELL BIOCHEM, V255, P171, DOI 10.1023/B:MCBI.0000007273.23747.67; Leonard SS, 2002, MOL CELL BIOCHEM, V234, P309, DOI 10.1023/A:1015917922980; Leonard SS, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-32; Leonard SS, 2010, J FOOD SCI, V75, pC14, DOI 10.1111/j.1750-3841.2009.01394.x; Lundborg M, 2006, ENVIRON RES, V100, P197, DOI 10.1016/j.envres.2005.08.007; Modis K, 2012, BIOCHEM PHARMACOL, V83, P633, DOI 10.1016/j.bcp.2011.12.014; Moulin JJ, 1997, SCAND J WORK ENV HEA, V23, P104, DOI 10.5271/sjweh.187; Msiska Z, 2010, AM J RESP CELL MOL, V43, P210, DOI 10.1165/rcmb.2009-0062OC; NIOSH, 2010, 7605 NIOSH; NIOSH, 1994, US DEP HLTH HUM PUBL, V98-119; OSTLING O, 1984, BIOCHEM BIOPH RES CO, V123, P291, DOI 10.1016/0006-291X(84)90411-X; Park EJ, 2008, TOXICOL LETT, V180, P222, DOI 10.1016/j.toxlet.2008.06.869; PRYOR WA, 1992, FREE RADICAL BIO MED, V13, P659; Renwick LC, 2001, TOXICOL APPL PHARM, V172, P119, DOI 10.1006/taap.2001.9128; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHUSTERMAN DJ, 1993, OCCUP MED, V8, P519; Sowards JW, 2011, WELD J, V90, p63S; Sriram K, 2010, FASEB J, V24, P4989, DOI 10.1096/fj.10-163964; Stefaniak AB, 2010, J OCCUP ENVIRON HYG, V7, P23, DOI 10.1080/15459620903349073; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; TKESHELASHVILI LK, 1993, CANCER RES, V53, P4172; Valavanidis A, 2008, J ENVIRON SCI HEAL C, V26, P339, DOI 10.1080/10590500802494538; Volke A, 2013, INT IMMUNOPHARMACOL, V15, P511, DOI 10.1016/j.intimp.2013.01.019; Ye JP, 1999, J BIOL CHEM, V274, P34974, DOI 10.1074/jbc.274.49.34974; Yin XJJ, 2007, J TOXICOL ENV HEAL A, V70, P820, DOI 10.1080/15287390701209766; Zeidler-Erdely PC, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-45; Zeidler-Erdely PC, 2011, INHAL TOXICOL, V23, P112, DOI 10.3109/08958378.2010.548838; Zeidler-Erdely PC, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-12; Zhang Z, 2001, MOL CELL BIOCHEM, V222, P77, DOI 10.1023/A:1017963307358; Zhou HW, 2007, AM J RESP CELL MOL, V36, P460, DOI 10.1165/rcmb.2006-0293OC	68	34	36	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101310	10.1371/journal.pone.0101310	http://dx.doi.org/10.1371/journal.pone.0101310			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977413	Green Submitted, Green Published, gold			2022-12-27	WOS:000338506400113
J	Yang, YM; Wang, QS; Chen, Q; Liao, RR; Zhang, XZ; Yang, HJ; Zheng, YM; Zhang, ZW; Pan, YC				Yang, Yumei; Wang, Qishan; Chen, Qiang; Liao, Rongrong; Zhang, Xiangzhe; Yang, Hongjie; Zheng, Youmin; Zhang, Zhiwu; Pan, Yuchun			A New Genotype Imputation Method with Tolerance to High Missing Rate and Rare Variants	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LINEAR MIXED MODELS; HERITABILITY; GENE; SNPS; INFERENCE; SELECTION; ACCURACY; CATTLE; PHASE	We report a novel algorithm, iBLUP, to impute missing genotypes by simultaneously and comprehensively using identity by descent and linkage disequilibrium information. The simulation studies showed that the algorithm exhibited drastically tolerance to high missing rate, especially for rare variants than other common imputation methods, e. g. BEAGLE and fastPHASE. At a missing rate of 70%, the accuracy of BEAGLE and fastPHASE dropped to 0.82 and 0.74 respectively while iBLUP retained an accuracy of 0.95. For minor allele, the accuracy of BEAGLE and fastPHASE decreased to -0.1 and 0.03, while iBLUP still had an accuracy of 0.61. We implemented the algorithm in a publicly available software package also named iBLUP. The application of iBLUP for processing real sequencing data in an outbred pig population was demonstrated.	[Yang, Yumei; Wang, Qishan; Chen, Qiang; Liao, Rongrong; Zhang, Xiangzhe; Pan, Yuchun] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China; [Yang, Hongjie; Zheng, Youmin] Natl Anim Husb Serv, Beijing, Peoples R China; [Zhang, Zhiwu] Cornell Univ, Inst Genom Div, Ithaca, NY 14850 USA; [Pan, Yuchun] Shanghai Key Lab Vet Biotechnol, Shanghai, Peoples R China; [Zhang, Zhiwu] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA	Shanghai Jiao Tong University; Cornell University; Washington State University	Zhang, ZW (corresponding author), Cornell Univ, Inst Genom Div, Ithaca, NY 14850 USA.	zhiwu.zhang@wsu.edu; panyc@sjtu.edu.cn	Zhang, zs/GXN-3521-2022; Zhang, Zhiwu/P-6156-2016	Zhang, Zhiwu/0000-0002-5784-9684	Ministry of Agriculture of China; National Natural Science Foundation of China [31370043, 31272414, 31101706]; National 948 Project of China [2012-Z26, 2011-G2A]	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 948 Project of China	This study was supported by the 2011-2012 animal germplasm resources conservation project from Ministry of Agriculture of China, the National Natural Science Foundation of China (grant no 31370043, 31272414, 31101706), and the National 948 Project of China (2012-Z26, 2011-G2A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral AJ, 2008, GENETICS, V179, P569, DOI 10.1534/genetics.107.084277; Andolfatto P, 2011, GENOME RES, V21, P610, DOI 10.1101/gr.115402.110; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Chen Q, 2013, PLOS ONE; Chen Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067500; CHURCH GM, 1988, SCIENCE, V240, P185, DOI 10.1126/science.3353714; Elsen Jean-Michel, 2012, BMC Proc, V6 Suppl 2, pS1, DOI 10.1186/1753-6561-6-S2-S1; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gengler N, 2007, ANIMAL, V1, P21, DOI 10.1017/S1751731107392628; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lin DY, 2008, AM J HUM GENET, V82, P444, DOI 10.1016/j.ajhg.2007.11.004; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/nmeth.1681, 10.1038/NMETH.1681]; Listgarten J, 2012, NAT METHODS, V9, P525, DOI 10.1038/nmeth.2037; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Mulder HA, 2010, ANIMAL, V4, P9, DOI 10.1017/S1751731109990838; Nicolae DL, 2006, GENET EPIDEMIOL, V30, P718, DOI 10.1002/gepi.20182; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Vingborg RKK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-134; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; Xu SZ, 2013, GENETICS, V195, P1209, DOI 10.1534/genetics.113.157032; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	36	20	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101025	10.1371/journal.pone.0101025	http://dx.doi.org/10.1371/journal.pone.0101025			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972110	Green Published, gold, Green Submitted			2022-12-27	WOS:000338512200085
J	Bhat, RK; Rudnick, W; Antony, JM; Maingat, F; Ellestad, KK; Wheatley, BM; Tonjes, RR; Power, C				Bhat, Rakesh K.; Rudnick, Wallis; Antony, Joseph M.; Maingat, Ferdinand; Ellestad, Kristofor K.; Wheatley, Blaise M.; Toenjes, Ralf R.; Power, Christopher			Human Endogenous Retrovirus-K(II) Envelope Induction Protects Neurons during HIV/AIDS	PLOS ONE			English	Article							K HERV-K; NEURAL CELL-LINES; MULTIPLE-SCLEROSIS; JAAGSIEKTE SHEEP; HIV-INFECTION; HUMAN GENOME; W ENV; EXPRESSION; VIRUS; GLYCOPROTEIN	Human endogenous retroviruses (HERVs) are differentially expressed depending on the cell type and physiological circumstances. HERV-K has been implicated in the pathogenesis of several diseases although the functional consequences of its expression remain unknown. Human immunodeficiency virus (HIV) infection causes neuroinflammation with neuronal damage and death. Herein, we investigated HERV-K(II)/(HML-2) envelope (Env) expression and its actions in the brain during HIV/AIDS. HERV-K(II) Env expression was assessed in healthy brain tissues, autopsied HIV HIV- infected (HIV+) and uninfected (HIV-) brains and in neural cell cultures by real time RT-PCR, massively parallel (deep) sequencing, immunoblotting and immunohistochemistry. Neuronal and neural stem cells expressing HERV-K(II) Env were analyzed in assays of host responses including cellular viability, immune responses and neurobehavioral outcomes. Deep sequencing of human brain transcriptomes disclosed that RNA sequences encoded by HERV-K were among the most abundant HERV sequences detected in human brain. Comparison of different cell types revealed that HERV-K(II) env RNA abundance was highest in cultured human neurons but was suppressed by epidermal growth factor exposure. HERV-K(II) Env immunoreactivity was increased in the cerebral cortex from persons with HIV/AIDS, principally localized in neurons. Human neuronal cells transfected with HERV-K(II) Env exhibited increased NGF and BDNF expression. Expression of HERV-K(II) Env in neuronal cells increased cellular viability and prevented neurotoxicity mediated by HIV-1 Vpr. Intracerebral delivery of HERV-K(II) Env expressed by neural stem cells suppressed TNF-alpha expression and microglial activation while also improving neurobehavioral deficits in vpr/RAG1(-/-) mice. HERV-K(II) Env was highly expressed in human neurons, especially during HIV/AIDS, but in addition exerted neuroprotective effects. These findings imply that HERV gene products might exert adaptive effects in circumstances of pathophysiological stress, perhaps underlying the conservation of HERVs within the human genome.	[Bhat, Rakesh K.; Rudnick, Wallis; Antony, Joseph M.; Maingat, Ferdinand; Ellestad, Kristofor K.; Power, Christopher] Univ Alberta, Dept Med Neurol, Edmonton, AB, Canada; [Wheatley, Blaise M.] Univ Alberta, Dept Surg Neurosurg, Edmonton, AB, Canada; [Toenjes, Ralf R.] Paul Ehrlich Inst, Div Med Biotechnol, Langen, Germany	University of Alberta; University of Alberta; Paul Ehrlich Institute	Power, C (corresponding author), Univ Alberta, Dept Med Neurol, Edmonton, AB, Canada.	chris.power@ualberta.ca	Bhat, Rakesh Kumar/AID-0687-2022; Antony, Joseph Mathew/W-7552-2019; Bhat, Rakesh/B-4320-2009	Bhat, Rakesh Kumar/0000-0001-7649-0470; Antony, Joseph Mathew/0000-0002-5700-7719; Power, Christopher/0000-0002-5131-9711; Rudnick, Wallis/0000-0003-3457-4216	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by Canadian Institutes of Health Research to (CP) and none of the authors have financial interests related to the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharjee S, 2010, FASEB J, V24, P4343, DOI 10.1096/fj.10-162313; Antony JM, 2004, NAT NEUROSCI, V7, P1088, DOI 10.1038/nn1319; Antony JM, 2007, AIDS RES HUM RETROV, V23, P1251, DOI 10.1089/aid.2006.0274; Antony JM, 2006, AIDS RES HUM RETROV, V22, P1253, DOI 10.1089/aid.2006.22.1253; Antony JM, 2007, J IMMUNOL, V179, P1210, DOI 10.4049/jimmunol.179.2.1210; Antony JM, 2011, BBA-MOL BASIS DIS, V1812, P162, DOI 10.1016/j.bbadis.2010.07.016; Bannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101; Barbulescu M, 1999, CURR BIOL, V9, P861, DOI 10.1016/S0960-9822(99)80390-X; BECKER Y, 1995, VIRUS GENES, V9, P211, DOI 10.1007/BF01702877; Belshaw R, 2005, J VIROL, V79, P12507, DOI 10.1128/JVI.79.19.12507-12514.2005; Bhat RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019176; Carlson NG, 1999, J IMMUNOL, V163, P3963; Cheeran MCJ, 2003, J VIROL, V77, P4502, DOI 10.1128/JVI.77.8.4502-4515.2003; Christensen T, 2010, J NEUROIMMUNE PHARM, V5, P326, DOI 10.1007/s11481-010-9214-y; Contreras-Galindo R, 2007, AIDS RES HUM RETROV, V23, P116, DOI 10.1089/aid.2006.0117; Contreras-Galindo R, 2006, AIDS RES HUM RETROV, V22, P979, DOI 10.1089/aid.2006.22.979; Contreras-Galindo R, 2012, J VIROL, V86, P262, DOI 10.1128/JVI.00602-11; CROW TJ, 1987, J PSYCHIAT RES, V21, P479, DOI 10.1016/0022-3956(87)90096-3; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Deslauriers AM, 2011, J IMMUNOL, V187, P4788, DOI 10.4049/jimmunol.1004111; Douville R, 2011, ANN NEUROL, V69, P141, DOI 10.1002/ana.22149; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Fuchs NV, 2011, J VIROL, V85, P3436, DOI 10.1128/JVI.02539-10; Garrison KE, 2007, PLOS PATHOG, V3, P1617, DOI 10.1371/journal.ppat.0030165; Herbein G, 2000, P SOC EXP BIOL MED, V223, P241, DOI 10.1046/j.1525-1373.2000.22335.x; Johnston JB, 2001, ANN NEUROL, V50, P434, DOI 10.1002/ana.1131; Jones GJ, 2007, J NEUROSCI, V27, P3703, DOI 10.1523/JNEUROSCI.5522-06.2007; Kim DE, 2006, RADIOLOGY, V241, P822, DOI 10.1148/radiol.2413050466; Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lower R, 1996, P NATL ACAD SCI USA, V93, P5177, DOI 10.1073/pnas.93.11.5177; Maeda N, 2001, P NATL ACAD SCI USA, V98, P4449, DOI 10.1073/pnas.071547598; Mallet Francois, 2004, Journal de la Societe de Biologie, V198, P399; McArthur JC, 2010, ANN NEUROL, V67, P699, DOI 10.1002/ana.22053; McCormick AL, 2008, NEUROLOGY, V70, P278, DOI 10.1212/01.wnl.0000297552.13219.b4; Moonen G, 1996, ACTA NEUROL BELG, V96, P203; Na H, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-44; NIXON DF, 1988, NATURE, V336, P484, DOI 10.1038/336484a0; Noorbakhsh F, 2010, FASEB J, V24, P1799, DOI 10.1096/fj.09-147819; Paces J, 2002, NUCLEIC ACIDS RES, V30, P205, DOI 10.1093/nar/30.1.205; Palmarini M, 1999, J VIROL, V73, P6964, DOI 10.1128/JVI.73.8.6964-6972.1999; Power C, 2003, ANN NEUROL, V53, P731, DOI 10.1002/ana.10553; Rakoff-Nahoum S, 2006, AIDS RES HUM RETROV, V22, P52, DOI 10.1089/aid.2006.22.52; Reynier F, 2009, SCAND J IMMUNOL, V70, P295, DOI 10.1111/j.1365-3083.2009.02271.x; RYDER EF, 1990, J NEUROBIOL, V21, P356, DOI 10.1002/neu.480210209; Sacha JB, 2012, J IMMUNOL, V189, P1467, DOI 10.4049/jimmunol.1200079; Silva C, 2003, ANN NEUROL, V54, P605, DOI 10.1002/ana.10729; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; SNYDER EY, 1995, P ASSOC AM PHYSICIAN, V107, P195; St Hillaire C, 2005, J NEUROVIROL, V11, P535, DOI 10.1080/13550280500385203; Tonjes RR, 1997, VIROLOGY, V233, P280, DOI 10.1006/viro.1997.8614; Turner G, 2001, CURR BIOL, V11, P1531, DOI 10.1016/S0960-9822(01)00455-9; van der Kuyl AC, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-6; van Marle G, 2004, VIROLOGY, V329, P302, DOI 10.1016/j.virol.2004.08.024; Vivithanaporn P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012856; Weiss RA, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-67; YAMADA M, 1994, BRAIN RES, V643, P173, DOI 10.1016/0006-8993(94)90023-X; Yolken RH, 2000, BRAIN RES REV, V31, P193, DOI 10.1016/S0165-0173(99)00037-5	58	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e97984	10.1371/journal.pone.0097984	http://dx.doi.org/10.1371/journal.pone.0097984			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988390	Green Published, gold, Green Submitted			2022-12-27	WOS:000341354100009
J	Cole, K; Roessler, CG; Mule, EA; Benson-Xu, EJ; Mullen, JD; Le, BA; Tieman, AM; Birone, C; Brown, M; Hernandez, J; Neff, S; Williams, D; Allaire, M; Orville, AM; Sweet, RM; Soares, AS				Cole, Krystal; Roessler, Christian G.; Mule, Elizabeth A.; Benson-Xu, Emma J.; Mullen, Jeffrey D.; Le, Benjamin A.; Tieman, Alanna M.; Birone, Claire; Brown, Maria; Hernandez, Jesus; Neff, Sherry; Williams, Daniel; Allaire, Marc; Orville, Allen M.; Sweet, Robert M.; Soares, Alexei S.			A Linear Relationship between Crystal Size and Fragment Binding Time Observed Crystallographically: Implications for Fragment Library Screening Using Acoustic Droplet Ejection	PLOS ONE			English	Article							X-RAY CRYSTALLOGRAPHY; PROTEIN; REFINEMENT; CRYSTALLIZATION; DIFFUSION	High throughput screening technologies such as acoustic droplet ejection (ADE) greatly increase the rate at which X-ray diffraction data can be acquired from crystals. One promising high throughput screening application of ADE is to rapidly combine protein crystals with fragment libraries. In this approach, each fragment soaks into a protein crystal either directly on data collection media or on a moving conveyor belt which then delivers the crystals to the X-ray beam. By simultaneously handling multiple crystals combined with fragment specimens, these techniques relax the automounter duty-cycle bottleneck that currently prevents optimal exploitation of third generation synchrotrons. Two factors limit the speed and scope of projects that are suitable for fragment screening using techniques such as ADE. Firstly, in applications where the high throughput screening apparatus is located inside the X-ray station (such as the conveyor belt system described above), the speed of data acquisition is limited by the time required for each fragment to soak into its protein crystal. Secondly, in applications where crystals are combined with fragments directly on data acquisition media (including both of the ADE methods described above), the maximum time that fragments have to soak into crystals is limited by evaporative dehydration of the protein crystals during the fragment soak. Here we demonstrate that both of these problems can be minimized by using small crystals, because the soak time required for a fragment hit to attain high occupancy depends approximately linearly on crystal size.	[Cole, Krystal; Mule, Elizabeth A.; Benson-Xu, Emma J.; Mullen, Jeffrey D.; Le, Benjamin A.; Tieman, Alanna M.] Brookhaven Natl Lab, Off Educ Programs, Upton, NY 11973 USA; [Roessler, Christian G.; Allaire, Marc; Orville, Allen M.; Sweet, Robert M.; Soares, Alexei S.] Brookhaven Natl Lab, Photon Sci Directorate, Upton, NY 11973 USA; [Birone, Claire] Babylon Jr Senior High Sch, Babylon, NY USA; [Brown, Maria] Sayville High Sch, West Sayville, NY USA; [Hernandez, Jesus] Queens Metropolitan High Sch, Forest Hills, NY USA; [Neff, Sherry] Shoreham Wading River High Sch, Shoreham, NY USA; [Williams, Daniel] Shelter Isl High Sch, Shelter Isl, NY USA; [Cole, Krystal] SUNY Coll Purchase, Purchase, NY 10577 USA; [Mule, Elizabeth A.] Freeport High Sch, Freeport, NY USA; [Benson-Xu, Emma J.] Georgetown Day Sch, Washington, DC USA; [Mullen, Jeffrey D.] Univ Oregon, Dept Phys, Eugene, OR 97403 USA; [Le, Benjamin A.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Tieman, Alanna M.] Univ Delaware, Dept Biol Sci, Newark, DE USA; [Orville, Allen M.; Sweet, Robert M.] Brookhaven Natl Lab, Dept Biosci, Upton, NY 11973 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Energy (DOE); Brookhaven National Laboratory; State University of New York (SUNY) System; University of Oregon; University System of Georgia; Georgia Institute of Technology; University of Delaware; United States Department of Energy (DOE); Brookhaven National Laboratory	Soares, AS (corresponding author), Brookhaven Natl Lab, Photon Sci Directorate, Upton, NY 11973 USA.	soares@bnl.gov		Orville, Allen M./0000-0002-7803-1777	Brookhaven National Laboratory/U.S. Department of Energy, Laboratory Directed Research and Development [11-008]; Office of Biological and Environmental Research of the US Department of Energy; National Center for Research Resources [P41RR012408]; National Institute of General Medical Sciences of the National Institutes of Health [P41GM103473]; Office of Basic Energy Sciences of the US Department of Energy; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103473, P41GM111244] Funding Source: NIH RePORTER	Brookhaven National Laboratory/U.S. Department of Energy, Laboratory Directed Research and Development(United States Department of Energy (DOE)); Office of Biological and Environmental Research of the US Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Personnel for this study were recruited largely through the 2010 and 2012 summer session of the Science Undergraduate Laboratory Internships Program (SULI), supported through the U.S. Department of Energy, Office of Science, Office of Workforce Development for Teachers and Scientists (WDTS). Major ongoing financial support for acoustic droplet ejection applications was through the Brookhaven National Laboratory/U.S. Department of Energy, Laboratory Directed Research and Development Grant 11-008 and from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy, and from the National Center for Research Resources (P41RR012408) and the National Institute of General Medical Sciences (P41GM103473) of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Cipriani F, 2012, ACTA CRYSTALLOGR D, V68, P1393, DOI 10.1107/S0907444912031459; Collins PM, 2007, ACTA CRYSTALLOGR D, V63, P415, DOI 10.1107/S090744490605270X; DAHLQUIST FW, 1968, BIOCHEMISTRY-US, V7, P3269, DOI 10.1021/bi00849a033; Danley DE, 2006, ACTA CRYSTALLOGR D, V62, P569, DOI 10.1107/S0907444906012601; DIAMOND R, 1974, J MOL BIOL, V82, P371, DOI 10.1016/0022-2836(74)90598-1; Ellson R., 2003, JALA J ASS LAB AUTOM, V8, P29; Erlanson DA, 2004, J MED CHEM, V47, P3463, DOI 10.1021/jm040031v; Geremia S, 2006, STRUCTURE, V14, P393, DOI 10.1016/j.str.2005.12.007; Hodgson KO, 2009, WORKSH NAT I HLTH NA; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; McNae IW, 2005, CRYSTALLOGR REV, V11, P61, DOI DOI 10.1080/08893110500078639; Otwinowski Z, 2001, CRYSTALLOGRAPHY BIOL, V2; RANDMEIR T, 1969, BIOCHEMISTRY-US, V8, P4206, DOI 10.1021/bi00838a044; Roessler CG, 2013, J SYNCHROTRON RADIAT, V20, P805, DOI 10.1107/S0909049513020372; Seemann KM, 2012, J PHYS CHEM B, V116, P9873, DOI 10.1021/jp2103512; Soares AS, 2011, BIOCHEMISTRY-US, V50, P4399, DOI 10.1021/bi200549x; Soares AS, 2003, ACTA CRYSTALLOGR D, V59, P1716, DOI 10.1107/S0907444903015403; Tanley SWM, 2012, ACTA CRYSTALLOGR D, V68, P601, DOI 10.1107/S0907444912006907; Villasenor AG, 2012, ACTA CRYSTALLOGR D, V68, P893, DOI 10.1107/S0907444912016617; Villasenor AG, 2010, ACTA CRYSTALLOGR D, V66, P568, DOI 10.1107/S0907444910005512; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Yin XY, 2014, ACTA CRYSTALLOGR D, V70, P1177, DOI 10.1107/S1399004713034603; Yu B, 1999, P NATL ACAD SCI USA, V96, P103, DOI 10.1073/pnas.96.1.103	24	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101036	10.1371/journal.pone.0101036	http://dx.doi.org/10.1371/journal.pone.0101036			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988328	Green Published, gold, Green Submitted			2022-12-27	WOS:000341354100056
J	Faruque, LI; Lin, M; Battistella, M; Wiebe, N; Reiman, T; Hemmelgarn, B; Thomas, C; Tonelli, M				Faruque, Labib Imran; Lin, Meng; Battistella, Marisa; Wiebe, Natasha; Reiman, Tony; Hemmelgarn, Brenda; Thomas, Chandra; Tonelli, Marcello			Systematic Review of the Risk of Adverse Outcomes Associated with Vascular Endothelial Growth Factor Inhibitors for the Treatment of Cancer	PLOS ONE			English	Article							ANTI-VEGF THERAPY; CELL LUNG-CANCER; ANTIANGIOGENIC THERAPY; GLIOBLASTOMA PATIENTS; TARGETED THERAPY; BEVACIZUMAB; QUALITY; HYPERTENSION; MANAGEMENT; TOXICITIES	Background: Anti-angiogenic therapy targeted at vascular endothelial growth factor (VEGF) is now used to treat several types of cancer. We did a systematic review of randomized controlled trials (RCTs) to summarize the adverse effects of vascular endothelial growth factor inhibitors (VEGFi), focusing on those with vascular pathogenesis. Methods and Findings: We searched MEDLINE, EMBASE and Cochrane Library until April 19, 2012 to identify parallel RCTs comparing a VEGFi with a control among adults with any cancer. We pooled the risk of mortality, vascular events (myocardial infarction, stroke, heart failure, and thromboembolism), hypertension and new proteinuria using random-effects models and calculated unadjusted relative risk (RR). We also did meta-regression and assessed publication bias. We retrieved 83 comparisons from 72 studies (n = 38,078) on 11 different VEGFi from 7901 identified citations. The risk of mortality was significantly lower among VEGFi recipients than controls (pooled RR 0.96, 95% confidence interval [CI] 0.94 to 0.98, I-2 = 0%, tau2 = 0; risk difference 2%). Compared to controls, VEGFi recipients had significantly higher risk of myocardial infarction (MI) (RR 3.54, 95% CI 1.61 to 7.80, I-2 = 0%, tau2 = 0), arterial thrombotic events (RR 1.80, 95% CI 1.24 to 2.59, I-2 = 0%, tau2 = 0); hypertension (RR 3.46, 95% CI 2.89 to 4.15, I-2 = 58%, tau2 = 0.16), and new proteinuria (RR 2.51, 95% CI 1.60 to 3.94, I-2 = 87%, tau2 = 0.65). The absolute risk difference was 0.8% for MI, 1% for arterial thrombotic events, 15% for hypertension and 12% for new proteinuria. Meta-regression did not suggest any statistically significant modifiers of the association between VEGFi treatment and any of the vascular events. Limitations include heterogeneity across the trials. Conclusions: VEGFi increases the risk of MI, hypertension, arterial thromboembolism and proteinuria. The absolute magnitude of the excess risk appears clinically relevant, as the number needed to harm ranges from 7 to 125. These adverse events must be weighed against the lower mortality associated with VEGFi treatment.	[Faruque, Labib Imran; Lin, Meng; Wiebe, Natasha; Tonelli, Marcello] Univ Alberta, Edmonton, AB, Canada; [Battistella, Marisa] Univ Toronto, Toronto, ON, Canada; [Reiman, Tony] Dalhousie Univ, Halifax, NS, Canada; [Hemmelgarn, Brenda; Thomas, Chandra] Univ Calgary, Calgary, AB, Canada	University of Alberta; University of Toronto; Dalhousie University; University of Calgary	Tonelli, M (corresponding author), Univ Alberta, Edmonton, AB, Canada.	mtonelli-admin@med.ualberta.ca	Wiebe, Natasha/V-7803-2019; Tonelli, Marcello/B-3028-2009	Wiebe, Natasha/0000-0002-5613-1582; Tonelli, Marcello/0000-0002-0846-3187; Battistella, Marisa/0000-0001-9456-4365	Alberta Heritage Foundation for Medical Research (AHFMR)	Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research)	Partial support for this work was provided by an Interdisciplinary Team Grant from the Alberta Heritage Foundation for Medical Research (AHFMR). No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez RH, 2011, ONCOLOGIST, V16, P1684, DOI 10.1634/theoncologist.2011-0113; Azizi M, 2008, NEW ENGL J MED, V358, P95, DOI 10.1056/NEJMc072330; Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Batchelor TT, 2013, P NATL ACAD SCI USA, V110, P19059, DOI 10.1073/pnas.1318022110; Bhargava P, 2009, AM J PHYSIOL-REG I, V297, pR1, DOI 10.1152/ajpregu.90502.2008; CHALMERS TC, 1981, CONTROL CLIN TRIALS, V2, P31, DOI 10.1016/0197-2456(81)90056-8; Cho MK, 1996, ANN INTERN MED, V124, P485, DOI 10.7326/0003-4819-124-5-199603010-00004; Coppin C, 2011, BJU INT, V108, P1556, DOI 10.1111/j.1464-410X.2011.10629.x; Copur MS, 2011, CLIN COLORECTAL CANC, V10, P151, DOI 10.1016/j.clcc.2011.03.021; Cordon CR, 2009, ANN PLAS SURG, V62, P707, DOI 10.1097/SAP.0b013e3181828141; Dreyfus B, 2013, CANCER EPIDEMIOL, V37, P191, DOI 10.1016/j.canep.2012.11.001; Elice F, 2012, THROMB RES, V129, pS50, DOI 10.1016/S0049-3848(12)70016-6; Evans T, 2012, ANTICANCER RES, V32, P4629; FDA, 2010, AV BEV PROC REM BREA; FDA, 2011, PROP WITHDR APPR BRE; Gaitskell K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007930.pub2; Gurevich F, 2009, AM J MED, V122, P322, DOI 10.1016/j.amjmed.2008.11.025; Hang XF, 2011, EUR J CLIN PHARMACOL, V67, P613, DOI 10.1007/s00228-010-0988-x; Hapani S, 2010, ONCOLOGY-BASEL, V79, P27, DOI 10.1159/000314980; Hurwitz HI, 2011, J CLIN ONCOL, V29, P1757, DOI 10.1200/JCO.2010.32.3220; Izzedine H, 2009, ANN ONCOL, V20, P807, DOI 10.1093/annonc/mdn713; Izzedine H, 2007, AM J KIDNEY DIS, V50, P203, DOI 10.1053/j.ajkd.2007.04.025; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Je YJ, 2009, LANCET ONCOL, V10, P967, DOI 10.1016/S1470-2045(09)70222-0; Kamba T, 2007, BRIT J CANCER, V96, P1788, DOI 10.1038/sj.bjc.6603813; Keefe D, 2011, ONCOLOGIST, V16, P432, DOI 10.1634/theoncologist.2010-0271; Kelly RJ, 2009, TARGET ONCOL, V4, P121, DOI 10.1007/s11523-009-0109-x; Liu F, 2011, J HUAZHONG U SCI-MED, V31, P799, DOI 10.1007/s11596-011-0680-0; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moser C, 2007, CLIN COLORECTAL CANC, V6, P564, DOI 10.3816/CCC.2007.n.023; Quesada AR, 2007, BIOESSAYS, V29, P1159, DOI 10.1002/bies.20655; Ranpura V, 2011, JAMA-J AM MED ASSOC, V305, P487, DOI 10.1001/jama.2011.51; Sandler A, 2012, LUNG CANCER, V78, P1, DOI 10.1016/j.lungcan.2012.07.004; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Sharma K, 2013, ANN PLAS SURG, V71, P434, DOI 10.1097/SAP.0b013e31824e5e57; Snider KL, 2009, TARGET ONCOL, V4, P67, DOI 10.1007/s11523-009-0106-0; Sorensen AG, 2012, CANCER RES, V72, P402, DOI 10.1158/0008-5472.CAN-11-2464; Stylianou K, 2011, NEPHROL DIAL TRANSPL, V26, P1742, DOI 10.1093/ndt/gfr093; Wagner AD, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008941.pub2; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Yang K, 2010, CLIN DRUG INVEST, V30, P229, DOI 10.2165/11532260-000000000-00000	42	48	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101145	10.1371/journal.pone.0101145	http://dx.doi.org/10.1371/journal.pone.0101145			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988441	Green Submitted, gold, Green Published			2022-12-27	WOS:000341354100066
J	Friebe, A; Evans, AL; Arnemo, JM; Blanc, S; Brunberg, S; Fleissner, G; Swenson, JE; Zedrosser, A				Friebe, Andrea; Evans, Alina L.; Arnemo, Jon M.; Blanc, Stephane; Brunberg, Sven; Fleissner, Guenther; Swenson, Jon E.; Zedrosser, Andreas			Factors Affecting Date of Implantation, Parturition, and Den Entry Estimated from Activity and Body Temperature in Free-Ranging Brown Bears	PLOS ONE			English	Article							BLACK URSUS-AMERICANUS; REPRODUCTIVE SUCCESS; DENNING CHRONOLOGY; HIBERNATION; ARCTOS; EVOLUTION; SIZE; PROGESTERONE; CONSTRAINTS; PHYSIOLOGY	Knowledge of factors influencing the timing of reproduction is important for animal conservation and management. Brown bears (Ursus arctos) are able to vary the birth date of their cubs in response to their fat stores, but little information is available about the timing of implantation and parturition in free-ranging brown bears. Body temperature and activity of pregnant brown bears is higher during the gestation period than during the rest of hibernation and drops at parturition. We compared mean daily body temperature and activity levels of pregnant and nonpregnant females during preimplantation, gestation, and lactation. Additionally we tested whether age, litter size, primiparity, environmental conditions, and the start of hibernation influence the timing of parturition. The mean date of implantation was 1 December (SD = 12), the mean date of parturition was 26 January (SD = 12), and the mean duration of the gestation period was 56 days (SD = 2). The body temperature of pregnant females was higher during the gestation and lactation periods than that of nonpregnant bears. The body temperature of pregnant females decreased during the gestation period. Activity recordings were also used to determine the date of parturition. The parturition dates calculated with activity and body temperature data did not differ significantly and were the same in 50% of the females. Older females started hibernation earlier. The start of hibernation was earlier during years with favorable environmental conditions. Dates of parturition were later during years with good environmental conditions which was unexpected. We suggest that free-ranging pregnant brown bears in areas with high levels of human activities at the beginning of the denning period, as in our study area, might prioritize investing energy in early denning than in early parturition during years with favorable environmental conditions, as a strategy to prevent disturbances caused by human.	[Friebe, Andrea; Fleissner, Guenther] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, Dept Biosci, D-60054 Frankfurt, Germany; [Evans, Alina L.] Hedmark Univ Coll, Dept Forestry & Wildlife Management, Elverum, Norway; [Arnemo, Jon M.] Hedmark Coll, Dept Forestry & Wildlife Management, Fac Appl Ecol, Elverum, Norway; [Blanc, Stephane] UDS, CNRS, Dept Ecol Physiol & Ethol, Inst Pluridisciplinaire Hubert Curien,UMR 7178, Strasbourg, France; [Brunberg, Sven; Swenson, Jon E.] Norwegian Univ Life Sci, Dept Ecol & Nat Resources Management, As, Norway; [Swenson, Jon E.] Norwegian Inst Nat Res, N-7004 Trondheim, Norway; [Zedrosser, Andreas] Telemark Univ Coll, Fac Arts & Sci, Dept Environm & Hlth Studies, Bo I Telemark, Norway; [Zedrosser, Andreas] Univ Nat Resources & Life Sci, Inst Wildlife Biol & Game Management, Vienna, Austria; [Arnemo, Jon M.] Swedish Univ Agr Sci, Fac Forest Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden	Goethe University Frankfurt; Inland Norway University of Applied Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Norwegian University of Life Sciences; Norwegian Institute Nature Research; University College of Southeast Norway; University of Natural Resources & Life Sciences, Vienna; Swedish University of Agricultural Sciences	Friebe, A (corresponding author), Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, Dept Biosci, D-60054 Frankfurt, Germany.	andrea.friebe@bearproject.info	Evans, Alina/AAH-8881-2019; Swenson, Jon/AAE-2890-2019		Swedish Environmental Protection Agency; Norwegian Directorate for Nature Management; Swedish Association for Hunting and Wildlife Management; Research Council of Norway; Austrian Science Foundation [P20182]; Scandinavian Brown Bear Research Project [168]	Swedish Environmental Protection Agency; Norwegian Directorate for Nature Management; Swedish Association for Hunting and Wildlife Management; Research Council of Norway(Research Council of Norway); Austrian Science Foundation(Austrian Science Fund (FWF)); Scandinavian Brown Bear Research Project	The authors thank the Swedish Environmental Protection Agency, the Norwegian Directorate for Nature Management, the Swedish Association for Hunting and Wildlife Management, the Research Council of Norway, and the Austrian Science Foundation (project P20182) for funding the Scandinavian Brown Bear Research Project. This is scientific paper no. 168 from the Scandinavian Brown Bear Research Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALT GL, 1983, J MAMMAL, V64, P305, DOI 10.2307/1380562; Arnemo J. M., 2012, BIOMEDICAL PROTOCOLS; ATKINSON SN, 1995, FUNCT ECOL, V9, P559, DOI 10.2307/2390145; Beecham JJ, 1980, POPULATION CHARACTER; Bellemain E, 2005, CONSERV BIOL, V19, P150, DOI 10.1111/j.1523-1739.2005.00549.x; Bieber C, 2014, FUNCT ECOL, V28, P167, DOI 10.1111/1365-2435.12173; Bridges AS, 2011, URSUS, V22, P1, DOI 10.2192/URSUS-D-10-00008.1; Bridges AS, 2002, WILDLIFE SOC B, V30, P1253; Bunnell F.L., 1981, P75; CRAIGHEAD F C JR, 1972, IUCN (International Union for Conservation of Nature and Natural Resources) Publications New Series, V23, P84; Dahle B, 2003, J ANIM ECOL, V72, P660, DOI 10.1046/j.1365-2656.2003.00737.x; Dahle B, 1998, WILDLIFE BIOL, V4, P147, DOI 10.2981/wlb.1998.017; Dehnhard M, 2006, THERIOGENOLOGY, V66, P1755, DOI 10.1016/j.theriogenology.2006.01.012; Dittrich L., 1963, Z SAUGETIERKD, V28, P129; Elfstrom M, 2008, WILDLIFE BIOL, V14, P176, DOI 10.2981/0909-6396(2008)14[176:SODHBS]2.0.CO;2; Elfstrom M, 2009, URSUS, V20, P85, DOI 10.2192/09GR005.1; ELOWE KD, 1989, J WILDLIFE MANAGE, V53, P962, DOI 10.2307/3809596; Evans AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040520; FORESMAN KR, 1983, J REPROD FERTIL, V68, P235; Friebe A, 2001, URSUS-SERIES, V12, P37; Friebe A, 2013, EUR J WILDLIFE RES, V59, P731, DOI 10.1007/s10344-013-0728-5; Gervasi V, 2006, WILDLIFE SOC B, V34, P1314, DOI 10.2193/0091-7648(2006)34[1314:AIMTMA]2.0.CO;2; Goldstein MI, 2010, J WILDLIFE MANAGE, V74, P35, DOI 10.2193/2008-490; HENSEL RJ, 1969, J WILDLIFE MANAGE, V33, P357, DOI 10.2307/3799836; HISSA R, 1994, COMP BIOCHEM PHYS A, V109, P781, DOI 10.1016/0300-9629(94)90222-4; Hissa R, 1997, ANN ZOOL FENN, V34, P267; Humphries MM, 2003, PHYSIOL BIOCHEM ZOOL, V76, P165, DOI 10.1086/367950; Iibuchi R, 2009, JPN J VET RES, V57, P13; Judd S.L., 1986, INT C BEAR RES MANAG, V6, P111, DOI 10.2307/3872814; Kordek W.S., 1980, Bear Biology Association Conference Series, P159; Laske Timothy G., 2011, BMC Physiology, V11, P13, DOI 10.1186/1472-6793-11-13; Linnell JDC, 2000, WILDLIFE SOC B, V28, P400; Lopez-Alfaro C, 2013, ECOL MODEL, V270, P1, DOI 10.1016/j.ecolmode1.2013.09.002; Manchi S, 2005, WILDLIFE BIOL, V11, P123, DOI 10.2981/0909-6396(2005)11[123:DBOSBB]2.0.CO;2; Martin J, 2013, J ANIM ECOL, V82, P290, DOI 10.1111/j.1365-2656.2012.02038.x; McLellan BN, 2011, CAN J ZOOL, V89, P546, DOI 10.1139/Z11-026; MCMILLIN JM, 1976, BIOL REPROD, V15, P163, DOI 10.1095/biolreprod15.2.163; MEAD RA, 1993, J EXP ZOOL, V266, P629, DOI 10.1002/jez.1402660611; MILLER SD, 1990, INT C BEAR, V8, P279; NELSON RA, 1973, MAYO CLIN PROC, V48, P733; NELSON RA, 1973, AM J PHYSIOL, V224, P491, DOI 10.1152/ajplegacy.1973.224.2.491; Ordiz A, 2013, J APPL ECOL, V50, P306, DOI 10.1111/1365-2664.12047; Ordiz A, 2012, BIOL CONSERV, V152, P21, DOI 10.1016/j.biocon.2012.04.006; Ordiz A, 2011, OECOLOGIA, V166, P59, DOI 10.1007/s00442-011-1920-5; Ordiz A, 2008, ECOLOGY, V89, P3327, DOI 10.1890/07-1921.1; PALMER SS, 1988, BIOL REPROD, V38, P1044, DOI 10.1095/biolreprod38.5.1044; Quest M, 2001, THESIS FREIE U BERLI; RAMSAY MA, 1986, AM NAT, V127, P735, DOI 10.1086/284522; Renfree MB, 2000, ANNU REV PHYSIOL, V62, P353, DOI 10.1146/annurev.physiol.62.1.353; Reynolds H.V., 1976, IUCN Publs (New Series), VNo. 40, P403; Robbins CT, 2012, J MAMMAL, V93, P1493, DOI 10.1644/11-MAMM-A-406.1; Robbins CT, 2012, J MAMMAL, V93, P540, DOI 10.1644/11-MAMM-A-155.1; Rogers L, 1976, EFFECT MAST BERRY CR, P431; Rogers L. L., 1987, WILDLIFE MONOGR, V97, P3; Ruby NF, 2003, J BIOL RHYTHM, V18, P275, DOI 10.1177/0748730403254971; Ryan CW, 1997, REPROD SURVIVAL DENN; Sahlen E, 2011, URSUS, V22, P152, DOI 10.2192/URSUS-D-10-00007.1; Sahlen V., 2013, THESIS NORWEGIAN U L; SANDELL M, 1990, Q REV BIOL, V65, P23, DOI 10.1086/416583; Sato M, 2000, J VET MED SCI, V62, P415, DOI 10.1292/jvms.62.415; Schoen JW, 1987, INT C BEAR RES MANAG, V7, P293, DOI DOI 10.2307/3872636; SCHOOLEY RL, 1994, J MAMMAL, V75, P466, DOI 10.2307/1382569; Schwarzenberger F., 2007, International Zoo Yearbook, V41, P52, DOI 10.1111/j.1748-1090.2007.00017.x; Servheen C., 1983, INT C BEAR RES MANAG, V5, P201, DOI 10.2307/3872539; Shimozuru M, 2013, J MAMMAL, V94, P618, DOI 10.1644/12-MAMM-A-246.1; Solberg KH, 2006, BIOL CONSERV, V128, P158, DOI 10.1016/j.biocon.2005.09.025; Spady TJ, 2007, MAMMAL REV, V37, P21, DOI 10.1111/j.1365-2907.2007.00096.x; Steyaert SMJG, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0624; Steyaert SMJG, 2013, J ANIMAL EC IN PRESS; Stringham SF, 1990, BEARS THEIR BIOL MAN, V8, P433, DOI DOI 10.2307/3872948; Swenson JE, 1997, WILDLIFE BIOL, V3, P35, DOI 10.2981/wlb.1997.005; Thom MD, 2004, EVOLUTION, V58, P175; Toien O, 2011, SCIENCE, V331, P906, DOI 10.1126/science.1199435; TSUBOTA T, 1990, INT C BEAR, V8, P125; Tsubota T, 2001, REPRODUCTION, V121, P587, DOI 10.1530/reprod/121.4.587; Tsubota T, 1987, INT C BEAR RES MANAG, V7, P355, DOI DOI 10.2307/3872643; Tsubota Toshio, 1993, Journal of Reproduction and Development, V39, P325, DOI 10.1262/jrd.39.325; VANDAELE LJ, 1990, INT C BEAR, V8, P257; Ware JV, 2012, ZOO BIOL, V31, P255, DOI 10.1002/zoo.20424; Welch CA, 1997, ECOLOGY, V78, P1105, DOI 10.2307/2265862; Wimsatt W.A., 1963, DELAYED IMPLANTATION, P49; Zedrosser A, 2006, J MAMMAL, V87, P510, DOI 10.1644/05-MAMM-A-218R1.1	82	42	43	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101410	10.1371/journal.pone.0101410	http://dx.doi.org/10.1371/journal.pone.0101410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988486	Green Submitted, Green Published, gold			2022-12-27	WOS:000341354100083
J	Li, C; Bi, XY; Huang, Y; Zhao, JJ; Li, ZY; Zhou, JG; Zhang, M; Huang, Z; Zhao, H; Cai, JQ				Li, Cong; Bi, Xinyu; Huang, Ying; Zhao, Jianjun; Li, Zhiyu; Zhou, Jianguo; Zhang, Meng; Huang, Zhen; Zhao, Hong; Cai, Jianqiang			Variants Identified by Hepatocellular Carcinoma and Chronic Hepatitis B Virus Infection Susceptibility GWAS Associated with Survival in HBV-Related Hepatocellular Carcinoma	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COLORECTAL-CANCER; POOR-PROGNOSIS; DLC-1 GENE; EXPRESSION; LOCUS; RISK; POPULATION; CHINESE; GROWTH	Recent genome-wide association studies (GWAS) have identified several common susceptibility loci associated with the risk of hepatocellular carcinoma (HCC) or chronic hepatitis B infection (CHB). However, the relationship between these genetic variants and survival of patients with hepatitis B virus (HBV)-related HCC is still unknown. In this study, 22 single nucleotide polymorphisms (SNPs) were genotyped among 330 HBV-related HCC patients using the MassARRAY system from Sequenom. Cox proportional hazards regression was used to examine the effects of genotype on survival time under an additive model with age, sex, smoking status and clinical stage as covariates. We identified four SNPs on 6p21 (rs1419881 T>C, rs7453920 G>A, rs3997872 G>A and rs7768538 T>C), and two SNPs on 8p12 (rs2275959 C>T and rs7821974 C>T) significantly associated with survival time of HBV-related HCC patients. Our results suggest that HCC or CHB susceptibility loci might also affect the prognosis of patients with HBV-related HCC.	[Li, Cong; Bi, Xinyu; Zhao, Jianjun; Li, Zhiyu; Zhou, Jianguo; Huang, Zhen; Zhao, Hong; Cai, Jianqiang] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Abdominal Surg Oncol, Beijing 100730, Peoples R China; [Li, Cong; Bi, Xinyu; Huang, Ying; Zhao, Jianjun; Li, Zhiyu; Zhou, Jianguo; Zhang, Meng; Huang, Zhen; Zhao, Hong; Cai, Jianqiang] Peking Union Med Coll, Beijing 100021, Peoples R China; [Huang, Ying; Zhang, Meng] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Etiol & Carcinogenesis, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Zhao, H (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, Dept Abdominal Surg Oncol, Beijing 100730, Peoples R China.	zhaohong9@sina.com; caijianqiang188@sina.com			National Natural Science Foundation of China [81201967]; Beijing Natural Science Foundation [7132-193]; Beijing Nova Program [2009A69]; State Key Project on Infectious Diseases of China (China National Science and Technology Major Project Grant during the Twelfth Five-year Plan Period) [2012ZX10002-016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Nova Program(Beijing Municipal Science & Technology Commission); State Key Project on Infectious Diseases of China (China National Science and Technology Major Project Grant during the Twelfth Five-year Plan Period)	This study was supported by grants from the National Natural Science Foundation of China (81201967), the Beijing Natural Science Foundation (7132-193), Beijing Nova Program (No. 2009A69), and the State Key Project on Infectious Diseases of China (China National Science and Technology Major Project Grant during the Twelfth Five-year Plan Period No. 2012ZX10002-016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qahtani A, 2013, J MED GENET, V50, P725, DOI 10.1136/jmedgenet-2013-101724; Bao BY, 2012, INT J CANCER, V130, P876, DOI 10.1002/ijc.26091; Bond AM, 2009, NAT NEUROSCI, V12, P1020, DOI 10.1038/nn.2371; Chan KYK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028798; Chen CJ, 2002, HEPATOLOGY, V36, P1046, DOI 10.1053/jhep.2002.37084; Cheung YH, 2011, HUM GENET, V129, P161, DOI 10.1007/s00439-010-0908-2; Clifford RJ, 2010, HEPATOLOGY, V52, P2034, DOI 10.1002/hep.23943; Dai JY, 2012, CARCINOGENESIS, V33, P1327, DOI 10.1093/carcin/bgs147; Diepolder HM, 2014, GUT; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Fares Nadim, 2013, Rev Prat, V63, P216; Ferlay J., 2013, IARC CANCERBASE, V11; Flecken T, 2014, HEPATOLOGY, V59, P1415, DOI 10.1002/hep.26731; He Y, 2014, CANCER LETT, V344, P20, DOI 10.1016/j.canlet.2013.10.021; Hu ZB, 2013, NAT GENET, V45, P1499, DOI 10.1038/ng.2809; Jiang DK, 2013, NAT GENET, V45, P72, DOI 10.1038/ng.2483; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kang MY, 2014, GENE, V536, P59, DOI 10.1016/j.gene.2013.11.087; Kim YJ, 2013, HUM MOL GENET, V22, P4233, DOI 10.1093/hmg/ddt266; KRISHNAN BR, 1995, GENOMICS, V30, P53; KU DH, 1991, CELL GROWTH DIFFER, V2, P179; Li SP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002791; Liao R, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-3; Liu LF, 2011, VIRAL IMMUNOL, V24, P397, DOI 10.1089/vim.2011.0027; Matoba K, 2005, INT J CANCER, V115, P231, DOI 10.1002/ijc.20860; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; Nishida N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039175; Oka A, 1999, HUM MOL GENET, V8, P2165, DOI 10.1093/hmg/8.12.2165; Pan QZ, 2013, CANCER IMMUNOL IMMUN, V62, P1675, DOI 10.1007/s00262-013-1471-1; Phipps AI, 2012, GASTROENTEROLOGY, V143, P51, DOI 10.1053/j.gastro.2012.04.052; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wong CM, 2003, CANCER RES, V63, P7646; Wu X, 2006, ONCOGENE, V25, P1832, DOI 10.1038/sj.onc.1209191; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638; Zhou XL, 2004, ONCOGENE, V23, P1308, DOI 10.1038/sj.onc.1207246	35	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101586	10.1371/journal.pone.0101586	http://dx.doi.org/10.1371/journal.pone.0101586			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987808	Green Published, gold, Green Submitted			2022-12-27	WOS:000341354100116
J	Bose, P; Hermetz, KE; Conneely, KN; Rudd, MK				Bose, Promita; Hermetz, Karen E.; Conneely, Karen N.; Rudd, M. Katharine			Tandem Repeats and G-Rich Sequences Are Enriched at Human CNV Breakpoints	PLOS ONE			English	Article							CHROMOSOMAL TRANSLOCATIONS; DNA; MECHANISMS; COMMON; RECOMBINATION; JUNCTIONS; BREAKAGE; ELEMENTS; CANCER; GENE	Chromosome breakage in germline and somatic genomes gives rise to copy number variation (CNV) responsible for genomic disorders and tumorigenesis. DNA sequence is known to play an important role in breakage at chromosome fragile sites; however, the sequences susceptible to double-strand breaks (DSBs) underlying CNV formation are largely unknown. Here we analyze 140 germline CNV breakpoints from 116 individuals to identify DNA sequences enriched at breakpoint loci compared to 2800 simulated control regions. We find that, overall, CNV breakpoints are enriched in tandem repeats and sequences predicted to form G-quadruplexes. G-rich repeats are overrepresented at terminal deletion breakpoints, which may be important for the addition of a new telomere. Interstitial deletions and duplication breakpoints are enriched in Alu repeats that in some cases mediate non-allelic homologous recombination (NAHR) between the two sides of the rearrangement. CNV breakpoints are enriched in certain classes of repeats that may play a role in DNA secondary structure, DSB susceptibility and/or DNA replication errors.	[Bose, Promita; Hermetz, Karen E.; Conneely, Karen N.; Rudd, M. Katharine] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Conneely, Karen N.] Emory Univ, Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA USA	Emory University; Emory University	Rudd, MK (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.	katie.rudd@emory.edu			National Institutes of Health [MH092902]; March of Dimes [12-FY11-203]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092902] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a grant from the National Institutes of Health (grant number MH092902 to MKR) and a grant from the March of Dimes (grant number #12-FY11-203 to MKR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the March of Dimes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeysinghe SS, 2003, HUM MUTAT, V22, P229, DOI 10.1002/humu.10254; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Ballif BC, 2003, HUM MOL GENET, V12, P2153, DOI 10.1093/hmg/ddg231; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Beck CR, 2011, ANNU REV GENOM HUM G, V12, P187, DOI 10.1146/annurev-genom-082509-141802; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Conrad DF, 2010, NAT GENET, V42, P385, DOI 10.1038/ng.564; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Costantini M, 2006, GENOME RES, V16, P536, DOI 10.1101/gr.4910606; De S, 2011, NAT STRUCT MOL BIOL, V18, P950, DOI 10.1038/nsmb.2089; Down TA, 2005, NUCLEIC ACIDS RES, V33, P1445, DOI 10.1093/nar/gki282; FLINT J, 1994, AM J HUM GENET, V55, P505; Gajecka M, 2008, GENOME RES, V18, P1733, DOI 10.1101/gr.077453.108; Gajecka M, 2006, HUM GENET, V120, P519, DOI 10.1007/s00439-006-0222-1; Glover TW, 2005, HUM MOL GENET, V14, pR197, DOI 10.1093/hmg/ddi265; Hermetz KE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004139; Hewett DR, 1998, MOL CELL, V1, P773, DOI 10.1016/S1097-2765(00)80077-5; Homann OR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-49; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Kim HM, 2008, EMBO J; Kruisselbrink E, 2008, CURR BIOL, V18, P900, DOI 10.1016/j.cub.2008.05.013; LAMB J, 1993, AM J HUM GENET, V52, P668; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEHRMAN MA, 1985, SCIENCE, V227, P140, DOI 10.1126/science.3155573; Luo Y, 2011, HUM MOL GENET, V20, P3769, DOI 10.1093/hmg/ddr293; Narayanan V, 2006, CELL, V125, P1283, DOI 10.1016/j.cell.2006.04.042; Popescu NC, 2003, CANCER LETT, V192, P1, DOI 10.1016/S0304-3835(02)00596-7; POUSI B, 1994, AM J HUM GENET, V55, P899; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; Rudd MK, 2009, HUM MOL GENET, V18, P2957, DOI 10.1093/hmg/ddp233; Rudd MK, 2007, SUBTELOMERES EVOLUTI; Rudd MK, 2014, SUBTELOMERES, P153; RUDIGER NS, 1995, NUCLEIC ACIDS RES, V23, P256, DOI 10.1093/nar/23.2.256; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; Shishkin AA, 2009, MOL CELL, V35, P82, DOI 10.1016/j.molcel.2009.06.017; Simsek D, 2010, NAT STRUCT MOL BIOL, V17, P410, DOI 10.1038/nsmb.1773; Sinclair PB, 2011, HUM MOL GENET, V20, P2591, DOI 10.1093/hmg/ddr159; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; Sutherland GR, 2003, CYTOGENET GENOME RES, V100, P77, DOI 10.1159/000072840; Vissers LELM, 2009, HUM MOL GENET, V18, P3579, DOI 10.1093/hmg/ddp306; Wang GL, 2006, MUTAT RES-FUND MOL M, V598, P103, DOI 10.1016/j.mrfmmm.2006.01.019; Yatsenko SA, 2009, HUM MOL GENET, V18, P1924, DOI 10.1093/hmg/ddp114; Yu S, 1997, CELL, V88, P367, DOI 10.1016/S0092-8674(00)81875-9; Zhang H, 2007, MOL CELL, V27, P367, DOI 10.1016/j.molcel.2007.06.012; Zhang YM, 2006, DNA REPAIR, V5, P1282, DOI 10.1016/j.dnarep.2006.05.020; Zlotorynski E, 2003, MOL CELL BIOL, V23, P7143, DOI 10.1128/MCB.23.20.7143-7151.2003	51	28	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101607	10.1371/journal.pone.0101607	http://dx.doi.org/10.1371/journal.pone.0101607			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983241	Green Published, Green Submitted, gold			2022-12-27	WOS:000339635000123
J	Graham, NAJ; Chong-Seng, KM; Huchery, C; Januchowski-Hartley, FA; Nash, KL				Graham, Nicholas A. J.; Chong-Seng, Karen M.; Huchery, Cindy; Januchowski-Hartley, Fraser A.; Nash, Kirsty L.			Coral Reef Community Composition in the Context of Disturbance History on the Great Barrier Reef, Australia	PLOS ONE			English	Article							ECOSYSTEM-BASED MANAGEMENT; MARINE RESERVE PROTECTION; FISH COMMUNITIES; PHASE-SHIFTS; RECOVERY; RESILIENCE; HABITAT; RECRUITMENT; BIOMASS; ASSEMBLAGES	Much research on coral reefs has documented differential declines in coral and associated organisms. In order to contextualise this general degradation, research on community composition is necessary in the context of varied disturbance histories and the biological processes and physical features thought to retard or promote recovery. We conducted a spatial assessment of coral reef communities across five reefs of the central Great Barrier Reef, Australia, with known disturbance histories, and assessed patterns of coral cover and community composition related to a range of other variables thought to be important for reef dynamics. Two of the reefs had not been extensively disturbed for at least 15 years prior to the surveys. Three of the reefs had been severely impacted by crown-of-thorns starfish outbreaks and coral bleaching approximately a decade before the surveys, from which only one of them was showing signs of recovery based on independent surveys. We incorporated wave exposure (sheltered and exposed) and reef zone (slope, crest and flat) into our design, providing a comprehensive assessment of the spatial patterns in community composition on these reefs. Categorising corals into life history groupings, we document major coral community differences in the unrecovered reefs, compared to the composition and covers found on the undisturbed reefs. The recovered reef, despite having similar coral cover, had a different community composition from the undisturbed reefs, which may indicate slow successional processes, or a different natural community dominance pattern due to hydrology and other oceanographic factors. The variables that best correlated with patterns in the coral community among sites included the density of juvenile corals, herbivore fish biomass, fish species richness and the cover of macroalgae. Given increasing impacts to the Great Barrier Reef, efforts to mitigate local stressors will be imperative to encouraging coral communities to persist into the future.	[Graham, Nicholas A. J.; Chong-Seng, Karen M.; Huchery, Cindy; Januchowski-Hartley, Fraser A.; Nash, Kirsty L.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Januchowski-Hartley, Fraser A.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England	James Cook University; University of Exeter	Graham, NAJ (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	nick.graham@jcu.edu.au	Nash, Kirsty L/B-5456-2015; Graham, Nicholas AJ/C-8360-2014; Januchowski-Hartley, Fraser A./H-8904-2019	Nash, Kirsty L/0000-0003-0976-3197; Graham, Nicholas AJ/0000-0002-0304-7467; Januchowski-Hartley, Fraser A./0000-0003-2468-8199; huchery, cindy/0000-0002-5657-7584; Chong-Seng, Karen/0000-0001-9178-5891	Queensland Smart Futures Fund; Australian Research Council	Queensland Smart Futures Fund; Australian Research Council(Australian Research Council)	This work was funded through research fellowships from the Queensland Smart Futures Fund and the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; ANDREWS JC, 1986, CONT SHELF RES, V6, P491, DOI 10.1016/0278-4343(86)90020-8; Ateweberhan M, 2011, CORAL REEFS, V30, P739, DOI 10.1007/s00338-011-0775-x; Australian Institute of Marine Science, 2013, REEF MON SURV; Ayre DJ, 2000, EVOLUTION, V54, P1590; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berumen ML, 2006, CORAL REEFS, V25, P647, DOI 10.1007/s00338-006-0145-2; Bozec YM, 2013, OIKOS, V122, P428, DOI 10.1111/j.1600-0706.2012.20576.x; Brinkman R, 2002, ESTUAR COAST SHELF S, V54, P655, DOI 10.1006/ecss.2001.0850; Brodie J, 2012, ESTUAR COAST SHELF S, V104, P1, DOI 10.1016/j.ecss.2012.03.012; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; Cheal AJ, 2010, CORAL REEFS, V29, P1005, DOI 10.1007/s00338-010-0661-y; Cheal AJ, 2013, ECOL APPL, V23, P174, DOI 10.1890/11-2253.1; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; Darling ES, 2013, GLOBAL CHANGE BIOL, V19, P1930, DOI 10.1111/gcb.12191; Darling ES, 2012, ECOL LETT, V15, P1378, DOI 10.1111/j.1461-0248.2012.01861.x; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Done T.J., 1982, Coral Reefs, V1, P95, DOI 10.1007/BF00301691; DONE TJ, 1991, CORAL REEFS, V9, P183, DOI 10.1007/BF00290420; Emslie MJ, 2008, MAR ECOL PROG SER, V371, P177, DOI 10.3354/meps07657; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GBRMPA, 2011, IMP TROP CYCL YAS GR; Gilmour JP, 2013, SCIENCE, V340, P69, DOI 10.1126/science.1232310; Graham NAJ, 2013, CORAL REEFS, V32, P315, DOI 10.1007/s00338-012-0984-y; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2003, ENVIRON CONSERV, V30, P200, DOI 10.1017/S0376892903000195; Graham NAJ, 2014, CURR OPIN ENV SUST, V7, P9, DOI 10.1016/j.cosust.2013.11.023; Graham NAJ, 2013, FRONT ECOL ENVIRON, V11, P541, DOI 10.1890/120305; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Harmelin-Vivien M.L., 1994, J COASTAL RES, V12, P211, DOI DOI 10.1111/NYAS.13322; Harris PT, 2013, ICES J MAR SCI, V70, P284, DOI 10.1093/icesjms/fss165; Hughes TP, 2012, CURR BIOL, V22, P736, DOI 10.1016/j.cub.2012.02.068; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Jackson J.B.C., 1979, Systematics Association Special Volume Series, P499; Johns KA, 2014, CORAL REEFS, V33, P553, DOI 10.1007/s00338-014-1148-z; KARLSON RH, 1993, CORAL REEFS, V12, P117, DOI 10.1007/BF00334469; Kleypas JA, 2001, INT J EARTH SCI, V90, P426, DOI 10.1007/s005310000125; Letourneur Y, 1998, NAGA, V21, P39; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Madin JS, 2006, NATURE, V444, P477, DOI 10.1038/nature05328; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; McClanahan TR, 2007, MAR ECOL PROG SER, V337, P1, DOI 10.3354/meps337001; McClanahan TR, 2011, P NATL ACAD SCI USA, V108, P17230, DOI 10.1073/pnas.1106861108; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; McCulloch M, 2003, NATURE, V421, P727, DOI 10.1038/nature01361; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Myers MR, 2009, AQUAT CONSERV, V19, P736, DOI 10.1002/aqc.1053; Olsson P, 2008, P NATL ACAD SCI USA, V105, P9489, DOI 10.1073/pnas.0706905105; Osborne K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017516; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; POLUNIN NVC, 1993, MAR ECOL PROG SER, V100, P167, DOI 10.3354/meps100167; Pratchett M, 2008, P 11 INT COR REEF S; Pratchett MS, 2011, CORAL REEFS, V30, P183, DOI 10.1007/s00338-010-0678-2; Pratchett MS, 2009, MAR ENVIRON RES, V67, P230, DOI 10.1016/j.marenvres.2009.03.001; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; SAMMARCO PW, 1991, LIMNOL OCEANOGR, V36, P496, DOI 10.4319/lo.1991.36.3.0496; Sheppard CRC, 2008, MAR ECOL PROG SER, V362, P109, DOI 10.3354/meps07436; Sheppard CRC, 2002, AMBIO, V31, P40, DOI 10.1639/0044-7447(2002)031[0040:EVROCR]2.0.CO;2; Shugart H.H., 1984, THEORY FOREST DYNAMI; Stockwell B, 2009, MAR ECOL PROG SER, V389, P1, DOI 10.3354/meps08150; Stoeckl N, 2011, ANN NY ACAD SCI, V1219, P113, DOI 10.1111/j.1749-6632.2010.05892.x; Sweatman H, 2011, CORAL REEFS, V30, P521, DOI 10.1007/s00338-010-0715-1; Sweatman H, 2008, CURR BIOL, V18, pR598, DOI 10.1016/j.cub.2008.05.033; TILMAN D, 1990, OIKOS, V58, P3, DOI 10.2307/3565355; Trapon ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057788; van Woesik R, 2011, MAR ECOL PROG SER, V434, P67, DOI 10.3354/meps09203; WILLIAMS DM, 1994, B MAR SCI, V54, P314; Williams GJ, 2013, PEERJ, V1, DOI 10.7717/peerj.81; Williams ID, 2001, CORAL REEFS, V19, P358, DOI 10.1007/s003380000121; Williamson DH, 2004, ENVIRON CONSERV, V31, P149, DOI 10.1017/S0376892904001262; Wilson SK, 2008, GLOBAL CHANGE BIOL, V14, P2796, DOI 10.1111/j.1365-2486.2008.01696.x; Wilson SK, 2007, MAR BIOL, V151, P1069, DOI 10.1007/s00227-006-0538-3; Wilson SK, 2012, CONSERV BIOL, V26, P995, DOI 10.1111/j.1523-1739.2012.01926.x	81	42	43	1	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101204	10.1371/journal.pone.0101204	http://dx.doi.org/10.1371/journal.pone.0101204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983747	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000339635000067
J	Karve, SS; Weiss, AA				Karve, Sayali S.; Weiss, Alison A.			Glycolipid Binding Preferences of Shiga Toxin Variants	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; B-SUBUNIT; SHIGELLA DIARRHEA; VIRULENCE FACTORS; CRYSTAL-STRUCTURE; HYBRID TOXINS; PATHOGENESIS; SITE; IDENTIFICATION; STABILITY	The major virulence factor of Shiga toxin producing E. coli, is Shiga toxin (Stx), an AB(5) toxin that consists of a ribosomal RNA-cleaving A-subunit surrounded by a pentamer of receptor-binding B subunits. The two major isoforms, Stx1 and Stx2, and Stx2 variants (Stx2a-h) significantly differ in toxicity. The exact reason for this toxicity difference is unknown, however different receptor binding preferences are speculated to play a role. Previous studies used enzyme linked immunosorbent assay (ELISA) to study binding of Stx1 and Stx2a toxoids to glycolipid receptors. Here, we studied binding of holotoxin and B-subunits of Stx1, Stx2a, Stx2b, Stx2c and Stx2d to glycolipid receptors globotriaosylceramide (Gb3) and globotetraosylceramide (Gb4) in the presence of cell membrane components such as phosphatidylcholine (PC), cholesterol (Ch) and other neutral glycolipids. In the absence of PC and Ch, holotoxins of Stx2 variants bound to mixtures of Gb3 with other glycolipids but not to Gb3 or Gb4 alone. Binding of all Stx holotoxins significantly increased in the presence of PC and Ch. Previously, Stx2a has been shown to form a less stable B-pentamer compared to Stx1. However, its effect on glycolipid receptor binding is unknown. In this study, we showed that even in the absence of the A-subunit, the B-subunits of both Stx1 and Stx2a were able to bind to the glycolipids and the more stable B-pentamer formed by Stx1 bound better than the less stable pentamer of Stx2a. B-subunit mutant of Stx1 L41Q, which shows similar stability as Stx2a B-subunits, lacked glycolipid binding, suggesting that pentamerization is more critical for binding of Stx1 than Stx2a.	[Karve, Sayali S.; Weiss, Alison A.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45220 USA	University of Cincinnati	Weiss, AA (corresponding author), Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45220 USA.	weissaa@ucmail.uc.edu		Weiss, Alison/0000-0002-4726-8376	National Institutes of Health [R01 AI 064893, U01 AI 075498]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064893, U01AI075498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants R01 AI 064893 and U01 AI 075498 (AAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betz J, 2011, J LIPID RES, V52, P618, DOI 10.1194/jlr.M010819; Bitzan M, 2009, KIDNEY INT, V75, pS62, DOI 10.1038/ki.2008.624; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; CARTER AO, 1987, NEW ENGL J MED, V317, P1496, DOI 10.1056/NEJM198712103172403; Collins C, 2010, PRACT GASTROENTEROL, V34, P41; Conrady DG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015153; DONOHUEROLFE A, 1984, J EXP MED, V160, P1767, DOI 10.1084/jem.160.6.1767; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Ethelberg S, 2004, EMERG INFECT DIS, V10, P842, DOI 10.3201/eid1005.030576; Flagler MJ, 2010, BIOCHEMISTRY-US, V49, P1649, DOI 10.1021/bi902084y; FRASER ME, 1994, NAT STRUCT BIOL, V1, P59, DOI 10.1038/nsb0194-59; Fraser ME, 2004, J BIOL CHEM, V279, P27511, DOI 10.1074/jbc.M401939200; Fuller CA, 2011, INFECT IMMUN, V79, P1329, DOI 10.1128/IAI.01182-10; Gallegos KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030368; Gould LH, 2009, CLIN INFECT DIS, V49, P1480, DOI 10.1086/644621; HEAD SC, 1991, J BIOL CHEM, V266, P3617; JACEWICZ M, 1986, J EXP MED, V163, P1391, DOI 10.1084/jem.163.6.1391; Jacobson JM, 2014, J BIOL CHEM, V289, P885, DOI 10.1074/jbc.M113.518886; Karmali MA, 1994, RECENT ADV VEROCYTOT, P245; Kawano K, 2008, EUR J CLIN MICROBIOL, V27, P227, DOI 10.1007/s10096-007-0420-3; Kitova EN, 2005, J AM SOC MASS SPECTR, V16, P1957, DOI 10.1016/j.jasms.2005.07.016; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Ling H, 1998, BIOCHEMISTRY-US, V37, P1777, DOI 10.1021/bi971806n; Ling H, 2000, STRUCTURE, V8, P253, DOI 10.1016/S0969-2126(00)00103-9; Lingwood CA, 1996, TRENDS MICROBIOL, V4, P147, DOI 10.1016/0966-842X(96)10017-2; Lingwood CA, 2010, CHEM PHYS LIPIDS, V163, P27, DOI 10.1016/j.chemphyslip.2009.09.001; MacDonald IAR, 1996, EPIDEMIOL INFECT, V116, P279, DOI 10.1017/S0950268800052584; Mahfoud R, 2010, J BIOL CHEM, V285, P36049, DOI 10.1074/jbc.M110.110189; Marcato P, 2003, INFECT IMMUN, V71, P6075, DOI 10.1128/IAI.71.10.6075-6078.2003; McGannon CM, 2010, ANTIMICROB AGENTS CH, V54, P3790, DOI 10.1128/AAC.01783-09; Melton-Celsa A, 2012, CURR TOP MICROBIOL, V357, P67, DOI 10.1007/82_2011_176; Millen SH, 2010, BIOCHEMISTRY-US, V49, P5954, DOI 10.1021/bi100474z; Nakajima H, 2001, J BIOL CHEM, V276, P42915, DOI 10.1074/jbc.M106015200; OBRIEN AD, 1992, CURR TOP MICROBIOL, V180, P65; Obrig TG, 2010, TOXINS, V2, P2769, DOI 10.3390/toxins2122769; Orth D, 2007, DIAGN MICR INFEC DIS, V59, P235, DOI 10.1016/j.diagmicrobio.2007.04.013; OSTROFF SM, 1989, J INFECT DIS, V160, P994, DOI 10.1093/infdis/160.6.994; Pina DG, 2008, FEBS LETT, V582, P185, DOI 10.1016/j.febslet.2007.11.086; ROWE PC, 1993, EPIDEMIOL INFECT, V110, P9, DOI 10.1017/S0950268800050627; Rutjes NWP, 2002, KIDNEY INT, V62, P832, DOI 10.1046/j.1523-1755.2002.00502.x; Saito M, 2012, J BIOL CHEM, V287, P16073, DOI 10.1074/jbc.M111.318196; SAXENA SK, 1989, J BIOL CHEM, V264, P596; Slutsker L, 1997, ANN INTERN MED, V126, P505, DOI 10.7326/0003-4819-126-7-199704010-00002; Soltyk AM, 2002, J BIOL CHEM, V277, P5351, DOI 10.1074/jbc.M107472200; STROCKBINE NA, 1986, INFECT IMMUN, V53, P135, DOI 10.1128/IAI.53.1.135-140.1986; Tilden J, 1996, AM J PUBLIC HEALTH, V86, P1142, DOI 10.2105/AJPH.86.8_Pt_1.1142; Torgersen ML, 2011, FEMS IMMUNOL MED MIC, V61, P63, DOI 10.1111/j.1574-695X.2010.00749.x; Trachtman H, 2012, NAT REV NEPHROL, V8, P658, DOI 10.1038/nrneph.2012.196; TYRRELL GJ, 1992, P NATL ACAD SCI USA, V89, P524, DOI 10.1073/pnas.89.2.524; Watanabe M, 2006, INFECT IMMUN, V74, P1984, DOI 10.1128/IAI.74.3.1984-1988.2006; WEINSTEIN DL, 1989, INFECT IMMUN, V57, P3743, DOI 10.1128/IAI.57.12.3743-3750.1989; Yasumura Y., 1963, NIHON RINSHO, V21, P1201; Zoja C, 2010, PEDIATR NEPHROL, V25, P2231, DOI 10.1007/s00467-010-1522-1	54	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101173	10.1371/journal.pone.0101173	http://dx.doi.org/10.1371/journal.pone.0101173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983355	gold, Green Published, Green Submitted			2022-12-27	WOS:000339635000064
J	Keshavarz, B; Hettinger, LJ; Kennedy, RS; Campos, JL				Keshavarz, Behrang; Hettinger, Lawrence J.; Kennedy, Robert S.; Campos, Jennifer L.			Demonstrating the Potential for Dynamic Auditory Stimulation to Contribute to Motion Sickness	PLOS ONE			English	Article							ILLUSORY SELF-MOTION; POSTURAL INSTABILITY; VECTION; PERCEPTION; NYSTAGMUS; INDUCTION; MOVEMENTS; ROTATION; ADULTS; CUES	Auditory cues can create the illusion of self-motion (vection) in the absence of visual or physical stimulation. The present study aimed to determine whether auditory cues alone can also elicit motion sickness and how auditory cues contribute to motion sickness when added to visual motion stimuli. Twenty participants were seated in front of a curved projection display and were exposed to a virtual scene that constantly rotated around the participant's vertical axis. The virtual scene contained either visual-only, auditory-only, or a combination of corresponding visual and auditory cues. All participants performed all three conditions in a counterbalanced order. Participants tilted their heads alternately towards the right or left shoulder in all conditions during stimulus exposure in order to create pseudo-Coriolis effects and to maximize the likelihood for motion sickness. Measurements of motion sickness (onset, severity), vection (latency, strength, duration), and postural steadiness (center of pressure) were recorded. Results showed that adding auditory cues to the visual stimuli did not, on average, affect motion sickness and postural steadiness, but it did reduce vection onset times and increased vection strength compared to pure visual or pure auditory stimulation. Eighteen of the 20 participants reported at least slight motion sickness in the two conditions including visual stimuli. More interestingly, six participants also reported slight motion sickness during pure auditory stimulation and two of the six participants stopped the pure auditory test session due to motion sickness. The present study is the first to demonstrate that motion sickness may be caused by pure auditory stimulation, which we refer to as "auditorily induced motion sickness".	[Keshavarz, Behrang; Campos, Jennifer L.] Toronto Rehabil Inst, Res Dept, Technol Team iDAPT, Toronto, ON, Canada; [Hettinger, Lawrence J.] Liberty Mutual Res Inst Safety, Ctr Behav Sci, Hopkinton, MA USA; [Kennedy, Robert S.] RSK Assessments Inc, Orlando, FL USA; [Campos, Jennifer L.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; Liberty Mutual Research Institute for Safety; University of Toronto	Keshavarz, B (corresponding author), Toronto Rehabil Inst, Res Dept, Technol Team iDAPT, Toronto, ON, Canada.	behrang.keshavarz@uhn.ca		Keshavarz, Behrang/0000-0002-7763-5325				Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Alais D, 2010, SEEING PERCEIVING, V23, P3, DOI 10.1163/187847510X488603; Alessandrini M, 2006, EUR ARCH OTO-RHINO-L, V263, P248, DOI 10.1007/s00405-005-0965-7; Bonato F, 2008, PRESENCE-TELEOP VIRT, V17, P283, DOI 10.1162/pres.17.3.283; Bos JE, 2004, AVIAT SPACE ENVIR MD, V75, P172; COLLINS WE, 1968, AEROSPACE MED, V39, P125; Crampton G.H., 1990, MOTION SPACE SICKNES; DICHGANS J, 1973, ACTA OTO-LARYNGOL, V76, P339, DOI 10.3109/00016487309121519; Easton RD, 1998, EXP BRAIN RES, V118, P541, DOI 10.1007/s002210050310; EBENHOLTZ SM, 1994, AVIAT SPACE ENVIR MD, V65, P1032; Ebenholtz SM., 1992, PRESENCE TELEOPERATO, V1, P302, DOI [10.1162/pres.1992.1.3.302, DOI 10.1162/PRES.1992.1.3.302]; Flanagan MB, 2004, J VESTIBUL RES-EQUIL, V14, P335; HENNEBERT P E, 1960, Acta Otolaryngol, V51, P412, DOI 10.3109/00016486009124512; Hettinger L J, 1990, Mil Psychol, V2, P171, DOI 10.1207/s15327876mp0203_4; Hettinger LJ, 2002, HUM FAC ER, P471; Ji JTT, 2009, HUM FACTORS, V51, P739, DOI 10.1177/0018720809349708; Kennedy R. S., 1993, INT J AVIAT PSYCHOL, V3, P203; Kennedy RS, 2010, APPL ERGON, V41, P494, DOI 10.1016/j.apergo.2009.11.006; Kennedy RS, 1996, INT J HUM-COMPUT INT, V8, P25, DOI 10.1080/10447319609526139; Keshavarz B., 2012, P HUM FACTORS ERGON, V56, P1763, DOI [DOI 10.1177/1071181312561354, 10.1177/1071181312561354]; Keshavarz B, HDB VIRTUAL ENV DESI; Keshavarz B, 2014, EXP BRAIN RES, V232, P827, DOI 10.1007/s00221-013-3793-9; Keshavarz B, 2012, PRESENCE-TELEOP VIRT, V21, P213, DOI 10.1162/PRES_a_00102; Keshavarz B, 2011, HUM FACTORS, V53, P415, DOI 10.1177/0018720811403736; LACKNER JR, 1977, AVIAT SPACE ENVIR MD, V48, P129; LACKNER JR, 1977, AVIAT SPACE ENVIR MD, V48, P248; Lawson BD, 2005, P 11 INT C HUMAN COM, P1; Lawson BD, 2001, USABILITY EVALUATION, V1, P1041; Lester G, 1967, P ANN CONV AM PSYCH, V2, P19; MARMEKARELSE AM, 1977, AGRESSOLOGIE, V18, P329; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Miller EF, 1970, NAMI1098; Nichols S, 2000, INT J HUM-COMPUT ST, V52, P471, DOI 10.1006/ijhc.1999.0343; Pinchover S, 2011, AVIAT SPACE ENV MED, V82, P242; REASON JT, 1978, J ROY SOC MED, V71, P819, DOI 10.1177/014107687807101109; Reason JT., 1975, MOTION SICKNESS; RICCIO G E, 1991, Ecological Psychology, V3, P195, DOI 10.1207/s15326969eco0303_2; Riecke BE, 2009, ACM T APPL PERCEPT, V6, DOI 10.1145/1498700.1498701; Riecke BE, 2008, APGV 2008: PROCEEDINGS OF THE SYMPOSIUM ON APPLIED PERCEPTION IN GRAPHICS AND VISUALIZATION, P147; Schmider E, 2010, METHODOLOGY-EUR, V6, P147, DOI 10.1027/1614-2241/a000016; Seno T, 2012, PERCEPTION, V41, P577, DOI 10.1068/p7184; Shupak A, 2006, AVIAT SPACE ENVIR MD, V77, P1213; Smart LJ, 2002, HUM FACTORS, V44, P451, DOI 10.1518/0018720024497745; STOFFREGEN T A, 1991, Ecological Psychology, V3, P159, DOI 10.1207/s15326969eco0303_1; Stoffregen TA, 2010, J VISUAL IMPAIR BLIN, V104, P73, DOI 10.1177/0145482X1010400203; Tanaka T, 2001, ERGONOMICS, V44, P1403, DOI 10.1080/00140130110110601; TIANDE Y, 1991, Aviation Space and Environmental Medicine, V62, P141; Valjamae A, 2009, BRAIN RES REV, V61, P240, DOI 10.1016/j.brainresrev.2009.07.001; WATSON JE, 1968, J AUD RES, V8, P161	49	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101016	10.1371/journal.pone.0101016	http://dx.doi.org/10.1371/journal.pone.0101016			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1UX	24983752	Green Submitted, gold, Green Published			2022-12-27	WOS:000339635000047
J	Ma, MJ; Ma, Z; Du, GZ				Ma, Miaojun; Ma, Zhen; Du, Guozhen			Effects of Water Level on Three Wetlands Soil Seed Banks on the Tibetan Plateau	PLOS ONE			English	Article							ALPINE MEADOW; VEGETATION; MARSH; DYNAMICS; PLANT; DEPTH; ESTABLISHMENT; REPRODUCTION; EMERGENCE; REGIME	Background: Although the effect of water level on germination in soil seed banks has been documented in many ecosystems, the mechanism is not fully understood, and to date no empirical studies on this subject exist. Further, no work has been done on the effect of water level on seed banks of drying and saline-alkaline wetlands in alpine areas on the Tibetan Plateau. Methodology: We examined the effects of water level (0 cm, 5 cm and 10 cm) on seed germination and seedling establishment from soil seed banks at 0-5 cm and 5-10 cm depths in typical, drying, and saline-alkaline wetlands. We also explore the potential role of soil seed bank in restoration of drying and saline-alkaline wetlands. Principal Findings: Species richness decreased with increase in water level, but there almost no change in seed density. A huge difference exists in species composition of the seed bank among different water levels in all three wetlands, especially between 0 cm and 5 cm and 0 cm and 10 cm. Similarity of species composition between seed bank and plant community was higher in 0 cm water level in drying wetland than in the other two wetlands. The similarity was much higher in 0 cm water level than in 5 cm and 10 cm water levels in all three wetlands. Species composition of the alpine wetland plant community changed significantly after drying and salinization, however, species composition of the seed bank was unchanged regardless of the environment change. Conclusions/Significance: Water level greatly affects seed bank recruitment and plant community establishment. Further, different water levels in restored habitats are likely to determine its species composition of the plant community. The seed bank is important in restoration of degraded wetlands. Successful restoration of drying and salinization wetlands could depend on the seed bank.	[Ma, Miaojun; Ma, Zhen; Du, Guozhen] Lanzhou Univ, Sch Life Sci, State Key Lab Grassland & Agroecosyst, Lanzhou 730000, Peoples R China	Lanzhou University	Du, GZ (corresponding author), Lanzhou Univ, Sch Life Sci, State Key Lab Grassland & Agroecosyst, Lanzhou 730000, Peoples R China.	guozdu@lzu.edu.cn	Ma, Miaojun/E-1320-2012	Ma, Miaojun/0000-0001-7046-9574	Natural Science Foundation of China [41101527]; Research Fund for the Doctoral Program of Higher Education of China [20110211120026]; Natural Science Foundation of Gansu Province, China [1308RJZA114]; Fundamental Research Funds for the Central Universities [lzujbky-2013-204]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Gansu Province, China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The study was funded by the Natural Science Foundation of China (Grant No. 41101527), the Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20110211120026), the Natural Science Foundation of Gansu Province, China (Grant No. 1308RJZA114), and the Fundamental Research Funds for the Central Universities (Grant No. lzujbky-2013-204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy VJ, 1999, PLANT ECOL, V140, P177, DOI 10.1023/A:1009779411686; Baskin C. C., 1998, Seeds: ecology, biogeography, and evolution of dormancy and germination.; Bekker RM, 1998, SEED SCI RES, V8, P399, DOI 10.1017/S0960258500004323; BONIS A, 1995, OIKOS, V74, P81, DOI 10.2307/3545677; Capon SJ, 2007, WETLANDS, V27, P904, DOI 10.1672/0277-5212(2007)27[904:EOFOSE]2.0.CO;2; Casanova MT, 2000, PLANT ECOL, V147, P237, DOI 10.1023/A:1009875226637; Farrell JM, 2010, HYDROBIOLOGIA, V647, P127, DOI 10.1007/s10750-009-0035-z; Fenner M, 1985, SEED ECOLOGY; GALINATO MI, 1986, AQUAT BOT, V26, P89; GERRITSEN J, 1989, ECOLOGY, V70, P750, DOI 10.2307/1940225; Griffith AB, 2003, PLANT ECOL, V167, P117, DOI 10.1023/A:1023952907092; Holzel N, 2001, J VEG SCI, V12, P209, DOI 10.2307/3236605; Hong JM, 2012, ECOL ENG, V42, P192, DOI 10.1016/j.ecoleng.2012.01.004; Johnson S, 2004, AQUAT BOT, V79, P311, DOI 10.1016/j.aquabot.2004.05.003; Klimkowska A, 2010, PERSPECT PLANT ECOL, V12, P245, DOI 10.1016/j.ppees.2010.02.004; Leck, 1989, ECOLOGY SOIL SEED BA; Liu GH, 2005, AQUAT BOT, V81, P1, DOI 10.1016/j.aquabot.2004.07.001; Ma MJ, 2013, PLANT SOIL, V369, P283, DOI 10.1007/s11104-012-1560-5; Ma MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080220; Ma MJ, 2012, ECOL ENG, V44, P18, DOI 10.1016/j.ecoleng.2012.03.017; Ma MJ, 2011, PLANT SOIL, V346, P19, DOI 10.1007/s11104-011-0790-2; Ma MJ, 2010, PLANT SOIL, V336, P291, DOI 10.1007/s11104-010-0480-5; Ma MJ, 2010, FLORA, V205, P128, DOI 10.1016/j.flora.2009.02.006; Ma MJ, 2009, ARCT ANTARCT ALP RES, V41, P469, DOI 10.1657/1938-4246-41.4.999; Nicol JM, 2003, PLANT ECOL, V168, P191, DOI 10.1023/A:1024430919811; Shibayama Y, 2007, AQUAT BOT, V87, P320, DOI 10.1016/j.aquabot.2007.07.004; SMITH LM, 1983, J APPL ECOL, V20, P673, DOI 10.2307/2403534; Smith SM, 2002, RESTOR ECOL, V10, P138, DOI 10.1046/j.1526-100X.2002.10115.x; VANDERVALK AG, 1978, ECOLOGY, V59, P322, DOI 10.2307/1936377; Volder A, 1997, AQUAT BOT, V58, P113, DOI 10.1016/S0304-3770(97)00018-1; Wang GD, 2013, AQUAT BOT, V106, P35, DOI 10.1016/j.aquabot.2012.12.008; Xiao C, 2010, AQUAT BOT, V92, P28, DOI 10.1016/j.aquabot.2009.09.004	32	10	13	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101458	10.1371/journal.pone.0101458	http://dx.doi.org/10.1371/journal.pone.0101458			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984070	Green Published, Green Submitted, gold			2022-12-27	WOS:000339635000112
J	Santoferrara, LF; Guida, S; Zhang, H; McManus, GB				Santoferrara, Luciana F.; Guida, Stephanie; Zhang, Huan; McManus, George B.			De Novo Transcriptomes of a Mixotrophic and a Heterotrophic Ciliate from Marine Plankton	PLOS ONE			English	Article							MONODEHYDROASCORBATE REDUCTASE; OXIDATIVE STRESS; ASCORBATE PEROXIDASE; MOLECULAR-CLONING; ALIGNMENT; RNA; METABOLISM; MODELS; FAMILY; GENE	Studying non-model organisms is crucial in the context of the current development of genomics and transcriptomics for both physiological experimentation and environmental characterization. We investigated the transcriptomes of two marine planktonic ciliates, the mixotrophic oligotrich Strombidium rassoulzadegani and the heterotrophic choreotrich Strombidinopsis sp., and their respective algal food using Illumina RNAseq. Our aim was to characterize the transcriptomes of these contrasting ciliates and to identify genes potentially involved in mixotrophy. We detected approximately 10,000 and 7,600 amino acid sequences for S. rassoulzadegani and Strombidinopsis sp., respectively. About half of these transcripts had significant BLASTP hits (E-value <10(-6)) against previously-characterized sequences, mostly from the model ciliate Oxytricha trifallax. Transcriptomes from both the mixotroph and the heterotroph species provided similar annotations for GO terms and KEGG pathways. Most of the identified genes were related to housekeeping activity and pathways such as the metabolism of carbohydrates, lipids, amino acids, nucleotides, and vitamins. Although S. rassoulzadegani can keep and use chloroplasts from its prey, we did not find genes clearly linked to chloroplast maintenance and functioning in the transcriptome of this ciliate. While chloroplasts are known sources of reactive oxygen species (ROS), we found the same complement of antioxidant pathways in both ciliates, except for one enzyme possibly linked to ascorbic acid recycling found exclusively in the mixotroph. Contrary to our expectations, we did not find qualitative differences in genes potentially related to mixotrophy. However, these transcriptomes will help to establish a basis for the evaluation of differential gene expression in oligotrichs and choreotrichs and experimental investigation of the costs and benefits of mixotrophy.	[Santoferrara, Luciana F.; Zhang, Huan; McManus, George B.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Guida, Stephanie] Natl Ctr Genome Resources, Santa Fe, NM USA	University of Connecticut; National Center for Genome Resources (NCGR)	Santoferrara, LF (corresponding author), Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA.	luciana.santoferrara@uconn.edu	McManus, George/AAW-9055-2020	Santoferrara, Luciana/0000-0001-5587-2111; McManus, George/0000-0002-2768-1286	Gordon and Betty Moore Foundation [GBMF2637]; US National Science Foundation [OCE1130033]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); US National Science Foundation(National Science Foundation (NSF))	This research was funded by the Gordon and Betty Moore Foundation through Grant GBMF2637 to NCGR and by the US National Science Foundation through Grant OCE1130033 to GBM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Agatha S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022466; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; Carter CJ, 2004, PLANT MOL BIOL, V54, P415, DOI 10.1023/B:PLAN.0000036373.84579.13; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; CLARK KB, 1990, VELIGER, V33, P339; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; DI MASCIO P, 1991, AM J CLIN NUTR, V53, pS194, DOI 10.1093/ajcn/53.1.194S; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellegren H, 2014, TRENDS ECOL EVOL, V29, P51, DOI 10.1016/j.tree.2013.09.008; Esteban GF, 2010, PROTIST, V161, P621, DOI 10.1016/j.protis.2010.08.002; Flores HS, 2012, AQUAT MICROB ECOL, V66, P199, DOI 10.3354/ame01570; Flynn KJ, 2013, J PLANKTON RES, V35, P3, DOI 10.1093/plankt/fbs062; Foyer CH, 2011, PLANT PHYSIOL, V155, P93, DOI 10.1104/pp.110.166181; Gabaldon T, 2010, PHILOS T R SOC B, V365, P765, DOI 10.1098/rstb.2009.0240; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Grant J.R., 2012, PROTIST GENOMICS, V1, P3; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; Hossain MA, 2011, ABIOTIC STRESS IN PLANTS - MECHANISMS AND ADAPTATIONS, P235; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Ishikawa T, 2008, BIOSCI BIOTECH BIOCH, V72, P1143, DOI 10.1271/bbb.80062; Johnson MD, 2007, NATURE, V445, P426, DOI 10.1038/nature05496; Johnson MD, 2011, J EUKARYOT MICROBIOL, V58, P185, DOI 10.1111/j.1550-7408.2011.00545.x; Johnson MD, 2011, PHOTOSYNTH RES, V107, P117, DOI 10.1007/s11120-010-9546-8; Kawano T, 2004, Z NATURFORSCH C, V59, P538; Keeling PJ, 2014, PLOS BIOL IN PRESS; Krauth-Siegel RL, 2012, ANTIOXID REDOX SIGN, V17, P583, DOI 10.1089/ars.2011.4392; Kuo RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060826; LAVALPEUTO M, 1988, HYDROBIOLOGIA, V159, P99, DOI 10.1007/BF00007371; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Leterrier M, 2005, PLANT PHYSIOL, V138, P2111, DOI 10.1104/pp.105.066225; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lottaz C, 2003, BIOINFORMATICS, V19, pII103, DOI 10.1093/bioinformatics/btg1067; Lunde C, 2006, PLANT MOL BIOL, V60, P259, DOI 10.1007/s11103-005-3881-8; Lynn D.H, 2008, CIL PROT CHAR CLASS, V3rd ed.; McManus GB, 2004, LIMNOL OCEANOGR, V49, P308, DOI 10.4319/lo.2004.49.1.0308; McManus GB, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00321; McManus GB, 2010, J EUKARYOT MICROBIOL, V57, P369, DOI 10.1111/j.1550-7408.2010.00485.x; Minnhagen S, 2008, ENVIRON MICROBIOL, V10, P2411, DOI 10.1111/j.1462-2920.2008.01666.x; Muller S, 2003, TRENDS PARASITOL, V19, P320, DOI 10.1016/S1471-4922(03)00141-7; MURTHY SS, 1994, J BIOL CHEM, V269, P31129; Ohkawa H, 2011, PLANT SIGNAL BEHAV, V6, P773, DOI 10.4161/psb.6.6.15239; Perez MT, 1997, MAR ECOL PROG SER, V155, P89, DOI 10.3354/meps155089; PIERCE RW, 1992, REV AQUAT SCI, V6, P139; Pierce SK, 2012, MOL BIOL EVOL, V29, P1545, DOI 10.1093/molbev/msr316; Pillet Loic, 2013, Mob Genet Elements, V3, pe24773; Pillet L, 2013, MOL BIOL EVOL, V30, P66, DOI 10.1093/molbev/mss226; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Santoferrara LF, 2011, J PLANKTON RES, V33, P457, DOI 10.1093/plankt/fbq128; Schoener DM, 2012, AQUAT MICROB ECOL, V67, P177, DOI 10.3354/ame01601; Sherr EB, 2002, ANTON LEEUW INT J G, V81, P293, DOI 10.1023/A:1020591307260; Shigeoka S, 2002, J EXP BOT, V53, P1305, DOI 10.1093/jexbot/53.372.1305; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoecker DK, 2009, AQUAT MICROB ECOL, V57, P279, DOI 10.3354/ame01340; Stoecker DK, 1998, EUR J PROTISTOL, V34, P281, DOI 10.1016/S0932-4739(98)80055-2; Strom SL, 2007, LIMNOL OCEANOGR, V52, P1480, DOI 10.4319/lo.2007.52.4.1480; Sun SL, 2011, NUCLEIC ACIDS RES, V39, pD546, DOI 10.1093/nar/gkq1102; Swart EC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001473; Takeda T, 1997, PHYSIOL PLANTARUM, V99, P49, DOI 10.1111/j.1399-3054.1997.tb03429.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vonlaufen N, 2008, CELL MICROBIOL, V10, P2387, DOI 10.1111/j.1462-5822.2008.01210.x; Wisecaver JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-366; Yoon HS, 2004, BBA-BIOENERGETICS, V1658, P181, DOI 10.1016/j.bbabio.2004.05.013; Zhang H, 2013, J EXP MAR BIOL ECOL, V446, P57, DOI 10.1016/j.jembe.2013.04.021; Zhang ZM, 2003, BIOINFORMATICS, V19, P307, DOI 10.1093/bioinformatics/19.2.307	75	19	19	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101418	10.1371/journal.pone.0101418	http://dx.doi.org/10.1371/journal.pone.0101418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983246	gold, Green Submitted, Green Published			2022-12-27	WOS:000339635000103
J	Chu, DK; Zhu, SJ; Li, JP; Ji, G; Wang, WZ; Wu, GS; Zheng, JY				Chu, Dake; Zhu, Shaojun; Li, Jipeng; Ji, Gang; Wang, Weizhong; Wu, Guosheng; Zheng, Jianyong			CD147 Expression in Human Gastric Cancer Is Associated with Tumor Recurrence and Prognosis	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE INDUCER; INCREASES CHEMOSENSITIVITY; CELL INVASION; EMMPRIN; OVEREXPRESSION; CHEMOTHERAPY; CISPLATIN; MARKER	CD147 is correlated with tumor aggressiveness in various human malignancies. Here, we investigated CD147 protein expression in 223 patients with gastric cancer by immunohistochemistry and analyzed its association with disease-free and overall survival. CD147 was increased in gastric cancer compared to normal tissues. Additionally, CD147 expression was associated with gastric cancer invasion, metastasis and TNM stage, whereas it was not related to age, sex, differentiation status, tumor site or Lauren classification. Kaplan-Meier analysis confirmed that CD147 was associated with disease-free and overall survival in patients with gastric cancer; i.e., patients with positive CD147 staining tend to have worse disease-free and overall survival. Moreover, Cox's proportional hazards analysis demonstrated that CD147 was an independent marker of disease-free and overall survival for patients with gastric cancer. These results confirm the association of CD147 with gastric cancer invasion and metastasis and prove that CD147 might be an indicator of tumor recurrence and prognosis in gastric cancer.	[Chu, Dake; Li, Jipeng; Ji, Gang; Wang, Weizhong; Wu, Guosheng; Zheng, Jianyong] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China; [Chu, Dake; Li, Jipeng; Ji, Gang; Wang, Weizhong; Wu, Guosheng; Zheng, Jianyong] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Chu, Dake] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China; [Chu, Dake] Fourth Mil Med Univ, Dept Biochem & Mol Biol, Xian 710032, Shaanxi, Peoples R China; [Zhu, Shaojun] Fourth Mil Med Univ, Tangdu Hosp, Dept Pathol, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Wu, GS (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China.	guosheng_w@yahoo.com; zhjy68@163.com	JI, Gang/AAG-9877-2020	JI, Gang/0000-0002-2415-6275	National Natural Science Foundation of China [81201927, 81272204, 31270812]; China Postdoctoral Science Foundation [2012M521862]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants from National Natural Science Foundation of China (No. 81201927, 81272204 and 31270812) and China Postdoctoral Science Foundation (No. 2012M521862). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso J, 2011, EJSO-EUR J SURG ONC, V37, P811, DOI 10.1016/j.ejso.2011.06.006; Als AB, 2007, CLIN CANCER RES, V13, P4407, DOI 10.1158/1078-0432.CCR-07-0109; An JY, 2012, ANN SURG ONCOL, V19, P2452, DOI 10.1245/s10434-012-2267-9; Bi XC, 2012, CLIN TRANSL ONCOL, V14, P190, DOI 10.1007/s12094-012-0783-5; Curran S, 2000, EUR J CANCER, V36, P1621, DOI 10.1016/S0959-8049(00)00156-8; Gabison EE, 2005, AM J PATHOL, V166, P209, DOI 10.1016/S0002-9440(10)62245-6; Gabison EE, 2005, BIOCHIMIE, V87, P361, DOI 10.1016/j.biochi.2004.09.023; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lescaille G, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-115; Liu FF, 2010, BREAST CANCER RES TR, V124, P677, DOI 10.1007/s10549-010-0790-6; Luo JQ, 2009, PROTEINS, V77, P1009, DOI 10.1002/prot.22577; Nakamura K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-191; Pan YQ, 2012, ONCOL REP, V27, P2003, DOI 10.3892/or.2012.1729; Parsons SL, 1997, BRIT J SURG, V84, P160, DOI 10.1002/bjs.1800840206; Pertega-Gomes N, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-312; Piao SL, 2012, J CANCER RES CLIN, V138, P627, DOI 10.1007/s00432-011-1142-6; Pinheiro C, 2009, EUR J CANCER, V45, P2418, DOI 10.1016/j.ejca.2009.06.018; Rhodes A, 2000, J CLIN PATHOL, V53, P125, DOI 10.1136/jcp.53.2.125; Ruiz S, 2008, J BIOL CHEM, V283, P5554, DOI 10.1074/jbc.M708566200; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Tang Y, 2004, MOL CANCER RES, V2, P73; Tian L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058069; Vigneswaran N, 2006, EXP MOL PATHOL, V80, P147, DOI 10.1016/j.yexmp.2005.09.011; Wang B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-61; Xue YJ, 2011, MED ONCOL, V28, P1363, DOI 10.1007/s12032-010-9582-4; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Yu XL, 2008, J BIOL CHEM, V283, P18056, DOI 10.1074/jbc.M802694200; Zheng HC, 2006, BRIT J CANCER, V95, P1371, DOI 10.1038/sj.bjc.6603425; Zhong X, 2012, ANN SURG ONCOL; Zou W, 2007, CANCER LETT, V248, P211, DOI 10.1016/j.canlet.2006.07.005	30	28	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101027	10.1371/journal.pone.0101027	http://dx.doi.org/10.1371/journal.pone.0101027			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979746	Green Published, gold, Green Submitted			2022-12-27	WOS:000338506400064
J	Cullen, CL; Burne, THJ; Lavidis, NA; Moritz, KM				Cullen, Carlie L.; Burne, Thomas H. J.; Lavidis, Nickolas A.; Moritz, Karen M.			Low Dose Prenatal Alcohol Exposure Does Not Impair Spatial Learning and Memory in Two Tests in Adult and Aged Rats	PLOS ONE			English	Article							ETHANOL EXPOSURE; MODERATE LEVELS; SYNAPTIC PLASTICITY; WATER-MAZE; SPECTRUM DISORDERS; POSTNATAL EXPOSURE; CRITICAL PERIODS; DENTATE GYRUS; CELL LOSS; FETAL	Consumption of alcohol during pregnancy can have detrimental impacts on the developing hippocampus, which can lead to deficits in learning and memory function. Although high levels of alcohol exposure can lead to severe deficits, there is a lack of research examining the effects of low levels of exposure. This study used a rat model to determine if prenatal exposure to chronic low dose ethanol would result in deficits in learning and memory performance and if this was associated with morphological changes within the hippocampus. Sprague Dawley rats were fed a liquid diet containing 6% (vol/vol) ethanol (EtOH) or an isocaloric control diet throughout gestation. Male and Female offspring underwent behavioural testing at 8 (Adult) or 15 months (Aged) of age. Brains from these animals were collected for stereological analysis of pyramidal neuron number and dendritic morphology within the CA1 and CA3 regions of the dorsal hippocampus. Prenatal ethanol exposed animals did not differ in spatial learning or memory performance in the Morris water maze or Y maze tasks compared to Control offspring. There was no effect of prenatal ethanol exposure on pyramidal cell number or density within the dorsal hippocampus. Overall, this study indicates that chronic low dose prenatal ethanol exposure in this model does not have long term detrimental effects on pyramidal cells within the dorsal hippocampus or impair spatial learning and memory performance.	[Cullen, Carlie L.; Lavidis, Nickolas A.; Moritz, Karen M.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Burne, Thomas H. J.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia	University of Queensland; University of Queensland	Moritz, KM (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia.	k.moritz1@uq.edu.au	Burne, Thomas H/C-5656-2009; Cullen, Carlie/J-7706-2014; Moritz, Karen/G-2508-2015	Burne, Thomas H/0000-0003-3502-9789; Cullen, Carlie/0000-0001-6929-6258; Moritz, Karen/0000-0002-8085-0034	National Health and Medical Research Council of Australia; Australian Post-graduate award	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Post-graduate award(Australian Government)	This work was supported by the National Health and Medical Research Council of Australia. CC was the recipient of an Australian Post-graduate award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL EL, 1980, PSYCHOL BULL, V87, P29; ABEL EL, 1983, NEUROBEH TOXICOL TER, V5, P363; ABEL EL, 1995, NEUROTOXICOL TERATOL, V17, P437, DOI 10.1016/0892-0362(95)00005-C; An L, 2013, ALCOHOL CLIN EXP RES, V37, P763, DOI 10.1111/acer.12040; Barr HM, 2006, AM J PSYCHIAT, V163, P1061, DOI 10.1176/appi.ajp.163.6.1061; Berman RE, 2000, HIPPOCAMPUS, V10, P94, DOI 10.1002/(SICI)1098-1063(2000)10:1<94::AID-HIPO11>3.3.CO;2-K; Brocardo PS, 2012, NEUROPHARMACOLOGY, V62, P1607, DOI 10.1016/j.neuropharm.2011.10.006; BROWN RT, 1991, NEUROTOXICOL TERATOL, V13, P369, DOI 10.1016/0892-0362(91)90085-B; CLAUSING P, 1995, NEUROTOXICOL TERATOL, V17, P545, DOI 10.1016/0892-0362(95)00014-I; Conrad CD, 2003, NEUROBIOL LEARN MEM, V79, P32, DOI 10.1016/S1074-7427(02)00018-7; Cronise K, 2001, BEHAV NEUROSCI, V115, P138, DOI 10.1037//0735-7044.115.1.138; Cullen CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054924; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Dobson CC, 2012, BEHAV BRAIN RES, V233, P162, DOI 10.1016/j.bbr.2012.04.042; Famy C, 1998, AM J PSYCHIAT, V155, P552, DOI 10.1176/ajp.155.4.552; GIANOULAKIS C, 1990, BEHAV BRAIN RES, V36, P217, DOI 10.1016/0166-4328(90)90060-R; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; Glavas MM, 2007, ALCOHOL CLIN EXP RES, V31, P1598, DOI 10.1111/j.1530-0277.2007.00460.x; Gonzalez-Burgos I, 2006, NEUROSCI RES, V56, P400, DOI 10.1016/j.neures.2006.08.007; Gray SP, 2010, J AM SOC NEPHROL, V21, P1891, DOI 10.1681/ASN.2010040368; Hamilton DA, 2003, BEHAV BRAIN RES, V143, P85, DOI 10.1016/S0166-4328(03)00028-7; Hamilton DA, 2010, BEHAV BRAIN RES, V207, P290, DOI 10.1016/j.bbr.2009.10.012; HOFF SF, 1988, BRAIN RES BULL, V21, P47, DOI 10.1016/0361-9230(88)90119-0; Hofmann CE, 2005, PHARMACOL BIOCHEM BE, V82, P549, DOI 10.1016/j.pbb.2005.10.010; Howell KK, 2006, J PEDIATR PSYCHOL, V31, P116, DOI 10.1093/jpepsy/jsj029; Iqbal U, 2005, J NEUROENDOCRINOL, V17, P600, DOI 10.1111/j.1365-2826.2005.01349.x; JONES KL, 1973, LANCET, V1, P1267; Kaminen-Ahola N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000811; KELLY SJ, 1988, BEHAV BRAIN RES, V27, P247, DOI 10.1016/0166-4328(88)90121-0; Kerns KA, 1997, J LEARN DISABIL-US, V30, P685, DOI 10.1177/002221949703000612; LEDIG M, 1988, ALCOHOL ALCOHOLISM, V23, P63; LIEBER CS, 1982, ALCOHOL CLIN EXP RES, V6, P523, DOI 10.1111/j.1530-0277.1982.tb05017.x; Livy DJ, 2003, NEUROTOXICOL TERATOL, V25, P447, DOI 10.1016/S0892-0362(03)00030-8; LOCHRY EA, 1980, NEUROTOXICOL TERATOL, V2, P107; Maier SE, 2001, ALCOHOL, V23, P49, DOI 10.1016/S0741-8329(00)00133-6; Mattson SN, 1999, J INT NEUROPSYCH SOC, V5, P462, DOI 10.1017/S1355617799555082; McAdam TD, 2008, BEHAV BRAIN RES, V191, P202, DOI 10.1016/j.bbr.2008.03.029; Miller MW, 1995, ALCOHOL CLIN EXP RES, V19, P1500, DOI 10.1111/j.1530-0277.1995.tb01014.x; Mineur YS, 2007, OPEN BEHAV SCI J, V1, P5; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Nagahara AH, 1997, ALCOHOL CLIN EXP RES, V21, P710, DOI 10.1111/j.1530-0277.1997.tb03826.x; O'Connor MJ, 2000, ALCOHOL CLIN EXP RES, V24, P1084, DOI 10.1097/00000374-200007000-00021; Olson HC, 1997, J AM ACAD CHILD PSY, V36, P1187, DOI 10.1097/00004583-199709000-00010; OSBORNE GL, 1980, PHARMACOL BIOCHEM BE, V12, P393, DOI 10.1016/0091-3057(80)90043-X; Probyn ME, 2012, REPROD FERT DEVELOP, V24, P859, DOI 10.1071/RD11200; Rasmussen C, 2011, CHILD CARE HLTH DEV, V37, P711, DOI 10.1111/j.1365-2214.2010.01152.x; REYES E, 1989, PHYSIOL BEHAV, V46, P45, DOI 10.1016/0031-9384(89)90319-3; Rice JP, 2012, ALCOHOL, V46, P577, DOI 10.1016/j.alcohol.2011.11.008; Richardson DP, 2002, EUR J NEUROSCI, V16, P1593, DOI 10.1046/j.1460-9568.2002.02214.x; Riley EP, 2005, EXP BIOL MED, V230, P357, DOI 10.1177/15353702-0323006-03; Savage DD, 2002, ALCOHOL CLIN EXP RES, V26, P1752, DOI 10.1097/01.ALC.0000038265.52107.20; Schneider ML, 2001, ALCOHOL CLIN EXP RES, V25, P1383; Sluyter F, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-5; Sowell ER, 2007, NEUROREPORT, V18, P635, DOI 10.1097/WNR.0b013e3280bad8dc; Streissguth A P, 2000, Semin Clin Neuropsychiatry, V5, P177, DOI 10.1053/scnp.2000.6729; STREISSGUTH AP, 1989, NEUROTOXICOL TERATOL, V11, P493, DOI 10.1016/0892-0362(89)90026-3; STREISSGUTH AP, 1990, ALCOHOL CLIN EXP RES, V14, P662, DOI 10.1111/j.1530-0277.1990.tb01224.x; STREISSGUTH AP, 1989, ANN NY ACAD SCI, V562, P145, DOI 10.1111/j.1749-6632.1989.tb21013.x; STREISSGUTH AP, 1991, JAMA-J AM MED ASSOC, V265, P1961, DOI 10.1001/jama.265.15.1961; Sutherland RJ, 2000, PSYCHOBIOLOGY, V28, P532; Sutherland RJ, 1997, HIPPOCAMPUS, V7, P232, DOI 10.1002/(SICI)1098-1063(1997)7:2<232::AID-HIPO9>3.0.CO;2-O; TANAKA H, 1991, INT J DEV NEUROSCI, V9, P509, DOI 10.1016/0736-5748(91)90037-M; Tarelo-Acuna L, 2000, NEUROSCI LETT, V286, P13, DOI 10.1016/S0304-3940(00)01075-2; Tomlinson D, 1998, PHYSIOL BEHAV, V63, P205, DOI 10.1016/S0031-9384(97)00424-1; Tran TD, 2003, NEUROTOXICOL TERATOL, V25, P519, DOI 10.1016/S0892-0362(03)00074-6; Vega MCS, 2013, BEHAV BRAIN RES, V252, P326, DOI 10.1016/j.bbr.2013.06.003; Watson C, 2006, RAT BRAIN STEREOTAXI; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Willford JA, 2004, ALCOHOL CLIN EXP RES, V28, P497, DOI 10.1097/01.ALC.0000117868.97486.2D; Willoughby KA, 2008, J INT NEUROPSYCH SOC, V14, P1022, DOI 10.1017/S1355617708081368	71	21	21	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101482	10.1371/journal.pone.0101482	http://dx.doi.org/10.1371/journal.pone.0101482			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978807	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400130
J	Fuller, JM; Wong, KK; Grunstein, R; Krass, I; Patel, J; Saini, B				Fuller, Joanne M.; Wong, Keith K.; Grunstein, Ronald; Krass, Ines; Patel, Jayshree; Saini, Bandana			A Comparison of Screening Methods for Sleep Disorders in Australian Community Pharmacies: A Randomized Controlled Trial	PLOS ONE			English	Article							APNEA; RISK; CARE; MORTALITY; INSOMNIA	Background: Community pharmacies may potentially assist in screening for chronic conditions such as sleep disorders, which remain both under-diagnosed and untreated. We aimed to compare a subjective risk-assessment-only questionnaire (RAO) for common sleep disorder screening against the same risk-assessment questionnaire plus a nasal flow monitor as an objective marker of possible underlying obstructive sleep apnea (OSA) (RA+) in a community pharmacy setting. The primary outcome was the number of participants identified in RAO or RA+ group who were likely to have and consequently be diagnosed with OSA. Further outcomes included the number of participants identified as being at risk for, referred for, taking-up referral for, and then diagnosed with OSA, insomnia, and/or restless legs syndrome (RLS) in either group. Methods: In a cluster-randomized trial, participants were recruited through 23 community pharmacies. Using validated instruments, 325 (RAO = 152, RA+ = 173) participants were screened for OSA, insomnia, and RLS. Findings: 218 (67%) participants were at risk of OSA, insomnia or RLS and these participants were referred to their primary physician. The proportion of screened participants identified as being at risk of OSA was significantly higher in the RA+ group (36% in RAO vs. 66% in RA+, OR 3.4, 95% CI (1.8-6.5), p<0.001). A 12-month follow-up was completed in 125 RAO and 155 RA+ participants. Actual referral uptake was 34% RAO, 26% RA+, OR 4.4, 95% CI (1.4-19.2), p = 0.31. The OSA diagnosis rate was higher in the RA+ arm (p = 0.01). To yield a single additional confirmed OSA diagnosis, 16 people would need to be screened using the RA+ protocol. Conclusions: These results demonstrate that utilising either screening method is feasible in identifying individuals in the community pharmacy setting who are likely to have OSA, insomnia and/or RLS. Secondly, adding an objective marker of OSA to a questionnaire-based prediction tool resulted in more confirmed OSA diagnoses.	[Fuller, Joanne M.; Krass, Ines; Patel, Jayshree; Saini, Bandana] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Fuller, Joanne M.; Wong, Keith K.; Grunstein, Ronald; Saini, Bandana] Univ Sydney, CIRUS, Sydney, NSW 2006, Australia; [Wong, Keith K.; Grunstein, Ronald] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Wong, Keith K.; Grunstein, Ronald] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney; Woolcock Institute of Medical Research	Fuller, JM (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.	joanne.fuller@sydney.edu.au	Fuller, Joanne/AAA-3145-2021	Krass, Ines/0000-0002-0466-9807; Wong, Keith K H/0000-0001-5191-5233; Fuller, Joanne M/0000-0003-3139-3532	Australian Government Department of Health and Ageing through The Pharmacy Guild of Australia's Fourth Community Pharmacy Agreement Research & Development scheme; NHMRC [264598, 571241]; Faculty of Pharmacy; CIRUS	Australian Government Department of Health and Ageing through The Pharmacy Guild of Australia's Fourth Community Pharmacy Agreement Research & Development scheme(Australian GovernmentDepartment of Health & Ageing); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Faculty of Pharmacy; CIRUS	This study was performed at the Faculty of Pharmacy, The University of Sydney, NSW, Australia, with the financial support of the Australian Government Department of Health and Ageing through The Pharmacy Guild of Australia's Fourth Community Pharmacy Agreement Research & Development scheme. The funded study was undertaken by independent researchers and, therefore, the views, hypotheses and subsequent findings of the research are not necessarily those of the Pharmacy Guild of Australia. Prof. Grunstein is a recipient of the NHMRC Practitioner Fellowship. Dr. Wong, Dr. Saini and Prof. Grunstein are investigators of CIRUS, the NHMRC Centre for Interdisciplinary Sleep Health (funding through NHMRC Grants 264598 and 571241). Ms. Fuller is a PhD Scholar supported through the Faculty of Pharmacy and CIRUS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alattar M, 2007, J AM BOARD FAM MED, V20, P365, DOI 10.3122/jabfm.2007.04.060153; AlGhanim N, 2008, LUNG, V186, P7, DOI 10.1007/s00408-007-9055-5; Allen H, 2012, IIG052 COPD; Allen RP, SLEEP, V4, P101; Australian Government Department of Health and Ageing, PRIM HLTH CAR REF AU; Australian Institute of Health and Welfare, 2008, AUSTR HLTH; Baraitser P, 2007, QUAL SAF HEALTH CARE, V16, P303, DOI 10.1136/qshc.2006.020883; Bartlett DJ, 2008, SLEEP MED, V9, P857, DOI 10.1016/j.sleep.2007.09.002; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bland JM, 2000, FAM PRACT, V17, pS17, DOI 10.1093/fampra/17.suppl_1.S17; Chai-Coetzer CL, 2011, THORAX, V66, P213, DOI 10.1136/thx.2010.152801; Committee on Sleep Medicine and Research, 2006, SLEEP DISORDERS SLEE; Crockett JA., 2008, INT J PHARM PRACT, V16, P65, DOI [10.1211/ijpp.16.2.0003, DOI 10.1211/ijpp.16.2.0003]; Deloitte Access Economics, 2011, RE AW AUSTR EC COST; Dikeos D, 2011, CURR OPIN PSYCHIATR, V24, P346, DOI 10.1097/YCO.0b013e3283473375; Effective Health Care Program Comparative Effectiveness Review Number, 2011, DIAGN TREATM OBSTR S; George CFP, 2001, THORAX, V56, P508, DOI 10.1136/thorax.56.7.508; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Hanes CA, 2014, INT J CLIN P; Hersberger KE, 2006, J CLIN PHARM THER, V31, P35, DOI 10.1111/j.1365-2710.2006.00698.x; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Krass I, 2007, DIABETES RES CLIN PR, V75, P339, DOI 10.1016/j.diabres.2006.06.022; Laugsand LE, 2011, CIRCULATION, V124, P2073, DOI 10.1161/CIRCULATIONAHA.111.025858; MAIMAN LA, 1992, AM J PUBLIC HEALTH, V82, P804, DOI 10.2105/AJPH.82.6.804; MAISLIN G, 1995, SLEEP, V18, P158, DOI 10.1093/sleep/18.3.158; Mangum Stacy A, 2003, J Am Pharm Assoc (Wash), V43, P50, DOI 10.1331/10865800360467042; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Marshall NS, 2008, SLEEP, V31, P1079; R Development Core Team, 2011, LANG ENV COMP R FOUN; Rofail LM, 2010, SLEEP, V33, P1097, DOI 10.1093/sleep/33.8.1097; Sharwood LN, 2012, SLEEP, V35, P469, DOI 10.5665/sleep.1726; Skaer TL, 2010, PHARMACOECONOMICS, V28, P1015, DOI 10.2165/11537390-000000000-00000; Snella KA, 2006, J AM PHARM ASSOC, V46, P370, DOI 10.1331/154434506777069598; The Pharmacy Guild of Australia, 2009, GUILD DIG; Tran A, 2009, PHARM WORLD SCI, V31, P473, DOI 10.1007/s11096-009-9301-4; Verne JECW, 1998, BRIT MED J, V317, P182, DOI 10.1136/bmj.317.7152.182; Young T, 2008, SLEEP, V31, P1071	37	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101003	10.1371/journal.pone.0101003	http://dx.doi.org/10.1371/journal.pone.0101003			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978952	Green Published, gold			2022-12-27	WOS:000338506400059
J	Huang, J; Ulanowicz, RE				Huang, Jiali; Ulanowicz, Robert E.			Ecological Network Analysis for Economic Systems: Growth and Development and Implications for Sustainable Development	PLOS ONE			English	Article							ENERGY; CONSUMPTION	The quantification of growth and development is an important issue in economics, because these phenomena are closely related to sustainability. We address growth and development from a network perspective in which economic systems are represented as flow networks and analyzed using ecological network analysis (ENA). The Beijing economic system is used as a case study and 11 input-output (I-O) tables for 1985-2010 are converted into currency networks. ENA is used to calculate system-level indices to quantify the growth and development of Beijing. The contributions of each direct flow toward growth and development in 2010 are calculated and their implications for sustainable development are discussed. The results show that during 1985-2010, growth was the main attribute of the Beijing economic system. Although the system grew exponentially, its development fluctuated within only a small range. The results suggest that system ascendency should be increased in order to favor more sustainable development. Ascendency can be augmented in two ways: (1) strengthen those pathways with positive contributions to increasing ascendency and (2) weaken those with negative effects.	[Huang, Jiali] Chinese Acad Sci, Inst Mt Hazards & Environm, Ctr Mt Dev, Chengdu, Sichuan, Peoples R China; [Ulanowicz, Robert E.] Univ Maryland, Chesapeake Biol Lab, Solomons, MD 20688 USA; [Ulanowicz, Robert E.] Univ Florida, Arthur R Marshall Lab, Gainesville, FL USA	Chinese Academy of Sciences; Institute of Mountain Hazards & Environment, CAS; University System of Maryland; University of Maryland Center for Environmental Science; State University System of Florida; University of Florida	Huang, J (corresponding author), Chinese Acad Sci, Inst Mt Hazards & Environm, Ctr Mt Dev, Chengdu, Sichuan, Peoples R China.	jialih@imde.ac.cn	Ulanowicz, Robert E/G-1021-2013		Chinese National Science Foundation for Distinguished Young Scholars [41201603]; "135" Program of the Institute of Mountain Hazards and Environment, CAS [SDS-135-1204-03]	Chinese National Science Foundation for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); "135" Program of the Institute of Mountain Hazards and Environment, CAS	This work was supported by grants from the Chinese National Science Foundation for Distinguished Young Scholars (41201603) and the "135" Program of the Institute of Mountain Hazards and Environment, CAS (grant number SDS-135-1204-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-mulali U, 2014, RENEW SUST ENERG REV, V30, P290, DOI 10.1016/j.rser.2013.10.006; Beijing Municipal Bureau of Statistics, 2011, BEIJ STAT YB 2011; Bodini A, 2012, ECOL MODEL, V245, P185, DOI 10.1016/j.ecolmodel.2012.02.022; Bodini A, 2012, ECOL INDIC, V15, P140, DOI 10.1016/j.ecolind.2011.09.032; Bowen A, 2012, CLIMATIC CHANGE, V113, P95, DOI 10.1007/s10584-011-0346-8; Colantonio E, 2010, PROCD SOC BEHV, V9, DOI 10.1016/j.sbspro.2010.12.148; Fath BD, 2007, ECOL MODEL, V208, P49, DOI 10.1016/j.ecolmodel.2007.04.029; Goerner SJ, 2009, ECOL ECON, V69, P76, DOI 10.1016/j.ecolecon.2009.07.018; HANNON B, 1973, J THEOR BIOL, V41, P535, DOI 10.1016/0022-5193(73)90060-X; Heymans JJ, 2002, ECOL MODEL, V149, P5, DOI 10.1016/S0304-3800(01)00511-7; Hudson J, 2013, WORLD DEV, V46, P66, DOI 10.1016/j.worlddev.2013.01.023; Jorgensen SE, 2009, ECOL MODEL, V220, P1893, DOI 10.1016/j.ecolmodel.2009.04.032; Kharrazi A, 2013, ECOL ECON, V90, P177, DOI 10.1016/j.ecolecon.2013.03.018; Leontief W.W., 1951, STRUCTURE AM EC 1919; Li Y, 2009, ECOL MODEL, V220, P3163, DOI 10.1016/j.ecolmodel.2009.08.007; Lietaer B, 2009, SAPIENS, V2, P1; Lietaer B, 2010, J FUTURES STUD, V14, P89; Mao XF, 2012, ECOL INFORM, V10, P17, DOI 10.1016/j.ecoinf.2011.05.006; National Bureau of Urban Social and Economic Survey, 2011, CHIN CIT STAT YB 201; Patricio J, 2006, HYDROBIOLOGIA, V555, P19, DOI 10.1007/s10750-005-1102-8; PATTEN BC, 1978, OHIO J SCI, V78, P206; Pizzol M, 2013, J ENVIRON MANAGE, V118, P21, DOI 10.1016/j.jenvman.2012.12.042; Rybarczyk H, 2003, ESTUAR COAST SHELF S, V58, P775, DOI 10.1016/S0272-7714(03)00184-7; Schaubroeck T, 2012, ECOL MODEL, V247, P144, DOI 10.1016/j.ecolmodel.2012.08.018; Schumacher I, 2011, ECOL ECON, V72, P97, DOI 10.1016/j.ecolecon.2011.09.002; Shahbaz M, 2013, RENEW SUST ENERG REV, V18, P87, DOI 10.1016/j.rser.2012.09.029; Shanghai Municipal Bureau of Statistics, 2011, SHANGH STAT YB 2011; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sharma SS, 2010, APPL ENERG, V87, P3565, DOI 10.1016/j.apenergy.2010.06.015; Stefan G, 2012, PROCD SOC BEHV, V62, P280, DOI 10.1016/j.sbspro.2012.09.045; Sun JW, 1998, ENERG ECON, V20, P85, DOI 10.1016/S0140-9883(97)00012-1; Ulanowicz R.E., 1997, ECOLOGY ASCENDENT PE; Ulanowicz R. E., 1986, GROWTH DEV ECOSYSTEM; ULANOWICZ RE, 1980, J THEOR BIOL, V85, P223, DOI 10.1016/0022-5193(80)90019-3; Ulanowicz RE, 2011, 2 VIENNESE TALKS RES; Ulanowicz RE, 2014, ECOL LETT, V17, P127, DOI 10.1111/ele.12216; Ulanowicz RE, 2009, ECOL COMPLEX, V6, P27, DOI 10.1016/j.ecocom.2008.10.005; Wang WW, 2013, ENERGY SUSTAIN DEV, V17, P62, DOI 10.1016/j.esd.2012.11.007; Welle-Strand A, 2012, ENERGY SUSTAIN DEV, V16, P26, DOI 10.1016/j.esd.2011.11.001; Zanin L, 2012, ECON MODEL, V29, P1328, DOI 10.1016/j.econmod.2012.03.007; Zhang JY, 2011, STOCH ENV RES RISK A, V25, P685, DOI 10.1007/s00477-011-0474-8	41	32	37	5	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100923	10.1371/journal.pone.0100923	http://dx.doi.org/10.1371/journal.pone.0100923			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK5ZO	24979465	Green Published, gold, Green Submitted			2022-12-27	WOS:000338506400049
J	Ro, J; Harvanek, ZM; Pletcher, SD				Ro, Jennifer; Harvanek, Zachary M.; Pletcher, Scott D.			FLIC: High-Throughput, Continuous Analysis of Feeding Behaviors in Drosophila	PLOS ONE			English	Article							TASTE; QUANTIFICATION; MELANOGASTER; RESTRICTION; FLY	We present a complete hardware and software system for collecting and quantifying continuous measures of feeding behaviors in the fruit fly, Drosophila melanogaster. The FLIC (Fly Liquid-Food Interaction Counter) detects analog electronic signals as brief as 50 mu s that occur when a fly makes physical contact with liquid food. Signal characteristics effectively distinguish between different types of behaviors, such as feeding and tasting events. The FLIC system performs as well or better than popular methods for simple assays, and it provides an unprecedented opportunity to study novel components of feeding behavior, such as time-dependent changes in food preference and individual levels of motivation and hunger. Furthermore, FLIC experiments can persist indefinitely without disturbance, and we highlight this ability by establishing a detailed picture of circadian feeding behaviors in the fly. We believe that the FLIC system will work hand-in-hand with modern molecular techniques to facilitate mechanistic studies of feeding behaviors in Drosophila using modern, high-throughput technologies.	[Ro, Jennifer] Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA; [Harvanek, Zachary M.; Pletcher, Scott D.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Harvanek, Zachary M.; Pletcher, Scott D.] Univ Michigan, Geriatr Ctr, Ann Arbor, MI 48109 USA; [Harvanek, Zachary M.] Univ Michigan, Med Scientist Training Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Pletcher, SD (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	spletch@umich.edu	Harvanek, Zachary/AGR-7656-2022; Harvanek, Zachary M/GPJ-9798-2022	Harvanek, Zachary/0000-0003-3702-1051; Ro, Jennifer/0000-0002-6351-2498	US National Institutes of Health [R01AG030593, TR01 AG043972, R01AG023166]; Glenn Foundation; American Federation for Aging Research; Ellison Medical Foundation; Glenn/AFAR Scholarship for Research in the Biology of Aging; Systems and Integrative Biology Training Grant [T32 GM008322]; Research Training in Biogerontology [T32 AG000114]; National Institute of Aging [P30-AG-013283]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315, T32GM007863, T32GM008322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283, R01AG043972, F31AG047696, R01AG030593, T32AG000114, R01AG023166] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation; American Federation for Aging Research; Ellison Medical Foundation(Lawrence Ellison Foundation); Glenn/AFAR Scholarship for Research in the Biology of Aging; Systems and Integrative Biology Training Grant; Research Training in Biogerontology; National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The research was supported by US National Institutes of Health (R01AG030593, TR01 AG043972, and R01AG023166), the Glenn Foundation, the American Federation for Aging Research, the Ellison Medical Foundation (to S. D. P.), a Glenn/AFAR Scholarship for Research in the Biology of Aging (to Z.M.H.), the Systems and Integrative Biology Training Grant (T32 GM008322 to Z.M.H.), and the Research Training in Biogerontology (T32 AG000114, to J.R.). This work utilized the Drosophila Aging Core of the Nathan Shock Center of Excellence in the Biology of Aging funded by the National Institute of Aging (P30-AG-013283). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson NS, 2009, J NEUROGENET, V23, P293, DOI 10.1080/01677060802572937; Carvalho GB, 2005, NAT METHODS, V2, P813, DOI 10.1038/NMETH798; Chatterjee A, 2010, FLY, V4, P283, DOI 10.4161/fly.4.4.13010; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; Dethier VG, 1976, HUNGRY FLY; Devineni AV, 2009, CURR BIOL, V19, P2126, DOI 10.1016/j.cub.2009.10.070; Dus M, 2011, P NATL ACAD SCI USA, V108, P11644, DOI 10.1073/pnas.1017096108; GEER BW, 1970, J INSECT PHYSIOL, V16, P33, DOI 10.1016/0022-1910(70)90110-1; Gordesky-Gold B, 2008, CHEM SENSES, V33, P301, DOI 10.1093/chemse/bjm088; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Itskov PM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00012; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; JACOBS HL, 1969, ANN NY ACAD SCI, V157, P1084, DOI 10.1111/j.1749-6632.1969.tb12939.x; Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223; Min KJ, 2006, MECH AGEING DEV, V127, P93, DOI 10.1016/j.mad.2005.09.004; Pfeiffenberger C, 2010, COLD SPRING HARB PRO; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; Tanoue S, 2008, CURR BIOL, V18, P787, DOI 10.1016/j.cub.2008.04.062; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Venken KJT, 2011, NEURON, V72, P202, DOI 10.1016/j.neuron.2011.09.021; Wong R, 2008, NAT METHODS, V5, P214, DOI 10.1038/nmeth0308-214; Wong R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006063; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006	23	76	76	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101107	10.1371/journal.pone.0101107	http://dx.doi.org/10.1371/journal.pone.0101107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978054	Green Published, gold, Green Submitted			2022-12-27	WOS:000338506400079
J	Stojmirovic, A; Yu, YK				Stojmirovic, Aleksandar; Yu, Yi-Kuo			Building a Hierarchical Organization of Protein Complexes Out of Protein Association Data	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; INFORMATION-FLOW; NETWORK; SUM; PURIFICATION; INTERACTOME; CHAPERONE; RESOURCE; GENES; ATLAS	Organizing experimentally determined protein associations as a hierarchy can be a good approach to elucidating the content of protein complexes and the modularity of subcomplexes. Several challenges exist. First, intrinsically sticky proteins, such as chaperones, are often falsely assigned to many functionally unrelated complexes. Second, the reported collections of proteins may not be true "complexes" in the sense that they bind together and perform a joint cellular function. Third, due to imperfect sensitivity of protein detection methods, both false positive and false negative assignments of a protein to complexes may occur. We mitigate the first issue by down-weighting sticky proteins by their occurrence frequencies. We approach the other two problems by merging nearly identical complexes and by constructing a directed acyclic graph (DAG) based on the relationship of partial inclusion. The constructed DAG, within which smaller complexes form parts of the larger, can reveal how different complexes are joined. By merging almost identical complexes one can deemphasize the influence of false positives, while allowing false negatives to be rescued by other nearly identical association data. We investigate several protein weighting schemes and compare their corresponding DAGs using yeast and human complexes. We find that the scheme incorporating weights based on information flow in the network of direct protein-protein interactions produces biologically most meaningful DAGs. In either yeast or human, isolated nodes form a large proportion of the final hierarchy. While most connected components encompass very few nodes, the largest one for each species contains a sizable portion of all nodes. By considering examples of subgraphs composed of nodes containing a specified protein, we illustrate that the graphs' topological features can correctly suggest the biological roles of protein complexes. The input data, final results and the source code are available at ftp://ftp.ncbi.nlm.nih.gov/pub/qmbpmn/ProteinComplexDAG/.	[Stojmirovic, Aleksandar; Yu, Yi-Kuo] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Yu, YK (corresponding author), Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA.	yyu@ncbi.nlm.nih.gov		Stojmirovic, Aleksandar/0000-0003-0957-6893	Intramural Research Program of the National Library of Medicine at the National Institutes of Health; NATIONAL LIBRARY OF MEDICINE [ZIALM092404] Funding Source: NIH RePORTER	Intramural Research Program of the National Library of Medicine at the National Institutes of Health; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the Intramural Research Program of the National Library of Medicine at the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Day RN, 2001, METHODS, V25, P4, DOI 10.1006/meth.2001.1211; Dutkowski J, 2013, NAT BIOTECHNOL, V31, P38, DOI 10.1038/nbt.2463; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gillis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017258; Gong YC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.26; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD436, DOI 10.1093/nar/gkj003; Havugimana PC, 2007, J CHROMATOGR B, V847, P54, DOI 10.1016/j.jchromb.2006.10.075; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Isserlin R, 2011, DATABASE-OXFORD, DOI 10.1093/database/baq037; Kemeny J.G., 1976, MARKOV CHAINS, V6; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Krogan NJ, 2001, MOL CELL BIOL, V21, P8203, DOI 10.1128/MCB.21.23.8203-8212.2001; Legrain P, 2000, FEBS LETT, V480, P32, DOI 10.1016/S0014-5793(00)01774-9; LUGANNANI R, 1980, ADV APPL PROBAB, V12, P475, DOI 10.2307/1426607; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; PHIZICKY EM, 1995, MICROBIOL REV, V59, P94, DOI 10.1128/MMBR.59.1.94-123.1995; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Qian WJ, 2006, MOL CELL PROTEOMICS, V5, P1727, DOI 10.1074/mcp.M600162-MCP200; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Shimoda Y, 2008, DNA RES, V15, P13, DOI 10.1093/dnares/dsm028; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Stellberger Thorsten, 2010, Proteome Sci, V8, P8, DOI 10.1186/1477-5956-8-8; Stojmircivic A, 2007, J COMPUT BIOL, V14, P1115, DOI 10.1089/cmb.2007.0069; Stojmirovic A, 2012, J COMPUT BIOL, V19, P379, DOI 10.1089/cmb.2010.0228; Stojmirovic A, 2012, BIOINFORMATICS, V28, P893, DOI 10.1093/bioinformatics/bts041; Stojmirovic A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar036; Stojmirovic A, 2010, BIOINFORMATICS, V26, P2752, DOI 10.1093/bioinformatics/btq511; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	46	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100098	10.1371/journal.pone.0100098	http://dx.doi.org/10.1371/journal.pone.0100098			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978199	Green Submitted, Green Published, gold			2022-12-27	WOS:000338506400020
J	Arata, S; Takeuchi, Y; Inoue, M; Mori, Y				Arata, Sayaka; Takeuchi, Yukari; Inoue, Mai; Mori, Yuji			"Reactivity to Stimuli'' Is a Temperamental Factor Contributing to Canine Aggression	PLOS ONE			English	Article							PURE-BRED DOGS; BEHAVIORAL TRAITS; UNITED-KINGDOM; DOMESTIC DOG; RISK-FACTORS; SHIBA INU; POLYMORPHISMS; PERSONALITY; ASSOCIATION; VALIDATION	Canine aggression is one of the most frequent problems in veterinary behavioral medicine, which in severe cases may result in relinquishment or euthanasia. As it is important to reveal underlying factors of aggression for both treatment and prevention, we recently developed a questionnaire on aggression and temperamental traits and found that "reactivity to stimuli" was associated with aggression toward owners, children, strangers, and other dogs of the Shiba Inu breed. In order to examine whether these associations were consistent in other breeds, we asked the owners of insured dogs of Anicom Insurance Inc. to complete our questionnaire. The top 17 contracted breeds were included. The questionnaire consisted of dogs' general information, four items related to aggression toward owners, children, strangers, and other dogs, and 20 other behavioral items. Aggression-related and behavioral items were rated on a five-point frequency scale. Valid responses (n = 5610) from owners of dogs aged 1 through 10 years were collected. Factor analyses on 18 behavioral items (response rate over 95%) extracted five largely consistent factors in 14 breeds: "sociability with humans," "fear of sounds," "chase proneness," "reactivity to stimuli," and "avoidance of aversive events." By stepwise multiple regression analyses, using the Schwartz's Bayesian information criterion (BIC) method with aggression points as objective variables and general information and temperamental factor points as explanatory variables, "reactivity to stimuli," i.e., physical reactivity to sudden movement or sound at home, was shown to be significantly associated with owner-directed aggression in 13 breeds, child-directed aggression in eight breeds, stranger-directed aggression in nine breeds, and dog-directed aggression in five breeds. These results suggest that "reactivity to stimuli" is simultaneously involved in several types of aggression. Therefore, it would be worth taking "reactivity to stimuli" into account in the treatment and prevention of canine aggression.	[Arata, Sayaka; Takeuchi, Yukari; Mori, Yuji] Univ Tokyo, Dept Anim Resource Sci, Tokyo, Japan; [Inoue, Mai] Anicom Insurance Inc, Claims Serv Dept, Tokyo, Japan	University of Tokyo	Takeuchi, Y (corresponding author), Univ Tokyo, Dept Anim Resource Sci, Tokyo, Japan.	aytake@mail.ecc.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [21380172, 26292163]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (21380172, and 26292163). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arata S, 2010, J VET MED SCI, V72, P539, DOI 10.1292/jvms.09-0512; Bamberger M, 2006, JAVMA-J AM VET MED A, V229, P1591, DOI 10.2460/javma.229.10.1591; Bradshaw JWS, 1996, VET REC, V138, P465, DOI 10.1136/vr.138.19.465; Casey RA, 2013, VET REC, V172, P127, DOI 10.1136/vr.100997; Christensen E, 2007, APPL ANIM BEHAV SCI, V106, P85, DOI 10.1016/j.applanim.2006.07.002; De Keuster T, 2006, VET J, V172, P482, DOI 10.1016/j.tvjl.2005.04.024; Duffy DL, 2008, APPL ANIM BEHAV SCI, V114, P441, DOI 10.1016/j.applanim.2008.04.006; Fatjo J, 2007, J VET BEHAV, V2, P158, DOI 10.1016/j.jveb.2007.07.008; Houpt KA, 2007, ACTA VET BRNO, V76, P431, DOI 10.2754/avb200776030431; Houpt KA, 2006, J VET BEHAV, V1, P39, DOI 10.1016/j.jveb.2006.04.006; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; Jones AC, 2005, APPL ANIM BEHAV SCI, V95, P1, DOI 10.1016/j.applanim.2005.04.008; Kaneko F, 2013, J VET MED SCI, V75, P1297, DOI 10.1292/jvms.13-0082; Konno A, 2011, BIOL LETTERS, V7, P658, DOI 10.1098/rsbl.2011.0087; Kroll TL, 2004, J AM ANIM HOSP ASSOC, V40, P13, DOI 10.5326/0400013; Netto WJ, 1997, APPL ANIM BEHAV SCI, V52, P243, DOI 10.1016/S0168-1591(96)01126-4; Notari L, 2007, APPL ANIM BEHAV SCI, V103, P118, DOI 10.1016/j.applanim.2006.03.018; Parker HG, 2005, PLOS GENET, V1, P507, DOI 10.1371/journal.pgen.0010058; Patronek GJ, 1996, J AM VET MED ASSOC, V209, P572; Serpell JA, 2001, APPL ANIM BEHAV SCI, V72, P347, DOI 10.1016/S0168-1591(00)00210-0; Starling MJ, 2013, BEHAV PROCESS, V97, P53, DOI 10.1016/j.beproc.2013.04.008; Svartberg K, 2005, APPL ANIM BEHAV SCI, V91, P103, DOI 10.1016/j.applanim.2004.08.030; TAKEUCHI Y, 2009, ANIM GENET, V40, P616, DOI DOI 10.1111/j.1365-2052.2009.01888.x; Takeuchi Y, 2006, J VET MED SCI, V68, P789, DOI 10.1292/jvms.68.789; Taylor KD, 2006, J VET BEHAV, V1, P94, DOI 10.1016/j.jveb.2006.09.002; Vage J, 2010, GENES BRAIN BEHAV, V9, P372, DOI 10.1111/j.1601-183X.2010.00568.x; van den Berg L, 2008, BEHAV GENET, V38, P55, DOI 10.1007/s10519-007-9179-7; van der Borg JAM, 2010, APPL ANIM BEHAV SCI, V128, P78, DOI 10.1016/j.applanim.2010.09.016; Wright H.F., 2011, INT J COMP PSYCH, V24, P210, DOI DOI 10.5811/westjem.2011.5.6700	29	12	12	4	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100767	10.1371/journal.pone.0100767	http://dx.doi.org/10.1371/journal.pone.0100767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972077	gold, Green Published, Green Submitted			2022-12-27	WOS:000338512200060
J	Ding, S; Xia, CY; Zhou, KL; Yang, SL; Shang, JS				Ding, Shuai; Xia, Chen-Yi; Zhou, Kai-Le; Yang, Shan-Lin; Shang, Jennifer S.			Decision Support for Personalized Cloud Service Selection through Multi-Attribute Trustworthiness Evaluation	PLOS ONE			English	Article							SYSTEM; SAAS	Facing a customer market with rising demands for cloud service dependability and security, trustworthiness evaluation techniques are becoming essential to cloud service selection. But these methods are out of the reach to most customers as they require considerable expertise. Additionally, since the cloud service evaluation is often a costly and time-consuming process, it is not practical to measure trustworthy attributes of all candidates for each customer. Many existing models cannot easily deal with cloud services which have very few historical records. In this paper, we propose a novel service selection approach in which the missing value prediction and the multi-attribute trustworthiness evaluation are commonly taken into account. By simply collecting limited historical records, the current approach is able to support the personalized trustworthy service selection. The experimental results also show that our approach performs much better than other competing ones with respect to the customer preference and expectation in trustworthiness assessment.	[Ding, Shuai; Zhou, Kai-Le; Yang, Shan-Lin] Hefei Univ Technol, Sch Management, Hefei, Peoples R China; [Ding, Shuai; Zhou, Kai-Le; Yang, Shan-Lin] Minist Educ, Key Lab Proc Optimizat & Intelligent Decis Making, Hefei, Peoples R China; [Xia, Chen-Yi] Tianjin Univ Technol, Minist Educ, Tianjin Key Lab Intelligence Comp & Novel Softwar, Tianjin, Peoples R China; [Xia, Chen-Yi] Tianjin Univ Technol, Minist Educ, Key Lab Comp Vis & Syst, Tianjin, Peoples R China; [Shang, Jennifer S.] Univ Pittsburgh, Joseph M Katz Grad Sch Business, Pittsburgh, PA 15260 USA	Hefei University of Technology; Tianjin University of Technology; Tianjin University of Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ding, S (corresponding author), Hefei Univ Technol, Sch Management, Hefei, Peoples R China.	dingshuai@hfut.edu.cn; xialooking@163.com	Xia, Chengyi/A-2752-2012	Xia, Chengyi/0000-0003-2686-5072	National Natural Science Foundation of China [61374169, 71131002, 71201042]; National Key Basic Research Program of China [2013CB329603]; Specialized Research Fund for the Doctoral Program of Higher Education of MOE of China [20120111110020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Specialized Research Fund for the Doctoral Program of Higher Education of MOE of China	This work was supported by the National Natural Science Foundation of China through grant Nos. 61374169, 71131002, and 71201042, the National Key Basic Research Program of China through grant No. 2013CB329603 and the Specialized Research Fund for the Doctoral Program of Higher Education of MOE of China through grant No. 20120111110020. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, INT J MACH LEARN COM, DOI DOI 10.7763/IJMLC.2011.V1.62; Benlian A, 2011, DECIS SUPPORT SYST, V52, P232, DOI 10.1016/j.dss.2011.07.007; Bobadilla J, 2012, INFORM SCIENCES, V185, P1, DOI 10.1016/j.ins.2011.09.014; Breese J. S., 1998, Uncertainty in Artificial Intelligence. Proceedings of the Fourteenth Conference (1998), P43; Chakraborty S., 2012, 2012 IEEE 11th International Conference on Trust, Security and Privacy in Computing and Communications (TrustCom), P937, DOI 10.1109/TrustCom.2012.84; Chen PY, 2013, INFORM SYST RES, V24, P750, DOI 10.1287/isre.1120.0451; Cheng HD, 1997, INFORM SCIENCES, V96, P163, DOI 10.1016/S0020-0255(96)00141-7; Cruz JM, 2012, DECIS SUPPORT SYST, V52, P562, DOI 10.1016/j.dss.2011.10.012; Cusumano M, 2010, COMMUN ACM, V53, P27, DOI 10.1145/1721654.1721667; Das S, 2011, INFORM SYST RES, V22, P756, DOI 10.1287/isre.1100.0288; Demirkan H, 2010, J MANAGE INFORM SYST, V26, P119, DOI 10.2753/MIS0742-1222260405; Deshpande M, 2004, ACM T INFORM SYST, V22, P143, DOI 10.1145/963770.963776; Ding S, 2014, KNOWL-BASED SYST, V56, P216, DOI 10.1016/j.knosys.2013.11.014; Ding S, 2012, KNOWL INF SYST, V33, P171, DOI 10.1007/s10115-011-0442-0; Donzelli P, 2006, J SYST SOFTWARE, V79, P107, DOI 10.1016/j.jss.2005.03.011; Garg SK, 2013, FUTURE GENER COMP SY, V29, P1012, DOI 10.1016/j.future.2012.06.006; Hackney R, 2006, EUR J OPER RES, V173, P1161, DOI 10.1016/j.ejor.2005.07.010; Hang CW, 2011, ACM T AUTON ADAP SYS, V6, DOI 10.1145/1921641.1921646; Hwang SY, 2013, DECIS SUPPORT SYST, V54, P1463, DOI 10.1016/j.dss.2012.12.017; Iosup A, 2011, IEEE T PARALL DISTR, V22, P931, DOI 10.1109/TPDS.2011.66; Jin R, 2005, SIGIR, P337; Jinhui Yao, 2011, Proceedings of the 2011 IEEE International Conference on Web Services (ICWS 2011), P299, DOI 10.1109/ICWS.2011.44; Karaoglanoglou K, 2011, J SYST SOFTWARE, V84, P465, DOI 10.1016/j.jss.2010.10.043; Katzan H, 2011, SERV SCI, V1, P256; Lecue F, 2010, IEEE INT C SEMANT CO, P200, DOI 10.1109/ICSC.2010.37; Limam N, 2010, IEEE T SOFTWARE ENG, V36, P559, DOI 10.1109/TSE.2010.2; Marston S, 2011, DECIS SUPPORT SYST, V51, P176, DOI 10.1016/j.dss.2010.12.006; Mehdi M., 2012, Proceedings of the 2012 IEEE 19th International Conference on Web Services (ICWS), P17, DOI 10.1109/ICWS.2012.17; Pal R, 2013, THEOR COMPUT SCI, V496, P113, DOI 10.1016/j.tcs.2012.11.001; RESNICK P, 1994, 1994 ACM C COMPUTER, P175, DOI [DOI 10.1145/192844.192905, 10.1145/192844.192905]; Rosario Sidney, 2008, IEEE Transactions on Services Computing, V1, P187, DOI 10.1109/TSC.2008.17; SEIFODDINI H, 1991, COMPUT IND ENG, V21, P263, DOI 10.1016/0360-8352(91)90099-R; Shao LS, 2007, 2007 IEEE INTERNATIONAL CONFERENCE ON WEB SERVICES, PROCEEDINGS, P439; Stolyar AL, 2013, OPER RES, V61, P1200, DOI 10.1287/opre.2013.1184; Sullivan M.W., 1993, MARKETING SCI, V12; Sundareswaran S., 2012, 2012 IEEE 5th International Conference on Cloud Computing (CLOUD), P558, DOI 10.1109/CLOUD.2012.119; Sunyaev A, 2013, COMMUN ACM, V56, P33, DOI 10.1145/2408776.2408789; Tao F, 2010, EUR J OPER RES, V201, P129, DOI 10.1016/j.ejor.2009.02.025; Tserpes K, 2012, FUTURE GENER COMP SY, V28, P1285, DOI 10.1016/j.future.2011.11.003; Tsesmetzis D, 2008, EUR J OPER RES, V191, P1101, DOI 10.1016/j.ejor.2007.07.015; Wang QA, 2011, IEEE T PARALL DISTR, V22, P847, DOI 10.1109/TPDS.2010.183; Xi Chen, 2010, 2010 IEEE International Conference on Web Services (ICWS), P9, DOI 10.1109/ICWS.2010.27; Zheng ZB, 2010, 2010 IEEE INT CONF W, P83, DOI DOI 10.1109/ICWS.2010.10; Zheng ZB, 2013, IEEE T PARALL DISTR, V24, P1213, DOI 10.1109/TPDS.2012.285; Zheng ZB, 2011, IEEE T SERV COMPUT, V4, P140, DOI 10.1109/TSC.2010.52	45	27	27	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e97762	10.1371/journal.pone.0097762	http://dx.doi.org/10.1371/journal.pone.0097762			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972237	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000338512200005
J	Veiga, ABG; Ribeiro, JMC; Francischetti, IMB; Xu, XQ; Guimaraes, JA; Andersen, JF				Veiga, Ana B. G.; Ribeiro, Jose M. C.; Francischetti, Ivo M. B.; Xu, Xueqing; Guimaraes, Jorge A.; Andersen, John F.			Examination of the Ligand-Binding and Enzymatic Properties of a Bilin-Binding Protein from the Poisonous Caterpillar Lonomia obliqua	PLOS ONE			English	Article							OXYGENASE HMU O; MANDUCA-SEXTA L; CORYNEBACTERIUM-DIPHTHERIAE; PSEUDOMONAS-AERUGINOSA; HEMORRHAGIC SYNDROME; MOLECULAR-STRUCTURE; OXIDATIVE CLEAVAGE; COUPLED OXIDATION; CRYSTAL-STRUCTURE; TOBACCO HORNWORM	The bilin-binding proteins (BBP) from lepidopteran insects are members of the lipocalin family of proteins and play a special role in pigmentation through the binding of biliverdin IX gamma. Lopap, a BBP-like protein from the venom of the toxic caterpillar Lonomia obliqua has been reported to act as a serine protease that activates the coagulation proenzyme prothrombin. Here we show that BBPLo, a variant of lopap from the same organism binds biliverdin IX gamma, forming a complex that is spectrally identical with previously described BBP proteins. Although BBPLo is nearly identical in sequence to lopap, no prothrombinase activity was detected in our recombinant preparations using reconstituted systems containing coagulation factors Xa and Va, as well as anionic phospholipids. In addition to biliverdin, BBPLo was found to form a 1:1 complex with heme prompting us to examine whether the unusual biliverdin IX gamma ligand of BBPs forms as a result of oxidation of bound heme in situ rather than by a conventional heme oxygenase. Using ascorbate or a NADPH+-ferredoxin reductase-ferredoxin system as a source of reducing equivalents, spectral changes are seen that suggest an initial reduction of heme to the Fe(II) state and formation of an oxyferrous complex. The complex then disappears and a product identified as a 5-coordinate carbonyl complex of verdoheme, an intermediate in the biosynthesis of biliverdin, is formed. However, further reaction to form biliverdin was not observed, making it unlikely that biliverdin IX gamma is formed by this pathway.	[Veiga, Ana B. G.; Ribeiro, Jose M. C.; Francischetti, Ivo M. B.; Xu, Xueqing; Andersen, John F.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA; [Veiga, Ana B. G.; Guimaraes, Jorge A.] Univ Fed Rio Grande do Sul, Ctr Biotechnol, Porto Alegre, RS, Brazil	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universidade Federal do Rio Grande do Sul	Andersen, JF (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.	jandersen@niaid.nih.gov	da Veiga, Ana Beatriz Gorini/N-8581-2013; Guimarães, Jorge Almeida/V-2196-2019; Ribeiro, Jose/J-7011-2015	da Veiga, Ana Beatriz Gorini/0000-0003-1462-5506; Ribeiro, Jose/0000-0002-9107-0818; Guimaraes, Jorge A./0000-0001-6354-6789	intramural research program of the NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001012, ZIAAI000810] Funding Source: NIH RePORTER	intramural research program of the NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the intramural research program of the NIAID, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JF, 1998, STRUCTURE, V6, P1315, DOI 10.1016/S0969-2126(98)00131-2; Andersen JF, 2000, J BIOL CHEM, V275, P30496, DOI 10.1074/jbc.M002857200; Andersen JF, 2003, J BIOL CHEM, V278, P4611, DOI 10.1074/jbc.M211438200; Avila L, 2003, J AM CHEM SOC, V125, P4103, DOI 10.1021/ja029311v; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Caignan GA, 2002, J AM CHEM SOC, V124, P14879, DOI 10.1021/ja0274960; de Montellano PRO, 2000, CURR OPIN CHEM BIOL, V4, P221; Francischetti IMB, 1999, BIOCHEMISTRY-US, V38, P16678, DOI 10.1021/bi991231p; GOODMAN WG, 1985, BIOCHEMISTRY-US, V24, P1168, DOI 10.1021/bi00326a017; Gudderra NP, 2005, J BIOL CHEM, V280, P25022, DOI 10.1074/jbc.M504386200; HOLDEN HM, 1987, EMBO J, V6, P1565, DOI 10.1002/j.1460-2075.1987.tb02401.x; HUBER R, 1987, J MOL BIOL, V198, P499, DOI 10.1016/0022-2836(87)90296-8; Monteiro RQ, 2005, BIOCHEM J, V387, P871, DOI 10.1042/BJ20041738; Reis CV, 2006, BIOCHEM J, V398, P295, DOI 10.1042/BJ20060325; RILEY CT, 1984, J BIOL CHEM, V259, P3159; Roberts SA, 2001, BIOCHEMISTRY-US, V40, P11327, DOI 10.1021/bi0109257; Robinson CR, 1997, BIOCHEMISTRY-US, V36, P16141, DOI 10.1021/bi971470h; Sigman JA, 2001, J AM CHEM SOC, V123, P6945, DOI 10.1021/ja015776u; Veiga ABG, 2005, GENE, V355, P11, DOI 10.1016/j.gene.2005.05.002; Veiga ABG, 2003, THROMB RES, V111, P95, DOI 10.1016/j.thromres.2003.08.020; Veiga ABG, 2001, TOXICON, V39, P1343, DOI 10.1016/S0041-0101(01)00086-1; Wegele R, 2004, J BIOL CHEM, V279, P45791, DOI 10.1074/jbc.M408303200; Wilks A, 2000, J BIOL CHEM, V275, P11686, DOI 10.1074/jbc.275.16.11686; Wilks A, 1996, BIOCHEMISTRY-US, V35, P930, DOI 10.1021/bi952405f; Wilks A, 1998, J BIOL CHEM, V273, P837, DOI 10.1074/jbc.273.2.837	25	1	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e95424	10.1371/journal.pone.0095424	http://dx.doi.org/10.1371/journal.pone.0095424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972000	Green Published, Green Submitted, gold			2022-12-27	WOS:000338512200003
J	Huber, K; Brigide, P; Bretas, EB; Canniatti-Brazaca, SG				Huber, Karina; Brigide, Priscila; Bretas, Eloa Bolis; Canniatti-Brazaca, Solange Guidolin			Effect of Thermal Processing and Maceration on the Antioxidant Activity of White Beans	PLOS ONE			English	Article							PHASEOLUS-VULGARIS L.; PHENOLIC-ACIDS; METHANOLIC EXTRACT; CHLOROGENIC ACID; SEED COAT; FLAVONOIDS; CAPACITY; POLYPHENOLS; COMPONENTS; PROFILES	Phenolic compounds, which naturally occur in beans, are known to have antioxidant activity, which may be partially lost during the processing of this legume. This study evaluated the effect of thermal processing and maceration on the phenolic acid and flavonoids profile and content and on the antioxidant activity of white beans. According to the results obtained from the 2,2-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) method, there were no significant differences among treatment groups analysed. When was using 1,1-diphenyl-2-pycrylhydrazyl method (DPPH), beans cooked without maceration present the higher antioxidant activity, and raw beans the lower. The phenolic acids found in greater amounts were gallic acid and chlorogenic acid. Kaempferol was only detected in the soaked and cooked samples; catechin and kaempferol-3-rutinoside were found in the highest concentrations. Quercetin and kaempferol-3-glucoside were not affected by the cooking process, either with or without maceration. In general, the heat treatment increased the antioxidant activity.	[Huber, Karina; Brigide, Priscila; Bretas, Eloa Bolis; Canniatti-Brazaca, Solange Guidolin] Univ Sao Paulo, Luiz De Queiroz Coll Agr, Agrifood Ind Food & Nutr Dept, Piracicaba, SP, Brazil	Universidade de Sao Paulo	Canniatti-Brazaca, SG (corresponding author), Univ Sao Paulo, Luiz De Queiroz Coll Agr, Agrifood Ind Food & Nutr Dept, Piracicaba, SP, Brazil.	sgcbraza@usp.br	Canniatti-Brazaca, Solange G/B-7693-2012	Canniatti-Brazaca, Solange G/0000-0001-5397-7112	CAPES	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The funders (schoolarship CAPES) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaby K, 2004, J AGR FOOD CHEM, V52, P4595, DOI 10.1021/jf0352879; Aguilera Y, 2011, FOOD RES INT, V44, P774, DOI 10.1016/j.foodres.2011.01.004; Amarowicz R, 2008, EUR J LIPID SCI TECH, V110, P865, DOI 10.1002/ejlt.200800114; Aparicio-Fernandez X, 2005, J FOOD SCI, V70, pS73, DOI 10.1111/j.1365-2621.2005.tb09068.x; Arabbi PR, 2004, J AGR FOOD CHEM, V52, P1124, DOI 10.1021/jf0499525; Arts MJTJ, 2004, FOOD CHEM, V88, P567, DOI 10.1016/j.foodchem.2004.02.008; Beninger CW, 2003, J AGR FOOD CHEM, V51, P7879, DOI 10.1021/jf0304324; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Campos-Vega R, 2010, FOOD RES INT, V43, P461, DOI 10.1016/j.foodres.2009.09.004; Cardador-Martinez A, 2006, PLANT FOOD HUM NUTR, V61, P161, DOI 10.1007/s11130-006-0026-4; D'Archivio M, 2010, INT J MOL SCI, V11, P1321, DOI 10.3390/ijms11041321; dos Santos MD, 2006, BIOL PHARM BULL, V29, P2236, DOI 10.1248/bpb.29.2236; Diaz-Batalla L, 2006, J AGR FOOD CHEM, V54, P2045, DOI 10.1021/jf051706l; Dinelli G, 2006, FOOD CHEM, V99, P105, DOI 10.1016/j.foodchem.2005.07.028; Elizabeth RGN, 2007, FOOD CHEM, V103, P521, DOI 10.1016/j.foodchem.2006.08.021; Espinosa-Alonso LG, 2006, J AGR FOOD CHEM, V54, P4436, DOI 10.1021/jf060185e; Fernandez-Panchon MS, 2008, CRIT REV FOOD SCI, V48, P649, DOI 10.1080/10408390701761845; Halliwell B, 2000, CARDIOVASC RES, V47, P410, DOI 10.1016/S0008-6363(00)00097-3; Howes MJR, 2003, PHYTOTHER RES, V17, P1, DOI 10.1002/ptr.1280; Itoh A, 2010, BIOL PHARM BULL, V33, P983, DOI 10.1248/bpb.33.983; Khadem S, 2010, MOLECULES, V15, P7985, DOI 10.3390/molecules15117985; Kosinska A, 2011, EUR FOOD RES TECHNOL, V233, P213, DOI 10.1007/s00217-011-1506-9; Kwon SH, 2010, EUR J PHARMACOL, V649, P210, DOI 10.1016/j.ejphar.2010.09.001; Lee CW, 2011, BIOMOL THER, V19, P181, DOI 10.4062/biomolther.2011.19.2.181; Lin JY, 2007, FOOD CHEM, V101, P140, DOI 10.1016/j.foodchem.2006.01.014; Lin LZ, 2008, FOOD CHEM, V107, P399, DOI 10.1016/j.foodchem.2007.08.038; Luthria DL, 2006, J FOOD COMPOS ANAL, V19, P205, DOI 10.1016/j.jfca.2005.09.003; Madhujith T, 2005, J FOOD SCI, V70, pS85, DOI 10.1111/j.1365-2621.2005.tb09071.x; Orhan I, 2007, Z NATURFORSCH C, V62, P829; Ranilla LG, 2007, J AGR FOOD CHEM, V55, P90, DOI 10.1021/jf062785j; Ranilla LG, 2009, J AGR FOOD CHEM, V57, P5734, DOI 10.1021/jf900527v; Rauter AP, 2012, FOOD CHEM, V132, P1930, DOI 10.1016/j.foodchem.2011.12.028; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Romani A, 2004, J AGR FOOD CHEM, V52, P3838, DOI 10.1021/jf0307402; SOARES Sergio Eduardo, 2002, Rev. Nutr., V15, P71, DOI 10.1590/S1415-52732002000100008; Statistical Analysis System Institute, 1998, SAS QC SOFTW US REF; Vadivel V, 2012, LWT-FOOD SCI TECHNOL, V47, P255, DOI 10.1016/j.lwt.2012.01.014; Valdes ST, 2011, LWT-FOOD SCI TECHNOL, V44, P2104, DOI 10.1016/j.lwt.2011.06.014; van den Berg R, 1999, FOOD CHEM, V66, P511, DOI 10.1016/S0308-8146(99)00089-8; Xu BJ, 2008, J FOOD SCI, V73, pH19, DOI 10.1111/j.1750-3841.2007.00625.x; Xu BJ, 2009, J AGR FOOD CHEM, V57, P4754, DOI 10.1021/jf900695s; Yeh CT, 2003, J AGR FOOD CHEM, V51, P1474, DOI 10.1021/jf0208132	43	6	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e99325	10.1371/journal.pone.0099325	http://dx.doi.org/10.1371/journal.pone.0099325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991931	Green Submitted, gold, Green Published			2022-12-27	WOS:000341253400010
J	Manchini, MT; Serra, AJ; Feliciano, RDS; Santana, ET; Antonio, EL; de Carvalho, PDC; Montemor, J; Crajoinas, RO; Girardi, ACC; Tucci, PJF; Silva, JA				Manchini, Martha Trindade; Serra, Andrey Jorge; Feliciano, Regiane dos Santos; Santana, Eduardo Tadeu; Antonio, Ednei Luis; Camillo de Carvalho, Paulo de Tarso; Montemor, Jairo; Crajoinas, Renato Oliveira; Costa Girardi, Adriana Castello; Ferreira Tucci, Paulo Jose; Silva, Jose Antonio, Jr.			Amelioration of Cardiac Function and Activation of Anti-Inflammatory Vasoactive Peptides Expression in the Rat Myocardium by Low Level Laser Therapy	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; NITRIC-OXIDE SYNTHASE; ENDOTHELIAL-CELL PROLIFERATION; HEART-FAILURE; INFARCT SIZE; MESSENGER-RNA; GROWTH-FACTOR; B2 RECEPTORS; KININ B1; IRRADIATION	Low-level laser therapy (LLLT) has been used as an anti-inflammatory treatment in several disease conditions, even when inflammation is a secondary consequence, such as in myocardial infarction (MI). However, the mechanism by which LLLT is able to protect the remaining myocardium remains unclear. The present study tested the hypothesis that LLLT reduces inflammation after acute MI in female rats and ameliorates cardiac function. The potential participation of the Renin-Angiotensin System (RAS) and Kallikrein-Kinin System (KKS) vasoactive peptides was also evaluated. LLLT treatment effectively reduced MI size, attenuated the systolic dysfunction after MI, and decreased the myocardial mRNA expression of interleukin-1 beta and interleukin-6 in comparison to the non-irradiated rat tissue. In addition, LLLT treatment increased protein and mRNA levels of the Mas receptor, the mRNA expression of kinin B2 receptors and the circulating levels of plasma kallikrein compared to non-treated post-MI rats. On the other hand, the kinin B1 receptor mRNA expression decreased after LLLT. No significant changes were found in the expression of vascular endothelial growth factor (VEGF) in the myocardial remote area between laser-irradiated and non-irradiated post-MI rats. Capillaries density also remained similar between these two experimental groups. The mRNA expression of the inducible nitric oxide synthase (iNOS) was increased three days after MI, however, this effect was blunted by LLLT. Moreover, endothelial NOS mRNA content increased after LLLT. Plasma nitric oxide metabolites (NOx) concentration was increased three days after MI in non-treated rats and increased even further by LLLT treatment. Our data suggest that LLLT diminishes the acute inflammation in the myocardium, reduces infarct size and attenuates left ventricle dysfunction post-MI and increases vasoactive peptides expression and nitric oxide (NO) generation.	[Manchini, Martha Trindade; Serra, Andrey Jorge; Feliciano, Regiane dos Santos; Santana, Eduardo Tadeu; Camillo de Carvalho, Paulo de Tarso; Silva, Jose Antonio, Jr.] Univ Nove Julho, UNINOVE, Sao Paulo, Brazil; [Antonio, Ednei Luis; Montemor, Jairo; Ferreira Tucci, Paulo Jose] Univ Fed Sao Paulo, UNIFESP, Sao Paulo, Brazil; [Crajoinas, Renato Oliveira; Costa Girardi, Adriana Castello] Univ Sao Paulo, Heart Inst InCor, Sao Paulo, Brazil	Universidade Nove de Julho; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Silva, JA (corresponding author), Univ Nove Julho, UNINOVE, Sao Paulo, Brazil.	josejr@uninove.br	Girardi, Adriana/C-4827-2012; Girardi, Adriana C. C./B-4334-2014; de Tarso C de Carvalho, Paulo/G-5333-2011; Silva, Jose Antonio/AAA-8100-2019; Antonio, Ednei/AGG-9987-2022; Serra, Andrey Jorge/E-7460-2015; Tucci, Paulo/D-1441-2015	Girardi, Adriana/0000-0003-3715-6917; Girardi, Adriana C. C./0000-0003-3715-6917; de Tarso C de Carvalho, Paulo/0000-0001-9624-4103; Silva, Jose Antonio/0000-0001-6904-9185; Antonio, Ednei/0000-0002-8254-5762; Serra, Andrey Jorge/0000-0002-5407-8183; Tucci, Paulo/0000-0001-9793-670X; Manchini, Martha/0000-0001-5785-0899	Sao Paulo Research Foundation (FAPESP); CNPq [477458/2009-2, 309715/2011-3, 479395/2012-8];  [2009/54225-8]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); 	This work was supported by the grant #2009/54225-8, Sao Paulo Research Foundation (FAPESP), and the CNPq #477458/2009-2, #309715/2011-3 and #479395/2012-8 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ad N, 2001, INT J CARDIOL, V80, P109, DOI 10.1016/S0167-5273(01)00503-4; Al-Maghrebi M, 2009, PHARMACOL RES, V59, P263, DOI 10.1016/j.phrs.2008.12.008; Araujo RC, 2006, BIOL CHEM, V387, P431, DOI 10.1515/BC.2006.057; Bader M, 2013, PFLUG ARCH EUR J PHY, V465, P79, DOI 10.1007/s00424-012-1120-0; Bortone F, 2008, INT IMMUNOPHARMACOL, V8, P206, DOI 10.1016/j.intimp.2007.09.004; Brovkovych V, 2011, J CELL MOL MED, V15, P258, DOI 10.1111/j.1582-4934.2009.00992.x; Burrell LM, 2005, EUR HEART J, V26, P369, DOI 10.1093/eurheartj/ehi114; Chen CH, 2008, LASER SURG MED, V40, P46, DOI 10.1002/lsm.20589; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Cury V, 2013, J PHOTOCH PHOTOBIO B, V125, P164, DOI 10.1016/j.jphotobiol.2013.06.004; de Almeida P, 2012, LASER MED SCI, V27, P453, DOI 10.1007/s10103-011-0957-3; De Mello W, 2003, REGUL PEPTIDES, V114, P87, DOI 10.1016/S0167-0115(03)00121-6; Dimmeler S, 2000, REGUL PEPTIDES, V90, P19, DOI 10.1016/S0167-0115(00)00105-1; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; dos Santos AA, 2013, INT J CARDIOL, V167, P357, DOI 10.1016/j.ijcard.2011.12.097; Dourado DM, 2011, PHOTOCHEM PHOTOBIOL, V87, P418, DOI 10.1111/j.1751-1097.2010.00878.x; Feng J, 2012, CELL SIGNAL, V24, P1116, DOI 10.1016/j.cellsig.2012.01.013; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Gross ER, 2006, CARDIOVASC RES, V70, P212, DOI 10.1016/j.cardiores.2005.12.019; Hamblin MR, 2010, LASER SURG MED, V42, P447, DOI 10.1002/lsm.20959; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; JOHNSTON CI, 1994, HYPERTENSION, V23, P258, DOI 10.1161/01.HYP.23.2.258; Kanashiro RM, 2006, J CARD FAIL, V12, P163, DOI 10.1016/j.cardfail.2005.09.007; Keidar S, 2007, CARDIOVASC RES, V73, P463, DOI 10.1016/j.cardiores.2006.09.006; KOIDE A, 1993, J PHYSIOL-LONDON, V467, pP125; Kompa AR, 2008, J PHARMACOL EXP THER, V325, P741, DOI 10.1124/jpet.107.133546; Kuhr F, 2010, NEUROPEPTIDES, V44, P145, DOI 10.1016/j.npep.2009.12.004; LAFOLLETTE L, 1987, J LAB CLIN MED, V110, P318; LINZ W, 1993, J HYPERTENS, V11, pS96; Loot AE, 2002, CIRCULATION, V105, P1548, DOI 10.1161/01.CIR.0000013847.07035.B9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu J, 2013, NEUROPEPTIDES, V47, P289, DOI 10.1016/j.npep.2013.09.002; Marchesi C, 2008, TRENDS PHARMACOL SCI, V29, P367, DOI 10.1016/j.tips.2008.05.003; Marcondes S., 2005, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V3, P33, DOI 10.2174/1568016052773351; Marketou M, 2010, AM J HYPERTENS, V23, P562, DOI 10.1038/ajh.2010.20; Oliveira FAM, 2012, PHOTOMED LASER SURG, V30, P705, DOI 10.1089/pho.2012.3272; Meng CB, 2013, J NEUROSCI, V33, P13505, DOI 10.1523/JNEUROSCI.0918-13.2013; Meotti FC, 2012, BRIT J PHARMACOL, V166, P1127, DOI 10.1111/j.1476-5381.2012.01830.x; Mercure C, 2008, CIRC RES, V103, P1319, DOI 10.1161/CIRCRESAHA.108.184911; MESTER E, 1971, AM J SURG, V122, P532, DOI 10.1016/0002-9610(71)90482-X; MISKO TP, 1993, ANAL BIOCHEM, V214, P11, DOI 10.1006/abio.1993.1449; Nadu AP, 2008, J AM SOC HYPERTENS, V2, P341, DOI 10.1016/j.jash.2008.04.012; Nozawa E, 2006, BRAZ J MED BIOL RES, V39, P687, DOI 10.1590/S0100-879X2006000500016; Oron U, 2001, LASER SURG MED, V28, P204, DOI 10.1002/lsm.1039; Oron U, 2001, CIRCULATION, V103, P296; Pereira MG, 2009, EUR J APPL PHYSIOL, V105, P843, DOI 10.1007/s00421-008-0967-4; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Pontes FL, 2008, INT IMMUNOPHARMACOL, V8, P261, DOI 10.1016/j.intimp.2007.09.001; Potier L, 2013, J PHARMACOL EXP THER, V346, P23, DOI 10.1124/jpet.113.203927; Sampaio WO, 2007, HYPERTENSION, V49, P185, DOI 10.1161/01.HYP.0000251865.35728.2f; Santos AA, 2009, J CARD FAIL, V15, P163, DOI 10.1016/j.cardfail.2008.10.017; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Santos RAS, 2006, HYPERTENSION, V47, P996, DOI 10.1161/01.HYP.0000215289.51180.5c; Scholkens BA, 1996, IMMUNOPHARMACOLOGY, V33, P209, DOI 10.1016/0162-3109(96)00061-6; Sharma JN, 2008, THESCIENTIFICWORLDJO, V8, DOI 10.1100/tsw.2008.53; Silva MP, 2011, REV BRAS FISIOTER, V15, P1; Silveira KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066082; Souza APS, 2013, CLIN SCI, V125, P449, DOI 10.1042/CS20120519; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Szymanska J, 2013, J PHYSIOL PHARMACOL, V64, P387; Tsai WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038235; van Nieuwenhoven FA, 2013, VASC PHARMACOL, V58, P182, DOI 10.1016/j.vph.2012.07.003; Venema RC, 2002, INT IMMUNOPHARMACOL, V2, P1755, DOI 10.1016/S1567-5769(02)00185-6; Westermann D, 2009, DIABETES, V58, P1373, DOI 10.2337/db08-0329; Whittaker P, 2000, LASER SURG MED, V27, P29, DOI 10.1002/1096-9101(2000)27:1<29::AID-LSM4>3.0.CO;2-8; Xu XH, 2008, J MOL CELL CARDIOL, V44, P114, DOI 10.1016/j.yjmcc.2007.10.004; Yang ZK, 2011, PHOTOMED LASER SURG, V29, P391, DOI 10.1089/pho.2010.2866; Yin H, 2007, PEPTIDES, V28, P1383, DOI 10.1016/j.peptides.2007.05.010; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Zhang YK, 2007, J BIOL CHEM, V282, P32453, DOI 10.1074/jbc.M706242200; Zisman LS, 2003, CIRCULATION, V108, P1707, DOI 10.1161/01.CIR.0000094734.67990.99	72	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101270	10.1371/journal.pone.0101270	http://dx.doi.org/10.1371/journal.pone.0101270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991808	gold, Green Published, Green Submitted			2022-12-27	WOS:000341253400057
J	Patil, SP; Brown, TT; Jacobson, LP; Margolick, JB; Laffan, A; Johnson-Hill, L; Godfrey, R; Johnson, J; Reynolds, S; Schwartz, AR; Smith, PL				Patil, Susheel P.; Brown, Todd T.; Jacobson, Lisa P.; Margolick, Joseph B.; Laffan, Alison; Johnson-Hill, Lisette; Godfrey, Rebecca; Johnson, Jacquett; Reynolds, Sandra; Schwartz, Alan R.; Smith, Philip L.			Sleep Disordered Breathing, Fatigue, and Sleepiness in HIV-Infected and -Uninfected Men	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; EXCESSIVE DAYTIME SLEEPINESS; MESSENGER-RNA EXPRESSION; MULTICENTER AIDS COHORT; SLOW-WAVE SLEEP; UPPER AIRWAY; ANTIRETROVIRAL THERAPY; INSULIN-RESISTANCE; FACTOR-ALPHA; PERIPHERAL LIPODYSTROPHY	Study Objectives: We investigated the association of HIV infection and highly active antiretroviral therapy (HAART) with sleep disordered breathing (SDB), fatigue, and sleepiness. Methods: HIV-uninfected men (HIV-; n = 60), HIV-infected men using HAART (HIV+/HAART+; n = 58), and HIV-infected men not using HAART (HIV+/HAART-; n = 41) recruited from two sites of the Multicenter AIDS cohort study (MACS) underwent a nocturnal sleep study, anthropometric assessment, and questionnaires for fatigue and the Epworth Sleepiness Scale. The prevalence of SDB in HIV- men was compared to that in men matched from the Sleep Heart Health Study (SHHS). Results: The prevalence of SDB was unexpectedly high in all groups: 86.7% for HIV-, 70.7% for HIV+/HAART+, and 73.2% for HIV+/HAART-, despite lower body-mass indices (BMI) in HIV+ groups. The higher prevalence in the HIV- men was significant in univariate analyses but not after adjustment for BMI and other variables. SDB was significantly more common in HIV- men in this study than those in SHHS, and was common in participants with BMIs <25 kg/m(2). HIV+ men reported fatigue more frequently than HIV- men (25.5% vs. 6.7%; p = 0.003), but self-reported sleepiness did not differ among the three groups. Sleepiness, but not fatigue, was significantly associated with SDB. Conclusions: SDB was highly prevalent in HIV- and HIV+ men, despite a normal or slightly elevated BMI. The high rate of SDB in men who have sex with men deserves further investigation. Sleepiness, but not fatigue, was related to the presence of SDB. Clinicians caring for HIV-infected patients should distinguish between fatigue and sleepiness when considering those at risk for SDB, especially in non-obese men.	[Patil, Susheel P.; Laffan, Alison; Schwartz, Alan R.; Smith, Philip L.] Johns Hopkins Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA; [Brown, Todd T.] Johns Hopkins Sch Med, Div Endocrinol & Metab, Baltimore, MD USA; [Jacobson, Lisa P.; Johnson-Hill, Lisette; Reynolds, Sandra] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Margolick, Joseph B.; Godfrey, Rebecca; Johnson, Jacquett] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Patil, SP (corresponding author), Johns Hopkins Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA.	spatil@jhmi.edu	Patil, Susheel/K-2554-2019	Patil, Susheel/0000-0001-6501-5957; Jacobson, Lisa P./0000-0003-1722-6826	NIH (Johns Hopkins Institute for Clinical and Translational Research; ICTR) [RO1-HL07955, K23-HL77137, K23-AT2862, UL1-RR-025005]; MACS - Baltimore site [U01-AI-35042]; MACS - Pittsburgh site [U01-AI-35041]; CAMACS [U01-AI-35043]; National Heart, Lung, and Blood Institute [U01HL53937]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [K23AT002862] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL053937, K23HL077137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035041, U01AI035042, UM1AI035043, U01AI035043] Funding Source: NIH RePORTER	NIH (Johns Hopkins Institute for Clinical and Translational Research; ICTR); MACS - Baltimore site; MACS - Pittsburgh site; CAMACS; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported through NIH grants RO1-HL07955, K23-HL77137, K23-AT2862, UL1-RR-025005 (Johns Hopkins Institute for Clinical and Translational Research; ICTR), U01-AI-35042 (MACS - Baltimore site), U01-AI-35041 (MACS - Pittsburgh site), and U01-AI-35043 (CAMACS). The Baltimore site of the SHHS was supported by the National Heart, Lung, and Blood Institute cooperative agreement U01HL53937. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams N, 2001, AM J RESP CRIT CARE, V163, P1626, DOI 10.1164/ajrccm.163.7.2004014; Aguillard RN, 1998, APPL PSYCHOPHYS BIOF, V23, P207, DOI 10.1023/A:1022257514209; [Anonymous], 1992, SLEEP, V15, P174; [Anonymous], 1988, BOD MEAS ANTHR; Arner P, 2001, BIOCHEM SOC T, V29, P72, DOI 10.1042/bst0290072; Barroso J, 1999, J Assoc Nurses AIDS Care, V10, P42, DOI 10.1016/S1055-3290(06)60342-7; Bixler EO, 1998, AM J RESP CRIT CARE, V157, P144, DOI 10.1164/ajrccm.157.1.9706079; Breitbart W, 2001, ARCH INTERN MED, V161, P411, DOI 10.1001/archinte.161.3.411; Brown T, 2006, JAIDS-J ACQ IMM DEF, V43, P356, DOI 10.1097/01.qai.0000243052.73321.8e; Brown TT, 2010, ANTIVIR THER, V15, P651, DOI 10.3851/IMP1572; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Carr A, 1998, LANCET, V351, P1881, DOI 10.1016/S0140-6736(98)03391-1; Chang FC, 2000, AM J PHYSIOL-REG I, V279, pR793, DOI 10.1152/ajpregu.2000.279.3.R793; Chervin RD, 2000, CHEST, V118, P372, DOI 10.1378/chest.118.2.372; Chow DC, 2003, HIV CLIN TRIALS, V4, P411, DOI 10.1310/5E7Q-PGWB-16UE-J48U; Darko D F, 1995, Focus, V10, P5; Darko DF, 1995, P NATL ACAD SCI USA, V92, P12080, DOI 10.1073/pnas.92.26.12080; DARKO DF, 1992, AM J PSYCHIAT, V149, P514; Dorey-Stein Zachariah, 2008, J Cardiometab Syndr, V3, P111, DOI 10.1111/j.1559-4572.2008.07552.x; Dusserre E, 2000, BBA-MOL BASIS DIS, V1500, P88, DOI 10.1016/S0925-4439(99)00091-5; Dybul M, 2002, ANN INTERN MED, V137, P381, DOI 10.7326/0003-4819-137-5_Part_2-200209031-00001; EPSTEIN LJ, 1995, SLEEP, V18, P368, DOI 10.1093/sleep/18.5.368; Fang JD, 1998, AM J PHYSIOL-REG I, V274, pR655, DOI 10.1152/ajpregu.1998.274.3.R655; Ferrando S, 1998, PSYCHOSOM MED, V60, P759, DOI 10.1097/00006842-199811000-00019; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Gemma C, 1999, J NEUROIMMUNOL, V97, P94, DOI 10.1016/S0165-5728(99)00052-1; Gemma C, 2000, CELL MOL NEUROBIOL, V20, P419, DOI 10.1023/A:1007053129686; Guilleminault C, 2009, SLEEP BREATH, V13, P341, DOI 10.1007/s11325-009-0253-7; GUILLEMINAULT C, 1993, CHEST, V104, P781, DOI 10.1378/chest.104.3.781; HAPONIK EF, 1983, AM REV RESPIR DIS, V127, P221; Hossain JL, 2005, J SLEEP RES, V14, P245, DOI 10.1111/j.1365-2869.2005.00466.x; Hossain JL, 2003, J SLEEP RES, V12, P223, DOI 10.1046/j.1365-2869.2003.00354.x; Hultin LE, 2007, CYTOM PART B-CLIN CY, V72B, P249, DOI 10.1002/cyto.b.20176; Huxtable AG, 2011, RESP PHYSIOL NEUROBI, V178, P482, DOI 10.1016/j.resp.2011.06.017; Iber C., 2007, AASM MANUAL SCORING; Isono S, 1997, J APPL PHYSIOL, V82, P1319, DOI 10.1152/jappl.1997.82.4.1319; Johns MW, 2000, J SLEEP RES, V9, P5, DOI 10.1046/j.1365-2869.2000.00177.x; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; Krueger JM, 2001, ANN NY ACAD SCI, V933, P211; Kubota T, 2002, BRAIN RES, V932, P37, DOI 10.1016/S0006-8993(02)02262-X; Martinez E, 2010, AIDS, V24, P353, DOI 10.1097/QAD.0b013e3283333666; NORMAN SE, 1990, AIDS, V4, P775, DOI 10.1097/00002030-199008000-00009; NORMAN SE, 1992, SLEEP, V15, P150, DOI 10.1093/sleep/15.2.150; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Opp MR, 1996, AM J PHYSIOL-REG I, V270, pR963, DOI 10.1152/ajpregu.1996.270.5.R963; Palella FJ, 2004, CLIN INFECT DIS, V38, P903, DOI 10.1086/381684; Patil SP, 2007, CHEST, V132, P325, DOI 10.1378/chest.07-0040; Pavlova MK, 2008, SLEEP, V31, P241, DOI 10.1093/sleep/31.2.241; Phillips Kenneth D, 2004, Biol Res Nurs, V6, P59, DOI 10.1177/1099800404264846; Punjabi NM, 1999, AM J RESP CRIT CARE, V159, P1703, DOI 10.1164/ajrccm.159.6.9808095; Punjabi NM, 2002, AM J RESP CRIT CARE, V165, P677, DOI 10.1164/ajrccm.165.5.2104087; Re VL, 2006, INT J STD AIDS, V17, P614, DOI 10.1258/095646206778113078; Resta O, 2001, INT J OBESITY, V25, P669, DOI 10.1038/sj.ijo.0801603; Salahuddin N, 2009, J ASSOC NURSE AIDS C, V20, P6, DOI 10.1016/j.jana.2008.05.007; Schulz R, 2003, CLIN INFECT DIS, V37, P1398, DOI 10.1086/379131; SCHWAB RJ, 1995, AM J RESP CRIT CARE, V152, P1673, DOI 10.1164/ajrccm.152.5.7582313; Schwartz Alan R, 2008, Proc Am Thorac Soc, V5, P185, DOI 10.1513/pats.200708-137MG; SCHWARTZ AR, 1988, J APPL PHYSIOL, V64, P535, DOI 10.1152/jappl.1988.64.2.535; Shen JH, 2006, SLEEP MED REV, V10, P63, DOI 10.1016/j.smrv.2005.05.004; SMITH PL, 1988, J APPL PHYSIOL, V64, P789, DOI 10.1152/jappl.1988.64.2.789; Spath-Schwalbe E, 1998, J CLIN ENDOCR METAB, V83, P1573, DOI 10.1210/jc.83.5.1573; STEPANSKI E, 1984, SLEEP, V7, P18, DOI 10.1093/sleep/7.1.18; Stepanski EJ, 2002, SLEEP, V25, P268, DOI 10.1093/sleep/25.3.268; Takahashi S, 1999, AM J PHYSIOL-REG I, V276, pR1132, DOI 10.1152/ajpregu.1999.276.4.R1132; Terao A, 1998, NEUROREPORT, V9, P3791, DOI 10.1097/00001756-199812010-00005; Vgontzas AN, 1997, J CLIN ENDOCR METAB, V82, P1313, DOI 10.1210/jc.82.5.1313; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P4409, DOI 10.1210/jc.2003-031929; Vgontzas AN, 1999, SLEEP, V22, pS331; Wand H, 2007, AIDS, V21, P2445, DOI 10.1097/QAD.0b013e3282efad32; Wilcox I, 1998, THORAX, V53, pS25; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	71	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e99258	10.1371/journal.pone.0099258	http://dx.doi.org/10.1371/journal.pone.0099258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991815	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400009
J	Shiomi, H; Tsuda, S; Suzuki, H; Yomo, T				Shiomi, Hideaki; Tsuda, Soichiro; Suzuki, Hiroaki; Yomo, Tetsuya			Liposome-Based Liquid Handling Platform Featuring Addition, Mixing, and Aliquoting of Femtoliter Volumes	PLOS ONE			English	Article							MEMBRANE-FUSION; VESICLES; MICROFLUIDICS; GENERATION; CHEMISTRY; FISSION; BIOLOGY; DEVICES	This paper describes the utilization of giant unilamellar vesicles (GUVs) as a platform for handling chemical and biochemical reagents. GUVs with diameters of 5 to 10 mm and containing chemical/biochemical reagents together with inert polymers were fused with electric pulses (electrofusion). After reagent mixing, the fused GUVs spontaneously deformed to a budding shape, separating the mixed solution into sub-volumes. We utilized a microfluidic channel and optical tweezers to select GUVs of interest, bring them into contact, and fuse them together to mix and aliquot the reaction product. We also show that, by lowering the ambient temperature close to the phase transition temperature T-m of the lipid used, daughter GUVs completely detached (fission). This process performs all the liquid-handing features used in bench-top biochemistry using the GUV, which could be advantageous for the membrane-related biochemical assays.	[Shiomi, Hideaki; Yomo, Tetsuya] Osaka Univ, Grad Sch Informat Sci & Technol, Osaka, Japan; [Tsuda, Soichiro] Univ Glasgow, Sch Chem, Glasgow, Lanark, Scotland; [Tsuda, Soichiro; Suzuki, Hiroaki; Yomo, Tetsuya] ERATO, JST, Tokyo, Japan; [Suzuki, Hiroaki] Chuo Univ, Fac Sci & Engn, Tokyo 112, Japan; [Yomo, Tetsuya] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan	Osaka University; University of Glasgow; Chuo University; Osaka University	Yomo, T (corresponding author), Osaka Univ, Grad Sch Informat Sci & Technol, Osaka, Japan.	yomo@ist.osaka-u.ac.jp	Suzuki, Hiroaki/T-8989-2019	Suzuki, Hiroaki/0000-0002-8899-0955	JSPS KAKENHI Grant [24710116, 24115514]; Grants-in-Aid for Scientific Research [26289038] Funding Source: KAKEN	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by JSPS KAKENHI Grant Numbers 24710116 and 24115514. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti JJ, 2010, P NATL ACAD SCI USA, V107, P4004, DOI 10.1073/pnas.0910781107; Boal D., 2012, MECH CELL; Caschera F, 2011, LANGMUIR, V27, P13082, DOI 10.1021/la202648h; Chiu DT, 2009, ACCOUNTS CHEM RES, V42, P649, DOI 10.1021/ar8002464; Choi K, 2012, ANNU REV ANAL CHEM, V5, P413, DOI 10.1146/annurev-anchem-062011-143028; Christensen AL, 2013, LAB CHIP, V13, P3613, DOI 10.1039/c3lc50492a; DOBEREINER HG, 1993, BIOPHYS J, V65, P1396; He MY, 2004, ANAL CHEM, V76, P1222, DOI 10.1021/ac035196a; Karlsson A, 2003, ANAL CHEM, V75, P2529, DOI 10.1021/ac0340206; Kelly BT, 2007, CHEM COMMUN, P1773, DOI 10.1039/b616252e; Koster S, 2008, LAB CHIP, V8, P1110, DOI 10.1039/b802941e; Leirer C, 2009, BIOPHYS CHEM, V143, P106, DOI 10.1016/j.bpc.2009.04.002; Lentz BR, 2007, EUR BIOPHYS J BIOPHY, V36, P315, DOI 10.1007/s00249-006-0097-z; Link DR, 2006, ANGEW CHEM INT EDIT, V45, P2556, DOI 10.1002/anie.200503540; Malloggi F, 2010, LANGMUIR, V26, P2369, DOI 10.1021/la9028047; Mazutis L, 2009, ANAL CHEM, V81, P4813, DOI 10.1021/ac900403z; Nishimura K, 2009, LANGMUIR, V25, P10439, DOI 10.1021/la902237y; Pantazatos DP, 1999, J MEMBRANE BIOL, V170, P27, DOI 10.1007/s002329900535; Paterson DJ, 2014, LAB CHIP, V14, P1806, DOI 10.1039/c4lc00199k; Peters RJRW, 2014, ANGEW CHEM INT EDIT, V53, P146, DOI 10.1002/anie.201308141; Robinson T, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4816712; Schaerli Y, 2009, MOL BIOSYST, V5, P1392, DOI 10.1039/b907578j; Shui LL, 2009, SOFT MATTER, V5, P2708, DOI 10.1039/b908498c; Stone HA, 2004, ANNU REV FLUID MECH, V36, P381, DOI 10.1146/annurev.fluid.36.050802.122124; Sunami T, 2010, LANGMUIR, V26, P15098, DOI 10.1021/la102689v; Tan YC, 2006, SENSOR ACTUAT B-CHEM, V114, P350, DOI 10.1016/j.snb.2005.06.008; Tanaka T, 2004, LANGMUIR, V20, P5160, DOI 10.1021/la049681s; Terasawa H, 2012, P NATL ACAD SCI USA, V109, P5942, DOI 10.1073/pnas.1120327109; Yeagle P. L, 2010, STRUCTURE BIOL MEMBR	29	20	20	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101820	10.1371/journal.pone.0101820	http://dx.doi.org/10.1371/journal.pone.0101820			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991878	Green Submitted, Green Published, gold			2022-12-27	WOS:000341253400122
J	Rodriguez, EA; Correa, MM; Ospina, S; Atehortua, SL; Jimenez, JN				Rodriguez, Erika A.; Correa, Margarita M.; Ospina, Sigifredo; Atehortua, Santiago L.; Natalia Jimenez, J.			Differences in Epidemiological and Molecular Characteristics of Nasal Colonization with Staphylococcus aureus (MSSA-MRSA) in Children from a University Hospital and Day Care Centers	PLOS ONE			English	Article							METHICILLIN-RESISTANT; HEALTHY-CHILDREN; MULTIPLEX PCR; CARRIAGE; SEQUENCE; RISK; PREVALENCE; VIRULENCE; GENES; POPULATION	Background: Clinical significance of Staphylococcus aureus colonization has been demonstrated in hospital settings; however, studies in the community have shown contrasting results regarding the relevance of colonization in infection by community-associated MRSA (CA-MRSA). In Colombia there are few studies on S. aureus colonization. The aim of this study was to determine the molecular and epidemiological characteristics of nasal colonization by S. aureus (MSSA-MRSA) in children from a university hospital and day care centers (DCCs) of Medellin, Colombia. Methods: An observational cross-sectional study was conducted in 400 children (200 in each setting), aged 0 months to 5 years, during 2011. Samples were collected from each nostril and epidemiological information was obtained from the parents. Genotypic analysis included spa typing, PFGE, MLST, SCCmec typing, detection of genes for virulence factors and agr groups. Results: Frequency of S. aureus colonization was 39.8% (n = 159) (hospital 44.5% and DCCs 35.0%) and by MRSA, 5.3% (n = 21) (hospital 7.0% and DCCs 3.5%). Most S. aureus colonized children were older than two years (p = 0.005), the majority of them boys (59.1%), shared a bedroom with a large number of people (p = 0.028), with history of beta-Lactamase inhibitors usage (p = 0.020). MSSA strains presented the greatest genotypic diversity with 15 clonal complexes (CC). MRSA isolates presented 6 CC, most of them (47.6%) belonged to CC8-SCCmec IVc and were genetically related to previously reported infectious MRSA strains. Conclusion: Differences in epidemiological and molecular characteristics between populations may be useful for the understanding of S. aureus nasal colonization dynamics and for the design of strategies to prevent S. aureus infection and dissemination. The finding of colonizing MRSA with similar molecular characteristics of those causing infection demonstrates the dissemination capacity of S. aureus and the risk of infection among the child population.	[Rodriguez, Erika A.; Correa, Margarita M.; Natalia Jimenez, J.] Univ Antioquia, Grp Microbiol Mol, Escuela Microbiol, Medellin, Colombia; [Rodriguez, Erika A.; Natalia Jimenez, J.] Univ Antioquia, Escuela Microbiol, Grp Invest Microbiol Basica & Aplicada MICROBA, Medellin, Colombia; [Ospina, Sigifredo; Atehortua, Santiago L.] San Vicente Fdn, Univ Hosp, Medellin, Colombia	Universidad de Antioquia; Universidad de Antioquia	Jimenez, JN (corresponding author), Univ Antioquia, Grp Microbiol Mol, Escuela Microbiol, Medellin, Colombia.	nataliajiudea@gmail.com	Rodríguez, Erika A./T-4200-2017	Rodríguez, Erika A./0000-0002-8582-8776; Jimenez, J Natalia/0000-0002-9183-1912	Comite para el Desarrollo de la Investigacion - CODI, Universidad de Antioquia [CIMB-032-11]; Estrategia para la Sostenibilidad de Grupos [EO1624]	Comite para el Desarrollo de la Investigacion - CODI, Universidad de Antioquia; Estrategia para la Sostenibilidad de Grupos	This research was supported by the Comite para el Desarrollo de la Investigacion - CODI, Universidad de Antioquia, Project: CIMB-032-11 and received support from Estrategia para la Sostenibilidad de Grupos 2011-2012, Code EO1624. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argudin MA, 2013, MICROB PATHOGENESIS, V54, P26, DOI 10.1016/j.micpath.2012.09.001; Arias CA, 2008, NEW ENGL J MED, V359, P2177, DOI 10.1056/NEJMc0804021; Bitterman Y, 2010, EUR J CLIN MICROBIOL, V29, P391, DOI 10.1007/s10096-009-0869-3; Blumental S, 2013, J ANTIMICROB CHEMOTH, V68, P1517, DOI 10.1093/jac/dkt080; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; BRAKSTAD OG, 1992, J CLIN MICROBIOL, V30, P1654, DOI 10.1128/JCM.30.7.1654-1660.1992; Chen CJ, 2011, J CLIN MICROBIOL, V49, P131, DOI 10.1128/JCM.01774-10; Ciftci IH, 2007, ACTA PAEDIATR, V96, P1043, DOI 10.1111/j.1651-2227.2007.00315.x; Creech CB, 2005, PEDIATR INFECT DIS J, V24, P617, DOI 10.1097/01.inf.0000168746.62226.a4; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; de Sousa MA, 2004, FEMS IMMUNOL MED MIC, V40, P101, DOI 10.1016/S0928-8244(03)00370-5; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Ellington MJ, 2008, J ANTIMICROB CHEMOTH, V61, P73, DOI 10.1093/jac/dkm422; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fan J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006216; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Gardella N, 2011, INFECT GENET EVOL, V11, P1066, DOI 10.1016/j.meegid.2011.03.019; Ghasemzadeh-Moghaddam H, 2011, INT J MED MICROBIOL, V301, P347, DOI 10.1016/j.ijmm.2010.10.004; Halablab MA, 2010, EPIDEMIOL INFECT, V138, P702, DOI 10.1017/S0950268809991233; Horowitz IN, 2012, AM J INFECT CONTROL, V40, P118, DOI 10.1016/j.ajic.2011.03.027; Huang YC, 2007, J CLIN MICROBIOL, V45, P3992, DOI 10.1128/JCM.01202-07; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Kuehnert MJ, 2006, J INFECT DIS, V193, P172, DOI 10.1086/499632; Lamaro-Cardoso J, 2009, J CLIN MICROBIOL, V47, P3991, DOI 10.1128/JCM.01322-09; Lebon A, 2008, J CLIN MICROBIOL, V46, P3517, DOI 10.1128/JCM.00641-08; Lebon A, 2010, J CLIN MICROBIOL, V48, P1995, DOI 10.1128/JCM.00022-10; Liu M, 2010, CURR MICROBIOL, V61, P435, DOI 10.1007/s00284-010-9635-0; Liu QZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037005; Lo WT, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-51; Lo WT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015791; Mathema Barun, 2008, V431, P285; McClure JA, 2006, J CLIN MICROBIOL, V44, P1141, DOI 10.1128/JCM.44.3.1141-1144.2006; Megevand C, 2010, CLIN MICROBIOL INFEC, V16, P1414, DOI 10.1111/j.1469-0691.2009.03090.x; Mehrotra M, 2000, J CLIN MICROBIOL, V38, P1032, DOI 10.1128/JCM.38.3.1032-1035.2000; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Miller LG, 2008, CLIN INFECT DIS, V46, P752, DOI 10.1086/526773; Milstone AM, 2011, CLIN INFECT DIS, V53, P853, DOI 10.1093/cid/cir547; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Mulvey MR, 2001, J CLIN MICROBIOL, V39, P3481, DOI 10.1128/JCM.39.10.3481-3485.2001; Jimenez JN, 2013, INT J MED MICROBIOL, V303, P76, DOI 10.1016/j.ijmm.2012.12.003; Jimenez JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038576; Jimenez JN, 2011, MEM I OSWALDO CRUZ, V106, P980, DOI 10.1590/S0074-02762011000800013; Pathak A, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-100; Portillo BC, 2010, INFECTIO, P73; Rebollo-Pérez Juan, 2011, Rev. salud pública, V13, P824; Regev-Yochay G, 2009, PEDIATR INFECT DIS J, V28, P960, DOI 10.1097/INF.0b013e3181a90883; Rolo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034768; Safdar N, 2008, AM J MED, V121, P310, DOI 10.1016/j.amjmed.2007.07.034; Sangvik M, 2011, J CLIN MICROBIOL, V49, P4213, DOI 10.1128/JCM.05290-11; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Shopsin B, 2003, J CLIN MICROBIOL, V41, P456, DOI 10.1128/JCM.41.1.456-459.2003; Strommenger B, 2006, J CLIN MICROBIOL, V44, P2533, DOI 10.1128/JCM.00420-06; Torano G, 2001, ENFERM INFEC MICR CL, V19, P367, DOI 10.1016/S0213-005X(01)72668-7; Tovar C, 2011, REV CHIL INFECT S2, V28, pS60; van Trijp MJCA, 2010, DIAGN MICR INFEC DIS, V66, P222, DOI 10.1016/j.diagmicrobio.2009.08.021; Velazquez-Guadarrama N, 2009, CLIN INVEST MED, V32, pE57; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9	59	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101417	10.1371/journal.pone.0101417	http://dx.doi.org/10.1371/journal.pone.0101417			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987854	Green Published, gold, Green Submitted			2022-12-27	WOS:000341354100084
J	Gottesman, WL; Reagan, AJ; Dodds, PS				Gottesman, William L.; Reagan, Andrew James; Dodds, Peter Sheridan			Collective Philanthropy: Describing and Modeling the Ecology of Giving	PLOS ONE			English	Article							INCOME-DISTRIBUTION; ZIPFS LAW; DISTRIBUTIONS; DONATION	Reflective of income and wealth distributions, philanthropic gifting appears to follow an approximate power-law size distribution as measured by the size of gifts received by individual institutions. We explore the ecology of gifting by analysing data sets of individual gifts for a diverse group of institutions dedicated to education, medicine, art, public support, and religion. We find that the detailed forms of gift-size distributions differ across but are relatively constant within charity categories. We construct a model for how a donor's income affects their giving preferences in different charity categories, offering a mechanistic explanation for variations in institutional gift-size distributions. We discuss how knowledge of gift-sized distributions may be used to assess an institution's gift-giving profile, to help set fundraising goals, and to design an institution-specific giving pyramid.	[Reagan, Andrew James; Dodds, Peter Sheridan] Univ Vermont, Dept Math & Stat, Burlington, VT 05405 USA; [Reagan, Andrew James; Dodds, Peter Sheridan] Univ Vermont, Ctr Complex Syst, Burlington, VT USA; [Gottesman, William L.; Reagan, Andrew James; Dodds, Peter Sheridan] Univ Vermont, Computat Story Lab, Burlington, VT 05405 USA; [Reagan, Andrew James; Dodds, Peter Sheridan] Univ Vermont, Vermont Adv Comp Core, Burlington, VT USA	University of Vermont; University of Vermont; University of Vermont; University of Vermont	Gottesman, WL (corresponding author), Univ Vermont, Computat Story Lab, Burlington, VT 05405 USA.	billgottesman@gmail.com; peter.dodds@uvm.edu	Dodds, Peter S/C-9119-2014	Dodds, Peter S/0000-0003-1973-8614; Reagan, Andrew/0000-0002-5907-2696	National Science Foundation CAREER Award [0846668]; National Aeronautics and Space Administration (NASA) [NNX 08A096G]	National Science Foundation CAREER Award(National Science Foundation (NSF)); National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA))	PSD was supported by National Science Foundation CAREER Award # 0846668. The authors are grateful for the computational resources provided by the Vermont Advanced Computing Core, which is supported by the National Aeronautics and Space Administration (NASA) (NNX 08A096G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstott J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085777; Chen Q, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/38001; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Clementi F, 2005, PHYSICA A, V350, P427, DOI 10.1016/j.physa.2004.11.038; Dodds PS, 2001, J THEOR BIOL, V209, P9, DOI 10.1006/jtbi.2000.2238; Dove KE, 2000, CONDUCTING SUCCESSFU, P72; Giving U. S. A. Foundation, 2011, GIVING US 2011 ANN R; Goldenfeld N. D, 1992, LECT PHASE TRANSITIO, V85; Graham C., 2011, COMMUNICATION; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Nirei M, 2007, REV INCOME WEALTH, V53, P440, DOI 10.1111/j.1475-4991.2007.00242.x; Pierpoint R, 1998, NEW DIRECTIONS PHILA, V21, P61; SIMON HA, 1955, BIOMETRIKA, V42, P425; The Center on Philanthropy at Indiana University, 2007, PATT HOUS CHAR GIV I; Wu YJ, 2011, PHYSICA A, V390, P4325, DOI 10.1016/j.physa.2011.06.058; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	16	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e98876	10.1371/journal.pone.0098876	http://dx.doi.org/10.1371/journal.pone.0098876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983864	Green Submitted, gold, Green Published			2022-12-27	WOS:000339635000008
J	Ishikawa, H; Takaki, A; Tsuzaki, R; Yasunaka, T; Koike, K; Shimomura, Y; Seki, H; Matsushita, H; Miyake, Y; Ikeda, F; Shiraha, H; Nouso, K; Yamamoto, K				Ishikawa, Hisashi; Takaki, Akinobu; Tsuzaki, Ryuichiro; Yasunaka, Tetsuya; Koike, Kazuko; Shimomura, Yasuyuki; Seki, Hiroyuki; Matsushita, Hiroshi; Miyake, Yasuhiro; Ikeda, Fusao; Shiraha, Hidenori; Nouso, Kazuhiro; Yamamoto, Kazuhide			L-Carnitine Prevents Progression of Non-Alcoholic Steatohepatitis in a Mouse Model with Upregulation of Mitochondrial Pathway	PLOS ONE			English	Article							FATTY LIVER-DISEASE; OXIDATIVE DNA-DAMAGE; VITAMIN-E; ATP HOMEOSTASIS; ANTIOXIDANTS; ASSOCIATION; EXPRESSION; OBESITY; STRESS; CANCER	Non-alcoholic steatohepatitis (NASH) is a severe form of non-alcoholic fatty liver disease characterized by lobular inflammation, hepatocellular ballooning, and fibrosis with an inherent risk for progression to cirrhosis and hepatocellular carcinoma (HCC). Mitochondrial dysfunction appears to play a role in the progression from simple steatosis to NASH. L-carnitine (L-b-hydroxy-g-N-trimethylaminobutyric acid), an essential nutrient that converts fat into energy in mitochondria, has been shown to ameliorate liver damage. The aim of the present study was to explore the preventive and therapeutic effect of L-carnitine in NASH model mice. Eight-week-old male STAM mice, a NASH-cirrhosis-hepatocarcinogenic model, were divided into 3 experimental groups and fed as follows: 1) high-fat diet (HFD) (control group); 2) HFD mixed with 0.28% L-carnitine (L-carnitine group); and 3) HFD mixed with 0.01% alpha-tocopherol (alpha-tocopherol group). After 4 or 8 weeks, mice were sacrificed. Blood samples and livers were collected, and hepatic tumors were counted and measured. Livers were subjected to histological study, immunohistochemical staining of 4-hydroxynonenal and ferritin, determination of 8-OHdG levels, mRNA and protein expressions for multiple genes, and metabolomic analysis. The intestinal microbiome was also analyzed. L-carnitine increased hepatic expression of genes related to long-chain fatty acid transport, mitochondrial beta-oxidation, and antioxidant enzymes following suppression of hepatic oxidative stress markers and inflammatory cytokines in NASH, and mice treated with L-carnitine developed fewer liver tumors. Although alpha-tocopherol resulted in NASH improvement in the same manner as L-carnitine, it increased periodontitis-related microbiotic changes and hepatic iron transport-related gene expression and led to less effective for anti-hepatocarcinogenesis. Conclusion: L-carnitine prevents progression of non-alcoholic steatohepatitis in a mouse model by upregulating the mitochondrial beta-oxidation and redox system.	[Ishikawa, Hisashi; Takaki, Akinobu; Tsuzaki, Ryuichiro; Yasunaka, Tetsuya; Koike, Kazuko; Shimomura, Yasuyuki; Seki, Hiroyuki; Matsushita, Hiroshi; Miyake, Yasuhiro; Ikeda, Fusao; Shiraha, Hidenori; Nouso, Kazuhiro; Yamamoto, Kazuhide] Okayama Univ, Dept Gastroenterol & Hepatol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan	Okayama University	Takaki, A (corresponding author), Okayama Univ, Dept Gastroenterol & Hepatol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	akitaka@md.okayama-u.ac.jp						Begriche K, 2006, MITOCHONDRION, V6, P1, DOI 10.1016/j.mito.2005.10.004; Begriche K, 2011, J HEPATOL, V54, P773, DOI 10.1016/j.jhep.2010.11.006; Bergmann OM, 2008, LAB INVEST, V88, P1349, DOI 10.1038/labinvest.2008.95; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Cave MC, 2008, NUTR CLIN PRACT, V23, P16, DOI 10.1177/011542650802300116; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Chang BJ, 2005, INT J CANCER, V113, P719, DOI 10.1002/ijc.20636; Chang CY, 2006, J CLIN GASTROENTEROL, V40, pS51; Cortez-Pinto H, 1999, JAMA-J AM MED ASSOC, V282, P1659, DOI 10.1001/jama.282.17.1659; Fujii M, 2013, MED MOL MORPHOL, V46, P141, DOI 10.1007/s00795-013-0016-1; Gohil K, 2010, MOL NUTR FOOD RES, V54, P693, DOI 10.1002/mnfr.200900575; Grattagliano I, 2012, CLIN BIOCHEM, V45, P610, DOI 10.1016/j.clinbiochem.2012.03.024; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Huang HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049062; Jo M, 2011, J GASTROENTEROL, V46, P809, DOI 10.1007/s00535-011-0392-z; KERNER J, 1990, BIOCHEMISTRY-US, V29, P4326, DOI 10.1021/bi00470a010; Kohgo Y, 2008, INT J HEMATOL, V88, P7, DOI 10.1007/s12185-008-0120-5; Kuwajima M, 2007, ENDOCR J, V54, P911, DOI 10.1507/endocrj.K07-044; Lavine JE, 2011, JAMA-J AM MED ASSOC, V305, P1659, DOI 10.1001/jama.2011.520; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Malaguarnera M, 2010, AM J GASTROENTEROL, V105, P1338, DOI 10.1038/ajg.2009.719; Malaguarnera M, 2011, AM J CLIN NUTR, V93, P799, DOI 10.3945/ajcn.110.007393; Masuoka HC, 2013, ANN NY ACAD SCI, V1281, P106, DOI 10.1111/nyas.12016; Mingrone G, 2004, ANN NY ACAD SCI, V1033, P99, DOI 10.1196/annals.1320.009; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Nagashima K, 2003, APPL ENVIRON MICROB, V69, P1251, DOI 10.1128/AEM.69.2.1251-1262.2003; Nelson JE, 2011, HEPATOLOGY, V53, P448, DOI 10.1002/hep.24038; Nishikawa T, 2009, LIVER INT, V29, P846, DOI 10.1111/j.1478-3231.2008.01963.x; Pilger A, 2006, INT ARCH OCC ENV HEA, V80, P1, DOI 10.1007/s00420-006-0106-7; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Schurks M, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5702; Selman C, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0432; Serviddio G, 2008, EUR J CLIN INVEST, V38, P245, DOI 10.1111/j.1365-2362.2008.01936.x; Sokol RJ, 1998, GASTROENTEROLOGY, V114, P164, DOI 10.1016/S0016-5085(98)70644-4; Steinhubl SR, 2008, AM J CARDIOL, V101, p14D, DOI 10.1016/j.amjcard.2008.02.003; Takaki A, 2013, INT J MOL SCI, V14, P20704, DOI 10.3390/ijms141020704; Tanaka S, 2013, J GASTROENTEROL, V48, P1249, DOI 10.1007/s00535-012-0739-0; Watt RK, 2011, BIOMETALS, V24, P489, DOI 10.1007/s10534-011-9415-8; Xia YQ, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-31; Yae T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1892; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347	41	57	63	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100627	10.1371/journal.pone.0100627	http://dx.doi.org/10.1371/journal.pone.0100627			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983359	Green Submitted, Green Published, gold			2022-12-27	WOS:000339635000034
J	Parra-Lopez, CA; Bernal-Estevez, D; Vargas, LE; Pulido-Calixto, C; Salazar, LM; Calvo-Calle, JM; Stern, LJ				Parra-Lopez, Carlos A.; Bernal-Estevez, David; Eduardo Vargas, Luis; Pulido-Calixto, Carolina; Salazar, Luz Mary; Calvo-Calle, J. Mauricio; Stern, Lawrence J.			An Unstable Th Epitope of P. falciparum Fosters Central Memory T Cells and Anti-CS Antibody Responses	PLOS ONE			English	Article							MHC CLASS-II; MAJOR HISTOCOMPATIBILITY COMPLEX; PEPTIDE MALARIA VACCINE; PLASMODIUM-FALCIPARUM; CIRCUMSPOROZOITE PROTEIN; HLA-DM; SYNTHETIC PEPTIDE; CRYSTAL-STRUCTURE; MONOCLONAL-ANTIBODIES; KINETIC STABILITY	Malaria is transmitted by Plasmodium-infected anopheles mosquitoes. Widespread resistance of mosquitoes to insecticides and resistance of parasites to drugs highlight the urgent need for malaria vaccines. The most advanced malaria vaccines target sporozoites, the infective form of the parasite. A major target of the antibody response to sporozoites are the repeat epitopes of the circumsporozoite (CS) protein, which span almost one half of the protein. Antibodies to these repeats can neutralize sporozoite infectivity. Generation of protective antibody responses to the CS protein (anti-CS Ab) requires help by CD4 T cells. A CD4 T cell epitope from the CS protein designated T* was previously identified by screening T cells from volunteers immunized with irradiated P. falciparum sporozoites. The T* sequence spans twenty amino acids that contains multiple T cell epitopes restricted by various HLA alleles. Subunit malaria vaccines including T* are highly immunogenic in rodents, non-human primates and humans. In this study we characterized a highly conserved HLA-DR beta 1*04: 01 (DR4) restricted T cell epitope (QNT-5) located at the C-terminus of T*. We found that a peptide containing QNT-5 was able to elicit long-term anti-CS Ab responses and prime CD4 T cells in HLA-DR4 transgenic mice despite forming relatively unstable MHC-peptide complexes highly susceptible to HLA-DM editing. We attempted to improve the immunogenicity of QNT-5 by replacing the P1 anchor position with an optimal tyrosine residue. The modified peptide QNT-Y formed stable MHC-peptide complexes highly resistant to HLA-DM editing. Contrary to expectations, a linear peptide containing QNT-Y elicited almost 10-fold lower long-term antibody and IFN-gamma responses compared to the linear peptide containing the wild type QNT-5 sequence. Some possibilities regarding why QNT-5 is more effective than QNT-Y in inducing long-term T cell and anti-CS Ab when used as vaccine are discussed.	[Parra-Lopez, Carlos A.; Bernal-Estevez, David; Eduardo Vargas, Luis; Pulido-Calixto, Carolina] Univ Nacl Colombia, Sch Med, Dept Microbiol, Bogota, Colombia; [Parra-Lopez, Carlos A.; Bernal-Estevez, David] Univ Nacl Colombia, Grad Sch Biomed Sci, Bogota, Colombia; [Salazar, Luz Mary] Univ Nacl Colombia, Fac Sci, Bogota, Colombia; [Bernal-Estevez, David] Fdn Salud Andes, Res Grp Immunol & Clin Oncol GIIOC, Bogota, Colombia; [Calvo-Calle, J. Mauricio; Stern, Lawrence J.] Univ Massachusetts, Sch Med, Dept Pathol & Biochem, Worcester, MA USA; [Calvo-Calle, J. Mauricio; Stern, Lawrence J.] Dept Mol Pharmacol, Worcester, MA USA	Universidad Nacional de Colombia; Universidad Nacional de Colombia; Universidad Nacional de Colombia; University of Massachusetts System; University of Massachusetts Worcester	Parra-Lopez, CA (corresponding author), Univ Nacl Colombia, Sch Med, Dept Microbiol, Bogota, Colombia.	caparral@unal.edu.co; Lawrence.Stern@umassmed.edu		PARRA LOPEZ, CARLOS ALBERTO/0000-0002-6084-8981; Bernal-Estevez, David Andres/0000-0002-7330-0333	COLCIENCIAS [RC-302-2010 (CD 110151928955)]; Universidad Nacional de Colombia - Bogota [8009074];  [NIH-AI38996];  [NIH-U19-57319]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI038996, R37AI038996, R01AI038996] Funding Source: NIH RePORTER	COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Universidad Nacional de Colombia - Bogota; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by COLCIENCIAS grant No. RC-302-2010 (CD 110151928955); by DIB grant (8009074) from Universidad Nacional de Colombia - Bogota and by NIH-AI38996 (LJS) and NIH-U19-57319 (LJS and JMCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25; AK M, 1993, INFECT IMMUN, V61, P2493, DOI 10.1128/IAI.61.6.2493-2497.1993; Amria S, 2008, EUR J IMMUNOL, V38, P1961, DOI 10.1002/eji.200738100; Anders AK, 2011, NAT IMMUNOL, V12, P54, DOI 10.1038/ni.1967; Belmares MP, 2002, J IMMUNOL, V169, P5109, DOI 10.4049/jimmunol.169.9.5109; Bolin DR, 2000, J MED CHEM, V43, P2135, DOI 10.1021/jm000034h; Calvo-Calle JM, 2006, INFECT IMMUN, V74, P6929, DOI 10.1128/IAI.01151-06; Calvo-Calle JM, 2005, J IMMUNOL, V175, P7575, DOI 10.4049/jimmunol.175.11.7575; CalvoCalle JM, 1997, J IMMUNOL, V159, P1362; Cameron TO, 2002, J IMMUNOL METHODS, V268, P51, DOI 10.1016/S0022-1759(02)00200-4; Carapau D, 2013, INFECT IMMUN, V81, P4350, DOI 10.1128/IAI.00263-13; CERAMI C, 1992, CELL, V70, P1021, DOI 10.1016/0092-8674(92)90251-7; CHAROENVIT Y, 1991, J IMMUNOL, V146, P1020; Chaves FA, 2006, BIOCHEMISTRY-US, V45, P6426, DOI 10.1021/bi060194g; Chou CL, 2000, J EXP MED, V192, P1697, DOI 10.1084/jem.192.12.1697; CLYDE DF, 1975, AM J TROP MED HYG, V24, P397, DOI 10.4269/ajtmh.1975.24.397; COCHRANE AH, 1985, INFECT IMMUN, V50, P58, DOI 10.1128/IAI.50.1.58-61.1985; COCHRANE AH, 1982, P NATL ACAD SCI-BIOL, V79, P5651, DOI 10.1073/pnas.79.18.5651; DELACRUZ VF, 1987, J BIOL CHEM, V262, P11935; Dessen A, 1997, IMMUNITY, V7, P473, DOI 10.1016/S1074-7613(00)80369-6; Doolan DL, 2000, J IMMUNOL, V165, P1123, DOI 10.4049/jimmunol.165.2.1123; EDELMAN R, 1993, J INFECT DIS, V168, P1066, DOI 10.1093/infdis/168.4.1066; Escalante AA, 2004, TRENDS PARASITOL, V20, P388, DOI 10.1016/j.pt.2004.06.002; Escalante AA, 2002, MOL BIOCHEM PARASIT, V125, P83, DOI 10.1016/S0166-6851(02)00216-5; Ferrante A, 2007, J IMMUNOL, V178, P7181, DOI 10.4049/jimmunol.178.11.7181; Frayser M, 1999, PROTEIN EXPRES PURIF, V15, P105, DOI 10.1006/prep.1998.0987; Gandhi K, 2012, AM J TROP MED HYG, V86, P775, DOI 10.4269/ajtmh.2012.11-0478; GOOD MF, 1988, P NATL ACAD SCI USA, V85, P1199, DOI 10.1073/pnas.85.4.1199; Guce AI, 2013, NAT STRUCT MOL BIOL, V20, P90, DOI 10.1038/nsmb.2460; GUTTINGER M, 1988, EMBO J, V7, P2555, DOI 10.1002/j.1460-2075.1988.tb03104.x; Gwadz R W, 1979, Bull World Health Organ, V57 Suppl 1, P165; GYSIN J, 1984, J EXP MED, V160, P935, DOI 10.1084/jem.160.3.935; Hall FC, 2002, EUR J IMMUNOL, V32, P662, DOI 10.1002/1521-4141(200203)32:3<662::AID-IMMU662>3.0.CO;2-5; HAMMER J, 1994, P NATL ACAD SCI USA, V91, P4456, DOI 10.1073/pnas.91.10.4456; Hennecke J, 2002, J EXP MED, V195, P571, DOI 10.1084/jem.20011194; HERRINGTON DA, 1987, NATURE, V328, P257, DOI 10.1038/328257a0; HERRINGTON DA, 1990, B WORLD HEALTH ORGAN, V68, P33; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; HOUGHTEN RA, 1985, P NATL ACAD SCI USA, V82, P5131, DOI 10.1073/pnas.82.15.5131; Jensen PE, 1998, CURR BIOL, V8, pR128, DOI 10.1016/S0960-9822(98)70988-1; Kasson PM, 2000, BIOCHEMISTRY-US, V39, P1048, DOI 10.1021/bi9921337; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; KLAR A, 1992, CELL, V69, P95, DOI 10.1016/0092-8674(92)90121-R; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Lazarski CA, 2005, IMMUNITY, V23, P29, DOI 10.1016/j.immuni.2005.05.009; Lazarski CA, 2006, J EXP MED, V203, P1319, DOI 10.1084/jem.20060058; McFarland BJ, 1999, J IMMUNOL, V163, P3567; McFarland BJ, 2005, J MOL BIOL, V350, P170, DOI 10.1016/j.jmb.2005.04.069; McFarland BJ, 2002, MED RES REV, V22, P168, DOI 10.1002/med.10006; Moorthy VS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-312; MORENO A, 1993, J IMMUNOL, V151, P489; MORENO A, 1991, INT IMMUNOL, V3, P997, DOI 10.1093/intimm/3.10.997; Moser JM, 2010, J IMMUNOL METHODS, V353, P8, DOI 10.1016/j.jim.2009.11.006; Narayan K, 2007, NAT IMMUNOL, V8, P92, DOI 10.1038/ni1414; Nardin E, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P397; NARDIN EH, 1982, J EXP MED, V156, P20, DOI 10.1084/jem.156.1.20; Nardin EH, 2001, J IMMUNOL, V166, P481, DOI 10.4049/jimmunol.166.1.481; NARDIN EH, 1989, SCIENCE, V246, P1603, DOI 10.1126/science.2480642; Nardin EH, 2000, J INFECT DIS, V182, P1486, DOI 10.1086/315871; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Parra-Lopez C, 2006, J BIOL CHEM, V281, P14907, DOI 10.1074/jbc.M511571200; Pashine A, 2003, IMMUNITY, V19, P183, DOI 10.1016/S1074-7613(03)00200-0; Pos W, 2012, CELL, V151, P1557, DOI 10.1016/j.cell.2012.11.025; Raddrizzani L, 1999, EUR J IMMUNOL, V29, P660, DOI 10.1002/(SICI)1521-4141(199902)29:02<660::AID-IMMU660>3.0.CO;2-I; Reece WHH, 2004, NAT MED, V10, P406, DOI 10.1038/nm1009; RIECKMANN KH, 1990, B WORLD HEALTH ORGAN, V68, P13; Rinderknecht CH, 2010, IMMUNOLOGY, V131, P18, DOI 10.1111/j.1365-2567.2010.03282.x; RODRIGUES M, 1993, IMMUNOLOGY, V80, P1; Rosloniec EF, 2002, J IMMUNOL, V168, P253, DOI 10.4049/jimmunol.168.1.253; Sant AJ, 2005, IMMUNOL REV, V207, P261, DOI 10.1111/j.0105-2896.2005.00307.x; Schwenk R, 2011, VACCINE, V29, P8847, DOI 10.1016/j.vaccine.2011.09.098; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Siklodi B, 1998, HUM IMMUNOL, V59, P463, DOI 10.1016/S0198-8859(98)00038-X; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Singh JPN, 2009, TROP MED INT HEALTH, V14, P957, DOI 10.1111/j.1365-3156.2009.02314.x; SINIGAGLIA F, 1988, NATURE, V336, P778, DOI 10.1038/336778a0; Sinnis P, 1997, TRENDS MICROBIOL, V5, P52, DOI 10.1016/S0966-842X(97)84657-4; Slansky JE, 2000, IMMUNITY, V13, P529, DOI 10.1016/S1074-7613(00)00052-2; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Stratikos E, 2004, J IMMUNOL, V172, P1109, DOI 10.4049/jimmunol.172.2.1109; Sun PF, 2003, J IMMUNOL, V171, P6961, DOI 10.4049/jimmunol.171.12.6961; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Tangri S, 2001, J EXP MED, V194, P833, DOI 10.1084/jem.194.6.833; Tucker RP, 2004, INT J BIOCHEM CELL B, V36, P969, DOI 10.1016/j.biocel.2003.12.011; Wang RB, 2004, J IMMUNOL, V172, P5561, DOI 10.4049/jimmunol.172.9.5561; Weedall GD, 2007, INT J PARASITOL, V37, P77, DOI 10.1016/j.ijpara.2006.09.001; WOODS A, 1994, J EXP MED, V180, P173, DOI 10.1084/jem.180.1.173; World Health Organization, 2011, WORLD HLTH STAT 2011; Yin LS, 2012, J IMMUNOL, V189, P3983, DOI 10.4049/jimmunol.1200626; YOSHIDA N, 1990, EXP PARASITOL, V71, P386, DOI 10.1016/0014-4894(90)90064-J; YOSHIDA N, 1980, SCIENCE, V207, P71, DOI 10.1126/science.6985745; ZAVALA F, 1983, J EXP MED, V157, P1947, DOI 10.1084/jem.157.6.1947; ZAVALA F, 1985, SCIENCE, V228, P1436, DOI 10.1126/science.2409595; Zeeshan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043430; ZEVERING Y, 1994, EUR J IMMUNOL, V24, P1418, DOI 10.1002/eji.1830240627; Zirlik KM, 2006, BLOOD, V108, P3865, DOI 10.1182/blood-2006-04-014415	97	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100639	10.1371/journal.pone.0100639	http://dx.doi.org/10.1371/journal.pone.0100639			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983460	Green Published, Green Submitted, gold			2022-12-27	WOS:000339635000035
J	Tang, WB; Kowgier, M; Loth, DW; Artigas, MS; Joubert, BR; Hodge, E; Gharib, SA; Smith, AV; Ruczinski, I; Gudnason, V; Mathias, RA; Harris, TB; Hansel, NN; Launer, LJ; Barnes, KC; Hansen, JG; Albrecht, E; Aldrich, MC; Allerhand, M; Barr, RG; Brusselle, GG; Couper, DJ; Curjuric, I; Davies, G; Deary, IJ; Dupuis, J; Fall, T; Foy, M; Franceschini, N; Gao, W; Glaser, S; Gu, XJ; Hancock, DB; Heinrich, J; Hofman, A; Imboden, M; Ingelsson, E; James, A; Karrasch, S; Koch, B; Kritchevsky, SB; Kumar, A; Lahousse, L; Li, G; Lind, L; Lindgren, C; Liu, YM; Lohman, K; Lumley, T; McArdle, WL; Meibohm, B; Morris, AP; Morrison, AC; Musk, B; North, KE; Palmer, LJ; Probst-Hensch, NM; Psaty, BM; Rivadeneira, F; Rotter, JI; Schulz, H; Smith, LJ; Sood, A; Starr, JM; Strachan, DP; Teumer, A; Uitterlinden, AG; Volzke, H; Voorman, A; Wain, LV; Wells, MT; Wilk, JB; Williams, OD; Heckbert, SR; Stricker, BH; London, SJ; Fornage, M; Tobin, MD; O'Connor, GT; Hall, IP; Cassano, PA				Tang, Wenbo; Kowgier, Matthew; Loth, Daan W.; Artigas, Maria Soler; Joubert, Bonnie R.; Hodge, Emily; Gharib, Sina A.; Smith, Albert V.; Ruczinski, Ingo; Gudnason, Vilmundur; Mathias, Rasika A.; Harris, Tamara B.; Hansel, Nadia N.; Launer, Lenore J.; Barnes, Kathleen C.; Hansen, Joyanna G.; Albrecht, Eva; Aldrich, Melinda C.; Allerhand, Michael; Barr, R. Graham; Brusselle, Guy G.; Couper, David J.; Curjuric, Ivan; Davies, Gail; Deary, Ian J.; Dupuis, Josee; Fall, Tove; Foy, Millennia; Franceschini, Nora; Gao, Wei; Glaeser, Sven; Gu, Xiangjun; Hancock, Dana B.; Heinrich, Joachim; Hofman, Albert; Imboden, Medea; Ingelsson, Erik; James, Alan; Karrasch, Stefan; Koch, Beate; Kritchevsky, Stephen B.; Kumar, Ashish; Lahousse, Lies; Li, Guo; Lind, Lars; Lindgren, Cecilia; Liu, Yongmei; Lohman, Kurt; Lumley, Thomas; McArdle, Wendy L.; Meibohm, Bernd; Morris, Andrew P.; Morrison, Alanna C.; Musk, Bill; North, Kari E.; Palmer, Lyle J.; Probst-Hensch, Nicole M.; Psaty, Bruce M.; Rivadeneira, Fernando; Rotter, Jerome I.; Schulz, Holger; Smith, Lewis J.; Sood, Akshay; Starr, John M.; Strachan, David P.; Teumer, Alexander; Uitterlinden, Andre G.; Voelzke, Henry; Voorman, Arend; Wain, Louise V.; Wells, Martin T.; Wilk, Jemma B.; Williams, O. Dale; Heckbert, Susan R.; Stricker, Bruno H.; London, Stephanie J.; Fornage, Myriam; Tobin, Martin D.; O'Connor, George T.; Hall, Ian P.; Cassano, Patricia A.			Large-Scale Genome-Wide Association Studies and Meta-Analyses of Longitudinal Change in Adult Lung Function	PLOS ONE			English	Article							FUNCTION DECLINE; GLOBAL BURDEN; HEARING-LOSS; INTERLEUKIN-16; EXPRESSION; ASTHMA; GENE; POLYMORPHISM; DISEASE; PROTEIN	Background: Genome-wide association studies (GWAS) have identified numerous loci influencing cross-sectional lung function, but less is known about genes influencing longitudinal change in lung function. Methods: We performed GWAS of the rate of change in forced expiratory volume in the first second (FEV1) in 14 longitudinal, population-based cohort studies comprising 27,249 adults of European ancestry using linear mixed effects model and combined cohort-specific results using fixed effect meta-analysis to identify novel genetic loci associated with longitudinal change in lung function. Gene expression analyses were subsequently performed for identified genetic loci. As a secondary aim, we estimated the mean rate of decline in FEV1 by smoking pattern, irrespective of genotypes, across these 14 studies using meta-analysis. Results: The overall meta-analysis produced suggestive evidence for association at the novel IL16/STARD5/TMC3 locus on chromosome 15 (P = 5.71 x 10(-7)). In addition, meta-analysis using the five cohorts with >= 3 FEV1 measurements per participant identified the novel ME3 locus on chromosome 11 (P = 2.18 x 10(-8)) at genome-wide significance. Neither locus was associated with FEV1 decline in two additional cohort studies. We confirmed gene expression of IL16, STARD5, and ME3 in multiple lung tissues. Publicly available microarray data confirmed differential expression of all three genes in lung samples from COPD patients compared with controls. Irrespective of genotypes, the combined estimate for FEV1 decline was 26.9, 29.2 and 35.7 mL/year in never, former, and persistent smokers, respectively. Conclusions: In this large-scale GWAS, we identified two novel genetic loci in association with the rate of change in FEV1 that harbor candidate genes with biologically plausible functional links to lung function.	[Tang, Wenbo; Hansen, Joyanna G.; Cassano, Patricia A.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Kowgier, Matthew; Palmer, Lyle J.] Univ Toronto, Ontario Inst Canc Res, Toronto, ON, Canada; [Kowgier, Matthew; Palmer, Lyle J.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Biostat, Toronto, ON, Canada; [Loth, Daan W.; Brusselle, Guy G.; Hofman, Albert; Lahousse, Lies; Stricker, Bruno H.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Loth, Daan W.; Stricker, Bruno H.] Netherlands Healthcare Inspectorate, The Hague, Netherlands; [Artigas, Maria Soler; Wain, Louise V.; Tobin, Martin D.] Univ Leicester, Genet Epidemiol Grp, Dept Hlth Sci, Leicester, Leics, England; [Artigas, Maria Soler; Wain, Louise V.; Tobin, Martin D.] Glenfield Gen Hosp, Leicester Resp Biomed Res Unit, NIHR, Leicester LE3 9QP, Leics, England; [Joubert, Bonnie R.; Hancock, Dana B.; London, Stephanie J.] NIEHS, Epidemiol Branch, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA; [Hodge, Emily; Hall, Ian P.] Univ Nottingham Hosp, Div Resp Med, Nottingham NG7 2UH, England; [Gharib, Sina A.] Univ Washington, Dept Med, Div Pulm & Crit Care Med, Computat Med Core,Ctr Lung Biol, Seattle, WA USA; [Smith, Albert V.; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Smith, Albert V.; Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Ruczinski, Ingo] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Mathias, Rasika A.; Hansel, Nadia N.; Barnes, Kathleen C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Harris, Tamara B.; Launer, Lenore J.] NIA, Lab Epidemiol Demog & Biometry, NIH, Bethesda, MD 20892 USA; [Albrecht, Eva] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany; [Aldrich, Melinda C.] Vanderbilt Univ, Med Ctr, Dept Thorac Surg, Nashville, TN USA; [Aldrich, Melinda C.] Vanderbilt Univ, Med Ctr, Div Epidemiol, Nashville, TN USA; [Allerhand, Michael; Davies, Gail; Deary, Ian J.; Starr, John M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Barr, R. Graham] Columbia Univ, Coll Phys & Surg, Dept Med, Div Gen Med Pulm Allergy & Crit Care, New York, NY USA; [Barr, R. Graham] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Brusselle, Guy G.; Lahousse, Lies] Ghent Univ Hosp, Dept Resp Med, Ghent, Belgium; [Brusselle, Guy G.] Erasmus MC, Dept Resp Med, Rotterdam, Netherlands; [Brusselle, Guy G.] Univ N Carolina, Dept Biostat 22, Chapel Hill, NC USA; [Curjuric, Ivan; Imboden, Medea; Kumar, Ashish; Probst-Hensch, Nicole M.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Curjuric, Ivan; Imboden, Medea; Kumar, Ashish; Probst-Hensch, Nicole M.] Univ Basel, Basel, Switzerland; [Davies, Gail] Univ Edinburgh, Med Genet Sect, Mol Med Ctr, Edinburgh, Midlothian, Scotland; [Davies, Gail] Western Gen Hosp, MRC, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Davies, Gail; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Dupuis, Josee; Gao, Wei] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Dupuis, Josee; Wilk, Jemma B.; O'Connor, George T.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Fall, Tove; Ingelsson, Erik] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden; [Foy, Millennia; Gu, Xiangjun; Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX 77030 USA; [Franceschini, Nora; North, Kari E.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Glaeser, Sven; Koch, Beate] Univ Med Greifswald, Dept Internal Med B, Field Res Pneumol & Pneumol Epidemiol, Greifswald, Germany; [Hancock, Dana B.] Res Triangle Inst, Behav Hlth Epidemiol Program, Res Triangle Pk, NC 27709 USA; [Heinrich, Joachim; Karrasch, Stefan; Schulz, Holger] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Heinrich, Joachim; Schulz, Holger] Comprehens Pneumol Ctr Munich CPC M, Munich, Germany; [Hofman, Albert; Rivadeneira, Fernando; Uitterlinden, Andre G.] Netherlands Consortium Healthy Aging, Rotterdam, Netherlands; [Ingelsson, Erik; Kumar, Ashish; Lindgren, Cecilia; Morris, Andrew P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Ingelsson, Erik; Kumar, Ashish; Lindgren, Cecilia; Morris, Andrew P.] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England; [James, Alan; Musk, Bill] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Karrasch, Stefan] Univ Munich, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany; [Karrasch, Stefan] Tech Univ Munich, Klinikum Rechts Isar, Univ Hosp, Inst Gen Practice, D-80290 Munich, Germany; [Kritchevsky, Stephen B.] Wake Forest Sch Med, Sticht Ctr Aging, Winston Salem, NC USA; [Li, Guo; Psaty, Bruce M.; Heckbert, Susan R.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Lind, Lars] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Lindgren, Cecilia] Broad Inst MIT & Harvard, Cambridge, MA USA; [Liu, Yongmei] Wake Forest Sch Med, Div Publ Hlth Sci, Dept Epidemiol & Prevent, Winston Salem, NC USA; [Lohman, Kurt] Wake Forest Sch Med, Div Publ Hlth Sci, Dept Biostat Sci, Winston Salem, NC USA; [Lumley, Thomas] Univ Auckland, Dept Stat, Auckland 1, New Zealand; [McArdle, Wendy L.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Meibohm, Bernd] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Memphis, TN 38163 USA; [Morrison, Alanna C.; Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA; [Palmer, Lyle J.] Univ Toronto, Toronto, ON, Canada; [Palmer, Lyle J.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Psaty, Bruce M.; Heckbert, Susan R.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.; Heckbert, Susan R.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA USA; [Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Rotter, Jerome I.] Los Angeles Biomed Res Inst, Inst Translat Genom & Populat Sci, Torrance, CA USA; [Rotter, Jerome I.] Harbor UCLA Med Ctr, Dept Pediat, Torrance, CA 90509 USA; [Smith, Lewis J.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Sood, Akshay] Univ New Mexico, Albuquerque, NM 87131 USA; [Starr, John M.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland; [Strachan, David P.] Univ London, Div Populat Hlth Sci & Educ, London, England; [Teumer, Alexander] Univ Med Greifswald, Dept Genet & Funct Genom, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Study Hlth Pomerania SHIP Clin Epidemiol Res, Greifswald, Germany; [Voorman, Arend] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Wells, Martin T.] Cornell Univ, Dept Stat Sci, Ithaca, NY USA; [Wilk, Jemma B.] Brigham & Womens Hosp, Dept Med, Div Aging, Boston, MA 02115 USA; [Wilk, Jemma B.] Harvard Univ, Sch Med, Boston, MA USA; [Williams, O. Dale] Florida Int Univ, Miami, FL 33199 USA; [O'Connor, George T.] Boston Univ, Sch Med, Dept Med, Sect Pulm Allergy & Crit Care Med, Boston, MA 02118 USA; [Cassano, Patricia A.] Weill Cornell Med Coll, Dept Hlth Care Policy & Res, Div Biostat & Epidemiol, New York, NY USA	Cornell University; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; Erasmus University Rotterdam; Erasmus MC; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Nottingham; University of Washington; University of Washington Seattle; Icelandic Heart Association; University of Iceland; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Vanderbilt University; Vanderbilt University; University of Edinburgh; Columbia University; Columbia University; Ghent University; Ghent University Hospital; Erasmus University Rotterdam; Erasmus MC; University of North Carolina; University of North Carolina Chapel Hill; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Edinburgh; University of Edinburgh; University of Edinburgh; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Uppsala University; University of Texas System; University of Texas Health Science Center Houston; University of North Carolina; University of North Carolina Chapel Hill; Greifswald Medical School; Research Triangle Institute; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Oxford; Wellcome Centre for Human Genetics; University of Liverpool; University of Western Australia; University of Munich; Technical University of Munich; University of Munich; Wake Forest University; University of Washington; University of Washington Seattle; Uppsala University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Wake Forest University; Wake Forest University; University of Auckland; University of Bristol; University of Tennessee System; University of Tennessee Health Science Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Washington; University of Washington Seattle; Erasmus University Rotterdam; Erasmus MC; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Northwestern University; Feinberg School of Medicine; University of New Mexico; University of Edinburgh; University of London; Greifswald Medical School; Greifswald Medical School; University of Washington; University of Washington Seattle; Cornell University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; State University System of Florida; Florida International University; Boston University; Cornell University	Cassano, PA (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.	pac6@cornell.edu	Schulz, Holger/J-5643-2015; Artigas, María Soler/L-6529-2013; Teumer, Alexander/S-7438-2019; Karrasch, Stefan/GQI-2691-2022; Fall, Tove/O-7226-2014; Lahousse, Lies/O-9426-2019; Smith, Albert Vernon/K-5150-2015; Palmer, Lyle John/K-3196-2014; Rotter, Jerome/AAY-6598-2021; Gudnason, Vilmundur/K-6885-2015; Rivadeneira, Fernando/O-5385-2015; Gudnason, Vilmundur/AAE-7126-2019; Deary, Ian J/C-6297-2009; Palmer, Lyle John/N-1948-2019; Heinrich, Joachim/N-1720-2013; London, Stephanie/C-3734-2019; Sood, Anoop Kumar/A-7344-2013	Schulz, Holger/0000-0002-1157-200X; Artigas, María Soler/0000-0002-3213-1107; Teumer, Alexander/0000-0002-8309-094X; Lahousse, Lies/0000-0002-3494-4363; Smith, Albert Vernon/0000-0003-1942-5845; Palmer, Lyle John/0000-0002-1628-3055; Gudnason, Vilmundur/0000-0001-5696-0084; Rivadeneira, Fernando/0000-0001-9435-9441; Gudnason, Vilmundur/0000-0001-5696-0084; Deary, Ian J/0000-0002-1733-263X; Palmer, Lyle John/0000-0002-1628-3055; Heinrich, Joachim/0000-0002-9620-1629; London, Stephanie/0000-0003-4911-5290; Sood, Anoop Kumar/0000-0001-5702-4108; Smith, Lewis J/0000-0002-4728-1562; Kumar, Ashish/0000-0002-7075-5930; Meibohm, Bernd/0000-0003-3923-3648; Cassano, Patricia A./0000-0003-4827-5073; Loth, Daan/0000-0003-1260-9326; Couper, David/0000-0002-4313-9235; Morrison, Alanna/0000-0001-6381-4296; Lindgren, Cecilia/0000-0002-4903-9374; Brusselle, Guy/0000-0001-7021-8505; Hancock, Dana/0000-0003-2240-3604; Wain, Louise/0000-0003-4951-1867; Tobin, Martin/0000-0002-3596-7874; Dupuis, Josee/0000-0003-2871-3603; Hall, Ian/0000-0001-9933-3216; Joubert, Bonnie/0000-0001-7952-1180; GHARIB, SINA A./0000-0002-2480-4367	NIH; US-EPA; Age UK; BBSRC; Boston University; MSD (Merck); BMBF (German Ministry for Research and Education); Actelion Pharma; Novartis Pharma; GSK; Pfizer; Boehringer Ingelheim; Bayer Pharma; MRC; Medical Research Council, UK; BMBF; German Academic Exchange Service; Research Network for Community Medicine of the University of Greifswald; Division of Intramural Research, NIEHS, NIH, DHHS; Sunovion, Inc.; manufacturer (Zoll LifeCor); Johnson Johnson; Merck Data Safety and Monitoring Board; Medical Research Council [G0902313]; National Institute for Health Research (NIHR), Leicester Respiratory Biomedical Research Unit; FAMRI; Biotechnology and Biological Sciences Research Council [BB/F019394/1] Funding Source: researchfish; Medical Research Council [G0000934, G1000861, MR/K026992/1, G0700704] Funding Source: researchfish; Chief Scientist Office [ETM/55, CZB/4/505] Funding Source: researchfish; BBSRC [BB/F019394/1] Funding Source: UKRI; MRC [G0000934, G0902313, G0700704, G1000861] Funding Source: UKRI; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195, N01HC085083, N01HC048048, N01HC085082, N01HC085080, N01HC045134, N01HC048049, N01HC095095, N01HC005187, N01HC085079, N01HC048047, N01HC048050, N01HC085081, N01HC055222, N01HC085086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R01HL103612, R01HL064278, R01HL085251, R01HL080295, R01HL084099, R01HL087641, R01HL086694, R01HL059367, R01HL087652, R01HL105756] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004446, U01HG004402, U01HG004729, U01HG004424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, T32DK007158, U01DK062418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES043012, Z01ES043012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR012459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG062101, R01AG028050, ZIAAG007380, RC1AG035835, ZIAAG007390, R01AG032098, N01AG012100, N01AG002103, R56AG023629, N01AG062106, R01AG023629, ZIAAG006000] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US-EPA(United States Environmental Protection Agency); Age UK; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Boston University; MSD (Merck)(Merck & Company); BMBF (German Ministry for Research and Education)(Federal Ministry of Education & Research (BMBF)); Actelion Pharma; Novartis Pharma; GSK(GlaxoSmithKline); Pfizer(Pfizer); Boehringer Ingelheim(Boehringer Ingelheim); Bayer Pharma; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BMBF(Federal Ministry of Education & Research (BMBF)); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Research Network for Community Medicine of the University of Greifswald; Division of Intramural Research, NIEHS, NIH, DHHS; Sunovion, Inc.; manufacturer (Zoll LifeCor); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Merck Data Safety and Monitoring Board; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR), Leicester Respiratory Biomedical Research Unit; FAMRI; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have read the journal's policy, and 57 of the 81 authors have declared that no competing interests exist. The following 24 authors have possible conflicts, as follows: Dr. Aldrich reports grants from NIH, during the conduct of the study; Dr. Barnes reports grants from NIH, during the conduct of the study; Dr. Barr reports grants from NIH and US-EPA, during the conduct of the study; Dr. Couper reports grants from NIH, during the conduct of the study; Dr. Deary reports grants from Age UK, grants from BBSRC, during the conduct of the study; Dr. Dupuis reports grants from Boston University, during the conduct of the study; Dr. Fall reports personal fees from MSD (Merck), outside the submitted work; Dr. Gudnason reports other from NIH, during the conduct of the study; Dr. Glaser reports grants from BMBF (German Ministry for Research and Education), during the conduct of the study; personal fees from Actelion Pharma, personal fees from Novartis Pharma, personal fees from GSK, personal fees from Pfizer, personal fees from Boehringer Ingelheim, personal fees from Bayer Pharma, all those apply outside of the submitted work; Dr. Hall reports grants received from MRC and Pfizer, and Vertex sponsored lecture at ERS, outside the submitted work; Dr. Hodge reports grants from The Medical Research Council, UK, during the conduct of the study; Dr. Koch reports grants from BMBF, during the conduct of the study, travel fees from Actelion Pharma, Pfizer, Bayer Pharma, the German Academic Exchange Service, and the Research Network for Community Medicine of the University of Greifswald, one research prize of the Society of Internal Medicine Mecklenburg-Vorpommern, Germany, outside the submitted work; Dr. Lahousse reports grant from Belgian Society of Pneumology, during the conduct of the study; Dr. London is funded in full by the Division of Intramural Research, NIEHS, NIH, DHHS; Dr. Lumley reports grants from NIH, during the conduct of the study; Dr. Mathias reports grants from NIH, during the conduct of the study; Dr. Meibohm reports grants from NIH, during the conduct of the study; Dr. O'Connor reports personal fees from Sunovion, Inc., outside the submitted work; Dr. Psaty reports grants from NIH, during the conduct of the study, and Dr. Psaty serves on the DSMB for a clinical trial of a device, which is funded by the manufacturer (Zoll LifeCor), and he is on the Steering Committee of the Yale Open Data Access Project funded by Johnson & Johnson; Dr. L Smith reports personal fees as member of Merck Data Safety and Monitoring Board, outside the submitted work; Dr. Tobin reports grants from Medical Research Council grant G0902313, grants from National Institute for Health Research (NIHR), Leicester Respiratory Biomedical Research Unit, during the conduct of the study (the views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health), grants from Pfizer for collaborative research project (on rare sequence variants and the smoking resistant lung, Nov. 2010 to Nov 2012), outside the submitted work; Dr. Wain reports grants from Pfizer collaborative research project (onrare sequence variants and the smoking resistant lung, Nov. 2010 to Nov 2012), outside the submitted work; Dr. Wilk reports grants from FAMRI, grants from NIH, during the conduct of the study; personal fees from Pfizer, outside the submitted work. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.	Akesson LS, 2005, CLIN EXP ALLERGY, V35, P327, DOI 10.1111/j.1365-2222.2005.02189.x; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; ARTIGAS MS, 2011, NAT GENET, V43, P1082, DOI DOI 10.1038/NG.941; BELLINI A, 1993, J ALLERGY CLIN IMMUN, V92, P412, DOI 10.1016/0091-6749(93)90120-5; Burkart KM, 2006, J ALLERGY CLIN IMMUN, V117, P86, DOI 10.1016/j.jaci.2005.10.011; Chang GG, 2003, BIOCHEMISTRY-US, V42, P12721, DOI 10.1021/bi035251+; Cruikshank W W, 1998, Int Rev Immunol, V16, P523, DOI 10.3109/08830189809043007; CRUIKSHANK WW, 1995, AM J RESP CELL MOL, V13, P738, DOI 10.1165/ajrcmb.13.6.7576712; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Eisner MD, 2010, AM J RESP CRIT CARE, V182, P693, DOI 10.1164/rccm.200811-1757ST; Finkel D, 2003, BEHAV GENET, V33, P107, DOI 10.1023/A:1022549700943; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Gottlieb DJ, 2001, AM J RESP CRIT CARE, V164, P1655, DOI 10.1164/ajrccm.164.9.2010122; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hansel NN, 2013, HUM GENET, V132, P79, DOI 10.1007/s00439-012-1219-6; Imboden M, 2012, J ALLERGY CLIN IMMUN, V129, P1218, DOI 10.1016/j.jaci.2012.01.074; Krug N, 2000, AM J RESP CRIT CARE, V162, P105, DOI 10.1164/ajrccm.162.1.9908055; Kurima K, 2003, GENOMICS, V82, P300, DOI 10.1016/S0888-7543(03)00154-X; Laberge S, 1997, AM J RESP CELL MOL, V17, P193, DOI 10.1165/ajrcmb.17.2.2750; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Montgomery SB, 2011, NAT REV GENET, V12, P277, DOI 10.1038/nrg2969; MOREADITH RW, 1984, J BIOL CHEM, V259, P6215; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Ramoz N, 2002, NAT GENET, V32, P579, DOI 10.1038/ng1044; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Rodriguez-Agudo D, 2005, J LIPID RES, V46, P1615, DOI 10.1194/jlr.M400501-JLR200; Rodriguez-Agudo D, 2012, J LIPID RES, V53, P2708, DOI 10.1194/jlr.M031997; Schunemann HJ, 2000, CHEST, V118, P656, DOI 10.1378/chest.118.3.656; TELLER JK, 1992, J BIOL CHEM, V267, P10423; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Vreugde S, 2002, NAT GENET, V30, P257, DOI 10.1038/ng848; Wilk JB, 2012, AM J RESP CRIT CARE; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Young RP, 2007, EUR RESPIR J, V30, P616, DOI 10.1183/09031936.00021707	35	45	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100776	10.1371/journal.pone.0100776	http://dx.doi.org/10.1371/journal.pone.0100776			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983941	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000339635000039
J	Zhang, YW; Calado, R; Rao, M; Hong, JA; Meeker, AK; Dumitriu, B; Atay, S; McCormick, PJ; Garfield, SH; Wangsa, D; Padilla-Nash, HM; Burkett, S; Zhang, M; Kunst, TF; Peterson, NR; Xi, SC; Inchauste, S; Altorki, NK; Casson, AG; Beer, DG; Harris, CC; Ried, T; Young, NS; Schrump, DS				Zhang, Yuwei; Calado, Rodrigo; Rao, Mahadev; Hong, Julie A.; Meeker, Alan K.; Dumitriu, Bogdan; Atay, Scott; McCormick, Peter J.; Garfield, Susan H.; Wangsa, Danny; Padilla-Nash, Hesed M.; Burkett, Sandra; Zhang, Mary; Kunst, Tricia F.; Peterson, Nathan R.; Xi, Sichuan; Inchauste, Suzanne; Altorki, Nasser K.; Casson, Alan G.; Beer, David G.; Harris, Curtis C.; Ried, Thomas; Young, Neal S.; Schrump, David S.			Telomerase Variant A279T Induces Telomere Dysfunction and Inhibits Non-Canonical Telomerase Activity in Esophageal Carcinomas	PLOS ONE			English	Article							BONE-MARROW FAILURE; REVERSE-TRANSCRIPTASE; CANCER-CELLS; APLASTIC-ANEMIA; BETA-CATENIN; MUTATIONS; TERT; BARRETTS; LENGTH; MAINTENANCE	Background: Although implicated in the pathogenesis of several chronic inflammatory disorders and hematologic malignancies, telomerase mutations have not been thoroughly characterized in human cancers. The present study was performed to examine the frequency and potential clinical relevance of telomerase mutations in esophageal carcinomas. Methods: Sequencing techniques were used to evaluate mutational status of telomerase reverse transcriptase (TERT) and telomerase RNA component (TERC) in neoplastic and adjacent normal mucosa from 143 esophageal cancer (EsC) patients. MTS, flow cytometry, time lapse microscopy, and murine xenograft techniques were used to assess proliferation, apoptosis, chemotaxis, and tumorigenicity of EsC cells expressing either wtTERT or TERT variants. Immunoprecipitation, immunoblot, immunofluorescence, promoter-reporter and qRT-PCR techniques were used to evaluate interactions of TERT and several TERT variants with BRG-1 and beta-catenin, and to assess expression of cytoskeletal proteins, and cell signaling. Fluorescence in-situ hybridization and spectral karyotyping techniques were used to examine telomere length and chromosomal stability. Results: Sequencing analysis revealed one deletion involving TERC (TERC del 341-360), and two non-synonymous TERT variants [A279T (2 homozygous, 9 heterozygous); A1062T (4 heterozygous)]. The minor allele frequency of the A279T variant was five-fold higher in EsC patients compared to healthy blood donors (p<0.01). Relative to wtTERT, A279T decreased telomere length, destabilized TERT-BRG-1-beta-catenin complex, markedly depleted beta-catenin, and down-regulated canonical Wnt signaling in cancer cells; these phenomena coincided with decreased proliferation, depletion of additional cytoskeletal proteins, impaired chemotaxis, increased chemosensitivity, and significantly decreased tumorigenicity of EsC cells. A279T expression significantly increased chromosomal aberrations in mouse embryonic fibroblasts (MEFs) following Zeocin (TM) exposure, as well as Li Fraumeni fibroblasts in the absence of pharmacologically-induced DNA damage. Conclusions: A279T induces telomere dysfunction and inhibits non-canonical telomerase activity in esophageal cancer cells. These findings warrant further analysis of A279T expression in esophageal cancers and premalignant esophageal lesions.	[Zhang, Yuwei; Rao, Mahadev; Hong, Julie A.; Atay, Scott; Zhang, Mary; Kunst, Tricia F.; Xi, Sichuan; Inchauste, Suzanne; Schrump, David S.] NCI, Thorac Surg Sect, Thorac & GI Oncol Branch, Bethesda, MD 20892 USA; [Calado, Rodrigo; Dumitriu, Bogdan; Peterson, Nathan R.; Young, Neal S.] NHLBI, Bethesda, MD 20892 USA; [Meeker, Alan K.] Johns Hopkins Univ Med, Dept Pathol, Baltimore, MD USA; [Meeker, Alan K.] Johns Hopkins Univ Med, Dept Oncol, Baltimore, MD USA; [McCormick, Peter J.] NCI, Cellular Oncol Lab, Bethesda, MD 20892 USA; [Garfield, Susan H.] NCI, Expt Carcinogenesis Lab, Bethesda, MD 20892 USA; [Wangsa, Danny; Padilla-Nash, Hesed M.] NCI, Sect Canc Genom, Bethesda, MD 20892 USA; [Burkett, Sandra] NCI, Comparat Mol Cytogenet Core Facil, Frederick, MD 21701 USA; [Altorki, Nasser K.] Weill Cornell Med Ctr, Dept Thorac Surg, New York, NY USA; [Casson, Alan G.] Univ Saskatchewan, Dept Surg, Saskatoon, SK, Canada; [Beer, David G.] Univ Michigan, Med Ctr, Thorac Surg Sect, Ann Arbor, MI USA; [Harris, Curtis C.] NCI, Human Carcinogenesis Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cornell University; University of Saskatchewan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Schrump, DS (corresponding author), NCI, Thorac Surg Sect, Thorac & GI Oncol Branch, Bethesda, MD 20892 USA.	David_Schrump@nih.gov	Calado, Rodrigo T./G-2619-2011; CTC USP, CEPID 13 18/J-8951-2014; McCormick, Peter/E-7387-2012	Calado, Rodrigo T./0000-0002-7966-6029; Burkett, Sandra/0000-0002-5476-4028; CTC USP, CEPID 13 18/0000-0002-7123-9524; McCormick, Peter/0000-0002-2225-5181	NIH; NATIONAL CANCER INSTITUTE [ZIABC011496, ZIABC011115] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006089] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a NIH intramural grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Arita H, 2013, ACTA NEUROPATHOL, V126, P267, DOI 10.1007/s00401-013-1141-6; Benjamin JM, 2008, SEMIN CANCER BIOL, V18, P53, DOI 10.1016/j.semcancer.2007.08.003; Berman AJ, 2011, NAT STRUCT MOL BIOL, V18, P1371, DOI 10.1038/nsmb.2174; Brandsma Inger, 2012, Genome Integr, V3, P9, DOI 10.1186/2041-9414-3-9; Calado RT, 2012, LEUKEMIA, V26, P700, DOI 10.1038/leu.2011.272; Calado RT, 2009, EUR J CLIN INVEST, V39, P1025, DOI 10.1111/j.1365-2362.2009.02209.x; Calado RT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007926; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Calado RT, 2009, P NATL ACAD SCI USA, V106, P1187, DOI 10.1073/pnas.0807057106; Cao K, 2011, J CLIN INVEST, V121, P2833, DOI 10.1172/JCI43578; Cerone MA, 2006, MOL CANCER THER, V5, P1669, DOI 10.1158/1535-7163.MCT-06-0033; Chiodi I, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00133; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Dai ZY, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-44; Davoli T, 2010, CELL, V141, P81, DOI 10.1016/j.cell.2010.01.031; Ding ZH, 2012, CELL, V148, P896, DOI 10.1016/j.cell.2012.01.039; Du HY, 2009, BLOOD, V113, P309, DOI 10.1182/blood-2008-07-166421; Gollahon LS, 1998, ONCOGENE, V17, P709, DOI 10.1038/sj.onc.1201987; Gosepath EM, 2008, INT J CANCER, V123, P2013, DOI 10.1002/ijc.23721; Grossmann TN, 2012, P NATL ACAD SCI USA, V109, P17942, DOI 10.1073/pnas.1208396109; He HP, 2012, CELL CYCLE, V11, P617, DOI 10.4161/cc.11.3.19115; Heaphy CM, 2011, AM J PATHOL, V179, P1608, DOI 10.1016/j.ajpath.2011.06.018; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Jaskelioff M, 2009, ONCOGENE, V28, P4225, DOI 10.1038/onc.2009.268; Jenkins GJS, 2003, BRIT J CANCER, V88, P1271, DOI 10.1038/sj.bjc.6600891; Kammori M, 2007, INT J MOL MED, V20, P793; Katoh M, 2008, CURR DRUG TARGETS, V9, P565, DOI 10.2174/138945008784911750; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Ma HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020466; Maida Y, 2014, MOL CELL BIOL, V34, P1576, DOI 10.1128/MCB.00093-14; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Martinez P, 2010, AGING CELL, V9, P653, DOI 10.1111/j.1474-9726.2010.00596.x; Miller CT, 2003, CLIN CANCER RES, V9, P4819; Morrish TA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000357; Mukherjee S, 2011, P NATL ACAD SCI USA, V108, pE1363, DOI 10.1073/pnas.1112414108; Murnane JP, 2012, MUTAT RES-FUND MOL M, V730, P28, DOI 10.1016/j.mrfmmm.2011.04.008; Nicholls C, 2011, PROTEIN CELL, V2, P726, DOI 10.1007/s13238-011-1093-3; Ohigashi T, 2005, PROSTATE, V62, P61, DOI 10.1002/pros.20117; Padilla-Nash HM, 2006, NAT PROTOC, V1, P3129, DOI 10.1038/nprot.2006.358; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Podlevsky JD, 2012, MUTAT RES-FUND MOL M, V730, P3, DOI 10.1016/j.mrfmmm.2011.11.002; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Rampazzo E, 2010, BRIT J CANCER, V102, P1300, DOI 10.1038/sj.bjc.6605644; Risques RA, 2007, CANCER EPIDEM BIOMAR, V16, P2649, DOI 10.1158/1055-9965.EPI-07-0624; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; Shay JW, 2012, SCIENCE, V336, P1388, DOI 10.1126/science.1222394; Shay JW, 2011, SEMIN CANCER BIOL, V21, P349, DOI 10.1016/j.semcancer.2011.10.001; Shiraishi H, 2009, SCAND J GASTROENTERO, V44, P538, DOI 10.1080/00365520902718705; Smith V, 2009, J CHEMOTHERAPY, V21, P542, DOI 10.1179/joc.2009.21.5.542; Streppel MM, 2013, CURR MOL MED; Taboski MAS, 2012, CELL REP, V1, P91, DOI 10.1016/j.celrep.2011.12.004; Uziel O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009132; Vulliamy TJ, 2005, BLOOD CELL MOL DIS, V34, P257, DOI 10.1016/j.bcmd.2004.12.008; Walne AJ, 2008, BLOOD, V112, P3594, DOI 10.1182/blood-2008-05-153445; Wege H, 2011, MOL CANCER RES, V9, P1222, DOI 10.1158/1541-7786.MCR-10-0474; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005; Wright WE, 2000, NAT MED, V6, P849, DOI 10.1038/78592; Xie MY, 2010, NUCLEIC ACIDS RES, V38, P1982, DOI 10.1093/nar/gkp1198; Xing JL, 2009, CANCER PREV RES, V2, P459, DOI 10.1158/1940-6207.CAPR-08-0227; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Zantl R, 2011, METHODS MOL BIOL, V769, P191, DOI 10.1007/978-1-61779-207-6_13; Zaug AJ, 2013, NUCLEIC ACIDS RES, V41, P8969, DOI 10.1093/nar/gkt653; Zhang H, 2006, CANCER GENET CYTOGEN, V165, P25, DOI 10.1016/j.cancergencyto.2005.07.016; Zhang Y, 2012, J BIOL CHEM, V287, P32494, DOI 10.1074/jbc.M112.368282	66	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101010	10.1371/journal.pone.0101010	http://dx.doi.org/10.1371/journal.pone.0101010			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983628	Green Published, Green Submitted, gold			2022-12-27	WOS:000339635000046
J	Gao, XY; Zhi, XY; Li, HW; Klenk, HP; Li, WJ				Gao, Xiao-Yang; Zhi, Xiao-Yang; Li, Hong-Wei; Klenk, Hans-Peter; Li, Wen-Jun			Comparative Genomics of the Bacterial Genus Streptococcus Illuminates Evolutionary Implications of Species Groups	PLOS ONE			English	Article							GROUP-B STREPTOCOCCUS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; PHYLOGENETIC-RELATIONSHIPS; VIRULENCE FACTOR; PAN-GENOME; PNEUMONIAE; PROTEIN; INSIGHTS; PLASMINOGEN; DIVERSITY	Members of the genus Streptococcus within the phylum Firmicutes are among the most diverse and significant zoonotic pathogens. This genus has gone through considerable taxonomic revision due to increasing improvements of chemotaxonomic approaches, DNA hybridization and 16S rRNA gene sequencing. It is proposed to place the majority of streptococci into "species groups". However, the evolutionary implications of species groups are not clear presently. We use comparative genomic approaches to yield a better understanding of the evolution of Streptococcus through genome dynamics, population structure, phylogenies and virulence factor distribution of species groups. Genome dynamics analyses indicate that the pan-genome size increases with the addition of newly sequenced strains, while the core genome size decreases with sequential addition at the genus level and species group level. Population structure analysis reveals two distinct lineages, one including Pyogenic, Bovis, Mutans and Salivarius groups, and the other including Mitis, Anginosus and Unknown groups. Phylogenetic dendrograms show that species within the same species group cluster together, and infer two main clades in accordance with population structure analysis. Distribution of streptococcal virulence factors has no obvious patterns among the species groups; however, the evolution of some common virulence factors is congruous with the evolution of species groups, according to phylogenetic inference. We suggest that the proposed streptococcal species groups are reasonable from the viewpoints of comparative genomics; evolution of the genus is congruent with the individual evolutionary trajectories of different species groups.	[Gao, Xiao-Yang; Li, Wen-Jun] Chinese Acad Sci, Key Lab Biogeog & Bioresource Arid Land, Xinjiang Inst Ecol & Geog, Urumqi, Peoples R China; [Zhi, Xiao-Yang; Li, Hong-Wei; Li, Wen-Jun] Yunnan Univ, Key Lab Microbial Div Southwest China, Minist Educ, Yunnan Inst Microbiol, Kunming, Peoples R China; [Zhi, Xiao-Yang; Li, Hong-Wei; Li, Wen-Jun] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Yunnan Inst Microbiol, Kunming, Peoples R China; [Li, Hong-Wei] Kunming Med Univ, Hosp Qujing City 1, Qujing Affiliated Hosp, Qujing, Peoples R China; [Klenk, Hans-Peter] Leibniz Inst DSMZ German Collect Microorganisms &, Braunschweig, Germany; [Gao, Xiao-Yang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Yunnan University; Yunnan University; Kunming Medical University; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Gao, XY (corresponding author), Chinese Acad Sci, Key Lab Biogeog & Bioresource Arid Land, Xinjiang Inst Ecol & Geog, Urumqi, Peoples R China.	gaoxiaoyang99@gmail.com; wjli@ynu.edu.cn			National Basic Research Program of China [2010CB833801]; Key Project of International Cooperation of Ministry of Science & Technology (MOST), China [2013DFA31980]; Key Project of Yunnan Provincial Natural Science Foundation [2013FA004]; Chinese Academy of Sciences	National Basic Research Program of China(National Basic Research Program of China); Key Project of International Cooperation of Ministry of Science & Technology (MOST), China; Key Project of Yunnan Provincial Natural Science Foundation; Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by grants from the National Basic Research Program of China (No. 2010CB833801) and Key Project of International Cooperation of Ministry of Science & Technology (MOST) (No. 2013DFA31980), China and Key Project of Yunnan Provincial Natural Science Foundation (2013FA004). W-J Li was also supported by 'Hundred Talents Program' of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz LD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-332; Baibai T, 2010, ACTA BIOCH BIOPH SIN, V42, P863, DOI 10.1093/abbs/gmq103; Barocchi MA, 2007, VACCINE, V25, P2963, DOI 10.1016/j.vaccine.2007.01.065; BENTLEY RW, 1991, INT J SYST BACTERIOL, V41, P487, DOI 10.1099/00207713-41-4-487; Bescos JG, 2003, MED CLIN-BARCELONA, V121, P48, DOI 10.1157/13048914; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Burke GR, 2011, GENOME BIOL EVOL, V3, P195, DOI 10.1093/gbe/evr002; Carroll RK, 2011, EPIDEMICS-NETH, V3, P159, DOI 10.1016/j.epidem.2011.07.001; COLLEN D, 1975, THROMB DIATH HAEMOST, V34, P403, DOI 10.1055/s-0038-1651399; De Vos P, 2009, BERGEYS MANUAL SYSTE, V3, P655; Dobrindt U, 2001, CURR OPIN MICROBIOL, V4, P550, DOI 10.1016/S1369-5274(00)00250-2; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; DOWSON CG, 1989, P NATL ACAD SCI USA, V86, P8842, DOI 10.1073/pnas.86.22.8842; DRUCKER DB, 1974, CAN J MICROBIOL, V20, P1723, DOI 10.1139/m74-266; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Enright MC, 2001, INFECT IMMUN, V69, P2416, DOI 10.1128/IAI.69.4.2416-2427.2001; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans JJ, 2008, J MED MICROBIOL, V57, P1369, DOI 10.1099/jmm.0.47815-0; Facklam R, 2002, CLIN MICROBIOL REV, V15, P613, DOI 10.1128/CMR.15.4.613-630.2002; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fraser-Liggett CM, 2005, GENOME RES, V15, P1603, DOI 10.1101/gr.3724205; GRATTEN M, 1993, MED J AUSTRALIA, V158, P340, DOI 10.5694/j.1326-5377.1993.tb121794.x; Gray CD, 2012, IBM SPSS STAT 19 MAD; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hildebrand F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001107; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Hoe NP, 1999, NAT MED, V5, P924, DOI 10.1038/11369; Hohwy J, 2001, INFECT IMMUN, V69, P6055, DOI 10.1128/IAI.69.10.6055-6063.2001; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Jensen R.A., 2001, GENOME BIOL, V2, P1002, DOI DOI 10.3201/eid1412.080591; Johri AK, 2006, NAT REV MICROBIOL, V4, P932, DOI 10.1038/nrmicro1552; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P406, DOI 10.1099/00207713-45-2-406; Keeling PJ, 2001, P NATL ACAD SCI USA, V98, P10745, DOI 10.1073/pnas.191337098; Kohler W, 2007, INT J MED MICROBIOL, V297, P133, DOI 10.1016/j.ijmm.2006.11.008; Konstantinidis KT, 2007, CURR OPIN MICROBIOL, V10, P504, DOI 10.1016/j.mib.2007.08.006; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Lapierrel P, 2009, TRENDS GENET, V25, P107, DOI 10.1016/j.tig.2008.12.004; LAW BA, 1978, J DAIRY RES, V45, P267, DOI 10.1017/S0022029900016447; Lee S, 2013, DIAGN MICR INFEC DIS, V76, P227, DOI 10.1016/j.diagmicrobio.2013.02.032; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; Li HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061528; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li ZY, 2013, J BIOMED NANOTECHNOL, V9, P1945, DOI 10.1166/jbn.2013.1694; Lunsford RD, 1996, J BACTERIOL, V178, P5831, DOI 10.1128/jb.178.19.5831-5835.1996; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Marri PR, 2006, MOL BIOL EVOL, V23, P2379, DOI 10.1093/molbev/msl115; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Murray PR, 1990, MED MICROBIOLOGY; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; PHYLIP LH, 1990, BIOCHEM BIOPH RES CO, V171, P439, DOI 10.1016/0006-291X(90)91412-L; Piast M, 2005, ACTA BIOCHIM POL, V52, P507; PLOTREE D, 1989, PHYLIP PHYLOGENY INF; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rusniok C, 2010, J BACTERIOL, V192, P2266, DOI 10.1128/JB.01659-09; SAKSELA O, 1988, ANNU REV CELL BIOL, V4, P93, DOI 10.1146/annurev.cb.04.110188.000521; SCHLEIFER KH, 1987, SYST APPL MICROBIOL, V10, P1, DOI 10.1016/S0723-2020(87)80002-4; Shanley TP, 1996, INFECT IMMUN, V64, P870, DOI 10.1128/IAI.64.3.870-877.1996; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Snel B, 2002, GENOME RES, V12, P17, DOI 10.1101/gr.176501; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI [10.1099/ijs.0.02360-0, 10.1099/00207713-52-3-1043]; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Takishita K, 2009, GENE, V441, P22, DOI 10.1016/j.gene.2008.03.001; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; THOMPSON JD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BIO203S00; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; WESSELS MR, 1991, P NATL ACAD SCI USA, V88, P8317, DOI 10.1073/pnas.88.19.8317; Wu H, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-2; Xu JP, 2006, MOL ECOL, V15, P1713, DOI 10.1111/j.1365-294X.2006.02882.x; Zhang AD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-523	78	60	62	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101229	10.1371/journal.pone.0101229	http://dx.doi.org/10.1371/journal.pone.0101229			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977706	Green Published, gold, Green Submitted			2022-12-27	WOS:000338506400102
J	Jasna, JM; Anandbabu, K; Bharathi, SR; Angayarkanni, N				Jasna, Jagan Mohan; Anandbabu, Kannadasan; Bharathi, Subramaniam Rajesh; Angayarkanni, Narayanasamy			Paraoxonase Enzyme Protects Retinal Pigment Epithelium from Chlorpyrifos Insult	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; SERUM PARAOXONASE; OXIDATIVE STRESS; INSECTICIDE CHLORPYRIFOS; BARRIER DYSFUNCTION; GENE-TRANSCRIPTION; HEART-DISEASE; RPE CELLS; KINASE-C; PON1	Retinal pigment epithelium (RPE) provides nourishment and protection to the eye. RPE dysfunction due to oxidative stress and inflammation is one of the major reason for many of the retinal disorders. Organophosphorus pesticides are widely used in the agricultural, industrial and household activities in India. However, their effects on the eye in the context of RPE has not been studied. In this study the defense of the ARPE19 cells exposed to Chlorpyrifos (1 nM to 100 mM) in terms of the enzyme paraoxonase (PON) was studied at 24 hr and 9 days of treatment. Chlorpyrifos was found to induce oxidative stress in the ARPE19 cells as seen by significant increase in ROS and decrease in glutathione (GSH) levels without causing cell death. Tissue resident Paraoxonase 2 (PON2) mRNA expression was elevated with chlorpyrifos exposure. The three enzymatic activities of PON namely, paraoxonase (PONase), arylesterase (PON AREase) and thiolactonase (PON HCTLase) were also found to be significantly altered to detoxify and as an antioxidant defense. Among the transcription factors regulating PON2 expression, SP1 was significantly increased with chlorpyrifos exposure. PON2 expression was found to be crucial as ARPE19 cells showed a significant loss in their ability to withstand oxidative stress when the cells were subjected to chlorpyrifos after silencing PON2 expression. Treatment with N-acetyl cysteine positively regulated the PON 2 expression, thus promoting the antioxidant defense put up by the cells in response to chlorpyrifos.	[Jasna, Jagan Mohan; Anandbabu, Kannadasan; Bharathi, Subramaniam Rajesh; Angayarkanni, Narayanasamy] Vis Res Fdn, RS Mehta Jain Dept Biochem & Cell Biol, Madras, Tamil Nadu, India		Angayarkanni, N (corresponding author), Vis Res Fdn, RS Mehta Jain Dept Biochem & Cell Biol, KBIRVO Block, Madras, Tamil Nadu, India.	drak@snmail.org	Narayanasamy, Angayarkanni/ABD-8584-2020; K, Anand Babu/AAN-8619-2020	K, Anand Babu/0000-0002-9910-2044	Indian Council of Medical Research (ICMR), India [5/8/4-18(Env)/08-NCD-1]	Indian Council of Medical Research (ICMR), India(Indian Council of Medical Research (ICMR))	The research work was financially supported by the Indian Council of Medical Research (ICMR), India. Grant number is 5/8/4-18(Env)/08-NCD-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2009, J ENVIRON BIOL, V30, P1047; Angayarkanni N, 2008, EYE, V22, P969, DOI 10.1038/sj.eye.6703062; Arii K, 2010, METABOLISM, V59, P1287, DOI 10.1016/j.metabol.2009.12.003; Bastiaans J, 2013, GRAEF ARCH CLIN EXP, V251, P1723, DOI 10.1007/s00417-013-2335-2; Bayram B, 2012, REJUV RES, V15, P71, DOI 10.1089/rej.2011.1245; BOYES WK, 1994, J APPL TOXICOL, V14, P135, DOI 10.1002/jat.2550140216; Cabana VG, 2003, J LIPID RES, V44, P780, DOI 10.1194/jlr.M200432-JLR200; Charlton-Menys V, 2006, CLIN CHEM, V52, P453, DOI 10.1373/clinchem.2005.063412; Chen WQ, 2012, NEUROSCI LETT, V528, P148, DOI 10.1016/j.neulet.2012.08.084; Cheng XG, 2012, J PHARMACOL EXP THER, V342, P688, DOI 10.1124/jpet.112.194803; Chiapella G, 2013, PLACENTA, V34, P792, DOI 10.1016/j.placenta.2013.06.007; Dahrouj M, 2013, J PHARMACOL EXP THER, V344, P96, DOI 10.1124/jpet.112.199307; Danell RM, 2000, J AM SOC MASS SPECTR, V11, P1107, DOI 10.1016/S1044-0305(00)00188-4; Deakin SP, 2008, PROTEINS CELL REG, V6, P241, DOI 10.1007/978-1-4020-6561-3_16; DEMENTI B, 1994, J APPL TOXICOL, V14, P119, DOI 10.1002/jat.2550140214; Devarajan A, 2012, MOL GENET METAB, V107, P416, DOI 10.1016/j.ymgme.2012.06.020; Draganov DI, 2000, J BIOL CHEM, V275, P33435, DOI 10.1074/jbc.M004543200; Draganov DI, 2005, J LIPID RES, V46, P1239, DOI 10.1194/jlr.M400511-JLR200; Ekinci D, 2010, CHEM BIOL DRUG DES, V76, P552, DOI 10.1111/j.1747-0285.2010.01036.x; Fuhrman B, 2009, CARDIOVASC RES, V84, P145, DOI 10.1093/cvr/cvp184; Garcia-Ramirez M, 2011, METHODS MOL BIOL, V763, P179, DOI 10.1007/978-1-61779-191-8_12; Geller AM, 2005, DOC OPHTHALMOL, V110, P79, DOI 10.1007/s10633-005-7347-8; Geller AM, 1998, INVEST OPHTH VIS SCI, V39, P1290; Hines CJ, 2001, ANN OCCUP HYG, V45, P309, DOI 10.1093/annhyg/45.4.309; Jin ML, 2005, INVEST OPHTH VIS SCI, V46, P4311, DOI 10.1167/iovs.05-0353; Kim JH, 2012, INT J BIOCHEM CELL B, V44, P808, DOI 10.1016/j.biocel.2012.02.005; Kim KY, 2001, J BIOL CHEM, V276, P40591, DOI 10.1074/jbc.M100975200; Koubaa N, 2008, CLIN CHEM LAB MED, V46, P187, DOI 10.1515/CCLM.2008.046; Loscalzo J, 2008, CIRC-CARDIOVASC GENE, V1, P79, DOI 10.1161/CIRCGENETICS.108.837179; Lu L, 2006, J CELL PHYSIOL, V206, P119, DOI 10.1002/jcp.20439; Martinelli N, 2013, ADV CLIN CHEM, V59, P65, DOI 10.1016/B978-0-12-405211-6.00003-6; MISRA UK, 1982, LANCET, V1, P288; Ng CJ, 2001, J BIOL CHEM, V276, P44444, DOI 10.1074/jbc.M105660200; Osaki F, 2004, ATHEROSCLEROSIS, V176, P279, DOI 10.1016/j.atherosclerosis.2004.05.029; Pauer GJT, 2010, AM J OPHTHALMOL, V149, P513, DOI 10.1016/j.ajo.2009.09.024; Perla-Kajan J, 2010, FASEB J, V24, P931, DOI 10.1096/fj.09-144410; Shamir R, 2005, FREE RADICAL BIO MED, V39, P336, DOI 10.1016/j.freeradbiomed.2005.03.016; Shiner M, 2007, ATHEROSCLEROSIS, V195, P313, DOI 10.1016/j.atherosclerosis.2007.01.007; Shirasawa M, 2013, EXP EYE RES, V110, P59, DOI 10.1016/j.exer.2013.02.012; TANDON P, 1994, TOXICOL APPL PHARM, V125, P271, DOI 10.1006/taap.1994.1073; Thyagarajan B, 2008, CLIN CHEM, V54, P738, DOI 10.1373/clinchem.2007.099044; Timchalk C, 2002, TOXICOL SCI, V66, P34, DOI 10.1093/toxsci/66.1.34; Tripathi S, 2013, MICROSC RES TECHNIQ, V76, P673, DOI 10.1002/jemt.22217; Verma Radhey Shyam, 2001, Indian Journal of Experimental Biology, V39, P174; Yoshikawa H, 1990, Nihon Eiseigaku Zasshi, V45, P884; Yu F, 2008, EXP TOXICOL PATHOL, V59, P415, DOI 10.1016/j.etp.2007.11.007; Yuan Jinyun, 2010, J Stem Cells, V5, P43, DOI jsc.2010.5.1.43	47	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101380	10.1371/journal.pone.0101380	http://dx.doi.org/10.1371/journal.pone.0101380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979751	Green Published, gold, Green Submitted			2022-12-27	WOS:000338506400124
J	Mehta, V; Abi-Nader, KN; Shangaris, P; Shaw, SWS; Filippi, E; Benjamin, E; Boyd, M; Peebles, DM; Martin, J; Zachary, I; David, AL				Mehta, Vedanta; Abi-Nader, Khalil N.; Shangaris, Panicos; Shaw, S. W. Steven; Filippi, Elisa; Benjamin, Elizabeth; Boyd, Michael; Peebles, Donald M.; Martin, John; Zachary, Ian; David, Anna L.			Local Over-Expression of VEGF-D-Delta N Delta C in the Uterine Arteries of Pregnant Sheep Results in Long-Term Changes in Uterine Artery Contractility and Angiogenesis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FETAL-GROWTH; BLOOD-FLOW; TROPHOBLAST INVASION; DEPENDENT RELAXATION; GENE-TRANSFER; NITRIC-OXIDE; RESTRICTION; CELLS; PREECLAMPSIA	Background: The normal development of the uteroplacental circulation in pregnancy depends on angiogenic and vasodilatory factors such as vascular endothelial growth factor (VEGF). Reduced uterine artery blood flow (UABF) is a common cause of fetal growth restriction; abnormalities in angiogenic factors are implicated. Previously we showed that adenovirus (Ad)-mediated VEGF-A(165) expression in the pregnant sheep uterine artery (UtA) increased nitric oxide synthase (NOS) expression, altered vascular reactivity and increased UABF. VEGF-D is a VEGF family member that promotes angiogenesis and vasodilatation but, in contrast to VEGF-A, does not increase vascular permeability. Here we examined the effect of Ad. VEGF-D-Delta N Delta C vector encoding a fully processed form of VEGF-D, on the uteroplacental circulation. Methods: UtA transit-time flow probes and carotid artery catheters were implanted in mid-gestation pregnant sheep (n = 5) to measure baseline UABF and maternal haemodynamics respectively. 7-14 days later, after injection of Ad.VEGF-D-Delta N Delta C vector (5x10(11) particles) into one UtA and an Ad vector encoding beta-galactosidase (Ad. LacZ) contralaterally, UABF was measured daily until scheduled post-mortem examination at term. UtAs were assessed for vascular reactivity, NOS expression and endothelial cell proliferation; NOS expression was studied in ex vivo transduced UtA endothelial cells (UAECs). Results: At 4 weeks post-injection, Ad.VEGF-D-Delta N Delta C treated UtAs showed significantly lesser vasoconstriction (E(max)144.0 v/s 184.2, p = 0.002). There was a tendency to higher UABF in Ad.VEGF-D-Delta N Delta C compared to Ad.LacZ transduced UtAs (50.58% v/s 26.94%, p = 0.152). There was no significant effect on maternal haemodynamics. An increased number of proliferating endothelial cells and adventitial blood vessels were observed in immunohistochemistry. Ad. VEGF-D DNDC expression in cultured UAECs upregulated eNOS and iNOS expression. Conclusions: Local over-expression of VEGF-D-Delta N Delta C in the UtAs of pregnant mid-gestation sheep reduced vasoconstriction, promoted endothelial cell proliferation and showed a trend towards increased UABF. Studies in cultured UAECs indicate that VEGF-D-Delta N Delta C may act in part through upregulation of eNOS and iNOS.	[Mehta, Vedanta; Abi-Nader, Khalil N.; Shangaris, Panicos; Shaw, S. W. Steven; Filippi, Elisa; Benjamin, Elizabeth; Peebles, Donald M.; David, Anna L.] UCL, Inst Womens Hlth, London, England; [Boyd, Michael] Univ London Royal Vet Coll, BSU, London, England; [Mehta, Vedanta; Martin, John; Zachary, Ian] UCL, Ctr Cardiovasc Biol & Med, Div Med, London, England	University of London; University College London; University of London; University of London Royal Veterinary College; University of London; University College London	Mehta, V (corresponding author), UCL, Inst Womens Hlth, London, England.	v.mehta@ucl.ac.uk	Shangaris, Panicos/AAJ-7725-2020	Shangaris, Panicos/0000-0003-2750-8405; David, Anna/0000-0002-0199-6140	University College London Hospital (UCLH) Charities; Dorothy Hodgkins Postgraduate Award from the UK Medical Research Council; UCLH Charities; BHF; Department of Health's NIHR Biomedical Research Center's funding scheme; British Heart Foundation [RG/11/11/29050] Funding Source: researchfish; Sparks Charity [12WTUCL02] Funding Source: researchfish	University College London Hospital (UCLH) Charities; Dorothy Hodgkins Postgraduate Award from the UK Medical Research Council; UCLH Charities; BHF(British Heart Foundation); Department of Health's NIHR Biomedical Research Center's funding scheme; British Heart Foundation(British Heart Foundation); Sparks Charity	This study was partly funded by University College London Hospital (UCLH) Charities. VM is supported by a Dorothy Hodgkins Postgraduate Award from the UK Medical Research Council and UCLH Charities. Work in IZ's group is funded by the BHF. This work was undertaken at UCLH/UCL who received a proportion of the funding from the Department of Health's NIHR Biomedical Research Center's funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Nader KN, 2010, REPROD SCI, V17, P13, DOI 10.1177/1933719109344772; ARDUINI D, 1992, OBSTET GYNECOL, V79, P605; Barbera A, 1995, AM J OBSTET GYNECOL, V173, P1765, DOI 10.1016/0002-9378(95)90424-7; Baschat AA, 2001, ULTRASOUND OBST GYN, V18, P571, DOI 10.1046/j.0960-7692.2001.00591.x; Baschat AA, 2000, ULTRASOUND OBST GYN, V16, P407, DOI 10.1046/j.1469-0705.2000.00284.x; Bird IM, 2000, ENDOCRINOLOGY, V141, P1107, DOI 10.1210/en.141.3.1107; David AL, 2008, GENE THER, V15, P1344, DOI 10.1038/gt.2008.102; Delotte J, 2009, EUR J OBSTET GYN R B, V145, P129, DOI 10.1016/j.ejogrb.2009.03.013; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Gifford SM, 2003, ENDOCRINOLOGY, V144, P3639, DOI 10.1210/en.2002-0006; HEISTAD DD, 1981, AM J PHYSIOL, V240, pH781, DOI 10.1152/ajpheart.1981.240.5.H781; Hemberger M, 2003, DEV DYNAM, V227, P185, DOI 10.1002/dvdy.10291; Jia HY, 2004, J BIOL CHEM, V279, P36148, DOI 10.1074/jbc.M401538200; KITANAKA T, 1989, AM J PHYSIOL, V256, pR1340, DOI 10.1152/ajpregu.1989.256.6.R1340; KU DD, 1993, AM J PHYSIOL, V265, pH586, DOI 10.1152/ajpheart.1993.265.2.H586; Laitinen M, 1997, HUM GENE THER, V8, P1737, DOI 10.1089/hum.1997.8.15-1737; Lang U, 2003, EUR J OBSTET GYN R B, V110, pS55, DOI 10.1016/S0301-2115(03)00173-8; Mehta V, 2012, GENE THER, V19, P925, DOI 10.1038/gt.2011.158; Naicker T, 2003, ACTA OBSTET GYN SCAN, V82, P722, DOI 10.1034/j.1600-0412.2003.00220.x; Ong SS, 2005, AM J OBSTET GYNECOL, V192, P572, DOI 10.1016/j.ajog.2004.08.015; Reister F, 2001, LAB INVEST, V81, P1143, DOI 10.1038/labinvest.3780326; Rissanen TT, 2003, CIRC RES, V92, P1098, DOI 10.1161/01.RES.0000073584.46059.E3; Rissanen TT, 2007, MOL THER, V15, P1233, DOI 10.1038/sj.mt.6300175; Savvidou MD, 2006, AM J OBSTET GYNECOL, V195, P1668, DOI 10.1016/j.ajog.2006.03.065; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Takeshita S, 1998, CIRCULATION, V98, P1261, DOI 10.1161/01.CIR.98.13.1261; Turam OM, 2008, ULTRASOUND OBST GYN, V32, P160, DOI 10.1002/uog.5386; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Wareing M, 2005, J CLIN ENDOCR METAB, V90, P2550, DOI 10.1210/jc.2004-1831; Werner A, 1998, J NEUROCYTOL, V27, P219, DOI 10.1023/A:1006928830251; Wheeler-Jones C, 1997, FEBS LETT, V420, P28, DOI 10.1016/S0014-5793(97)01481-6; Yang RH, 1996, J CARDIOVASC PHARM, V27, P838, DOI 10.1097/00005344-199606000-00011; Zezula-Szpyra A, 1997, Rocz Akad Med Bialymst, V42 Suppl 2, P134; Zhou Y, 2002, AM J PATHOL, V160, P1405, DOI 10.1016/S0002-9440(10)62567-9	35	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100021	10.1371/journal.pone.0100021	http://dx.doi.org/10.1371/journal.pone.0100021			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977408	Green Published, gold, Green Submitted			2022-12-27	WOS:000338506400017
J	Mercadel, L; Metzger, M; Haymann, JP; Thervet, E; Boffa, JJ; Flamant, M; Vrtovsnik, F; Houillier, P; Froissart, M; Stengel, B				Mercadel, Lucile; Metzger, Marie; Haymann, Jean Philippe; Thervet, Eric; Boffa, Jean-Jacques; Flamant, Martin; Vrtovsnik, Francois; Houillier, Pascal; Froissart, Marc; Stengel, Benedicte		NephroTest Study Grp	The Relation of Hepcidin to Iron Disorders, Inflammation and Hemoglobin in Chronic Kidney Disease	PLOS ONE			English	Article							SERUM HEPCIDIN; ERYTHROPOIETIN THERAPY; HEMODIALYSIS; ANEMIA; PATHOGENESIS; PROHEPCIDIN; DEFICIENCY; EXPRESSION; FERRITIN	The metabolism of hepcidin is profoundly modified in chronic kidney disease (CKD). We investigated its relation to iron disorders, inflammation and hemoglobin (Hb) level in 199 non-dialyzed, non-transplanted patients with CKD stages 1-5. All had their glomerular filtration rate measured by Cr-51-EDTA renal clearance (mGFR), as well as measurements of iron markers including hepcidin and of erythropoietin (EPO). Hepcidin varied from 0.2 to 193 ng/mL. The median increased from 23.3 ng/mL [8.8-28.7] to 36.1 ng/mL [14.1-92.3] when mGFR decreased from >= 60 to <15 mL/min/1.73 m(2) (p = 0.02). Patients with absolute iron deficiency (transferrin saturation (TSAT) <20% and ferritin <40 ng/mL) had the lowest hepcidin levels (5.0 ng/mL [0.7-11.7]), and those with a normal iron profile (TSAT >= 20% and ferritin >= 40), the highest (34.5 ng/mL [23.7-51.6]). In multivariate analysis, absolute iron deficiency was associated with lower hepcidin values, and inflammation combined with a normal or functional iron profile with higher values, independent of other determinants of hepcidin concentration, including EPO, mGFR, and albuminemia. The hepcidin level, although it rose overall when mGFR declined, collapsed in patients with absolute iron deficiency. There was a significant interaction with iron status in the association between Hb and hepcidin. Except in absolute iron deficiency, hepcidin's negative association with Hb level indicates that it is not downregulated in CKD anemia.	[Mercadel, Lucile; Metzger, Marie; Froissart, Marc; Stengel, Benedicte] INSERM, U1018, Ctr Res Epidemiol & Populat Hlth, Epidemiol Diabet Obes & Kidney Dis Team, Villejuif, France; [Mercadel, Lucile] Hop La Pitie Salpetriere, Assistance Publ Hop Paris, Dept Nephrol, Paris, France; [Metzger, Marie; Stengel, Benedicte] Univ Paris 11, U1018, Villejuif, France; [Haymann, Jean Philippe] Univ Paris 06, INSERM, U702, Hop Tenon,Assistance Publ Hop Paris,Dept Physiol, Paris, France; [Thervet, Eric] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Dept Nephrol, Paris, France; [Boffa, Jean-Jacques] Univ Paris 06, Hop Tenon, Assistance Publ Hop Paris, Dept Nephrol, Paris, France; [Flamant, Martin] Hop Bichat Claude Bernard, Assistance Publ Hop Paris, Dept Physiol, F-75877 Paris, France; [Flamant, Martin; Vrtovsnik, Francois] INSERM, U699, Paris, France; [Vrtovsnik, Francois] Univ Paris 06, Hop Bichat, Assistance Publ Hop Paris, Dept Nephrol, Paris, France; [Houillier, Pascal] Univ Paris 05, Hop Europe G Pompidou, Assistance Publ Hop Paris, Dept Physiol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Mercadel, L (corresponding author), INSERM, U1018, Ctr Res Epidemiol & Populat Hlth, Epidemiol Diabet Obes & Kidney Dis Team, Villejuif, France.	lucile.mercadal@psl.aphp.fr	Stengel, Benedicte/G-5730-2015; Froissart, Marc/L-7493-2014; Houillier, Pascal/AAD-4903-2019; Metzger, Marie/K-9772-2018	Stengel, Benedicte/0000-0001-9469-0804; Froissart, Marc/0000-0002-4010-3173; Houillier, Pascal/0000-0003-4953-6917; Metzger, Marie/0000-0003-3597-5409; Vidal-Petiot, Emmanuelle/0000-0001-9356-7302; DAUGAS, Eric/0000-0001-7256-7979; Eladari, Dominique/0000-0003-1067-0844; Vrtovsnik, Francois/0000-0003-1554-314X	Inserm GIS-IReSP [AO 8113LS TGIR]; French Ministry of Health [AOM 09114]; Inserm [AO 8022LS]; Agence de la Biomedecine [RO 8156LL]; AURA; Roche [2009-152-447G]; F. Hoffman-La Roche Ltd.	Inserm GIS-IReSP; French Ministry of Health; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence de la Biomedecine; AURA; Roche(Roche Holding); F. Hoffman-La Roche Ltd.	The NephroTest CKD cohort study is supported by grants from Inserm GIS-IReSP AO 8113LS TGIR (BS); French Ministry of Health AOM 09114 (MFr); Inserm AO 8022LS (BS); Agence de la Biomedecine RO 8156LL (BS), AURA (MFr), and Roche 2009-152-447G (MFr). The Nephrotest initiative was also sponsored by unrestricted grants from F. Hoffman-La Roche Ltd. (LM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby DR, 2009, KIDNEY INT, V75, P976, DOI 10.1038/ki.2009.21; Bartnikas TB, 2011, BLOOD, V117, P630, DOI 10.1182/blood-2010-05-287359; Bekri S, 2006, GASTROENTEROLOGY, V131, P788, DOI 10.1053/j.gastro.2006.07.007; Canavesi Elena, 2012, World J Nephrol, V1, P166, DOI 10.5527/wjn.v1.i6.166; Costa E, 2009, ACTA HAEMATOL-BASEL, V122, P226, DOI 10.1159/000253590; Ford BA, 2010, KIDNEY INT, V78, P769, DOI 10.1038/ki.2010.254; Galesloot TE, 2011, BLOOD, V117, pE218, DOI 10.1182/blood-2011-02-337907; Gkouvatsos K, 2012, BBA-GEN SUBJECTS, V1820, P188, DOI 10.1016/j.bbagen.2011.10.013; Grebenchtchikov N, 2009, BRIT J HAEMATOL, V146, P317, DOI 10.1111/j.1365-2141.2009.07758.x; Hintze Korry J, 2011, Adv Hematol, V2011, P510304, DOI 10.1155/2011/510304; Kato A, 2008, AM J NEPHROL, V28, P115, DOI 10.1159/000109968; Kim A, 2014, BLOOD, V123, P1129, DOI 10.1182/blood-2013-08-521419; Li Hongyan, 2009, Journal of Pharmacological and Toxicological Methods, V59, P171, DOI 10.1016/j.vascn.2009.02.004; Lipschitz D A, 1992, Nutrition, V8, P443; Malyszko J, 2009, TRANSPL P, V41, P3056, DOI 10.1016/j.transproceed.2009.08.003; Malyszko J, 2009, RENAL FAILURE, V31, P544, DOI 10.1080/08860220903082606; Mercadal L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084144; Mercadal L, 2012, CLIN J AM SOC NEPHRO, V7, P35, DOI 10.2215/CJN.04690511; Moranne O, 2009, J AM SOC NEPHROL, V20, P164, DOI 10.1681/ASN.2008020159; Pelusi S, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-48; Peters HPE, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-70; Peters HPE, 2010, NEPHROL DIAL TRANSPL, V25, P848, DOI 10.1093/ndt/gfp546; Theurl I, 2009, BLOOD, V113, P5277, DOI 10.1182/blood-2008-12-195651; Tomosugi N, 2006, BLOOD, V108, P1381, DOI 10.1182/blood-2005-10-4043; Uehata T, 2012, NEPHROL DIAL TRANSPL, V27, P1076, DOI 10.1093/ndt/gfr431; Ulukol B, 2007, ACTA HAEMATOL-BASEL, V118, P70, DOI 10.1159/000102606; Valenti L, 2013, CLIN CHEM LAB MED, V14, P1; van der Weerd NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039783; Zaritsky J, 2010, CLIN J AM SOC NEPHRO, V5, P1010, DOI 10.2215/CJN.08161109; Zaritsky J, 2009, CLIN J AM SOC NEPHRO, V4, P1051, DOI 10.2215/CJN.05931108	30	43	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e99781	10.1371/journal.pone.0099781	http://dx.doi.org/10.1371/journal.pone.0099781			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978810	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400010
J	Shawish, HB; Wong, WY; Wong, YL; Loh, SW; Looi, CY; Hassandarvish, P; Phan, AYL; Wong, WF; Wang, H; Paterson, IC; Ea, CK; Mustafa, MR; Maah, MJ				Shawish, Hana Bashir; Wong, Wan Ying; Wong, Yi Li; Loh, Sheng Wei; Looi, Chung Yeng; Hassandarvish, Pouya; Phan, Alicia Yi Ling; Wong, Won Fen; Wang, Hao; Paterson, Ian C.; Ea, Chee Kwee; Mustafa, Mohd Rais; Maah, Mohd Jamil			Nickel(II) Complex of Polyhydroxybenzaldehyde N4-Thiosemicarbazone Exhibits Anti-Inflammatory Activity by Inhibiting NF-kappa B Transactivation	PLOS ONE			English	Article							ANTIOXIDANT CAPACITY; INDUCED APOPTOSIS; INFLAMMATION; THIOSEMICARBAZONE; CANCER; TNF; COPPER(II); CHLORIDE; AGENTS; ASSAYS	Background: The biological properties of thiosemicarbazone have been widely reported. The incorporation of some transition metals such as Fe, Ni and Cu to thiosemicarbazone complexes is known to enhance its biological effects. In this study, we incorporated nickel(II) ions into thiosemicarbazone with N4-substitution groups H3L (H; H3L1, CH3; H3L2, C6H5; H3L3 and C2H5; H3L4) and examined its potential anti-inflammatory activity. Methodology/Principal Findings: Four ligands (1-4) and their respective nickel-containing complexes (5-8) were synthesized and characterized. The compounds synthesized were tested for their effects on NF-kappa B nuclear translocation, pro-inflammatory cytokines secretion and NF-kappa B transactivation activity. The active compound was further evaluated on its ability to suppress carrageenan-induced acute inflammation in vivo. A potential binding target of the active compound was also predicted by molecular docking analysis. Conclusions/Significance: Among all synthesized compounds tested, we found that complex [Ni(H2L1)(PPh3)]Cl (5) (complex 5), potently inhibited I kappa B alpha degradation and NF-kappa B p65 nuclear translocation in LPS-stimulated RAW264.7 cells as well as TNF alpha-stimulated HeLa S3 cells. In addition, complex 5 significantly down-regulated LPS- or TNF alpha-induced transcription of NF-kappa B target genes, including genes that encode the pro-inflammatory cytokines TNF alpha, IFN beta and IL6. Luciferase reporter assays confirmed that complex 5 inhibited the transactivation activity of NF-kappa B. Furthermore, the anti-inflammatory effect of complex 5 was also supported by its suppressive effect on carrageenan-induced paw edema formation in wild type C57BL/6 mice. Interestingly, molecular docking study showed that complex 5 potentially interact with the active site of IKK beta. Taken together, we suggest complex 5 as a novel NF-kappa B inhibitor with potent anti-inflammatory effects.	[Shawish, Hana Bashir; Maah, Mohd Jamil] Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur 59100, Malaysia; [Wong, Wan Ying; Loh, Sheng Wei; Ea, Chee Kwee] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Wong, Yi Li; Looi, Chung Yeng; Mustafa, Mohd Rais] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia; [Hassandarvish, Pouya; Phan, Alicia Yi Ling; Wong, Won Fen] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia; [Wang, Hao] Ningxia Med Univ, Sch Pharm, Ningxia, Peoples R China; [Wang, Hao; Paterson, Ian C.] Univ Malaya, Fac Dent, Dept Oral Biol & Biomed Sci, Kuala Lumpur, Malaysia; [Wang, Hao; Paterson, Ian C.] Univ Malaya, Fac Dent, Oral Canc Res & Coordinating Ctr, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Ningxia Medical University; Universiti Malaya; Universiti Malaya	Looi, CY (corresponding author), Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia.	looicy@um.edu.my; mjamil@um.edu.my	Mohd Jamil Maah, DPhil/Professor/B-5230-2010; Paterson, Ian/G-8688-2011; Mustafa, Mohamed R/B-1647-2009; Hassandarvish, Pouya/K-8112-2012; Looi, Chung Yeng/A-2623-2013; Wong, Won Fen/D-3087-2012	Mohd Jamil Maah, DPhil/Professor/0000-0002-0381-8954; Paterson, Ian/0000-0001-9156-401X; Mustafa, Mohamed R/0000-0002-7864-5189; Hassandarvish, Pouya/0000-0003-0364-5587; Looi, Chung Yeng/0000-0002-4830-3495; Wong, Won Fen/0000-0003-1082-1956	Postgraduate Research Fund [PS 484/ 2010B]; University of Malaya [RG206-11AFR]; University of Malaya High Impact Research Grant [UM.C/625/1/HIR/MOHE/CHAN-02: H-50001-A000022]	Postgraduate Research Fund; University of Malaya(Universiti Malaya); University of Malaya High Impact Research Grant	This study was supported by Postgraduate Research Fund (PS 484/ 2010B) and RG206-11AFR from University of Malaya. C.K. Ea is supported by the University of Malaya High Impact Research Grant UM.C/625/1/HIR/MOHE/CHAN-02: H-50001-A000022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrasiabi Z, 2005, J INORG BIOCHEM, V99, P1526, DOI 10.1016/j.jinorgbio.2005.04.012; [Anonymous], 2007, APEX2 SAINT; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Beg AA, 2004, NAT IMMUNOL, V5, P14, DOI 10.1038/ni0104-14; Botelho FV, 2007, J INORG BIOCHEM, V101, P935, DOI 10.1016/j.jinorgbio.2007.03.007; Bukhari SB, 2009, SPECTROCHIM ACTA A, V71, P1901, DOI 10.1016/j.saa.2008.07.030; Conner EM, 1996, NUTRITION, V12, P274, DOI 10.1016/S0899-9007(96)00000-8; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; Dilovic I, 2008, BIOORGAN MED CHEM, V16, P5189, DOI 10.1016/j.bmc.2008.03.006; Farrugia L.J., 1997, J APPL CRYSTALLOGR, V30, P565, DOI 10.1107/S0021889897003117; Ferrari MB, 2002, J INORG BIOCHEM, V90, P113, DOI 10.1016/S0162-0134(02)00428-2; GERAN RI, 1972, CANC CHEMOTHER REP, V3, P1; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; KLAYMAN DL, 1979, J MED CHEM, V22, P855, DOI 10.1021/jm00193a020; Krishnamoorthy S, 2006, CANCER METAST REV, V25, P481, DOI 10.1007/s10555-006-9016-0; KUBONISHI I, 1983, International Journal of Cell Cloning, V1, P105; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Looi CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056643; Looi CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023640; Makarov SS, 2000, MOL MED TODAY, V6, P441, DOI 10.1016/S1357-4310(00)01814-1; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pelosi G., 2010, OPEN CRYSTALLOGR J, V3, P16, DOI [10.1021/jm1007616, DOI 10.2174/1874846501003020016, 10.2174/1874846501003010016]; Prior RL, 1999, FREE RADICAL BIO MED, V27, P1173, DOI 10.1016/S0891-5849(99)00203-8; Ragsdale SW, 2009, J BIOL CHEM, V284, P18571, DOI 10.1074/jbc.R900020200; Sankaraperumal A, 2013, POLYHEDRON, V50, P264, DOI 10.1016/j.poly.2012.11.006; Shawish HB, 2010, ACTA CRYSTALLOGR E, V66, pM1366, DOI 10.1107/S1600536810039292; Shawish HB, 2010, ACTA CRYSTALLOGR E, V66, pM1074, DOI 10.1107/S1600536810031065; Sheldrick G.M., 1996, SADABS; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Swesi AT FY, 2007, SAINS MALAYS, V36, P21; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; VENANZI LM, 1958, J CHEM SOC, P719, DOI 10.1039/jr9580000719; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang SL, 2009, CELL MOL IMMUNOL, V6, P327, DOI 10.1038/cmi.2009.43; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Xu GZ, 2011, NATURE, V472, P325, DOI 10.1038/nature09853; Zulueta A, 2009, FOOD CHEM, V114, P310, DOI 10.1016/j.foodchem.2008.09.033	38	48	48	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100933	10.1371/journal.pone.0100933	http://dx.doi.org/10.1371/journal.pone.0100933			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977407	gold, Green Published, Green Submitted			2022-12-27	WOS:000338506400053
J	Sugisaki, N; Kurokawa, S; Okada, J; Kanehisa, H				Sugisaki, Norihide; Kurokawa, Sadao; Okada, Junichi; Kanehisa, Hiroaki			Difference in the Recruitment of Hip and Knee Muscles between Back Squat and Plyometric Squat Jump	PLOS ONE			English	Article							KINETIC CHAIN EXERCISES; MUSCULAR ENDURANCE; ELECTROMYOGRAPHIC ACTIVITY; POWER OUTPUT; FIBER-TYPE; PROTON T2; MR-IMAGES; INTENSITY; LOAD; BIOMECHANICS	Athletes who aim to improve both muscular endurance and power often perform exercises that involve similar joint actions under different lifting conditions, such as changes in the load or speed, which are implemented at different times during a periodized exercise program or simultaneously. The prescribed exercises are considered to recruit the same muscles even if the lifting conditions differ to each other. The present study aimed to clarify this by examining whether the recruitment of individual hip and knee muscles during the squat exercise differs between lifting conditions adopted for muscular endurance and power training regimens. Moderately trained men performed back squats (BS), with a load of approximately 60% of one repetition maximum, as a muscular endurance training exercise, and they performed plyometric squat jumping (PSJ) for power training. During each exercise, the lower limb joint torques and the recruitment of five hip and knee muscles were determined with inverse-dynamics and T2-weighted magnetic resonance imaging, respectively. While the maximal and mean knee joint torques were greater during PSJ than during BS (p<0.01), the T2 values for the quadriceps femoris muscle did not differ between the exercises. In contrast, the T2 values of the gluteus maximus and hip adductor muscles were higher during PSJ (p<0.05) than during BS, although there was no significant difference in the mean hip extension torque between the two exercises. The current results indicate that the individual use of the agonist muscles differs between BS and PSJ, and it does not always correspond with the joint kinetics during the exercises. Therefore, in addition to the exercise type, the lifting condition should also be taken into consideration as a determinant of the major muscles trained during a resistance exercise.	[Sugisaki, Norihide] Chiba Univ, Ctr Environm Hlth & Field Sci, Kashiwa, Chiba, Japan; [Sugisaki, Norihide] Waseda Univ, Waseda Inst Sport Sci, Tokorozawa, Saitama, Japan; [Kurokawa, Sadao] Meiji Gakuin Univ, Ctr Liberal Arts, Yokohama, Kanagawa, Japan; [Okada, Junichi] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Kanehisa, Hiroaki] Natl Inst Fitness & Sports Kanoya, Kanoya, Kagoshima, Japan	Chiba University; Waseda University; Waseda University; National Institute Fitness & Sports Kanoya	Sugisaki, N (corresponding author), Chiba Univ, Ctr Environm Hlth & Field Sci, Kashiwa, Chiba, Japan.	sugisaki@chiba-u.jp			JSPS [24700667]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by JSPS Grant-in-Aid for Scientific Research (24700667), (http://www.jsps.go.jp/j-grantsinaid/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS GR, 1992, J APPL PHYSIOL, V73, P1578, DOI 10.1152/jappl.1992.73.4.1578; ADAMS GR, 1993, J APPL PHYSIOL, V74, P532, DOI 10.1152/jappl.1993.74.2.532; Baechle T. R., 2008, ESSENTIALS STRENGTH, P414; Baker D, 2001, J STRENGTH COND RES, V15, P92; Ball N, 2011, EUR J SPORT SCI, V11, P447, DOI 10.1080/17461391.2010.536583; CAVAGNA GA, 1968, J APPL PHYSIOL, V24, P21, DOI 10.1152/jappl.1968.24.1.21; DOSTAL WF, 1986, PHYS THER, V66, P351, DOI 10.1093/ptj/66.3.351; Earle R. W., 2008, ESSENTIALS STRENGTH, V3th, P325; EDMAN KAP, 1979, J PHYSIOL-LONDON, V291, P143, DOI 10.1113/jphysiol.1979.sp012804; ELDER GCB, 1982, J APPL PHYSIOL, V53, P1473, DOI 10.1152/jappl.1982.53.6.1473; Enocson AG, 2005, EUR J APPL PHYSIOL, V94, P357, DOI 10.1007/s00421-005-1339-y; Escamilla RF, 1998, MED SCI SPORT EXER, V30, P556, DOI 10.1097/00005768-199804000-00014; Escamilla RF, 2001, MED SCI SPORT EXER, V33, P1552, DOI 10.1097/00005768-200109000-00020; Farina D, 2004, J APPL PHYSIOL, V96, P1486, DOI 10.1152/japplphysiol.01070.2003; Farina D, 2006, EXERC SPORT SCI REV, V34, P121, DOI 10.1249/00003677-200607000-00006; FISHER MJ, 1990, INVEST RADIOL, V25, P480, DOI 10.1097/00004424-199005000-00003; FLECKENSTEIN JL, 1993, J APPL PHYSIOL, V74, P2855, DOI 10.1152/jappl.1993.74.6.2855; Ishikawa M, 2003, ACTA PHYSIOL SCAND, V178, P205, DOI 10.1046/j.1365-201X.2003.01149.x; JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3; Kawakami Y, 2006, AM J HUM BIOL, V18, P845, DOI 10.1002/ajhb.20561; Newton RU, 1997, EUR J APPL PHYSIOL O, V75, P333, DOI 10.1007/s004210050169; PLOUTZSNYDER LL, 1995, AM J PHYSIOL-REG I, V269, pR536, DOI 10.1152/ajpregu.1995.269.3.R536; Potach DH., 2008, ESSENTIALS STRENGTH, P413; Price TB, 1998, MED SCI SPORT EXER, V30, P1374, DOI 10.1097/00005768-199809000-00006; Prior BM, 2001, J APPL PHYSIOL, V90, P615, DOI 10.1152/jappl.2001.90.2.615; Ratamess A, 2011, ACSMS FDN STRENGTH T, P192; Ratamess A, 2011, ACSMS FDN STRENGTH T, P331; Rhea MR, 2003, J STRENGTH COND RES, V17, P82; Sedano S, 2013, J STRENGTH COND RES, V27, P2433, DOI 10.1519/JSC.0b013e318280cc26; Smilios I, 2010, J STRENGTH COND RES, V24, P2122, DOI 10.1519/JSC.0b013e3181a5bc44; Taipale RS, 2013, EUR J APPL PHYSIOL, V113, P325, DOI 10.1007/s00421-012-2440-7; Voigt M, 1998, ACTA PHYSIOL SCAND, V163, P181; Wakahara T, 2012, EUR J APPL PHYSIOL, V112, P1569, DOI 10.1007/s00421-011-2121-y; Wathen D., 2008, ESSENTIALS STRENGTH, V3rd, P507; Weiss LW, 2000, J ORTHOP SPORT PHYS, V30, P143, DOI 10.2519/jospt.2000.30.3.143; Wilk KE, 1996, AM J SPORT MED, V24, P518, DOI 10.1177/036354659602400418; Willardson JM, 2006, J STRENGTH COND RES, V20, P400; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Yamaguchi GT., 1990, MULTIPLE MUSCLE SYST, P717; [No title captured]	40	9	9	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101203	10.1371/journal.pone.0101203	http://dx.doi.org/10.1371/journal.pone.0101203			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979707	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400099
J	Sun, LJ; Liu, M; Hu, JJ; Liang, XH				Sun, Linjia; Liu, Min; Hu, Jiajia; Liang, Xiaohui			A Chinese Character Teaching System Using Structure Theory and Morphing Technology	PLOS ONE			English	Article							RECOGNITION	This paper proposes a Chinese character teaching system by using the Chinese character structure theory and the 2D contour morphing technology. This system, including the offline phase and the online phase, automatically generates animation for the same Chinese character from different writing stages to intuitively show the evolution of shape and topology in the process of Chinese characters teaching. The offline phase builds the component models database for the same script and the components correspondence database for different scripts. Given two or several different scripts of the same Chinese character, the online phase firstly divides the Chinese characters into components by using the process of Chinese character parsing, and then generates the evolution animation by using the process of Chinese character morphing. Finally, two writing stages of Chinese characters, i.e., seal script and clerical script, are used in experiment to show the ability of the system. The result of the user experience study shows that the system can successfully guide students to improve the learning of Chinese characters. And the users agree that the system is interesting and can motivate them to learn.	[Sun, Linjia; Liu, Min; Liang, Xiaohui] Beihang Univ, Sch Comp Sci & Engn, State Key Lab Virtual Real Technol & Syst, Beijing 100191, Peoples R China; [Hu, Jiajia] Beijing Normal Univ, Sch Chinese Language & Literature, Beijing 100875, Peoples R China	Beihang University; Beijing Normal University	Liang, XH (corresponding author), Beihang Univ, Sch Comp Sci & Engn, State Key Lab Virtual Real Technol & Syst, Beijing 100191, Peoples R China.	lxh@vrlab.buaa.edu.cn			Natural Science Foundation of China [61170186]; National Key Technology Research and Development Program of China [2014BAK18B01]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research and Development Program of China(National Key Technology R&D ProgramNational High Technology Research and Development Program of China)	This work is supported by the Natural Science Foundation of China (Grant No. 61170186) and the National Key Technology Research and Development Program of China(Grant No. 2014BAK18B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter WV, 2009, IEEE T VIS COMPUT GR, V15, P867, DOI 10.1109/TVCG.2009.38; Belongie S, 2002, IEEE T PATTERN ANAL, V24, P509, DOI 10.1109/34.993558; Cao R, 2000, INT C PATT RECOG, P368, DOI 10.1109/ICPR.2000.902935; Cheng-Lin Liu, 1999, Proceedings of the Fifth International Conference on Document Analysis and Recognition. ICDAR '99 (Cat. No.PR00318), P378, DOI 10.1109/ICDAR.1999.791803; CHEW LP, 1989, ALGORITHMICA, V4, P97, DOI 10.1007/BF01553881; Chiu HP, 1999, PATTERN RECOGN, V32, P1947, DOI 10.1016/S0031-3203(99)00003-5; Felzenszwalb P.F., 2007, P 2007 IEEE C COMP V, P1, DOI [DOI 10.1109/CVPR.2007.383018, 10.1109/CVPR.2007.383018]; Gupta H, 1997, J ALGORITHM, V22, P142, DOI 10.1006/jagm.1995.0808; Kato N, 1999, IEEE T PATTERN ANAL, V21, P258, DOI 10.1109/34.754617; Kim IJ, 2003, IEEE T PATTERN ANAL, V25, P1422, DOI 10.1109/TPAMI.2003.1240117; Lee CN, 1998, PATTERN RECOGN, V31, P651, DOI 10.1016/S0031-3203(97)00080-0; Liu LG, 2004, 12TH PACIFIC CONFERENCE ON COMPUTER GRAPHICS AND APPLICATIONS, PROCEEDINGS, P111; Ma Xiaohu, 1995, Journal of Computer Science and Technology (English Language Edition), V10, P42, DOI 10.1007/BF02939521; Manay S, 2006, IEEE T PATTERN ANAL, V28, P1602, DOI 10.1109/TPAMI.2006.208; Schmidt FR, 2007, LECT NOTES COMPUT SC, V4679, P39; SEDERBERG TW, 1992, COMP GRAPH, V26, P25, DOI 10.1145/142920.134001; Shi D, 2003, IEEE T PATTERN ANAL, V25, P277, DOI 10.1109/TPAMI.2003.1177158; SIMON JC, 1992, P IEEE, V80, P1150, DOI 10.1109/5.156476; Surazhsky V, 2002, P 11 INT MESH ROUNDT, P183; Tang YY, 1998, IEEE T PATTERN ANAL, V20, P556, DOI 10.1109/34.682186; Wang AB, 2001, PATTERN RECOGN, V34, P15, DOI 10.1016/S0031-3203(99)00207-1; Wang N, 2003, SERIES BOOKS HIST CH; Wang N, 2003, RES CHINESE CHARACTE; Wang N, 2005, RES CHINESE CHARACTE; Wong PK, 1998, IEEE T PATTERN ANAL, V20, P1016, DOI 10.1109/34.713366; Zeng J, 2010, INFORM SCIENCES, V180, P301, DOI 10.1016/j.ins.2009.09.011	26	6	6	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100987	10.1371/journal.pone.0100987	http://dx.doi.org/10.1371/journal.pone.0100987			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978171	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400056
J	Gustine, DD; Brinkman, TJ; Lindgren, MA; Schmidt, JI; Rupp, TS; Adams, LG				Gustine, David D.; Brinkman, Todd J.; Lindgren, Michael A.; Schmidt, Jennifer I.; Rupp, T. Scott; Adams, Layne G.			Climate-Driven Effects of Fire on Winter Habitat for Caribou in the Alaskan-Yukon Arctic	PLOS ONE			English	Article							LANDSCAPE CHARACTERISTICS; NORTHWEST-TERRITORIES; VEGETATION-RESPONSE; SEWARD PENINSULA; LICHEN ABUNDANCE; FEMALE CARIBOU; TUNDRA FIRE; DYNAMICS; IMPACTS; DENSITY	Climatic warming has direct implications for fire-dominated disturbance patterns in northern ecosystems. A transforming wildfire regime is altering plant composition and successional patterns, thus affecting the distribution and potentially the abundance of large herbivores. Caribou (Rangifer tarandus) are an important subsistence resource for communities throughout the north and a species that depends on terrestrial lichen in late-successional forests and tundra systems. Projected increases in area burned and reductions in stand ages may reduce lichen availability within caribou winter ranges. Sufficient reductions in lichen abundance could alter the capacity of these areas to support caribou populations. To assess the potential role of a changing fire regime on winter habitat for caribou, we used a simulation modeling platform, two global circulation models (GCMs), and a moderate emissions scenario to project annual fire characteristics and the resulting abundance of lichen-producing vegetation types (i.e., spruce forests and tundra >60 years old) across a modeling domain that encompassed the winter ranges of the Central Arctic and Porcupine caribou herds in the Alaskan-Yukon Arctic. Fires were less numerous and smaller in tundra compared to spruce habitats throughout the 90-year projection for both GCMs. Given the more likely climate trajectory, we projected that the Porcupine caribou herd, which winters primarily in the boreal forest, could be expected to experience a greater reduction in lichen-producing winter habitats (-21%) than the Central Arctic herd that wintered primarily in the arctic tundra (-11%). Our results suggest that caribou herds wintering in boreal forest will undergo fire-driven reductions in lichen-producing habitats that will, at a minimum, alter their distribution. Range shifts of caribou resulting from fire-driven changes to winter habitat may diminish access to caribou for rural communities that reside in fire-prone areas.	[Gustine, David D.; Adams, Layne G.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA; [Brinkman, Todd J.; Lindgren, Michael A.; Schmidt, Jennifer I.; Rupp, T. Scott] Univ Alaska, Scenarios Network Alaska & Arctic Planning, Fairbanks, AK 99701 USA	United States Department of the Interior; United States Geological Survey; University of Alaska System; University of Alaska Fairbanks	Gustine, DD (corresponding author), US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA.	dgustine@usgs.gov	Schmidt, Jennifer/W-1638-2019	Schmidt, Jennifer/0000-0002-0945-3204	USGS Ecosystem Mission Area; Division Of Environmental Biology [1026415] Funding Source: National Science Foundation	USGS Ecosystem Mission Area; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work is part of the U.S. Geological Survey's (USGS) Changing Arctic Ecosystem Initiative and is supported by funding from the Wildlife Program of the USGS Ecosystem Mission Area. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMCZEWSKI JZ, 1993, CAN J ZOOL, V71, P1221, DOI 10.1139/z93-167; Arthur SM, 2009, EFFECTS OIL FIELD DE; Barrett CM, 2013, ECOLOGY, V94, P389, DOI 10.1890/12-0840.1; Barrett K, 2011, ECOL APPL, V21, P2380, DOI 10.1890/10-0896.1; Barrett K, 2012, REMOTE SENS LETT, V3, P729, DOI 10.1080/2150704X.2012.676741; Barrier TA, 2012, ECOSCIENCE, V19, P177, DOI 10.2980/19-2-3508; Bret-Harte MS, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0490; Brinkman T.J., 2013, WILDLIFE PROFESSIONA, V7, P38; Cahoon SMP, 2012, GLOBAL CHANGE BIOL, V18, P469, DOI 10.1111/j.1365-2486.2011.02528.x; Cameron RD, 2005, ARCTIC, V58, P1; CAMERON RD, 1979, J WILDLIFE MANAGE, V43, P626, DOI 10.2307/3808740; Chapin FS, 2008, BIOSCIENCE, V58, P531, DOI 10.1641/B580609; Collins WB, 2011, J WILDLIFE MANAGE, V75, P369, DOI 10.1002/jwmg.39; Duffy PA, 2005, ECOL APPL, V15, P1317, DOI 10.1890/04-0739; Duffy PA, 2006, INTERACTIONS CLIMATE; Duffy PA, 2007, INT J WILDLAND FIRE, V16, P277, DOI 10.1071/WF06034; Fauria MM, 2008, PHILOS T R SOC B, V363, P2317, DOI 10.1098/rstb.2007.2202; Festa-Bianchet M, 2011, CAN J ZOOL, V89, P419, DOI [10.1139/z11-025, 10.1139/Z11-025]; Field CB, 2008, ECOLOGICAL IMPACTS C; Flannigan MD, 2005, CLIMATIC CHANGE, V72, P1, DOI 10.1007/s10584-005-5935-y; Gustine DD, 2014, RAPID COMMUN MASS SP, V28, P625, DOI 10.1002/rcm.6825; Gustine DD, 2012, J MAMMAL, V93, P778, DOI 10.1644/11-MAMM-A-164.1; Higuera PE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001744; Higuera PE, 2011, ECOL APPL, V21, P3211, DOI 10.1890/11-0387.1; Higuera PE, 2009, ECOL MONOGR, V79, P201, DOI 10.1890/07-2019.1; Hijmans RJ, 2013, RASTER GEOGRAPHIC DA; Hinkes MT, 2005, J WILDLIFE MANAGE, V69, P1147, DOI 10.2193/0022-541X(2005)069[1147:IOPGOC]2.0.CO;2; Hu FS, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001270; Hummel M., 2008, CARIBOU N SHARED FUT, DOI DOI 10.1139/er-2013-0042; IPCC, 2013, CLIM CHANG 2013 PHYS, P127; Jandt R, 2008, ARCT ANTARCT ALP RES, V40, P89, DOI 10.1657/1523-0430(06-122)[JANDT]2.0.CO;2; Johnson CJ, 2005, WILDLIFE MONOGR, P1; Joly K, 2003, CAN J ZOOL, V81, P1192, DOI 10.1139/Z03-109; Joly K, 2007, ARCTIC, V60, P401; Joly K, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00012.1; Joly K, 2011, ECOGRAPHY, V34, P345, DOI 10.1111/j.1600-0587.2010.06377.x; Joly K, 2010, ECOSCIENCE, V17, P321, DOI 10.2980/17-3-3337; Kasischke ES, 2010, CAN J FOREST RES, V40, P1313, DOI 10.1139/X10-098; Kasischke ES., 2006, GEOPHYS RES LETT, V33; Klein David R., 2005, P597; KLEIN DR, 1982, J RANGE MANAGE, V35, P390, DOI 10.2307/3898326; Kochtubajda B, 2006, ARCTIC, V59, P211; Kofinas G, 2000, POLAR RES, V19, P3, DOI 10.1111/j.1751-8369.2000.tb00323.x; Kofinas G., 2005, ANTHROPOLOGICA, V49, P179; Kofinas GP, 2010, CAN J FOREST RES, V40, P1347, DOI 10.1139/X10-108; LANDHAUSSER SM, 1993, J ECOL, V81, P665, DOI 10.2307/2261664; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Lenart EA, 2011, CARIBOU MANAGEMENT R, P299; Maier JAK, 2005, CAN J FOREST RES, V35, P2233, DOI 10.1139/X05-123; Martin P.D., 2009, WILDLIFE RESPONSES E, P138; McDonald RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006802; McMullen C. P., 2009, CLIM CHANG SCI COMP; McNeeley SM, 2011, GLOBAL ENVIRON CHANG, V21, P464, DOI 10.1016/j.gloenvcha.2011.02.003; Nagy JA, 2011, ECOL APPL, V21, P2334, DOI 10.1890/10-1410.1; Nakicenovic N., 2000, INTERGOVERNMENTAL PA, P599; Nelson JL, 2008, ECOSYSTEMS, V11, P156, DOI 10.1007/s10021-007-9114-z; Northrup JM, 2013, ECOL LETT, V16, P112, DOI 10.1111/ele.12009; Racine C, 2004, ARCT ANTARCT ALP RES, V36, P1, DOI 10.1657/1523-0430(2004)036[0001:TFAVCA]2.0.CO;2; Rupp TS, 2006, ECOL APPL, V16, P1730, DOI 10.1890/1051-0761(2006)016[1730:STIOVF]2.0.CO;2; Rupp TS, 2007, EARTH INTERACT, V11, DOI 10.1175/EI189.1; Rupp TS, 2000, LANDSCAPE ECOL, V15, P383, DOI 10.1023/A:1008168418778; Rupp TS, 2000, GLOBAL CHANGE BIOL, V6, P541, DOI 10.1046/j.1365-2486.2000.00337.x; Russell D.E., 1984, P117; Russell DE, 1993, RANGIFER, V8, P1, DOI DOI 10.7557/2.13.5.1057; SCHAEFER JA, 1991, WILDLIFE MONOGR, P1; SCOTTER G. W., 1697, CAN FIELD NAT, V81, P31; SKOGLAND T, 1985, J ANIM ECOL, V54, P359, DOI 10.2307/4484; SKOGLAND T, 1986, J WILDLIFE MANAGE, V50, P314, DOI 10.2307/3801919; Skoog RO, 1968, THESIS U CALIFORNIA; Stocks BJ, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000484; Tape K, 2006, GLOBAL CHANGE BIOL, V12, P686, DOI 10.1111/j.1365-2486.2006.01128.x; Tews J, 2007, ECOL MODEL, V207, P85, DOI 10.1016/j.ecolmodel.2007.04.011; Thomas D., 1998, TECHNICAL REPORT SER, V312; Thomas DC, 1998, TECHNICAL REPORT SER, V311; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Tveraa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056450; Tyler NJC, 2008, ECOLOGY, V89, P1675, DOI 10.1890/07-0416.1; U.S. Geological Survey, 2005, N AM LAND COV 250 M; Valkenburg P, 2001, ALCES-N AM MOOSE CON, V37, P457; Walsh JE, 2008, J CLIMATE, V21, P6156, DOI 10.1175/2008JCLI2163.1; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; White Robert G., 1992, P407; Witter LA, 2012, ECOL APPL, V22, P1838, DOI 10.1890/11-0569.1; Wolfe S.A., 2000, THESIS U ALASKA FAIR; Zamin TJ, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034027	85	28	29	1	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100588	10.1371/journal.pone.0100588	http://dx.doi.org/10.1371/journal.pone.0100588			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991804	gold, Green Published, Green Submitted			2022-12-27	WOS:000341253400025
J	Steiner, M; Claes, L; Ignatius, A; Simon, U; Wehner, T				Steiner, Malte; Claes, Lutz; Ignatius, Anita; Simon, Ulrich; Wehner, Tim			Numerical Simulation of Callus Healing for Optimization of Fracture Fixation Stiffness	PLOS ONE			English	Article							TIBIAL SHAFT; INTERFRAGMENTARY MOTION; INTRAMEDULLARY NAIL; PLATE REMOVAL; BLOOD-FLOW; LOCKING; BONE; DYNAMIZATION; REFRACTURE; STABILITY	The stiffness of fracture fixation devices together with musculoskeletal loading defines the mechanical environment within a long bone fracture, and can be quantified by the interfragmentary movement. In vivo results suggested that this can have acceleratory or inhibitory influences, depending on direction and magnitude of motion, indicating that some complications in fracture treatment could be avoided by optimizing the fixation stiffness. However, general statements are difficult to make due to the limited number of experimental findings. The aim of this study was therefore to numerically investigate healing outcomes under various combinations of shear and axial fixation stiffness, and to detect the optimal configuration. A calibrated and established numerical model was used to predict fracture healing for numerous combinations of axial and shear fixation stiffness under physiological, superimposed, axial compressive and translational shear loading in sheep. Characteristic maps of healing outcome versus fixation stiffness (axial and shear) were created. The results suggest that delayed healing of 3 mm transversal fracture gaps will occur for highly flexible or very rigid axial fixation, which was corroborated by in vivo findings. The optimal fixation stiffness for ovine long bone fractures was predicted to be 1000-2500 N/mm in the axial and >300 N/mm in the shear direction. In summary, an optimized, moderate axial stiffness together with certain shear stiffness enhances fracture healing processes. The negative influence of one improper stiffness can be compensated by adjustment of the stiffness in the other direction.	[Steiner, Malte; Claes, Lutz; Ignatius, Anita; Wehner, Tim] Univ Hosp Ulm, Ctr Musculoskeletal Res Ulm, Inst Orthopaed Res & Biomech, Ulm, Germany; [Simon, Ulrich] Univ Ulm, Sci Comp Ctr Ulm, D-89069 Ulm, Germany	Ulm University; Ulm University	Steiner, M (corresponding author), Univ Hosp Ulm, Ctr Musculoskeletal Res Ulm, Inst Orthopaed Res & Biomech, Ulm, Germany.	malte.steiner@uni-ulm.de	Ignatius, Anita/M-6012-2013; Claes, Lutz/O-4697-2014	Ignatius, Anita/0000-0002-4782-1979; 	Center of Musculoskeletal Research Ulm, University of Ulm, Germany	Center of Musculoskeletal Research Ulm, University of Ulm, Germany	This study was intramurally funded by the Center of Musculoskeletal Research Ulm, University of Ulm, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augat P, 2003, J ORTHOP RES, V21, P1011, DOI 10.1016/S0736-0266(03)00098-6; Beaupre GS, 1996, J ORTHOP TRAUMA, V10, P87, DOI 10.1097/00005131-199602000-00003; Bhandari M, 2001, J BONE JOINT SURG AM, V83A, P1746, DOI 10.2106/00004623-200111000-00020; Bhandari M, 2001, J BONE JOINT SURG BR, V83B, P62, DOI 10.1302/0301-620X.83B1.10986; Bhandari M, 2003, J ORTHOP TRAUMA, V17, P353, DOI 10.1097/00005131-200305000-00006; Bishop NE, 2006, CLIN ORTHOP RELAT R, P307, DOI 10.1097/01.blo.0000191272.34786.09; Bottlang M, 2011, J ORTHOP TRAUMA, V25, pS21, DOI 10.1097/BOT.0b013e318207885b; Bottlang M, 2010, J BONE JOINT SURG AM, V92A, P12, DOI 10.2106/JBJS.J.00780; Bottlang M, 2010, J BONE JOINT SURG AM, V92A, P1652, DOI 10.2106/JBJS.I.01111; Brinker MR, 2004, J BONE JOINT SURG AM, V86A, P290, DOI 10.2106/00004623-200402000-00011; CARTER DR, 1988, J ORTHOP RES, V6, P736, DOI 10.1002/jor.1100060517; Claes L, 1997, J ORTHOP RES, V15, P577, DOI 10.1002/jor.1100150414; CLAES L, 1981, ARCH ORTHOP TRAUM SU, V98, P257, DOI 10.1007/BF00378878; Claes L, 2002, LANGENBECK ARCH SURG, V387, P146, DOI 10.1007/s00423-002-0306-x; CLAES LE, 1995, CLIN BIOMECH, V10, P227, DOI 10.1016/0268-0033(95)99799-8; Claes LE, 1998, CLIN ORTHOP RELAT R, pS132; Claes LE, 1999, J BIOMECH, V32, P255, DOI 10.1016/S0021-9290(98)00153-5; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Dailey HL, 2012, CLIN BIOMECH, V27, P182, DOI 10.1016/j.clinbiomech.2011.08.009; Davison BL, 2003, ORTHOPEDICS, V26, P157; Dobele S, 2010, LANGENBECK ARCH SURG, V395, P421, DOI 10.1007/s00423-010-0636-z; Duda GN, 2002, CLIN ORTHOP RELAT R, P163; Duda GN, 1998, J BIOMECH, V31, P201, DOI 10.1016/S0021-9290(97)00127-9; EINHORN TA, 1995, J BONE JOINT SURG AM, V77A, P940, DOI 10.2106/00004623-199506000-00016; Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7; Epari DR, 2007, J BONE JOINT SURG AM, V89A, P1575, DOI 10.2106/JBJS.F.00247; Gardner TN, 1997, CLIN ORTHOP RELAT R, P216; GOODSHIP AE, 1993, J BIOMECH, V26, P1027, DOI 10.1016/S0021-9290(05)80002-8; Grasa J, 2010, ANN BIOMED ENG, V38, P605, DOI 10.1007/s10439-009-9889-5; Heller MO, 2005, MATERIALWISS WERKST, V36, P775, DOI 10.1002/mawe.200500969; Hente R, 2004, J ORTHOP RES, V22, P709, DOI 10.1016/j.orthres.2003.11.007; Karladani AH, 2001, ARCH ORTHOP TRAUM SU, V121, P325, DOI 10.1007/s004020000252; KENWRIGHT J, 1991, J BONE JOINT SURG BR, V73, P654, DOI 10.1302/0301-620X.73B4.2071654; Larsson S, 2001, CLIN ORTHOP RELAT R, P240; Lujan TJ, 2010, J ORTHOP TRAUMA, V24, P156, DOI 10.1097/BOT.0b013e3181be6720; Marsh D, 1998, CLIN ORTHOP RELAT R, pS22; Ochs BG, 2012, UNFALLCHIRURG, V115, P323, DOI 10.1007/s00113-012-2155-6; PAUWELS F, 1960, Z Anat Entwicklungsgesch, V121, P478, DOI 10.1007/BF00523401; Penzkofer R, 2009, ARCH ORTHOP TRAUM SU, V129, P525, DOI 10.1007/s00402-008-0700-0; Perren S M, 1969, Acta Orthop Scand Suppl, V125, P19; Plecko M, 2013, INJURY, V44, P1346, DOI 10.1016/j.injury.2012.10.022; Praemer A, 1992, MUSCULOSKELETAL COND; RHINELANDER FW, 1974, CLIN ORTHOP RELAT R, P34; Schell H, 2008, J BIOMECH, V41, P3066, DOI 10.1016/j.jbiomech.2008.06.038; Simon U, 2011, COMPUT METHOD BIOMEC, V14, P79, DOI 10.1080/10255842.2010.499865; Steiner M, 2014, J ORTHOP RE IN PRESS; Steiner M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0389; STRACHAN RK, 1990, J BONE JOINT SURG BR, V72, P391, DOI 10.1302/0301-620X.72B3.2341434; TRIFFITT PD, 1993, J ORTHOPAED RES, V11, P49, DOI 10.1002/jor.1100110107; Wehner T, 2011, CLIN BIOMECH, V26, P147, DOI 10.1016/j.clinbiomech.2010.09.009; Wehner T, 2010, CLIN BIOMECH, V25, P606, DOI 10.1016/j.clinbiomech.2010.03.003; Wehner T, 2009, CLIN BIOMECH, V24, P299, DOI 10.1016/j.clinbiomech.2008.12.007; Wolf S, 1998, CLIN BIOMECH, V13, P359, DOI 10.1016/S0268-0033(98)00097-7; YAMAGISHI M, 1955, J BONE JOINT SURG AM, V37, P1035, DOI 10.2106/00004623-195537050-00013	54	32	34	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101370	10.1371/journal.pone.0101370	http://dx.doi.org/10.1371/journal.pone.0101370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991809	gold, Green Published, Green Submitted			2022-12-27	WOS:000341253400065
J	Yu, Q; Long, C; Lv, YH; Shao, HF; He, PF; Duan, ZG				Yu, Qi; Long, Chao; Lv, Yanhua; Shao, Hongfang; He, Peifeng; Duan, Zhiguang			Predicting Co-Author Relationship in Medical Co-Authorship Networks	PLOS ONE			English	Article							LINK-PREDICTION; MARKOV-CHAINS	Research collaborations are encouraged because a synergistic effect yielding good results often appears. However, creating and organizing a strong research group is a difficult task. One of the greatest concerns of an individual researcher is locating potential collaborators whose expertise complement his best. In this paper, we propose a method that makes link predictions in co-authorship networks, where topological features between authors such as Adamic/Adar, Common Neighbors, Jaccard's Coefficient, Preferential Attachment, Katz(beta), and PropFlow may be good indicators of their future collaborations. Firstly, these topological features were systematically extracted from the network. Then, supervised models were used to learn the best weights associated with different topological features in deciding co-author relationships. Finally, we tested our models on the co-authorship networks in the research field of Coronary Artery Disease and obtained encouraging accuracy (the precision, recall, F1 score and AUC were, respectively, 0.696, 0.677, 0.671 and 0.742 for Logistic Regression, and respectively, 0.697, 0.678, 0.671 and 0.743 for SVM). This suggests that our models could be used to build and manage strong research groups.	[Yu, Qi; Lv, Yanhua; He, Peifeng] Shanxi Med Univ, Dept Med Informat Management, Taiyuan, Shanxi, Peoples R China; [Long, Chao] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Shao, Hongfang] Shanxi Med Univ, Dept Sci & Technol, Taiyuan, Shanxi, Peoples R China; [Yu, Qi; Duan, Zhiguang] Shanxi Med Univ, Sch Publ Hlth, Taiyuan, Shanxi, Peoples R China	Shanxi Medical University; Stanford University; Shanxi Medical University; Shanxi Medical University	Duan, ZG (corresponding author), Shanxi Med Univ, Sch Publ Hlth, Taiyuan, Shanxi, Peoples R China.	dzg52827@aliyun.com		Duan, zhiguang/0000-0002-2063-5236; Lv, Yanhua/0000-0003-4463-0314	project "Cooperation Analysis of Technology Innovation Team Member Based on Knowledge Network-Empirical Evidence in the Biology and Biomedicine Field" by National Natural Science Foundation of China [71103114]; project "Scientific and Technological Collaboration in the Field of Biomedicine" by National Natural Science Foundation of China [71240006]	project "Cooperation Analysis of Technology Innovation Team Member Based on Knowledge Network-Empirical Evidence in the Biology and Biomedicine Field" by National Natural Science Foundation of China; project "Scientific and Technological Collaboration in the Field of Biomedicine" by National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research reported in this paper was done as part of the project "Cooperation Analysis of Technology Innovation Team Member Based on Knowledge Network-Empirical Evidence in the Biology and Biomedicine Field (No. 71103114)" supported by National Natural Science Foundation of China, and the project "Scientific and Technological Collaboration in the Field of Biomedicine - Using Co-authorship and Co-inventorship Analysis (No. 71240006)" supported by National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; CHAO W, 2007, IEEE INT C DAT MIN I, P322; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Cronin B, 2001, J AM SOC INF SCI TEC, V52, P558, DOI 10.1002/asi.1097; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fegley BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070299; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; HAO NC, 2012, IEEE T NEURAL NETWOR, V23, P1793; Huang Z, 2009, INFORMS J COMPUT, V21, P286, DOI 10.1287/ijoc.1080.0292; Katz JS, 1997, RES POLICY, V26, P1, DOI 10.1016/S0048-7333(96)00917-1; Katz L., 1953, PSYCHOMETRIKA, V18, P39, DOI [DOI 10.1007/BF02289026, 10.1007/BF02289026]; Lei CW, 2013, BIOINFORMATICS, V29, P355, DOI 10.1093/bioinformatics/bts688; LEROY V, [No title captured]; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Lichtenwalter R.N., 2010, P 16 ACM SIGKDD INT, P243; Lichtenwalter RN, 2011, J MACH LEARN RES, V12, P2489; Lin J, 2013, ANAL METHODS-UK, V5, P6120, DOI 10.1039/c3ay41290c; Liu Z, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/48007; Lu LY, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/18001; Lu LY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046122; Meng B, 2011, CHINESE PHYS B, V20, DOI 10.1088/1674-1056/20/12/128902; Mood C, 2010, EUR SOCIOL REV, V26, P67, DOI 10.1093/esr/jcp006; MUNASINGHE L, 2012, 26 ANN C JAP SOC ART, P1; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; PAVLOV MA, 2007, P WORKSH FIND EXP WE, P42; Sarukkai RR, 2000, COMPUT NETW, V33, P377, DOI 10.1016/S1389-1286(00)00044-X; Shibata N, 2012, J AM SOC INF SCI TEC, V63, P78, DOI 10.1002/asi.21664; Smalheiser NR, 2009, ANNU REV INFORM SCI, V43, P287; Sun YZ, 2011, 2011 INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM 2011), P121, DOI 10.1109/ASONAM.2011.112; Symeonidis P, 2013, DATA KNOWL ENG, V87, P226, DOI 10.1016/j.datak.2013.05.008; Zhu JH, 2002, LECT NOTES COMPUT SC, V2311, P60; Zhu JH, 2001, LECT NOTES ARTIF INT, V2109, P298	32	21	22	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101214	10.1371/journal.pone.0101214	http://dx.doi.org/10.1371/journal.pone.0101214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3RT	24991920	gold, Green Published, Green Submitted			2022-12-27	WOS:000341253400050
J	De Martino, A; De Martino, D; Mulet, R; Pagnani, A				De Martino, Andrea; De Martino, Daniele; Mulet, Roberto; Pagnani, Andrea			Identifying All Moiety Conservation Laws in Genome-Scale Metabolic Networks	PLOS ONE			English	Article							CHEMICAL-REACTION SYSTEMS; ESCHERICHIA-COLI; BIOCHEMICAL NETWORKS; NULL SPACE; ALGORITHM; RECONSTRUCTION; ESSENTIALITY; ORGANIZATION; SIZE	The stoichiometry of a metabolic network gives rise to a set of conservation laws for the aggregate level of specific pools of metabolites, which, on one hand, pose dynamical constraints that cross-link the variations of metabolite concentrations and, on the other, provide key insight into a cell's metabolic production capabilities. When the conserved quantity identifies with a chemical moiety, extracting all such conservation laws from the stoichiometry amounts to finding all non-negative integer solutions of a linear system, a programming problem known to be NP-hard. We present an efficient strategy to compute the complete set of integer conservation laws of a genome-scale stoichiometric matrix, also providing a certificate for correctness and maximality of the solution. Our method is deployed for the analysis of moiety conservation relationships in two large-scale reconstructions of the metabolism of the bacterium E. coli, in six tissue-specific human metabolic networks, and, finally, in the human reactome as a whole, revealing that bacterial metabolism could be evolutionarily designed to cover broader production spectra than human metabolism. Convergence to the full set of moiety conservation laws in each case is achieved in extremely reduced computing times. In addition, we uncover a scaling relation that links the size of the independent pool basis to the number of metabolites, for which we present an analytical explanation.	[De Martino, Andrea] CNR IPCF, Unita Roma Sapienza, Rome, Italy; [De Martino, Andrea] Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy; [De Martino, Andrea; De Martino, Daniele] Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy; [Mulet, Roberto] Univ Havana, Fac Phys, Henri Poincare Grp Complex Syst, Havana, Cuba; [Mulet, Roberto] Univ Havana, Fac Phys, Dept Theoret Phys, Havana, Cuba; [Pagnani, Andrea] Politecn Torino, DISAT, Turin, Italy; [Pagnani, Andrea] Politecn Torino, Ctr Computat Sci, Turin, Italy; [Pagnani, Andrea] Human Genet Fdn, Turin, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per i Processi Chimico-Fisici (IPCF-CNR); Sapienza University Rome; Istituto Italiano di Tecnologia - IIT; Universidad de la Habana; Universidad de la Habana; Polytechnic University of Turin; Polytechnic University of Turin	De Martino, D (corresponding author), Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy.	daniele.demartino@roma1.infn.it	De Martino, Daniele/GQA-9589-2022; de martino, daniele/L-6519-2017; De Martino, Andrea/AAY-4120-2020; Pagnani, Andrea/J-2363-2015	Pagnani, Andrea/0000-0002-6509-0807; De Martino, Daniele/0000-0002-5214-4706; Mulet, Roberto/0000-0001-5168-5116; De Martino, Andrea/0000-0001-7590-6542	DREAM Seed Project of the Italian Institute of Technology (IIT); IIT/Sapienza Lab "Nanomedicine"	DREAM Seed Project of the Italian Institute of Technology (IIT); IIT/Sapienza Lab "Nanomedicine"	Work was supported by the DREAM Seed Project of the Italian Institute of Technology (IIT) and by the joint IIT/Sapienza Lab "Nanomedicine". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker BM, 1999, J BIOL CHEM, V274, P14551, DOI 10.1074/jbc.274.21.14551; Baldassi C, 2007, P NATL ACAD SCI USA, V104, P11079, DOI 10.1073/pnas.0700324104; Beard D. A., 2008, CHEM BIOPHYSICS; Behre J, 2012, METHODS MOL BIOL, V804, P377, DOI 10.1007/978-1-61779-361-5_20; Braunstein A, 2005, RANDOM STRUCT ALGOR, V27, P201, DOI 10.1002/rsa.20057; Braunstein A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-240; COLEMAN TF, 1986, SIAM J ALGEBRA DISCR, V7, P527, DOI 10.1137/0607059; CONTEJEAN E, 1994, INFORM COMPUT, V113, P143, DOI 10.1006/inco.1994.1067; CONTI P, 1991, LECT NOTES COMPUT SC, V539, P130; De Martino A, 2007, J STAT MECH-THEORY E, V2007; Eisenbrand F, 2006, OPER RES LETT, V34, P564, DOI 10.1016/j.orl.2005.09.008; Famili I, 2003, BIOPHYS J, V85, P16, DOI 10.1016/S0006-3495(03)74450-6; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Fell DA, 2000, NAT BIOTECHNOL, V18, P1121, DOI 10.1038/81025; Gevorgyan A, 2008, BIOINFORMATICS, V24, P2245, DOI 10.1093/bioinformatics/btn425; Heinrich R., 1996, REGULATION CELLULAR; Henk Martin, 1997, RESULTS MATH, V32, P298, DOI [10.1007/BF03322141, DOI 10.1007/BF03322141]; Imielinski M, 2006, BIOPHYS J, V90, P2659, DOI 10.1529/biophysj.105.069278; Imielinski M, 2005, BIOINFORMATICS, V21, P2008, DOI 10.1093/bioinformatics/bti245; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Joyce Andrew R., 2008, V416, P433, DOI 10.1007/978-1-59745-321-9_30; Kim J., 1983, INT JOINT C ART INT, P190; Koch I, 2010, MOL INFORM, V29, P838, DOI 10.1002/minf.201000086; Krauth W, 1998, LECT NOTES PHYS, V501, P1; KRAUTH W, 1987, J PHYS A-MATH GEN, V20, pL745, DOI 10.1088/0305-4470/20/11/013; Kschischang FR, 2001, IEEE T INFORM THEORY, V47, P498, DOI 10.1109/18.910572; Martelli C, 2009, P NATL ACAD SCI USA, V106, P2607, DOI 10.1073/pnas.0813229106; Mezard M, 2002, SCIENCE, V297, P812, DOI 10.1126/science.1073287; Mezard M., 2009, INFORM PHYS COMPUTAT, pp 584, DOI [10.1093/acprof:oso/9780198570837.001.0001, DOI 10.1093/ACPROF:OSO/9780198570837.001, DOI 10.1093/ACPROF:OSO/9780198570837.001.0001]; Mulet R, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.268701; Nikolaev EV, 2005, BIOPHYS J, V88, P37, DOI 10.1529/biophysj.104.043489; Palsson BO., 2006, SYSTEMS BIOL PROPERT; Papadimitrou C, 2000, COMBINATORIAL OPTIMI; Papin JA, 2002, J THEOR BIOL, V215, P67, DOI 10.1006/jtbi.2001.2499; Pasechnik DV, 2001, THEOR COMPUT SCI, V263, P37, DOI 10.1016/S0304-3975(00)00229-2; Pearl J., 1982, P AM ASS ART INT NAT, P133; Price ND, 2004, BIOPHYS J, V87, P2172, DOI 10.1529/biophysj.104.043000; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Ricci Tersenghi F, 2009, JSTAT, V2009; Sauro HM, 2004, BIOPHYS CHEM, V109, P1, DOI 10.1016/j.bpc.2003.08.009; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schrijver A., 1998, THEORY LINEAR INTEGE; Schuster S, 1999, TRENDS BIOTECHNOL, V17, P53, DOI 10.1016/S0167-7799(98)01290-6; SCHUSTER S, 1995, J PHYS CHEM-US, V99, P8017, DOI 10.1021/j100020a026; SCHUSTER S, 1991, J CHEM SOC FARADAY T, V87, P2561, DOI 10.1039/ft9918702561; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Thiele I, 2005, J BIOL CHEM, V280, P11683, DOI 10.1074/jbc.M409072200; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Vallabhajosyula RR, 2006, BIOINFORMATICS, V22, P346, DOI 10.1093/bioinformatics/bti800; Wiback SJ, 2004, J THEOR BIOL, V228, P437, DOI 10.1016/j.jtbi.2004.02.006; Yedidia JS, 2000, ADV NEURAL INFORM PR, V13, P689; Yeung M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-363; Zhu DX, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-8	54	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100750	10.1371/journal.pone.0100750	http://dx.doi.org/10.1371/journal.pone.0100750			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988199	Green Published, gold, Green Submitted			2022-12-27	WOS:000341354100039
J	Fan, GQ; Du, GH; Li, HJ; Lin, F; Sun, ZY; Yang, W; Feng, C; Zhu, GC; Li, YS; Chen, Y; Jiao, H; Zhou, FK				Fan, Guangqin; Du, Guihua; Li, Huijun; Lin, Fen; Sun, Ziyong; Yang, Wei; Feng, Chang; Zhu, Gaochun; Li, Yanshu; Chen, Ying; Jiao, Huan; Zhou, Fankun			The Effect of the Hemochromatosis (HFE) Genotype on Lead Load and Iron Metabolism among Lead Smelter Workers	PLOS ONE			English	Article							HIGHER BLOOD LEAD; HEREDITARY HEMOCHROMATOSIS; TRANSFERRIN RECEPTOR; H63D MUTATIONS; GENE-MUTATIONS; MOUSE-LIVER; POPULATION; DEFICIENCY; EXPRESSION; CHILDREN	Background: Both an excess of toxic lead (Pb) and an essential iron disorder have been implicated in many diseases and public health problems. Iron metabolism genes, such as the hemochromatosis (HFE) gene, have been reported to be modifiers for lead absorption and storage. However, the HFE gene studies among the Asian population with occupationally high lead exposure are lacking. Objectives: To explore the modifying effects of the HFE genotype (wild-type, H63D variant and C282Y variant) on the Pb load and iron metabolism among Asian Pb-workers with high occupational exposure. Methods: Seven hundred and seventy-one employees from a lead smelter manufacturing company were tested to determine their Pb intoxication parameters, iron metabolic indexes and identify the HFE genotype. Descriptive and multivariate analyses were conducted. Results: Forty-five H63D variant carriers and no C282Y variant carrier were found among the 771 subjects. Compared with subjects with the wild-type genotype, H63D variant carriers had higher blood lead levels, even after controlling for factors such as age, sex, marriage, education, smoking and lead exposure levels. Multivariate analyses also showed that the H63D genotype modifies the associations between the blood lead levels and the body iron burden/transferrin. Conclusions: No C282Y variant was found in this Asian population. The H63D genotype modified the association between the lead and iron metabolism such that increased blood lead is associated with a higher body iron content or a lower transferrin in the H63D variant. It is indicated that H63D variant carriers may be a potentially highly vulnerable sub-population if they are exposed to high lead levels occupationally.	[Fan, Guangqin; Du, Guihua; Lin, Fen; Feng, Chang; Zhu, Gaochun; Li, Yanshu; Chen, Ying; Jiao, Huan; Zhou, Fankun] Nanchang Univ, Sch Publ Hlth, Dept Occupat Hlth & Toxicol, Nanchang, Peoples R China; [Li, Huijun; Sun, Ziyong] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Clin Lab, Wuhan 430074, Peoples R China; [Lin, Fen] Gannan Med Univ, Sch Med, Dept Prevent Med, Ganzhou, Peoples R China; [Yang, Wei] Univ Nevada, Sch Community Hlth Sci, Nevada Ctr Hlth Stat & Informat, Reno, NV 89557 USA	Nanchang University; Huazhong University of Science & Technology; Gannan Medical University; Nevada System of Higher Education (NSHE); University of Nevada Reno	Fan, GQ (corresponding author), Nanchang Univ, Sch Publ Hlth, Dept Occupat Hlth & Toxicol, Nanchang, Peoples R China.	fanfgq@126.com			National Nature Science Foundation of China [30960324, 81273120, 21267017]; Jiangxi Provincial Natural Science Foundation [20132BAB205069]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangxi Provincial Natural Science Foundation	This work was supported by The National Nature Science Foundation of China (Nos. 30960324, 81273120, 21267017), Jiangxi Provincial Natural Science Foundation (No. 20132BAB205069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN GS, 1993, NEUROTOXICOLOGY, V14, P273; Bacon BR, 1999, ANN INTERN MED, V130, P953, DOI 10.7326/0003-4819-130-12-199906150-00002; Barnum-Huckins K, 2000, CELL BIOL INT, V24, P71, DOI 10.1006/cbir.1999.0456; BARTON JC, 1994, J LAB CLIN MED, V124, P193; BARTON JC, 1978, J LAB CLIN MED, V92, P536; Beutler E, 1997, AM J HUM GENET, V61, P762; Bradman A, 2001, ENVIRON HEALTH PERSP, V109, P1079, DOI 10.2307/3454964; Burke W, 2000, GENET MED, V2, P271, DOI 10.1097/00125817-200009000-00001; Cardoso EMP, 1998, J INTERN MED, V243, P203; Cook JD, 2003, BLOOD, V101, P3359, DOI 10.1182/blood-2002-10-3071; Dupic F, 2002, GUT, V51, P648, DOI 10.1136/gut.51.5.648; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Gao A, 2010, SCI TOTAL ENVIRON, V408, P4052, DOI 10.1016/j.scitotenv.2010.04.024; Geier A, 2004, LIVER INT, V24, P285, DOI 10.1111/j.1478-3231.2004.0928.x; Giambattistelli F, 2012, NEUROBIOL AGING, V33, P1633, DOI 10.1016/j.neurobiolaging.2011.03.005; Gochee PA, 2002, GASTROENTEROLOGY, V122, P646, DOI 10.1016/S0016-5085(02)80116-0; Hammad TA, 1996, ANN EPIDEMIOL, V6, P30, DOI 10.1016/1047-2797(95)00097-6; Hopkins MR, 2008, ENVIRON HEALTH PERSP, V116, P1261, DOI 10.1289/ehp.11233; Jahanshad N, 2012, P NATL ACAD SCI USA, V109, pE851, DOI 10.1073/pnas.1105543109; Leong I, 2003, AM J CLIN NUTR, V78, P1203, DOI 10.1093/ajcn/78.6.1203; Lin A, 2007, TISSUE ANTIGENS, V70, P252, DOI 10.1111/j.1399-0039.2007.00877.x; LOPAREV VN, 1991, J VIROL METHODS, V34, P105, DOI 10.1016/0166-0934(91)90126-K; MARCUS AH, 1987, ENVIRON RES, V44, P221, DOI 10.1016/S0013-9351(87)80230-X; Njajou OT, 2003, EUR J HUM GENET, V11, P225, DOI 10.1038/sj.ejhg.5200955; Pietrangelo A, 1999, NEW ENGL J MED, V341, P725, DOI 10.1056/NEJM199909023411003; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Punnonen K, 1997, BLOOD, V89, P1052, DOI 10.1182/blood.V89.3.1052; Sassi R, 2004, ANN GENET-PARIS, V47, P325, DOI 10.1016/j.anngen.2004.05.001; Scinicariello F, 2007, ENVIRON HEALTH PERSP, V115, P35, DOI 10.1289/ehp.9448; SIX KM, 1972, J LAB CLIN MED, V79, P128; Weyermann M, 1997, ARCH ENVIRON HEALTH, V52, P233, DOI 10.1080/00039899709602892; Whitfield JB, 2007, ENVIRON HEALTH PERSP, V115, P1224, DOI 10.1289/ehp.8847; Wright RO, 2003, J PEDIATR-US, V142, P9, DOI 10.1067/mpd.2003.mpd0344; Wright RO, 2004, ENVIRON HEALTH PERSP, V112, P746, DOI 10.1289/ehp.6581; Zhao Y, 2007, J TOXICOL ENV HEAL A, V70, P1986, DOI 10.1080/15287390701550946; Zhu GC, 2013, TOXICOL LETT, V216, P108, DOI 10.1016/j.toxlet.2012.11.024	37	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101537	10.1371/journal.pone.0101537	http://dx.doi.org/10.1371/journal.pone.0101537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988074	gold, Green Published, Green Submitted			2022-12-27	WOS:000341354100110
J	Hirano, K; Okuno, A; Hobo, T; Ordonio, R; Shinozaki, Y; Asano, K; Kitano, H; Matsuoka, M				Hirano, Ko; Okuno, Ayako; Hobo, Tokunori; Ordonio, Reynante; Shinozaki, Yusuke; Asano, Kenji; Kitano, Hidemi; Matsuoka, Makoto			Utilization of Stiff Culm Trait of Rice smos1 Mutant for Increased Lodging Resistance	PLOS ONE			English	Article								Although the introduction of semi-dwarf trait into rice has led to improved lodging resistance making it capable of supporting high grain yield, lodging still remains a concern when attempting to further increase the grain yield of rice. However, improving the lodging resistance in rice by depending on the semi-dwarf trait alone is possible only up to a certain limit, beyond which other traits may be needed for reinforcement. To search for alternative traits relating to high lodging resistance, we identified 9 rice mutant lines possessing improved culm strength. To evaluate whether such lines can be useful for breeding lodging resistant rice, small organ size1 (smos1) mutant having increased lodging resistance but low tiller number and low grain yield, was chosen as a representative for a breeding trial. smos1 was crossed with ST-4 (from the Stock rice collection of Nagoya University Togo field #4), a cultivar with high tiller number and high grain yield, and from their progeny, LRC1 (lodging resistance candidate-1) was selected. Although the low tiller number trait of smos1 was not fully reversed in LRC1, this was compensated by an increase in grain weight per panicle, thereby resulting in high grain yield per plant. This important attribute of LRC1 was further enhanced by the improved lodging resistance trait inherited from smos1. Such improved lodging resistance in LRC1 and smos1 was revealed to be mainly due to increased culm diameter and culm thickness, which led to a high section modulus (SM) value, a parameter defining the physical strength of the culm. Since smos1 possesses high breaking-type lodging resistance which is different from semi-dwarf plants with high bending-type lodging resistance, an alternative approach of using thick culm lines for the creation of rice with increased lodging resistance is hereby proposed.	[Hirano, Ko; Okuno, Ayako; Hobo, Tokunori; Ordonio, Reynante; Shinozaki, Yusuke; Asano, Kenji; Kitano, Hidemi; Matsuoka, Makoto] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan	Nagoya University	Matsuoka, M (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan.	makoto@agr.nagoya-u.ac.jp			Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics-based for Agricultural Improvement) [RBS2003]; Ministry of Education, Science, Sports and Culture of Japan	Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics-based for Agricultural Improvement); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics-based for Agricultural Improvement, RBS2003) and Grants-in-Aid from the NC-CARP project, the Ministry of Education, Science, Sports and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aya K, 2014, PLANT CELL PHYSL; Dalrymple DG, 1986, Development and spread of high -yielding wheat varieties in developing countries, V7th; GRAFIUS JE, 1954, AGRON J, V46, P414, DOI 10.2134/agronj1954.00021962004600090006x; HARGROVE TR, 1979, BIOSCIENCE, V29, P731, DOI 10.2307/1307667; HOSHIKAWA K, 1990, JPN J CROP SCI, V59, P809, DOI 10.1626/jcs.59.809; Islam MS, 2007, FIELD CROP RES, V101, P240, DOI 10.1016/j.fcr.2006.12.002; Kashiwagi T., 2007, Japanese Journal of Crop Science, V76, P1, DOI 10.1626/jcs.76.1; Khush GS, 1999, GENOME, V42, P646, DOI 10.1139/gen-42-4-646; Kono M, 1995, SCI RICE PLANT PHYSL, V2, P971; Okuno A, 2014, PLOS ONE, V19; OOKAWA T, 1993, JPN J CROP SCI, V62, P378, DOI 10.1626/jcs.62.378; Ookawa T, 2010, PLANT PROD SCI, V13, P56; Takeda T, 2003, PLANT J, V33, P513, DOI 10.1046/j.1365-313X.2003.01648.x; WATANABE T, 1997, SCI RICE PLANT, V3, P567; Zhang BS, 2011, J GENET GENOMICS, V38, P411, DOI 10.1016/j.jgg.2011.08.002	15	32	39	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e96009	10.1371/journal.pone.0096009	http://dx.doi.org/10.1371/journal.pone.0096009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987959	gold, Green Published, Green Submitted			2022-12-27	WOS:000341354100005
J	Morgan, N; Irwin, MR; Chung, M; Wang, CC				Morgan, Nani; Irwin, Michael R.; Chung, Mei; Wang, Chenchen			The Effects of Mind-Body Therapies on the Immune System: Meta-Analysis	PLOS ONE			English	Article							QUALITY-OF-LIFE; INFLAMMATORY GENE-EXPRESSION; RANDOMIZED CONTROLLED-TRIAL; ACUTE PSYCHOLOGICAL STRESS; BREAST-CANCER SURVIVORS; VARICELLA-ZOSTER-VIRUS; NECROSIS-FACTOR-ALPHA; TAI CHI CHUAN; NF-KAPPA-B; OLDER-ADULTS	Importance: Psychological and health-restorative benefits of mind-body therapies have been investigated, but their impact on the immune system remain less defined. Objective: To conduct the first comprehensive review of available controlled trial evidence to evaluate the effects of mind-body therapies on the immune system, focusing on markers of inflammation and anti-viral related immune responses. Methods: Data sources included MEDLINE, CINAHL, SPORTDiscus, and PsycINFO through September 1, 2013. Randomized controlled trials published in English evaluating at least four weeks of Tai Chi, Qi Gong, meditation, or Yoga that reported immune outcome measures were selected. Studies were synthesized separately by inflammatory (n = 18), anti-viral related immunity (n = 7), and enumerative (n = 14) outcomes measures. We performed random-effects meta-analyses using standardized mean difference when appropriate. Results: Thirty-four studies published in 39 articles (total 2, 219 participants) met inclusion criteria. For inflammatory measures, after 7 to 16 weeks of mind-body intervention, there was a moderate effect on reduction of C-reactive protein (effect size [ES], 0.58; 95% confidence interval [CI], 0.04 to 1.12), a small but not statistically significant reduction of interleukin-6 (ES, 0.35; 95% CI, -0.04 to 0.75), and negligible effect on tumor necrosis factor-alpha (ES, 0.21; 95% CI, -0.15 to 0.58). For anti-viral related immune and enumerative measures, there were negligible effects on CD4 counts (ES, 0.15; 95% CI, -0.04 to 0.34) and natural killer cell counts (ES, 0.12, 95% CI -0.21 to 0.45). Some evidence indicated mind-body therapies increase immune responses to vaccination. Conclusions: Mind-body therapies reduce markers of inflammation and influence virus-specific immune responses to vaccination despite minimal evidence suggesting effects on resting anti-viral or enumerative measures. These immunomodulatory effects, albeit incomplete, warrant further methodologically rigorous studies to determine the clinical implications of these findings for inflammatory and infectious disease outcomes.	[Morgan, Nani; Wang, Chenchen] Tufts Univ Sch Med, Div Rheumatol, Ctr Integrat Med, Tufts Med Ctr, Boston, MA 02111 USA; [Irwin, Michael R.] Univ Calif Los Angeles, Cousins Ctr Psychoneuroimmunol, UCLA Semel Inst Neurosci, Los Angeles, CA USA; [Chung, Mei] Tufts Univ Sch Med, Dept Publ Hlth & Community Med, Nutr Infect Unit, Boston, MA USA	Tufts Medical Center; Tufts University; University of California System; University of California Los Angeles; Massachusetts Department of Public Health; Tufts University	Wang, CC (corresponding author), Tufts Univ Sch Med, Div Rheumatol, Ctr Integrat Med, Tufts Med Ctr, Boston, MA 02111 USA.	cwang2@tuftsmedicalcenter.org	Irwin, Michael R./H-4870-2013	Irwin, Michael R./0000-0002-1502-8431	National Center for Complementary and Alternative Medicine [K24 AT007323, R01 AT006367, R01 AT005521, R01 AT006367-01A1]; Cousins Center for Psychoneuroimmunology at the Semel Institute for Neuroscience; National Institutes of Health [R01-AG034588, R01-AG026364, R01 CA160245-01, R01-CA119159, R01 HL095799, R01 DA032922-01, P30-AG028748]; National Institutes of Health (UCLA CTSI) [UL1TR000124]; NATIONAL CANCER INSTITUTE [R01CA160245, R01CA119159] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT006367, R01AT005521] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [K24AT007323] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034588, R01AG026364, P30AG028748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA032922] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Cousins Center for Psychoneuroimmunology at the Semel Institute for Neuroscience; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (UCLA CTSI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Dr. Wang is supported by the National Center for Complementary and Alternative Medicine (K24 AT007323, R01 AT006367, R01 AT005521, R01 AT006367-01A1). Dr. Irwin is supported by the Cousins Center for Psychoneuroimmunology at the Semel Institute for Neuroscience, and by the National Institutes of Health (R01-AG034588; R01-AG026364; R01 CA160245-01; R01-CA119159; R01 HL095799; R01 DA032922-01; P30-AG028748; and UCLA CTSI UL1TR000124). The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the NCCAM. The investigators are solely responsible for the content of the manuscript and the decision to submit for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoni MH, 2007, PSYCHONEUROIMMUNOLOGY, VOLS I AND II, 4TH EDITION, P675; Antoni MH, 2012, BIOL PSYCHIAT, V71, P366, DOI 10.1016/j.biopsych.2011.10.007; Arias AJ, 2006, J ALTERN COMPLEM MED, V12, P817, DOI 10.1089/acm.2006.12.817; Barnes Patricia M, 2008, Natl Health Stat Report, P1; Barrett B, 2012, ANN FAM MED, V10, P337, DOI 10.1370/afm.1376; Bierhaus A, 2003, P NATL ACAD SCI USA, V100, P1920, DOI 10.1073/pnas.0438019100; Black DS, 2013, PSYCHONEUROENDOCRINO, V38, P348, DOI 10.1016/j.psyneuen.2012.06.011; Bower JE, 2007, BRAIN BEHAV IMMUN, V21, P251, DOI 10.1016/j.bbi.2006.08.001; Bussing A, 2012, J PAIN, V13, P1, DOI 10.1016/j.jpain.2011.10.001; Cade WT, 2010, HIV MED, V11, P379, DOI 10.1111/j.1468-1293.2009.00801.x; Chen E, 2009, THORAX, V64, P38, DOI 10.1136/thx.2007.095091; Chen HH, 2006, AM J CHINESE MED, V34, P741, DOI 10.1142/S0192415X06004259; Chen SC, 2010, J ALTERN COMPLEM MED, V16, P1153, DOI 10.1089/acm.2009.0560; Chiesa A, 2011, J ALTERN COMPLEM MED, V17, P83, DOI 10.1089/acm.2009.0546; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cole SW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r189; Cole SW, 2011, P NATL ACAD SCI USA, V108, P3080, DOI 10.1073/pnas.1014218108; Cole SW, 2010, P NATL ACAD SCI USA, V107, P5681, DOI 10.1073/pnas.0911515107; Cole SW, 1998, J IMMUNOL, V161, P610; Creswell JD, 2012, BRAIN BEHAV IMMUN, V26, P1095, DOI 10.1016/j.bbi.2012.07.006; Creswell JD, 2009, BRAIN BEHAV IMMUN, V23, P184, DOI 10.1016/j.bbi.2008.07.004; Davidson RJ, 2003, PSYCHOSOM MED, V65, P564, DOI 10.1097/01.PSY.0000077505.67574.E3; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Elsenbruch S, 2005, PSYCHOTHER PSYCHOSOM, V74, P277, DOI 10.1159/000086318; Esposito K, 2003, JAMA-J AM MED ASSOC, V289, P1799, DOI 10.1001/jama.289.14.1799; Fan YX, 2010, J ALTERN COMPLEM MED, V16, P151, DOI 10.1089/acm.2009.0234; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Goebel MU, 2000, PSYCHOSOM MED, V62, P591, DOI 10.1097/00006842-200007000-00019; Gopal Aravind, 2011, Int J Yoga, V4, P26, DOI 10.4103/0973-6131.78178; Grebe KM, 2010, J IMMUNOL, V184, P540, DOI 10.4049/jimmunol.0903395; Grossman P, 2004, J PSYCHOSOM RES, V57, P35, DOI 10.1016/S0022-3999(03)00573-7; Haaland DA, 2008, CLIN J SPORT MED, V18, P539, DOI 10.1097/JSM.0b013e3181865eec; Haaz S, 2011, RHEUM DIS CLIN N AM, V37, P33, DOI 10.1016/j.rdc.2010.11.001; Hamer M, 2007, PSYCHOSOM MED, V69, P660, DOI 10.1097/PSY.0b013e318148c4c0; HERBERT TB, 1993, PSYCHOL BULL, V113, P472, DOI 10.1037/0033-2909.113.3.472; HERBERT TB, 1993, PSYCHOSOM MED, V55, P364, DOI 10.1097/00006842-199307000-00004; Hidderley Margaret, 2004, Eur J Oncol Nurs, V8, P61, DOI 10.1016/j.ejon.2003.09.003; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Irwin M, 2014, J NATL CANC IN PRESS; Irwin MR, 2007, J AM GERIATR SOC, V55, P511, DOI 10.1111/j.1532-5415.2007.01109.x; Irwin MR, 2012, AM J GERIAT PSYCHIAT, V20, P764, DOI 10.1097/JGP.0b013e3182330fd3; Irwin MR, 2011, NAT REV IMMUNOL, V11, P625, DOI 10.1038/nri3042; Irwin MR, 2003, PSYCHOSOM MED, V65, P824, DOI 10.1097/01.PSY.0000088591.86103.8F; Jahnke Roger, 2010, Am J Health Promot, V24, pe1, DOI 10.4278/ajhp.081013-LIT-248; Janelsins MC, 2011, CLIN BREAST CANCER, V11, P161, DOI 10.1016/j.clbc.2011.03.013; Keng SL, 2011, CLIN PSYCHOL REV, V31, P1041, DOI 10.1016/j.cpr.2011.04.006; Kiecolt-Glaser JK, 2002, J CONSULT CLIN PSYCH, V70, P537, DOI 10.1037//0022-006X.70.3.537; Lavretsky H, 2011, AM J GERIAT PSYCHIAT, V19, P839, DOI 10.1097/JGP.0b013e31820ee9ef; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Lengacher CA, 2013, BIOL RES NURS, V15, P37, DOI 10.1177/1099800411419245; Li AW, 2012, ALTERN MED REV, V17, P21; Malarkey WB, 2013, BRAIN BEHAV IMMUN, V27, P145, DOI 10.1016/j.bbi.2012.10.009; Manzaneque JM, 2004, MED SCI MONITOR, V10, pCR264; Manzaneque JM, 2009, J HEALTH PSYCHOL, V14, P60, DOI 10.1177/1359105308097946; Mars TS, 2010, INT J OSTEOPATH MED, V13, P56, DOI 10.1016/j.ijosm.2009.07.005; McCain NL, 2008, J CONSULT CLIN PSYCH, V76, P431, DOI 10.1037/0022-006X.76.3.431; Medicine TNCfCaA, 2011, EXPL SCI COMPL ALT M; Miller GE, 2001, HEALTH PSYCHOL, V20, P47, DOI 10.1037/0278-6133.20.1.47; Miller G, 2009, ANNU REV PSYCHOL, V60, P501, DOI 10.1146/annurev.psych.60.110707.163551; Miller GE, 2008, BIOL PSYCHIAT, V64, P266, DOI 10.1016/j.biopsych.2008.03.017; Miller GE, 2009, PSYCHOSOM MED, V71, P57, DOI 10.1097/PSY.0b013e318190d7de; Motivala S, 2005, PSYCHOSOMATIC MED; Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008; Oh B, 2010, ANN ONCOL, V21, P608, DOI 10.1093/annonc/mdp479; Oh B, 2008, AM J CHINESE MED, V36, P459, DOI 10.1142/S0192415X08005904; Oh B, 2012, SUPPORT CARE CANCER, V20, P1235, DOI 10.1007/s00520-011-1209-6; Oken BS, 2010, J ALTERN COMPLEM MED, V16, P1031, DOI 10.1089/acm.2009.0733; Pace TWW, 2006, AM J PSYCHIAT, V163, P1630, DOI 10.1176/appi.ajp.163.9.1630; Pace TWW, 2009, PSYCHONEUROENDOCRINO, V34, P87, DOI 10.1016/j.psyneuen.2008.08.011; PaninaBordignon P, 1997, J CLIN INVEST, V100, P1513, DOI 10.1172/JCI119674; Posadzki P, 2011, CLIN RHEUMATOL, V30, P1257, DOI 10.1007/s10067-011-1764-8; Powell ND, 2013, P NATL ACAD SCI USA, V110, P16574, DOI 10.1073/pnas.1310655110; Powell ND, 2011, BRAIN BEHAV IMMUN, V25, P46, DOI 10.1016/j.bbi.2010.07.243; Pullen PR, 2008, J CARD FAIL, V14, P407, DOI 10.1016/j.cardfail.2007.12.007; Pullen PR, 2010, MED SCI SPORT EXER, V42, P651, DOI 10.1249/MSS.0b013e3181bf24c4; Raman Gowri, 2013, J Sleep Disord Ther, V2, DOI 10.4172/2167-0277.1000141; Rao Raghavendra M, 2008, Int J Yoga, V1, P11, DOI [10.4103/0973-6131.36795, 10.4103/0973-6131.36789]; Roland KP, 2011, J AGING PHYS ACTIV, V19, P62, DOI 10.1123/japa.19.1.62; Rosenkranz MA, 2013, BRAIN BEHAV IMMUN, V27, P174, DOI 10.1016/j.bbi.2012.10.013; SEVERN A, 1992, J IMMUNOL, V148, P3441; SeyedAlinaghi S, 2012, PSYCHOSOM MED, V74, P620, DOI 10.1097/PSY.0b013e31825abfaa; Solberg EE, 1995, BRIT J SPORT MED, V29, P255, DOI 10.1136/bjsm.29.4.255; Sprod LK, 2012, J CANCER SURVIV, V6, P146, DOI 10.1007/s11764-011-0205-7; Steensberg A, 2003, AM J PHYSIOL-ENDOC M, V285, pE433, DOI 10.1152/ajpendo.00074.2003; Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011; Subramanian Swapna, 2012, Int J Yoga, V5, P21, DOI 10.4103/0973-6131.91702; TAYLOR DN, 1995, PSYCHOL REP, V76, P451, DOI 10.2466/pr0.1995.76.2.451; van Westerloo DJ, 2011, MOL MED, V17, P180, DOI 10.2119/molmed.2010.00204; vanderPoll T, 1996, J CLIN INVEST, V97, P713, DOI 10.1172/JCI118469; Vogler Juliane, 2011, Int J Yoga Therap, P61; Wang C, 2005, RHEUMATOLOGY, V44, P685, DOI 10.1093/rheumatology/keh572; Wang CC, 2004, ARCH INTERN MED, V164, P493, DOI 10.1001/archinte.164.5.493; Wang Chenchen, 2010, BMC Complement Altern Med, V10, P23, DOI 10.1186/1472-6882-10-23; Wang CC, 2012, CURR RHEUMATOL REP, V14, P598, DOI 10.1007/s11926-012-0294-y; Wang CC, 2011, RHEUM DIS CLIN N AM, V37, P19, DOI 10.1016/j.rdc.2010.11.002; Wang CC, 2010, NEW ENGL J MED, V363, P743, DOI 10.1056/NEJMoa0912611; Wang CC, 2009, ARTHRIT RHEUM-ARTHR, V61, P1545, DOI 10.1002/art.24832; Wang Chenchen, 2008, V52, P218, DOI 10.1159/000134302; Wang MY, 2011, BIOL SPORT, V28, P45, DOI 10.5604/935875; Zautra AJ, 2008, J CONSULT CLIN PSYCH, V76, P408, DOI 10.1037/0022-006X.76.3.408; Zorrilla EP, 2001, BRAIN BEHAV IMMUN, V15, P199, DOI 10.1006/brbi.2000.0597	103	136	143	4	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100903	10.1371/journal.pone.0100903	http://dx.doi.org/10.1371/journal.pone.0100903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BA	24988414	Green Submitted, Green Published, gold			2022-12-27	WOS:000341354100049
J	Somervuo, P; Kvist, J; Ikonen, S; Auvinen, P; Paulin, L; Koskinen, P; Holm, L; Taipale, M; Duplouy, A; Ruokolainen, A; Saarnio, S; Siren, J; Kohonen, J; Corander, J; Frilander, MJ; Ahola, V; Hanski, I				Somervuo, Panu; Kvist, Jouni; Ikonen, Suvi; Auvinen, Petri; Paulin, Lars; Koskinen, Patrik; Holm, Liisa; Taipale, Minna; Duplouy, Anne; Ruokolainen, Annukka; Saarnio, Suvi; Siren, Jukka; Kohonen, Jukka; Corander, Jukka; Frilander, Mikko J.; Ahola, Virpi; Hanski, Ilkka			Transcriptome Analysis Reveals Signature of Adaptation to Landscape Fragmentation	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; CHAPERONE-MEDIATED AUTOPHAGY; GENE-EXPRESSION; LIFE-HISTORY; DISPERSAL RATE; DROSOPHILA; FLIGHT; METAPOPULATION; EVOLUTION; PROTEINS	We characterize allelic and gene expression variation between populations of the Glanville fritillary butterfly (Melitaea cinxia) from two fragmented and two continuous landscapes in northern Europe. The populations exhibit significant differences in their life history traits, e. g. butterflies from fragmented landscapes have higher flight metabolic rate and dispersal rate in the field, and higher larval growth rate, than butterflies from continuous landscapes. In fragmented landscapes, local populations are small and have a high risk of local extinction, and hence the long-term persistence at the landscape level is based on frequent re-colonization of vacant habitat patches, which is predicted to select for increased dispersal rate. Using RNA-seq data and a common garden experiment, we found that a large number of genes (1,841) were differentially expressed between the landscape types. Hexamerin genes, the expression of which has previously been shown to have high heritability and which correlate strongly with larval development time in the Glanville fritillary, had higher expression in fragmented than continuous landscapes. Genes that were more highly expressed in butterflies from newly-established than old local populations within a fragmented landscape were also more highly expressed, at the landscape level, in fragmented than continuous landscapes. This result suggests that recurrent extinctions and re-colonizations in fragmented landscapes select a for specific expression profile. Genes that were significantly up-regulated following an experimental flight treatment had higher basal expression in fragmented landscapes, indicating that these butterflies are genetically primed for frequent flight. Active flight causes oxidative stress, but butterflies from fragmented landscapes were more tolerant of hypoxia. We conclude that differences in gene expression between the landscape types reflect genomic adaptations to landscape fragmentation. A	[Somervuo, Panu; Kvist, Jouni; Koskinen, Patrik; Holm, Liisa; Duplouy, Anne; Ruokolainen, Annukka; Saarnio, Suvi; Siren, Jukka; Ahola, Virpi; Hanski, Ilkka] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Somervuo, Panu; Kvist, Jouni; Auvinen, Petri; Paulin, Lars; Holm, Liisa; Frilander, Mikko J.] Univ Helsinki, Inst Biotechnol, Genome Biol Program, Helsinki, Finland; [Ikonen, Suvi] Univ Helsinki, Lammi Biol Stn, Lammi, Finland; [Taipale, Minna] Karolinska Inst, Sci Life Lab, Dept Biosci & Nutr, Stockholm, Sweden; [Taipale, Minna] Univ Helsinki, Genome Scale Biol Res Program, Helsinki, Finland; [Taipale, Minna] Univ Helsinki, Inst Biomed, Helsinki, Finland; [Siren, Jukka; Kohonen, Jukka; Corander, Jukka] Univ Helsinki, Dept Math & Stat, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Karolinska Institutet; University of Helsinki; University of Helsinki; University of Helsinki	Hanski, I (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.	ilkka.hanski@helsinki.fi	Auvinen, Petri/D-5044-2009; Auvinen, Petri/AAP-8117-2021; Duplouy, Anne/J-2182-2015; Frilander, Mikko J/B-6660-2009	Auvinen, Petri/0000-0002-3947-4778; Frilander, Mikko J/0000-0002-1732-4808; Kvist, Jouni/0000-0002-4089-8877; Taipale, Minna/0000-0002-1905-2551; Siren, Jukka/0000-0002-2680-0597; Duplouy, Anne/0000-0002-7147-5199; Koskinen, Patrik/0000-0003-1485-4990	Finnish National Research Council [250444, 256453, 251170]; European Research Council [232826, 239784]	Finnish National Research Council; European Research Council(European Research Council (ERC)European Commission)	This research has been supported by grants to IH from the Finnish National Research Council (250444 and 256453) and the European Research Council (232826), and to JC from the Finnish National Research Council (251170) and the European Research Council (239784). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attias H, 2000, ADV NEUR IN, V12, P209; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; BARTHOLOMEW GA, 1978, J EXP BIOL, V76, P11; Bina S, 2010, EMBO REP, V11, P201, DOI 10.1038/embor.2010.1; Blanco E, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-94; Bonte D, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P161; Borgstrom E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019119; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Cheng L, 2013, MOL BIOL EVOL, V30, P1224, DOI 10.1093/molbev/mst028; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Dudley R, 2000, ANNU REV PHYSIOL, V62, P135, DOI 10.1146/annurev.physiol.62.1.135; Duplouy A, 2013, ECOL EVOL, V3, P5141, DOI 10.1002/ece3.885; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fahrig L, 1997, J WILDLIFE MANAGE, V61, P603, DOI 10.2307/3802168; Flatt T, 2008, J EXP BIOL, V211, P2712, DOI 10.1242/jeb.014878; Fraichard S, 2010, DEV BIOL, V340, P504, DOI 10.1016/j.ydbio.2010.02.008; Gao LY, 2011, BIOINFORMATICS, V27, P662, DOI 10.1093/bioinformatics/btr005; Gibson MC, 1999, DEVELOPMENT, V126, P1591; Gkouvitsas T, 2009, INSECT MOL BIOL, V18, P253, DOI 10.1111/j.1365-2583.2009.00866.x; Haag CR, 2005, P ROY SOC B-BIOL SCI, V272, P2449, DOI 10.1098/rspb.2005.3235; Hanski I, 2004, ECOL LETT, V7, P958, DOI 10.1111/j.1461-0248.2004.00654.x; Hanski I, 2000, NATURE, V404, P755, DOI 10.1038/35008063; Hanski I., 1999, METAPOPULATION ECOLO; Hanski I., 2005, SHRINKING WORLD ECOL; Hanski I, 2006, PLOS BIOL, V4, P719, DOI 10.1371/journal.pbio.0040129; Hanski I, 2011, ECOL LETT, V14, P1025, DOI 10.1111/j.1461-0248.2011.01671.x; Hanski IA, 2011, P NATL ACAD SCI USA, V108, P14397, DOI 10.1073/pnas.1110020108; HASTINGS A, 1994, ANNU REV ECOL SYST, V25, P167; Heino M, 2001, AM NAT, V157, P495, DOI 10.1086/319927; Helm A, 2006, ECOL LETT, V9, P72, DOI 10.1111/j.1461-0248.2005.00841.x; Hubbi ME, 2013, J BIOL CHEM, V288, P10703, DOI 10.1074/jbc.M112.414771; Hughes JB, 1997, SCIENCE, V278, P689, DOI 10.1126/science.278.5338.689; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kaushik S, 2012, TRENDS CELL BIOL, V22, P407, DOI 10.1016/j.tcb.2012.05.006; Kvist J, 2013, MOL ECOL, V22, P602, DOI 10.1111/j.1365-294X.2012.05521.x; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Lyne R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r129; Manohar D, 2010, J INSECT PHYSIOL, V56, P1224, DOI 10.1016/j.jinsphys.2010.03.026; Marden JH, 2013, EVOLUTION, V67, P1105, DOI 10.1111/evo.12004; Martins JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029006; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Niitepold K, 2009, ECOLOGY, V90, P2223, DOI 10.1890/08-1498.1; Niven JE, 2005, BIOL LETTERS, V1, P346, DOI 10.1098/rsbl.2005.0311; Ojanen SP, 2013, ECOL EVOL, V3, P3713, DOI 10.1002/ece3.733; Ou CY, 2007, DEV BIOL, V308, P106, DOI 10.1016/j.ydbio.2007.05.008; Ovaskainen O, 2008, P NATL ACAD SCI USA, V105, P19090, DOI 10.1073/pnas.0802066105; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Rastas P, 2013, BIOINFORMATICS, V29, P3128, DOI 10.1093/bioinformatics/btt563; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ronce Ophelie, 2004, P227, DOI 10.1016/B978-012323448-3/50012-X; Rus F, 2013, EMBO J, V32, P1626, DOI 10.1038/emboj.2013.100; Saastamoinen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081289; Saastamoinen M, 2009, P ROY SOC B-BIOL SCI, V276, P1313, DOI 10.1098/rspb.2008.1464; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; SAMMON JW, 1969, IEEE T COMPUT, VC 18, P401, DOI 10.1109/T-C.1969.222678; Schiffers K, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0083; SHIRRAS AD, 1989, P NATL ACAD SCI USA, V86, P4559, DOI 10.1073/pnas.86.12.4559; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Siren J, 2011, MOL BIOL EVOL, V28, P673, DOI 10.1093/molbev/msq236; Stec Wojciech J, 2011, J Signal Transduct, V2011, P894510, DOI 10.1155/2011/894510; Suarez RK, 2000, PHYSIOL BIOCHEM ZOOL, V73, P765, DOI 10.1086/318112; TELFER WH, 1991, ANNU REV ENTOMOL, V36, P205, DOI 10.1146/annurev.en.36.010191.001225; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Travis JMJ, 1999, P ROY SOC B-BIOL SCI, V266, P723, DOI 10.1098/rspb.1999.0696; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Vaha JP, 2007, MOL ECOL, V16, P2638, DOI 10.1111/j.1365-294X.2007.03329.x; Wahlberg N, 2007, EUR J ENTOMOL, V104, P675, DOI 10.14411/eje.2007.085; Wheat CW, 2011, MOL ECOL, V20, P1813, DOI 10.1111/j.1365-294X.2011.05062.x; Wheeler DE, 2000, J INSECT PHYSIOL, V46, P951, DOI 10.1016/S0022-1910(99)00202-4; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102; Zhao HW, 2011, J BIOL CHEM, V286, P6211, DOI 10.1074/jbc.M110.181206; Zheng CZ, 2009, PHILOS T R SOC B, V364, P1519, DOI 10.1098/rstb.2009.0005; Zhou D, 2011, P NATL ACAD SCI USA, V108, P2349, DOI 10.1073/pnas.1010643108; Zhou D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000221; Zhou XG, 2007, DEVELOPMENT, V134, P601, DOI 10.1242/dev.02755; Zhu L, 2013, INSECT BIOCHEM MOLEC, V43, P664, DOI 10.1016/j.ibmb.2013.04.004	79	21	22	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101467	10.1371/journal.pone.0101467	http://dx.doi.org/10.1371/journal.pone.0101467			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988207	Green Published, gold			2022-12-27	WOS:000341354100095
J	Yehia, BR; Schranz, AJ; Umscheid, CA; Lo Re, V				Yehia, Baligh R.; Schranz, Asher J.; Umscheid, Craig A.; Lo Re, Vincent, III			The Treatment Cascade for Chronic Hepatitis C Virus Infection in the United States: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							COST-EFFECTIVENESS; ANTIVIRAL THERAPY; HCV TREATMENT; HIV CARE; MANAGEMENT; PREDICTORS; ENGAGEMENT; RECOMMENDATIONS; MORTALITY; CIRRHOSIS	Background: Identifying gaps in care for people with chronic hepatitis C virus (HCV) infection is important to clinicians, public health officials, and federal agencies. The objective of this study was to systematically review the literature to provide estimates of the proportion of chronic HCV-infected persons in the United States (U.S.) completing each step along a proposed HCV treatment cascade: (1) infected with chronic HCV; (2) diagnosed and aware of their infection; (3) with access to outpatient care; (4) HCV RNA confirmed; (5) liver fibrosis staged by biopsy; (6) prescribed HCV treatment; and (7) achieved sustained virologic response (SVR). Methods: We searched MEDLINE, EMBASE, and the Cochrane Database of Systematic Reviews for articles published between January 2003 and July 2013. Two reviewers independently identified articles addressing each step in the cascade. Studies were excluded if they focused on specific populations, did not present original data, involved only a single site, were conducted outside of the U.S., or only included data collected prior to 2000. Results: 9,581 articles were identified, 117 were retrieved for full text review, and 10 were included. Overall, 3.5 million people were estimated to have chronic HCV in the U.S. Fifty percent (95% CI 43-57%) were diagnosed and aware of their infection, 43% (CI 40-47%) had access to outpatient care, 27% (CI 27-28%) had HCV RNA confirmed, 17% (CI 16-17%) underwent liver fibrosis staging, 16% (CI 15-16%) were prescribed treatment, and 9% (CI 9-10%) achieved SVR. Conclusions: Continued efforts are needed to improve HCV care in the U. S. The proposed HCV treatment cascade provides a framework for evaluating the delivery of HCV care over time and within subgroups, and will be useful in monitoring the impact of new screening efforts and advances in antiviral therapy.	[Yehia, Baligh R.; Umscheid, Craig A.; Lo Re, Vincent, III] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Yehia, Baligh R.; Umscheid, Craig A.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Yehia, Baligh R.; Umscheid, Craig A.; Lo Re, Vincent, III] Univ Penn, Ctr Clin Epidemiol & Biostat, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Schranz, Asher J.] NYU, Sch Med, Dept Med, New York, NY USA; [Umscheid, Craig A.] Univ Penn Hlth Syst, Ctr Evidenced Based Practice, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; New York University; University of Pennsylvania	Yehia, BR (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA.	byehia@upenn.edu	Re, Vincent Lo/N-7817-2015	Schranz, Asher/0000-0002-7497-7717; Umscheid, Craig/0000-0003-1853-1013	National Institutes of Health [K23 MH097647, K01 AI070001]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI070001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH097647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health [K23 MH097647 to BRY and K01 AI070001 to VLR]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghemo A, 2013, HEPATOLOGY, V58, P428, DOI 10.1002/hep.26371; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Arora S, 2011, NEW ENGL J MED, V364, P2199, DOI 10.1056/NEJMoa1009370; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Brau N, 2013, CLIN INFECT DIS, V56, P853, DOI 10.1093/cid/cis957; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Butt AA, 2006, ALIMENT PHARM THER, V24, P585, DOI 10.1111/j.1365-2036.2006.03020.x; Butt AA, 2009, HIV CLIN TRIALS, V10, P25, DOI [10.1310/hct1001-025, 10.1310/hct1001-25]; Chan K, 2013, CLIN GASTROENTEROL H, V11, P1503, DOI 10.1016/j.cgh.2013.05.014; Chou R, 2013, ANN INTERN MED, V158, P807, DOI 10.7326/0003-4819-158-11-201306040-00005; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Cornberg M, 2011, LIVER INT, V31, P30, DOI 10.1111/j.1478-3231.2011.02539.x; Denniston MM, 2012, HEPATOLOGY, V55, P1652, DOI 10.1002/hep.25556; Edlin BR, 2011, NATURE, V474, pS18, DOI 10.1038/474S18a; El Khoury AC, 2012, DIGEST DIS SCI, V57, P2995, DOI 10.1007/s10620-012-2233-1; FDA, 2011, GUID IND PROC VAL GE, P1; Fleishman JA, 2012, JAIDS-J ACQ IMM DEF, V60, P249, DOI 10.1097/QAI.0b013e318258c696; Garcia-Tsao G, 2001, GASTROENTEROLOGY, V120, P726, DOI 10.1053/gast.2001.22580; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gray KM, 2013, AM J PUBLIC HEALTH, V103, P141, DOI 10.2105/AJPH.2012.300859; Groessl EJ, 2012, J HEPATOL, V57, P252, DOI 10.1016/j.jhep.2012.03.021; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holmberg SD, 2013, NEW ENGL J MED, V368, P1859, DOI 10.1056/NEJMp1302973; Hull MW, 2012, CURR OPIN HIV AIDS, V7, P579, DOI 10.1097/COH.0b013e3283590617; Institute of Medicine, 2010, HEP LIV CANC NAT STR; Kanwal F, 2007, HEPATOLOGY, V46, P1741, DOI 10.1002/hep.21927; Kanwal F, 2012, CLIN GASTROENTEROL H, V10, P1270, DOI 10.1016/j.cgh.2012.07.015; Kanwal F, 2010, ANN INTERN MED, V153, P231, DOI 10.7326/0003-4819-153-4-201008170-00005; Kramer JR, 2012, J HEPATOL, V56, P320, DOI 10.1016/j.jhep.2011.05.032; Lo Re V, 2011, ANN INTERN MED, V155, P353, DOI 10.7326/0003-4819-155-6-201109200-00003; Mitra D, 2010, VALUE HEALTH, V13, P479, DOI 10.1111/j.1524-4733.2009.00691.x; Moorman AC, 2013, CLIN INFECT DIS, V56, P40, DOI 10.1093/cid/cis815; Moyer VA, 2013, ANN INTERN MED, V159, P349, DOI 10.7326/0003-4819-159-5-201309030-00672; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Rein DB, 2012, ANN INTERN MED, V156, P263, DOI 10.7326/0003-4819-156-4-201202210-00378; Russell M, 2012, HEPATOLOGY, V56, P1223, DOI 10.1002/hep.25755; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Thomas David L, 2012, Top Antivir Med, V20, P5; Umscheid CA, 2013, CLIN INFECT DIS, V57, P725, DOI 10.1093/cid/cit333; Veterans Health Administration, 2009, STAT CAR VET HIV AID; Yee HS, 2012, AM J GASTROENTEROL, V107, P669, DOI 10.1038/ajg.2012.48; Yehia Baligh, 2011, Am J Public Health, V101, pe4, DOI 10.2105/AJPH.2011.300259; Younossi ZM, 2013, J VIRAL HEPATITIS, V20, P550, DOI 10.1111/jvh.12080	44	270	271	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101554	10.1371/journal.pone.0101554	http://dx.doi.org/10.1371/journal.pone.0101554			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988388	gold, Green Published, Green Submitted			2022-12-27	WOS:000341354100113
J	Gill, K; Nigam, L; Singh, R; Kumar, S; Subbarao, N; Chauhan, SS; Dey, S				Gill, Kamaldeep; Nigam, Lokesh; Singh, Ratnakar; Kumar, Suresh; Subbarao, Naidu; Chauhan, Shyam Singh; Dey, Sharmistha			The Rational Design of Specific Peptide Inhibitor against p38 alpha MAPK at Allosteric-Site: A Therapeutic Modality for HNSCC	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; P38; CANCER; BINDING; HEAD; SECRETION; CARCINOMA; BIRB-796; TARGETS; JNK	p38 alpha is a significant target for drug designing against cancer. The overproduction of p38 alpha MAPK promotes tumorigenesis in head and neck squamous cell carcinoma (HNSCC). The ATP binding and an allosteric site referred as DFG are the key sites of the p38 alpha mitogen activated protein kinase (MAPK) exploited for the design of inhibitors. This study demonstrated design of peptide inhibitor on the basis of allosteric site using Glide molecular docking software and the biochemical analysis of the best modeled peptide. The best fitted tetrapeptide (FWCS) in the allosteric site inhibited the pure recombinant and serum p38 alpha of HNSCC patients by 74 and 72%, respectively. The potency of the peptide was demonstrated by its IC50 (4.6 nM) and K-D (3.41x10(-10) M) values, determined by ELISA and by surface plasmon resonance (SPR) technology, respectively. The cell viability of oral cancer i.e. KB cell line was reduced in dose dependent manner by 60 and 97% by the treatment of peptide and the IC50 was 600 and 210 mu M after 24 and 72 h incubation, respectively. Our result provides an insight for the development of a proficient small peptide as a promising anticancer agent targeting DFG site of p38 alpha kinase.	[Gill, Kamaldeep; Kumar, Suresh; Dey, Sharmistha] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India; [Singh, Ratnakar; Chauhan, Shyam Singh] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India; [Nigam, Lokesh; Subbarao, Naidu] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; Jawaharlal Nehru University, New Delhi	Dey, S (corresponding author), All India Inst Med Sci, Dept Biophys, New Delhi 110029, India.	sharmistha_d@hotmail.com	Singh, Ratnakar/K-2848-2018; Subbarao, Prof Naidu/AAZ-1832-2020	Singh, Ratnakar/0000-0002-3226-3847; Subbarao, Prof Naidu/0000-0002-1720-2165; Nigam, Lokesh/0000-0003-2350-9910; Kumar, Suresh/0000-0003-0710-2520	Research Section of All India Institute of Medical Sciences (AIIMS), New Delhi, India; Indian Council Medical Research, Government of India	Research Section of All India Institute of Medical Sciences (AIIMS), New Delhi, India; Indian Council Medical Research, Government of India(Indian Council of Medical Research (ICMR))	Author acknowledge Research Section of All India Institute of Medical Sciences (AIIMS), New Delhi, India, for providing funds for the consumable items; Indian Council Medical Research, Government of India, for the fellowship of Kamaldeep Gill and are thankful to Prof. Jiahuai Han, The Scripps Research Institute, United States of America, for providing p38 alpha cDNA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, GLID VERS 9 1; Boussac M, 2000, ELECTROPHORESIS, V21, P665, DOI 10.1002/(SICI)1522-2683(20000201)21:3<665::AID-ELPS665>3.0.CO;2-U; Davidson B, 2006, GYNECOL ONCOL, V102, P453, DOI 10.1016/j.ygyno.2006.01.034; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dietrich J, 2010, BIOORGAN MED CHEM, V18, P5738, DOI 10.1016/j.bmc.2010.05.063; Forrer P, 1998, BIOL CHEM, V379, P1101, DOI 10.1515/bchm.1998.379.8-9.1101; Gill K, 2013, BBA-GEN SUBJECTS, V1830, P2763, DOI 10.1016/j.bbagen.2012.12.001; Gill K, 2012, CLIN CHIM ACTA, V413, P219, DOI 10.1016/j.cca.2011.09.031; Greenberg AK, 2002, AM J RESP CELL MOL, V26, P558, DOI 10.1165/ajrcmb.26.5.4689; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kinter M., 2000, PROTEIN SEQUENCING I, DOI 10.1002/0471721980; Klebl B, 2003, METHODS PRINCIPLES M; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Kroe RR, 2003, J MED CHEM, V46, P4669, DOI 10.1021/jm030120s; Kulkarni RG, 2006, CURR PHARM DESIGN, V12, P2437, DOI 10.2174/138161206777698945; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; Liang B, 2005, WORLD J GASTROENTERO, V11, P623, DOI 10.3748/wjg.v11.i5.623; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; Morphy R, 2010, J MED CHEM, V53, P1413, DOI 10.1021/jm901132v; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Okaniwa M, 2013, J MED CHEM, V56, P6478, DOI 10.1021/jm400778d; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Riebe C, 2007, INT J MOL MED, V20, P883; Schaefer Martina, 2007, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V6, P5, DOI 10.2174/187152307779939778; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simard JR, 2009, J AM CHEM SOC, V131, P18478, DOI 10.1021/ja907795q; Vulpetti Anna, 2004, Farmaco (Lausanne), V59, P759; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; Yasui H, 2007, BRIT J HAEMATOL, V136, P414, DOI 10.1111/j.1365-2141.2006.06443.x; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116; Zhou TJ, 2011, CHEM BIOL DRUG DES, V77, P1, DOI 10.1111/j.1747-0285.2010.01054.x; Zuccotto F, 2010, J MED CHEM, V53, P2681, DOI 10.1021/jm901443h	39	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101525	10.1371/journal.pone.0101525	http://dx.doi.org/10.1371/journal.pone.0101525			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983631	Green Submitted, Green Published, gold			2022-12-27	WOS:000339635000116
J	Silva, PA; Monnerat-Cahli, G; Pereira-Acacio, A; Luzardo, R; Sampaio, LS; Luna-Leite, MA; Lara, LS; Einicker-Lamas, M; Panizzutti, R; Madeira, C; Vieira, LD; Castro-Chaves, C; Ribeiro, VS; Paixao, ADO; Medei, E; Vieyra, A				Silva, Paulo A.; Monnerat-Cahli, Gustavo; Pereira-Acacio, Amaury; Luzardo, Ricardo; Sampaio, Luzia S.; Luna-Leite, Marcia A.; Lara, Lucienne S.; Einicker-Lamas, Marcelo; Panizzutti, Rogerio; Madeira, Caroline; Vieira-Filho, Leucio D.; Castro-Chaves, Carmen; Ribeiro, Valdilene S.; Paixao, Ana D. O.; Medei, Emiliano; Vieyra, Adalberto			Mechanisms Involving Ang II and MAPK/ERK1/2 Signaling Pathways Underlie Cardiac and Renal Alterations during Chronic Undernutrition	PLOS ONE			English	Article							ANGIOTENSIN-II; BLOOD-PRESSURE; PROTEIN RESTRICTION; SODIUM-PUMP; NA+-ATPASE; KIDNEY; ACTIVATION; HYPERTENSION; EXPRESSION; RECEPTORS	Background: Several studies have correlated protein restriction associated with other nutritional deficiencies with the development of cardiovascular and renal diseases. The driving hypothesis for this study was that Ang II signaling pathways in the heart and kidney are affected by chronic protein, mineral and vitamin restriction. Methodology/Principal Findings: Wistar rats aged 90 days were fed from weaning with either a control or a deficient diet that mimics those used in impoverished regions worldwide. Such restriction simultaneously increased ouabain-insensitive Na+-ATPase and decreased (Na++K+) ATPase activity in the same proportion in cardiomyocytes and proximal tubule cells. Type 1 angiotensin II receptor (AT(1)R) was downregulated by that restriction in both organs, whereas AT(2)R decreased only in the kidney. The PKC/PKA ratio increased in both tissues and returned to normal values in rats receiving Losartan daily from weaning. Inhibition of the MAPK pathway restored Na+-ATPase activity in both organs. The undernourished rats presented expanded plasma volume, increased heart rate, cardiac hypertrophy, and elevated systolic pressure, which also returned to control levels with Losartan. Such restriction led to electrical cardiac remodeling represented by prolonged ventricular repolarization parameters, induced triggered activity, early after-depolarization and delayed after-depolarization, which were also prevented by Losartan. Conclusion/Significance: The mechanisms responsible for these alterations are underpinned by an imbalance in the PKC- and PKA-mediated pathways, with participation of angiotensin receptors and by activation of the MAPK/ERK1/2 pathway. These cellular and molecular alterations culminate in cardiac electric remodeling and in the onset of hypertension in adulthood.	[Silva, Paulo A.; Monnerat-Cahli, Gustavo; Pereira-Acacio, Amaury; Luzardo, Ricardo; Sampaio, Luzia S.; Luna-Leite, Marcia A.; Einicker-Lamas, Marcelo; Medei, Emiliano; Vieyra, Adalberto] Univ Fed Rio de Janeiro, Carlos Chagas Filho Inst Biophys, Rio De Janeiro, Brazil; [Silva, Paulo A.; Monnerat-Cahli, Gustavo; Pereira-Acacio, Amaury; Luzardo, Ricardo; Sampaio, Luzia S.; Lara, Lucienne S.; Einicker-Lamas, Marcelo; Panizzutti, Rogerio; Madeira, Caroline; Vieira-Filho, Leucio D.; Castro-Chaves, Carmen; Ribeiro, Valdilene S.; Paixao, Ana D. O.; Medei, Emiliano; Vieyra, Adalberto] Natl Inst Sci & Technol Struct Biol & Bioimaging, Rio De Janeiro, Brazil; [Lara, Lucienne S.; Panizzutti, Rogerio; Madeira, Caroline] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil; [Vieira-Filho, Leucio D.; Castro-Chaves, Carmen; Ribeiro, Valdilene S.; Paixao, Ana D. O.] Univ Fed Pernambuco, Dept Physiol & Pharmacol, Recife, PE, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal de Pernambuco	Vieyra, A (corresponding author), Univ Fed Rio de Janeiro, Carlos Chagas Filho Inst Biophys, Rio De Janeiro, Brazil.	avieyra@biof.ufrj.br	Monnerat, Gustavo/J-6907-2019; Morcillo, Lucienne/F-5771-2017; monnerat cahli, gustavo/M-2647-2014; monnerat, gustavo/E-3398-2015; Sampaio, Luzia/X-9805-2019	Morcillo, Lucienne/0000-0002-2204-8799; monnerat, gustavo/0000-0002-1010-6314; Sampaio, Luzia/0000-0002-4944-7116; Vieira, Leucio/0000-0002-6041-1720; Medei, Emiliano/0000-0002-0044-1311	Brazilian National Research Council [302513/2008-6, 474712/2010-9, 470740/2010/8]; Carlos Chagas Filho Rio de Janeiro State Research Foundation [E-26/102.764/2008]; Pernambuco State Research Foundation [IBPG-1228-2.07/08]; Ministry of Science and Technology/CNPq-Department of Science and Technology/Ministry of Health [552162/2005-1]; Brazilian Federal Agency for Support and Evaluation of Graduate Education [00852NF]; National Institute of Science and Technology for Structural Biology and Bioimaging, Brazil [573767/2008-4]	Brazilian National Research Council(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlos Chagas Filho Rio de Janeiro State Research Foundation; Pernambuco State Research Foundation(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); Ministry of Science and Technology/CNPq-Department of Science and Technology/Ministry of Health; Brazilian Federal Agency for Support and Evaluation of Graduate Education; National Institute of Science and Technology for Structural Biology and Bioimaging, Brazil	This work was funded by the Brazilian National Research Council (grants 302513/2008-6 to A. V., 474712/2010-9 to E. M., and 470740/2010/8 to A. D. P.), the Carlos Chagas Filho Rio de Janeiro State Research Foundation (grant E-26/102.764/2008 to A. V.), the Pernambuco State Research Foundation (grant IBPG-1228-2.07/08 to A.D.O.P.), the Ministry of Science and Technology/CNPq-Department of Science and Technology/Ministry of Health (grant 552162/2005-1 to A. V.), the Brazilian Federal Agency for Support and Evaluation of Graduate Education (grant 00852NF), and the National Institute of Science and Technology for Structural Biology and Bioimaging (grant 573767/2008-4), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Alwasel SH, 2009, CLIN SCI, V117, P75, DOI 10.1042/CS20080294; APERIA A, 1994, FASEB J, V8, P436, DOI 10.1096/fasebj.8.6.8168694; Auerbach DS, 2011, J PHYSIOL-LONDON, V589, P2363, DOI 10.1113/jphysiol.2010.200576; Beilin LJ, 1999, AM J HYPERTENS, V12, P934, DOI 10.1016/S0895-7061(99)00057-6; Beltowski J, 2007, CLIN EXP HYPERTENS, V29, P189, DOI 10.1080/10641960701361585; BENABE JE, 1993, KIDNEY INT, V44, P285, DOI 10.1038/ki.1993.243; Benabe JE, 1998, MINER ELECTROL METAB, V24, P20, DOI 10.1159/000057346; Cabral LMP, 2010, ARCH BIOCHEM BIOPHYS, V498, P57, DOI 10.1016/j.abb.2010.04.004; Calcia MA, 2012, SCHIZOPHR RES, V142, P83, DOI 10.1016/j.schres.2012.09.014; CAMEJO JL, 1995, COMP BIOCHEM PHYS B, V110, P345, DOI 10.1016/0305-0491(94)00150-S; Cang CL, 2013, CELL, V152, P778, DOI 10.1016/j.cell.2013.01.023; Cardoso HD, 2009, PEDIATR NEPHROL, V24, P1959, DOI 10.1007/s00467-009-1247-1; Ceravolo GS, 2007, LIFE SCI, V80, P782, DOI 10.1016/j.lfs.2006.11.006; Cleal JK, 2007, P NATL ACAD SCI USA, V104, P9529, DOI 10.1073/pnas.0610373104; Cornock R, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-105; Costa-Silva JH, 2009, EUR J NUTR, V48, P437, DOI 10.1007/s00394-009-0032-z; Crowley SD, 2006, P NATL ACAD SCI USA, V103, P17985, DOI 10.1073/pnas.0605545103; Dostanic I, 2004, J BIOL CHEM, V279, P54053, DOI 10.1074/jbc.M410737200; Fernandez-Twinn DS, 2006, AM J PHYSIOL-REG I, V291, pR429, DOI 10.1152/ajpregu.00608.2005; Fowden AL, 2006, PHYSIOLOGY, V21, P29, DOI 10.1152/physiol.00050.2005; Fryer RM, 2001, J PHARMACOL EXP THER, V296, P642; Gildea JJ, 2012, HYPERTENSION, V60, P396, DOI 10.1161/HYPERTENSIONAHA.112.194175; HASHIMOTO A, 1992, J CHROMATOGR-BIOMED, V582, P41, DOI 10.1016/0378-4347(92)80300-F; HE J, 1994, AM J EPIDEMIOL, V139, P380, DOI 10.1093/oxfordjournals.aje.a117010; Herrera M, 2013, HYPERTENSION, V61, P253, DOI 10.1161/HYPERTENSIONAHA.112.203679; Hoppe CC, 2007, AM J PHYSIOL-REG I, V292, pR462, DOI 10.1152/ajpregu.00079.2006; ICHIKAWA I, 1980, J CLIN INVEST, V65, P982, DOI 10.1172/JCI109784; IKEDA K, 1991, LAB ANIM-UK, V25, P26, DOI 10.1258/002367791780808176; Kaufman JS, 1999, HUM BIOL, V71, P641; Kovacs K, 2009, MOL CELL BIOCHEM, V321, P155, DOI 10.1007/s11010-008-9929-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langley-Evans SC, 1999, LIFE SCI, V64, P965, DOI 10.1016/S0024-3205(99)00022-3; Lara LS, 2010, ARCH BIOCHEM BIOPHYS, V496, P117, DOI 10.1016/j.abb.2010.02.005; LAW CM, 1993, BRIT MED J, V306, P24, DOI 10.1136/bmj.306.6869.24; Li XC, 2012, AM J PHYSIOL-RENAL, V303, pF1617, DOI 10.1152/ajprenal.00219.2012; Li XC, 2011, KIDNEY INT, V80, P620, DOI 10.1038/ki.2011.161; Liu L, 2011, AM J PHYSIOL-RENAL, V301, pF1195, DOI 10.1152/ajprenal.00339.2011; Lo J, 2013, EXP PHYSIOL, V98, P109, DOI 10.1113/expphysiol.2012.067165; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luzardo R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021232; Maia J.C.C., 1983, GENES ANTIGENES PARA, P146; MARTINEZMALDONADO M, 1993, AM J PHYSIOL, V264, pF981, DOI 10.1152/ajprenal.1993.264.6.F981; Medei E, 2010, J MOL CELL CARDIOL, V49, P165, DOI 10.1016/j.yjmcc.2010.04.014; Mesquita FF, 2010, BRAZ J MED BIOL RES, V43, P1010, DOI [10.1590/S0100-879X2010007500113, 10.1590/S0100-879X2010001100001]; Miura S, 2010, BIOCHEM BIOPH RES CO, V391, P85, DOI 10.1016/j.bbrc.2009.11.008; Monteiro CA, 2009, REV SAUDE PUBL, V43, P35, DOI 10.1590/S0034-89102009000100005; Rangel LBA, 2005, REGUL PEPTIDES, V127, P177, DOI 10.1016/j.regpep.2004.12.007; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Rocafull MA, 2012, PFLUG ARCH EUR J PHY, V463, P755, DOI 10.1007/s00424-012-1101-3; Rocafull MA, 2011, BBA-BIOMEMBRANES, V1808, P1684, DOI 10.1016/j.bbamem.2011.02.010; Rodrigues-Ferreira S, 2010, TRENDS ENDOCRIN MET, V21, P684, DOI 10.1016/j.tem.2010.08.009; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Sebrell W., 1954, VITAMINS, V3, P2; Sicouri S, 2011, J CARDIOVASC ELECTR, V22, P698, DOI 10.1111/j.1540-8167.2010.01972.x; Szymanski MK, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0242-4; Tanaka Y, 2005, FEBS LETT, V579, P1579, DOI 10.1016/j.febslet.2005.01.068; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; TEODOSIO NR, 1990, ARCH LATINOAM NUTR, V40, P533; Tian J, 2009, J BIOL CHEM, V284, P14921, DOI 10.1074/jbc.M808355200; Vehaskari VM, 2001, KIDNEY INT, V59, P238, DOI 10.1046/j.1523-1755.2001.00484.x; Vieira LD, 2014, BRIT J NUTR, V111, P1932, DOI 10.1017/S0007114513004236; Vieira LD, 2011, ARCH BIOCHEM BIOPHYS, V505, P91, DOI 10.1016/j.abb.2010.09.025; Vieira LD, 2009, CLIN EXP PHARMACOL P, V36, P1157, DOI 10.1111/j.1440-1681.2009.05212.x; VIEYRA A, 1986, J BIOL CHEM, V261, P4247; WHITTEMB.G, 1970, PFLUG ARCH EUR J PHY, V316, P1, DOI 10.1007/BF00587893; Wu W, 2011, CIRCULATION, V123, P53, DOI 10.1161/CIRCULATIONAHA.110.970673	68	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100410	10.1371/journal.pone.0100410	http://dx.doi.org/10.1371/journal.pone.0100410			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983243	gold, Green Submitted, Green Published			2022-12-27	WOS:000339635000023
J	Vazquez-Alcocer, A; Garzon-Cortes, DL; Sanchez-Casas, RM				Vazquez-Alcocer, Alan; Ladislao Garzon-Cortes, Daniel; Maria Sanchez-Casas, Rosa			LADES: A Software for Constructing and Analyzing Longitudinal Designs in Biomedical Research	PLOS ONE			English	Article							POWER ANALYSIS; MODELS	One of the most important steps in biomedical longitudinal studies is choosing a good experimental design that can provide high accuracy in the analysis of results with a minimum sample size. Several methods for constructing efficient longitudinal designs have been developed based on power analysis and the statistical model used for analyzing the final results. However, development of this technology is not available to practitioners through user-friendly software. In this paper we introduce LADES (Longitudinal Analysis and Design of Experiments Software) as an alternative and easy-to-use tool for conducting longitudinal analysis and constructing efficient longitudinal designs. LADES incorporates methods for creating cost-efficient longitudinal designs, unequal longitudinal designs, and simple longitudinal designs. In addition, LADES includes different methods for analyzing longitudinal data such as linear mixed models, generalized estimating equations, among others. A study of European eels is reanalyzed in order to show LADES capabilities. Three treatments contained in three aquariums with five eels each were analyzed. Data were collected from 0 up to the 12th week post treatment for all the eels (complete design). The response under evaluation is sperm volume. A linear mixed model was fitted to the results using LADES. The complete design had a power of 88.7% using 15 eels. With LADES we propose the use of an unequal design with only 14 eels and 89.5% efficiency. LADES was developed as a powerful and simple tool to promote the use of statistical methods for analyzing and creating longitudinal experiments in biomedical research.	[Vazquez-Alcocer, Alan] Ctr Invest Matemat, Guanajuato, Mexico; [Ladislao Garzon-Cortes, Daniel; Maria Sanchez-Casas, Rosa] Univ Autonoma Nuevo Leon, Fac Med Vet & Zootecn, Escobedo, Nuevo Leon, Mexico; [Ladislao Garzon-Cortes, Daniel; Maria Sanchez-Casas, Rosa] Univ Autonoma Nuevo Leon, Ctr Invest & Desarrollo Ciencias Salud, Monterrey, Nuevo Leon, Mexico	CIMAT - Centro de Investigacion en Matematicas; Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon	Vazquez-Alcocer, A (corresponding author), Ctr Invest Matemat, Guanajuato, Mexico.	alan.vazquez@cimat.mx		SANCHEZ CASAS, ROSA MARIA/0000-0002-2626-7227	Centro de Investigacion en Matematicas; Facultad de Medicina Veterinaria y Zootecnia; Centro de investigacion y Desarrollo en Ciencias de la Salud of the Universidad Autonoma de Nuevo Leon	Centro de Investigacion en Matematicas; Facultad de Medicina Veterinaria y Zootecnia; Centro de investigacion y Desarrollo en Ciencias de la Salud of the Universidad Autonoma de Nuevo Leon	This work was funded with internal funding of the Centro de Investigacion en Matematicas, the Facultad de Medicina Veterinaria y Zootecnia and the Centro de investigacion y Desarrollo en Ciencias de la Salud of the Universidad Autonoma de Nuevo Leon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnau J, 2010, PERCEPT MOTOR SKILL, V110, P547, DOI 10.2466/PMS.110.2.547-566; Asturiano JF, 2006, THERIOGENOLOGY, V66, P1012, DOI 10.1016/j.theriogenology.2006.02.041; Atkinson A.C., 1992, OXFORD STAT SCI SERI; Cohen J.E., 1988, STAT POWER ANAL BEHA; De Jong K, 2010, PSYCHOTHER RES, V20, P273, DOI 10.1080/10503300903376320; Dell Ralph B, 2002, ILAR J, V43, P207; Diggle P, 1994, OXFORD STAT SCI SERI; Festing Michael F W, 2002, ILAR J, V43, P244; Gromping U, 2014, J STAT SOFTW, V56, P1; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; HELMS RW, 1992, STAT MED, V11, P1889, DOI 10.1002/sim.4780111411; Hintze J., 2013, PASS 12; Huang WZ, 2005, J R STAT SOC B, V67, P135, DOI 10.1111/j.1467-9868.2005.00492.x; Kornbrot D, 1998, BRIT J MATH STAT PSY, V51, P367; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; PETERMAN RM, 1990, CAN J FISH AQUAT SCI, V47, P2, DOI 10.1139/f90-001; Pinheiro J, 2020, R PACKAGE VERSION 31; Pinheiro JC, 2009, STAT COMPUTING; R Core Team, 2021, R LANGUAGE ENV STAT; Raudenbush ea SW, 2011, OPTIMAL DESIGN SOFTW; Reboussin BA, 2002, J ROY STAT SOC C-APP, V51, P69, DOI 10.1111/1467-9876.04742; Reich NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035564; Roy A, 2007, BIOMETRICS, V63, P699, DOI 10.1111/j.1541-0420.2007.00769.x; Stegmaier J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055723; Verbeke G, 2009, SPRINGER SER STAT, P1; Wheeler B, 2011, ALGDESIGN ALGORITHMI; WHEELER RE, 1974, TECHNOMETRICS, V16, P193, DOI 10.2307/1267939; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; Zuur A, 2009, MIXED EFFECTS MODELS	32	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100570	10.1371/journal.pone.0100570	http://dx.doi.org/10.1371/journal.pone.0100570			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983945	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000339635000029
J	Wang, BH; Wu, BL; Liu, J; Yao, WM; Xia, D; Li, L; Chen, ZQ; Ye, ZQ; Yu, X				Wang, Bohan; Wu, Bolin; Liu, Jun; Yao, Weimin; Xia, Ding; Li, Lu; Chen, Zhiqiang; Ye, Zhangqun; Yu, Xiao			Analysis of Altered MicroRNA Expression Profiles in Proximal Renal Tubular Cells in Response to Calcium Oxalate Monohydrate Crystal Adhesion: Implications for Kidney Stone Disease	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; EPITHELIAL-CELLS; OXIDATIVE STRESS; HK-2; RISK; LINE	Background: Calcium oxalate monohydrate (COM) is the major crystalline component in kidney stones and its adhesion to renal tubular cells leads to tubular injury. However, COM-induced toxic effects in renal tubular cells remain ambiguous. MicroRNAs (miRNAs) play an important role in gene regulation at the posttranscriptional levels. Objective: The present study aimed to assess the potential changes in microRNAs of proximal renal tubular cells in response to the adhesion of calcium oxalate monohydrate (COM) crystals. Methodology: Lactate dehydrogenase (LDH) activity and DAPI staining were used to measure the toxic effects of HK-2 cells exposed to COM crystals. MicroRNA microarray and mRNA microarray were applied to evaluate the expression of HK-2 cells exposed to COM crystals. Quantitative real-time PCR (qRT-PCR) technology was used to validate the microarray results. Target prediction, Gene Ontology (GO) analysis and pathway analysis were applied to predict the potential roles of microRNAs in biological processes. Principal Findings: Our study showed that COM crystals significantly altered the global expression profile of miRNAs in vitro. After 24 h treatment with a dose (1 mmol/L), 25 miRNAs were differentially expressed with a more than 1.5-fold change, of these miRNAs, 16 were up-regulated and 9 were down-regulated. A majority of these differentially expressed miRNAs were associated with cell death, mitochondrion and metabolic process. Target prediction and GO analysis suggested that these differentially expressed miRNAs potentially targeted many genes which were related to apoptosis, regulation of metabolic process, intracellular signaling cascade, insulin signaling pathway and type 2 diabetes. Conclusion: Our study provides new insights into the role of miRNAs in the pathogenesis associated with nephrolithiasis.	[Wu, Bolin; Yao, Weimin; Xia, Ding; Li, Lu; Chen, Zhiqiang; Ye, Zhangqun; Yu, Xiao] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Urinary Surg, Wuhan 430074, Hubei Province, Peoples R China; [Wang, Bohan] Zhejiang Univ, Affiliated Hosp 2, Dept Urinary Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Jun] Suining Ctr Hosp, Dept Urinary Surg, Suining, Sichuan Provinc, Peoples R China	Huazhong University of Science & Technology; Zhejiang University	Yu, X (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Urinary Surg, Wuhan 430074, Hubei Province, Peoples R China.	yujiuhu8366@126.com			National Natural Science Foundation of China [81000292]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81000292). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Asselman M, 2003, J AM SOC NEPHROL, V14, P3155, DOI 10.1097/01.ASN.0000099380.18995.F7; Chaturvedi LS, 2002, J BIOL CHEM, V277, P13321, DOI 10.1074/jbc.M108203200; Chen SS, 2010, UROL RES, V38, P7, DOI 10.1007/s00240-009-0226-0; Chung SD, 2011, J UROLOGY, V186, P1888, DOI 10.1016/j.juro.2011.07.011; Coe FL, 2005, J CLIN INVEST, V115, P2598, DOI 10.1172/JCI26662; Eisner BH, 2010, J UROLOGY, V183, P2244, DOI 10.1016/j.juro.2010.02.007; Han HJ, 2004, AM J PHYSIOL-CELL PH, V287, pC1058, DOI 10.1152/ajpcell.00063.2004; Hovda KE, 2010, TOXICOL LETT, V192, P365, DOI 10.1016/j.toxlet.2009.11.013; Huang MY, 2005, KIDNEY INT, V68, P497, DOI 10.1111/j.1523-1755.2005.00427.x; Khan Saeed R, 2004, Clin Exp Nephrol, V8, P75; Khan SR, 2012, UROL RES, V40, P95, DOI 10.1007/s00240-011-0448-9; Khaskhali MH, 2009, UROL RES, V37, P1, DOI 10.1007/s00240-008-0160-6; Koul HK, 2002, J BIOL CHEM, V277, P36845, DOI 10.1074/jbc.M200832200; Koul S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043886; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lieske JC, 1997, KIDNEY INT, V51, P679, DOI 10.1038/ki.1997.98; Mahn R, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2011.01.020; Peerapen P, 2013, SCI REP-UK, V3, DOI 10.1038/srep01041; Rabinovich YI, 2006, J COLLOID INTERF SCI, V300, P131, DOI 10.1016/j.jcis.2006.03.070; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Schubert G, 2006, UROL RES, V34, P146, DOI 10.1007/s00240-005-0028-y; Sheng XX, 2005, J AM SOC NEPHROL, V16, P1904, DOI 10.1681/ASN.2005040400; SHUM DKY, 1995, UROL RES, V23, P103, DOI 10.1007/BF00307940; THALASSINOS NC, 1993, DIABETIC MED, V10, P341, DOI 10.1111/j.1464-5491.1993.tb00076.x; Thongboonkerd V, 2008, J PROTEOME RES, V7, P4689, DOI 10.1021/pr8002408; Tozawa K, 2008, INT J UROL, V15, P924, DOI 10.1111/j.1442-2042.2008.02131.x; Weinberg AE, 2014, EUR UROL, V65, P242, DOI 10.1016/j.eururo.2013.03.026; Zhang BH, 2009, GENE, V443, P100, DOI 10.1016/j.gene.2009.04.027; Zhang H, 2012, UROLOGY, V80, P1298, DOI 10.1016/j.urology.2012.08.013; Zhou LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015224	32	27	29	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101306	10.1371/journal.pone.0101306	http://dx.doi.org/10.1371/journal.pone.0101306			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983625	Green Published, Green Submitted, gold			2022-12-27	WOS:000339635000086
J	Bodnar, M; Hovington, CL; Buchy, L; Malla, AK; Joober, R; Lepage, M				Bodnar, Michael; Hovington, Cindy L.; Buchy, Lisa; Malla, Ashok K.; Joober, Ridha; Lepage, Martin			Cortical Thinning in Temporo-Parietal Junction (TPJ) in Non-Affective First-Episode of Psychosis Patients with Persistent Negative Symptoms	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; TRANSCRANIAL MAGNETIC STIMULATION; AUTOMATED 3-D EXTRACTION; 1ST EPISODE; GRAY-MATTER; AUDITORY HALLUCINATIONS; BRAIN VOLUMES; FALSE POSITIVES; SCHIZOPHRENIA; THICKNESS	Background: Negative symptoms represent an unmet therapeutic need in many patients with schizophrenia. In an extension to our previous voxel-based morphometry findings, we employed a more specific, vertex-based approach to explore cortical thinning in relation to persistent negative symptoms (PNS) in non-affective first-episode of psychosis (FEP) patients to advance our understanding of the pathophysiology of primary negative symptoms. Methods: This study included 62 non-affective FEP patients and 60 non-clinical controls; 16 patients were identified with PNS (i.e., at least 1 primary negative symptom at moderate or greater severity sustained for at least 6 consecutive months). Using cortical thickness analyses, we explored for differences between PNS and non-PNS patients as well as between each patient group and healthy controls; cut-off threshold was set at p<0.01, corrected for multiple comparisons. Results: A thinner cortex prominently in the right superior temporal gyrus extending into the temporo-parietal junction (TPJ), right parahippocampal gyrus, and left orbital frontal gyrus was identified in PNS patients vs. non-PNS patients. Compared with healthy controls, PNS patients showed a thinner cortex prominently in the right superior temporal gyrus, right parahippocampal gyrus, and right cingulate; non-PNS patients showed a thinner cortex prominently in the parahippocampal gyrus bi-laterally. Conclusion: Cortical thinning in the early stages of non-affective psychosis is present in the frontal and temporo-parietal regions in patients with PNS. With these brain regions strongly related to social cognitive functioning, our finding suggests a potential link between primary negative symptoms and social cognitive deficits through common brain etiologies.	[Bodnar, Michael; Malla, Ashok K.; Joober, Ridha; Lepage, Martin] Douglas Mental Hlth Univ Inst, Prevent & Early Intervent Program Psychoses PEPP, Montreal, PQ, Canada; [Bodnar, Michael; Lepage, Martin] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Hovington, Cindy L.; Buchy, Lisa; Lepage, Martin] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Malla, Ashok K.; Joober, Ridha; Lepage, Martin] McGill Univ, Dept Psychiat, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Lepage, M (corresponding author), Douglas Mental Hlth Univ Inst, Prevent & Early Intervent Program Psychoses PEPP, Montreal, PQ, Canada.	martin.lepage@mcgill.ca			CIHR [68961]; Sackler Foundation; Fonds de la Recherche en Sante du Quebec (FRSQ); Canada Research Chairs Program	CIHR(Canadian Institutes of Health Research (CIHR)); Sackler Foundation; Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Canada Research Chairs Program(Canada Research Chairs)	The study was supported by operating grants from CIHR (#68961) and the Sackler Foundation to Drs. M. Lepage/A.K Malla; Fonds de la Recherche en Sante du Quebec (FRSQ) (salary award to M. L.); Canada Research Chairs Program (to A. K. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ad-Dabbagh Y, 2006, P 12 ANN M ORG HUM B; ADDINGTON D, 1993, BRIT J PSYCHIAT, V163, P39, DOI 10.1192/S0007125000292581; Andreasen N. C., 1984, SCALE ASSESSMENT POS; Andreasen NC., 1984, MODIFIED SCALE ASSES; Arzy S, 2006, NATURE, V443, P287, DOI 10.1038/443287a; Benoit Audrey, 2012, Front Psychiatry, V3, P42, DOI 10.3389/fpsyt.2012.00042; Blanke O, 2002, NATURE, V419, P269, DOI 10.1038/419269a; Bodnar M, 2012, PSYCHIAT RES-NEUROIM, V201, P40, DOI 10.1016/j.pscychresns.2011.07.012; Bodnar Michael, 2011, Clin Schizophr Relat Psychoses, V4, P217, DOI 10.3371/CSRP.4.4.2; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Buchanan RW, 2007, SCHIZOPHRENIA BULL, V33, P1013, DOI 10.1093/schbul/sbl057; Buchanan RW, 2012, J CLIN PSYCHOPHARM, V32, P36, DOI 10.1097/JCP.0b013e31823f880a; Buchy L, 2010, J PSYCHIAT RES; Carter RM, 2012, SCIENCE, V337, P109, DOI 10.1126/science.1219681; Cascella NG, 2010, SCHIZOPHR RES, V120, P63, DOI 10.1016/j.schres.2010.03.039; Cassidy CM, 2010, J CLIN PSYCHOPHARM, V30, P64, DOI 10.1097/JCP.0b013e3181ca03df; Chang WC, 2011, SCHIZOPHR RES, V133, P22, DOI 10.1016/j.schres.2011.09.006; Chechlacz M, 2013, CORTEX, V49, P487, DOI 10.1016/j.cortex.2011.11.008; Chiao JY, 2009, NEUROPSYCHOLOGIA, V47, P354, DOI 10.1016/j.neuropsychologia.2008.09.023; Chung MK, 2003, NEUROIMAGE, V18, P198, DOI 10.1016/S1053-8119(02)00017-4; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Colloby SJ, 2011, J AFFECT DISORDERS, V133, P158, DOI 10.1016/j.jad.2011.04.010; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Crespo-Facorro B, 2011, PSYCHOL MED, V41, P1449, DOI 10.1017/S003329171000200X; Davatzikos C, 2004, NEUROIMAGE, V23, P17, DOI 10.1016/j.neuroimage.2004.05.010; First M. B., 1998, STRUCTURED CLIN INTE; Freitas C, 2009, SCHIZOPHR RES, V108, P11, DOI 10.1016/j.schres.2008.11.027; Galderisi S, 2008, SCHIZOPHRENIA BULL, V34, P393, DOI 10.1093/schbul/sbm097; Galderisi S, 2013, EUR NEUROPSYCHOPHARM, V23, P196, DOI 10.1016/j.euroneuro.2012.04.019; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gernsbacher MA, 2003, ANNU REV PSYCHOL, V54, P91, DOI 10.1146/annurev.psych.54.101601.145128; Grabner G, 2006, LECT NOTES COMPUT SC, V4191, P58; Hampton AN, 2008, P NATL ACAD SCI USA, V105, P6741, DOI 10.1073/pnas.0711099105; Harris JM, 2004, BIOL PSYCHIAT, V55, P141, DOI 10.1016/S0006-3223(03)00789-3; Ho BC, 2011, ARCH GEN PSYCHIAT, V68, P128, DOI 10.1001/archgenpsychiatry.2010.199; Hobbs N, 2008, VBM VOXEL BASED MORP, V37; Hoffman RE, 2005, BIOL PSYCHIAT, V58, P97, DOI 10.1016/j.biopsych.2005.03.041; Hollingshead AB, 1965, 2 FACTOR INDEX SOCIA; Hovington CL, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-224; Hovington CL, 2012, EXPERT REV NEUROTHER, V12, P53, DOI [10.1586/ERN.11.173, 10.1586/ern.11.173]; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Jardri R, 2007, MOL PSYCHIATR, V12, P320, DOI 10.1038/sj.mp.4001968; Jensen B, 2012, DRUG COMPARISON CHAR; Jhamnani K, 2013, J NEUROPSYCH CLIN N, V25, pE6, DOI 10.1176/appi.neuropsych.11120376; Kabani N, 2001, NEUROIMAGE, V13, P375, DOI 10.1006/nimg.2000.0652; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; KIRKPATRICK B, 1989, PSYCHIAT RES, V30, P119, DOI 10.1016/0165-1781(89)90153-4; Koutsouleris N, 2008, NEUROIMAGE, V39, P1600, DOI 10.1016/j.neuroimage.2007.10.029; Kulynych JJ, 1997, BIOL PSYCHIAT, V41, P995, DOI 10.1016/S0006-3223(96)00292-2; Lehmann M, 2011, NEUROBIOL AGING, V32, P1466, DOI 10.1016/j.neurobiolaging.2009.08.017; Lepage M, 2011, PSYCHOL MED, V41, P1833, DOI 10.1017/S0033291711000031; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Leung M, 2011, SCHIZOPHRENIA BULL, V37, P199, DOI 10.1093/schbul/sbp099; Lyttelton O, 2007, NEUROIMAGE, V34, P1535, DOI 10.1016/j.neuroimage.2006.10.041; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; Malla A, 2003, AUST NZ J PSYCHIAT, V37, P407, DOI 10.1046/j.1440-1614.2003.01194.x; Malla AK, 2004, J NERV MENT DIS, V192, P455, DOI 10.1097/01.nmd.0000131804.34977.c1; Martin RC, 2003, ANNU REV PSYCHOL, V54, P55, DOI 10.1146/annurev.psych.54.101601.145201; Meyer-Lindenberg A, 2008, NEUROIMAGE, V40, P655, DOI 10.1016/j.neuroimage.2007.11.058; Moncrieff J, 2010, PSYCHOL MED, V40, P1409, DOI 10.1017/S0033291709992297; Narr KL, 2005, CEREB CORTEX, V15, P708, DOI 10.1093/cercor/bhh172; Nesvag R, 2012, SCHIZOPHR RES, V142, P209, DOI 10.1016/j.schres.2012.10.004; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palaniyappan L, 2012, J PSYCHIATR NEUROSCI, V37, P399, DOI 10.1503/jpn.110119; Palaniyappan L, 2012, SCHIZOPHR RES, V137, P169, DOI 10.1016/j.schres.2012.01.038; Palaniyappan L, 2012, NEUROIMAGE, V60, P693, DOI 10.1016/j.neuroimage.2011.12.058; Park HJ, 2004, NEUROIMAGE, V22, P1231, DOI 10.1016/j.neuroimage.2004.03.009; Pletson JE, 2007, PSYCHOL SCHIZOPHRENI; Poulet E, 2005, BIOL PSYCHIAT, V57, P188, DOI 10.1016/j.biopsych.2004.10.007; Puri BK, 2011, EXPERT REV NEUROTHER, V11, P943, DOI [10.1586/ern.11.87, 10.1586/ERN.11.87]; Quarantelli M, 2002, NEUROIMAGE, V17, P373, DOI 10.1006/nimg.2002.1157; ROBBINS SM, 2004, ANATOMICAL STANDARDI, P315; Roiz-Santianez R, 2010, PSYCHIAT RES-NEUROIM, V182, P216, DOI 10.1016/j.pscychresns.2010.03.001; Sanfilipo M, 2000, ARCH GEN PSYCHIAT, V57, P471, DOI 10.1001/archpsyc.57.5.471; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Saxe R, 2006, PSYCHOL SCI, V17, P692, DOI 10.1111/j.1467-9280.2006.01768.x; Schultz CC, 2012, BIOL PSYCHIAT, V71, P146, DOI 10.1016/j.biopsych.2011.08.015; Schultz CC, 2010, SCHIZOPHR RES, V123, P137, DOI 10.1016/j.schres.2010.08.033; Schultz CC, 2010, SCHIZOPHR RES, V116, P204, DOI 10.1016/j.schres.2009.11.001; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Sigmundsson T, 2001, AM J PSYCHIAT, V158, P234, DOI 10.1176/appi.ajp.158.2.234; Silver M, 2011, NEUROIMAGE, V54, P992, DOI 10.1016/j.neuroimage.2010.08.049; Singh V, 2005, 11 ANN M ORG HUM BRA; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; Tang JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040247; Thacker NA, 2008, TURORIAL CRITICAL AN; TURETSKY B, 1995, ARCH GEN PSYCHIAT, V52, P1061; Venkatasubramanian G, 2008, ACTA PSYCHIAT SCAND, V117, P420, DOI 10.1111/j.1600-0447.2008.01198.x; Voineskos AN, 2013, JAMA PSYCHIAT, V6, P1; Wechsler D., 1997, WECHSLER ADULT INTEL; Wheeler DG, 2007, PROG NEURO-PSYCHOPH, V31, P319, DOI 10.1016/j.pnpbp.2006.09.009; Wible CG, 2012, SCHIZOPHR RES TREAT, V2012, DOI 10.1155/2012/920485; Williams Leanne M, 2008, Expert Rev Neurother, V8, P1049, DOI 10.1586/14737175.8.7.1049; Woods S.W., 2011, CHLORPROMAZINE EQUIV, P1; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; Zijdenbos AP, 2002, IEEE T MED IMAGING, V21, P1280, DOI 10.1109/TMI.2002.806283; Zink CF, 2008, NEURON, V58, P273, DOI 10.1016/j.neuron.2008.01.025	100	33	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101372	10.1371/journal.pone.0101372	http://dx.doi.org/10.1371/journal.pone.0101372			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979583	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400122
J	Lundholm, J; Heim, A; Tran, S; Smith, T				Lundholm, Jeremy; Heim, Amy; Tran, Stephanie; Smith, Tyler			Leaf and Life History Traits Predict Plant Growth in a Green Roof Ecosystem	PLOS ONE			English	Article							LAND-USE; FUNCTIONAL TYPES; PERFORMANCE; ECOLOGY; DEPTH	Green roof ecosystems are constructed to provide services such as stormwater retention and urban temperature reductions. Green roofs with shallow growing media represent stressful conditions for plant survival, thus plants that survive and grow are important for maximizing economic and ecological benefits. While field trials are essential for selecting appropriate green roof plants, we wanted to determine whether plant leaf traits could predict changes in abundance ( growth) to provide a more general framework for plant selection. We quantified leaf traits and derived life-history traits ( Grime's C-S-R strategies) for 13 species used in a four-year green roof experiment involving five plant life forms. Changes in canopy density in monocultures and mixtures containing one to five life forms were determined and related to plant traits using multiple regression. We expected traits related to stress-tolerance would characterize the species that best grew in this relatively harsh setting. While all species survived to the end of the experiment, canopy species diversity in mixture treatments was usually much lower than originally planted. Most species grew slower in mixture compared to monoculture, suggesting that interspecific competition reduced canopy diversity. Species dominant in mixture treatments tended to be fast-growing ruderals and included both native and non-native species. Specific leaf area was a consistently strong predictor of final biomass and the change in abundance in both monoculture and mixture treatments. Some species in contrasting life-form groups showed compensatory dynamics, suggesting that life-form mixtures can maximize resilience of cover and biomass in the face of environmental fluctuations. This study confirms that plant traits can be used to predict growth performance in green roof ecosystems. While rapid canopy growth is desirable for green roofs, maintenance of species diversity may require engineering of conditions that favor less aggressive species.	[Lundholm, Jeremy; Heim, Amy; Tran, Stephanie] St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada; [Lundholm, Jeremy; Heim, Amy; Tran, Stephanie] St Marys Univ, Dept Environm Sci, Halifax, NS B3H 3C3, Canada; [Smith, Tyler] Agr & Agri Food Canada, Eastern Cereal & Oilseen Resarch Ctr, Ottawa, ON, Canada	Saint Marys University - Canada; Saint Marys University - Canada; Agriculture & Agri Food Canada	Lundholm, J (corresponding author), St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada.	jlundholm@smu.ca		Smith, Tyler William/0000-0001-7683-2653	NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by an NSERC Discovery grant to J. Lundholm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boivin MA, 2001, HORTTECHNOLOGY, V11, P409, DOI 10.21273/HORTTECH.11.3.409; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Butler C, 2012, URBAN FOR URBAN GREE, V11, P1, DOI 10.1016/j.ufug.2011.11.002; Butler C, 2011, ECOL ENG, V37, P1796, DOI 10.1016/j.ecoleng.2011.06.025; Cook-Patton SC, 2012, J ENVIRON MANAGE, V106, P85, DOI 10.1016/j.jenvman.2012.04.003; Craine JM, 2002, FUNCT ECOL, V16, P563, DOI 10.1046/j.1365-2435.2002.00660.x; de Bello F, 2013, J ECOL, V101, P1237, DOI 10.1111/1365-2745.12139; Diaz S, 1997, J VEG SCI, V8, P463, DOI 10.2307/3237198; Dunnett N., 2004, PLANTING GREEN ROOFS; Dunnett Nigel, 2008, Urban Ecosystems, V11, P373, DOI 10.1007/s11252-007-0042-7; Eumorfopoulou E, 1998, ENERG BUILDINGS, V27, P29, DOI 10.1016/S0378-7788(97)00023-6; Farrell C, 2013, PLANT SOIL, V372, P177, DOI 10.1007/s11104-013-1725-x; FLOYD DA, 1987, J ECOL, V75, P221, DOI 10.2307/2260547; Gleason H.A., 1991, MANUAL VASCULAR PLAN, V2nd ed.; Grime JP, 1997, OIKOS, V79, P259, DOI 10.2307/3546011; GRIME JP, 1974, NATURE, V250, P26, DOI 10.1038/250026a0; Harper J. L., 1977, Population biology of plants.; Helsen K, 2012, OIKOS, V121, P2121, DOI 10.1111/j.1600-0706.2012.20499.x; Hodgson JG, 1999, OIKOS, V85, P282, DOI 10.2307/3546494; Kadas Gyongyver, 2006, Urban Habitats, V4, P66; Kohler M, 2010, ECOL ENG, V36, P722, DOI 10.1016/j.ecoleng.2009.12.019; Kohler M., 2006, URBAN HABITATS, V4, P3; Lundholm J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009677; MacIvor JS, 2011, ECOL ENG, V37, P407, DOI 10.1016/j.ecoleng.2010.10.004; McGuire KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058020; McIntyre S, 2008, AGR ECOSYST ENVIRON, V128, P251, DOI 10.1016/j.agee.2008.06.015; Monterusso MA, 2005, HORTSCIENCE, V40, P391, DOI 10.21273/HORTSCI.40.2.391; Gross N, 2007, J VEG SCI, V18, P289, DOI 10.1111/j.1654-1103.2007.tb02540.x; Oberndorfer EC, 2009, BIODIVERS CONSERV, V18, P1523, DOI 10.1007/s10531-008-9539-5; Owen E., 1998, ROLANDS FLORA NOVA S; Quested H, 2007, FUNCT ECOL, V21, P1016, DOI 10.1111/j.1365-2435.2007.01324.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ranalli M., 2008, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V3, DOI 10.1079/PAVSNNR20083034; Ranalli M, 2008, 6 N AM GREEN ROOF C; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Reich PB, 2014, J ECOL, V102, P275, DOI 10.1111/1365-2745.12211; Rowe DB, 2012, LANDSCAPE URBAN PLAN, V104, P310, DOI 10.1016/j.landurbplan.2011.11.010; Speak AF, 2013, URBAN CLIM, V3, P40, DOI 10.1016/j.uclim.2013.01.001; VanWoert ND, 1995, J ENVIRON QUAL, V34, P1036; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729	41	29	31	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101395	10.1371/journal.pone.0101395	http://dx.doi.org/10.1371/journal.pone.0101395			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978031	Green Submitted, gold, Green Published			2022-12-27	WOS:000338506400127
J	Martins, R; Simard, F; Monchi, O				Martins, Ruben; Simard, France; Monchi, Oury			Differences between Patterns of Brain Activity Associated with Semantics and Those Linked with Phonological Processing Diminish with Age	PLOS ONE			English	Article							WORKING-MEMORY; FRONTAL-CORTEX; OLDER-ADULTS; AGING BRAIN; LANGUAGE; ACTIVATION; COMPREHENSION; PERFORMANCE; TASK; SET	It is widely believed that language function tends to show little age-related performance decline. Indeed, some older individuals seem to use compensatory mechanisms to maintain a high level of performance when submitted to lexical tasks. However, how these mechanisms affect cortical and subcortical activity during semantic and phonological processing has not been extensively explored. The purpose of this study was to look at the effect of healthy aging on cortico-subcortical routes related to semantic and phonological processing using a lexical analogue of the Wisconsin Cart-Sorting Task. Our results indicate that while young adults tend to show increased activity in the ventrolateral prefrontal cortex, the dorsolateral prefrontal cortex, the fusiform gyrus, the ventral temporal lobe and the caudate nucleus during semantic decisions and in the posterior Broca's area (area 44), the temporal lobe (area 37), the temporoparietal junction (area 40) and the motor cortical regions during phonological decisions, older individuals showed increased activity in the dorsolateral prefrontal cortex and motor cortical regions during both semantic and phonological decisions. Furthermore, when semantic and phonological decisions were contrasted with each other, younger individuals showed significant brain activity differences in several regions while older individuals did not. Therefore, in older individuals, the semantic and phonological routes seem to merge into a single pathway. These findings represent most probably neural reserve/compensation mechanisms, characterized by a decrease in specificity, on which the elderly rely to maintain an adequate level of performance.	[Martins, Ruben; Monchi, Oury] Inst Univ Geriatrie Montreal, Ctr Rech, Montreal, PQ, Canada; [Monchi, Oury] Univ Montreal, Fac Med, Dept Radiol, Montreal, PQ H3C 3J7, Canada; [Simard, France] Univ Quebec, Dept Kinanthropol, Montreal, PQ H3C 3P8, Canada	Universite de Montreal; Universite de Montreal; University of Quebec; University of Quebec Montreal	Monchi, O (corresponding author), Inst Univ Geriatrie Montreal, Ctr Rech, Montreal, PQ, Canada.	oury.monchi@umontreal.ca	Monchi, Oury/N-8417-2019		Natural Sciences and Engineering Research Council of Canada [RGPIN: 327518]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by an individual Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (RGPIN: 327518) to OM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansado J, 2013, EUR J NEUROSCI, V37, P1887, DOI 10.1111/ejn.12252; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bonin P, 2003, BEHAV RES METH INS C, V35, P158, DOI 10.3758/BF03195507; Burke DM, 2000, DEBATES PSYCHOL, P204; Burke DM, 2008, HDB AGEING COGNITION, P373; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Cabeza R., 2004, COGNITIVE NEUROSCIEN, P3; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; DEMONET JF, 1994, NEUROSCI LETT, V182, P25, DOI 10.1016/0304-3940(94)90196-1; Dennis N. A., 2008, HDB AGING COGNITION, P1, DOI DOI 10.4324/9780203837665.CH1; Devlin JT, 2008, NEURAL CORRELATES TH, pxv; Duffau H, 2005, BRAIN, V128, P797, DOI 10.1093/brain/awh423; Duffau H, 2008, NEUROPSYCHOLOGIA, V46, P3197, DOI 10.1016/j.neuropsychologia.2008.07.017; FIEZ JA, 1995, J COGNITIVE NEUROSCI, V7, P357, DOI 10.1162/jocn.1995.7.3.357; Fristoe NM, 1997, NEUROPSYCHOLOGY, V11, P428, DOI 10.1037/0894-4105.11.3.428; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; GRADY CL, 1994, J NEUROSCI, V14, P1450, DOI 10.1523/JNEUROSCI.14-03-01450.1994; Grady CL, 2005, NEUROPSYCHOLOGIA, V43, P1466, DOI 10.1016/j.neuropsychologia.2004.12.016; Grossman M, 2002, BRAIN LANG, V80, P296, DOI 10.1006/brln.2001.2581; Hampshire A, 2008, J COGNITIVE NEUROSCI, V20, P1670, DOI 10.1162/jocn.2008.20115; Hazlett EA, 1998, NEUROBIOL AGING, V19, P437, DOI 10.1016/S0197-4580(98)00075-X; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Humphries C, 2006, J COGNITIVE NEUROSCI, V18, P665, DOI 10.1162/jocn.2006.18.4.665; Ivnik RJ, 1996, CLIN NEUROPSYCHOL, V10, P262, DOI 10.1080/13854049608406689; Jonides J, 1998, J NEUROSCI, V18, P5026; Just MA, 1996, SCIENCE, V274, P114, DOI 10.1126/science.274.5284.114; Kemper S, 2001, PSYCHOL AGING, V16, P312, DOI 10.1037//0882-7974.16.2.312; Madden DJ, 1997, HUM BRAIN MAPP, V5, P389, DOI 10.1002/(SICI)1097-0193(1997)5:6<389::AID-HBM1>3.0.CO;2-#; Martins R, 2012, CEREB CORTEX, V22, P1395, DOI 10.1093/cercor/bhr222; Monchi O, 2001, J NEUROSCI, V21, P7733, DOI 10.1523/JNEUROSCI.21-19-07733.2001; Monchi O, 2004, J NEUROSCI, V24, P702, DOI 10.1523/JNEUROSCI.4860-03.2004; New B, 2004, BEHAV RES METH INS C, V36, P516, DOI 10.3758/BF03195598; Nixon P, 2004, J COGNITIVE NEUROSCI, V16, P289, DOI 10.1162/089892904322984571; Obler LK, 2010, BRAIN LANG, V113, P113, DOI [10.1016/j.band1.2010.03.001, 10.1016/j.bandl.2010.03.001]; Parkin AJ, 1999, NEUROPSYCHOLOGY, V13, P539, DOI 10.1037/0894-4105.13.4.539; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Paulesu E, 1997, NEUROREPORT, V8, P2011, DOI 10.1097/00001756-199705260-00042; Persson J, 2004, NEUROIMAGE, V23, P1382, DOI 10.1016/j.neuroimage.2004.08.004; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; Price CJ, 1998, TRENDS COGN SCI, V2, P281, DOI 10.1016/S1364-6613(98)01201-7; Resnick SM, 2003, J NEUROSCI, V23, P3295; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; Seghier ML, 2004, HUM BRAIN MAPP, V23, P140, DOI 10.1002/hbm.20053; Shafto MA, 2007, J COGNITIVE NEUROSCI, V19, P2060, DOI 10.1162/jocn.2007.19.12.2060; Simard F, 2011, NEW LEXICAL CARD SOR; Simard F, 2011, CEREB CORTEX, V21, P1084, DOI 10.1093/cercor/bhq182; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Stromswold K, 1996, BRAIN LANG, V52, P452, DOI 10.1006/brln.1996.0024; Talairach J., 1988, COPLANAR STEREOTAXIC; Tyler LK, 2010, CEREB CORTEX, V20, P352, DOI 10.1093/cercor/bhp105; Van der Linden M, 1999, AGING NEUROPSYCHOL C, V6, P32, DOI 10.1076/anec.6.1.32.791; Verhaeghen P, 2003, PSYCHOL AGING, V18, P332, DOI 10.1037/0882-7974.18.2.332; Waters G, 2005, MEMORY, V13, P403, DOI 10.1080/09658210344000459; Weissman DH, 2005, CEREB CORTEX, V15, P229, DOI 10.1093/cercor/bhh125; Wierenga CE, 2008, NEUROBIOL AGING, V29, P436, DOI 10.1016/j.neurobiolaging.2006.10.024; Wingfield A, 2006, J NEUROPHYSIOL, V96, P2830, DOI 10.1152/jn.00628.2006; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933; Worsley KJ, 2005, NEUROIMAGE, V28, P1056, DOI 10.1016/j.neuroimage.2005.06.053; Zarahn E, 2007, NEUROBIOL AGING, V28, P784, DOI 10.1016/j.neurobiolaging.2006.03.002	63	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e99710	10.1371/journal.pone.0099710	http://dx.doi.org/10.1371/journal.pone.0099710			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK6BK	24972020	Green Submitted, Green Published, gold			2022-12-27	WOS:000338512200012
J	Ariel, G; Ophir, Y; Levi, S; Ben-Jacob, E; Ayali, A				Ariel, Gil; Ophir, Yotam; Levi, Sagi; Ben-Jacob, Eshel; Ayali, Amir			Individual Pause-and-Go Motion Is Instrumental to the Formation and Maintenance of Swarms of Marching Locust Nymphs	PLOS ONE			English	Article							COLLECTIVE MOTION; STOCHASTICITY; CANNIBALISM; RESPONSES; MOVEMENT; NEURON; SYSTEM; NOISE; FIELD; DCMD	The principal interactions leading to the emergence of order in swarms of marching locust nymphs was studied both experimentally, using small groups of marching locusts in the lab, and using computer simulations. We utilized a custom tracking algorithm to reveal fundamental animal-animal interactions leading to collective motion. Uncovering this behavior introduced a new agent-based modeling approach in which pause-and-go motion is pivotal. The behavioral and modeling findings are largely based on motion-related visual sensory inputs obtained by the individual locust. Results suggest a generic principle, in which intermittent animal motion can be considered as a sequence of individual decisions as animals repeatedly reassess their situation and decide whether or not to swarm. This interpretation implies, among other things, some generic characteristics regarding the build-up and emergence of collective order in swarms: in particular, that order and disorder are generic meta-stable states of the system, suggesting that the emergence of order is kinetic and does not necessarily require external environmental changes. This work calls for further experimental as well as theoretical investigation of the neural mechanisms underlying locust coordinative behavior.	[Ariel, Gil; Levi, Sagi] Bar Ilan Univ, Dept Math, Ramat Gan, Israel; [Ophir, Yotam; Ayali, Amir] Tel Aviv Univ, Dept Zool, Fac Life Sci, IL-69978 Tel Aviv, Israel; [Ben-Jacob, Eshel] Tel Aviv Univ, Sackler Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Ben-Jacob, Eshel] Rice Univ, Ctr Theoret Biol Phys, Houston, TX USA; [Ben-Jacob, Eshel; Ayali, Amir] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	Bar Ilan University; Tel Aviv University; Tel Aviv University; Rice University; Tel Aviv University	Ariel, G (corresponding author), Bar Ilan Univ, Dept Math, Ramat Gan, Israel.	arielg@math.biu.ac.il; ayali@post.tau.ac.il	Ayali, Amir/B-1050-2008	Ayali, Amir/0000-0001-6152-2927	EU Marie-Curie IRG grant; Tauber Family Foundation; Maguy-Glass Chair in Physics of Complex Systems at Tel Aviv University; Center for Theoretical Biological Physics - NSF at Rice University [PHY-1308264]; Israel's Ministry of Agriculture [891-0277-13]; Israel Science Foundation [792/12]	EU Marie-Curie IRG grant; Tauber Family Foundation; Maguy-Glass Chair in Physics of Complex Systems at Tel Aviv University; Center for Theoretical Biological Physics - NSF at Rice University; Israel's Ministry of Agriculture; Israel Science Foundation(Israel Science Foundation)	GA's research has been partially supported by an EU Marie-Curie IRG grant. EBJ's research has been supported by the Tauber Family Foundation and the Maguy-Glass Chair in Physics of Complex Systems at Tel Aviv University, and the Center for Theoretical Biological Physics sponsored by the NSF (Grant PHY-1308264) at Rice University. AA's research has been supported by grant no. 891-0277-13 from Israel's Ministry of Agriculture. AA would like to thank the Israel Science Foundation, grant 792/12, for partial support of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Bazazi S, 2008, CURR BIOL, V18, P735, DOI 10.1016/j.cub.2008.04.035; Bazazi S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002498; Bazazi S, 2011, P ROY SOC B-BIOL SCI, V278, P356, DOI 10.1098/rspb.2010.1447; Ben-Jacob E, 2012, TRENDS MICROBIOL, V20, P403, DOI 10.1016/j.tim.2012.06.001; Beni G, 1993, ROBOTS BIOL SYSTEMS, V102, P703, DOI [DOI 10.1007/978-3-642-58069-7_38, 10.1007/978-3-642-58069-7, DOI 10.1007/978-3-642-58069-7]; Bhattacharya K, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/9/093019; Bode NWF, 2010, J THEOR BIOL, V267, P292, DOI 10.1016/j.jtbi.2010.08.034; Bonabeau E, 1999, SWARM INTELLIGENCE N, V4; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Buhl J, 2011, BEHAV ECOL SOCIOBIOL, V65, P265, DOI 10.1007/s00265-010-1041-x; Dick PC, 2014, J NEUROPHYSIOL, V111, P1736, DOI 10.1152/jn.00499.2013; Dorigo M, 2004, AUTON ROBOT, V17, P111, DOI 10.1023/B:AURO.0000034008.48988.2b; Edelstein-Keshet L, 1998, J MATH BIOL, V36, P515, DOI 10.1007/s002850050112; Ellis P. E., 1964, Behaviour, V23, P193, DOI 10.1163/156853964X00148; Ellis PE, 1951, ANTILOCUST B, P7; Fish Frank E., 2010, P90, DOI 10.1201/b10190-5; Fuchs E, 2003, J NEUROBIOL, V57, P152, DOI 10.1002/neu.10261; Gabbiani F, 1999, J NEUROSCI, V19, P1122; Hansen MJ, 2011, BEHAV ECOL SOCIOBIOL, V65, P1715, DOI 10.1007/s00265-011-1179-1; Helbing D, 2001, REV MOD PHYS, V73, P1067, DOI 10.1103/RevModPhys.73.1067; Hemelrijk CK, 2012, INTERFACE FOCUS, V2, P726, DOI 10.1098/rsfs.2012.0025; Huepe C, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.168701; Judge SJ, 1997, J EXP BIOL, V200, P2209; Klarreich E, 2006, SCI NEWS, V170, P347; Kolpas A, 2007, P NATL ACAD SCI USA, V104, P5931, DOI 10.1073/pnas.0608270104; Kramer DL, 2001, AM ZOOL, V41, P137, DOI 10.1668/0003-1569(2001)041[0137:TBEOIL]2.0.CO;2; Matheson T, 2004, J NEUROPHYSIOL, V91, P1, DOI 10.1152/jn.00795.2003; OBRIEN WJ, 1990, AM SCI, V78, P152; Pener MP, 2009, ADV INSECT PHYSIOL, V36, P1, DOI 10.1016/S0065-2806(08)36001-9; Ribak G, 2012, J COMP PHYSIOL A, V198, P541, DOI 10.1007/s00359-012-0728-z; RIND FC, 1992, J NEUROPHYSIOL, V68, P1654, DOI 10.1152/jn.1992.68.5.1654; Simmons PJ, 2013, J EXP BIOL, V216, P2266, DOI 10.1242/jeb.083360; Simpson SJ, 1999, BIOL REV, V74, P461, DOI 10.1017/S000632319900540X; Toner J, 2005, ANN PHYS-NEW YORK, V318, P170, DOI 10.1016/j.aop.2005.04.011; Topaz CM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002642; Tunstrom K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002915; Uvarov B. P., 1921, Bulletin of Entomological Research London, V12, P135, DOI 10.1017/S0007485300044989; Uvarov BP, 1966, HDB GEN ACRIDOLOGY, V1; Verlinden H, 2009, GEN COMP ENDOCR, V162, P79, DOI 10.1016/j.ygcen.2008.11.016; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Yates CA, 2009, P NATL ACAD SCI USA, V106, P5464, DOI 10.1073/pnas.0811195106	43	19	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101636	10.1371/journal.pone.0101636	http://dx.doi.org/10.1371/journal.pone.0101636			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988464	gold, Green Published, Green Submitted			2022-12-27	WOS:000341354100123
J	Dijkstra, N; Kraal, P; Kuypers, MMM; Schnetger, B; Slomp, CP				Dijkstra, Nikki; Kraal, Peter; Kuypers, Marcel M. M.; Schnetger, Bernhard; Slomp, Caroline P.			Are Iron-Phosphate Minerals a Sink for Phosphorus in Anoxic Black Sea Sediments?	PLOS ONE			English	Article							AUTHIGENIC APATITE FORMATION; ANAEROBIC METHANE OXIDATION; WATER-COLUMN ANOXIA; ORGANIC-MATTER; SULFATE REDUCTION; MARINE-SEDIMENTS; CARBON; PRESERVATION; BURIAL; ZONE	Phosphorus (P) is a key nutrient for marine organisms. The only long-term removal pathway for P in the marine realm is burial in sediments. Iron (Fe) bound P accounts for a significant proportion of this burial at the global scale. In sediments underlying anoxic bottom waters, burial of Fe-bound P is generally assumed to be negligible because of reductive dissolution of Fe(III) (oxyhydr) oxides and release of the associated P. However, recent work suggests that Fe-bound P is an important burial phase in euxinic (i.e. anoxic and sulfidic) basin sediments in the Baltic Sea. In this study, we investigate the role of Fe-bound P as a potential sink for P in Black Sea sediments overlain by oxic and euxinic bottom waters. Sequential P extractions performed on sediments from six multicores along two shelf-to-basin transects provide evidence for the burial of Fe-bound P at all sites, including those in the euxinic deep basin. In the latter sediments, Fe-bound P accounts for more than 20% of the total sedimentary P pool. We suggest that this P is present in the form of reduced Fe-P minerals. We hypothesize that these minerals may be formed as inclusions in sulfur-disproportionating Deltaproteobacteria. Further research is required to elucidate the exact mineral form and formation mechanism of this P burial phase, as well as its role as a sink for P in sulfide-rich marine sediments.	[Dijkstra, Nikki; Kraal, Peter; Slomp, Caroline P.] Univ Utrecht, Fac Geosci, Dept Earth Sci Geochem, Utrecht, Netherlands; [Kuypers, Marcel M. M.] Max Planck Inst Marine Microbiol, Dept Biogeochem, Bremen, Germany; [Schnetger, Bernhard] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, D-26111 Oldenburg, Germany	Utrecht University; Max Planck Society; Carl von Ossietzky Universitat Oldenburg	Dijkstra, N (corresponding author), Univ Utrecht, Fac Geosci, Dept Earth Sci Geochem, Utrecht, Netherlands.	n.dijkstra@uu.nl	Slomp, Caroline P/A-9406-2012; Kraal, Peter/H-4899-2019	Slomp, Caroline P/0000-0002-7272-0109; Schnetger, Bernhard/0000-0003-1638-3977; Kraal, Peter/0000-0002-6650-5680	Netherlands Organisation for Scientific Research (NWO) [86405.004, 822.01013]; Max-Planck-Gesellschaft; European Research Council under the European Community [278364]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Max-Planck-Gesellschaft(Max Planck Society); European Research Council under the European Community(European Research Council (ERC))	This research was funded by the Netherlands Organisation for Scientific Research (NWO Vidi grant 86405.004 and Open Competition grant 822.01013), the Max-Planck-Gesellschaft and the European Research Council under the European Community's Seventh Framework Programme for ERC Starting Grant #278364 to C.P. Slomp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algeo TJ, 2007, PALAEOGEOGR PALAEOCL, V256, P130, DOI 10.1016/j.palaeo.2007.02.029; Arthur MA, 1998, PALEOCEANOGRAPHY, V13, P395, DOI 10.1029/98PA01161; Basen M, 2011, ENVIRON MICROBIOL, V13, P1370, DOI 10.1111/j.1462-2920.2011.02443.x; Byrne ME, 2010, P NATL ACAD SCI USA, V107, P12263, DOI 10.1073/pnas.1001290107; CANFIELD DE, 1992, AM J SCI, V292, P659, DOI 10.2475/ajs.292.9.659; CLINE JD, 1969, ENVIRON SCI TECHNOL, V3, P838, DOI 10.1021/es60032a004; Creveling JR, 2014, GEOL SOC AM BULL, V126, P145, DOI 10.1130/B30819.1; Delaney ML, 1998, GLOBAL BIOGEOCHEM CY, V12, P563, DOI 10.1029/98GB02263; Dellwig O, 2010, GEOCHIM COSMOCHIM AC, V74, P7100, DOI 10.1016/j.gca.2010.09.017; Foncelius S.H., 1974, BLACK SEA GEOLOGY CH, P144; FROELICH PN, 1982, AM J SCI, V282, P474, DOI 10.2475/ajs.282.4.474; Gieskes J, 1986, WATER CHEM PROCEDURE; Goldhammer T, 2010, NAT GEOSCI, V3, P557, DOI [10.1038/ngeo913, 10.1038/NGEO913]; Harrison BK, 2009, APPL ENVIRON MICROB, V75, P1487, DOI 10.1128/AEM.01812-08; Ingall E, 1997, MAR GEOL, V139, P219, DOI 10.1016/S0025-3227(96)00112-0; INGALL ED, 1993, GEOCHIM COSMOCHIM AC, V57, P303, DOI 10.1016/0016-7037(93)90433-W; Jilbert T, 2011, BIOGEOSCIENCES, V8, P1699, DOI 10.5194/bg-8-1699-2011; Jilbert T, 2013, GEOCHIM COSMOCHIM AC, V107, P155, DOI 10.1016/j.gca.2013.01.005; Jorgensen BB, 2001, DEEP-SEA RES PT I, V48, P2097, DOI 10.1016/S0967-0637(01)00007-3; Kraal P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096859; Kraal P, 2010, CHEM GEOL, V277, P167, DOI 10.1016/j.chemgeo.2010.08.003; Kraal P, 2009, GEOCHIM COSMOCHIM AC, V73, P3277, DOI 10.1016/j.gca.2009.02.026; Lefevre CT, 2009, ENVIRON MICROBIOL, V11, P1646, DOI 10.1111/j.1462-2920.2009.01887.x; Lukkari K, 2009, BIOGEOCHEMISTRY, V94, P141, DOI 10.1007/s10533-009-9315-y; Lyons T.W, 1991, BLACK SEA OCEANOGRAP, V4, P401, DOI DOI 10.1007/978-94-011-2608-3_25; Lyons TW, 2006, GEOCHIM COSMOCHIM AC, V70, P5698, DOI 10.1016/j.gca.2006.08.021; Marz C, 2008, MAR GEOL, V255, P118, DOI 10.1016/j.margeo.2008.05.013; Milucka J, 2012, NATURE, V491, P541, DOI 10.1038/nature11656; Moodley L, 2005, GEOLOGY, V33, P889, DOI 10.1130/G21731.1; MOORE PB, 1971, AM MINERAL, V56, P1; Mort HP, 2010, GEOCHIM COSMOCHIM AC, V74, P1350, DOI 10.1016/j.gca.2009.11.016; NEMBRINI GP, 1983, GEOCHIM COSMOCHIM AC, V47, P1459, DOI 10.1016/0016-7037(83)90304-6; Ozsoy E, 1997, EARTH-SCI REV, V42, P231, DOI 10.1016/S0012-8252(97)81859-4; POLAT SC, 1995, CONT SHELF RES, V15, P1115; Poulton SW, 2005, CHEM GEOL, V214, P209, DOI 10.1016/j.chemgeo.2004.09.003; Raiswell R, 2012, GEOCHEM PERSPECT, V1, P1, DOI 10.7185/geochempersp.1.1; REDFIELD AC, 1958, AM SCI, V46, P205; Reed DC, 2011, LIMNOL OCEANOGR, V56, P1075, DOI 10.4319/lo.2011.56.3.1075; Reichart GJ, 1997, PALAEOGEOGR PALAEOCL, V134, P149, DOI 10.1016/S0031-0182(97)00071-0; Reitner J, 2005, PALAEOGEOGR PALAEOCL, V227, P18, DOI 10.1016/j.palaeo.2005.04.033; Ross D., 1974, BLACK SEA GEOLOGY CH, P183; ROUZIES D, 1993, HYPERFINE INTERACT, V77, P19, DOI 10.1007/BF02320295; RUTTENBERG KC, 1993, GEOCHIM COSMOCHIM AC, V57, P991, DOI 10.1016/0016-7037(93)90035-U; RUTTENBERG KC, 1992, LIMNOL OCEANOGR, V37, P1460, DOI 10.4319/lo.1992.37.7.1460; Sarazin G, 1999, WATER RES, V33, P290, DOI 10.1016/S0043-1354(98)00168-7; Schulz HN, 2005, SCIENCE, V307, P416, DOI 10.1126/science.1103096; Seeberg-Elverfeldt J, 2005, LIMNOL OCEANOGR-METH, V3, P361, DOI 10.4319/lom.2005.3.361; SHAFFER G, 1986, NATURE, V321, P515, DOI 10.1038/321515a0; Slomp CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062386; Slomp CP, 1996, J MAR RES, V54, P1179, DOI 10.1357/0022240963213745; Strickland TDH, 1972, PRACTICAL HDB SEAWAT; Strokal M, 2013, REG ENVIRON CHANGE, V13, P179, DOI 10.1007/s10113-012-0328-z; Teodoru CR, 2007, MAR CHEM, V105, P52, DOI 10.1016/j.marchem.2006.12.013; TUREKIAN KK, 1961, GEOL SOC AM BULL, V72, P175, DOI 10.1130/0016-7606(1961)72[175:DOTEIS]2.0.CO;2; Van Santvoort PJM, 2002, AQUAT GEOCHEM, V8, P153, DOI 10.1023/A:1024271706896; Zaitsev Y.P., 1997, MARINE BIOL DIVERSIT; Zhu KL, 2010, RES MICROBIOL, V161, P276, DOI 10.1016/j.resmic.2010.02.003	58	39	40	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101139	10.1371/journal.pone.0101139	http://dx.doi.org/10.1371/journal.pone.0101139			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988389	Green Submitted, gold, Green Published			2022-12-27	WOS:000341354100065
J	Lahti, J; Holstila, A; Lahelma, E; Rahkonen, O				Lahti, Jouni; Holstila, Ansku; Lahelma, Eero; Rahkonen, Ossi			Leisure-Time Physical Activity and All-Cause Mortality	PLOS ONE			English	Article							HEALTH BEHAVIORS; COHORT; INTENSITY; CANCER; MEN; METAANALYSIS; FINLAND; DOMAINS; IMPACT; WOMEN	Background: Physical inactivity is a major public health problem associated with increased mortality risk. It is, however, poorly understood whether vigorous physical activity is more beneficial for reducing mortality risk than activities of lower intensity. The aim of this study was to examine associations of the intensity and volume of leisure-time physical activity with all-cause mortality among middle-aged women and men while considering sociodemographic and health related factors as covariates. Methods: Questionnaire survey data collected in 2000-02 among 40-60-year-old employees of the City of Helsinki (N = 8960) were linked with register data on mortality (74% gave permission to the linkage) providing a mean follow-up time of 12-years. The analysis included 6429 respondents (79% women). The participants were classified into three groups according to intensity of physical activity: low moderate, high moderate and vigorous. The volume of physical activity was classified into three groups according to tertiles. Cox regression analysis was used to calculate hazard ratios (HR) and 95% confidence intervals (CIs) for all-cause mortality. Results: During the follow up 205 participants died. Leisure-time physical activity was associated with reduced risk of mortality. After adjusting for covariates the vigorous group (HR = 0.54, 95% CI 0.34-0.86) showed a reduced risk of mortality compared with the low moderate group whereas for the high moderate group the reductions in mortality risk (HR = 0.72, 95% CI 0.48-1.08) were less clear. Adjusting for the volume of physical activity did not affect the point estimates. Higher volume of leisure-time physical activity was also associated with reduced mortality risk; however, adjusting for the covariates and the intensity of physical activity explained the differences. Conclusions: For healthy middle-aged women and men who engage in some physical activity vigorous exercise may provide further health benefits preventing premature deaths.	[Lahti, Jouni; Holstila, Ansku; Lahelma, Eero; Rahkonen, Ossi] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland	University of Helsinki	Lahti, J (corresponding author), Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland.	jouni.mm.lahti@helsinki.fi	Lahelma, Eero/ABC-8716-2020; Lahti, Jouni/AAG-1771-2020	Lahelma, Eero/0000-0002-1064-1333; Rahkonen, Ossi/0000-0002-7202-3274	University of Helsinki; Ministry of Education and Culture [6303383]; Juho Vainio Foundation [4702850]; Academy of Finland [1257362]	University of Helsinki; Ministry of Education and Culture; Juho Vainio Foundation; Academy of Finland(Academy of Finland)	The study was funded by the University of Helsinki (www.helsinki.fi/university/), theMinistry of Education and Culture (www.minedu.fi/OPM/?lang = en) grant #6303383, the Juho Vainio Foundation (www.juhovainionsaatio.fi/pages/in-english/home.php) grant #4702850 and the Academy of Finland (www.aka.fi/en-GB/A/) grant #1257362. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093; Friedenreich CM, 2002, J NUTR, V132, p3456S, DOI 10.1093/jn/132.11.3456S; Janssen I, 2012, INT J EPIDEMIOL, V41, P1132, DOI 10.1093/ije/dys038; Johnsen NF, 2013, EPIDEMIOLOGY, V24, P717, DOI 10.1097/EDE.0b013e31829e3dda; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Kujala UM, 1998, JAMA-J AM MED ASSOC, V279, P440, DOI 10.1001/jama.279.6.440; Laaksonen M, 2001, EUR J PUBLIC HEALTH, V11, P294, DOI 10.1093/eurpub/11.3.294; Laaksonen M, 2008, J CLIN EPIDEMIOL, V61, P900, DOI 10.1016/j.jclinepi.2007.09.010; Lahelma E, 2005, EUR J PUBLIC HEALTH, V15, P504, DOI 10.1093/eurpub/cki022; Lahelma E, 2013, INT J EPIDEMIOL, V42, P722, DOI 10.1093/ije/dys039; Lahti J, 2010, SCAND J MED SCI SPOR, V20, P191, DOI 10.1111/j.1600-0838.2009.00886.x; Lahti J, 2010, PREV MED, V50, P246, DOI 10.1016/j.ypmed.2010.02.007; Lee IM, 2000, AM J EPIDEMIOL, V151, P293, DOI 10.1093/oxfordjournals.aje.a010205; Martinez-Gonzalez MA, 2001, MED SCI SPORT EXER, V33, P1142, DOI 10.1097/00005768-200107000-00011; Monninkhof EM, 2007, EPIDEMIOLOGY, V18, P137, DOI 10.1097/01.ede.0000251167.75581.98; Moore SC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001335; Official Statistics of Finland (OSF), 2013, CAUS DEATH; PEKKANEN J, 1995, BRIT MED J, V311, P589, DOI 10.1136/bmj.311.7005.589; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Roshanaei-Moghaddam B, 2009, GEN HOSP PSYCHIAT, V31, P306, DOI 10.1016/j.genhosppsych.2009.04.002; Sabia S, 2012, AM J PUBLIC HEALTH, V102, P698, DOI 10.2105/AJPH.2011.300257; Samitz G, 2011, INT J EPIDEMIOL, V40, P1382, DOI 10.1093/ije/dyr112; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; SCHOFIELD A, 1988, BRIT J ADDICT, V83, P761; Slattery ML, 2004, SPORTS MED, V34, P239, DOI 10.2165/00007256-200434040-00004; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; Tanasescu N, 2002, JAMA-J AM MED ASSOC, V288, P1994, DOI 10.1001/jama.288.16.1994; van Poppel MNM, 2010, SPORTS MED, V40, P565, DOI 10.2165/11531930-000000000-00000; Ware J., 1993, SF 36 HLTH SURVEY MA; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104	31	34	34	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101548	10.1371/journal.pone.0101548	http://dx.doi.org/10.1371/journal.pone.0101548			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BA	24988295	gold, Green Published, Green Submitted			2022-12-27	WOS:000341354100112
J	Li, J; Shen, FH; Guan, CW; Wang, WW; Sun, XZ; Fu, XL; Huang, M; Jin, J; Huang, ZY				Li, Jia; Shen, Feihai; Guan, Cuiwen; Wang, Wenwen; Sun, Xiaozhe; Fu, Xinlu; Huang, Min; Jin, Jing; Huang, Zhiying			Activation of Nrf2 Protects against Triptolide-Induced Hepatotoxicity	PLOS ONE			English	Article							TRIPTERYGIUM-WILFORDII; CARBON-TETRACHLORIDE; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; SULFORAPHANE; CYTOTOXICITY; PATHWAY; CELLS; RATS	Triptolide, the major active component of Tripterygium wilfordii Hook f. (TWHF), has a wide range of pharmacological activities. However, the toxicities of triptolide, particularly the hepatotoxicity, limit its clinical application. The hepatotoxicity of triptolide has not been well characterized yet. The aim of this study was to investigate the role of NF-E2-related factor 2 (Nrf2) in triptolide-induced toxicity and whether activation of Nrf2 could protect against triptolide-induced hepatotoxicity. The results showed that triptolide caused oxidative stress and cell damage in HepG2 cells, and these toxic effects could be aggravated by Nrf2 knockdown or be counteracted by overexpression of Nrf2. Treatment with a typical Nrf2 agonist, sulforaphane (SFN), attenuated triptolide-induced liver dysfunction, structural damage, glutathione depletion and decrease in antioxidant enzymes in BALB/C mice. Moreover, the hepatoprotective effect of SFN on triptolide-induced liver injury was associated with the activation of Nrf2 and its downstream targets. Collectively, these results indicate that Nrf2 activation protects against triptolide-induced hepatotoxicity.	[Li, Jia; Shen, Feihai; Guan, Cuiwen; Wang, Wenwen; Sun, Xiaozhe; Huang, Min; Jin, Jing; Huang, Zhiying] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China; [Li, Jia] Guangzhou Med Univ, Affiliated Canc Hosp, Dept Pharmaceut, Guangzhou, Guangdong, Peoples R China; [Fu, Xinlu; Huang, Zhiying] Sun Yat Sen Univ, Ctr Lab Anim, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Guangzhou Medical University; Sun Yat Sen University	Jin, J (corresponding author), Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China.	jinjing@mail.sysu.edu.cn; hzhiying@mail.sysu.edu.cn			Natural Science Foundation of China [81102886]; National Science and Technology Pillar Program of China [2008BAI55B03]; Guangzhou Medical University	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Pillar Program of China; Guangzhou Medical University	This study was supported by grants obtained from the Natural Science Foundation of China (Grant: 81102886), the Key Projects in the National Science and Technology Pillar Program of China (Grant No. 2008BAI55B03), and the Doctor's Startup Project of Guangzhou Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek SH, 2008, BIOSCI BIOTECH BIOCH, V72, P1176, DOI 10.1271/bbb.70545; Baird L, 2011, ARCH TOXICOL, V85, P241, DOI 10.1007/s00204-011-0674-5; Balasubramanian Thirumalaiswamy, 2013, J Tradit Complement Med, V3, P175, DOI 10.4103/2225-4110.114904; Chae HJ, 2014, NUTR RES PRACT, V8, P40, DOI 10.4162/nrp.2014.8.1.40; Choi C, 2003, BIOSCI BIOTECH BIOCH, V67, P1916, DOI 10.1271/bbb.67.1916; Curtis DK, 2010, TOXICOL APPL PHARM, V244, P57; Guerrero-Beltran CE, 2012, EXP TOXICOL PATHOL, V64, P503, DOI 10.1016/j.etp.2010.11.005; Guerrero-Beltran CE, 2010, TOXICOL LETT, V192, P278, DOI 10.1016/j.toxlet.2009.11.007; Fu Q, 2011, FITOTERAPIA, V82, P1241, DOI 10.1016/j.fitote.2011.08.019; GUO J, 1981, CHINESE MED J-PEKING, V94, P405; Hong D, 2004, CHINESE HERBAL MED, V27, P115; Kang KW, 2005, ANTIOXID REDOX SIGN, V7, P1664, DOI 10.1089/ars.2005.7.1664; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; KUPCHAN SM, 1972, J AM CHEM SOC, V94, P7194, DOI 10.1021/ja00775a078; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Li J, 2012, TOXICOL LETT, V213, P194, DOI 10.1016/j.toxlet.2012.07.008; Li L S, 1982, Zhonghua Yi Xue Za Zhi, V62, P581; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Lu H, 1999, TRANSPLANT P, V31, P2056, DOI 10.1016/S0041-1345(99)00262-6; Mei ZN, 2005, PHARMACOL RES, V51, P345, DOI 10.1016/j.phrs.2004.10.007; Movahedian Ahmad, 2014, Adv Biomed Res, V3, P12, DOI 10.4103/2277-9175.124641; Piao CS, 2010, PHARMACOL RES, V61, P342, DOI 10.1016/j.phrs.2009.11.009; Qiu Daoming, 2003, Drugs R D, V4, P1, DOI 10.2165/00126839-200304010-00001; Rubio V, 2011, TOXICOL IN VITRO, V25, P521, DOI 10.1016/j.tiv.2010.10.021; Shamon LA, 1997, CANCER LETT, V112, P113, DOI 10.1016/S0304-3835(96)04554-5; Shao F, 2007, BIOL PHARM BULL, V30, P702, DOI 10.1248/bpb.30.702; Srividhya R, 2008, INT J DEV NEUROSCI, V26, P217, DOI 10.1016/j.ijdevneu.2007.12.003; Tan KP, 2008, FREE RADICAL BIO MED, V45, P1663, DOI 10.1016/j.freeradbiomed.2008.09.010; Xiu JW, 2007, J CAPITAL MED U, V28, P220; Yao JC, 2008, BIOL PHARM BULL, V31, P592, DOI 10.1248/bpb.31.592; ZHENG YL, 1994, ACTA PHARM SINIC, V15, P540; Zhi C, 2011, CHINESE J EXPT TRADI, V17, P243; 骆永伟, 2009, [毒理学杂志, Journal of Toxicology], V23, P74	33	66	79	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100685	10.1371/journal.pone.0100685	http://dx.doi.org/10.1371/journal.pone.0100685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988078	gold, Green Published, Green Submitted			2022-12-27	WOS:000341354100038
J	Meise, K; Mueller, B; Zein, B; Trillmich, F				Meise, Kristine; Mueller, Birte; Zein, Beate; Trillmich, Fritz			Applicability of Single-Camera Photogrammetry to Determine Body Dimensions of Pinnipeds: Galapagos Sea Lions as an Example	PLOS ONE			English	Article							ELEPHANT SEAL; SIZE; MASS; DIMORPHISM; WHALES	Morphological features correlate with many life history traits and are therefore of high interest to behavioral and evolutionary biologists. Photogrammetry provides a useful tool to collect morphological data from species for which measurements are otherwise difficult to obtain. This method reduces disturbance and avoids capture stress. Using the Galapagos sea lion (Zalophus wollebaeki) as a model system, we tested the applicability of single-camera photogrammetry in combination with laser distance measurement to estimate morphological traits which may vary with an animal's body position. We assessed whether linear morphological traits estimated by photogrammetry can be used to estimate body length and mass. We show that accurate estimates of body length (males: +/- 2.0%, females: +/- 2.6%) and reliable estimates of body mass are possible (males: +/- 6.8%, females: 14.5%). Furthermore, we developed correction factors that allow the use of animal photos that diverge somewhat from a flat-out position. The product of estimated body length and girth produced sufficiently reliable estimates of mass to categorize individuals into 10 kg-classes of body mass. Data of individuals repeatedly photographed within one season suggested relatively low measurement errors (body length: 2.9%, body mass: 8.1%). In order to develop accurate sex-and age-specific correction factors, a sufficient number of individuals from both sexes and from all desired age classes have to be captured for baseline measurements. Given proper validation, this method provides an excellent opportunity to collect morphological data for large numbers of individuals with minimal disturbance.	[Meise, Kristine; Mueller, Birte; Zein, Beate; Trillmich, Fritz] Univ Bielefeld, Dept Anim Behav, D-33615 Bielefeld, Germany	University of Bielefeld	Meise, K (corresponding author), Univ Bielefeld, Dept Anim Behav, D-33615 Bielefeld, Germany.	kristine.meise@uni-bielefeld.de		Zein, Beate/0000-0002-5487-8535	German Research Foundation [TR 105/18, TR 105/18-2]; Ethological Society; German Academic Exchange Service; Volkswagen Foundation; Friends of Galapagos, Switzerland; Deutsche Forschungsgemeinschaft; Bielefeld University Library	German Research Foundation(German Research Foundation (DFG)); Ethological Society; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Volkswagen Foundation(Volkswagen); Friends of Galapagos, Switzerland; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bielefeld University Library	This study was funded by the German Research Foundation (TR 105/18, TR 105/18-2; http://www.dfg.de/), the Ethological Society (http://www.etholges.org/), the German Academic Exchange Service (https://www.daad.de/en/index.html), the Volkswagen Foundation(http://www.volkswagenstiftung.de/) and the Friends of Galapagos, Switzerland. The authors acknowledge support for the Article Processing Charge by the Deutsche Forschungsgemeinschaft and the Open Access Publication Funds of Bielefeld University Library. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ALTMANN J, 1993, AM J PRIMATOL, V30, P149, DOI 10.1002/ajp.1350300207; [Anonymous], 1994, SEXUAL SELECTION; Bell CM, 1997, MAR MAMMAL SCI, V13, P669, DOI 10.1111/j.1748-7692.1997.tb00090.x; BLUEWEISS L, 1978, OECOLOGIA, V37, P257, DOI 10.1007/BF00344996; Breuer T, 2007, AM J PHYS ANTHROPOL, V134, P369, DOI 10.1002/ajpa.20678; Clutton-Brock T.H., 1988, P325; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; Coltman DW, 1998, PHYSIOL ZOOL, V71, P387, DOI 10.1086/515418; de Bruyn PJN, 2009, AQUAT BIOL, V5, P31, DOI 10.3354/ab00135; DEUTSCH CJ, 1990, CAN J ZOOL, V68, P2580, DOI 10.1139/z90-360; Durban JW, 2006, MAR MAMMAL SCI, V22, P735, DOI 10.1111/j.1748-7692.2006.00068.x; HALEY MP, 1991, MAR MAMMAL SCI, V7, P157, DOI 10.1111/j.1748-7692.1991.tb00562.x; Jaquet N, 2006, MAR MAMMAL SCI, V22, P862, DOI 10.1111/j.1748-7692.2006.00060.x; Johnson MD, 2007, CONDOR, V109, P489, DOI 10.1650/8347.1; Kurita H, 2012, PRIMATES, V53, P7, DOI 10.1007/s10329-011-0280-4; Labocha MK, 2012, J ORNITHOL, V153, P1, DOI 10.1007/s10336-011-0706-1; Lankton S, 2008, IEEE T IMAGE PROCESS, V17, P2029, DOI 10.1109/TIP.2008.2004611; McDonell W., 1972, Journal Wildl Dis, V8, P287; McElligott AG, 2001, BEHAV ECOL SOCIOBIOL, V49, P266, DOI 10.1007/s002650000293; McFadden Katherine W., 2006, Aquatic Mammals, V32, P31, DOI 10.1578/AM.32.1.2006.31; Meise K, 2013, BEHAV ECOL SOCIOBIOL, V67, P1001, DOI 10.1007/s00265-013-1526-5; MILLAR JS, 1990, FUNCT ECOL, V4, P5, DOI 10.2307/2389646; Miller CA, 2012, MAR ECOL PROG SER, V459, P135, DOI 10.3354/meps09675; Porschmann U, 2010, MOL ECOL, V19, P2574, DOI 10.1111/j.1365-294X.2010.04665.x; R Development Core Team, 2010, LANG ENV STAT COMP; Shrader AM, 2006, S AFR J WILDL RES, V36, P1; Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556; Trillmich F., 1991, PINNIPEDS NINO RESPO, V88, P66; Trillmich F, 2014, SOC ECOL INTERACT GA, P61, DOI 10.1007/978-3-319-02769-2_3; Webster T, 2010, MAR MAMMAL SCI, V26, P296, DOI 10.1111/j.1748-7692.2009.00326.x; Willisch CS, 2013, MAMM BIOL, V78, P351, DOI 10.1016/j.mambio.2013.02.004; Zein B, 2013, THESIS U BIELEFELD; [No title captured]	34	16	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101197	10.1371/journal.pone.0101197	http://dx.doi.org/10.1371/journal.pone.0101197			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987983	Green Published, Green Submitted, gold			2022-12-27	WOS:000341354100069
J	Mu, TT; Chen, SY; Zhang, YC; Guo, P; Chen, H; Meng, FD				Mu, Taotao; Chen, Siying; Zhang, Yinchao; Guo, Pan; Chen, He; Meng, Fandong			Motor Oil Classification Based on Time-Resolved Fluorescence	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; VIRGIN OLIVE OIL; CRUDE OILS; NIR SPECTROSCOPY; ADULTERATION; CHEMOMETRICS; PREDICTION; LIFETIME; SAMPLES; CANCER	A time-resolved fluorescence (TRF) technique is presented for classifying motor oils. The system is constructed with a third harmonic Nd:YAG laser, a spectrometer, and an intensified charge coupled device (ICCD) camera. Steady-state and time-resolved fluorescence (TRF) measurements are reported for several motor oils. It is found that steady-state fluorescence is insufficient to distinguish the motor oil samples. Then contour diagrams of TRF intensities (CDTRFIs) are acquired to serve as unique fingerprints to identify motor oils by using the distinct TRF of motor oils. CDTRFIs are preferable to steady-state fluorescence spectra for classifying different motor oils, making CDTRFIs a particularly choice for the development of fluorescence-based methods for the discrimination and characterization of motor oils. The two-dimensional fluorescence contour diagrams contain more information, not only the changing shapes of the LIF spectra but also the relative intensity. The results indicate that motor oils can be differentiated based on the new proposed method, which provides reliable methods for analyzing and classifying motor oils.	[Mu, Taotao; Chen, Siying; Zhang, Yinchao; Guo, Pan; Chen, He; Meng, Fandong] Beijing Inst Technol, Sch Optoelect, Beijing 100081, Peoples R China	Beijing Institute of Technology	Chen, SY (corresponding author), Beijing Inst Technol, Sch Optoelect, Beijing 100081, Peoples R China.	csy@bit.edu.cn	CHEN, SI/GZL-4800-2022					Al-Ghouti MA, 2010, TALANTA, V81, P1096, DOI 10.1016/j.talanta.2010.02.003; Balabin RM, 2008, FUEL, V87, P2745, DOI 10.1016/j.fuel.2008.02.014; Balabin RM, 2011, MICROCHEM J, V98, P121, DOI 10.1016/j.microc.2010.12.007; Bassbasi M, 2013, FUEL, V104, P798, DOI 10.1016/j.fuel.2012.05.058; Blanco M, 2002, TRAC-TREND ANAL CHEM, V21, P240, DOI 10.1016/S0165-9936(02)00404-1; CAMAGNI P, 1988, IEEE T GEOSCI REMOTE, V26, P22, DOI 10.1109/36.2995; Chen ZW, 2012, ABSTRACTS PAPERS AM; Chung H, 2003, APPL SPECTROSC, V57, P545, DOI 10.1366/000370203321666579; Cooper JB, 2011, APPL SPECTROSC, V65, P187, DOI 10.1366/10-06076; Cramer JA, 2009, ENERG FUEL, V23, P1132, DOI 10.1021/ef8007739; De Peinder P, 2008, APPL SPECTROSC, V62, P414, DOI 10.1366/000370208784046849; Gharekhan AH, 2012, APPL SPECTROSC, V66, P820, DOI 10.1366/11-06515; Giruts MV, 2013, PETROL CHEM+, V53, P209, DOI 10.1134/S096554411304004X; Guan L, 2008, ANAL CHIM ACTA, V628, P117, DOI 10.1016/j.aca.2008.09.004; Guedes CLB, 2006, INT J PHOTOENERGY, V2006, DOI 10.1155/IJP/2006/48462; Hegazi E, 2002, TALANTA, V56, P989, DOI 10.1016/S0039-9140(01)00589-6; Hegazi E, 2001, APPL SPECTROSC, V55, P202, DOI 10.1366/0003702011951515; Ionita I, 2009, OPTOELECTRON ADV MAT, V3, P1122; Khanmohammadi M, 2013, FUEL, V111, P96, DOI 10.1016/j.fuel.2013.04.001; KUDASHEVA FK, 1989, IZV VUZ KHIM KH TEKH, V32, P63; Mu TT, 2014, ANAL METHODS-UK, V6, P940, DOI 10.1039/c3ay41552j; Pantoja PA, 2011, ENERG FUEL, V25, P3598, DOI 10.1021/ef200567x; Poulli KI, 2007, FOOD CHEM, V105, P369, DOI 10.1016/j.foodchem.2006.12.021; Poulli KI, 2006, ANAL BIOANAL CHEM, V386, P1571, DOI 10.1007/s00216-006-0729-2; Ralston CY, 1996, APPL SPECTROSC, V50, P1563, DOI 10.1366/0003702963904601; Ryder AG, 2004, APPL SPECTROSC, V58, P613, DOI 10.1366/000370204774103462; Ryder AG, 2002, SPECTROCHIM ACTA A, V58, P1025, DOI 10.1016/S1386-1425(01)00579-0; Wan W., 2013, J PETROLEUM ENG TECH, V3, P18; Wang CY, 2006, SPECTROSC SPECT ANAL, V26, P728; WANG X, 1994, APPL SPECTROSC, V48, P977, DOI 10.1366/0003702944029703; Wu SB, 2013, J CHROMATOGR A, V1314, P154, DOI 10.1016/j.chroma.2013.09.017; Yuvaraj M, 2014, J PHOTOCH PHOTOBIO B, V130, P153, DOI 10.1016/j.jphotobiol.2013.11.006; Zhao Y, 2009, SPECTROSC SPECT ANAL, V29, P3335, DOI 10.3964/j.issn.1000-0593(2009)12-3335-04	33	7	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100555	10.1371/journal.pone.0100555	http://dx.doi.org/10.1371/journal.pone.0100555			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988439	gold, Green Published, Green Submitted			2022-12-27	WOS:000341354100034
J	Radford, S; Eames, C; Brennan, K; Lambert, G; Crane, C; Williams, JMG; Duggan, DS; Barnhofer, T				Radford, Sholto; Eames, Catrin; Brennan, Kate; Lambert, Gwladys; Crane, Catherine; Williams, J. Mark G.; Duggan, Danielle S.; Barnhofer, Thorsten			Trait Mindfulness as a Limiting Factor for Residual Depressive Symptoms: An Explorative Study Using Quantile Regression	PLOS ONE			English	Article							COGNITIVE REACTIVITY; RELAPSE; REMISSION; DISORDER; THERAPY; WELL; ACTIVATION; PREVENTION; PLACEBO; IMPACT	Mindfulness has been suggested to be an important protective factor for emotional health. However, this effect might vary with regard to context. This study applied a novel statistical approach, quantile regression, in order to investigate the relation between trait mindfulness and residual depressive symptoms in individuals with a history of recurrent depression, while taking into account symptom severity and number of episodes as contextual factors. Rather than fitting to a single indicator of central tendency, quantile regression allows exploration of relations across the entire range of the response variable. Analysis of self-report data from 274 participants with a history of three or more previous episodes of depression showed that relatively higher levels of mindfulness were associated with relatively lower levels of residual depressive symptoms. This relationship was most pronounced near the upper end of the response distribution and moderated by the number of previous episodes of depression at the higher quantiles. The findings suggest that with lower levels of mindfulness, residual symptoms are less constrained and more likely to be influenced by other factors. Further, the limiting effect of mindfulness on residual symptoms is most salient in those with higher numbers of episodes.	[Radford, Sholto; Eames, Catrin] Bangor Univ, Ctr Mindfulness Res & Practice, Bangor, Gwynedd, Wales; [Brennan, Kate; Crane, Catherine; Williams, J. Mark G.; Duggan, Danielle S.; Barnhofer, Thorsten] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England; [Lambert, Gwladys] Bangor Univ, Sch Ocean Sci, Menai Bridge, Gwynedd, Wales	Bangor University; University of Oxford; Bangor University	Radford, S (corresponding author), Bangor Univ, Ctr Mindfulness Res & Practice, Dean St Bldg, Bangor, Gwynedd, Wales.	s.radford@bangor.ac.uk	Eames, Catrin/GWV-4358-2022	Eames, Catrin/0000-0002-9893-1182	Wellcome Trust [GR067797]	Wellcome Trust(Wellcome TrustEuropean Commission)	This study was funded by Wellcome Trust Grant GR067797, awarded to J. Mark G. Williams and Ian T. Russell (Trial Registration Number: ISRCTN97185214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504; Barnhofer T, 2010, BEHAV RES THER, V48, P275, DOI 10.1016/j.brat.2009.12.005; Bech P, 2010, J CLIN PSYCHIAT, V71, P121, DOI 10.4088/JCP.08m04749blu; Beck AT, 1996, PSYCHOL ASSESS; Bilias Y, 2000, J ECONOMETRICS, V99, P373, DOI 10.1016/S0304-4076(00)00042-7; Brown KW, 2009, J RES PERS, V43, P727, DOI 10.1016/j.jrp.2009.07.002; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Cade BS, 1999, ECOLOGY, V80, P311, DOI 10.1890/0012-9658(1999)080[0311:EEOLFW]2.0.CO;2; Carmody J, 2008, J BEHAV MED, V31, P23, DOI 10.1007/s10865-007-9130-7; Cash M., 2010, MINDFULNESS, V1, P177, DOI [https://doi.org/10.1007/s12671-010-0023-4, DOI 10.1007/S12671-010-0023-4, 10.1007/s12671-010-0023-4]; Chambers R, 2008, COGNITIVE THER RES, V32, P303, DOI 10.1007/s10608-007-9119-0; Christopher MS, 2012, MINDFULNESS, V3, P124, DOI 10.1007/s12671-011-0086-x; Dane E, 2011, J MANAGE, V37, P997, DOI 10.1177/0149206310367948; Dekeyser M, 2008, PERS INDIV DIFFER, V44, P1235, DOI 10.1016/j.paid.2007.11.018; First MB, 2001, STRUCTURED CLIN INTE; Grossman P, 2008, J PSYCHOSOM RES, V64, P405, DOI 10.1016/j.jpsychores.2008.02.001; Holzel BK, 2011, PERSPECT PSYCHOL SCI, V6, P537, DOI 10.1177/1745691611419671; Judd LL, 2000, AM J PSYCHIAT, V157, P1501, DOI 10.1176/appi.ajp.157.9.1501; Judd LL, 1998, J AFFECT DISORDERS, V50, P97, DOI 10.1016/S0165-0327(98)00138-4; Kendler KS, 2001, AM J PSYCHIAT, V158, P582, DOI 10.1176/appi.ajp.158.4.582; Kennedy N, 2004, J AFFECT DISORDERS, V80, P135, DOI 10.1016/S0165-0327(03)00054-5; Khoury B, 2013, CLIN PSYCHOL REV, V33, P763, DOI 10.1016/j.cpr.2013.05.005; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Koenker R, 1999, J AM STAT ASSOC, V94, P1296, DOI 10.2307/2669943; Koenker R., 2010, ECONOMETRIC SOC MONO, V2005, P295; Kuyken W, 2010, BEHAV RES THER, V48, P1105, DOI 10.1016/j.brat.2010.08.003; Lambert GI, 2011, MAR ECOL PROG SER, V430, P71, DOI 10.3354/meps09112; Lau MA, 2004, BEHAV RES THER, V42, P1001, DOI 10.1016/j.brat.2004.03.003; Lobbestael J, 2011, CLIN PSYCHOL PSYCHOT, V18, P75, DOI 10.1002/cpp.693; Marchetti I, 2012, NEUROPSYCHOL REV, V22, P229, DOI 10.1007/s11065-012-9199-9; Miranda J., 1998, COGNITIVE VULNERABIL; Murray C. J. L., 1996, GLOBAL BURDEN DIS; Nierenberg AA, 2010, PSYCHOL MED, V40, P41, DOI 10.1017/S0033291709006011; Pagnoni G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003083; PAYKEL ES, 1995, PSYCHOL MED, V25, P1171, DOI 10.1017/S0033291700033146; Piet J, 2011, CLIN PSYCHOL REV, V31, P1032, DOI 10.1016/j.cpr.2011.05.002; Raes F., 2010, MINDFULNESS, V1, P199, DOI [10.1007/s12671-010-0021-6, DOI 10.1007/S12671-010-0021-6]; Rosch E, 2007, PSYCHOL INQ, V18, P258, DOI 10.1080/10478400701598371; Scher CD, 2005, CLIN PSYCHOL REV, V25, P487, DOI 10.1016/j.cpr.2005.01.005; Segal Z. V., 2002, MINDFULNESS BASED CO; Segal ZV, 2006, ARCH GEN PSYCHIAT, V63, P749, DOI 10.1001/archpsyc.63.7.749; Segal ZV, 2010, ARCH GEN PSYCHIAT, V67, P1256, DOI 10.1001/archgenpsychiatry.2010.168; Segal ZV, 1996, PSYCHOL MED, V26, P371, DOI 10.1017/S0033291700034760; Segal ZV, 2009, PSYCHOL INQ, V3, P219; Taylor DJ, 2010, J AFFECT DISORDERS, V123, P181, DOI 10.1016/j.jad.2009.08.007; Van Dam NT, 2009, PERS INDIV DIFFER, V47, P516, DOI 10.1016/j.paid.2009.05.005; Vaz S, 2008, J APPL ECOL, V45, P204, DOI 10.1111/j.1365-2664.2007.01392.x; Walach H, 2006, PERS INDIV DIFFER, V40, P1543, DOI 10.1016/j.paid.2005.11.025; Way BM, 2010, EMOTION, V10, P12, DOI 10.1037/a0018312; Williams JMG, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-23; Williams JMG, 2005, J ABNORM PSYCHOL, V114, P421, DOI 10.1037/0021-843X.114.3.421; World Health Organization, 2004, GLOBAL BURDEN DIS; Zimmerman M, 2012, J AFFECT DISORDERS, V142, P77, DOI 10.1016/j.jad.2012.03.044	54	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100022	10.1371/journal.pone.0100022	http://dx.doi.org/10.1371/journal.pone.0100022			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BA	24988072	Green Published, gold, Green Submitted			2022-12-27	WOS:000341354100022
J	Bennitt, E; Bonyongo, MC; Harris, S				Bennitt, Emily; Bonyongo, Mpaphi Casper; Harris, Stephen			Habitat Selection by African Buffalo (Syncerus caffer) in Response to Landscape-Level Fluctuations in Water Availability on Two Temporal Scales	PLOS ONE			English	Article							MOUNTAIN-NATIONAL-PARK; OKAVANGO DELTA; POPULATION-DYNAMICS; DENSITY-DEPENDENCE; RESOURCE SELECTION; EQUUS-BURCHELLI; PROTECTED AREAS; CLIMATE-CHANGE; TRADE-OFF; SOIL TYPE	Seasonal fluctuations in water availability cause predictable changes in the profitability of habitats in tropical ecosystems, and animals evolve adaptive behavioural and spatial responses to these fluctuations. However, stochastic changes in the distribution and abundance of surface water between years can alter resource availability at a landscape scale, causing shifts in animal behaviour. In the Okavango Delta, Botswana, a flood-pulsed ecosystem, the volume of water entering the system doubled between 2008 and 2009, creating a sudden change in the landscape. We used African buffalo (Syncerus caffer) to test the hypotheses that seasonal habitat selection would be related to water availability, that increased floodwater levels would decrease forage abundance and affect habitat selection, and that this would decrease buffalo resting time, reduce reproductive success and decrease body condition. Buffalo selected contrasting seasonal habitats, using habitats far from permanent water during the rainy season and seasonally-flooded habitats close to permanent water during the early and late flood seasons. The 2009 water increase reduced forage availability in seasonally-flooded habitats, removing a resource buffer used by the buffalo during the late flood season, when resources were most limited. In response, buffalo used drier habitats in 2009, although there was no significant change in the time spent moving or resting, or daily distance moved. While their reproductive success decreased in 2009, body condition increased. A protracted period of high water levels could prove detrimental to herbivores, especially to smaller-bodied species that require high quality forage. Stochastic annual fluctuations in water levels, predicted to increase as a result of anthropogenically-induced climate change, are likely to have substantial impacts on the functioning of water-driven tropical ecosystems, affecting environmental conditions within protected areas. Buffer zones around critical seasonal resources are essential to allow animals to engage in compensatory behavioural and spatial mechanisms in response to changing environmental conditions.	[Bennitt, Emily; Harris, Stephen] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Bonyongo, Mpaphi Casper] Univ Botswana, Okavango Res Inst, Maun, Botswana	University of Bristol; University of Botswana	Bennitt, E (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	Emily.Bennitt@gmail.com	Bonyongo, Mpaphi Casper/AAS-1423-2021; Bennitt, Emily/AAB-6032-2020		Dulverton Trust; Idea Wild; North of England Zoological Society; Roberts Fund; Wilderness Safaris Wildlife Trust	Dulverton Trust; Idea Wild; North of England Zoological Society; Roberts Fund; Wilderness Safaris Wildlife Trust	This work was funded by Jenny & Martin Bennitt, the Dulverton Trust (www.dulverton.org), Harry Ferguson, Ian Fuhr, Rodney Fuhr, Dane Hawk, Idea Wild (www.ideawild.org), the North of England Zoological Society (www.chesterzoo.org/global/about-us/north-of-england-zoological-society), the Roberts Fund and the Wilderness Safaris Wildlife Trust (www.wildernesstrust.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson L, 2006, J HYDROL, V331, P43, DOI 10.1016/j.jhydrol.2006.04.039; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Bartlam-Brooks HLA, 2013, ECOL EVOL, V3, P2795, DOI 10.1002/ece3.676; Benhamou S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014592; Benhamou S, 2010, J WILDLIFE MANAGE, V74, P1353, DOI 10.2193/2009-441; Bennitt E., 2012, THESIS U BRISTOL; Bonenfant C, 2009, ADV ECOL RES, V41, P313, DOI 10.1016/S0065-2504(09)00405-X; Bonyongo MC, 2007, AFR J ECOL, V45, P527, DOI 10.1111/j.1365-2028.2007.00764.x; Boone Randall B., 2004, African Journal of Range & Forage Science, V21, P147, DOI 10.2989/10220110409485847; Bradley J, 2012, THESIS U BRISTOL; BRANSBY DI, 1977, AGRON J, V69, P393, DOI 10.2134/agronj1977.00021962006900030016x; Brooks CJ, 2008, ANIM BEHAV, V76, P277, DOI 10.1016/j.anbehav.2008.02.005; Burthe S, 2011, J ANIM ECOL, V80, P1134, DOI 10.1111/j.1365-2656.2011.01865.x; Calenge C, 2007, J STAT SOFTW, V22, P1; Chamaille-Jammes S, 2007, AUSTRAL ECOL, V32, P740, DOI 10.1111/j.1442-9993.2007.01761.x; Christensen RHB, 2013, ANAL ORDINAL DATA CI; Colchero F, 2009, J ANIM ECOL, V78, P666, DOI 10.1111/j.1365-2656.2009.01528.x; de Wit M, 2006, SCIENCE, V311, P1917, DOI 10.1126/science.1119929; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; ELLERY WN, 1993, AFR J ECOL, V31, P118, DOI 10.1111/j.1365-2028.1993.tb00526.x; FARRAR TJ, 1994, REMOTE SENS ENVIRON, V50, P121, DOI 10.1016/0034-4257(94)90039-6; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Fynn RWS, 2011, AFR J ECOL, V49, P175, DOI 10.1111/j.1365-2028.2010.01245.x; Gaidet N, 2008, CAN J ZOOL, V86, P24, DOI 10.1139/Z07-111; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Ganskopp DC, 2007, RANGELAND ECOL MANAG, V60, P350, DOI 10.2111/1551-5028(2007)60[350:GEISAA]2.0.CO;2; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Gustine DD, 2006, J WILDLIFE MANAGE, V70, P1601, DOI 10.2193/0022-541X(2006)70[1601:IRSADS]2.0.CO;2; Hassler SK, 2010, J ARID ENVIRON, V74, P1516, DOI 10.1016/j.jaridenv.2010.05.021; Heinl M, 2006, LANDSCAPE ECOL, V21, P699, DOI 10.1007/s10980-005-5243-y; Higginson AD, 2012, AM NAT, V179, P338, DOI 10.1086/664457; Holdo RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016370; HOUSTON AI, 1993, PHILOS T ROY SOC B, V341, P375, DOI 10.1098/rstb.1993.0123; Hu JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022873; Hughes DA, 2011, HYDROL EARTH SYST SC, V15, P931, DOI 10.5194/hess-15-931-2011; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kumar L, 2002, ECOL MODEL, V149, P143, DOI 10.1016/S0304-3800(01)00520-8; KUTILEK MJ, 1979, J WILDLIFE MANAGE, V43, P899, DOI 10.2307/3808273; Lewis JS, 2007, J APPL ECOL, V44, P663, DOI 10.1111/j.1365-2664.2007.01286.x; Loarie SR, 2009, BIOL CONSERV, V142, P3099, DOI 10.1016/j.biocon.2009.08.021; Lorrilliere R, 2012, ECOL MODEL, V224, P103, DOI 10.1016/j.ecolmodel.2011.10.015; Manly B.F.J., 2002, RESOURCE SELECTION A; Mbatha K. R., 2006, African Journal of Range & Forage Science, V23, P131, DOI 10.2989/10220110609485896; Midgley GF, 2011, REG ENVIRON CHANGE, V11, pS127, DOI 10.1007/s10113-010-0191-8; Millspaugh JJ, 2006, J WILDLIFE MANAGE, V70, P384, DOI 10.2193/0022-541X(2006)70[384:AORSUU]2.0.CO;2; Murray-Hudson M, 2006, J HYDROL, V331, P73, DOI 10.1016/j.jhydrol.2006.04.041; Musters CJM, 2000, SCIENCE, V287, P1759, DOI 10.1126/science.287.5459.1759; NEU CW, 1974, J WILDLIFE MANAGE, V38, P541, DOI 10.2307/3800887; Ogutu Joseph O., 2013, Open Conservation Biology Journal, V7, P11, DOI 10.2174/1874839201307010011; Ogutu Joseph O., 2012, Open Ecology Journal, V5, P1, DOI 10.2174/1874213001205010001; Ogutu JO, 2012, BIODIVERS CONSERV, V21, P1033, DOI 10.1007/s10531-012-0239-9; Owen-Smith N, 2004, LANDSCAPE ECOL, V19, P761, DOI 10.1007/s10980-005-0247-2; Owen-Smith N, 2010, PHILOS T R SOC B, V365, P2267, DOI 10.1098/rstb.2010.0095; Owen-Smith Norman, 2008, V23, P159; Patterson L, 1978, STUDIES POPULATION B; Peinetti HR, 2002, LANDSCAPE ECOL, V17, P341, DOI 10.1023/A:1020530710891; Poilecot P, 2011, AFR J ECOL, V49, P150, DOI 10.1111/j.1365-2028.2010.01241.x; Prins HHT, 1996, ECOLOGY BEHAV AFRICA; Pulido F, 2010, P NATL ACAD SCI USA, V107, P7341, DOI 10.1073/pnas.0910361107; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ramberg L, 2006, AQUAT SCI, V68, P310, DOI 10.1007/s00027-006-0857-y; Rivrud IM, 2010, J ANIM ECOL, V79, P1280, DOI 10.1111/j.1365-2656.2010.01731.x; Ryan SJ, 2006, J WILDLIFE MANAGE, V70, P764, DOI 10.2193/0022-541X(2006)70[764:RAHSOA]2.0.CO;2; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sinclair A.R.E., 1972, East African Wildlife Journal, V10, P143; Singh NJ, 2011, J APPL ECOL, V48, P35, DOI 10.1111/j.1365-2664.2010.01905.x; Smit IPJ, 2011, ECOGRAPHY, V34, P67, DOI 10.1111/j.1600-0587.2010.06029.x; Taolo CL, 2003, THESIS NORWEGIAN U S; THOMAS DL, 1990, J WILDLIFE MANAGE, V54, P322, DOI 10.2307/3809050; TROLLOPE W, 2000, SIMPLIFIED TECHNIQUE; Tuomainen U, 2011, BIOL REV, V86, P640, DOI 10.1111/j.1469-185X.2010.00164.x; Van der Boogaart KG, 2006, GEOL SOC SPEC PUBL, V264, P119, DOI 10.1144/GSL.SP.2006.264.01.09; Van Moorter B, 2010, J WILDLIFE MANAGE, V74, P588, DOI 10.2193/2009-155; Wada Y, 2011, HYDROL EARTH SYST SC, V15, P3785, DOI 10.5194/hess-15-3785-2011; WALKER BH, 1987, J APPL ECOL, V24, P381, DOI 10.2307/2403882; Wang GM, 2002, CLIMATIC CHANGE, V54, P205, DOI 10.1023/A:1015725103348; Watson R. M., 1965, East African Wildlife Journal, V3, P95; Wiens JA, 2011, BIOL CONSERV, V144, P2119, DOI 10.1016/j.biocon.2011.05.002; Wilmshurst JF, 2000, P ROY SOC B-BIOL SCI, V267, P345, DOI 10.1098/rspb.2000.1007; Winnie JA, 2008, ECOLOGY, V89, P1457, DOI 10.1890/07-0772.1; Zhang XY, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005263; Zweifel-Schielly B, 2009, ECOGRAPHY, V32, P103, DOI 10.1111/j.1600-0587.2008.05178.x	83	34	36	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101346	10.1371/journal.pone.0101346	http://dx.doi.org/10.1371/journal.pone.0101346			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983377	Green Published, gold, Green Submitted			2022-12-27	WOS:000339635000094
J	Eren, MK; Tabor, V				Eren, Mehtap Kilic; Tabor, Vedrana			The Role of Hypoxia Inducible Factor-1 Alpha in Bypassing Oncogene-Induced Senescence	PLOS ONE			English	Article							CELL-CYCLE ARREST; RAS-INDUCED SENESCENCE; REPLICATIVE LIFE-SPAN; DNA-DAMAGE RESPONSE; PREMATURE SENESCENCE; HUMAN FIBROBLASTS; FACTOR 1-ALPHA; HUMAN CANCER; P53; SUPPRESSION	Oncogene induced senescence (OIS) is a sustained anti-proliferative response acutely induced in primary cells via activation of mitogenic oncogenes such as Ras/BRAF. This mechanism acts as an initial barrier preventing normal cells transformation into malignant cell. Besides oncogenic activation and DNA damage response (DDR), senescence is modulated by a plethora of other factors, and one of the most important one is oxygen tension of the tissue. The aim of this study was to determine the impact of hypoxia on Ras(V12)-induced senescence in human diploid fibroblasts (HDFs). We showed here that hypoxia prevents execution of oncogene induced senescence (OIS), through a strong down-regulation of senescence hallmarks, such as SA-beta-galactosidase, H3K9me3, HP1 gamma, p53, p21(CIP1) and p16(INK4a) in association with induction of hypoxia inducible factor-1 alpha (HIF-1 alpha). In addition, hypoxia also decreased marks of H-Ras(V12)-induced DDR in both cell lines through down-regulation of ATM/ATR, Chk1 and Chk2 phosphorylation as well as decreased gamma-H2AX positivity. Utilizing shRNA system targeting HIF-1a we show that HIF-1a is directly involved in down regulation of p53 and its target p21(CIP1) but not p16(INK4a). In line with this finding we found that knock down of HIF-1a leads to a strong induction of apoptotic response, but not restoration of senescence in Ras expressing HDFs in hypoxia. This indicates that HIF-1a is an important player in early steps of tumorigenesis, leading to suppression of senescence through its negative regulation of p53 and p21(CIP1). In our work we describe a mechanism through which hypoxia and specifically HIF-1 alpha preclude cells from maintaining senescence-driven anti proliferative response. These findings indicate the possible mechanism through which hypoxic environment helps premalignant cells to evade impingement of cellular failsafe pathways.	[Eren, Mehtap Kilic] Adnan Menderes Univ Med Sch, Dept Med Biol, Aydin, Turkey; [Eren, Mehtap Kilic] ADU BILTEM, Aydin, Turkey; [Tabor, Vedrana] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden	Adnan Menderes University; Karolinska Institutet	Eren, MK (corresponding author), Adnan Menderes Univ Med Sch, Dept Med Biol, Aydin, Turkey.	mkilic@adu.edu.tr		Tabor, Vedrana/0000-0001-9224-208X	TUBITAK [108S379, Cost -BM0703 CANGENIN]; Adnan Menderes University Scientific Research Foundation; Swedish Cancer Society (Cancerfonden); TUBITAK, Scientific and Technological Research Council of Turkey	TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Adnan Menderes University Scientific Research Foundation(Adnan Menderes University); Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society); TUBITAK, Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	MK-E: TUBITAK (108S379, Cost -BM0703 CANGENIN) and Adnan Menderes University Scientific Research Foundation. V.T. Swedish Cancer Society (Cancerfonden). (http://www.tubitak.gov.tr/en) for TUBITAK (as grant supplier) The Scientific and Technological Research Council of Turkey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bell EL, 2007, MOL CELL BIOL, V27, P5737, DOI 10.1128/MCB.02265-06; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Ben-Porath I, 2004, J CLIN INVEST, V113, P8, DOI 10.1172/JCI200420663; Benanti JA, 2004, CELL CYCLE, V3, P715; Benanti JA, 2004, MOL CELL BIOL, V24, P2842, DOI 10.1128/MCB.24.7.2842-2852.2004; BOS JL, 1989, CANCER RES, V49, P4682; Box AH, 2004, CARCINOGENESIS, V25, P2325, DOI 10.1093/carcin/bgh274; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brookes S, 2002, EMBO J, V21, P2936, DOI 10.1093/emboj/cdf289; Collado M, 2005, CELL CYCLE, V4, P1722, DOI 10.4161/cc.4.12.2260; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ferbeyre G, 2000, GENE DEV, V14, P2015; FRANZA BR, 1986, CELL, V44, P409, DOI 10.1016/0092-8674(86)90462-9; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Hammond EM, 2004, DNA REPAIR, V3, P1117, DOI 10.1016/j.dnarep.2004.03.035; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hueber AO, 1998, TRENDS GENET, V14, P364, DOI 10.1016/S0168-9525(98)01520-0; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Kilic M, 2007, ONCOGENE, V26, P2027, DOI 10.1038/sj.onc.1210008; Kilic M., 2008, APOPTOSIS CELLULAR O, P273, DOI [10.3109/9781420020502-17, DOI 10.3109/9781420020502-17]; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; LAND H, 1983, SCIENCE, V222, P771, DOI 10.1126/science.6356358; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Maldonado JL, 2004, AM J PATHOL, V164, P1783, DOI 10.1016/S0002-9440(10)63736-4; Mallette FA, 2004, ONCOGENE, V23, P91, DOI 10.1038/sj.onc.1206886; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; PACKER L, 1977, NATURE, V267, P423, DOI 10.1038/267423a0; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Ravi R, 2000, GENE DEV, V14, P34; Rodier F, 2009, CELL CYCLE, V8, P3632; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shamma A, 2009, CANCER CELL, V15, P255, DOI 10.1016/j.ccr.2009.03.001; Sullivan R, 2008, MOL CANCER THER, V7, P1961, DOI 10.1158/1535-7163.MCT-08-0198; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; Welford SM, 2006, GENE DEV, V20, P3366, DOI 10.1101/gad.1471106; Welford SM, 2011, MOL CANCER RES, V9, P538, DOI 10.1158/1541-7786.MCR-11-0065	45	19	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101064	10.1371/journal.pone.0101064	http://dx.doi.org/10.1371/journal.pone.0101064			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984035	Green Published, Green Submitted, gold			2022-12-27	WOS:000339635000052
J	Freitas, LB; Chen, ZG; Muqui, EF; Boldrini, NAT; Miranda, AE; Spano, LC; Burk, RD				Freitas, Luciana Bueno; Chen, Zigui; Muqui, Elaine Freire; Tosato Boldrini, Neide Aparecida; Miranda, Angelica Espinosa; Spano, Liliana Cruz; Burk, Robert D.			Human Papillomavirus 16 Non-European Variants Are Preferentially Associated with High-Grade Cervical Lesions	PLOS ONE			English	Article							LONG CONTROL REGION; GENITAL HUMAN-PAPILLOMAVIRUS; TYPE-16 VARIANTS; MOLECULAR VARIANTS; HUMAN-PAPILLOMAVIRUS-16 E6; INTRAEPITHELIAL NEOPLASIA; INTRATYPIC VARIANTS; VIRAL PERSISTENCE; POOLED ANALYSIS; CENTRAL BRAZIL	HPV16 accounts for 50-70% of cervical cancer cases worldwide. Characterization of HPV16 variants previously indicated that they differ in risks for viral persistence, progression to cervical precancer and malignant cancer. The aim of this study was to examine the association of severity of disease with HPV16 variants identified in specimens (n = 281) obtained from a Cervical Pathology and Colposcopy outpatient clinic in the University Hospital of Espirito Santo State, Southeastern Brazil, from April 2010 to November 2011. All cytologic and histologic diagnoses were determined prior to definitive treatment. The DNA was isolated using QIAamp DNA Mini Kit and HPV was detected by amplification with PGMY09/11 primers and positive samples were genotyped by RFLP analyses and reverse line blot. The genomes of the HPV16 positive samples were sequenced, from which variant lineages were determined. Chi(2) statistics was performed to test the association of HPV16 variants between case and control groups. The prevalence of HR-HPV types in <CIN1, CIN2 and CIN3+ were 33.7%, 84.4% and 91.6%, respectively. Thirty-eight of 49 (78%) HPV16 positive samples yielded HPV16 sequence information; of which, 32 complete genomes were sequenced and an additional 6 samples were partially sequenced. Phylogenetic analysis and patterns of variations identified 65.8% (n = 25) as HPV16 European (E) and 34.2% (n = 13) as non-European (NE) variants. Classification of disease into CIN3+ vs. <CIN3 indicated that NE types were associated with high-grade disease with an OR = 4.6 (1.07-20.2, p = 0.05). The association of HPV16 NE variants with an increased risk of CIN3+ is consistent with an HPV16 genetically determined enhanced oncogenicity. The prevalence of genetic variants of HPV16 is distributed across different geographical areas and with recent population admixture, only empiric data will provide information on the highest risk HPV16 variants within a given population.	[Freitas, Luciana Bueno; Tosato Boldrini, Neide Aparecida; Miranda, Angelica Espinosa; Spano, Liliana Cruz] Univ Fed Espirito Santo, Postgrad Program Infect Dis, Vitoria, Brazil; [Chen, Zigui; Burk, Robert D.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA; [Muqui, Elaine Freire; Spano, Liliana Cruz] Univ Fed Espirito Santo, Dept Pathol, Ctr Hlth Sci, Vitoria, Brazil; [Burk, Robert D.] Albert Einstein Coll Med, Dept Microbiol & Addresses Immunol, Bronx, NY 10467 USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Obstet Gynecol & Womans Hlth, Bronx, NY 10467 USA	Universidade Federal do Espirito Santo; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Universidade Federal do Espirito Santo; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Freitas, LB (corresponding author), Univ Fed Espirito Santo, Postgrad Program Infect Dis, Vitoria, Brazil.	freitas_lb@yahoo.com.br	Miranda, Angelica/AAE-5571-2021; Chen, Zigui/E-8490-2017	Chen, Zigui/0000-0002-8577-1298; Miranda, Angelica/0000-0002-5556-8379	Fundacao de Amparo a Pesquisa do Espirito Santo [FAPES/MS/CNPq/SESA003/2009]; National Cancer Institute, National Institutes of Health (NIH) [U01 CA78527]; CAPES Foundation; Ministry of Education of Brazil; CAPES-PDSE; NATIONAL CANCER INSTITUTE [P30CA013330, U01CA078527, R01CA078527] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Espirito Santo; National Cancer Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ministry of Education of Brazil; CAPES-PDSE(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the FAPES/MS/CNPq/SESA003/2009 (Fundacao de Amparo a Pesquisa do Espirito Santo) and in part by National Cancer Institute, National Institutes of Health (NIH) (U01 CA78527). The first author has a scholarship from CAPES Foundation, Ministry of Education of Brazil and obtained the funding for Sandwich Doctoral Program from CAPES-PDSE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AI, 2013, INFECT GENET EVOL, V18, P151, DOI 10.1016/j.meegid.2013.05.013; Alencar TR, 2007, VIRUS GENES, V35, P1, DOI 10.1007/s11262-006-0040-5; Andersson S, 2000, BRIT J CANCER, V83, P307, DOI 10.1054/bjoc.2000.1247; Bernard E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-373; Bernard HU, 2013, INFECT GENET EVOL, V18, P357, DOI 10.1016/j.meegid.2013.03.011; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; BERNARD HU, 1994, J INFECT DIS, V170, P1077, DOI 10.1093/infdis/170.5.1077; Berumen J, 2001, JNCI-J NATL CANCER I, V93, P1325, DOI 10.1093/jnci/93.17.1325; Bogovac Z, 2011, ACTA DERMATOVEN ALP, V20, P135; Burk RD, 2003, CANCER RES, V63, P7215; Burk RD, 2013, VIROLOGY, V445, P232, DOI 10.1016/j.virol.2013.07.018; Bzhalava D, 2013, VIROLOGY, V445, P224, DOI 10.1016/j.virol.2013.07.015; Castellsague Xavier, 2003, J Natl Cancer Inst Monogr, P20; Castellsague X, 2008, GYNECOL ONCOL, V110, pS4, DOI 10.1016/j.ygyno.2008.07.045; Castro MM, 2011, GENET MOL RES, V10, P186, DOI 10.4238/vol10-1gmr992; Chang YJ, 2013, J MED VIROL, V85, P1567, DOI 10.1002/jmv.23651; Chen ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020183; Chimeddorj B, 2008, ASIAN PAC J CANCER P, V9, P563; Cornet I, 2013, BRIT J CANCER, V108, P240, DOI 10.1038/bjc.2012.508; Cornet I, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-4; Cruz MR, 2004, MEM I OSWALDO CRUZ, V99, P281, DOI 10.1590/S0074-02762004000300007; Cubie HA, 2013, VIROLOGY, V445, P21, DOI 10.1016/j.virol.2013.06.007; Souza PSD, 2009, FUTURE ONCOL, V5, P359, DOI [10.2217/fon.09.8, 10.2217/FON.09.8]; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; de Villiers EM, 2013, VIROLOGY, V445, P2, DOI 10.1016/j.virol.2013.04.023; DONG XP, 1994, INT J CANCER, V58, P803, DOI 10.1002/ijc.2910580609; Estrade C, 2011, J CLIN MICROBIOL, V49, P3474, DOI 10.1128/JCM.05039-11; Ferenczy A, 2002, LANCET ONCOL, V3, P11, DOI 10.1016/S1470-2045(01)00617-9; Gheit T, 2006, VIRAL IMMUNOL, V19, P340, DOI 10.1089/vim.2006.19.340; Gheit T, 2011, CANCER EPIDEM BIOMAR, V20, P1315, DOI 10.1158/1055-9965.EPI-10-1187; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hildesheim A, 2002, VIRUS RES, V89, P229, DOI 10.1016/S0168-1702(02)00191-0; Junes-Gill K, 2008, J MED VIROL, V80, P1639, DOI 10.1002/jmv.21238; Kammer C, 2000, J GEN VIROL, V81, P1975, DOI 10.1099/0022-1317-81-8-1975; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; KrennHrubec K, 2011, J MED VIROL, V83, P651, DOI 10.1002/jmv.22011; Lee K, 2008, VIRUS RES, V131, P106, DOI 10.1016/j.virusres.2007.08.003; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Londesborough P, 1996, INT J CANCER, V69, P364; MAY M, 1994, EMBO J, V13, P1460, DOI 10.1002/j.1460-2075.1994.tb06400.x; Mazumder D, 2011, GYNECOL ONCOL, V123, P597, DOI 10.1016/j.ygyno.2011.08.004; Mendoza L, 2013, INT J GYNECOL OBSTET, V122, P44, DOI 10.1016/j.ijgo.2013.01.020; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Pande S, 2008, J CLIN MICROBIOL, V46, P1060, DOI 10.1128/JCM.02202-07; Picconi MA, 2003, J MED VIROL, V69, P546, DOI 10.1002/jmv.10343; Pientong C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-30; Qmichou Z, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-378; Quint KD, 2010, GYNECOL ONCOL, V117, P297, DOI 10.1016/j.ygyno.2010.02.003; Rabelo-Santos SH, 2006, INT J GYNECOL PATHOL, V25, P393, DOI 10.1097/01.pgp.0000215302.17029.0c; Roura E, 2014, INT J CANCER, V135, P453, DOI 10.1002/ijc.28666; Rozen S, 2000, Methods Mol Biol, V132, P365; Rumbold AR, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-243; Sabol I, 2008, J MED VIROL, V80, P2134, DOI 10.1002/jmv.21304; Sabol I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041045; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Schiffman M, 2010, CANCER RES, V70, P3159, DOI 10.1158/0008-5472.CAN-09-4179; Schiffman Mark, 2009, Infect Agent Cancer, V4, P8, DOI 10.1186/1750-9378-4-8; Sichero L, 2006, BRAZ J MED BIOL RES, V39, P707, DOI 10.1590/S0100-879X2006000600002; Sichero L, 2007, INT J CANCER, V120, P1763, DOI 10.1002/ijc.22481; Sichero L, 2012, VIROLOGY, V432, P127, DOI 10.1016/j.virol.2012.06.011; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Smith JS, 2004, INT J CANCER, V111, P431, DOI 10.1002/ijc.20257; Terai M, 2001, J GEN VIROL, V82, P2035, DOI 10.1099/0022-1317-82-9-2035; Tonon SA, 2007, INT J INFECT DIS, V11, P76, DOI 10.1016/j.ijid.2006.01.002; Tsakogiannis D, 2014, ARCH VIROL, V159, P51, DOI 10.1007/s00705-013-1790-8; Vaccarella S, 2008, INT J EPIDEMIOL, V37, P536, DOI 10.1093/ije/dyn033; Villa LL, 2000, J GEN VIROL, V81, P2959, DOI 10.1099/0022-1317-81-12-2959; Vosa L, 2012, J VIROL, V86, P348, DOI 10.1128/JVI.05606-11; Wheeler CM, 2008, OBSTET GYN CLIN N AM, V35, P519, DOI 10.1016/j.ogc.2008.09.006; Winer RL, 2014, INT J CANCER, V134, P1889, DOI 10.1002/ijc.28509; XI LF, 1995, J INFECT DIS, V172, P747, DOI 10.1093/infdis/172.3.747; Xi LF, 2007, CANCER EPIDEM BIOMAR, V16, P4, DOI 10.1158/1055-9965.EPI-06-0670; Xi LF, 2006, J NATL CANCER I, V98, P1045, DOI 10.1093/jnci/djj297; Zehbe I, 1998, LANCET, V352, P1441, DOI 10.1016/S0140-6736(05)61263-9; Zehbe I, 2001, INT J CANCER, V94, P711, DOI 10.1002/ijc.1520; Zuna RE, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-19; Zuna RE, 2009, INT J CANCER, V125, P2609, DOI 10.1002/ijc.24706; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	81	57	59	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100746	10.1371/journal.pone.0100746	http://dx.doi.org/10.1371/journal.pone.0100746			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983739	Green Published, Green Submitted, gold			2022-12-27	WOS:000339635000037
J	Rijken, MJ; De Livera, AM; Lee, SJ; Boel, ME; Rungwilailaekhiri, S; Wiladphaingern, J; Paw, MK; Pimanpanarak, M; Pukrittayakamee, S; Simpson, JA; Nosten, F; McGready, R				Rijken, Marcus J.; De Livera, Alysha M.; Lee, Sue J.; Boel, Machteld E.; Rungwilailaekhiri, Suthatsana; Wiladphaingern, Jacher; Paw, Moo Kho; Pimanpanarak, Mupawjay; Pukrittayakamee, Sasithon; Simpson, Julie A.; Nosten, Francois; McGready, Rose			Quantifying Low Birth Weight, Preterm Birth and Smallf-or-Gestational-Age Effects of Malaria in Pregnancy: A Population Cohort Study	PLOS ONE			English	Article							PROSPECTIVE ULTRASOUND; FETAL-GROWTH; MORTALITY; RISK	Background: The association between malaria during pregnancy and low birth weight (LBW) is well described. This manuscript aims to quantify the relative contribution of malaria to small-for-gestational-age (SGA) infants and preterm birth (PTB) in pregnancies accurately dated by ultrasound on the Thai-Myanmar border at the Shoklo Malaria Research Unit. Methods and Findings: From 2001 to 2010 in a population cohort of prospectively followed pregnancies, we analyzed all singleton newborns who were live born, normal, weighed in the first hour of life and with a gestational age (GA) between 28+0 and 41+6 weeks. Fractional polynomial regression was used to determine the mean birthweight and standard deviation as functions of GA. Risk differences and factors of LBW and SGA were studied across the range of GA for malaria and non-malaria pregnancies. From 10,264 newborns records, population centiles were created. Women were screened for malaria by microscopy a median of 22 [range 1-38] times and it was detected and treated in 12.6% (1,292) of pregnancies. Malaria was associated with LBW, PTB, and SGA compared to those without malaria. Nearly two-thirds of PTB were classified as LBW (68% (539/789)), most of which 83% (447/539) were not SGA. After GA 39 weeks, 5% (298/5,966) of non-LBW births were identified as SGA. Low body mass index, primigravida, hypertension, smoking and female sex of the newborn were also significantly and independently associated with LBW and SGA consistent with previous publications. Conclusions: Treated malaria in pregnancy was associated with an increased risk for LBW, PTB, and SGA, of which the latter are most important for infant survival. Using LBW as an endpoint without adjusting for GA incorrectly estimated the effects of malaria in pregnancy. Ultrasound should be used for dating pregnancies and birth weights should be expressed as a function (or adjusted for GA) of GA in future malaria in pregnancy studies.	[Rijken, Marcus J.; Lee, Sue J.; Boel, Machteld E.; Rungwilailaekhiri, Suthatsana; Wiladphaingern, Jacher; Paw, Moo Kho; Pimanpanarak, Mupawjay; Nosten, Francois; McGready, Rose] Mahidol Univ, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Fac Trop Med, Mae Sot, Thailand; [De Livera, Alysha M.; Simpson, Julie A.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Lee, Sue J.; Nosten, Francois; McGready, Rose] Univ Oxford, Ctr Trop Med, Nuffield Dept Med, Oxford, England; [Pukrittayakamee, Sasithon] Mahidol Univ, Fac Trop Med, Bangkok, Thailand	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Melbourne; University of Oxford; Mahidol University	Rijken, MJ (corresponding author), Mahidol Univ, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Fac Trop Med, Mae Sot, Thailand.	marcus@shoklo-unit.com	McGready, Rose/A-3290-2014; Simpson, Julie A/P-7299-2014; Nosten, Francois/AAC-5509-2019; De Livera, Alysha/AAU-6661-2021	McGready, Rose/0000-0003-1621-3257; Nosten, Francois/0000-0002-7951-0745; De Livera, Alysha/0000-0003-4981-4155; Rijken, Marcus/0000-0003-0914-5508; Paw, Moo Kho/0000-0002-4008-3168; Simpson, Julie/0000-0002-2660-2013	Wellcome Trust of Great Britain; Christophe Merieux Prize; National Health & Medical Research Centre of Australia (NHMRC) Centre of Research Excellence [1035261]	Wellcome Trust of Great Britain(Wellcome Trust); Christophe Merieux Prize; National Health & Medical Research Centre of Australia (NHMRC) Centre of Research Excellence	The Shoklo Malaria Research Unit is part of the Mahidol Oxford University Research Unit, at the Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand and supported by the Wellcome Trust of Great Britain. MJR and MEB were supported by the Christophe Merieux Prize to FN (2008). AL was supported by the National Health & Medical Research Centre of Australia (NHMRC) Centre of Research Excellence 1035261, awarded to the Victorian Centre for Biostatistics (ViCBiostat). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001152; Ambler G, 2001, J STAT COMPUT SIM, V69, P89, DOI 10.1080/00949650108812083; Benner A, 2005, R NEWS, V5, P20; Huynh BT, 2011, AM J TROP MED HYG, V85, P214, DOI 10.4269/ajtmh.2011.11-0103; Butt K, 2014, J OBSTET GYNAECOL CA, V36, P171, DOI 10.1016/S1701-2163(15)30664-2; Carrara VI, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-45; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9; Kayentao K, 2013, JAMA-J AM MED ASSOC, V309, P594, DOI 10.1001/jama.2012.216231; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Landis SH, 2009, EPIDEMIOL INFECT, V137, P294, DOI 10.1017/S0950268808000915; Leung TN, 2008, ULTRASOUND OBST GYN, V31, P321, DOI 10.1002/uog.5192; Marchant T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001292; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; McGready R, 2012, LANCET INFECT DIS, V12, P388, DOI 10.1016/S1473-3099(11)70339-5; Mikolajczyk RT, 2011, LANCET, V377, P1855, DOI 10.1016/S0140-6736(11)60364-4; Owen P, 1998, BRIT J OBSTET GYNAEC, V105, P536, DOI 10.1111/j.1471-0528.1998.tb10155.x; Piola P, 2010, LANCET INFECT DIS, V10, P762, DOI 10.1016/S1473-3099(10)70202-4; Pulver LS, 2009, PEDIATRICS, V123, pE1072, DOI 10.1542/peds.2008-3288; Rijken MJ, 2011, BJOG-INT J OBSTET GY, V118, P671, DOI 10.1111/j.1471-0528.2010.02880.x; Rijken MJ, 2009, ULTRASOUND OBST GYN, V34, P395, DOI 10.1002/uog.7350; Rijken MJ, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-222; Rijken MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031411; Rijken MJ, 2012, LANCET INFECT DIS, V12, P75, DOI 10.1016/S1473-3099(11)70315-2; ROBINSON HP, 1975, BRIT J OBSTET GYNAEC, V82, P702, DOI 10.1111/j.1471-0528.1975.tb00710.x; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Royston P, 1998, ULTRASOUND OBST GYN, V11, P30, DOI 10.1046/j.1469-0705.1998.11010030.x; Schmiegelow C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053794; Umbers AJ, 2011, TRENDS PARASITOL, V27, P168, DOI 10.1016/j.pt.2011.01.007; Verburg BO, 2008, ULTRASOUND OBST GYN, V31, P388, DOI 10.1002/uog.5225; Wylie BJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-183; Zhang J, 2010, AM J OBSTET GYNECOL, V202, P522, DOI 10.1016/j.ajog.2009.10.889	32	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100247	10.1371/journal.pone.0100247	http://dx.doi.org/10.1371/journal.pone.0100247			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983755	Green Published, gold, Green Submitted			2022-12-27	WOS:000339635000017
J	Su, B; Gao, LQ; Baranowski, C; Gillard, B; Wang, JM; Ransom, R; Ko, HK; Gelman, IH				Su, Bing; Gao, Lingqiu; Baranowski, Catherine; Gillard, Bryan; Wang, Jianmin; Ransom, Ryan; Ko, Hyun-Kyung; Gelman, Irwin H.			A Genome-Wide RNAi Screen Identifies FOXO4 as a Metastasis-Suppressor through Counteracting PI3K/AKT Signal Pathway in Prostate Cancer	PLOS ONE			English	Article							ANDROGEN RECEPTOR; CELL-MIGRATION; RUNX2; EXPRESSION; PROTEIN; INVASIVENESS; PROGRESSION; MECHANISMS; BINDING; MODELS	Activation of the PI3K/AKT signal pathway is a known driving force for the progression to castration-recurrent prostate cancer (CR-CaP), which constitutes the major lethal phenotype of CaP. Here, we identify using a genomic shRNA screen the PI3K/AKT-inactivating downstream target, FOXO4, as a potential CaP metastasis suppressor. FOXO4 protein levels inversely correlate with the invasive potential of a panel of human CaP cell lines, with decreased mRNA levels correlating with increased incidence of clinical metastasis. Knockdown (KD) of FOXO4 in human LNCaP cells causes increased invasion in vitro and lymph node (LN) metastasis in vivo without affecting indices of proliferation or apoptosis. Increased Matrigel invasiveness was found by KD of FOXO1 but not FOXO3. Comparison of differentially expressed genes affected by FOXO4-KD in LNCaP cells in culture, in primary tumors and in LN metastases identified a panel of upregulated genes, including PIP, CAMK2N1, PLA2G16 and PGC, which, if knocked down by siRNA, could decrease the increased invasiveness associated with FOXO4 deficiency. Although only some of these genes encode FOXO promoter binding sites, they are all RUNX2-inducible, and RUNX2 binding to the PIP promoter is increased in FOXO4-KD cells. Indeed, the forced expression of FOXO4 reversed the increased invasiveness of LNCaP/shFOXO4 cells; the forced expression of FOXO4 did not alter RUNX2 protein levels, yet it decreased RUNX2 binding to the PIP promoter, resulting in PIP downregulation. Finally, there was a correlation between FOXO4, but not FOXO1 or FOXO3, downregulation and decreased metastasis-free survival in human CaP patients. Our data strongly suggest that increased PI3K/AKT-mediated metastatic invasiveness in CaP is associated with FOXO4 loss, and that mechanisms to induce FOXO4 re-expression might suppress CaP metastatic aggressiveness.	[Su, Bing] Shenzhen PKU HKUST Med Ctr, Biomed Res Inst, Shenzhen, Guangdong, Peoples R China; [Su, Bing; Gao, Lingqiu; Baranowski, Catherine; Ransom, Ryan; Gelman, Irwin H.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Gillard, Bryan] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Wang, Jianmin] Roswell Pk Canc Inst, Dept Biostat & Bioinformat, Buffalo, NY 14263 USA; [Ko, Hyun-Kyung] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Yale University	Gelman, IH (corresponding author), Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA.	irwin.gelman@roswellpark.org	Ko, Hyun-Kyung/H-7596-2017; wang, jian/GVS-0711-2022	Ko, Hyun-Kyung/0000-0002-7896-362X; 	Department of Defense [PC040256, PC061246]; National Cancer Institute [CA94108]; National Cancer Center Support Grant [2P30 CA016056]; National Natural Science Foundation of China [81272380]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Center Support Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	IHG was supported by Department of Defense, (www.army.mil) grants PC040256 and PC061246, National Cancer Institute (www.cancer.gov) grant CA94108 (I.H.G.), and National Cancer Center Support Grant 2P30 CA016056. BS was supported by National Natural Science Foundation of China No. 81272380. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akech J, 2010, ONCOGENE, V29, P811, DOI 10.1038/onc.2009.389; Azzouni F, 2012, UROL CLIN N AM, V39, P435, DOI 10.1016/j.ucl.2012.07.002; Baniwal SK, 2012, J CELL PHYSIOL, V227, P2276, DOI 10.1002/jcp.22966; Baniwal SK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-258; Benelli R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-142; Bitting RL, 2013, ENDOCR-RELAT CANCER, V20, pR83, DOI 10.1530/ERC-12-0394; Bjerke GA, 2013, ONCOGENE IN PRESS; Blyth K, 2010, BLOOD CELL MOL DIS, V45, P117, DOI 10.1016/j.bcmd.2010.05.007; Bu YH, 2011, INT J CANCER, V128, P1836, DOI 10.1002/ijc.25524; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Chen QH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015288; Dong XY, 2006, CANCER RES, V66, P6998, DOI 10.1158/0008-5472.CAN-06-0411; Egan A, 2014, CANCER TREAT REV, V40, P426, DOI 10.1016/j.ctrv.2013.09.011; Eijkelenboom A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.74; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Ittmann M, 2013, CANCER RES, V73, P2718, DOI 10.1158/0008-5472.CAN-12-4213; Kikuno N, 2007, ONCOGENE, V26, P7647, DOI 10.1038/sj.onc.1210572; Lam EWF, 2013, NAT REV CANCER, V13, P482, DOI 10.1038/nrc3539; Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031; LaTulippe E, 2002, CANCER RES, V62, P4499; Lee MJ, 2009, GASTROENTEROLOGY, V137, P1138, DOI 10.1053/j.gastro.2009.04.015; Lin D, 2013, CURR OPIN UROL, V23, P214, DOI 10.1097/MOU.0b013e32835e9f07; Little GH, 2014, CANCER RES, V74, P2857, DOI 10.1158/0008-5472.CAN-13-2003; Little GH, 2012, NUCLEIC ACIDS RES, V40, P3538, DOI 10.1093/nar/gkr1219; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Park SI, 2008, CANCER RES, V68, P3323, DOI 10.1158/0008-5472.CAN-07-2997; Sarker D, 2009, CLIN CANCER RES, V15, P4799, DOI 10.1158/1078-0432.CCR-08-0125; Sharifi N, 2013, ENDOCRINOLOGY, V154, P4010, DOI 10.1210/en.2013-1466; Shin DJ, 2012, NUCLEIC ACIDS RES, V40, P11499, DOI 10.1093/nar/gks932; Shukla S, 2013, PROSTATE, V73, P1507, DOI 10.1002/pros.22698; Su B, 2010, J BIOL CHEM, V285, P4578, DOI 10.1074/jbc.M109.073494; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thiolloy S, 2011, SEMIN CANCER BIOL, V21, P89, DOI 10.1016/j.semcancer.2010.12.008; van der Vos KE, 2011, ANTIOXID REDOX SIGN, V14, P579, DOI 10.1089/ars.2010.3419; van Duijn PW, 2010, PROSTATE, V70, P135, DOI 10.1002/pros.21045; Webber MM, 1997, PROSTATE, V30, P136, DOI 10.1002/(SICI)1097-0045(19970201)30:2<136::AID-PROS9>3.0.CO;2-M; Yang JY, 2011, CURR DRUG TARGETS, V12, P1284, DOI 10.2174/138945011796150299; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Yuan X, 2014, ONCOGENE, V33, P2815, DOI 10.1038/onc.2013.235; Yun SJ, 2012, PROSTATE CANCER P D, V15, P369, DOI 10.1038/pcan.2012.31; Zhang HJ, 2011, CANCER RES, V71, P3257, DOI 10.1158/0008-5472.CAN-10-2603; Zhang YQ, 2011, CANCER BIOL THER, V12, P253, DOI 10.4161/cbt.12.4.15954	44	41	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101411	10.1371/journal.pone.0101411	http://dx.doi.org/10.1371/journal.pone.0101411			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983969	gold, Green Submitted, Green Published			2022-12-27	WOS:000339635000100
J	Zhang, N; Ying, MD; Wu, YP; Zhou, ZH; Ye, ZM; Li, H; Lin, DS				Zhang, Ning; Ying, Mei-Dan; Wu, Yong-Ping; Zhou, Zhi-Hong; Ye, Zhao-Ming; Li, Hang; Lin, Ding-Sheng			Hyperoside, a Flavonoid Compound, Inhibits Proliferation and Stimulates Osteogenic Differentiation of Human Osteosarcoma Cells	PLOS ONE			English	Article							CANCER-STEM-CELLS; APOPTOSIS; THERAPY; HYPERIN; BETA	Osteosarcoma, one of the most common malignant bone tumours, is generally considered a differentiation disease caused by genetic and epigenetic disruptions in the terminal differentiation of osteoblasts. Novel therapies based on the non-cytotoxic induction of cell differentiation-responsive pathways could represent a significant advance in treating osteosarcoma; however, effective pharmaceuticals to induce differentiation are lacking. In the present study, we investigated the effect of hyperoside, a flavonoid compound, on the osteoblastic differentiation of U2OS and MG63 osteosarcoma cells in vitro. Our results demonstrated that hyperoside inhibits the proliferation of osteosarcoma cells by inducing G(0)/G(1) arrest in the cell cycle, without causing obvious cell death. Cell migration assay further suggested that hyperoside could inhibit the invasion potential of osteosarcoma cells. Additionally, osteopontin and runt-related transcription factor 2 protein levels and osteocalcin activation were upregulated dramatically in hyperoside-treated osteosarcoma cells, suggesting that hyperoside may stimulates osteoblastic differentiation in osteosarcoma cells. This differentiation was accompanied by the activation of transforming growth factor (TGF)-beta and bone morphogenetic protein-2, suggesting that the hyperoside-induced differentiation involves the TGF-beta signalling pathway. To our knowledge, this study is the first to evaluate the differentiation effect of hyperoside in osteosarcoma cells and assess the possible potential for hyperoside treatment as a future therapeutic approach for osteosarcoma differentiation therapy.	[Zhang, Ning; Wu, Yong-Ping; Ye, Zhao-Ming; Li, Hang] Zhejiang Univ, Sch Med, Dept Orthopaed, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Ying, Mei-Dan] Zhejiang Univ, Inst Pharmacol & Toxicol, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Zhi-Hong] Zhejiang Chinese Med Univ, Affiliated Hosp 3, Dept Orthopaed, Hangzhou, Zhejiang, Peoples R China; [Lin, Ding-Sheng] Affiliated Second Hosp, Wenzhou Med College, Dept Orthopaed, Wenzhou, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang Chinese Medical University	Ye, ZM (corresponding author), Zhejiang Univ, Sch Med, Dept Orthopaed, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China.	yezhaominghz@163.com; zrorthopaedics@gmail.com			Zhejiang Provincial Natural Science Foundation of China [LY13H160021, Y2100897]; TCM Young Scientists of Zhejiang [2012ZQ018]; Science and Technology Bureau of Zhejiang Province [2014C33218]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); TCM Young Scientists of Zhejiang; Science and Technology Bureau of Zhejiang Province	This work was supported by grants from Zhejiang Provincial Natural Science Foundation of China No. LY13H160021; Y2100897, TCM Young Scientists of Zhejiang No. 2012ZQ018, the Science and Technology Bureau of Zhejiang Province No. 2014C33218. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari AS, 2010, CANCER RES, V70, P4602, DOI 10.1158/0008-5472.CAN-09-3463; Balooch G, 2005, P NATL ACAD SCI USA, V102, P18813, DOI 10.1073/pnas.0507417102; BONEWALD LF, 1992, J BIOL CHEM, V267, P8943; Bruland OS, 1997, EUR J CANCER, V33, P1725, DOI 10.1016/S0959-8049(97)00252-9; Burns BS, 2001, CLIN ORTHOP RELAT R, P259; Cao F, 2006, EUR J PHARM SCI, V29, P385, DOI 10.1016/j.ejps.2006.07.007; Cao J, 2009, FREE RADICAL BIO MED, V47, P536, DOI 10.1016/j.freeradbiomed.2009.05.024; Choi RCY, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nen085; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Di Fiore R, 2009, J CELL PHYSIOL, V219, P301, DOI 10.1002/jcp.21667; Ferguson WS, 2001, CANCER INVEST, V19, P292, DOI 10.1081/CNV-100102557; Glass DA, 2007, ENDOCRINOLOGY, V148, P2630, DOI 10.1210/en.2006-1372; Haydon RC, 2002, CLIN CANCER RES, V8, P1288; He BC, 2010, CLIN CANCER RES, V16, P2235, DOI 10.1158/1078-0432.CCR-09-2499; Lee S, 2004, ARCH PHARM RES, V27, P628, DOI 10.1007/BF02980162; Li ZL, FREE RADIC BIOL MED, V57, P132; Liu PPL, 1996, ONCOLOGY, V53, P275; Longhi A, 2006, CANCER TREAT REV, V32, P423, DOI 10.1016/j.ctrv.2006.05.005; Luo P, 2010, ONCOGENE, V29, P2772, DOI 10.1038/onc.2010.50; Luo PH, 2007, STEM CELLS, V25, P2628, DOI 10.1634/stemcells.2007-0264; NODA M, 1995, ANN NY ACAD SCI, V760, P242, DOI 10.1111/j.1749-6632.1995.tb44634.x; Nozaki K, 1999, J VET MED SCI, V61, P649, DOI 10.1292/jvms.61.649; O'Brien CA, 2010, CLIN CANCER RES, V16, P3113, DOI 10.1158/1078-0432.CCR-09-2824; Pensak MJ, 2013, CURR PHARM DESIGN, V19, P3466, DOI 10.2174/1381612811319190012; Pitha-Rowe I, 2003, LEUKEMIA, V17, P1723, DOI 10.1038/sj.leu.2403065; Sun H, 2013, FITOTERAPIA, V84, P174, DOI 10.1016/j.fitote.2012.11.010; Tang N, 2008, CLIN ORTHOP RELAT R, V466, P2114, DOI 10.1007/s11999-008-0335-z; Testi AM, 2005, BLOOD, V106, P447, DOI 10.1182/blood-2004-05-1971; Tirino V, 2011, FASEB J, V25, P2022, DOI 10.1096/fj.10-179036; Tirino V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003469; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Wang L, 2013, INT J ONCOL, V43, P1095, DOI 10.3892/ijo.2013.2030; Wang WQ, 1996, ACTA PHARM SINIC, V17, P341; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Xiao YY, 2006, INT J PHARMACEUT, V319, P162, DOI 10.1016/j.ijpharm.2006.03.037; Xiao YY, 2006, INT J PHARMACEUT, V307, P77, DOI 10.1016/j.ijpharm.2005.10.001; Ying M, 2013, ONCOGENE; Ying MD, 2008, J PHARMACOL EXP THER, V325, P758, DOI 10.1124/jpet.107.135657; Ying MD, 2013, MOL CANCER THER, V12, P195, DOI 10.1158/1535-7163.MCT-12-0433; Zenmyo M, 2001, HUM PATHOL, V32, P410, DOI 10.1053/hupa.2001.23524; Zou YP, 2004, J AGR FOOD CHEM, V52, P5032, DOI 10.1021/jf049571r	41	44	52	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e98973	10.1371/journal.pone.0098973	http://dx.doi.org/10.1371/journal.pone.0098973			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983940	Green Submitted, gold, Green Published			2022-12-27	WOS:000339635000009
J	Kim, SK; Jung, WH; Koo, JS				Kim, Sang Kyum; Jung, Woo Hee; Koo, Ja Seung			Differential Expression of Enzymes Associated with Serine/Glycine Metabolism in Different Breast Cancer Subtypes	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; MOLECULAR SUBTYPE; OXIDATIVE STRESS; FIBROBLASTS; PROTEINS; GLYCINE; GLUT-1; GROWTH; CELLS; CAIX	Purpose: Glycine and serine are well-known, classic metabolites of glycolysis. Here, we profiled the expression of enzymes associated with serine/glycine metabolism in different molecular subtypes of breast cancer and discuss their potential clinical implications. Methods: We used western blotting and immunohistochemistry to examine five serine-/glycine-metabolism-associated proteins (PHGDH, PSAT, PSPH, SHMT, and GLDC) in six breast cancer cell lines and 709 breast cancer cases using tissue microarray (TMA). Results: PHGDH and PSPH, associated with serine metabolism, were highly expressed in the TNBC cells. GLDC, associated with glycine metabolism, was highly expressed in HER-2-positive MDA-MB-453 and TNBC-related MDA-MB-435S. TMA showed that the TNBC-type breast cancer tissues highly expressed PHGDH, PSPH, and SHMT1, but not the luminal-A-type tissues (p<0.001). PSPH and SHMT1 expression in the tumor stroma of HER-2-type cancers was the highest, but the luminal-A tissues showed the lowest expression (p<0.001). GLDC was most frequently expressed in cancer cells and stroma of the HER-2-positive cancers and least frequently in TNBC (p<0.001). By Cox multivariate analysis, tumor PSPH positivity (hazard ratio [HR]: 2.068, 95% confidence interval [CI]: 1.049-4.079, p = 0.036), stromal PSPH positivity (HR: 2.152, 95% CI: 1.107-4.184, p = 0.024), and stromal SHMT1 negativity (HR: 2.142, 95% CI: 1.219-3.764, p = 0.008) were associated with short overall survival. Conclusions: Expression of serine-metabolism-associated proteins was increased in TNBC and decreased in the luminal-A cancers. Expression of glycine-metabolism-associated proteins was high in the tumor and stroma of HER-2-positive cancers.	[Kim, Sang Kyum; Jung, Woo Hee; Koo, Ja Seung] Yonsei Univ Coll Med, Brain Korea PLUS Project Med Sci 21, Dept Pathol, Severance Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System	Koo, JS (corresponding author), Yonsei Univ Coll Med, Brain Korea PLUS Project Med Sci 21, Dept Pathol, Severance Hosp, Seoul, South Korea.	kjs1976@yuhs.ac		Kim, Sang Kyum/0000-0003-0768-9923; koo, ja seung/0000-0003-4546-4709	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A1002886]; Yonsei University College of Medicine [6-2013-0146]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Yonsei University College of Medicine(General Electric)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A1002886). This study was supported by a faculty research grant from Yonsei University College of Medicine for 2013 (6-2013-0146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonuccelli G, 2010, CELL CYCLE, V9, P3506, DOI 10.4161/cc.9.17.12731; Choi J, 2013, PATHOBIOLOGY, V80, P41, DOI 10.1159/000339513; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Kim S, 2013, J BREAST CANCER, V16, P146, DOI 10.4048/jbc.2013.16.2.146; Kim S, 2013, ENDOCR-RELAT CANCER, V20, P339, DOI 10.1530/ERC-12-0398; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P3256, DOI 10.4161/cc.9.16.12553; Mullarky E, 2011, PIGM CELL MELANOMA R, V24, P1112, DOI 10.1111/j.1755-148X.2011.00919.x; Pavlides S, 2010, CELL CYCLE, V9, P2201, DOI 10.4161/cc.9.11.11848; Pavlides S, 2009, CELL CYCLE, V8, P3984, DOI 10.4161/cc.8.23.10238; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pinheiro C, 2011, HISTOL HISTOPATHOL, V26, P1279, DOI 10.14670/HH-26.1279; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stackhouse BL, 2005, BREAST CANCER RES TR, V93, P247, DOI 10.1007/s10549-005-5158-y; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Won KY, 2010, HUM PATHOL, V41, P107, DOI 10.1016/j.humpath.2009.07.006; Younes M, 1995, ANTICANCER RES, V15, P2895; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050	23	59	61	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101004	10.1371/journal.pone.0101004	http://dx.doi.org/10.1371/journal.pone.0101004			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979213	gold, Green Published, Green Submitted			2022-12-27	WOS:000338506400060
J	Lorenzi, T; Nitulescu, EA; Zizzi, A; Lorenzi, M; Paolinelli, F; Aspriello, SD; Banita, M; Craitoiu, S; Goteri, G; Barbatelli, G; Lombardi, T; Di Felice, R; Marzioni, D; Rubini, C; Castellucci, M				Lorenzi, Teresa; Nitulescu, Elena Annabel; Zizzi, Antonio; Lorenzi, Maria; Paolinelli, Francesca; Aspriello, Simone Domenico; Banita, Monica; Craitoiu, Stefania; Goteri, Gaia; Barbatelli, Giorgio; Lombardi, Tommaso; Di Felice, Roberto; Marzioni, Daniela; Rubini, Corrado; Castellucci, Mario			The Novel Role of HtrA1 in Gingivitis, Chronic and Aggressive Periodontitis	PLOS ONE			English	Article							SERINE-PROTEASE HTRA1; 5TH EUROPEAN WORKSHOP; TISSUE DESTRUCTION; CONSENSUS REPORT; NECROSIS-FACTOR; EXPRESSION; DISEASE; METALLOPROTEINASES; FAMILY	Proteolytic tissue degradation is a typical phenomenon in inflammatory periodontal diseases HtrA1 (High temperature requirement A 1) has a serine protease activity and is able to degrade fibronectin whose fragments induce the expression and secretion of several matrix metalloproteinases (MMPs). The aim of this study was to investigate for the first time if HtrA1 has a role in gingivitis and in generalized forms of chronic and aggressive periodontitis. Expression of HtrA1 was investigated in clinically healthy gingiva, 16 gingivitis, 4 generalized chronic periodontitis and 10 generalized aggressive periodontitis by immunohistochemistry and real PCR. Statistical comparisons were performed by the Kruskall-Wallis test. Significantly higher levels of HtrA1 mRNA and protein expression were observed in pathological respect to healthy tissues. In particular, we detected an increase of plasma cell HtrA1 immunostaining from gingivitis to chronic and aggressive periodontitis, with the higher intensity in aggressive disease. In addition we observed the presence of HtrA1 in normal and pathological epithelium, an increased expression, particularly in its superficial layer, associated with increasingly severe forms of periodontal disease. We can affirm that HtrA1 expression in plasma cells could be correlated with the destruction of pathological periodontal tissue, probably due to its ability to trigger the overproduction of MMPs and to increase the inflammatory mediators TNF-alpha and IL-1 beta by inhibition of TGF-beta. Moreover, epithelial HtrA1 immunostaining suggests a participation of the molecule in the host inflammatory immune responses for the control of periodontal infection.	[Lorenzi, Teresa; Lorenzi, Maria; Paolinelli, Francesca; Barbatelli, Giorgio; Marzioni, Daniela; Castellucci, Mario] Univ Politecn Marche, Dept Expt & Clin Med, Ancona, Italy; [Nitulescu, Elena Annabel; Banita, Monica; Craitoiu, Stefania] Univ Med & Pharm Craiova, Dept Histol, Craiova, Romania; [Zizzi, Antonio; Goteri, Gaia; Rubini, Corrado] Univ Politecn Marche, United Hosp, Dept Med Sci & Publ Hlth, Ancona, Italy; [Aspriello, Simone Domenico] Univ Politecn Marche, Dept Clin Specialist & Dent Sci, Ancona, Italy; [Lombardi, Tommaso] Univ Geneva, Div Stomatol & Oral Surg, Lab Oral & Maxillofacial Pathol, Geneva, Switzerland; [Di Felice, Roberto] San Benedetto Tronto, Ascoli Piceno, Italy	Marche Polytechnic University; University of Medicine & Pharmacy of Craiova; Marche Polytechnic University; Marche Polytechnic University; University of Geneva	Lorenzi, T (corresponding author), Univ Politecn Marche, Dept Expt & Clin Med, Ancona, Italy.	teresalorenzi@yahoo.it; d.marzioni@univpm.it		Zizzi, Antonio/0000-0001-5253-693X; Lorenzi, Teresa/0000-0002-3723-5378	Universita Politecnica delle Marche; European Union - AM POS-DRU project [-7603]	Universita Politecnica delle Marche; European Union - AM POS-DRU project	This work was funded by Universita Politecnica delle Marche with grants to G. G., G.B., D.M., C.R., M.C. EAN was supported by a fellowship from European Union - AM POS-DRU project with title "Supporting young people through PhD doctoral scholarships " ID -7603. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Artese L, 2011, CLIN ORAL INVEST, V15, P233, DOI 10.1007/s00784-009-0374-1; Aspriello SD, 2011, J PERIODONTAL RES, V46, P164, DOI 10.1111/j.1600-0765.2010.01324.x; Bedford L, 2010, TRENDS CELL BIOL, V20, P391, DOI 10.1016/j.tcb.2010.03.007; Beklen A, 2007, J DENT RES, V86, P347, DOI 10.1177/154405910708600409; Berglundh T, 2005, J CLIN PERIODONTOL, V32, P87, DOI 10.1111/j.1600-051X.2005.00820.x; Bugaut A, 2012, NUCLEIC ACIDS RES, V40, P4727, DOI 10.1093/nar/gks068; Chien J, 2004, ONCOGENE, V23, P1636, DOI 10.1038/sj.onc.1207271; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Cutler CW, 2004, PERIODONTOL 2000, V35, P135, DOI 10.1111/j.0906-6713.2004.003560.x; Ford PJ, 2010, PERIODONTOL 2000, V53, P111, DOI 10.1111/j.1600-0757.2010.00349.x; Garlet GP, 2007, CLIN EXP IMMUNOL, V147, P128, DOI 10.1111/j.1365-2249.2006.03260.x; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Goncalves LDR, 2008, J PERIODONTAL RES, V43, P570, DOI 10.1111/j.1600-0765.2008.01101.x; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Graves DT, 2003, J PERIODONTOL, V74, P391, DOI 10.1902/jop.2003.74.3.391; Haffajee AD, 2005, PERIODONTOL 2000, V38, P9, DOI 10.1111/j.1600-0757.2005.00112.x; Hannas AR, 2007, ACTA ODONTOL SCAND, V65, P1, DOI 10.1080/00016350600963640; Lorenzi T, 2009, PLACENTA, V30, P35, DOI 10.1016/j.placenta.2008.10.016; Marzioni D, 2009, HISTOL HISTOPATHOL, V24, P1213, DOI 10.14670/HH-24.1213; Nie GY, 2006, DEV DYNAM, V235, P3448, DOI 10.1002/dvdy.20999; Offenbacher S, 1996, Ann Periodontol, V1, P821, DOI 10.1902/annals.1996.1.1.821; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Okada H, 1998, CRIT REV ORAL BIOL M, V9, P248, DOI 10.1177/10454411980090030101; Sanz M, 2005, J CLIN PERIODONTOL, V32, P54, DOI 10.1111/j.1600-051X.2005.00827.x; Stanton H, 2002, BIOCHEM J, V364, P181, DOI 10.1042/bj3640181; Steinsvoll S, 1999, J CLIN PERIODONTOL, V26, P366, DOI 10.1034/j.1600-051X.1999.260606.x; Tocharus J, 2004, DEV GROWTH DIFFER, V46, P257; Tonetti MS, 2005, J CLIN PERIODONTOL, V32, P210, DOI 10.1111/j.1600-051X.2005.00822.x	30	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e96978	10.1371/journal.pone.0096978	http://dx.doi.org/10.1371/journal.pone.0096978			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979214	gold, Green Published, Green Submitted			2022-12-27	WOS:000338506400001
J	Milovanovic, I; Njuieyon, F; Deghmoun, S; Chevenne, D; Levy-Marchal, C; Beltrand, J				Milovanovic, Ivana; Njuieyon, Falucar; Deghmoun, Samia; Chevenne, Didier; Levy-Marchal, Claire; Beltrand, Jacques			SGA Children with Moderate Catch-Up Growth Are Showing the Impaired Insulin Secretion at the Age of 4	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; FOR-GESTATIONAL-AGE; BETA-CELL MASS; ORAL GLUCOSE-TOLERANCE; X-RAY ABSORPTIOMETRY; SKINFOLD MEASUREMENTS; METABOLIC SYNDROME; PROSPECTIVE COHORT; POSTNATAL-GROWTH; BODY-COMPOSITION	Background: Being born small for gestational age (SGA) is a risk factor for later development of type 2 diabetes. The development of glucose tolerance disorders in adults involves insulin resistance and impaired insulin secretion. Objective: To evaluate insulin secretion and insulin sensitivity in a 4-yr old cohort of SGA. Methods: 85 children were prospectively followed from mid-gestation to 4 years of age. Fetal growth velocity (FGV) was measured using ultrasound measurements. Body composition and hormonal profile were measured at birth, 1 and 4 years. Results: 23 SGA babies had lower birth weight compared to 62 AGA (-1.9 +/- 0.3 vs. 0.6 +/- 0.8 z-score; p<0.0001) and they were thinner at birth (ponderal index 24.8 +/- 1.8 vs. 26.3 +/- 3.1 kg/m3; p=0.01 and fat mass 11 +/- 2.6 vs. 12.9 +/- 3.1%; p =0.01). No significant differences in other measured metabolic and hormonal parameters were observed between two groups at birth. SGA infants experienced an early catch-up growth in weight (mean gain of 1.1 +/- 0.6 SD) during the first year of life. At 4 years, SGA children remain lighter than AGA, but with weight z-score in the normal range (-0.1 +/- 1.3 vs. 0.5 +/- 1.3 z-score; p = 0.05). No excess of fat mass was observed (19 +/- 4.8 vs. 19.7 +/- 4.1%; pz=0.45). 120-min plasma glucose was significantly higher (6.2 +/- 1.1 vs. 5.6 +/- 0.9 mmol/1; p =0.006) and insulinogenic index was significantly lower (0.28 +/- 0.15 vs. 0.40 +/- 2.4; p=0.02) in the SGA group at 4-yrs of life contrasting with a preserved insulin sensitivity (QUICK! 0.47 +/- 0.09 vs. 0.43 +/- 0.05; p = 0.06). Conclusion: SGA children with compensatory catch-up growth in first year of life show mild disturbances of glucose tolerance associated to a lower insulinogenic index at 4-yrs of age suggesting impairment of 13-cell function.	[Milovanovic, Ivana; Njuieyon, Falucar; Deghmoun, Samia; Levy-Marchal, Claire] Hop Robert Debre, INSERM, CIE 05, Unite Epidemiol Clin, F-75019 Paris, France; [Chevenne, Didier] Hop Robert Debre, Serv Biochimie & Hormonol, F-75019 Paris, France; [Beltrand, Jacques] Hop Necker Enfants Malad, Paris, France; [Beltrand, Jacques] Univ Paris 05, Rene Descartes, Paris, France; [Beltrand, Jacques] INSERM, U845, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Milovanovic, I (corresponding author), Hop Robert Debre, INSERM, CIE 05, Unite Epidemiol Clin, F-75019 Paris, France.	ivana.milovanovic@inserm.fr	beltrand, jacques/AAV-6455-2021	beltrand, jacques/0000-0002-3759-3490	Institut National de la Sante et de la Recherche Medicale (INSERM); Programme Hospitalier de Recherche Clinique [06-136]; Pfizer Inc.; Institut Appert; INSERM; SFEDP	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Programme Hospitalier de Recherche Clinique; Pfizer Inc.(Pfizer); Institut Appert(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); SFEDP	This work was supported by a grant from the "Institut National de la Sante et de la Recherche Medicale (INSERM)", a grant from the "Programme Hospitalier de Recherche Clinique" (AOM 06-136, 2006) and from Pfizer Inc. Jacques Beltrand was supported by a fellowship from the "Institut Appert" (France, 2006) and by INSERM (Poste d'accueil, 2007). Ivana Milovanovic was supported by a fellowship SFP 2011. Falucar Njuieyon was supported by a fellowship SFEDP 2009. Claire Levy-Marchal was awarded a Contrat d'Interface de Recherche Hospitaliere 2007-2012 from Assistance Publique-Hopitaux de Paris. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2007, DIABETES CARE, V30, P1544, DOI 10.2337/dc06-1331; Beltrand J, 2008, J CLIN ENDOCR METAB, V93, P4027, DOI 10.1210/jc.2008-0562; Beltrand J, 2008, BEST PRACT RES CL EN, V22, P503, DOI 10.1016/j.beem.2008.01.015; Beltrand J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005343; BROOK CGD, 1971, ARCH DIS CHILD, V46, P182, DOI 10.1136/adc.46.246.182; COOK JTE, 1993, BRIT MED J, V306, P302, DOI 10.1136/bmj.306.6873.302; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Ezzahir N, 2005, PEDIATR RES, V58, P243, DOI 10.1203/01.PDR.0000169980.35179.89; Fagerberg B, 2004, J INTERN MED, V256, P254, DOI 10.1111/j.1365-2796.2004.01361.x; GARDOSI J, 1995, ULTRASOUND OBST GYN, V6, P168, DOI 10.1046/j.1469-0705.1995.06030168.x; GARDOSI J, 1992, LANCET, V339, P283, DOI 10.1016/0140-6736(92)91342-6; Garofano A, 1998, DIABETOLOGIA, V41, P1114, DOI 10.1007/s001250051038; Garofano A, 1999, DIABETOLOGIA, V42, P711, DOI 10.1007/s001250051219; Garofano A, 1997, DIABETOLOGIA, V40, P1231, DOI 10.1007/s001250050812; HADLOCK FP, 1985, AM J OBSTET GYNECOL, V151, P333, DOI 10.1016/0002-9378(85)90298-4; Hanson RL, 2000, AM J EPIDEMIOL, V151, P190; Holness MJ, 1996, AM J PHYSIOL-ENDOC M, V270, pE946, DOI 10.1152/ajpendo.1996.270.6.E946; Jaquet D, 2000, J CLIN ENDOCR METAB, V85, P1401, DOI 10.1210/jc.85.4.1401; Jensen CB, 2002, DIABETES, V51, P1271, DOI 10.2337/diabetes.51.4.1271; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kerkhof GF, 2012, J CLIN ENDOCR METAB, V97, P2637, DOI 10.1210/jc.2012-1426; Kumar PU, 2013, INDIAN J MED RES, V137, P302; Leroy B, 1971, Rev Fr Gynecol Obstet, V66, P391; Limesand SW, 2005, AM J PHYSIOL-REG I, V288, pR1297, DOI 10.1152/ajpregu.00494.2004; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Meas T, 2010, DIABETOLOGIA, V53, P907, DOI 10.1007/s00125-009-1650-y; Mericq V, 2005, DIABETOLOGIA, V48, P2609, DOI 10.1007/s00125-005-0036-z; Ong KK, 2004, DIABETOLOGIA, V47, P1064, DOI 10.1007/s00125-004-1405-8; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; PHILLIPS DIW, 1994, DIABETIC MED, V11, P286, DOI 10.1111/j.1464-5491.1994.tb00273.x; Picaud JC, 2003, J CLIN DENSITOM, V6, P17, DOI 10.1385/JCD:6:1:17; Rigo J, 1998, J PEDIATR GASTR NUTR, V27, P184, DOI 10.1097/00005176-199808000-00011; Rodriguez G, 2005, ARCH DIS CHILD-FETAL, V90, P273, DOI 10.1136/adc.2004.060723; ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13; Schou JH, 2005, J CLIN ENDOCR METAB, V90, P4912, DOI 10.1210/jc.2005-0382; SEMPE M, 1977, ARCH FR PEDIATR, V34, P687; Silva AAM, 2012, NUTR METAB CARDIOVAS, V22, P533, DOI 10.1016/j.numecd.2010.09.012; SIRI W E, 1956, Adv Biol Med Phys, V4, P239; Soto N, 2003, J CLIN ENDOCR METAB, V88, P3645, DOI 10.1210/jc.2002-030031; Stefan N, 2004, METABOLISM, V53, P904, DOI 10.1016/j.metabol.2004.01.014; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Yuan QX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025167	42	40	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100337	10.1371/journal.pone.0100337	http://dx.doi.org/10.1371/journal.pone.0100337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979613	Green Published, gold, Green Submitted			2022-12-27	WOS:000338506400026
J	Vandrovcova, M; Jirka, I; Novotna, K; Lisa, V; Frank, O; Kolska, Z; Stary, V; Bacakova, L				Vandrovcova, Marta; Jirka, Ivan; Novotna, Katarina; Lisa, Vera; Frank, Otakar; Kolska, Zdenka; Stary, Vladimir; Bacakova, Lucie			Interaction of Human Osteoblast-Like Saos-2 and MG-63 Cells with Thermally Oxidized Surfaces of a Titanium-Niobium Alloy	PLOS ONE			English	Article							MARROW STROMAL CELLS; DIOXIDE FILMS; IN-VITRO; GROWTH; EXPRESSION; ADHESION; BIOCOMPATIBILITY; DIFFERENTIATION; TOPOGRAPHY; MEMBRANES	An investigation was made of the adhesion, growth and differentiation of osteoblast-like MG-63 and Saos-2 cells on titanium (Ti) and niobium (Nb) supports and on TiNb alloy with surfaces oxidized at 165 degrees C under hydrothermal conditions and at 600 degrees C in a stream of air. The oxidation mode and the chemical composition of the samples tuned the morphology, topography and distribution of the charge on their surfaces, which enabled us to evaluate the importance of these material characteristics in the interaction of the cells with the sample surface. Numbers of adhered MG-63 and Saos-2 cells correlated with the number of positively-charged (related with the Nb2O5 phase) and negatively-charged sites (related with the TiO2 phase) on the alloy surface. Proliferation of these cells is correlated with the presence of positively-charged (i. e. basic) sites of the Nb2O5 alloy phase, while cell differentiation is correlated with negatively-charged (acidic) sites of the TiO2 alloy phase. The number of charged sites and adhered cells was substantially higher on the alloy sample oxidized at 600 degrees C than on the hydrothermally treated sample at 165 degrees C. The expression values of osteoblast differentiation markers (collagen type I and osteocalcin) were higher for cells grown on the Ti samples than for those grown on the TiNb samples. This was more particularly apparent in the samples treated at 165 degrees C. No considerable immune activation of murine macrophage-like RAW 264.7 cells on the tested samples was found. The secretion of TNF-alpha by these cells into the cell culture media was much lower than for either cells grown in the presence of bacterial lipopolysaccharide, or untreated control samples. Thus, oxidized Ti and TiNb are both promising materials for bone implantation; TiNb for applications where bone cell proliferation is desirable, and Ti for induction of osteogenic cell differentiation.	[Vandrovcova, Marta; Novotna, Katarina; Lisa, Vera; Bacakova, Lucie] Acad Sci Czech Republ, Inst Physiol, Prague, Czech Republic; [Jirka, Ivan; Frank, Otakar] Acad Sci Czech Republ, J Heyrovsky Inst Phys Chem, Prague, Czech Republic; [Kolska, Zdenka] Univ JE Purkyne, Fac Sci, Usti Nad Labem, Czech Republic; [Stary, Vladimir] Czech Tech Univ, Fac Mech Engn, CR-16635 Prague, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; J. Heyrovsky Institute of Physical Chemistry of the Czech Academy of Sciences; University of Jan Evangelista Purkyne; Czech Technical University Prague	Bacakova, L (corresponding author), Acad Sci Czech Republ, Inst Physiol, Prague, Czech Republic.	lucy@biomed.cas.cz	Kolska, Zdenka/B-1938-2009; Jirka, Ivan/G-7224-2014; Bacakova, Lucie/C-2664-2012; Frank, Otakar/D-9231-2011; Vandrovcova, Marta/C-2217-2012	Jirka, Ivan/0000-0002-0222-4855; Bacakova, Lucie/0000-0002-1818-9484; Frank, Otakar/0000-0002-9661-6250; Vandrovcova, Marta/0000-0001-8632-5321; Kolska, Zdenka/0000-0003-0239-9046	Grant Agency of the Czech Republic [P108/10/1858, P107/12/1025]; Ministry of Industry and Trade [FR-TI3/088]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Industry and Trade	This study was financially supported by the Grant Agency of the Czech Republic (grants No. P108/10/1858 and P107/12/1025), and by the Ministry of Industry and Trade (grant No. FR-TI3/088). The funders had no role in the design of the study, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacakova L, 2001, J BIOMED MATER RES, V54, P567; Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004; Bello SA, 2010, J MATER SCI-MATER M, V21, P1739, DOI 10.1007/s10856-010-4016-6; Born AK, 2009, EUR CELLS MATER, V18, P49; Buttiglieri S, 2003, BIOMATERIALS, V24, P2731, DOI 10.1016/S0142-9612(03)00088-7; Chrzanowski W, 2008, J MATER SCI-MATER M, V19, P1553, DOI 10.1007/s10856-008-3374-9; CLOVER J, 1994, BONE, V15, P585, DOI 10.1016/8756-3282(94)90305-0; Czekanska EM, 2012, EUR CELLS MATER, V24, P1473; Dadsetan M, 2011, ACTA BIOMATER, V7, P2080, DOI 10.1016/j.actbio.2011.01.012; Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.0.CO;2-C; Dubiel EA, 2011, CHEM REV, V111, P2900, DOI 10.1021/cr9002598; Hamdan M, 2006, CLIN IMPLANT DENT R, V8, P32, DOI 10.2310/j.6480.2005.00028.x; Helth A, 2014, J BIOMED MATER RES B, V102, P31, DOI 10.1002/jbm.b.32976; Horton MA, 1997, INT J BIOCHEM CELL B, V29, P721, DOI 10.1016/S1357-2725(96)00155-0; Hovgaard MB, 2008, J PHYS CHEM B, V112, P8241, DOI 10.1021/jp801103n; Jirka I, 2013, MAT SCI ENG C-MATER, V33, P1636, DOI 10.1016/j.msec.2012.12.073; Kokubo T, 2010, J R SOC INTERFACE, V7, pS503, DOI 10.1098/rsif.2010.0129.focus; Kosmulski M., 2001, CHEM PROPERTIES MAT; Lai M, 2013, J BIOMED MATER RES A, V101, P653, DOI 10.1002/jbm.a.34371; Lee S, 2011, ACTA BIOMATER, V7, P2337, DOI 10.1016/j.actbio.2011.01.006; Lee YJ, 2012, J PERIODONTAL IMPLAN, V42, P81, DOI 10.5051/jpis.2012.42.3.81; Lesny P, 2006, J MATER SCI-MATER M, V17, P829, DOI 10.1007/s10856-006-9842-1; Lim JY, 2007, BIOMATERIALS, V28, P1787, DOI 10.1016/j.biomaterials.2006.12.020; Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001; Luxbacher T, 2006, DESALINATION, V199, P376, DOI 10.1016/j.desal.2006.03.085; Olivares-Navarrete R, 2011, COATINGS, V1, P72, DOI 10.3390/coatings1010072; Parizek M, 2012, INT J NANOMED, V7, P1931, DOI 10.2147/IJN.S26665; Park YJ, 2007, J MATER SCI-MATER M, V18, P565, DOI 10.1007/s10856-007-2303-7; Qiu Q, 1998, J BIOMED MATER RES, V42, P117, DOI 10.1002/(SICI)1097-4636(199810)42:1<117::AID-JBM15>3.3.CO;2-0; Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075; Saldana L, 2006, J BIOMED MATER RES A, V77A, P220, DOI 10.1002/jbm.a.30599; Saldana L, 2005, J BIOMED MATER RES A, V73A, P97, DOI 10.1002/jbm.a.30264; Saldana L, 2011, ACTA BIOMATER, V7, P4210, DOI 10.1016/j.actbio.2011.07.019; Schneider GB, 2004, BIOMATERIALS, V25, P3023, DOI 10.1016/j.biomaterials.2003.09.084; Sista S, 2011, J BIOMED MATER RES A, V97A, P27, DOI 10.1002/jbm.a.33013; STEIN GS, 1990, FASEB J, V4, P3111, DOI 10.1096/fasebj.4.13.2210157; Steinemann SG, 1998, PERIODONTOL 2000, V17, P7, DOI 10.1111/j.1600-0757.1998.tb00119.x; Treves C, 2010, J BIOMED MATER RES A, V92A, P1623, DOI 10.1002/jbm.a.32507; Tsou HK, 2012, J BIOMED MATER RES A, V100A, P2787, DOI 10.1002/jbm.a.34215; Vandrovcova M, 2012, J BIOMED MATER RES A, V100A, P1016, DOI 10.1002/jbm.a.34047; Velten D, 2004, J MATER SCI-MATER M, V15, P457, DOI 10.1023/B:JMSM.0000021120.86985.f7; Zaveri TD, 2010, BIOMATERIALS, V31, P2999, DOI 10.1016/j.biomaterials.2009.12.055; Zhao XB, 2013, ACS APPL MATER INTER, V5, P8203, DOI 10.1021/am402319a; Zorn G, 2006, SURF COAT TECH, V201, P612, DOI 10.1016/j.surfcoat.2005.12.009	45	45	45	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100475	10.1371/journal.pone.0100475	http://dx.doi.org/10.1371/journal.pone.0100475			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977704	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400030
J	Zhang, TT; Liu, D; Calabro, S; Eisenbarth, SC; Cattoretti, G; Haberman, AM				Zhang, Ting-ting; Liu, Dong; Calabro, Samuele; Eisenbarth, Stephanie C.; Cattoretti, Giorgio; Haberman, Ann M.			Dynamic Expression of BCL6 in Murine Conventional Dendritic Cells during In Vivo Development and Activation	PLOS ONE			English	Article							CENTER B-CELLS; TRANSCRIPTIONAL REPRESSOR BCL6; GERMINAL CENTER FORMATION; STEADY-STATE; SIGNALING PATHWAY; DOWN-REGULATION; FACTOR ZDC; RECEPTOR; DIFFERENTIATION; LINEAGE	The transcriptional repressor BCL6 plays an essential role in the development of germinal center B cells and follicular helper T cells. However, much less is known about the expression and function of BCL6 in other cell types. Here we report that during murine dendritic cell (DC) ontogeny in vivo, BCL6 is not expressed in bone marrow hematopoietic stem cells, common DC precursors and committed precursors of conventional DCs (pre-cDCs), but is elevated in peripheral pre-cDCs. BCL6 protein levels rise as pre-cDCs differentiate into cDCs in secondary lymphoid organs. Elevated protein levels of Bcl6 are observed in all cDC subsets, with CD8 alpha(+) cDCs displaying the greatest levels. Co-staining of Ki-67 revealed BCL6(hi) cDCs to be more proliferative than BCL6(lo) cDCs. After adjuvant inoculation, BCL6 levels are significantly reduced in the CD11c(int) MHC class IIhi CD86(hi) cDCs. Activation-induced BCL6 reduction correlated with reduced proliferation. A LPS injection study further confirmed that, in response to microbial stimuli, BCL6 levels are dynamically regulated during the maturation of CD11c(int) MHC class IIhi splenic cDCs. This reduction of BCL6 levels in cDCs does not occur after LPS injection in MyD88(-/-) TRIF-/- mice. Thus, regulation of Bcl6 protein levels is dynamic in murine cDCs during development, maturation and activation in vivo.	[Zhang, Ting-ting; Liu, Dong; Calabro, Samuele; Eisenbarth, Stephanie C.; Haberman, Ann M.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA; [Zhang, Ting-ting; Liu, Dong; Calabro, Samuele; Eisenbarth, Stephanie C.; Haberman, Ann M.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Cattoretti, Giorgio] Univ Milano Bicocca, Dept Pathol, Monza, MB, Italy	Yale University; Yale University; University of Milano-Bicocca	Haberman, AM (corresponding author), Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA.	ann.haberman@yale.edu		Eisenbarth, Stephanie/0000-0002-1244-208X; Cattoretti, Giorgio/0000-0003-3799-3221; Zhang, Ting-ting/0000-0002-7868-9624	National Institutes of Health [R01 A1080850]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a grant from the National Institutes of Health (R01 A1080850) tp A.M.H and TT.Z was supported by a Canadian Institutes of Health Research Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Basso K, 2012, J EXP MED, V209, P2455, DOI 10.1084/jem.20121387; Basso K, 2012, IMMUNOL REV, V247, P172, DOI 10.1111/j.1600-065X.2012.01112.x; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Belz GT, 2012, NAT REV IMMUNOL, V12, P101, DOI 10.1038/nri3149; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fukuda T, 1997, J EXP MED, V186, P439, DOI 10.1084/jem.186.3.439; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Liu XD, 2013, IMMUNOL REV, V252, P139, DOI 10.1111/imr.12040; Liu XD, 2012, J EXP MED, V209, P1841, DOI 10.1084/jem.20120219; Maldonado-Lopez R, 2001, SEMIN IMMUNOL, V13, P275, DOI 10.1006/smim.2001.0323; Maruyama M, 2000, NATURE, V407, P636, DOI 10.1038/35036600; Mckee AS, 2013, P NATL ACAD SCI USA, V110, pE1122, DOI 10.1073/pnas.1300392110; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Meredith MM, 2012, J EXP MED, V209, P1583, DOI 10.1084/jem.20121003; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Niu HF, 2003, J EXP MED, V198, P211, DOI 10.1084/jem.20021395; Niu HF, 1998, GENE DEV, V12, P1953, DOI 10.1101/gad.12.13.1953; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Ohtsuka H, 2011, J IMMUNOL, V186, P255, DOI 10.4049/jimmunol.0903714; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Pantano S, 2006, EXP CELL RES, V312, P1312, DOI 10.1016/j.yexcr.2005.12.020; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Sawant DV, 2013, MOL IMMUNOL, V54, P435, DOI 10.1016/j.molimm.2013.01.006; Shen H, 2008, J IMMUNOL, V181, P1849, DOI 10.4049/jimmunol.181.3.1849; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Toney LM, 2000, NAT IMMUNOL, V1, P214, DOI 10.1038/79749; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamazaki S, 2008, J IMMUNOL, V181, P6923, DOI 10.4049/jimmunol.181.10.6923	42	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101208	10.1371/journal.pone.0101208	http://dx.doi.org/10.1371/journal.pone.0101208			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979752	gold, Green Published, Green Submitted			2022-12-27	WOS:000338506400100
J	Zhu, LG; Zhai, XJ; Zhu, YF; Xu, WG; Bao, CJ; Peng, H; Bian, Q; Yang, HT; Wang, H; Hu, ZB; Shen, HB				Zhu, Liguo; Zhai, Xiangjun; Zhu, Yefei; Xu, Weiguo; Bao, Changjun; Peng, Hong; Bian, Qian; Yang, Haitao; Wang, Hua; Hu, Zhibin; Shen, Hongbing			Evaluation of the Impact of Hepatitis B Vaccination in Adults in Jiangsu Province, China	PLOS ONE			English	Article							VIRUS-INFECTION; NATURAL-HISTORY; RISK-FACTORS; SEROPREVALENCE; EPIDEMIOLOGY; POPULATION; DISEASE	Hepatitis B immunization programs for newborns, children, and adolescents in China have shown remarkable results. To establish whether there would be any benefit in extending the program to cover older individuals, we examined both the epidemiology of hepatitis B virus (HBV) infection and the coverage of hepatitis B vaccinations among adults born before routine vaccinations were implemented. We then evaluated the impact of hepatitis B vaccination in adults aged 20-59 years. A large-scale cross-sectional epidemiological survey of HBV infection was performed in the province of Jiangsu, southeast China, between September 2009 and March 2010. A total of 86,732 adults aged 20-59 years were included, of which 8,615 (9.9%, 95% CI = 9.7-10.1%) were HBsAg sero-positive. Self-reported vaccination status suggested that the coverage was approximately 23.7% (95% CI = 23.4-24.0%). It was shown that higher HBV vaccination coverage was associated with a lower rate of HBsAg seropositivity among adults. There was a negative correlation between hepatitis B vaccination coverage and HBsAg prevalence (correlation coefficient = 20.805, p = 0.016), which might demonstrate the combined effects of vaccination and pre-vaccination HBsAg screening. In the unvaccinated group, the HBsAg-positive rate had an obvious upward trend with age growing among 20-39 year-olds (Trend chi(2) = 22.605, P < 0.001), while the vaccinated group showed no such trend (Trend chi(2) = 3.462, P = 0.063). Overall, hepatitis B vaccination in adults might reduce the rate of HBsAg positivity. Therefore, routine immunization of adults aged 20-39 years should be seriously considered.	[Zhu, Liguo; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China; [Zhu, Liguo; Zhai, Xiangjun; Zhu, Yefei; Xu, Weiguo; Bao, Changjun; Peng, Hong; Bian, Qian; Yang, Haitao; Wang, Hua] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Jiangsu Provincial Center for Disease Control & Prevention	Shen, HB (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China.	hbshen@njmu.edu.cn			National Major ST Projects [2009ZX10004-904, 2011ZX10004-902, 2013ZX10004-905]; National Natural Science Foundation of China [81072344]; Development Project with Science and Education of Jiangsu Provincial Center for Disease Control and Prevention [JKRC2011020]	National Major ST Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Development Project with Science and Education of Jiangsu Provincial Center for Disease Control and Prevention	Support for this survey was provided by National Major S&T Projects (grant number 2009ZX10004-904; 2011ZX10004-902; 2013ZX10004-905), National Natural Science Foundation of China (grant number 81072344) and Development Project with Science and Education of Jiangsu Provincial Center for Disease Control and Prevention (grant number JKRC2011020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, Wkly Epidemiol Rec, V86, P180; Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P441; Baig S, 2009, JCPSP-J COLL PHYSICI, V19, P598, DOI 09.2009/JCPSP.598600; Chen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056444; Chinese Society of Hepatology and Chinese Society of Infectious Diseases Chinese Medical Association, 2011, Zhonghua Gan Zang Bing Za Zhi, V19, P13, DOI 10.3760/cma.j.issn.1007-3418.2011.01.007; Du GuoMing, 2009, Modern Preventive Medicine, V36, P4560; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Hutton DW, 2010, HEPATOLOGY, V51, P405, DOI 10.1002/hep.23310; HYAMS KC, 1995, CLIN INFECT DIS, V20, P992, DOI 10.1093/clinids/20.4.992; Kew MC, 2010, PATHOL BIOL, V58, P273, DOI 10.1016/j.patbio.2010.01.005; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Leung N, 2009, HEPATOL INT, V3, pS24, DOI 10.1007/s12072-009-9142-1; Li XQ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-272; Liang Xiao-feng, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P655; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liao SS, 1999, VACCINE, V17, P2661, DOI 10.1016/S0264-410X(99)00031-6; Lu PJ, 2011, VACCINE, V29, P7049, DOI 10.1016/j.vaccine.2011.07.030; McMahon BJ, 2009, HEPATOLOGY, V49, pS45, DOI 10.1002/hep.22898; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Pereira LMMB, 2009, AM J TROP MED HYG, V81, P240; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Wang YB, 2011, EUR REV MED PHARMACO, V15, P592; WHO, 2010, VACC PREV DIS MON SY; Zhang H, 2011, INT J MED SCI, V8, P321, DOI 10.7150/ijms.8.321; Zhou XL, 2003, OCCUPATION HLTH, V19, P85	25	9	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101501	10.1371/journal.pone.0101501	http://dx.doi.org/10.1371/journal.pone.0101501			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979048	Green Published, gold, Green Submitted			2022-12-27	WOS:000338506400131
J	Scalici, F; Schulz, PJ				Scalici, Francesca; Schulz, Peter J.			Influence of Perceived Parent and Peer Endorsement on Adolescent Smoking Intentions: Parents Have More Say, But Their Influence Wanes as Kids Get Older	PLOS ONE			English	Article							INJUNCTIVE NORMS; DESCRIPTIVE NORMS; SOCIAL-INFLUENCE; MARIJUANA USE; SUBSTANCE USE; PREDICTORS; CIGARETTE; BEHAVIOR; COMMUNICATION; DISAPPROVAL	Purpose: The aim of the study is to investigate how adolescents' perception of parents' and peers' smoking approval influences adolescent smoking intention, and how age affects this influence in a Swiss sample of adolescents. To know the influence of age can help to develop specific prevention programs tailored to the age groups needs. Method: in a cross sectional survey, students aged between 11 and 14 from public and private middle schools in the Italian region of Switzerland (Ticino) answered questions on smoking habits, parents' and peers' approval and intention to smoke. Results: peers' and parents' approval significantly influence students' smoking intention, and students' age significantly moderates this relation: the effect of parents' approval decreases for older adolescents, while the effect of peers' approval increases with age. No difference is found between girls and boys, while non-Swiss are more likely to smoke than Swiss students. Conclusions: as literature suggests, results evidence the role parents play during early adolescence. Prevention programs targeting parent-child communication in early adolescence for preventing children's tobacco consumption are strongly supported.	[Scalici, Francesca; Schulz, Peter J.] Univ Svizzera Italiana, Inst Commun & Hlth, Lugano, Switzerland	Universita della Svizzera Italiana	Scalici, F (corresponding author), Univ Svizzera Italiana, Inst Commun & Hlth, Lugano, Switzerland.	scalicif@usi.ch	Schulz, Peter/AAM-9816-2020; Schulz, Peter/GQQ-1290-2022	Schulz, Peter/0000-0003-4281-489X; Schulz, Peter/0000-0003-4281-489X	Universita della Svizzera Italiana; Association of Non-Smokers in the Italian region of Switzerland	Universita della Svizzera Italiana; Association of Non-Smokers in the Italian region of Switzerland	The project has been funded by the Universita della Svizzera Italiana and the Association of Non-Smokers in the Italian region of Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JA, 1993, J EARLY ADOLESC, V13, P285, DOI [10.1177/0272431693013003004, DOI 10.1177/0272431693013003004]; Arbour-Nicitopoulos KP, 2011, J AM COLL HEALTH, V59, P191, DOI 10.1080/07448481.2010.502194; Borsari B, 2003, J STUD ALCOHOL, V64, P331, DOI 10.15288/jsa.2003.64.331; Brooks-Russell A, 2014, PREV SCI, V15, P497, DOI 10.1007/s11121-013-0391-9; CHASSIN L, 1986, DEV PSYCHOL, V22, P327, DOI 10.1037/0012-1649.22.3.327; CIALDINI RB, 1990, J PERS SOC PSYCHOL, V58, P1015, DOI 10.1037/0022-3514.58.6.1015; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; de Vries H, 2006, TOB CONTROL, V15, P83, DOI 10.1136/tc.2003.007237; de Vries H, 2003, HEALTH EDUC RES, V18, P627, DOI 10.1093/her/cyg032; DiClemente RJ, 2001, PEDIATRICS, V107, P1363, DOI 10.1542/peds.107.6.1363; Dieterich SE, 2013, J PRIM PREV, V34, P209, DOI 10.1007/s10935-013-0311-6; Distefan JM, 1998, J ADOLESCENT HEALTH, V22, P466, DOI 10.1016/S1054-139X(98)00013-5; Dittus PJ, 1999, J APPL SOC PSYCHOL, V29, P1927, DOI 10.1111/j.1559-1816.1999.tb00158.x; Elder JP, 2000, PREV MED, V31, P115, DOI 10.1006/pmed.2000.0693; Elek E, 2006, J DRUG ISSUES, V36, P147, DOI 10.1177/002204260603600107; ENNETT ST, 1994, ADDICT BEHAV, V19, P295, DOI 10.1016/0306-4603(94)90031-0; Fishbein M., 1975, BELIEF ATTITUDE INTE; Franca LR, 2009, SUBST ABUSE TREAT PR, V4, DOI 10.1186/1747-597X-4-4; GALBO JJ, 1986, CHILD YOUTH SERV REV, V8, P37, DOI 10.1016/0190-7409(86)90024-1; Guilamo-Ramos V, 2010, PARENTAL MONITORING, P176; Guilamo-Ramos V, 2008, YOUTH SOC, V40, P86, DOI 10.1177/0044118X07308072; HEMMELSTEIN N, 1995, J ALCOHOL DRUG EDUC, V41, P1; Jaccard J, 1998, CHILD DEV, V69, P247, DOI 10.1111/j.1467-8624.1998.tb06146.x; Jaccard J., 2003, INTERACTION EFFECTS; JACKSON C, 1994, HEALTH EDUC QUART, V21, P103, DOI 10.1177/109019819402100110; Kodl MM, 2004, ADDICT BEHAV, V29, P17, DOI 10.1016/S0306-4603(03)00087-X; Kristjansson AL, 2010, ADDICT BEHAV, V35, P256, DOI 10.1016/j.addbeh.2009.10.002; LaBrie JW, 2010, J STUD ALCOHOL DRUGS, V71, P904, DOI 10.15288/jsad.2010.71.904; Lantz PM, 2000, TOB CONTROL, V9, P47, DOI 10.1136/tc.9.1.47; Litrownik AJ, 2000, PREV MED, V31, P124, DOI 10.1006/pmed.2000.0698; Mazanov J, 2002, BRIT J HEALTH PSYCH, V7, P185, DOI 10.1348/135910702169439; Repubblica e Cantone Ticino, 2013, MIS LEG AMB PREV TAB; Sargent JD, 2001, PEDIATRICS, V108, P1256, DOI 10.1542/peds.108.6.1256; Sawyer TM, 2008, J PRIM PREV, V29, P465, DOI 10.1007/s10935-008-0156-6; Simons-Morton BG, 2010, J PRIM PREV, V31, P191, DOI 10.1007/s10935-010-0220-x; Spoth RL, 2001, J CONSULT CLIN PSYCH, V69, P627, DOI 10.1037//0022-006X.69.4.627; Steiner I.D., 1965, CURR STUD SOC PSYCH, P301; Vitoria PD, 2011, BRIT J HEALTH PSYCH, V16, P779, DOI 10.1111/j.2044-8287.2010.02014.x; Vitoria PD, 2009, BRIT J HEALTH PSYCH, V14, P681, DOI 10.1348/135910709X421341; Voisine S, 2008, FAM SOC, V89, P264, DOI 10.1606/1044-3894.3742; WANG MQ, 1995, J ADOLESCENT HEALTH, V16, P200, DOI 10.1016/1054-139X(94)00097-X; Windlin M, 2011, ZEITLICHE ENTWICKLUN; [No title captured]	43	18	18	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101275	10.1371/journal.pone.0101275	http://dx.doi.org/10.1371/journal.pone.0101275			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3RT	24991921	Green Submitted, gold, Green Published			2022-12-27	WOS:000341253400058
J	Zhou, WM; Tan, XY; Li, YM; Tan, WJ				Zhou, Weimin; Tan, Xinyi; Li, Yamin; Tan, Wenjie			Human Herpes Viruses Are Associated with Classic Fever of Unknown Origin (FUO) in Beijing Patients	PLOS ONE			English	Article							CYTOMEGALOVIRUS; MANAGEMENT; CHILDREN	Background: Few reports have examined the viral aetiology of fever of unknown origin (FUO). Objective: This study determined the prevalence of human herpes virus (HHV) DNA in blood of Chinese patients with classic FUO using the polymerase chain reaction (PCR) and explored the possible role of HHV. Study design: Blood samples were collected from 186 patients (151 children, 35 adults) with classic FUO and 143 normal individuals in Beijing during the years 2009-2012. The HHV DNA, including Herpes simplex virus (HSV)-1/2, Varicella zoster virus (VZV), Cytomegalovirus (CMV), Epstein-Barr virus (EBV), and Human herpes virus (HHV)-6 and -7, was detected by multiplex PCR. The epidemiological and clinical features were also analysed. Results: HHV DNA was detected in 63 (33.9%) of the FUO patients, and the prevalence of EBV and HHV-6 was significantly higher than in the normal cohort. HHV co-infection was also frequent (10.2%) in the patients with FUO. The majority of patients with HHV infection present with a fever only. Our data also revealed that EBV infection was associated with hepatitis and abnormal blood indices, HHV-6 was associated with a cough, and HHV-7 was associated with hepatitis. Conclusions: HHVs are associated with Chinese patients (especially for children) with classic FUO. Our study adds perspective to the aetiological and clinical characteristics of classic FUO in beijing patients.	[Zhou, Weimin; Li, Yamin; Tan, Wenjie] China CDC, Natl Inst Viral Dis Control & Prevent, Key Lab Med Virol, Minist Hlth, Beijing, Peoples R China; [Tan, Xinyi] High Sch, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Tan, WJ (corresponding author), China CDC, Natl Inst Viral Dis Control & Prevent, Key Lab Med Virol, Minist Hlth, Beijing, Peoples R China.	tanwj28@yahoo.cn			State Megaproject for Infectious Disease Research of China [2011ZX10004-001, 2013ZX10004601]	State Megaproject for Infectious Disease Research of China	This work was supported by grants from the State Megaproject for Infectious Disease Research of China (2011ZX10004-001, 2013ZX10004601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpede G O, 2001, Paediatr Drugs, V3, P169, DOI 10.2165/00128072-200103030-00002; Akpede GO, 2001, PEDIATR DRUGS, V3, P247, DOI 10.2165/00128072-200103040-00002; Chow A, 2011, WORLD J PEDIATR, V7, P5, DOI 10.1007/s12519-011-0240-5; Finkelstein JA, 2000, PEDIATRICS, V105, P260; Hot A, 2007, INFECT DIS CLIN N AM, V21, P1013, DOI 10.1016/j.idc.2007.08.003; Jones MS, 2007, J CLIN MICROBIOL, V45, P2144, DOI 10.1128/JCM.00174-07; Li Wen-gang, 2011, Zhonghua Yi Xue Za Zhi, V91, P604; Manfredi R, 2006, INFECTION, V34, P87, DOI 10.1007/s15010-006-5012-0; Pasic S, 2006, ACTA PAEDIATR, V95, P463, DOI 10.1080/08035250500437549; Perersdorf RG, 1961, MEDICINE, V40, P1; Persson L, 2003, CLIN MICROBIOL INFEC, V9, P640, DOI 10.1046/j.1469-0691.2003.00578.x; Rigante D, 2013, INT J IMMUNOPATH PH, V26, P315, DOI 10.1177/039463201302600205; Sherman JM, 2012, CURR OPIN PEDIATR, V24, P400, DOI 10.1097/MOP.0b013e32835333e3; Shi XC, 2013, CHINESE MED J-PEKING, V126, P808, DOI 10.3760/cma.j.issn.0366-6999.20121799; Tanaka T, 2009, BIOMED RES-TOKYO, V30, P279, DOI 10.2220/biomedres.30.279; Zhou WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079477	16	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101619	10.1371/journal.pone.0101619	http://dx.doi.org/10.1371/journal.pone.0101619			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991930	Green Published, gold, Green Submitted			2022-12-27	WOS:000341253400098
J	Alvarez-Arellano, L; Cortes-Reynosa, P; Sanchez-Zauco, N; Salazar, E; Torres, J; Maldonado-Bernal, C				Alvarez-Arellano, Lourdes; Cortes-Reynosa, Pedro; Sanchez-Zauco, Norma; Salazar, Eduardo; Torres, Javier; Maldonado-Bernal, Carmen			TLR9 and NF-kappa B Are Partially Involved in Activation of Human Neutrophils by Helicobacter pylori and Its Purified DNA	PLOS ONE			English	Article							BACTERIAL-DNA; STREPTOCOCCUS-PNEUMONIAE; SIGNALING PATHWAYS; GENE-EXPRESSION; IMMUNE-RESPONSE; GASTRIC-CANCER; CPG-DNA; INTERLEUKIN-8; INFECTION; RECEPTOR	Helicobacter pylori infection represents one of the most common bacterial infections worldwide. The inflammatory response to this bacterium involves a large influx of neutrophils to the lamina propria of the gastric mucosa. However, little is known about the receptors and molecular mechanisms involved in activation of these neutrophils. In this study, we aimed to determine the role of toll-like receptor 9 (TLR9) in the response of human neutrophils to H. pylori and purified H. pylori DNA (Hp-DNA). Neutrophils were isolated from the blood of adult volunteers and challenged with either H. pylori or Hp-DNA. We found that both, H. pylori and Hp-DNA induced increased expression and release of IL-8. Furthermore, we showed that TLR9 is involved in the induction of IL-8 production by H. pylori and Hp-DNA. IL-8 production induced by H. pylori but not by Hp-DNA was partially mediated by NF-kappa B. In conclusion, this study showed for first time that both, H. pylori and Hp-DNA activate TLR9 and induce a different inflammatory response that leads to activation of neutrophils.	[Alvarez-Arellano, Lourdes; Sanchez-Zauco, Norma; Torres, Javier; Maldonado-Bernal, Carmen] Inst Mexicano Seguro Social, Hosp Pediat, Unidad Invest Enfermedades Infecciosas, Mexico City, DF, Mexico; [Alvarez-Arellano, Lourdes] Univ Nacl Autonoma Mexico, Lab Neuroinmunobiol, Dept Med Mol & Bioproc, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico; [Cortes-Reynosa, Pedro; Salazar, Eduardo] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Biol Celular, Mexico City, DF, Mexico; [Sanchez-Zauco, Norma; Maldonado-Bernal, Carmen] Hosp Infantil Mexico Dr Federico Gomez, Lab Invest Inmunol & Prote, Mexico City, DF, Mexico	Instituto Mexicano del Seguro Social; Universidad Nacional Autonoma de Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Hospital Infantil de Mexico Federico Gomez	Maldonado-Bernal, C (corresponding author), Inst Mexicano Seguro Social, Hosp Pediat, Unidad Invest Enfermedades Infecciosas, Mexico City, DF, Mexico.	cmaldobe@yahoo.com		Alvarez-Arellano, Lourdes/0000-0002-3469-1407; Sanchez-Zauco, Norma/0000-0001-8375-1499; Maldonado-Bernal, Carmen/0000-0003-0663-2888	Instituto Mexicano del Seguro Social [FIS/IMSS/PROT/C2007/053]	Instituto Mexicano del Seguro Social	This work was supported by Instituto Mexicano del Seguro Social, grant FIS/IMSS/PROT/C2007/053. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LAH, 2001, CURR OPIN INFECT DIS, V14, P273, DOI 10.1097/00001432-200106000-00005; Alvarez ME, 2006, J IMMUNOL, V177, P4037, DOI 10.4049/jimmunol.177.6.4037; Alvarez-Arellano L, 2007, FEMS IMMUNOL MED MIC, V51, P473, DOI 10.1111/j.1574-695X.2007.00327.x; Sanchez-Zauco NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064623; Bass JIF, 2008, LAB INVEST, V88, P926, DOI 10.1038/labinvest.2008.59; Bellocchio S, 2004, J IMMUNOL, V173, P7406, DOI 10.4049/jimmunol.173.12.7406; Chang YJ, 2005, J IMMUNOL, V175, P8242, DOI 10.4049/jimmunol.175.12.8242; Chuang TH, 2002, J LEUKOCYTE BIOL, V71, P538; Collison KS, 2002, J LEUKOCYTE BIOL, V71, P433; El Kebir D, 2008, ARCH IMMUNOL THER EX, V56, P41, DOI 10.1007/s00005-008-0008-3; El Kebir D, 2009, J IMMUNOL, V182, P4386, DOI 10.4049/jimmunol.0803044; Francois S, 2005, J IMMUNOL, V174, P3633, DOI 10.4049/jimmunol.174.6.3633; Fujita Y, 2005, HELICOBACTER, V10, P567, DOI 10.1111/j.1523-5378.2005.00364.x; Gianfagna F, 2008, CURR GENOMICS, V9, P361, DOI 10.2174/138920208785699544; Grande R, 2012, J APPL MICROBIOL, V113, P669, DOI 10.1111/j.1365-2672.2012.05351.x; Agren J, 2006, SCAND J IMMUNOL, V64, P61, DOI 10.1111/j.1365-3083.2006.01779.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Ibrahim ZA, 2013, MOL IMMUNOL, V56, P739, DOI 10.1016/j.molimm.2013.07.008; Ismail HF, 2003, J IMMUNOL, V170, P3782, DOI 10.4049/jimmunol.170.7.3782; Jozsef L, 2004, FASEB J, V18, P1776, DOI 10.1096/fj.04-2048fje; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kawahara T, 2001, INFECT IMMUN, V69, P4382, DOI 10.1128/IAI.69.7.4382-4389.2001; Lindau D, 2013, EUR J IMMUNOL, V43, P2101, DOI 10.1002/eji.201142143; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Moscoso M, 2004, MOL MICROBIOL, V54, P783, DOI 10.1111/j.1365-2958.2004.04305.x; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Obonyo M, 2007, INFECT IMMUN, V75, P2408, DOI 10.1128/IAI.01794-06; Rad R, 2009, GASTROENTEROLOGY, V136, P2247, DOI 10.1053/j.gastro.2009.02.066; Rieke C, 2011, BIOL CHEM, V392, P387, DOI 10.1515/BC.2011.029; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Schmausser B, 2004, CLIN EXP IMMUNOL, V136, P521, DOI 10.1111/j.1365-2249.2004.02464.x; Schroder AK, 2006, HUM IMMUNOL, V67, P676, DOI 10.1016/j.humimm.2006.05.004; Sirois CM, 2013, J EXP MED, V210, P2447, DOI 10.1084/jem.20120201; Smith MF, 2003, J BIOL CHEM, V278, P32552, DOI 10.1074/jbc.M305536200; Steinmoen H, 2002, P NATL ACAD SCI USA, V99, P7681, DOI 10.1073/pnas.112464599; Suzuki T, 2004, SCAND J GASTROENTERO, V39, P313, DOI 10.1080/00365520310008610; Taguchi A, 2005, CANCER EPIDEM BIOMAR, V14, P2487, DOI 10.1158/1055-9965.EPI-05-0326; Trevani AS, 2003, EUR J IMMUNOL, V33, P3164, DOI 10.1002/eji.200324334; van Doorn LJ, 1998, GASTROENTEROLOGY, V115, P58, DOI 10.1016/S0016-5085(98)70365-8; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Yanai A, 2008, INFECT IMMUN, V76, P781, DOI 10.1128/IAI.01046-07	41	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101342	10.1371/journal.pone.0101342	http://dx.doi.org/10.1371/journal.pone.0101342			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987851	Green Published, Green Submitted, gold			2022-12-27	WOS:000341354100076
J	Gilbert, MJ; Kik, M; Timmerman, AJ; Severs, TT; Kusters, JG; Duim, B; Wagenaar, JA				Gilbert, Maarten J.; Kik, Marja; Timmerman, Arjen J.; Severs, Tim T.; Kusters, Johannes G.; Duim, Birgitta; Wagenaar, Jaap A.			Occurrence, Diversity, and Host Association of Intestinal Campylobacter, Arcobacter, and Helicobacter in Reptiles	PLOS ONE			English	Article							FETUS; IDENTIFICATION; HYOINTESTINALIS; SALMONELLA; MATRIX	Campylobacter, Arcobacter, and Helicobacter species have been isolated from many vertebrate hosts, including birds, mammals, and reptiles. Multiple studies have focused on the prevalence of these Epsilonproteobacteria genera in avian and mammalian species. However, little focus has been given to the presence within reptiles, and their potential zoonotic and pathogenic roles. In this study, occurrence, diversity, and host association of intestinal Epsilonproteobacteria were determined for a large variety of reptiles. From 2011 to 2013, 444 cloacal swabs and fecal samples originating from 417 predominantly captive-held reptiles were screened for Epsilonproteobacteria. Campylobacter, Arcobacter, and Helicobacter genus specific PCRs were performed directly on all samples. All samples were also cultured on selective media and screened for the presence of Epsilonproteobacteria. Using a tiered approach of AFLP, atpA, and 16S rRNA sequencing, 432 Epsilonproteobacteria isolates were characterized at the species level. Based on PCR, Campylobacter, Arcobacter, and Helicobacter were detected in 69.3% of the reptiles; 82.5% of the chelonians, 63.8% of the lizards, and 58.0% of the snakes were positive for one or more of these genera. Epsilonproteobacteria were isolated from 22.1% of the reptiles and were isolated most frequently from chelonians (37.0%), followed by lizards (19.6%) and snakes (3.0%). The most commonly isolated taxa were Arcobacter butzleri, Arcobacter skirrowii, reptile-associated Campylobacter fetus subsp. testudinum, and a putative novel Campylobacter taxon. Furthermore, a clade of seven related putative novel Helicobacter taxa was isolated from lizards and chelonians. This study shows that reptiles carry various intestinal Epsilonproteobacteria taxa, including several putative novel taxa.	[Gilbert, Maarten J.; Timmerman, Arjen J.; Duim, Birgitta; Wagenaar, Jaap A.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Kik, Marja] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands; [Severs, Tim T.; Kusters, Johannes G.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Duim, Birgitta; Wagenaar, Jaap A.] WHO Collaborating Ctr Campylobacter, OIE Reference Lab Campylobacteriosis, Utrecht, Netherlands; [Wagenaar, Jaap A.] Wageningen UR, Cent Vet Inst, Lelystad, Netherlands	Utrecht University; Utrecht University; Utrecht University; Utrecht University Medical Center; Wageningen University & Research	Gilbert, MJ (corresponding author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands.	m.j.gilbert@uu.nl						Benejat L, 2014, LETT APPL MICROBIOL, V58, P338, DOI 10.1111/lam.12194; Bertrand S., 2008, Eurosurveillance, V13, P18902; Coldham T, 2011, APPL ENVIRON MICROB, V77, P1581, DOI 10.1128/AEM.01960-10; Collado L, 2011, CLIN MICROBIOL REV, V24, P174, DOI 10.1128/CMR.00034-10; de Boer RF, 2013, J CLIN MICROBIOL, V51, P253, DOI 10.1128/JCM.01716-12; Debruyne L, 2008, CAMPYLOBACTER, 3RD EDITION, P3; Dingle KE, 2010, J CLIN MICROBIOL, V48, P977, DOI 10.1128/JCM.01439-09; Duim B, 1999, APPL ENVIRON MICROB, V65, P2369; EDMONDS P, 1987, J CLIN MICROBIOL, V25, P685, DOI 10.1128/JCM.25.4.685-691.1987; Fitzgerald C, 2014, INT J SYST EVOL MICR, DOI 10.1099; Girling S., 2004, BSAVA MANUAL REPTILE; Harmon KM, 1996, LETT APPL MICROBIOL, V23, P241, DOI 10.1111/j.1472-765X.1996.tb00074.x; HARVEY S, 1985, J CLIN MICROBIOL, V21, P260, DOI 10.1128/JCM.21.2.260-261.1985; Maiwald M., 2004, MOL MICROBIOLOGY DIA, P379; Marshall SM, 1999, J CLIN MICROBIOL, V37, P4158, DOI 10.1128/JCM.37.12.4158-4160.1999; Miller WG, 2005, J CLIN MICROBIOL, V43, P2315, DOI 10.1128/JCM.43.5.2315-2329.2005; Miller WG, 2014, LETT APPL MICROBIOL, DOI 10.1111; Miller WG, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00045; Nachamkin I, 2008, CAMPYLOBACTER, 3RD EDITION, P1; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; On SLW, 1996, J APPL BACTERIOL, V81, P425; Pasmans F, 2008, VET J, V175, P53, DOI 10.1016/j.tvjl.2006.12.009; Patrick ME, 2013, EMERG INFECT DIS, V19, P1678, DOI 10.3201/eid1910.130883; Richards JM, 2004, J ZOO WILDLIFE MED, V35, P562, DOI 10.1638/03-070; Scheelings TF, 2011, J WILDLIFE DIS, V47, P1, DOI 10.7589/0090-3558-47.1.1; Shi HT, 2008, ORYX, V42, P147, DOI 10.1017/S0030605308000562; Solnick JV, 2001, CLIN MICROBIOL REV, V14, P59, DOI 10.1128/CMR.14.1.59-97.2001; Stacy BA, 2010, J VET DIAGN INVEST, V22, P660, DOI 10.1177/104063871002200431; Tu ZC, 2004, J CLIN MICROBIOL, V42, P4405, DOI 10.1128/JCM.42.9.4405-4407.2004; Vandenberg O, 2004, EMERG INFECT DIS, V10, P1863, DOI 10.3201/eid1010.040241; Vitt LJ, 2013, HERPETOLOGY INTRO BI; Wang CM, 2013, VET MICROBIOL, V164, P67, DOI 10.1016/j.vetmic.2013.01.008	32	30	31	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101599	10.1371/journal.pone.0101599	http://dx.doi.org/10.1371/journal.pone.0101599			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988130	Green Published, Green Submitted, gold			2022-12-27	WOS:000341354100119
J	Kim, S; Lee, YC; Cho, DH; Lee, HU; Huh, YS; Kim, GJ; Kim, HS				Kim, Sora; Lee, Young-Chul; Cho, Dae-Hyun; Lee, Hyun Uk; Huh, Yun Suk; Kim, Geun-Joong; Kim, Hee-Sik			A Simple and Non-Invasive Method for Nuclear Transformation of Intact-walled Chlamydomonas reinhardtii	PLOS ONE			English	Article							FUNCTIONALIZED MAGNESIUM PHYLLOSILICATES; OLEAGINOUS CHLORELLA SP; ORGANO-BUILDING BLOCKS; GREEN-ALGA; BACTERIAL TRANSFORMATION; GENETIC-TRANSFORMATION; ANTIMICROBIAL ACTIVITY; EUKARYOTIC MICROALGAE; BIOFUEL PRODUCTION; AMINOCLAY	Genetic engineering in microalgae is gaining attraction but nuclear transformation methods available so far are either inefficient or require special equipment. In this study, we employ positively charged nanoparticles, 3-aminopropyl-functionalized magnesium phyllosilicate (aminoclay, approximate unit cell composition of [H2N(CH2)(3)](8)Si8Mg6O12(OH)(4)), for nuclear transformation into eukaryotic microalgae. TEM and EDX analysis of the process of transformation reveals that aminoclay coats negatively-charged DNA biomolecules and forms a self-assembled hybrid nanostructure. Subsequently, when this nanostructure is mixed with microalgal cells and plated onto selective agar plates with high friction force, cell wall is disrupted facilitating delivery of plasmid DNA into the cell and ultimately to the nucleus. This method is not only simple, inexpensive, and non-toxic to cells but also provides efficient transformation (5.03x10(2) transformants/mg DNA), second only to electroporation which needs advanced instrumentation. We present optimized parameters for efficient transformation including pre-treatment, friction force, concentration of foreign DNA/aminoclay, and plasticity of agar plates. It is also confirmed the successful integration and stable expression of foreign gene in Chlamydomonas reinhardtii through molecular methods.	[Kim, Sora; Kim, Hee-Sik] Univ Sci & Technol, Taejon, South Korea; [Lee, Young-Chul] Gachon Univ, Dept BioNano Technol, Songnam, South Korea; [Cho, Dae-Hyun; Kim, Hee-Sik] Korea Res Inst Biosci & Biotechnol, Environm Biotechnol Res Ctr, Taejon, South Korea; [Lee, Hyun Uk] Korea Basic Sci Inst, Div Mat Sci, Taejon, South Korea; [Huh, Yun Suk] Inha Univ, Dept Biol Engn, Coll Engn, Inchon, South Korea; [Kim, Geun-Joong] Chonnam Natl Univ, Dept Biol Sci, Coll Nat Sci, Kwangju, South Korea	Gachon University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Basic Science Institute (KBSI); Inha University; Chonnam National University	Lee, YC (corresponding author), Gachon Univ, Dept BioNano Technol, Songnam, South Korea.	dreamdbs@gachon.ac.kr; hkim@kribb.re.kr	Zhou, Xuewen/E-5782-2015	Dae-Hyun, Cho/0000-0001-8975-2468	Advanced Biomass R&D Center (ABC) of Global Frontier Project - Ministry of Education, Science and Technology [ABC-2011-0031351, ABC-2010-0029728]; Intelligent Synthetic Biology Center of the Global Frontier project from the MEST [20110031950]	Advanced Biomass R&D Center (ABC) of Global Frontier Project - Ministry of Education, Science and Technology; Intelligent Synthetic Biology Center of the Global Frontier project from the MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Advanced Biomass R&D Center (ABC) of Global Frontier Project funded by the Ministry of Education, Science and Technology (ABC-2011-0031351 and ABC-2010-0029728). This work was also supported by the Intelligent Synthetic Biology Center of the Global Frontier project (20110031950) from the MEST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cha TS, 2012, WORLD J MICROB BIOT, V28, P1771, DOI 10.1007/s11274-011-0991-0; Chandrasekaran G, 2011, APPL CLAY SCI, V53, P729, DOI 10.1016/j.clay.2011.07.001; Choi HA, 2013, J MICROBIOL METH, V95, P97, DOI 10.1016/j.mimet.2013.07.018; Choi MH, 2014, ECOTOX ENVIRON SAFE, V102, P34, DOI 10.1016/j.ecoenv.2014.01.005; Choi YJ, 2013, NATURE, V502, P571, DOI 10.1038/nature12536; Coll JM, 2006, SPAN J AGRIC RES, V4, P316; Farooq W, 2013, GREEN CHEM, V15, P749, DOI 10.1039/c3gc36767c; Han HK, 2011, ACS APPL MATER INTER, V3, P2564, DOI 10.1021/am200406k; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Hwangbo K, 2014, PLANT BIOTECHNOL REP, V8, P135, DOI 10.1007/s11816-013-0302-3; Kim SI, 2013, WORLD J MICROB BIOT, V29, P1129, DOI 10.1007/s11274-013-1262-z; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; KINDLE KL, 1989, J CELL BIOL, V109, P2589, DOI 10.1083/jcb.109.6.2589; Kindle KL, 1998, MOL BIOL CHLOROPLAST, P41; Kumar SV, 2004, PLANT SCI, V166, P731, DOI 10.1016/j.plantsci.2003.11.012; Lee YC, 2014, BIORESOURCE TECHNOL, V153, P365, DOI 10.1016/j.biortech.2013.11.103; Lee YC, 2014, RSC ADV, V4, P4122, DOI 10.1039/c3ra46602g; Lee YC, 2013, APPL CLAY SCI, V83-84, P474, DOI 10.1016/j.clay.2012.10.007; Lee YC, 2013, RSC ADV, V3, P12802, DOI 10.1039/c3ra23266b; Lee YC, 2013, BIORESOURCE TECHNOL, V132, P440, DOI 10.1016/j.biortech.2013.01.102; Lee YC, 2013, SCI REP-UK, V3, DOI 10.1038/srep01292; Lee YC, 2013, BIOSENS BIOELECTRON, V42, P373, DOI 10.1016/j.bios.2012.10.092; Lee YC, 2011, J HAZARD MATER, V196, P101, DOI 10.1016/j.jhazmat.2011.08.077; Lee YC, 2011, J HAZARD MATER, V190, P652, DOI 10.1016/j.jhazmat.2011.03.093; Leon R, 2007, ADV EXP MED BIOL, V616, P1; Mann S, 1997, CHEM MATER, V9, P2300, DOI 10.1021/cm970274u; Mann S, 2009, NAT MATER, V8, P781, DOI [10.1038/NMAT2496, 10.1038/nmat2496]; Olof SN, 2012, NANO LETT, V12, P6018, DOI 10.1021/nl303585w; Patil AJ, 2005, J MATER CHEM, V15, P3838, DOI 10.1039/b504288g; Patil AJ, 2004, ANGEW CHEM INT EDIT, V43, P4928, DOI 10.1002/anie.200453868; Patil AJ, 2003, ADV MATER, V15, P1816, DOI 10.1002/adma.200305426; Patil AJ, 2007, NANO LETT, V7, P2660, DOI 10.1021/nl071052q; Proschold T, 2005, GENETICS, V170, P1601, DOI 10.1534/genetics.105.044503; Qin S, 2012, BIOTECHNOL ADV, V30, P1602, DOI 10.1016/j.biotechadv.2012.05.004; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; Shimogawara K, 1998, GENETICS, V148, P1821; SODEINDE OA, 1993, P NATL ACAD SCI USA, V90, P9199, DOI 10.1073/pnas.90.19.9199; Vickery JL, 2009, MOL BIOSYST, V5, P744, DOI 10.1039/b903652k; Wayama M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053618; Wilharm G, 2010, J MICROBIOL METH, V80, P215, DOI 10.1016/j.mimet.2009.12.002; Yamano T, 2013, J BIOSCI BIOENG, V115, P691, DOI 10.1016/j.jbiosc.2012.12.020; Yoshida N, 2001, FEMS MICROBIOL LETT, V195, P133, DOI 10.1111/j.1574-6968.2001.tb10510.x; Yoshida N, 2009, APPL MICROBIOL BIOT, V83, P791, DOI 10.1007/s00253-009-2042-4; Zemke-White WL, 2000, J EXP MAR BIOL ECOL, V245, P57, DOI 10.1016/S0022-0981(99)00151-3	44	23	25	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101018	10.1371/journal.pone.0101018	http://dx.doi.org/10.1371/journal.pone.0101018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988123	gold, Green Submitted, Green Published			2022-12-27	WOS:000341354100054
J	Wang, B; Yu, Y; Wang, L				Wang, Bo; Yu, Yun; Wang, Long			Penicillium fusisporum and P. zhuangii, Two New Monoverticillate Species with Apical-Swelling Stipes of Section Aspergilloides Isolated from Plant Leaves in China	PLOS ONE			English	Article								Two new Penicillium species isolated from plant leaves are reported here, namely, P. fusisporum (type strain AS3.15338(T) = NRRL 62805(T) = CBS 137463(T)) and P. zhuangii (type strain AS3.15341(T) = NRRL 62806(T) = CBS 137464(T)). P. fusisporum is characterized by fast growth rate, apical-swelling monoverticillate penicilli, verrucose stipes, fusiform to oblong conidia about 3.5-462-2.5 mu m and cinnamon-colored sclerotia. While P. zhuangii presents a moderate growth rate, it also bears apical-swelling monoverticillate penicilli but its stipes are smooth-walled, and produces ovoid to globose smooth-walled conidia about 3-3.5 mu m. Both species belong to section Aspergilloides, and P. fusisporum is related to "P. thomii var. flavescens'', while P. zhuangii is morphologically similar to P. lividum. Phylogenetic analyses of sequences of calmodulin and beta-tubulin genes both show that the two new taxa form distinct monophyletic clades.	[Wang, Bo] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China; [Yu, Yun] Yangtze Univ, Coll Life Sci, Jinzhou, Hubei, Peoples R China; [Wang, Long] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China	Northwest A&F University - China; Yangtze University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Wang, L (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China.	wl_dgk@hotmail.com			National Natural Science Foundation of China (NSFC) [31270539]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work is supported by National Natural Science Foundation of China (NSFC no. 31270539 to LW, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 1956, J GEN APPL MICROBIOL, V2, P50; Barreto MC, 2011, FUNGAL DIVERS, V49, P23, DOI 10.1007/s13225-011-0090-4; CHRISTENSEN M, 1961, MYCOLOGIA, V53, P451, DOI 10.2307/3756303; Frisvad JC, 2004, STUD MYCOL, P1; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Houbraken J, 2011, STUD MYCOL, P1, DOI 10.3114/sim.2011.70.01; Kulik MM, 1968, AGR HDB, V351; Nakase T, 1993, RIKEN REV, V3, P33; Peterson SW, 2000, INTEGRATION MODERN T, P163; Pitt J. I., 1979, The genus Penicillium and its teleomorphic states Eupenicillium and Talaromyces.; Pitt J.I., 2000, INTEGRATION MODERN T, P9; PITT JI, 1985, MYCOTAXON, V22, P197; Pitt JI., 2000, INTEGRATION MODERN T, P225; Raper KB, 1949, MANUAL PENICILLIA; Ridgway R., 1912, COLOR STANDARDS COLO; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang B, 2013, MYCOLOGIA, V105, P1547, DOI 10.3852/13-022; Wang L, 2012, MYCOTAXON, V120, P373, DOI 10.5248/120.373; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315	21	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101454	10.1371/journal.pone.0101454	http://dx.doi.org/10.1371/journal.pone.0101454			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988489	gold, Green Published, Green Submitted			2022-12-27	WOS:000341354100091
J	Aduda, DSO; Ouma, C; Onyango, R; Onyango, M; Bertrand, J				Aduda, Dickens S. Omondi; Ouma, Collins; Onyango, Rosebella; Onyango, Mathews; Bertrand, Jane			Systematic Monitoring of Male Circumcision Scale-Up in Nyanza, Kenya: Exploratory Factor Analysis of Service Quality Instrument and Performance Ranking	PLOS ONE			English	Article							OF-CARE; HEALTH-CARE; SATISFACTION; INDICATORS	Background: Considerable conceptual and operational complexities related to service quality measurements and variability in delivery contexts of scaled-up medical male circumcision, pose real challenges to monitoring implementation of quality and safety. Clarifying latent factors of the quality instruments can enhance contextual applicability and the likelihood that observed service outcomes are appropriately assessed. Objective: To explore factors underlying SYMMACS service quality assessment tool (adopted from the WHO VMMC quality toolkit) and; determine service quality performance using composite quality index derived from the latent factors. Study design: Using a comparative process evaluation of Voluntary Medical Male Circumcision Scale-Up in Kenya site level data was collected among health facilities providing VMMC over two years. Systematic Monitoring of the Medical Male Circumcision Scale-Up quality instrument was used to assess availability of guidelines, supplies and equipment, infection control, and continuity of care services. Exploratory factor analysis was performed to clarify quality structure. Results:Fifty four items and 246 responses were analyzed. Based on Eigenvalue >1.00 cut-off, factors 1,2 & 3 were retained each respectively having eigenvalues of 5.78; 4.29; 2.99. These cumulatively accounted for 29.1% of the total variance (12.9%; 9.5%; 6.7%) with final communality estimates being 13.06. Using a cut-off factor loading value of >= 0.4, fifteen items loading on factor 1, five on factor 2 and one on factor 3 were retained. Factor 1closely relates to preparedness to deliver safe male circumcisions while factor two depicts skilled task performance and compliance with protocols. Of the 28 facilities, 32% attained between 90th and 95th percentile (excellent); 45% between 50th and 75th percentiles (average) and 14.3% below 25th percentile (poor). Conclusion: the service quality assessment instrument may be simplified to have nearly 20 items that relate more closely to service outcomes. Ranking of facilities and circumcision procedure using a composite index based on these items indicates that majority performed above average.	[Aduda, Dickens S. Omondi] Maseno Univ, Sch Publ Hlth & Community Dev, Maseno, Kenya; [Ouma, Collins] Maseno Univ, Sch Publ Hlth & Community Dev, Dept Biomed Sci & Technol, Maseno, Kenya; [Onyango, Rosebella] Maseno Univ, Sch Publ Hlth & Community Dev, Dept Publ Hlth, Maseno, Kenya; [Onyango, Mathews] Kisumu Off, FHI360, Kisumu, Kenya; [Bertrand, Jane] Tulane Univ, Dept Global Hlth Syst & Dev, New Orleans, LA 70118 USA	Maseno University; Maseno University; Maseno University; Tulane University	Aduda, DSO (corresponding author), Maseno Univ, Sch Publ Hlth & Community Dev, Maseno, Kenya.	omondisda@yahoo.com		Ouma, Collins/0000-0001-8205-8887	USAID\Project SEARCH - US Agency for International Development [GHH-I-00-07-00032-00]; President's Emergency Plan for AIDS Relief	USAID\Project SEARCH - US Agency for International Development(United States Agency for International Development (USAID)); President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by USAID vertical bar Project SEARCH, Task Order No. 2, funded by the US Agency for International Development under Contract No. GHH-I-00-07-00032-00, beginning 30 September 2008, and supported by the President's Emergency Plan for AIDS Relief. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babikako HM, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-6; Bellows J, 2004, BACKGROUND PAPER COU; Bertrand JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082518; Bickler SW, 2010, WORLD J SURG, V34, P386, DOI 10.1007/s00268-009-0273-2; Brown LD, QUALITY ASSURANCE ME; Campbell SM, 2000, SOC SCI MED, V51, P1611, DOI 10.1016/S0277-9536(00)00057-5; Casey Sara E, 2009, Confl Health, V3, P12, DOI 10.1186/1752-1505-3-12; Costello A.M., 2005, PRACT ASSESS RES EVA, V10, P7, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868]; Derose SF, 2003, ANNU REV PUBL HEALTH, V24, P363, DOI 10.1146/annurev.publhealth.24.100901.140847; Derose SF, 2002, ANNU REV PUBL HEALTH, V23, P1, DOI 10.1146/annurev.publhealth.23.092601.095644; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; English M, 2004, LANCET, V364, P1622, DOI 10.1016/S0140-6736(04)17318-2; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; Grimshaw J, 2003, QUAL SAF HEALTH CARE, V12, P298, DOI 10.1136/qhc.12.4.298; Hathorn E, 2011, SEX TRANSM INFECT, V87, P508, DOI 10.1136/sextrans-2011-050107; Herman-Roloff A, 2012, B WORLD HEALTH ORGAN, V90, P773, DOI 10.2471/BLT.12.106112; Hong R, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-79; Jennings L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0079524; Jolliffe Ian, 2011, PRINCIPAL COMPONENT; Kredo T, 2012, HEALTH RES POLICY SY, V10, DOI 10.1186/1478-4505-10-1; Landgren F, 2008, GUIDE USING DATA HLT; Landrum MB, 2000, HLTH SERVICES OUTCOM, V1, P23, DOI [10.1023/A:1010093701870, DOI 10.1023/A:1010093701870]; Lazar EJ, 2013, ANNU REV MED, V64, P485, DOI 10.1146/annurev-med-061511-135544; Mahler HR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001131; Mangham LJ, 2010, HLTH POLICY PLANNING; Mangione-Smith R, 2007, NEW ENGL J MED, V357, P1515, DOI 10.1056/NEJMsa064637; Matsunaga M, 2010, INT J PSYCHOL RES, V3, P97, DOI 10.21500/20112084.854; Ministry of Health, 2005, REV TRENDS 2 NAT HLT; MOPHS, 2011, PROV MMC TASK FORC R; Nalwadda G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027908; NASCOP, 2008, MAN MAL CIRC LOC AN; National AIDS and STI Control Programme (NASCOP), 2009, KEN NAT STRAT VOL ME; National Aids Control Council, 2020, KEN AIDS STRAT FRAM; National AIDS/STI Control Programme (NASCOP), 2008, NAT GUID VOL MAL CIR; Nietert PJ, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-11; PARASURAMAN A, 1985, J MARKETING, V49, P41, DOI 10.2307/1251430; Piligrimiene Z, 2008, INZ EKON, P104; Rapkin B, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-20; Shahidzadeh-Mahani A, 2008, INT J QUAL HEALTH C, V20, P284, DOI 10.1093/intqhc/mzn016; Shaller D, 2004, PEDIATRICS, V113, P217; Sofaer S, 2005, ANNU REV PUBL HEALTH, V26, P513, DOI 10.1146/annurev.publhealth.25.050503.153958; Sower V, 2001, HEALTH CARE MANAGE R, V26, P47, DOI 10.1097/00004010-200104000-00005; Stevens J. P, 1992, APPL MULTIVARIATE ST; Tabrizi J, 2011, J RES HLTH SCI N AM, V9, P1; van Duong D, 2004, INT J QUAL HEALTH C, V16, P447, DOI 10.1093/intqhc/mzh073; Vyas S, 2006, DO NOT DO CONSTRUCTI; World Health Organization, 2009, MAL CIRC SERV QUAL A; World Health Organization, 2006, QUAL CAR PROC MAK ST; Zaslavsky AM, 2002, HEALTH CARE FINANC R, V23, P101	49	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101235	10.1371/journal.pone.0101235	http://dx.doi.org/10.1371/journal.pone.0101235			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1UX	24983242	gold, Green Published, Green Submitted			2022-12-27	WOS:000339635000073
J	Clark, MA; Goheen, MM; Spidale, NA; Kasthuri, RS; Fulford, A; Cerami, C				Clark, Martha A.; Goheen, Morgan M.; Spidale, Nicholas A.; Kasthuri, Raj S.; Fulford, Anthony; Cerami, Carla			RBC Barcoding Allows for the Study of Erythrocyte Population Dynamics and P-falciparum Merozoite Invasion	PLOS ONE			English	Article							RED-BLOOD-CELLS; MALARIA PARASITE INVASION; FLOW-CYTOMETRY; INSIGHTS; LIGAND; ASSAY; MATURATION; INFECTION; BIOTIN; ANEMIA	Plasmodium falciparum invasion of host erythrocytes is essential for the propagation of the blood stage of malaria infection. Additionally, the brief extracellular merozoite stage of P. falciparum represents one of the rare windows during which the parasite is directly exposed to the host immune response. Therefore, efficient invasion of the host erythrocyte is necessary not only for productive host erythrocyte infection, but also for evasion of the immune response. Host traits, such as hemoglobinopathies and differential expression of erythrocyte invasion ligands, can protect individuals from malaria by impeding parasite erythrocyte invasion. Here we combine RBC barcoding with flow cytometry to study P. falciparum invasion. This novel high-throughput method allows for the (i) direct comparison of P. falciparum invasion into different erythrocyte populations and (ii) assessment of the impact of changing erythrocyte population dynamics on P. falciparum invasion.	[Clark, Martha A.; Goheen, Morgan M.; Spidale, Nicholas A.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Kasthuri, Raj S.] Univ N Carolina, Div Hematol, Chapel Hill, NC USA; [Fulford, Anthony] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Cerami, Carla] London Sch Hyg & Trop Med, Med Res Council Int Nutr Grp, London WC1, England; [Cerami, Carla] Med Res Council Keneba, Serrekunda, Gambia	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Cerami, C (corresponding author), London Sch Hyg & Trop Med, Med Res Council Int Nutr Grp, London WC1, England.	ccerami@unc.edu	, UNC Flow Cytometry Core/AGU-9839-2022	Cerami, Carla/0000-0002-7634-0955	National Institute of Child Health and Human Development [U01HD061235]; NCI Center [P30CA06086]; NCI [CA16086-36]; Lineberger Comprehensive Cancer Center; UNC Department of Pathology & Laboratory Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD061235] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NCI Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lineberger Comprehensive Cancer Center; UNC Department of Pathology & Laboratory Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by the National Institute of Child Health and Human Development under award number U01HD061235 (to CC). The UNC Flow Cytometry Core Facility is supported in part by an NCI Center Core Grant number P30CA06086. The UNC Microscopy Core facility is supported by NCI grant CA16086-36 and the Lineberger Comprehensive Cancer Center Core Grant and the UNC Department of Pathology & Laboratory Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badiane AS, 2013, CLIN VACCINE IMMUNOL, V20, P1238, DOI 10.1128/CVI.00135-13; Baum J, 2003, INFECT IMMUN, V71, P1856, DOI 10.1128/IAI.71.4.1856-1863.2003; Bei AK, 2012, INT J PARASITOL, V42, P575, DOI 10.1016/j.ijpara.2012.03.006; Bei AK, 2010, AM J HEMATOL, V85, P234, DOI 10.1002/ajh.21642; Boyle MJ, 2013, INT J PARASITOL, V43, P1, DOI 10.1016/j.ijpara.2012.11.002; Brandao MM, 2009, CLIN HEMORHEOL MICRO, V43, P217, DOI 10.3233/CH-2009-1211; BREUER WV, 1983, BIOCHIM BIOPHYS ACTA, V755, P263, DOI 10.1016/0304-4165(83)90213-1; Clark M, 2013, BRIT J HAEMATOL, V161, P262, DOI 10.1111/bjh.12234; Cordero JF, 2004, CELL BIOL INT, V28, P423, DOI 10.1016/j.cellbi.2004.03.002; Cowman AF, 2012, J CELL BIOL, V198, P961, DOI 10.1083/jcb.201206112; Cromer D, 2009, J THEOR BIOL, V257, P533, DOI 10.1016/j.jtbi.2008.12.019; Franco RS, 2013, AM J HEMATOL, V88, P44, DOI 10.1002/ajh.23344; Gifford SC, 2006, BRIT J HAEMATOL, V135, P395, DOI 10.1111/j.1365-2141.2006.06279.x; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Lantos PM, 2009, PARASITOLOGY, V136, P1, DOI 10.1017/S0031182008005167; Lobo CA, 2006, MOL BIOCHEM PARASIT, V149, P246, DOI 10.1016/j.molbiopara.2006.05.011; Lopez-Perez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047913; Nagababu E, 2008, FREE RADICAL RES, V42, P824, DOI 10.1080/10715760802459879; Pattanapanyasat K, 1996, CYTOMETRY, V25, P287, DOI 10.1002/(SICI)1097-0320(19961101)25:3&lt;287::AID-CYTO10&gt;3.0.CO;2-S; Pattanapanyasat K, 1999, BLOOD, V93, P3116; Ribaut C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-45; ROTH EF, 1983, P NATL ACAD SCI-BIOL, V80, P298, DOI 10.1073/pnas.80.1.298; Rowe JA, 2009, CURR OPIN HEMATOL, V16, P480, DOI 10.1097/MOH.0b013e3283313de0; SANSONE G, 1963, Pathologica, V55, P371; Shapiro HM, 2013, CURR PROTOC CYTOM ED; Taylor SM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003327; Tham WH, 2010, P NATL ACAD SCI USA, V107, P17327, DOI 10.1073/pnas.1008151107; Theron M, 2010, CYTOM PART A, V77A, P1067, DOI 10.1002/cyto.a.20972; Walker P S, 2010, Immunohematology, V26, P60; WHO, WORLD MAL REP 2011; Wright GJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003943	31	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101041	10.1371/journal.pone.0101041	http://dx.doi.org/10.1371/journal.pone.0101041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984000	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000339635000051
J	Maeda, S; Sun, DW; Singhal, A; Foggetta, M; Schmid, G; Standfuss, J; Hennig, M; Dawson, RJP; Veprintsev, DB; Schertler, GFX				Maeda, Shoji; Sun, Dawei; Singhal, Ankita; Foggetta, Marcello; Schmid, Georg; Standfuss, Joerg; Hennig, Michael; Dawson, Roger J. P.; Veprintsev, Dmitry B.; Schertler, Gebhard F. X.			Crystallization Scale Preparation of a Stable GPCR Signaling Complex between Constitutively Active Rhodopsin and G-Protein	PLOS ONE			English	Article							COUPLED RECEPTOR RHODOPSIN; NANOSCALE LIPID-BILAYERS; NATIVE DISC MEMBRANES; TRANSDUCIN COMPLEX; PROTONATION SWITCHES; THERMAL-STABILITY; CRYSTAL-STRUCTURE; METARHODOPSIN-II; ACTIVATION; MUTANT	The activation of the G-protein transducin (Gt) by rhodopsin (Rho) has been intensively studied for several decades. It is the best understood example of GPCR activation mechanism and serves as a template for her GPCRs. The structure of the Rho/G protein complex, which is transiently formed during the signaling reaction, is of particular interest. It can help understanding the molecular details of how retinal isomerization leads to the G protein activation, as well as shed some on how GPCR recognizes its cognate G protein. The native Rho/Gt complex isolated from bovine retina suffers from low stability and loss of the retinal ligand. Recently, we reported that constitutively active mutant of rhodopsin E113Q forms a Rho/Gt complex that is stable In detergent solution. Here, we introduce methods for a large scale preparation of he formed formed by the thermo-stabilized and constitutively active rhodopsin mutant N2C/M257Y/D282C(RhoM257Y) and he native Gt purified from bovine retinas We demonstrate that the light-activated rhodopsin in this complex contains a covalently bound unprotonated retinal and therefore corresponds to the active metarhodopin II state; ha the isolated complex is active and dissociates upon addition of GTP gamma S; and that the stoichiometry corresponds to a 11 molar ratio of rhodopsin to the heterotrimeric G-protein. And finally, we show that the rhodopsin also forms stable complex with Gi. This complex has significantly higher thermostability than RhoM257Y/Gt complex and is resistant to a variety of detergents. Overall, our data suggest that the RhoM257Y/Gi complex is an ideal target for future structural and mechanistic studies of signaling in the visual system	[Maeda, Shoji; Sun, Dawei; Singhal, Ankita; Standfuss, Joerg; Veprintsev, Dmitry B.; Schertler, Gebhard F. X.] Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland; [Maeda, Shoji; Sun, Dawei; Singhal, Ankita; Standfuss, Joerg; Veprintsev, Dmitry B.; Schertler, Gebhard F. X.] ETH, Dept Biol, Zurich, Switzerland; [Foggetta, Marcello; Schmid, Georg; Hennig, Michael; Dawson, Roger J. P.] F Hoffmann La Roche & Co Ltd, PRED Pharma Res & Early Dev, Small Mol Res, Discovery Technol, CH-4002 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich; Novartis; Roche Holding	Veprintsev, DB (corresponding author), Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland.	dmitry.veprintsev@psi.ch; gebhard.schertler@psi.ch	Schertler, Gebhard/M-9512-2014; Standfuss, Joerg/G-5126-2011; Veprintsev, Dmitry B/H-2228-2012	Veprintsev, Dmitry B/0000-0002-3583-5409; Schertler, Gebhard F.X./0000-0002-5846-6810; Maeda, Shoji/0000-0002-7762-9793; Sun, Dawei/0000-0002-2010-6051; Dawson, Roger/0000-0003-2161-5883	Roche [RPF113]; Swiss National Science Foundation [133810, 135754, 141898, 132815, 141235]; NCCR Structural Biology	Roche(Roche Holding); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR Structural Biology(Swiss National Science Foundation (SNSF))	SM is supported by the Roche postdoctoral fellowship (RPF113, www.roche.com). This work was supported by the Swiss National Science Foundation (www.snf.ch) grants 133810 (DBV, JS, GFXS), 135754 (DBV), 141898 (DBV, GFXS), 132815 (GFXS, JS), 141235 (JS) and NCCR Structural Biology (GFXS). Roche provided funding in the form of salaries for the employees and co-authors (MF, GS, MH and RJPD). The Swiss National Science Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; Caffrey M, 2012, BIOCHEMISTRY-US, V51, P6266, DOI 10.1021/bi300010w; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; D'Antona AM, 2014, BIOCHEMISTRY-US, V53, P127, DOI 10.1021/bi4012995; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Han M, 2000, METHOD ENZYMOL, V315, P251; Han M, 1998, BIOCHEMISTRY-US, V37, P8253, DOI 10.1021/bi980147r; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Insel PA, 2007, BBA-BIOMEMBRANES, V1768, P994, DOI 10.1016/j.bbamem.2006.09.029; JAGER F, 1994, BIOCHEMISTRY-US, V33, P10878; Jastrzebska B, 2013, J STRUCT BIOL, V182, P164, DOI 10.1016/j.jsb.2013.02.014; Jastrzebska B, 2013, FASEB J, V27, P1572, DOI 10.1096/fj.12-225383; Jastrzebska B, 2011, J STRUCT BIOL, V176, P387, DOI 10.1016/j.jsb.2011.08.016; Jastrzebska B, 2009, BIOCHEMISTRY-US, V48, P5159, DOI 10.1021/bi900284x; Jastrzebska B, 2009, FASEB J, V23, P371, DOI 10.1096/fj.07-114835; KANAHO Y, 1984, J BIOL CHEM, V259, P7378; KLEUSS C, 1987, J CHROMATOGR, V407, P281, DOI 10.1016/S0021-9673(01)92625-1; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Kuhn H, 1984, PROGR RETINAL RES, V3, P123; Mahalingam M, 2008, P NATL ACAD SCI USA, V105, P17795, DOI 10.1073/pnas.0804541105; Melia TJ, 1997, BIOPHYS J, V73, P3182, DOI 10.1016/S0006-3495(97)78344-9; Moukhametzianov R, 2008, ACTA CRYSTALLOGR D, V64, P158, DOI 10.1107/S090744490705812X; Orban T, 2012, STRUCTURE, V20, P826, DOI 10.1016/j.str.2012.03.017; Preininger AM, 2013, J MOL BIOL, V425, P2288, DOI 10.1016/j.jmb.2013.04.011; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Riekel C, 2005, CURR OPIN STRUC BIOL, V15, P556, DOI 10.1016/j.sbi.2005.08.013; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008; Singhal A, 2013, EMBO REP, V14, P520, DOI 10.1038/embor.2013.44; Standfuss J, 2008, J MOL BIOL, V380, P145, DOI 10.1016/j.jmb.2008.04.055; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Steyaert J, 2011, CURR OPIN STRUC BIOL, V21, P567, DOI 10.1016/j.sbi.2011.06.011; Suda K, 2004, MOL MEMBR BIOL, V21, P435, DOI 10.1080/09687860400020291; Tate CG, 2012, TRENDS BIOCHEM SCI, V37, P343, DOI 10.1016/j.tibs.2012.06.003; Vogel R, 2007, PHOTOCHEM PHOTOBIOL, V83, P286, DOI 10.1562/2006-06-19-IR-937; Webb DR, 2013, BIOCHEM PHARMACOL, V85, P147, DOI 10.1016/j.bcp.2012.08.021; WESSLINGRESNICK M, 1987, J BIOL CHEM, V262, P3697; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Xie GF, 2003, BIOCHEMISTRY-US, V42, P1995, DOI 10.1021/bi020611z; Xie GF, 2011, BIOCHEMISTRY-US, V50, P10399, DOI 10.1021/bi201126r	53	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e98714	10.1371/journal.pone.0098714	http://dx.doi.org/10.1371/journal.pone.0098714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979345	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400002
J	McMahon, PM; Meza, R; Plevritis, SK; Black, WC; Tammemagi, CM; Erdogan, A; ten Haaf, K; Hazelton, W; Holford, TR; Jeon, J; Clarke, L; Kong, CY; Choi, SE; Munshi, VN; Han, SS; van Rosmalen, J; Pinsky, PF; Moolgavkar, S; de Koning, HJ; Feuer, EJ				McMahon, Pamela M.; Meza, Rafael; Plevritis, Sylvia K.; Black, William C.; Tammemagi, C. Martin; Erdogan, Ayca; ten Haaf, Kevin; Hazelton, William; Holford, Theodore R.; Jeon, Jihyoun; Clarke, Lauren; Kong, Chung Yin; Choi, Sung Eun; Munshi, Vidit N.; Han, Summer S.; van Rosmalen, Joost; Pinsky, Paul F.; Moolgavkar, Suresh; de Koning, Harry J.; Feuer, Eric J.			Comparing Benefits from Many Possible Computed Tomography Lung Cancer Screening Programs: Extrapolating from the National Lung Screening Trial Using Comparative Modeling	PLOS ONE			English	Article							THORACIC-SURGERY GUIDELINES; AMERICAN ASSOCIATION; POTENTIAL BENEFITS; ELDERLY-PATIENTS; DECISION-MAKING; RISK MODEL; SMOKING; MORTALITY; PROSTATE; SCANS	Background. The National Lung Screening Trial (NLST) demonstrated that in current and former smokers aged 55 to 74 years, with at least 30 pack-years of cigarette smoking history and who had quit smoking no more than 15 years ago, 3 annual computed tomography (CT) screens reduced lung cancer-specific mortality by 20% relative to 3 annual chest X-ray screens. We compared the benefits achievable with 576 lung cancer screening programs that varied CT screen number and frequency, ages of screening, and eligibility based on smoking. Methods and Findings: We used five independent microsimulation models with lung cancer natural history parameters previously calibrated to the NLST to simulate life histories of the US cohort born in 1950 under all 576 programs. 'Efficient' (within model) programs prevented the greatest number of lung cancer deaths, compared to no screening, for a given number of CT screens. Among 120 'consensus efficient (identified as efficient across models) programs, the average starting age was 55 years, the stopping age was 80 or 85 years, the average minimum pack-years was 27, and the maximum years since quitting was 20. Among consensus efficient programs, 11% to 40% of the cohort was screened, and 153 to 846 lung cancer deaths were averted per 100,000 people. In all models, annual screening based on age and smoking eligibility in NLST was not efficient; continuing screening to age 80 or 85 years was more efficient. Conclusions:Consensus results from five models identified a set of efficient screening programs that include annual CT lung cancer screening using criteria like NLST eligibility but extended to older ages. Guidelines for screening should also consider harms of screening and individual patient characteristics.	[McMahon, Pamela M.; Kong, Chung Yin; Choi, Sung Eun; Munshi, Vidit N.] Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA; [McMahon, Pamela M.; Kong, Chung Yin] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Meza, Rafael] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Plevritis, Sylvia K.; Erdogan, Ayca; Han, Summer S.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Black, William C.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Radiol, Hanover, NH 03756 USA; [Tammemagi, C. Martin] Brock Univ, Dept Community Hlth Sci, St Catharines, ON L2S 3A1, Canada; [ten Haaf, Kevin; van Rosmalen, Joost; de Koning, Harry J.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Hazelton, William] Fred Hutchinson Canc Res Ctr, Program Computat Biol, Seattle, WA 98104 USA; [Holford, Theodore R.] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT USA; [Jeon, Jihyoun; Moolgavkar, Suresh] Fred Hutchinson Canc Res Ctr, Dept Biostat & Biomath, Seattle, WA 98104 USA; [Clarke, Lauren] Cornerstone Syst Northwest Inc, Lynden, WA USA; [Pinsky, Paul F.] NCI, Canc Prevent Div, Bethesda, MD 20892 USA; [Moolgavkar, Suresh] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Feuer, Eric J.] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; Stanford University; Dartmouth College; Brock University; Erasmus University Rotterdam; Erasmus MC; Fred Hutchinson Cancer Center; Yale University; Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	McMahon, PM (corresponding author), Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA.	pamela@mgh-ita.org	Haaf, Kevin ten/AAI-3998-2020; de+Koning, Harry/AAF-9062-2019	Haaf, Kevin ten/0000-0001-5006-6938; de+Koning, Harry/0000-0003-4682-3646; van Rosmalen, Joost/0000-0002-9187-244X; Tammemagi, Martin/0000-0002-4989-5058	Agency for Healthcare Research and Quality; NATIONAL CANCER INSTITUTE [P30CA016359, U01CA152956, K25CA133141] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This report is based on research conducted by the Cancer Intervention and Surveillance Modeling Network under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Administrative Supplement to U01 CA152956). The National Cancer Institute supported the infrastructure for the CISNET models. The Agency for Healthcare Research and Quality funded this work and provided review. The authors worked witah USPSTF members to specify the overall questions. The findings and conclusions in this document are those of the authors, who are responsible for its contents, and do not necessarily represent the views of AHRQ. No statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CM, 2012, RISK ANAL, V32, pS14, DOI 10.1111/j.1539-6924.2011.01703.x; Bach PB, 2003, JNCI-J NATL CANCER I, V95, P470, DOI 10.1093/jnci/95.6.470; Bach PB, 2012, JAMA-J AM MED ASSOC, P1; Bach PB, 2012, ANN INTERN MED, V157, P571, DOI 10.7326/0003-4819-157-8-201210160-00524; Barry SA, 2012, JNCI-J NATL CANCER I, V104, P1647, DOI 10.1093/jnci/djs398; Cassidy A, 2008, BRIT J CANCER, V98, P270, DOI 10.1038/sj.bjc.6604158; CHARNES A, 1978, EUR J OPER RES, V2, P429, DOI 10.1016/0377-2217(78)90138-8; de Koning HJ, 2014, ANN INTERN MED, V160, P311, DOI 10.7326/M13-2316; Dominioni L, 2010, J THORACIC ONCOLOGY; Doria-Rose VP, 2012, USE LUNG CANC SCREEN; Duke SL, 2011, EXPERT REV ANTICANC, V11, P1833, DOI [10.1586/era.11.185, 10.1586/ERA.11.185]; Holford TR, 2014, AM J PREV MED, V46, pE31, DOI 10.1016/j.amepre.2013.10.022; Humphrey LL, 2013, ANN INTERN MED, V159, P411, DOI 10.7326/0003-4819-159-6-201309170-00690; Jacobson FL, 2012, J THORAC CARDIOV SUR, V144, P25, DOI 10.1016/j.jtcvs.2012.05.059; Jaklitsch MT, 2012, J THORAC CARDIOV SUR, V144, P33, DOI 10.1016/j.jtcvs.2012.05.060; Jonnalagadda S, 2012, LUNG CANC; Ma J, 2013, CANCER, V25, P27813; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; McMahon PM, 2008, RADIOLOGY, V248, P278, DOI 10.1148/radiol.2481071446; McMahon PM, 2012, RISK ANAL, V32, pS166, DOI 10.1111/j.1539-6924.2011.01714.x; Mery CM, 2005, CHEST, V128, P237, DOI 10.1378/chest.128.1.237; Meza R, 2014, CANCER-AM CANCER SOC, V120, P1713, DOI 10.1002/cncr.28623; MOOLGAVKAR SH, 1988, RISK ANAL, V8, P383, DOI 10.1111/j.1539-6924.1988.tb00502.x; Moolgavkar SH, 2012, JNCI-J NATL CANCER I, V104, P541, DOI 10.1093/jnci/djs136; Oken MM, 2011, JAMA-J AM MED ASSOC, V306, P1865, DOI 10.1001/jama.2011.1591; Ostroff JS, 2001, PREV MED, V33, P613, DOI 10.1006/pmed.2001.0935; Park ER, 2012, CANCER, V20, P27925; Patel ARC, 2011, NEW ENGL J MED, V365, P2035, DOI 10.1056/NEJMc1110293; Pinsky PF, 2007, AM J EPIDEMIOL, V165, P874, DOI 10.1093/aje/kwk075; Pinsky PF, 2012, J MED SCREEN; Pinsky PF, 2013, SUBSET HISTOLOGICAL; Pirie K, 2013, LANCET, V381, P133, DOI 10.1016/S0140-6736(12)61720-6; Raji OY, 2012, ANN INTERN MED, V157, P242, DOI 10.7326/0003-4819-157-4-201208210-00004; Rosenberg MA, 2012, RISK ANAL, V32, pS25, DOI 10.1111/j.1539-6924.2011.01662.x; Tammemagi MC, 2013, NEW ENGL J MED, V368, P728, DOI 10.1056/NEJMoa1211776; Tammemagi CM, 2011, JNCI-J NATL CANCER I, V103, P1058, DOI 10.1093/jnci/djr173; van der Aalst CM, 2010, THORAX, V65, P600, DOI 10.1136/thx.2009.133751; van der Aalst CM, 2011, LUNG CANC; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Wender R, 2013, CA-CANCER J CLIN, V63, P107, DOI 10.3322/caac.21172; Wood DE, 2012, J NATL COMPR CANC NE, V10, P240, DOI 10.6004/jnccn.2012.0022	42	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e99978	10.1371/journal.pone.0099978	http://dx.doi.org/10.1371/journal.pone.0099978			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979231	Green Published, gold, Green Submitted			2022-12-27	WOS:000338506400012
J	Sharma, P; Mantri, SS				Sharma, Parichit; Mantri, Shrikant S.			WImpiBLAST: Web Interface for mpiBLAST to Help Biologists Perform Large-Scale Annotation Using High Performance Computing	PLOS ONE			English	Article							SEARCH; BLAST; PROTEIN	The function of a newly sequenced gene can be discovered by determining its sequence homology with known proteins. BLAST is the most extensively used sequence analysis program for sequence similarity search in large databases of sequences. With the advent of next generation sequencing technologies it has now become possible to study genes and their expression at a genome-wide scale through RNA-seq and metagenome sequencing experiments. Functional annotation of all the genes is done by sequence similarity search against multiple protein databases. This annotation task is computationally very intensive and can take days to obtain complete results. The program mpiBLAST, an open-source parallelization of BLAST that achieves superlinear speedup, can be used to accelerate large-scale annotation by using supercomputers and high performance computing (HPC) clusters. Although many parallel bioinformatics applications using the Message Passing Interface (MPI) are available in the public domain, researchers are reluctant to use them due to lack of expertise in the Linux command line and relevant programming experience. With these limitations, it becomes difficult for biologists to use mpiBLAST for accelerating annotation. No web interface is available in the open-source domain for mpiBLAST. We have developed WImpiBLAST, a user-friendly open-source web interface for parallel BLAST searches. It is implemented in Struts 1.3 using a Java backbone and runs atop the open-source Apache Tomcat Server. WImpiBLAST supports script creation and job submission features and also provides a robust job management interface for system administrators. It combines script creation and modification features with job monitoring and management through the Torque resource manager on a Linux-based HPC cluster. Use case information highlights the acceleration of annotation analysis achieved by using WImpiBLAST. Here, we describe the WImpiBLAST web interface features and architecture, explain design decisions, describe workflows and provide a detailed analysis.	[Sharma, Parichit] C DAC, Pune, Maharashtra, India; [Mantri, Shrikant S.] Natl Agri Food Biotechnol Inst NABI, Mohali, India	Centre for Development of Advanced Computing (C-DAC); Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI)	Mantri, SS (corresponding author), Natl Agri Food Biotechnol Inst NABI, Mohali, India.	shrikant@nabi.res.in		Sharma, Parichit/0000-0003-0822-1089; Mantri, Shrikant/0000-0002-7493-459X	National Agri-Food Biotechnology Institute (NABI), Mohali, India; Department of Biotechnology, Government of India	National Agri-Food Biotechnology Institute (NABI), Mohali, India; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was financially supported by the core grant of National Agri-Food Biotechnology Institute (NABI), Mohali, India and the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; COULSON AFW, 1987, COMPUT J, V30, P420, DOI 10.1093/comjnl/30.5.420; Darling AE., 2003, 4 INT C LIN CLUST CL; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; GOTOH O, 1986, NUCLEIC ACIDS RES, V14, P57, DOI 10.1093/nar/14.1.57; Hunter AA, 2012, SOURCE CODE BIOL MED, V7, DOI 10.1186/1751-0473-7-1; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Letondal C, 2001, BIOINFORMATICS, V17, P73, DOI 10.1093/bioinformatics/17.1.73; Lim A, 1999, BIOINFORMATICS, V15, P1068, DOI 10.1093/bioinformatics/15.12.1068; Lin H, 2008, INT C IEEE; Matsunaga A., 2008, ESCIENCE 2008 ESCIEN, P222, DOI DOI 10.1109/ESCIENCE.2008.62; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Misra, 2011, INT C HIGH PERF COMP, P12; Papadopoulos A, 2013, INTEGRATION, V46, P230, DOI 10.1016/j.vlsi.2012.10.003; Priyam A, SEQUENCESERVER BLAST; Rekapalli B, 2013, BMC BIOINFORMATIC S2, V35, pW71; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vouzis PD, 2011, BIOINFORMATICS, V27, P182, DOI 10.1093/bioinformatics/btq644; Yang CT, 2009, CONCURR COMP-PRACT E, V21, P225, DOI 10.1002/cpe.1346	20	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101144	10.1371/journal.pone.0101144	http://dx.doi.org/10.1371/journal.pone.0101144			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979410	gold, Green Published			2022-12-27	WOS:000338506400085
J	Subramanian, S; Gomez, RD				Subramanian, Sowmya; Gomez, Romel D.			An Empirical Approach for Quantifying Loop-Mediated Isothermal Amplification (LAMP) Using Escherichia coli as a Model System	PLOS ONE			English	Article							RAPID DETECTION; DNA; DIAGNOSIS; ACCURATE; ASSAY	Loop mediated isothermal amplification (LAMP) is a highly efficient, selective and rapid DNA amplification technique for genetic screening of pathogens. However, despite its popularity, there is yet no mathematical model to quantify the outcome and no well-defined metric for comparing results that are available. LAMP is intrinsically complex and involves multiple pathways for gene replication, making fundamental modelling nearly intractable. To circumvent this difficulty, an alternate, empirical model is introduced that will allow one to extract a set of parameters from the concentration versus time curves. A simple recipe to deduce the time to positive, T-p - a parameter analogous to the threshold cycling time in polymerase chain reaction (PCR), is also provided. These parameters can be regarded as objective and unambiguous indicators of LAMP amplification. The model is exemplified on Escherichia coli strains by using the two gene fragments responsible for vero-toxin (VT) production and tested against VT-producing (O157 and O45) and non-VT producing (DH5 alpha) strains. Selective amplification of appropriate target sequences was made using well established LAMP primers and protocols, and the concentrations of the amplicons were measured using a Qubit 2.0 fluorometer at specific intervals of time. The data is fitted to a generalized logistic function. Apart from providing precise screening indicators, representing the data with a small set of numbers offers significant advantages. It facilitates comparisons of LAMP reactions independently of the sampling technique. It also eliminates subjectivity in interpretation, simplifies data analysis, and allows easy data archival, retrieval and statistical analysis for large sample populations. To our knowledge this work represents a first attempt to quantitatively model LAMP and offer a standard method that could pave the way towards high throughput automated screening.	[Subramanian, Sowmya; Gomez, Romel D.] Univ Maryland, Dept Elect & Comp Engn, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Gomez, RD (corresponding author), Univ Maryland, Dept Elect & Comp Engn, College Pk, MD 20742 USA.	rdgomez@umd.edu	Subramanian, Sowmya/AAW-3878-2021		JIFSAN at the University of Maryland	JIFSAN at the University of Maryland	The authors acknowledge support from JIFSAN at the University of Maryland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fekedulegn D, 1999, SILVA FENN, V33, P327, DOI 10.14214/sf.653; Ge BL, 2009, JALA-J LAB AUTOM, V14, P235, DOI 10.1016/j.jala.2008.12.012; Gould L. Hannah, 2009, Morbidity and Mortality Weekly Report, V58, P1; Hara-Kudo Y, 2007, J MED MICROBIOL, V56, P398, DOI 10.1099/jmm.0.46819-0; Hill J, 2008, J CLIN MICROBIOL, V46, P2800, DOI 10.1128/JCM.00152-08; Hsieh KW, 2012, ANGEW CHEM INT EDIT, V51, P4896, DOI 10.1002/anie.201109115; Kaneko H, 2007, J BIOCHEM BIOPH METH, V70, P499, DOI 10.1016/j.jbbm.2006.08.008; Mori Y, 2013, J INFECT CHEMOTHER, V19, P404, DOI 10.1007/s10156-013-0590-0; Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Parida M, 2008, REV MED VIROL, V18, P407, DOI 10.1002/rmv.593; Soleimani M, 2013, J APPL MICROBIOL, V115, P828, DOI 10.1111/jam.12290; Thorpe CM, 2004, CLIN INFECT DIS, V38, P1298, DOI 10.1086/383473; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57; Tomlinson JA, 2010, LETT APPL MICROBIOL, V51, P650, DOI 10.1111/j.1472-765X.2010.02949.x; Toumazou C, 2013, NAT METHODS, V10, P641, DOI 10.1038/nmeth.2520; Veigas B, 2014, BIOSENS BIOELECTRON, V52, P50, DOI 10.1016/j.bios.2013.08.029	18	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100596	10.1371/journal.pone.0100596	http://dx.doi.org/10.1371/journal.pone.0100596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979038	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400035
J	Yu, Y; Su, FC; Callaghan, BC; Goutman, SA; Batterman, SA; Feldman, EL				Yu, Yu; Su, Feng-Chiao; Callaghan, Brian C.; Goutman, Stephen A.; Batterman, Stuart A.; Feldman, Eva L.			Environmental Risk Factors and Amyotrophic Lateral Sclerosis (ALS): A Case-Control Study of ALS in Michigan	PLOS ONE			English	Article							WESTERN WASHINGTON-STATE; MOTOR-NEURON DISEASE; GULF-WAR VETERANS; NEURODEGENERATIVE DISEASES; ELECTROMAGNETIC-FIELDS; OCCUPATIONAL-EXPOSURE; CEREBROSPINAL-FLUID; CIGARETTE-SMOKING; PHYSICAL-ACTIVITY; UTILITY WORKERS	An interim report of a case-control study was conducted to explore the role of environmental factors in the development of amyotrophic lateral sclerosis (ALS). Sixty-six cases and 66 age-and gender-matched controls were recruited. Detailed information regarding residence history, occupational history, smoking, physical activity, and other factors was obtained using questionnaires. The association of ALS with potential risk factors, including smoking, physical activity and chemical exposure, was investigated using conditional logistic regression models. As compared to controls, a greater number of our randomly selected ALS patients reported exposure to fertilizers to treat private yards and gardens and occupational exposure to pesticides in the last 30 years than our randomly selected control cases. Smoking, occupational exposures to metals, dust/fibers/fumes/gas and radiation, and physical activity were not associated with ALS when comparing the randomly selected ALS patients to the control subjects. To further explore and confirm results, exposures over several time frames, including 0-10 and 10-30 years earlier, were considered, and analyses were stratified by age and gender. Pesticide and fertilizer exposure were both significantly associated with ALS in the randomly selected ALS patients. While study results need to be interpreted cautiously given the small sample size and the lack of direct exposure measures, these results suggest that environmental and particularly residential exposure factors warrant close attention in studies examining risk factors of ALS.	[Yu, Yu; Su, Feng-Chiao; Batterman, Stuart A.] Univ Michigan, Ann Arbor, MI 48109 USA; [Callaghan, Brian C.; Goutman, Stephen A.; Feldman, Eva L.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Batterman, SA (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.	stuartb@umich.edu; efeldman@umich.edu	Yu, Yu/AAV-4449-2020	Goutman, Stephen/0000-0001-8780-6637; Batterman, Stuart/0000-0001-9894-5325; Feldman, Eva/0000-0002-9162-2694	Agency for Toxic Substances and Disease Registry [200-2013-56856]; National Institutes of Health (National Institute of Environmental Health Sciences (NIEHS)) [P30ES017885]; National Institutes of Health (National Institute for Occupational Safety and Health (NIOSH)) [5T42OH008455-08]; University of Michigan; A. Alfred Taubman Medical Research Institute; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [T42OH008455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES017885] Funding Source: NIH RePORTER	Agency for Toxic Substances and Disease Registry(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health (National Institute of Environmental Health Sciences (NIEHS))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health (National Institute for Occupational Safety and Health (NIOSH)); University of Michigan(University of Michigan System); A. Alfred Taubman Medical Research Institute; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding support was provided by the Agency for Toxic Substances and Disease Registry (contract # 200-2013-56856), the National Institutes of Health (National Institute of Environmental Health Sciences (NIEHS) P30ES017885 and National Institute for Occupational Safety and Health (NIOSH) 5T42OH008455-08), the University of Michigan MCubed funding program, and the A. Alfred Taubman Medical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2011, NEUROL CLIN, V29, P689, DOI 10.1016/j.ncl.2011.06.001; Alonso A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-6; ANNEGERS JF, 1991, ARCH NEUROL-CHICAGO, V48, P589, DOI 10.1001/archneur.1991.00530180041015; ARMON C, 1991, NEUROLOGY, V41, P1077, DOI 10.1212/WNL.41.7.1077; Armon C, 2009, NEUROLOGY, V73, P1693, DOI 10.1212/WNL.0b013e3181c1df48; Bergomi M, 2002, ENVIRON RES, V89, P116, DOI 10.1006/enrs.2002.4361; BHARUCHA NE, 1983, NEUROLOGY, V33, P911, DOI 10.1212/WNL.33.7.911; BOBOWICK AR, 1973, NEW ENGL J MED, V288, P1047, DOI 10.1056/NEJM197305172882005; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Brown RC, 2005, ENVIRON HEALTH PERSP, V113, P1250, DOI 10.1289/ehp.7567; Callaghan B, 2011, NEURODEGENER DIS, V8, P1, DOI 10.1159/000315405; CDC NCHS, 2013, NAT HLTH NUTR EX SUR; CHANCELLOR AM, 1992, J NEUROL NEUROSUR PS, V55, P1106, DOI 10.1136/jnnp.55.12.1106; CHIBA M, 1992, B WORLD HEALTH ORGAN, V70, P269; Davanipour Z, 1997, BIOELECTROMAGNETICS, V18, P28, DOI 10.1002/(SICI)1521-186X(1997)18:1<28::AID-BEM6>3.0.CO;2-7; Elbaz A, 2007, CR BIOL, V330, P318, DOI 10.1016/j.crvi.2007.02.018; Fang F, 2010, AM J EPIDEMIOL, V171, P1126, DOI 10.1093/aje/kwq063; Fang F, 2009, ENVIRON HEALTH PERSP, V117, P1387, DOI 10.1289/ehp.0900580; FARRELL DF, 1968, NEUROLOGY, V18, P601, DOI 10.1212/WNL.18.6.601; Gallo V, 2009, ANN NEUROL, V65, P378, DOI 10.1002/ana.21653; GIAGHEDDU M, 1983, ACTA NEUROL SCAND, V68, P394, DOI 10.1111/j.1600-0404.1983.tb04849.x; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Horner RD, 2008, NEUROEPIDEMIOLOGY, V31, P28, DOI 10.1159/000136648; Johansen C, 2000, EPIDEMIOLOGY, V11, P539, DOI 10.1097/00001648-200009000-00009; KALFAKIS N, 1991, NEUROEPIDEMIOLOGY, V10, P170, DOI 10.1159/000110266; Kamel F, 2002, EPIDEMIOLOGY, V13, P311, DOI 10.1097/00001648-200205000-00012; KAPAKI E, 1989, EXPERIENTIA, V45, P1108, DOI 10.1007/BF01950171; Kasarskis EJ, 2009, AMYOTROPH LATERAL SC, V10, P35, DOI 10.1080/17482960802351029; Kreyling WG, 2002, J TOXICOL ENV HEAL A, V65, P1513, DOI 10.1080/00984100290071649; Lockman PR, 2004, J DRUG TARGET, V12, P635, DOI 10.1080/10611860400015936; Longstreth WT, 1998, ARCH NEUROL-CHICAGO, V55, P201, DOI 10.1001/archneur.55.2.201; LONGSTRETH WT, 1991, MED HYPOTHESES, V34, P144, DOI 10.1016/0306-9877(91)90183-Y; Malek AM, 2013, ENV OCCUPATIONAL RIS; McGuire V, 1996, NEUROLOGY, V47, P571, DOI 10.1212/WNL.47.2.571; McGuire V, 1997, AM J EPIDEMIOL, V145, P1076, DOI 10.1093/oxfordjournals.aje.a009070; Morahan JM, 2006, NEUROEPIDEMIOLOGY, V27, P130, DOI 10.1159/000095552; MORIWAKA F, 1993, J NEUROL SCI, V118, P38, DOI 10.1016/0022-510X(93)90243-R; MORROW JD, 1995, NEW ENGL J MED, V332, P1198, DOI 10.1056/NEJM199505043321804; Nelson LM, 2000, AM J EPIDEMIOL, V151, P156, DOI 10.1093/oxfordjournals.aje.a010183; Nelson LM, 1996, CLIN NEUROSCI, V3, P327; NINDS, 2012, AM LET SCLER ALS FAC; Noonan CW, 2002, SCAND J WORK ENV HEA, V28, P42, DOI 10.5271/sjweh.645; Oberdorster G, 2002, J TOXICOL ENV HEAL A, V65, P1531, DOI 10.1080/00984100290071658; Park RM, 2005, AM J IND MED, V48, P63, DOI 10.1002/ajim.20178; Qureshi MM, 2006, AMYOTROPH LATERAL SC, V7, P173, DOI 10.1080/14660820600640596; Riggs JE, 2001, MIL MED, V166, P731, DOI 10.1093/milmed/166.8.731; SAVETTIERI G, 1991, NEUROEPIDEMIOLOGY, V10, P242, DOI 10.1159/000110279; Savitz DA, 1998, ARCH ENVIRON HEALTH, V53, P71, DOI 10.1080/00039899809605691; Savitz DA, 1998, EPIDEMIOLOGY, V9, P398, DOI 10.1097/00001648-199807000-00009; STOBER T, 1983, J NEUROL SCI, V61, P21, DOI 10.1016/0022-510X(83)90051-5; Stozicka Z, 2007, ACTA VIROL, V51, P205; Strickland D, 1996, ARCH NEUROL-CHICAGO, V53, P730, DOI 10.1001/archneur.1996.00550080044011; Sutedja NA, 2007, NEUROLOGY, V69, P1508, DOI 10.1212/01.wnl.0000277463.87361.8c; Sutedja NA, 2009, AMYOTROPH LATERAL SC, V10, P302, DOI 10.3109/17482960802455416; Traynor BJ, 1999, NEUROLOGY, V52, P504, DOI 10.1212/WNL.52.3.504; Vinceti M, 1997, ITAL J NEUROL SCI, V18, P87, DOI 10.1007/BF01999568; Weisskopf MG, 2009, J NEUROL NEUROSUR PS, V80, P558, DOI 10.1136/jnnp.2008.156976; Weisskopf MG, 2009, ANN NEUROL, V65, P361, DOI 10.1002/ana.21700; Weisskopf MG, 2004, AM J EPIDEMIOL, V160, P26, DOI 10.1093/aje/kwh179; Weisskopf MG, 2005, AM J EPIDEMIOL, V162, P1146, DOI 10.1093/aje/kwi343; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179	62	52	53	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101186	10.1371/journal.pone.0101186	http://dx.doi.org/10.1371/journal.pone.0101186			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979055	Green Submitted, gold, Green Published			2022-12-27	WOS:000338506400095
J	Zhang, DF; Xia, T; Yan, MM; Dai, XG; Xu, J; Li, SX; Yin, TM				Zhang, Defang; Xia, Tao; Yan, Maomao; Dai, Xiaogang; Xu, Jin; Li, Shuxian; Yin, Tongming			Genetic Introgression and Species Boundary of Two Geographically Overlapping Pine Species Revealed by Molecular Markers	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; HYBRID ZONE; TIBETAN PLATEAU; POPULATION DIFFERENTIATION; REPRODUCTIVE ISOLATION; HYBRIDIZATION; EXTINCTION; SPECIATION; MASSONIANA; MORPHOLOGY	Gene introgression and hybrid barriers have long been a major focus of studies of geographically overlapping species. Two pine species, Pinus massoniana and P. hwangshanensis, are frequently observed growing adjacent to each other, where they overlap in a narrow hybrid zone. As a consequence, these species constitute an ideal system for studying genetic introgression and reproductive barriers between naturally hybridizing, adjacently distributed species. In this study, we sampled 270 pine trees along an elevation gradient in Anhui Province, China and analyzed these samples using EST-SSR markers. The molecular data revealed that direct gene flow between the two species was fairly low, and that the majority of gene introgression was intermediated by backcrossing. On the basis of empirical observation, the on-site distribution of pines was divided into a P. massoniana zone, a hybrid zone, and a P. hwangshanensis zone. STRUCTURE analysis revealed the existence of a distinct species boundary between the two pine species. The genetic boundary of the hybrid zone, on the other hand, was indistinct owing to intensive backcrossing with parental species. Compared with P. massoniana, P. hwangshanensis was found to backcross with the hybrids more intensively, consistent with the observation that morphological and anatomical characteristics of trees in the contact zone were biased towards P. hwangshanensis. The introgression ability of amplified alleles varied across species, with some being completely blocked from interspecific introgression. Our study has provided a living example to help explain the persistence of adjacently distributed species coexisting with their interfertile hybrids.	[Zhang, Defang; Xia, Tao; Yan, Maomao; Dai, Xiaogang; Xu, Jin; Li, Shuxian; Yin, Tongming] Nanjing Forestry Univ, Southern Modern Forestry Collaborat Innovat Ctr, Nanjing, Jiangsu, Peoples R China	Nanjing Forestry University	Yin, TM (corresponding author), Nanjing Forestry Univ, Southern Modern Forestry Collaborat Innovat Ctr, Nanjing, Jiangsu, Peoples R China.	tmyin@njfu.com.cn			Natural Science Foundation [31125008, 31270661]; Program for Innovative Research Team in Universities of Jiangsu Province; Priority Academic Program Development (PAPD) program at Nanjing Forestry University Program of Scientific Innovation Research of College Graduate in Jiangsu Province [CXZZ13-0528]; Educational Department of China	Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Program for Innovative Research Team in Universities of Jiangsu Province; Priority Academic Program Development (PAPD) program at Nanjing Forestry University Program of Scientific Innovation Research of College Graduate in Jiangsu Province; Educational Department of China	Natural Science Foundation (31125008, 31270661) Program for Innovative Research Team in Universities of Jiangsu Province and the Educational Department of China. Priority Academic Program Development (PAPD) program at Nanjing Forestry University Program of Scientific Innovation Research of College Graduate in Jiangsu Province (CXZZ13-0528). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnold ML, 1997, NATURE HYBRIDIZATION, P20; Barluenga M, 2011, HEREDITY, V106, P13, DOI 10.1038/hdy.2010.38; Barton NH, 1993, HYBRID ZONES EVOLUTI, P13, DOI DOI 10.1111/J.1558-5646.2009.00849.X; Bridle JR, 2001, BIOL J LINN SOC, V72, P373, DOI 10.1111/j.1095-8312.2001.tb01324.x; Burton RS, 2013, ANNU REV ECOL EVOL S, V44, P281, DOI 10.1146/annurev-ecolsys-110512-135758; Chen ZY, 1986, NATURAL HYBRIDIZATIO, V1, P38; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Cullingham CI, 2012, EVOL APPL, V5, P879, DOI 10.1111/j.1752-4571.2012.00266.x; DONG J, 1993, THEOR APPL GENET, V86, P573, DOI 10.1007/BF00838711; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Du FK, 2011, NEW PHYTOL, V192, P1024, DOI 10.1111/j.1469-8137.2011.03853.x; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; ENNOS RA, 1994, HEREDITY, V72, P250, DOI 10.1038/hdy.1994.35; Falush D, 2003, GENETICS, V164, P1567; Fu L, 1999, FLORA CHINA; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Jensen AB, 2005, MOL ECOL, V14, P93, DOI 10.1111/j.1365-294X.2004.02399.x; Jiang WB, 2008, HIST HUANGSHAN MMOUN, P320; Kawakami T, 2012, HYBRID ZONES EVOLUTI, V1, P1; Ke BF, 1983, J ANHUI AGR U, V2, P1; Levin DA, 1996, CONSERV BIOL, V10, P10, DOI 10.1046/j.1523-1739.1996.10010010.x; Li SX, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-37; Luo ShiJia, 2001, Scientia Silvae Sinicae, V37, P118; Mao JF, 2011, AM NAT, V177, P424, DOI 10.1086/658905; Martinsen GD, 2001, EVOLUTION, V55, P1325, DOI 10.1111/j.0014-3820.2001.tb00655.x; Panwar P, 2010, MOL BIOL REP, V37, P4075, DOI 10.1007/s11033-010-0067-5; Pritchard JK, 2000, GENETICS, V155, P945; Qi CJ, 1988, BOT RES, V3, P143; Qu JiTeng, 2012, Journal of Nanjing Forestry University (Natural Sciences Edition), V36, P143; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Rogers SM, 2006, J EVOLUTION BIOL, V19, P1979, DOI 10.1111/j.1420-9101.2006.01150.x; Runyeon-Lager H, 2000, CAN J BOT, V78, P1384, DOI 10.1139/cjb-78-11-1384; Schilthuizen M, 2013, J EVOLUTION BIOL, V26, P288, DOI 10.1111/jeb.12056; Song YC, 1980, CHINESE VEGETATION, P234; STRAUSS SH, 1993, THEOR APPL GENET, V86, P605, DOI 10.1007/BF00838716; Tongming Y, 2012, TREE GENETICS MOL BR, V2, P1, DOI [10.5376/tgmb.2012.02.0001, DOI 10.5376/TGMB.2012.02.0001]; Vines TH, 2003, EVOLUTION, V57, P1876; Wang B., 2011, PLOS ONE, P8; Wang BS, 2011, MOL ECOL, V20, P3796, DOI 10.1111/j.1365-294X.2011.05157.x; Watano Y, 2004, AM J BOT, V91, P65, DOI 10.3732/ajb.91.1.65; Wolf DE, 2001, CONSERV BIOL, V15, P1039, DOI 10.1046/j.1523-1739.2001.0150041039.x; Wright S, 1978, VARIABILITY NATURAL, V4; Xing YH, 1992, J ANHUI FOR SCI TECH, V4, P5; Yeh F.C., 1999, MICROSOFT WINDOWS BA; Yin TM, 2004, THEOR APPL GENET, V109, P451, DOI 10.1007/s00122-004-1653-5; Zhou YF, 2010, EVOLUTION, V64, P2342, DOI 10.1111/j.1558-5646.2010.00988.x	48	4	4	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101106	10.1371/journal.pone.0101106	http://dx.doi.org/10.1371/journal.pone.0101106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24977711	gold, Green Submitted, Green Published			2022-12-27	WOS:000338506400078
J	Jovanovic, K; Loos, B; Dias, BDC; Penny, C; Weiss, SFT				Jovanovic, Katarina; Loos, Ben; Dias, Bianca Da Costa; Penny, Clement; Weiss, Stefan F. T.			High Resolution Imaging Study of Interactions between the 37 kDa/67 kDa Laminin Receptor and APP, Beta-Secretase and Gamma-Secretase in Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; CELLULAR PRION PROTEIN; INFECTED NEURONAL CELLS; LIPID RAFTS; PRPSC PROPAGATION; PLASMA-MEMBRANE; BINDING-SITES; CLEAVAGE; MICROSCOPY; BACE1	Alzheimer's disease (AD) is the most prevalent form of dementia affecting the elderly. Neurodegeneration is caused by the amyloid beta (A beta) peptide which is generated from the sequential proteolytic cleavage of the Amyloid Precursor Protein (APP) by the beta- and gamma-secretases. Previous reports revealed that the 37 kDa/67 kDa laminin receptor (LRP/LR) is involved in APP processing, however, the exact mechanism by which this occurs remains largely unclear. This study sought to assess whether LRP/LR interacted with APP, beta- or gamma-secretase. Detailed confocal microscopy revealed that LRP/LR showed a strong co-localisation with APP, beta- and gamma-secretase, respectively, at various sub-cellular locations. Superresolution Structured Illumination Microscopy (SR-SIM) showed that interactions were unlikely between LRP/LR and APP and beta-secretase, respectively, while there was strong co-localisation between LRP/LR and gamma-secretase at this 80 nm resolution. FRET was further employed to assess the possibility of protein-protein interactions and only an interaction between LRP/LR and gamma-secretase was found. FLAG co-immunoprecipitation confirmed these findings as LRP/LR co-immunoprecipitated with gamma-secretase, but failed to do so with APP. These findings indicate that LRP/LR exerts its influence on A beta shedding via a direct interaction with the gamma-secretase and possibly an indirect interaction with the beta-secretase.	[Jovanovic, Katarina; Dias, Bianca Da Costa; Weiss, Stefan F. T.] Univ Witwatersrand, Sch Mol & Cell Biol, Johannesburg, South Africa; [Loos, Ben] Univ Stellenbosch, Dept Physiol Sci, ZA-7600 Stellenbosch, South Africa; [Penny, Clement] Univ Witwatersrand, Dept Internal Med, Johannesburg, South Africa	University of Witwatersrand; Stellenbosch University; University of Witwatersrand	Weiss, SFT (corresponding author), Univ Witwatersrand, Sch Mol & Cell Biol, Johannesburg, South Africa.	Stefan.weiss@wits.ac.za		Loos, Ben/0000-0002-5517-373X	National Research Foundation (NRF), the Republic of South Africa (RSA)	National Research Foundation (NRF), the Republic of South Africa (RSA)	This work is based upon research supported by the National Research Foundation (NRF), the Republic of South Africa (RSA). Any opinions, findings and conclusions or recommendations expressed in this material are those of the author(s), and therefore, the National Research Foundation does not accept any liability in this regard thereto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Beckman M, 2006, BIOCHEMISTRY-US, V45, P6703, DOI 10.1021/bi052498t; Chetty C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096268; Chyung JH, 2005, J BIOL CHEM, V280, P4383, DOI 10.1074/jbc.M409272200; Da Costa Dias B, 2013, SCI REPORTS, V3, P2702; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Gauczynski S, 2006, J INFECT DIS, V194, P702, DOI 10.1086/505914; Griffiths HH, 2011, J BIOL CHEM, V286, P33489, DOI 10.1074/jbc.M111.278556; Heintzmann R, 1999, P SOC PHOTO-OPT INS, V3568, P185, DOI 10.1117/12.336833; Herl L, 2006, BIOCHEM BIOPH RES CO, V340, P668, DOI 10.1016/j.bbrc.2005.12.063; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; Jovanovic K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02699; Khumalo T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066297; Khusal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058888; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Leucht C, 2003, EMBO REP, V4, P290, DOI 10.1038/sj.embor.embor768; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Mbazima V, 2010, FRONT BIOSCI-LANDMRK, V15, P1150, DOI 10.2741/3667; Moodley K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057409; Morel E, 2005, AM J PATHOL, V167, P1033, DOI 10.1016/S0002-9440(10)61192-3; Mount C, 2006, NAT MED, V12, P780, DOI 10.1038/nm0706-780; Nikles D, 2008, BBA-MOL BASIS DIS, V1782, P335, DOI 10.1016/j.bbadis.2008.02.003; Omar A, 2012, J MOL BIOL, V419, P102, DOI 10.1016/j.jmb.2012.02.035; Omar A, 2011, EXPERT OPIN THER PAT, V21, P35, DOI 10.1517/13543776.2011.539203; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Patey SJ, 2005, BIOCHEM SOC T, V33, P1116, DOI 10.1042/BST0331116; Patra SK, 2008, J PHYSIOL PHARMACOL, V59, P217; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; Scholefield Z, 2003, J CELL BIOL, V163, P97, DOI 10.1083/jcb.200303059; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Shmakov AN, 2000, J PATHOL, V191, P318, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH640>3.0.CO;2-4; Uemura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007893; Um JW, 2013, PRION, V7, P37, DOI 10.4161/pri.22212; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Vana K, 2006, J MOL BIOL, V358, P57, DOI 10.1016/j.jmb.2006.02.011; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Verdier Y, 2004, CURR PROTEIN PEPT SC, V5, P19, DOI 10.2174/1389203043486937; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; von Arnim CAF, 2004, J CELL SCI, V117, P5437, DOI 10.1242/jcs.01422; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Wimo A, 2013, ALZHEIMERS DEMENT, V9, P1, DOI 10.1016/j.jalz.2012.11.006; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109; Zuber C, 2008, J MOL BIOL, V378, P530, DOI 10.1016/j.jmb.2008.02.004	48	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100373	10.1371/journal.pone.0100373	http://dx.doi.org/10.1371/journal.pone.0100373			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972054	Green Published, Green Submitted, gold			2022-12-27	WOS:000338512200029
J	Choi, JW; Liao, XP; Stothard, P; Chung, WH; Jeon, HJ; Miller, SP; Choi, SY; Lee, JK; Yang, B; Lee, KT; Han, KJ; Kim, HC; Jeong, D; Oh, JD; Kim, N; Kim, TH; Lee, HK; Lee, SJ				Choi, Jung-Woo; Liao, Xiaoping; Stothard, Paul; Chung, Won-Hyong; Jeon, Heoyn-Jeong; Miller, Stephen P.; Choi, So-Young; Lee, Jeong-Koo; Yang, Bokyoung; Lee, Kyung-Tai; Han, Kwang-Jin; Kim, Hyeong-Cheol; Jeong, Dongkee; Oh, Jae-Don; Kim, Namshin; Kim, Tae-Hun; Lee, Hak-Kyo; Lee, Sung-Jin			Whole-Genome Analyses of Korean Native and Holstein Cattle Breeds by Massively Parallel Sequencing	PLOS ONE			English	Article							COPY NUMBER VARIATIONS; NITRIC-OXIDE SYNTHASE; MAMMARY-GLAND; MILK-PRODUCTION; BLACK ANGUS; BOS-TAURUS; SNP; IDENTIFICATION; EXPRESSION; SIGNATURES	A main goal of cattle genomics is to identify DNA differences that account for variations in economically important traits. In this study, we performed whole-genome analyses of three important cattle breeds in Korea-Hanwoo, Jeju Heugu, and Korean Holstein-using the Illumina HiSeq 2000 sequencing platform. We achieved 25.5-, 29.6-, and 29.5-fold coverage of the Hanwoo, Jeju Heugu, and Korean Holstein genomes, respectively, and identified a total of 10.4 million single nucleotide polymorphisms (SNPs), of which 54.12% were found to be novel. We also detected 1,063,267 insertions-deletions (InDels) across the genomes (78.92% novel). Annotations of the datasets identified a total of 31,503 nonsynonymous SNPs and 859 frameshift InDels that could affect phenotypic variations in traits of interest. Furthermore, genome-wide copy number variation regions (CNVRs) were detected by comparing the Hanwoo, Jeju Heugu, and previously published Chikso genomes against that of Korean Holstein. A total of 992, 284, and 1881 CNVRs, respectively, were detected throughout the genome. Moreover, 53, 65, 45, and 82 putative regions of homozygosity (ROH) were identified in Hanwoo, Jeju Heugu, Chikso, and Korean Holstein respectively. The results of this study provide a valuable foundation for further investigations to dissect the molecular mechanisms underlying variation in economically important traits in cattle and to develop genetic markers for use in cattle breeding.	[Choi, Jung-Woo; Miller, Stephen P.] Univ Guelph, Ctr Genet Improvement Livestock Anim & Poultry Sc, Guelph, ON N1G 2W1, Canada; [Liao, Xiaoping; Stothard, Paul] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Chung, Won-Hyong; Kim, Namshin] Korea Bioinformat Ctr, Korea Res Inst Biosci & Biotechnol, Taejon, South Korea; [Choi, Jung-Woo; Jeon, Heoyn-Jeong; Lee, Kyung-Tai; Kim, Tae-Hun] Natl Inst Anim Sci, Rural Dev Adm, Div Anim Genom & Bioinformat, Suwon, South Korea; [Choi, So-Young; Lee, Jeong-Koo; Lee, Sung-Jin] Kangwon Natl Univ, Coll Anim Life Sci, Chunchon, South Korea; [Yang, Bokyoung] TheragenEtex, Theragen BiO Inst, Suwon, South Korea; [Han, Kwang-Jin] Natl Agr Cooperat Fed, Dairy Cattle Improvement Ctr, Goyang Si, South Korea; [Kim, Hyeong-Cheol] Natl Inst Anim Sci, Rural Dev Adm, Hanwoo Expt Stn, Chunchon, Gangwon Do, South Korea; [Jeong, Dongkee] Jeju Natl Univ, Dept Biotechnol, Cheju, South Korea; [Oh, Jae-Don; Lee, Hak-Kyo] Hankyong Natl Univ, Dept Biotechnol, Anseong, South Korea	University of Guelph; University of Alberta; Korea Research Institute of Bioscience & Biotechnology (KRIBB); National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Kangwon National University; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Jeju National University; Hankyong National University	Lee, HK (corresponding author), Hankyong Natl Univ, Dept Biotechnol, Anseong, South Korea.	breedlee@empas.com; sjlee@kangwon.ac.kr	Kim, Namshin/Q-6491-2017	Kim, Namshin/0000-0001-6361-274X; Lee, Sung-Jin/0000-0001-9348-8356	BioGreen 21 Program [PJ008196]; Cooperative Research Program for Agriculture Science AMP; Technology Development, Rural Development Administration [PJ009153012014, PJ006405]; Animal Promotion Resource Institute, Jeju and Kangwon National University, Republic of Korea [120131448]; Genome Canada project entitled "Whole Genome Selection Through Genome Wide Imputation in Beef Cattle"	BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Cooperative Research Program for Agriculture Science AMP; Technology Development, Rural Development Administration; Animal Promotion Resource Institute, Jeju and Kangwon National University, Republic of Korea; Genome Canada project entitled "Whole Genome Selection Through Genome Wide Imputation in Beef Cattle"	This research was supported by the grant from the BioGreen 21 Program (No. PJ008196), the Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration (No. PJ009153012014, PJ006405), Animal Promotion Resource Institute, Jeju and Kangwon National University (No. 120131448), Republic of Korea. Xiaoping Liao was funded by the Genome Canada project entitled "Whole Genome Selection Through Genome Wide Imputation in Beef Cattle". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Bae JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-232; Barendse W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-178; Bickhart DM, 2012, GENOME RES, V22, P778, DOI 10.1101/gr.133967.111; Bolormaa S, 2011, J ANIM SCI, V89, P1684, DOI 10.2527/jas.2010-3079; Choi JW, 2013, MOL CELLS, V36, P203, DOI 10.1007/s10059-013-2347-0; Choi JW, 2013, MAMM GENOME, V24, P151, DOI 10.1007/s00335-013-9449-z; Choi TJ, 2009, THESIS; Dadi H, 2012, ASIAN AUSTRAL J ANIM, V25, P1223, DOI 10.5713/ajas.2012.12122; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Eck SH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r82; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Fujimoto A, 2010, NAT GENET, V42, P931, DOI 10.1038/ng.691; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Grant JR, 2011, BIOINFORMATICS, V27, P2300, DOI 10.1093/bioinformatics/btr372; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Hou YL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-376; Hou YL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-127; Iizuka T, 1998, PEDIATR RES, V44, P197, DOI 10.1203/00006450-199808000-00010; Jiang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048732; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Jo C., 2012, Animal Frontiers, V2, P32, DOI 10.2527/af.2012-0060; KLUNGLAND H, 1995, MAMM GENOME, V6, P636, DOI 10.1007/BF00352371; Kolbehdari D, 2009, J ANIM BREED GENET, V126, P216, DOI 10.1111/j.1439-0388.2008.00793.x; Lee KT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-519; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao SF, 2009, J DAIRY SCI, V92, P1124, DOI 10.3168/jds.2008-1521; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Mc Parland S, 2007, J DAIRY SCI, V90, P4411, DOI 10.3168/jds.2007-0227; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MERCHEN NR, 1992, J ANIM SCI, V70, P3238, DOI 10.2527/1992.70103238x; Ministry for Food Agriculture Forestry and Fisheries, 2013, 2012 DAIR HERD IMPR; National Institute of Animal Science, 2012, STAT LOC LIV BREEDS; National Institute of Animal Science (NIAS), 2011, NAT I AN SCI NIAS AN; Oakes SR, 2008, J MAMMARY GLAND BIOL, V13, P13, DOI 10.1007/s10911-008-9069-5; Qanbari S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-318; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Seo KS, 2007, VET DERMATOL, V18, P392, DOI 10.1111/j.1365-3164.2007.00634.x; Sherman EL, 2010, J ANIM SCI, V88, P16, DOI 10.2527/jas.2008-1759; Stothard P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-559; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80; Zaragoza R, 2005, BIOCHEM J, V391, P581, DOI 10.1042/BJ20050507; Zaragoza R, 2010, BIOCHEM J, V428, P451, DOI 10.1042/BJ20091091; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	48	31	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101127	10.1371/journal.pone.0101127	http://dx.doi.org/10.1371/journal.pone.0101127			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992012	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400043
J	Piir, K; Tamm, T; Kisly, I; Tammsalu, T; Remme, J				Piir, Kerli; Tamm, Tiina; Kisly, Ivan; Tammsalu, Triin; Remme, Jaanus			Stepwise Splitting of Ribosomal Proteins from Yeast Ribosomes by LiCl	PLOS ONE			English	Article							ESCHERICHIA-COLI RIBOSOMES; EUKARYOTIC RIBOSOME; CRYSTAL-STRUCTURE; 50-S SUBUNIT; MATURATION; INITIATION; RNA; IDENTIFICATION; PROTEOMICS; PATHWAY	Structural studies have revealed that the core of the ribosome structure is conserved among ribosomes of all kingdoms. Kingdom-specific ribosomal proteins (r-proteins) are located in peripheral parts of the ribosome. In this work, the interactions between rRNA and r-proteins of eukaryote Saccharomyces cerevisiae ribosome were investigated applying LiCl induced splitting and quantitative mass spectrometry. R-proteins were divided into four groups according to their binding properties to the rRNA. Most yeast r-proteins are removed from rRNA by 0.5-1 M LiCl. Eukaryote-specific r-proteins are among the first to dissociate. The majority of the strong binders are known to be required for the early ribosome assembly events. As compared to the bacterial ribosome, yeast r-proteins are dissociated from rRNA at lower ionic strength. Our results demonstrate that the nature of protein-RNA interactions in the ribosome is not conserved between different kingdoms.	[Piir, Kerli; Tamm, Tiina; Kisly, Ivan; Tammsalu, Triin; Remme, Jaanus] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia	University of Tartu	Remme, J (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Ulikooli 18, EE-50090 Tartu, Estonia.	jremme@ut.ee	Tamm, Tiina/D-4004-2014; Remme, Jaanus/L-1830-2019; Remme, Jaanus/A-4614-2011	Remme, Jaanus/0000-0002-4011-6580; Remme, Jaanus/0000-0002-4011-6580; Kisly, Ivan/0000-0002-4479-2447; Tamm, Tiina/0000-0001-9943-2097	Estonian Research Foundation [9289]; Estonian Research Council Institutional Research [14021]	Estonian Research Foundation; Estonian Research Council Institutional Research	This work was supported by Estonian Research Foundation Grant Nr. 9289 and Estonian Research Council Institutional Research Grant Nr. 14021 (URL:www.etag.ee/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armache JP, 2010, P NATL ACAD SCI USA, V107, P19754, DOI 10.1073/pnas.1010005107; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Bernstein KA, 2004, EUKARYOT CELL, V3, P1619, DOI 10.1128/EC.3.6.1619-1626.2004; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dresios J, 2006, MOL MICROBIOL, V59, P1651, DOI 10.1111/j.1365-2958.2006.05054.x; ELBARADI TTAL, 1984, EUR J BIOCHEM, V144, P393, DOI 10.1111/j.1432-1033.1984.tb08477.x; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; HEROLD M, 1987, J BIOL CHEM, V262, P8826; HOMANN HE, 1971, EUR J BIOCHEM, V20, P249, DOI 10.1111/j.1432-1033.1971.tb01388.x; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Lecompte O, 2002, NUCLEIC ACIDS RES, V30, P5382, DOI 10.1093/nar/gkf693; Lo KY, 2010, MOL CELL, V39, P196, DOI 10.1016/j.molcel.2010.06.018; Melnikov S, 2012, NAT STRUCT MOL BIOL, V19, P560, DOI 10.1038/nsmb.2313; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Poll G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008249; Pulk A, 2010, MOL MICROBIOL, V75, P801, DOI 10.1111/j.1365-2958.2009.07002.x; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Saveanu C, 2003, MOL CELL BIOL, V23, P4449, DOI 10.1128/MCB.23.13.4449-4460.2003; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Strunk BS, 2011, SCIENCE, V333, P1449, DOI 10.1126/science.1208245; Wilson DN, 2005, CRIT REV BIOCHEM MOL, V40, P243, DOI 10.1080/10409230500256523; WYSTUP G, 1979, EUR J BIOCHEM, V100, P101, DOI 10.1111/j.1432-1033.1979.tb02038.x	25	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101561	10.1371/journal.pone.0101561	http://dx.doi.org/10.1371/journal.pone.0101561			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991888	Green Published, gold, Green Submitted			2022-12-27	WOS:000341253400090
J	Liu, Q; Spitsbergen, JM; Cariou, R; Huang, CY; Jiang, N; Goetz, G; Hutz, RJ; Tonellato, PJ; Carvan, MJ				Liu, Qing; Spitsbergen, Jan M.; Cariou, Ronan; Huang, Chun-Yuan; Jiang, Nan; Goetz, Giles; Hutz, Reinhold J.; Tonellato, Peter J.; Carvan, Michael J., III			Histopathologic Alterations Associated with Global Gene Expression Due to Chronic Dietary TCDD Exposure in Juvenile Zebrafish	PLOS ONE			English	Article							2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; RAINBOW-TROUT; PATHOLOGICAL ALTERATIONS; SPECIES-DIFFERENCES; BLOOD-FLOW; TOXICITY; DIOXIN; DISEASE; EMBRYO; CELLS	The goal of this project was to investigate the effects and possible developmental disease implication of chronic dietary TCDD exposure on global gene expression anchored to histopathologic analysis in juvenile zebrafish by functional genomic, histopathologic and analytic chemistry methods. Specifically, juvenile zebrafish were fed Biodiet starter with TCDD added at 0, 0.1, 1, 10 and 100 ppb, and fish were sampled following 0, 7, 14, 28 and 42 d after initiation of the exposure. TCDD accumulated in a dose-and time-dependent manner and 100 ppb TCDD caused TCDD accumulation in female (15.49 ppb) and male (18.04 ppb) fish at 28 d post exposure. Dietary TCDD caused multiple lesions in liver, kidney, intestine and ovary of zebrafish and functional dysregulation such as depletion of glycogen in liver, retrobulbar edema, degeneration of nasal neurosensory epithelium, underdevelopment of intestine, and diminution in the fraction of ovarian follicles containing vitellogenic oocytes. Importantly, lesions in nasal epithelium and evidence of endocrine disruption based on alternatively spliced vasa transcripts are two novel and significant results of this study. Microarray gene expression analysis comparing vehicle control to dietary TCDD revealed dysregulated genes involved in pathways associated with cardiac necrosis/cell death, cardiac fibrosis, renal necrosis/cell death and liver necrosis/cell death. These baseline toxicological effects provide evidence for the potential mechanisms of developmental dysfunctions induced by TCDD and vasa as a biomarker for ovarian developmental disruption.	[Liu, Qing; Hutz, Reinhold J.; Carvan, Michael J., III] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53211 USA; [Liu, Qing; Carvan, Michael J., III] Univ Wisconsin, Sch Freshwater Sci, Milwaukee, WI 53201 USA; [Spitsbergen, Jan M.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Cariou, Ronan] LUNAM Univ, Oniris, Lab Etud Residus & Contaminants Aliments LABERCA, Nantes, France; [Huang, Chun-Yuan; Tonellato, Peter J.] Univ Wisconsin, Zilber Sch Publ Hlth, Milwaukee, WI 53201 USA; [Jiang, Nan] Roche NimbleGen Inc, Madison, WI USA; [Goetz, Giles] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Tonellato, Peter J.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Tonellato, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA USA	University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee; Oregon State University; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; University of Wisconsin System; University of Wisconsin Milwaukee; Roche Holding; University of Washington; University of Washington Seattle; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Carvan, MJ (corresponding author), Univ Wisconsin, Dept Biol Sci, Lapham Hall, Milwaukee, WI 53211 USA.	carvanmj@uwm.edu	Liu, Qing/M-2162-2018; Cariou, Ronan/M-5549-2014; JIANG, NAN/AHB-1945-2022	Cariou, Ronan/0000-0002-4669-1834; Carvan, Michael/0000-0002-9190-9417	University of Wisconsin Sea Grant Institute from the National Sea Grant College Program, National Oceanic and Atmospheric Administration, U.S. Department of Commerce; State of Wisconsin; UWM Children's Environmental Health Sciences Core Center (NIEHS) [2P30ES004184]; Shaw Fund of the Greater Milwaukee Foundation;  [NA060AR4170011];  [R/BT-21]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES004184] Funding Source: NIH RePORTER	University of Wisconsin Sea Grant Institute from the National Sea Grant College Program, National Oceanic and Atmospheric Administration, U.S. Department of Commerce; State of Wisconsin; UWM Children's Environmental Health Sciences Core Center (NIEHS); Shaw Fund of the Greater Milwaukee Foundation; ; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the University of Wisconsin Sea Grant Institute under grants from the National Sea Grant College Program, National Oceanic and Atmospheric Administration, U.S. Department of Commerce, and from the State of Wisconsin. Federal grant number NA060AR4170011, project number R/BT-21. This work was also supported by the UWM Children's Environmental Health Sciences Core Center (NIEHS 2P30ES004184), and the Shaw Fund of the Greater Milwaukee Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 1999, TOXICOL APPL PHARM, V159, P41, DOI 10.1006/taap.1999.8719; Amatruda JF, 1999, DEV BIOL, V216, P1, DOI 10.1006/dbio.1999.9462; Antignac JP, 2006, ANAL BIOANAL CHEM, V384, P271, DOI 10.1007/s00216-005-0129-z; Antkiewicz DS, 2005, TOXICOL SCI, V84, P368, DOI 10.1093/toxsci/kfi073; Bello SM, 2004, TOXICOL SCI, V78, P258, DOI 10.1093/toxsci/kfh065; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertazzi PA, 1998, ENVIRON HEALTH PERSP, V106, P625, DOI 10.2307/3433813; Braat AK, 1999, DEV DYNAM, V216, P153, DOI 10.1002/(SICI)1097-0177(199910)216:2<153::AID-DVDY6>3.0.CO;2-1; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Carvalho PSM, 2004, ENVIRON SCI TECHNOL, V38, P6300, DOI 10.1021/es034857i; Carvan MJ, 2007, ZEBRAFISH, V4, P9, DOI 10.1089/zeb.2006.9998; Carvan MJ, 2005, BIOCH MOLEC, V6, P3; Collins LL, 2008, TOXICOL SCI, V103, P125, DOI 10.1093/toxsci/kfn017; Dong W, 2002, TOXICOL SCI, V69, P191, DOI 10.1093/toxsci/69.1.191; Elonen GE, 1998, ENVIRON TOXICOL CHEM, V17, P472, DOI 10.1002/etc.5620170319; Heiden TCK, 2008, REPROD TOXICOL, V25, P47, DOI 10.1016/j.reprotox.2007.07.013; Heiden TK, 2006, TOXICOL SCI, V90, P490, DOI 10.1093/toxsci/kfj085; Heiden TK, 2005, TOXICOL SCI, V87, P497, DOI 10.1093/toxsci/kfi201; Hill A, 2004, J FISH BIOL, V64, P911, DOI 10.1111/j.1095-8649.2004.0352.x; Hill A, 2003, TOXICOL SCI, V76, P392, DOI 10.1093/toxsci/kfg241; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; Hornug MW, 1999, TOXICOL SCI, V47, P40, DOI 10.1093/toxsci/47.1.40; Humblet O, 2008, ENVIRON HEALTH PERSP, V116, P1443, DOI 10.1289/ehp.11579; Hutz R J, 2006, Tren Reprod Bio, V2, P1; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ito T, 2008, TOXICOL LETT, V177, P31, DOI 10.1016/j.toxlet.2007.12.011; Ivanovski O, 2009, Prilozi, V30, P71; Ivnitski I, 2001, TERATOLOGY, V64, P201, DOI 10.1002/tera.1065; Kim SY, 2005, EXP MOL MED, V37, P58, DOI 10.1038/emm.2005.8; King Heiden TC, 2009, TOXICOL SCI, V109, P75, DOI 10.1093/toxsci/kfp048; KLEEMAN JM, 1988, FUND APPL TOXICOL, V10, P206, DOI 10.1016/0272-0590(88)90304-1; Knaut H, 2000, J CELL BIOL, V149, P875, DOI 10.1083/jcb.149.4.875; KOCIBA RJ, 1978, TOXICOL APPL PHARM, V46, P279, DOI 10.1016/0041-008X(78)90075-3; Krovel AV, 2004, DEV BIOL, V271, P190, DOI 10.1016/j.ydbio.2004.04.004; Lanham KA, 2012, TOXICOL SCI, V127, P360, DOI 10.1093/toxsci/kfs103; Laurent C, 2005, CHEMOSPHERE, V60, P929, DOI 10.1016/j.chemosphere.2005.01.041; Liu Q, 2013, AQUAT TOXICOL, V140, P356, DOI 10.1016/j.aquatox.2013.06.018; Lonergan KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009162; Marchand P, 2010, CHEMOSPHERE, V80, P634, DOI 10.1016/j.chemosphere.2010.04.057; Markowski VP, 2001, ENVIRON HEALTH PERSP, V109, P621, DOI 10.2307/3455037; Murante FG, 2000, TOXICOL SCI, V54, P374, DOI 10.1093/toxsci/54.2.374; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; Nyska A, 2005, TOXICOL PATHOL, V33, P371, DOI 10.1080/01926230590930209; RYAN JJ, 1984, ENVIRON SCI TECHNOL, V18, P719, DOI 10.1021/es00127a015; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Seo BW, 1999, NEUROTOXICOL TERATOL, V21, P231, DOI 10.1016/S0892-0362(98)00049-X; SPITSBERGEN JM, 1988, J TOXICOL ENV HEALTH, V23, P359, DOI 10.1080/15287398809531120; SPITSBERGEN JM, 1991, AQUAT TOXICOL, V19, P41, DOI 10.1016/0166-445X(91)90027-7; Steenland K, 1999, J NATL CANCER I, V91, P779, DOI 10.1093/jnci/91.9.779; Teraoka H, 2002, TOXICOL SCI, V65, P192, DOI 10.1093/toxsci/65.2.192; Teraoka H, 2009, TOXICOL APPL PHARM, V234, P33, DOI 10.1016/j.taap.2008.09.021; Turyk ME, 2012, ENVIRON HEALTH PERSP, V120, P11, DOI 10.1289/ehp.1003396; UNKILA M, 1995, INT J BIOCHEM CELL B, V27, P443, DOI 10.1016/1357-2725(95)00023-I; WANNEMACHER R, 1992, CHEMOSPHERE, V24, P1361, DOI 10.1016/0045-6535(92)90059-Z; WEST G, 1990, AUST J MAR FRESH RES, V41, P199, DOI 10.1071/MF9900199; White SS, 2009, J ENVIRON SCI HEAL C, V27, P197, DOI 10.1080/10590500903310047; Yamauchi M, 2006, AQUAT TOXICOL, V80, P166, DOI 10.1016/j.aquatox.2006.08.006; Zodrow JM, 2004, AQUAT TOXICOL, V66, P25, DOI 10.1016/j.aquatox.2003.07.002; Zodrow JM, 2003, TOXICOL SCI, V76, P151, DOI 10.1093/toxsci/kfg205	60	12	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100910	10.1371/journal.pone.0100910	http://dx.doi.org/10.1371/journal.pone.0100910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988445	Green Published, gold			2022-12-27	WOS:000341354100050
J	Merino, H; Singla, DK				Merino, Hilda; Singla, Dinender K.			Notch-1 Mediated Cardiac Protection following Embryonic and Induced Pluripotent Stem Cell Transplantation in Doxorubicin-Induced Heart Failure	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; INDUCED CARDIOMYOPATHY; MYOCYTE DIFFERENTIATION; INDUCED CARDIOTOXICITY; INHIBIT APOPTOSIS; OXIDATIVE STRESS; MECHANISMS; CARDIOMYOCYTES; PROLIFERATION; REGENERATION	Doxorubicin (DOX), an effective chemotherapeutic drug used in the treatment of various cancers, is limited in its clinical applications due to cardiotoxicity. Recent studies suggest that transplanted adult stem cells inhibit DOX-induced cardiotoxicity. However, the effects of transplanted embryonic stem (ES) and induced pluripotent stem (iPS) cells are completely unknown in DOX-induced left ventricular dysfunction following myocardial infarction (MI). In brief, C57BL/6 mice were divided into five groups: Sham, DOX-MI, DOX-MI+ cell culture (CC) media, DOX-MI+ ES cells, and DOX-MI+ iPS cells. Mice were injected with cumulative dose of 12 mg/kg of DOX and 2 weeks later, MI was induced by coronary artery ligation. Following ligation, 5x10(4) ES or iPS cells were delivered into the peri-infarct region. At day 14 post-MI, echocardiography was performed, mice were sacrificed, and hearts were harvested for further analyses. Our data reveal apoptosis was significantly inhibited in ES and iPS cell transplanted hearts compared with respective controls (DOX-MI+ES: 0.48 +/- 0.06% and DOX-MI+iPS: 0.33 +/- 0.05% vs. DOX-MI: 1.04 +/- 0.07% and DOX-MI+CC: 0.96 +/- 0.21%; p<0.05). Furthermore, a significant increase in levels of Notch-1 (p<0.05), Hes1 (p<0.05), and pAkt (p<0.05) were observed whereas a decrease in the levels of PTEN (p<0.05), a negative regulator of Akt, was evident following stem cell transplantation. Moreover, hearts transplanted with stem cells demonstrated decreased vascular and interstitial fibrosis (p<0.05) as well as MMP-9 expression (p<0.01) compared with controls. Additionally, heart function was significantly improved (p<0.05) in both cell-transplanted groups. In conclusion, our data show that transplantation of ES and iPS cells blunt DOX-induced adverse cardiac remodeling, which is associated with improved cardiac function, and these effects are mediated by the Notch pathway.	[Merino, Hilda; Singla, Dinender K.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Biomol Sci Ctr, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Singla, DK (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Biomol Sci Ctr, Orlando, FL 32816 USA.	Dinender.Singla@ucf.edu			National Institutes of Health [1R01HL090646-01, 5R01HL094467-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090646, R01HL094467] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in part, from grants from the National Institutes of Health [1R01HL090646-01, and 5R01HL094467-02 to DKS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no additional funding sources for this study.	Agbulut O, 2003, CARDIOVASC RES, V58, P451, DOI 10.1016/S0008-6363(03)00281-5; Boni A, 2008, P NATL ACAD SCI USA, V105, P15529, DOI 10.1073/pnas.0808357105; Collesi C, 2008, J CELL BIOL, V183, P117, DOI 10.1083/jcb.200806091; Das J, 2011, BIOCHEM PHARMACOL, V81, P891, DOI 10.1016/j.bcp.2011.01.008; De Angelis A, 2010, CIRCULATION, V121, P276, DOI 10.1161/CIRCULATIONAHA.109.895771; Garbade J, 2009, J CARDIAC SURG, V24, P591, DOI 10.1111/j.1540-8191.2009.00844.x; Geisberg CA, 2010, CURR HYPERTENS REP, V12, P404, DOI 10.1007/s11906-010-0146-y; Glass C, 2012, CELL TRANSPLANT, V21, P1931, DOI 10.3727/096368911X627561; Glass C, 2011, AM J PHYSIOL-HEART C, V301, pH2038, DOI 10.1152/ajpheart.00271.2011; Gopinath S, 2010, BIOCHEM BIOPH RES CO, V395, P367, DOI 10.1016/j.bbrc.2010.04.021; Gude NA, 2008, CIRC RES, V102, P1025, DOI 10.1161/CIRCRESAHA.107.164749; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; Hershman DL, 2008, J CLIN ONCOL, V26, P3159, DOI 10.1200/JCO.2007.14.1242; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Hodgson DM, 2004, AM J PHYSIOL-HEART C, V287, pH471, DOI 10.1152/ajpheart.01247.2003; Horenstein MS, 2000, MOL GENET METAB, V71, P436, DOI 10.1006/mgme.2000.3043; Ichihara S, 2007, BIOCHEM BIOPH RES CO, V359, P27, DOI 10.1016/j.bbrc.2007.05.027; Kumar D, 2005, CORONARY ARTERY DIS, V16, P41, DOI 10.1097/00019501-200502000-00008; Kumar D, 2002, HERZ, V27, P662, DOI 10.1007/s00059-002-2430-3; Li TM, 2000, CIRCULATION, V102, P2105, DOI 10.1161/01.CIR.102.17.2105; Li YX, 2011, CIRCULATION, V123, P866, DOI 10.1161/CIRCULATIONAHA.110.947531; Ludke ARL, 2009, CAN J PHYSIOL PHARM, V87, P756, DOI 10.1139/Y09-059; Menna P, 2010, CHEM RES TOXICOL, V23, P6, DOI 10.1021/tx9003424; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Miranda CJ, 2003, BLOOD, V102, P2574, DOI 10.1182/blood-2003-03-0869; Nemir M., 2012, EUR HEART J; Nemir M, 2008, J MOL CELL CARDIOL, V45, P495, DOI 10.1016/j.yjmcc.2008.02.273; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Oliveira Maira S, 2013, J Cancer Sci Ther, V5, P52; Psaltis PJ, 2011, INT J CARDIOVAS IMAG, V27, P25, DOI 10.1007/s10554-010-9657-5; Singal P, 2000, MOL CELL BIOCHEM, V207, P77, DOI 10.1023/A:1007094214460; Singal PK, 1997, FASEB J, V11, P931, DOI 10.1096/fasebj.11.12.9337145; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Singla DK, 2007, AM J PHYSIOL-HEART C, V293, pH1308, DOI 10.1152/ajpheart.01277.2006; Singla DK, 2009, ANTIOXID REDOX SIGN, V11, P1857, DOI [10.1089/ars.2009.2491, 10.1089/ARS.2009.2491]; Singla DK, 2012, CELL TRANSPLANT, V21, P1919, DOI 10.3727/096368911X627552; Singla DK, 2011, MOL PHARMACEUT, V8, P1573, DOI 10.1021/mp2001704; Singla DK, 2006, J MOL CELL CARDIOL, V40, P195, DOI 10.1016/j.yjmcc.2005.09.001; Singla DK, 2005, BIOCHEM BIOPH RES CO, V335, P637, DOI 10.1016/j.bbrc.2005.06.105; Singla DK, 2014, CELL TRANSPLANT; Swerdlow AJ, 2007, J NATL CANCER I, V99, P206, DOI 10.1093/jnci/djk029; Wong GW, 2012, BLOOD, V120, P1439, DOI 10.1182/blood-2011-12-395319; Yan BB, 2013, MOL PHARMACEUT, V10, P3425, DOI 10.1021/mp400258d	44	34	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101024	10.1371/journal.pone.0101024	http://dx.doi.org/10.1371/journal.pone.0101024			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988225	Green Published, gold			2022-12-27	WOS:000341354100055
J	Campbell, J; Huang, YM; Liu, YJ; Schenken, R; Arulanandam, B; Zhong, GM				Campbell, Jessica; Huang, Yumeng; Liu, Yuanjun; Schenken, Robert; Arulanandam, Bernard; Zhong, Guangming			Bioluminescence Imaging of Chlamydia muridarum Ascending Infection in Mice	PLOS ONE			English	Article							GENITAL-TRACT INFECTION; PELVIC-INFLAMMATORY-DISEASE; TRACHOMATIS PLASMID; TRANSCRIPTIONAL REGULATOR; PROTECTIVE IMMUNITY; VIRULENCE; DISSEMINATION; HYDROSALPINX; CONTRIBUTES; PATHOLOGY	Chlamydial pathogenicity in the upper genital tract relies on chlamydial ascending from the lower genital tract. To monitor chlamydial ascension, we engineered a luciferase-expressing C. muridarum. In cells infected with the luciferase-expressing C. muridarum, luciferase gene expression and enzymatic activity (measured as bioluminescence intensity) correlated well along the infection course, suggesting that bioluminescence can be used for monitoring chlamydial replication. Following an intravaginal inoculation with the luciferase-expressing C. muridarum, 8 of 10 mice displayed bioluminescence signal in the lower with 4 also in the upper genital tracts on day 3 after infection. By day 7, all 10 mice developed bioluminescence signal in the upper genital tracts. The bioluminescence signal was maintained in the upper genital tract in 6 and 2 mice by days 14 and 21, respectively. The bioluminescence signal was no longer detectable in any of the mice by day 28. The whole body imaging approach also revealed an unexpected airway infection following the intravaginal inoculation. Although the concomitant airway infection was transient and did not significantly alter the genital tract infection time courses, caution should be taken during data interpretation. The above observations have demonstrated that C. muridarum can not only achieve rapid ascending infection in the genital tract but also cause airway infection following a genital tract inoculation. These findings have laid a foundation for further optimizing the C. muridarum intravaginal infection murine model for understanding chlamydial pathogenic mechanisms.	[Huang, Yumeng; Liu, Yuanjun; Zhong, Guangming] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Campbell, Jessica; Schenken, Robert] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, San Antonio, TX 78229 USA; [Arulanandam, Bernard] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas at San Antonio (UTSA)	Zhong, GM (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	Zhongg@UTHSCSA.edu	Arulanandam, Bernard P/O-9501-2014		US NIH [R01AI064537, R01AI047997]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047997, R01AI064537] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by US NIH grants R01AI064537 and R01AI047997. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANKS J, 1970, Infection and Immunity, V1, P259; Barry MA, 2012, METHODS MOL BIOL, V797, P79, DOI 10.1007/978-1-61779-340-0_6; Carlson JH, 2008, INFECT IMMUN, V76, P2273, DOI 10.1128/IAI.00102-08; Chen LL, 2010, J IMMUNOL, V184, P2602, DOI 10.4049/jimmunol.0901593; Cheng W, 2008, INFECT IMMUN, V76, P515, DOI 10.1128/IAI.01064-07; COTTER TW, 1995, INFECT IMMUN, V63, P4704, DOI 10.1128/IAI.63.12.4704-4714.1995; Cotter TW, 1997, INFECT IMMUN, V65, P2145, DOI 10.1128/IAI.65.6.2145-2152.1997; Davies B, 2013, SEX TRANSM DIS, V40, P230, DOI 10.1097/OLQ.0b013e31827b9d75; Dong XH, 2014, INFECT IMMUN, V82, P1833, DOI 10.1128/IAI.01668-13; Gong SQ, 2013, J BACTERIOL, V195, P3819, DOI 10.1128/JB.00511-13; Gonzalez RJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-147; Kong Ying, 2011, Curr Protoc Microbiol, VChapter 2, DOI [10.1002/9780471729259.mc02c04s21, 10.1002/9780471729259.mc02c03s21]; Last AR, 2014, J CLIN MICROBIOL, V52, P324, DOI 10.1128/JCM.02618-13; Lei L, 2014, INFECT IMMUN, V82, P983, DOI 10.1128/IAI.01543-13; Liu YJ, 2014, J BACTERIOL, V196, P989, DOI 10.1128/JB.01161-13; Lu CX, 2012, VACCINE, V30, P475, DOI 10.1016/j.vaccine.2011.10.059; Perry LL, 1999, INFECT IMMUN, V67, P3686, DOI 10.1128/IAI.67.7.3686-3689.1999; Price MJ, 2013, AM J EPIDEMIOL, V178, P484, DOI 10.1093/aje/kws583; Schachter J, 2003, J CLIN MICROBIOL, V41, P3784, DOI 10.1128/JCM.41.8.3784-3789.2003; Shah AA, 2005, SEX TRANSM DIS, V32, P49, DOI 10.1097/01.olq.0000148299.14513.11; Sigar IM, 2014, PATHOG DIS, V70, P61, DOI 10.1111/2049-632X.12086; Song LH, 2013, INFECT IMMUN, V81, P636, DOI 10.1128/IAI.01305-12; Tang LL, 2014, VACCINE, V32, P1407, DOI 10.1016/j.vaccine.2013.10.018; Tang LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060345; Wang YB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002258; Yeruva L, 2013, PATHOG DIS, V68, P88, DOI 10.1111/2049-632X.12052	26	30	30	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101634	10.1371/journal.pone.0101634	http://dx.doi.org/10.1371/journal.pone.0101634			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983626	Green Published, gold, Green Submitted			2022-12-27	WOS:000339635000126
J	Chen, J; Shao, JS; Cai, RT; Shen, YZ; Zhang, RF; Liu, L; Qi, TK; Lu, HZ				Chen, Jun; Shao, Jiasheng; Cai, Rentian; Shen, Yinzhong; Zhang, Renfang; Liu, Li; Qi, Tangkai; Lu, Hongzhou			Anti-Retroviral Therapy Decreases but Does Not Normalize Indoleamine 2,3-Dioxygenase Activity in HIV-Infected Patients	PLOS ONE			English	Article							T-CELL; INTERFERON-GAMMA; MICROBIAL TRANSLOCATION; TRYPTOPHAN CATABOLISM; IMMUNE ACTIVATION; DENDRITIC CELLS; KYNURENINE; INDUCTION; PROLIFERATION; DEGRADATION	Background: Indoleamine 2,3-dioxygenase (IDO), which is mainly expressed in activated dendritic cells, catabolizes tryptophan to kynurenine and other downstream catabolites. It is known to be an immune mediator in HIV pathogenesis. The impact of anti-retroviral therapy on its activity has not been well established. Methods: We measured systemic IDO activity (the ratio of plasma kynurenine to tryptophan) in HIV-infected patients before and after highly active antiretroviral therapy (HAART) and its association with a microbial translocation marker, soluble CD14 (sCD14). Results: Among 76 participants, higher baseline IDO activity was associated with lower CD4(+) T cell counts (P<0.05) and higher plasma sCD14 levels (P<0.001). After 1 year of HAART, IDO activity decreased significantly (P<0.01), but was still higher than in healthy controls (P<0.05). The baseline IDO activity did not predict CD4(+) T cell recovery after 1 year of therapy. The percentages of myeloid and plasmacytoid dendritic cells were not correlated with IDO activity. Conclusions: IDO activity is elevated in HIV-infected patients, which is partially associated with microbial translocation. HAART reduced, but did not normalize the activity of IDO.	[Chen, Jun; Shao, Jiasheng; Cai, Rentian; Shen, Yinzhong; Zhang, Renfang; Liu, Li; Qi, Tangkai; Lu, Hongzhou] Fudan Univ, Dept Infect Dis, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China; [Lu, Hongzhou] Fudan Univ, HuaShan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China; [Lu, Hongzhou] Fudan Univ, Dept Internal Med, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Lu, HZ (corresponding author), Fudan Univ, Dept Infect Dis, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China.	luhongzhou@fudan.edu.cn	Chen, Jun/K-2085-2012	Chen, Jun/0000-0002-3850-4875	National Natural Science Foundation of China [81301420, 81071353]; Program for the 12th Five-year Plan [2012ZX10001003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for the 12th Five-year Plan	JC and HL received grant from National Natural Science Foundation of China (No. 81301420 and 81071353, http://www.nsfc.gov.cn/). HL also received funding from Program for the 12th Five-year Plan (grant No. 2012ZX10001003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boasso A, 2007, J VIROL, V81, P11593, DOI 10.1128/JVI.00760-07; Boasso A, 2007, BLOOD, V109, P3351, DOI 10.1182/blood-2006-07-034785; Byakwaga H, 2014, J INFECT DIS; BYRNE GI, 1986, INFECT IMMUN, V53, P347, DOI 10.1128/IAI.53.2.347-351.1986; Cassol E, 2010, J INFECT DIS, V202, P723, DOI 10.1086/655229; Davies NWS, 2010, INT J TRYPTOPHAN RES, V3, P121; Dinel AL, 2014, PSYCHONEUROENDOCRINO, V40, P48, DOI 10.1016/j.psyneuen.2013.10.014; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Favre D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000295; Frick B, 2004, CLIN BIOCHEM, V37, P684, DOI 10.1016/j.clinbiochem.2004.02.007; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Grant RS, 2000, REDOX REP, V5, P105, DOI 10.1179/135100000101535366; Guillemin GJ, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-16; HASSANAIN HH, 1993, J BIOL CHEM, V268, P5077; Hattab S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-122; Huengsberg M, 1998, CLIN CHEM, V44, P858; Jenabian MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078146; Kamat A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030881; Karris MY, 2014, AIDS, V28, P841, DOI 10.1097/QAD.0000000000000149; Le Floc'h N, 2011, AMINO ACIDS, V41, P1195, DOI 10.1007/s00726-010-0752-7; Leonhardt RM, 2007, INFECT IMMUN, V75, P5105, DOI 10.1128/IAI.00668-07; Loughman JA, 2012, J INFECT DIS, V205, P1830, DOI 10.1093/infdis/jis280; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P702, DOI 10.1016/j.pnpbp.2010.12.017; Maes M, 2011, NEUROENDOCRINOL LETT, V32, P7; Manches O, 2008, J CLIN INVEST, V118, P3431, DOI 10.1172/JCI34823; Martinez P, 2014, JAIDS-J ACQ IMM DEF, V65, P456, DOI 10.1097/QAI.0000000000000062; Mellor A, 2005, BIOCHEM BIOPH RES CO, V338, P20, DOI 10.1016/j.bbrc.2005.08.232; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Mendez-Lagares G, 2013, J INFECT DIS, V207, P1221, DOI 10.1093/infdis/jit025; Nixon DE, 2010, CURR OPIN HIV AIDS, V5, P498, DOI 10.1097/COH.0b013e32833ed6f4; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Pertovaara M, 2006, MECH AGEING DEV, V127, P497, DOI 10.1016/j.mad.2006.01.020; PFEFFERKORN ER, 1984, P NATL ACAD SCI-BIOL, V81, P908, DOI 10.1073/pnas.81.3.908; Planes R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074551; Samikkannu T, 2010, J NEUROVIROL, V16, P255, DOI 10.3109/13550284.2010.497809; Sandler NG, 2012, NAT REV MICROBIOL, V10, P655, DOI 10.1038/nrmicro2848; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; Thackray SJ, 2008, BIOCHEM SOC T, V36, P1120, DOI 10.1042/BST0361120; Vujkovic-Cvijin I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006438; Wirthgen E, 2014, INNATE IMMUN-LONDON, V20, P30, DOI 10.1177/1753425913481252; Zangerle R, 2002, CLIN IMMUNOL, V104, P242, DOI 10.1006/clim.2002.5231; Zhang XQ, 2009, J CHROMATOGR B, V877, P1678, DOI 10.1016/j.jchromb.2009.04.013	43	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100446	10.1371/journal.pone.0100446	http://dx.doi.org/10.1371/journal.pone.0100446			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983463	Green Published, Green Submitted, gold			2022-12-27	WOS:000339635000025
J	Frederick, DT; Fragomeni, RAS; Schalck, A; Ferreiro-Neira, I; Hoff, T; Cooper, ZA; Haq, R; Panka, DJ; Kwong, LN; Davies, MA; Cusack, JC; Flaherty, KT; Fisher, DE; Mier, JW; Wargo, JA; Sullivan, RJ				Frederick, Dennie T.; Fragomeni, Roberto A. Salas; Schalck, Aislyn; Ferreiro-Neira, Isabel; Hoff, Taylor; Cooper, Zachary A.; Haq, Rizwan; Panka, David J.; Kwong, Lawrence N.; Davies, Michael A.; Cusack, James C.; Flaherty, Keith T.; Fisher, David E.; Mier, James W.; Wargo, Jennifer A.; Sullivan, Ryan J.			Clinical Profiling of BCL-2 Family Members in the Setting of BRAF Inhibition Offers a Rationale for Targeting De Novo Resistance sing BH3 Mimetics	PLOS ONE			English	Article							ACQUIRED-RESISTANCE; METASTATIC MELANOMA; SOLID TUMORS; PHASE-I; POTENTIAL MECHANISM; DOWN-REGULATION; BIM EXPRESSION; V600E MUTATION; HUMAN CANCERS; SURVIVAL	While response rates to BRAF inhibitiors (BRAFi) are high, disease progression emerges quickly. One strategy to delay the onset of resistance is to target anti-apoptotic proteins such as BCL-2, known to be associated with a poor prognosis. We analyzed BCL-2 family member expression levels of 34 samples from 17 patients collected before and 10 to 14 days after treatment initiation with either vemurafenib or dabrafenib/trametinib combination. The observed changes in mRNA and protein levels with BRAFi treatment led us to hypothesize that combining BRAFi with a BCL-2 inhibitor (the BH3-mimetic navitoclax) would improve outcome. We tested this hypothesis in cell lines and in mice. Pretreatment mRNA levels of BCL-2 negatively correlated with maximal tumor regression. Early increases in mRNA levels were seen in BIM, BCL-XL, BID and BCL2-W, as were decreases in MCL-1 and BCL2A. No significant changes were observed with BCL-2. Using reverse phase protein array (RPPA), significant increases in protein levels were found in BIM and BID. No changes in mRNA or protein correlated with response. Concurrent BRAF (PLX4720) and BCL2 (navitoclax) inhibition synergistically reduced viability in BRAF mutant cell lines and correlated with down-modulation of MCL-1 and BIM induction after PLX4720 treatment. In xenograft models, navitoclax enhanced the efficacy of PLX4720. The combination of a selective BRAF inhibitor with a BH3-mimetic promises to be an important therapeutic strategy capable of enhancing the clinical efficacy of BRAF inhibition in many patients that might otherwise succumb quickly to de novo resistance.	[Frederick, Dennie T.; Fragomeni, Roberto A. Salas; Ferreiro-Neira, Isabel; Hoff, Taylor; Cusack, James C.] Massachusetts Gen Hosp, Div Surg Oncol, Boston, MA 02114 USA; [Fragomeni, Roberto A. Salas; Haq, Rizwan; Panka, David J.; Cusack, James C.; Flaherty, Keith T.; Fisher, David E.; Mier, James W.; Sullivan, Ryan J.] Harvard Univ, Sch Med, Boston, MA 02138 USA; [Schalck, Aislyn; Haq, Rizwan; Flaherty, Keith T.; Sullivan, Ryan J.] Massachusetts Gen Hosp, Ctr Canc, Div Med Oncol, Boston, MA USA; [Cooper, Zachary A.; Kwong, Lawrence N.; Davies, Michael A.; Wargo, Jennifer A.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol & Genom Med, Houston, TX 77030 USA; [Panka, David J.; Mier, James W.] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA; [Fisher, David E.] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital	Sullivan, RJ (corresponding author), Harvard Univ, Sch Med, Boston, MA 02138 USA.	rsullivan7@partners.org	Fisher, David/AAH-2878-2019; Davies, Michael/GWV-2527-2022; Akbar, Noreen Sher/ABA-2946-2021; Nadeem, Sohail/I-5248-2013	Akbar, Noreen Sher/0000-0003-4530-5978; Nadeem, Sohail/0000-0002-1052-011X; Cooper, Zachary/0000-0003-1059-0940; Schalck, Aislyn/0000-0002-4020-1822	MGH; Eugene Michael Egan Translational Research Fund at BIDMC; NATIONAL CANCER INSTITUTE [R01CA166480, P01CA163222, UM1CA186709, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER	MGH; Eugene Michael Egan Translational Research Fund at BIDMC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding Sources for this work include: 1. Internal sundry funds at MGH. 2. The Eugene Michael Egan Translational Research Fund at BIDMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Boisvert-Adamo K, 2008, ONCOGENE, V27, P3301, DOI 10.1038/sj.onc.1211003; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Cartlidge RA, 2008, PIGM CELL MELANOMA R, V21, P534, DOI 10.1111/j.1755-148X.2008.00491.x; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Chetoui N, 2008, MOL CANCER RES, V6, P42, DOI 10.1158/1541-7786.MCR-07-0080; Chiappori AA, 2012, BRIT J CANCER, V106, P839, DOI 10.1038/bjc.2012.21; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cragg MS, 2008, J CLIN INVEST, V118, P3651, DOI 10.1172/JCI35437; Falchook GS, 2012, LANCET, V379, P1893, DOI 10.1016/S0140-6736(12)60398-5; Gradilone A, 2003, J CLIN ONCOL, V21, P306, DOI 10.1200/JCO.2003.08.066; Haq R, 2013, P NATL ACAD SCI USA, V110, P4321, DOI 10.1073/pnas.1205575110; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Hughes R, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-69; Hwang JJ, 2010, CLIN CANCER RES, V16, P4038, DOI 10.1158/1078-0432.CCR-10-0822; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Lee JT, 2010, PIGM CELL MELANOMA R, V23, P820, DOI 10.1111/j.1755-148X.2010.00763.x; Long GV, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12098; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Nathanson KL, 2011, CHICAGO J CLIN ONC S; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Paik PK, 2010, CANCER CHEMOTH PHARM, V66, P1079, DOI 10.1007/s00280-010-1265-5; Paraiso KHT, 2011, CANCER RES, V71, P2750, DOI 10.1158/0008-5472.CAN-10-2954; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; SAENZSANTAMARIA MC, 1994, J CUTAN PATHOL, V21, P393; Salas Fragomeni RA, 2013, MOL CANC THERAPEUTIC; Sheridan C, 2008, J BIOL CHEM, V283, P22128, DOI 10.1074/jbc.M800271200; Shi HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1727; Smalley KSM, 2008, MOL CANCER THER, V7, P2876, DOI 10.1158/1535-7163.MCT-08-0431; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Tahir SK, 2010, MOL CANCER THER, V9, P545, DOI 10.1158/1535-7163.MCT-09-0651; Tap WD, 2010, NEOPLASIA, V12, P637, DOI 10.1593/neo.10414; Trunzer K, 2013, J CLIN ONCOL, V31, P1767, DOI 10.1200/JCO.2012.44.7888; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Vlaykova T, 2002, ONCOLOGY-BASEL, V62, P259, DOI 10.1159/000059574; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Wang HS, 2011, CANCER RES, V71, P5535, DOI 10.1158/0008-5472.CAN-10-4351; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Wroblewski D, 2013, CARCINOGENESIS, V34, P237, DOI 10.1093/carcin/bgs330; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	44	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101286	10.1371/journal.pone.0101286	http://dx.doi.org/10.1371/journal.pone.0101286			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983357	Green Published, gold, Green Submitted			2022-12-27	WOS:000339635000084
J	Laillou, A; Prak, S; de Groot, R; Whitney, S; Conkle, J; Horton, L; Un, SO; Dijkhuizen, MA; Wieringa, FT				Laillou, Arnaud; Prak, Sophonneary; de Groot, Richard; Whitney, Sophie; Conkle, Joel; Horton, Lindsey; Un, Sam Oeurn; Dijkhuizen, Marjoleine A.; Wieringa, Frank T.			Optimal Screening of Children with Acute Malnutrition Requires a Change in Current WHO Guidelines as MUAC and WHZ Identify Different Patient Groups	PLOS ONE			English	Article							BODY-COMPOSITION; OVERWEIGHT; NUTRITION; WEIGHT; LEPTIN; RISK	BACKGROUND: Timely treatment of acute malnutrition in children <5 years of age could prevent >500,000 deaths annually. Screening at community level is essential to identify children with malnutrition. Current WHO guidelines for community screening for malnutrition recommend a Mid Upper Arm Circumference (MUAC) of <115 mm to identify severe acute malnutrition (SAM). However, it is currently unclear how MUAC relates to the other indicator used to define acute malnutrition: weight-for-height Z-score (WHZ). METHODS:Secondary data from >11,000 Cambodian children, obtained by different surveys between 2010 and 2012, was used to calculate sensitivity and ROC curves for MUAC and WHZ. FINDINGS: The secondary analysis showed that using the current WHO cut-off of 115 mm for screening for severe acute malnutrition over 90% of children with a weight-for-height z-score (WHZ) <-3 would have been missed. Reversely, WHZ< -3 missed 80% of the children with a MUAC<115 mm. CONCLUSIONS:The current WHO cut-off for screening for SAM should be changed upwards from the current 115 mm. In the Cambodian data-set, a cut-off of 133 mm would allow inclusion of >65% of children with a WHZ< -3. Importantly, MUAC and WHZ identified different sub-groups of children with acute malnutrition, therefore these 2 indicators should be regarded as independent from each other. We suggest a 2-step model with MUAC used a screening at community level, followed by MUAC and WHZ measured at a primary health care unit, with both indicators used independently to diagnose severe acute malnutrition. Current guidelines should be changed to reflect this, with treatment initiated when either MUAC <115 mm or WHZ< -3.	[Laillou, Arnaud; Conkle, Joel; Un, Sam Oeurn] UNICEF, Maternal Child Hlth & Nutr Sect, Phnom Penh, Cambodia; [Prak, Sophonneary] Maternal & Child Hlth Ctr, Natl Nutr Program, Phnom Penh, Cambodia; [Whitney, Sophie] World Food Programme, Phnom Penh, Cambodia; [Horton, Lindsey] World Food Programme, Bangkok, Thailand; [Dijkhuizen, Marjoleine A.] Univ Copenhagen, Dept Human Nutr, Frederiksberg C, Denmark; [Wieringa, Frank T.] IRD Montpellier1 Montpellier2 SupAgro NUTRIPASS, UMR 204, Inst Rech Dev, Montpellier, France	University of Copenhagen; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Wieringa, FT (corresponding author), IRD Montpellier1 Montpellier2 SupAgro NUTRIPASS, UMR 204, Inst Rech Dev, Montpellier, France.	franck.wieringa@ird.fr	Wieringa, Frank Tammo/K-7565-2017	Wieringa, Frank Tammo/0000-0002-6010-355X; Conkle, Joel/0000-0003-2603-5052				Andersen GS, 2011, PEDIATR RES, V70, P501, DOI 10.1203/PDR.0b013e31822d7470; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Briend A, 2012, MATERN CHILD NUTR, V8, P130, DOI 10.1111/j.1740-8709.2011.00340.x; Chomtho S, 2006, PEDIATR RES, V59, P860, DOI 10.1203/01.pdr.0000219395.83159.91; Collins S, 2006, LANCET, V368, P1992, DOI 10.1016/S0140-6736(06)69443-9; Dairo M D, 2012, Int J Biomed Sci, V8, P140; Fernandez MAL, 2010, PEDIATRICS, V126, pE195, DOI 10.1542/peds.2009-2175; Grimble RF, 2001, P NUTR SOC, V60, P389, DOI 10.1079/PNS2001102; Iikuni Noriko, 2008, Current Immunology Reviews, V4, P70, DOI 10.2174/157339508784325046; Mancuso P, 2006, AM J RESP CRIT CARE, V173, P212, DOI 10.1164/rccm.200506-909OC; Rosner B., 2006, FUNDAMENTALS BIOSTAT; Wells JCK, 2006, INT J OBESITY, V30, P1506, DOI 10.1038/sj.ijo.0803402; Wells JCK, 2009, INT J EPIDEMIOL, V38, P63, DOI 10.1093/ije/dyn183; WHO, 2013, GUID UPD MAN SEV AC	16	59	59	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101159	10.1371/journal.pone.0101159	http://dx.doi.org/10.1371/journal.pone.0101159			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983995	Green Published, gold, Green Submitted			2022-12-27	WOS:000339635000061
J	Dumble, M; Crouthamel, MC; Zhang, SY; Schaber, M; Levy, D; Robell, K; Liu, Q; Figueroa, DJ; Minthorn, EA; Seefeld, MA; Rouse, MB; Rabindran, SK; Heerding, DA; Kumar, R				Dumble, Melissa; Crouthamel, Ming-Chih; Zhang, Shu-Yun; Schaber, Michael; Levy, Dana; Robell, Kimberly; Liu, Qi; Figueroa, David J.; Minthorn, Elisabeth A.; Seefeld, Mark A.; Rouse, Meagan B.; Rabindran, Sridhar K.; Heerding, Dirk A.; Kumar, Rakesh			Discovery of Novel AKT Inhibitors with Enhanced Anti-Tumor Effects in Combination with the MEK Inhibitor	PLOS ONE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; PROTEIN-KINASE; BREAST-CANCER; ACTIVATING MUTATION; PHOSPHORYLATION; INDUCTION; APOPTOSIS; RICTOR; EGFR	Tumor cells upregulate many cell signaling pathways, with AKT being one of the key kinases to be activated in a variety of malignancies. GSK2110183 and GSK2141795 are orally bioavailable, potent inhibitors of the AKT kinases that have progressed to human clinical studies. Both compounds are selective, ATP-competitive inhibitors of AKT 1, 2 and 3. Cells treated with either compound show decreased phosphorylation of several substrates downstream of AKT. Both compounds have desirable pharmaceutical properties and daily oral dosing results in a sustained inhibition of AKT activity as well as inhibition of tumor growth in several mouse tumor models of various histologic origins. Improved kinase selectivity was associated with reduced effects on glucose homeostasis as compared to previously reported ATP-competitive AKT kinase inhibitors. In a diverse cell line proliferation screen, AKT inhibitors showed increased potency in cell lines with an activated AKT pathway (via PI3K/PTEN mutation or loss) while cell lines with activating mutations in the MAPK pathway (KRAS/BRAF) were less sensitive to AKT inhibition. Further investigation in mouse models of KRAS driven pancreatic cancer confirmed that combining the AKT inhibitor, GSK2141795 with a MEK inhibitor (GSK2110212; trametinib) resulted in an enhanced antitumor effect accompanied with greater reduction in phospho-S6 levels. Taken together these results support clinical evaluation of the AKT inhibitors in cancer, especially in combination with MEK inhibitor.	[Dumble, Melissa; Crouthamel, Ming-Chih; Zhang, Shu-Yun; Levy, Dana; Robell, Kimberly; Liu, Qi; Figueroa, David J.; Minthorn, Elisabeth A.; Seefeld, Mark A.; Rouse, Meagan B.; Rabindran, Sridhar K.; Heerding, Dirk A.; Kumar, Rakesh] GlaxoSmithKline, Oncol R&D, Collegeville, PA 19426 USA; [Schaber, Michael] GlaxoSmithKline, Platform Technol & Sci, Collegeville, PA USA	GlaxoSmithKline; GlaxoSmithKline	Kumar, R (corresponding author), GlaxoSmithKline, Oncol R&D, Collegeville, PA 19426 USA.	rakesh.2.kumar@gsk.com	Kumar, Rakesh/ABD-1065-2020	Kumar, Rakesh/0000-0001-7664-0803	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	Funding for the work was provided by GlaxoSmithKline. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Burris HA, 2011, J CLIN ONCOL S, V29, P2003; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Corcoran RB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005753; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Davies BR, 2012, MOL CANCER THER, V11, P873, DOI 10.1158/1535-7163.MCT-11-0824-T; Davies MA, 2008, BRIT J CANCER, V99, P1265, DOI 10.1038/sj.bjc.6604637; Ebi H, 2013, P NATL ACAD SCI USA, V110, P21124, DOI 10.1073/pnas.1314124110; Elkabets M, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005747; Faber AC, 2009, P NATL ACAD SCI USA, V106, P19503, DOI 10.1073/pnas.0905056106; Gilmartin AG, 2011, CLIN CANCER RES, V17, P989, DOI 10.1158/1078-0432.CCR-10-2200; Han EKH, 2007, ONCOGENE, V26, P5655, DOI 10.1038/sj.onc.1210343; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Hussain K, 2011, SCIENCE, V334, P474, DOI 10.1126/science.1210878; Lin J, 2013, CLIN CANCER RES, V19, P1760, DOI 10.1158/1078-0432.CCR-12-3072; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Majumder PK, 2005, ONCOGENE, V24, P7465, DOI 10.1038/sj.onc.1209096; Mirzoeva OK, 2009, CANCER RES, V69, P565, DOI 10.1158/0008-5472.CAN-08-3389; Morgan MA, 2001, BLOOD, V97, P1823, DOI 10.1182/blood.V97.6.1823; Rhodes N, 2008, CANCER RES, V68, P2366, DOI 10.1158/0008-5472.CAN-07-5783; Ricciardi MR, 2012, J MOL MED, V90, P1133, DOI 10.1007/s00109-012-0886-z; Rodon J, 2013, NAT REV CLIN ONCOL, V10, P143, DOI 10.1038/nrclinonc.2013.10; Saleh M, 2013, AM ASS CANC RES ANN; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Serra V, 2011, ONCOGENE, V30, P2547, DOI 10.1038/onc.2010.626; Shoji K, 2009, BRIT J CANCER, V101, P145, DOI 10.1038/sj.bjc.6605109; Sos ML, 2009, P NATL ACAD SCI USA, V106, P18351, DOI 10.1073/pnas.0907325106; Spencer A, 2011, P 53 AM SOC HEM ANN; Takaishi H, 1999, P NATL ACAD SCI USA, V96, P11836, DOI 10.1073/pnas.96.21.11836; Turke AB, 2012, CANCER RES, V72, P1; Wu WI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012913; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Yoon YK, 2009, MOL CANCER THER, V8, P2526, DOI 10.1158/1535-7163.MCT-09-0300; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	38	88	91	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100880	10.1371/journal.pone.0100880	http://dx.doi.org/10.1371/journal.pone.0100880			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978597	Green Submitted, gold, Green Published			2022-12-27	WOS:000338506400045
J	Kaldenbach, M; Cubero, FJ; Erschfeld, S; Liedtke, C; Trautwein, C; Streetz, K				Kaldenbach, Michaela; Cubero, Francisco Javier; Erschfeld, Stephanie; Liedtke, Christian; Trautwein, Christian; Streetz, Konrad			Hepatic Tissue Environment in NEMO-Deficient Mice Critically Regulates Positive Selection of Donor Cells after Hepatocyte Transplantation	PLOS ONE			English	Article							NF-KAPPA-B; LIVER-INJURY; HEPATOCELLULAR-CARCINOMA; IN-VIVO; CIRRHOSIS; RATS; REGENERATION; REPOPULATION; REPLACEMENT; PROGRESSION	Background: Hepatocyte transplantation (HT) is a promising alternative treatment strategy for end-stage liver diseases compared with orthotopic liver transplantation. A limitation for this approach is the low engraftment of donor cells. The deletion of the I-kappa B kinase-regulatory subunit IKK gamma/NEMO in hepatocytes prevents nuclear factor (NF)-kB activation and triggers spontaneous liver apoptosis, chronic hepatitis and the development of liver fibrosis and hepatocellular carcinoma. We hypothesized that NEMO Delta hepa mice may therefore serve as an experimental model to study HT. Methods: Pre-conditioned NEMO Delta hepa mice were transplanted with donor-hepatocytes from wildtype (WT) and mice deficient for the pro-apoptotic mediator Caspase-8 (CaspehePa). Results: Transplantation of isolated WT-hepatocytes into pre-conditioned NEMO Delta hepa mice resulted in a 6-7 fold increase of donor cells 12 weeks after HT, while WT-recipients showed no liver repopulation. The use of apoptosis-resistant Casp8(Delta hepa)-derived donor cells further enhanced the selection 3-fold after 12-weeks and up to 10-fold increase after 52 weeks compared with WT donors. While analysis of NEMO Delta hepa mice revealed strong liver injury, HT-recipient NEMO Delta hepa mice showed improved liver morphology and decrease in serum transaminases. Concomitant with these findings, the histological examination elicited an improved liver tissue architecture associated with significantly lower levels of apoptosis, decreased proliferation and a lesser amount of liver fibrogenesis. Altogether, our data clearly support the therapeutic benefit of the HT procedure into NEMO Delta hepa mice. Conclusion: This study demonstrates the feasibility of the NEMO Delta hepa mouse as an in vivo tool to study liver repopulation after HT. The improvement of the characteristic phenotype of chronic liver injury in NEMO Delta hepa ice after HT suggests the therapeutic potential of HT in liver diseases with a chronic inflammatory phenotype and opens a new door for the applicability of this technique to combat liver disease in the human clinic.	[Kaldenbach, Michaela; Cubero, Francisco Javier; Erschfeld, Stephanie; Liedtke, Christian; Trautwein, Christian; Streetz, Konrad] Rhein Westfal TH Aachen, Univ Hosp, Dept Internal Med 3, D-52062 Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital	Streetz, K (corresponding author), Rhein Westfal TH Aachen, Univ Hosp, Dept Internal Med 3, D-52062 Aachen, Germany.	kstreetz@ukaachen.de	Liedtke, Christian/DTV-1874-2022	Liedtke, Christian/0000-0003-4681-7887; Cubero, Francisco Javier/0000-0003-1499-650X	Deutsche Forschungsgemeinschaft (DFG) [5TR661/4-2]; DFG SFB/TRR [57]; faculty of medicine [691405]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG SFB/TRR(German Research Foundation (DFG)); faculty of medicine	KS, MK, SE were supported by a grant of the Deutsche Forschungsgemeinschaft (DFG) grant nr. 5TR661/4-2. CL and CT were supported by a grant of the DFG SFB/TRR 57, and FJC was supported by the faculty of medicine grant nr. 691405. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Beraza N, 2009, J EXP MED, V206, P1727, DOI 10.1084/jem.20082152; Chaudhary K, 2013, J HEPATOL, V59, P1292, DOI 10.1016/j.jhep.2013.07.026; Christ B, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00168; Cubero FJ, 2013, CELL DEATH DIFFER, V20, P1580, DOI 10.1038/cdd.2013.112; FITZGERALD MJ, 1995, CELL GROWTH DIFFER, V6, P417; Fox IJ, 1998, NEW ENGL J MED, V338, P1422, DOI 10.1056/NEJM199805143382004; Freimuth J, 2013, HEPATOLOGY; Grompe M, 2001, J INHERIT METAB DIS, V24, P231, DOI 10.1023/A:1010375203539; Guha C, 2001, ARTIF ORGANS, V25, P522, DOI 10.1046/j.1525-1594.2001.025007522.x; Kaldenbach M, 2012, GUT, V61, P1209, DOI 10.1136/gutjnl-2011-301345; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kobayashi N, 2000, HEPATOLOGY, V31, P851, DOI 10.1053/he.2000.5636; Krampera M, 2007, STEM CELLS DEV, V16, P797, DOI 10.1089/scd.2007.0024; Laconi S, 2001, AM J PATHOL, V158, P771, DOI 10.1016/S0002-9440(10)64019-9; Liedtke C, 2011, GASTROENTEROLOGY, V141, P2176, DOI 10.1053/j.gastro.2011.08.037; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Nagata H, 2003, GASTROENTEROLOGY, V124, P422, DOI 10.1053/gast.2003.50065; Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266; Pareja E, 2013, EUR SURG RES, V50, P273, DOI 10.1159/000351332; PONDER KP, 1991, P NATL ACAD SCI USA, V88, P1217, DOI 10.1073/pnas.88.4.1217; QUINN PS, 1965, AM J PATHOL, V47, P353; Quintanilha LF, 2008, CELL TRANSPLANT, V17, P943, DOI 10.3727/096368908786576453; Sakaida I, 2004, HEPATOLOGY, V40, P1304, DOI 10.1002/hep.20452; SHEN RF, 1987, NUCLEIC ACIDS RES, V15, P8399, DOI 10.1093/nar/15.20.8399; Streetz KL, 2008, HEPATOLOGY, V47, P706, DOI 10.1002/hep.22012; Tschaharganeh DF, 2010, LIVER TRANSPLANT, V16, P23, DOI 10.1002/lt.21962; van Poll D, 2008, HEPATOLOGY, V47, P1634, DOI 10.1002/hep.22236; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	32	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100786	10.1371/journal.pone.0100786	http://dx.doi.org/10.1371/journal.pone.0100786			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979756	gold, Green Published, Green Submitted			2022-12-27	WOS:000338506400040
J	Kwatra, G; Adrian, PV; Shiri, T; Buchmann, EJ; Cutland, CL; Madhi, SA				Kwatra, Gaurav; Adrian, Peter V.; Shiri, Tinevimbo; Buchmann, Eckhart J.; Cutland, Clare L.; Madhi, Shabir A.			Serotype-Specific Acquisition and Loss of Group B Streptococcus Recto-Vaginal Colonization in Late Pregnancy	PLOS ONE			English	Article							RISK-FACTORS; WOMEN; AGALACTIAE; DISEASE; SUSCEPTIBILITY; PREVALENCE; CARRIAGE; ANTIBODY; BURDEN	Background: Maternal recto-vaginal colonization with Group B Streptococcus (GBS) and consequent vertical transmission to the newborn predisposes neonates to early-onset invasive GBS disease. This study aimed to determine the acquisition and loss of serotype-specific recto-vaginal GBS colonization from 20-37+ weeks of gestational age. Methods: Vaginal and rectal swabs were collected from HIV-uninfected women at 20-25 weeks of gestation age and at 5-6 weekly intervals thereafter. Swabs were cultured for GBS and isolates were serotyped by latex agglutination. Serologically non-typable isolates and pilus islands were characterized by PCR. Results: The prevalence of recto-vaginal GBS colonization was 33.0%, 32.7%, 28.7% and 28.4% at 20-25 weeks, 26-30 weeks, 31-35 weeks and 37+ weeks of gestational age, respectively. The most common identified serotypes were Ia (39.2%), III (32.8%) and V (12.4%). Of 507 participants who completed all four study visits, the cumulative overall recto-vaginal acquisition rate of new serotypes during the study was 27.9%, including 11.2%, 8.2% and 4.3% for serotypes Ia, III and V, respectively. Comparing the common colonizing serotypes, serotype III was more likely to be associated with persistent colonization throughout the study (29%) than Ia (18%; p = 0.045) or V (6%; p = 0.002). The median duration of recto-vaginal GBS colonization for serotype III was 6.35 weeks, which was longer than other serotypes. Pilus island proteins were detected in all GBS isolates and their subtype distribution was associated with specific serotypes. Conclusion: South African pregnant women have a high prevalence of GBS recto-vaginal colonization from 20 weeks of gestational age onwards, including high GBS acquisition rates in the last pregnancy-trimesters. There are differences in specific-serotype colonization patterns during pregnancy.	[Kwatra, Gaurav; Adrian, Peter V.; Shiri, Tinevimbo; Cutland, Clare L.; Madhi, Shabir A.] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn Vaccine Preventable Dis, Johannesburg, South Africa; [Kwatra, Gaurav; Adrian, Peter V.; Shiri, Tinevimbo; Cutland, Clare L.; Madhi, Shabir A.] Univ Witwatersrand, MRC, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; [Madhi, Shabir A.] Natl Inst Communicable Dis, Johannesburg, South Africa; [Buchmann, Eckhart J.] Univ Witwatersrand, Dept Obstet & Gynaecol, Johannesburg, South Africa	National Research Foundation - South Africa; University of Witwatersrand; University of Witwatersrand; National Institute for Communicable Diseases (NICD); University of Witwatersrand	Adrian, PV (corresponding author), Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn Vaccine Preventable Dis, Johannesburg, South Africa.	adrianp@rmpru.co.za	Cutland, Clare L./GXE-9967-2022	Cutland, Clare L./0000-0001-8250-8307; Shiri, Tinevimbo/0000-0002-9092-3268	South African Research Chairs Initiative in Vaccine Preventable Diseases of the Department of Science and Technology; National Research Foundation; Novartis Vaccines, Italy	South African Research Chairs Initiative in Vaccine Preventable Diseases of the Department of Science and Technology; National Research Foundation; Novartis Vaccines, Italy	This work was funded by research supported by the South African Research Chairs Initiative in Vaccine Preventable Diseases of the Department of Science and Technology and National Research Foundation. Part-funding was also granted by Novartis Vaccines, Italy. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Afshar B, 2011, J CLIN MICROBIOL, V49, P1475, DOI 10.1128/JCM.02365-10; BAKER CJ, 1981, PEDIATRICS, V68, P544; BAKER CJ, 1976, NEW ENGL J MED, V294, P753, DOI 10.1056/NEJM197604012941404; BAKER CJ, 1975, AM J OBSTET GYNECOL, V122, P820, DOI 10.1016/0002-9378(75)90721-8; Chan SHS WK, 2000, HONG KONG J PAEDIATR, V5, P8; Davies HD, 2001, J INFECT DIS, V184, P285, DOI 10.1086/322029; Dzowela T, 2005, MALAWI MED J, V17, P97, DOI 10.4314/mmj.v17i3.10888; Edwards MS, 2013, VACCINE, V31, pD66, DOI 10.1016/j.vaccine.2012.11.046; Foxman B, 2006, AM J EPIDEMIOL, V163, P544, DOI 10.1093/aje/kwj075; Gilbert GL, 2002, AUST NZ J OBSTET GYN, V42, P497, DOI 10.1111/j.0004-8666.2002.00497.x; Goodman J R, 1997, Infect Dis Obstet Gynecol, V5, P237, DOI 10.1155/S1064744997000409; Hansen SM, 2004, J CLIN MICROBIOL, V42, P83, DOI 10.1128/JCM.42.1.83-89.2004; Ippolito DL, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-336; Joachim A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-437; Kwatra G, 2013, J CLIN MICROBIOL, V51, P2515, DOI 10.1128/JCM.00251-13; Madhi SA, 2003, ANN TROP PAEDIATR, V23, P15, DOI 10.1179/000349803125002814; Madzivhandila M, 2013, J MED MICROBIOL, V62, P249, DOI 10.1099/jmm.0.052951-0; Madzivhandila M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017861; Manning SD, 2008, CLIN INFECT DIS, V46, P1829, DOI 10.1086/588296; Margarit I, 2009, J INFECT DIS, V199, P108, DOI 10.1086/595564; Mavenyengwa RT, 2010, ACTA OBSTET GYN SCAN, V89, P250, DOI 10.3109/00016340903398029; Meyn LA, 2002, AM J EPIDEMIOL, V155, P949, DOI 10.1093/aje/155.10.949; Mohammed M, 2012, ETHIOP J HEALTH DEV, V26, P36; Motlova J, 2004, INDIAN J MED RES, V119, P84; Moyo S. R., 2000, Central African Journal of Medicine, V46, P115; Poyart C, 2007, J CLIN MICROBIOL, V45, P1985, DOI 10.1128/JCM.00159-07; Schrag SJ, 2004, CLIN INFECT DIS, V38, P1209, DOI 10.1086/382889; Slotved HC, 2007, J CLIN MICROBIOL, V45, P2929, DOI 10.1128/JCM.00117-07; SUARA RO, 1994, J INFECT DIS, V170, P1316, DOI 10.1093/infdis/170.5.1316; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Zamzami TY, 2011, ARCH GYNECOL OBSTET, V284, P677, DOI 10.1007/s00404-010-1752-2	32	63	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e98778	10.1371/journal.pone.0098778	http://dx.doi.org/10.1371/journal.pone.0098778			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979575	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400003
J	Leslie, HH; Karasek, DA; Harris, LF; Chang, E; Abdulrahim, N; Maloba, M; Huchko, MJ				Leslie, Hannah H.; Karasek, Deborah A.; Harris, Laura F.; Chang, Emily; Abdulrahim, Naila; Maloba, May; Huchko, Megan J.			Cervical Cancer Precursors and Hormonal Contraceptive Use in HIV-Positive Women: Application of a Causal Model and Semi-Parametric Estimation Methods	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; ORAL-CONTRACEPTIVES; DISEASE; RISK; INFERENCE	Objective: To demonstrate the application of causal inference methods to observational data in the obstetrics and gynecology field, particularly causal modeling and semi-parametric estimation. Background: Human immunodeficiency virus (HIV)-positive women are at increased risk for cervical cancer and its treatable precursors. Determining whether potential risk factors such as hormonal contraception are true causes is critical for informing public health strategies as longevity increases among HIV-positive women in developing countries. Methods: We developed a causal model of the factors related to combined oral contraceptive (COC) use and cervical intraepithelial neoplasia 2 or greater (CIN2+) and modified the model to fit the observed data, drawn from women in a cervical cancer screening program at HIV clinics in Kenya. Assumptions required for substantiation of a causal relationship were assessed. We estimated the population-level association using semi-parametric methods: g-computation, inverse probability of treatment weighting, and targeted maximum likelihood estimation. Results: We identified 2 plausible causal paths from COC use to CIN2+: via HPV infection and via increased disease progression. Study data enabled estimation of the latter only with strong assumptions of no unmeasured confounding. Of 2,519 women under 50 screened per protocol, 219 (8.7%) were diagnosed with CIN2+. Marginal modeling suggested a 2.9% (95% confidence interval 0.1%, 6.9%) increase in prevalence of CIN2+ if all women under 50 were exposed to COC; the significance of this association was sensitive to method of estimation and exposure misclassification. Conclusion: Use of causal modeling enabled clear representation of the causal relationship of interest and the assumptions required to estimate that relationship from the observed data. Semi-parametric estimation methods provided flexibility and reduced reliance on correct model form. Although selected results suggest an increased prevalence of CIN2+ associated with COC, evidence is insufficient to conclude causality. Priority areas for future studies to better satisfy causal criteria are identified.	[Leslie, Hannah H.; Karasek, Deborah A.] Univ Calif Berkeley, Div Epidemiol, Berkeley, CA 94720 USA; [Harris, Laura F.] Univ Calif Berkeley, Joint Med Program, Berkeley, CA 94720 USA; [Harris, Laura F.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Chang, Emily] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Abdulrahim, Naila] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Maloba, May] FACES, Kisumu, Kenya; [Huchko, Megan J.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kenya Medical Research Institute; University of California System; University of California San Francisco	Leslie, HH (corresponding author), Univ Calif Berkeley, Div Epidemiol, Berkeley, CA 94720 USA.	Hannah.leslie@berkeley.edu	Huchko, Megan/S-6063-2019	Chang, Emily/0000-0002-5542-261X; Leslie, Hannah Hogan/0000-0002-7464-3645	NIH/NCRR/ODUCSF-CTSI [KL2 RR024130]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000143] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER	NIH/NCRR/ODUCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Financial support for the original study was provided by NIH/NCRR/ODUCSF-CTSI grant no. KL2 RR024130. No financial support was provided the authors for this secondary analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern J, 2009, AM J EPIDEMIOL, V169, P1140, DOI 10.1093/aje/kwp015; Appleby P, 2007, LANCET, V370, P1609, DOI 10.1016/S0140-6736(07)61684-5; Cogliano V, 2005, LANCET ONCOL, V6, P552, DOI 10.1016/S1470-2045(05)70273-4; Cremer M, 2011, INT J GYNECOL OBSTET, V113, P68, DOI 10.1016/j.ijgo.2010.10.018; de Gonzalez AB, 2007, INT J CANCER, V120, P885, DOI 10.1002/ijc.22357; De Vuyst H, 2008, EUR J CANCER PREV, V17, P545, DOI 10.1097/CEJ.0b013e3282f75ea1; Denny L, 2008, OBSTET GYNECOL, V111, P1380, DOI 10.1097/AOG.0b013e3181743327; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gilbert SA, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.02.002; Glymour M., 2008, CAUSAL DIAGRAMS MODE, P183; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Greenland S, 2002, INT J EPIDEMIOL, V31, P1030, DOI 10.1093/ije/31.5.1030; Gruber S., 2009, UC BERKELEY DIV BIOS; Hannaford PC, 2007, BRIT MED J, V335, P651, DOI 10.1136/bmj.39289.649410.55; Heard I, 2000, OBSTET GYNECOL, V96, P403, DOI 10.1016/S0029-7844(00)00948-0; Heard I, 2004, ANTIVIR THER, V9, P13; Huchko MJ, 2014, INT J CANCER, V134, P740, DOI 10.1002/ijc.28401; JEWELL N. P., 2004, STAT EPIDEMIOLOGY; Lash TL, 2011, APPL QUANTITATIVE BI; Lippman SA, 2010, SEX TRANSM DIS, V37, P512, DOI 10.1097/OLQ.0b013e3181d73feb; Little RJ, 2000, ANNU REV PUBL HEALTH, V21, P121, DOI 10.1146/annurev.publhealth.21.1.121; Maldonado G, 2002, INT J EPIDEMIOL, V31, P422, DOI 10.1093/ije/31.2.422; Miller K, 2004, CONTRACEPTION, V69, P347, DOI 10.1016/j.contraception.2003.12.012; Munoz ID, 2012, BIOMETRICS, V68, P541, DOI 10.1111/j.1541-0420.2011.01685.x; Palefsky J, 2009, CURR OPIN HIV AIDS, V4, P52, DOI 10.1097/COH.0b013e32831a7246; Pearl J, 2009, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Pearl J, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1203; Pellati D, 2008, EUR J OBSTET GYN R B, V140, P3, DOI 10.1016/j.ejogrb.2008.03.009; Petersen ML, 2012, STAT METHODS MED RES, V21, P31, DOI 10.1177/0962280210386207; Polley E, 2012, SUPERLEARNER SUPER L; Poole C, 2010, EPIDEMIOLOGY, V21, P3, DOI 10.1097/EDE.0b013e3181c30eba; Ralph LJ, 2013, LANCET, V382, P1467, DOI 10.1016/S0140-6736(13)61420-8; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Rose S, 2011, SPRINGER SER STAT, P3, DOI 10.1007/978-1-4419-9782-1; Smith JS, 2003, LANCET, V361, P1159, DOI 10.1016/S0140-6736(03)12949-2; UNAIDS, 2012, GLOBAL REPORT UNAIDS; UNAIDS, 2012, WOM OUT LOUD WOM LIV; Vaccarella S, 2006, CANCER EPIDEM BIOMAR, V15, P2148, DOI 10.1158/1055-9965.EPI-06-0556; van der Laan MJ, 2006, INT J BIOSTAT, V2, P11, DOI [10.2202/1557-4679.1043, DOI 10.2202/1557-4679.1043]; van der Laan MJ, 2007, STAT APPL GENET MOL, V6, pe25; Vessey M, 2013, CONTRACEPTION, V88, P678, DOI 10.1016/j.contraception.2013.08.008; Westreich D, 2013, AM J EPIDEMIOL, V177, P292, DOI 10.1093/aje/kws412; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067	43	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101090	10.1371/journal.pone.0101090	http://dx.doi.org/10.1371/journal.pone.0101090			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979709	Green Published, gold, Green Submitted			2022-12-27	WOS:000338506400075
J	Wang, J; Guo, XF; Yu, SJ; Song, J; Zhang, JX; Cao, Z; Wang, J; Liu, M; Dong, WG				Wang, Jun; Guo, Xufeng; Yu, Shijie; Song, Jia; Zhang, Jixiang; Cao, Zhuo; Wang, Jing; Liu, Min; Dong, Weiguo			Association between CD14 Gene Polymorphisms and Cancer Risk: A Meta-Analysis	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; ACUTE LYMPHOBLASTIC-LEUKEMIA; PROMOTER POLYMORPHISMS; FUNCTIONAL-SIGNIFICANCE; CHINESE; DISEASE; SUSCEPTIBILITY; TLR4; RECOGNITION; REGION	Background: Two polymorphisms, -260C/T and -651C/T, in the CD14 gene have been implicated in susceptibility to cancer. However, the results remain inconclusive. This meta-analysis aimed to investigate the association between the two polymorphisms and risk of cancer. Methods: All eligible case-control studies published up to March 2014 were identified by searching PubMed, Web of Science, CNKI and Wan Fang database. Pooled odds ratio (OR) with 95% confidence interval (CI) were used to access the strength of this association in fixed- or random-effects model. Results: 17 case-control studies from fourteen articles were included. Of those, there were 17 studies (4198 cases and 4194 controls) for -260C/T polymorphism and three studies (832 cases and 1190 controls) for -651C/T polymorphism. Overall, no significant associations between the two polymorphisms of CD14 gene and cancer risk were found. When stratified by ethnicity, cancer type and source of control, similar results were observed among them. In addition, in further subgroups analysis by Helicobacter pylori (H. pylori) infection status and tumor location in gastric cancer subgroup, we found that the CD14 -260C/T polymorphism may increase the risk of gastric cancer in H. pylori-infected individuals. Conclusions: This meta-analysis suggests that the CD14 -260C/T polymorphism may increase the risk of gastric cancer in H. pylori-infected individuals. However, large and well-designed studies are warranted to validate our findings.	[Wang, Jun; Guo, Xufeng; Yu, Shijie; Song, Jia; Zhang, Jixiang; Cao, Zhuo; Wang, Jing; Liu, Min; Dong, Weiguo] Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430072, Hubei Province, Peoples R China	Wuhan University	Dong, WG (corresponding author), Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430072, Hubei Province, Peoples R China.	dwg@whu.edu.cn						Andrie E, 2009, EUR J HAEMATOL, V83, P334, DOI 10.1111/j.1600-0609.2009.01288.x; Areeshi MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064747; Baldini M, 1999, AM J RESP CELL MOL, V20, P976, DOI 10.1165/ajrcmb.20.5.3494; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Boccia S, 2010, EUR J EPIDEMIOL, V25, P765, DOI 10.1007/s10654-010-9503-z; Bredberg A, 2011, CANCER-AM CANCER SOC, V117, P440, DOI 10.1002/cncr.25440; Castano-Rodriguez N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060327; Chao YC, 2005, WORLD J GASTROENTERO, V11, P6043, DOI 10.3748/wjg.v11.i38.6043; [陈丽珊 CHEN Lishan], 2006, [中华消化杂志, Chinese Journal of Digestion], V26, P735; Companioni O, 2014, INT J CANCER, V134, P92, DOI 10.1002/ijc.28357; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; GOYERT SM, 1988, SCIENCE, V239, P497, DOI 10.1126/science.2448876; Gu W, 2008, CRIT CARE MED, V36, P2274, DOI 10.1097/CCM.0b013e318180b1ed; Guo QS, 2006, J GASTROEN HEPATOL, V21, P92, DOI 10.1111/j.1440-1746.2005.04156.x; Hartel C, 2008, HUM IMMUNOL, V69, P338, DOI 10.1016/j.humimm.2008.04.011; HAO WY, 2010, INFLUENCE CD14260 65; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hold GL, 2009, EUR J CANCER PREV, V18, P117, DOI 10.1097/CEJ.0b013e3283101292; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Karhukorpi J, 2002, CLIN EXP IMMUNOL, V128, P326, DOI 10.1046/j.1365-2249.2002.01837.x; Landi S, 2006, J NEGAT RESULTS BIOM, V5, DOI 10.1186/1477-5751-5-15; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; LeVan TD, 2001, J IMMUNOL, V167, P5838, DOI 10.4049/jimmunol.167.10.5838; Liang XH, 2006, PHARMACOGENET GENOM, V16, P229; Lin BK, 2006, AM J EPIDEMIOL, V164, P1, DOI 10.1093/aje/kwj175; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mason TE, 2010, PROSTATE, V70, P262, DOI 10.1002/pros.21060; Miedema KGE, 2012, LEUKEMIA, V26, P1203, DOI 10.1038/leu.2011.341; MIN ZC, 2012, J MOD UROL, V17, P118; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Pu H, 2013, MOL BIOL REP, V40, P4001, DOI 10.1007/s11033-012-2478-y; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; Tahara T., 2007, Inflammopharmacology, V15, P124, DOI 10.1007/s10787-006-1567-8; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Ture-Ozdemir F, 2008, ANTICANCER RES, V28, P3697; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Wang ZT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045144; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Wu MS, 2006, HEPATO-GASTROENTEROL, V53, P807; XU Y, 2013, EUR ARCH OTORHINOLAR; Yu X, 2011, DNA CELL BIOL, V30, P777, DOI 10.1089/dna.2011.1223; Zeljic K, 2014, ORAL DIS, V20, P416, DOI 10.1111/odi.12144; Zeng T, 2013, EUR J GASTROEN HEPAT, V25, P1183, DOI 10.1097/MEG.0b013e3283612ff1; Zhang AQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071237; Zhang L, 2011, ASS SHIFT WORK RHYTH; Zhao D, 2007, CLIN CANCER RES, V13, P2362, DOI 10.1158/1078-0432.CCR-06-2612; Zhao LL, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-93; Zhou W, 2014, ONCOTARGETS THER, V7, P5, DOI 10.2147/OTT.S54547	49	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100122	10.1371/journal.pone.0100122	http://dx.doi.org/10.1371/journal.pone.0100122			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978812	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400022
J	Boehler, CJ; Raines, AM; Sunde, RA				Boehler, Christopher J.; Raines, Anna M.; Sunde, Roger A.			Toxic-Selenium and Low-Selenium Transcriptomes in Caenorhabditis elegans: Toxic Selenium Up-Regulates Oxidoreductase and Down-Regulates Cuticle-Associated Genes	PLOS ONE			English	Article							MESSENGER-RNA LEVELS; THIOREDOXIN REDUCTASE; MICROARRAY ANALYSIS; CANCER PREVENTION; ESCHERICHIA-COLI; OXIDATIVE STRESS; CONTROLLED TRIAL; PROSTATE-CANCER; VITAMIN-E; SUPPLEMENTATION	Selenium (Se) is an element that in trace quantities is both essential in mammals but also toxic to bacteria, yeast, plants and animals, including C. elegans. Our previous studies showed that selenite was four times as toxic as selenate to C. elegans, but that deletion of thioredoxin reductase did not modulate Se toxicity. To characterize Se regulation of the full transcriptome, we conducted a microarray study in C. elegans cultured in axenic media supplemented with 0, 0.05, 0.1, 0.2, and 0.4 mM Se as selenite. C. elegans cultured in 0.2 and 0.4 mM Se displayed a significant delay in growth as compared to 0, 0.05, or 0.1 mM Se, indicating Se-induced toxicity, so worms were staged to mid-L4 larval stage for these studies. Relative to 0.1 mM Se treatment, culturing C. elegans at these Se concentrations resulted in 1.9, 9.7, 5.5, and 2.3%, respectively, of the transcriptome being altered by at least 2-fold. This toxicity altered the expression of 295 overlapping transcripts, which when filtered against gene sets for sulfur and cadmium toxicity, identified a dataset of 182 toxic-Se specific genes that were significantly enriched in functions related to oxidoreductase activity, and significantly depleted in genes related to structural components of collagen and the cuticle. Worms cultured in low Se (0 mM Se) exhibited no signs of deficiency, but low Se was accompanied by a transcriptional response of 59 genes changed >= 2-fold when compared to all other Se concentrations, perhaps due to decreases in Se-dependent TRXR-1 activity. Overall, these results suggest that Se toxicity in C. elegans causes an increase in ROS and stress responses, marked by increased expression of oxidoreductases and reduced expression of cuticle-associated genes, which together underlie the impaired growth observed in these studies.	[Boehler, Christopher J.; Raines, Anna M.; Sunde, Roger A.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Sunde, RA (corresponding author), Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA.	sunde@nutrisci.wisc.edu			Wisconsin Agricultural Experiment Station [WIS-01435]; UW Foundation Selenium Nutrition Research fund [12046295]	Wisconsin Agricultural Experiment Station; UW Foundation Selenium Nutrition Research fund	This work was supported by the Wisconsin Agricultural Experiment Station project WIS-01435 and by the UW Foundation Selenium Nutrition Research fund no. 12046295. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alehagen U, 2013, INT J CARDIOL, V167, P1860, DOI 10.1016/j.ijcard.2012.04.156; Altun ZF, 2012, WORMATLAS; Barnes KM, 2009, J NUTR, V139, P199, DOI 10.3945/jn.108.098624; Bjornstedt M, 2010, EPMA J, V1, P389, DOI 10.1007/s13167-010-0033-2; Boehler CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071525; Bosse AC, 2010, BIOSCIENCE REP, V30, P293, DOI 10.1042/BSR20090089; BRENNER S, 1974, GENETICS, V77, P71; Buettner C, 1999, J BIOL CHEM, V274, P21598, DOI 10.1074/jbc.274.31.21598; BURTON GA, 1987, APPL ENVIRON MICROB, V53, P185, DOI 10.1128/AEM.53.1.185-188.1987; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; COX GN, 1981, J CELL BIOL, V90, P7, DOI 10.1083/jcb.90.1.7; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; El-Bayoumy K, 2003, CARCINOGENESIS, V24, P1505, DOI 10.1093/carcin/bgg103; Food and Nutrition Board USA Institute of Medicine, 2000, DIET REF INT VIT C V, P284; GERRARD TL, 1974, J BACTERIOL, V119, P1057, DOI 10.1128/JB.119.3.1057-1060.1974; Gladyshev V.N., 2001, CURR PROTOC PROTEIN, DOI DOI 10.1002/0471140864.PS0308S20.:UNIT; Gladyshev VN, 1999, BIOCHEM BIOPH RES CO, V259, P244, DOI 10.1006/bbrc.1999.0765; Goulet AC, 2007, CANCER BIOL THER, V6, P494, DOI 10.4161/cbt.6.4.3813; Greenwald P, 2004, J NUTR, V134, p3507S, DOI 10.1093/jn/134.12.3507S; Hooven LA, 2006, BIOL TRACE ELEM RES, V109, P173, DOI 10.1385/BTER:109:2:173; Hurst R, 2008, CANCER LETT, V269, P117, DOI 10.1016/j.canlet.2008.04.025; Johansson L, 2005, BBA-GEN SUBJECTS, V1726, P1, DOI 10.1016/j.bbagen.2005.05.010; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; KUCHARZ EJ, 1993, TOXICOL LETT, V68, P295, DOI 10.1016/0378-4274(93)90020-X; KUMAR S, 1992, EUR J BIOCHEM, V207, P435, DOI 10.1111/j.1432-1033.1992.tb17068.x; LAPAGE SP, 1968, J APPL BACTERIOL, V31, P568, DOI 10.1111/j.1365-2672.1968.tb00407.x; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; MacFarquhar JK, 2010, ARCH INTERN MED, V170, P256, DOI 10.1001/archinternmed.2009.495; McDermott JR, 2010, MOL BIOL CELL, V21, P3934, DOI 10.1091/mbc.E10-06-0513; Miller DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025476; Morgan KL, 2010, TOXICOL SCI, V118, P530, DOI 10.1093/toxsci/kfq273; Page A. P., 2007, CUTICLE; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinson B, 2000, MOL MICROBIOL, V36, P679, DOI 10.1046/j.1365-2958.2000.01890.x; Raines AM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-26; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Rao L, 2001, J NUTR, V131, P3175, DOI 10.1093/jn/131.12.3175; Rosenfeld I, 1964, SELENIUM GEOBOTANY B, P142; SAFER B, 1980, J BIOL CHEM, V255, P6913; SALBE AD, 1990, J NUTR, V120, P200, DOI 10.1093/jn/120.2.200; Salin H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-333; SCALA J, 1962, ARCH BIOCHEM BIOPHYS, V99, P363, DOI 10.1016/0003-9861(62)90280-1; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stenvall J, 2011, P NATL ACAD SCI USA, V108, P1064, DOI 10.1073/pnas.1006328108; Stranges S, 2006, AM J EPIDEMIOL, V163, P694, DOI 10.1093/aje/kwj097; Stranges S, 2007, ANN INTERN MED, V147, P217, DOI 10.7326/0003-4819-147-4-200708210-00175; Sunde R. A., 1997, Handbook of nutritionally essential mineral elements., P493; Sunde RA, 2010, J NUTR BIOCHEM, V21, P665, DOI 10.1016/j.jnutbio.2009.11.012; Sunde RA, 2009, BIOSCIENCE REP, V29, P329, DOI 10.1042/BSR20080146; Thein MC, 2009, J BIOL CHEM, V284, P17549, DOI 10.1074/jbc.M900831200; Towns WL, 2012, DNA CELL BIOL, V31, P434, DOI 10.1089/dna.2011.1437; Tsavachidou D, 2009, JNCI-J NATL CANCER I, V101, P306, DOI 10.1093/jnci/djn512; Turanov AA, 2011, ADV NUTR, V2, P122, DOI 10.3945/an.110.000265; Wallenberg M, 2010, BIOCHEM J, V429, P85, DOI 10.1042/BJ20100368; Waterhouse RM, 2013, NUCLEIC ACIDS RES, V41, pD358, DOI 10.1093/nar/gks1116; WILBER CG, 1980, CLIN TOXICOL, V17, P171, DOI 10.3109/15563658008985076; Winter AD, 2007, DEV BIOL, V308, P449, DOI 10.1016/j.ydbio.2007.05.041; YANG G, 1994, J TRACE ELEM ELECT H, V8, P159; YANG GQ, 1983, AM J CLIN NUTR, V37, P872, DOI 10.1093/ajcn/37.5.872; Youngman MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002082; Zhang Haitao, 2005, Cancer Genomics & Proteomics, V2, P97	61	13	14	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101408	10.1371/journal.pone.0101408	http://dx.doi.org/10.1371/journal.pone.0101408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971995	Green Published, gold, Green Submitted			2022-12-27	WOS:000338512200116
J	Zhang, XM; Kampuansai, J; Qi, XB; Yan, S; Yang, ZH; Serey, B; Sovannary, T; Bunnath, L; Aun, HS; Samnom, H; Kutanan, W; Luo, X; Liao, SY; Kangwanpong, D; Jin, L; Shi, H; Su, B				Zhang, Xiaoming; Kampuansai, Jatupol; Qi, Xuebin; Yan, Shi; Yang, Zhaohui; Serey, Bun; Sovannary, Tuot; Bunnath, Long; Aun, Hong Seang; Samnom, Ham; Kutanan, Wibhu; Luo, Xin; Liao, Shiyu; Kangwanpong, Daoroong; Jin, Li; Shi, Hong; Su, Bing			An Updated Phylogeny of the Human Y-Chromosome Lineage O2a-M95 with Novel SNPs	PLOS ONE			English	Article							EAST-ASIA; GENETIC-STRUCTURE; POPULATION; MITOCHONDRIAL; LANDSCAPE; DIVERSITY; SUGGESTS; ORIGINS	Though the Y-chromosome O2a-M95 lineage is one of the major haplogroups present in eastern Asian populations, especially among Austro-Asiatic speaking populations from Southwestern China and mainland Southeast Asia, to date its phylogeny lacks structure due to only one downstream SNP marker (M88) assigned to the lineage. A recent array-capture-based Y chromosome sequencing of Asian samples has yielded a variety of novel SNPs purportedly belonging to the O2a-M95 lineage, but their phylogenetic positions have yet to be determined. In this study, we sampled 646 unrelated males from 22 Austro-Asiatic speaking populations from Cambodia, Thailand and Southwestern China, and genotyped 12 SNP makers among the sampled populations, including 10 of the newly reported markers. Among the 646 males, 343 belonged to the O2a-M95 lineage, confirming the supposed dominance of this Y chromosome lineage in Austro-Asiatic speaking populations. We further characterized the phylogeny of O2a-M95 by defining 5 sub-branches: O2a1*-M95, O2a1a-F789, O2a1b*-F1252, O2a1b1*-M88 and O2a1b1a -F761. This updated phylogeny not only improves the resolution of this lineage, but also allows for greater tracing of the prehistory of human populations in eastern Asia and the Pacific, which may yield novel insights into the patterns of language diversification and population movement in these regions.	[Zhang, Xiaoming; Qi, Xuebin; Yang, Zhaohui; Luo, Xin; Liao, Shiyu; Shi, Hong; Su, Bing] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Kampuansai, Jatupol; Kangwanpong, Daoroong] Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai 50000, Thailand; [Yan, Shi; Jin, Li] Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Yan, Shi; Jin, Li] Fudan Univ, Key Lab Contemporary Anthropol, Sch Life Sci, Minist Educ, Shanghai 200433, Peoples R China; [Yan, Shi; Jin, Li] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; Royal Univ Phnom Penh, Dept Geog & Land Management, Phnom Penh, Cambodia; [Samnom, Ham] Capac Dev Facilitator Handicap Int Federat & Free, Battambang, Cambodia; [Zhang, Xiaoming; Yang, Zhaohui; Luo, Xin; Liao, Shiyu] Univ Chinese Acad Sci, Kunming Coll Life Sci, Beijing, Peoples R China; [Kutanan, Wibhu] Khon Kaen Univ, Fac Sci, Dept Biol, Khon Kaen, Thailand	Chinese Academy of Sciences; Kunming Institute of Zoology; Chiang Mai University; Fudan University; Fudan University; Fudan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Khon Kaen University	Shi, H (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	shihong@mail.kiz.ac.cn; sub@mail.kiz.ac.cn	Jin, Li/C-1468-2009; Yan, Shi/GYR-3441-2022; yang, zhaohui/AAD-2158-2019; Kutanan, Wibhu/AAG-5801-2019; Zhang, Xiaoming/AFS-9807-2022; Xuebin, Qi/L-7139-2019; Jin, Li/M-5063-2019	Jin, Li/0000-0002-4546-2415; Yan, Shi/0000-0001-8304-8445; Zhang, Xiaoming/0000-0003-3139-2361; yang, zhaohui/0000-0003-0958-4439	National 973 Program of China [2012CB518202]; National Natural Science Foundation of China [31130051, 91231203, 31371268, 91131001, 31371269]; Natural Science Foundation of Yunnan Province [2010CI044]	National 973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province)	This study was supported by the National 973 Program of China (2012CB518202 to X. Q.), the National Natural Science Foundation of China (31130051 and 91231203 to B. S., 31371268 and 91131001 to H. S. and 31371269 to X. Q.) and the Natural Science Foundation of Yunnan Province (2010CI044 to H. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; [Anonymous], 2013, Y CHROMOSOMES 40 CHI; Cai XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024282; Chaubey G, 2011, MOL BIOL EVOL, V28, P1013, DOI 10.1093/molbev/msq288; Delfin F, 2011, EUR J HUM GENET, V19, P224, DOI 10.1038/ejhg.2010.162; Firasat S, 2007, EUR J HUM GENET, V15, P121, DOI 10.1038/sj.ejhg.5201726; Fornarino S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-154; Gan RJ, 2008, J HUM GENET, V53, P303, DOI 10.1007/s10038-008-0250-x; He JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036437; Inagaki Sachiyo, 2002, Leg Med (Tokyo), V4, P202, DOI 10.1016/S1344-6223(02)00032-9; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Karafet TM, 2010, MOL BIOL EVOL, V27, P1833, DOI 10.1093/molbev/msq063; Karafev TM, 2005, HUM BIOL, V77, P93, DOI 10.1353/hub.2005.0030; Kumar V, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-47; Lewis M. P., 2009, ETHNOLOGUE LANGUAGES; Li DN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002168; Li H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-146; Shi H, 2005, AM J HUM GENET, V77, P408, DOI 10.1086/444436; Shi H, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-45; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Su B, 2000, P NATL ACAD SCI USA, V97, P8225, DOI 10.1073/pnas.97.15.8225; Sykes B, 2000, AM J HUM GENET, V66, P1417, DOI 10.1086/302850; Wen B, 2004, NATURE, V431, P302, DOI 10.1038/nature02878; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; Yan S, 2011, EUR J HUM GENET, V19, P1013, DOI 10.1038/ejhg.2011.64; Zhang XM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3599; Zhong H, 2011, MOL BIOL EVOL, V28, P717, DOI 10.1093/molbev/msq247	29	7	9	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101020	10.1371/journal.pone.0101020	http://dx.doi.org/10.1371/journal.pone.0101020			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972021	Green Published, gold, Green Submitted			2022-12-27	WOS:000338512200084
J	Chen, X; Deng, AQ; Zhou, TQ; Ding, F				Chen, Xia; Deng, Aiqing; Zhou, Tianqiu; Ding, Fei			Pretreatment with 2-(4-Methoxyphenyl)ethyl-2-acetamido-2-deoxy-beta-D-pyranoside Attenuates Cerebral Ischemia/Reperfusion-Induced Injury In Vitro and In Vivo	PLOS ONE			English	Article							ISCHEMIC BRAIN-INJURY; CULTURED HIPPOCAMPAL-NEURONS; INDUCED OXIDATIVE STRESS; NITRIC-OXIDE SYNTHASE; BCL-2 FAMILY PROTEINS; GLUCOSE DEPRIVATION; REPERFUSION INJURY; CORTICAL-NEURONS; CELL-DEATH; COGNITIVE IMPAIRMENT	Salidroside, extracted from the root of Rhodiola rosea L, is known for its pharmacological properties, in particular its neuroprotective effects. 2-(4-Methoxyphenyl) ethyl-2-acetamido-2-deoxy-beta-D- pyranoside (GlcNAc-Sal), an analog of salidroside, was recently synthesized and shown to possess neuroprotective properties. The purpose of the current study was to investigate the neuroprotective effects of GlcNAc-Sal against oxygen-glucose deprivation-reperfusion (OGD-R)-induced neurotoxicity in vitro and global cerebral ischemia-reperfusion (GCI-R) injury in vivo. Cell viability tests and Hoechst 33342 staining confirmed that GlcNAc-Sal pretreatment markedly attenuated OGD-R induced apoptotic cell death in immortalized mouse hippocampal HT22 cells. Western blot, immunofluorescence and PCR analyses revealed that GlcNAc-Sal pretreatment restored the balance of pro-and anti-apoptotic proteins and inhibited the activation of caspase-3 and PARP induced by OGD-R treatment. Further analyses showed that GlcNAc-Sal pretreatment antagonized reactive oxygen species (ROS) generation, iNOS-derived NO production and NO-related apoptotic cell death during OGD-R stimulation. GCI-R was induced by bilateral common carotid artery occlusion (BCCAO) and reperfusion in mice in vivo. Western blot analysis showed that GlcNAc-Sal pretreatment decreased the expression of caspase-3 and increased the expression of Bcl-2 (B-cell lymphoma 2)/Bax (Bcl-2-associated X protein) induced by GCI-R treatment. Our findings suggest that GlcNAc-Sal pretreatment prevents brain ischemia reperfusion injury by the direct or indirect suppression of cell apoptosis and GlcNAc-Sal could be developed as a broad-spectrum agent for the prevention and/or treatment of cerebral ischemic injury.	[Chen, Xia] Nantong Univ, Basic Med Res Ctr, Sch Med, Nantong, Peoples R China; [Deng, Aiqing] Nantong Univ, Affiliated Hosp, Dept Pharm, Nantong, Peoples R China; [Zhou, Tianqiu] Nantong Univ, Affiliated Hosp, Dept Ophthalmol, Nantong, Peoples R China; [Ding, Fei] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong, Peoples R China	Nantong University; Nantong University; Nantong University; Nantong University	Ding, F (corresponding author), Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong, Peoples R China.	dingfei@ntu.edu.cn			Natural Science Foundation of the Jiangsu Higher Education Institutions of China [12KJD310002]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Project supported by the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (Grant No. 12KJD310002) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronowski J, 1997, J CEREBR BLOOD F MET, V17, P1048, DOI 10.1097/00004647-199710000-00006; ArunaDevi R, 2010, NITRIC OXIDE-BIOL CH, V22, P1, DOI 10.1016/j.niox.2009.10.002; Bar-Am O, 2005, FASEB J, V19, P1899, DOI 10.1096/fj.05-3794fje; Bruer U, 1997, FEBS LETT, V414, P117, DOI 10.1016/S0014-5793(97)00954-X; Cardenas A, 2000, J NEUROCHEM, V74, P2041, DOI 10.1046/j.1471-4159.2000.0742041.x; Chen H, 2011, ANTIOXID REDOX SIGN, V14, P1505, DOI 10.1089/ars.2010.3576; Chen QG, 2009, PHYTOMEDICINE, V16, P830, DOI 10.1016/j.phymed.2009.03.011; Chen T, 2011, NEUROSCIENCE, V183, P203, DOI 10.1016/j.neuroscience.2011.03.038; Chen X, 2008, BRAIN RES, V1238, P189, DOI 10.1016/j.brainres.2008.07.051; Chen X, 2013, MOL CELL BIOCHEM, V383, P149, DOI 10.1007/s11010-013-1763-y; Chen X, 2009, MOL CELL BIOCHEM, V332, P85, DOI 10.1007/s11010-009-0177-3; Chen YC, 1998, J CELL PHYSIOL, V177, P324, DOI 10.1002/(SICI)1097-4652(199811)177:2<324::AID-JCP14>3.0.CO;2-9; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; DELATORRE JC, 1992, BRAIN RES, V582, P186, DOI 10.1016/0006-8993(92)90132-S; Farkas E, 2007, BRAIN RES REV, V54, P162, DOI 10.1016/j.brainresrev.2007.01.003; Galluzzi L, 2009, BBA-BIOENERGETICS, V1787, P402, DOI 10.1016/j.bbabio.2008.09.006; Gazzolo Diego, 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P108; Griffiths C, 2002, EUR J NEUROSCI, V15, P962, DOI 10.1046/j.1460-9568.2002.01930.x; Gu JH, 2013, PLOS ONE, V8; Guo YB, 2010, CHEM PHARM BULL, V58, P1627, DOI 10.1248/cpb.58.1627; Ha JS, 2006, NEUROSCI LETT, V393, P165, DOI 10.1016/j.neulet.2005.09.056; Harukuni I, 2006, NEUROL CLIN, V24, P1, DOI 10.1016/j.ncl.2005.10.004; Heeba GH, 2012, LIFE SCI, V90, P388, DOI 10.1016/j.lfs.2011.12.001; Herrera F, 2007, J NEUROCHEM, V100, P736, DOI 10.1111/j.1471-4159.2006.04228.x; IADECOLA C, 1995, J CEREBR BLOOD F MET, V15, P378, DOI 10.1038/jcbfm.1995.47; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kilicdag H, 2013, EARLY HUM DEV, V89, P355, DOI 10.1016/j.earlhumdev.2012.12.002; Kim DH, 2009, FOOD CHEM TOXICOL, V47, P1473, DOI 10.1016/j.fct.2009.03.028; Koh PO, 2012, J PINEAL RES, V53, P358, DOI 10.1111/j.1600-079X.2012.01005.x; Koizumi H, 2011, NEUROL MED-CHIR, V51, P337, DOI 10.2176/nmc.51.337; Kumar A, 2008, PEDIATRICS, V122, pE722, DOI 10.1542/peds.2008-0269; Kumar P, 2009, PSYCHOPHARMACOLOGY, V207, P257, DOI 10.1007/s00213-009-1652-y; Liu RL, 2012, BRAIN RES, V1469, P164, DOI 10.1016/j.brainres.2012.06.044; Los M, 2002, MOL BIOL CELL, V13, P978, DOI 10.1091/mbc.01-05-0272; Lu J, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-105; Mahesh R, 2011, TOXICOL IN VITRO, V25, P177, DOI 10.1016/j.tiv.2010.10.016; Mao GX, 2010, MECH AGEING DEV, V131, P723, DOI 10.1016/j.mad.2010.10.003; Mattson MP, 2000, CELL TISSUE RES, V301, P173, DOI 10.1007/s004419900154; Meng Y, 2011, BIOORGAN MED CHEM, V19, P5577, DOI 10.1016/j.bmc.2011.07.031; Nakka VP, 2008, MOL NEUROBIOL, V37, P7, DOI 10.1007/s12035-007-8013-9; Ohshima M, 2012, EXP NEUROL, V233, P481, DOI 10.1016/j.expneurol.2011.11.025; Perez-Pinzon MA, 2005, ANTIOXID REDOX SIGN, V7, P1150, DOI 10.1089/ars.2005.7.1150; Qu ZQ, 2009, BIOMED ENVIRON SCI, V22, P318, DOI 10.1016/S0895-3988(09)60062-3; Sarti C, 2002, J NEUROL SCI, V203, P263, DOI 10.1016/S0022-510X(02)00302-7; Ten VS, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/542976; van Diermen D, 2009, J ETHNOPHARMACOL, V122, P397, DOI 10.1016/j.jep.2009.01.007; Vasiljevic B, 2012, SRP ARK CELOK LEK, V140, P35, DOI 10.2298/SARH1202035V; Wang J, 2010, ACTA PHARMACOL SIN, V31, P791, DOI 10.1038/aps.2010.71; Wang T, 2009, FREE RADICAL BIO MED, V47, P229, DOI 10.1016/j.freeradbiomed.2009.02.027; Wang WP, 2006, BRAIN RES, V1084, P210, DOI 10.1016/j.brainres.2006.02.024; Weyhenmeyer B., 2012, Experimental Oncology, V34, P192; Winters L, 2013, NEUROSCIENCE, V238, P87, DOI 10.1016/j.neuroscience.2013.02.001; Xing CH, 2012, INT J STROKE, V7, P378, DOI 10.1111/j.1747-4949.2012.00839.x; Yan B, 2007, BEHAV BRAIN RES, V182, P36, DOI 10.1016/j.bbr.2007.05.002; Yang TM, 2009, AM J RESP CELL MOL, V41, P14, DOI 10.1165/rcmb.2008-0320OC; Yoon SW, 2010, CELL PROLIFERAT, V43, P584, DOI 10.1111/j.1365-2184.2010.00708.x; Yu S, 2008, CELL MOL NEUROBIOL, V28, P1067, DOI 10.1007/s10571-008-9284-z; Zhang JY, 2012, J TRAUMA ACUTE CARE, V72, P982, DOI 10.1097/TA.0b013e3182405459; Zhang P, 2012, NEUROSCIENCE, V201, P297, DOI 10.1016/j.neuroscience.2011.11.005; Zhang SQ, 2011, MOL CELL BIOCHEM, V354, P161, DOI 10.1007/s11010-011-0815-4; Zhang Wen-sheng, 2004, Zhongguo Zhong Yao Za Zhi, V29, P459; Zhao Q, 2012, NEUROCHEM INT, V60, P134, DOI 10.1016/j.neuint.2011.11.013; Zhao YL, 2008, MOL CELL BIOCHEM, V311, P19, DOI 10.1007/s11010-007-9688-y	63	13	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100126	10.1371/journal.pone.0100126	http://dx.doi.org/10.1371/journal.pone.0100126			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991917	Green Published, gold, Green Submitted			2022-12-27	WOS:000341253400018
J	Brown, AW; Allison, DB				Brown, Andrew W.; Allison, David B.			Using Crowdsourcing to Evaluate Published Scientific Literature: Methods and Example	PLOS ONE			English	Article								Systematically evaluating scientific literature is a time consuming endeavor that requires hours of coding and rating. Here, we describe a method to distribute these tasks across a large group through online crowdsourcing. Using Amazon's Mechanical Turk, crowdsourced workers (microworkers) completed four groups of tasks to evaluate the question, "Do nutrition-obesity studies with conclusions concordant with popular opinion receive more attention in the scientific community than do those that are discordant?'' 1) Microworkers who passed a qualification test (19% passed) evaluated abstracts to determine if they were about human studies investigating nutrition and obesity. Agreement between the first two raters' conclusions was moderate (kappa = 0.586), with consensus being reached in 96% of abstracts. 2) Microworkers iteratively synthesized free-text answers describing the studied foods into one coherent term. Approximately 84% of foods were agreed upon, with only 4 and 8% of ratings failing manual review in different steps. 3) Microworkers were asked to rate the perceived obesogenicity of the synthesized food terms. Over 99% of responses were complete and usable, and opinions of the microworkers qualitatively matched the authors' expert expectations (e.g., sugar-sweetened beverages were thought to cause obesity and fruits and vegetables were thought to prevent obesity). 4) Microworkers extracted citation counts for each paper through Google Scholar. Microworkers reached consensus or unanimous agreement for all successful searches. To answer the example question, data were aggregated and analyzed, and showed no significant association between popular opinion and attention the paper received as measured by Scimago Journal Rank and citation counts. Direct microworker costs totaled $221.75, (estimated cost at minimum wage: $312.61). We discuss important points to consider to ensure good quality control and appropriate pay for microworkers. With good reliability and low cost, crowdsourcing has potential to evaluate published literature in a cost-effective, quick, and reliable manner using existing, easily accessible resources.	[Brown, Andrew W.; Allison, David B.] Univ Alabama Birmingham, Sch Publ Hlth, Nutr Obes Res Ctr, Off Energet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Brown, AW (corresponding author), Univ Alabama Birmingham, Sch Publ Hlth, Nutr Obes Res Ctr, Off Energet, Birmingham, AL 35294 USA.	awbrown@uab.edu	Brown, Andrew W/N-1826-2013	Brown, Andrew W/0000-0002-1758-8205; Allison, David/0000-0003-3566-9399	National Institutes of Health [NIDDK P30DK056336, NIDDK T32DK62710-01A1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336, T32DK062710, P30DK079626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by National Institutes of Health (http://nih.gov) grants NIDDK P30DK056336 and NIDDK T32DK62710-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aday LA, 2011, DESIGNING CONDUCTING, V3rd; Brown AW, 2013, AM J CLIN NUTR, V98, P1298, DOI 10.3945/ajcn.113.064410; CONGER AJ, 1980, PSYCHOL BULL, V88, P322, DOI 10.1037/0033-2909.88.2.322; Harzing AW, 2013, SCIENTOMETRICS, V94, P1057, DOI 10.1007/s11192-012-0777-7; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mortensen Jonathan M, 2013, AMIA Annu Symp Proc, V2013, P1020; NAACL, 2010, WORKSH CREAT SPEECH; Warby SC, 2014, NAT METHODS, V11, P385, DOI [10.1038/nmeth.2855, 10.1038/NMETH.2855]; Yavchitz A, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001308	9	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100647	10.1371/journal.pone.0100647	http://dx.doi.org/10.1371/journal.pone.0100647			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988466	Green Published, gold, Green Submitted			2022-12-27	WOS:000341354100035
J	Luczak, M; Marczak, L; Stobiecki, M				Luczak, Magdalena; Marczak, Lukasz; Stobiecki, Maciej			Optimization of Plasma Sample Pretreatment for Quantitative Analysis Using iTRAQ Labeling and LC-MALDI-TOF/TOF	PLOS ONE			English	Article							LOW-ABUNDANCE PROTEINS; MASS-SPECTROMETRY; SERUM PROTEOME; RATIO COMPRESSION; HIGH-RESOLUTION; CANCER PATIENTS; MOUSE MODEL; DISCOVERY; SEPARATION; PEPTIDES	Shotgun proteomic methods involving iTRAQ (isobaric tags for relative and absolute quantitation) peptide labeling facilitate quantitative analyses of proteomes and searches for useful biomarkers. However, the plasma proteome's complexity and the highly dynamic plasma protein concentration range limit the ability of conventional approaches to analyze and identify a large number of proteins, including useful biomarkers. The goal of this paper is to elucidate the best approach for plasma sample pretreatment for MS-and iTRAQ-based analyses. Here, we systematically compared four approaches, which include centrifugal ultrafiltration, SCX chromatography with fractionation, affinity depletion, and plasma without fractionation, to reduce plasma sample complexity. We generated an optimized protocol for quantitative protein analysis using iTRAQ reagents and an UltrafleXtreme (Bruker Daltonics) MALDI TOF/TOF mass spectrometer. Moreover, we used a simple, rapid, efficient, but inexpensive sample pretreatment technique that generated an optimal opportunity for biomarker discovery. We discuss the results from the four sample pretreatment approaches and conclude that SCX chromatography without affinity depletion is the best plasma sample preparation pretreatment method for proteome analysis. Using this technique, we identified 1,780 unique proteins, including 1,427 that were quantified by iTRAQ with high reproducibility and accuracy.	[Luczak, Magdalena; Marczak, Lukasz; Stobiecki, Maciej] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Luczak, M (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland.	magdalu@ibch.poznan.pl	Luczak, Magdalena/E-2936-2012; Marczak, Lukasz/C-9069-2011	Luczak, Magdalena/0000-0002-2182-5699; Marczak, Lukasz/0000-0001-8602-0077	National Science Center, Poland [2012/05/B/NZ2/02189]	National Science Center, Poland(National Science Centre, Poland)	This study has been supported by National Science Center, Poland (2012/05/B/NZ2/02189). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aggarwal Kunal, 2006, Briefings in Functional Genomics & Proteomics, V5, P112, DOI 10.1093/bfgp/ell018; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Bergen HR, 2003, DIS MARKERS, V19, P239; Bortner JD, 2011, J PROTEOME RES, V10, P1151, DOI 10.1021/pr100925p; Brand J, 2006, PROTEOMICS, V6, P3236, DOI 10.1002/pmic.200500864; Chong PK, 2010, PROTEOMICS, V10, P3210, DOI 10.1002/pmic.201000127; Ernoult E, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/927917; Esteban-Fernandez D, 2012, J MASS SPECTROM, V47, P760, DOI 10.1002/jms.3013; Faca V, 2007, J PROTEOME RES, V6, P3558, DOI 10.1021/pr070233q; Fuller HR, 2012, INTECH; Gao MX, 2008, PROTEOMICS, V8, P939, DOI 10.1002/pmic.200600099; Georgiou HM, 2001, PROTEOMICS, V1, P1503, DOI 10.1002/1615-9861(200111)1:12<1503::AID-PROT1503>3.0.CO;2-M; Gilar M, 2005, J SEP SCI, V28, P1694, DOI 10.1002/jssc.200500116; Greening DW, 2010, J PROTEOMICS, V73, P637, DOI 10.1016/j.jprot.2009.09.013; Gundry RL, 2007, PROTEOM CLIN APPL, V1, P73, DOI 10.1002/prca.200600276; Gupta MK, 2009, PROTEOMICS, V9, P4834, DOI 10.1002/pmic.200900310; Hergenroeder G, 2008, J NEUROTRAUM, V25, P79, DOI 10.1089/neu.2007.0386; Hoffman SA, 2007, J CHROMATOGR B, V849, P43, DOI 10.1016/j.jchromb.2006.10.069; Hood BL, 2005, J AM SOC MASS SPECTR, V16, P1221, DOI 10.1016/j.jasms.2005.02.005; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Jing LH, 2011, PROTEOMICS, V11, P2763, DOI 10.1002/pmic.201000202; Keshishian H, 2007, MOL CELL PROTEOMICS, V6, P2212, DOI 10.1074/mcp.M700354-MCP200; Kolla V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/952047; Kuzyk MA, 2009, PROTEOMICS, V9, P3328, DOI 10.1002/pmic.200800412; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Lill J, 2003, MASS SPECTROM REV, V22, P182, DOI 10.1002/mas.10048; Lippitz BE, 2013, LANCET ONCOL, V14, pE218, DOI 10.1016/S1470-2045(12)70582-X; Lowenthal MS, 2005, CLIN CHEM, V51, P1933, DOI 10.1373/clinchem.2005.052944; Luczak M, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-25; Mackay F, 2002, CURR OPIN IMMUNOL, V14, P783, DOI 10.1016/S0952-7915(02)00407-7; Maksym RB, 2009, EUR J PHARMACOL, V625, P31, DOI 10.1016/j.ejphar.2009.04.071; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; Millioni R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019603; Muthusamy B, 2005, PROTEOMICS, V5, P3531, DOI 10.1002/pmic.200401335; Orvisky E, 2006, PROTEOMICS, V6, P2895, DOI 10.1002/pmic.200500443; Ow SY, 2011, PROTEOMICS, V11, P2341, DOI 10.1002/pmic.201000752; Pernemalm M, 2009, PROTEOMICS, V9, P1420, DOI 10.1002/pmic.200800377; Peterson AC, 2012, MOL CELL PROTEOMICS, V11, P1475, DOI 10.1074/mcp.O112.020131; Petricoin EF, 2004, CURR OPIN BIOTECH, V15, P24, DOI 10.1016/j.copbio.2004.01.005; Pieper R, 2003, PROTEOMICS, V3, P422, DOI 10.1002/pmic.200390057; Pietrowska M, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-60; Polanski M, 2006, BIOMARK INSIGHTS, V1, P1; Savitski MM, 2013, J PROTEOME RES, V12, P3586, DOI 10.1021/pr400098r; Shen YF, 2004, ANAL CHEM, V76, P1134, DOI 10.1021/ac034869m; Shirran SL, 2010, J PROTEOMICS, V73, P1391, DOI 10.1016/j.jprot.2010.03.003; Shuford CM, 2010, ANAL CHEM, V82, P10179, DOI 10.1021/ac102248d; Song XM, 2008, J PROTEOME RES, V7, P2952, DOI 10.1021/pr800072x; Stempfer R, 2008, ELECTROPHORESIS, V29, P4316, DOI 10.1002/elps.200800211; Tang HY, 2005, PROTEOMICS, V5, P3329, DOI 10.1002/pmic.200401275; Tirumalai RS, 2003, MOL CELL PROTEOMICS, V2, P1096, DOI 10.1074/mcp.M300031-MCP200; Wiederin JL, 2010, J PROTEOME RES, V9, P4721, DOI 10.1021/pr1004345; Yadav AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024442; Ye HG, 2010, MOL CELL BIOCHEM, V343, P91, DOI 10.1007/s11010-010-0502-x	55	12	13	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101694	10.1371/journal.pone.0101694	http://dx.doi.org/10.1371/journal.pone.0101694			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988083	Green Published, Green Submitted, gold			2022-12-27	WOS:000341354100126
J	Abdul-Majeed, S; Mell, B; Nauli, SM; Joe, B				Abdul-Majeed, Shakila; Mell, Blair; Nauli, Surya M.; Joe, Bina			Cryptorchidism and Infertility in Rats with Targeted Disruption of the Adamts16 Locus	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; RODENT GUBERNACULUM; TESTICULAR DESCENT; EXPRESSION; METALLOPROTEINASES; OVULATION; SPERMATOGENESIS; HYPERTENSION; INHIBITORS; FOLLICLES	A Disintegrin And Metalloproteinase with ThromboSpondin motifs16 (ADAMTS-16) is a member of a family of metalloproteinases. Using a novel zinc-finger nuclease based gene-edited rat model harboring a targeted mutation of the Adamts16 locus, we previously reported this gene to be linked to blood pressure regulation. Here we document our observation with this model that Adamts16 is essential for normal development of the testis. Absence of Adamts16 in the homozygous Adamts16(mutant) males resulted in cryptorchidism and male sterility. Heterozygous Adamts16(mutant) males were normal, indicating that this is a recessive trait. Testes of homozygous Adamts16(mutant) males were significantly smaller with significant histological changes associated with the lack of sperm production. Temporal histological assessments of the testis demonstrated that the seminiferous tubules did not support active spermatogenesis, but progressively lost germ cells, accumulated vacuoles and did not have any sperm. These observations, taken together with our previous report of renal abnormalities observed with the same Adamts16(mutant) rats, suggest an important mechanistic link between Adamts16 and the functioning of the male genitourinary system.	[Abdul-Majeed, Shakila; Mell, Blair; Joe, Bina] Univ Toledo, Ctr Hypertens & Personalized Med, Program Physiol Gen, Dept Physiol & Pharmacol,Coll Med, Toledo, OH 43606 USA; [Nauli, Surya M.] Univ Toledo, Dept Pharmacol, Coll Pharm, Toledo, OH 43606 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Joe, B (corresponding author), Univ Toledo, Ctr Hypertens & Personalized Med, Program Physiol Gen, Dept Physiol & Pharmacol,Coll Med, 2801 W Bancroft St, Toledo, OH 43606 USA.	bina.joe@utoledo.edu			National Institutes of Health [HL112641, HL020176]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL020176, R01HL112641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by RO1 grants from the National Institutes of Health to Bina Joe. Grant numbers: HL112641 and HL020176. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoulnik AI, 2012, METHODS MOL BIOL, V825, P127, DOI 10.1007/978-1-61779-436-0_11; Brown HM, 2006, DEV BIOL, V300, P699, DOI 10.1016/j.ydbio.2006.10.012; Chen N, 2011, J PEDIATR SURG, V46, P2363, DOI 10.1016/j.jpedsurg.2011.09.032; Churchill JA, 2011, J PEDIATR SURG, V46, P2353, DOI 10.1016/j.jpedsurg.2011.09.025; Costa WS, 2002, J UROLOGY, V167, P2171, DOI 10.1016/S0022-5347(05)65122-1; Darnell DK, 2010, RNA, V16, P632, DOI 10.1261/rna.1775610; Davidson RK, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2013; Dun MD, 2012, INT J ANDROL, V35, P572, DOI 10.1111/j.1365-2605.2011.01235.x; Espey LL, 2000, BIOL REPROD, V62, P1090, DOI 10.1095/biolreprod62.4.1090; Gao S, 2007, MOL HUM REPROD, V13, P465, DOI 10.1093/molehr/gam037; Gopalakrishnan K, 2012, P NATL ACAD SCI USA, V109, P20555, DOI 10.1073/pnas.1211290109; Hutson JM, 2009, THER ADV UROL, V1, P115, DOI 10.1177/1756287209105266; Jacobi CLJ, 2013, J BIOL CHEM, V288, P18811, DOI 10.1074/jbc.M113.464644; Joe B, 2009, HUM MOL GENET, V18, P2825, DOI 10.1093/hmg/ddp218; Kevorkian L, 2004, ARTHRITIS RHEUM-US, V50, P131, DOI 10.1002/art.11433; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Kutz WE, 2011, J BIOL CHEM, V286, P17156, DOI 10.1074/jbc.M111.231571; Lee PA, 2013, CURR OPIN ENDOCRINOL, V20, P210, DOI 10.1097/MED.0b013e32835ffc7d; Madan P, 2003, BIOL REPROD, V69, P1506, DOI 10.1095/biolreprod.102.013714; McGrath LM, 2013, AM J MED GENET B, V162, P779, DOI 10.1002/ajmg.b.32190; Mittaz L, 2004, BIOL REPROD, V70, P1096, DOI 10.1095/biolreprod.103.023911; Nation TR, 2011, ANAT REC, V294, P1249, DOI 10.1002/ar.21393; Ohnishi J, 2005, BBA-PROTEINS PROTEOM, V1751, P95, DOI 10.1016/j.bbapap.2005.05.002; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Richards JS, 2005, BIOL REPROD, V72, P1241, DOI 10.1095/biolreprod.104.038083; Robker RL, 2000, P NATL ACAD SCI USA, V97, P4689, DOI 10.1073/pnas.080073497; Sakamoto N, 2010, CANCER SCI, V101, P1038, DOI 10.1111/j.1349-7006.2009.01477.x; SAPSFORD CS, 1963, J ANAT, V97, P225; Siu MKY, 2008, ADV EXP MED BIOL, V636, P74, DOI 10.1007/978-0-387-09597-4_5; Surridge AK, 2009, MATRIX BIOL, V28, P416, DOI 10.1016/j.matbio.2009.07.001; Tortorella MD, 2009, CURR PHARM DESIGN, V15, P2359, DOI 10.2174/138161209788682433; Wang XN, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003645	32	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100967	10.1371/journal.pone.0100967	http://dx.doi.org/10.1371/journal.pone.0100967			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983376	Green Published, gold, Green Submitted			2022-12-27	WOS:000339635000044
J	Bolwerk, A; Mack-Andrick, J; Lang, FR; Dorfler, A; Maihofner, C				Bolwerk, Anne; Mack-Andrick, Jessica; Lang, Frieder R.; Doerfler, Arnd; Maihoefner, Christian			How Art Changes Your Brain: Differential Effects of Visual Art Production and Cognitive Art Evaluation on Functional Brain Connectivity	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; ANTI-CORRELATED NETWORKS; DEFAULT-MODE NETWORK; RESTING-STATE FMRI; CHRONIC PAIN; RESILIENCE; CREATIVITY; HEALTH; IMPACT; MEMORY	Visual art represents a powerful resource for mental and physical well-being. However, little is known about the underlying effects at a neural level. A critical question is whether visual art production and cognitive art evaluation may have different effects on the functional interplay of the brain's default mode network (DMN). We used fMRI to investigate the DMN of a non-clinical sample of 28 post-retirement adults (63.71 years +/-3.52 SD) before (T0) and after (T1) weekly participation in two different 10-week-long art interventions. Participants were randomly assigned to groups stratified by gender and age. In the visual art production group 14 participants actively produced art in an art class. In the cognitive art evaluation group 14 participants cognitively evaluated artwork at a museum. The DMN of both groups was identified by using a seed voxel correlation analysis (SCA) in the posterior cingulated cortex (PCC/preCUN). An analysis of covariance (ANCOVA) was employed to relate fMRI data to psychological resilience which was measured with the brief German counterpart of the Resilience Scale (RS-11). We observed that the visual art production group showed greater spatial improvement in functional connectivity of PCC/preCUN to the frontal and parietal cortices from T0 to T1 than the cognitive art evaluation group. Moreover, the functional connectivity in the visual art production group was related to psychological resilience (i.e., stress resistance) at T1. Our findings are the first to demonstrate the neural effects of visual art production on psychological resilience in adulthood.	[Bolwerk, Anne; Maihoefner, Christian] Univ Hosp Erlangen, Dept Neurol, Erlangen, Germany; [Bolwerk, Anne; Maihoefner, Christian] Univ Erlangen Nurnberg, Dept Physiol & Pathophysiol, D-91054 Erlangen, Germany; [Mack-Andrick, Jessica] Museums Nuremberg, Dept Educ, Nurnberg, Germany; [Lang, Frieder R.] Univ Erlangen Nurnberg, Inst Psychogerontol, Nurnberg, Germany; [Doerfler, Arnd] Univ Hosp Erlangen, Dept Neuroradiol, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Maihofner, C (corresponding author), Univ Hosp Erlangen, Dept Neurol, Erlangen, Germany.	christian.maihoefner@uk-erlangen.de	Lang, Frieder R./A-9846-2012	Lang, Frieder R./0000-0002-2660-1619	STAEDTLER Foundation	STAEDTLER Foundation	This work was supported by the STAEDTLER Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Buckner RL, 2007, NEUROIMAGE, V37, P1091, DOI 10.1016/j.neuroimage.2007.01.010; Cauda F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004542; Clow A., 2006, J HOLIST HEALTHC, V3, P29; Cohen GD, 2006, GERONTOLOGIST, V46, P726, DOI 10.1093/geront/46.6.726; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Csikszentmihalyi M., 1996, CREATIVITY FLOW PSYC; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Fehr R, 2012, AM PSYCHOL, V67, P76, DOI 10.1037/a0026574; Fink A, 2007, METHODS, V42, P68, DOI 10.1016/j.ymeth.2006.12.001; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Geue K, 2010, COMPLEMENT THER MED, V18, P160, DOI 10.1016/j.ctim.2010.04.001; Goh JO, 2009, RESTOR NEUROL NEUROS, V27, P391, DOI 10.3233/RNN-2009-0493; Grady CL, 2010, CEREB CORTEX, V20, P1432, DOI 10.1093/cercor/bhp207; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; He W, 2005, 65 US CURRENT POPULA; HERZOG AR, 1991, PSYCHOL AGING, V6, P202, DOI 10.1037/0882-7974.6.2.202; Jang JH, 2011, NEUROSCI LETT, V487, P358, DOI 10.1016/j.neulet.2010.10.056; Jung RE, 2010, HUM BRAIN MAPP, V31, P398, DOI 10.1002/hbm.20874; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Lacey S, 2011, NEUROIMAGE, V55, P420, DOI 10.1016/j.neuroimage.2010.11.027; Leckey J, 2011, J PSYCHIATR MENT HLT, V18, P501, DOI 10.1111/j.1365-2850.2011.01693.x; Leppert K, 2005, PSYCHOTHER PSYCH MED, V55, P365, DOI 10.1055/s-2005-866873; Maier SF, 2010, BRAIN RES, V1355, P52, DOI 10.1016/j.brainres.2010.08.039; Maihofner C, 2007, BRAIN, V130, P2671, DOI 10.1093/brain/awm131; Maihofner C, 2005, NEUROIMAGE, V28, P996, DOI 10.1016/j.neuroimage.2005.06.049; Malinen S, 2010, P NATL ACAD SCI USA, V107, P6493, DOI 10.1073/pnas.1001504107; Marshall VW, 2001, RES AGING, V23, P379, DOI 10.1177/0164027501234001; Mihov KM, 2010, BRAIN COGNITION, V72, P442, DOI 10.1016/j.bandc.2009.12.007; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Packer J., 2008, CURATOR, V51, P33, DOI [10.1111/j.2151-6952.2008.tb00293.x, DOI 10.1111/J.2151-6952.2008.TB00293.X]; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Peez G, 2002, QUALITATIVE EMPIRISC; Pyka M, 2011, NEUROIMAGE, V56, P2173, DOI 10.1016/j.neuroimage.2011.03.078; Raichle ME, 2006, SCIENCE, V314, P1249, DOI 10.1126/science.1134405; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sambataro F, 2010, NEUROBIOL AGING, V31, P839, DOI 10.1016/j.neurobiolaging.2008.05.022; Schumacher J, 2005, Z KLIN PSYCH PSYCHIA, V53, P16; Silverman L.H., 2010, SOCIAL WORK MUSEUMS; Stuckey HL, 2010, AM J PUBLIC HEALTH, V100, P254, DOI 10.2105/AJPH.2008.156497; Talairach J., 1988, COPLANAR STEREOTAXIC; Voss MW, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00032; Voss MW, 2010, NEUROPSYCHOLOGIA, V48, P1394, DOI 10.1016/j.neuropsychologia.2010.01.005; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Wagnild G M, 1993, J Nurs Meas, V1, P165; Williamson P, 2007, SCHIZOPHRENIA BULL, V33, P994, DOI 10.1093/schbul/sbm043; Windle G, 2010, REV CLIN GERONTO, V21, P1, DOI DOI 10.1017/S0959259810000420; Wu JT, 2011, NEUROSCI LETT, V504, P62, DOI 10.1016/j.neulet.2011.08.059	54	62	63	6	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101035	10.1371/journal.pone.0101035	http://dx.doi.org/10.1371/journal.pone.0101035			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1UX	24983951	Green Submitted, gold, Green Published			2022-12-27	WOS:000339635000049
J	Chapman, CD; Nilsson, VC; Thune, HA; Cedernaes, J; Le Greves, M; Hogenkamp, PS; Benedict, C; Schioth, HB				Chapman, Colin D.; Nilsson, Victor C.; Thune, Hanna A.; Cedernaes, Jonathan; Le Greves, Madeleine; Hogenkamp, Pleunie S.; Benedict, Christian; Schioth, Helgi B.			Watching TV and Food Intake: The Role of Content	PLOS ONE			English	Article							ENVIRONMENTAL-FACTORS; TELEVISION; METAANALYSIS; BOREDOM; MEMORY; EAT	Obesity is a serious and growing health concern worldwide. Watching television (TV) represents a condition during which many habitually eat, irrespective of hunger level. However, as of yet, little is known about how the content of television programs being watched differentially impacts concurrent eating behavior. In this study, eighteen normal-weight female students participated in three counter-balanced experimental conditions, including a 'Boring' TV condition (art lecture), an 'Engaging' TV condition (Swedish TV comedy series), and a no TV control condition during which participants read (a text on insects living in Sweden). Throughout each condition participants had access to both high-calorie (M&Ms) and low-calorie (grapes) snacks. We found that, relative to the Engaging TV condition, Boring TV encouraged excessive eating (+52% g, P = 0.009). Additionally, the Engaging TV condition actually resulted in significantly less concurrent intake relative to the control 'Text' condition (235% g, P = 0.05). This intake was driven almost entirely by the healthy snack, grapes; however, this interaction did not reach significance (P = 0.07). Finally, there was a significant correlation between how bored participants were across all conditions, and their concurrent food intake (beta = 0.317, P = 0.02). Intake as measured by kcals was similarly patterned but did not reach significance. These results suggest that, for women, different TV programs elicit different levels of concurrent food intake, and that the degree to which a program is engaging (or alternately, boring) is related to that intake. Additionally, they suggest that emotional content (e. g. boring vs. engaging) may be more associated than modality (e. g. TV vs. text) with concurrent intake.	[Chapman, Colin D.; Nilsson, Victor C.; Thune, Hanna A.; Cedernaes, Jonathan; Le Greves, Madeleine; Hogenkamp, Pleunie S.; Benedict, Christian; Schioth, Helgi B.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Uppsala University	Chapman, CD (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	colin.chapman@neuro.uu.se	Schioth, Helgi/AAQ-7239-2020; Benedict, Christian/K-2190-2017; Cedernaes, Jonathan/AAM-3973-2021	Benedict, Christian/0000-0002-8911-4068; Cedernaes, Jonathan/0000-0002-9052-8372	Swedish Research Council; Swedish Brain Research Foundation; Tore Nilsson Foundation; Ake Wiberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Research Foundation; Tore Nilsson Foundation; Ake Wiberg Foundation	This work is supported by the Swedish Research Council, the Swedish Brain Research Foundation, Tore Nilsson Foundation, and Ake Wiberg Foundation. The funding sources had no input in the design and conduct of this study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Aasheim ET, 2011, LANCET, V377, P1916, DOI 10.1016/S0140-6736(11)60804-0; ABRAMSON EE, 1977, ADDICT BEHAV, V2, P181, DOI 10.1016/0306-4603(77)90015-6; Bellisle F, 2009, APPETITE, V53, P309, DOI 10.1016/j.appet.2009.07.006; Benedict C, 2012, J CLIN ENDOCR METAB, V97, pE443, DOI 10.1210/jc.2011-2759; Berthoud HR, 2012, P NUTR SOC, V71, P478, DOI 10.1017/S0029665112000602; Blass EM, 2006, PHYSIOL BEHAV, V88, P597, DOI 10.1016/j.physbeh.2006.05.035; Chapman CD, 2012, AM J CLIN NUTR, V96, P492, DOI 10.3945/ajcn.112.039750; HILL AJ, 1991, APPETITE, V17, P187, DOI 10.1016/0195-6663(91)90021-J; Hogenkamp PS, 2013, PSYCHONEUROENDOCRINO; Koball AM, 2012, HEALTH PSYCHOL, V31, P521, DOI 10.1037/a0025893; Martin CK, 2009, AM J CLIN NUTR, V89, P37, DOI 10.3945/ajcn.2008.26310; Mekhmoukh A, 2012, APPETITE, V59, P90, DOI 10.1016/j.appet.2012.03.021; Ogden J, 2013, APPETITE, V62, P119, DOI 10.1016/j.appet.2012.11.023; Peneau S, 2009, BRIT J NUTR, V102, P1854, DOI 10.1017/S0007114509991280; Pettigrew S, 2012, APPETITE, V58, P496, DOI 10.1016/j.appet.2011.12.014; Robinson E, 2013, AM J CLIN NUTR, V97, P728, DOI 10.3945/ajcn.112.045245; ROLLS BJ, 1991, HEALTH PSYCHOL, V10, P133, DOI 10.1037/0278-6133.10.2.133; Stickney MI, 1999, INT J EAT DISORDER, V26, P195, DOI 10.1002/(SICI)1098-108X(199909)26:2&lt;195::AID-EAT9&gt;3.0.CO;2-2; van Strien T, 2013, APPETITE, V66, P20, DOI 10.1016/j.appet.2013.02.016	19	28	28	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100602	10.1371/journal.pone.0100602	http://dx.doi.org/10.1371/journal.pone.0100602			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1UX	24983245	Green Published, gold, Green Submitted			2022-12-27	WOS:000339635000033
J	Liu, H; Yazdani, A; Murray, LM; Beauvais, A; Kothary, R				Liu, Hong; Yazdani, Armin; Murray, Lyndsay M.; Beauvais, Ariane; Kothary, Rashmi			The Smn-Independent Beneficial Effects of Trichostatin A on an Intermediate Mouse Model of Spinal Muscular Atrophy	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; MOTOR-NEURON GENE; SINGLE NUCLEOTIDE; PROTEIN-LEVEL; VALPROIC ACID; SURVIVAL; INCREASES; MICE; INACTIVATION; SEVERITY	Spinal muscular atrophy is an autosomal recessive neuromuscular disease characterized by the progressive loss of alpha motor neurons in the spinal cord. Trichostatin A (TSA) is a histone deacetylase inhibitor with beneficial effects in spinal muscular atrophy mouse models that carry the human SMN2 transgene. It is currently unclear whether TSA specifically targets the SMN2 gene or whether other genes respond to TSA and in turn provide neuroprotection in SMA mice. We have taken advantage of the Smn(2B/-) mouse model that does not harbor the human SMN2 transgene, to test the hypothesis that TSA has its beneficial effects through a non-SMN mediated pathway. TSA increased the median lifespan of Smn(2B/-) mice from twenty days to eight weeks. As well, there was a significant attenuation of weight loss and improved motor behavior. Pen test and righting reflex both showed significant improvement, and motor neurons in the spinal cord of Smn(2B/-) mice were protected from degeneration. Both the size and maturity of neuromuscular junctions were significantly improved in TSA treated Smn(2B/-) mice. Of interest, TSA treatment did not increase the levels of Smn protein in mouse embryonic fibroblasts or myoblasts obtained from the Smn(2B/-) mice. In addition, no change in the level of Smn transcripts or protein in the brain or spinal cord of TSA-treated SMA model mice was observed. Furthermore, TSA did not increase Smn protein levels in the hind limb muscle, heart, or liver of Smn(2B/-) mice. We therefore conclude that TSA likely exerts its effects independent of the endogenous mouse Smn gene. As such, identification of the pathways regulated by TSA in the Smn(2B/-) mice could lead to the development of novel therapeutics for treating SMA.	[Liu, Hong; Yazdani, Armin; Murray, Lyndsay M.; Beauvais, Ariane; Kothary, Rashmi] Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON, Canada; [Yazdani, Armin; Murray, Lyndsay M.; Kothary, Rashmi] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Kothary, Rashmi] Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	Kothary, R (corresponding author), Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON, Canada.	rkothary@ohri.ca		Kothary, Rashmi/0000-0002-9239-7310	Canadian Institutes of Health Research [MOP-298871]; Families of Spinal Muscular Atrophy [KT1415]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Families of Spinal Muscular Atrophy	Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca) grant number MOP-298871 and Families of Spinal Muscular Atrophy (http://www.fsma.org) grant number KT1415. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; Bowerman M, 2012, NEUROMUSCULAR DISORD, V22, P263, DOI 10.1016/j.nmd.2011.09.007; Bowerman M, 2010, HUM MOL GENET, V19, P1468, DOI 10.1093/hmg/ddq021; Boyer JG, 2014, HUM MOL GENET, P1; Boyer JG, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-24; Brichta L, 2003, HUM MOL GENET, V12, P2481, DOI 10.1093/hmg/ddg256; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Germain-Desprez D, 2001, GENE, V279, P109, DOI 10.1016/S0378-1119(01)00758-2; Hahnen E, 2006, J NEUROCHEM, V98, P193, DOI 10.1111/j.1471-4159.2006.03868.x; Hammond SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015887; Hayashi M, 2002, BRAIN DEV-JPN, V24, P770, DOI 10.1016/S0387-7604(02)00103-1; HUANG KW, 1983, J NEUROL SCI, V61, P249, DOI 10.1016/0022-510X(83)90009-6; Kernochan LE, 2005, HUM MOL GENET, V14, P1171, DOI 10.1093/hmg/ddi130; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Leng Y, 2006, J NEUROSCI, V26, P7502, DOI 10.1523/JNEUROSCI.0096-06.2006; Liu H, 2010, J NEUROSCI RES, V88, P111, DOI 10.1002/jnr.22189; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Mishra N, 2003, J CLIN INVEST, V111, P539, DOI 10.1172/JC1200316153; Miyabara EH, 2012, PFLUG ARCH EUR J PHY, V463, P733, DOI 10.1007/s00424-012-1087-x; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Monani UR, 1999, BBA-GENE STRUCT EXPR, V1445, P330, DOI 10.1016/S0167-4781(99)00060-3; Murray L, 2014, JOVE-J VIS EXP, DOI 10.3791/51162; Murray LM, 2013, NEUROBIOL DIS, V49, P57, DOI 10.1016/j.nbd.2012.08.019; Narver HL, 2008, ANN NEUROL, V64, P465, DOI 10.1002/ana.21449; Piepers S, 2011, J NEUROL NEUROSUR PS, V82, P850, DOI 10.1136/jnnp.2009.200253; Rak K, 2009, NEUROBIOL DIS, V36, P477, DOI 10.1016/j.nbd.2009.08.014; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Riessland M, 2006, HUM GENET, V120, P101, DOI 10.1007/s00439-006-0186-1; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Soler-Botija C, 2003, J NEUROPATH EXP NEUR, V62, P420, DOI 10.1093/jnen/62.4.420; Wu XF, 2008, INT J NEUROPSYCHOPH, V11, P1123, DOI 10.1017/S1461145708009024	35	17	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101225	10.1371/journal.pone.0101225	http://dx.doi.org/10.1371/journal.pone.0101225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984019	Green Submitted, gold, Green Published			2022-12-27	WOS:000339635000071
J	Rivera, D; Mejias, V; Jauregui, BM; Costa-Tenorio, M; Lopez-Archilla, AI; Peco, B				Rivera, Desiree; Mejias, Violeta; Jauregui, Berta M.; Costa-Tenorio, Marga; Isabel Lopez-Archilla, Ana; Peco, Begona			Spreading Topsoil Encourages Ecological Restoration on Embankments: Soil Fertility, Microbial Activity and Vegetation Cover	PLOS ONE			English	Article							SEMIARID MEDITERRANEAN ENVIRONMENTS; SEED BANK; AGRICULTURAL MANAGEMENT; MOTORWAY SLOPES; WATER EROSION; PLANT; RESPIRATION; CARBON; COMMUNITY; REVEGETATION	The construction of linear transport infrastructure has severe effects on ecosystem functions and properties, and the restoration of the associated roadslopes contributes to reduce its impact. This restoration is usually approached from the perspective of plant cover regeneration, ignoring plant-soil interactions and the consequences for plant growth. The addition of a 30 cm layer of topsoil is a common practice in roadslope restoration projects to increase vegetation recovery. However topsoil is a scarce resource. This study assesses the effects of topsoil spreading and its depth (10 to 30 cm) on two surrogates of microbial activity (beta-glucosidase and phosphatase enzymes activity and soil respiration), and on plant cover, plant species richness and floristic composition of embankment vegetation. The study also evaluates the differences in selected physic-chemical properties related to soil fertility between topsoil and the original embankment substrate. Topsoil was found to have higher values of organic matter (11%), nitrogen (44%), assimilable phosphorous (50%) and silt content (54%) than the original embankment substrate. The topsoil spreading treatment increased microbial activity, and its application increased beta-glucosidase activity (45%), phosphatase activity (57%) and soil respiration (60%). Depth seemed to affect soil respiration, beta-glucosidase and phosphatase activity. Topsoil application also enhanced the species richness of restored embankments in relation to controls. Nevertheless, the depth of the spread topsoil did not significantly affect the resulting plant cover, species richness or floristic composition, suggesting that both depths could have similar effects on short-term recovery of the vegetation cover. A significant implication of these results is that it permits the application of thinner topsoil layers, with major savings in this scarce resource during the subsequent slope restoration work, but the quality of topsoil relative to the original substrate should be previously assessed on a site by site basis.	[Rivera, Desiree; Mejias, Violeta; Isabel Lopez-Archilla, Ana; Peco, Begona] Univ Autonoma Madrid, Dept Ecol, Madrid, Spain; [Jauregui, Berta M.] OHL Construcc, Direcc Tecn, Madrid, Spain; [Costa-Tenorio, Marga] Univ Complutense, Dept Biol Vegetal 1, E-28040 Madrid, Spain	Autonomous University of Madrid; Complutense University of Madrid	Peco, B (corresponding author), Univ Autonoma Madrid, Dept Ecol, Madrid, Spain.	begonna.peco@uam.es	Peco, Begoña/C-1197-2012	Peco, Begoña/0000-0003-2149-1438; Lopez Archilla, Ana Isabel/0000-0002-3673-6189	Ministry of Science and Innovation's Centre for Industrial and Technology Development (CDTI); Madrid Regional Government grants for research groups; REMEDINAL 2 from the Spanish Ministry of Science and Innovation; Ministry of Science and Innovation; Science and Innovation Ministry	Ministry of Science and Innovation's Centre for Industrial and Technology Development (CDTI); Madrid Regional Government grants for research groups; REMEDINAL 2 from the Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)); Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Science and Innovation Ministry	Grants were received from the Ministry of Science and Innovation's Centre for Industrial and Technology Development (CDTI). The project is jointly funded by Madrid Regional Government grants for research groups, REMEDINAL 2 from the Spanish Ministry of Science and Innovation, and assistance from the Torres Quevedo Sub-program for the employment of Dr. BMJ by OHL, under the auspices of the Ministry of Science and Innovation. Thanks also go to the Science and Innovation Ministry for the Salvador de Madariaga Mobility grant awarded to BP. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT LK, 1992, METHOD MICROBIOL, V24, P1, DOI 10.1016/S0580-9517(08)70084-9; Alvear M., 2006, J SOIL SCI PLANT NUT, V2, P38, DOI [10.4067/S0718-27912006000200004, DOI 10.4067/S0718-27912006000200004]; Araujo Ademir S. F., 2009, Sustainability, V1, P268, DOI 10.3390/su1020268; ARNOLD G, 1992, PLANT SOIL, V142, P41, DOI 10.1007/BF00010173; Bandick AK, 1999, SOIL BIOL BIOCHEM, V31, P1471, DOI 10.1016/S0038-0717(99)00051-6; Bardgett RD, 2007, BIOLOGY LETT, V3, P487, DOI 10.1098/rsbl.2007.0242; Bergstrom DW, 1998, SOIL SCI SOC AM J, V62, P1302, DOI 10.2136/sssaj1998.03615995006200050022x; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Bochet E, 2004, RESTOR ECOL, V12, P166, DOI 10.1111/j.1061-2971.2004.0325.x; Bochet E, 2010, LAND DEGRAD DEV, V21, P110, DOI 10.1002/ldr.911; Bochet E, 2007, RESTOR ECOL, V15, P88, DOI 10.1111/j.1526-100X.2006.00193.x; Bowen CK, 2005, ARID LAND RES MANAG, V19, P267, DOI 10.1080/15324980590951441; Castillo-Monroy AP, 2010, THESIS, P67; Cerda A, 2007, SCI TOTAL ENVIRON, V378, P151, DOI 10.1016/j.scitotenv.2007.01.041; Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; Coffin AW, 2007, J TRANSP GEOGR, V15, P396, DOI 10.1016/j.jtrangeo.2006.11.006; COLLINS HP, 1992, SOIL SCI SOC AM J, V56, P783, DOI 10.2136/sssaj1992.03615995005600030018x; Cottenie A., 1975, Pedologie, V25, P134; Davidson EA, 2002, AGR FOREST METEOROL, V113, P39, DOI 10.1016/S0168-1923(02)00101-6; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Day P.R., 1965, METHODS SOIL ANAL PA, V9, P545, DOI [10.2134/agronmonogr9.1.c43, DOI 10.2134/AGRONMONOGR9.1.C43]; de la Riva EG, 2011, J VEG SCI, V22, P292, DOI 10.1111/j.1654-1103.2010.01248.x; Dick A, 1992, SOIL MICROBIAL ECOLO, P95; Dorr H., 1987, TELLUS B, V39, P114, DOI [10.3402/tellusb.v39i1-2.15329, DOI 10.1111/J.1600-0889.1987.TB00276.X, DOI 10.3402/TELLUSB.V39I1-2.15329]; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Garcia-Fayos P, 2000, J VEG SCI, V11, P77, DOI 10.2307/3236778; Garcia-Orenes F, 2010, SOIL TILL RES, V109, P110, DOI 10.1016/j.still.2010.05.005; Gonzalez-Alday J, 2009, ECOL ENG, V35, P1062, DOI 10.1016/j.ecoleng.2009.03.007; Hall SL, 2010, RESTOR ECOL, V18, P834, DOI 10.1111/j.1526-100X.2008.00509.x; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Hobbs RJ, 1996, RESTOR ECOL, V4, P93, DOI 10.1111/j.1526-100X.1996.tb00112.x; Holmes PM, 2001, RESTOR ECOL, V9, P71, DOI 10.1046/j.1526-100x.2001.009001071.x; Jasper DA, 2007, RESTOR ECOL, V15, pS74, DOI 10.1111/j.1526-100X.2007.00295.x; Jensen LS, 1996, SOIL BIOL BIOCHEM, V28, P1297, DOI 10.1016/S0038-0717(96)00136-8; Jochimsen ME, 2001, ECOL ENG, V17, P187, DOI 10.1016/S0925-8574(00)00158-0; JORDAN D, 1995, BIOL FERT SOILS, V19, P297, DOI 10.1007/BF00336098; King JA, 2002, COMMUN SOIL SCI PLAN, V33, P403, DOI 10.1081/CSS-120002753; Lagomarsino A, 2009, ECOL INDIC, V9, P518, DOI 10.1016/j.ecolind.2008.07.003; LAKANEN E., 1971, Acta Agralia Fennica, V123, P223; Litton CM, 2003, GLOBAL CHANGE BIOL, V9, P680, DOI 10.1046/j.1365-2486.2003.00626.x; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Maestre FT, 2011, SOIL BIOL BIOCHEM, V43, P1746, DOI 10.1016/j.soilbio.2011.04.023; Maestre FT, 2009, APPL SOIL ECOL, V41, P342, DOI 10.1016/j.apsoil.2008.12.007; Makoi JHJR, 2008, AFR J BIOTECHNOL, V7, P181; Matesanz S, 2006, RESTOR ECOL, V14, P297, DOI 10.1111/j.1526-100X.2006.00132.x; Melero S, 2009, SOIL TILL RES, V104, P292, DOI 10.1016/j.still.2009.04.001; Mitchell DJ, 2003, SOIL USE MANAGE, V19, P182, DOI 10.1079/SUM2002165; Mola I, 2011, RESTOR ECOL, V19, P83, DOI 10.1111/j.1526-100X.2009.00547.x; Moro MJ, 2000, ANN BOT-LONDON, V86, P1065, DOI 10.1006/anbo.2000.1269; Moynahan OS, 2002, RESTOR ECOL, V10, P77, DOI 10.1046/j.1526-100X.2002.10108.x; Ortega M, 1997, J BIOGEOGR, V24, P177, DOI 10.1046/j.1365-2699.1997.00080.x; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Rokich DP, 2000, RESTOR ECOL, V8, P196, DOI 10.1046/j.1526-100x.2000.80027.x; Ros M, 2003, SOIL BIOL BIOCHEM, V35, P463, DOI 10.1016/S0038-0717(02)00298-5; Ryan MG, 2005, BIOGEOCHEMISTRY, V73, P3, DOI 10.1007/s10533-004-5167-7; Shannon C.E., 1963, MATH THEORY COMMUNIC; Sinsabaugh RL, 2002, BIOGEOCHEMISTRY, V60, P1, DOI 10.1023/A:1016541114786; Smilauer P, 1993, CANODRAW 3 0; SPELLERBERG IF, 1998, ECOLOGICAL EFFECTS N; Tabatabai M. A., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P903; TABATABAI M. A., 1969, Soil Biology and Biochemistry, V1, P301, DOI 10.1016/0038-0717(69)90012-1; Tang JW, 2005, BIOGEOCHEMISTRY, V73, P183, DOI 10.1007/s10533-004-5889-6; Tejada M, 2007, SOIL TILL RES, V93, P197, DOI 10.1016/j.still.2006.04.002; TERBRAAK CJF, 1990, CANOCO FORTRAN PROGR; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Thompson K., 1997, SOIL SEED BANKS N W; Tormo J, 2007, RESTOR ECOL, V15, P97, DOI 10.1111/j.1526-100X.2006.00194.x; Traba J, 2006, J VEG SCI, V17, P5, DOI 10.1111/j.1654-1103.2006.tb02417.x; Traba J, 2004, SEED SCI RES, V14, P297, DOI 10.1079/SSR2004179; Turner BL, 2002, APPL SOIL ECOL, V20, P157, DOI 10.1016/S0929-1393(02)00020-3; Turner BL, 2002, SOIL BIOL BIOCHEM, V34, P27, DOI 10.1016/S0038-0717(01)00144-4; Valladares F, 2008, J VEG SCI, V19, P381, DOI 10.3170/2008-8-18378; Van den Brink PJ, 1999, ENVIRON TOXICOL CHEM, V18, P138, DOI [10.1897/1551-5028(1999)018&lt;0138:PRCAOT&gt;2.3.CO;2, 10.1002/etc.5620180207]; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Putten WH, 2009, OECOLOGIA, V161, P1, DOI 10.1007/s00442-009-1351-8; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Zhang ZQ, 2001, RESTOR ECOL, V9, P378, DOI 10.1046/j.1526-100X.2001.94007.x; Zornoza R, 2006, SOIL BIOL BIOCHEM, V38, P2125, DOI 10.1016/j.soilbio.2006.01.010	79	30	32	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101413	10.1371/journal.pone.0101413	http://dx.doi.org/10.1371/journal.pone.0101413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984137	Green Submitted, gold, Green Published			2022-12-27	WOS:000339635000102
J	Thaler, AD; Plouviez, S; Saleu, W; Alei, F; Jacobson, A; Boyle, EA; Schultz, TF; Carlsson, J; Van Dover, CL				Thaler, Andrew David; Plouviez, Sophie; Saleu, William; Alei, Freddie; Jacobson, Alixandra; Boyle, Emily A.; Schultz, Thomas F.; Carlsson, Jens; Van Dover, Cindy Lee			Comparative Population Structure of Two Deep-Sea Hydrothermal-Vent-Associated Decapods (Chorocaris sp 2 and Munidopsis lauensis) from Southwestern Pacific Back-Arc Basins	PLOS ONE			English	Article							POLYMORPHIC MICROSATELLITE LOCI; GULF-OF-MEXICO; GENETIC DIFFERENTIATION; SQUAT-LOBSTER; DISPERSAL; BATHYMODIOLUS; GALATHEIDAE; SOFTWARE; DNA; ALVINICONCHA	Studies of genetic connectivity and population structure in deep-sea chemosynthetic ecosystems often focus on endosymbiont-hosting species that are directly dependent on chemical energy extracted from vent effluent for survival. Relatively little attention has been paid to vent-associated species that are not exclusively dependent on chemosynthetic ecosystems. Here we assess connectivity and population structure of two vent-associated invertebrates-the shrimp Chorocaris sp. 2 and the squat lobster Munidopsis lauensis-that are common at deep-sea hydrothermal vents in the western Pacific. While Chorocaris sp. 2 has only been observed at hydrothermal vent sites, M. lauensis can be found throughout the deep sea but occurs in higher abundance around the periphery of active vents We sequenced mitochondrial COI genes and deployed nuclear microsatellite markers for both species at three sites in Manus Basin and either North Fiji Basin (Chorocaris sp. 2) or Lau Basin (Munidopsis lauensis). We assessed genetic differentiation across a range of spatial scales, from approximately 2.5 km to more than 3000 km. Population structure for Chorocaris sp. 2 was comparable to that of the vent-associated snail Ifremeria nautilei, with a single seemingly well-mixed population within Manus Basin that is genetically differentiated from conspecifics in North Fiji Basin. Population structure for Munidopsis lauensis was more complex, with two genetically differentiated populations in Manus Basin and a third well-differentiated population in Lau Basin. The unexpectedly high level of genetic differentiation between M. lauensis populations in Manus Basin deserves further study since it has implications for conservation and management of diversity in deep-sea hydrothermal vent ecosystems.	[Thaler, Andrew David; Plouviez, Sophie; Jacobson, Alixandra; Boyle, Emily A.; Schultz, Thomas F.; Van Dover, Cindy Lee] Duke Univ, Marine Lab, Nicholas Sch Environm, Beaufort, NC 28516 USA; [Saleu, William] Nautilus Minerals, Port Moresby, NCD, Papua N Guinea; [Alei, Freddie] Univ Papua New Guinea, Sch Nat & Phys Sci, Environm Sci & Geog Div, Port Moresby, Papua N Guinea; [Carlsson, Jens] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland	Duke University; University of Papua New Guinea; University College Dublin	Thaler, AD (corresponding author), Duke Univ, Marine Lab, Nicholas Sch Environm, Beaufort, NC 28516 USA.	andrew.david.thaler@gmail.com		Schultz, Thomas/0000-0001-9694-9920; Carlsson, Jens/0000-0002-9262-5627; Van Dover, Cindy/0000-0001-9845-8391	Nautilus Minerals Niugini Ltd.; Duke University; InterRidge; International Seabed Authority; National Science Foundation [OCE-1031050]; NSF [OCE-0241613]	Nautilus Minerals Niugini Ltd.; Duke University; InterRidge; International Seabed Authority; National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	Funding was provided by a research contract from Nautilus Minerals Niugini Ltd. (CLVD, JC, TFS), Duke University (ADT, CLVD), InterRidge (ADT and FA), the International Seabed Authority (WS) and the National Science Foundation (OCE-1031050 to CLVD). Samples from North Fiji and Lau Basin were provided by Dr. Robert Vrijenhoek (NSF Grant: OCE-0241613). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, GALATHEA REP, V20, P1; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Avise J, 2004, MOL MARKERS NATURAL; Bailie DA, 2010, J CRUSTACEAN BIOL, V30, P664, DOI 10.1651/09-3252.1; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Beinart RA, 2012, P NATL ACAD SCI USA, V109, pE3241, DOI 10.1073/pnas.1202690109; Benson DA, 1997, NUCLEIC ACIDS RES, V25, P1, DOI 10.1093/nar/25.1.1; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Boyle EA, 2013, CONSERV GENET RESOUR, V5, P647, DOI 10.1007/s12686-013-9872-1; Cabezas P, 2009, CONSERV GENET, V10, P673, DOI 10.1007/s10592-008-9611-4; Carlsson J, 2008, J HERED, V99, P616, DOI 10.1093/jhered/esn048; Carney SL, 2006, DEEP-SEA RES PT I, V53, P1061, DOI 10.1016/j.dsr.2006.03.002; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coffey Natural Systems, 2008, DROP; COHEN D, 1991, THEOR POPUL BIOL, V39, P63, DOI 10.1016/0040-5809(91)90041-D; Collins PC, 2012, MAR ECOL PROG SER, V452, P89, DOI 10.3354/meps09646; Collins PC, 2013, MAR POLICY, V42, P334, DOI 10.1016/j.marpol.2013.03.002; Cordes EE, 2007, DEEP-SEA RES PT I, V54, P637, DOI 10.1016/j.dsr.2007.01.001; Cornuet JM, 1996, GENETICS, V144, P2001; Cowart DA, 2013, MOL ECOL, V22, P4147, DOI 10.1111/mec.12379; Coykendall DK, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-96; CRADDOCK C, 1995, MAR BIOL, V124, P137, DOI 10.1007/BF00349155; Creasey S, 2000, DEEP-SEA RES PT II, V47, P87, DOI 10.1016/S0967-0645(99)00098-3; Cubelio SS, 2007, J CRUSTACEAN BIOL, V27, P513, DOI 10.1651/0278-0372(2007)27[513:VAMDAG]2.0.CO;2; DENIS F, 1993, BIOCHEM SYST ECOL, V21, P431, DOI 10.1016/0305-1978(93)90101-V; Desbruyeres D, 2006, GEOPHYS MONOGR SER, V166, P215; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Erickson KL, 2009, DEEP-SEA RES PT II, V56, P1577, DOI 10.1016/j.dsr2.2009.05.002; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FU YX, 1995, THEOR POPUL BIOL, V48, P172, DOI 10.1006/tpbi.1995.1025; Galkin SV, 1997, MAR GEOL, V142, P197, DOI 10.1016/S0025-3227(97)00051-0; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GRASSLE JP, 1985, B BIOL SOC WASH, V6, P429; Hurtado LA, 2004, MOL ECOL, V13, P2603, DOI 10.1111/j.1365-294X.2004.02287.x; Ilves KL, 2010, MOL ECOL, V19, P4505, DOI 10.1111/j.1365-294X.2010.04790.x; Johnson SB, 2006, BIOL BULL-US, V210, P140, DOI 10.2307/4134603; Jones WJ, 2007, J CRUSTACEAN BIOL, V27, P477, DOI 10.1651/S-2791.1; Kojima S, 2001, BIOL BULL-US, V200, P298, DOI 10.2307/1543511; Kojima S, 2000, ZOOL SCI, V17, P1167, DOI 10.2108/zsj.17.1167; Komai T, 2008, J SHELLFISH RES, V27, P21, DOI 10.2983/0730-8000(2008)27[21:TROTHV]2.0.CO;2; Konovalov DA, 2004, MOL ECOL NOTES, V4, P779, DOI 10.1111/j.1471-8286.2004.00796.x; Kyuno Akiko, 2009, Journal of Marine Biology, V2009, P1; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maas PAY, 1999, BIOL BULL, V196, P265, DOI 10.2307/1542951; Macpherson Enrique, 2005, Zootaxa, V1095, P1; Marsh AG, 2001, NATURE, V411, P77, DOI 10.1038/35075063; Matabos M, 2011, J BIOGEOGR, V38, P575, DOI 10.1111/j.1365-2699.2010.02418.x; McClain CR, 2010, P ROY SOC B-BIOL SCI, V277, P3533, DOI 10.1098/rspb.2010.1057; MORAGA D, 1994, DEEP-SEA RES PT I, V41, P1551, DOI 10.1016/0967-0637(94)90060-4; Olu K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011967; Plouviez S, 2009, MOL ECOL, V18, P3903, DOI 10.1111/j.1365-294X.2009.04325.x; Plouviez S, 2013, DEEP-SEA RES PT I, V82, P73, DOI 10.1016/j.dsr.2013.08.004; Plouviez S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-220; Pritchard JK, 2000, GENETICS, V155, P945; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Samadi S, 2006, MAR BIOL, V149, P1463, DOI 10.1007/s00227-006-0306-4; Schlotterer C, 2000, CHROMOSOMA, V109, P365, DOI 10.1007/s004120000089; Shank TM, 1999, MOL PHYLOGENET EVOL, V13, P244, DOI 10.1006/mpev.1999.0642; Shulman MJ, 1998, AUST J ECOL, V23, P216, DOI 10.1111/j.1442-9993.1998.tb00723.x; Suzuki Y, 2006, APPL ENVIRON MICROB, V72, P1388, DOI 10.1128/AEM.72.2.1388-1393.2006; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teixeira S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038521; Teixeira S, 2011, J BIOGEOGR, V38, P564, DOI 10.1111/j.1365-2699.2010.02408.x; Thaler AD, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-372; Thomson RE, 2003, NATURE, V424, P545, DOI 10.1038/nature01824; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vrijenhoek RC, 2010, MOL ECOL, V19, P4391, DOI 10.1111/j.1365-294X.2010.04789.x; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Wares JP, 2001, EVOLUTION, V55, P2455; WILKENS H, 1990, J CRUSTACEAN BIOL, V10, P667, DOI 10.2307/1548411; Won Y, 2003, MOL ECOL, V12, P169, DOI 10.1046/j.1365-294X.2003.01726.x; Yearsley JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023063; Young CR, 2008, MOL ECOL, V17, P1718, DOI 10.1111/j.1365-294X.2008.03609.x; Zelnio KA, 2010, CONSERV GENET RESOUR, V2, P223, DOI 10.1007/s12686-010-9243-0; Zenk W, 2005, PROG OCEANOGR, V67, P245, DOI 10.1016/j.pocean.2005.05.003	81	25	26	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101345	10.1371/journal.pone.0101345	http://dx.doi.org/10.1371/journal.pone.0101345			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983244	gold, Green Published, Green Submitted			2022-12-27	WOS:000339635000093
J	Chen, HJ; Qiang, H; Fan, KC; Wang, SS; Zheng, ZC				Chen, Hongjie; Qiang, Hao; Fan, Kaichun; Wang, Shousen; Zheng, Zhaocong			The snoRNA MBII-52 Regulates Cocaine-Induced Conditioned Place Preference and Locomotion in Mice	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS; IN-VIVO; SEROTONIN2C RECEPTORS; CONSTITUTIVE ACTIVITY; ADDICTION; BEHAVIOR; RATS; IDENTIFICATION; REINFORCEMENT; REINSTATEMENT	Cocaine dependence involves in the brain's reward circuit as well as nucleus accumbens (NAc), a key region of the mesolimbic dopamine pathway. Many studies have documented altered expression of genes and identified transcription factor networks and epigenetic processes that are fundamental to cocaine addiction. However, all these investigations have focused on mRNA and/or miRNA, which may not reflect the involvement of small nucleolar RNAs (snoRNAs), which has been implied in a broad range of biological processes and complex diseases including brain development and neuropathologocal process. To further address the role of snoRNA in cocaine addiction, we show that repeated exposure and conditioned place preference (CPP) training to cocaine negatively regulates the expression of MBII-52 mRNA level, which is a brain-specific C/D box snoRNA, but not influences the serotonin receptor 2C (5HT2CR) mRNA level in NAc. Furthemore, we show, developing lentiviral vector (LV)-expressing MBII-52 and LV-5HT2CR for stable and regulatable MBII-52 and LV-5HT2CR expression. LV-MBII-52 and LV-5HT2CR expression in NAc attenuate cocaine induced CPP and locomotor activity. Taken together, these findings show that MBII-52 and 5HT2CR exert an inhibitory influence on the behavioral responses to cocaine exposure.	[Chen, Hongjie; Wang, Shousen; Zheng, Zhaocong] Second Mil Med Univ, Fuzhou Gen Hosp, Dept Neurosurg, Fuzhou, Fujian, Peoples R China; [Qiang, Hao] Second Mil Med Univ, Changhai Hosp, Dept Radiol, Shanghai, Peoples R China; [Fan, Kaichun] Chinese Peoples Liberat Army Gen Hosp, Dept Gastroenterol, Beijing, Peoples R China	Naval Medical University; Naval Medical University; Chinese People's Liberation Army General Hospital	Wang, SS (corresponding author), Second Mil Med Univ, Fuzhou Gen Hosp, Dept Neurosurg, Fuzhou, Fujian, Peoples R China.	shousenwang@163.com			Shanghai Science and Technology Committee [10411952700]	Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This study was supported by grants from Funded by Shanghai Science and Technology Committee (NO. 10411952700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baler RD, 2006, TRENDS MOL MED, V12, P559, DOI 10.1016/j.molmed.2006.10.005; Boothman L, 2006, BRIT J PHARMACOL, V149, P861, DOI 10.1038/sj.bjp.0706935; Bu Q, 2012, J NEUROCHEMISTRY; CALCAGNETTI DJ, 1995, LIFE SCI, V56, P475, DOI 10.1016/0024-3205(94)00414-N; Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; Chandrasekar V, 2011, NEUROPSYCHOPHARMACOL, V36, P1149, DOI 10.1038/npp.2010.250; Craige CP, 2012, BEHAV BRAIN RES; De Deurwaerdere P, 2004, J NEUROSCI, V24, P3235, DOI 10.1523/JNEUROSCI.0112-04.2004; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Doe CM, 2009, HUM MOL GENET, V18, P2140, DOI 10.1093/hmg/ddp137; Eipper-Mains JE, 2011, RNA, V17, P1529, DOI 10.1261/rna.2775511; Hioki H, 2007, GENE THER, V14, P872, DOI 10.1038/sj.gt.3302924; Hollander JA, 2010, NATURE, V466, P197, DOI 10.1038/nature09202; Huttenhofer A, 2002, CURR OPIN CHEM BIOL, V6, P835, DOI 10.1016/S1367-5931(02)00397-6; Jonkman S, 2012, NEUROPSYCHOPHARMACOL; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Kuroda H, 2008, J GENE MED, V10, P1163, DOI 10.1002/jgm.1249; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Larson EB, 2011, J NEUROSCI, V31, P16447, DOI 10.1523/JNEUROSCI.3070-11.2011; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; Navailles S, 2008, NEUROPSYCHOPHARMACOL, V33, P237, DOI 10.1038/sj.npp.1301414; Navailles S, 2006, J NEUROCHEM, V99, P1311, DOI 10.1111/j.1471-4159.2006.04188.x; Neisewander JL, 2007, BEHAV PHARMACOL, V18, P791, DOI 10.1097/FBP.0b013e3282f1c94b; Nestler EJ, 2004, TRENDS PHARMACOL SCI, V25, P210, DOI 10.1016/j.tips.2004.02.005; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; O'Brien CP, 2005, PHARMACOL THERAPEUT, V108, P18, DOI 10.1016/j.pharmthera.2005.06.018; Pritchard LM, 2012, PSYCHOPHARMACOLOGY, P1; Valjent E, 2006, P NATL ACAD SCI USA, V103, P2932, DOI 10.1073/pnas.0511030103; WHITE NM, 1985, PHARMACOL BIOCHEM BE, V23, P37, DOI 10.1016/0091-3057(85)90127-3	30	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e99986	10.1371/journal.pone.0099986	http://dx.doi.org/10.1371/journal.pone.0099986			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979384	Green Submitted, Green Published, gold			2022-12-27	WOS:000338506400013
J	Rijkenberg, MJA; Middag, R; Laan, P; Gerringa, LJA; van Aken, HM; Schoemann, V; de Jong, JTM; de Baar, HJW				Rijkenberg, Micha J. A.; Middag, Rob; Laan, Patrick; Gerringa, Loes J. A.; van Aken, Hendrik M.; Schoemann, Veronique; de Jong, Jeroen T. M.; de Baar, Hein J. W.			The Distribution of Dissolved Iron in the West Atlantic Ocean	PLOS ONE			English	Article							SOUTHERN-OCEAN; NORTH-ATLANTIC; TROPICAL ATLANTIC; BIOGEOCHEMICAL CYCLES; MARINE-PHYTOPLANKTON; COMPLEXING LIGANDS; TRACE-ELEMENTS; SAHARAN DUST; INDIAN-OCEAN; RIVER PLUME	Iron (Fe) is an essential trace element for marine life. Extremely low Fe concentrations limit primary production and nitrogen fixation in large parts of the oceans and consequently influence ocean ecosystem functioning. The importance of Fe for ocean ecosystems makes Fe one of the core chemical trace elements in the international GEOTRACES program. Despite the recognized importance of Fe, our present knowledge of its supply and biogeochemical cycle has been limited by mostly fragmentary datasets. Here, we present highly accurate dissolved Fe (DFe) values measured at an unprecedented high intensity (1407 samples) along the longest full ocean depth transect (17500 kilometers) covering the entire western Atlantic Ocean. DFe measurements along this transect unveiled details about the supply and cycling of Fe. External sources of Fe identified included off-shelf and river supply, hydrothermal vents and aeolian dust. Nevertheless, vertical processes such as the recycling of Fe resulting from the remineralization of sinking organic matter and the removal of Fe by scavenging still dominated the distribution of DFe. In the northern West Atlantic Ocean, Fe recycling and lateral transport from the eastern tropical North Atlantic Oxygen Minimum Zone (OMZ) dominated the DFe-distribution. Finally, our measurements showed that the North Atlantic Deep Water (NADW), the major driver of the so-called ocean conveyor belt, contains excess DFe relative to phosphate after full biological utilization and is therefore an important source of Fe for biological production in the global ocean.	[Rijkenberg, Micha J. A.; Middag, Rob; Laan, Patrick; Gerringa, Loes J. A.; van Aken, Hendrik M.; Schoemann, Veronique; de Jong, Jeroen T. M.; de Baar, Hein J. W.] Royal Netherlands Inst Sea Res, Dept Biol Oceanog, Den Burg, Netherlands; [Middag, Rob] Univ Otago, Dept Chem, Dunedin, New Zealand; [de Baar, Hein J. W.] Univ Groningen, Dept Ocean Ecosyst, Groningen, Netherlands	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Otago; University of Groningen	Rijkenberg, MJA (corresponding author), Royal Netherlands Inst Sea Res, Dept Biol Oceanog, Den Burg, Netherlands.	micha.rijkenberg@nioz.nl	Middag, Rob/D-6423-2013	Middag, Rob/0000-0002-3326-530X; de Jong, Jeroen/0000-0002-3034-5929	Dutch National Program Sea and Coastal Research (ZKO) of the Netherlands Organisation for Scientific Research (NWO) [839.08.410]	Dutch National Program Sea and Coastal Research (ZKO) of the Netherlands Organisation for Scientific Research (NWO)	This research was funded by the Dutch National Program Sea and Coastal Research (ZKO, project number 839.08.410) of the Netherlands Organisation for Scientific Research (NWO, www.nwo.nl/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON LA, 1995, DEEP-SEA RES PT I, V42, P1675, DOI 10.1016/0967-0637(95)00072-E; Bennett SA, 2008, EARTH PLANET SC LETT, V270, P157, DOI 10.1016/j.epsl.2008.01.048; Blain S, 2008, BIOGEOSCIENCES, V5, P269, DOI 10.5194/bg-5-269-2008; Blain S, 2008, DEEP-SEA RES PT II, V55, P594, DOI 10.1016/j.dsr2.2007.12.028; Borer PM, 2005, MAR CHEM, V93, P179, DOI 10.1016/j.marchem.2004.08.006; Boyd PW, 2010, LIMNOL OCEANOGR, V55, P1271, DOI 10.4319/lo.2010.55.3.1271; Boye M, 2010, MAR CHEM, V122, P20, DOI 10.1016/j.marchem.2010.09.001; Broecker W. S., 1991, OCEANOGRAPHY, V4, P79, DOI [10.5670/oceanog.1991.07, DOI 10.5670/0CEAN0G.1991.07, DOI 10.5670/OCEANOG.1991.07]; Bruland KW, 2014, TREATISE GEOCHEMISTR, P19, DOI DOI 10.1016/B978-0-08-095975-7.00602-1; DAI MH, 1995, EARTH PLANET SC LETT, V131, P127, DOI 10.1016/0012-821X(95)00021-4; Dammshauser A, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049847; De Baar HJW, 2008, MAR CHEM, V111, P4, DOI 10.1016/j.marchem.2007.07.009; de Baar H.J.W., 2001, BIOGEOCHEMISTRY IRON; de Baar HJW, 2003, MARINE SCIENCE FRONTIERS FOR EUROPE, P79; de Baar HJW, 2012, OC SCI M SALT LAK CI; de Jong J, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001679; DEBAAR HJW, 1990, MAR ECOL PROG SER, V65, P105, DOI 10.3354/meps065105; DEBAAR HJW, 1995, NATURE, V373, P412, DOI 10.1038/373412a0; Deng FF, 2014, EARTH PLANET SC LETT, V390, P93, DOI 10.1016/j.epsl.2013.12.038; Duce RA, 1991, GLOBAL BIOGEOCHEM CY, V5, P193, DOI 10.1029/91GB01778; Dulaquais G, 2014, BIOGEOSCIENCES, V11, P1561, DOI 10.5194/bg-11-1561-2014; Elrod VA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020216; Erickson DJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017241; Fabri MC, 2011, J MAR BIOL ASSOC UK, V91, P1, DOI 10.1017/S0025315410000731; Fitzsimmons JN, 2013, MAR CHEM, V154, P87, DOI 10.1016/j.marchem.2013.05.009; FOX LE, 1988, GEOCHIM COSMOCHIM AC, V52, P771, DOI 10.1016/0016-7037(88)90337-7; Gasso S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027693; German CR, 2008, EARTH PLANET SC LETT, V273, P332, DOI 10.1016/j.epsl.2008.06.048; Gerringa LJA, 2012, DEEP-SEA RES PT II, V71-76, P16, DOI 10.1016/j.dsr2.2012.03.007; GLEDHILL M, 1994, MAR CHEM, V47, P41, DOI 10.1016/0304-4203(94)90012-4; Gonzalez-Silvera A, 2004, CONT SHELF RES, V24, P983, DOI 10.1016/j.csr.2004.03.002; Grasshoff K., 1999, METHODS SEAWATER ANA, V3rd; Haase KM, 2009, MAR GEOL, V266, P52, DOI 10.1016/j.margeo.2009.07.012; Hassler CS, 2009, BIOGEOSCIENCES, V6, P2281, DOI 10.5194/bg-6-2281-2009; Hawkes JA, 2013, EARTH PLANET SC LETT, V375, P280, DOI 10.1016/j.epsl.2013.05.047; Hawkes JA, 2014, GEOPHYS RES LETT, V41; Hayes CT, 2013, EARTH PLANET SC LETT, V383, P16, DOI 10.1016/j.epsl.2013.09.025; Henderson GM, 2007, CHEM ERDE-GEOCHEM, V67, P85, DOI 10.1016/j.chemer.2007.02.001; Hopkinson BM, 2007, MAR CHEM, V106, P2, DOI 10.1016/j.marchem.2006.02.008; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; Johnson CM, 2008, ANNU REV EARTH PL SC, V36, P457, DOI 10.1146/annurev.earth.36.031207.124139; Johnson KS, 1997, MAR CHEM, V57, P137, DOI 10.1016/S0304-4203(97)00043-1; Karstensen J, 2008, PROG OCEANOGR, V77, P331, DOI 10.1016/j.pocean.2007.05.009; Klunder MB, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007135; Klunder MB, 2011, DEEP-SEA RES PT II, V58, P2678, DOI 10.1016/j.dsr2.2010.10.042; Klunder MB, 2014, BIOGEOSCIENCES, V10, P7433; Kondo Y, 2013, DEEP-SEA RES PT I, V73, P73, DOI 10.1016/j.dsr.2012.11.014; Kuma K, 1996, LIMNOL OCEANOGR, V41, P396, DOI 10.4319/lo.1996.41.3.0396; Lam PJ, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002557; Lannuzel D, 2011, DEEP-SEA RES PT II, V58, P2094, DOI 10.1016/j.dsr2.2011.05.027; Liu XW, 2002, MAR CHEM, V77, P43, DOI 10.1016/S0304-4203(01)00074-3; Lohan MC, 2006, MAR CHEM, V98, P260, DOI 10.1016/j.marchem.2005.10.003; Lyons TW, 2014, NATURE, V506, P307, DOI 10.1038/nature13068; Maldonado MT, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002481; MARTIN JH, 1988, NATURE, V331, P341, DOI 10.1038/331341a0; Measures CI, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003042; Melchert B, 2008, EARTH PLANET SC LETT, V275, P61, DOI 10.1016/j.epsl.2008.08.010; Middag R, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007434; Middag R, 2011, DEEP-SEA RES PT II, V58, P2647, DOI 10.1016/j.dsr2.2011.03.001; Moore CM, 2009, NAT GEOSCI, V2, P867, DOI 10.1038/ngeo667; Nishioka J, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC004055; Nishioka J, 2013, EARTH PLANET SC LETT, V361, P26, DOI 10.1016/j.epsl.2012.11.040; Noble AE, 2012, LIMNOL OCEANOGR, V57, P989, DOI 10.4319/lo.2012.57.4.0989; Parekh P, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002280; Piola AR, 2008, CONT SHELF RES, V28, P1639, DOI 10.1016/j.csr.2008.03.013; Planquette H, 2007, DEEP-SEA RES PT II, V54, P1999, DOI 10.1016/j.dsr2.2007.06.019; Powell RT, 2003, ESTUAR COAST SHELF S, V58, P757, DOI 10.1016/S0272-7714(03)00182-3; PROSPERO JM, 1972, J GEOPHYS RES, V77, P5255, DOI 10.1029/JC077i027p05255; Rijkenberg MJA, 2008, MAR CHEM, V109, P29, DOI 10.1016/j.marchem.2007.12.001; Rijkenberg MJA, 2008, MAR CHEM, V110, P56, DOI 10.1016/j.marchem.2008.02.006; Rijkenberg MJA, 2006, GEOCHIM COSMOCHIM AC, V70, P2790, DOI 10.1016/j.gca.2006.03.004; Rijkenberg MJA, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004264; Rijkenberg MJA, 2006, MAR CHEM, V100, P11, DOI 10.1016/j.marchem.2005.10.005; Rijkenberg MJA, 2005, MAR CHEM, V93, P119, DOI 10.1016/j.marchem.2004.03.021; Ruth C, 2000, DEEP-SEA RES PT I, V47, P1059, DOI 10.1016/S0967-0637(99)00077-1; Ryan-Keogh TJ, 2013, LIMNOL OCEANOGR, V58, P533, DOI 10.4319/lo.2013.58.2.0533; Saito MA, 2003, INORG CHIM ACTA, V356, P308, DOI 10.1016/S0020-1693(03)00442-0; Saito MA, 2013, NATURE GEOSCI; Santana-Casiano JM, 2005, ENVIRON SCI TECHNOL, V39, P2073, DOI 10.1021/es049748y; Schott FA, 1998, J PHYS OCEANOGR, V28, P1904, DOI 10.1175/1520-0485(1998)028<1904:TAPOTU>2.0.CO;2; SHOLKOVITZ ER, 1978, EARTH PLANET SC LETT, V40, P130, DOI 10.1016/0012-821X(78)90082-1; Stramma L, 1999, J GEOPHYS RES-OCEANS, V104, P20863, DOI 10.1029/1999JC900139; Stramma L, 1999, DEEP-SEA RES PT II, V46, P279, DOI 10.1016/S0967-0645(98)00109-X; Stramma L, 2004, DEEP-SEA RES PT I, V51, P1033, DOI 10.1016/j.dsr.2004.04.001; Stramma L, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004369; Tagliabue A, 2011, BIOGEOSCIENCES, V8, P3025, DOI 10.5194/bg-8-3025-2011; Tagliabue A, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003363; Tagliabue A, 2010, NAT GEOSCI, V3, P252, DOI 10.1038/NGEO818; Thuroczy CE, 2010, DEEP-SEA RES PT I, V57, P1444, DOI 10.1016/j.dsr.2010.08.004; Tovar-Sanchez A, 2011, BIOGEOSCIENCES, V8, P217, DOI 10.5194/bg-8-217-2011; Turner DR, 2001, IUPAC SERIES ANAL PH, P1; Twining BS, 2013, ANNU REV MAR SCI, V5, P191, DOI 10.1146/annurev-marine-121211-172322; van Aken H.M., 2007, OCEANIC THERMOHALINE; Wacey D, 2011, NAT GEOSCI, V4, P698, DOI 10.1038/NGEO1238; WELLS ML, 1995, MAR CHEM, V48, P157, DOI 10.1016/0304-4203(94)00055-I; Wen LS, 1999, MAR CHEM, V63, P185, DOI 10.1016/S0304-4203(98)00062-0; Witter AE, 2000, DEEP-SEA RES PT II, V47, P1517, DOI 10.1016/S0967-0645(99)00152-6	97	109	110	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101323	10.1371/journal.pone.0101323	http://dx.doi.org/10.1371/journal.pone.0101323			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978190	Green Published, gold, Green Submitted			2022-12-27	WOS:000338506400116
J	Tandogan, N; Abadian, PN; Epstein, S; Aoi, Y; Goluch, ED				Tandogan, Nil; Abadian, Pegah N.; Epstein, Slava; Aoi, Yoshiteru; Goluch, Edgar D.			Isolation of Microorganisms Using Sub-Micrometer Constrictions	PLOS ONE			English	Article							HIGH-THROUGHPUT; SINGLE-CELL; SHEAR-STRESS; CULTIVATION; GROWTH; ANTIBIOTICS; DIVERSITY; DETACHMENT; CHEMOSTAT; BACTERIA	We present an automated method for isolating pure bacterial cultures from samples containing multiple species that exploits the cell's own physiology to perform the separation. Cells compete to reach a chamber containing nutrients via a constriction whose cross-sectional area only permits a single cell to enter, thereby blocking the opening and preventing other cells from entering. The winning cell divides across the constriction and its progeny populate the chamber. The devices are passive and require no user interaction to perform their function. Device fabrication begins with the creation of a master mold that contains the desired constriction and chamber features. Replica molding is used to create patterned polymer chips from the master, which are bonded to glass microscope cover slips to create the constrictions. We tested constriction geometries ranging from 500 nanometers to 5 micrometers in width, 600 to 950 nanometers in height, and 10 to 40 micrometers in length. The devices were used to successfully isolate a pure Pseudomonas aeruginosa culture from a mixture that also contained Escherichia coli. We demonstrated that individual strains of the same species can be separated out from mixtures using red and green fluorescently-labeled E. coli. We also used the devices to isolate individual environmental species. Roseobacter sp. was separated from another marine species, Psychroserpens sp.	[Tandogan, Nil; Abadian, Pegah N.; Goluch, Edgar D.] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA; [Epstein, Slava; Aoi, Yoshiteru] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Aoi, Yoshiteru] Hiroshima Univ, Inst Sustainable Sci & Dev, Hiroshima, Japan	Northeastern University; Northeastern University; Hiroshima University	Epstein, S (corresponding author), Northeastern Univ, Dept Biol, Boston, MA 02115 USA.	s.epstein@neu.edu; yoshiteruaoi@hiroshima-u.ac.jp; e.goluch@neu.edu	Goluch, Edgar/AAK-1528-2020; Goluch, Edgar D/C-2344-2008	Goluch, Edgar D/0000-0001-9319-8906	National Science Foundation [1125535]; Northeastern University; Div Of Biological Infrastructure [1353853] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Northeastern University; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This material is based upon work supported in part by the National Science Foundation under grant number 1125535 and a Northeastern University Tier 1 Interdisciplinary Research Seed Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Ben-Dov E, 2009, FEMS MICROBIOL ECOL, V68, P363, DOI 10.1111/j.1574-6941.2009.00682.x; Bollmann A, 2007, APPL ENVIRON MICROB, V73, P6386, DOI 10.1128/AEM.01309-07; Chambless JD, 2006, APPL ENVIRON MICROB, V72, P2005, DOI 10.1128/AEM.72.3.2005-2013.2006; Cho JC, 2004, APPL ENVIRON MICROB, V70, P432, DOI 10.1128/AEM.70.1.432-440.2004; Choi YC, 2003, WATER SCI TECHNOL, V47, P69, DOI 10.2166/wst.2003.0284; Connell JL, 2010, MBIO, V1, DOI 10.1128/mBio.00202-10; Connon SA, 2002, APPL ENVIRON MICROB, V68, P3878, DOI 10.1128/AEM.68.8.3878-3885.2002; EBERSOLE RC, 1993, BIO-TECHNOL, V11, P1278; Fitzsimons MS, 2013, GENOME RES, V23, P878, DOI 10.1101/gr.142208.112; Fotouhi L, 2010, COLLOID SURFACE B, V81, P110, DOI 10.1016/j.colsurfb.2010.06.030; HARRIS RD, 1995, SENSOR ACTUAT B-CHEM, V29, P261, DOI 10.1016/0925-4005(95)01692-9; HASSAN HM, 1980, J BACTERIOL, V141, P156, DOI 10.1128/JB.141.1.156-163.1980; Hu XY, 2005, P NATL ACAD SCI USA, V102, P15757, DOI 10.1073/pnas.0507719102; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Ingham CJ, 2008, LAB CHIP, V8, P1604, DOI 10.1039/b804790a; Ingham CJ, 2007, P NATL ACAD SCI USA, V104, P18217, DOI 10.1073/pnas.0701693104; Jara CC, 2007, APPL CATAL B-ENVIRON, V70, P479, DOI 10.1016/j.apcatb.2005.11.035; Jones PV, 2014, ANAL BIOANAL CHEM, V406, P183, DOI 10.1007/s00216-013-7437-5; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Keller M, 2004, NAT REV MICROBIOL, V2, P141, DOI 10.1038/nrmicro819; Kim MC, 2011, LAB CHIP, V11, P1089, DOI [10.1039/c0lc00362j, 10.1039/c01c00362j]; LaCourse WR, 1999, J PHARMACEUT BIOMED, V19, P239, DOI 10.1016/S0731-7085(98)00089-2; Long Z, 2013, LAB CHIP, V13, P947, DOI 10.1039/c2lc41196b; Mannik J, 2009, P NATL ACAD SCI USA, V106, P14861, DOI 10.1073/pnas.0907542106; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Moffitt JR, 2012, LAB CHIP, V12, P1487, DOI 10.1039/c2lc00009a; Nam KH, 2010, J MICROELECTROMECH S, V19, P375, DOI 10.1109/JMEMS.2010.2040459; Nichols D, 2010, APPL ENVIRON MICROB, V76, P2445, DOI 10.1128/AEM.01754-09; Paul E, 2012, WATER RES, V46, P5499, DOI 10.1016/j.watres.2012.07.029; Pham VHT, 2012, TRENDS BIOTECHNOL, V30, P475, DOI 10.1016/j.tibtech.2012.05.007; Pires L, 2013, BIOSENS BIOELECTRON, V47, P157, DOI 10.1016/j.bios.2013.03.015; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Sangwan P, 2005, APPL ENVIRON MICROB, V71, P8402, DOI 10.1128/AEM.71.12.8402-8410.2005; Sipkema D, 2011, APPL ENVIRON MICROB, V77, P2130, DOI 10.1128/AEM.01203-10; Sizova MV, 2012, APPL ENVIRON MICROB, V78, P194, DOI 10.1128/AEM.06813-11; Takeuchi S, 2005, NANO LETT, V5, P1819, DOI 10.1021/nl0507360; Tamaki H, 2005, APPL ENVIRON MICROB, V71, P2162, DOI 10.1128/AEM.71.4.2162-2169.2005; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045; WHITAKER GW, 1988, J LIQ CHROMATOGR, V11, P3011, DOI 10.1080/01483918808076776; Zago A, 2009, ENCY MICROBIOLOGY, VThird, P245, DOI DOI 10.1016/B978-012373944-5.00203-0	41	16	18	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101429	10.1371/journal.pone.0101429	http://dx.doi.org/10.1371/journal.pone.0101429			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978477	gold, Green Submitted, Green Published			2022-12-27	WOS:000338506400129
J	Elfrink, MEC; Moll, HA; Kiefte-de Jong, JC; Jaddoe, VWV; Hofman, A; ten Cate, JM; Veerkamp, JSJ				Elfrink, Marlies E. C.; Moll, Henriette A.; Kiefte-de Jong, Jessica C.; Jaddoe, Vincent W. V.; Hofman, Albert; ten Cate, Jacob M.; Veerkamp, Jaap S. J.			Pre- and Postnatal Determinants of Deciduous Molar Hypomineralisation in 6-Year-Old Children. The Generation R Study	PLOS ONE			English	Article							2ND PRIMARY MOLARS; LOW-BIRTH-WEIGHT; INCISOR-HYPOMINERALISATION; DEVELOPMENTAL DEFECTS; ENAMEL DEFECTS; RISK-FACTORS; PREVALENCE; ETIOLOGY; DIOXINS; CARIES	Background: Deciduous Molar Hypomineralisation (DMH) and Molar Incisor Hypomineralisation (MIH) are common developmental disturbances in pediatric dentistry. Their occurrence is related. The same determinants as suggested for MIH are expected for DMH, though somewhat earlier in life. Perinatal medical problems may influence the prevalence of DMH but this has not been studied sufficiently. Objective: This study aimed to identify possible determinants of DMH in a prospective cohort study among 6-year-old children. Study Design: This study was embedded in the Generation R Study, a population-based prospective cohort study from fetal life until young adulthood. The the data were used to identify the determinants of DMH. Clinical photographs of clean, moist teeth were taken with an intra-oral camera in 6690 children (mean age 6.2 years; 49.9% girls). Data on possible determinants that had occurred during pregnancy and/or the child's first year of life were on the basis of manual standardized measurements (like length and weight) and questionnaires. Multivariate analyse with backward and forward selection was performed. Results: A number of factors in the pre-, peri-and postnatal phase were found to be associated with DMH. After multivariate logistic regression analyses, Dutch ethnic background, low birth weight, maternal alcohol consumption during pregnancy, and fever episodes in the first year of the child's life were found to play a role in the development of DMH in 6-year-old children. Conclusion: This study shows that Dutch ethnicity, low birth weight, alcohol consumption by the mother during pregnancy and any fever in the first year of the child's life are associated with DMH. Not only childhood factors but also prenatal lifestyle factors need to be taken into account when studying determinants for DMH.	[Elfrink, Marlies E. C.; ten Cate, Jacob M.; Veerkamp, Jaap S. J.] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Cariol Endodontol & Pedodontol, Amsterdam, Netherlands; [Elfrink, Marlies E. C.; ten Cate, Jacob M.; Veerkamp, Jaap S. J.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Moll, Henriette A.; Kiefte-de Jong, Jessica C.; Jaddoe, Vincent W. V.] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Pediat, Rotterdam, Netherlands; [Kiefte-de Jong, Jessica C.; Jaddoe, Vincent W. V.] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Generat R Study Grp, Rotterdam, Netherlands; [Jaddoe, Vincent W. V.; Hofman, Albert] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Epidemiol, Rotterdam, Netherlands	Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital	Elfrink, MEC (corresponding author), Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Cariol Endodontol & Pedodontol, Amsterdam, Netherlands.	m.elfrink@acta.nl	Kiefte-de Jong, Jessica/GLV-3216-2022; Veerkamp, Jaap/AAI-5937-2020	Kiefte-de Jong, Jessica/0000-0002-8136-0918; 	ErasmusMC Rotterdam, Erasmus University Rotterdam; Netherlands Organization for Health Research and Development (ZonMw); GABA, Therwil, Switzerland; Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam; VU University Amsterdam, Amsterdam, The Netherlands	ErasmusMC Rotterdam, Erasmus University Rotterdam; Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); GABA, Therwil, Switzerland; Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam; VU University Amsterdam, Amsterdam, The Netherlands(Netherlands Government)	Unrestricted financial support was given by the ErasmusMC Rotterdam, Erasmus University Rotterdam and the Netherlands Organization for Health Research and Development (ZonMw), and for the dental part of the research an additional and unrestricted grant of GABA, Therwil, Switzerland and financial support from the Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam and VU University Amsterdam, Amsterdam, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi R, 2012, IRAN J PEDIATR, V22, P245; Aine L, 2000, J ORAL PATHOL MED, V29, P403, DOI 10.1034/j.1600-0714.2000.290806.x; Alaluusua S, 1996, ENVIRON TOXICOL PHAR, V1, P193, DOI 10.1016/1382-6689(96)00007-5; Alaluusua S, 2010, EUR ARCH PAEDIATR DE, V11, P53, DOI 10.1007/BF03262713; [Anonymous], 2004, STAND OND IND 2003; [Anonymous], 2004, ALL NED 2004; Beentjes V E, 2002, Eur J Paediatr Dent, V3, P9; Biondi Ana M, 2012, Acta odontol. latinoam., V25, P224; BUTLER PM, 1967, ARCH ORAL BIOL, V12, P1245, DOI 10.1016/0003-9969(67)90126-4; Crombie F, 2009, INT J PAEDIATR DENT, V19, P73, DOI 10.1111/j.1365-263X.2008.00966.x; Elfrink M, 2012, ORALPROPHYLAXE KINDE, V34, P166; Elfrink MEC, 2008, CARIES RES, V42, P282, DOI 10.1159/000135674; Elfrink MEC, 2012, J DENT RES, V91, P551, DOI 10.1177/0022034512440450; Elfrink MEC, 2009, EUR ARCH PAEDIATR DE, V10, P5, DOI 10.1007/BF03262693; Elfrink MEC, 2010, INT J PAEDIATR DENT, V20, P151, DOI 10.1111/j.1365-263X.2009.01026.x; Elfrink ME, 2013, DRUG SAFETY IN PRESS; Fagrell TG, 2011, SWED DENT J, V35, P57; Ghanim A, 2012, INT J PAEDIAT DENT; Ghanim AM, 2012, EUR ARCH PAEDIATR DE, V13, P111, DOI 10.1007/BF03262856; Ghanim A, 2013, INT J PAEDIATR DENT, V23, P48, DOI 10.1111/j.1365-263X.2012.01223.x; Ghanim A, 2011, INT J PAEDIATR DENT, V21, P413, DOI 10.1111/j.1365-263X.2011.01143.x; Hargreaves J A, 1989, Adv Dent Res, V3, P110; Jaddoe VWV, 2007, ANN EPIDEMIOL, V17, P834, DOI 10.1016/j.annepidem.2007.04.001; Jaddoe VWV, 2006, EUR J EPIDEMIOL, V21, P475, DOI 10.1007/s10654-006-9022-0; Jaddoe VWV, 2010, EUR J EPIDEMIOL, V25, P823, DOI 10.1007/s10654-010-9516-7; Jalevik B, 2010, EUR ARCH PAEDIATR DE, V11, P59; Jasulaityte L, 2008, EUR ARCH PAEDIATR DE, V9, P218, DOI 10.1007/BF03262638; Jimenez-Farfan D, 2005, BIRTH DEFECTS RES A, V73, P980, DOI 10.1002/bdra.20198; Laisi S, 2008, EUR ARCH PAEDIATR DE, V9, P224, DOI 10.1007/BF03262639; Laisi S, 2009, J DENT RES, V88, P132, DOI 10.1177/0022034508328334; Parikh DR, 2012, EUR ARCH PAEDIATR DE, V13, P21, DOI 10.1007/BF03262836; Rugg-Gunn AJ, 1998, CARIES RES, V32, P181, DOI 10.1159/000016451; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Stockley L, 2008, PUBLIC HEALTH NUTR, V11, P807, DOI 10.1017/S1368980008002346; Strand Bjorn Heine, 2003, Tidsskr Nor Laegeforen, V123, P2849; Troe E.J.W.M., 2008, ETHNIC DIFFERENCES F; Tung K, 2006, ARCH ORAL BIOL, V51, P464, DOI 10.1016/j.archoralbio.2005.12.001; Vello MA, 2010, ORAL DIS, V16, P257, DOI 10.1111/j.1601-0825.2009.01629.x; Weerheijm K L, 2003, Eur J Paediatr Dent, V4, P114; Weerheijm K L, 2003, Eur J Paediatr Dent, V4, P110; William V, 2006, PEDIATR DENT, V28, P224	41	39	39	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e91057	10.1371/journal.pone.0091057	http://dx.doi.org/10.1371/journal.pone.0091057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988443	gold, Green Published, Green Submitted			2022-12-27	WOS:000341354100002
J	Hu, Q; Lu, RJ; Peng, K; Duan, XJ; Wang, YQ; Zhao, YJ; Wang, W; Lou, YL; Tan, WJ				Hu, Qin; Lu, Roujian; Peng, Kun; Duan, Xijie; Wang, Yanqun; Zhao, Yanjie; Wang, Wen; Lou, Yongliang; Tan, Wenjie			Prevalence and Genetic Diversity Analysis of Human Coronavirus OC43 among Adult Patients with Acute Respiratory Infections in Beijing, 2012	PLOS ONE			English	Article							NUCLEOCAPSID PROTEIN; TRACT INFECTIONS; REAL-TIME; DIAGNOSIS; SEQUENCE; VIRUSES; HKU1; PCR; EPIDEMIOLOGY; EVOLUTION	To determine the prevalence, epidemiology and genetic diversity of human coronavirus OC43 (HCoV-OC43) among adult patients with acute respiratory infections (ARI) in Beijing, five hundred and fifty-nine nasopharyngeal swab samples were collected from adult patients with ARI in Beijing. The prevalence of HCoV-OC43 infection among these patients was assessed using two different OneStep reverse transcription polymerase chain reaction (RT-PCR) assays. The epidemiological profiles of the patients with HCoV-OC43 infection were described. Partial S and N genes of HCoV-OC43 circulating strains were sequenced followed by phylogenetic analysis and amino acid alignment. Our results showed that the prevalence of HCoV-OC43 infection was 12.52% (95% CI: 9.78-15.26%), and the epidemic peak occurred in autumn. Fifty partial S and 40 partial N fragments were obtained from these patients. Phylogenetic analysis based on neighbour-joining method showed that at least three distinct clusters (A, B, C/D) of HCoV-OC43 strains were circulating among adult patients with ARI in Beijing. In addition, some novel unique clusters (UNT) of HCoV-OC43 were found in the S-and N-based phylogenetic trees. Furthermore, consensus amino acids substitutes for each cluster were also found after alignment of partial S or N sequence coding region in this study. In conclusion, we herein describe the prevalence of HCoV-OC43 among adult patients and provide substantial evidence for the genetic diversity of HCoV-OC43 circulating in Beijing.	[Hu, Qin; Zhao, Yanjie; Lou, Yongliang; Tan, Wenjie] Wenzhou Med Univ, Inst Med Virol, Wenzhou, Zhejiang, Peoples R China; [Hu, Qin; Lu, Roujian; Wang, Yanqun; Zhao, Yanjie; Wang, Wen; Tan, Wenjie] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Key Lab Med Virol, Minist Hlth, Beijing, Peoples R China; [Peng, Kun] Beijing Sixth Hosp, Beijing, Peoples R China; [Duan, Xijie] CAMS, Peking Union Med Coll Hosp, Beijing, Peoples R China	Wenzhou Medical University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Lou, YL (corresponding author), Wenzhou Med Univ, Inst Med Virol, Wenzhou, Zhejiang, Peoples R China.	louyongliang2013@163.com; tanwj28@yahoo.cn			State Megaproject for Infectious Disease Research of China [2011ZX10004-001, 2013ZX10004601]; National Science Funds of China [81100062]	State Megaproject for Infectious Disease Research of China; National Science Funds of China	This work was supported by grants from the State Megaproject for Infectious Disease Research of China (2011ZX10004-001, 2013ZX10004601) and National Science Funds of China (81100062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, 9 INT COMM TAX VIR; Arbour N, 2000, J VIROL, V74, P8913, DOI 10.1128/JVI.74.19.8913-8921.2000; Bidokhti MRM, 2013, J GEN VIROL, V94, P2036, DOI 10.1099/vir.0.054940-0; Birch CJ, 2005, EPIDEMIOL INFECT, V133, P273, DOI 10.1017/S0950268804003346; Blanchard EG, 2011, J VIROL METHODS, V177, P100, DOI 10.1016/j.jviromet.2011.07.005; Cabeca TK, 2013, INFLUENZA OTHER RESP, V7, P1040, DOI 10.1111/irv.12101; Druce J, 2005, J MED VIROL, V75, P122, DOI 10.1002/jmv.20246; Esper F, 2010, J CLIN VIROL, V48, P131, DOI 10.1016/j.jcv.2010.03.007; Gagneur A, 2002, J HOSP INFECT, V51, P59, DOI 10.1053/jhin.2002.1179; Gaunt ER, 2010, J CLIN MICROBIOL, V48, P2940, DOI 10.1128/JCM.00636-10; Gerna G, 2006, J MED VIROL, V78, P938, DOI 10.1002/jmv.20645; GERNA G, 1985, J INFECT DIS, V151, P796, DOI 10.1093/infdis/151.5.796; Greenberg SB, 2011, SEMIN RESP CRIT CARE, V32, P433, DOI 10.1055/s-0031-1283283; Jean A, 2013, PEDIATR INFECT DIS J, V32, P325, DOI 10.1097/INF.0b013e3182812787; LAI MMC, 1992, MICROBIOL REV, V56, P61, DOI 10.1128/MMBR.56.1.61-79.1992; LARSON HE, 1980, J MED VIROL, V5, P221, DOI 10.1002/jmv.1890050306; Lau SKP, 2006, J CLIN MICROBIOL, V44, P2063, DOI 10.1128/JCM.02614-05; Lau SKP, 2011, J VIROL, V85, P11325, DOI 10.1128/JVI.05512-11; Liang FY, 2013, J VIROL METHODS, V187, P413, DOI 10.1016/j.jviromet.2012.11.009; Lu RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038638; MCINTOSH K, 1974, J INFECT DIS, V130, P502, DOI 10.1093/infdis/130.5.502; MCINTOSH K, 1967, P NATL ACAD SCI USA, V58, P2268, DOI 10.1073/pnas.58.6.2268; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Ren LL, 2011, J MED VIROL, V83, P291, DOI 10.1002/jmv.21956; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; St-Jean JR, 2004, J VIROL, V78, P8824, DOI 10.1128/JVI.78.16.8824-8834.2004; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TYRRELL DA, 1966, LANCET, V1, P76; Vabret A, 2003, CLIN INFECT DIS, V36, P985, DOI 10.1086/374222; Vabret A, 2001, J VIROL METHODS, V97, P59, DOI 10.1016/S0166-0934(01)00343-3; Vabret A, 2006, J GEN VIROL, V87, P3349, DOI 10.1099/vir.0.82065-0; van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; van der Hoek L, 2007, ANTIVIR THER, V12, P651; Vijaykrishna D, 2007, J VIROL, V81, P4012, DOI 10.1128/JVI.02605-06; Vijgen L, 2005, J CLIN MICROBIOL, V43, P5452, DOI 10.1128/JCM.43.11.5452-5456.2005; Vijgen L, 2005, VIROLOGY, V337, P85, DOI 10.1016/j.virol.2005.04.010; Vijgen L, 2005, J VIROL, V79, P1595, DOI 10.1128/JVI.79.3.1595-1604.2005; Vijgen L, 2006, J VIROL, V80, P7270, DOI 10.1128/JVI.02675-05; Woo PCY, 2010, VIRUSES-BASEL, V2, P1804, DOI 10.3390/v2081803; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Yu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032174; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	44	10	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100781	10.1371/journal.pone.0100781	http://dx.doi.org/10.1371/journal.pone.0100781			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987849	gold, Green Submitted, Green Published			2022-12-27	WOS:000341354100044
J	Park, JY; Zhang, X; Nguyen, N; Souza, RF; Spechler, SJ; Cheng, E				Park, Jason Y.; Zhang, Xi; Nathalie Nguyen; Souza, Rhonda F.; Spechler, Stuart J.; Cheng, Edaire			Proton Pump Inhibitors Decrease Eotaxin-3 Expression in the Proximal Esophagus of Children with Esophageal Eosinophilia	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX; CONSENSUS RECOMMENDATIONS; SWALLOWED FLUTICASONE; GENE-EXPRESSION; SQUAMOUS-CELLS; ESOMEPRAZOLE; HEALTHY	Objective: Besides reducing gastric acid secretion, proton pump inhibitors (PPIs) suppress Th2-cytokine-stimulated expression of an eosinophil chemoattractant (eotaxin-3) by esophageal epithelial cells through acid-independent, anti-inflammatory mechanisms. To explore acid-inhibitory and acid-independent, anti-inflammatory PPI effects in reducing esophageal eosinophilia, we studied eotaxin-3 expression by the proximal and distal esophagus of children with esophageal eosinophilia before and after PPI therapy. In vitro, we studied acid and bile salt effects on IL-13-stimulated eotaxin-3 expression by esophageal epithelial cells. Design: Among 264 children with esophageal eosinophilia seen at a tertiary pediatric hospital from 2008 through 2012, we identified 10 with esophageal biopsies before and after PPI treatment alone. We correlated epithelial cell eotaxin-3 immunostaining with eosinophil numbers in those biopsies. In vitro, we measured eotaxin-3 protein secretion by esophageal squamous cells stimulated with IL-13 and exposed to acid and/or bile salt media, with or without omeprazole. Results: There was strong correlation between peak eosinophil numbers and peak eotaxin-3-positive epithelial cell numbers in esophageal biopsies. Eotaxin-3 expression decreased significantly with PPIs only in the proximal esophagus. In esophageal cells, exposure to acid-bile salt medium significantly suppressed IL-13-induced eotaxin-3 secretion; omeprazole added to the acid-bile salt medium further suppressed that eotaxin-3 secretion, but not as profoundly as at pH-neutral conditions. Conclusion: In children with esophageal eosinophilia, PPIs significantly decrease eotaxin-3 expression in the proximal but not the distal esophagus. In esophageal squamous cells, acid and bile salts decrease Th2 cytokine-stimulated eotaxin-3 secretion profoundly, possibly explaining the disparate PPI effects on the proximal and distal esophagus. In the distal esophagus, where acid reflux is greatest, a PPI-induced reduction in acid reflux (an effect that could increase eotaxin-3 secretion induced by Th2 cytokines) might mask the acid-independent, anti-inflammatory PPI effect of decreasing cytokine-stimulated eotaxin-3 secretion.	[Park, Jason Y.; Zhang, Xi] Eugene McDermott Ctr Human Growth & Dev, Childrens Med Ctr, Dept Pathol, Esophageal Dis Ctr, Dallas, TX USA; [Park, Jason Y.; Zhang, Xi; Nathalie Nguyen; Souza, Rhonda F.; Spechler, Stuart J.; Cheng, Edaire] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Cheng, Edaire] VA North Texas Hlth Care Syst, Esophageal Dis Ctr, Dept Internal Med, Dallas, TX 75216 USA; [Nathalie Nguyen; Cheng, Edaire] Childrens Med Ctr, Dept Pediat, Dallas, TX 75235 USA; [Souza, Rhonda F.; Spechler, Stuart J.] VA North Texas Hlth Care Syst, Harold C Simmons Comprehens Canc Ctr, Esophageal Dis Ctr, Dept Internal Med, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	Cheng, E (corresponding author), VA North Texas Hlth Care Syst, Esophageal Dis Ctr, Dept Internal Med, Dallas, TX 75216 USA.	edaire.cheng@utsouthwestern.edu		Park, Jason/0000-0001-6797-4000	Office of Medical Research, Departments of Veterans Affairs; National Institutes of Health [R01-DK63621, R01-CA134571, K12-HD068369, K08-DK099383]; NASPGHAN Foundation/AstraZeneca Award; AGA Research Scholar Award; AAP Resident Research Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD068369] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA134571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063621, K08DK099383] Funding Source: NIH RePORTER	Office of Medical Research, Departments of Veterans Affairs; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASPGHAN Foundation/AstraZeneca Award; AGA Research Scholar Award; AAP Resident Research Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Office of Medical Research, Departments of Veterans Affairs (RFS, SJS), the National Institutes of Health (R01-DK63621 to RFS and SJS, R01-CA134571 to RFS and SJS, K12-HD068369 to EC, K08-DK099383 to EC), NASPGHAN Foundation/AstraZeneca Award (EC), AGA Research Scholar Award (EC), and AAP Resident Research Grant (NN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchard C, 2006, J CLIN INVEST, V116, P536, DOI 10.1172/JCI26679; Blanchard C, 2007, J ALLERGY CLIN IMMUN, V120, P1292, DOI 10.1016/j.jaci.2007.10.024; Cheng E, 2013, GUT, V62, P824, DOI 10.1136/gutjnl-2012-302250; Cortes JR, 2009, J ALLERGY CLIN IMMUN, V124, P607, DOI 10.1016/j.jaci.2009.06.023; DeBrosse CW, 2011, J ALLERGY CLIN IMMUN, V128, P132, DOI 10.1016/j.jaci.2011.05.006; Dellon ES, 2013, AM J GASTROENTEROL, V108, P1854, DOI 10.1038/ajg.2013.363; Dranove JE, 2009, J PEDIATR, V154, P96, DOI 10.1016/j.jpeds.2008.07.042; Frazzoni M, 2011, ALIMENT PHARM THER, V33, P601, DOI 10.1111/j.1365-2036.2010.04550.x; Furuta GT, 2007, GASTROENTEROLOGY, V133, P1342, DOI 10.1053/j.gastro.2007.08.017; Handa O, 2006, INFLAMM RES, V55, P476, DOI 10.1007/s00011-006-6056-4; Hirano I, 2007, AM J GASTROENTEROL, V102, P668, DOI 10.1111/j.1572-0241.2006.00936.x; Huo XF, 2014, GUT, V63, P1042, DOI 10.1136/gutjnl-2013-305533; Kauer WKH, 1997, SURGERY, V122, P874, DOI 10.1016/S0039-6060(97)90327-5; Kedika RR, 2009, DIGEST DIS SCI, V54, P2312, DOI 10.1007/s10620-009-0951-9; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Liu T, 2007, CARCINOGENESIS, V28, P488, DOI 10.1093/carcin/bgl176; Moawad FJ, 2013, AM J GASTROENTEROL, V108, P366, DOI 10.1038/ajg.2012.443; Molina-Infante J, 2013, GASTROENTEROLOGY, V144, pS484; Molina-Infante J, 2011, CLIN GASTROENTEROL H, V9, P110, DOI 10.1016/j.cgh.2010.09.019; Olsen EA, 2013, CURR OPIN ANESTHESIO, V26, P677, DOI 10.1097/ACO.0000000000000016; Peterson KA, 2010, DIGEST DIS SCI, V55, P1313, DOI 10.1007/s10620-009-0859-4; RICHTER JE, 1992, DIGEST DIS SCI, V37, P849, DOI 10.1007/BF01300382; Sasaki T, 2005, EUR J PHARMACOL, V509, P201, DOI 10.1016/j.ejphar.2004.12.042; Sayej WN, 2009, J PEDIATR GASTR NUTR, V49, P393, DOI 10.1097/MPG.0b013e31819c4b3e; Schroeder S, 2013, J PEDIATR GASTR NUTR, V56, P166, DOI 10.1097/MPG.0b013e3182716b7a; Spechler SJ, 2007, AM J GASTROENTEROL, V102, P1301, DOI 10.1111/j.1572-0241.2007.01179.x; Straumann A, 2001, J ALLERGY CLIN IMMUN, V108, P954, DOI 10.1067/mai.2001.119917; Straumann A, 2005, INFLAMM BOWEL DIS, V11, P720, DOI 10.1097/01.MIB.0000172557.39767.53; Straumann A, 2003, GASTROENTEROLOGY, V125, P1660, DOI 10.1053/j.gastro.2003.09.024; VANDENPLAS Y, 1991, PEDIATRICS, V88, P834; Zhang HY, 2008, AM J PHYSIOL-GASTR L, V295, pG470, DOI 10.1152/ajpgi.90262.2008; Zhang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050037	32	29	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101391	10.1371/journal.pone.0101391	http://dx.doi.org/10.1371/journal.pone.0101391			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988451	Green Published, Green Submitted, gold			2022-12-27	WOS:000341354100082
J	Wagh, K; Bhatia, A; Greenbaum, BD; Bhanot, G				Wagh, Kshitij; Bhatia, Aatish; Greenbaum, Benjamin D.; Bhanot, Gyan			Bird to Human Transmission Biases and Vaccine Escape Mutants in H5N1 Infections	PLOS ONE			English	Article							AVIAN INFLUENZA-VIRUS; HEMAGGLUTININ; EVOLUTION; ADAPTATION; MUTATIONS; SELECTION; BINDING; THREAT; EGYPT	Background: The avian influenza A H5N1 virus occasionally infects humans, with high mortality rates. Although all current human infections are from avian-to-human transmission, it has been shown that H5N1 can be evolved to transmit between mammals, and is therefore a pandemic threat. For H5N1 surveillance, it is of interest to identify the avian isolates most likely to infect humans. In this study, we develop a method to identify mutations significantly associated with avian to human transmission. Method: Using protein sequences for the surface glycoprotein hemagglutinin from avian and human H5N1 isolates in China, Egypt, and Indonesia from the years 1996-2011, we used Principle Component Analysis and a Maximum Likelihood Multinomial method to identify mutations associated with avian to human transmission. In each geographic region, transmission bias residues were identified using two signatures: a) significantly different amino-acid frequencies in human isolates compared to avian isolates from the same year, and b) significantly low probability of neutral evolution of the human isolates from the avian viral pool of the previous year. Results: In each geographic region, we find specific transmission bias mutations associated with human infections. These mutations are located in antigenic regions and receptor binding, glycosylation and polybasic cleavage sites of HA. We show that human isolates derive from a limited, subset of the avian pool characterized by geography specific mutations. In Egypt, two of three PCA clusters have very few human isolates but are highly enriched in mutations associated with a vaccine escape mutant H5N1 avian sub-clade that is known to be resistant to the Mexican H5N2 vaccine Furthermore, at these transmission bias associated residues, the mutations characteristic of these two clusters are distinct from those associated with the cluster enriched in human isolates, suggesting that vaccine resistant avian strains are unable to infect humans. Our results are relevant for surveillance and vaccination strategies for human H5N1 infections.	[Wagh, Kshitij; Bhatia, Aatish; Bhanot, Gyan] Rutgers State Univ, Dept Phys, Piscataway, NJ 08854 USA; [Wagh, Kshitij; Bhanot, Gyan] Canc Inst New Jersey, New Brunswick, NJ USA; [Greenbaum, Benjamin D.] Icahn Sch Med Mt Sinai, Dept Med, Div Hematol & Med Oncol, New York, NY 10029 USA; [Greenbaum, Benjamin D.] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Greenbaum, Benjamin D.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Greenbaum, Benjamin D.; Bhanot, Gyan] Simons Ctr Syst Biol, Inst Adv Study, Princeton, NJ USA; [Bhanot, Gyan] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA; [Bhanot, Gyan] Rutgers State Univ, BioMaPS Inst, Piscataway, NJ 08855 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Institute for Advanced Study - USA; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Bhanot, G (corresponding author), Rutgers State Univ, Dept Phys, Piscataway, NJ 08854 USA.	gyanbhanot@gmail.com	Wagh, Kshitij/ABB-5002-2020		Kavli Institute for Theoretical Physics at the University of California at Santa Barbara [NSF PHY11-25915]; Aspen Center for Physics through NSF [1066293]	Kavli Institute for Theoretical Physics at the University of California at Santa Barbara(University of California System); Aspen Center for Physics through NSF	BG was the Eric and Wendy Schmidt Member of the Institute for Advanced Study when this work was begun and would like to thank them for their support. GB thanks the Kavli Institute for Theoretical Physics at the University of California at Santa Barbara and the Aspen Center for Physics for partial support through NSF grant numbers NSF PHY11-25915 and 1066293 respectively, during the time this work was done. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwhab EM, 2012, VIRUS GENES, V45, P14, DOI 10.1007/s11262-012-0758-1; Arafa A, 2012, ARCH VIROL, V157, P1931, DOI 10.1007/s00705-012-1385-9; Cattoli G, 2011, J VIROL, V85, P8718, DOI 10.1128/JVI.02403-10; Cuong CD, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-99; Das SR, 2011, P NATL ACAD SCI USA, V108, pE1417, DOI 10.1073/pnas.1108754108; Duvvuri Venkata R. S. K., 2009, Genomics Proteomics & Bioinformatics, V7, P47, DOI 10.1016/S1672-0229(08)60032-7; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jones E., 2001, SCIPY OPEN SOURCE SC; Li CJ, 2014, TRENDS BIOTECHNOL, V32, P147, DOI 10.1016/j.tibtech.2014.01.001; Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068; Pan K, 2011, J R SOC INTERFACE, V8, P1644, DOI 10.1098/rsif.2011.0105; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Sambhara S, 2010, ANNU REV MED, V61, P187, DOI 10.1146/annurev.med.050908.132031; Smith GJD, 2006, VIROLOGY, V350, P258, DOI 10.1016/j.virol.2006.03.048; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Terregino C, 2010, AVIAN PATHOL, V39, P215, DOI 10.1080/03079451003781858; To KKW, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.24; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; Vijaykrishna D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000161; Watanabe Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002068; Wei KF, 2012, VIRUS GENES, V44, P450, DOI 10.1007/s11262-012-0717-x; World Health Organization, CUM NUMB CONF HUM CA; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264	28	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100754	10.1371/journal.pone.0100754	http://dx.doi.org/10.1371/journal.pone.0100754			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988306	Green Submitted, gold, Green Published			2022-12-27	WOS:000341354100040
J	Bari, MF; Weickert, MO; Sivakumar, K; James, SG; Snead, DRJ; Tan, BK; Randeva, HS; Bastie, CC; Vatish, M				Bari, Muhammad Furqan; Weickert, Martin O.; Sivakumar, Kavitha; James, Sean G.; Snead, David R. J.; Tan, Bee Kang; Randeva, Harpal Singh; Bastie, Claire Cecile; Vatish, Manu			Elevated Soluble CD163 in Gestational Diabetes Mellitus: Secretion from Human Placenta and Adipose Tissue	PLOS ONE			English	Article							HEMOGLOBIN SCAVENGER RECEPTOR; INSULIN-RESISTANCE; MACROPHAGE ACCUMULATION; SKELETAL-MUSCLE; PREGNANT-WOMEN; OBESITY; IDENTIFICATION; OVERWEIGHT; EXPRESSION; MANAGEMENT	Recently soluble CD163 (sCD163), a cleaved form of the macrophage receptor CD163, was identified as a macrophage-specific risk-predictor for developing Type 2 Diabetes. Here, we investigate circulating levels of sCD163 in gestational diabetes mellitus (GDM). Furthermore, given the role of the placenta in the pathogenesis of GDM, we assessed placental contribution to sCD163 secretion. Paired maternal (venous) and umbilical vein blood samples from GDM (n = 18) and Body Mass Index (BMI) matched control women (n = 20) delivered by caesarean section at 39-40 week gestation were assessed for circulating levels of sCD163, Tumour necrosis factor alpha (TNF-alpha) and Interleukin 6 (IL-6). Media from explant culture of maternal subcutaneous fat and corresponding placental tissues were assayed for these same molecules. CD163 positive cell numbers were determined in placental and adipose tissues of GDM and control women. We found significantly elevated circulating sCD163 levels in GDM mothers (688.4 +/- 46.9 ng/ml vs. 505.6 +/- 38.6 ng/ml) and their offspring (418.2 +/- 26.6 ng/ml vs. 336.3 +/- 24.4 ng/ml [p<0.05 for both]) as compared to controls, together with elevated circulating TNF-alpha and IL-6 levels. Moreover, both GDM placentae (268.1 +/- 10.8 ng/ml/mg vs. 187.6 +/- 20.6 ng/ml/mg) and adipose explants (41.1 +/- 2.7 ng/ml/mg vs. 26.6 +/- 2.4 ng/ml/mg) released significantly more sCD163 than controls. Lastly, significantly more CD163 positive cells were observed in GDM placentae (25.7 +/- 1.1 vs. 22.1 +/- 1.2) and adipose tissue (19.1 +/- 1.1 vs 12.7 +/- 0.9) compared to controls. We describe elevated sCD163 levels in GDM and identify human placenta as a novel source of sCD163 suggesting that placental tissues might contribute to the increased levels of circulating sCD163 in GDM pregnancies.	[Bari, Muhammad Furqan] Dow Int Med Coll, Dept Pathol, Karachi, Pakistan; [Bari, Muhammad Furqan; Weickert, Martin O.; Sivakumar, Kavitha; Tan, Bee Kang; Randeva, Harpal Singh; Bastie, Claire Cecile] Warwick Med Sch, Div Reprod & Metab, Coventry, W Midlands, England; [Bari, Muhammad Furqan; Weickert, Martin O.; Sivakumar, Kavitha; Tan, Bee Kang; Randeva, Harpal Singh; Bastie, Claire Cecile] Warwick Med Sch, Div Vasc Hlth, Coventry, W Midlands, England; [Weickert, Martin O.; James, Sean G.; Snead, David R. J.; Randeva, Harpal Singh] Univ Hosp Coventry & Warwickshire NHS Trust, Dept Pathol, Coventry, W Midlands, England; [Weickert, Martin O.; James, Sean G.; Snead, David R. J.; Randeva, Harpal Singh] Univ Hosp Coventry & Warwickshire NHS Trust, Dept Endocrinol, Coventry, W Midlands, England; [Bastie, Claire Cecile] Albert Einstein Coll Med, Dept Med & Endocrinol, Bronx, NY 10467 USA; [Vatish, Manu] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England	Dow University of Health Sciences; University of Warwick; University of Warwick; University of Warwick; University of Warwick; Yeshiva University; Albert Einstein College of Medicine; University of Oxford	Vatish, M (corresponding author), Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England.	manu.vatish@obs-gyn.ox.ac.uk	Vatish, Manu/B-4458-2018; vatish, manu/AAY-8750-2020	vatish, manu/0000-0002-6012-2574; Bastie, Claire/0000-0001-8178-4748; Weickert, Martin O/0000-0002-4070-8164	Nuffield Department of Obstetrics & Gynaecology, University of Oxford; National Institutes of Health [DK81412]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081412] Funding Source: NIH RePORTER	Nuffield Department of Obstetrics & Gynaecology, University of Oxford; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding for this study was provided by Nuffield Department of Obstetrics & Gynaecology, University of Oxford (MV) and the National Institutes of Health (DK81412)(CCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ategbo JM, 2006, J CLIN ENDOCR METAB, V91, P4137, DOI 10.1210/jc.2006-0980; Barbour LA, 2007, DIABETES CARE, V30, pS112, DOI 10.2337/dc07-s202; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; Challier JC, 2008, PLACENTA, V29, P274, DOI 10.1016/j.placenta.2007.12.010; Dabelea D, 2005, DIABETES CARE, V28, P579, DOI 10.2337/diacare.28.3.579; Desoye G, 2007, DIABETES CARE, V30, pS120, DOI 10.2337/dc07-s203; Endo S, 2006, GYNECOL ENDOCRINOL, V22, P343, DOI 10.1080/09513590600724836; GABBE SG, 1986, OBSTET GYNECOL, V67, P121; Gillman MW, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.3.e221; Gould PS, 2010, HYPERTENSION, V56, P172, DOI 10.1161/HYPERTENSIONAHA.110.152074; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Kracmerova J, 2014, J CLIN ENDOCRINOLOGY; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Lappas M, 2004, J CLIN ENDOCR METAB, V89, P5627, DOI 10.1210/jc.2003-032097; Levy AP, 2007, CIRC RES, V101, P106, DOI 10.1161/CIRCRESAHA.107.149435; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moller HJ, 2002, BLOOD, V99, P378, DOI 10.1182/blood.V99.1.378; Moller HJ, 2012, SCAND J CLIN LAB INV, V72, P1, DOI 10.3109/00365513.2011.626868; Moller HJ, 2011, CLIN CHEM, V57, P291, DOI 10.1373/clinchem.2010.154724; Paidas MJ, 2004, J THROMB HAEMOST, V2, P1009, DOI 10.1111/j.1538-7836.2004.00681.x; Parkner T, 2012, DIABETOLOGIA, V55, P1856, DOI 10.1007/s00125-012-2533-1; Rieusset J, 2004, DIABETES, V53, P2232, DOI 10.2337/diabetes.53.9.2232; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Siman CM, 2001, AM J PHYSIOL-REG I, V280, pR1116, DOI 10.1152/ajpregu.2001.280.4.R1116; Svensson J, 2011, J IMMUNOL, V187, P3671, DOI 10.4049/jimmunol.1100130; Tan BK, 2007, J CLIN ENDOCR METAB, V92, P2764, DOI 10.1210/jc.2007-0091; Tang ZH, 2013, ENDOCRINOLOGY, V154, P471, DOI 10.1210/en.2012-1575; Virjee S, 2001, J ROY SOC MED, V94, P502, DOI 10.1177/014107680109401003; Walker JD, 2008, DIABETIC MED, V25, P1025, DOI 10.1111/j.1464-5491.2008.02532.x; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Zanni MV, 2012, CLIN ENDOCRINOL, V77, P385, DOI 10.1111/j.1365-2265.2011.04284.x; Zeyda M, 2007, IMMUNOL LETT, V112, P61, DOI 10.1016/j.imlet.2007.07.003; ZWADLO G, 1987, EXP CELL BIOL, V55, P295	33	34	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101327	10.1371/journal.pone.0101327	http://dx.doi.org/10.1371/journal.pone.0101327			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983948	Green Published, gold			2022-12-27	WOS:000339635000089
J	Barnea, ER; Lubman, DM; Liu, YH; Absalon-Medina, V; Hayrabedyan, S; Todorova, K; Gilbert, RO; Guingab, J; Barder, TJ				Barnea, Eytan R.; Lubman, David M.; Liu, Yan-Hui; Absalon-Medina, Victor; Hayrabedyan, Soren; Todorova, Krassimira; Gilbert, Robert O.; Guingab, Joy; Barder, Timothy J.			Insight into PreImplantation Factor (PIF*) Mechanism for Embryo Protection and Development: Target Oxidative Stress and Protein Misfolding (PDI and HSP) through Essential RIPK Binding Site	PLOS ONE			English	Article							GROWTH-FACTOR-I; STATISTICAL-MODEL; PEP-FOLD; PREGNANCY; APOPTOSIS; EXPRESSION; BOVINE; THIOREDOXIN; RECEPTOR; SUBUNIT	Background: Endogenous PIF, upon which embryo development is dependent, is secreted only by viable mammalian embryos, and absent in non-viable ones. Synthetic PIF (sPIF) administration promotes singly cultured embryos development and protects against their demise caused by embryo-toxic serum. To identify and characterize critical sPIF-embryo protein interactions novel biochemical and bio-analytical methods were specifically devised. Methods: FITC-PIF uptake/binding by cultured murine and equine embryos was examined and compared with scrambled FITC-PIF (control). Murine embryo (d10) lysates were fractionated by reversed-phase HPLC, fractions printed onto microarray slides and probed with Biotin-PIF, IDE and Kv1.3 antibodies, using fluorescence detection. sPIF-based affinity column was developed to extract and identify PIF-protein interactions from lysates using peptide mass spectrometry (LC/MS/MS). In silico evaluation examined binding of PIF to critical targets, using mutation analysis. Results: PIF directly targets viable cultured embryos as compared with control peptide, which failed to bind. Multistep Biotin-PIF targets were confirmed by single-step PIF-affinity column based isolation. PIF binds protein disulfide isomerases a prolyl-4-hydroxylase beta-subunit, (PDI, PDIA4, PDIA6-like) containing the antioxidant thioredoxin domain. PIF also binds protective heat shock proteins (70&90), co-chaperone, BAG-3. Remarkably, PIF targets a common RIPK site in PDI and HSP proteins. Further, single PIF amino acid mutation significantly reduced peptide-protein target bonding. PIF binds promiscuous tubulins, neuron backbones and ACTA-1,2 visceral proteins. Significant anti-IDE, while limited anti-Kv1.3b antibody-binding to Biotin-PIF positive lysates HPLC fractions were documented. Conclusion: Collectively, data identifies PIF shared targets on PDI and HSP in the embryo. Such are known to play a critical role in protecting against oxidative stress and protein misfolding. PIF-affinity-column is a novel utilitarian method for small molecule targets direct identification. Data reveals and completes the understanding of mechanisms involved in PIF-induced autotrophic and protective effects on the embryo.	[Barnea, Eytan R.] SIEP Soc Invest Early Pregnancy, Cherry Hill, NJ 08003 USA; [Barnea, Eytan R.] BioIncept LLC, Res & Dev, Cherry Hill, NJ USA; [Barnea, Eytan R.] UMDNJ Robert Wood Johnson Med Sch, Dept Obstet Gynecol & Reprod, Camden, NJ USA; [Lubman, David M.; Liu, Yan-Hui] Univ Michigan, Med Ctr, Dept Surg, Ann Arbor, MI 48109 USA; [Absalon-Medina, Victor; Gilbert, Robert O.] Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA; [Hayrabedyan, Soren; Todorova, Krassimira] Bulgarian Acad Sci, Inst Biol & Immunol Reprod, BU-1113 Sofia, Bulgaria; [Guingab, Joy] Banyan Biomarkers, Chem Biol & Prote, Alachua, FL USA; [Barder, Timothy J.] Eprogen, Res & Dev, Downers Grove, IL USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Michigan System; University of Michigan; Cornell University; Bulgarian Academy of Sciences; Banyan Biomarkers Inc.	Barnea, ER (corresponding author), SIEP Soc Invest Early Pregnancy, Cherry Hill, NJ 08003 USA.	barnea@earlypregnancy.org	Barnea, Eytan/AAK-9467-2021; Hayrabedyan, Soren B/M-7527-2013; Barnea, Eytan/AAC-9910-2021; Gilbert, Robert/J-9107-2012	Barnea, Eytan/0000-0003-4677-4370; Hayrabedyan, Soren B/0000-0002-2147-1982; Gilbert, Robert/0000-0002-1528-243X; Todorova, Krassimira/0000-0002-4841-9156				Almogi-Hazan O., 2014, ROLE NITRIC OXIDE TO; Azar Y, 2013, BIOL BLOOD MARROW TR, V19, P519, DOI 10.1016/j.bbmt.2012.12.011; Barnea ER, 2004, AM J REPROD IMMUNOL, V51, P319, DOI 10.1111/j.1600-0897.2004.00159.x; Barnea ER, 1999, AM J REPROD IMMUNOL, V42, P95; BARNEA ER, 1994, AM J REPROD IMMUNOL, V32, P133, DOI 10.1111/j.1600-0897.1994.tb01103.x; Barnea ER, 2007, ANN NY ACAD SCI, V1110, P602, DOI 10.1196/annals.1423.064; Barnea ER, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.017; Barnea ER, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-50; Block J, 2007, THERIOGENOLOGY, V67, P1518, DOI 10.1016/j.theriogenology.2007.03.012; Brison Daniel R., 2000, Hum Fertil (Camb), V3, P36, DOI 10.1080/1464727002000198671; COULAM CB, 1995, AM J REPROD IMMUNOL, V34, P88, DOI 10.1111/j.1600-0897.1995.tb00923.x; Diaz-Cueto L, 2000, DEV BIOL, V217, P406, DOI 10.1006/dbio.1999.9564; Duzyj CM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.060; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930; Jeong DW, 2004, MOL CELLS, V17, P156; Jousan FD, 2008, MOL REPROD DEV, V75, P681, DOI 10.1002/mrd.20830; Kawamura K, 2005, ENDOCRINOLOGY, V146, P4105, DOI 10.1210/en.2004-1646; Kawamura K, 2007, BIOL REPROD, V76, P611, DOI 10.1095/biolreprod.106.058008; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kobayashi M, 2000, ANTIOXID REDOX SIGN, V2, P653, DOI 10.1089/ars.2000.2.4-653; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Matwee C, 2001, MOL HUM REPROD, V7, P829, DOI 10.1093/molehr/7.9.829; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; Migliara G, 2014, SIICA FLOR IT; Muller M, 2013, DGPM GERM C PER MED; Muller M, 2014, PREIMPLANTATION FACT; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Paidas MJ, 2012, AM J REPROD IMMUNOL, V68, P456, DOI 10.1111/j.1600-0897.2012.01170.x; Paidas MJ, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.024; Ramu S, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-105; ROUSSEV RG, 1995, AM J REPROD IMMUNOL, V33, P68, DOI 10.1111/j.1600-0897.1995.tb01140.x; Roussev RG, 1996, AM J REPROD IMMUNOL, V35, P281; Roussev RG, 2013, REPROD BIOMED ONLINE, V26, P79, DOI 10.1016/j.rbmo.2012.09.017; Ruan L, 2011, ARTERIOSCL THROM VAS, V31, P392, DOI 10.1161/ATVBAHA.110.213181; Shainer R, 2013, C PAPERS MED, V2013, P1; Sjoblom C, 2002, BIOL REPROD, V67, P1817, DOI 10.1095/biolreprod.101.001503; Stamatkin CW, 2011, REPROD BIOMED ONLINE, V23, P517, DOI 10.1016/j.rbmo.2011.06.009; Stamatkin CW, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-63; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Thevenet P, 2012, NUCLEIC ACIDS RES, V40, pW288, DOI 10.1093/nar/gks419; Turner K, 1997, J REPROD FERTIL, V111, P259, DOI 10.1530/jrf.0.1110259; Walls JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002853; Wei ZX, 2001, MOL REPROD DEV, V60, P457, DOI 10.1002/mrd.1110; Weiss L, 2012, J NEUROL SCI, V312, P146, DOI 10.1016/j.jns.2011.07.050; Weiss L, 2011, ENDOCRINE, V40, P41, DOI 10.1007/s12020-011-9438-5; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Xu JS, 2004, HUM REPROD, V19, P2919, DOI 10.1093/humrep/deh497	47	27	29	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100263	10.1371/journal.pone.0100263	http://dx.doi.org/10.1371/journal.pone.0100263			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983882	gold, Green Published, Green Submitted			2022-12-27	WOS:000339635000018
J	Dai, CQ; Wang, Y				Dai, Chao-Qing; Wang, Yan			Three-Dimensional Structures of the Spatiotemporal Nonlinear Schrodinger Equation with Power-Law Nonlinearity in PT-Symmetric Potentials	PLOS ONE			English	Article							SOLITONS	The spatiotemporal nonlinear Schrodinger equation with power-law nonlinearity in PT-symmetric potentials is investigated, and two families of analytical three-dimensional spatiotemporal structure solutions are obtained. The stability of these solutions is tested by the linear stability analysis and the direct numerical simulation. Results indicate that solutions are stable below some thresholds for the imaginary part of PT-symmetric potentials in the self-focusing medium, while they are always unstable for all parameters in the self-defocusing medium. Moreover, some dynamical properties of these solutions are discussed, such as the phase switch, power and transverse power-flow density. The span of phase switch gradually enlarges with the decrease of the competing parameter k in PT-symmetric potentials. The power and power-flow density are all positive, which implies that the power flow and exchange from the gain toward the loss domains in the PT cell.	[Dai, Chao-Qing] Zhejiang Agr & Forestry Univ, Sch Sci, Linan, Zhejiang, Peoples R China; [Dai, Chao-Qing] Australian Natl Univ, Opt Sci Grp, Res Sch Phys & Engn, Canberra, ACT, Australia; [Wang, Yan] Shanxi Univ, Inst Theoret Phys, Taiyuan, Peoples R China	Zhejiang A&F University; Australian National University; Shanxi University	Dai, CQ (corresponding author), Zhejiang Agr & Forestry Univ, Sch Sci, Linan, Zhejiang, Peoples R China.	dcq424@126.com	Dai, Chaoqing/K-3299-2013	Dai, Chao-Qing/0000-0001-9743-0143	National Natural Science Foundation of China [11375007]; Zhejiang Provincial Natural Science Foundation of China [LY13F050006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	Funded by the National Natural Science Foundation of China (Grant No. 11375007), the Zhejiang Provincial Natural Science Foundation of China (Grant No. LY13F050006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz M., 1965, HDB MATH FUNCTIONS F, P555; Achilleos V, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.013808; Bender CM, 1998, PHYS REV LETT, V80, P5243, DOI 10.1103/PhysRevLett.80.5243; Bronski JC, 2001, PHYS REV LETT, V86, P1402, DOI 10.1103/PhysRevLett.86.1402; Dai CQ, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.013834; Dai CQ, 2014, LASER PHYS, V24, DOI 10.1088/1054-660X/24/3/035401; Dai CQWangYY, 2010, OPT LETT, V35, P1437, DOI DOI 10.1364/OL.35.001437; Guo A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.093902; Khare A, 2012, PHYS LETT A, V376, P2880, DOI 10.1016/j.physleta.2012.09.047; Liu WJ, 2013, LASER PHYS, V23, DOI 10.1088/1054-660X/23/9/095401; Lu X, 2013, NONLINEAR DYNAM, V73, P405, DOI 10.1007/s11071-013-0795-x; Midya B, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.045803; Musslimani ZH, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.030402; Naher H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064618; Ruter CE, 2010, NAT PHYS, V6, P192, DOI 10.1038/NPHYS1515; Serkin VN, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.074102; Weise LD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021934; Xu YJ, 2014, OPT COMMUN, V318, P112, DOI 10.1016/j.optcom.2013.12.087; Yang J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021128, 10.1371/journal.pone.0024111]; Zhong WP, 2012, NONLINEAR DYNAM, V70, P2027, DOI 10.1007/s11071-012-0594-9; Zhu HP, 2013, NONLINEAR DYNAM, V72, P873, DOI 10.1007/s11071-013-0759-1	21	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100484	10.1371/journal.pone.0100484	http://dx.doi.org/10.1371/journal.pone.0100484			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983624	gold, Green Submitted, Green Published			2022-12-27	WOS:000339635000026
J	Grassilli, E; Ianzano, L; Bonomo, S; Missaglia, C; Cerrito, MG; Giovannoni, R; Masiero, L; Lavitrano, M				Grassilli, Emanuela; Ianzano, Leonarda; Bonomo, Sara; Missaglia, Carola; Cerrito, Maria Grazia; Giovannoni, Roberto; Masiero, Laura; Lavitrano, Marialuisa			GSK3A Is Redundant with GSK3B in Modulating Drug Resistance and Chemotherapy-Induced Necroptosis	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; PANCREATIC-CANCER; ACTIVATION; PATHWAYS; REPAIR; GLYCOGEN-SYNTHASE-KINASE-3-BETA; MAINTENANCE; INHIBITION; APOPTOSIS; GROWTH	Glycogen Synthase Kinase-3 alpha (GSK3A) and beta (GSK3B) isoforms are encoded by distinct genes, are 98% identical within their kinase domain and perform similar functions in several settings; however, they are not completely redundant and, depending on the cell type and differentiative status, they also play unique roles. We recently identified a role for GSK3B in drug resistance by demonstrating that its inhibition enables necroptosis in response to chemotherapy in p53-null drug-resistant colon carcinoma cells. We report here that, similarly to GSK3B, also GSK3A silencing/inhibition does not affect cell proliferation or cell cycle but only abolishes growth after treatment with DNA-damaging chemotherapy. In particular, blocking GSK3A impairs DNA repair upon exposure to DNA-damaging drugs. As a consequence, p53-null cells overcome their inability to undergo apoptosis and mount a necroptotic response, characterized by absence of caspase activation and RIP1-independent, PARP-dependent AIF nuclear re-localization. We therefore conclude that GSK3A is redundant with GSK3B in regulating drug-resistance and chemotherapy-induced necroptosis and suggest that inhibition of only one isoform, or rather partial inhibition of overall cellular GSK3 activity, is enough to re-sensitize drug-resistant cells to chemotherapy.	[Grassilli, Emanuela; Ianzano, Leonarda; Bonomo, Sara; Missaglia, Carola; Cerrito, Maria Grazia; Giovannoni, Roberto; Masiero, Laura; Lavitrano, Marialuisa] Univ Milano Bicocca, Dept Surg & Traslat Med, Sch Med, Monza, Italy; [Grassilli, Emanuela] BiOnSil Srl, Monza, Italy	University of Milano-Bicocca	Grassilli, E (corresponding author), Univ Milano Bicocca, Dept Surg & Traslat Med, Sch Med, Via Cadore 48, Monza, Italy.	emanuela.grassilli@unimib.it; marialuisa.lavitrano@unimib.it	grassilli, emanuela/ABB-7845-2020; Cerrito, Maria Grazia/AAA-1190-2019; Giovannoni, Roberto/A-1413-2009; Grassilli, Emanuela/L-7296-2013	grassilli, emanuela/0000-0001-5387-5925; Cerrito, Maria Grazia/0000-0002-3347-5817; Giovannoni, Roberto/0000-0002-7706-0672; Grassilli, Emanuela/0000-0001-5387-5925; Lavitrano, Marialuisa/0000-0003-4852-1318	MIUR [PON01_02782]; University of Milano-Bicocca	MIUR(Ministry of Education, Universities and Research (MIUR)); University of Milano-Bicocca	All authors are supported by PON01_02782 from MIUR and F. A. R. grants from the University of Milano-Bicocca to ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Deng H, 2008, J BIOL CHEM, V283, P10198, DOI 10.1074/jbc.M800624200; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Gatz SA, 2006, CELL DEATH DIFFER, V13, P1003, DOI 10.1038/sj.cdd.4401903; Giannopoulou M, 2008, AM J PATHOL, V173, P30, DOI 10.2353/ajpath.2008.070583; Grassilli E, 2004, J BIOL CHEM, V279, P21318, DOI 10.1074/jbc.M313532200; Grassilli E, 2013, CLIN CANCER RES, V19, P3820, DOI 10.1158/1078-0432.CCR-12-3289; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Ivanov A, 2003, J CELL SCI, V116, P4095, DOI 10.1242/jcs.00740; Liang MH, 2006, J BIOL CHEM, V281, P30479, DOI 10.1074/jbc.M607468200; MacAulay K, 2007, CELL METAB, V6, P329, DOI 10.1016/j.cmet.2007.08.013; Madhunapantula SV, 2013, PIGM CELL MELANOMA R, V26, P886, DOI DOI 10.1111/PCMR.12156; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Mills CN, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00047; Mishra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-144; Oakley GG, 2010, FRONT BIOSCI-LANDMRK, V15, P883, DOI 10.2741/3652; Ougolkov AV, 2006, CLIN CANCER RES, V12, P5074, DOI 10.1158/1078-0432.CCR-06-0196; Piazza F, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-526; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Schutz SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025341; Sigoillot FD, 2011, ACS CHEM BIOL, V6, P47, DOI 10.1021/cb100358f; Tanioka T, 2011, J BIOL CHEM, V286, P29388, DOI 10.1074/jbc.M110.192732; Thorn CF, 2011, PHARMACOGENET GENOM, V21, P237, DOI 10.1097/FPC.0b013e32833c6107; Wang Z, 2008, NATURE, V455, P1205, DOI 10.1038/nature07284; Wilson W, 2008, CANCER RES, V68, P8156, DOI 10.1158/0008-5472.CAN-08-1061; Zhou JB, 2013, J CLIN INVEST, V123, P1821, DOI 10.1172/JCI64398	28	21	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100947	10.1371/journal.pone.0100947	http://dx.doi.org/10.1371/journal.pone.0100947			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984063	Green Published, Green Submitted, gold			2022-12-27	WOS:000339635000042
J	Robker, RL; Watson, LN; Robertson, SA; Dunning, KR; McLaughlin, EA; Russell, DL				Robker, Rebecca L.; Watson, Laura N.; Robertson, Sarah A.; Dunning, Kylie R.; McLaughlin, Eileen A.; Russell, Darryl L.			Identification of Sites of STAT3 Action in the Female Reproductive Tract through Conditional Gene Deletion	PLOS ONE			English	Article							SIGNAL TRANSDUCER; TROPHOBLAST INVASION; GROWTH-FACTORS; PREIMPLANTATION EMBRYO; OVARIAN-FOLLICLE; GRANULOSA-CELLS; EXPRESSION; MOUSE; IMPLANTATION; ACTIVATION	The STAT3 transcription factor is a pleiotropic transducer of signalling by hormones, growth factors and cytokines that has been identified in the female reproductive tract from oocytes and granulosa cells of the ovary to uterine epithelial and stromal cells. In the present study we used transgenic models to investigate the importance of STAT3 for reproductive performance in these different tissues. The Cre-LoxP system was used to delete STAT3 in oocytes by crossing Stat3(fl/fl) with Zp3-cre+ mice, or in ovarian granulosa cells and uterine stroma by crossing with Amhr2-Cre+ mice. Surprisingly, deletion of STAT3 in oocytes had no effect on fertility indicating that the abundance of STAT3 protein in maturing oocytes and fertilized zygotes is not essential to these developmental stages. In Stat3(fl/fl);Amhr2-cre+ females impaired fertility was observed through significantly fewer litters and smaller litter size. Ovulation rate, oocyte fertilization and development to blastocyst were unaffected in this line; however, poor recombination efficiency in granulosa cells had yielded no net change in STAT3 protein abundance. In contrast, uteri from these mice showed STAT3 protein depletion selectively from the stomal compartment. A significant reduction in number of viable fetuses on gestational day 18, increased fetal resorptions and disrupted placental morphology were evident causes of the reduced fertility. In conclusion, this study defines an important role for STAT3 in uterine stromal cells during embryo implantation and the development of a functional placenta.	[Robker, Rebecca L.; Watson, Laura N.; Robertson, Sarah A.; Dunning, Kylie R.; Russell, Darryl L.] Univ Adelaide, Robinson Res Inst, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia; [McLaughlin, Eileen A.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia	Robinson Research Institute; University of Adelaide; University of Newcastle	Russell, DL (corresponding author), Univ Adelaide, Robinson Res Inst, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia.	Darryl.Russell@adelaide.edu.au	Robertson, Sarah A/C-8182-2009; Russell, Darryl L/I-6654-2012; McLaughlin, Eileen/AAF-5588-2021; McLaughlin, Eileen A/G-7620-2013; Dunning, Kylie/GLU-0471-2022	Robertson, Sarah A/0000-0002-9967-0084; Russell, Darryl L/0000-0002-4930-7658; Dunning, Kylie/0000-0002-0462-6479; McLaughlin, Eileen/0000-0002-5837-3876; Robker, Rebecca/0000-0002-1538-4604	Australian Research Council [DP0878355]; Future Fellowship [FT0990785]	Australian Research Council(Australian Research Council); Future Fellowship(Australian Research Council)	Supported by the Australian Research Council through Discovery Grant DP0878355 and Future Fellowship to DLR FT0990785, www.arc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzi T, 2001, MOL CELL BIOL, V21, P1621, DOI 10.1128/MCB.21.5.1621-1632.2001; Boyer A, 2010, FASEB J, V24, P3010, DOI 10.1096/fj.09-145789; Brown HM, 2010, BIOL REPROD, V83, P549, DOI 10.1095/biolreprod.110.084434; Burton GJ, 2012, PLACENTA, V33, pS23, DOI 10.1016/j.placenta.2011.11.013; Cheng JG, 2001, P NATL ACAD SCI USA, V98, P8680, DOI 10.1073/pnas.151180898; Do DV, 2013, GENE DEV, V27, P1378, DOI 10.1101/gad.221176.113; Dimitriadis E, 2005, HUM REPROD UPDATE, V11, P613, DOI 10.1093/humupd/dmi023; Dimitriadis E, 2010, PLACENTA, V31, pS99, DOI 10.1016/j.placenta.2009.12.027; Ernst M, 2001, J EXP MED, V194, P189, DOI 10.1084/jem.194.2.189; Fitzgerald JS, 2008, HUM REPROD UPDATE, V14, P335, DOI 10.1093/humupd/dmn010; Fowden AL, 2008, J NEUROENDOCRINOL, V20, P439, DOI 10.1111/j.1365-2826.2008.01663.x; Gonzalez G, 2009, MOL REPROD DEV, V76, P678, DOI 10.1002/mrd.21010; Hardy K, 2002, J ENDOCRINOL, V172, P221, DOI 10.1677/joe.0.1720221; Jamin SP, 2002, NAT GENET, V32, P408, DOI 10.1038/ng1003; Kim H, 2009, BIOL REPROD, V81, P1002, DOI 10.1095/biolreprod.108.070599; Lague MN, 2010, AM J PHYSIOL-ENDOC M, V299, pE936, DOI 10.1152/ajpendo.00255.2010; Lee JH, 2013, FASEB J, V27, P2553, DOI 10.1096/fj.12-225664; Lei L, 2010, MOL CELL ENDOCRINOL, V315, P63, DOI 10.1016/j.mce.2009.09.021; Liu ZL, 2009, ENDOCRINOLOGY, V150, P3360, DOI 10.1210/en.2008-1532; Merhi Z, 2013, HUM REPROD, V28, P1661, DOI 10.1093/humrep/det072; Murphy K, 2005, GENE EXPR PATTERNS, V5, P475, DOI 10.1016/j.modgep.2004.12.007; Nakamura H, 2006, FEBS LETT, V580, P2717, DOI 10.1016/j.febslet.2006.04.029; Patterson AL, 2013, STEM CELLS DEV, V22, P964, DOI 10.1089/scd.2012.0435; Pawar S, 2013, MOL ENDOCRINOL; Poehlmann TG, 2005, PLACENTA, V26, pS37, DOI 10.1016/j.placenta.2005.01.007; Prins JR, 2012, J REPROD IMMUNOL, V95, P1, DOI 10.1016/j.jri.2012.05.004; Regis G, 2008, SEMIN CELL DEV BIOL, V19, P351, DOI 10.1016/j.semcdb.2008.06.004; Ren Y, 2009, MOL ENDOCRINOL, V23, P711, DOI 10.1210/me.2008-0391; Richards JS, 2010, J CLIN INVEST, V120, P963, DOI 10.1172/JCI41350; Richards JS, 2002, RECENT PROG HORM RES, V57, P195, DOI 10.1210/rp.57.1.195; Richter KS, 2008, CURR OPIN OBSTET GYN, V20, P292, DOI 10.1097/GCO.0b013e3282fe743b; Robb L, 1998, NAT MED, V4, P303, DOI 10.1038/nm0398-303; Ruiz-Cortes ZT, 2003, BIOL REPROD, V68, P789, DOI 10.1095/biolreprod.102.010702; Russell DL, 1999, MOL ENDOCRINOL, V13, P2049, DOI 10.1210/me.13.12.2049; Russell DL, 1996, BIOL REPROD, V55, P1029, DOI 10.1095/biolreprod55.5.1029; Sferruzzi-Perri AN, 2009, BIOL REPROD, V81, P207, DOI 10.1095/biolreprod.108.073312; Shen XH, 2009, MOL REPROD DEV, V76, P854, DOI 10.1002/mrd.21048; Singh M, 2011, J ENDOCRINOL, V210, P5, DOI 10.1530/JOE-10-0461; Sirard MA, 2011, J ASSIST REPROD GEN, V28, P483, DOI 10.1007/s10815-011-9554-4; Sobinoff AP, 2013, MOL HUM REPROD, V19, P265, DOI 10.1093/molehr/gas065; Suman P, 2009, J REPROD IMMUNOL, V82, P1, DOI 10.1016/j.jri.2009.07.002; Sutherland JM, 2012, J CELL PHYSIOL, V227, P1188, DOI 10.1002/jcp.22837; Teng CB, 2004, MOL REPROD DEV, V69, P1, DOI 10.1002/mrd.20149; Teng CB, 2004, REPRODUCTION, V128, P197, DOI 10.1530/rep.1.00053; Truchet S, 2004, BIOL REPROD, V71, P1330, DOI 10.1095/biolreprod.104.029405; Wen LH, 2006, REPRODUCTION, V132, P511, DOI 10.1530/rep.1.01055; Zhang XH, 2013, MOL CELL ENDOCRINOL, V381, P272, DOI 10.1016/j.mce.2013.08.011	47	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101182	10.1371/journal.pone.0101182	http://dx.doi.org/10.1371/journal.pone.0101182			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983622	Green Published, gold			2022-12-27	WOS:000339635000066
J	Tuite, AR; Burchell, AN; Fisman, DN				Tuite, Ashleigh R.; Burchell, Ann N.; Fisman, David N.			Cost-Effectiveness of Enhanced Syphilis Screening among HIV-Positive Men Who Have Sex with Men: A Microsimulation Model	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; SINGLE-DOSE AZITHROMYCIN; UNITED-STATES; SECONDARY SYPHILIS; SEROLOGIC TESTS; TRANSMISSION; RESURGENCE; COMMUNITY; THERAPY; PREVALENCE	Background: Syphilis co-infection risk has increased substantially among HIV-infected men who have sex with men (MSM). Frequent screening for syphilis and treatment of men who test positive might be a practical means of controlling the risk of infection and disease sequelae in this population. Purpose: We evaluated the cost-effectiveness of strategies that increased the frequency and population coverage of syphilis screening in HIV-infected MSM receiving HIV care, relative to current standard of care. Methods: We developed a state-transition microsimulation model of syphilis natural history and medical care in HIV-infected MSM receiving care for HIV. We performed Monte Carlo simulations using input data derived from a large observational cohort in Ontario, Canada, and from published biomedical literature. Simulations compared usual care (57% of the population screened annually) to different combinations of more frequent (3-or 6-monthly) screening and higher coverage (100% screened). We estimated expected disease-specific outcomes, quality-adjusted survival, costs, and cost-effectiveness associated with each strategy from the perspective of a public health care payer. Results: Usual care was more costly and less effective than strategies with more frequent or higher coverage screening. Higher coverage strategies (with screening frequency of 3 or 6 months) were expected to be cost-effective based on usually cited willingness-to-pay thresholds. These findings were robust in the face of probabilistic sensitivity analyses, alternate cost-effectiveness thresholds, and alternate assumptions about duration of risk, program characteristics, and management of underlying HIV. Conclusions: We project that higher coverage and more frequent syphilis screening of HIV-infected MSM would be a highly cost-effective health intervention, with many potentially viable screening strategies projected to both save costs and improve health when compared to usual care. The baseline requirement for regular blood testing in this group (i.e., for viral load monitoring) makes intensification of syphilis screening appear readily practicable.	[Tuite, Ashleigh R.; Fisman, David N.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Tuite, Ashleigh R.; Burchell, Ann N.; Fisman, David N.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Burchell, Ann N.] Ontario HIV Treatment Network, Toronto, ON, Canada; [Fisman, David N.] Univ Toronto, Fac Med, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto	Tuite, AR (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.	ashleigh.tuite@utoronto.ca			Frederick Banting and Charles Best Canada Graduate Scholarship from the Canadian Institutes of Health Research (CIHR); CIHR New Investigator award	Frederick Banting and Charles Best Canada Graduate Scholarship from the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR New Investigator award(Canadian Institutes of Health Research (CIHR))	ART is supported by a Frederick Banting and Charles Best Canada Graduate Scholarship from the Canadian Institutes of Health Research (CIHR). ANB is supported by a CIHR New Investigator award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ONT HLTH INS SCHED B; Aral SO, 2007, SEX TRANSM INFECT, V83; Ballini A, 2012, J SEX MED, V9, P372, DOI 10.1111/j.1743-6109.2011.02515.x; BECK JR, 1982, AM J MED, V73, P883, DOI 10.1016/0002-9343(82)90786-0; Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51; Bissessor M, 2009, INT J STD AIDS, V20, P52, DOI 10.1258/ijsa.2008.008254; Bissessor M, 2010, JAIDS-J ACQ IMM DEF, V55, P211, DOI 10.1097/QAI.0b013e3181e583bf; Blandford JM, 2003, SEX TRANSM DIS, V30, P502, DOI 10.1097/00007435-200306000-00006; Blandford JM, 2007, SEX TRANSM DIS, V34, pS61, DOI 10.1097/01.olq.0000258314.20752.5f; Blank LJ, 2011, SEX TRANSM INFECT, V87, P9, DOI 10.1136/sti.2010.043893; Briggs A, 2005, VALUE HEALTH, V8, P1, DOI 10.1111/j.1524-4733.2005.08101.x; Burchell AN, 2012, 21 ANN CAN C HIV AID; Burchell AN, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-246; Canadian Agency for Drugs and Technologies in Health (CADTH), 2017, GUID EC EV HLTH TECH; Chanem KG, 2008, AIDS, V22, P1145, DOI 10.1097/QAD.0b013e32830184df; Cook J, 1999, AIDS RES HUM RETROV, V15, P499, DOI 10.1089/088922299311024; Deeks SG, 1999, AIDS, V13, pF35, DOI 10.1097/00002030-199904160-00001; Drusano GL, 1998, ANTIMICROB AGENTS CH, V42, P358; Fenton KA, 2001, SEX TRANSM INFECT, V77, P309, DOI 10.1136/sti.77.5.309; Fenton KA, 2008, LANCET INFECT DIS, V8, P244, DOI 10.1016/S1473-3099(08)70065-3; Fisman DN, 2012, VACCINE, V30, P7601, DOI 10.1016/j.vaccine.2012.10.034; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Garnett GP, 1997, SEX TRANSM DIS, V24, P185, DOI 10.1097/00007435-199704000-00002; Golden MR, 2003, JAMA-J AM MED ASSOC, V290, P1510, DOI 10.1001/jama.290.11.1510; Goswami ND, 2013, SEX TRANSM DIS, V40, P839, DOI 10.1097/OLQ.0000000000000025; Grap MJ, 2012, J EMERG MED, V42, P353, DOI 10.1016/j.jemermed.2010.05.042; Gray RT, 2010, SEX TRANSM DIS, V37, P298, DOI 10.1097/OLQ.0b013e3181ca3c0a; Heffelfinger JD, 2007, AM J PUBLIC HEALTH, V97, P1076, DOI 10.2105/AJPH.2005.070417; JACKMAN JD, 1989, AM J MED, V87, P425, DOI 10.1016/S0002-9343(89)80826-5; Kourbatova EV, 2008, SEX TRANSM DIS, V35, P453, DOI 10.1097/OLQ.0b013e31816f1c65; Kwong JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044103; Larsen SA, 1998, MANUAL TESTS SYPHILI; Leber A, 2008, CAN J PUBLIC HEALTH, V99, P401, DOI 10.1007/BF03405250; Lee Ma, 2007, Morbidity and Mortality Weekly Report, V56, P625; Lukehart SA, 2006, SEX TRANSM DIS, P311; Marcus U, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-181; Marra CM, 2004, J INFECT DIS, V189, P369, DOI 10.1086/381227; Mishra S, 2011, SEX TRANSM DIS, V38, P190, DOI 10.1097/OLQ.0b013e3181f07e91; Mocroft A, 1998, AIDS, V12, P2161, DOI 10.1097/00002030-199816000-00011; Muldoon E, 2011, INT J STD AIDS, V22, P493, DOI 10.1258/ijsa.2011.010438; Owusu-Edusei K, 2013, SEX TRANSM DIS, V40, P197, DOI 10.1097/OLQ.0b013e318285c6d2; Owusu-Edusei K, 2011, SEX TRANSM DIS, V38, P448, DOI 10.1097/OLQ.0b013e3182036a0f; Owusu-Edusei K, 2011, SEX TRANSM DIS, V38, P1, DOI 10.1097/OLQ.0b013e3181ec51f1; Pathela P, 2011, JAIDS-J ACQ IMM DEF, V58, P408, DOI 10.1097/QAI.0b013e318230e1ca; Pepper PV, 2002, MED DECIS MAKING, V22, pS45, DOI 10.1177/027298902237705; Pitman R, 2012, MED DECIS MAKING, V32, P712, DOI 10.1177/0272989X12454578; Public Health Agency of Canada, 2010, CAN GUID SEX TRANSM; Rhone SA, 1998, AIDS, V12, P619, DOI 10.1097/00002030-199806000-00011; Riedner G, 2005, NEW ENGL J MED, V353, P1236, DOI 10.1056/NEJMoa044284; Rolfs RT, 1997, NEW ENGL J MED, V337, P307, DOI 10.1056/NEJM199707313370504; Rourke SB, 2013, INT J EPIDEMIOL, V42, P402, DOI 10.1093/ije/dyr230; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Sena AC, 2010, CLIN INFECT DIS, V51, P700, DOI 10.1086/655832; SHAFER JK, 1954, PUBLIC HEALTH REP, V69, P684, DOI 10.2307/4588863; Siebert U, 2012, MED DECIS MAKING, V32, P690, DOI 10.1177/0272989X12455463; Singh AE, 1999, CLIN MICROBIOL REV, V12, P187, DOI 10.1128/CMR.12.2.187; Statistics Canada, 2006, COMPL LIF TABL CAN 2; Sullivan PS, 2009, ANN EPIDEMIOL, V19, P423, DOI 10.1016/j.annepidem.2009.03.004; Torrone EA, 2011, JAIDS-J ACQ IMM DEF, V58, P328, DOI 10.1097/QAI.0b013e31822e1075; TSEVAT J, 1989, AM J PUBLIC HEALTH, V79, P739, DOI 10.2105/AJPH.79.6.739; Tuite AR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-606; Turnbull DK, 2003, BRIT J ANAESTH, V91, P718, DOI 10.1093/bja/aeg231; Ward MJ, 2012, ACAD EMERG MED, V19, P1134, DOI 10.1111/j.1553-2712.2012.01455.x; WHO-CHOICE, CHOOS INT AR COST EF; World Health Organization, 2008, GLOBAL BURDEN DIS	65	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101240	10.1371/journal.pone.0101240	http://dx.doi.org/10.1371/journal.pone.0101240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1UX	24983455	gold, Green Submitted, Green Published			2022-12-27	WOS:000339635000075
J	Akilzhanova, A; Guelly, C; Nuralinov, O; Nurkina, Z; Nazhat, D; Smagulov, S; Tursunbekov, A; Alzhanova, A; Rashbayeva, G; Abdrakhmanov, A; Dosmagambet, S; Trajanoski, S; Zhumadilov, Z; Sharman, A; Bekbosynova, M				Akilzhanova, Ainur; Guelly, Christian; Nuralinov, Omirbek; Nurkina, Zhannur; Nazhat, Dinara; Smagulov, Shalkhar; Tursunbekov, Azat; Alzhanova, Anar; Rashbayeva, Gulzhaina; Abdrakhmanov, Ayan; Dosmagambet, Sholpan; Trajanoski, Slave; Zhumadilov, Zhaxybay; Sharman, Almaz; Bekbosynova, Mahabbat			RYR2 Sequencing Reveals Novel Missense Mutations in a Kazakh Idiopathic Ventricular Tachycardia Study Cohort	PLOS ONE			English	Article							LONG-QT SYNDROME; RYANODINE RECEPTOR GENE; SUDDEN-DEATH; ARRHYTHMIAS; VARIANTS; CHANNELOPATHIES; MANAGEMENT; RELEASE; CHANNEL; ARVD2	Channelopathies, caused by disturbed potassium or calcium ion management in cardiac myocytes are a major cause of heart failure and sudden cardiac death worldwide. The human ryanodine receptor 2 (RYR2) is one of the key players tightly regulating calcium efflux from the sarcoplasmic reticulum to the cytosol and found frequently mutated (<60%) in context of catecholaminergic polymorphic ventricular tachycardia (CPVT1). We tested 35 Kazakhstani patients with episodes of ventricular arrhythmia, two of those with classical CPVT characteristics and 33 patients with monomorphic idiopathic ventricular arrhythmia, for variants in the hot-spot regions of the RYR2 gene. This approach revealed two novel variants; one de-novo RYR2 mutation (c13892A>T; p.D4631V) in a CPVT patient and a novel rare variant (c5428G>C; p.V1810L) of uncertain significance in a patient with VT of idiopathic origin which we suggest represents a low-penetrance or susceptibility variant. In addition we identified a known variant previously associated with arrhythmogenic right ventricular dysplasia type2 (ARVD2). Combining sets of prediction scores and reference databases appeared fundamental to predict the pathogenic potential of novel and rare missense variants in populations where genotype data are rare.	[Akilzhanova, Ainur; Nurkina, Zhannur; Zhumadilov, Zhaxybay; Sharman, Almaz] Nazarbayev Univ, Ctr Life Sci, Dept Genom & Personalized Med, Astana, Kazakhstan; [Guelly, Christian; Trajanoski, Slave] Med Univ Graz, Med Res Ctr, Graz, Austria; [Nuralinov, Omirbek; Nazhat, Dinara; Smagulov, Shalkhar; Tursunbekov, Azat; Alzhanova, Anar; Rashbayeva, Gulzhaina; Abdrakhmanov, Ayan; Dosmagambet, Sholpan; Bekbosynova, Mahabbat] Natl Sci Cardiac Surg Ctr, Astana, Kazakhstan	Nazarbayev University; Medical University of Graz; National Research Cardiac Surgery Center	Akilzhanova, A (corresponding author), Nazarbayev Univ, Ctr Life Sci, Dept Genom & Personalized Med, Astana, Kazakhstan.	akilzhanova@nu.edu.kz	Sharman, Almaz/AGJ-4693-2022; Akilzhanova, Ainur R/N-6931-2015; Abdrakhmanov, Ayan/ABD-5999-2021	Akilzhanova, Ainur R/0000-0001-6161-8355; Abdrakhmanov, Ayan/0000-0001-6315-5016; Abilova(Nurkina), Zannur/0000-0001-9671-4574	Ministry of Education and Science of the Republic of Kazakhstan	Ministry of Education and Science of the Republic of Kazakhstan(Government of the Republic of KazakhstanMinistry of Education and Science of the Republic of Kazakhstan)	This study was supported by a Grant -in-Aid from Ministry of Education and Science of the Republic of Kazakhstan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bhuiyan ZA, 2007, J CARDIOVASC ELECTR, V18, P1060, DOI 10.1111/j.1540-8167.2007.00913.x; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; d'Amati G, 2005, HUM PATHOL, V36, P761, DOI 10.1016/j.humpath.2005.04.019; Fisher JD, 1999, J AM COLL CARDIOL, V34, P2015, DOI 10.1016/S0735-1097(99)00438-6; Giudicessi JR, 2012, CIRC-CARDIOVASC GENE, V5, P519, DOI 10.1161/CIRCGENETICS.112.963785; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Jabbari J, 2013, CIRC-CARDIOVASC GENE, V6, P481, DOI 10.1161/CIRCGENETICS.113.000118; Jones PP, 2008, BIOCHEM J, V412, P171, DOI 10.1042/BJ20071287; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LEENHARDT A, 1995, CIRCULATION, V91, P1512, DOI 10.1161/01.CIR.91.5.1512; Marban E, 2002, NATURE, V415, P213, DOI 10.1038/415213a; Martin CA, 2011, POSTGRAD MED, V123, P84, DOI 10.3810/pgm.2011.03.2266; Medeiros-Domingo A, 2009, J AM COLL CARDIOL, V54, P2065, DOI 10.1016/j.jacc.2009.08.022; Priori SG, 2002, CIRCULATION, V106, P69, DOI 10.1161/01.CIR.0000020013.73106.D8; Priori SG, 2001, CIRCULATION, V103, P196; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Schwartz PJ, 2013, J AM COLL CARDIOL, V62, P169, DOI 10.1016/j.jacc.2013.04.044; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Tiso N, 2002, BIOCHEM BIOPH RES CO, V299, P594, DOI 10.1016/S0006-291X(02)02689-X; Tiso N, 2001, HUM MOL GENET, V10, P189, DOI 10.1093/hmg/10.3.189	23	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101059	10.1371/journal.pone.0101059	http://dx.doi.org/10.1371/journal.pone.0101059			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978818	gold, Green Published, Green Submitted			2022-12-27	WOS:000338506400070
J	Liu, G; Neelamegham, S				Liu, Gang; Neelamegham, Sriram			A Computational Framework for the Automated Construction of Glycosylation Reaction Networks	PLOS ONE			English	Article							MATHEMATICAL-MODEL; SELECTIN; TRANSPORT	Glycosylation is among the most common and complex post-translational modifications identified to date. It proceeds through the catalytic action of multiple enzyme families that include the glycosyltransferases that add monosaccharides to growing glycans, and glycosidases which remove sugar residues to trim glycans. The expression level and specificity of these enzymes, in part, regulate the glycan distribution or glycome of specific cell/tissue systems. Currently, there is no systematic method to describe the enzymes and cellular reaction networks that catalyze glycosylation. To address this limitation, we present a streamlined machine-readable definition for the glycosylating enzymes and additional methodologies to construct and analyze glycosylation reaction networks. In this computational framework, the enzyme class is systematically designed to store detailed specificity data such as enzymatic functional group, linkage and substrate specificity. The new classes and their associated functions enable both single-reaction inference and automated full network reconstruction, when given a list of reactants and/or products along with the enzymes present in the system. In addition, graph theory is used to support functions that map the connectivity between two or more species in a network, and that generate subset models to identify rate-limiting steps regulating glycan biosynthesis. Finally, this framework allows the synthesis of biochemical reaction networks using mass spectrometry (MS) data. The features described above are illustrated using three case studies that examine: i) O-linked glycan biosynthesis during the construction of functional selectin-ligands; ii) automated N-linked glycosylation pathway construction; and iii) the handling and analysis of glycomics based MS data. Overall, the new computational framework enables automated glycosylation network model construction and analysis by integrating knowledge of glycan structure and enzyme biochemistry. All the implemented features are provided as part of the Glycosylation Network Analysis Toolbox (GNAT), an open-source, platform-independent, MATLAB based toolbox for studies of Systems Glycobiology.	[Liu, Gang] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA; SUNY Buffalo, NY State Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Liu, G (corresponding author), SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.	gangliu@buffalo.edu; neel@buffalo.edu	; Liu, Gang/F-7414-2011	Neelamegham, Sriram/0000-0002-1371-8500; Liu, Gang/0000-0002-8758-1797	National Institutes of Health [HL103411, HL63014]; Program of Excellence in Glycosciences grant [HL107146]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103411, R01HL063014, P01HL107146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Program of Excellence in Glycosciences grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by the National Institutes of Health grants HL103411 and HL63014, and Program of Excellence in Glycosciences grant HL107146. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeed PA, 1998, GLYCOCONJUGATE J, V15, P975, DOI 10.1023/A:1006985825141; Aoki-Kinoshita Kiyoko F, 2013, Methods Mol Biol, V951, P257, DOI 10.1007/978-1-62703-146-2_17; Bennun SV, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002813; Bohne-Lang A, 2001, CARBOHYD RES, V336, P1, DOI 10.1016/S0008-6215(01)00230-0; Ceroni A, 2007, SOURCE CODE BIOL MED, V2, DOI 10.1186/1751-0473-2-3; Costa AR, 2013, GLYCOSYLATION IMPACT; del Val IJ, 2011, BIOTECHNOL PROGR, V27, P1730, DOI 10.1002/btpr.688; Hossler P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000713; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Ismail MN, 2011, GLYCOBIOLOGY, V21, P82, DOI 10.1093/glycob/cwq134; Konishi Y, 2012, GLYCOMEATLAS TOOL VI; Krambeck FJ, 2005, BIOTECHNOL BIOENG, V92, P711, DOI 10.1002/bit.20645; Krambeck FJ, 2009, GLYCOBIOLOGY, V19, P1163, DOI 10.1093/glycob/cwp081; Liu G, 2013, BIOINFORMATICS, V29, P404, DOI 10.1093/bioinformatics/bts703; Liu G, 2008, BIOINFORMATICS, V24, P2740, DOI 10.1093/bioinformatics/btn515; Lo CY, 2013, J BIOL CHEM, V288, P13974, DOI 10.1074/jbc.M113.463653; Neelamegham S, 2004, CELL COMMUN ADHES, V11, P35, DOI 10.1080/15419060490471793; Neelamegham S, 2011, GLYCOBIOLOGY, V21, P1541, DOI 10.1093/glycob/cwr036; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; Novotny MV, 2013, CURR OPIN CHEM BIOL; Puri A, 2012, ANN BIOMED ENG, V40, P816, DOI 10.1007/s10439-011-0464-5; Ribeiro JP, 2013, CURR OPIN CHEM BIOL; Rillahan CD, 2011, ANNU REV BIOCHEM, V80, P797, DOI 10.1146/annurev-biochem-061809-152236; Taniguchi N, 2002, HDB GLYCOSYLTRANSFER, pxviii; Umana P, 1997, BIOTECHNOL BIOENG, V55, P890, DOI 10.1002/(SICI)1097-0290(19970920)55:6<890::AID-BIT7>3.0.CO;2-B; Varki A., 2009, ESSENTIALS GLYCOBIOL	26	22	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100939	10.1371/journal.pone.0100939	http://dx.doi.org/10.1371/journal.pone.0100939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978019	Green Published, gold			2022-12-27	WOS:000338506400055
J	Ruiz-Grosso, P; Ramos, M; Samalvides, F; Vega-Dienstmaier, J; Kruger, H				Ruiz-Grosso, Paulo; Ramos, Mariana; Samalvides, Frine; Vega-Dienstmaier, Johann; Kruger, Hever			Common Mental Disorders in Public Transportation Drivers in Lima, Peru	PLOS ONE			English	Article							GENDER-DIFFERENCES; ALCOHOL-USE; WORKERS; ACCULTURATION; AMERICANS; DRINKING; ABUSE; INDIA; RISK	Background: Traffic related injuries are leading contributors to burden of disease worldwide. In developing countries a high proportion of them can be attributed to public transportation vehicles. Several mental disorders including alcohol and drug abuse, psychotic disorders, mental stress, productivity pressure, and low monetary income were found predictors of high rates of traffic related injuries in public transportation drivers. The goal of this study was to estimate the prevalence of common mental disorders in the population of public transportation drivers of buses and rickshaws in Lima, Peru. Methodology/Principal Findings: Cross sectional study. A sample of bus and rickshaw drivers was systematically selected from formal public transportation companies using a snowball approach. Participants completed self-administered questionnaires for assessing major depressive episode, anxiety symptoms, alcohol abuse, and burnout syndrome. Socio demographic information was also collected. The analyses consisted of descriptive measurement of outcomes taking into account both between and within cluster standard deviation (BCSD and WCSD). A total of 278 bus and 227 rickshaw drivers out of 25 companies agreed to participate in the study. BCSD for major depressive episode, anxiety symptoms and burnout syndrome was not found significant (p>0.05). The estimated prevalence of each variable was 13.7% (IC95%: 10.7-16.6%), 24.1% (IC95%: 19.4-28.8%) and 14.1% (IC95%: 10.8-17.4%) respectively. The estimated prevalence of alcohol abuse was 75.4% (IC95%: 69-81.7%, BCSD = 12.2%, WCSD = 41.9%, intra class correlation (ICC): 7.8%). Conclusion: Common mental disorders such as alcohol abuse, major depressive episode, anxiety symptoms and burnout syndrome presented higher rates in public transportation drivers than general population.	[Ruiz-Grosso, Paulo; Ramos, Mariana; Vega-Dienstmaier, Johann; Kruger, Hever] Univ Peruana Cayetano Heredia, Mental Hlth Working Grp, Lima, Peru; [Ruiz-Grosso, Paulo; Samalvides, Frine; Vega-Dienstmaier, Johann; Kruger, Hever] Univ Peruana Cayetano Heredia, Alberto Hurtado Med Sch, Lima, Peru; [Samalvides, Frine; Vega-Dienstmaier, Johann] Hosp Nacl Cayetano Heredia, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia	Ruiz-Grosso, P (corresponding author), Univ Peruana Cayetano Heredia, Mental Hlth Working Grp, Lima, Peru.	paulo.ruiz@upch.pe	Vega-Dienstmaier, Johann/Q-6709-2019; Ruiz-Grosso, Paulo/D-1779-2018	Vega-Dienstmaier, Johann/0000-0002-5686-4014; Ruiz-Grosso, Paulo/0000-0001-8003-5171	Ministry of Transportation of the Peruvian Goverment	Ministry of Transportation of the Peruvian Goverment	The research team received limited funding from the Ministry of Transportation of the Peruvian Goverment. The funding was limited to data collection procedures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaniz ML, 2002, SUBST USE MISUSE, V37, P1253, DOI 10.1081/JA-120004182; Bernstein KS, 2011, COMMUNITY MENT HLT J, V47, P24, DOI 10.1007/s10597-009-9261-0; Choquehuanca-Vilca Víctor, 2010, Rev. perú. med. exp. salud publica, V27, P162, DOI 10.1590/s1726-46342010000200002; da Silva FP, 2009, SOC PSYCH PSYCH EPID, V44, P125, DOI 10.1007/s00127-008-0412-3; Devaud LL, 1999, PHARMACOL BIOCHEM BE, V64, P841, DOI 10.1016/S0091-3057(99)00164-1; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Gururaj G, 2008, NATL MED J INDIA, V21, P14; Hermansson U, 2003, OCCUP MED-OXFORD, V53, P518, DOI 10.1093/occmed/kqg104; Keyes KM, 2011, ALCOHOL CLIN EXP RES, V35, P2101, DOI 10.1111/j.1530-0277.2011.01562.x; Lai Daniel W L, 2005, J Chin Med Assoc, V68, P118, DOI 10.1016/S1726-4901(09)70232-1; Mabuchi AD, 2007, REV LAT-AM ENFERM, V15, P446, DOI 10.1590/S0104-11692007000300013; Marchand A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-333; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Nguyen HT, 2004, PSYCHIAT RES, V126, P177, DOI 10.1016/j.psychres.2004.02.004; Nolen-Hoeksema S, 2006, J GEN PSYCHOL, V133, P357, DOI 10.3200/GENP.133.4.357-374; Radloff LS, 1977, APPL PSYCH MEAS, V1, P401; Saavedra J, 2002, INFORME GEN ANALES S; Saitz R, 1999, ARCH INTERN MED, V159, P718, DOI 10.1001/archinte.159.7.718; Silva MC, 2003, ALCOHOL ALCOHOLISM, V38, P79, DOI 10.1093/alcalc/agg016; Takeuchi DT, 2007, AM J PUBLIC HEALTH, V97, P84, DOI 10.2105/AJPH.2006.088401; TARNOPOLSKY A, 1975, PSYCHOL MED, V5, P193, DOI 10.1017/S0033291700056464; Toroyan T, 2009, INJURY PREV, V15, P286, DOI 10.1136/ip.2009.023697; Velásquez Aníbal, 2009, Rev. perú. med. exp. salud publica, V26, P222; Watson J M, 1997, NIDA Res Monogr, V168, P443; WHO (World Health Organization), 2013, SCHIST PROGR REP 200; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371	27	9	10	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101066	10.1371/journal.pone.0101066	http://dx.doi.org/10.1371/journal.pone.0101066			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK5ZO	24979057	Green Submitted, Green Published, gold			2022-12-27	WOS:000338506400071
J	Shen, Z; Fahey, JV; Bodwell, JE; Rodriguez-Garcia, M; Kashuba, ADM; Wira, CR				Shen, Zheng; Fahey, John V.; Bodwell, Jack E.; Rodriguez-Garcia, Marta; Kashuba, Angela D. M.; Wira, Charles R.			Sex Hormones Regulate Tenofovir-Diphosphate in Female Reproductive Tract Cells in Culture	PLOS ONE			English	Article							EPITHELIAL-CELLS; HIV PREVENTION; PREEXPOSURE PROPHYLAXIS; ADAPTIVE IMMUNITY; MENSTRUAL-CYCLE; INNATE IMMUNITY; GENITAL-TRACT; SECRETION; PHARMACOKINETICS; FIBROBLASTS	The conflicting results of recent pre-exposure prophylaxis (PrEP) trials utilizing tenofovir (TFV) to prevent HIV infection in women led us to evaluate the accumulation of intracellular TFV-diphosphate (TFV-DP) in cells from the female reproductive tract (FRT) and whether sex hormones influence the presence of TFV-DP in these cells. Following incubation with TFV, isolated epithelial cells, fibroblasts, CD4(+) T cells and CD14(+) cells from the FRT as well as blood CD4(+) T cells and monocyte-derived macrophages convert TFV to TFV-DP. Unexpectedly, we found that TFV-DP concentrations (fmol/million cells) vary significantly with the cell type analyzed and the site within the FRT. Epithelial cells had 5-fold higher TFV-DP concentrations than fibroblasts; endometrial epithelial cells had higher TFV-DP concentrations than cells from the ectocervix. Epithelial cells had 125-fold higher TFV-DP concentrations than FRT CD4(+) T cells, which were comparable to that measured in peripheral blood CD4(+) T cells. These findings suggest the existence of a TFV-DP gradient in the FRT where epithelial cells > fibroblasts > CD4(+) T cells and macrophages. In other studies, estradiol increased TFV-DP concentrations in endometrial and endocervical/ectocervical epithelial cells, but had no effect on fibroblasts or CD4(+) T cells from FRT tissues. In contrast, progesterone alone and in combination with estradiol decreased TFV-DP concentrations in FRT CD4(+) T cells. Our results suggest that epithelial cells and fibroblasts are a repository of TFV-DP that is under hormonal control. These cells might act either as a sink to decrease TFV availability to CD4(+) T cells and macrophages in the FRT, or upon conversion of TFV-DP to TFV increase TFV availability to HIV-target cells. In summary, these results indicate that intracellular TFV-DP varies with cell type and location in the FRT and demonstrate that estradiol and/or progesterone regulate the intracellular concentrations of TFV-DP in FRT epithelial cells and CD4(+) T cells.	[Shen, Zheng; Fahey, John V.; Bodwell, Jack E.; Rodriguez-Garcia, Marta; Wira, Charles R.] Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Lebanon, NH 03756 USA; [Kashuba, Angela D. M.] Univ N Carolina, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC USA	Dartmouth College; University of North Carolina; University of North Carolina Chapel Hill	Wira, CR (corresponding author), Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Lebanon, NH 03756 USA.	Charles.R.Wira@Dartmouth.edu			NIH - Advanced BioScience Laboratories, Inc. [HHSN272201000001C]; NIH [AI102838, AI071761, AI013541]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071761, R01AI102838, R37AI013541, R55AI013541, R01AI117739, P30AI050410, R56AI071761, R01AI013541] Funding Source: NIH RePORTER	NIH - Advanced BioScience Laboratories, Inc.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this study was supported by NIH contract HHSN272201000001C, which was DISPERSED indirectly funded by Advanced BioScience Laboratories, Inc., and by NIH grants AI102838, AI071761 and AI013541 (CRW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham P, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-61; Anderson PL, 2011, J ANTIMICROB CHEMOTH, V66, P240, DOI 10.1093/jac/dkq447; [Anonymous], 2017, 2013 UNAIDS REP GLOB; [Anonymous], 2012, HIV AIDS; CAC, 2003, HIV AIDS SURVEILLANC; Chen JM, 2012, JAIDS-J ACQ IMM DEF, V61, P593, DOI 10.1097/QAI.0b013e3182717c98; Coleman J, 2012, 19 INT AIDS C AIDS 2; Coleman KD, 2009, FERTIL STERIL, V92, P1107, DOI 10.1016/j.fertnstert.2008.10.047; Fahey JV, 2005, HUM REPROD, V20, P1439, DOI 10.1093/humrep/deh806; Fahey JV, 2002, J INFECT DIS, V185, P1606, DOI 10.1086/340512; Ghosh M, 2013, AM J REPROD IMMUNOL, V69, P51, DOI 10.1111/aji.12027; Givan AL, 1997, AM J REPROD IMMUNOL, V38, P350; Hendrix CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055013; Heneine W, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007419; Hickey DK, 2011, J REPROD IMMUNOL, V88, P185, DOI 10.1016/j.jri.2011.01.005; Hunsucker SA, 2005, PHARMACOL THERAPEUT, V107, P1, DOI 10.1016/j.pharmthera.2005.01.003; Kashuba ADM, 2012, LANCET, V379, P2409, DOI 10.1016/S0140-6736(11)61852-7; Kohler JJ, 2011, METHODS MOL BIOL, V755, P267, DOI 10.1007/978-1-61779-163-5_22; Kohler JJ, 2009, LAB INVEST, V89, P513, DOI 10.1038/labinvest.2009.14; Koumas L, 2001, AM J PATHOL, V159, P925, DOI 10.1016/S0002-9440(10)61768-3; MacDonald EM, 2007, BIOL REPROD, V77, P1049, DOI 10.1095/biolreprod.107.063933; MCNATTY KP, 1976, J ENDOCRINOL, V71, P77, DOI 10.1677/joe.0.0710077; Meter RA, 2005, FERTIL STERIL, V84, P191, DOI 10.1016/j.fertnstert.2005.01.104; Murphy AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005539; Patel MV, 2013, AM J REPROD IMMUNOL, V69, P463, DOI 10.1111/aji.12078; Patterson KB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003174; Rodriguez-Garcia M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062069; Rohan LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009310; Romano J, 2013, AIDS RES HUM RETROV, V29, P1418, DOI [10.1089/aid.2013.0122, 10.1089/AID.2013.0122]; Shen Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069854; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272; Wira CR, 2008, AIDS, V22, P1909, DOI 10.1097/QAD.0b013e3283060ea4; Wira CR, 2010, AM J REPROD IMMUNOL, V63, P544, DOI 10.1111/j.1600-0897.2010.00842.x; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x	34	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100863	10.1371/journal.pone.0100863	http://dx.doi.org/10.1371/journal.pone.0100863			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978212	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400044
J	Wang, B; Liu, ZH; Chen, QJ; Gao, ZM; Fang, F; Chang, HY; Chen, JJ; Xu, B; Chen, Z				Wang, Ba; Liu, Zhihua; Chen, Quanjiao; Gao, Zhimin; Fang, Fang; Chang, Haiyan; Chen, Jianjun; Xu, Bing; Chen, Ze			Genotype Diversity of H9N2 Viruses Isolated from Wild Birds and Chickens in Hunan Province, China	PLOS ONE			English	Article							INFLUENZA-A VIRUSES; HUMAN INFECTION; SOUTHERN CHINA; MAINLAND CHINA; HONG-KONG; EVOLUTION; POULTRY; GENES; PATHOGENICITY; DUCKS	Three H9N2 avian influenza viruses were isolated from the Dongting Lake wetland, among which one was from fresh egret feces, the other two were from chicken cloacal swabs in poultry markets. Phylogenetic analyses suggested that eight genes of the egret-derived H9N2 virus might come from Korean-like or American-like lineages. The two poultry-derived H9N2 viruses were reassortants between the CK/BJ/94-like and G1-like viruses. Except the PB1 genes (90.6%), the nucleotide sequence of other internal genes of the two viruses exhibited high homology (>95%). In addition, they also exhibited high homology (96-98.3%) with some genes of the H7N9 virus that caused an epidemic in China in 2013. Nucleotide sequence of the poultry-derived and egret-derived H9N2 viruses shared low homology. Infection studies showed that the egret-derived H9N2 virus was non-pathogenic to both mice and chickens, and the virus was unable to infect chickens even through 8 passages continuously in the lung. On the other hand, the chickens infected by poultry-derived viruses showed obvious clinical symptoms and even died; the infected mice showed no noticeable clinical symptoms and weight loss, but viruses could be detected in their lungs. In conclusion, for the egret-derived H9N2 virus, it would take a long adaptation process to achieve cross-species transmission in poultry and mammals. H9N2 viruses isolated at different times from the same host species in the same geographical region presented different evolutionary status, and virus isolated from different hosts in the same geographical region exhibited genetic diversity. Therefore, it is important to continue the H9N2 virus surveillance for understanding their evolutionary trends so as to provide guidance for disease control and prevention.	[Chen, Quanjiao; Gao, Zhimin; Chen, Jianjun; Chen, Ze] Chinese Acad Sci, State Key Lab Virol, Ctr Emerging Infect Dis, Wuhan Inst Virol, Wuhan, Hubei, Peoples R China; [Wang, Ba; Liu, Zhihua; Fang, Fang; Chang, Haiyan; Chen, Ze] Hunan Normal Univ, Coll Life Sci, Changsha, Hunan, Peoples R China; [Chen, Ze] Shanghai Inst Biol Prod, Shanghai, Peoples R China; [Xu, Bing] Tsinghua Univ, Dept Environm Sci & Engn, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Hunan Normal University; Tsinghua University	Chen, QJ (corresponding author), Chinese Acad Sci, State Key Lab Virol, Ctr Emerging Infect Dis, Wuhan Inst Virol, Wuhan, Hubei, Peoples R China.	chenqj@wh.iov.cn; chenze2005@hotmail.com	Xu, Bing/C-7732-2015		National 973 Project [2010CB530301]; National Natural Science Foundation of China [81172738, 31070141, 31100132]	National 973 Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the following research funds: National 973 Project (no. 2010CB530301) and National Natural Science Foundation of China (no. 81172738, no. 31070141, no. 31100132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamir UB, 2007, VIROLOGY, V361, P45, DOI 10.1016/j.virol.2006.10.037; BUCKLERWHITE AJ, 1986, J VIROL, V57, P697, DOI 10.1128/JVI.57.2.697-700.1986; Chen B, 1994, CHIN J VET MED, V22, P3; Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Guo YJ, 2000, VIROLOGY, V267, P279, DOI 10.1006/viro.1999.0115; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; HOMME PJ, 1970, AVIAN DIS, V14, P277, DOI 10.2307/1588472; Hulse-Post DJ, 2007, J VIROL, V81, P8515, DOI 10.1128/JVI.00435-07; Lang AS, 2008, J GEN VIROL, V89, P509, DOI 10.1099/vir.0.83369-0; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Lu JH, 2005, VIRUS GENES, V31, P163, DOI 10.1007/s11262-005-1790-1; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Sun YP, 2010, VET MICROBIOL, V146, P215, DOI 10.1016/j.vetmic.2010.05.010; Suzuki Hiroshi, 2003, Journal of Infection and Chemotherapy, V9, P195; Tosh C, 2008, ARCH VIROL, V153, P1433, DOI 10.1007/s00705-008-0131-9; Wan XF, 2011, J VIROL, V85, P13432, DOI 10.1128/JVI.05266-11; WARD AC, 1995, ARCH VIROL, V140, P383, DOI 10.1007/BF01309872; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07; Zhang HB, 2011, ARCH VIROL, V156, P95, DOI 10.1007/s00705-010-0836-4	26	10	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101287	10.1371/journal.pone.0101287	http://dx.doi.org/10.1371/journal.pone.0101287			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979703	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400111
J	Yang, H; Aprecio, RM; Zhou, XD; Wang, Q; Zhang, W; Ding, Y; Li, YM				Yang, Heng; Aprecio, Raydolfo M.; Zhou, Xiaodong; Wang, Qi; Zhang, Wu; Ding, Yi; Li, Yiming			Therapeutic Effect of TSG-6 Engineered iPSC-Derived MSCs on Experimental Periodontitis in Rats: A Pilot Study	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; ANTIINFLAMMATORY PROTEIN TSG-6; INTER-ALPHA-INHIBITOR; MARROW STROMAL CELLS; LINK MODULE; IN-VIVO; BONE; REGENERATION; INFLAMMATION; GENERATION	Background: We derived mesenchymal stem cells (MSCs) from rat induced pluripotent stem cells (iPSCs) and transduced them with tumor necrosis factor alpha-stimulated gene-6 (TSG-6), to test whether TSG-6 overexpression would boost the therapeutic effects of iPSC-derived MSCs in experimental periodontitis. Methods: A total of 30 female Sprague-Dawley (SD) rats were randomly divided into four groups: healthy control group (Group-N, n = 5), untreated periodontitis group (Group-P, n = 5), iPS-MSCs-treated and iPSC-MSCs/TSG-6-treated periodontitis groups (Group-P1 and P2, n = 10 per group). Experimental periodontitis was established by ligature and infection with Porphyromonas gingivalis around the maxillae first molar bilaterally. MSC-like cells were generated from rat iPSCs, and transducted with TSG-6. iPSC-MSCs or iPSC-MSCs/TSG-6 were administrated to rats in Group-P1 or P2 intravenously and topically, once a week for three weeks. Blood samples were obtained one week post-injection for the analysis of serum pro-inflammatory cytokines. All animals were killed 3 months post-treatment; maxillae were then dissected for histological analysis, tartrate-resistant acid phosphatase (TRAP) staining, and morphological analysis of alveolar bone loss. Results: Administration of iPSC-MSC/TSG-6 significantly decreased serum levels of IL-1 beta and TNF-alpha in the Group-P2 rats (65.78 pg/ml and 0.56 pg/ml) compared with those in Group-P (168.31 pg/ml and 1.15 pg/ml respectively) (p<0.05). Both alveolar bone loss and the number of TRAP-positive osteoclasts showed a significant decrease in rats that received iPSC-MSC/TSG-6 treatment compared to untreated rats in Group-P (p<0.05), Conclusions: We demonstrated that overexpression of TSG-6 in rat iPSC-derived MSCs were capable of decreasing inflammation in experimental periodontitis and inhibiting alveolar bone resorption. This may potentially serve as an alternative stem-cell-based approach in the treatment and regeneration of periodontal tissues.	[Yang, Heng; Wang, Qi] Sichuan Univ, State Key Lab Oral Dis, Chengdu 610064, Sichuan, Peoples R China; [Aprecio, Raydolfo M.; Zhou, Xiaodong; Zhang, Wu; Li, Yiming] Loma Linda Univ, Sch Dent, Dent Res Ctr, Loma Linda, CA 92350 USA; [Ding, Yi] Sichuan Univ, Dept Periodontol, West China Hosp Stomatol, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Loma Linda University; Sichuan University	Ding, Y (corresponding author), Sichuan Univ, Dept Periodontol, West China Hosp Stomatol, Chengdu 610064, Sichuan, Peoples R China.	jessie.yh@163.com		Ding, Yi/0000-0002-0948-4991	Loma Linda University Grants for Research and School Partnerships (GRASP) [699310-2938]	Loma Linda University Grants for Research and School Partnerships (GRASP)	This study was supported by Loma Linda University Grants for Research and School Partnerships (GRASP) number 699310-2938. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CCP, 2006, J PERIODONTOL, V77, P350, DOI 10.1902/jop.2006.050184; Bardos T, 2001, AM J PATHOL, V159, P1711, DOI 10.1016/S0002-9440(10)63018-0; Bianco P, 2011, BEST PRACT RES CL HA, V24, P37, DOI 10.1016/j.beha.2011.01.005; Cao TV, 2004, MICROCIRCULATION, V11, P615, DOI 10.1080/10739680490503438; Chang MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009838; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; de Hemptinne I, 2004, J NEUROCHEM, V91, P155, DOI 10.1111/j.1471-4159.2004.02709.x; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Emerton KB, 2011, J DENT RES, V90, P1416, DOI 10.1177/0022034511423665; Furth ME, 2009, J CELL BIOCHEM, V106, P507, DOI 10.1002/jcb.22000; Getting SJ, 2002, J BIOL CHEM, V277, P51068, DOI 10.1074/jbc.M205121200; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Katsara O, 2011, STEM CELLS DEV, V20, P1550, DOI 10.1089/scd.2010.0280; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Lian QZ, 2010, CIRCULATION, V121, P1113, DOI 10.1161/CIRCULATIONAHA.109.898312; Mahoney DJ, 2008, J BIOL CHEM, V283, P25952, DOI 10.1074/jbc.M802138200; Mahoney DJ, 2011, ARTHRITIS RHEUM-US, V63, P1034, DOI 10.1002/art.30201; Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Meng XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037569; Meng XM, 2012, MOL THER, V20, P408, DOI 10.1038/mt.2011.258; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Roddy GW, 2011, STEM CELLS, V29, P1572, DOI 10.1002/stem.708; Stavropoulos A, 2011, J PERIODONTOL, V82, P462, DOI 10.1902/jop.2010.100331; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tu YK, 2012, J CLIN PERIODONTOL, V39, P303, DOI 10.1111/j.1600-051X.2011.01844.x; Villa-Diaz LG, 2012, STEM CELLS, V30, P1174, DOI 10.1002/stem.1084; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; Wisniewski HG, 1996, J IMMUNOL, V156, P1609; Yilmaz S, 2010, J CLIN PERIODONTOL, V37, P544, DOI 10.1111/j.1600-051X.2010.01567.x; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001	37	48	52	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100285	10.1371/journal.pone.0100285	http://dx.doi.org/10.1371/journal.pone.0100285			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979372	gold, Green Published, Green Submitted			2022-12-27	WOS:000338506400025
J	Zhu, JH; Mu, XY; Zeng, J; Xu, CY; Liu, J; Zhang, MS; Li, CP; Chen, J; Li, TY; Wang, YP				Zhu, Jiahong; Mu, Xinyi; Zeng, Jin; Xu, Chunyan; Liu, Jun; Zhang, Mengsi; Li, Chengpeng; Chen, Jie; Li, Tinyu; Wang, Yaping			Ginsenoside Rg1 Prevents Cognitive Impairment and Hippocampus Senescence in a Rat Model of D-Galactose-Induced Aging	PLOS ONE			English	Article							NEURAL STEM-CELLS; DENTATE GYRUS; ADVANCED GLYCATION; DEPENDENT KINASES; OXIDATIVE DAMAGE; GENE-EXPRESSION; MEMORY LOSS; MICE; NEUROGENESIS; ASTROCYTES	Neurogenesis continues throughout the lifetime in the hippocampus, while the rate declines with brain aging. It has beenhypothesized that reduced neurogenesis may contribute to age-related cognitive impairment. Ginsenoside Rg1 is an active ingredient of Panax ginseng in traditional Chinese medicine, which exerts anti-oxidative and anti-aging effects. This study explores the neuroprotective effect of ginsenoside Rg1 on the hippocampus of the D-gal (D-galactose) induced aging rat model. Sub-acute aging was induced in male SD rats by subcutaneous injection of D-gal (120 mg/kg.d) for 42 days, and the rats were treated with ginsenoside Rg1 (20 mg/kg.d, intraperitoneally) or normal saline for 28 days after 14 days of D-gal injection. In another group, normal male SD rats were treated with ginsenoside Rg1 alone (20 mg/kg.d, intraperitoneally) for 28 days. It showed that administration of ginsenoside Rg1 significantly attenuated all the D-gal-induced changes in the hippocampus, including cognitive capacity, senescence-related markers and hippocampal neurogenesis, compared with the D-gal-treated rats. Further investigation showed that ginsenoside Rg1 protected NSCs/NPCs (neural stem cells/progenitor cells) shown by increased level of SOX-2 expression; reduced astrocytes activation shown by decrease level of Aeg-1 expression; increased the hippocampal cell proliferation; enhanced the activity of the antioxidant enzymes GSH-Px (glutathione peroxidase) and SOD (Superoxide Dismutase); decreased the levels of IL-1 beta, IL-6 and TNF-alpha, which are the proinflammatory cytokines; increased the telomere lengths and telomerase activity; and down-regulated the mRNA expression of cellular senescence associated genes p53, p21(Cip1/Waf1) and p19(Arf) in the hippocampus of aged rats. Our data provides evidence that ginsenoside Rg1 can improve cognitive ability, protect NSCs/NPCs and promote neurogenesis by enhancing the antioxidant and anti-inflammatory capacity in the hippocampus.	[Zhu, Jiahong; Mu, Xinyi; Xu, Chunyan; Liu, Jun; Zhang, Mengsi; Li, Chengpeng; Wang, Yaping] Chongqing Med Univ, Dept Histol & Embryol, Lab Stem Cells & Tissue Engn, Chongqing, Peoples R China; [Zeng, Jin] Land Force Lintong Sanat, Xian, Shanxi, Peoples R China; [Chen, Jie; Li, Tinyu] Chongqing Stem Cell Therapy Engn Tech Ctr, Chongqing, Peoples R China	Chongqing Medical University	Wang, YP (corresponding author), Chongqing Med Univ, Dept Histol & Embryol, Lab Stem Cells & Tissue Engn, Chongqing, Peoples R China.	ypwangcq@aliyun.com		Mu, Xinyi/0000-0002-3738-0882	National Natural Science Foundation of China [30973818]; Science Foundation of Ministry of Education of China [20125503110006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Ministry of Education of China(Ministry of Education, China)	The work was supported by National Natural Science Foundation of China (No 30973818), and the Science Foundation of Ministry of Education of China (No 20125503110006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonafe M, 2001, EUR J IMMUNOL, V31, P2357, DOI 10.1002/1521-4141(200108)31:8<2357::AID-IMMU2357>3.3.CO;2-O; Bruunsgaard H, 1999, J GERONTOL A-BIOL, V54, pM357, DOI 10.1093/gerona/54.7.M357; Chen C, 2014, ACTA PHARMACOL SIN, V35, P143, DOI 10.1038/aps.2013.136; Chen XC, 2008, J GERONTOL A-BIOL, V63, P253, DOI 10.1093/gerona/63.3.253; Cheng Y, 2005, ACTA PHARMACOL SIN, V26, P143, DOI 10.1111/j.1745-7254.2005.00034.x; CLARKE SR, 1994, NEUROREPORT, V5, P1885, DOI 10.1097/00001756-199410000-00011; Cui X, 2006, J NEUROSCI RES, V84, P647, DOI 10.1002/jnr.20899; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Draberova E, 2008, J NEUROPATH EXP NEUR, V67, P341, DOI 10.1097/NEN.0b013e31816a686d; Dulcy CP, 2012, J NEUROSCI RES, V90, P2053, DOI 10.1002/jnr.23080; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Ershler WB, 2000, ANNU REV MED, V51, P245, DOI 10.1146/annurev.med.51.1.245; Fang F, 2012, BBA-MOL BASIS DIS, V1822, P286, DOI 10.1016/j.bbadis.2011.10.004; Ferron SR, 2009, J NEUROSCI, V29, P14394, DOI 10.1523/JNEUROSCI.3836-09.2009; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; Geloso MC, 2004, NEUROSCI LETT, V357, P103, DOI 10.1016/j.neulet.2003.11.076; Gemma C, 2010, AGING DIS, V1, P232; Geng YQ, 2010, BIOCHEM BIOPH RES CO, V396, P866, DOI 10.1016/j.bbrc.2010.05.011; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Groth A, 2000, J BIOL CHEM, V275, P27473; HARPER JW, 1993, CELL, V75, P805; Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206; Imura T, 2006, GLIA, V53, P277, DOI 10.1002/glia.20281; Jeong K, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-14; Jiang H, 2007, Z GERONTOL GERIATR, V40, P314, DOI 10.1007/s00391-007-0480-0; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Kim JH, 2012, J GINSENG RES, V36, P16, DOI 10.5142/jgr.2012.36.1.16; Kinsner A, 2005, J NEUROCHEM, V95, P1132, DOI 10.1111/j.1471-4159.2005.03422.x; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lei M, 2008, BIOCHEM BIOPH RES CO, V369, P1082, DOI 10.1016/j.bbrc.2008.02.151; Limoli CL, 2006, INT J RADIAT BIOL, V82, P640, DOI 10.1080/09553000600887816; Lu J, 2006, BEHAV BRAIN RES, V171, P251, DOI 10.1016/j.bbr.2006.03.043; Mrak RE, 2000, J NEUROPATH EXP NEUR, V59, P471, DOI 10.1093/jnen/59.6.471; OLANOW CW, 1992, ANN NEUROL, V32, pS2, DOI 10.1002/ana.410320703; Park D, 2010, STEM CELLS, V28, P2162, DOI 10.1002/stem.541; [彭彬 Peng Bin], 2011, [中国细胞生物学学报, Chinese Journal of Cell Biology], V33, P1116; Peng Bin (et al), 2011, Journal of Chongqing Medical University, V36, P419; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Sama MA, 2008, J BIOL CHEM, V283, P21953, DOI 10.1074/jbc.M800148200; SCHENK F, 1985, EXP BRAIN RES, V58, P11; Seki T, 1995, NEUROREPORT, V6, P2479, DOI 10.1097/00001756-199512150-00010; Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6; Vivar C, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00015; Wang Z, 2002, ACTA PHARMACOL SIN, V23, P974; Wei HF, 2008, CELL MOL NEUROBIOL, V28, P781, DOI 10.1007/s10571-007-9177-6; Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003; Yoo DY, 2012, NEUROCHEM RES, V37, P223, DOI 10.1007/s11064-011-0597-9; Yoo DY, 2012, J PINEAL RES, V52, P21, DOI 10.1111/j.1600-079X.2011.00912.x; Zhang XP, 2013, CELL BIOL INT, V37, P940, DOI 10.1002/cbin.10121; Zhang XL, 2008, FOOD CHEM TOXICOL, V46, P2888, DOI 10.1016/j.fct.2008.05.032	52	126	148	7	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e101291	10.1371/journal.pone.0101291	http://dx.doi.org/10.1371/journal.pone.0101291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979747	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400112
J	Manguan-Garcia, C; Pintado-Berninches, L; Carrillo, J; Machado-Pinilla, R; Sastre, L; Perez-Quilis, C; Esmoris, I; Gimeno, A; Garcia-Gimenez, JL; Pallardo, FV; Perona, R				Manguan-Garcia, Cristina; Pintado-Berninches, Laura; Carrillo, Jaime; Machado-Pinilla, Rosario; Sastre, Leandro; Perez-Quilis, Carme; Esmoris, Isabel; Gimeno, Amparo; Luis Garcia-Gimenez, Jose; Pallardo, Federico V.; Perona, Rosario			Expression of the Genetic Suppressor Element 24.2 (GSE24.2) Decreases DNA Damage and Oxidative Stress in X-Linked Dyskeratosis Congenita Cells	PLOS ONE			English	Article							BONE-MARROW FAILURE; TELOMERASE ACTIVITY; LIPID-PEROXIDATION; END-PROTECTION; MUTATIONS; CANCER; LENGTH; 53BP1; ACCUMULATION; REPLICATION	The predominant X-linked form of Dyskeratosis congenita results from mutations in DKC1, which encodes dyskerin, a protein required for ribosomal RNA modification that is also a component of the telomerase complex. We have previously found that expression of an internal fragment of dyskerin (GSE24.2) rescues telomerase activity in X-linked dyskeratosis congenita (X-DC) patient cells. Here we have found that an increased basal and induced DNA damage response occurred in X-DC cells in comparison with normal cells. DNA damage that is also localized in telomeres results in increased heterochromatin formation and senescence. Expression of a cDNA coding for GSE24.2 rescues both global and telomeric DNA damage. Furthermore, transfection of bacterial purified or a chemically synthesized GSE24.2 peptide is able to rescue basal DNA damage in X-DC cells. We have also observed an increase in oxidative stress in X-DC cells and expression of GSE24.2 was able to diminish it. Altogether our data indicated that supplying GSE24.2, either from a cDNA vector or as a peptide reduces the pathogenic effects of Dkc1 mutations and suggests a novel therapeutic approach.	[Manguan-Garcia, Cristina; Pintado-Berninches, Laura; Carrillo, Jaime; Machado-Pinilla, Rosario; Sastre, Leandro; Perona, Rosario] Inst Invest Biomed CSIC UAM, Madrid, Spain; [Manguan-Garcia, Cristina; Machado-Pinilla, Rosario; Sastre, Leandro; Luis Garcia-Gimenez, Jose; Pallardo, Federico V.; Perona, Rosario] CIBER Enfermedades Raras, Valencia, Spain; [Perez-Quilis, Carme; Esmoris, Isabel; Gimeno, Amparo; Luis Garcia-Gimenez, Jose; Pallardo, Federico V.] Biomed Res Inst INCLIVA, Valencia, Spain; [Perez-Quilis, Carme; Esmoris, Isabel; Gimeno, Amparo; Luis Garcia-Gimenez, Jose; Pallardo, Federico V.] Univ Valencia, Dept Physiol, Fac Med & Dent, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Valencia	Perona, R (corresponding author), Inst Invest Biomed CSIC UAM, Madrid, Spain.	RPerona@iib.uam.es	Pallardo, Federico V./T-1156-2017; García, Jaime Carrillo/AAC-5144-2020	Pallardo, Federico V./0000-0003-3715-1980; Carrillo Garcia, Jaime/0000-0002-2861-3015; Pintado-Berninches, Laura/0000-0002-3331-7130; Garcia-Gimenez, Jose Luis/0000-0001-7547-7872; Sastre, Leandro/0000-0003-3613-5938; Gimeno, Amparo/0000-0002-8112-5221	Ministerio de Ciencia e Innovacion [PI11-0949, PI12/02263 FIS, SAF2008-01338]; Generalitat Valenciana [PROMETEO2010/074]; Fundacion Salud; CIBER de Enfermedades Raras	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Fundacion Salud; CIBER de Enfermedades Raras	This work was supported by grants: PI11-0949 and PI12/02263 FIS, SAF2008-01338 from the Ministerio de Ciencia e Innovacion. Grants, PROMETEO2010/074 from Generalitat Valenciana and Fundacion Salud 2000 to FVP. CMG, JLGG and CPQ are supported by CIBER de Enfermedades Raras. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed M, 2006, CLIN CHIM ACTA, V374, P176, DOI 10.1016/j.cca.2006.06.029; Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372; Alter BP, 2009, BLOOD, V113, P6549, DOI 10.1182/blood-2008-12-192880; Carrillo J, 2013, CLIN TRANSL ONCOL; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Gu BW, 2008, P NATL ACAD SCI USA, V105, P10173, DOI 10.1073/pnas.0803559105; Gu BW, 2011, AGING CELL, V10, P338, DOI 10.1111/j.1474-9726.2011.00674.x; Hartwig FF, 2013, AGEING RES REV, V12, P642, DOI 10.1016/j.arr.2013.03.003; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Hockemeyer D, 2008, GENE DEV, V22, P1773, DOI 10.1101/gad.1679208; Kalinin A, 2001, PROTEIN EXPRES PURIF, V22, P84, DOI 10.1006/prep.2001.1423; Kang HJ, 2004, J NEUROSCI, V24, P1280, DOI 10.1523/JNEUROSCI.4082-03.2004; Kirwan M, 2008, CLIN GENET, V73, P103, DOI 10.1111/j.1399-0004.2007.00923.x; Kirwan M, 2011, BRIT J HAEMATOL, V153, P634, DOI 10.1111/j.1365-2141.2011.08679.x; Knight SW, 1999, AM J HUM GENET, V65, P50, DOI 10.1086/302446; Machado-Pinilla R, 2008, BLOOD, V111, P2606, DOI 10.1182/blood-2007-04-083261; Machado-Pinilla R, 2012, CLIN TRANSL ONCOL, V14, P755, DOI 10.1007/s12094-012-0865-4; Martinez P, 2012, J CELL BIOL, V197, P283, DOI 10.1083/jcb.201110124; Martinez P, 2010, AGING CELL, V9, P653, DOI 10.1111/j.1474-9726.2010.00596.x; MEIER UT, 1994, J CELL BIOL, V127, P1505, DOI 10.1083/jcb.127.6.1505; Mochizuki Y, 2004, P NATL ACAD SCI USA, V101, P10756, DOI 10.1073/pnas.0402560101; Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X; Osterhage JL, 2009, J BIOL CHEM, V284, P16061, DOI 10.1074/jbc.R900011200; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Patel KJ, 2007, DNA REPAIR, V6, P885, DOI 10.1016/j.dnarep.2007.02.002; Pereboeva L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076473; Perona R, 2008, CLIN TRANSL ONCOL, V10, P538, DOI 10.1007/s12094-008-0248-5; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Sanchez-Perez I, 1998, ONCOGENE, V16, P533, DOI 10.1038/sj.onc.1201578; Saretzki G, 2003, AGING CELL, V2, P141, DOI 10.1046/j.1474-9728.2003.00040.x; Saretzki G, 2009, EXP GERONTOL, V44, P485, DOI 10.1016/j.exger.2009.05.004; Stewart JA, 2012, MUTAT RES-FUND MOL M, V730, P12, DOI 10.1016/j.mrfmmm.2011.08.011; Taghizadeh K, 2008, NAT PROTOC, V3, P1287, DOI 10.1038/nprot.2008.119; Tchirkov A, 2003, HUM MOL GENET, V12, P227, DOI 10.1093/hmg/ddg023; Tejera AM, 2010, DEV CELL, V18, P775, DOI [10.1016/j.devcel.2010.03.011, 10.1016/j.devce1.2010.03.011]; Voss P, 2006, FREE RADICAL RES, V40, P1339, DOI 10.1080/10715760600953859; Vulliamy TJ, 2006, BLOOD, V107, P2680, DOI 10.1182/blood-2005-07-2622; Walne AJ, 2008, BLOOD, V112, P3594, DOI 10.1182/blood-2008-05-153445; Westin ER, 2011, ANTIOXID REDOX SIGN, V14, P985, DOI 10.1089/ars.2010.3444; WRIGHT WE, 1995, NUCLEIC ACIDS RES, V23, P3794, DOI 10.1093/nar/23.18.3794; Xu C, 2012, FEBS LETT, V586, P3920, DOI 10.1016/j.febslet.2012.09.030; Yang YF, 2000, MOL BIOL CELL, V11, P567, DOI 10.1091/mbc.11.2.567; Young NS, 2012, HEMATOLOGY, V17, pS18, DOI 10.1179/102453312X13336169155132; Zeng XL, 2012, HUM MOL GENET, V21, P721, DOI 10.1093/hmg/ddr504; Zhang RG, 2007, MOL CELL BIOL, V27, P2343, DOI 10.1128/MCB.02019-06	49	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101424	10.1371/journal.pone.0101424	http://dx.doi.org/10.1371/journal.pone.0101424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987982	Green Submitted, Green Published, gold			2022-12-27	WOS:000341354100085
J	Mora, M; Hanzu, FA; Pradas-Juni, M; Aranda, GB; Halperin, I; Puig-Domingo, M; Aguilo, S; Fernandez-Rebollo, E				Mora, Mireia; Hanzu, Felicia A.; Pradas-Juni, Marta; Aranda, Gloria B.; Halperin, Irene; Puig-Domingo, Manuel; Aguilo, Sira; Fernandez-Rebollo, Eduardo			New Splice Site Acceptor Mutation in AIRE Gene in Autoimmune Polyendocrine Syndrome Type 1	PLOS ONE			English	Article							CANDIDIASIS-ECTODERMAL-DYSTROPHY; SYNDROME TYPE-I; REGULATOR GENE; PROTEIN; PREDICTION; NONSENSE; DISEASE; THYMUS; SP100; TIME	Autoimmune polyglandular syndrome type 1 (APS-1, OMIM 240300) is a rare autosomal recessive disorder, characterized by the presence of at least two of three major diseases: hypoparathyroidism, Addison's disease, and chronic mucocutaneous candidiasis. We aim to identify the molecular defects and investigate the clinical and mutational characteristics in an index case and other members of a consanguineous family. We identified a novel homozygous mutation in the splice site acceptor (SSA) of intron 5 (c.653-1G>A) in two siblings with different clinical outcomes of APS-1. Coding DNA sequencing revealed that this AIRE mutation potentially compromised the recognition of the constitutive SSA of intron 5, splicing upstream onto a nearby cryptic SSA in intron 5. Surprisingly, the use of an alternative SSA entails the uncovering of a cryptic donor splice site in exon 5. This new transcript generates a truncated protein (p.A214fs67X) containing the first 213 amino acids and followed by 68 aberrant amino acids. The mutation affects the proper splicing, not only at the acceptor but also at the donor splice site, highlighting the complexity of recognizing suitable splicing sites and the importance of sequencing the intron-exon junctions for a more precise molecular diagnosis and correct genetic counseling. As both siblings were carrying the same mutation but exhibited a different APS-1 onset, and one of the brothers was not clinically diagnosed, our finding highlights the possibility to suspect mutations in the AIRE gene in cases of childhood chronic candidiasis and/or hypoparathyroidism otherwise unexplained, especially when the phenotype is associated with other autoimmune diseases.	[Mora, Mireia; Hanzu, Felicia A.; Aranda, Gloria B.; Halperin, Irene] Hosp Clin Barcelona, Dept Endocrinol & Nutr, Barcelona, Spain; [Mora, Mireia; Hanzu, Felicia A.; Aranda, Gloria B.; Halperin, Irene] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Lab Endocrine Disorders, Barcelona, Spain; [Mora, Mireia; Hanzu, Felicia A.; Pradas-Juni, Marta; Aranda, Gloria B.; Fernandez-Rebollo, Eduardo] Spanish Biomed Res Ctr Diabet & Associated Metab, Barcelona, Spain; [Pradas-Juni, Marta; Fernandez-Rebollo, Eduardo] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Puig-Domingo, Manuel] Univ Autonoma Barcelona, Dept Endocrinol & Nutr, Hosp Germans Trias & Pujol Res Inst & Hosp, Badalona, Spain; [Aguilo, Sira] Hosp Clin Barcelona, Dept Internal Med, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Autonomous University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona	Fernandez-Rebollo, E (corresponding author), Spanish Biomed Res Ctr Diabet & Associated Metab, Barcelona, Spain.	edu.ferrebo@gmail.com	Puig-Domingo, Manel/S-2169-2019; , EFR1981/AAV-6334-2020; Mora, Mireia/R-6696-2018	Puig-Domingo, Manel/0000-0002-6744-7195; , EFR1981/0000-0002-4378-7590; Hanzu, Felicia Alexandra/0000-0002-2399-4023; Mora, Mireia/0000-0002-5887-5016; Halperin Rabinovich, Irene/0000-0003-3151-5990	IDIBAPS [01/2012]; FPI [BES-2011-044579, SAF2010-19527]; BIOTRACK Postdoctoral Fellowship in IDIBAPS (EC) [229673]	IDIBAPS; FPI(Spanish Government); BIOTRACK Postdoctoral Fellowship in IDIBAPS (EC)	This work was sponsored by the STARTUP 01/2012 grant from IDIBAPS. MP-J is a recipient of a FPI grant BES-2011-044579 (SAF2010-19527) and EF-R is a recipient of a BIOTRACK Postdoctoral Fellowship in IDIBAPS (EC FP7/2009-2013) under the agreement no. 229673. CIBER de Diabetes y Enfermedades Metabolicas Asociadas is an initiative of ISCIII (Spanish Ministry of Science and Innovation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen J, 1997, GENOME RES, V7, P820, DOI 10.1101/gr.7.8.820; Akirav EM, 2011, NAT REV ENDOCRINOL, V7, P25, DOI 10.1038/nrendo.2010.200; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bjorses P, 2000, AM J HUM GENET, V66, P378, DOI 10.1086/302765; Bjorses P, 1996, AM J HUM GENET, V59, P879; Buzi F, 2003, J CLIN ENDOCR METAB, V88, P3146, DOI 10.1210/jc.2002-021495; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cervato S, 2009, CLIN ENDOCRINOL, V70, P421, DOI 10.1111/j.1365-2265.2008.03318.x; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Dogan RI, 2007, NUCLEIC ACIDS RES, V35, pW285, DOI 10.1093/nar/gkm407; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Gibson TJ, 1998, TRENDS BIOCHEM SCI, V23, P242, DOI 10.1016/S0968-0004(98)01231-6; Guldner HH, 1999, J CELL SCI, V112, P733; Gylling M, 2003, J CLIN ENDOCR METAB, V88, P4602, DOI 10.1210/jc.2003-030700; Halonen M, 2002, J CLIN ENDOCR METAB, V87, P2568, DOI 10.1210/jc.87.6.2568; Husebye ES, 2009, J INTERN MED, V265, P514, DOI 10.1111/j.1365-2796.2009.02090.x; Ishii T, 2000, J CLIN ENDOCR METAB, V85, P2922, DOI 10.1210/jc.85.8.2922; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Kluger N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00232; Liston Adrian, 2005, Novartis Found Symp, V267, P180; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Martinez Lopez Ma M, 2006, An Pediatr (Barc), V64, P583; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Michels AW, 2010, NAT REV ENDOCRINOL, V6, P270, DOI 10.1038/nrendo.2010.40; Mittaz L, 1999, BIOCHEM BIOPH RES CO, V255, P483, DOI 10.1006/bbrc.1999.0223; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Pearce SHS, 1998, AM J HUM GENET, V63, P1675, DOI 10.1086/302145; Perheentupa J, 2006, J CLIN ENDOCR METAB, V91, P2843, DOI 10.1210/jc.2005-2611; Stenson P. D., 2013, HUM GENET; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Sternsdorf T, 1997, IMMUNOBIOLOGY, V198, P307, DOI 10.1016/S0171-2985(97)80051-4; Wang M, 2006, GENE, V366, P219, DOI 10.1016/j.gene.2005.07.015; Weiler FG, 2012, ARQ BRAS ENDOCRINOL, V56, P54, DOI 10.1590/S0004-27302012000100009; Wolff ASB, 2007, J CLIN ENDOCR METAB, V92, P595, DOI 10.1210/jc.2006-1873; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; ZLOTOGORA J, 1992, J MED GENET, V29, P824, DOI 10.1136/jmg.29.11.824	38	10	11	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101616	10.1371/journal.pone.0101616	http://dx.doi.org/10.1371/journal.pone.0101616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988226	Green Submitted, Green Published, gold			2022-12-27	WOS:000341354100120
J	Staab, M; Ohl, M; Zhu, CD; Klein, AM				Staab, Michael; Ohl, Michael; Zhu, Chao-Dong; Klein, Alexandra-Maria			A Unique Nest-Protection Strategy in a New Species of Spider Wasp	PLOS ONE			English	Article							HYMENOPTERA; POMPILIDAE; BEHAVIOR; HYDROCARBONS; RECOGNITION; PHYLOGENY; DIVERSITY; EVOLUTION; HISTORY; FOREST	Hymenoptera show a great variation in reproductive potential and nesting behavior, from thousands of eggs in sawflies to just a dozen in nest-provisioning wasps. Reduction in reproductive potential in evolutionary derived Hymenoptera is often facilitated by advanced behavioral mechanisms and nesting strategies. Here we describe a surprising nesting behavior that was previously unknown in the entire animal kingdom: the use of a vestibular cell filled with dead ants in a new spider wasp (Hymenoptera: Pompilidae) species collected with trap nests in South-East China. We scientifically describe the 'Bone-house Wasp' as Deuteragenia ossarium sp. nov., named after graveyard bone-houses or ossuaries. We show that D. ossarium nests are less vulnerable to natural enemies than nests of other sympatric trap-nesting wasps, suggesting an effective nest protection strategy, most likely by utilizing chemical cues emanating from the dead ants.	[Staab, Michael; Klein, Alexandra-Maria] Univ Freiburg, Inst Earth & Environm Sci, Dept Nat Conservat & Landscape Ecol, D-79106 Freiburg, Germany; [Staab, Michael; Klein, Alexandra-Maria] Univ Luneburg, Inst Ecol, Ecosyst Funct Grp, D-21335 Luneburg, Germany; [Ohl, Michael] Leibniz Inst Res Evolut & Biodivers, Museum Nat Kunde, Berlin, Germany; [Zhu, Chao-Dong] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China	University of Freiburg; Leuphana University Luneburg; Leibniz Institut fur Evolutions und Biodiversitatsforschung; Chinese Academy of Sciences; Institute of Zoology, CAS	Staab, M (corresponding author), Univ Freiburg, Inst Earth & Environm Sci, Dept Nat Conservat & Landscape Ecol, Hugstetter Str 55, D-79106 Freiburg, Germany.	michael.staab@nature.uni-freiburg.de	ZHU, Chao-Dong/E-5961-2011; Staab, Michael/I-6544-2019; Klein, Alexandra-Maria/J-5871-2016	ZHU, Chao-Dong/0000-0002-9347-3178; Staab, Michael/0000-0003-0894-7576; Klein, Alexandra-Maria/0000-0003-2139-8575	German Research Foundation [FOR 891/2, KL 1849/6-1]; National Natural Science Foundation of China [J1210002]	German Research Foundation(German Research Foundation (DFG)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was granted by the German Research Foundation (FOR 891/2, KL 1849/6-1, www.dfg.de) to MS and AMK, and by the National Natural Science Foundation of China (J1210002, www.nsfc.gov.cn) to CDZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1967, TRAP NESTING WASPS B; Asis JD, 2007, J INSECT BEHAV, V20, P289, DOI 10.1007/s10905-007-9080-5; Auko TH, 2013, TROP ZOOL, V26, P140, DOI 10.1080/03946975.2013.835636; Baer B, 2009, INSECT SOC, V56, P289, DOI 10.1007/s00040-009-0026-0; Barthelemy C, 2012, J HYMENOPT RES, V28, P13, DOI 10.3897/JHR.28.3010; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Brandstaetter AS, 2008, NATURWISSENSCHAFTEN, V95, P601, DOI 10.1007/s00114-008-0360-5; Bruelheide H, 2011, ECOL MONOGR, V81, P25, DOI 10.1890/09-2172.1; Day MC, 1988, HYMENOPTERA POMPILID; Evans H. E., 1962, Behaviour Leiden, V19, P239, DOI 10.1163/156853962X00041; Franzen M, 2007, ANN ZOOL FENN, V44, P405; Geissler C, 2012, CATENA, V91, P85, DOI 10.1016/j.catena.2010.10.009; HASSELL MP, 1984, ANNU REV ENTOMOL, V29, P89, DOI 10.1146/annurev.en.29.010184.000513; Holldobler B., 1990, pi; Klein AM, 2006, J ANIM ECOL, V75, P315, DOI 10.1111/j.1365-2656.2006.01042.x; Lahav S, 1999, NATURWISSENSCHAFTEN, V86, P246, DOI 10.1007/s001140050609; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; LELEI A S, 1986, Entomologicheskoe Obozrenie, V65, P799; LELEJ AS, 2012, FAR EAST ENTOMOL NOV, P1; Lopez-Pujol J, 2006, BIODIVERS CONSERV, V15, P3983, DOI 10.1007/s10531-005-3015-2; Martin SJ, 2009, BIOL J LINN SOC, V96, P732, DOI 10.1111/j.1095-8312.2008.01158.x; Martin SJ, 2009, J CHEM ECOL, V35, P368, DOI 10.1007/s10886-009-9612-x; Morato EF, 2006, NEOTROP ENTOMOL, V35, P285, DOI 10.1590/S1519-566X2006000300001; O'Neill K., 2001, CORNELL S ARTHR BIOL, pXIV + 406; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Paivinen J, 2003, OECOLOGIA, V134, P587, DOI 10.1007/s00442-002-1141-z; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; Pierce NE, 2002, ANNU REV ENTOMOL, V47, P733, DOI 10.1146/annurev.ento.47.091201.145257; Pitts JP, 2006, ZOOL SCR, V35, P63, DOI 10.1111/j.1463-6409.2005.00217.x; R Core Team, 2021, R LANGUAGE ENV STAT; Schmidt JO, 2004, J KANSAS ENTOMOL SOC, V77, P402, DOI 10.2317/E-39.1; Seidelmann K, 1999, APIDOLOGIE, V30, P19, DOI 10.1051/apido:19990103; Shimizu A, 2004, J KANSAS ENTOMOL SOC, V77, P383, DOI 10.2317/E-30.1; Shimizu Akira, 2003, Entomological Science, V6, P165, DOI 10.1046/j.1343-8786.2003.00015.x; Shimizu A, 2010, ZOOL J LINN SOC-LOND, V160, P88, DOI 10.1111/j.1096-3642.2009.00592.x; Shimizu Akira, 2002, Entomological Science, V5, P219; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Tscharntke T, 1998, J APPL ECOL, V35, P708, DOI 10.1046/j.1365-2664.1998.355343.x; WCISLO W T, 1988, Journal of Insect Behavior, V1, P247, DOI 10.1007/BF01054524; Zuur Alain F., 2009, P1	40	11	16	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101592	10.1371/journal.pone.0101592	http://dx.doi.org/10.1371/journal.pone.0101592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987876	Green Published, gold			2022-12-27	WOS:000341354100117
J	Darby, AC; McInnes, CJ; Kjaer, KH; Wood, AR; Hughes, M; Martensen, PM; Radford, AD; Hall, N; Chantrey, J				Darby, Alistair C.; McInnes, Colin J.; Kjaer, Karina Hansen; Wood, Ann R.; Hughes, Margaret; Martensen, Pia Moller; Radford, Alan D.; Hall, Neil; Chantrey, Julian			Novel Host-Related Virulence Factors Are Encoded by Squirrelpox Virus, the Main Causative Agent of Epidemic Disease in Red Squirrels in the UK	PLOS ONE			English	Article							PROTEIN-KINASE PKR; SCIURUS-VULGARIS; GREY SQUIRRELS; POXVIRUS; VACCINIA; GENE; INTERFERON; BINDING; E3L; IDENTIFICATION	Squirrelpox virus (SQPV) shows little evidence for morbidity or mortality in North American grey squirrels (Sciurus carolinensis), in which the virus is endemic. However, more recently the virus has emerged to cause epidemics with high mortality in Eurasian red squirrels (S. vulgaris) in Great Britain, which are now threatened. Here we report the genome sequence of SQPV. Comparison with other Poxviridae revealed a core set of poxvirus genes, the phylogeny of which showed SQPV to be in a new Chordopoxvirus subfamily between the Molluscipoxviruses and Parapoxviruses. A number of SQPV genes were related to virulence, including three major histocomaptibility class I homologs, and one CD47 homolog. In addition, a novel potential virulence factor showing homology to mammalian oligoadenylate synthetase (OAS) was identified. This family of proteins normally causes activation of an endoribonuclease (RNaseL) within infected cells. The putative function of this novel SQPV protein was predicted in silico.	[Darby, Alistair C.; Hughes, Margaret; Radford, Alan D.; Hall, Neil; Chantrey, Julian] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [McInnes, Colin J.; Wood, Ann R.] Moredun Res Inst, Penicuik, Midlothian, Scotland; [Kjaer, Karina Hansen; Martensen, Pia Moller] Univ Aarhus, Aarhus, Denmark; [Hall, Neil] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia	University of Liverpool; Moredun Research Institute; Aarhus University; King Abdulaziz University	Hall, N (corresponding author), Univ Liverpool, Liverpool L69 3BX, Merseyside, England.	Neil.Hall@liv.ac.uk	Darby, Alistair/I-6485-2012; Martensen, Pia/I-3996-2012	Darby, Alistair/0000-0002-3786-6209; McInnes, Colin/0000-0002-1465-9901; Martensen, Pia Moller/0000-0002-1259-0226; Radford, Alan/0000-0002-4590-1334; Hall, Neil/0000-0003-2808-0009	Royal College of Veterinary Surgeons trust; Danish Council for Independent Research/Natural Sciences	Royal College of Veterinary Surgeons trust; Danish Council for Independent Research/Natural Sciences(Det Frie Forskningsrad (DFF))	We thank the Wildlife Ark Trust for their funding of this work, as part of their overall strategy to develop a vaccine against squirrel poxvirus. ACD was funded by the Royal College of Veterinary Surgeons trust. KHK and PMM were supported by the The Danish Council for Independent Research/Natural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Brandt TA, 2001, J VIROL, V75, P850, DOI 10.1128/JVI.75.2.850-856.2001; Bruemmer CM, 2010, EPIDEMIOL INFECT, V138, P941, DOI 10.1017/S0950268810000816; BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991; Cameron CM, 2005, VIROLOGY, V337, P55, DOI 10.1016/j.virol.2005.03.037; CHANG HW, 1993, VIROLOGY, V194, P537, DOI 10.1006/viro.1993.1292; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gardai SJ, 2006, J LEUKOCYTE BIOL, V79, P896, DOI 10.1189/jlb.1005550; Gil J, 2001, J GEN VIROL, V82, P3027, DOI 10.1099/0022-1317-82-12-3027; Gubser C, 2004, J GEN VIROL, V85, P105, DOI 10.1099/vir.0.19565-0; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haga IR, 2005, PARASITOLOGY, V130, pS11, DOI 10.1017/S0031182005008127; Haller O, 2007, CYTOKINE GROWTH F R, V18, P425, DOI 10.1016/j.cytogfr.2007.06.001; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Hovanessian AG, 2007, BIOCHIMIE, V89, P779, DOI 10.1016/j.biochi.2007.02.003; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Kjaer KH, 2009, J MOL EVOL, V69, P612, DOI 10.1007/s00239-009-9299-1; Lewis-Jones S, 2004, CURR OPIN INFECT DIS, V17, P81, DOI 10.1097/00001432-200404000-00003; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; McInnes CJ, 2009, VET REC, V164, P528, DOI 10.1136/vr.164.17.528; McInnes CJ, 2006, J GEN VIROL, V87, P2115, DOI 10.1099/vir.0.81966-0; Moss B, 2001, FIELDS VIROLOGY, P2849; Orange JS, 2002, NAT IMMUNOL, V3, P1006, DOI 10.1038/ni1102-1006; Perdiguero B, 2009, J INTERF CYTOK RES, V29, P581, DOI 10.1089/jir.2009.0073; Pettersen RD, 2000, APOPTOSIS, V5, P299, DOI 10.1023/A:1009612821625; Rushton SP, 2006, EPIDEMIOL INFECT, V134, P521, DOI 10.1017/S0950268805005303; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sainsbury AW, 2008, ECOHEALTH, V5, P305, DOI 10.1007/s10393-008-0191-z; Sainsbury AW, 2000, ANIM CONSERV, V3, P229, DOI 10.1017/S1367943000000949; SCOTT AC, 1981, VET REC, V109, P202, DOI 10.1136/vr.109.10.202; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; Senkevich TG, 1998, VIROLOGY, V250, P397, DOI 10.1006/viro.1998.9390; Sharp TV, 1998, VIROLOGY, V250, P302, DOI 10.1006/viro.1998.9365; Smith VP, 2000, J GEN VIROL, V81, P1223, DOI 10.1099/0022-1317-81-5-1223; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Taylor JM, 2006, VIROLOGY, V344, P139, DOI 10.1016/j.virol.2005.09.032; Tompkins DM, 2002, P ROY SOC B-BIOL SCI, V269, P529, DOI 10.1098/rspb.2001.1897; Wauters LA, 2000, ECOL RES, V15, P271, DOI 10.1046/j.1440-1703.2000.00354.x	42	20	21	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e96439	10.1371/journal.pone.0096439	http://dx.doi.org/10.1371/journal.pone.0096439			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983354	Green Submitted, gold, Green Published			2022-12-27	WOS:000339635000004
J	Villamor, A; Costantini, F; Abbiati, M				Villamor, Adriana; Costantini, Federica; Abbiati, Marco			Genetic Structuring across Marine Biogeographic Boundaries in Rocky Shore Invertebrates	PLOS ONE			English	Article							MACARONESIAN ISLANDS; POPULATION-GROWTH; MEDITERRANEAN SEA; RANGE EXPANSION; PHYLOGEOGRAPHY; FLOW; CONNECTIVITY; REVEALS; EASTERN; HISTORY	Biogeography investigates paw patterns of species distribution. Discontinuities in species distribution are identified boundaries between biogeographic areas. Do these boundaries affect genetic connectivity? To address his question multifactorial hierarchical sampling design, across three of the major marine biogeographic boundaries in the cent Mediterranean Sea (Ligurian-Tyrrhenian, Tyrrhenian-Ionian and Ionian-Adriatic) was carried out. Mitochondrial COI sequence polymorphism of seven species of Mediterranean benthic invertebrates was analysed. Two species showed significant genetic structure across the Tyrrhenian-Ionian boundary, as well as two other species across the Ionian Sea, a previously unknown phylogeographic barrier. The hypothesized barrier in the Ligurian-Tyrrhenian cannot be detected in the genetic structure of the investigated species. Connectivity patterns across species at distances up to 800 km apart confirmed that estimates of pelagic larval dispersal were poor predictors of the genetic structure. The detected genetic discontinuities seem more related to the effect of past historical events, though maintained by present day oceanographic processes. Multivariate statistical tools were used to test the consistency of the patterns across species, providing a conceptual framework for across-species barrier locations and strengths. Additional sequences retrieved from public databases supported our findings. Heterogeneity of phylogeographic patterns shown by the 7 investigated species is relevant to the understanding of the genetic diversity, and carry implications for conservation biology.	[Villamor, Adriana; Costantini, Federica; Abbiati, Marco] Univ Bologna, Dept Biol Geol & Environm Sci, Ravenna, Emilia Romagna, Italy; [Abbiati, Marco] CNR, Inst Marine Sci, Bologna, Emilia Romagna, Italy	University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Villamor, A (corresponding author), Univ Bologna, Dept Biol Geol & Environm Sci, Ravenna, Emilia Romagna, Italy.	adriana.villamor@unibo.it	COSTANTINI, FEDERICA/ABH-9194-2020; CNR, Ismar/P-1247-2014	COSTANTINI, FEDERICA/0000-0002-8813-1923; Abbiati, Marco/0000-0002-2426-4524; CNR, Ismar/0000-0001-5351-1486	MIUR project (PRIN project on "Coastal bioconstructions: structure, function and management") of the Italian Government	MIUR project (PRIN project on "Coastal bioconstructions: structure, function and management") of the Italian Government	The study was funded by a MIUR project (PRIN 2011 project on "Coastal bioconstructions: structure, function and management") of the Italian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astraldi M, 1999, PROG OCEANOGR, V44, P65, DOI 10.1016/S0079-6611(99)00021-X; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Ayre DJ, 2009, MOL ECOL, V18, P1887, DOI 10.1111/j.1365-294X.2009.04127.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Bianchi C.N., 2004, NOTIZIARIO SIBM, V46, P57; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Bird CE, 2007, MOL ECOL, V16, P3173, DOI 10.1111/j.1365-294X.2007.03385.x; Blanco-Bercial L, 2011, J EXP MAR BIOL ECOL, V404, P108, DOI 10.1016/j.jembe.2011.05.011; BROWN SK, 1985, J CRUSTACEAN BIOL, V5, P574, DOI 10.2307/1548236; Campo D, 2010, MAR BIOL, V157, P147, DOI 10.1007/s00227-009-1305-z; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Coleman MA, 2011, J ECOL, V99, P1026, DOI 10.1111/j.1365-2745.2011.01822.x; COLL M, 2010, PLOS ONE, V5, DOI DOI 10.1371/JOURNAL.PONE.0011842; Collins CJ, 2010, MOL ECOL, V19, P4572, DOI 10.1111/j.1365-294X.2010.04842.x; CorteReal HBSM, 1996, MAR BIOL, V125, P141, DOI 10.1007/BF00350768; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; CRISP DJ, 1960, BIOL BULL, V118, P31, DOI 10.2307/1539053; Desai B. N., 1966, Proceedings of the Malacological Society of London, V37, P1; Dodd J. M., 1957, PUBBLICAZIONI STAZIO, V29, P172; Domingues VS, 2005, MOL ECOL, V14, P4051, DOI 10.1111/j.1365-294X.2005.02723.x; Drew JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047710; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duran S, 2004, MOL ECOL, V13, P109, DOI 10.1046/j.1365-294X.2003.02022.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; Gaither MR, 2010, J BIOGEOGR, V37, P133, DOI 10.1111/j.1365-2699.2009.02188.x; Galarza JA, 2009, P NATL ACAD SCI USA, V106, P1473, DOI 10.1073/pnas.0806804106; Gharbi A, 2011, J MAR BIOL ASSOC UK, V91, P1599, DOI 10.1017/S0025315411000245; Hellberg ME, 2001, SCIENCE, V292, P1707, DOI 10.1126/science.1060102; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; Kim WJ, 2012, BIOCHEM SYST ECOL, V44, P128, DOI 10.1016/j.bse.2012.04.020; Lahbib Y, 2010, MAR BIOL RES, V6, P600, DOI 10.1080/17451000903437075; Lessios HA, 2006, P ROY SOC B-BIOL SCI, V273, P2201, DOI 10.1098/rspb.2006.3543; Luttikhuizen PC, 2008, MOL PHYLOGENET EVOL, V46, P1015, DOI 10.1016/j.ympev.2007.11.011; Maggio T, 2009, ICES J MAR SCI, V66, P1883, DOI 10.1093/icesjms/fsp160; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Marko PB, 2011, TRENDS ECOL EVOL, V26, P448, DOI 10.1016/j.tree.2011.05.007; Marko PB, 2010, MOL ECOL, V19, P146, DOI 10.1111/j.1365-294X.2009.04417.x; Marske KA, 2013, ECOGRAPHY, V36, P1169, DOI 10.1111/j.1600-0587.2013.00244.x; Marti-Puig Patricia, 2014, Advances in Oceanography and Limnology, V4, P138, DOI 10.1080/19475721.2013.850445; Millot C, 1999, J MARINE SYST, V20, P423, DOI 10.1016/S0924-7963(98)00078-5; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Papetti C, 2012, J BIOGEOGR, V39, P1361, DOI 10.1111/j.1365-2699.2011.02682.x; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Peres J.M, 1964, RECUEIL TRAVAUX STAT, V31, P1; Perez-Losada M, 2007, MOL ECOL, V16, P2667, DOI 10.1111/j.1365-294X.2007.03333.x; Perez-Portela R, 2010, MAR BIOL, V157, P2015, DOI 10.1007/s00227-010-1470-0; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2007, TRACER V1 4; Riesgo A, 2008, INVERTEBR BIOL, V127, P357, DOI 10.1111/j.1744-7410.2008.00128.x; Riginos C, 2011, ECOGRAPHY, V34, P566, DOI 10.1111/j.1600-0587.2010.06511.x; Rock J, 2007, HEREDITY, V99, P102, DOI 10.1038/sj.hdy.6800971; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Ryland JS, 1995, HDB MARINE FAUNA N W; Sa-Pinto A, 2005, J EXP MAR BIOL ECOL, V325, P95, DOI 10.1016/j.jembe.2005.04.025; Sa-Pinto A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050330; Santic M, 2010, ARCH BIOL SCI, V62, P1007, DOI 10.2298/ABS1004007S; SCHIFANO G, 1983, PALAEOGEOGR PALAEOCL, V44, P215, DOI 10.1016/0031-0182(83)90104-9; Serra IA, 2010, MOL ECOL, V19, P557, DOI 10.1111/j.1365-294X.2009.04462.x; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Sotka EE, 2004, MOL ECOL, V13, P2143, DOI 10.1111/j.1365-294X.2004.02225.x; Stefanni S, 2003, MOL PHYLOGENET EVOL, V28, P601, DOI 10.1016/S1055-7903(03)00054-X; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TEMPLETON AR, 1987, GENETICS, V117, P343; Teske PR, 2011, MOL ECOL, V20, P5025, DOI 10.1111/j.1365-294X.2011.05307.x; Vasconcelos P, 2004, INVERTEBR REPROD DEV, V46, P125, DOI 10.1080/07924259.2004.9652616; Virgilio M, 2009, MOL ECOL, V18, P1980, DOI 10.1111/j.1365-294X.2009.04170.x; Wares JP, 2001, EVOLUTION, V55, P2455; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; Xavier JR, 2010, MOL PHYLOGENET EVOL, V56, P13, DOI 10.1016/j.ympev.2010.03.030	74	43	43	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101135	10.1371/journal.pone.0101135	http://dx.doi.org/10.1371/journal.pone.0101135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983738	Green Published, Green Submitted, gold			2022-12-27	WOS:000339635000057
J	Blum, Y; Vejdani, HR; Birn-Jeffery, AV; Hubicki, CM; Hurst, JW; Daley, MA				Blum, Yvonne; Vejdani, Hamid R.; Birn-Jeffery, Aleksandra V.; Hubicki, Christian M.; Hurst, Jonathan W.; Daley, Monica A.			Swing-Leg Trajectory of Running Guinea Fowl Suggests Task-Level Priority of Force Regulation Rather than Disturbance Rejection	PLOS ONE			English	Article							TERRESTRIAL LOCOMOTION; ENERGY CHANGES; BODY-SIZE; BIPEDAL LOCOMOTION; PASSIVE DYNAMICS; MUSCLE MECHANICS; UNEVEN TERRAIN; LIMB POSTURE; STABILITY; MODEL	To achieve robust and stable legged locomotion in uneven terrain, animals must effectively coordinate limb swing and stance phases, which involve distinct yet coupled dynamics. Recent theoretical studies have highlighted the critical influence of swing-leg trajectory on stability, disturbance rejection, leg loading and economy of walking and running. Yet, simulations suggest that not all these factors can be simultaneously optimized. A potential trade-off arises between the optimal swing-leg trajectory for disturbance rejection (to maintain steady gait) versus regulation of leg loading (for injury avoidance and economy). Here we investigate how running guinea fowl manage this potential trade-off by comparing experimental data to predictions of hypothesis-based simulations of running over a terrain drop perturbation. We use a simple model to predict swing-leg trajectory and running dynamics. In simulations, we generate optimized swing-leg trajectories based upon specific hypotheses for task-level control priorities. We optimized swing trajectories to achieve i) constant peak force, ii) constant axial impulse, or iii) perfect disturbance rejection (steady gait) in the stance following a terrain drop. We compare simulation predictions to experimental data on guinea fowl running over a visible step down. Swing and stance dynamics of running guinea fowl closely match simulations optimized to regulate leg loading (priorities i and ii), and do not match the simulations optimized for disturbance rejection (priority iii). The simulations reinforce previous findings that swing-leg trajectory targeting disturbance rejection demands large increases in stance leg force following a terrain drop. Guinea fowl negotiate a downward step using unsteady dynamics with forward acceleration, and recover to steady gait in subsequent steps. Our results suggest that guinea fowl use swing-leg trajectory consistent with priority for load regulation, and not for steadiness of gait. Swing-leg trajectory optimized for load regulation may facilitate economy and injury avoidance in uneven terrain.	[Blum, Yvonne; Birn-Jeffery, Aleksandra V.; Daley, Monica A.] Royal Vet Coll, Dept Comparat Biomed Sci, Hatfield, Herts, England; [Vejdani, Hamid R.; Hubicki, Christian M.; Hurst, Jonathan W.] Oregon State Univ, Corvallis, OR 97331 USA; [Birn-Jeffery, Aleksandra V.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA	University of London; University of London Royal Veterinary College; Oregon State University; University of California System; University of California Riverside	Daley, MA (corresponding author), Royal Vet Coll, Dept Comparat Biomed Sci, Hatfield, Herts, England.	mdaley@rvc.ac.uk	Daley, Monica A/AAE-5079-2019	Daley, Monica A/0000-0001-8584-2052; Vejdani, Hamid/0000-0001-5352-9846; Hubicki, Christian/0000-0002-2092-3772	Human Frontier Science Program (HFSP) [RGY0062/2010]	Human Frontier Science Program (HFSP)(Human Frontier Science Program)	This study was funded by grant RGY0062/2010 of the Human Frontier Science Program (HFSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RM, 2002, COMP BIOCHEM PHYS A, V133, P1001; Andrews B, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/2/026009; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Biewener AA, 2005, J EXP BIOL, V208, P1665, DOI 10.1242/jeb.01520; Birn-Jeffery AV, 2012, J EXP BIOL, V215, P2117, DOI 10.1242/jeb.065557; BLICKHAN R, 1989, J BIOMECH, V22, P1217, DOI 10.1016/0021-9290(89)90224-8; Blum Y, 2010, BIOINSPIR BIOMIM, V5, DOI 10.1088/1748-3182/5/2/026006; Blum Y, 2011, J THEOR BIOL, V281, P97, DOI 10.1016/j.jtbi.2011.04.029; Byl K, 2009, INT J ROBOT RES, V28, P1040, DOI 10.1177/0278364909340446; Cavagna GA, 2006, J EXP BIOL, V209, P4051, DOI 10.1242/jeb.02344; CAVAGNA GA, 1988, J PHYSIOL-LONDON, V399, P81; CAVAGNA GA, 1964, J APPL PHYSIOL, V19, P249, DOI 10.1152/jappl.1964.19.2.249; Daley MA, 2007, J EXP BIOL, V210, P383, DOI 10.1242/jeb.02668; Daley MA, 2006, P NATL ACAD SCI USA, V103, P15681, DOI 10.1073/pnas.0601473103; Daley MA, 2011, PHILOS T R SOC B, V366, P1580, DOI 10.1098/rstb.2010.0338; Daley MA, 2010, BIOL LETTERS, V6, P418, DOI 10.1098/rsbl.2010.0175; Daley MA, 2009, J PHYSIOL-LONDON, V587, P2693, DOI 10.1113/jphysiol.2009.171017; De Wit B, 2000, J BIOMECH, V33, P269, DOI 10.1016/S0021-9290(99)00192-X; Dingwell JB, 2007, J BIOMECH ENG-T ASME, V129, P586, DOI 10.1115/1.2746383; DOW SM, 1991, EQUINE VET J, V23, P266, DOI 10.1111/j.2042-3306.1991.tb03715.x; Ernst M, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/4/046002; Ernst M, 2009, INT C CLIMB WALK ROB; FARLEY CT, 1993, J EXP BIOL, V185, P71; FEDAK MA, 1982, J EXP BIOL, V97, P23; Ferris DP, 1999, J BIOMECH, V32, P787, DOI 10.1016/S0021-9290(99)00078-0; Full RJ, 1999, J EXP BIOL, V202, P3325; Garcia M, 2000, DYNAM STABIL SYST, V15, P75, DOI 10.1080/713603737; GATESY SM, 1991, J ZOOL, V224, P127, DOI 10.1111/j.1469-7998.1991.tb04794.x; Geyer H, 2006, P R SOC B, V273, P2861, DOI 10.1098/rspb.2006.3637; Grimmer S, 2008, J EXP BIOL, V211, P2989, DOI 10.1242/jeb.014357; Harrison SM, 2010, J EXP BIOL, V213, P3998, DOI 10.1242/jeb.044545; HEGLUND NC, 1982, J EXP BIOL, V97, P57; HEGLUND NC, 1982, J EXP BIOL, V97, P41; Herr HM, 2001, INT J ROBOT RES, V20, P26, DOI 10.1177/02783640122067255; Hobbelen DGE, 2007, IEEE T ROBOT, V23, P1213, DOI 10.1109/TRO.2007.904908; Karssen J. G. Daniel, 2011, 2011 IEEE International Conference on Robotics and Automation (ICRA 2011), P4000, DOI 10.1109/ICRA.2011.5980168; KER RF, 1988, J ZOOL, V216, P309, DOI 10.1111/j.1469-7998.1988.tb02432.x; KRAM R, 1990, NATURE, V346, P265, DOI 10.1038/346265a0; Kuo AD, 2002, J BIOMECH ENG-T ASME, V124, P113, DOI 10.1115/1.1427703; MCGEER T, 1993, J THEOR BIOL, V163, P277, DOI 10.1006/jtbi.1993.1121; MCMAHON TA, 1990, J BIOMECH, V23, P65, DOI 10.1016/0021-9290(90)90042-2; Minetti AE, 1997, J THEOR BIOL, V186, P467, DOI 10.1006/jtbi.1997.0407; More HL, 2010, P ROY SOC B-BIOL SCI, V277, P3563, DOI 10.1098/rspb.2010.0898; Moritz CT, 2004, J APPL PHYSIOL, V97, P1313, DOI 10.1152/japplphysiol.00393.2004; Poulakakis I, 2006, INT J ROBOT RES, V25, P669, DOI 10.1177/0278364906066768; Riese S, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/1/016006; Roberts TJ, 1998, J EXP BIOL, V201, P2745; Rubenson J, 2011, J R SOC INTERFACE, V8, P740, DOI 10.1098/rsif.2010.0466; Schmitt J, 2009, BIOINSPIR BIOMIM, V4, DOI 10.1088/1748-3182/4/4/046005; Seipel J, 2007, REGUL CHAOTIC DYN, V12, P502, DOI 10.1134/S1560354707050048; Seipel JE, 2004, BIOL CYBERN, V91, P76, DOI 10.1007/s00422-004-0498-y; Seyfarth A, 2003, J EXP BIOL, V206, P2547, DOI 10.1242/jeb.00463; Spence AJ, 2010, J EXP BIOL, V213, P1907, DOI 10.1242/jeb.042515; Srinivasan M, 2006, NATURE, V439, P72, DOI 10.1038/nature04113; Srinivasan M, 2011, J R SOC INTERFACE, V8, P74, DOI 10.1098/rsif.2009.0544; Vejdani HR, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/4/046006; Wisse M, 2005, IEEE T ROBOT, V21, P393, DOI 10.1109/TRO.2004.838030	57	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100399	10.1371/journal.pone.0100399	http://dx.doi.org/10.1371/journal.pone.0100399			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24979750	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000338506400028
J	Rumaney, MB; Bitoungui, VJN; Vorster, AA; Ramesar, R; Kengne, AP; Ngogang, J; Wonkam, A				Rumaney, Maryam Bibi; Bitoungui, Valentina Josiane Ngo; Vorster, Anna Alvera; Ramesar, Raj; Kengne, Andre Pascal; Ngogang, Jeanne; Wonkam, Ambroise			The Co-Inheritance of Alpha-Thalassemia and Sickle Cell Anemia Is Associated with Better Hematological Indices and Lower Consultations Rate in Cameroonian Patients and Could Improve Their Survival	PLOS ONE			English	Article							GENETIC MODIFIERS; CHILDREN; DISEASE; RISK; HEMOGLOBIN; SEVERITY; ALPHA(+)-THALASSEMIA; POLYMORPHISMS; EPIDEMIOLOGY; DETERMINANTS	Background: Co-inheritance of alpha-thalassemia was reported to be associated with a delayed age of disease onset among Cameroonian Sickle Cell Anemia (SCA) patients. The present study aimed to explore the correlation between alpha-thalassemia, hematological indices, and clinical events in these patients. Methods and Findings: We studied 161 Cameroonian SCA patients and 103 controls (59.1% HbAA) with median ages of 17.5 and 23 years. RFLP-PCR was used to confirm SCA genotype and to describe haplotypes in the HBB-like genes cluster. Multiplex Gap-PCR was performed to investigate the 3.7 kb alpha-globin gene deletions. SNaPshot PCR, capillary electrophoresis and cycle sequencing were used for the genotyping of 10 SNPs in BCL11A, HMIP1/2, OR51B5/6 and HBG loci, known to influence HbF levels. Generalised linear regression models adjusted for age, sex and SNPs genotypes was used to investigate effects of alpha-thalassemia on clinical and hematological indices. The median rate of vaso-occlusive painful crisis and hospitalisations was two and one per year, respectively. Stroke was reported in eight cases (7.4%). Benin haplotype was the most prevalent (66.3%; n = 208 chromosomes). Among patients, 37.3% (n = 60) had at least one 3.7 kb deletion, compared to 10.9% (n = 6) among HbAA controls (p<0.001). Among patients, the median RBC count increased with the number of 3.7 kb deletions [2.6, 3.0 and 3.4 million/dl, with no, one and two deletions (p = 0.01)]. The median MCV decreased with the number of 3.7 kb deletion [86, 80, and 68fl, with no, one and two deletions (p<0.0001)], as well as median WBC counts [13.2, 10.5 and 9.8x10(9)/L (p<0.0001. The co-inheritance of alpha-thalassemia was associated with lower consultations rate (p = 0.038). Conclusion: The co-inheritance of alpha-thalassemia and SCA is associated with improved hematological indices, and lower consultations rate in this group of patients. This could possibly improve their survival and explain the higher proportion of alpha-thalassemia among patients than controls.	[Rumaney, Maryam Bibi; Vorster, Anna Alvera; Ramesar, Raj; Wonkam, Ambroise] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med IDM, Div Human Genet, ZA-7925 Cape Town, South Africa; [Bitoungui, Valentina Josiane Ngo; Ngogang, Jeanne] Univ Yaounde I, Fac Med & Biomed Sci, Dept Microbiol Parasitol & Haematol, Yaounde, Cameroon; [Ramesar, Raj] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med IDM, MRC,Human Genet Res Unit, ZA-7925 Cape Town, South Africa; [Kengne, Andre Pascal] South African Med Res Council, Noncommunicable Dis Res Unit, Cape Town, South Africa; [Kengne, Andre Pascal] Univ Cape Town, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Yaounde I; University of Cape Town; South African Medical Research Council; University of Cape Town	Wonkam, A (corresponding author), Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med IDM, Div Human Genet, ZA-7925 Cape Town, South Africa.	ambroise.wonkam@uct.ac.za	Kengne, Andre Pascal/ABB-3696-2020; Wonkam, Ambroise/AFU-6901-2022; Ramesar, Raj S/I-6941-2015	Ramesar, Raj S/0000-0001-5688-1634; Kengne, Andre Pascal/0000-0002-5183-131X; Rumaney, Maryam Bibi/0000-0003-3463-336X	National Health Laboratory Services, South Africa; University Research Committee; Carnegie Research Development Grant, University of Cape Town, South Africa; National Research Foundation-DAAD scholarship, South Africa; Third World Academy of Sciences	National Health Laboratory Services, South Africa; University Research Committee; Carnegie Research Development Grant, University of Cape Town, South Africa; National Research Foundation-DAAD scholarship, South Africa; Third World Academy of Sciences	The molecular experiments of the study were funded by the National Health Laboratory Services, South Africa; the University Research Committee and Carnegie Research Development Grant, University of Cape Town, South Africa. The students' bursaries were provided by the National Research Foundation-DAAD scholarship, South Africa, and the Third World Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsultan A, 2012, J PEDIAT HEMATOL ONC, V34, P79, DOI 10.1097/MPH.0b013e3182422844; Bae HT, 2012, BLOOD, V120, P1961, DOI 10.1182/blood-2012-06-432849; Bartolucci P, 2012, CURR OPIN HEMATOL, V19, P149, DOI 10.1097/MOH.0b013e328351c35f; Belisario AR, 2010, HEMOGLOBIN, V34, P516, DOI 10.3109/03630269.2010.526003; Bernaudin F, 2008, BLOOD, V112, P4314, DOI 10.1182/blood-2008-03-143891; Chong SS, 2000, BLOOD, V95, P360; Coelho A, 2012, EUR J HAEMATOL, V89, P501, DOI 10.1111/ejh.12011; Cox SE, 2013, INT SCHOLARLARY RES, P1; Darbari DS, 2012, J PEDIATR-US, V160, P286, DOI 10.1016/j.jpeds.2011.07.018; Day TG, 2012, HAEMATOL-HEMATOL J, V97, P201, DOI 10.3324/haematol.2011.050336; El-Hazmi MAF, 1999, J TROP PEDIATRICS, V45, P370, DOI 10.1093/tropej/45.6.370; Embury SH, 2012, EUR J HAEMATOL, V88, P363, DOI 10.1111/j.1600-0609.2011.01743.x; Enevold A, 2007, J INFECT DIS, V196, P451, DOI 10.1086/519390; FABRY ME, 1984, BLOOD, V64, P1042; Flanagan JM, 2011, BLOOD, V117, P6681, DOI 10.1182/blood-2011-01-332205; Foote EM, 2013, AM J TROP MED HYG, V88, P757, DOI 10.4269/ajtmh.12-0560; Gahutu JB, 2012, T ROY SOC TROP MED H, V106, P63, DOI 10.1016/j.trstmh.2011.09.002; Galanello R, 2011, GENET MED, V13, P83, DOI 10.1097/GIM.0b013e3181fcb468; Grosse SD, 2011, AM J PREV MED, V41, pS398, DOI 10.1016/j.amepre.2011.09.013; Guasch A, 1999, J AM SOC NEPHROL, V10, P1014; Harteveld CL, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-13; Hsu LL, 2003, J PEDIAT HEMATOL ONC, V25, P622, DOI 10.1097/00043426-200308000-00007; Martinez G, 1996, BLOOD, V88, P1898; Miller ST, 2000, NEW ENGL J MED, V342, P83, DOI 10.1056/NEJM200001133420203; Millimono TS, 2012, HEMOGLOBIN, V50, P118; Mouele R, 2000, HUM HERED, V50, P118, DOI 10.1159/000022899; Nebor D, 2010, BLOOD CELL MOL DIS, V45, P154, DOI 10.1016/j.bcmd.2010.06.003; Njamnshi AK, 2006, J NEUROL SCI, V250, P79, DOI 10.1016/j.jns.2006.07.003; Nourale M, 2013, HAEMATOLOGICA, V98, P464, DOI 10.3324/haematol.2012.068965; Ondei LS, 2007, GENET MOL RES, V6, P453; Pandey Sanjay, 2011, Korean J Hematol, V46, P192, DOI 10.5045/kjh.2011.46.3.192; Piel FB, 2013, LANCET, V381, P142, DOI 10.1016/S0140-6736(12)61229-X; Ruffieux N, 2013, CHILD NEUROPSYCHOL, V19, P143, DOI 10.1080/09297049.2011.640932; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Sheehan VA, 2013, AM J HEMATOL, V88, P571, DOI 10.1002/ajh.23457; Steinberg MH, 2012, AM J HEMATOL, V87, P795, DOI 10.1002/ajh.23232; Steinberg MH, 1998, AM J HEMATOL, V59, P121, DOI 10.1002/(SICI)1096-8652(199810)59:2<121::AID-AJH4>3.0.CO;2-#; Tarer V, 2006, EUR J HAEMATOL, V76, P193, DOI 10.1111/j.1600-0609.2005.00590.x; Vasavda N, 2007, BRIT J HAEMATOL, V138, P263, DOI 10.1111/j.1365-2141.2007.06643.x; Wali YA, 2002, PEDIATR HEMAT ONCOL, V19, P491, DOI 10.1080/08880010290097314; Ware RE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002120; Weatherall DJ, 2001, B WORLD HEALTH ORGAN, V79, P704; Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660; Wonkam A, 2014, AM J HEMATOL, V89, P664, DOI 10.1002/ajh.23711; Wonkam A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092506; Wonkam A, 2014, J GENET COUNS, V23, P192, DOI 10.1007/s10897-013-9630-2; World Bank, 2010, 48373CM WORLD BANK, P1	47	63	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2014	9	6							e100516	10.1371/journal.pone.0100516	http://dx.doi.org/10.1371/journal.pone.0100516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5ZO	24978191	Green Published, Green Submitted, gold			2022-12-27	WOS:000338506400032
J	Eltom, S; Dale, N; Raemdonck, KRG; Stevenson, CS; Snelgrove, RJ; Sacitharan, PK; Recchi, C; Wavre-Shapton, S; McAuley, DF; O'Kane, C; Belvisi, MG; Birrell, MA				Eltom, Suffwan; Dale, Nicole; Raemdonck, Kristof R. G.; Stevenson, Christopher S.; Snelgrove, Robert J.; Sacitharan, Pradeep K.; Recchi, Chiara; Wavre-Shapton, Silene; McAuley, Daniel F.; O'Kane, Cecilia; Belvisi, Maria G.; Birrell, Mark A.			Respiratory Infections Cause the Release of Extracellular Vesicles: Implications in Exacerbation of Asthma/COPD	PLOS ONE			English	Article							INDUCED AIRWAY INFLAMMATION; INDUCED LUNG INJURY; GLOBAL BURDEN; PULMONARY; SECRETION; SMOKE; PREVALENCE; RECEPTORS; COPD	Background: Infection-related exacerbations of respiratory diseases are a major health concern; thus understanding the mechanisms driving them is of paramount importance. Despite distinct inflammatory profiles and pathological differences, asthma and COPD share a common clinical facet: raised airway ATP levels. Furthermore, evidence is growing to suggest that infective agents can cause the release of extracellular vesicle (EVs) in vitro and in bodily fluids. ATP can evoke the P2X(7)/caspase 1 dependent release of IL-1 beta/IL-18 from EVs; these cytokines are associated with neutrophilia and are increased during exacerbations. Thus we hypothesized that respiratory infections causes the release of EVs in the airway and that the raised ATP levels, present in respiratory disease, triggers the release of IL-1b/IL-18, neutrophilia and subsequent disease exacerbations. Methods: To begin to test this hypothesis we utilised human cell-based assays, ex vivo murine BALF, in vivo pre-clinical models and human samples to test this hypothesis. Results: Data showed that in a murine model of COPD, known to have increased airway ATP levels, infective challenge causes exacerbated inflammation. Using cell-based systems, murine models and samples collected from challenged healthy subjects, we showed that infection can trigger the release of EVs. When exposed to ATP the EVs release IL-1 beta/IL-18 via a P2X(7)/caspase-dependent mechanism. Furthermore ATP challenge can cause a P2X(7) dependent increase in LPS-driven neutrophilia. Conclusions: This preliminary data suggests a possible mechanism for how infections could exacerbate respiratory diseases and may highlight a possible signalling pathway for drug discovery efforts in this area.	[Eltom, Suffwan; Dale, Nicole; Raemdonck, Kristof R. G.; Snelgrove, Robert J.; Sacitharan, Pradeep K.; Recchi, Chiara; Belvisi, Maria G.; Birrell, Mark A.] Univ London Imperial Coll Sci Technol & Med, London, England; [Stevenson, Christopher S.] Novartis, Horsham, W Sussex, England; [Wavre-Shapton, Silene] UCL, Inst Ophthalmol, London, England; [McAuley, Daniel F.; O'Kane, Cecilia] Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland; [Belvisi, Maria G.; Birrell, Mark A.] Univ London Imperial Coll Sci Technol & Med, MRC Asthma UK Ctr Allerg Mech Asthma, London, England	Imperial College London; Novartis; University of London; University College London; Queens University Belfast; Imperial College London; University of London; King's College London	Birrell, MA (corresponding author), Univ London Imperial Coll Sci Technol & Med, London, England.	m.birrell@imperial.ac.uk	Raemdonck, Kristof/Y-7125-2019; Sacitharan, Pradeep Kumar/AAA-6866-2019; Raemdonck, Kristof/K-5554-2013	Sacitharan, Pradeep Kumar/0000-0003-1487-3059; Raemdonck, Kristof/0000-0002-7073-7484; Recchi, Chiara/0000-0003-1605-0945; McAuley, Daniel/0000-0002-3283-1947; O'Kane, Cecilia/0000-0002-7138-5396	Rosetree Trust [A523]; Medical Research Council [G1000758B, G1000758] Funding Source: researchfish; Rosetrees Trust [M376] Funding Source: researchfish; Asthma UK [MRC-AsthmaUKCentre] Funding Source: researchfish; Public Health Agency [CDV/3778/08] Funding Source: researchfish	Rosetree Trust(Rosetrees Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust); Asthma UK; Public Health Agency	The Rosetree Trust helped with the funding for the Nanosight work (grant - A523). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, ANN RES DAY DIV PULM; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Birrell MA, 2003, RESPIR RES, V4, DOI 10.1186/rr197; Botelho FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028457; Cicko S, 2010, J IMMUNOL, V185, P688, DOI 10.4049/jimmunol.0904042; de Kluijver J, 2003, CLIN EXP ALLERGY, V33, P1415, DOI 10.1046/j.1365-2222.2003.01770.x; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Eltom S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024097; Gessner C, 2005, RESP MED, V99, P1229, DOI 10.1016/j.rmed.2005.02.041; Gulinelli S, 2012, EUR J IMMUNOL, P1; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Haddad E, 2001, BRIT J PHARMACOL, V132, P1715, DOI 10.1038/sj.bjp.0704022; Hardaker EL, 2010, BRIT J PHARMACOL, V160, P1985, DOI 10.1111/j.1476-5381.2010.00857.x; Harris P, 2013, MUCOSAL IMMUNOL, V6, P474, DOI 10.1038/mi.2012.86; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Jackson DJ, 2011, J ALLERGY CLIN IMMUN, V128, P1165, DOI 10.1016/j.jaci.2011.10.024; LeVine AM, 2000, J IMMUNOL, V165, P3934, DOI 10.4049/jimmunol.165.7.3934; Lommatzsch M, 2010, AM J RESP CRIT CARE, V181, P928, DOI 10.1164/rccm.200910-1506OC; Lucattelli M, 2011, AM J RESP CELL MOL, V44, P423, DOI 10.1165/rcmb.2010-0038OC; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Marin A, 2012, COPD, V9, P121, DOI 10.3109/15412555.2011.636407; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Mohsenin A, 2006, CURR OPIN PULM MED, V12, P54, DOI 10.1097/01.mcp.0000199002.46038.cb; Moncao-Ribeiro LC, 2011, RESP PHYSIOL NEUROBI, V179, P314, DOI 10.1016/j.resp.2011.09.015; O'Byrne PM, 2009, ALLERGY ASTHMA IMMUN, V1, P3, DOI 10.4168/aair.2009.1.1.3; O'Byrne PM, 2009, AM J RESP CRIT CARE, V179, P19, DOI 10.1164/rccm.200807-1126OC; Organisation WH, 2007, GLOB SURV PREV CONTR, P12; Pauwels Romain A, 2004, Proc Am Thorac Soc, V1, P73, DOI 10.1513/pats.2306024; Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169; Pizzirani C, 2007, BLOOD, V109, P3856, DOI 10.1182/blood-2005-06-031377; Polosa R, 2006, TRENDS PHARMACOL SCI, V30, P528; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Qu Y, 2009, J IMMUNOL, V182, P5052, DOI 10.4049/jimmunol.0802968; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Schwenkglenks M, 2003, VALUE HEALTH, V6, P75, DOI 10.1046/j.1524-4733.2003.00206.x; Shyamsundar M, 2009, AM J RESP CRIT CARE, V179, P1107, DOI 10.1164/rccm.200810-1584OC; Soo CY, 2012, IMMUNOLOGY, V136, P192, DOI 10.1111/j.1365-2567.2012.03569.x; van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983; Wang JG, 2011, BLOOD, V118, P2366, DOI 10.1182/blood-2011-01-330878; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8	41	29	30	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101087	10.1371/journal.pone.0101087	http://dx.doi.org/10.1371/journal.pone.0101087			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24972036	Green Published, gold, Green Submitted			2022-12-27	WOS:000338512200092
J	Kuypers, KPC; de la Torre, R; Farre, M; Yubero-Lahoz, S; Dziobek, I; Van den Bos, W; Ramaekers, JG				Kuypers, Kim P. C.; de la Torre, Rafael; Farre, Magi; Yubero-Lahoz, Samanta; Dziobek, Isabel; Van den Bos, Wouter; Ramaekers, Johannes G.			No Evidence that MDMA-Induced Enhancement of Emotional Empathy Is Related to Peripheral Oxytocin Levels or 5-HT1a Receptor Activation	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; SOCIAL-BEHAVIOR; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; INTRANASAL OXYTOCIN; PROSOCIAL FEELINGS; HEALTHY-VOLUNTEERS; VERBAL MEMORY; BETA-BLOCKER; ECSTASY; HUMANS	The present study aimed at investigating the effect of MDMA on measures of empathy and social interaction, and the roles of oxytocin and the 5-HT1A receptor in these effects. The design was placebo-controlled within-subject with 4 treatment conditions: MDMA (75 mg), with or without pindolol (20 mg), oxytocin nasal spray (40 IU+16 IU) or placebo. Participants were 20 healthy poly-drug MDMA users, aged between 18-26 years. Cognitive and emotional empathy were assessed by means of the Reading the Mind in the Eyes Test and the Multifaceted Empathy Test. Social interaction, defined as trust and reciprocity, was assessed by means of a Trust Game and a Social Ball Tossing Game. Results showed that MDMA selectively affected emotional empathy and left cognitive empathy, trust and reciprocity unaffected. When combined with pindolol, these effects remained unchanged. Oxytocin did not affect measures of empathy and social interaction. Changes in emotional empathy were not related to oxytocin plasma levels. It was concluded that MDMA (75 mg) selectively enhances emotional empathy in humans. While the underlying neurobiological mechanism is still unknown, it is suggested that peripheral oxytocin does not seem to be the main actor in this; potential candidates are the serotonin 2A and the vasopressin 1A receptors.	[Kuypers, Kim P. C.; Ramaekers, Johannes G.] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands; [de la Torre, Rafael; Farre, Magi; Yubero-Lahoz, Samanta] Hosp Mar, IMIM, Res Inst, Human Pharmacol & Clin Neurosci Res Grp, Barcelona, Spain; [Dziobek, Isabel] Free Univ Berlin, Berlin, Germany; [Van den Bos, Wouter] Max Planck Inst Human Dev, Ctr Adapt Rational ARC, Berlin, Germany	Maastricht University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Free University of Berlin; Max Planck Society	Kuypers, KPC (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands.	k.kuypers@maastrichtuniversity.nl	de la Torre, Rafael/D-3561-2018; Dziobek, isabel/ABB-4928-2020; Kuypers, Kim/L-1206-2019	de la Torre, Rafael/0000-0002-6765-1866; Kuypers, Kim/0000-0001-7634-3809; van den Bos, Wouter/0000-0002-8017-3790	Netherlands Organization for Scientific Research (NWO) [400-07-2013]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organization for Scientific Research (NWO), Grant number: 400-07-2013, awarded to JR and KK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andari E, 2010, P NATL ACAD SCI USA, V107, P4389, DOI 10.1073/pnas.0910249107; Bankson MG, 2001, J PHARMACOL EXP THER, V297, P846; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Bartels A, 2012, NEUROPSYCHOPHARMACOL, V37, P1795, DOI 10.1038/npp.2012.71; Bedi G, 2010, BIOL PSYCHIAT, V68, P1134, DOI 10.1016/j.biopsych.2010.08.003; Bedi G, 2009, PSYCHOPHARMACOLOGY, V207, P73, DOI 10.1007/s00213-009-1635-z; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; Bright P, 2002, J INT NEUROPSYCH SOC, V8, P847, DOI 10.1017/S1355617702860131; Bull EJ, 2004, NEUROPHARMACOLOGY, V46, P202, DOI 10.1016/j.neuropharm.2003.08.004; Campbell A, 2010, PERS SOC PSYCHOL REV, V14, P281, DOI 10.1177/1088868310363594; Crawford JR, 2001, PSYCHOL MED, V31, P451, DOI 10.1017/S0033291701003634; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Wit H, 2002, NEUROPSYCHOPHARMACOL, V27, P813, DOI 10.1016/S0893-133X(02)00343-3; Declerck CH, 2010, HORM BEHAV, V57, P368, DOI 10.1016/j.yhbeh.2010.01.006; Domes G, 2007, BIOL PSYCHIAT, V61, P731, DOI 10.1016/j.biopsych.2006.07.015; Dumont GJH, 2009, SOC NEUROSCI-UK, V4, P359, DOI 10.1080/17470910802649470; Dumont GJH, 2006, J PSYCHOPHARMACOL, V20, P176, DOI 10.1177/0269881106063271; Emanuele E, 2006, MED HYPOTHESES, V67, P1250, DOI 10.1016/j.mehy.2006.05.021; Fertuck EA, 2009, PSYCHOL MED, V39, P1979, DOI 10.1017/S003329170900600X; Frye CG, 2014, PHARMACOL BIOCHEM BE, V117, P1, DOI 10.1016/j.pbb.2013.11.030; Gossen A, 2012, NEUROPEPTIDES, V46, P211, DOI 10.1016/j.npep.2012.07.001; Guroglu B, 2010, SOC COGN AFFECT NEUR, V5, P414, DOI 10.1093/scan/nsq013; Harkness KL, 2005, COGNITION EMOTION, V19, P999, DOI 10.1080/02699930541000110; Hasler F, 2009, J PSYCHOPHARMACOL, V23, P923, DOI 10.1177/0269881108094650; HOLM S, 1979, SCAND J STAT, V6, P65; Hurlemann R, 2010, J NEUROSCI, V30, P4999, DOI 10.1523/JNEUROSCI.5538-09.2010; Hysek CM, 2010, EMERG MED J, V27, P586, DOI 10.1136/emj.2009.079905; Hysek CM, 2014, SOC COGN AFFECT NEUR, V9, P1645, DOI 10.1093/scan/nst161; Hysek CM, 2012, PSYCHOPHARMACOLOGY, V222, P293, DOI 10.1007/s00213-012-2645-9; Jorgensen H, 2003, J NEUROENDOCRINOL, V15, P242, DOI 10.1046/j.1365-2826.2003.00978.x; Kirkpatrick MG, 2014, NEUROPSYCHOPHARMACOL, V39, P1654, DOI 10.1038/npp.2014.12; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Kuypers KPC, 2013, BRIT J PHARMACOL, V168, P607, DOI 10.1111/j.1476-5381.2012.02196.x; McElrath K, 2002, J PSYCHOACTIVE DRUGS, V34, P199, DOI 10.1080/02791072.2002.10399954; Mithoefer MC, 2013, J PSYCHOPHARMACOL, V27, P28, DOI 10.1177/0269881112456611; Nejtek VA, 2002, PSYCHONEUROENDOCRINO, V27, P337, DOI 10.1016/S0306-4530(01)00055-5; PEROUTKA SJ, 1988, NEUROPSYCHOPHARMACOL, V1, P273; Pizarro N, 2002, J ANAL TOXICOL, V26, P157, DOI 10.1093/jat/26.3.157; Rabiner EA, 2000, NEUROPSYCHOPHARMACOL, V23, P285, DOI 10.1016/S0893-133X(00)00109-3; Ramos L, 2013, NEUROPSYCHOPHARMACOL, V38, P2249, DOI 10.1038/npp.2013.125; Rey A., 1958, CLIN EXAMINATION PSY; Scahill L, 2010, BIOL PSYCHIAT, V68, P1082, DOI 10.1016/j.biopsych.2010.10.020; Schmand B, 1991, Tijdschr Gerontol Geriatr, V22, P15; Shamay-Tsoory SG, 2009, BIOL PSYCHIAT, V66, P864, DOI 10.1016/j.biopsych.2009.06.009; Singer T, 2008, EMOTION, V8, P781, DOI 10.1037/a0014195; Striepens N, 2013, SCI REP-UK, V3, DOI 10.1038/srep03440; Sumnall HR, 2006, J PSYCHOPHARMACOL, V20, P670, DOI 10.1177/0269881106060764; Thompson MR, 2007, NEUROSCIENCE, V146, P509, DOI 10.1016/j.neuroscience.2007.02.032; van den Bos W, 2014, SOC COGN AFFECT NEUR, V9, P2059, DOI 10.1093/scan/nsu003; van den Bos W, 2011, PSYCHOL SCI, V22, P60, DOI 10.1177/0956797610391102; van den Bos W, 2009, SOC COGN AFFECT NEUR, V4, P294, DOI 10.1093/scan/nsp009; Van der Meulen W.M.H., 1980, SLEEP; van Wel JHP, 2011, NEUROPSYCHOPHARMACOL, V36, P1932, DOI 10.1038/npp.2011.80; van Wel JHP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040187	54	59	59	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100719	10.1371/journal.pone.0100719	http://dx.doi.org/10.1371/journal.pone.0100719			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK6BK	24972084	gold, Green Published, Green Submitted			2022-12-27	WOS:000338512200053
J	Nieminen, MT; Novak-Frazer, L; Rautemaa, V; Rajendran, R; Sorsa, T; Ramage, G; Bowyer, P; Rautemaa, R				Nieminen, Mikko T.; Novak-Frazer, Lily; Rautemaa, Vilma; Rajendran, Ranjith; Sorsa, Timo; Ramage, Gordon; Bowyer, Paul; Rautemaa, Riina			A Novel Antifungal Is Active against Candida albicans Biofilms and Inhibits Mutagenic Acetaldehyde Production In Vitro	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TRANSCRIPTIONAL RESPONSE; SURFACE-PROTEINS; ACETYL-COENZYME; ORAL CANDIDOSIS; GENOME DATABASE; ALCOHOL; GROWTH; SUSCEPTIBILITY; IDENTIFICATION	The ability of C. albicans to form biofilms is a major virulence factor and a challenge for management. This is evident in biofilm-associated chronic oral-oesophageal candidosis, which has been shown to be potentially carcinogenic in vivo. We have previously shown that most Candida spp. can produce significant levels of mutagenic acetaldehyde (ACH). ACH is also an important mediator of candidal biofilm formation. We have also reported that D,L-2-hydroxyisocaproic acid (HICA) significantly inhibits planktonic growth of C. albicans. The aim of the present study was to investigate the effect of HICA on C. albicans biofilm formation and ACH production in vitro. Inhibition of biofilm formation by HICA, analogous control compounds or caspofungin was measured using XTT to measure biofilm metabolic activity and PicoGreen as a marker of biomass. Biofilms were visualised by scanning electron microscopy (SEM). ACH levels were measured by gas chromatography. Transcriptional changes in the genes involved in ACH metabolism were measured using RT-qPCR. The mean metabolic activity and biomass of all pre-grown (4, 24, 48 h) biofilms were significantly reduced after exposure to HICA (p<0.05) with the largest reductions seen at acidic pH. Caspofungin was mainly active against biofilms pre-grown for 4 h at neutral pH. Mutagenic levels (>40 mu M) of ACH were detected in 24 and 48 h biofilms at both pHs. Interestingly, no ACH production was detected from D-glucose in the presence of HICA at acidic pH (p<.05). Expression of genes responsible for ACH catabolism was up-regulated by HICA but down-regulated by caspofungin. SEM showed aberrant hyphae and collapsed hyphal structures during incubation with HICA at acidic pH. We conclude that HICA has potential as an antifungal agent with ability to inhibit C. albicans cell growth and biofilm formation. HICA also significantly reduces the mutagenic potential of C. albicans biofilms, which may be important when treating bacterial-fungal biofilm infections.	[Nieminen, Mikko T.; Rautemaa, Riina] Univ Helsinki, Res Unit Acetaldehyde & Canc, Helsinki, Finland; [Nieminen, Mikko T.; Sorsa, Timo] Univ Helsinki, Dept Periodontol, Inst Dent, SF-00300 Helsinki, Finland; [Nieminen, Mikko T.; Rautemaa, Riina] Univ Helsinki, Dept Bacteriol & Immunol, Haartman Inst, Helsinki, Finland; [Sorsa, Timo; Rautemaa, Riina] Univ Helsinki, Cent Hosp Finland, Dept Oral & Maxillofacial Dis, Helsinki, Finland; [Nieminen, Mikko T.; Novak-Frazer, Lily; Rautemaa, Vilma; Bowyer, Paul; Rautemaa, Riina] Univ Manchester, Univ S Manchester Hosp, Wythenshawe Hosp, Inst Inflammat & Repair,Manchester Acad Hlth Sci, Manchester, Lancs, England; [Rajendran, Ranjith; Ramage, Gordon] Univ Glasgow, Sch Med, Coll Med Vet & Life Sci, Infect & Immun Res Grp,Glasgow Dent Sch & Hosp, Glasgow, Lanark, Scotland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Glasgow	Rautemaa, R (corresponding author), Univ Helsinki, Res Unit Acetaldehyde & Canc, Helsinki, Finland.	riina.richardson@manchester.ac.uk	Frazer, LilyAnn Novak/O-1831-2017; Ramage, Gordon/AAX-1315-2020	Frazer, LilyAnn Novak/0000-0002-1434-3915; Rautemaa, Vilma/0000-0003-2493-2198; bowyer, paul/0000-0002-1083-9286; Rajendran, Ranjith/0000-0002-1069-7986; Nieminen, Mikko/0000-0001-6427-3196; Richardson, Riina/0000-0002-1071-6040	Yrjo Jahsson Foundation; Orion Research Foundation; Finnish Dental Society Apollonia; National Aspergillosis Centre, UK; EU; Helsinki University Central Hospital Research Foundation	Yrjo Jahsson Foundation; Orion Research Foundation; Finnish Dental Society Apollonia; National Aspergillosis Centre, UK; EU(European Commission); Helsinki University Central Hospital Research Foundation	MN received funding from Yrjo Jahsson Foundation (www.yjs.fi), Orion Research Foundation (http://www.orion.fi/Tutkimus-ja-tuotekehitys/Orion-Farmos-Tutkimussaatio/) and Finnish Dental Society Apollonia (www.apollonia.fi). R. Rautemaa, VR and LNF were supported by the National Aspergillosis Centre, UK (www.uhsm.nhs.uk/nac/Pages/default.aspx). PB received funding from EU framework 7 (http://cordis.europa.eu/fp7/home_en.html). TS was supported by Helsinki University Central Hospital Research Foundation (http://www.hus.fi/tutkijalle/tutkimusrahoitus/Sivut/default.aspx). GR and R. Rajendran received no funding towards this piece of work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 1996, NUCLEIC ACIDS RES, V24, P2623, DOI 10.1093/nar/24.13.2623; Bachmann SP, 2002, ANTIMICROB AGENTS CH, V46, P3591, DOI 10.1128/AAC.46.11.3591-3596.2002; Baillie GS, 1999, METHOD ENZYMOL, V310, P644; Bertram G, 1996, YEAST, V12, P115, DOI 10.1002/(SICI)1097-0061(199602)12:2<115::AID-YEA889>3.0.CO;2-E; BOEBEL KP, 1982, J NUTR, V112, P1929, DOI 10.1093/jn/112.10.1929; Brooks PJ, 2005, ALCOHOL, V35, P187, DOI 10.1016/j.alcohol.2005.03.009; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Carman AJ, 2008, EUKARYOT CELL, V7, P1733, DOI 10.1128/EC.00253-08; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Cornely OA, 2012, CLIN MICROBIOL INFEC, V18, P19, DOI 10.1111/1469-0691.12039; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crowley S, 2012, J APPL MICROBIOL, V113, P1417, DOI 10.1111/jam.12012; Crowley S, 2013, FOLIA MICROBIOL, V58, P291, DOI 10.1007/s12223-012-0209-3; Deresinski SC, 2003, CLIN INFECT DIS, V36, P1445, DOI 10.1086/375080; Dowd SE, 2011, J WOUND CARE, V20, P40, DOI 10.12968/jowc.2011.20.1.40; Erlandsen SL, 2004, J HISTOCHEM CYTOCHEM, V52, P1427, DOI 10.1369/jhc.4A6428.2004; Flores CL, 2000, FEMS MICROBIOL REV, V24, P507, DOI 10.1111/j.1574-6976.2000.tb00553.x; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Guo JH, 2012, BIOENGINEERED, V3, P104, DOI 10.4161/bbug.19624; Hennicke F, 2013, EUKARYOT CELL, V12, P604, DOI 10.1128/EC.00336-12; HIETALA PK, 1979, NUTR METAB, V23, P227; Homann N, 1997, CARCINOGENESIS, V18, P1739, DOI 10.1093/carcin/18.9.1739; Ingham CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035478; Inglis DO, 2012, NUCLEIC ACIDS RES, V40, pD667, DOI 10.1093/nar/gkr945; Kim J, 2011, J MICROBIOL, V49, P171, DOI 10.1007/s12275-011-1064-7; Kohler Gerwald A, 2012, Infect Dis Obstet Gynecol, V2012, P636474, DOI 10.1155/2012/636474; Kucharikova S, 2011, J MED MICROBIOL, V60, P1261, DOI 10.1099/jmm.0.032037-0; LAND GA, 1975, INFECT IMMUN, V12, P119, DOI 10.1128/IAI.12.1.119-127.1975; Hernaez ML, 2010, J PROTEOMICS, V73, P1404, DOI 10.1016/j.jprot.2010.02.008; Maestre O, 2008, APPL ENVIRON MICROB, V74, P702, DOI 10.1128/AEM.01805-07; Marstorp H, 1999, SOIL BIOL BIOCHEM, V31, P1443, DOI 10.1016/S0038-0717(99)00065-6; Martinez-Gomariz M, 2009, PROTEOMICS, V9, P2230, DOI 10.1002/pmic.200700594; Marttila E, 2013, MOL ORAL MICROBIOL, V28, P281, DOI 10.1111/omi.12024; Marttila E, 2013, OR SURG OR MED OR PA, V116, P61, DOI 10.1016/j.oooo.2013.02.009; Mero AA, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-1; Monteoliva L, 2011, J PROTEOME RES, V10, P502, DOI 10.1021/pr100710g; Mousa HAL, 1999, BURNS, V25, P145, DOI 10.1016/S0305-4179(98)00148-X; Mukherjee PK, 2006, INFECT IMMUN, V74, P3804, DOI 10.1128/IAI.00161-06; Nailis H, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-25; Nieminen MT, 2009, ORAL ONCOL, V45, pE245, DOI 10.1016/j.oraloncology.2009.08.002; Nobile CJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000133; Odds FC, 1979, CANDIDA CANDIDOSIS; Park S, 2003, J BACTERIOL, V185, P1942, DOI 10.1128/JB.185.6.1942-1950.2003; Peng Giia-Sheun, 2009, Human Genomics, V3, P121; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaller M, 2011, J CLIN MICROBIOL, V49, P624, DOI 10.1128/JCM.02120-10; Pfaller MA, 2006, J CLIN MICROBIOL, V44, P760, DOI 10.1128/JCM.44.3.760-763.2006; Pierce JV, 2013, EUKARYOT CELL, V12, P37, DOI 10.1128/EC.00236-12; Ramage G, 2005, METH MOLEC MED, V118, P71; Ramage G, 2002, FEMS MICROBIOL LETT, V214, P95, DOI 10.1111/j.1574-6968.2002.tb11330.x; Ramage G, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00220; Ramage G, 2009, CRIT REV MICROBIOL, V35, P340, DOI 10.3109/10408410903241436; Rautemaa R, 2007, ORAL ONCOL, V43, P607, DOI 10.1016/j.oraloncology.2006.07.005; Rautemaa R, 2011, CRIT REV MICROBIOL, V37, P328, DOI 10.3109/1040841X.2011.585606; Saint-Prix F, 2004, MICROBIOL-SGM, V150, P2209, DOI 10.1099/mic.0.26999-0; Sakko M, 2014, MYCOSES, V57, P214, DOI 10.1111/myc.12145; Sakko M, 2012, INT J ANTIMICROB AG, V39, P539, DOI 10.1016/j.ijantimicag.2012.02.006; Salaspuro M, 2009, SCAND J GASTROENTERO, V44, P912, DOI 10.1080/00365520902912563; Samaranayake LP, 2009, PERIODONTOL 2000, V49, P39, DOI 10.1111/j.1600-0757.2008.00291.x; Saravanan P, 2009, J HAZARD MATER, V162, P476, DOI 10.1016/j.jhazmat.2008.05.069; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Seneviratne CJ, 2008, PROTEOMICS, V8, P2936, DOI 10.1002/pmic.200701097; Setiadi ER, 2006, J MOL BIOL, V361, P399, DOI 10.1016/j.jmb.2006.06.040; Shirtliff ME, 2009, ANTIMICROB AGENTS CH, V53, P2392, DOI 10.1128/AAC.01551-08; Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9; Stevens DA, 2004, ANTIMICROB AGENTS CH, V48, P3407, DOI 10.1128/AAC.48.9.3407-3411.2004; Stichternoth C, 2009, APPL ENVIRON MICROB, V75, P3663, DOI 10.1128/AEM.00098-09; Strijbis K, 2008, EUKARYOT CELL, V7, P610, DOI 10.1128/EC.00017-08; Strijbis K, 2009, FASEB J, V23, P2349, DOI 10.1096/fj.08-127985; Taff HT, 2013, FUTURE MICROBIOL, V8, P1325, DOI 10.2217/fmb.13.101; Thomas DP, 2006, PROTEOMICS, V6, P6033, DOI 10.1002/pmic.200600321; Tirosh A, 2005, NEW ENGL J MED, V353, P1454, DOI 10.1056/NEJMoa050080; Tumbarello Mario, 2012, PLoS One, V7, pe33705, DOI 10.1371/journal.pone.0033705; Uittamo J, 2009, INT J CANCER, V124, P754, DOI 10.1002/ijc.23976; Uittamo J, 2011, INT J CANCER, V129, P2038, DOI 10.1002/ijc.25844; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vediyappan G, 2010, ANTIMICROB AGENTS CH, V54, P2096, DOI 10.1128/AAC.01638-09; Vellucci VF, 2007, FUNGAL GENET BIOL, V44, P979, DOI 10.1016/j.fgb.2006.12.003; Vylkova S, 2011, MBIO, V2, DOI 10.1128/mBio.00055-11; WAIN WH, 1975, SABOURAUDIA, V13, P74; Walker LA, 2013, ANTIMICROB AGENTS CH, V57, P146, DOI 10.1128/AAC.01486-12; Walraven CJ, 2013, ANTIMICROB AGENTS CH, V57, P1, DOI 10.1128/AAC.01351-12; Westermarck HW, 1997, Patent, Patent No. [EP 0871438 B1, 0871438]; Wilson K., 2001, CURR PROTOC MOL BIOL, V71, P27, DOI [10.1002/0471142727.mb0204s56, DOI 10.1002/0471142727.MB0204S56]; WINSTEN S, 1956, J BACTERIOL, V71, P738, DOI 10.1128/JB.71.6.738-738.1956	86	21	21	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97864	10.1371/journal.pone.0097864	http://dx.doi.org/10.1371/journal.pone.0097864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24867320	Green Published, gold, Green Accepted			2022-12-27	WOS:000336914100024
J	Kim, MC; Lee, SW; Ryu, DY; Cui, FJ; Bhak, J; Kim, Y				Kim, Myung-Chul; Lee, Seung-Woo; Ryu, Doug-Young; Cui, Feng-Ji; Bhak, Jong; Kim, Yongbaek			Identification and Characterization of MicroRNAs in Normal Equine Tissues by Next Generation Sequencing	PLOS ONE			English	Article							ADIPOSE-TISSUE; EXPRESSION; HORSE; RNA; PRINCIPLES; DISORDERS; MIR-17-92; CARTILAGE; GENOMICS; PLANT	The role of microRNAs (miRNAs) as a post-transcriptional gene regulator has been elucidated in a broad range of organisms including domestic animals. Characterization of miRNAs in normal tissues is an important step to investigate the functions of miRNAs in various physiological and pathological conditions. Using Illumina Next Generation Sequencing (NGS) technology, we identified a total of 292 known and 329 novel miRNAs in normal horse tissues including skeletal muscle, colon and liver. Distinct sets of miRNAs were differentially expressed in a tissue-specific manner. The miRNA genes were distributed across all the chromosomes except chromosomes 29 and 31 in the horse reference genome. In some chromosomes, multiple miRNAs were clustered and considered to be polycistronic transcript. A base composition analysis showed that equine miRNAs had a higher frequency of A+U than G+C. Furthermore, U tended to be more frequent at the 59 end of miRNA sequences. This is the first experimental study that identifies and characterizes the global miRNA expression profile in normal horse tissues. The present study enriches the horse miRNA database and provides useful information for further research dissecting biological functions of miRNAs in horse.	[Kim, Myung-Chul; Cui, Feng-Ji; Kim, Yongbaek] Seoul Natl Univ, Coll Vet Med, Clin Pathol Lab, Seoul, South Korea; [Lee, Seung-Woo; Ryu, Doug-Young] Seoul Natl Univ, Coll Vet Med, Lab Environm Hlth, Seoul, South Korea; [Ryu, Doug-Young; Kim, Yongbaek] Seoul Natl Univ, Coll Vet Med, Res Inst Vet Sci, Seoul, South Korea; [Bhak, Jong] Theragen Bio Inst, Suwon, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, Y (corresponding author), Seoul Natl Univ, Coll Vet Med, Clin Pathol Lab, Seoul, South Korea.	yongbaek@snu.ac.kr			Bio-industry Technology Development Program of iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries), Ministry of Agriculture, Food and Rural Affairs, Republic of Korea [1111594]; Brain Korea 21 Plus Program for Creative Veterinary Science Research, College of Veterinary Medicine, Seoul National University	Bio-industry Technology Development Program of iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries), Ministry of Agriculture, Food and Rural Affairs, Republic of Korea; Brain Korea 21 Plus Program for Creative Veterinary Science Research, College of Veterinary Medicine, Seoul National University	This study was supported by Bio-industry Technology Development Program (Grant no. 1111594) of iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries), Ministry of Agriculture, Food and Rural Affairs, Republic of Korea. Myung-Chul Kim and Seung-Woo Lee were additionally supported by the Brain Korea 21 Plus Program for Creative Veterinary Science Research, College of Veterinary Medicine, Seoul National University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai L, 2012, PARASITOL RES, V110, P2373, DOI 10.1007/s00436-011-2773-x; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Barrey E, 2010, EQUINE VET J, V42, P561, DOI 10.1111/j.2042-3306.2010.00267.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Boggs RM, 2008, MAMM GENOME, V19, P561, DOI 10.1007/s00335-008-9128-7; Boggs RM, 2007, GENE, V404, P25, DOI 10.1016/j.gene.2007.08.015; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chi XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027530; Chowdhary BP, 2008, ANIM REPROD SCI, V107, P208, DOI 10.1016/j.anireprosci.2008.04.010; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; Das PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056535; Dunn W, 2009, ARTHRITIS RHEUM-US, V60, P2333, DOI 10.1002/art.24678; Engels BM, 2006, ONCOGENE, V25, P6163, DOI 10.1038/sj.onc.1209909; Fleischhacker SN, 2013, VET J, V197, P688, DOI 10.1016/j.tvjl.2013.03.027; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; FREESTONE JF, 1991, EQUINE VET J, V23, P86, DOI 10.1111/j.2042-3306.1991.tb02726.x; GALUPPO LD, 1995, AM J VET RES, V56, P518; Gu ZL, 2007, FEBS LETT, V581, P981, DOI 10.1016/j.febslet.2007.01.081; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Ji ZB, 2012, MOL BIOL REP, V39, P9361, DOI 10.1007/s11033-012-1779-5; Jin WW, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-90; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lacourt M, 2012, OSTEOARTHR CARTILAGE, V20, P572, DOI 10.1016/j.joca.2012.02.004; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Li GX, 2011, J CELL BIOCHEM, V112, P1318, DOI 10.1002/jcb.23045; Li HL, 2012, MOL MED REP, V5, P1457, DOI 10.3892/mmr.2012.831; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Mair T., 2002, MANUAL EQUINE GASTRO; Mair TS, 2005, EQUINE VET J, V37, P296, DOI 10.2746/0425164054529409; McKenzie E, 2011, EQUINE VET J, V43, P637, DOI 10.1111/j.2042-3306.2011.00468.x; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Nicholas FW, 2003, NUCLEIC ACIDS RES, V31, P275, DOI 10.1093/nar/gkg074; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Song GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007829; Thatcher EJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-253; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; Voelkerding KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/clinchem.2008.112789; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Wang LW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-154; Wei LQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r53; West HJ, 1996, EQUINE VET J, V28, P146, DOI 10.1111/j.2042-3306.1996.tb01607.x; Yang Hong, 2010, Yichuan, V32, P211, DOI 10.3724/SP.J.1005.2010.00211; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhou M, 2009, GENOMICS, V94, P125, DOI 10.1016/j.ygeno.2009.04.006	48	28	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93662	10.1371/journal.pone.0093662	http://dx.doi.org/10.1371/journal.pone.0093662			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24988450	Green Published, Green Submitted, gold			2022-12-27	WOS:000334103000099
J	Wang, J; Bian, YJ; Wang, ZR; Li, D; Wang, CM; Li, QZ; Gao, XJ				Wang, Jie; Bian, Yanjie; Wang, Zhuoran; Li, Dan; Wang, Chunmei; Li, Qingzhang; Gao, Xuejun			MicroRNA-152 Regulates DNA Methyltransferase 1 and Is Involved in the Development and Lactation of Mammary Glands in Dairy Cows	PLOS ONE			English	Article							GENE-EXPRESSION; METHYLATION; MILK; TARGETS; CANCER; CELLS; DNMT1; GROWTH; RNAS; 3B	MicroRNAs (miRNAs) are a class of small non-coding, endogenous regulatory RNAs that function by controlling gene expression at the post-transcriptional level. Using small RNA sequencing and qRT-PCR techniques, we found that the expression of miR-152 was significantly increased during lactation in the mammary glands of dairy cows producing high quality milk compared with that in cows producing low quality milk. Furthermore, DNA methyltransferase 1 (DNMT1), which is a target of miR-152, was inversely correlated with the expression levels of miR-152 in the mammary glands of dairy cows. Dairy cow mammary epithelial cells (DCMECs) were used as in vitro cell models to study the function of miR-152. The forced expression of miR-152 in DCMECs resulted in a marked reduction of DNMT1 at both mRNA and protein levels. This in turn led to a decrease in global DNA methylation and increased the expression of two lactation-related genes, serine/threonine protein kinase Akt (Akt) and peroxisome proliferator-activated receptor gamma (Ppar gamma). In contrast, inhibition of miR-152 showed the opposite results. By using an electronic Coulter counter (CASY-TT) and flow cytometer, we discovered that miR-152 enhanced the viability and multiplication capacity of DCMECs. In conclusion, miR-152 plays an important role in the development and lactation processes in the mammary glands of dairy cows. Our data provide insights into dairy cow mammary gland development and lactation.	[Wang, Jie; Bian, Yanjie; Wang, Zhuoran; Li, Dan; Wang, Chunmei; Li, Qingzhang; Gao, Xuejun] Northeast Agr Univ, Educ Minist, Key Lab Dairy Sci, Harbin, Heilongjiang, Peoples R China	Northeast Agricultural University - China	Wang, CM (corresponding author), Northeast Agr Univ, Educ Minist, Key Lab Dairy Sci, Harbin, Heilongjiang, Peoples R China.	wangcm-1@163.com		HONG, SEUNGUG/0000-0002-6228-3312; Bose, Shambunath/0000-0003-0737-5713; Wang, jing-hua/0000-0002-2034-7429	Major State Basic Research Development Program of China (973 Program) [2011CB100804]; Heilongjiang Department of Education Project Program [1154z1004]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Heilongjiang Department of Education Project Program	This study was supported by Major State Basic Research Development Program of China (973 Program, No. 2011CB100804); Heilongjiang Department of Education Project Program, No. 1154z1004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; Bionaz M, 2011, BIOINFORM BIOL INSIG, V5, P83, DOI 10.4137/BBI.S7003; Bionaz M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-366; Boutinaud M, 2004, REPROD NUTR DEV, V44, P499, DOI 10.1051/rnd:2004054; Boxer RB, 2006, CELL METAB, V4, P475, DOI 10.1016/j.cmet.2006.10.011; Braconi C, 2010, HEPATOLOGY, V51, P881, DOI 10.1002/hep.23381; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Chiam K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025634; Cui W, 2011, MOL CELL BIOCHEM, V355, P17, DOI 10.1007/s11010-011-0834-1; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Gerlach D, 2009, NUCLEIC ACIDS RES, V37, pD111, DOI 10.1093/nar/gkn707; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hassler MR, 2012, BIOCHIMIE, V94, P2297, DOI 10.1016/j.biochi.2012.05.029; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; Hu H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007636; Huang JF, 2010, HEPATOLOGY, V52, P60, DOI 10.1002/hep.23660; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Ji WD, 2013, CARCINOGENESIS, V34, P446, DOI 10.1093/carcin/bgs343; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Lee JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061658; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li HM, 2012, MOLECULES, V17, P12037, DOI 10.3390/molecules171012037; Liu XF, 2012, IN VITRO CELL DEV-AN, V48, P554, DOI 10.1007/s11626-012-9545-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Neville MC, 2002, J MAMMARY GLAND BIOL, V7, P49, DOI 10.1023/A:1015770423167; Robert MF, 2003, NAT GENET, V33, P61, DOI 10.1038/ng1068; Schwertfeger KL, 2003, J LIPID RES, V44, P1100, DOI 10.1194/jlr.M300045-JLR200; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Tanaka T, 2009, DIFFERENTIATION, V77, P181, DOI 10.1016/j.diff.2008.10.001; Vanselow J, 2006, J MOL ENDOCRINOL, V37, P463, DOI 10.1677/jme.1.02131; Wan YH, 2007, GENE DEV, V21, P1895, DOI 10.1101/gad.1567207; Wang Chunmei, 2007, Journal of Genetics and Genomics, V34, P966, DOI 10.1016/S1673-8527(07)60109-X; Wang H, 2011, CARCINOGENESIS, V32, P1033, DOI 10.1093/carcin/bgr081; Xiang Y, 2013, ONCOGENE; Xu Q, 2013, J MOL CELL BIOL, V5, P3, DOI 10.1093/jmcb/mjs049; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	41	90	100	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101358	10.1371/journal.pone.0101358	http://dx.doi.org/10.1371/journal.pone.0101358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24475077	Green Submitted, Green Published, gold			2022-12-27	WOS:000341354100077
